Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692112-42721298	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"NK-cell: 1.4;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001141			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	22.7	5.9	3.5	8.2	3.7	3.8	15.3	1.4	3.8	21.2	12.0	2.3	32.6	4.8	13.0	16.9	15.0	11.7	11.0	26.8	2.3	1.3	30.0	4.4	14.0	6.4	2.9	3.0	11.8	3.4	1.4	7.7	12.6	2.9	15.4	2.1	9.9	15.4	39.8	12.5	8.7	7.0	18.6	5.3	11.4	11.3	6.7	2.4	1.3	10.7	13.0	10.1	16.1	25.6	0.1	3.4	0.0	0.0	1.4	0.0	0.0	0.6	7.4	0.0	0.0	21.9	17.9	11.2	2.9	3.2	0.6	1.1	2.3	1.2	7.2	5.2	5.2	3.8	0.7	7.1	3.5	0.1	0.0	1.4	0.1	11.8	0.2	6.6	0.0	0.5	10.5	1.0	3.1	0.5	1.0	2.6	0.0	0.0	0.0	2.8	10.1	0.0	0.0	0.9	0.5	1.8	0.0	1.7	0.7	14.8	12.7	0.1	0.0	9.1	0.2	0.0	1.4	5.8	0.8	15.7	0.0	1.4	13.4	3.8	1.5	6.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	3.5	3.7	1.4	3.8	2.3	1.3	2.9	3.0	2.9	2.4	0.0	0.3	1.4	28.5	8.1	0.0	14.6	2.5	2.7	9.1	17.4	0.0	36.7	11.6	18.0	0.4	40.9	0.0	23.3	1.0	26.1	24.9	31.4	1.1	0.2	4.8	0.0	0.0	22.1	1.8	1.5	42.8	5.4	6.8	52.3	0.0	0.5	3.7	0.0	28.3	45.6	0.4	38.8	39.6	0.4	0.4	7.8	7.9	1.0	0.0	69.8
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	9.7	7.3	9.6	17.6	5.7	5.2	12.7	8.0	4.1	8.5	8.2	7.9	5.3	10.7	12.8	3.5	9.0	7.3	10.6	11.5	3.3	7.5	16.9	12.4	7.1	9.3	3.7	11.5	11.1	4.4	7.3	6.8	7.3	5.2	7.2	15.0	14.6	10.5	4.5	10.9	9.6	9.9	7.1	28.1	7.1	11.5	5.8	7.3	4.4	8.8	22.8	8.2	6.9	7.8	10.7	6.7	7.2	15.0	6.1	9.2	9.3	5.7	10.0	6.2	5.7	11.0	5.2	10.2	15.9	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1	6.0	3.5	2.4	1.9	0.6	6.3	2.8	7.6	4.0	3.4	0.0	11.8	4.4	0.0	2.1	2.2	2.9	4.4	0.0	0.3	4.4	1.4	1.2	0.0	2.4	2.7	0.0	0.0	3.7	2.8	0.4	4.4	1.6	0.0	5.4	1.4	1.5	1.1	0.0	4.2	0.8	6.7	0.0	1.4	3.3	7.0	0.4	4.5	2.2	3.3	1.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81117295-81166077	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;intestine: 28.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	6	"CACO-2: 30.3;SH-SY5Y: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	2.8	4.7	14.3	3.2	16.6	3.7	0.9	19.0	29.0	1.2	3.3	16.5	0.0	28.7	1.0	1.1	1.7	1.2	2.7	2.3	23.6	13.9	1.2	1.2	9.7	1.5	20.1	13.6	1.0	17.9	3.6	6.4	2.6	11.0	2.4	1.1	4.1	5.6	3.6	1.1	1.9	20.3	1.3	35.3	5.9	4.5	1.3	9.8	0.0	1.3	0.0	1.0	1.3	1.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	1.2	1.4	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.1	0.5	0.3	0.1	1.3	2.5	0.2	0.0	0.0	2.9	10.4	0.2	0.0	1.5	0.1	0.3	0.8	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	14.3	16.6	19.0	22.3	23.6	13.9	20.1	13.6	11.0	9.8	29.8	23.6	0.0	0.8	0.2	43.5	2.2	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.1	6.9	0.0	1.6	0.1	0.4	1.0	5.8	0.0	2.0	20.6	1.7	0.6	4.1	0.0	1.4	0.6	5.0	0.0	4.5	8.3	1.3	4.5	2.5	0.8	4.1	0.0	0.8	0.5	0.2	0.3	1.9	0.7	7.2	0.1
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		NA	NA		22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	9.9	2.0	12.5	14.0	5.0	12.3	3.7	3.4	4.1	4.1	15.2	2.1	0.1	19.1	3.6	2.2	21.4	0.2	1.5	1.3	6.3	2.2	15.5	10.9	27.9	16.9	0.0	5.2	7.3	1.8	2.7	0.0	6.1	7.1	2.1	13.1	1.9	2.7	5.1	1.0	0.1	3.1	23.0	4.1	5.2	6.3	0.6	2.2	0.2	7.4	7.9	7.7	18.3	8.1	8.0	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.0	4.0	0.0	6.2	0.1	7.3	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	4.0	2.3	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.7	0.0	0.2	0.9	0.2	0.3	0.2	0.0	0.0	0.0
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.6	11.3	11.7	14.7	7.7	19.2	5.6	8.2	9.2	7.5	12.9	14.1	17.2	18.2	15.8	6.7	15.8	12.1	22.4	10.4	12.8	19.6	18.7	12.3	22.8	10.4	6.3	19.8	10.7	13.6	9.9	10.1	13.3	14.9	16.2	16.7	13.3	23.6	8.1	7.0	14.9	14.6	19.8	18.4	15.9	15.2	22.4	21.3	9.7	11.6	13.9	9.3	19.3	17.8	11.0	19.3	8.0	14.0	8.4	7.7	15.0	16.0	7.9	7.7	19.5	16.5	7.5	23.9	8.1	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2	8.9	7.2	15.2	12.1	14.1	9.2	43.6	10.2	10.7	7.9	10.4	5.9	19.5	10.0	14.8	0.3	11.1	8.5	0.0	11.6	9.8	12.7	9.0	21.9	11.5	17.9	23.8	13.3	9.8	19.7	0.4	13.6	14.9	10.1	16.2	9.8	12.0	10.6	5.8	12.4	15.9	7.6	32.3	12.4	3.8	9.4	14.1	18.7	13.1	17.8	9.5
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10"	Q9NUJ1	3	111979010-111993363	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		85000	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	8.5	18.3	17.5	8.1	27.5	7.6	12.4	23.2	23.2	9.9	11.3	13.7	8.6	9.4	9.4	42.4	7.0	12.5	8.4	19.8	18.6	19.6	39.1	26.6	9.7	14.0	17.0	21.6	16.8	12.1	8.8	26.1	8.8	19.1	17.1	12.3	12.6	19.8	12.0	10.4	8.2	8.6	8.9	14.8	12.4	11.6	12.6	15.1	16.6	25.3	6.7	12.6	8.7	7.9	18.3	19.7	17.7	14.8	7.8	12.7	10.8	18.7	16.3	18.0	5.9	10.4	14.0	9.7	19.9	10.5	16.4	15.8	16.8	10.9	17.0	11.2	8.3	11.2	10.4	7.9	11.0	22.5	5.7	10.0	14.0	8.0	14.5	8.3	28.0	15.1	8.5	8.3	8.4	21.2	11.3	17.5	20.4	6.4	7.3	17.9	6.3	26.4	13.1	11.7	20.9	25.9	23.9	11.5	7.8	17.0	8.2	12.1	8.9	15.9	11.6	18.5	7.4	13.0	10.3	9.8	9.8	12.6	7.0	10.3	11.7	4.1	29.0	9.9	15.4	10.4	17.7	11.8	17.5	7.4	14.8	12.7	18.3	9.3	8.4	19.7	15.9	12.0	10.5	1.8	7.8	11.6	12.5	8.8	10.8	17.5	27.5	23.2	23.2	18.6	19.6	17.0	21.6	19.1	15.1	0.0	4.5	17.1	8.5	6.3	20.8	20.0	7.6	18.7	9.1	10.4	7.9	15.2	29.9	4.3	0.7	7.5	5.3	0.0	6.9	12.2	9.4	5.4	9.2	22.5	12.6	39.7	11.6	11.6	20.8	1.9	9.8	11.2	10.1	2.8	10.9	18.9	4.7	2.9	7.1	27.8	12.6	0.0	10.7	29.6	34.3	7.2	4.6	10.9	10.5	4.2
ABHD11	"PP1226, WBSCR21"	ENSG00000106077	"Abhydrolase domain containing 11"	Q8NFV4	7	73736094-73738867	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 161.7;Urothelial cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.7;SK-BR-3: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024042, HPA049641"	Approved		Supported	Mitochondria		NA	NA		450000	Mitochondria		"HPA024042: AB_1844445, HPA049641: AB_2680838"	"unprognostic (4.74e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.66e-7)"	"unprognostic (3.61e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.29e-2)"	5.6	8.9	7.7	11.5	8.7	4.2	12.2	8.8	9.2	8.1	28.5	8.3	14.8	15.7	6.0	12.7	8.3	14.0	17.0	20.1	7.1	8.1	21.6	6.6	8.4	6.9	8.6	5.6	5.0	18.9	7.3	10.8	40.2	10.0	14.7	17.5	7.8	23.9	22.2	9.8	7.9	28.1	5.6	5.9	5.2	8.3	6.1	5.6	6.9	20.1	8.4	12.6	5.8	5.4	8.3	12.9	12.2	21.0	9.7	6.7	8.0	17.5	4.1	2.8	6.4	1.4	2.0	15.6	8.1	3.4	5.0	5.9	5.0	19.8	8.3	2.4	3.4	6.8	7.8	1.2	4.6	3.4	3.1	6.0	4.1	2.7	3.1	2.6	4.4	4.5	1.8	1.9	6.4	3.0	1.8	3.5	2.9	5.5	4.8	4.7	34.7	3.3	5.6	3.2	11.1	15.1	1.9	4.5	15.4	11.5	8.3	7.2	3.0	6.6	44.2	2.7	2.1	14.3	2.9	3.4	4.3	4.0	18.2	8.4	2.9	1.5	5.6	6.8	4.2	7.9	6.1	13.1	12.2	6.0	21.0	4.8	6.3	6.7	6.2	12.9	8.3	6.3	4.4	10.5	9.7	20.7	6.3	4.4	8.0	7.7	8.7	8.8	9.2	7.1	8.1	8.6	5.6	10.0	5.6	41.7	11.2	11.1	58.4	4.8	14.7	15.3	40.8	83.0	36.4	54.1	3.9	68.1	61.3	45.0	1.0	8.4	161.7	0.0	35.7	109.7	8.7	56.7	15.0	7.8	24.5	4.8	60.0	6.2	8.9	2.1	8.3	14.8	13.5	9.0	63.5	26.4	35.6	108.7	3.2	34.8	14.2	0.0	12.0	5.4	8.0	5.5	106.8	13.1	94.5	241.0
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0;skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Intestinal endocrine cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	4.0	3.8	8.2	1.9	19.1	0.8	2.1	4.0	26.0	1.4	2.1	2.3	0.0	1.1	1.2	1.3	10.5	1.4	1.7	5.7	3.4	5.1	2.5	1.2	1.8	1.4	2.8	7.6	1.1	3.3	2.4	6.1	1.2	9.9	1.8	2.1	1.3	2.6	1.2	71.8	3.8	1.8	2.1	1.8	14.8	1.8	1.5	4.0	0.0	2.4	1.9	2.3	1.5	1.7	0.7	0.5	0.0	0.2	0.0	3.0	0.2	1.0	0.0	0.2	1.5	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.3	2.9	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.6	1.9	0.1	0.0	1.2	2.7	0.9	0.1	1.0	0.6	0.2	0.0	13.2	1.0	5.8	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	3.0	0.0	2.5	0.0	0.5	0.7	1.2	0.9	0.0	0.0	0.2	0.0	1.2	0.2	8.2	19.1	4.0	26.0	3.4	5.1	2.8	7.6	9.9	4.0	0.0	1.4	0.0	0.1	2.3	5.1	3.6	0.0	2.7	0.0	3.5	0.0	0.0	0.0	3.0	1.7	2.7	7.5	0.0	3.8	0.5	0.4	0.3	2.3	0.4	0.1	11.1	10.3	1.3	0.3	4.2	0.0	0.0	0.0	0.0	3.0	2.7	3.4	4.5	3.5	0.3	2.9	6.5	4.2	0.0	1.5	5.5	0.0	0.0	5.2	0.1
AC004556.1		ENSG00000276345			Unmapped	2585-11802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 13.0"	"Cell type enhanced"	"Detected in many"	17	"Distal tubular cells: 26.6;Hofbauer cells: 22.3;Kupffer cells: 73.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 25.6;K-562: 21.5;MOLT-4: 24.1;NB-4: 46.5;PC-3: 43.4;WM-115: 31.2"									HPA050406	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"																		0.9	0.0		0.9		0.0	8.3		3.7	0.0	3.8			0.0	1.3	5.9	0.0	1.5	1.7	9.3			1.6	3.0	0.0	0.0			2.4	2.0	0.0		0.0		1.5	0.0		2.2	0.0	6.1	1.4	3.6	0.0		0.9	1.2	0.0			0.3		0.0	1.4		2.8	4.7	13.0	9.6	3.2	6.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	8.4	12.0	13.0	9.4	25.6	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	14.4	0.0	8.7	13.4	21.5	11.8	0.1	0.1	24.1	46.5	0.0	0.0	43.4	0.1	7.6	0.0	12.1	7.3	0.0	0.1	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	31.2	13.0	5.6	3.1	2.8	9.6	2.4	2.5	4.5	6.0	4.1	2.8	4.5	5.2	1.0	3.2	4.0	4.7	5.9	4.0											0.0	0.0	8.7	0.1	0.0	0.0	0.0	2.5	4.0	2.3	17.4	0.0	2.8	26.6	0.0	0.9	0.0	0.0	0.0	0.3	10.9	0.0	0.0	0.0	1.1	22.3	0.0	0.0	17.2	73.1	2.8	3.7	0.2	0.0	0.0	1.1	0.0	0.1	0.2	0.4	6.9	0.0	0.0	0.0	3.5	5.9	0.0	3.3	3.8	0.4	0.1
AC004754.1		ENSG00000269881			16	249547-269943	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"intestine: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9"									"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-2)"	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.3	0.6	0.6	0.2			15.3	0.3	0.3	0.1	0.2	0.0	0.9	0.4	1.4	0.3	0.1	0.0	0.0	0.7		0.1	1.7	0.0	0.2	0.0		0.2	0.0		0.0	0.3	1.0	0.1	7.4	0.2	0.7	0.0	0.1	0.9			0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.4	1.8	2.4	2.4	0.5	0.0	1.2	0.0	0.1	0.3	0.1	0.0	5.1	1.1	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	1.0	0.0	0.2	1.0	2.9	0.7	0.1	0.0	0.3	0.0	2.1	0.0	0.2	1.2	0.6	0.0	1.3	0.0	0.0	0.9	0.0	0.3	1.0	0.0	0.0	0.4	0.2	1.0	0.6	0.0	0.4	0.0	1.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.8	0.0	0.5	1.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC007325.2		ENSG00000277196			Unmapped	138082-161852	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 12.8;skin 1: 12.6"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 5.1;Distal tubular cells: 6.6"									"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"	"Group enriched"	"Detected in some"	13	"OE19: 84.6;RPTEC TERT1: 44.7"									HPA020361	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"																		0.0	0.0		0.0		0.0	0.6		6.4	0.0	0.0			11.1	0.0	0.0	2.1	0.0	0.0	2.8			4.5	1.6	7.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	3.0	12.6	12.8	0.0		0.0	0.0	0.0			1.1		1.8	0.5		0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.6	1.2	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.1	0.0	0.0	2.4	4.5	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	84.6	0.0	0.0	0.0	0.0	44.7	0.1	0.1	0.1	0.0	1.7	0.3	4.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
AC008982.1		ENSG00000268083			19	38817471-38840178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"NB-4: 25.7"					"Low region specificity"	"Detected in all"			"HPA002907, HPA051748"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA002907: AB_1847964, HPA051748: AB_2681588"																	"unprognostic (1.36e-2)"	1.7	1.0	0.5	0.4	1.0	4.3	0.7	0.8	3.3	0.5	3.1	0.2	0.2	2.2	1.4	3.5	1.1	0.5	0.3	4.9	0.5	0.6	1.6	6.3	5.0	5.3	0.8	0.2	1.3	1.3	0.0	0.5	0.8	0.8	1.3	0.2	0.2	0.6	0.5	5.8	1.0	1.8	0.2	0.8	2.6	1.1	3.2	0.7	2.5	1.0	2.4	0.2	0.7	1.0	1.9	5.9	2.4	2.5	2.5	3.6	2.2	1.4	0.0	0.2	0.3	0.1	0.1	1.6	0.4	0.0	0.5	0.1	0.7	0.1	0.2	1.3	0.1	0.1	0.8	0.0	0.0	0.1	1.3	0.4	0.9	0.0	0.0	0.1	0.4	0.9	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.5	0.4	0.0	1.0	1.1	25.7	1.9	0.0	0.0	1.5	0.7	0.6	0.3	0.3	0.6	3.6	0.0	0.0	4.6	0.0	0.4	5.9	0.0	0.1	2.6	1.8	2.3	1.1	0.9	2.0	0.1	0.7	0.1	1.6	2.5	2.4	2.5	2.0	3.6	1.6	2.5	2.7	2.4	1.9	2.3	2.9	0.2	2.5	1.1	5.9	3.4	2.2	0.5	1.0	0.8	3.3	0.5	0.6	0.8	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011455.2		ENSG00000269547			19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;ovary: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4"									"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					1.3	2.6	0.3	1.7	0.3	0.0	0.1	0.4	1.1	0.3	0.1			0.0	1.2	0.5	0.1	0.4	0.8	1.1	0.1	0.1	1.6	1.1	0.2	0.0	0.2		3.0	0.6	0.0	0.1	0.5		0.2	0.0		0.1	0.0	0.2	0.2	0.2	0.0	0.3	0.1	0.1	0.5			0.1		0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.2	0.0	2.8	0.9	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.5	0.3	1.2	0.5	0.5	0.0	1.2	0.3	2.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	0.2	0.0	1.4	1.4	0.0	6.4	0.0	0.6	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC024592.3		ENSG00000267740			19	5866171-5903787	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.9;Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA072209			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA072209: AB_2686495"					"unprognostic (2.12e-2)"					"unprognostic (2.24e-1)"				"unprognostic (3.38e-1)"				8.8	15.0	8.4	8.8	8.5	11.1	10.9	8.0	17.4	10.6	9.8	5.0	8.9	10.8	9.9	7.8	12.7	6.7	9.6	24.1	7.8	9.9	8.5	14.4	8.0	11.5	9.6	10.0	8.2	16.3	3.2	7.1	6.6	7.5	7.0	3.9	7.5	12.3	8.8	22.7	12.3	10.0	9.9	8.6	7.4	7.3	5.6	5.3	7.9	8.0	16.6	7.0	12.7	8.2	7.2	10.4	6.4	8.5	5.5	7.5	12.1	5.1	6.9	2.2	5.8	4.2	0.8	1.9	3.4	4.9	6.6	4.7	2.5	4.4	4.2	3.4	2.7	3.1	3.6	1.3	4.1	1.3	1.8	2.1	1.1	3.1	5.6	2.8	1.9	2.3	1.8	7.0	5.1	2.4	2.0	2.2	6.1	1.8	5.6	1.0	4.2	6.9	1.5	3.2	2.2	3.3	6.5	2.2	5.4	3.2	1.6	3.5	4.9	2.6	3.5	3.4	1.0	2.1	6.3	4.2	1.3	3.2	8.0	6.6	5.3	5.6	2.1	4.2	6.7	2.9	6.4	8.5	4.0	6.0	7.1	5.3	7.2	6.3	5.8	8.6	6.7	7.3	5.8	4.8	5.5	6.3	10.4	7.5	12.1	8.4	8.5	8.0	17.4	7.8	9.9	9.6	10.0	7.5	5.3	3.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC093155.3		ENSG00000267561			1	86993009-87169204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.8"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 4.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.0;HEL: 13.2;HMC-1: 16.8;THP-1: 11.4"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	10.8	3.2	0.6	0.9	0.8	0.0	3.7	0.8	0.6	2.1	1.3			0.6	0.8	0.5	1.1	0.5	2.1	4.1	0.6	0.6	0.8	4.3	2.5	0.3	0.7		3.7	0.6	0.0	0.5	2.7		0.6	1.2		0.9	0.7	1.6	0.6	1.0	2.0	0.8	0.8	0.7	2.4			0.6		0.0	2.2	0.6	0.1	0.9	4.6	0.1	0.4	0.2	0.1	0.0	0.1	0.8	2.0	2.4	9.0	0.2	0.0	0.1	0.0	0.3	0.6	0.8	0.0	0.2	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.5	13.2	0.4	0.1	0.1	0.3	16.8	1.5	0.3	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.2	0.2	0.3	1.1	0.0	0.2	0.3	0.0	0.4	0.4	0.1	0.4	0.3	0.0	0.4	0.9	0.2	11.4	0.0	0.3	0.7	0.1	1.3	0.9	3.5	0.0	0.6	0.0	0.4	2.0	0.1	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.4	0.0	0.9	0.0	0.1											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC131160.1		ENSG00000283765			3	183815568-183884889	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 12.1"									HPA019545	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"																		3.8	3.8	2.9	2.2	3.8	3.2	2.3	2.8	12.7	2.4	2.9	3.3	2.3	1.2	2.2	3.1	4.5	1.7	2.6	4.2	3.0		2.5	3.3	2.8	3.7	2.3	2.5	2.3	7.9	3.2	2.5	2.0	2.3	2.3	3.1	3.6	5.4	5.1	9.7	3.2	3.8	6.0	1.7	2.2	2.2	7.1	2.2	2.8	2.6	3.5	3.3	3.0	0.5	1.0	1.0	3.1	1.2	0.2	1.0	0.6	1.4	0.0	1.6	0.5	0.4	0.4	0.0	1.1	0.7	0.7	0.5	3.7	0.2	1.6	0.2	0.5	1.8	0.0	4.5	0.4	1.9	1.8	1.6	2.4	1.2	1.2	0.0	1.3	0.4	1.0	0.9	1.0	0.0	0.1	0.0	2.6	0.5	1.8	2.4	2.4	2.8	0.1	2.7	0.0	0.3	2.9	1.0	3.2	0.5	2.2	1.8	1.7	0.5	1.7	1.5	0.0	12.1	0.0	0.0	0.0	2.0	0.2	1.4	2.8	3.6	2.3	0.8	3.0	0.9	0.0	1.0	3.1	1.0	0.5	0.9	1.0	0.4	0.5	0.1	0.4	0.8	0.6	1.1	0.2	1.2	1.0	0.3	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC139530.2		ENSG00000262660			17	81703371-81720539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;MOLT-4: 18.5;SK-BR-3: 7.0"									"HPA022853, HPA023043, HPA023048"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950"		"unprognostic (2.36e-3)"					"unprognostic (1.17e-1)"		"unprognostic (2.87e-1)"								"unprognostic (3.83e-1)"	2.4	3.6	2.3	2.3	3.0	1.5	6.3	2.7	5.7	2.3	4.6	0.8	2.7	13.8	3.4	1.5	4.6	2.3	2.7	16.3	2.4	2.3	4.9	16.6	3.0	4.2	2.5	1.5	2.3	9.9	3.6	2.3	3.4	2.2	2.4	1.5	1.1	3.1	2.4	15.5	2.4	5.9	1.6	2.3	3.3	2.6	2.6	0.6	3.0	2.4	12.6	3.0	2.3	2.3	0.0	0.4	0.0	0.1	0.8	0.6	0.1	1.3	0.6	1.8	4.7	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.3	0.3	0.9	0.3	0.0	1.7	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.6	0.7	0.3	0.1	0.0	6.6	0.0	0.8	18.5	0.8	1.0	0.7	0.0	3.3	0.3	1.2	0.0	0.0	3.2	1.6	0.0	7.0	1.8	0.4	3.0	1.6	0.0	0.5	1.1	1.0	1.7	0.6	0.0	0.7	1.2	0.5	2.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	2.3	3.0	2.7	3.7	2.4	2.3	2.5	1.5	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 686.3;Proximal tubular cells: 536.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.8	14.1	23.6	21.6	31.3	16.6	12.0	7.2	11.8	12.2	9.5	30.0	12.3	12.6	15.5	26.6	12.6	0.9	39.3	4.6	12.1	38.6	9.2	8.9	18.5	35.6	14.8	0.1	16.9	21.9	1.5	19.7	6.2	9.9	20.0	18.3	7.7	11.9	33.9	16.3	0.5	19.5	21.4	5.3	5.7	31.0	50.5	46.2	41.3	0.6	33.9	26.9	0.5	16.6	1.1	19.5	9.4	13.1	9.5	10.4	13.1	15.7	7.9	24.2	27.9	32.2	7.4	18.2	9.5	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5	35.7	38.9	45.7	10.9	3.2	5.9	161.7	229.3	29.4	30.7	52.4	3.9	30.0	250.4	111.1	56.2	32.3	191.9	0.0	40.7	49.6	32.6	10.2	44.9	686.3	101.9	1.6	38.5	46.6	63.1	122.0	44.5	46.6	18.6	61.3	59.2	53.2	84.8	76.3	35.0	536.1	27.2	19.4	17.6	27.7	39.6	4.3	22.5	68.2	98.9	4.5
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128916067	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	18.1	20.6	14.0	13.1	15.4	8.0	15.4	14.7	17.9	13.6	13.4	15.9	21.1	11.3	16.9	13.1	21.6	15.6	16.4	21.6	10.7	13.2	15.8	24.0	11.6	10.4	13.6	17.8	13.1	21.1	30.6	14.2	13.8	13.6	13.0	12.4	16.0	19.0	16.0	30.8	45.0	10.1	13.8	10.2	12.1	14.6	19.5	10.8	13.9	14.8	18.2	14.9	12.6	14.0	7.2	14.0	4.1	18.1	5.0	7.5	8.9	25.1	13.2	10.6	7.9	16.4	11.6	11.3	12.5	13.8	24.1	20.7	18.5	15.3	18.7	11.7	15.7	16.3	21.1	18.5	24.5	16.0	12.3	12.6	17.0	26.7	13.1	12.0	13.3	7.9	12.6	9.6	14.0	15.8	13.9	19.4	14.9	8.0	9.1	16.0	25.4	19.6	11.1	6.4	26.0	18.9	15.2	10.0	19.0	16.9	16.1	12.3	7.9	19.5	18.3	12.1	10.0	24.2	28.8	11.5	10.1	8.8	10.2	11.9	9.1	4.4	16.3	16.1	12.4	12.7	3.1	12.0	4.1	7.5	14.7	7.2	7.2	6.8	6.4	14.0	4.9	5.7	7.3	1.0	5.0	18.1	7.9	6.5	8.9	14.0	15.4	14.7	17.9	10.7	13.2	13.6	17.8	13.6	10.8	14.9	23.7	9.7	10.0	5.6	14.5	26.4	7.6	10.7	11.4	14.0	9.8	22.7	18.3	18.4	14.9	9.8	8.1	0.0	15.5	15.2	10.1	7.5	16.1	23.3	26.7	9.5	5.2	17.8	9.5	12.6	9.5	8.4	15.1	16.2	6.3	15.8	13.0	7.6	13.8	18.0	10.9	12.9	13.3	15.6	10.0	12.4	25.6	7.5	14.1	6.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 481.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		63000	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.7	7.0	5.2	9.5	7.1	8.9	4.6	6.0	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5.0	7.5	5.1	6.5	4.3	3.8	3.5	9.0	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1.0	6.0	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3.0	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6.0	7.4	6.8	0.0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12.0	25.2	13.8	15.7	10.7
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		19000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.5	32.1	13.2	18.1	57.0	21.0	25.0	24.7	34.4	28.1	17.5	12.9	30.3	18.0	20.6	51.7	10.1	25.9	8.8	27.0	24.9	56.9	9.1	9.6	22.8	19.7	27.4	9.1	25.0	23.3	24.7	23.5	37.1	43.6	25.3	22.1	12.3	21.9	45.1	12.7	9.4	11.0	6.2	35.2	12.7	13.2	14.6	42.6	62.6	30.6	3.5	8.7	34.8	44.3	20.2	12.9	20.3	14.0	25.1	24.9	18.7	12.6	24.1	20.6	9.6	0.9	45.9	16.1	18.1	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6	56.6	73.4	64.0	249.7	77.5	39.6	397.7	150.3	17.4	43.3	191.9	58.9	369.3	157.5	241.9	107.0	71.4	453.8	23.3	66.5	164.5	100.7	311.9	89.7	297.9	171.6	31.8	172.2	51.5	68.0	184.1	115.3	93.1	77.6	423.8	144.6	37.1	129.2	196.4	124.8	276.8	38.8	103.5	102.3	100.5	34.7	76.5	554.7	68.2	215.2	275.4
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	16.1	13.3	10.5	30.2	34.0	30.1	5.9	15.5	16.7	16.9	19.7	36.5	16.8	8.9	26.7	17.3	26.5	17.1	30.4	14.7	18.4	17.9	24.9	25.8	15.1	33.1	23.5	24.3	15.3	27.2	16.3	14.7	27.6	19.4	17.9	20.5	35.8	13.3	26.8	9.3	14.4	22.8	10.3	21.0	29.7	20.1	20.7	86.8	23.1	10.6	16.8	20.0	25.3	32.9	17.0	9.2	28.0	20.0	19.9	18.1	10.6	16.5	18.6	4.5	13.2	16.8	8.1	48.9	12.8	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2	50.6	77.4	72.9	45.6	38.2	28.8	404.6	79.0	85.6	26.1	99.5	25.5	38.2	591.9	37.4	319.5	68.1	61.5	93.5	53.3	35.3	44.8	27.3	26.6	643.6	86.3	36.5	28.8	95.8	65.2	38.7	61.5	42.1	55.6	58.7	33.3	35.0	46.6	90.8	77.4	1104.9	23.8	64.7	64.3	159.1	28.1	42.3	21.1	42.4	83.1	20.7
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597237-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 35.6;salivary gland: 29.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;monocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 88.7"	"Group enriched"	"Detected in some"	7	"cerebellum: 5.3;pons and medulla: 1.6"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	13.9	1.9	0.3	2.9	0.4	0.5	10.9	0.4	0.4	3.7	8.7	0.2	4.5	16.2	5.6	7.1	5.7	2.6	9.8	7.1	0.6	0.6	6.6	2.0	10.0	2.7	0.6	0.2	2.1	3.0	0.0	8.2	0.7	0.6	5.2	1.2	1.3	29.0	2.0	3.1	10.7	35.6	5.0	0.4	1.5	10.5	3.4	0.1	0.8	1.8	12.8	1.5	8.2	4.5	0.2	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.4	3.4	0.0	14.5	88.7	0.9	2.5	0.0	0.1	1.0	0.0	9.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	35.7	1.4	0.0	0.4	5.8	1.8	0.7	0.0	1.4	2.3	5.2	5.9	0.2	0.0	0.2	2.1	5.1	1.3	0.0	10.8	0.0	4.1	0.4	0.0	0.0	0.4	1.6	0.0	9.8	0.8	0.0	2.0	0.0	1.7	11.8	0.0	1.1	6.6	0.0	2.5	2.4	3.1	0.0	1.9	0.1	0.0	5.6	0.2	0.0	0.6	1.0
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 174.5;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.5	8.7	6.8	10.7	53.1	28.8	3.1	18.1	44.5	8.3	6.6	9.2	3.0	1.9	5.8	18.9	22.8	1.3	13.5	17.3	16.8	6.0	3.6	14.0	9.5	10.0	26.7	1.3	5.6	25.0	5.3	21.4	15.1	25.7	21.5	7.4	5.0	4.1	23.7	2.5	7.4	6.7	7.1	6.0	9.4	5.8	10.1	1.9	31.7	8.8	0.9	2.8	18.8	0.7	1.9	7.6	4.4	3.4	23.2	30.4	10.3	10.1	4.7	2.1	3.9	3.8	21.2	4.7	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9	3.0	25.5	7.5	6.9	3.9	18.8	39.8	45.9	8.1	9.1	22.7	21.6	39.8	16.6	14.3	6.3	18.2	29.7	0.0	35.8	17.8	21.6	11.2	2.3	174.5	13.3	31.8	4.7	14.1	12.7	5.1	21.9	7.2	6.8	2.8	32.4	30.7	23.2	21.0	21.9	160.8	13.9	19.4	22.3	6.1	16.2	4.6	44.7	8.7	26.9	7.1
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 244.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		4000000	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	13.9	16.2	16.3	33.7	28.2	18.4	22.9	12.8	16.3	21.6	20.2	23.9	18.2	32.0	21.0	19.1	18.1	32.1	30.3	23.5	11.4	21.2	21.6	15.5	22.7	25.4	24.6	41.3	23.8	32.6	18.9	22.4	23.9	16.7	21.4	17.1	20.0	35.0	17.0	26.1	21.1	14.0	11.1	79.8	32.6	28.6	11.2	44.4	27.9	27.7	11.7	10.0	31.6	37.3	23.8	14.0	21.7	22.1	15.2	18.5	20.7	16.8	14.0	20.8	25.8	22.4	29.9	18.1	19.9	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1	23.8	35.1	48.4	42.0	16.7	52.7	8.1	53.5	38.8	18.2	57.6	76.6	84.6	111.0	47.3	10.7	21.1	193.9	23.3	37.3	50.2	22.9	31.1	40.3	50.4	81.0	50.9	51.1	16.5	27.5	6.8	22.5	35.7	33.7	87.4	92.9	56.0	39.9	87.7	26.2	244.6	62.4	58.2	31.1	23.6	36.4	14.1	161.6	34.6	88.8	55.9
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 210.9;granulocytes: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		100000	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.9	4.5	5.6	6.0	21.1	13.2	4.4	20.5	22.7	20.0	20.9	4.4	9.7	10.0	8.0	14.8	24.6	4.0	4.8	19.7	31.6	3.5	5.0	39.4	6.4	46.6	9.7	9.3	81.7	11.4	7.7	22.8	16.7	11.6	15.0	6.4	1.1	12.3	22.9	0.9	8.1	12.3	7.0	3.1	8.2	5.9	10.3	8.2	28.7	4.5	3.7	2.8	24.5	0.0	12.6	11.5	0.3	10.0	27.7	18.3	5.2	28.9	18.8	6.1	7.0	9.4	32.3	20.9	11.6	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7	71.5	210.9	20.6	16.2	19.8	34.7	32.3	10.2	17.4	64.8	69.8	2.0	5.7	43.1	24.1	1.2	28.6	0.7	23.3	22.2	29.6	17.9	10.6	598.2	1.7	22.2	6.4	7.5	17.8	68.3	2.0	5.2	45.1	15.1	64.9	2.9	11.7	26.4	1.4	9.6	10.0	14.5	0.0	22.3	3.9	3.8	7.0	26.4	13.8	1.7	12.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261205	"Enzymes, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 42.8;Hepatocytes: 47.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 8.3;neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	19.6	18.3	7.4	1.9	8.3	1.0	8.1	2.7	7.7	13.2	2.6	5.5	10.8	1.2	18.2	14.4	2.0	8.3	8.1	10.9	6.4	3.9	24.4	37.1	8.8	1.7	7.4	6.5	16.7	2.6	21.3	11.0	4.1	6.5	7.1	1.6	10.3	20.4	11.4	9.8	2.1	1.9	6.6	5.5	2.8	1.9	4.0	4.1	0.0	9.2	2.9	1.6	3.5	6.3	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	9.4	10.7	0.0	1.5	7.0	1.1	1.2	0.3	0.0	0.1	0.0	3.1	3.3	0.1	0.0	0.0	0.7	0.0	1.7	0.0	0.1	26.5	3.2	0.3	0.0	7.2	0.0	0.3	0.0	9.1	0.2	0.0	0.0	0.0	5.0	0.6	0.0	0.1	3.2	0.0	0.0	0.0	12.3	1.7	0.0	0.0	2.1	0.0	0.0	11.6	0.0	4.8	5.2	0.3	0.0	1.9	1.8	0.2	0.7	0.1	0.1	0.0	2.3	0.0	2.1	8.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	7.4	8.3	2.7	7.7	6.4	3.9	7.4	6.5	6.5	4.1	20.8	42.8	0.0	7.0	0.8	31.6	19.3	15.3	6.7	5.7	12.2	3.9	1.3	5.0	4.0	33.3	1.0	0.0	0.0	2.6	0.6	4.3	4.4	0.0	47.4	0.6	27.0	0.0	3.1	2.4	6.4	22.2	0.4	0.0	0.0	0.0	19.7	0.2	0.0	22.3	26.7	4.5	6.5	5.7	4.2	0.5	0.1	0.5	0.0	0.0	2.0
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	16	"Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.3	10.4	0.0	15.4	7.3	0.0	5.4	13.9	7.1	8.8	0.0	0.0	0.0	0.0	3.7	12.6	0.3	0.2	7.0	10.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	5.8	0.0	20.2	5.3	36.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	12.2	15.6	0.1	3.2	1.8	1.3	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	3.3	0.4	0.0	0.0	0.2	0.2	12.8	0.1	0.0	0.0	0.5	0.0	0.0	17.8	0.3	2.5	20.4	0.0	6.8	0.0	0.0	6.7	0.2	0.0	16.6	2.2	0.2	51.8	14.2	0.2	1.7	0.6	0.7	0.0	0.0	0.1
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.5	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.1	3.3	0.0	4.7	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.8	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.2	0.7	0.0	0.3	0.8	0.4	1.1	0.1	0.1	0.3	1.7	0.1	2.5	0.5	3.2	0.1	0.1	0.0	1.1	0.1	0.1	0.1	0.2	5.6	0.1	0.2	0.1	3.2	4.8	8.9	2.1	0.5	0.2	0.1	4.6	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	2.8	2.8	11.5	0.7	11.7	0.4	6.8	22.7	29.0	7.8	0.9	2.0	0.0	0.7	2.7	1.1	1.2	2.4	1.2	4.0	11.6	4.0	1.8	9.6	1.0	0.8	5.8	13.4	1.2	3.6	1.0	1.5	0.9	6.2	4.1	1.0	5.0	0.8	2.1	9.2	0.6	0.7	1.6	2.2	1.0	1.8	3.9	1.2	0.0	3.0	0.2	0.8	1.0	1.5	0.5	0.4	0.6	0.1	0.0	0.2	0.0	0.5	3.9	1.5	2.2	2.9	0.0	2.7	0.1	0.0	0.5	0.2	0.4	0.0	0.0	0.2	0.1	4.0	1.2	2.5	0.2	0.0	7.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	3.4	1.9	0.3	15.3	0.0	0.1	5.8	0.2	4.7	0.2	4.6	0.0	0.0	5.7	3.3	0.0	0.0	0.0	7.6	0.0	3.8	9.2	17.6	1.4	0.0	20.3	2.2	1.3	2.3	0.0	0.4	2.9	0.3	2.3	0.0	0.0	0.0	0.0	0.0	11.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	11.5	11.7	22.7	29.0	11.6	4.0	5.8	13.4	6.2	1.2	0.0	0.0	0.0	0.4	0.2	35.8	9.0	0.0	0.0	0.0	0.0	490.9	0.1	1.7	0.0	2.3	1.0	0.0	0.0	0.8	0.1	1.9	2.6	0.0	34.7	0.3	39.7	30.0	18.4	3.2	0.4	1.7	0.0	3.3	0.0	0.2	11.9	0.9	0.0	7.1	0.2	145.7	0.0	5.0	0.7	6.8	0.1	0.0	0.0	0.5	0.3
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.9"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2	3.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	121.8	14.8	0.0	3.9	0.0	0.0	0.0	236.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.2	2.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.2	3.0	0.0	0.0	0.0	0.0	0.0
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell type enhanced"	"Detected in some"	14	"Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	8.7	0.0	13.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	3.3	0.2	0.0	0.0	0.0	3.0	9.6	0.1	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	16.0
ADNP2	"KIAA0863, ZNF508"	ENSG00000101544	"ADNP homeobox 2"	Q6IQ32	18	80109031-80147523	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007126	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA007126: AB_1080729"	"unprognostic (4.93e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.64e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (9.90e-4)"	"unprognostic (5.19e-2)"	11.3	8.8	9.1	7.6	10.4	40.5	10.9	8.4	12.5	7.7	8.6	14.4	7.1	10.8	10.2	13.5	12.5	10.0	11.1	10.2	9.8	7.0	8.4	11.3	10.3	11.6	8.0	10.4	12.7	10.4	12.7	12.4	11.4	10.4	9.2	8.2	12.6	9.1	8.9	4.0	16.5	9.7	13.1	10.1	8.7	11.2	24.4	6.7	14.3	10.1	8.1	10.4	11.3	10.8	2.4	2.3	1.7	3.0	1.4	4.4	1.5	11.2	8.8	18.4	13.5	4.2	6.0	13.9	8.2	9.3	9.7	12.3	8.2	5.7	0.1	3.2	6.5	12.2	10.3	17.9	10.5	10.6	10.2	8.9	15.8	6.8	9.0	7.7	23.1	17.7	6.1	9.9	9.9	13.6	6.5	9.8	18.2	15.2	16.8	5.7	7.9	21.2	4.7	12.5	5.0	10.3	8.0	20.6	8.0	5.8	15.1	12.6	16.1	9.3	9.1	6.4	9.4	8.9	17.6	6.5	11.6	29.1	4.8	8.9	6.0	11.0	23.4	7.8	9.7	7.8	0.0	1.1	0.7	3.4	1.7	2.4	2.4	4.4	2.9	0.6	1.1	2.4	4.1	1.7	1.4	3.0	2.3	2.1	1.5	9.1	10.4	8.4	12.5	9.8	7.0	8.0	10.4	10.4	6.7	17.9	18.1	2.9	21.0	35.0	19.0	14.9	10.2	5.3	11.4	3.5	25.5	8.0	0.0	6.8	6.7	11.3	10.7	0.0	9.5	6.7	11.4	19.3	11.5	16.3	8.2	23.8	21.4	16.0	9.7	7.2	6.9	11.0	13.5	1.8	14.4	8.6	9.0	13.9	11.0	5.7	29.2	0.0	14.5	38.4	36.9	37.8	8.1	8.6	12.1	26.2
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 121.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.7	16.6	8.0	11.8	9.5	19.5	26.5	6.5	12.2	20.2	21.0	10.5	18.9	11.1	27.4	16.6	15.8	18.6	15.3	22.4	10.3	5.3	27.6	15.5	18.4	12.9	9.3	5.5	24.7	19.0	28.6	18.5	121.7	9.5	16.8	14.3	27.0	16.0	25.6	58.8	18.6	16.2	20.3	11.5	13.9	15.0	6.7	10.3	17.0	38.8	21.1	13.9	19.5	26.5	11.3	14.6	21.1	5.4	5.1	8.8	2.8	7.9	7.3	6.1	6.4	10.1	12.1	8.6	8.0	11.8	6.1	9.2	7.7	14.8	9.0	11.0	9.8	7.8	3.6	9.6	12.1	8.5	15.4	3.8	18.8	19.1	6.4	7.8	18.0	14.9	9.8	8.8	10.5	9.3	8.9	22.5	7.6	11.5	25.6	2.6	2.1	16.2	5.2	8.1	13.3	2.6	12.9	3.6	11.5	18.1	7.6	13.9	2.5	12.3	8.1	3.9	13.4	4.8	15.1	11.3	11.4	10.4	6.9	4.4	22.2	12.3	15.6	9.4	20.8	4.1	3.5	5.4	11.7	6.7	4.1	7.4	8.0	8.8	6.6	6.0	11.3	4.7	4.4	21.1	5.1	2.2	14.6	7.5	2.8	8.0	9.5	6.5	12.2	10.3	5.3	9.3	5.5	9.5	10.3	38.7	57.2	25.4	12.5	21.4	44.7	96.4	40.8	40.2	31.8	87.2	212.1	0.9	3.3	11.6	6.6	38.8	30.8	46.7	10.9	3.8	14.6	24.9	23.3	27.7	11.3	17.5	31.0	65.1	43.0	5.4	27.0	25.6	21.9	8.2	40.8	22.0	11.1	31.7	26.9	40.9	150.1	25.8	15.6	3.5	6.4	27.7	27.5	15.2	25.3	14.4
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	15.0	15.4	11.0	12.4	12.7	14.0	14.7	16.9	16.8	24.2	17.8	23.8	9.3	43.4	18.6	15.3	21.5	15.2	27.8	19.4	19.8	10.1	11.9	13.0	16.9	22.3	17.4	48.9	19.5	15.4	21.3	22.9	30.3	13.4	17.6	15.6	29.2	25.7	11.8	23.9	17.5	15.0	15.3	74.6	11.4	19.7	34.8	36.2	20.8	33.5	20.6	14.4	26.5	28.8	23.7	14.8	13.2	22.1	13.3	28.9	24.8	27.4	22.0	18.1	20.8	27.8	15.8	19.3	13.2	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1	38.7	35.6	27.6	31.2	19.7	46.8	69.2	40.8	28.1	33.0	33.2	47.1	50.2	61.3	33.0	4.2	23.3	78.3	46.7	32.4	29.6	23.8	24.6	13.9	71.5	32.6	28.6	37.6	18.4	22.3	2.7	30.5	25.6	21.9	20.8	71.9	29.1	36.4	31.7	28.3	54.2	55.2	25.8	20.6	47.7	72.0	27.4	77.6	17.5	75.2	29.8
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 68.8;Hepatocytes: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.5"	"Group enriched"	"Detected in all"	5	"B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	5.9	3.5	12.1	5.4	17.1	4.6	33.0	27.1	18.3	6.1	7.5	44.8	11.7	8.5	7.5	7.0	7.7	11.3	11.4	9.4	17.3	12.0	39.4	78.7	10.6	5.2	29.7	13.3	15.9	27.7	6.9	4.1	12.4	18.1	10.7	9.2	5.8	24.7	11.8	7.9	15.5	7.1	6.6	27.0	6.2	10.2	6.2	23.9	3.9	6.5	5.6	6.2	6.7	7.4	5.1	6.7	1.7	14.5	1.6	1.1	1.5	7.0	10.0	8.8	8.0	10.0	11.7	4.8	10.1	5.8	7.2	8.6	10.6	5.9	22.1	6.7	7.7	4.2	6.1	14.9	8.9	10.1	14.0	11.9	17.8	11.8	62.3	8.7	14.7	9.2	15.6	9.4	8.3	10.9	11.8	13.4	6.7	18.0	7.8	5.5	7.0	11.2	22.4	7.2	17.2	17.3	12.8	9.0	26.5	9.7	6.5	19.7	14.6	8.7	26.3	8.2	9.2	7.9	14.3	6.6	11.0	7.2	6.9	7.1	11.9	7.8	22.7	9.1	7.2	2.8	1.1	6.1	0.7	0.7	14.5	1.1	5.1	1.0	1.1	6.7	2.0	0.6	0.6	1.7	1.6	9.3	4.4	0.9	1.5	12.1	17.1	27.1	18.3	17.3	12.0	29.7	13.3	18.1	23.9	14.9	13.6	10.0	19.1	23.5	1.4	11.5	68.8	17.4	12.5	61.1	3.9	10.9	14.9	10.4	0.3	14.7	12.9	0.0	7.4	9.5	15.0	15.8	2.3	100.2	9.5	1.6	12.6	21.5	21.9	1.5	20.8	18.3	28.7	10.8	20.6	1.7	8.6	24.9	20.5	39.6	1.5	0.0	7.5	1.2	11.8	35.9	9.6	4.4	25.0	12.2
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: AB_2682164"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.4	13.5	13.4	11.0	10.6	13.2	9.1	13.2	12.9	21.2	21.2	10.5	9.6	14.0	11.8	12.6	20.0	9.3	18.7	15.4	22.9	16.5	16.6	13.0	6.4	10.4	15.8	9.0	7.0	14.7	13.6	18.6	18.2	9.9	16.2	16.1	19.3	20.0	10.2	12.5	24.3	4.1	14.2	9.6	15.2	15.7	2.3	41.9	13.6	10.6	11.7	16.1	13.7	16.6	13.6	14.1	8.9	9.9	9.1	9.8	7.7	13.1	19.0	15.2	15.0	6.7	16.2	4.2	27.0	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0	0.0	5.9	3.7	5.1	2.7	10.7	16.8	5.1	6.7	5.7	12.2	7.9	13.4	8.3	6.3	10.0	5.8	2.0	0.0	6.1	6.7	5.4	2.6	8.1	4.5	6.1	14.3	0.0	3.1	4.7	8.5	6.4	4.7	6.8	18.0	2.9	9.8	4.6	0.0	9.9	6.1	16.4	0.0	6.2	4.6	4.9	2.4	7.7	11.4	5.6	2.7
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708357-6759666	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.9	12.5	20.0	8.5	20.7	5.1	9.8	10.0	21.2	6.0	12.2	16.5	6.8	9.3	9.3	19.1	8.4	9.7	5.9	4.0	19.3	16.9	14.2	14.3	5.1	16.8	18.7	9.5	6.4	16.2	11.4	18.5	16.3	14.2	11.0	12.3	3.3	5.4	16.0	10.2	5.1	8.4	8.6	30.6	8.6	11.0	30.8	12.7	14.3	7.3	6.8	10.4	7.3	5.7	11.0	8.4	3.0	4.8	5.3	3.9	2.9	9.4	7.6	11.9	7.0	3.1	5.1	10.6	5.0	5.2	7.5	7.3	4.7	7.5	20.7	3.3	3.3	10.5	11.2	9.1	10.1	13.2	4.5	6.2	25.4	5.9	10.6	7.9	10.6	11.1	6.8	8.6	7.3	9.8	6.9	13.1	8.7	18.7	11.1	12.3	6.1	19.2	13.1	20.8	12.7	5.9	13.9	14.3	8.1	6.8	13.3	24.4	12.8	4.8	8.8	9.5	7.3	4.0	14.0	5.4	12.3	5.8	4.7	13.9	4.2	12.8	11.3	7.2	12.8	14.6	3.0	4.1	2.6	1.9	4.8	3.9	8.7	3.0	3.3	2.7	11.0	2.3	2.7	0.4	5.3	4.2	8.4	2.7	2.9	20.0	20.7	10.0	14.6	19.3	16.9	18.7	9.5	14.2	12.7	3.0	4.1	16.6	10.5	8.0	7.7	5.3	12.7	10.7	7.9	7.0	2.0	7.7	3.3	8.4	29.8	15.8	11.4	0.0	8.5	10.7	5.7	13.4	17.4	29.2	11.0	6.4	21.2	8.6	14.0	22.9	14.7	6.4	6.8	1.0	7.9	37.9	8.0	8.6	14.5	17.4	8.8	6.5	13.2	20.9	8.6	9.2	15.4	4.4	20.0	10.6
AIFM1	"AIF, CMTX4, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130129362-130165887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 66.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 148.9;Proximal tubular cells: 209.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		160000	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	9.9	28.9	7.1	11.3	8.6	5.3	7.1	7.5	8.9	10.4	14.2	8.4	10.0	19.6	9.9	11.7	8.6	13.0	11.4	34.2	7.2	7.0	66.8	50.5	5.8	9.8	8.2	7.1	7.3	14.6	16.8	7.7	6.1	8.8	6.9	14.2	12.3	13.1	9.4	35.7	5.8	23.2	8.9	6.4	8.7	14.9	14.9	7.2	19.5	7.9	16.1	9.7	8.4	6.0	10.8	22.0	9.8	18.3	15.8	12.8	8.0	16.8	31.2	12.8	32.0	14.6	10.4	16.9	10.7	9.3	16.5	13.3	22.1	12.5	36.4	37.3	9.8	19.6	16.3	39.4	13.9	17.6	13.9	24.0	23.1	23.5	30.0	18.6	20.2	24.3	12.9	13.7	17.5	15.0	9.2	13.9	27.5	19.8	16.9	11.6	40.6	20.5	31.7	9.2	34.0	24.2	18.6	14.3	42.1	37.3	17.1	16.5	9.6	12.5	28.9	27.8	15.2	14.9	18.3	10.1	7.9	7.6	21.4	20.3	9.0	14.6	17.0	10.1	33.9	11.8	2.9	14.8	9.8	9.1	18.3	9.6	10.8	9.7	11.2	22.0	8.1	9.6	9.7	2.1	15.8	15.5	10.6	12.8	8.0	7.1	8.6	7.5	8.9	7.2	7.0	8.2	7.1	8.8	7.2	14.9	15.3	20.1	8.0	7.7	17.8	148.9	20.4	21.4	15.9	38.4	21.6	48.7	77.9	21.8	1.3	10.2	33.3	0.0	18.1	22.0	13.9	6.9	10.4	83.4	33.5	14.3	9.2	14.7	15.5	3.9	16.1	14.0	10.1	17.2	17.6	12.2	17.3	17.3	16.3	209.8	36.6	6.5	9.0	3.9	32.1	5.9	33.2	13.1	32.6	8.9
AIFM3	"AIFL, FLJ30473"	ENSG00000183773	"Apoptosis inducing factor, mitochondria associated 3"	Q96NN9	22	20965108-20981360	"Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.7;intestine: 28.0"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 42.3;Mucus-secreting cells: 33.7;Paneth cells: 29.1;Undifferentiated cells: 39.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4"	"Group enriched"	"Detected in many"	22	"dendritic cells: 3.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.8;HMC-1: 13.1;T-47d: 6.4;THP-1: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001271			Supported	Mitochondria		NA	NA			Mitochondria		"HPA001271: AB_1078114"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.49e-2)"	"unprognostic (9.99e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.13e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"prognostic favorable (7.13e-5)"	1.3	1.3	20.3	4.6	19.0	5.4	0.8	14.4	18.4	1.2	28.0	9.7	0.0	4.3	0.9	0.8	0.9	1.2	1.6	0.9	14.6	9.9	0.9	0.8	1.5	1.4	14.8	12.4	1.0	0.9	0.9	1.9	1.3	21.7	1.2	13.0	5.0	2.2	1.9	0.7	0.9	3.4	1.9	9.6	2.7	1.6	1.1	7.6	0.0	1.0	0.0	0.8	1.9	0.1	0.2	3.8	0.0	5.7	0.0	0.0	0.9	1.2	2.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	3.5	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.3	0.0	2.2	0.0	8.8	0.2	0.0	13.1	0.6	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.0	0.4	0.0	0.1	0.0	1.4	0.0	1.5	1.8	1.1	1.0	0.1	0.0	0.1	6.4	9.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.7	0.0	0.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.9	20.3	19.0	14.4	18.4	14.6	9.9	14.8	12.4	21.7	7.6	0.0	1.0	1.7	1.6	0.6	10.9	2.4	0.0	0.0	0.0	1.8	5.9	0.9	10.0	0.7	0.0	0.7	42.3	0.0	0.6	0.6	0.4	2.9	1.1	1.8	2.9	0.0	9.9	1.3	3.7	0.0	0.0	2.2	0.0	0.0	33.7	18.1	0.6	29.1	0.0	6.0	2.9	0.0	0.8	0.0	0.7	0.6	0.7	0.0	39.2	2.2
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Group enriched"	"Detected in some"	6	"B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.3	0.0	0.3	0.0	0.0	4.4	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	44.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	2.9	0.0	2.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.1	14.8	11.1	0.3	13.7	1.2	2.3	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4	0.0	0.0	18.9	0.1	0.0	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	19.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.9	24.1	0.3	1.0	3.3	1.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	2.1	0.0	0.4
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		5500000	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	45.7	20.3	19.2	22.3	13.3	16.7	19.5	25.8	20.0	38.9	40.9	39.0	41.5	85.2	30.7	19.1	27.9	33.2	44.6	43.9	41.9	37.2	32.6	56.4	39.1	29.7	31.2	100.3	32.0	16.5	33.2	33.3	67.3	21.7	26.5	36.0	59.9	32.1	23.1	23.0	37.9	55.5	26.8	44.1	31.2	44.3	32.7	56.1	38.3	27.6	28.3	16.6	29.5	32.8	82.3	23.8	26.6	71.4	19.4	23.6	28.5	36.3	48.3	33.5	43.8	79.4	32.0	95.0	27.2	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0	47.6	66.5	38.7	80.7	111.2	21.1	86.7	71.4	46.8	83.0	106.4	78.5	137.4	217.2	94.6	81.6	64.2	135.8	0.0	107.9	138.4	58.1	76.3	39.3	127.8	84.9	7.9	48.5	31.9	41.6	29.1	43.4	51.1	82.7	58.7	70.5	20.1	99.6	51.8	41.4	362.4	38.8	51.8	59.5	97.9	21.1	107.3	181.1	37.4	94.5	113.8
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 86.8;HEL: 55.6"	"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria		NA	NA		68000	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.8	7.5	12.8	5.2	17.9	13.2	0.9	11.3	26.5	7.1	10.6	1.3	9.9	8.3	3.8	14.3	3.9	5.8	9.3	10.8	12.0	86.8	7.0	55.6	13.3	22.5	14.1	5.8	2.9	20.8	9.7	6.0	8.4	16.5	20.8	8.5	4.2	11.3	21.1	5.3	5.6	16.9	11.4	17.4	2.8	7.6	4.6	4.1	20.6	12.5	21.1	13.3	13.2	4.3	7.5	13.0	6.0	11.7	12.8	5.9	6.0	15.5	8.8	2.9	1.8	10.2	10.9	4.4	4.2	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9	53.6	88.6	32.0	59.7	65.9	11.9	155.8	66.2	45.5	68.2	62.8	21.6	83.2	218.8	74.1	2.6	56.6	104.3	0.0	61.0	10.9	79.1	116.1	44.0	282.7	40.3	14.3	105.2	74.3	36.8	1.9	100.7	36.7	70.9	53.3	103.3	22.3	61.2	57.5	140.7	148.4	8.8	103.5	59.8	6.6	15.3	91.2	179.0	38.5	135.0	92.5
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 223.0;Proximal tubular cells: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		18000	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.6	1.4	1.6	7.0	15.6	14.9	3.5	3.5	4.4	7.6	21.2	31.0	2.5	11.1	9.2	5.4	9.5	13.4	5.5	26.1	30.6	9.3	6.3	10.8	7.0	59.4	0.7	8.3	1.3	8.2	14.7	7.4	21.9	12.6	0.2	3.5	13.4	0.2	11.6	8.8	0.3	0.3	7.2	0.3	12.4	0.0	12.1	2.0	11.2	0.9	6.1	4.5	6.2	0.4	4.9	8.0	8.7	3.7	1.2	12.7	10.9	0.9	5.9	11.7	5.2	0.6	20.5	3.1	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0	0.0	0.3	4.9	19.8	44.2	14.7	91.5	61.1	5.3	6.8	29.6	2.0	1.2	48.0	16.1	1.6	17.5	13.5	0.0	11.0	13.9	10.3	33.2	0.0	223.0	3.3	15.9	5.2	5.5	5.6	4.2	3.7	2.7	23.6	7.2	6.7	27.4	22.8	3.5	8.9	422.4	6.2	6.5	27.4	2.1	5.1	65.0	4.1	1.0	22.9	16.6
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121349	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.1;testis: 75.4"	"Group enriched"	"Detected in many"	9	"Early spermatids: 596.3;Late spermatids: 1760.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	16.4	6.1	13.5	9.2	16.3	2.8	14.7	13.4	12.5	10.3	28.1	8.7	9.3	22.6	10.2	14.3	18.1	12.5	19.2	35.0	10.0	6.6	11.9	26.4	8.3	4.4	13.6	9.9	9.0	16.4	18.8	7.1	3.3	7.9	15.5	20.6	9.3	13.6	13.9	80.1	10.2	25.2	23.5	8.4	4.9	22.2	75.4	10.1	4.7	14.9	19.7	7.4	20.5	9.8	3.3	6.5	2.8	3.3	6.0	7.4	2.1	16.2	20.4	28.3	9.3	7.3	4.8	17.0	6.8	6.6	9.0	6.4	21.8	14.6	26.1	19.4	5.2	9.5	25.9	15.8	14.9	9.0	14.3	23.0	22.2	18.0	41.3	6.9	20.8	8.6	4.2	14.9	9.9	13.9	5.1	9.1	8.0	14.8	10.1	5.2	13.9	26.3	7.9	10.4	34.4	21.9	20.2	12.0	21.3	6.0	19.3	21.7	14.3	5.4	15.8	8.8	6.4	10.9	21.5	6.7	7.9	8.8	10.2	15.3	10.0	12.5	19.7	5.0	16.3	7.0	2.8	1.7	0.6	4.7	3.3	4.1	3.3	3.8	3.8	4.0	2.4	7.4	4.0	0.2	6.0	0.9	6.5	2.8	2.1	13.5	16.3	13.4	12.5	10.0	6.6	13.6	9.9	7.9	10.1	32.8	37.5	15.1	21.0	20.0	35.4	133.6	33.1	6.7	45.5	5.2	45.2	18.0	1.7	15.3	596.3	10.7	60.0	0.0	14.4	10.0	9.5	23.9	3.5	54.6	8.4	35.0	44.1	10.4	8.5	1760.2	18.1	7.7	6.8	6.4	85.1	6.8	10.7	43.2	13.1	5.8	71.0	45.3	45.3	13.9	10.0	17.2	5.7	6.4	92.8	11.8
AL021546.1		ENSG00000111780			12	120438198-120460006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.9;HEK 293: 12.5;U-266/84: 11.1"									HPA062394	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062394: AB_2684749"		"unprognostic (3.79e-2)"			"unprognostic (1.74e-1)"	"unprognostic (2.79e-1)"		"unprognostic (2.90e-1)"		"unprognostic (1.71e-1)"		"unprognostic (1.33e-1)"	"unprognostic (9.54e-4)"	"unprognostic (2.04e-1)"				4.8	6.0	12.8	3.6	11.6	4.7	4.5	8.4	14.8	4.6	16.3	4.2	3.3	3.6	5.1	3.6	6.0	7.1	3.6	6.7	8.9	6.3	11.5	12.1	5.3	4.2	10.5	7.2	9.6	10.3	3.6	4.9	5.8	11.6	6.5	3.6	3.1	5.4	4.3	4.3	4.1	11.4	3.6	5.9	9.2	7.1	4.8	7.7	3.5	6.3	3.8	4.0	6.6	5.1	6.5	12.9	5.8	10.7	2.8	7.4	4.3	2.2	3.1	0.0	0.7	0.0	0.0	0.0	2.1	0.4	0.5	0.0	9.9	0.0	0.6	3.8	0.0	1.0	1.0	0.0	0.5	0.0	1.8	12.5	0.8	0.0	0.0	0.0	4.3	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	3.6	0.4	0.4	0.0	5.0	2.0	1.4	1.1	0.0	0.0	5.3	0.4	3.3	1.0	0.0	0.0	1.0	0.5	2.8	1.7	0.5	0.0	1.5	1.1	11.1	4.0	0.7	1.5	0.0	2.0	5.8	5.8	6.5	10.7	7.4	6.5	4.0	7.4	12.9	6.0	4.5	4.0	1.7	2.8	8.1	10.0	7.2	4.3	12.8	11.6	8.4	14.8	8.9	6.3	10.5	7.2	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL139011.2		ENSG00000258465			1	160217464-160285130	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0"									"HPA027218, HPA027381, HPA044837"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496"	"unprognostic (4.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.04e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-3)"	8.6	4.0	3.7	3.0	10.2	2.0	4.4	15.4	11.4	4.8	4.7	8.6	2.5	3.5	6.3	4.2	5.3	6.4	4.6	16.7	3.8	3.9	6.2	10.8	4.1	3.2	3.6	5.9	7.6	4.0	6.7	4.1	5.0	9.1	5.5	3.5	6.1	5.5	3.0	14.6	4.0	4.2	7.8	4.1	3.7	4.3	4.8	4.1	2.5	7.9	3.8	3.4	5.8	4.7	5.8	8.9	6.7	6.5	8.0	5.0	8.0	0.1	2.1	0.3	0.5	6.7	1.9	0.6	0.9	5.9	3.3	0.8	0.0	0.8	0.2	6.6	1.0	5.2	0.8	1.1	0.2	0.0	6.0	0.0	0.3	0.7	0.2	3.4	0.0	0.3	3.2	0.2	3.0	3.4	3.5	0.5	0.8	1.0	4.7	0.5	0.3	1.1	0.0	0.3	0.6	0.6	0.5	0.0	0.3	0.3	0.8	0.6	0.8	0.2	1.4	0.0	1.0	2.8	5.6	0.0	0.8	0.8	0.0	0.2	0.8	3.4	0.5	0.4	0.3	0.3	6.4	6.3	6.2	3.6	6.5	5.0	5.8	4.4	4.7	8.9	3.9	2.5	3.2	6.7	8.0	6.3	2.5	4.9	8.0	3.7	10.2	15.4	11.4	3.8	3.9	3.6	5.9	9.1	4.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AL139260.3		ENSG00000274944			1	38864501-38881617	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.3;testis: 15.5"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 8.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA041188, HPA078331"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (8.00e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-3)"	"unprognostic (4.27e-4)"	"unprognostic (4.64e-7)"	"unprognostic (2.59e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.09e-6)"	"unprognostic (1.30e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-3)"	1.2	0.0	0.4	1.3	0.9	0.0	0.4	0.4	1.0	0.4	3.3	0.6	0.4	2.0	0.4	0.4	3.0	0.0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	7.3	2.8	4.0	0.0	1.7	0.0	12.4	1.3	3.3	0.0	0.6	0.0	3.6	0.4	0.0	0.0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0.0	0.9	0.0	7.9	2.1	2.8	2.5	2.2	0.0	17.0	5.0	0.0	0.0	1.6	1.1	1.5	2.0	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8.0	12.6	0.0	7.0	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0.0	1.3	0.2	0.5	1.9	1.1	3.0	0.2	0.5	4.2	2.0	0.4	0.4	2.8	0.0	4.0	7.3	1.7	0.0											0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL360181.3		ENSG00000254536			10	133390834-133420495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 23.7"									"HPA037826, HPA037827"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (3.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.06e-2)"	"unprognostic (9.86e-4)"	0.5	0.2	0.7	1.3	0.2	1.0	0.1	2.3	0.8	0.2	0.5			3.6	0.2	0.0	4.3	0.2	0.8	0.4	0.5	0.0	0.4	2.1	0.3	2.4	0.4		0.3	2.2	0.7	0.4	0.0		1.3	0.4		0.9	1.1	0.7	1.1	2.0	0.0	0.3	1.5	0.3	3.8			0.1		1.1	0.1	1.0	3.0	1.5	0.4	0.9	1.6	1.0	1.4	0.7	0.0	0.2	2.8	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.3	1.3	0.6	0.4	1.1	0.2	0.4	0.1	0.0	0.3	0.0	0.2	0.5	0.0	0.1	0.0	23.7	0.1	0.4	0.1	1.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.9	0.0	0.1	0.6	0.0	0.0	5.1	1.6	0.3	0.2	0.0	0.1	0.0	0.4	0.4	0.7	0.6	0.6	3.0	0.7	1.0	1.5	1.9	0.8	0.5	0.0	1.6	0.9	1.3	0.7	1.4											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453169-49471048	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved		Approved	Mitochondria		NA	NA		910000	Mitochondria		"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	13.3	11.0	6.9	16.9	9.6	13.3	10.5	6.0	8.2	12.3	14.2	6.6	7.4	21.0	12.5	7.7	11.4	9.9	15.3	6.2	4.8	3.0	10.5	22.0	8.7	14.2	12.1	3.1	8.9	15.1	6.5	6.0	10.8	8.5	7.8	4.0	6.2	8.0	9.6	6.5	15.2	19.9	5.6	5.2	21.8	12.4	4.5	9.6	16.8	9.4	10.6	14.6	9.6	9.9	13.2	12.0	12.0	19.8	5.8	7.4	4.5	11.5	15.7	3.8	8.9	1.7	1.2	12.4	7.4	2.4	5.8	6.0	8.0	4.4	17.5	11.9	1.0	1.3	8.0	1.5	4.3	0.7	10.9	9.1	13.5	5.6	11.5	2.5	8.2	30.4	2.1	2.5	2.8	2.2	1.1	3.7	6.0	9.4	18.1	1.4	11.7	5.9	23.5	8.1	5.0	0.0	9.9	5.4	13.0	2.8	13.7	6.7	7.7	6.7	7.5	6.1	0.9	6.8	9.5	8.4	8.6	5.7	3.9	8.2	15.2	17.5	5.0	2.1	11.7	6.0	7.6	7.1	12.0	6.8	17.7	7.4	12.5	6.8	7.4	11.3	13.2	6.3	6.4	1.3	5.8	19.8	12.0	5.4	4.5	6.9	9.6	6.0	8.2	4.8	3.0	12.1	3.1	8.5	9.6	6.0	7.8	18.6	22.3	8.9	7.2	3.5	15.3	12.0	4.5	10.4	7.9	30.8	5.0	18.8	1.2	13.5	30.2	0.0	21.3	25.9	16.0	10.3	17.3	13.7	40.0	1.6	12.6	13.5	25.6	2.3	25.9	18.9	15.1	36.1	11.3	6.7	15.0	20.1	7.8	19.0	5.2	19.4	8.6	2.1	13.6	9.3	33.8	12.2	15.6	30.4
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.4	0.4	0.2	9.6	23.0	31.5	0.5	14.2	9.2	1.8	4.9	0.5	0.0	0.0	0.6	35.7	0.0	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	20.3	1.8	0.0	25.5	1.1	4.8	9.1	0.0	1.0	0.0	0.7	12.9	3.7	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.2	0.1	2.1	15.2	0.1	1.4	1.4	0.0	0.7	16.0	4.2	0.0	5.8	6.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3	0.0	1.1	0.0	0.1	0.5	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	3.7	0.1	0.0	0.0	8.3	0.3	4.3	0.3	0.0	0.0	0.4	4.8	0.0	1.8	0.3	4.5	3.4	1.1	5.0	6.4	0.0	1.2	5.6	0.0	6.3	0.0	0.5	0.0	3.1	0.4	0.0	0.5	0.2	0.0	0.0	0.1
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ALKBH7	"MGC10974, SPATA11"	ENSG00000125652	"AlkB homolog 7"	Q9BT30	19	6372433-6375251	"Predicted intracellular proteins"	Necrosis	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 2375.8;Late spermatids: 5313.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008539, HPA039571, HPA039872"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710"	"unprognostic (5.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (7.83e-6)"	"unprognostic (7.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	10.8	14.7	13.7	14.1	15.2	12.7	13.6	16.3	15.8	12.3	25.0	11.1	28.4	30.9	12.4	18.8	17.2	15.4	18.7	49.3	12.6	11.9	17.1	32.7	20.2	26.3	14.2	11.9	19.0	65.0	10.2	14.0	7.9	15.8	15.5	9.8	16.0	29.7	21.5	62.9	11.9	29.6	15.8	15.9	9.9	14.2	96.5	7.3	29.9	19.4	29.5	16.2	12.6	13.6	34.3	43.8	19.7	32.8	18.4	45.9	28.4	9.8	8.6	7.6	13.2	4.3	12.1	9.4	5.9	6.4	6.5	6.9	15.1	6.4	12.7	22.3	9.1	4.6	7.6	3.4	6.0	1.3	12.9	12.0	6.8	6.3	14.0	12.6	4.1	10.3	13.8	12.1	5.6	4.4	6.3	8.0	14.4	7.7	28.6	4.9	20.0	20.1	14.1	10.5	11.7	35.9	14.2	3.9	26.8	7.2	7.8	10.1	15.0	4.0	12.9	24.8	3.8	14.6	15.5	5.3	6.5	8.4	23.8	6.8	41.2	29.8	8.4	12.2	13.4	5.6	9.9	32.8	4.9	17.1	26.5	23.5	34.3	29.8	23.3	38.8	31.6	45.9	36.0	19.7	18.4	20.4	43.8	25.3	28.4	13.7	15.2	16.3	15.8	12.6	11.9	14.2	11.9	15.8	7.3	56.6	70.3	108.8	116.9	74.4	87.5	95.6	99.3	38.8	48.9	62.8	62.8	75.6	265.2	90.7	2375.8	82.3	579.2	0.0	213.1	109.8	89.1	123.5	65.7	258.2	170.0	39.7	211.6	89.6	138.9	5313.3	95.5	116.1	126.5	202.0	317.0	99.5	112.2	399.8	83.4	312.4	107.3	90.5	100.1	945.7	49.4	88.0	91.1	82.2	334.4	200.6
AMBRA1	"DCAF3, FLJ20294, KIAA1736, WDR94"	ENSG00000110497	"Autophagy and beclin 1 regulator 1"	Q9C0C7	11	46396414-46594125	"Predicted intracellular proteins"	"Autophagy, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017825, HPA038535"	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB017825: , HPA038535: AB_2676068"	"unprognostic (1.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.98e-2)"	15.4	26.4	15.8	18.4	20.6	19.4	20.5	25.6	24.6	16.6	15.4	23.5	12.0	18.9	18.7	15.1	15.5	18.0	15.5	13.1	14.5	11.4	13.7	14.6	14.7	15.0	15.5	18.4	21.4	13.7	33.5	23.2	17.8	15.8	15.3	14.0	20.2	17.0	20.4	18.7	25.8	17.0	17.4	12.7	17.4	15.7	18.9	17.4	26.3	16.9	10.8	18.2	14.6	14.9	3.4	3.0	12.9	2.9	2.0	4.5	2.2	6.9	18.8	13.0	14.0	13.8	10.4	8.1	7.0	13.4	11.4	12.0	14.2	12.2	14.1	7.2	12.3	13.6	12.7	6.5	12.3	8.5	12.2	21.1	9.6	11.9	18.0	9.0	13.8	12.3	14.3	9.8	7.2	13.8	12.5	11.8	12.3	16.4	9.8	8.4	17.2	17.5	9.7	21.7	15.8	10.3	17.3	17.8	7.8	11.0	12.6	10.5	11.7	12.0	13.9	12.7	8.9	14.3	9.4	12.5	10.6	9.5	12.2	10.4	11.1	8.8	14.8	9.4	7.8	9.3	12.9	2.9	2.2	3.8	1.5	3.2	3.4	2.8	2.9	2.8	3.4	2.9	2.6	3.4	2.0	2.6	3.0	4.5	2.2	15.8	20.6	25.6	24.6	14.5	11.4	15.5	18.4	15.8	17.4	3.0	6.4	3.4	2.2	3.7	6.6	6.7	7.6	4.0	4.5	0.0	2.0	3.2	0.0	5.9	9.3	3.7	8.8	0.0	8.0	1.8	4.1	3.4	4.6	3.2	4.5	4.8	9.2	3.1	4.4	5.2	4.9	3.1	5.0	2.8	7.2	3.0	6.7	6.8	7.4	2.9	5.6	12.9	2.7	1.8	0.9	4.0	5.7	4.9	5.2	3.4
AMMECR1		ENSG00000101935	"Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1"	Q9Y4X0	X	110194186-110440233	"Disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	7.2	6.6	2.4	10.1	4.5	17.0	5.3	2.9	6.5	6.3	6.2	3.9	5.0	4.6	5.3	6.0	15.9	6.3	6.5	3.0	3.1	2.9	7.5	8.5	5.9	5.8	2.6	3.2	12.4	7.4	5.0	9.5	22.7	6.6	4.3	6.1	9.7	6.5	7.0	3.2	14.2	7.8	4.5	2.4	9.7	5.8	4.0	2.3	12.5	6.0	11.1	11.3	6.8	8.9	4.3	2.9	1.5	4.8	1.2	6.7	1.9	11.3	5.6	4.1	2.0	4.7	7.0	4.5	7.9	7.1	6.5	9.6	8.9	8.3	6.7	3.8	10.4	5.2	5.4	13.1	8.9	6.7	4.7	5.9	9.3	12.9	1.8	11.9	7.4	3.9	3.9	15.9	7.4	13.3	3.5	5.1	3.3	25.9	20.2	4.9	9.5	3.5	2.6	18.9	9.7	11.0	7.7	4.4	11.9	11.0	9.6	6.6	3.2	13.3	13.1	11.1	5.2	3.2	7.4	2.3	4.5	2.8	13.3	7.1	4.2	4.7	10.8	6.9	15.5	15.0	1.3	1.9	1.5	3.4	1.3	4.6	3.3	6.7	5.4	2.9	4.3	4.6	3.9	1.3	1.2	4.8	1.3	4.6	1.9	2.4	4.5	2.9	6.5	3.1	2.9	2.6	3.2	6.6	2.3	0.0	9.8	8.2	3.8	8.5	29.6	3.8	5.1	5.3	3.4	3.5	49.1	19.3	19.9	8.0	0.4	4.2	7.9	70.0	10.4	9.3	11.3	5.9	2.3	6.0	6.1	1.6	14.5	25.2	7.8	0.8	11.8	4.0	3.3	7.2	10.2	5.8	9.8	0.0	16.3	8.2	93.5	12.9	4.7	1.8	6.9	23.3	72.3	10.0	9.9	11.5
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.4	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.3	29.9	1.1	0.0	0.1	0.3	0.7	0.0	0.4	1.1	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.2	5.4	0.0	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.9	0.1	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4	3.0	11.6	3.7	11.4	2.5	17.2	18.3	17.8	6.7	7.9	0.0	19.6	22.7	0.0	0.7	1.7	2.7	19.7	0.0	0.6	6.5	4.7	10.1	7.0	37.3	4.4	7.9	12.2	3.1	2.7	1.6	9.8	3.5	5.0	0.0	16.2	21.5	0.5	14.0	6.0	0.7	17.7	6.5	4.3	1.4	0.4	2.4	8.6	5.7	31.1	8.6
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 393.0;Proximal tubular cells: 267.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	35.5	29.5	29.0	10.8	24.0	9.7	26.2	14.6	26.7	21.3	20.0	14.8	19.6	13.2	18.7	46.5	24.5	19.2	19.3	37.5	25.3	36.3	47.1	54.4	22.1	17.3	33.3	13.3	30.1	36.0	29.6	34.3	34.8	29.2	29.1	18.3	23.4	30.5	22.6	36.8	14.4	25.4	20.7	23.2	19.2	20.1	20.4	12.4	14.1	44.3	22.2	13.4	27.3	16.9	25.5	26.9	69.4	30.5	18.7	30.0	22.8	21.1	13.3	21.0	17.9	35.8	47.6	16.2	27.6	25.5	20.2	19.1	16.6	12.6	14.4	60.0	40.4	24.4	12.5	19.6	19.7	29.2	7.2	9.1	14.7	10.8	27.7	25.8	24.0	10.5	31.6	21.6	20.3	38.1	22.7	31.3	14.1	19.5	12.3	63.7	27.2	12.2	23.6	14.3	36.7	13.0	9.8	16.5	26.2	39.4	13.2	8.6	14.1	24.5	9.0	24.0	23.5	22.5	23.6	21.8	28.2	11.4	39.5	12.1	13.6	14.7	29.8	17.3	13.3	24.0	28.9	28.3	24.2	16.4	30.5	21.3	25.5	24.6	21.4	26.9	18.6	30.0	25.2	69.4	18.7	29.6	20.5	20.5	22.8	29.0	24.0	14.6	26.7	25.3	36.3	33.3	13.3	29.2	12.4	32.8	43.1	47.7	44.5	37.4	40.5	107.7	56.0	49.5	20.5	80.3	11.8	81.7	393.0	47.8	34.9	60.7	30.8	0.0	47.0	87.8	59.7	60.7	17.4	58.7	70.2	19.1	39.2	50.3	63.1	66.9	46.9	40.0	92.8	13.6	36.6	50.4	36.3	39.1	41.4	267.1	26.5	19.4	61.3	39.2	65.8	44.3	58.8	34.5	32.7	45.2
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.7	7.0	11.4	9.7	8.7	12.9	10.2	7.2	12.0	11.5	11.5	4.7	6.5	8.5	6.6	7.1	6.4	6.9	13.1	6.9	11.7	15.9	7.9	8.5	5.6	4.6	9.6	8.4	10.2	7.9	8.9	9.0	9.3	9.8	9.7	7.7	9.8	8.8	13.2	2.9	9.6	5.7	26.9	4.8	5.1	4.9	20.5	8.9	9.0	5.9	5.6	16.3	8.6	11.7	13.3	12.7	9.0	6.2	7.2	9.5	5.1	11.7	10.9	6.5	6.2	5.7	10.7	6.3	8.7	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9	44.7	9.8	14.6	7.5	6.2	21.3	12.6	17.8	28.1	15.9	12.2	9.8	12.8	10.0	8.7	1.2	11.3	6.7	0.0	9.2	12.6	10.6	8.8	16.2	11.5	10.5	27.0	6.4	11.6	19.2	1.5	14.4	11.3	3.3	10.8	9.2	13.4	8.4	7.0	13.1	13.5	17.6	19.4	9.0	7.4	16.2	6.0	9.2	18.1	8.8	6.2
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67288547-67302485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	9.1	9.1	18.2	18.1	17.6	80.8	18.9	20.2	18.7	9.0	7.6	7.7	13.7	8.0	9.0	10.4	14.6	10.2	11.9	8.8	20.2	14.0	8.3	4.5	12.4	20.8	12.4	11.4	9.4	7.7	6.0	17.0	9.2	10.7	12.7	4.5	10.9	17.5	12.0	4.2	28.1	8.6	9.9	9.6	24.1	8.9	6.8	12.0	9.6	6.4	6.2	14.4	14.3	13.4	2.6	8.1	11.4	4.6	3.8	6.7	1.9	6.3	4.5	3.4	8.1	5.2	5.1	6.4	3.9	3.8	4.6	2.9	5.3	7.0	6.9	6.6	4.4	6.2	10.6	2.5	5.0	0.7	9.7	3.0	5.8	6.8	3.0	8.1	6.4	23.5	5.5	7.9	4.1	5.3	6.9	4.3	7.0	4.1	8.4	4.0	10.3	8.6	49.8	3.9	9.8	5.7	21.6	3.7	4.8	6.5	8.7	4.0	6.8	3.4	10.2	27.2	2.7	10.5	18.3	5.5	7.3	4.7	7.4	5.1	8.5	6.1	4.1	9.6	18.0	4.7	7.2	3.3	11.4	6.7	4.6	4.4	2.6	3.8	5.4	1.9	2.4	2.4	5.8	10.8	3.8	3.8	8.1	2.8	1.9	18.2	17.6	20.2	18.7	20.2	14.0	12.4	11.4	10.7	12.0	0.0	22.6	9.3	10.5	12.6	49.4	4.5	2.5	18.7	10.3	15.7	70.7	6.9	1.7	7.8	17.6	14.2	2.6	0.0	6.0	6.4	13.6	15.3	24.3	2.4	17.5	39.7	10.4	25.2	48.3	5.1	20.4	28.1	11.8	14.4	6.2	25.2	7.9	2.9	15.9	1.4	45.9	12.9	12.1	2.8	5.5	22.0	6.3	29.9	6.9	15.7
ANKRD33B		ENSG00000164236	"Ankyrin repeat domain 33B"	A6NCL7	5	10564330-10657816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.3"	"Cell type enriched"	"Detected in many"	5	"Cone photoreceptor cells: 329.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.1;memory B-cell: 1.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.4;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HMC-1: 18.5"	"Group enriched"	"Detected in many"	9	"amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5"	"Group enriched"	"Detected in all"	6	"amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0"	HPA056974	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056974: AB_2683295"	"unprognostic (6.19e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.16e-5)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.47e-2)"	3.8	1.1	6.3	8.6	9.3	13.2	3.6	1.4	25.3	5.2	3.2	0.1	0.4	0.9	7.8	1.1	3.3	5.4	1.9	7.0	8.4	2.3	10.0	1.5	3.0	5.4	2.0	7.5	1.7	2.7	0.5	1.7	3.5	1.3	3.5	2.0	12.7	2.3	4.4	9.0	11.3	3.3	6.9	1.7	11.1	3.1	5.2	1.1	7.2	1.6	12.5	7.2	4.9	16.6	1.4	0.0	2.1	0.0	0.0	0.4	0.4	2.5	3.8	0.2	0.3	9.0	4.3	11.4	0.7	1.2	1.5	1.8	4.7	2.1	14.0	12.8	2.4	1.8	2.6	1.3	1.3	1.7	27.4	0.9	5.5	3.4	0.0	4.1	4.2	18.5	2.1	1.0	0.8	5.2	0.3	1.9	1.0	1.2	6.8	0.4	0.0	0.2	5.0	3.0	0.0	1.1	1.1	2.9	0.4	5.1	1.8	0.0	0.1	0.0	0.2	0.4	10.0	0.0	5.2	5.4	0.9	5.6	4.6	1.3	8.0	8.7	1.2	0.2	6.8	0.3	0.0	0.0	2.1	0.2	0.0	0.0	1.4	0.4	0.1	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.4	6.3	9.3	1.4	25.3	8.4	2.3	2.0	7.5	1.3	1.1	11.9	1.0	1.9	1.7	0.3	14.4	4.5	0.0	0.0	1.2	3.5	329.9	1.0	1.7	1.8	4.9	2.3	0.0	0.0	0.2	0.8	5.0	3.1	0.0	0.0	0.2	6.4	0.0	2.5	0.0	0.0	1.4	0.7	1.7	26.2	0.0	5.8	0.2	0.0	0.0	18.3	67.9	0.0	0.2	0.0	1.9	1.0	0.5	0.5	0.0	1.7
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	46.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.7	0.0	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ANKRD34C		ENSG00000235711	"Ankyrin repeat domain 34C"	P0C6C1	15	79293285-79298235	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 5.8;skin 1: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 14.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045329			Approved	Mitochondria		NA	NA			Mitochondria		"HPA045329: AB_2679291"	"unprognostic (3.20e-1)"			"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"						"unprognostic (1.81e-1)"		"unprognostic (3.42e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.48e-1)"			0.5	0.3	0.6	0.0	0.5	0.0	0.0	5.8	5.0	0.5	0.0			0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.9	5.0	0.1	0.0	0.3	0.0	2.4		0.0	0.7	0.1	1.2	0.0		0.1	0.1		0.0	0.2	0.2	3.0	0.1	0.0	0.3	0.0	0.1	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.2	0.9	0.7	3.6	4.9	3.1	3.4	2.9	2.2	2.1	4.7	1.5	1.8	3.0	1.2	5.3	4.4	2.4	3.4	3.7	2.7	8.5	0.9	2.0	3.2	4.5	2.1	1.9	4.7	0.6	4.0	2.0	2.8	15.7	2.7	2.0	3.1	5.1	5.9	1.6	1.6	7.5	1.0	0.6	5.0	0.5	1.0	8.2	2.6	0.5	5.0	8.9	2.0	2.0	8.6	2.7	1.8	1.2	3.5	4.6	3.7	2.6	3.3	9.6	2.8	1.3	13.1	1.4	5.3	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2	20.8	23.7	16.6	23.8	52.8	24.8	1.2	0.0	101.7	22.7	8.7	27.5	15.7	21.6	17.9	3.7	11.7	61.7	23.3	20.0	36.6	28.6	40.4	63.2	20.4	13.8	9.5	115.1	10.4	6.7	2.0	8.6	24.5	135.0	28.9	93.8	89.4	40.5	35.1	11.0	15.7	103.2	6.5	35.0	13.3	15.1	42.0	70.6	11.7	31.3	16.2
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 34.7;lymphoid tissue: 38.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"	6.0	6.0	4.9	29.4	8.8	12.5	4.3	3.7	5.1	8.6	6.7	10.8	3.9	3.2	6.5	3.9	4.3	4.9	7.6	6.4	6.4	4.7	5.6	4.5	15.4	36.7	9.4	4.7	5.1	3.5	6.0	6.1	6.4	6.4	5.0	4.8	7.4	8.0	4.7	2.9	3.0	12.6	9.6	8.0	17.8	5.6	7.1	8.9	38.2	5.1	3.0	27.0	9.0	9.8	15.7	9.4	34.7	11.4	12.0	13.4	6.3	1.0	0.6	1.6	1.7	3.9	1.6	0.3	2.5	1.1	1.3	1.2	0.4	0.6	9.0	1.1	2.1	2.3	0.1	0.6	0.5	1.0	26.6	2.3	0.3	3.2	0.1	0.2	6.5	20.7	0.8	0.3	1.3	0.1	1.9	1.7	2.2	1.5	15.0	1.9	1.5	3.1	5.3	0.2	0.3	1.7	5.7	1.9	12.3	3.1	0.8	1.7	7.4	0.8	0.6	7.0	1.3	0.9	6.4	9.3	4.6	2.5	1.3	1.8	3.7	4.4	11.4	3.1	8.2	2.6	21.8	9.5	21.0	13.1	9.8	12.4	11.6	9.8	11.1	9.4	15.7	11.3	13.4	34.7	12.0	11.4	6.2	9.3	6.3	4.9	8.8	3.7	5.1	6.4	4.7	9.4	4.7	6.4	8.9	14.9	19.2	93.2	4.0	3.1	5.0	7.8	25.5	12.0	13.6	10.4	3.9	3.9	1.7	3.0	10.6	6.7	1.1	0.0	4.0	0.7	5.8	3.2	52.0	7.4	16.4	3.2	2.4	44.2	57.8	12.9	14.4	60.1	35.4	19.8	1.1	10.8	3.8	3.5	16.6	1.1	11.1	19.4	6.1	3.0	3.6	3.1	1.1	81.3	0.8	4.3
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	10.7	23.2	12.3	13.2	19.6	12.1	10.8	23.1	23.5	10.8	11.6	15.6	9.1	11.9	13.8	8.9	10.9	11.5	12.7	12.0	12.7	13.4	13.2	8.3	9.8	12.3	13.3	14.7	14.6	14.1	28.4	14.5	12.6	22.8	11.9	12.1	14.8	11.6	13.6	30.8	15.8	13.0	15.8	8.8	11.9	10.9	8.5	13.5	10.5	12.4	11.4	13.4	12.3	11.8	1.1	1.1	2.4	0.6	0.3	1.2	0.5	11.7	29.2	13.0	23.5	10.6	8.4	9.2	23.6	10.5	21.2	9.6	18.9	6.6	12.6	15.1	23.0	7.4	15.4	14.3	10.3	12.3	12.1	14.5	22.6	19.0	7.2	7.3	17.7	13.2	8.6	11.7	19.7	10.0	15.6	12.3	10.4	9.2	6.9	19.8	16.4	14.2	5.9	5.4	7.7	13.5	11.2	9.0	5.0	14.0	15.1	9.9	9.0	25.7	16.5	9.4	10.5	13.3	6.9	16.9	22.2	19.5	12.4	14.7	6.4	8.4	6.2	22.8	5.9	14.4	2.4	0.6	0.9	1.2	0.1	1.0	0.8	0.4	0.7	0.3	1.1	0.6	0.7	0.3	0.3	0.4	1.1	0.3	0.5	12.3	19.6	23.1	23.5	12.7	13.4	13.3	14.7	22.8	13.5	6.0	4.0	4.7	2.9	10.0	4.7	5.6	2.5	0.0	0.0	12.2	25.5	5.1	0.0	8.4	0.3	4.8	8.3	0.0	8.0	6.2	5.3	4.5	1.1	6.0	6.2	7.9	9.2	6.2	6.5	0.8	5.8	3.9	10.1	4.6	6.8	3.7	12.4	9.0	4.6	5.8	6.1	0.0	5.2	6.7	8.1	9.5	3.1	4.8	7.3	3.7
ANKRD63		ENSG00000230778	"Ankyrin repeat domain 63"	C9JTQ0	15	40281444-40282586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HEK 293: 5.5;HEL: 2.7;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 4.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 50.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.3"	HPA066743			Approved	Mitochondria		NA	NA			Mitochondria		"HPA066743: "					"unprognostic (9.36e-2)"					"unprognostic (7.45e-2)"				"unprognostic (8.32e-2)"	"unprognostic (4.42e-1)"			0.2	0.2	1.8	0.4	22.4	0.2	0.2	0.3	4.7	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.2	0.7	0.3	0.5	0.3	0.4	1.3	0.2	0.2	0.3	0.3	1.1	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.5	0.2	0.0	0.7	0.3	0.7	1.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.5	2.7	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.1	0.0	0.0	0.2	1.9	0.2	0.0	0.4	1.4	0.0	0.4	0.0	0.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	22.4	0.3	2.8	0.3	0.4	0.3	1.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Horizontal cells: 58.8;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 9.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.7;TIME: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	35.1	9.1	18.4	5.1	25.5	7.2	20.9	7.6	30.1	13.9	10.8	42.9	8.3	7.9	14.2	5.9	9.0	11.6	15.8	18.8	19.4	15.1	17.0	13.9	17.5	6.7	34.3	16.8	31.5	10.1	9.8	10.2	16.3	29.8	8.4	8.2	13.7	7.6	10.3	22.4	10.6	6.0	14.4	30.7	13.2	10.1	8.8	35.1	2.3	32.9	5.3	5.4	11.8	15.4	9.4	0.3	0.6	0.4	0.2	0.1	0.4	5.3	2.7	6.2	8.6	21.3	16.4	13.7	10.4	13.6	4.2	7.4	9.5	11.4	9.9	5.9	4.6	12.7	1.6	11.0	14.4	7.7	0.3	2.2	0.1	6.7	6.3	20.7	5.5	0.3	24.4	7.8	12.5	13.0	18.0	41.7	5.7	0.3	0.2	27.0	4.7	1.8	1.0	5.1	2.8	5.2	14.8	17.9	11.5	6.2	2.5	8.3	4.8	3.3	2.0	2.1	7.6	5.0	0.6	55.2	6.0	17.4	4.1	18.0	2.5	5.1	12.0	6.6	9.1	7.1	0.6	0.4	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.3	9.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.4	18.4	25.5	7.6	24.6	19.4	15.1	34.3	16.8	29.8	35.1	74.5	12.6	0.8	3.6	9.5	6.2	13.6	15.3	4.0	7.9	8.7	5.9	12.6	6.6	3.6	13.9	32.4	4.6	0.0	5.6	2.1	18.8	2.1	1.1	12.1	2.7	58.8	2.9	45.4	5.6	15.2	33.1	3.1	6.8	0.0	3.8	11.2	5.4	4.9	35.0	4.8	7.2	58.2	24.7	3.6	9.8	10.5	5.0	0.5	6.4	2.7
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515131	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"salivary gland: 39.2;smooth muscle: 10.9"	"Cell type enhanced"	"Detected in single"	29	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 43.4;hTEC/SVTERT24-B: 15.4;HUVEC TERT2: 15.6;TIME: 30.5;U-87 MG: 19.2"					"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria		No	No			Mitochondria		"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.5	0.6	0.2	0.6	0.2	0.0	5.2	0.6	0.1	3.3	1.2	0.1	0.0	0.1	2.4	0.2	0.8	0.0	2.1	5.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	3.6	0.7	3.2	39.2	1.7	0.6	0.9	0.8	10.9	0.3	0.0	0.6	0.1	0.0	0.0	0.1	1.0	0.6	6.1	5.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	9.2	0.0	0.9	0.7	0.0	2.8	0.0	0.0	43.4	0.2	0.4	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.3	0.0	15.4	0.2	3.1	15.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	6.5	0.4	0.0	8.5	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.7	13.5	22.7	15.8	3.8	8.7	3.6	7.4	9.1	15.8	16.7	8.0	7.1	12.8	9.3	6.8	20.6	12.2	28.6	14.8	17.6	13.5	20.3	6.5	13.4	12.6	9.0	16.3	7.3	9.7	8.8	17.4	13.0	8.5	11.0	16.1	9.1	14.5	14.6	13.9	16.4	17.6	20.7	19.4	21.9	12.7	11.3	30.7	30.9	7.6	15.4	11.2	16.1	15.4	15.8	23.3	26.6	7.3	2.7	10.2	6.2	36.5	11.2	11.3	19.8	11.6	16.5	8.1	14.9	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8	14.9	7.8	15.6	14.2	12.5	19.3	55.7	25.5	87.0	9.1	22.7	13.7	16.6	152.5	24.6	16.8	8.7	14.4	0.0	14.1	7.3	12.6	14.5	3.5	11.9	20.3	19.1	6.9	9.8	10.1	11.7	10.6	11.2	27.0	55.9	17.6	40.5	12.0	18.4	14.9	67.7	23.7	6.5	6.2	14.0	50.7	6.0	10.4	10.0	20.9	15.4
APOOL	"AAIR8193, CXorf33, FAM121A, Mic27, UNQ8193"	ENSG00000155008	"Apolipoprotein O like"	Q6UXV4	X	85003826-85093316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000612	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA000612: AB_1078594"	"prognostic unfavorable (2.68e-5)"	"unprognostic (2.72e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (4.27e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.77e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.35e-12)"	"unprognostic (2.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.11e-2)"	"unprognostic (7.51e-2)"	9.9	13.2	6.2	5.2	11.2	4.5	8.6	4.3	11.9	7.8	8.2	7.1	6.6	8.2	8.6	8.4	14.0	7.7	6.3	16.1	8.3	6.8	16.2	20.1	6.7	4.3	8.4	7.4	8.0	14.2	17.0	12.9	7.3	14.0	7.8	9.2	7.4	9.9	6.4	20.4	9.2	10.4	8.9	8.8	4.9	9.2	4.6	8.2	7.3	12.7	11.1	5.6	11.0	9.4	7.8	5.9	7.1	6.7	3.6	5.2	2.1	11.5	9.5	6.5	7.9	16.6	11.4	7.4	7.8	7.4	6.6	7.9	8.3	7.4	8.4	8.7	8.2	15.9	8.7	19.6	7.5	11.5	9.0	8.0	8.9	11.9	7.4	9.9	16.3	8.8	12.2	9.9	11.7	19.4	6.6	9.4	11.3	16.1	13.6	10.5	8.9	6.5	4.8	5.7	9.1	14.5	7.4	14.9	8.5	7.0	9.1	0.6	9.1	14.9	11.9	7.2	7.7	7.7	6.3	11.0	8.0	12.3	17.2	8.8	6.4	27.1	8.4	9.1	12.8	7.7	7.1	4.7	3.4	4.7	6.7	3.9	7.8	4.4	3.6	5.0	4.5	5.2	4.7	1.0	3.6	5.5	5.9	3.0	2.1	6.2	11.2	4.3	11.9	8.3	6.8	8.4	7.4	14.0	8.2	14.9	15.5	9.3	11.2	4.9	25.7	45.1	15.3	10.7	9.1	19.2	13.7	13.8	11.6	15.6	0.0	11.7	9.8	0.0	12.2	9.6	7.1	20.2	20.8	41.2	10.2	20.6	35.6	14.1	12.4	0.2	12.7	10.9	0.0	3.6	15.0	15.1	14.9	16.4	14.5	24.8	15.6	19.4	8.9	2.4	7.2	3.0	16.2	4.5	14.7	14.8
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	12.2	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	42.8	6.8	0.0	0.9	0.0	0.0	1.9	0.0	74.1	0.7	0.0	0.0	0.0	0.3	2.0	23.0	0.2	0.0	0.7	75.5	4.4	161.4	0.1	0.0	0.0	0.1	0.0	1.6	46.5	0.0	0.0	0.0	8.8	4.9	0.0	0.0	0.0	4.2	0.3	0.0	0.0	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0	184.6	339.4	82.8	759.9	994.1	0.0	30.5	71.4	92.3	310.5	48.8	0.0	1.3	0.0	52.7	45.1	3.9	632.3	0.0	8.6	1.2	28.2	73.6	633.9	2.9	31.8	0.0	39.8	10.4	189.5	5.9	0.3	134.1	32.1	1.8	188.0	0.0	301.5	221.0	1.1	0.5	0.0	19.4	4.4	52.0	45.0	299.4	0.9	149.6	119.9	1407.8
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619798-67651720	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 53.7;thyroid gland: 75.4"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 140.3;Collecting duct cells: 157.1;Syncytiotrophoblasts: 502.9;Urothelial cells: 134.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 24.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	1.5	3.9	2.4	1.7	6.4	0.6	2.7	8.3	5.3	9.3	5.4	0.5	2.0	2.1	3.7	2.3	7.3	0.8	4.9	2.1	3.3	5.5	41.4	2.0	1.7	0.6	3.2	1.7	8.8	2.6	32.1	22.5	4.4	4.6	53.7	1.1	3.4	26.6	3.8	17.2	0.8	10.4	2.2	3.9	0.7	1.4	1.9	2.1	0.1	75.4	13.6	2.2	5.3	4.1	2.5	1.7	2.0	1.4	0.3	2.9	3.4	3.5	0.5	6.2	4.0	0.9	0.0	8.4	2.7	7.5	9.0	15.3	15.3	1.8	6.0	0.7	1.8	4.1	0.8	24.9	11.3	11.0	0.2	6.2	2.7	1.1	17.4	2.7	0.6	16.3	0.4	14.7	4.4	21.5	0.7	15.3	16.1	7.9	0.0	0.6	1.7	0.9	0.6	11.8	1.5	0.2	0.2	0.8	6.8	7.3	5.9	13.8	5.2	1.7	1.7	2.6	15.0	6.4	0.2	3.1	2.7	6.9	0.2	2.0	0.5	0.9	2.0	5.5	3.1	4.6	0.3	1.4	2.0	1.1	0.5	0.5	0.7	0.3	0.9	1.7	2.5	0.6	0.6	1.7	0.3	1.2	0.1	2.9	3.4	2.4	6.4	8.3	5.3	3.3	5.5	3.2	1.7	4.6	2.1	0.0	4.3	3.7	140.3	7.8	5.0	5.0	2.5	2.7	27.3	157.1	9.8	82.0	31.5	9.2	12.3	3.0	14.8	23.3	2.8	5.2	3.7	84.0	6.9	1.5	12.3	9.5	35.3	1.8	0.3	1.0	0.3	3.9	10.1	1.0	4.3	40.7	4.5	3.5	0.4	75.6	16.0	6.5	4.1	7.2	2.6	4.6	502.9	5.0	3.3	134.9
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.6	14.8	67.4	15.1	10.7	18.6	15.0	29.7	9.0	10.0	15.2	30.2	38.8	32.4	10.2	11.6	11.7	30.2	14.2	12.2	18.8	42.1	15.1	37.2	91.5	15.5	9.5	60.0	24.8	16.6	16.1	9.1	12.3	25.0	12.7	22.5	13.4	25.2	12.8	9.4	23.7	31.9	17.8	19.6	5.6	40.9	16.9	15.4	11.2	31.1	17.6	25.3	14.0	22.5	6.7	27.9	17.7	31.1	23.0	13.4	13.4	14.9	16.6	28.3	23.3	38.8	27.7	38.5	15.3	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2	131.0	200.7	147.3	175.2	232.4	221.8	78.3	101.9	224.9	215.0	108.2	127.6	118.5	84.6	100.9	28.5	282.9	157.6	93.5	97.9	120.4	173.1	219.9	158.9	69.6	87.5	287.6	180.1	188.4	85.6	18.1	236.2	133.0	121.4	162.3	134.2	304.1	112.4	133.3	204.7	39.4	283.1	213.4	189.5	194.6	112.8	229.2	154.9	147.4	126.3	268.6
ARHGAP20	KIAA1391	ENSG00000137727	"Rho GTPase activating protein 20"	Q9P2F6	11	110577042-110713189	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Leydig cells: 45.1;Peritubular cells: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;ASC TERT1: 7.7;HHSteC: 5.1;SiHa: 6.4;U-2197: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038458, HPA038459, HPA076303"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792"	"unprognostic (1.69e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.84e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.21e-3)"	"unprognostic (4.10e-2)"	14.4	4.6	5.9	2.6	13.0	0.6	8.4	7.7	12.0	9.1	3.7	1.9	9.2	2.0	8.3	7.0	4.4	6.2	4.4	1.3	4.8	6.2	1.2	3.4	7.6	2.3	3.4	6.3	4.3	0.8	1.6	2.0	3.4	5.8	7.7	5.5	9.7	2.7	16.8	2.0	2.2	2.9	12.1	3.0	2.7	3.9	14.1	2.2	0.0	8.9	2.1	1.9	6.3	4.9	1.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	7.7	0.0	1.0	3.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.3	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.0	0.0	0.1	0.0	1.9	0.8	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	13.0	7.7	12.0	4.8	6.2	3.4	6.3	5.8	2.2	0.0	2.9	0.0	3.5	0.7	5.8	0.8	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	8.4	1.4	0.0	0.0	0.3	0.1	3.1	0.8	1.1	2.1	0.2	3.2	0.0	9.2	1.0	2.6	45.1	1.4	3.3	0.0	0.0	0.4	0.4	0.0	34.3	0.0	1.3	0.0	1.8	2.9	10.4	0.4	0.6	0.0	0.0	0.7
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	15.3	13.8	14.9	19.0	22.5	34.1	15.9	32.8	17.6	19.7	13.4	19.2	18.2	9.1	18.7	18.1	12.0	15.0	15.2	10.6	15.2	14.5	13.1	14.0	15.5	22.3	26.9	13.9	21.8	16.8	23.8	25.7	14.7	20.3	17.9	10.7	12.0	16.7	17.0	12.3	12.3	14.2	14.6	19.8	19.8	14.7	19.5	23.4	33.7	20.2	8.2	18.9	18.2	18.6	17.1	11.7	35.9	11.8	16.6	17.0	6.0	12.2	9.2	16.2	12.5	11.9	12.5	13.3	14.0	12.3	9.7	9.5	9.5	13.1	14.4	16.3	10.5	6.9	10.9	13.1	5.9	14.1	18.5	14.2	11.6	11.1	7.9	9.1	12.4	17.1	8.4	8.0	11.9	10.2	12.7	13.1	9.2	15.0	20.7	9.1	5.5	18.5	11.3	14.8	8.8	6.1	6.9	11.5	12.0	10.6	10.3	13.2	18.3	17.8	14.8	13.8	4.9	15.6	20.1	18.0	12.0	9.1	14.6	13.6	20.2	16.0	14.4	8.2	9.1	16.0	24.6	7.1	19.5	16.1	7.6	14.7	15.6	17.0	13.7	6.8	17.1	16.9	14.4	35.9	16.6	11.8	11.7	13.6	6.0	14.9	22.5	32.8	17.6	15.2	14.5	26.9	13.9	20.3	23.4	95.3	99.9	54.7	68.9	110.4	111.2	62.2	35.7	91.0	101.2	29.6	113.9	55.7	16.6	62.0	329.6	108.9	41.9	46.7	41.8	58.1	114.7	81.5	105.3	23.1	39.4	106.5	86.4	65.7	52.4	349.2	93.7	99.4	79.2	108.2	45.8	77.7	57.3	49.9	72.9	15.0	150.5	45.3	129.6	212.6	167.8	93.1	131.0	129.6	39.6	111.5
ARL6IP4	"SFRS20, SR-25, SRp25, SRrp37"	ENSG00000182196	"ADP ribosylation factor like GTPase 6 interacting protein 4"	Q66PJ3	12	122980060-122982913	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052098	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052098: AB_2681724"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.04e-3)"	"unprognostic (6.48e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.03e-5)"	"unprognostic (4.01e-2)"	"unprognostic (8.41e-8)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.43e-2)"	"prognostic favorable (1.08e-4)"	42.1	59.6	63.3	35.7	46.8	55.3	40.3	36.9	55.9	36.7	43.0	32.2	38.9	43.7	33.8	30.7	38.9	42.9	40.1	57.0	42.8	40.9	45.2	59.1	33.9	51.6	45.2	38.3	50.0	94.4	30.0	34.7	29.7	35.1	38.9	24.7	39.7	59.7	41.2	131.1	30.7	44.9	64.3	36.1	38.1	41.6	35.2	27.7	35.5	39.1	43.4	39.9	39.5	39.9	54.4	72.4	58.1	81.5	46.5	59.6	61.3	49.0	53.6	35.3	23.6	24.8	32.9	27.7	28.3	34.1	42.6	32.4	26.4	20.9	46.9	35.6	35.8	19.9	26.0	28.1	45.9	19.0	41.5	29.3	77.9	47.5	51.8	47.8	42.4	34.4	34.0	37.1	32.7	43.1	46.8	46.8	37.9	34.5	22.8	34.0	57.9	49.3	77.2	27.7	29.7	34.0	37.6	38.8	55.4	36.8	41.9	34.3	41.1	26.7	44.8	65.1	16.1	58.7	55.3	41.8	24.7	45.0	23.5	35.2	49.0	23.6	53.4	35.6	49.8	30.8	32.9	58.4	58.1	47.4	72.2	51.0	54.4	57.0	52.5	72.4	50.6	55.1	49.4	16.1	46.5	81.5	49.3	59.6	61.3	63.3	46.8	36.9	55.9	42.8	40.9	45.2	38.3	35.1	27.7	86.4	116.6	229.3	258.2	181.7	102.3	0.0	173.3	87.0	80.8	200.7	41.2	248.7	437.7	251.9	151.9	255.7	444.9	46.7	552.1	221.9	252.2	285.2	160.8	400.6	340.2	92.2	214.5	213.6	390.7	256.2	206.0	341.0	357.7	480.7	268.3	146.1	343.4	291.0	170.1	721.8	106.3	174.6	249.2	209.1	156.8	177.7	200.9	256.7	288.4	330.8
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 81.2;Late spermatids: 192.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2"					"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.6	0.5	1.2	2.9	0.1	0.9	0.5	2.1	2.1	0.5	0.7	0.7	0.0	1.5	0.1	0.2	0.4	0.2	1.2	0.1	0.1	0.3	0.0	0.1	2.8	0.3	0.7	4.4	0.7	1.9	0.4	0.4	2.1	0.2	0.2	0.9	2.0	0.0	0.3	0.1	2.2	0.1	1.3	8.7	0.0	0.1	0.1	0.3	9.2	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.4	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6	0.0	1.4	0.0	0.8	5.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	81.2	0.2	0.0	0.0	0.2	0.1	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.3	192.4	1.4	0.0	5.0	0.0	0.3	1.0	0.6	0.0	1.1	0.3	0.0	0.0	0.2	12.2	0.9	1.4	0.0	0.0	0.4	0.3
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602456-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavorable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.2	16.5	25.5	13.1	25.6	11.5	19.2	30.4	32.3	17.1	19.0	22.6	10.2	15.8	19.7	17.8	17.7	14.1	12.3	21.6	26.9	24.0	22.9	23.5	12.6	18.1	24.5	18.7	20.4	15.2	18.4	18.9	16.7	27.1	19.2	17.6	13.1	15.1	18.8	22.2	11.6	15.3	22.5	27.5	15.0	14.5	10.0	18.9	20.7	15.4	10.4	20.0	20.4	14.0	8.8	6.1	20.7	7.9	9.6	10.5	5.8	22.7	16.3	15.9	14.8	15.8	14.5	11.6	20.5	15.3	21.8	16.1	11.9	18.5	35.5	5.2	18.5	23.7	15.3	28.4	16.5	29.7	20.1	14.8	27.5	10.4	17.3	21.1	10.3	15.0	13.2	19.1	17.9	24.7	17.2	22.3	25.3	28.3	25.3	23.3	14.6	38.1	13.6	16.5	28.5	18.1	22.2	19.9	12.5	17.2	10.8	11.8	12.8	12.9	16.4	19.3	16.9	26.3	12.2	13.2	20.7	15.2	15.6	19.1	18.8	19.8	24.0	19.6	19.3	20.0	20.7	4.8	6.1	7.6	7.9	10.5	8.8	9.1	9.1	6.1	6.8	9.4	9.3	0.6	9.6	7.2	5.3	9.5	5.8	25.5	25.6	30.4	32.3	26.9	24.0	24.5	18.7	27.1	18.9	38.7	20.1	24.4	9.6	14.1	23.1	28.3	12.7	16.0	27.3	15.7	21.6	29.7	46.4	22.5	6.2	16.3	15.7	23.3	24.4	37.1	21.1	14.3	10.4	21.3	22.4	19.1	22.4	26.4	15.1	4.3	24.2	16.9	20.3	28.9	18.5	44.1	23.2	10.5	31.5	32.1	20.5	6.5	25.5	31.8	21.7	16.2	31.5	20.1	21.7	7.6
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.6	10.8	6.4	12.4	13.4	12.8	6.4	8.9	9.7	6.4	7.8	5.8	15.0	22.8	19.3	7.8	18.4	11.4	9.0	9.9	9.2	8.5	10.3	8.0	4.6	2.8	13.5	22.0	9.6	8.3	17.5	8.1	13.3	19.6	14.6	12.9	19.6	14.1	11.4	23.4	16.1	17.1	14.3	21.7	11.7	9.8	6.7	29.6	16.3	8.9	7.2	9.9	12.1	18.3	13.4	11.6	7.4	11.0	9.7	10.0	9.5	23.4	13.3	21.7	33.9	18.3	11.3	20.5	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6	23.8	17.0	26.1	49.5	69.9	22.6	15.4	22.9	6.7	15.9	26.2	13.7	38.2	56.3	15.6	10.1	27.0	15.3	0.0	13.3	39.5	28.9	60.5	17.3	34.7	41.8	7.9	14.5	25.2	32.4	6.3	31.4	31.1	43.9	2.8	33.1	24.5	20.4	10.5	32.2	71.6	26.5	32.3	47.6	11.6	30.8	91.1	37.6	30.5	39.3	65.2
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing, X-linked 1"	Q9P291	X	101550531-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	17.5	29.8	13.6	7.4	16.5	2.7	18.9	13.4	21.5	24.4	18.7	9.6	15.9	6.2	27.3	19.0	12.3	16.3	14.8	26.6	13.3	18.4	12.1	3.8	11.6	4.4	13.7	14.6	42.6	10.2	20.1	18.0	12.5	16.4	25.8	7.0	13.0	12.0	21.1	22.7	8.1	7.6	26.3	9.1	11.4	10.0	8.1	10.5	3.5	14.0	11.6	3.3	26.8	29.7	0.2	9.9	0.5	4.3	2.1	3.7	2.1	0.7	0.2	5.6	0.0	26.9	24.2	0.0	8.7	17.2	11.0	27.8	0.0	0.1	0.0	7.5	13.4	12.1	0.7	0.0	1.2	6.2	0.0	0.0	5.0	1.7	0.0	14.2	0.0	0.0	20.2	1.7	8.3	0.0	9.1	6.6	0.0	0.1	0.1	24.4	0.3	0.0	0.0	8.0	0.0	0.0	0.0	30.8	0.0	7.5	0.0	5.5	4.6	0.0	0.1	15.0	1.6	0.9	3.7	8.7	6.7	3.5	19.4	0.1	0.0	0.1	0.0	6.5	0.0	4.1	0.0	4.3	0.5	0.0	3.9	0.7	0.0	0.6	0.3	9.9	0.2	1.5	3.7	0.1	2.1	1.1	5.1	0.9	2.1	13.6	16.5	13.4	19.9	13.3	18.4	13.7	14.6	16.4	10.5	23.8	6.1	0.0	23.8	29.5	26.3	54.8	7.6	5.3	5.7	22.7	5.9	1.4	11.6	14.6	0.3	23.2	0.5	0.0	6.0	2.1	52.1	21.0	24.2	0.4	23.6	20.6	5.2	17.8	9.4	0.9	43.7	11.0	55.6	6.4	1.0	31.1	7.5	0.0	41.8	11.4	13.3	45.3	48.4	1.7	0.7	19.1	2.2	1.0	0.6	7.4
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	14.9	0.1	13.3	12.1	0.1	16.3	20.5	0.4	0.4	0.0	6.3	0.0	0.0	21.4	0.0	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.5	0.0	14.1	0.1	0.0	19.1	5.2	12.8	0.1	20.2	17.3	0.0	0.0	0.1	48.1	0.0	0.0	0.2	34.7	0.9	0.1	4.0	26.6	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	27.9	7.6	0.0	3.8	18.4	19.6	11.5	0.1	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7	14.9	5.4	4.4	13.8	3.8	11.2	22.2	7.6	2.7	15.9	31.4	7.9	1.0	3.3	8.0	0.1	13.0	0.0	0.0	1.8	0.4	20.2	13.8	2.3	0.4	3.6	1.6	8.7	16.0	2.1	0.4	22.5	4.0	5.0	11.8	2.2	7.0	3.1	0.0	23.0	4.2	9.7	58.2	26.4	1.4	1.1	2.6	4.2	2.5	1.2	6.2
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869516-102901899	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 92.8;parathyroid gland: 30.0"	"Cell type enhanced"	"Detected in single"	20	"Club cells: 1.2"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	2.0	92.8	3.7	0.7	8.6	0.5	2.6	4.5	6.4	4.0	2.0	2.2	0.4	1.3	3.8	3.2	2.1	2.1	5.2	10.0	5.7	3.1	7.4	22.4	1.7	0.9	2.8	4.4	3.9	8.7	30.0	2.4	0.5	4.6	4.2	0.8	8.9	2.2	3.4	6.0	1.8	1.3	3.9	2.7	5.6	1.7	3.5	1.6	0.3	3.2	1.0	0.7	1.8	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	3.9	14.3	8.9	0.3	0.3	2.6	4.1	3.5	6.2	7.6	10.6	0.6	0.2	1.2	5.4	0.3	0.2	12.1	0.7	6.4	0.0	3.5	0.0	1.7	10.4	4.1	0.2	0.1	1.9	1.6	0.8	0.0	11.2	0.2	13.2	0.0	0.2	5.5	0.1	2.4	0.3	6.8	0.0	0.6	27.2	0.0	0.1	1.3	0.1	0.4	14.6	0.0	0.2	1.9	4.9	22.7	0.3	0.1	1.3	0.0	2.0	0.0	0.3	0.2	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.7	8.6	4.5	6.4	5.7	3.1	2.8	4.4	4.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATAD1	FLJ14600	ENSG00000138138	"ATPase family, AAA domain containing 1"	Q8NBU5	10	87751512-87841343	"Enzymes, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 802.3;Late spermatids: 1314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	"Nucleoli rim,Mitochondria"		NA	NA			"Nucleoli rim"	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	16.2	21.3	20.4	15.1	26.2	8.0	19.4	22.4	29.8	19.2	15.9	14.4	16.0	13.5	19.6	17.0	17.3	14.8	13.3	39.9	20.4	22.2	20.6	22.1	14.1	14.2	20.4	17.1	19.1	12.6	25.6	24.9	30.2	31.2	24.3	18.4	19.8	15.8	20.4	32.1	14.4	14.1	18.4	18.2	12.5	14.0	19.8	14.7	18.0	20.1	18.5	15.7	18.9	15.2	9.0	7.3	6.7	7.6	9.8	13.5	7.4	9.9	9.4	12.0	11.4	14.5	12.8	9.1	10.1	16.7	10.4	11.7	8.4	28.8	9.6	7.7	8.4	6.1	16.5	10.0	8.6	12.1	8.5	13.5	7.9	13.1	10.4	17.2	21.4	5.4	12.7	23.9	11.0	27.3	19.0	6.9	9.7	7.6	12.5	11.5	6.0	13.7	14.5	8.9	7.7	6.6	9.4	7.6	10.5	15.9	7.6	7.6	16.7	8.9	6.3	20.2	12.7	16.6	10.1	8.4	9.5	8.4	6.4	13.1	16.8	15.4	12.3	10.5	14.9	7.3	6.7	3.8	5.7	9.2	5.9	13.5	9.0	10.3	11.4	7.3	7.6	11.8	11.6	2.2	9.8	7.6	5.5	9.3	7.4	20.4	26.2	22.4	29.8	20.4	22.2	20.4	17.1	31.2	14.7	50.6	28.3	26.2	34.8	23.8	46.9	66.0	25.5	40.2	25.0	21.0	33.4	32.0	19.9	34.6	802.3	18.5	22.5	0.0	24.4	24.9	28.9	35.7	28.8	24.5	24.0	66.7	21.9	12.9	14.8	1314.1	33.1	25.4	30.4	15.4	23.3	53.3	31.9	26.4	44.2	23.7	46.8	58.2	38.7	58.1	20.9	26.3	73.9	29.9	22.1	44.1
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family, AAA domain containing 3A"	Q9NVI7	1	1512151-1534687	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.8	13.9	11.2	16.3	11.3	25.0	9.3	9.3	14.8	9.2	11.0	11.1	12.5	16.4	10.4	7.6	16.8	9.3	11.9	15.9	9.2	8.2	12.9	26.7	9.7	13.9	10.5	13.3	8.5	20.4	8.1	16.6	11.3	8.3	10.7	6.2	9.6	19.5	9.5	31.1	13.3	12.2	8.9	8.5	12.4	13.0	12.7	9.1	14.0	12.4	21.1	14.3	9.3	9.4	3.3	4.7	1.3	6.2	5.1	4.0	2.1	21.1	11.9	5.3	13.5	2.7	3.2	12.6	17.5	5.2	15.5	9.4	30.5	14.6	11.7	12.1	6.9	5.7	18.1	7.4	10.3	2.6	11.2	32.0	20.4	29.3	20.4	5.1	29.3	13.1	3.7	3.4	12.5	5.2	2.0	6.7	12.9	31.8	9.0	5.5	14.9	22.0	26.8	10.8	7.1	25.6	24.0	10.0	24.2	4.2	8.9	26.7	10.5	10.8	16.5	13.7	1.9	7.2	14.5	9.1	15.8	12.3	24.1	21.3	13.5	13.2	47.1	15.4	44.0	7.0	0.2	4.0	1.3	3.3	2.9	2.5	3.3	3.8	4.0	4.7	3.0	3.4	1.5	0.1	5.1	6.2	4.4	2.8	2.1	11.2	11.3	9.3	14.8	9.2	8.2	10.5	13.3	8.3	9.1	3.0	7.0	11.9	8.0	18.1	10.3	9.5	7.6	1.4	4.5	7.0	5.9	16.8	6.6	21.0	7.6	11.1	10.0	0.0	18.2	36.3	8.9	11.6	9.2	13.1	19.8	22.3	13.2	4.3	5.0	8.2	5.2	7.7	15.1	5.4	13.0	10.2	20.6	5.8	7.4	9.7	9.0	0.0	10.3	5.4	25.6	21.2	16.5	5.3	20.7	12.2
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family, AAA domain containing 3B"	Q5T9A4	1	1471769-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	13.7	7.6	7.5	18.9	9.5	24.3	10.4	11.6	10.8	7.4	9.6	8.7	8.2	12.1	10.0	7.0	11.3	8.1	8.4	6.4	7.5	6.5	9.9	14.5	9.8	17.3	9.5	8.1	10.1	16.5	3.2	13.6	10.3	7.6	11.0	3.8	8.8	16.3	16.5	9.9	15.8	12.3	8.8	6.8	14.5	15.4	9.3	8.2	7.9	9.3	6.6	13.1	5.9	10.0	0.3	0.8	1.4	3.7	0.2	2.0	0.5	6.9	0.0	2.1	11.6	0.6	0.9	15.9	11.2	2.6	11.0	8.4	25.7	20.5	9.8	3.5	4.3	6.6	12.8	14.1	7.0	2.3	8.3	13.3	6.8	16.8	15.7	2.6	11.3	8.0	2.5	0.4	18.1	1.1	0.2	3.8	3.2	20.2	2.2	4.0	3.5	13.4	13.2	22.6	4.6	25.7	10.8	3.4	7.1	3.2	4.6	8.9	7.2	8.3	10.7	9.5	1.4	1.6	4.0	4.7	3.0	6.4	17.4	11.8	6.4	8.8	23.8	9.5	18.8	3.3	0.0	0.7	1.4	1.6	3.7	2.0	0.3	1.0	1.4	0.8	0.0	0.3	0.1	0.0	0.2	1.9	0.5	0.0	0.5	7.5	9.5	11.6	10.8	7.5	6.5	9.5	8.1	7.6	8.2	6.0	26.1	12.0	6.7	23.4	14.1	4.0	10.2	1.4	7.9	8.7	19.6	10.1	1.7	7.4	3.2	6.8	8.4	0.0	6.5	33.5	8.1	6.7	11.5	7.6	10.8	12.7	6.9	4.9	2.8	1.8	4.0	6.3	10.1	3.6	9.1	7.8	9.4	8.0	2.8	1.7	15.6	6.5	8.2	5.1	9.6	20.6	14.9	8.4	10.6	10.2
ATAD3C	FLJ34599	ENSG00000215915	"ATPase family, AAA domain containing 3C"	Q5T2N8	1	1449689-1470158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 17.5;Collecting duct cells: 19.2;Distal tubular cells: 38.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 16.5"									HPA065305			Approved	Mitochondria		NA	NA			Mitochondria		"HPA065305: AB_2685459"	"unprognostic (9.23e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.79e-2)"	"prognostic favorable (5.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.12e-3)"	0.7	0.0	2.1	1.7	2.3	0.7	2.7	0.3	1.5	1.3	1.8			0.9	1.4	2.6	0.7	2.5	1.3	0.4	2.8	1.5	3.1	4.9	2.2	0.7	2.6		1.1	5.0	0.1	1.5	0.3		4.0	0.6		5.4	4.5	0.2	1.2	0.5	1.3	4.3	0.5	0.5	0.7			4.1		0.9	2.2	0.9	2.1	0.6	2.9	0.6	1.6	4.3	0.7	0.3	0.0	0.3	0.5	0.5	0.1	0.4	0.1	0.1	0.2	0.1	1.6	3.3	0.3	0.4	0.1	0.1	0.4	1.3	0.5	0.1	0.1	1.3	0.3	0.9	2.0	0.2	0.3	0.3	0.0	0.2	0.2	1.0	0.1	0.0	0.4	0.3	3.9	0.1	0.9	0.5	1.0	0.6	0.1	0.2	0.4	0.1	16.5	1.1	0.4	2.8	1.0	0.0	0.6	0.2	3.0	3.6	0.3	0.3	0.2	0.3	0.5	0.2	1.9	2.7	0.6	0.2	0.4	0.1	2.9	0.6	1.1	1.1	0.4	4.3	2.1	1.5	1.3	0.1	1.3	1.9	1.4	2.5	1.6	0.3	0.6	2.0	0.7											6.0	17.5	0.8	3.2	3.1	4.3	3.3	0.0	1.4	3.4	19.2	15.7	0.7	38.1	4.6	0.3	3.6	0.6	0.0	8.0	0.2	1.0	3.5	3.5	5.9	1.6	6.4	4.1	3.1	2.1	1.1	1.1	1.3	3.3	0.0	1.6	2.8	4.5	0.0	4.6	10.8	8.0	0.0	1.0	0.5	0.9	5.0	0.7	2.9	1.2	2.2
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell type enriched"	"Detected in some"	36	"Mucus-secreting cells: 198.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HL-60: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.2	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 678.0;Distal tubular cells: 994.7;Proximal tubular cells: 716.2;Syncytiotrophoblasts: 483.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		51000000	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	30.1	60.0	34.7	30.3	45.8	22.4	33.9	52.6	65.0	27.0	52.1	20.5	39.3	55.6	25.2	30.5	44.4	30.0	27.9	196.2	31.4	36.1	94.0	64.8	25.2	40.2	42.3	31.8	28.6	49.0	73.2	35.9	25.7	41.5	28.3	54.9	37.6	42.6	42.8	182.2	34.0	50.4	36.6	22.6	32.1	46.7	24.0	19.9	45.6	35.1	99.7	41.1	31.5	26.4	58.7	110.9	17.9	64.5	44.2	63.6	124.8	43.2	44.1	58.7	55.1	71.5	79.5	65.1	50.1	71.1	77.2	67.7	66.0	34.2	102.6	30.7	60.6	41.4	80.7	101.1	76.9	72.1	45.6	56.8	67.8	56.9	81.7	46.9	143.4	64.4	73.2	54.0	55.6	58.0	62.1	79.6	55.7	54.7	60.7	66.0	45.0	73.7	70.6	55.0	42.4	46.6	73.0	68.3	138.6	104.7	105.9	59.8	55.8	36.7	45.9	61.5	57.6	59.1	83.8	46.3	42.5	36.8	22.3	43.6	69.7	59.6	66.1	42.4	86.3	45.2	11.8	64.5	17.9	43.5	58.2	55.8	58.7	52.4	47.5	110.9	44.0	63.6	52.8	6.7	44.2	52.2	54.0	58.9	124.8	34.7	45.8	52.6	65.0	31.4	36.1	42.3	31.8	41.5	19.9	157.8	126.7	0.0	0.0	0.0	0.0	0.0	0.0	175.3	184.2	162.3	0.0	678.0	994.7	285.1	0.0	0.0	0.0	0.0	236.7	359.7	0.0	0.0	82.5	0.0	363.9	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	313.8	0.0	0.0	195.3	0.0	0.0	716.2	0.0	0.0	0.0	0.0	0.0	0.0	483.5	0.0	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	66.5	81.0	64.4	99.3	58.1	62.1	113.8	67.7	63.2	117.1	66.8	131.5	74.3	118.4	73.4	83.4	49.0	89.2	135.6	82.1	106.1	55.5	93.9	129.9	75.6	80.6	72.0	145.2	92.0	76.1	82.9	91.5	118.2	89.2	96.2	88.4	116.9	136.5	98.2	61.7	107.5	85.4	108.4	88.2	156.0	103.7	72.1	150.9	127.5	118.6	73.7	65.5	103.5	148.2	115.1	70.7	139.1	109.8	65.2	46.1	51.4	67.3	73.1	65.9	81.9	122.5	69.4	97.2	70.6	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3	125.0	160.8	0.0	0.0	0.0	0.0	0.0	0.0	188.7	149.0	263.5	0.0	693.2	1049.5	441.8	0.0	0.0	0.0	0.0	323.3	482.8	0.0	0.0	133.7	0.0	535.7	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	490.5	0.0	0.0	298.7	0.0	0.0	698.1	0.0	0.0	0.0	0.0	0.0	0.0	952.2	0.0	0.0	0.0
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA		1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.6	23.7	13.9	13.2	10.5	11.5	16.6	20.5	10.2	17.6	17.3	22.8	33.5	32.3	30.9	12.4	6.6	27.9	15.9	20.4	13.9	24.1	53.6	27.6	102.7	30.7	11.4	21.0	28.0	13.3	33.9	15.6	12.6	17.2	16.8	38.6	48.8	29.5	12.5	30.3	31.2	38.9	46.3	17.2	29.3	29.9	15.4	45.6	34.2	30.4	28.2	20.3	25.4	26.5	26.1	14.2	39.3	23.3	17.3	5.7	15.7	22.2	24.1	76.4	46.0	44.6	27.0	57.7	6.6	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2	190.6	249.0	0.0	0.0	0.0	0.0	0.0	0.0	1141.6	276.4	518.2	0.0	390.3	877.0	342.1	0.0	0.0	0.0	0.0	585.4	173.6	0.0	0.0	159.3	0.0	316.5	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	214.6	0.0	0.0	472.8	0.0	0.0	988.7	0.0	0.0	0.0	0.0	0.0	0.0	210.5	0.0	0.0	0.0
ATP5MD	"bA792D24.4, DAPIT, MGC14697, USMG5"	ENSG00000173915	"ATP synthase membrane subunit DAPIT"	Q96IX5	10	103389041-103396466	"Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044798			Supported	Mitochondria		NA	NA			Mitochondria		"HPA044798: AB_2679091"	"unprognostic (4.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.03e-2)"	48.0	46.2	91.7	26.2	67.0	26.6	56.1	33.5	71.7	38.4	77.9	21.2	29.2	43.8	22.1	72.3	56.3	28.8	31.0	131.5	67.8	57.4	79.3	92.5	24.6	27.7	65.2	44.4	19.7	58.1	21.1	38.2	25.9	46.0	30.0	75.8	23.4	52.7	43.3	146.9	22.4	57.3	39.1	41.4	26.1	40.9	20.2	30.7	22.9	31.3	125.5	39.8	41.2	28.9	71.3	109.1	101.2	85.2	50.7	76.6	66.4	60.6	64.4	61.0	72.7	68.2	85.7	39.9	58.4	73.7	59.7	66.8	103.7	67.7	34.9	33.9	66.0	47.2	62.2	57.1	59.5	82.4	45.8	102.5	36.2	83.0	115.9	66.3	73.8	56.2	69.1	93.4	53.6	84.8	102.3	76.9	56.6	47.4	58.3	99.7	94.1	59.9	127.2	45.3	93.2	109.2	38.9	37.2	54.3	141.9	98.9	23.1	53.5	30.8	47.3	84.0	89.1	42.0	68.6	43.5	29.6	45.3	44.8	76.4	61.5	100.4	58.2	62.5	75.8	22.3	101.2	65.9	88.7	55.9	85.2	63.3	71.3	76.6	65.7	73.3	51.5	65.9	65.6	55.8	50.7	80.6	109.1	71.7	66.4	91.7	67.0	33.5	71.7	67.8	57.4	65.2	44.4	46.0	30.7	196.5	169.5	0.0	0.0	0.0	0.0	0.0	0.0	222.1	167.2	368.2	0.0	256.1	1135.7	625.1	0.0	0.0	0.0	0.0	623.7	361.7	0.0	0.0	109.3	0.0	478.9	0.0	0.0	0.0	0.0	0.0	0.0	129.1	0.0	754.8	0.0	0.0	789.0	0.0	0.0	951.7	0.0	0.0	0.0	0.0	0.0	0.0	255.7	0.0	0.0	0.0
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674338	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		220000	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	41.2	48.1	69.3	30.8	69.0	34.4	34.2	27.7	67.6	29.3	66.6	28.2	44.4	60.0	20.5	34.1	40.1	23.1	31.6	95.8	62.0	49.2	47.5	68.9	25.8	25.2	68.6	48.7	26.2	57.9	24.5	26.6	19.6	62.2	23.9	43.9	17.8	40.7	37.2	221.8	22.3	55.6	45.8	67.2	23.3	40.7	14.1	47.7	10.9	22.1	98.7	28.1	18.9	31.1	166.1	148.1	142.2	135.7	107.4	127.6	158.4	49.9	47.3	68.2	55.5	57.4	53.4	38.0	48.7	39.0	37.0	32.9	45.4	49.5	25.9	46.9	51.5	60.1	32.0	54.9	76.8	20.3	22.9	101.4	76.2	87.7	113.3	59.7	97.0	33.6	66.2	45.1	42.4	43.0	57.8	45.2	51.7	63.0	28.4	41.9	72.0	83.6	127.1	80.1	88.1	123.8	51.0	49.8	56.4	70.7	87.2	66.2	52.0	35.4	47.7	54.0	44.7	54.5	66.9	52.4	33.3	31.6	29.3	67.9	66.4	109.5	81.9	48.9	66.9	36.4	103.7	135.7	142.2	98.5	112.1	101.0	166.1	121.1	109.2	135.4	123.2	110.3	110.3	122.3	107.4	97.7	148.1	127.6	158.4	69.3	69.0	27.7	67.6	62.0	49.2	68.6	48.7	62.2	47.7	142.9	207.3	0.0	0.0	0.0	0.0	0.0	0.0	337.3	224.1	840.9	0.0	343.2	1465.6	413.4	0.0	0.0	0.0	0.0	598.1	265.5	0.0	0.0	112.8	0.0	580.0	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	485.1	0.0	0.0	478.0	0.0	0.0	1359.9	0.0	0.0	0.0	0.0	0.0	0.0	229.9	0.0	0.0	0.0
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466331	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067267, HPA070412"	Approved		Supported	"Nuclear membrane,Mitochondria"		NA	NA		1400000	Mitochondria	"Nuclear membrane"	"HPA067267: AB_2685815, HPA070412: AB_2686266"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	42.4	49.0	68.0	36.6	52.0	46.4	42.8	37.3	58.8	30.7	62.7	19.0	39.9	62.9	21.2	41.2	57.4	24.8	36.6	94.5	53.9	49.8	59.6	93.5	30.0	35.5	54.6	43.6	20.7	63.6	16.3	36.7	33.4	36.3	35.0	47.3	30.9	57.1	45.2	178.8	27.8	61.5	24.6	33.0	35.6	43.4	58.3	25.5	52.9	37.9	98.0	37.6	27.8	30.2	68.3	129.7	117.2	104.1	58.3	84.0	140.0	86.7	76.6	64.6	104.3	50.9	51.7	40.9	57.6	44.9	61.9	67.1	81.3	80.2	81.4	60.8	35.7	105.4	53.5	71.4	66.0	66.2	58.6	91.7	55.1	122.5	104.8	38.4	93.9	63.1	58.9	63.7	53.8	57.0	54.2	58.9	70.6	111.7	89.7	64.8	203.9	140.4	163.0	91.9	174.2	90.2	62.9	53.9	139.1	130.5	96.5	62.1	68.5	75.4	186.6	54.5	100.7	47.0	121.9	49.9	54.5	87.2	90.0	84.0	51.4	118.1	169.8	63.1	91.9	83.7	90.0	104.0	117.2	54.2	104.1	51.7	68.3	63.5	61.0	129.7	56.9	55.8	59.5	49.7	58.3	79.2	102.7	84.0	140.0	68.0	52.0	37.3	58.8	53.9	49.8	54.6	43.6	36.3	25.5	20.8	44.7	0.0	0.0	0.0	0.0	0.0	0.0	93.7	67.1	366.4	0.0	700.3	1212.0	418.8	0.0	0.0	0.0	0.0	501.7	525.7	0.0	0.0	59.3	0.0	681.7	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	591.5	0.0	0.0	502.5	0.0	0.0	993.9	0.0	0.0	0.0	0.0	0.0	0.0	364.9	0.0	0.0	0.0
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	"ATP5MF-PTCD1 readthrough"		7	99419749-99466197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"Ciliated cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (1.15e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.84e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.50e-2)"	9.3	10.3	7.5	8.6	9.2	1.2	8.1	8.2	13.0	9.6	12.4	3.6	9.2	8.7	10.4	8.1	14.8	11.0	8.3	18.6	8.3	6.7	14.5	23.6	7.0	7.8	6.2	10.2	9.0	15.6	11.5	7.1	8.3	8.3	12.3	7.2	6.8	13.9	12.1	35.7	8.7	15.0	8.4	6.7	8.3	8.9	14.2	5.4	12.7	8.7	24.8	8.6	14.1	10.4	4.2	8.7	1.8	8.3	6.2	6.1	6.8	5.5	6.1	5.1	14.4	6.3	3.7	10.9	3.8	4.6	9.7	8.8	23.3	9.2	7.3	9.5	3.6	9.0	5.5	8.7	7.9	4.1	8.1	8.2	4.2	4.1	4.8	6.7	5.7	4.5	6.3	7.1	8.7	7.1	3.6	4.0	8.6	13.9	11.1	6.2	11.6	13.1	7.5	9.0	9.6	7.9	7.1	4.8	19.3	5.2	1.9	6.7	6.7	8.2	14.0	8.3	3.6	6.9	9.1	2.4	6.8	6.1	14.2	10.0	8.9	7.6	11.5	5.0	6.5	12.1	1.8	6.3	1.7	5.5	8.3	5.8	3.6	4.6	4.6	8.7	4.2	4.9	6.1	0.5	6.2	4.8	4.3	3.5	6.8	7.5	9.2	8.2	13.0	8.3	6.7	6.2	10.2	8.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401154-118431496	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 1200.8;Distal tubular cells: 2463.7;Hofbauer cells: 1173.9;monocytes: 1183.1;Proximal tubular cells: 1669.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria		NA	NA		590000	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	32.3	42.4	45.3	31.8	46.7	36.0	39.6	38.1	40.4	25.6	39.0	21.1	30.3	33.8	33.9	40.4	27.9	26.5	30.1	85.8	37.5	38.4	55.6	42.6	29.1	41.9	39.2	23.6	31.3	70.1	25.8	31.1	23.6	28.3	26.3	41.5	39.0	71.9	29.5	68.4	20.9	39.5	47.3	27.8	30.7	29.5	17.9	15.7	53.2	33.7	60.2	43.7	30.0	23.6	42.7	54.6	30.8	48.0	32.5	53.5	98.1	21.4	11.1	29.3	28.4	25.4	28.4	23.5	22.0	25.0	20.2	21.5	28.1	34.8	42.6	46.0	23.9	31.7	27.4	29.5	30.8	22.5	34.0	19.4	67.3	10.5	16.9	26.0	38.2	32.3	30.2	29.2	24.9	23.7	23.8	27.1	32.3	30.7	35.7	28.1	38.4	53.4	47.7	18.6	60.6	31.0	36.7	24.6	46.8	52.5	18.5	23.3	17.6	33.2	53.8	16.2	33.9	39.1	35.7	26.6	16.7	18.7	14.3	25.1	16.3	22.3	43.3	12.4	44.6	20.8	28.8	48.0	30.8	27.1	33.3	39.3	42.7	42.9	35.5	49.9	34.6	53.5	40.2	24.0	32.5	31.5	54.6	45.8	98.1	45.3	46.7	38.1	40.4	37.5	38.4	39.2	23.6	28.3	15.7	336.5	314.3	0.0	0.0	0.0	0.0	0.0	0.0	345.3	306.0	579.3	0.0	1200.8	2463.7	680.9	0.0	0.0	0.0	0.0	858.6	734.2	0.0	0.0	238.3	0.0	1173.9	0.0	0.0	0.0	0.0	0.0	0.0	317.5	0.0	1183.1	0.0	0.0	798.2	0.0	0.0	1669.9	0.0	0.0	0.0	0.0	0.0	0.0	837.4	0.0	0.0	0.0
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 3.9;bone marrow: 4.5"	"Cell type enhanced"	"Detected in some"	10	"Cytotrophoblasts: 9.5;Distal tubular cells: 5.0;Extravillous trophoblasts: 7.3;Hofbauer cells: 9.6;Syncytiotrophoblasts: 8.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 2.5"									HPA044629	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA044629: AB_2679028"	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.4	0.7	0.4	0.0	0.4	4.5	0.3	0.6	0.5	0.0	0.2			0.4	0.4	2.4	0.3	0.4	0.4	1.2	0.3	0.4	0.4	0.7	0.2	1.0	0.3		0.5	0.4	0.0	0.4	0.0		0.3	0.0		0.9	0.1	0.7	3.1	0.5	0.0	0.3	0.4	1.0	0.3			0.5		0.1	0.5	0.2	1.2	1.0	3.9	1.2	0.6	1.0	1.1	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.3	1.7	0.3	1.0	0.2	0.6	0.3	0.2	0.0	0.0	0.8	0.6	1.2	0.0	2.0	0.7	0.0	0.0	1.2	0.0	0.0	1.0	0.5	0.5	0.8	0.0	0.0	1.4	0.0	0.5	0.8	1.7	1.6	0.1	0.0	0.2	0.0	0.6	0.0	2.5	0.2	0.1	0.0	0.7	0.2	0.4	0.2	0.0	0.0	1.2	0.8	0.9	0.6	0.6	1.2	0.1	0.3	0.7	1.0	2.3	1.2	0.7	0.6	0.6	0.5	1.2	0.9	0.6	0.5	1.2	1.0	0.7	3.9	0.6	0.7	1.0	0.7	1.1											0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.8	0.0	9.5	5.0	0.4	0.0	0.0	0.0	0.0	1.0	7.3	0.0	0.0	2.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA058978: AB_2683867, HPA060520: AB_2684302"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	23.1	34.5	69.4	19.3	64.3	40.2	34.9	31.0	91.7	21.0	43.0	16.0	26.8	44.1	16.5	39.1	27.3	21.3	20.5	87.5	57.5	44.7	43.0	45.2	15.7	28.6	54.0	41.4	22.1	38.2	17.2	29.2	20.5	30.4	22.1	45.6	20.1	28.9	30.3	117.3	17.3	33.6	24.6	28.5	19.5	25.8	17.5	24.4	18.9	23.6	58.9	30.9	18.4	17.2	51.8	63.1	91.6	91.0	32.8	54.6	98.1	37.9	43.8	38.0	36.1	45.5	47.3	37.5	29.7	33.7	37.3	32.7	37.8	27.0	39.8	31.4	30.4	30.1	32.4	48.9	35.8	50.6	32.9	49.3	44.4	37.1	58.1	30.1	53.6	30.9	49.6	48.8	25.3	27.1	42.9	41.9	53.7	26.9	42.7	41.0	112.7	51.8	76.6	29.7	88.5	83.8	33.3	33.2	36.1	56.8	54.0	32.9	39.3	24.9	46.7	56.0	43.9	57.8	63.8	22.5	14.7	23.0	39.6	24.3	32.8	55.7	55.7	34.4	30.6	24.7	54.8	91.0	55.0	37.5	68.0	41.7	51.8	47.8	42.3	63.1	43.6	54.6	48.4	91.6	32.8	65.0	61.2	46.5	98.1	69.4	64.3	31.0	91.7	57.5	44.7	54.0	41.4	30.4	24.4	205.4	192.2	0.0	0.0	0.0	0.0	0.0	0.0	269.0	169.5	392.6	0.0	537.4	1357.9	448.4	0.0	0.0	0.0	0.0	495.8	570.0	0.0	0.0	86.0	0.0	793.2	0.0	0.0	0.0	0.0	0.0	0.0	158.5	0.0	585.3	0.0	0.0	512.8	0.0	0.0	1064.7	0.0	0.0	0.0	0.0	0.0	0.0	593.8	0.0	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		640000	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	11.6	16.0	16.8	11.4	22.6	8.0	10.4	30.7	28.8	10.7	30.0	10.4	11.3	16.1	14.4	10.7	21.1	13.7	9.7	57.1	16.4	15.4	30.5	26.2	10.2	14.2	16.1	15.5	12.6	15.3	18.0	13.3	16.3	22.8	13.4	17.8	9.8	20.4	12.4	83.6	9.7	25.4	13.7	13.9	13.7	13.1	11.4	10.1	18.7	18.6	34.0	15.4	15.5	11.5	8.3	10.8	4.3	10.0	5.9	11.9	22.9	15.3	3.5	13.0	10.1	8.4	7.6	8.4	17.0	18.8	17.7	14.7	6.2	7.8	20.9	15.8	11.1	3.8	16.0	18.9	21.0	15.8	16.6	7.4	20.9	4.9	4.1	6.1	26.3	21.1	6.6	9.0	19.4	18.2	4.1	14.1	2.9	18.4	9.2	10.1	7.1	44.9	6.1	9.9	4.0	24.0	11.6	40.6	8.2	14.0	5.2	9.5	3.0	13.2	18.9	13.9	3.1	15.2	9.5	13.6	8.3	14.7	16.2	16.8	12.7	12.1	49.8	20.1	20.0	15.5	1.9	10.0	4.3	9.7	6.4	8.6	7.5	10.8	9.2	10.8	8.3	11.9	7.3	2.9	5.9	5.0	5.9	9.0	22.9	16.8	22.6	30.7	28.8	16.4	15.4	16.1	15.5	22.8	10.1	62.5	73.9	0.0	0.0	0.0	0.0	0.0	0.0	136.5	105.8	118.7	0.0	297.5	391.3	205.2	0.0	0.0	0.0	0.0	172.3	335.0	0.0	0.0	82.5	0.0	328.7	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	172.3	0.0	0.0	151.6	0.0	0.0	348.8	0.0	0.0	0.0	0.0	0.0	0.0	290.7	0.0	0.0	0.0
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 968.2;Proximal tubular cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria		NA	NA		1600000	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	38.8	38.5	54.3	28.6	48.6	25.6	37.8	34.5	50.4	30.0	52.9	19.6	33.2	46.6	25.8	47.4	58.9	25.7	31.0	143.6	47.7	44.8	78.8	86.2	24.8	29.2	45.7	39.2	28.5	43.3	38.5	29.8	35.4	40.3	33.1	53.1	35.4	56.8	36.3	184.2	35.5	59.9	39.1	32.8	32.7	40.4	15.7	21.3	30.3	48.7	88.5	33.7	45.8	29.0	72.5	100.7	90.9	103.8	54.9	100.0	86.2	63.5	55.8	42.8	55.7	69.8	85.4	57.5	54.7	72.2	61.4	58.6	43.6	50.0	43.1	36.4	68.4	57.9	58.0	51.5	71.7	82.4	20.9	43.7	44.0	46.5	85.9	68.7	56.0	28.9	72.5	57.1	49.9	71.4	49.1	81.7	33.7	45.8	58.8	75.4	61.7	55.4	63.0	32.6	146.1	79.4	39.4	124.0	79.9	126.9	62.2	43.1	47.4	64.6	103.0	87.1	66.8	102.1	57.2	42.1	76.5	53.5	66.4	63.8	47.3	37.3	44.1	68.5	56.3	49.2	67.2	90.5	90.9	58.3	103.8	67.4	72.5	100.0	71.6	100.7	57.6	90.9	83.5	50.7	54.9	83.1	89.8	94.6	86.2	54.3	48.6	34.5	50.4	47.7	44.8	45.7	39.2	40.3	21.3	160.8	115.9	0.0	0.0	0.0	0.0	0.0	0.0	186.0	188.8	246.0	0.0	327.6	968.2	259.9	0.0	0.0	0.0	0.0	330.1	269.2	0.0	0.0	81.4	0.0	401.2	0.0	0.0	0.0	0.0	0.0	0.0	121.7	0.0	364.3	0.0	0.0	268.3	0.0	0.0	714.6	0.0	0.0	0.0	0.0	0.0	0.0	281.2	0.0	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 2012.7;Proximal tubular cells: 1143.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031069	Supported		Supported	Mitochondria		NA	NA		720000	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	39.8	46.8	49.0	20.3	43.6	23.0	32.6	30.8	46.6	25.9	48.6	26.1	22.4	43.0	24.0	57.4	45.2	21.6	19.2	148.9	41.1	37.1	72.8	111.0	18.7	22.2	47.0	27.0	23.9	37.4	31.2	37.5	33.9	45.7	32.6	47.9	33.9	47.1	37.5	164.7	18.7	57.9	46.9	32.8	25.0	37.6	21.0	25.8	31.4	32.1	69.9	29.9	42.0	23.1	87.8	102.4	80.9	91.5	69.1	95.2	112.2	41.8	30.1	38.4	43.1	41.4	38.1	47.7	37.0	43.1	36.2	35.4	69.1	33.0	51.5	24.5	36.5	57.9	22.9	51.4	44.4	39.9	45.0	54.6	107.4	61.2	68.6	46.8	78.4	35.2	37.2	54.8	34.6	31.1	49.3	42.0	49.8	67.0	63.4	52.8	46.7	54.3	79.4	69.0	94.8	54.7	42.5	74.7	97.3	77.2	57.2	43.9	48.8	62.2	62.9	57.0	56.8	45.5	70.7	31.7	27.7	33.2	25.8	31.8	63.3	103.5	65.2	42.5	82.1	34.7	69.2	88.8	80.9	60.3	91.5	64.0	87.8	80.2	74.6	102.4	71.6	79.6	78.0	56.9	69.1	89.7	96.4	95.2	112.2	49.0	43.6	30.8	46.6	41.1	37.1	47.0	27.0	45.7	25.8	157.8	157.2	0.0	0.0	0.0	0.0	0.0	0.0	261.0	194.5	397.8	0.0	553.9	2012.7	380.3	0.0	0.0	0.0	0.0	410.7	419.1	0.0	0.0	101.1	0.0	458.5	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.0	395.0	0.0	0.0	402.6	0.0	0.0	1143.7	0.0	0.0	0.0	0.0	0.0	0.0	592.2	0.0	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915980	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 1520.3;Proximal tubular cells: 981.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		4000000	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	32.6	26.8	49.3	27.7	43.5	34.9	37.8	35.0	44.8	28.7	45.0	21.6	24.2	48.2	25.1	34.3	44.2	28.9	30.3	139.4	40.8	36.7	61.3	57.5	20.6	31.5	45.6	38.4	38.0	40.1	29.5	19.2	25.1	46.4	32.5	52.4	27.2	38.8	28.6	130.6	28.7	57.5	34.8	29.3	27.3	43.2	25.4	20.1	42.7	37.4	98.0	36.2	39.4	26.5	71.9	94.0	48.5	71.5	46.8	73.3	112.2	41.5	19.5	54.4	53.3	37.4	48.0	60.6	23.8	41.8	40.1	39.3	57.2	40.4	55.8	20.5	36.1	39.9	23.6	58.6	81.3	47.5	41.5	58.5	83.6	31.2	56.8	43.1	63.3	29.0	48.8	49.8	38.8	63.7	45.2	55.1	46.1	67.1	72.4	51.5	42.8	48.2	62.2	62.1	105.6	57.8	49.8	53.8	105.2	109.8	37.0	44.0	25.5	40.9	61.2	54.1	49.3	61.7	70.0	31.1	26.4	31.5	47.0	26.9	47.8	52.2	58.4	48.6	108.7	38.0	33.4	69.9	48.5	44.5	71.5	53.0	71.9	58.8	52.9	94.0	59.0	73.3	61.5	17.2	46.8	62.6	55.9	70.1	112.2	49.3	43.5	35.0	44.8	40.8	36.7	45.6	38.4	46.4	20.1	226.3	164.6	0.0	0.0	0.0	0.0	0.0	0.0	187.4	223.0	211.1	0.0	511.4	1520.3	335.0	0.0	0.0	0.0	0.0	367.3	532.1	0.0	0.0	105.8	0.0	543.7	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	380.5	0.0	0.0	302.9	0.0	0.0	981.3	0.0	0.0	0.0	0.0	0.0	0.0	453.3	0.0	0.0	0.0
ATP5S	"ATPW, HSU79253"	ENSG00000125375	"ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)"	Q99766	14	50312326-50335558	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 234.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046967, HPA062690"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA046967: AB_2679880, HPA062690: AB_2684836"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (5.73e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.37e-8)"	"unprognostic (5.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.95e-1)"	5.5	5.0	8.4	6.0	12.5	10.0	7.0	5.6	11.0	5.9	5.2	13.9	7.9	9.4	7.0	7.6	7.9	6.0	5.7	9.0	8.8	9.0	6.8	5.0	5.4	6.6	10.0	10.5	6.3	7.3	3.3	11.2	3.5	10.1	5.6	4.6	8.3	5.6	4.7	11.6	11.7	6.5	3.6	12.4	5.4	5.4	19.8	10.3	5.1	10.1	8.0	6.1	5.1	5.1	17.0	14.2	15.4	14.1	9.2	12.9	9.6	7.9	2.0	3.8	2.1	4.7	8.5	12.0	2.9	3.7	5.0	7.3	3.3	6.0	9.1	2.7	4.7	3.4	4.9	1.3	2.7	3.1	5.2	2.4	4.8	4.1	13.9	1.1	7.1	7.4	7.6	6.7	0.7	1.4	2.1	3.6	6.7	1.6	16.1	3.4	7.2	1.7	5.3	2.5	6.3	4.2	5.2	5.6	4.7	2.4	11.4	5.5	3.5	2.4	7.6	5.4	1.6	8.1	3.7	2.2	6.4	9.1	3.9	3.0	8.1	5.3	5.3	1.0	5.4	5.1	9.8	10.4	15.4	11.4	11.4	10.0	17.0	9.4	11.0	7.7	14.1	11.9	12.9	1.1	9.2	14.1	14.2	10.8	9.6	8.4	12.5	5.6	11.0	8.8	9.0	10.0	10.5	10.1	10.3	20.8	20.5	18.2	24.5	13.6	25.6	57.7	17.8	37.5	22.7	24.4	21.6	30.9	28.2	25.5	234.6	18.6	18.0	23.3	37.3	20.1	16.7	20.9	40.5	21.2	25.1	35.0	23.7	16.5	23.7	98.5	24.7	26.0	15.1	31.5	21.0	27.3	25.0	14.4	15.6	28.9	61.8	19.4	18.6	38.2	20.6	17.9	34.9	23.2	26.8	30.3
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 40.6;SK-BR-3: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.3	1.5	0.0	0.0	40.6	0.6	0.0	0.0	0.0	0.8	1.0	1.0	0.8	0.0	0.6	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.4	2.0	0.0	1.2	0.3	1.5	1.0	0.6	0.4	0.8	0.7	3.3	0.0	0.9	1.1	1.3	0.3	14.5	0.4	5.5	1.4	2.1	0.2	0.5	1.0	0.6	0.5	3.5	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4	0.0	1.6	0.0	4.2	0.3	0.0	1.0	0.0	2.7	2.3	7.0	0.0	101.4	38.1	0.0	0.6	0.1	0.0	0.0	0.2	23.0	0.5	0.6	2.3	0.0	12.0	0.0	39.9	0.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	2.0	141.4	0.0	0.6	0.3
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 73.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	20.6	32.0	32.9	7.5	34.5	7.9	14.0	15.9	31.0	11.1	15.2	16.1	9.3	12.0	7.8	10.8	10.6	9.8	9.0	73.4	22.3	20.8	33.3	31.9	7.5	8.6	28.2	24.9	10.6	18.8	39.5	14.6	11.0	28.5	11.6	16.9	11.9	15.9	10.8	66.9	5.7	11.7	12.7	18.6	6.9	12.8	13.4	18.2	10.8	13.0	13.1	9.4	9.8	6.1	3.1	2.4	5.8	4.2	9.2	6.6	1.8	20.8	17.0	23.0	20.5	25.2	20.4	19.3	15.6	19.6	23.5	19.0	13.6	9.1	12.4	21.0	19.7	20.9	16.2	36.2	20.3	31.8	27.1	28.6	21.9	21.2	23.6	20.3	21.6	1.3	19.9	24.4	25.1	22.0	18.8	14.7	23.3	10.0	24.6	17.9	18.9	31.8	12.0	36.2	18.1	25.7	13.8	6.2	26.9	26.8	16.6	27.3	20.4	26.5	28.2	40.7	27.8	26.0	30.5	12.7	8.1	20.0	16.2	21.2	30.6	27.7	8.5	13.3	8.4	15.1	0.0	2.5	5.8	3.5	4.2	4.6	3.1	3.7	4.0	2.4	1.7	5.2	2.4	2.1	9.2	1.7	1.8	6.6	1.8	32.9	34.5	15.9	31.0	22.3	20.8	28.2	24.9	28.5	18.2	3.0	15.2	20.4	17.4	8.4	34.1	236.9	22.9	8.1	12.5	29.6	25.5	54.8	145.9	19.3	241.4	11.3	22.6	0.0	17.5	23.1	16.9	15.2	16.1	37.5	32.6	44.5	18.5	8.0	16.4	261.4	17.5	11.1	23.6	10.8	33.8	29.9	12.2	10.5	25.1	85.7	23.3	25.8	29.3	25.6	40.1	11.8	39.2	12.5	43.6	16.1
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948992	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA		33000000	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.9	11.7	8.6	0.7	15.9	0.3	2.1	2.2	26.0	0.9	2.3	2.1	1.1	0.8	12.0	1.1	1.5	1.0	0.8	2.9	9.3	5.8	4.8	2.9	0.6	1.0	4.0	15.7	17.5	2.3	0.3	11.1	3.3	8.4	6.9	0.9	2.0	1.8	8.3	3.8	0.6	1.0	13.4	2.0	0.8	0.9	13.0	2.5	0.0	2.0	0.0	0.9	1.1	1.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	20.5	0.0	0.0	0.0	0.1	0.4	3.0	4.4	0.1	0.1	0.0	1.4	0.5	4.2	0.0	1.1	0.0	3.5	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	8.6	0.0	8.6	0.0	6.9	9.4	0.2	8.0	0.0	6.7	0.0	0.1	5.9	13.7	8.9	3.1	0.0	3.4	9.9	0.0	0.0	0.2	3.8	1.2	0.0	0.0	0.0	2.5	0.0	2.9	11.3	0.0	3.3	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	15.9	2.2	26.0	9.3	5.8	4.0	15.7	8.4	2.5	0.0	0.0	0.0	0.1	0.6	40.4	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.6	37.4	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.0	0.0	2.2	9.5	0.0	32.5	3.2	28.8	1.4	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.7	0.3	4.4	0.0	0.4	41.3	5.3	0.1	0.2	0.0	0.0	0.0
AURKAIP1	"AIP, AKIP, FLJ20608"	ENSG00000175756	"Aurora kinase A interacting protein 1"	Q9NWT8	1	1373730-1375495	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Late spermatids: 2457.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031821	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA031821: AB_10601458"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.31e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.34e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.84e-1)"	26.6	29.3	30.3	19.6	30.5	20.9	16.3	17.8	40.5	14.1	27.9	18.7	18.3	33.5	14.3	18.3	25.0	14.5	22.9	55.2	25.3	23.4	35.0	59.1	14.4	17.6	29.0	23.0	14.8	41.2	16.8	18.7	23.6	21.9	17.2	13.6	20.0	35.8	20.4	115.9	20.2	29.5	15.9	18.5	16.9	24.7	73.8	12.6	16.0	27.1	41.4	20.7	18.2	15.2	53.4	81.9	82.5	67.5	36.1	61.6	59.2	38.9	23.7	13.0	23.3	11.5	14.6	24.0	23.7	15.8	37.6	26.8	41.5	36.2	20.6	35.4	16.0	18.9	28.9	17.8	31.4	10.9	24.7	50.3	16.6	31.0	38.3	22.7	21.4	22.6	19.1	14.2	26.3	10.7	11.0	20.4	19.7	32.7	28.5	21.8	29.7	26.2	76.5	24.6	24.6	67.5	30.7	16.0	44.2	29.7	10.4	41.8	31.3	17.0	59.4	56.3	8.3	25.7	50.1	15.2	23.3	29.9	27.7	34.9	37.3	34.0	43.2	32.5	31.7	15.7	60.8	67.5	70.6	51.1	53.6	48.4	53.1	53.9	53.7	58.0	53.4	50.7	49.3	82.5	36.1	46.0	81.9	61.6	59.2	30.3	30.5	17.8	40.5	25.3	23.4	29.0	23.0	21.9	12.6	44.7	60.9	130.3	137.2	144.1	107.1	195.9	180.9	89.7	56.9	157.1	60.9	351.3	573.6	261.8	1001.4	114.7	553.0	116.8	362.4	394.1	140.0	198.9	86.5	355.2	260.5	98.5	195.6	106.2	140.4	2457.2	126.0	155.3	205.8	225.4	267.9	199.3	331.2	287.5	111.4	527.2	88.0	155.2	136.5	419.6	143.7	172.8	366.4	100.2	314.0	225.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.5	1.0	0.4	2.2	0.2	0.1	1.0	0.1	0.0	0.3	0.7	3.5	0.5	0.5	1.0	0.0	0.4	2.0	2.7	2.2	0.2	8.2	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.9	0.1	0.5	0.8	0.0	2.0	1.6	0.7	0.2	4.9	0.0	0.7	0.6	0.2	2.0	0.4	0.6	1.0	1.4	0.6	1.4	1.8	1.6	1.0	0.5	0.9	7.6	0.1	0.1	0.5	2.8	0.5	0.3	0.6	5.0	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3	0.0	2.6	0.0	0.7	1.1	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.4	1.7	1.0	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	6.1	0.1	0.0	0.2	0.5	2.6	1.3	0.5	0.5	0.3	0.4
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	23.1	23.2	35.3	12.6	30.7	17.7	20.6	15.9	43.9	21.2	25.7	22.7	20.1	24.0	18.3	19.7	18.8	23.2	22.5	30.3	32.7	23.8	21.4	22.3	17.7	14.3	29.6	20.2	18.8	26.9	19.4	15.2	24.9	18.4	22.9	13.6	23.1	39.9	27.0	23.9	20.4	21.1	17.2	22.9	14.9	37.8	18.6	14.8	19.3	29.2	15.8	14.1	18.2	14.4	26.5	42.0	43.5	32.3	24.0	30.7	23.1	32.3	30.4	8.9	13.4	10.8	13.2	13.1	13.8	16.1	21.2	16.9	18.5	18.6	6.9	24.8	12.8	16.6	17.2	5.8	21.7	4.2	27.0	21.3	8.6	27.6	8.8	16.7	7.5	16.2	12.7	18.7	16.3	10.0	16.2	13.4	15.3	3.3	15.0	9.2	32.1	16.7	16.9	3.5	9.3	38.9	15.9	5.2	19.5	12.9	15.3	18.4	24.7	13.9	16.5	16.8	3.5	24.7	11.2	11.0	26.0	17.6	40.3	15.1	28.6	21.2	7.1	21.3	5.4	14.2	32.5	32.3	43.5	25.3	24.0	25.8	26.0	26.9	24.6	22.5	26.5	19.4	20.0	41.7	24.0	22.6	42.0	30.7	23.1	35.3	30.7	15.9	43.9	32.7	23.8	29.6	20.2	18.4	14.8	29.8	43.4	37.4	59.5	91.7	63.3	42.1	63.7	49.5	20.5	50.6	17.7	138.0	116.0	88.3	29.3	45.0	146.4	23.3	96.2	163.4	112.5	51.0	24.2	45.0	63.9	44.5	99.9	51.0	25.6	67.7	68.7	35.1	104.6	69.5	94.0	52.4	95.9	140.3	80.2	115.9	36.1	58.2	78.3	87.6	27.7	104.1	213.3	43.6	85.3	55.6
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	11.8	34.1	6.7	10.9	7.7	3.8	15.0	15.0	10.7	11.9	16.7	11.3	15.8	10.2	12.9	9.8	24.6	11.9	15.2	25.1	6.8	6.9	22.6	8.0	19.9	16.3	9.8	7.8	22.3	42.6	9.0	12.3	27.5	22.0	16.8	12.1	6.3	24.7	17.2	23.3	9.8	10.3	17.5	7.6	10.9	22.8	15.9	10.7	12.5	19.1	23.3	16.7	29.2	12.2	15.0	18.2	1.8	9.8	8.8	15.4	7.1	17.5	21.1	5.6	11.9	23.4	7.9	10.0	7.8	4.0	9.6	9.4	21.2	10.8	20.7	8.9	6.9	3.0	8.3	8.6	13.6	4.8	12.8	21.9	7.6	9.5	1.4	22.7	10.2	7.1	11.5	8.7	7.1	10.3	9.4	13.3	16.0	9.6	12.7	3.5	21.0	13.9	10.8	4.9	27.9	10.3	21.2	9.7	22.8	9.1	72.7	30.3	8.6	11.8	19.5	5.7	4.1	12.4	5.0	7.4	9.4	9.0	11.0	9.7	12.0	15.9	9.9	5.1	16.0	6.1	0.0	8.7	1.8	9.7	9.8	13.6	15.0	11.7	12.4	16.1	12.8	10.8	9.6	0.4	8.8	3.7	18.2	15.4	7.1	6.7	7.7	15.0	10.7	6.8	6.9	9.8	7.8	22.0	10.7	26.8	34.4	9.0	26.7	5.4	8.2	22.1	20.4	6.7	13.6	12.2	19.6	54.6	61.3	34.2	5.8	13.5	15.6	0.0	18.6	15.8	11.7	16.4	23.1	8.3	23.4	1.6	19.1	12.3	4.7	6.2	16.1	8.6	23.6	33.3	25.8	5.6	19.8	14.0	28.3	28.2	11.2	19.4	16.1	7.0	17.1	6.1	38.3	7.0	30.3	40.4
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
BCKDK		ENSG00000103507	"Branched chain ketoacid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA017995: AB_1845309, HPA056067: AB_2683024"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	15.4	29.7	11.9	13.1	15.0	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16.0	19.9	11.2	9.3	8.0	11.7	25.9	10.6	15.3	12.0	6.9	26.8	26.6	33.0	6.3	6.8	13.6	18.2	20.5	11.6	17.4	14.3	14.4	12.6	15.9	19.6	24.8	24.3	13.4	12.2	17.1	23.1	19.8	12.1	12.7	8.2	27.7	16.0	13.8	25.4	18.5	13.9	24.3	25.2	9.6	17.0	21.1	11.2	21.2	17.7	22.8	26.4	13.1	9.3	16.2	37.1	31.1	8.8	12.7	9.8	8.5	16.6	17.9	16.9	31.5	18.9	12.6	17.9	16.4	12.3	30.5	9.9	10.4	18.4	9.2	16.9	18.9	10.9	19.4	13.2	16.9	6.0	6.1	21.5	13.9	17.7	12.2	33.0	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5.0	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15.0	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3	17.9	17.8	27.4	21.2	16.5	11.0	32.1	25.5	13.4	9.1	19.2	0.0	47.3	68.0	57.7	2.2	20.9	39.3	0.0	68.3	54.7	20.7	26.1	33.4	34.7	83.9	11.1	19.1	27.0	41.9	3.6	19.2	56.7	11.8	95.6	20.5	22.1	49.3	40.3	24.1	65.3	7.2	45.3	28.9	16.7	15.2	24.0	58.0	14.4	26.7	19.3
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	30.8	21.4	25.1	16.4	34.3	57.0	40.7	27.7	40.7	28.2	22.6	37.0	13.0	31.3	18.7	12.2	36.9	31.5	35.9	26.9	27.0	23.7	42.6	39.3	40.6	17.8	43.4	24.3	11.5	28.5	17.5	22.8	29.0	33.4	24.8	21.4	31.5	33.8	21.5	21.9	26.1	30.4	19.2	28.8	26.6	28.0	30.2	38.4	56.4	25.8	15.4	20.7	24.5	22.4	3.9	7.8	17.0	8.9	12.5	27.2	16.5	64.0	38.2	7.1	6.8	38.0	27.5	22.6	15.3	25.1	16.1	15.4	90.1	31.1	10.5	39.2	22.1	31.2	21.7	9.4	43.4	11.4	11.0	2.4	48.0	8.2	44.8	28.5	4.8	28.5	19.7	18.1	20.3	44.2	21.8	23.0	18.4	29.7	8.0	54.3	18.3	14.1	4.6	9.7	31.8	34.1	8.9	21.3	33.3	65.8	17.9	18.3	8.6	18.8	18.6	8.8	13.5	36.9	5.5	31.8	20.3	23.5	8.1	27.5	5.3	29.7	8.7	29.9	21.1	12.8	17.0	8.1	15.4	27.2	8.2	21.0	3.9	12.4	18.1	7.8	3.7	5.7	13.0	9.8	12.5	8.9	4.7	13.8	16.5	25.1	34.3	27.7	40.7	27.0	23.7	43.4	24.3	33.4	38.4	14.9	11.6	8.2	49.1	16.4	21.1	9.0	101.9	21.4	5.7	36.6	43.2	22.9	72.9	88.0	6.3	31.5	38.7	93.5	56.7	9.6	15.0	56.5	12.7	32.5	33.2	27.0	23.7	20.9	17.2	4.2	17.5	12.2	16.9	127.2	22.5	15.8	125.9	17.5	40.3	57.4	27.1	45.3	20.2	26.5	12.6	8.5	15.8	30.5	18.5	125.1
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168447	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	10.0	7.9	4.9	18.9	5.6	24.8	17.9	1.6	4.7	6.9	15.7	5.1	17.7	5.3	7.9	6.6	10.8	7.8	10.3	7.0	3.8	3.0	14.6	16.3	9.7	46.7	5.5	4.1	12.2	15.1	12.2	21.3	13.3	4.6	8.6	8.8	7.8	11.4	21.8	13.9	6.2	13.7	3.8	4.2	31.5	7.2	19.1	5.5	40.4	32.3	8.6	16.0	10.3	11.8	4.9	3.4	8.3	8.2	2.4	9.5	2.2	3.5	1.4	5.1	4.6	4.0	2.1	13.7	0.6	1.0	1.4	1.4	3.7	11.0	13.8	3.4	0.5	8.9	4.1	4.3	1.6	1.0	10.6	8.7	16.6	3.5	4.5	2.1	6.1	4.3	2.1	4.6	1.9	1.7	3.3	2.0	6.7	8.7	21.2	0.3	2.8	7.3	6.2	5.9	3.3	3.5	8.7	4.5	18.2	1.9	6.0	4.7	11.8	4.9	6.3	3.8	3.3	2.7	13.7	0.9	0.9	6.0	1.8	1.8	41.9	8.1	19.6	1.3	4.4	0.7	6.1	5.6	3.3	2.6	3.8	3.0	4.9	3.9	3.1	3.4	3.2	2.7	2.1	8.3	2.4	8.2	0.7	9.5	2.2	4.9	5.6	1.6	4.7	3.8	3.0	5.5	4.1	4.6	5.5	3.0	6.9	40.9	14.7	15.5	4.7	16.1	7.6	14.7	6.8	8.7	9.8	3.6	11.6	9.8	85.7	10.8	16.8	46.7	5.8	6.7	8.7	12.8	10.5	10.5	9.4	0.0	20.6	12.3	29.4	27.6	5.5	17.5	21.9	36.9	17.7	15.1	7.7	14.4	3.5	4.6	20.2	0.0	11.3	5.7	17.0	9.5	4.8	23.5	9.8	13.6
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	15.3	17.4	13.3	7.6	14.2	10.9	17.3	13.0	17.4	9.2	11.9	14.8	8.8	8.3	10.5	10.7	14.5	11.7	10.0	18.9	12.7	12.2	18.9	20.9	10.6	9.3	14.4	13.4	10.4	22.0	25.8	12.3	14.1	12.2	11.1	14.1	15.2	12.4	9.5	61.2	15.5	12.4	11.7	13.0	8.3	11.2	22.9	11.5	12.1	13.5	14.5	12.3	14.6	10.2	6.5	11.3	4.7	17.3	10.4	8.3	9.5	13.8	6.2	9.9	9.4	16.6	15.9	13.2	9.9	17.4	14.7	16.8	7.0	9.2	12.0	7.2	14.2	14.8	19.0	11.4	15.3	15.4	11.5	8.7	11.3	5.6	3.6	20.6	15.7	9.8	12.9	17.9	12.6	34.1	18.4	12.8	10.0	28.1	11.3	16.0	9.3	8.0	5.0	7.8	22.4	7.7	8.4	15.3	4.5	15.3	9.6	14.1	8.8	13.1	13.3	23.7	25.8	9.1	15.6	12.8	8.8	4.5	12.5	9.5	9.7	8.8	10.3	13.1	12.1	15.0	3.8	17.3	4.7	4.6	15.6	5.7	6.5	6.2	5.7	11.3	5.4	5.5	4.5	4.4	10.4	11.0	5.7	8.3	9.5	13.3	14.2	13.0	17.4	12.7	12.2	14.4	13.4	12.2	11.5	20.8	11.8	21.7	29.2	21.9	182.7	38.9	12.7	14.7	29.6	17.4	11.8	42.2	44.7	26.6	26.6	14.3	28.3	23.3	27.5	28.8	15.8	31.6	8.1	30.6	23.9	46.1	22.4	12.9	27.2	9.5	13.0	22.7	15.1	58.7	26.7	45.9	28.7	14.4	14.5	33.8	30.9	0.0	15.5	21.7	21.4	23.7	80.2	19.1	22.9	31.8
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 20.3;U-937: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.4	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.4	3.1	9.4	3.5	0.0	15.6	0.3	0.4	4.9	4.7	2.5	2.1	0.1	0.0	5.5	3.6	3.2	4.0	12.3	5.8	1.6	2.9	2.1	4.6	0.5	1.3	6.3	0.0	4.2	0.1	18.6	9.5	8.3	4.1	20.3	1.9	9.0	2.0	14.3	5.8	4.8	9.9	4.3	3.8	0.5	2.0	0.2	12.5	10.3	0.1	0.3	1.8	0.0	9.8	4.8	9.1	0.1	0.3	35.0	0.6	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6	3.0	6.5	8.0	8.1	8.2	20.4	35.0	17.8	49.5	10.3	12.2	19.6	1.6	44.7	4.7	7.8	1.5	56.7	0.0	4.9	3.6	5.1	6.8	1.1	92.8	7.2	17.5	26.2	4.9	3.3	10.3	5.2	5.5	15.1	0.0	38.7	16.2	2.2	31.6	3.9	12.1	32.8	0.0	5.4	14.1	4.7	9.5	1.6	9.6	56.2	11.9
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	NA	NA	16000000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.7	0.2	0.0	2.4	1.9	0.0	22.7	4.4	17.4	13.2	0.0	2.6	0.0	2.1	8.2	0.3	1.0	0.1	0.2	16.7	0.1	0.1	0.0	2.2	0.0	10.1	0.1	0.1	5.9	2.2	3.8	2.2	10.6	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.1	0.0	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	1.0	0.1	0.0	7.5	24.4	4.1	9.4	5.0	0.3	0.0	0.0	9.4	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0	35.7	0.3	0.0	0.2	0.6	4.7	9.6	0.0	0.0	0.0	1.8	3.9	0.2	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.3	4.1	0.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.5	0.0	6.6	0.4	0.7	0.0	0.6	0.0	0.0	0.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 9.0;Ito cells: 19.0"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	21000	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.6	0.1	0.4	0.0	0.0	0.0	2.0	5.6	8.7	0.5	0.3	0.3	6.0	0.0	0.0	0.2	1.0	3.8	59.0	0.0	0.0	30.6	0.0	0.1	0.0	0.0	0.3	0.2	4.2	0.2	0.0	5.3	0.2	0.0	4.4	0.0	25.7	0.0	0.0	3.9	0.0	0.0	27.0	0.0	1.7	0.1	0.8	3.9	13.4	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1											0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.5	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	19.0	1.0	1.8	0.0	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 467.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	17.9	6.9	16.4	11.1	45.7	28.8	13.9	18.2	53.5	17.1	37.9	3.1	8.7	5.5	17.2	34.2	23.9	9.2	8.1	23.4	57.0	3.6	4.5	22.9	7.1	5.4	25.5	2.0	39.8	34.6	18.4	19.3	11.6	56.7	21.8	13.7	10.3	13.4	35.8	7.8	14.2	7.6	5.3	11.3	7.5	7.6	20.8	10.9	17.7	11.7	17.5	15.6	8.8	1.7	13.8	18.8	9.0	4.3	28.6	32.1	13.9	20.0	4.1	19.7	8.9	7.4	48.9	4.1	7.2	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9	80.4	113.7	54.1	47.2	87.7	108.8	31.1	30.6	89.7	69.4	97.7	31.4	24.2	41.4	101.3	153.2	88.4	28.4	467.2	33.9	141.0	136.5	90.8	116.8	23.2	118.2	77.9	115.7	155.9	197.5	155.5	296.6	132.1	101.3	70.3	45.5	412.0	125.0	28.8	326.7	215.8	62.1	142.3	150.4	113.3	98.5	110.7	135.9	55.4	28.1	62.0
BOLA3		ENSG00000163170	"BolA family member 3"	Q53S33	2	74135398-74147994	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 267.6;Distal tubular cells: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046393, HPA053162"	Uncertain		Supported	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Nuclear bodies, Mitochondria"	Cytosol	"HPA046393: , HPA053162: AB_2682063"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.86e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.40e-1)"	18.5	16.1	23.2	11.7	26.0	18.0	20.4	15.6	29.8	11.0	24.0	7.5	12.1	18.4	10.0	13.8	12.6	11.2	12.5	56.8	18.9	21.0	22.0	15.7	14.1	14.7	24.1	18.1	6.9	27.8	12.8	12.3	7.7	17.6	11.5	19.7	11.9	21.5	14.2	57.2	5.9	15.3	14.4	15.8	8.8	16.8	8.2	10.6	7.7	12.1	27.9	11.1	8.9	9.1	14.3	20.7	3.4	9.7	15.2	32.0	13.9	23.4	30.5	11.1	10.9	20.5	19.5	27.5	21.9	12.9	24.4	16.7	39.6	10.9	15.5	20.0	18.9	24.6	12.4	25.5	31.2	21.9	30.4	42.0	19.7	21.2	60.4	18.4	38.6	9.7	15.5	23.9	23.6	29.4	11.2	18.0	34.7	41.2	18.4	26.3	36.1	32.2	28.8	16.3	45.3	46.9	21.2	28.9	31.8	32.2	23.7	16.8	10.0	15.5	25.6	27.0	15.4	14.6	24.5	9.9	20.2	34.5	22.5	43.4	16.9	29.7	21.2	21.3	31.0	18.1	3.4	4.8	1.1	23.2	9.1	25.3	14.3	32.0	24.5	12.1	12.4	28.0	24.1	0.9	15.2	9.7	20.7	27.8	13.9	23.2	26.0	15.6	29.8	18.9	21.0	24.1	18.1	17.6	10.6	8.9	28.0	16.4	39.3	20.1	27.8	267.6	56.0	46.8	30.7	80.3	15.7	50.8	298.4	83.8	13.0	34.9	78.6	186.9	96.3	140.3	38.4	51.5	25.3	87.3	98.4	25.4	73.1	36.2	31.6	5.4	30.5	28.8	94.5	91.0	107.7	29.9	82.6	51.8	43.5	165.7	37.6	19.4	43.8	63.5	96.7	14.8	18.7	29.9	160.6	37.4
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Cell type enhanced"	"Detected in many"	12	"Proximal tubular cells: 218.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		13000	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.9	11.0	18.0	16.0	11.3	10.6	8.6	7.1	12.0	15.9	14.0	13.0	15.0	16.6	14.3	11.7	14.8	13.8	16.2	16.5	37.0	19.7	10.5	8.1	8.3	16.8	3.6	10.0	4.4	8.5	7.6	15.6	23.1	9.8	23.3	13.3	7.2	8.5	24.5	20.5	12.2	6.0	13.4	14.7	24.7	12.8	20.2	16.5	12.8	15.8	17.3	13.6	10.6	5.7	27.5	23.1	17.4	4.9	8.2	19.9	16.5	11.8	13.2	7.1	21.6	13.7	4.3	5.8	22.4	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8	6.0	9.4	4.7	8.7	7.9	11.6	3.9	35.7	45.5	14.8	15.7	19.6	23.1	59.7	24.9	0.4	7.1	17.1	0.0	11.8	27.7	12.2	7.5	2.3	62.1	19.8	15.9	15.4	3.7	1.8	0.7	13.8	10.5	30.4	21.6	10.1	11.0	17.9	10.8	13.1	218.9	7.2	6.5	9.5	6.7	21.5	8.2	11.7	5.3	16.3	6.8
BRD8	"p120, SMAP"	ENSG00000112983	"Bromodomain containing 8"	Q9H0E9	5	138139766-138178986	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001841	Supported		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA001841: AB_1845438"	"unprognostic (1.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (1.73e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-2)"	11.9	14.1	21.0	10.4	22.1	14.0	18.2	28.9	24.8	17.1	15.7	21.1	14.4	11.1	20.0	31.2	13.8	18.9	12.0	11.6	16.5	16.6	15.5	14.2	14.0	13.5	18.5	16.8	24.9	17.8	19.8	37.0	17.7	22.1	17.2	18.4	15.4	14.7	18.5	15.3	16.8	12.8	18.7	16.6	16.4	14.3	54.6	20.7	25.5	20.5	7.7	15.3	14.3	14.0	9.7	10.6	17.8	9.6	20.7	15.3	8.3	11.4	15.0	26.5	42.4	19.3	18.2	24.0	17.8	19.8	25.9	27.3	22.5	25.8	11.5	17.9	16.5	26.6	13.5	27.9	17.2	28.0	20.1	20.7	15.6	35.7	15.2	10.8	9.4	16.5	13.5	11.4	20.5	18.7	20.9	16.4	21.6	13.9	14.9	17.2	12.8	19.1	15.1	11.9	13.3	7.8	18.7	21.9	14.0	17.4	16.9	23.5	11.8	21.3	9.3	16.2	37.5	16.0	17.5	10.2	12.8	14.9	8.8	15.4	13.3	14.7	15.9	9.8	14.0	11.8	12.7	9.6	11.9	14.1	6.9	14.8	9.7	12.0	12.4	10.6	9.6	15.3	15.1	17.8	20.7	7.1	7.4	11.0	8.3	21.0	22.1	28.9	24.8	16.5	16.6	18.5	16.8	22.1	20.7	23.8	28.1	13.4	8.4	6.2	29.9	31.6	12.7	40.2	37.5	26.2	35.3	22.4	16.6	14.7	69.4	21.5	13.6	23.3	10.8	10.9	16.2	15.0	22.1	15.1	10.3	28.6	30.0	11.6	14.2	29.1	29.1	15.4	23.6	36.1	19.4	28.9	14.4	14.4	22.6	9.2	33.8	25.8	10.3	193.0	44.5	6.0	21.2	15.2	18.3	6.7
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993700-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.8	3.2	10.8	12.6	13.7	4.7	6.8	13.4	16.0	3.8	16.8	8.8	2.4	22.5	2.9	3.0	10.7	5.0	9.8	3.0	11.0	10.8	8.3	7.5	3.4	14.2	10.9	10.3	2.2	11.2	9.8	4.0	2.6	10.5	3.8	17.8	4.7	4.1	3.1	2.0	8.0	21.8	3.3	12.6	7.3	9.0	2.6	7.7	11.1	5.4	4.5	17.8	3.6	4.3	2.4	5.7	9.5	2.5	1.5	1.2	0.7	9.4	12.5	4.6	4.3	4.0	2.1	5.0	6.7	1.5	4.0	1.9	7.9	6.5	38.1	7.9	1.7	2.8	11.7	10.8	6.0	3.9	7.0	5.9	17.5	5.6	7.1	0.7	25.4	22.0	0.9	3.5	4.7	2.6	1.9	1.7	13.9	6.0	2.2	4.2	10.1	13.0	11.4	2.5	10.3	4.9	8.3	7.7	8.3	6.2	14.5	6.2	4.0	8.2	9.0	3.0	1.6	16.0	21.0	2.0	3.6	3.8	3.8	6.7	7.4	13.3	46.8	3.8	9.5	9.8	4.5	2.5	9.5	1.2	1.7	1.1	1.8	0.9	0.9	2.4	2.4	0.8	1.2	3.8	1.5	1.6	5.7	0.8	0.7	10.8	13.7	13.4	16.0	11.0	10.8	10.9	10.3	10.5	7.7	8.9	7.2	26.7	7.9	10.9	35.5	6.3	45.9	8.1	5.7	8.7	13.7	8.8	3.3	9.0	23.9	3.0	55.2	0.0	9.2	18.3	5.5	8.0	18.4	25.2	17.3	23.8	7.5	3.7	28.3	128.6	1.1	15.5	10.1	3.6	39.6	13.2	14.1	35.1	3.9	10.9	25.6	0.0	5.9	0.9	8.1	15.9	4.3	8.7	67.9	7.8
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	9.6	21.8	11.9	12.3	11.7	12.3	25.8	22.4	16.7	11.9	15.2	10.9	28.3	13.5	16.0	13.4	9.5	10.8	10.6	10.9	10.3	9.1	15.9	16.5	9.6	7.7	10.4	11.7	15.2	20.8	18.1	18.8	8.7	7.4	15.2	15.3	8.0	16.5	31.0	22.9	14.5	17.0	12.2	9.8	9.8	12.4	22.9	11.8	11.8	18.3	4.4	7.1	13.9	22.3	0.8	0.5	3.0	0.2	0.1	2.0	0.6	6.7	6.5	16.4	12.8	9.1	7.7	14.0	10.2	10.8	14.4	11.4	19.0	6.4	10.5	11.0	10.0	18.2	6.6	14.4	7.3	12.7	9.9	8.9	7.4	6.0	11.2	9.6	5.7	10.4	9.8	6.3	17.1	8.6	10.5	10.7	5.1	15.4	9.7	7.8	9.6	6.5	2.5	8.2	8.3	5.6	19.1	6.7	3.2	4.7	13.9	23.5	7.4	8.3	9.1	8.7	10.6	10.2	15.9	11.2	15.1	12.9	4.1	11.8	8.0	10.3	7.9	2.5	9.2	17.7	3.0	0.2	1.4	1.9	0.2	2.0	0.8	0.5	0.6	0.2	0.4	0.9	0.6	1.5	0.1	0.1	0.5	1.2	0.6	11.9	11.7	22.4	16.7	10.3	9.1	10.4	11.7	7.4	11.8	6.0	10.1	2.9	6.8	8.5	10.1	10.9	12.7	2.7	5.7	5.2	5.9	4.2	0.0	4.7	13.2	7.1	15.1	0.0	9.2	3.7	9.5	10.3	2.3	16.6	3.7	0.0	18.9	11.6	5.0	10.4	10.3	2.5	6.8	5.4	26.5	4.3	10.0	10.5	8.9	11.4	6.7	0.0	6.2	17.9	12.2	9.9	6.9	4.3	13.9	8.4
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.7;U-266/70: 28.3"									HPA051504	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.0	12.4	3.2	22.6	5.2	2.7	7.5	29.0	5.2	8.5	5.7	5.1	4.8	5.2	10.2	10.6	7.4	6.7	7.9	9.5	4.1	3.7	7.5	6.1	15.6	21.8	4.4	3.3	10.3	5.8	12.9	5.5	2.8	9.7	8.8	8.0	11.5	9.3	7.9	2.7	8.0	9.9	8.2	5.3	18.0	7.2	5.1	4.2	13.0	7.0	6.2	26.0	8.5	7.6	20.2	14.9	7.8	9.1	5.1	6.3	4.7	4.8	3.1	6.3	6.7	2.1	3.3	0.4	5.3	14.0	8.4	14.5	1.9	1.9	4.4	5.8	9.5	6.8	4.5	5.0	4.1	11.2	13.7	8.4	6.9	5.8	3.8	4.4	1.5	2.4	7.1	1.3	16.1	5.5	10.0	7.7	8.7	5.5	34.7	3.7	2.1	5.4	2.0	2.3	0.2	3.1	12.8	9.0	13.5	6.0	2.7	6.0	8.5	3.4	1.3	14.5	3.8	6.4	3.0	9.1	3.1	3.6	2.7	8.1	28.3	17.3	7.7	3.1	6.2	7.7	1.2	8.7	1.5	4.2	9.1	3.9	16.2	3.3	3.7	14.9	20.2	2.8	3.4	7.8	5.1	3.6	6.2	6.3	4.7	3.2	5.2	29.0	5.2	4.1	3.7	4.4	3.3	9.7	4.2	8.9	9.3	13.7	6.2	3.4	0.4	2.2	2.5	4.0	9.1	3.5	0.0	2.0	0.0	8.2	0.2	14.0	1.0	23.3	4.9	0.9	2.1	6.9	18.5	2.5	8.1	0.0	1.7	5.5	8.8	0.0	6.1	18.0	6.8	12.6	7.0	17.3	6.6	0.0	4.6	1.7	0.7	0.0	3.9	0.5	1.3	4.0	0.8	7.5	1.6	3.1
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 35.7;Ciliated cells: 49.5;Late spermatids: 23.1;Spermatocytes: 63.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.3;SiHa: 8.5"									HPA038131	Approved		Approved	Vesicles,Microtubules,Mitochondria		NA	No			"Vesicles, Microtubules, Mitochondria"		"HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.7	0.1	2.4	0.2	0.2	1.6	0.2	5.3	0.2	0.7	1.7	0.5	0.4	0.1	0.7	0.4	1.0	0.1	0.0	0.6	1.7	0.7	1.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.1	0.2	0.4	1.7	0.4	0.9	0.4	8.5	0.4	0.1	0.3	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.1	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6	35.7	3.7	0.0	0.0	2.5	0.1	1.1	0.0	49.5	3.4	0.0	0.0	0.0	1.7	0.2	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	12.2	0.8	6.5	0.0	63.7	2.1	1.1	0.0	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299193-49327487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 104.2;tongue: 35.0"	"Cell type enriched"	"Detected in single"	478	"Cardiomyocytes: 47.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"K-562: 9.2;RH-30: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057556			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.0	1.7	0.1	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	3.3	15.3	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	104.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.5	35.0	3.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 12.7;testis: 44.7"	"Group enriched"	"Detected in some"	97	"Early spermatids: 967.9;Late spermatids: 1530.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	127	"basophil: 12.7"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 12.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043022			Approved	Mitochondria		Yes	NA			Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.4	1.1	0.4	0.9	1.2	0.2	1.0	0.8	3.3	0.4	0.7	0.0	1.0	0.3	0.3	1.5	1.2	0.3	0.3	0.5	0.4	1.3	0.5	0.3	0.2	0.2	0.4	0.9	3.2	0.9	0.2	1.2	0.3	4.1	1.1	0.4	0.6	1.8	1.1	0.2	0.4	0.6	0.7	2.0	0.3	0.4	44.7	0.0	0.0	3.3	0.0	0.2	0.4	1.9	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.8	3.3	0.4	1.3	0.4	0.9	4.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	967.9	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1530.3	8.3	0.0	1.7	0.0	0.8	0.0	0.1	0.0	4.9	0.0	0.0	12.9	0.0	10.2	7.8	0.0	0.0	0.0	0.6	0.3
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123232916-123257959	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"		"Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	Yes			"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favorable (7.82e-5)"	7.8	15.7	13.2	11.3	15.1	9.6	9.0	21.6	18.2	14.1	10.8	12.3	11.6	13.8	14.9	16.5	10.7	11.7	11.1	17.4	13.2	15.2	12.1	15.6	10.6	18.8	11.5	13.2	21.3	12.4	8.8	24.6	9.2	15.0	15.1	9.7	13.1	21.2	10.8	14.3	17.7	12.6	10.5	14.2	14.7	11.7	17.3	12.2	80.9	15.3	7.9	15.5	14.3	13.7	23.6	10.0	22.6	4.6	17.1	28.9	10.0	14.2	9.9	11.2	21.9	5.6	6.0	6.8	11.9	7.6	12.1	8.9	10.6	8.5	17.8	10.3	3.8	12.3	10.5	12.1	6.5	11.6	13.3	10.8	21.0	9.7	9.2	12.6	9.7	10.6	6.3	15.8	8.8	18.2	18.7	7.8	25.5	22.1	7.4	8.0	6.2	23.3	18.0	8.5	12.1	15.2	17.4	13.3	16.5	11.3	8.2	23.8	10.3	13.3	6.8	12.4	8.4	10.8	11.4	8.8	13.2	15.8	11.9	12.0	12.2	14.0	16.3	8.6	12.9	17.2	22.6	3.5	14.0	15.9	3.8	19.8	23.6	22.0	21.1	6.0	20.2	28.9	24.7	3.7	17.1	4.6	10.0	18.5	10.0	13.2	15.1	21.6	18.2	13.2	15.2	11.5	13.2	15.0	12.2	38.7	45.0	27.9	34.0	40.3	32.8	41.3	15.3	17.4	20.5	24.4	13.7	36.6	51.4	17.6	17.3	20.3	14.7	23.3	9.4	19.4	29.7	17.7	14.0	27.0	12.6	42.9	9.2	16.5	7.5	5.0	35.1	13.2	23.6	37.9	16.9	33.9	12.4	13.3	39.6	23.9	34.3	12.9	33.9	63.0	26.2	31.6	9.0	44.9	20.0	7.1
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"	NA	NA			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favorable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.1	16.9	10.3	4.9	6.4	11.0	6.4	3.9	7.2	5.9	11.8	5.2	7.0	8.6	3.9	6.3	9.6	10.0	8.2	5.5	10.1	20.3	10.6	16.3	14.8	7.2	15.6	9.7	5.7	9.4	3.6	6.4	17.6	6.6	20.6	13.6	4.8	6.6	6.8	17.3	23.6	8.2	5.7	19.0	10.0	6.3	6.9	9.4	8.0	27.7	9.5	6.5	11.3	14.9	7.6	19.3	8.5	3.3	8.8	4.9	6.5	6.5	13.1	20.1	14.7	10.0	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8	6.0	5.0	6.7	8.5	5.4	16.5	14.9	7.6	13.4	5.7	8.7	0.0	9.7	23.2	20.3	59.5	6.7	9.2	0.0	10.6	10.4	7.6	8.0	9.2	11.6	14.8	7.9	10.9	6.2	8.3	25.4	8.1	7.1	1.7	11.8	10.9	12.3	16.5	3.5	8.1	17.7	13.1	6.5	7.2	23.1	21.2	4.5	7.4	4.9	11.5	7.0
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23094765-23100462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	28.2	35.0	16.3	22.0	18.5	9.2	38.9	11.6	17.3	30.4	28.4	17.0	23.9	22.6	29.9	30.3	32.0	23.5	22.4	29.6	16.3	19.9	36.3	24.6	30.4	37.3	22.4	15.1	25.2	39.4	16.7	28.1	32.2	23.1	27.9	35.8	27.1	28.0	28.1	21.2	20.7	27.4	33.5	20.1	33.8	28.2	33.0	16.7	27.2	40.0	26.3	33.1	25.8	24.0	34.6	37.4	72.7	40.2	30.2	45.0	43.7	13.8	13.7	20.7	12.5	45.7	39.8	16.7	23.2	34.4	30.7	36.6	10.8	21.5	10.5	12.1	37.6	37.3	23.7	19.6	30.8	42.7	16.7	9.6	15.9	11.4	46.2	36.0	23.7	24.8	48.5	27.9	25.8	19.1	28.1	33.5	19.2	10.5	11.8	33.6	19.8	11.1	18.4	13.0	32.2	21.0	9.9	15.4	12.1	34.8	22.3	10.0	9.1	19.4	18.3	20.1	24.1	12.3	13.8	26.9	14.6	12.8	21.9	10.4	11.1	13.0	12.9	13.4	15.1	13.0	63.7	40.2	72.7	32.6	25.7	37.1	34.6	37.2	36.2	37.4	28.5	39.1	38.3	23.8	30.2	17.3	25.2	45.0	43.7	16.3	18.5	11.6	17.3	16.3	19.9	22.4	15.1	23.1	16.7	44.7	41.3	39.3	73.7	23.6	28.7	21.4	30.6	38.8	46.6	29.6	7.9	76.0	109.5	81.1	13.7	45.7	39.3	23.3	74.5	84.3	43.6	40.4	52.1	27.7	93.8	19.1	27.2	43.6	42.9	11.4	59.2	57.9	45.5	111.0	43.7	31.3	81.5	43.2	45.6	76.4	15.4	32.3	37.6	25.0	24.6	29.6	119.7	48.4	45.4	67.4
C18orf63	DKFZP781G0119	ENSG00000206043	"Chromosome 18 open reading frame 63"	Q68DL7	18	74315813-74359187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 17.4"	"Cell type enriched"	"Detected in some"	14	"Spermatocytes: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.1"					"Not detected"	"Not detected"			HPA042233			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042233: AB_10960843"								"unprognostic (1.40e-1)"					"unprognostic (1.43e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	47.2	3.4	0.0	0.0	0.0	0.0	0.0
C19orf70	"MIC13, P117, QIL1"	ENSG00000174917	"Chromosome 19 open reading frame 70"	Q5XKP0	19	5678421-5680896	"Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	13	"Late spermatids: 2933.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	20.2	23.6	32.9	14.5	28.4	13.2	16.0	11.0	29.8	13.0	22.2	13.5	17.8	25.4	12.2	26.8	22.7	16.7	24.0	70.2	27.2	26.5	30.5	38.4	12.7	21.1	32.1	21.1	13.5	24.2	13.2	15.6	12.4	16.9	16.6	11.7	13.6	28.7	22.7	79.1	17.6	20.7	14.7	20.9	14.1	18.2	33.4	12.3	11.6	20.3	45.0	12.6	15.4	11.8	43.6	48.2	11.6	42.2	27.4	39.5	40.7	24.2	20.1	7.0	13.4	16.5	17.1	9.1	16.1	15.3	18.6	15.4	16.0	12.7	10.6	26.2	14.0	9.9	18.1	3.6	22.8	5.3	17.4	38.4	10.3	14.0	17.8	23.3	14.1	13.0	20.0	20.6	10.0	13.9	11.7	13.3	16.3	15.9	33.1	14.0	21.9	21.3	16.8	7.4	17.8	64.4	11.7	8.5	38.7	20.3	15.3	16.4	20.9	4.9	31.8	22.5	4.7	19.4	17.4	13.5	18.3	7.8	33.4	22.7	50.0	33.1	8.4	27.3	22.6	18.5	8.9	35.5	11.6	33.6	42.2	39.5	43.6	38.6	37.2	41.2	35.6	38.1	35.9	5.6	27.4	35.6	48.2	30.9	40.7	32.9	28.4	11.0	29.8	27.2	26.5	32.1	21.1	16.9	12.3	65.5	61.7	101.3	135.8	87.3	47.7	288.5	122.3	167.3	76.2	150.1	25.5	132.2	623.4	178.9	798.0	106.8	325.2	46.7	265.1	165.3	137.3	120.3	92.3	251.0	214.9	17.5	154.8	98.8	146.2	2933.3	115.3	157.0	163.6	263.3	176.9	49.5	211.4	214.0	112.8	383.4	42.2	109.9	170.0	106.7	73.5	109.3	105.3	94.8	219.4	109.5
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 27.7;Spermatogonia: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	3.4	3.1	3.3	7.4	4.9	10.1	5.0	8.4	3.6	5.2	3.2	5.0	2.2	1.5	4.8	3.5	4.0	2.2	1.8	2.3	2.7	2.4	2.6	5.2	2.6	7.4	5.0	1.5	3.3	2.6	20.1	3.7	4.2	4.5	3.2	5.3	4.9	3.3	4.9	1.9	3.1	3.3	3.6	3.6	4.2	3.0	19.7	5.9	24.6	3.2	2.9	9.5	4.0	3.3	2.9	2.7	4.3	4.9	4.9	1.6	1.6	16.5	8.9	11.7	6.0	1.9	2.6	17.3	11.0	5.7	16.2	16.5	9.9	14.6	14.8	5.0	3.6	5.7	13.6	14.6	7.7	18.6	8.7	8.6	14.0	12.0	7.2	0.6	18.2	6.2	0.8	1.1	12.0	2.9	1.9	6.8	9.1	22.5	25.3	13.1	4.0	15.8	5.1	15.4	11.8	6.4	12.0	13.1	10.0	2.2	8.4	8.6	9.0	6.9	11.6	3.6	11.6	11.0	9.5	4.9	13.1	10.4	9.5	14.9	6.9	10.3	15.7	4.9	13.6	12.6	4.3	1.8	2.2	1.3	4.5	1.0	2.9	1.6	1.4	2.7	2.8	0.6	1.4	0.3	4.9	4.9	0.7	1.6	1.6	3.3	4.9	8.4	3.6	2.7	2.4	5.0	1.5	4.5	5.9	0.0	3.5	2.2	2.6	1.5	3.8	0.4	0.0	2.7	1.2	0.0	5.9	6.0	0.0	2.3	5.9	2.1	0.9	0.0	3.0	7.4	2.3	0.8	4.6	3.0	5.0	1.6	0.0	4.3	3.1	3.1	2.0	3.0	3.3	1.0	1.0	2.6	2.5	0.0	3.5	0.4	6.5	6.5	1.2	27.7	17.7	0.9	3.2	1.9	1.6	1.4
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	49.5	77.1	27.3	44.0	20.4	25.2	36.9	38.0	31.1	88.6	54.6	73.7	16.6	106.5	37.7	28.7	32.0	44.4	87.6	51.6	82.0	24.3	150.8	49.0	40.0	85.6	32.5	59.7	39.0	27.7	47.5	48.7	70.4	21.4	45.1	63.3	58.2	27.3	34.4	34.6	84.7	43.2	61.5	56.3	46.1	67.6	38.6	58.1	51.1	37.6	21.9	41.1	31.2	40.2	53.0	28.6	25.4	30.3	26.5	28.5	26.0	32.3	82.6	14.3	21.8	46.8	27.2	57.5	43.6	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2	26.8	23.3	138.5	155.3	215.9	60.0	72.6	68.8	16.0	27.3	78.5	25.5	269.8	265.2	184.9	64.3	105.7	64.2	23.3	178.3	380.4	101.4	99.0	62.2	125.2	179.0	57.2	76.1	74.3	73.1	64.4	110.7	119.7	148.5	174.1	146.5	91.7	174.3	77.2	92.6	338.8	60.8	84.1	121.5	45.2	160.8	223.2	149.7	85.6	301.5	214.0
C21orf2	"A2, LRRC76, YF5"	ENSG00000160226	"Chromosome 21 open reading frame 2"	O43822	21	44328944-44339402	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	18.8	13.4	19.8	11.3	21.6	19.7	9.2	10.3	23.4	13.8	14.7	18.2	14.3	13.4	12.6	19.1	6.9	14.7	13.2	11.3	19.5	16.6	18.0	11.6	12.8	12.4	16.4	19.1	15.2	14.5	7.4	17.6	12.4	13.2	12.3	3.9	14.3	16.1	17.2	21.0	22.3	15.4	5.8	12.6	16.1	21.1	16.7	11.2	10.9	16.4	8.1	13.0	8.1	7.0	10.8	21.7	1.2	8.5	12.1	9.7	4.9	8.0	3.4	3.2	4.2	2.1	1.4	12.9	4.2	2.5	1.7	0.9	6.1	2.4	5.8	8.4	1.4	3.4	3.8	0.6	0.8	0.4	8.8	8.4	6.0	2.7	7.1	2.8	6.5	6.5	2.0	1.5	0.7	1.5	2.9	1.0	4.4	7.3	10.0	1.0	9.9	7.1	15.9	8.1	4.1	5.2	18.1	4.2	12.9	1.9	11.8	8.6	7.9	5.8	1.4	6.9	2.0	6.2	14.3	4.7	3.6	4.7	3.9	3.1	16.3	8.6	4.0	8.9	13.1	6.5	1.2	7.1	1.0	7.1	8.5	8.5	10.8	7.3	9.7	7.3	8.6	8.5	8.2	0.9	12.1	6.2	21.7	4.0	4.9	19.8	21.6	10.3	22.4	19.5	16.6	16.4	19.1	13.2	11.2	3.0	16.5	25.0	18.4	14.4	43.7	2.2	35.7	32.1	9.1	12.2	35.3	25.4	66.3	24.9	73.3	10.0	27.6	0.0	51.4	12.3	38.1	21.2	19.5	18.1	31.3	35.0	31.6	9.2	14.5	196.9	24.5	17.6	40.5	31.5	29.6	34.1	20.6	31.1	29.7	36.0	24.8	12.9	18.9	40.3	10.9	13.6	27.3	20.8	31.8	18.6
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 29.2;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0"									HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA		1800000	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.5	9.1	14.2	18.5	10.4	14.6	11.1	22.2	0.2	43.8	0.3	0.1	0.6	0.2	0.1	8.7	6.5	9.6	21.3	1.2	3.6	11.9	10.6	0.6	0.3	0.1	0.9	4.0	0.7	7.4	0.7	10.6	8.3	13.8	5.0	1.6	0.5	1.2	0.4	1.6	0.6	0.4	0.1	15.5	0.9	0.3	14.6	0.2	0.2	0.5	14.2	0.3	1.0	1.5	9.0	5.6	0.3	11.0	0.1	37.2	31.0	0.9	0.6	2.9	6.7	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1	6.0	3.5	14.3	0.4	14.5	1.9	0.0	17.8	8.1	3.4	0.0	0.0	2.1	0.0	0.0	1.9	2.9	10.6	0.0	0.0	1.6	4.3	0.5	9.2	2.4	8.1	0.0	7.5	16.5	29.2	1.4	9.2	6.0	38.8	0.0	13.3	7.8	0.0	11.5	16.3	0.0	1.5	12.9	0.0	5.2	12.4	12.7	2.2	15.4	27.5	0.1
C2orf49	"asw, MGC5509"	ENSG00000135974	"Chromosome 2 open reading frame 49"	Q9BVC5	2	105337359-105349211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043846, HPA060814"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA043846: AB_2678698, HPA060814: AB_2684372"	"unprognostic (4.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (6.51e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.04e-2)"	15.9	14.8	17.2	15.8	20.4	24.3	17.3	25.6	22.4	19.7	15.0	21.9	19.9	13.4	22.0	13.5	18.6	19.0	14.2	21.3	20.0	16.0	13.4	15.0	14.0	16.9	25.3	19.9	30.7	19.3	13.0	12.0	19.2	18.1	17.2	15.1	12.4	15.9	17.2	28.2	14.3	14.8	18.3	22.9	15.3	19.7	19.2	22.1	26.5	18.8	13.1	18.8	18.1	21.2	16.7	18.4	17.9	13.5	8.2	11.7	6.4	13.6	9.8	12.4	12.5	13.9	17.2	22.1	13.8	14.4	12.2	16.8	21.3	13.7	16.2	17.3	11.8	33.0	13.2	16.9	11.7	15.9	21.0	12.9	17.5	8.4	16.4	17.2	14.5	14.5	12.4	20.5	17.2	15.7	17.5	10.9	12.8	24.3	13.4	17.1	10.7	17.6	16.8	16.2	9.2	11.8	11.8	18.2	18.5	13.7	13.2	14.7	11.7	12.2	11.1	16.1	14.4	10.9	16.4	17.9	13.0	18.3	9.2	11.1	17.0	13.8	17.0	13.0	14.8	12.5	10.2	13.5	11.1	9.4	7.9	9.2	14.3	10.5	9.1	8.8	16.7	11.7	9.8	17.9	8.2	10.6	18.4	11.6	6.4	17.2	20.4	25.6	22.4	20.0	16.0	25.3	19.9	18.1	22.1	14.9	11.0	27.3	12.2	25.8	36.0	25.4	12.7	46.8	22.7	24.4	27.5	18.6	21.6	19.7	30.9	16.9	14.7	0.0	15.8	23.4	13.6	10.4	16.1	19.5	14.3	22.3	10.9	14.1	13.6	30.0	25.6	16.2	6.8	13.6	15.0	37.4	19.7	15.2	27.3	14.3	42.6	19.4	15.5	29.7	29.0	21.7	30.8	18.1	13.6	14.8
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: AB_2681360"	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.6	8.1	13.3	10.0	13.7	6.8	9.0	4.0	5.3	6.7	8.9	7.3	10.6	11.8	6.1	7.3	6.2	9.6	7.3	8.0	7.2	6.2	15.3	20.2	11.9	7.6	11.3	10.8	10.7	10.4	9.3	5.0	13.3	9.7	10.9	13.2	10.2	13.3	6.4	9.9	12.3	10.6	6.4	10.6	7.0	13.8	25.4	11.6	8.6	9.2	17.1	12.3	6.2	8.3	8.0	8.2	9.4	5.5	6.4	4.8	13.3	5.4	3.8	17.2	12.0	11.0	7.1	11.0	5.8	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3	59.6	76.5	21.4	16.8	5.3	17.5	9.3	38.2	25.4	34.2	33.2	33.4	38.5	14.9	14.0	3.3	9.0	23.5	0.0	17.1	14.2	11.3	12.3	32.5	19.2	20.3	23.8	18.5	19.0	31.3	7.0	22.5	24.2	13.5	14.4	15.8	10.8	17.3	10.5	12.7	19.2	23.7	19.4	7.6	37.2	20.6	8.5	20.8	28.0	16.8	17.6
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 262.3;Late spermatids: 107.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA			"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.1	5.1	0.0	0.0	0.0	4.6	25.5	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	8.7	25.5	0.0	0.0	1.8	0.0	0.1	0.0	12.4	262.3	0.0	0.0	0.0	2.9	0.1	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	107.1	1.7	0.0	3.3	1.0	0.0	6.7	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.8	18.1	1.1	0.0	0.0	0.1
C5orf63	"FLJ44606, YDR286C"	ENSG00000164241	"Chromosome 5 open reading frame 63"	A6NC05	5	127042558-127073492	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 32.7"									HPA043240	Approved	Approved	Approved	Mitochondria		NA	NA			Mitochondria		"HPA043240: AB_10962511"	"unprognostic (2.71e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-4)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	4.4	4.4	3.3	10.1	4.6	2.8	5.9	6.8	21.4	2.9	10.9	5.5	3.3	5.6	7.5	4.8	7.6	4.2	3.8	7.3	4.4	4.9	8.0	7.0	4.6	6.8	4.6	4.8	4.4	7.5	9.2	27.7	2.7	6.8	5.5	11.0	11.3	13.7	3.9	6.6	3.3	9.2	3.2	6.2	5.6	6.8	13.8	3.0	8.5	9.0	5.1	9.1	4.9	5.1	11.9	9.8	3.9	1.5	12.3	10.1	2.9	0.5	2.5	0.7	1.4	1.9	3.0	0.4	2.7	0.3	3.3	2.0	6.1	7.7	0.0	11.2	2.1	4.9	1.0	4.7	2.9	4.8	1.0	3.8	6.2	9.4	7.3	4.7	3.6	0.3	3.1	7.5	4.3	2.2	2.4	2.8	2.7	0.4	1.2	3.3	5.0	0.1	3.3	0.4	5.2	1.9	2.7	1.6	4.3	3.7	3.8	6.2	5.1	3.5	1.6	0.2	1.4	6.4	5.4	2.2	7.1	6.5	8.1	1.7	3.8	9.7	0.2	32.7	0.4	3.6	3.4	0.3	3.9	6.7	1.5	5.3	11.9	6.1	7.1	3.0	10.8	9.2	6.8	1.4	12.3	0.4	9.8	10.1	2.9	3.3	4.6	6.8	3.2	4.4	4.9	4.6	4.8	6.8	3.0	6.0	13.2	11.9	9.8	0.9	10.3	29.0	5.1	16.0	3.4	15.7	13.7	9.2	16.6	13.8	20.7	3.3	8.4	0.0	8.6	7.4	2.7	7.2	9.3	8.1	4.5	0.0	10.4	3.7	0.8	12.1	2.3	1.9	8.5	1.8	10.6	10.9	10.6	15.3	2.1	5.1	9.8	6.5	1.7	46.5	13.4	1.0	2.3	4.4	13.2	11.9
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309607	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 329.2;Early spermatids: 104.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.4;SCLC-21H: 4.3"					"Low region specificity"	"Detected in many"			"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.3	0.3	4.4	0.3	11.4	0.3	0.3	0.1	0.8	1.5	0.3	7.5	0.1	0.3	1.0	7.2	0.3	23.9	0.3	0.3	4.3	2.7	0.3	0.3	4.7	0.3	0.3	1.0	3.4	0.3	0.3	10.4	0.3	14.5	0.3	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.3	0.8	0.3	0.3	9.6	3.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.4	0.1	0.8	4.3	2.7	0.3	1.0	14.5	3.9	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	329.2	22.7	0.0	0.0	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.0	0.9	0.0	0.0	0.0	0.0	0.1
C7orf31		ENSG00000153790	"Chromosome 7 open reading frame 31"	Q8N865	7	25134697-25180356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 60.9"	"Group enriched"	"Detected in many"	17	"Early spermatids: 399.0;Late spermatids: 665.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA020346			Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA020346: AB_1845758"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.12e-3)"	"unprognostic (8.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-2)"	2.4	6.2	1.5	4.8	3.1	1.3	2.3	4.0	1.6	3.3	5.1	2.9	2.0	3.3	3.3	2.9	2.4	2.6	3.7	3.1	1.9	1.5	2.6	1.2	2.8	7.0	2.0	2.2	4.6	1.8	4.3	2.1	1.1	2.3	3.2	3.6	4.1	6.0	2.3	0.9	1.8	3.9	2.4	2.9	3.7	3.4	60.9	2.4	5.9	4.6	0.9	3.3	3.5	5.1	3.0	5.9	2.3	1.3	2.8	2.8	0.9	2.8	2.0	4.5	5.2	1.8	1.0	2.5	1.2	4.9	3.7	5.6	3.9	2.7	7.2	1.9	2.2	14.6	1.1	5.0	1.4	4.0	3.4	4.9	3.4	0.2	5.2	4.3	5.5	8.3	3.1	3.9	3.0	0.7	2.6	0.7	6.2	5.1	4.0	0.9	0.0	5.6	7.0	1.8	6.6	1.8	7.0	5.2	1.1	2.5	3.6	1.3	3.8	1.2	4.9	4.6	6.6	0.8	9.2	1.0	2.3	6.2	0.0	1.8	18.0	5.7	10.3	0.7	5.3	10.6	1.4	1.3	2.3	1.7	0.6	2.3	3.0	1.1	1.5	1.7	2.1	2.8	2.2	0.1	2.8	0.8	5.9	2.8	0.9	1.5	3.1	4.0	1.6	1.9	1.5	2.0	2.2	2.3	2.4	0.0	5.3	2.9	2.3	1.0	0.9	1.0	2.5	5.3	0.0	0.0	0.0	2.8	3.3	1.0	399.0	2.2	2.5	0.0	3.4	2.1	2.5	0.9	0.0	1.0	2.4	0.0	4.1	1.8	5.0	665.4	6.6	2.9	3.3	4.6	2.8	7.7	3.2	6.5	4.9	0.6	0.5	0.0	2.1	31.4	12.4	0.5	1.9	4.3	6.0	0.9
C9orf129	bA165J3.3	ENSG00000204352	"Chromosome 9 open reading frame 129"	Q5T035	9	93318199-93346414	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in many"	4	"brain: 12.7;testis: 4.3"	"Group enriched"	"Detected in some"	41	"Early spermatids: 17.5;Late spermatids: 49.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 7.0"									HPA071515			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA071515: "	"unprognostic (1.12e-1)"				"unprognostic (2.46e-2)"	"unprognostic (1.23e-1)"		"unprognostic (9.47e-2)"		"unprognostic (1.25e-1)"		"unprognostic (1.84e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.45e-1)"			0.7	0.6	5.9	1.3	7.2	0.7	0.7	4.7	12.7	1.4	0.8	0.7	0.0	1.1	0.9	2.0	1.0	1.3	0.6	0.9	4.3	5.7	0.6	0.7	0.7	0.7	3.2	9.3	0.6	1.1	0.6	0.6	0.8	4.3	1.0	0.8	0.6	0.6	1.2	1.3	0.6	0.8	1.0	2.1	1.0	1.1	4.3	1.1	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.2	4.7	12.7	4.3	5.7	3.2	9.3	4.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 46.6"	"Group enriched"	"Detected in some"	32	"Early spermatids: 99.2;Late spermatids: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.0;RT4: 14.0"					"Not detected"	"Not detected"			HPA022029			Approved	Mitochondria		NA	NA			Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.2	0.1	0.2	0.2	0.3	1.3	0.3	0.6	0.3	1.0	0.2	0.2	0.2	0.0	2.2	0.8	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.7	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.2	46.6	0.2	0.2	0.3	0.2	0.2	0.3	0.2	1.0	0.1	2.7	0.5	0.9	1.4	0.0	3.4	0.1	0.3	0.8	0.7	0.0	1.0	1.0	0.0	0.0	0.0	0.9	1.8	0.7	0.3	0.0	1.2	2.2	0.0	0.0	0.4	0.3	0.5	1.2	4.0	0.9	0.0	0.4	1.2	0.0	0.5	0.0	0.0	0.0	0.5	1.4	3.4	2.4	0.0	0.5	0.7	1.8	0.6	1.0	0.0	0.0	0.3	0.0	0.3	14.0	0.3	0.0	1.2	0.0	0.5	0.6	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.9	1.3	0.3	0.5	1.5	2.7	0.5	0.0	0.5	0.0	0.0	0.5	0.4	1.4	0.0	1.0	0.5	0.8	1.3	0.9	0.0	0.1	0.1	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	99.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	26.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788409	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.7;fHDF/TERT166: 17.9;hTERT-HME1: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012618: AB_1846000"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.59e-5)"	"unprognostic (2.50e-1)"	"unprognostic (6.89e-4)"	"unprognostic (4.11e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.66e-6)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.08e-1)"	9.3	4.6	10.6	4.9	11.1	4.1	10.2	3.1	7.8	28.7	3.6	11.5	1.4	2.2	9.8	3.7	8.1	9.5	9.1	6.5	9.9	8.2	10.3	7.8	7.3	8.8	12.2	6.7	15.2	4.4	16.8	4.4	3.9	13.1	6.2	4.7	29.5	8.3	6.2	2.0	7.5	4.1	9.4	7.1	5.3	5.4	23.0	8.1	2.3	8.9	10.9	11.6	6.3	9.4	4.3	3.5	2.7	3.6	7.9	13.3	7.0	2.7	1.7	2.0	3.2	5.9	15.7	1.1	2.9	3.7	2.2	3.2	0.8	1.9	0.8	3.1	17.9	4.2	3.0	6.9	3.3	3.9	0.7	3.3	1.5	2.1	0.7	5.8	1.9	3.4	3.6	3.6	2.9	23.5	3.9	3.2	2.3	0.8	2.1	10.3	1.5	1.6	1.5	0.8	0.5	12.5	0.9	1.4	1.4	3.3	2.0	1.7	3.7	4.1	1.5	2.6	2.4	2.1	1.9	4.3	2.6	1.7	13.9	1.6	1.5	1.5	0.9	2.9	3.9	4.8	2.7	3.0	0.3	13.1	3.6	11.4	3.6	13.3	12.3	3.5	4.3	9.8	8.3	1.7	7.9	2.3	0.5	10.0	7.0	10.6	11.1	3.1	7.8	9.9	8.2	12.2	6.7	13.1	8.1	0.0	9.3	7.2	5.3	3.8	8.9	1.6	0.0	17.4	10.3	1.8	15.7	1.4	1.7	3.6	0.9	10.7	0.5	23.3	3.5	1.2	7.2	9.7	2.3	2.4	1.7	1.6	2.9	3.7	7.8	1.3	7.2	9.6	3.3	1.0	2.4	37.2	3.8	0.9	4.9	2.2	8.0	6.5	7.2	3.3	5.9	4.0	1.6	15.9	1.7	6.3
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 21.2"	"Low region specificity"	"Detected in all"							"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4	0.0	0.0	0.0	0.0	0.0	5.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	2.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.0	0.0
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	24.2	10.5	3.7	10.2	3.8	1.8	28.7	1.9	7.1	34.1	9.2	3.9	8.0	5.6	36.0	18.4	13.4	19.7	18.2	17.0	3.9	2.2	5.7	3.7	11.1	15.9	4.8	5.4	32.5	4.5	1.9	4.0	23.6	4.8	18.2	4.0	10.7	7.6	10.0	8.9	8.9	9.0	19.8	5.5	24.4	7.2	14.1	3.1	3.0	11.0	9.2	10.8	19.9	24.1	7.1	36.6	11.2	47.9	14.0	21.5	17.1	5.3	3.8	0.9	1.2	14.3	23.8	4.6	18.8	19.1	5.8	8.2	1.6	2.6	1.6	2.1	21.5	0.3	2.5	1.9	0.0	1.1	0.2	10.8	3.8	1.1	0.3	6.5	0.6	0.3	8.1	0.0	1.7	0.0	10.8	6.8	4.1	0.8	10.0	3.7	12.3	1.4	1.7	2.4	1.1	3.4	4.5	1.5	3.6	0.5	0.4	2.7	1.2	0.7	3.1	1.0	0.4	0.6	1.2	12.1	1.8	2.3	6.4	1.3	1.5	3.5	1.9	15.9	11.8	0.3	11.2	22.7	0.4	21.5	42.2	17.5	7.1	14.8	17.6	36.6	1.5	2.9	11.2	0.9	14.0	47.9	4.2	18.9	17.1	3.7	3.8	1.9	7.1	3.9	2.2	4.8	5.4	4.8	3.1	3.0	1.1	3.4	2.8	4.7	0.0	2.8	2.5	0.0	0.0	3.5	0.0	2.0	0.0	3.1	0.8	20.4	0.0	0.0	0.2	63.7	23.4	0.8	8.1	0.0	47.4	0.0	1.2	28.3	27.5	0.8	42.3	14.7	8.5	1.8	0.0	0.3	0.2	0.0	15.2	0.3	0.0	19.4	29.8	0.7	0.2	3.3	16.0	17.3	0.0	1.0
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987652	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	9.8	6.4	27.0	9.2	25.2	6.4	5.4	63.6	44.9	6.2	8.0	6.4	3.8	7.3	6.2	3.1	8.4	6.8	6.1	8.0	33.8	17.4	5.5	4.2	8.8	6.2	11.7	19.1	6.7	11.7	14.8	21.3	5.1	18.5	6.8	8.0	5.5	8.7	9.1	20.1	8.6	9.0	10.5	6.5	8.7	8.0	9.0	8.8	2.7	6.5	2.9	6.5	6.5	4.7	1.3	2.2	5.7	8.1	1.1	2.7	2.1	8.0	14.4	2.7	3.8	18.1	12.6	5.6	7.8	8.7	7.4	6.6	3.6	2.2	9.5	7.6	12.2	6.3	8.2	10.2	12.2	4.2	13.3	13.2	6.0	7.8	4.0	10.4	3.5	25.8	8.7	15.3	7.0	11.0	9.0	12.3	7.4	9.7	8.7	6.9	5.3	6.2	2.2	0.4	9.6	6.0	5.4	3.0	3.7	8.4	8.5	3.7	3.2	4.9	9.0	2.4	4.8	7.9	3.5	16.3	5.9	3.5	6.2	12.7	4.4	4.7	3.4	14.4	7.0	5.7	1.0	2.2	1.8	2.7	3.0	2.1	1.3	1.2	2.5	1.4	0.9	1.8	2.0	5.7	1.1	8.1	2.2	1.1	2.1	27.0	25.2	63.6	44.9	33.8	17.4	11.7	19.1	18.5	8.8	3.0	13.7	8.3	3.5	6.2	12.1	5.9	15.3	5.3	3.4	10.4	9.8	5.2	1.7	6.8	29.0	6.9	16.3	0.0	9.8	6.8	6.8	5.5	12.7	11.9	7.7	33.4	10.9	14.1	9.2	39.5	9.5	8.0	3.3	8.2	13.1	4.3	9.1	12.4	8.9	10.5	9.6	12.9	12.3	5.2	7.6	9.2	10.4	10.2	9.5	3.4
CARD16	"COP, COP1, PSEUDO-ICE"	ENSG00000204397	"Caspase recruitment domain family member 16"	Q5EG05	11	105041326-105101431	"Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 126.3;lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 242.8;Macrophages: 269.3;monocytes: 172.3;Paneth cells: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.8;HHSteC: 68.1;HUVEC TERT2: 31.2;TIME: 28.5"									"HPA053981, HPA062805"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA053981: AB_2682332, HPA062805: AB_2684871"	"unprognostic (2.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.93e-7)"	"unprognostic (2.81e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.19e-1)"	11.4	4.0	3.8	21.9	6.8	20.9	8.1	2.3	4.3	5.5	13.3	1.7	4.2	16.3	4.4	4.9	9.0	5.4	11.1	6.4	4.7	2.6	8.1	7.3	30.2	14.5	6.4	3.0	7.6	7.2	0.0	3.2	28.5	6.2	8.2	11.8	4.1	5.8	4.4	4.1	5.6	20.2	5.6	9.2	52.1	7.5	2.1	6.2	6.2	5.5	7.4	11.5	10.9	12.8	23.4	57.8	126.3	110.3	19.4	47.9	68.9	0.3	0.0	0.0	38.8	1.0	5.3	0.2	0.8	2.7	0.1	0.7	0.3	0.0	4.0	5.4	2.3	5.8	2.7	0.3	5.6	0.0	16.5	0.0	0.8	0.7	0.4	68.1	5.3	0.0	9.6	2.9	3.9	2.7	0.4	31.2	0.2	0.0	0.0	0.0	0.0	1.8	4.6	0.0	0.0	0.1	4.4	0.1	5.1	0.1	2.5	0.0	0.0	6.1	0.8	19.4	1.4	0.8	12.8	28.5	2.7	0.3	1.7	0.1	0.0	0.8	0.0	3.1	17.9	0.6	44.0	85.3	61.6	26.4	110.3	25.1	23.4	24.1	25.3	57.8	17.9	14.3	21.8	126.3	19.4	97.2	6.7	47.9	68.9	3.8	6.8	2.3	4.3	4.7	2.6	6.4	3.0	6.2	6.2	26.8	49.5	67.7	15.9	23.8	0.0	8.7	28.1	18.7	42.1	14.0	0.0	7.7	1.7	5.9	0.2	66.1	70.9	0.0	19.4	3.1	27.9	3.8	59.9	2.1	81.0	0.0	15.7	50.3	242.8	0.7	19.0	269.3	13.5	172.3	70.7	0.0	7.0	336.9	17.0	0.4	0.0	6.5	9.9	0.1	0.6	13.7	10.9	108.6	47.2	28.3
CARD19	"bA370F5.1, BinCARD, C9orf89, MGC11115"	ENSG00000165233	"Caspase recruitment domain family member 19"	Q96LW7	9	93096218-93113283	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010921, HPA010990, HPA038297"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938"	"unprognostic (7.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	15.1	17.8	9.9	8.1	10.6	6.8	19.6	19.8	15.0	13.5	18.1	13.9	6.4	13.7	13.8	14.2	12.9	12.3	13.0	14.5	9.7	7.5	18.1	12.2	12.0	7.8	14.8	10.7	9.6	9.1	6.1	8.1	7.6	13.7	10.2	7.6	9.9	12.1	10.7	15.5	14.6	12.2	12.5	12.5	12.5	15.7	19.9	10.3	5.3	10.0	13.4	7.1	15.5	12.6	5.6	17.3	23.0	21.7	9.2	11.5	12.3	12.1	11.9	1.4	3.5	1.9	3.7	5.0	10.1	5.0	7.1	3.2	2.9	4.1	2.6	7.1	3.6	5.1	21.2	1.2	8.1	0.6	50.0	4.7	4.6	2.5	6.7	8.1	4.1	4.4	9.3	2.6	5.1	2.0	7.0	8.2	2.3	2.0	4.9	4.8	24.1	4.4	11.1	1.4	7.7	27.1	2.9	8.0	10.6	8.7	4.5	3.7	6.7	5.4	2.6	11.0	0.0	6.0	4.3	8.1	3.6	7.3	6.8	3.1	3.9	3.6	0.5	14.9	4.2	12.4	14.1	21.7	12.8	6.1	16.0	6.2	5.6	6.0	6.5	17.3	3.3	5.5	5.5	23.0	9.2	9.1	6.2	11.5	12.3	9.9	10.6	19.8	15.0	9.7	7.5	14.8	10.7	13.7	10.3	20.8	18.1	6.7	38.6	0.0	10.2	0.0	25.5	4.0	10.3	15.7	15.7	18.5	53.0	70.5	28.5	24.8	23.6	0.0	51.8	27.7	20.8	42.0	27.9	12.4	72.1	4.8	15.2	34.4	46.4	9.3	42.3	64.9	0.0	71.3	25.5	15.1	83.4	7.0	41.1	43.9	21.6	58.2	0.0	75.2	29.6	0.0	18.1	22.4	21.0	66.8
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA041776: AB_2677666"	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	19.6	28.1	11.9	24.8	13.0	25.6	37.1	18.2	14.5	21.8	20.2	17.6	21.2	17.8	18.5	23.0	20.2	16.8	26.9	26.0	9.9	10.3	17.0	21.4	19.9	26.7	11.3	14.1	17.6	31.7	11.5	19.7	12.5	11.7	17.5	15.0	16.6	19.0	21.3	39.7	16.1	20.1	22.1	11.7	19.7	17.9	11.2	11.4	21.8	19.2	18.5	21.9	16.9	16.7	3.4	4.0	3.1	6.8	0.6	2.2	1.7	35.4	11.8	6.8	16.5	18.1	17.0	9.2	15.8	14.5	16.0	19.7	16.6	16.0	16.6	22.2	17.2	24.4	18.9	11.6	19.8	13.1	15.1	19.3	10.3	25.0	18.9	18.5	25.2	12.6	21.2	15.8	13.9	16.8	11.4	11.4	12.6	7.1	5.2	22.5	8.2	11.2	8.2	5.7	27.2	11.7	16.6	5.0	6.8	17.1	10.4	12.1	9.2	12.7	19.7	18.2	7.6	9.5	28.1	10.2	13.4	5.0	16.9	15.8	9.4	10.7	9.6	65.5	15.1	13.2	0.0	4.7	0.7	2.0	5.1	2.2	3.4	0.6	0.8	4.0	1.4	2.0	1.0	3.1	0.6	6.8	3.4	0.7	1.7	11.9	13.0	18.2	14.5	9.9	10.3	11.3	14.1	11.7	11.4	8.9	15.7	17.6	19.1	11.4	22.3	34.3	12.7	2.7	7.9	26.2	23.6	21.5	43.1	14.9	53.5	10.8	19.0	0.0	4.1	25.5	14.3	16.8	16.1	23.1	25.1	22.3	18.0	9.8	26.7	173.5	19.0	29.2	11.8	13.6	17.0	23.0	12.9	7.0	17.0	29.6	24.7	6.5	18.6	7.2	4.7	11.8	14.1	12.9	22.3	18.2
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA		2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	83.9	0.6	0.0	0.0	0.1
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		310000	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.3	4.7	18.7	8.9	11.6	15.5	10.8	25.3	19.2	17.8	10.3	8.5	7.1	11.7	4.0	12.3	8.4	7.2	14.8	9.0	20.3	30.0	8.1	18.7	3.7	19.7	13.9	15.2	17.8	21.1	11.0	11.3	9.1	12.8	22.0	12.1	15.4	74.2	18.3	3.6	24.0	14.2	18.5	9.3	5.9	17.4	8.8	11.3	15.3	13.8	10.7	11.7	10.9	10.0	14.2	19.4	5.4	9.9	14.9	8.1	7.5	6.0	11.7	34.5	32.3	8.0	9.9	10.6	11.5	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9	17.9	12.0	18.6	18.8	43.3	17.6	14.1	5.1	25.4	20.5	12.2	0.0	41.4	11.6	16.0	7.6	23.3	28.6	0.0	20.9	27.1	16.9	14.4	17.3	12.9	20.5	12.7	17.3	20.9	25.1	3.2	6.9	17.5	28.7	55.9	34.1	13.8	20.4	19.9	7.1	6.5	10.2	12.9	14.4	7.5	14.2	25.0	43.0	36.2	21.5	31.5
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	7.4	24.1	7.8	8.2	9.3	8.9	5.5	11.1	8.7	8.3	9.3	10.2	18.9	5.2	11.9	16.5	7.5	13.4	29.1	10.2	8.3	7.2	11.6	9.4	10.8	12.6	10.7	4.3	33.4	29.0	15.6	18.5	14.7	8.8	10.2	6.4	8.7	6.6	19.0	8.2	2.8	13.3	7.8	9.0	11.0	6.7	14.4	7.1	6.2	14.8	7.2	14.6	7.3	8.1	11.2	11.7	23.3	11.2	13.0	5.1	6.1	7.2	10.6	4.1	7.2	9.5	4.7	3.8	5.3	7.0	7.9	10.2	7.4	8.8	10.6	12.5	7.2	10.2	2.6	7.0	5.6	9.2	3.7	8.7	7.6	23.6	7.4	8.8	7.3	8.9	6.5	10.4	12.1	3.7	7.8	8.5	9.6	17.0	9.9	4.7	3.7	2.5	8.3	4.1	10.5	5.9	4.9	10.4	12.3	9.8	4.2	3.6	6.9	7.6	1.8	12.6	9.5	4.5	5.3	3.3	10.6	4.8	11.4	3.5	9.6	14.4	12.0	8.1	8.0	3.5	22.7	11.2	23.3	5.1	8.2	3.7	9.6	3.0	3.6	11.7	11.2	1.7	2.6	16.0	13.0	7.9	5.2	2.8	6.1	7.8	9.3	11.1	8.7	8.3	7.2	10.7	4.3	8.8	7.1	3.0	3.0	4.7	7.9	2.6	3.2	6.7	5.1	10.7	9.1	17.4	5.9	15.4	1.7	6.6	9.9	3.0	6.8	0.0	7.8	9.0	5.0	4.5	1.1	4.3	8.5	4.8	2.9	3.7	4.3	4.1	2.0	8.7	0.0	3.6	5.6	6.5	7.9	5.8	3.5	4.2	6.2	0.0	9.9	15.8	5.7	2.0	29.9	4.9	4.5	5.4
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861450-38872314	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	15.0	15.0	44.7	14.5	35.1	21.7	7.4	27.8	53.8	14.0	19.5	15.3	9.8	6.5	19.3	14.2	12.9	18.8	10.9	14.0	40.6	18.3	12.1	5.9	13.0	12.0	15.8	21.8	23.4	13.1	62.2	15.5	4.7	19.3	16.1	7.4	17.0	12.5	25.4	5.5	7.7	9.2	23.8	12.1	11.2	12.0	5.0	12.0	11.3	13.4	4.5	13.8	16.6	9.5	4.7	26.9	2.6	7.4	5.2	11.7	9.2	16.6	17.7	3.9	13.4	30.4	17.1	1.2	18.2	10.5	9.5	8.9	8.8	15.6	27.3	13.7	12.4	6.6	19.9	7.3	7.7	5.2	26.2	22.9	2.7	7.6	3.0	16.6	13.4	13.6	25.4	3.9	21.6	10.3	13.1	10.7	7.9	6.1	13.9	6.4	18.8	8.2	3.9	3.5	9.6	13.7	12.5	13.2	10.7	13.4	15.8	19.3	4.3	11.7	15.6	9.8	1.4	10.7	8.0	13.8	8.3	25.5	14.3	12.4	14.3	13.7	10.0	16.2	14.1	17.1	1.1	5.5	2.6	11.7	7.4	9.7	4.2	8.1	8.2	5.4	4.7	6.7	8.2	2.3	5.2	6.8	26.9	4.6	9.2	44.7	35.1	27.8	53.8	40.6	18.3	15.8	21.8	19.3	12.0	14.9	14.3	23.1	30.9	30.1	95.1	23.3	38.2	5.3	13.6	69.8	37.3	9.4	29.9	79.7	0.5	30.3	1.3	0.0	43.0	1.9	41.4	21.2	5.8	29.7	17.5	117.6	117.7	33.7	40.3	0.9	68.7	20.0	77.6	119.0	0.7	80.1	41.4	7.0	76.0	41.9	56.5	71.1	86.3	2.1	6.0	29.6	3.9	35.8	0.5	68.7
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 33.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4"					"Not detected"	"Not detected"			"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: AB_2680309"	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	8.7	4.2	6.4	4.7	7.1	1.3	4.4	3.2	8.0	4.2	4.8	4.9	2.9	2.3	4.0	6.4	4.7	2.9	16.9	4.7	6.0	5.4	5.9	3.3	16.4	11.5	7.0	5.0	3.3	3.1	3.2	5.0	33.7	8.7	4.0	6.1	4.0	3.2	2.2	2.1	2.9	3.9	6.4	9.3	3.3	4.7	4.3	7.0	1.7	6.8	5.0	2.9	16.9	4.0	0.9	11.5	0.4	0.3	1.3	2.6	0.3	0.0	0.0	2.9	0.2	2.7	10.8	0.2	0.6	20.8	0.2	0.3	0.1	0.3	0.1	0.4	18.7	0.3	0.2	0.1	0.2	0.3	0.9	0.3	0.6	0.0	0.9	5.3	0.1	0.3	11.5	0.4	0.3	2.6	0.4	0.1	1.4	0.0	7.4	1.7	0.0	0.4	0.2	0.6	0.1	0.3	0.9	0.2	0.3	0.1	0.0	1.3	1.1	0.1	0.0	0.0	1.2	0.2	0.9	2.9	0.4	0.2	0.1	0.2	3.2	0.2	0.5	1.5	1.2	1.8	0.0	0.1	0.4	1.4	0.3	1.3	0.6	0.8	1.1	0.3	0.9	2.6	1.6	0.0	1.3	0.2	11.5	0.3	0.3	6.4	7.1	3.2	8.0	6.0	5.4	7.0	5.0	8.7	7.0	0.0	2.1	0.5	0.6	0.6	5.6	7.4	0.0	1.4	3.4	3.5	5.9	0.7	5.0	0.6	113.6	4.5	0.0	0.0	1.5	0.5	3.6	0.5	2.3	0.6	3.0	6.4	0.0	4.3	2.2	49.0	30.0	3.1	0.0	2.8	0.2	10.8	0.3	0.3	8.5	4.5	12.2	77.6	22.5	1.6	2.7	0.5	0.2	1.0	0.4	0.5
CCDC120	JM11	ENSG00000147144	"Coiled-coil domain containing 120"	Q96HB5	X	49053572-49069857	"Cancer-related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 14.4;BEWO: 20.7;HaCaT: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000561			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA000561: AB_2244190"	"unprognostic (1.65e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.34e-3)"	3.3	3.1	5.8	3.1	4.7	2.9	5.0	17.3	5.8	8.4	6.8	1.6	10.4	12.0	5.5	9.9	27.6	5.1	4.1	2.1	4.0	1.6	7.0	4.8	4.4	2.6	1.5	3.3	6.5	7.0	6.1	12.2	13.3	4.0	6.0	3.3	4.7	11.4	10.2	1.5	26.1	12.5	2.5	1.8	3.8	7.7	5.8	1.5	6.0	5.6	8.8	15.1	7.4	12.2	2.5	2.2	3.9	0.8	1.6	1.5	0.4	14.4	1.9	3.2	0.1	0.0	0.0	20.7	0.5	0.7	1.1	1.7	4.8	6.2	0.6	2.3	0.8	2.4	13.9	2.4	8.2	0.1	3.7	4.6	1.3	3.3	1.6	1.1	0.0	2.4	1.8	6.6	1.3	0.4	2.2	1.8	3.8	2.0	0.2	0.0	12.1	5.0	0.4	3.7	6.8	0.1	4.5	2.4	1.3	6.3	7.8	4.4	3.4	2.6	5.2	1.5	4.6	12.6	1.9	0.8	0.1	3.8	0.1	0.1	4.7	3.2	0.1	0.1	0.0	0.6	2.9	0.8	1.5	1.4	0.2	0.9	0.8	1.5	1.3	0.3	2.5	1.5	1.4	3.9	1.6	0.4	2.2	0.5	0.4	5.8	4.7	17.3	5.8	4.0	1.6	1.5	3.3	4.0	1.5	6.0	1.9	0.8	3.2	4.5	5.8	1.2	2.5	2.7	2.3	12.2	3.9	10.2	0.0	4.7	0.1	2.9	6.2	0.0	5.7	2.6	1.5	5.1	0.0	1.9	1.9	9.5	5.8	3.7	2.7	0.0	2.0	0.0	0.0	0.0	5.5	2.3	9.7	6.2	1.1	2.4	6.1	0.0	0.8	1.1	0.7	8.2	14.1	1.0	3.9	7.6
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183584-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 51.8;Sertoli cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	2.0	11.4	9.0	2.3	14.4	0.8	1.3	14.9	30.5	3.0	1.8	2.2	0.1	1.1	6.1	1.3	1.7	1.3	3.3	1.9	9.3	17.6	1.3	1.3	1.5	1.0	11.5	10.6	8.8	1.3	8.7	7.3	5.1	23.7	1.6	1.5	0.8	0.9	2.3	2.2	1.5	2.1	3.6	3.6	1.4	1.5	5.1	0.4	0.0	1.2	0.5	0.8	2.1	1.8	0.0	0.3	0.6	0.2	0.0	1.2	0.3	0.0	4.2	9.9	0.4	0.8	0.8	0.0	0.3	1.8	0.5	0.8	0.5	0.1	0.0	0.2	0.3	2.6	0.1	1.0	0.2	0.1	2.3	0.2	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.1	0.0	3.8	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	6.7	0.8	0.1	0.2	0.2	0.0	0.0	0.2	1.1	4.0	0.0	0.2	0.0	0.0	0.0	5.0	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.2	0.4	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	9.0	14.4	14.9	30.5	9.3	17.6	11.5	10.6	23.7	0.4	0.0	0.0	0.0	0.2	0.0	2.3	0.6	0.0	9.4	1.2	0.0	0.0	0.7	0.0	0.2	51.8	1.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.9	4.8	5.1	8.6	0.0	10.9	0.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	2.1	0.0	6.6	45.3	2.7	5.6	0.9	0.0	1.3	0.0	0.0	0.0
CCDC191	KIAA1407	ENSG00000163617	"Coiled-coil domain containing 191"	Q8NCU4	3	113964137-114056613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 191.4;Spermatocytes: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047833	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047833: AB_10961639"	"unprognostic (2.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.45e-4)"	3.8	4.5	6.3	4.5	13.3	4.2	7.6	3.0	9.7	7.6	4.0	11.7	11.5	2.9	8.2	12.4	3.4	18.5	5.7	2.4	8.2	7.8	7.7	2.4	7.2	6.1	6.2	9.8	7.7	6.6	16.7	31.1	3.4	12.5	6.5	5.2	7.1	5.0	7.9	1.6	11.4	5.1	7.0	8.9	7.5	4.8	12.7	7.9	3.6	11.3	2.4	6.1	5.2	4.5	10.0	4.4	5.3	0.9	0.8	2.2	1.0	4.9	2.8	4.4	3.6	1.2	6.6	1.4	1.2	2.2	1.7	2.7	0.6	5.8	1.3	2.0	2.3	1.3	6.2	1.3	2.4	4.0	0.9	1.1	0.9	0.9	0.5	1.8	1.6	0.7	2.8	6.3	2.2	3.3	3.0	3.3	3.8	0.4	3.1	1.0	2.4	3.0	0.6	0.8	3.4	2.1	2.0	0.9	2.9	6.1	2.5	2.5	4.3	2.0	0.5	2.1	2.3	10.6	0.6	3.4	2.7	0.8	1.4	0.8	4.5	3.6	5.0	3.8	0.8	1.4	0.1	0.9	1.8	1.1	0.9	1.2	10.0	2.2	1.8	1.0	9.4	1.1	1.8	5.3	0.8	0.6	4.4	1.6	1.0	6.3	13.3	3.0	9.7	8.2	7.8	6.2	9.8	12.5	7.9	11.9	11.8	7.3	3.8	0.0	8.7	0.0	0.0	191.4	29.6	12.2	35.3	1.4	11.6	3.7	21.9	1.4	1.1	0.0	3.1	0.4	1.5	2.6	1.1	0.8	2.7	19.1	4.7	5.5	1.8	10.9	3.7	0.7	0.0	1.0	3.0	20.1	2.4	0.0	4.9	3.6	39.1	0.0	0.0	76.7	12.3	0.0	0.2	0.0	3.2	1.7
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.7	11.9	7.2	8.4	10.6	11.3	19.7	6.5	6.0	13.1	10.7	18.8	16.4	21.2	9.3	5.1	9.8	14.3	17.6	21.2	8.0	9.9	11.6	18.1	18.9	14.1	16.4	8.8	8.3	8.5	48.2	16.1	17.7	7.1	7.4	12.5	10.0	6.2	12.3	9.3	10.2	11.4	15.7	21.0	19.3	7.1	8.4	16.3	17.7	12.2	5.9	12.5	10.7	11.7	17.4	7.0	12.6	13.7	5.6	7.6	10.3	18.8	12.4	10.0	14.6	11.1	10.1	19.1	7.1	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9	11.9	1.6	8.9	3.0	4.1	6.8	7.3	22.9	5.3	5.7	8.7	0.0	35.3	19.9	13.2	2.5	5.3	12.6	0.0	10.8	15.3	10.7	3.7	3.5	11.9	14.1	7.9	5.2	3.1	3.8	2.2	11.2	4.1	13.5	13.6	6.3	10.1	12.4	5.8	12.4	27.0	9.5	6.5	3.1	4.8	17.3	4.1	5.6	4.3	12.4	3.1
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047777, HPA051965"	Approved		Approved	Nucleoli,Mitochondria		No	No			Mitochondria	Nucleoli	"HPA047777: AB_2680152, HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	9.5	13.3	8.7	6.8	8.1	7.1	9.2	6.9	12.6	8.2	13.3	7.1	12.4	10.6	7.3	12.4	14.0	5.8	7.7	12.4	7.2	7.0	21.9	23.3	5.4	10.0	8.6	5.3	8.8	9.3	3.1	7.7	6.7	8.5	8.2	14.4	6.5	7.2	6.9	35.2	6.9	10.2	6.3	7.2	8.6	9.1	8.7	9.3	5.5	8.8	24.5	9.6	8.7	7.1	13.9	18.3	1.7	10.2	11.4	16.1	4.6	34.9	11.1	21.2	13.5	7.9	11.1	27.3	13.4	14.6	32.6	32.1	31.3	17.7	25.7	23.2	10.2	25.4	24.5	34.4	23.0	39.1	8.8	12.2	30.2	7.9	37.8	13.2	44.9	10.8	9.1	11.9	20.0	21.9	13.9	15.0	22.9	34.2	11.2	17.1	17.4	28.6	32.2	40.7	38.6	21.0	19.0	25.2	31.6	22.4	18.6	21.5	10.5	15.6	16.6	37.3	18.7	16.5	29.6	8.6	18.3	23.4	7.7	26.7	8.9	11.9	55.4	20.8	21.8	16.1	0.4	5.0	1.7	10.2	10.2	12.0	13.9	13.6	13.4	10.3	13.5	16.1	14.9	0.9	11.4	8.5	18.3	10.5	4.6	8.7	8.1	6.9	12.6	7.2	7.0	8.6	5.3	8.5	9.3	3.0	17.1	19.3	16.0	13.6	9.4	23.0	25.5	32.1	20.5	12.2	9.8	19.1	46.4	27.4	0.3	11.3	13.4	0.0	25.7	38.8	10.2	10.9	19.8	46.1	15.7	0.0	5.2	11.6	7.6	0.7	11.8	12.4	8.5	26.2	14.7	6.6	31.7	14.0	7.8	78.7	8.8	12.9	8.0	13.5	23.4	16.2	12.7	7.1	22.4	21.2
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 347.8;Spermatocytes: 279.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	15.8	32.0	25.0	11.1	23.3	11.6	18.0	14.3	17.9	15.4	14.5	14.6	17.2	12.1	12.6	29.3	14.3	13.5	15.2	18.2	22.3	25.6	16.4	31.3	11.0	15.0	29.9	14.9	19.4	16.6	15.2	29.5	18.3	24.5	16.3	14.9	8.4	14.5	14.8	12.2	11.6	18.2	14.9	43.9	17.1	13.6	42.2	28.3	15.5	21.6	12.3	13.5	14.8	13.0	18.5	12.7	32.6	19.0	22.5	21.1	12.4	7.2	10.8	18.4	5.9	25.0	18.9	11.3	14.8	12.7	9.4	10.0	12.6	25.3	17.7	19.5	21.9	19.4	9.3	8.1	19.0	12.5	12.4	6.4	10.9	7.3	10.4	21.1	11.0	9.5	21.0	25.7	12.0	34.7	18.5	21.3	19.6	16.1	15.2	34.1	12.9	11.0	14.1	15.2	31.7	13.5	12.8	16.6	15.2	19.4	10.8	9.0	20.8	10.4	8.4	9.6	25.9	21.7	10.3	20.4	18.4	11.6	34.5	10.0	14.8	19.3	18.0	7.4	8.9	18.1	30.8	8.9	32.6	12.3	19.0	15.6	18.5	17.9	17.0	12.7	16.9	15.5	15.5	4.5	22.5	19.0	9.3	21.1	12.4	25.0	23.3	14.3	17.9	22.3	25.6	29.9	14.9	24.5	28.3	11.9	12.5	34.2	43.7	20.9	33.7	49.1	15.3	24.1	15.9	34.9	13.7	62.9	58.0	53.7	347.8	38.6	19.2	0.0	42.7	46.4	36.0	35.2	47.4	39.9	56.5	39.7	32.2	26.4	28.8	188.9	39.4	41.6	20.3	61.3	31.8	23.0	58.7	35.1	24.1	57.7	44.3	25.8	30.1	279.8	83.5	25.3	43.3	28.8	30.4	38.0
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	13.6	15.1	9.1	18.0	17.2	15.1	6.7	16.6	13.7	11.9	16.1	10.9	14.2	19.3	12.8	21.0	37.8	17.9	5.6	21.4	7.9	21.5	10.8	8.5	12.1	7.7	15.2	3.5	23.1	17.0	14.1	20.9	9.0	11.1	21.6	28.3	9.8	15.7	23.8	20.6	16.9	46.8	10.5	11.4	16.8	9.0	5.2	15.6	12.1	13.2	17.5	13.6	13.6	10.7	7.3	12.3	12.3	16.1	16.3	16.2	13.8	16.2	15.8	28.1	22.0	38.9	15.9	12.7	19.5	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5	17.9	20.8	51.3	20.1	41.6	18.3	12.5	17.8	6.7	21.6	14.0	3.9	22.8	21.6	27.6	5.8	25.3	21.7	0.0	33.3	31.3	26.3	15.3	34.7	50.4	43.3	77.9	15.0	27.0	34.3	8.0	19.5	45.2	32.1	208.2	13.4	21.4	35.1	11.5	19.1	17.0	11.9	19.4	27.8	16.2	36.4	20.1	8.7	56.6	13.5	16.1
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell type enriched"	"Detected in many"	6	"monocytes: 2758.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 175.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"prognostic favorable (3.84e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	175.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.0	5.9	116.5	1.4	4.4	0.0	0.3	0.0	0.0	2.3	1.8	0.0	111.5	0.0	0.4	0.1	0.1	0.0	0.0	6.9	6.3	3.3	0.0	2.3	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	12.9	15.1	2758.4	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	3.9	0.2	0.5	3.9	432.7	16.2	0.0	3.3
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;lung: 17.5"	"Cell type enhanced"	"Detected in some"	9	"Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 25.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		NA	NA		42000	Mitochondria		"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.9	1.7	0.8	11.3	1.1	5.7	0.8	0.2	1.1	1.3	5.0	0.6	1.2	4.6	1.7	0.4	1.8	1.5	1.4	2.6	1.1	0.5	1.3	0.8	17.5	4.0	1.3	0.2	1.0	2.3	0.0	0.8	0.5	1.1	1.6	3.2	0.7	2.1	1.3	0.5	1.8	10.9	1.6	2.0	7.8	1.8	0.9	1.2	6.4	0.9	2.4	7.4	2.4	1.8	0.1	12.2	33.7	17.4	0.0	1.2	2.5	0.4	0.0	0.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.2	1.9	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.0	0.1	25.3	0.3	1.3	0.0	0.1	0.2	0.2	0.5	0.1	0.6	0.1	1.5	0.0	2.9	0.8	0.0	0.0	0.0	0.5	0.0	0.6	0.7	0.4	0.6	0.4	0.5	0.3	0.6	0.9	0.6	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.7	1.9	1.5	0.0	7.6	33.7	0.1	10.0	0.7	0.1	0.2	1.2	12.2	0.0	0.3	1.2	0.3	0.0	17.4	0.0	1.1	2.5	0.8	1.1	0.2	1.1	1.1	0.5	1.3	0.2	1.1	1.2	0.0	1.4	0.5	0.1	1.1	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.5	0.0	0.2	0.1	1.1	0.4	0.7	0.0	1.7	0.0	6.2	1.3	0.3	7.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.2	0.0	0.0	1.4	0.0	4.6	0.1	0.1
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541108-74546143	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 46.8"	"Group enriched"	"Detected in some"	12	"granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 32.5;monocytes: 46.8"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4"									"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	9.8	2.8	3.6	9.0	4.6	10.9	1.8	0.4	2.9	1.2	1.7	2.9	0.0	1.5	1.4	1.9	1.0	1.9	2.8	3.4	2.0	1.7	1.9	2.1	11.2	12.3	5.3	1.3	1.1	1.3	0.5	1.2	3.8	3.9	1.9	1.8	1.8	1.8	0.7	1.1	0.9	2.3	4.1	7.1	14.2	1.6	0.9	2.7	0.1	1.6	0.1	1.4	3.5	1.1	0.4	32.5	8.4	46.8	8.6	0.1	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.4	0.0	8.4	28.6	1.4	0.1	46.8	0.1	0.4	0.0	0.0	32.5	0.3	0.0	0.0	1.0	8.6	46.4	2.1	0.0	10.7	3.6	4.6	0.4	2.9	2.0	1.7	5.3	1.3	3.9	2.7	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	15.0	0.0	29.5	0.0	0.0	0.0	28.1	0.0	0.0	33.8	1.7	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CD3EAP	"ASE-1, CAST, PAF49"	ENSG00000117877	"CD3e molecule associated protein"	O15446	19	45406209-45410766	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-251 MG: 65.8"					"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	7.3	5.9	7.7	8.4	9.7	4.0	7.1	14.9	9.0	5.6	5.5	6.5	2.9	4.9	6.4	3.0	9.9	7.1	6.4	6.7	7.1	6.4	5.2	6.8	4.5	7.2	8.1	6.0	8.7	18.3	6.6	7.3	5.1	8.0	5.2	4.9	3.1	7.2	4.6	14.2	8.4	4.3	6.6	5.6	5.8	4.3	5.2	9.3	3.6	6.1	7.8	8.5	5.5	5.8	3.5	15.9	1.3	3.7	3.2	4.1	2.1	10.4	10.8	1.7	7.9	2.6	2.1	7.0	5.0	1.7	8.9	5.2	10.6	7.5	16.3	5.3	3.7	7.2	10.1	15.6	14.3	6.3	8.0	10.1	9.0	4.1	7.8	4.4	9.1	3.2	3.2	9.2	12.9	7.1	2.2	6.4	6.0	20.5	3.3	8.6	12.3	6.9	2.6	12.7	11.6	9.1	9.4	6.9	10.7	3.5	7.8	10.8	4.0	10.7	14.3	2.3	3.8	7.2	5.5	6.2	12.7	13.3	7.3	65.8	5.9	23.4	17.3	6.3	13.0	9.1	0.9	2.8	0.3	1.7	3.7	3.4	2.8	2.2	2.4	5.0	3.5	3.1	4.1	1.3	3.2	3.3	15.9	1.2	2.1	7.7	9.7	14.9	9.0	7.1	6.4	8.1	6.0	8.0	9.3	6.0	12.8	10.0	23.3	109.3	4.5	1.2	7.6	6.7	12.5	1.8	9.8	13.7	1.7	15.9	0.2	9.0	1.7	0.0	5.8	19.4	6.6	7.7	5.7	4.2	10.0	11.1	4.6	4.9	2.6	0.5	8.9	7.0	11.8	2.8	4.3	3.5	11.0	0.0	10.6	6.1	5.8	0.0	8.9	0.5	18.9	96.7	6.4	0.0	9.5	11.5
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell type enriched"	"Detected in some"	4	"B-cells: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.9	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.7	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.6	0.0	2.8	0.0	8.2	0.7	0.0	0.2	1.7	0.1	0.0	0.1	5.3	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	28.3	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2	0.0	1.1	82.7	0.3	0.9	0.0	0.6	2.5	1.4	0.0	3.5	0.0	0.1	0.0	0.6	0.1	0.5	0.5	0.0	0.6	0.2	0.6	0.4	0.0	0.0	19.7	0.0	1.7	0.6	16.7	0.0	0.9	8.0	0.0	1.8	0.0	0.5	1.2	0.0	0.4	0.3	0.7	0.0	0.8	0.2	1.2	1.0	0.2	4.9	0.3	0.1
CDK5RAP1	"C20orf34, C42, CGI-05, HSPC167"	ENSG00000101391	"CDK5 regulatory subunit associated protein 1"	Q96SZ6	20	33358839-33401561	"Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066301			Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA066301: AB_2685653"	"unprognostic (2.86e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.18e-2)"	"unprognostic (5.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-1)"	13.9	12.8	15.1	13.0	23.0	20.8	14.8	29.2	22.4	11.1	12.2	18.3	12.3	11.3	15.4	15.4	13.2	12.8	8.3	15.0	11.2	9.5	11.8	14.6	12.5	14.7	12.2	16.2	14.0	12.4	16.6	17.9	13.1	15.5	11.5	16.2	15.5	19.7	12.0	29.2	19.0	14.5	14.1	10.1	15.8	13.0	14.8	15.9	14.4	15.8	11.2	18.7	13.4	12.5	16.0	14.2	8.5	16.3	15.6	17.4	10.8	11.0	11.5	8.0	7.2	7.6	5.9	17.7	6.7	9.6	19.5	20.5	48.5	10.0	19.6	9.0	7.2	12.6	16.4	13.6	19.0	15.1	3.6	7.2	23.6	11.9	18.4	9.0	14.9	7.5	7.7	8.2	12.9	15.7	4.9	10.7	5.6	14.9	8.2	8.4	11.1	15.2	11.2	5.9	12.4	17.0	11.3	18.2	15.0	10.6	9.8	11.0	6.1	21.3	10.2	14.1	9.6	14.8	7.2	7.9	14.4	11.8	9.8	11.2	7.1	8.0	14.5	8.6	16.1	6.8	3.3	12.7	8.5	14.7	16.3	17.4	16.0	14.5	14.0	14.2	9.8	13.1	11.3	0.7	15.6	13.0	9.9	12.4	10.8	15.1	23.0	29.2	22.4	11.2	9.5	12.2	16.2	15.5	15.9	14.9	18.3	13.4	9.5	10.8	25.5	14.2	12.7	9.4	3.4	7.0	25.5	27.3	11.6	14.6	1.5	10.7	10.1	23.3	15.9	14.6	8.0	6.7	28.9	13.4	15.2	11.1	12.1	4.3	10.5	2.5	12.0	15.9	10.1	15.4	9.4	15.1	10.4	10.5	9.9	12.4	37.2	19.4	10.8	25.0	21.5	9.2	13.4	19.2	11.9	7.8
CDRT4	FLJ36674	ENSG00000239704	"CMT1A duplicated region transcript 4"		17	15436015-15503608	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"testis: 36.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 68.3;Late spermatids: 129.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.9;NK-cells: 1.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.2;NB-4: 10.0"					"Low region specificity"	"Detected in many"			HPA021590	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA021590: AB_1848906"	"unprognostic (5.46e-6)"	"unprognostic (9.47e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.74e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-5)"	"unprognostic (2.00e-3)"	"unprognostic (1.74e-6)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (9.27e-2)"	2.0	3.2	2.0	2.0	2.3	3.3	6.5	3.7	2.6	2.6	2.3	2.3	2.0	0.2	2.5	17.7	2.0	4.4	2.0	2.0	2.0	2.4	2.0	2.0	3.7	2.8	2.7	2.8	5.3	4.1	0.9	10.9	2.0	2.0	4.1	3.0	2.0	5.0	2.7	2.0	14.6	2.0	2.0	2.0	2.9	2.7	36.8	2.0	2.0	5.3	2.0	2.0	2.1	2.8	0.4	0.3	3.9	0.1	1.1	1.8	0.5	3.2	3.2	4.0	1.2	3.0	2.3	3.8	1.1	3.1	1.4	1.3	1.9	1.1	0.0	1.5	1.6	0.2	1.2	4.4	3.6	2.2	0.6	0.6	0.4	2.0	13.2	0.9	1.1	5.5	3.1	4.4	2.0	4.9	6.1	3.3	1.4	0.7	2.0	3.4	0.5	1.2	10.0	1.6	0.4	1.1	0.9	0.1	0.0	3.3	2.5	0.6	1.7	1.1	0.7	1.0	8.1	1.4	2.5	3.3	0.8	1.5	1.5	1.2	2.7	1.0	0.2	0.0	0.3	0.4	3.9	0.0	0.4	0.9	0.0	0.6	0.4	0.4	0.8	0.1	0.4	0.1	0.4	0.2	1.1	0.1	0.3	1.8	0.5	2.0	2.3	3.7	2.6	2.0	2.4	2.7	2.8	2.0	2.0	0.0	0.6	0.0	0.1	0.1	1.4	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.5	68.3	0.0	0.3	0.0	0.0	0.3	0.2	0.3	2.3	0.0	0.1	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	1.0	1.7	0.3	0.7	1.5	0.0	0.0	1.6	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.6	0.3
CEACAM19	CEAL1	ENSG00000186567	"Carcinoembryonic antigen related cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	1.6	2.9	1.1	0.8	1.9	1.0	2.4	4.3	1.7	3.1	2.4			2.7	2.7	1.4	2.4	4.3	2.1	4.1	1.2	1.8	3.3	4.3	3.8	0.6	0.6		4.0	4.7	1.2	3.9	1.8		4.1	3.3		2.9	3.0	12.5	10.8	2.9	3.0	0.9	1.8	2.0	3.0			3.4		1.7	1.0	4.4	1.7	0.5	1.7	1.0	1.0	0.7	0.6	4.2	8.8	1.3	0.9	3.1	3.6	3.3	2.4	3.6	0.8	1.6	0.3	1.0	0.1	0.8	3.2	0.9	5.3	2.2	0.9	0.7	1.2	5.0	0.1	4.6	1.4	3.2	0.2	0.8	1.1	8.7	2.2	5.4	10.7	2.0	0.6	0.3	0.2	1.2	1.0	0.0	0.5	0.8	1.1	1.0	0.0	1.6	0.2	13.7	1.0	1.7	0.4	0.9	0.9	0.8	1.3	1.2	0.3	17.7	0.3	6.1	1.3	0.7	0.1	0.3	0.0	0.4	1.7	1.4	1.7	1.0	0.6	0.6	0.4	0.3	0.5	0.3	0.6	0.2	1.7	0.4	0.7	1.6	1.0	0.5	0.5	0.3	0.6											3.0	2.1	0.0	0.9	1.8	2.6	4.1	2.5	1.4	2.3	0.0	0.0	0.0	0.0	1.6	0.7	3.1	1.7	0.0	2.9	0.1	0.9	1.3	0.0	1.9	0.2	0.0	1.7	4.9	1.2	0.2	2.8	0.5	0.0	0.0	2.6	0.1	3.5	3.5	2.5	0.2	0.5	0.0	2.8	3.2	0.4	5.3	0.0	0.0	2.2	0.9
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787104-790123	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 85.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 89.3;Horizontal cells: 71.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.6;Karpas-707: 17.0;SCLC-21H: 30.5;SH-SY5Y: 11.4;U-266/70: 11.9;U-87 MG: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	1.9	8.2	28.5	2.9	34.7	1.8	1.8	46.5	85.2	1.8	2.3	8.3	1.3	2.5	1.9	2.0	2.2	1.8	1.9	2.1	34.2	25.3	2.1	1.8	1.8	2.1	32.0	30.7	1.8	1.9	1.9	5.1	1.8	42.4	3.2	1.9	2.1	1.8	3.6	1.8	1.9	2.7	2.3	10.2	1.8	1.9	1.9	5.9	0.0	1.8	0.0	2.0	2.1	0.1	3.6	0.2	0.0	0.7	0.0	1.9	0.3	0.0	0.4	0.4	0.7	0.1	0.1	0.1	0.7	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.3	7.6	0.3	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	17.0	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	30.5	11.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.5	11.9	3.2	0.7	15.9	0.1	0.2	0.0	0.0	0.0	0.9	0.7	0.3	3.6	1.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.3	28.5	34.7	46.5	65.2	34.2	25.3	32.0	30.7	42.4	5.9	0.0	0.0	0.0	0.1	0.1	89.3	0.4	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	71.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	17.6	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 29.5;fallopian tube: 46.9;testis: 26.8"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 149.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6.0	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.7	1.3	0.9	0.9	0.0	0.1	0.0	0.0	0.1	3.9	0.0	0.4	0.0	1.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	4.8	0.0	0.7	0.3	6.2	0.2	3.3	0.0	0.1	0.4	0.9	0.8	0.0	0.7	1.3	0.0	0.9	2.9	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	8.4	0.3	2.5	5.9	6.0	0.5	0.5	29.5	3.5	0.0	2.9	0.0	0.2	0.0	0.4	0.3	0.0	149.9	18.2	0.0	5.9	0.5	1.7	0.0	21.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	1.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.8	0.2	2.0	0.0	0.0	25.2	0.3	0.0	0.8	0.0	0.0	0.1
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 29.9;Exocrine glandular cells: 24.3;Pancreatic endocrine cells: 16.5;Urothelial cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;HHSteC: 26.8;hTCEpi: 42.4;SK-MEL-30: 30.0;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.8	1.4	1.0	3.6	17.0	35.1	1.8	5.0	4.7	0.7	0.8	1.3	1.5	5.6	1.9	3.8	1.4	1.3	3.2	0.7	0.7	0.5	0.0	26.8	2.2	0.0	12.0	42.4	5.5	7.7	0.5	1.7	19.6	2.3	4.0	1.5	1.6	1.6	0.0	1.6	9.7	6.6	1.4	0.0	3.8	0.9	1.1	1.7	2.5	0.5	3.0	30.0	1.1	1.1	16.0	0.5	0.3	5.3	0.4	3.0	26.3	5.6	3.4	1.6	3.1	4.0	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0	0.0	1.3	1.5	3.4	2.5	2.3	3.5	2.5	0.0	1.2	0.0	2.0	0.2	29.9	7.5	0.1	0.5	2.8	0.0	24.3	0.2	0.5	5.1	0.0	0.4	0.3	0.0	3.4	1.8	0.8	0.0	0.3	0.4	5.0	1.8	1.5	0.3	16.5	0.3	0.0	0.1	0.4	0.0	0.5	1.4	0.7	3.8	2.9	0.0	1.5	11.8
CHCHD1	"C10orf34, FLJ25854"	ENSG00000172586	"Coiled-coil-helix-coiled-coil-helix domain containing 1"	Q96BP2	10	73782047-73783652	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 114.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039046	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Nucleoli fibrillar center"	"HPA039046: AB_10673234"	"unprognostic (4.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.42e-4)"	16.4	33.6	22.6	21.7	21.5	16.5	32.0	21.3	29.4	16.4	24.7	9.2	25.9	28.0	16.8	38.6	29.5	17.8	25.3	36.1	19.3	18.4	32.9	37.8	28.9	23.8	19.4	20.9	15.6	47.2	16.3	19.7	25.3	21.2	21.5	20.8	12.7	31.9	28.7	45.1	16.6	24.3	22.0	15.3	24.8	23.4	24.8	15.6	21.0	29.5	31.6	20.6	17.0	18.1	30.7	38.2	22.2	27.3	17.9	32.1	18.2	22.5	17.2	14.5	20.5	12.0	11.7	14.6	11.8	13.8	11.9	16.1	15.4	20.6	11.2	13.1	10.4	12.2	16.0	14.1	15.3	9.9	17.1	26.9	8.6	14.4	23.7	14.1	13.1	13.8	10.9	19.1	10.1	6.9	18.1	16.5	15.6	13.0	12.8	15.7	22.8	16.1	29.0	13.8	21.5	114.1	15.4	11.2	14.6	19.4	12.7	7.2	14.1	7.3	51.5	24.1	12.4	28.8	18.3	9.7	7.6	16.6	12.5	20.2	12.8	13.3	17.7	17.7	26.6	5.9	22.2	27.0	15.9	19.7	27.3	23.7	30.7	24.2	23.5	26.6	26.1	20.3	20.5	11.1	17.9	21.5	38.2	32.1	18.2	22.6	21.5	21.3	29.4	19.3	18.4	19.4	20.9	21.2	15.6	38.7	36.6	58.1	32.1	31.1	26.0	66.9	33.1	77.6	54.6	57.6	21.6	127.4	169.1	72.5	37.4	31.2	94.4	46.7	76.3	142.6	26.2	45.5	28.9	109.7	118.2	19.1	59.4	50.3	55.3	7.6	52.3	50.1	38.8	82.0	88.4	53.2	83.5	89.6	51.9	145.7	27.7	51.8	26.8	44.5	49.1	38.0	107.1	39.9	89.5	42.2
CHCHD10	"C22orf16, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23768443	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 127.0;skeletal muscle: 226.6"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 2117.1;Enterocytes: 1174.4;Hepatocytes: 1666.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	23.1	14.9	25.8	16.4	33.9	5.7	20.0	11.8	31.0	17.3	39.4	9.6	18.3	30.6	6.1	15.5	20.2	7.6	11.3	127.0	23.7	23.5	40.4	86.1	8.3	16.9	25.8	18.4	4.8	24.3	36.4	12.7	11.7	14.5	11.7	31.6	24.3	33.7	22.2	226.6	7.2	30.2	12.8	12.2	13.0	17.3	4.1	9.6	3.0	27.8	73.1	15.8	13.8	9.3	9.4	7.3	7.6	7.8	0.8	5.0	1.0	5.8	16.0	4.9	20.7	10.9	6.9	8.0	2.1	5.6	5.9	6.8	29.8	8.0	18.0	5.5	10.1	3.2	18.9	27.0	8.5	5.3	5.8	29.4	4.6	12.6	28.1	18.5	13.3	21.4	13.4	22.5	8.9	2.4	1.2	7.1	3.9	8.2	11.6	5.2	29.7	4.1	8.4	3.6	47.6	40.5	15.6	0.8	41.5	27.6	13.3	8.7	4.6	2.8	35.5	27.2	9.7	12.7	10.4	3.1	0.2	0.1	3.6	0.0	4.5	2.0	12.4	4.8	11.1	2.6	0.2	3.9	7.6	2.8	7.8	1.9	9.4	3.2	4.0	1.7	7.8	5.0	3.6	0.1	0.8	6.9	7.3	3.7	1.0	25.8	33.9	11.8	31.0	23.7	23.5	25.8	18.4	14.5	9.6	11.9	8.0	277.6	303.6	42.7	134.9	422.5	295.5	4.0	11.4	397.8	108.0	25.5	2117.1	75.8	24.6	33.8	1174.4	46.7	46.5	229.6	58.5	151.0	86.1	1666.3	550.7	93.8	298.3	76.1	204.5	13.0	45.1	214.4	354.3	26.2	653.9	94.8	45.8	623.8	27.6	877.4	179.8	122.9	200.9	26.5	44.5	38.3	88.0	85.8	692.8	383.5
CHCHD2	C7orf17	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101569-56106576	"Disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 224.0"	"Low region specificity"	"Detected in all"							"HPA027407, HPA052510"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	41.5	112.8	57.2	33.0	59.5	73.0	46.0	39.3	56.9	38.0	46.6	33.2	45.5	51.9	34.2	53.8	50.1	39.2	44.3	75.3	46.8	50.2	56.2	66.9	34.2	62.6	58.3	49.0	43.8	77.8	28.4	42.8	38.4	42.3	41.3	40.1	45.3	56.5	70.0	147.2	33.0	49.3	45.7	42.6	34.1	44.2	27.1	28.1	48.9	62.1	65.9	38.8	38.5	30.9	63.2	107.7	52.6	69.1	51.5	72.8	121.3	224.0	39.2	25.9	53.4	20.5	28.3	19.2	33.0	31.3	42.5	41.2	35.9	37.5	65.7	43.7	20.2	55.1	38.2	32.7	36.1	34.3	42.7	59.6	38.8	33.1	51.1	38.1	52.2	62.7	25.2	41.4	31.9	39.1	23.1	31.7	58.1	81.3	40.0	34.6	31.1	70.3	161.7	56.0	61.6	62.6	47.4	25.2	107.9	38.1	29.3	49.4	61.5	26.0	64.1	41.4	18.5	73.2	74.7	25.3	26.3	61.6	108.7	48.5	37.0	52.6	117.2	41.4	56.4	32.5	40.5	69.1	52.6	53.1	61.0	54.8	63.2	57.2	56.3	79.5	57.8	51.6	52.8	37.0	51.5	59.5	107.7	72.8	121.3	57.2	59.5	39.3	56.9	46.8	50.2	58.3	49.0	42.3	28.1	238.2	265.3	489.1	766.8	637.3	337.7	148.9	461.1	385.4	275.3	392.6	58.9	829.8	1576.7	867.5	105.9	435.3	847.1	303.7	1153.3	1054.3	581.8	939.9	386.6	693.4	849.1	465.6	519.8	355.4	420.9	153.5	568.7	575.0	723.7	764.7	720.0	545.6	1044.9	757.6	475.6	1300.4	258.3	420.4	656.7	417.0	565.7	628.8	1027.6	495.9	809.6	1069.0
CHCHD3	"FLJ20420, Mic19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784868-133082088	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042935	Enhanced		Supported	Mitochondria		NA	NA		110000	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	15.2	15.8	9.9	13.4	11.6	15.4	13.7	10.1	14.2	10.5	17.3	9.8	7.9	19.9	13.2	9.7	10.5	9.7	10.4	42.6	9.5	8.9	23.2	17.9	11.7	10.6	10.4	8.0	11.6	9.8	13.9	17.0	10.7	10.9	10.5	18.3	11.5	10.6	11.1	109.1	9.0	20.5	13.9	9.7	12.2	13.9	6.4	10.8	19.7	14.6	30.1	13.2	12.9	13.6	19.0	28.2	15.4	29.9	21.2	19.9	15.3	23.4	24.1	24.5	33.8	17.7	16.3	14.5	23.0	21.9	26.3	29.2	28.3	26.1	19.5	9.2	14.6	58.5	16.5	28.3	19.8	37.2	25.5	26.8	20.1	24.9	16.4	35.2	45.1	15.0	14.7	13.7	36.0	37.7	13.2	18.3	25.8	42.8	17.9	24.3	30.9	65.6	39.6	40.2	37.9	27.9	32.7	35.9	27.9	25.6	19.5	31.3	39.1	19.1	15.1	43.5	17.5	12.6	27.1	15.1	25.2	10.8	39.4	41.2	17.3	22.1	49.2	39.7	38.7	35.3	14.9	21.8	15.4	16.1	29.9	15.3	19.0	14.7	15.5	28.2	11.7	13.0	14.5	3.1	21.2	24.1	24.6	19.9	15.3	9.9	11.6	10.1	14.2	9.5	8.9	10.4	8.0	10.9	10.8	23.8	19.2	25.3	26.1	31.0	23.1	116.2	40.8	29.4	28.4	14.0	21.6	64.7	106.1	46.3	76.6	29.3	40.2	0.0	53.2	67.5	37.3	25.3	33.5	19.2	67.5	14.3	34.4	16.0	24.0	74.9	29.1	38.1	35.4	59.5	46.7	22.9	42.8	21.0	33.2	67.4	23.8	32.3	50.9	12.7	24.7	35.3	57.2	35.5	71.7	35.4
CHCHD4	"FLJ31709, MIA40, TIMM40"	ENSG00000163528	"Coiled-coil-helix-coiled-coil-helix domain containing 4"	Q8N4Q1	3	14112077-14124870	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034688, HPA063727"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034688: AB_10696361, HPA063727: AB_2685103"	"unprognostic (3.89e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.63e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.65e-2)"	"unprognostic (7.85e-3)"	11.4	13.3	15.0	8.8	16.4	3.3	12.8	11.6	17.7	9.2	15.8	12.6	9.5	15.7	8.7	11.7	12.1	10.9	9.8	27.3	13.7	13.5	22.3	20.1	7.8	8.9	17.0	10.7	11.5	18.8	21.7	9.3	9.2	13.5	12.7	17.2	9.6	10.7	13.8	32.2	8.9	12.7	15.3	11.1	9.6	11.9	9.4	14.3	7.2	13.4	12.4	13.2	14.0	16.4	14.1	19.8	7.9	18.1	16.6	14.3	8.6	8.0	16.8	8.8	8.6	7.6	8.6	25.5	8.7	8.2	10.8	9.6	9.9	6.6	17.5	8.6	6.6	11.0	6.6	18.1	18.1	13.4	10.9	18.1	20.4	12.5	13.0	12.8	13.7	8.8	7.5	19.3	17.7	28.4	7.7	12.1	14.1	21.1	15.7	11.5	17.1	17.1	8.3	13.5	25.3	22.7	12.4	8.8	37.2	12.2	8.9	7.3	8.9	9.8	31.7	12.7	7.9	15.2	14.0	4.3	9.9	7.2	12.3	15.9	8.8	23.1	17.4	9.8	21.2	7.2	5.7	12.5	7.9	6.6	18.1	11.4	11.2	11.0	9.9	19.8	14.1	14.3	9.7	5.4	16.6	17.5	8.1	12.2	8.6	15.0	16.4	11.6	17.7	13.7	13.5	17.0	10.7	13.5	14.3	14.9	7.5	18.2	10.7	8.4	7.6	21.8	12.7	5.3	6.8	8.7	0.0	20.2	71.3	16.6	1.9	8.1	15.9	0.0	11.7	16.8	9.9	11.4	10.4	16.3	18.5	4.8	4.7	3.7	6.9	4.0	10.6	8.2	8.5	7.2	12.1	7.4	10.7	13.5	9.6	37.8	5.6	6.5	7.8	16.6	36.8	10.3	10.9	7.5	17.9	10.9
CHCHD5	"C2orf9, MGC11104, MIC14, MIX14"	ENSG00000125611	"Coiled-coil-helix-coiled-coil-helix domain containing 5"	Q9BSY4	2	112584240-112589275	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038263	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038263: AB_10671525"	"unprognostic (3.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.18e-3)"	"unprognostic (8.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	12.7	17.8	15.1	11.4	15.0	15.7	15.6	9.0	13.4	10.5	12.4	11.7	19.8	17.5	11.4	17.5	16.2	20.0	16.7	20.3	12.0	12.1	20.3	36.6	12.9	17.6	16.7	11.4	10.7	36.8	10.2	20.0	11.9	10.1	13.4	6.5	11.0	12.6	37.7	33.3	12.9	16.1	11.8	12.1	11.7	15.2	50.0	12.9	20.7	20.2	23.4	8.6	13.0	12.1	27.9	40.2	32.1	35.4	28.6	37.1	28.6	13.3	22.4	10.1	0.0	4.1	8.7	9.5	5.9	7.8	12.3	8.8	24.3	16.6	10.3	23.6	8.2	10.4	9.9	3.8	13.2	1.6	11.1	18.4	13.9	7.3	19.2	18.1	11.7	9.8	11.7	11.3	16.2	10.0	5.7	6.7	0.0	14.3	15.7	7.7	33.3	10.5	18.6	11.1	10.0	11.1	0.3	8.3	20.2	16.1	12.2	12.9	14.5	7.5	11.3	13.2	2.8	14.5	10.4	9.3	12.3	17.4	7.4	8.4	28.2	26.5	11.9	17.1	3.2	14.5	11.1	35.4	32.1	26.3	31.6	22.3	24.0	25.1	24.9	31.8	27.9	26.1	26.9	19.2	28.6	28.7	40.2	37.1	28.6	15.1	15.0	9.0	13.2	12.0	12.1	16.7	11.4	10.1	12.9	8.9	15.2	54.1	60.0	38.2	19.2	30.3	101.9	40.2	23.9	78.5	9.8	114.1	185.6	95.9	138.2	39.4	145.2	46.7	153.5	94.3	60.9	61.4	24.3	180.9	108.7	6.4	88.1	50.3	119.7	199.0	28.4	59.4	50.6	95.6	80.7	31.0	111.8	144.0	26.5	166.5	20.8	12.9	43.8	100.6	34.5	50.7	77.6	55.4	82.6	66.3
CHCHD6	"CHCM1, MGC13016, Mic25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704220-126960406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 136.0;Melanocytes: 163.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047673, HPA051975"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047673: AB_10961761, HPA051975: AB_2681679"	"unprognostic (3.94e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	5.5	13.8	23.2	5.8	20.8	3.8	8.7	8.9	27.0	7.4	5.3	8.7	4.9	4.1	6.7	5.6	7.2	14.6	5.6	11.6	31.1	17.0	7.5	6.1	8.3	3.7	15.3	18.8	14.5	15.1	6.7	7.7	4.4	11.4	7.0	3.4	7.6	14.2	8.9	4.0	8.1	4.6	5.8	9.9	4.8	7.4	34.0	7.6	3.3	12.3	5.9	4.3	5.0	7.4	10.5	6.3	1.8	3.5	6.3	11.1	4.3	18.9	11.1	9.8	23.8	3.5	5.4	5.6	7.3	5.0	8.6	8.4	15.2	8.3	8.3	17.1	4.3	9.4	11.1	7.3	20.1	4.2	2.3	20.0	6.8	8.1	14.8	10.4	14.9	4.6	5.4	12.3	4.1	8.8	7.0	5.6	15.0	6.2	5.0	7.5	14.2	21.7	14.9	11.8	10.8	12.6	11.7	15.0	20.0	7.5	8.3	18.1	11.2	7.5	12.9	23.4	5.0	7.5	5.6	5.0	9.7	12.1	13.0	7.5	6.4	3.0	10.3	10.9	4.9	9.0	0.0	2.3	1.8	6.9	3.5	8.7	7.8	9.8	8.1	6.3	10.5	9.5	11.1	0.0	6.3	3.3	4.4	8.9	4.3	23.2	20.8	8.9	25.6	31.1	17.0	15.3	18.8	11.4	7.6	17.9	8.4	6.5	16.7	26.3	12.6	12.6	5.1	37.5	21.6	14.0	17.7	27.5	49.7	22.8	69.0	6.8	2.6	0.0	21.3	9.3	13.9	13.7	13.9	5.9	136.0	19.1	7.5	6.2	6.6	82.1	14.7	9.4	163.6	3.6	9.1	14.0	15.3	7.0	20.8	22.3	13.5	0.0	18.8	64.1	46.7	26.3	12.9	5.3	12.0	17.3
CIAPIN1	Anamorsin	ENSG00000005194	"Cytokine induced apoptosis inhibitor 1"	Q6FI81	16	57428169-57447528	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 158.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041350, HPA042182"	Enhanced		Supported	Mitochondria		No	No		6400	Mitochondria		"HPA041350: AB_10796665, HPA042182: AB_10794646"	"unprognostic (1.78e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.41e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.61e-2)"	"unprognostic (3.86e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.16e-1)"	13.5	21.0	12.8	12.6	19.1	11.5	12.2	18.3	29.3	10.6	19.3	14.8	8.7	14.5	11.9	10.7	18.9	10.8	15.9	23.9	12.8	16.5	20.7	19.7	13.1	14.1	15.6	17.6	10.5	17.2	18.9	11.9	21.8	21.0	11.7	17.3	14.2	15.0	11.3	35.3	17.5	15.0	14.2	10.6	14.4	13.7	44.0	10.7	19.2	15.8	18.0	20.9	13.1	12.1	22.7	32.4	17.3	27.5	27.5	48.8	45.5	16.0	24.0	25.8	19.9	14.8	10.2	22.3	18.9	16.0	32.8	15.4	26.9	13.1	17.3	27.3	14.2	10.5	31.0	34.5	25.2	28.4	10.0	21.1	22.2	21.0	28.2	24.3	26.9	23.1	16.1	27.8	23.6	30.2	12.9	31.9	21.8	31.0	10.6	18.8	15.9	26.6	21.6	35.0	18.6	35.3	49.7	31.1	36.1	21.9	18.3	22.7	28.5	40.4	28.9	18.2	21.9	21.1	23.6	20.4	14.5	18.8	14.5	21.0	28.5	36.1	57.8	17.5	25.8	22.7	13.9	27.5	17.3	26.9	25.7	24.8	22.7	22.7	28.3	32.4	22.3	48.8	43.0	6.7	27.5	20.8	27.7	24.3	45.5	12.8	19.1	18.3	29.3	12.8	16.5	15.6	17.6	21.0	10.7	14.9	22.4	13.4	13.2	12.7	27.8	33.0	22.9	12.0	17.0	21.0	9.8	78.3	33.2	50.4	14.5	20.3	15.4	0.0	45.2	38.8	14.3	13.0	10.4	15.7	34.7	22.3	17.9	19.6	10.5	25.4	13.0	17.7	23.6	57.7	17.2	26.1	42.5	24.6	19.4	28.0	14.6	38.8	12.2	158.4	51.5	13.9	88.8	14.6	23.8	13.2
CISD1	"C10orf70, MDS029, mitoNEET, ZCD1"	ENSG00000122873	"CDGSH iron sulfur domain 1"	Q9NZ45	10	58269058-58289586	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 63.1"	"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 606.8;Proximal tubular cells: 437.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074383	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA074383: AB_2686684"	"prognostic unfavorable (1.11e-4)"	"unprognostic (8.60e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (6.69e-4)"	4.7	8.9	14.0	5.4	21.6	1.4	5.4	14.8	24.9	6.2	10.3	3.7	3.6	17.8	5.2	3.9	9.5	5.7	6.4	32.1	16.2	17.6	20.8	13.2	4.1	4.9	14.7	19.5	6.4	4.8	63.1	10.5	5.0	16.6	6.9	7.7	5.8	8.0	6.7	43.9	7.2	16.7	8.9	9.0	4.2	6.4	3.0	6.0	3.5	8.7	20.4	5.1	8.3	4.4	7.6	9.5	3.0	5.8	6.1	8.3	5.1	12.1	6.2	4.9	9.0	6.7	7.5	2.9	10.3	11.9	10.3	14.2	14.5	11.5	21.7	8.7	10.6	6.0	8.0	13.4	9.2	9.3	9.7	18.2	5.7	10.3	11.7	7.6	10.0	4.5	9.3	7.6	9.8	15.1	8.8	12.0	11.0	12.5	10.2	7.1	4.1	8.5	10.8	5.3	9.3	19.5	6.6	18.3	11.4	13.9	4.3	15.7	5.6	7.9	21.2	7.3	4.5	14.1	5.4	11.8	4.4	8.0	12.8	12.2	10.4	16.9	16.3	11.9	10.0	4.3	0.0	5.8	0.3	5.7	4.2	6.7	7.6	6.6	6.6	9.5	6.0	7.7	7.5	3.0	6.1	2.6	6.2	8.3	5.1	14.0	21.6	14.8	24.9	16.2	17.6	14.7	19.5	16.6	6.0	56.6	40.8	43.2	69.2	114.4	85.6	290.3	127.4	66.9	55.7	127.4	41.2	139.3	606.8	85.2	163.9	59.9	102.8	23.3	70.7	53.7	53.8	54.1	34.5	218.9	59.2	39.7	216.5	78.0	41.4	266.7	39.1	30.5	173.7	19.8	105.2	33.6	75.5	104.0	37.8	437.6	44.2	32.3	59.0	46.8	59.2	99.9	60.8	26.6	102.8	57.1
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 303.7;Extravillous trophoblasts: 535.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.7	82.4	61.8	33.5	8.9	9.2	49.4	27.8	21.6	60.4	48.4	79.6	88.4	56.9	47.6	18.4	33.9	55.5	61.2	39.9	56.8	51.1	39.7	38.5	36.7	55.9	2.7	46.3	35.4	5.3	17.3	51.6	71.6	12.4	30.3	39.5	62.5	77.4	45.4	59.4	43.4	35.8	78.4	57.4	74.4	43.7	50.9	72.9	21.5	21.9	25.2	63.7	42.0	39.9	46.0	74.9	53.4	64.8	16.8	39.2	40.6	32.4	66.2	47.8	92.7	80.3	24.9	39.5	54.1	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5	11.9	26.6	58.1	85.2	193.2	2.1	8.9	68.8	40.2	40.9	27.9	0.0	103.2	68.0	71.4	12.5	39.5	35.7	303.7	98.8	535.3	106.1	48.1	20.7	75.7	110.7	1.6	19.7	30.1	33.8	18.8	70.5	54.9	108.0	55.9	35.3	15.6	87.5	41.8	43.2	64.8	2.4	19.4	106.1	117.9	120.7	178.0	110.3	47.9	49.4	87.8
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 581.2;Spermatogonia: 464.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	84.0	72.1	44.1	29.5	13.0	11.9	32.2	50.1	27.0	55.5	44.5	29.6	41.8	63.0	29.7	18.7	98.8	59.2	52.9	38.6	63.9	49.1	42.8	31.9	52.8	78.5	5.6	65.0	36.4	4.3	8.9	39.7	35.1	21.2	51.3	51.9	38.0	55.2	71.1	63.1	51.0	114.6	64.4	99.0	66.6	44.2	48.5	37.6	43.5	19.3	37.4	22.3	41.6	40.4	40.4	43.2	48.6	37.8	29.1	24.0	45.6	58.0	72.8	44.8	90.7	50.8	35.4	37.7	34.1	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6	35.7	93.0	97.3	70.9	248.9	4.2	55.0	5.1	12.0	17.0	14.0	0.0	149.0	19.9	15.2	25.4	26.7	39.1	350.4	9.7	329.6	72.5	59.4	147.1	19.5	152.7	0.0	117.0	28.3	40.0	59.4	23.9	84.8	133.3	33.3	56.8	24.6	23.3	46.9	15.6	148.6	6.0	45.3	99.9	581.2	464.7	261.3	166.8	40.1	104.9	59.3
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361452-6368910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	22.1	27.3	18.4	22.5	18.8	20.1	19.9	16.6	20.9	16.1	23.2	17.9	22.2	25.4	16.9	15.1	26.6	15.3	19.2	28.9	17.4	16.7	28.5	64.7	15.5	35.5	19.0	15.2	23.7	32.7	11.6	18.5	18.4	13.6	19.1	14.1	18.6	26.3	23.4	73.1	17.8	26.0	14.8	16.7	21.2	21.3	21.1	11.4	54.8	27.0	25.1	25.3	20.7	23.2	29.7	37.5	14.9	20.0	27.6	46.3	32.9	31.6	21.1	15.4	28.1	9.7	13.5	16.0	18.8	13.8	26.8	24.1	16.9	11.6	31.9	29.3	15.0	15.3	19.8	15.3	23.7	10.2	33.1	47.9	23.5	18.6	25.0	26.3	21.2	31.1	17.1	17.4	18.6	20.8	18.4	26.0	42.3	23.3	43.3	17.5	37.0	36.3	22.2	22.2	24.5	49.5	25.6	18.6	48.4	19.9	17.7	25.5	24.5	11.9	29.2	27.6	10.0	15.0	30.4	18.2	17.8	16.5	41.6	35.4	55.6	46.4	30.7	24.3	30.0	28.2	5.5	20.0	10.5	28.0	17.7	33.2	28.3	39.9	34.5	24.1	29.7	35.2	34.1	14.9	27.6	12.1	37.5	46.3	32.9	18.4	18.8	16.6	20.9	17.4	16.7	19.0	15.2	13.6	11.4	20.8	35.7	37.2	49.7	40.0	30.7	40.3	58.6	36.1	17.0	41.8	11.8	60.5	122.7	78.4	82.6	46.3	64.7	23.3	84.4	102.0	37.0	67.2	25.4	81.5	71.6	20.6	33.9	49.1	31.4	188.9	39.4	35.5	52.3	93.8	43.9	34.4	88.0	56.1	40.7	126.3	20.5	12.9	36.0	68.8	45.8	32.4	48.3	53.2	60.6	56.1
CLPX		ENSG00000166855	"Caseinolytic mitochondrial matrix peptidase chaperone subunit"	O76031	15	65148219-65185342	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.9"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 189.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040262, HPA048199"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA040262: AB_10793961, HPA048199: AB_2680312"	"unprognostic (2.78e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.93e-9)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.50e-2)"	10.4	12.8	11.3	8.9	12.7	7.7	10.2	10.9	10.7	11.7	13.4	11.2	4.7	9.3	9.8	10.3	15.5	8.9	9.6	15.9	10.7	9.2	16.8	50.9	9.4	8.8	12.8	8.1	10.8	10.6	11.0	6.3	10.6	9.8	9.7	8.9	7.4	8.9	7.1	25.8	15.6	12.6	10.8	9.7	9.7	9.9	9.3	12.6	17.8	12.9	14.7	10.2	12.5	9.5	7.7	9.8	11.4	7.1	8.2	9.2	4.4	5.3	9.1	8.0	10.1	8.5	11.0	8.6	6.1	6.9	6.8	7.1	9.1	7.5	16.6	5.2	8.2	5.0	11.5	29.3	8.1	7.3	6.5	5.3	12.5	8.9	11.5	12.2	15.9	7.3	13.1	11.2	6.2	11.9	7.8	8.6	9.0	11.4	5.9	7.9	6.8	7.5	14.1	9.0	10.6	4.1	14.8	9.5	17.1	12.7	12.4	7.0	5.7	8.3	13.3	9.0	11.0	6.1	13.5	7.5	6.9	6.0	5.5	5.7	6.3	9.6	8.7	6.7	20.2	5.3	3.5	7.1	10.3	7.6	5.7	7.0	7.7	6.7	5.6	6.4	7.2	9.2	7.3	11.4	8.2	5.1	9.8	5.7	4.4	11.3	12.7	10.9	10.7	10.7	9.2	12.8	8.1	9.8	12.6	32.8	28.6	14.9	17.9	17.1	27.3	62.7	28.1	33.5	33.0	31.4	13.7	35.1	18.3	32.5	87.1	17.9	15.6	0.0	27.4	27.2	19.7	20.0	15.1	79.9	19.8	30.2	9.9	22.1	23.9	189.0	26.7	16.0	16.9	26.2	22.4	24.3	27.3	17.5	28.0	28.4	24.1	25.8	16.0	33.9	29.6	26.3	74.6	19.1	23.3	18.4
CMC2	"C16orf61, DC13, MGC45036"	ENSG00000103121	"C-X9-C motif containing 2"	Q9NRP2	16	80966448-81020270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006871, CAB026396"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB026396: , HPA006871: AB_1845581"	"unprognostic (2.43e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.57e-3)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-1)"	8.2	17.0	31.5	8.9	30.9	25.5	15.0	18.7	28.7	7.2	11.8	22.2	8.7	12.8	6.4	11.9	12.5	5.5	11.5	42.3	28.3	27.9	24.7	29.1	9.5	13.3	30.7	16.0	5.7	19.7	19.2	11.1	11.0	23.9	15.2	11.8	7.0	10.3	9.3	32.0	6.2	13.5	10.6	27.8	9.5	13.5	28.1	20.3	9.8	10.3	13.0	11.0	11.8	7.0	21.9	25.3	20.1	17.9	24.7	34.6	10.3	22.1	31.7	23.8	14.2	7.9	8.0	14.0	22.6	10.3	20.1	10.4	21.6	15.3	10.3	16.9	10.8	19.8	16.0	16.1	13.1	26.8	15.1	19.4	15.7	22.6	23.1	13.1	12.8	26.8	7.0	7.4	24.3	13.7	9.2	17.8	25.4	37.0	13.8	19.5	42.4	20.0	41.6	14.0	18.0	19.1	25.2	12.9	13.1	15.6	11.2	20.0	11.6	34.3	12.2	25.8	12.9	24.3	11.9	10.2	18.3	25.7	17.6	22.6	14.2	30.9	57.1	14.0	16.6	21.3	14.9	16.6	20.1	17.4	16.0	16.3	21.9	22.1	17.9	17.8	18.9	15.7	17.8	7.1	24.7	17.9	25.3	34.6	10.3	31.5	30.9	18.7	28.7	28.3	27.9	30.7	16.0	23.9	20.3	32.8	44.6	52.4	56.6	86.7	30.0	177.4	35.7	33.5	28.4	45.4	51.1	35.1	134.3	31.7	74.7	35.1	25.7	46.7	32.9	52.1	47.6	68.0	91.4	80.0	46.5	28.6	36.8	28.3	51.5	128.4	22.7	64.0	62.4	25.2	36.6	25.0	35.2	31.6	27.6	119.0	15.4	58.2	55.6	265.1	102.6	89.3	31.8	58.9	37.9	64.1
CMC4	"MTCP1, MTCP1NB, p8, P8MTCP1"	ENSG00000182712	"C-X9-C motif containing 4"	P56277	X	155061622-155071362	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 8.1;Club cells: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 36.5"	"Low region specificity"	"Detected in all"							HPA045866	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA045866: AB_10964642"										"unprognostic (4.54e-3)"				"unprognostic (7.31e-2)"				11.5	9.2	13.4	9.2	12.6	6.2	26.7	7.1	8.9	11.0	11.3	6.7	13.2	9.7	9.9	13.6	12.5	8.9	8.3	49.6	10.9	10.0	12.0	21.8	15.0	26.2	13.7	5.7	11.9	34.6	7.1	11.4	6.8	11.6	10.5	6.0	7.6	14.5	12.6	21.2	8.2	11.4	15.2	15.8	8.3	8.5	7.3	7.4	5.4	14.5	10.0	7.7	12.4	8.7	11.3	10.8	11.8	7.5	12.0	9.0	4.6	19.9	5.1	3.0	6.7	8.5	8.2	4.7	4.0	5.7	5.7	9.7	3.8	3.8	13.7	10.5	4.4	16.0	6.6	4.0	5.2	4.0	14.5	10.3	2.3	3.5	4.5	8.7	4.2	3.1	7.8	8.6	5.9	7.6	5.3	4.7	8.3	2.3	5.0	5.9	7.5	5.7	8.0	1.8	7.9	14.5	4.4	7.1	8.9	6.4	1.2	6.2	5.1	5.3	5.9	6.8	3.9	4.4	2.5	5.6	8.7	5.4	5.6	5.3	20.6	20.6	36.5	8.2	9.9	5.7	1.1	7.5	11.8	9.0	4.2	8.7	11.0	7.1	8.3	10.8	11.3	2.2	5.9	0.8	12.0	1.5	2.1	8.2	4.6	13.4	12.6	7.1	8.9	10.9	10.0	13.7	5.7	11.6	7.4	0.0	2.6	0.0	0.9	0.7	1.0	0.0	2.5	8.1	10.3	0.0	0.0	0.9	3.3	0.8	0.0	0.0	1.1	0.0	0.4	0.8	1.5	0.4	4.7	3.6	0.9	0.0	1.7	2.5	1.0	1.3	3.4	1.2	1.7	1.0	0.9	1.8	0.9	0.3	1.8	2.8	0.3	0.0	0.3	1.5	0.4	2.0	1.0	2.5	1.7	0.6
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	8.8	3.8	3.0	6.8	8.1	14.5	4.2	0.9	5.0	2.7	4.2	4.0	1.3	5.0	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4.0	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3.0	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3.0	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	14.2	12.9	0.0	1.4	3.1	0.8	0.0	3.7	0.2	0.0	0.0	0.0	0.3	0.2	20.1	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.0	4.9	0.1	0.0	0.1	11.0	3.7	0.3	0.0	1.1	3.5	0.0	0.0	0.0	0.4	0.3	0.5	0.2	0.0	1.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3.0	8.1	0.9	5.0	3.3	3.9	3.2	5.7	3.6	0.4	3.0	6.9	2.7	0.8	0.3	1.6	1.4	0.0	4.0	0.0	1.8	0.0	2.0	1.7	2.4	2.5	4.7	5.3	70.0	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0.0	6.9	7.4	6.7	1.1	1.4	5.1	0.0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0.0	2.0	0.1	4.1	0.4	0.7	4.3	0.9	1.6
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.9	13.1	13.0	18.7	9.2	10.9	13.4	13.5	7.3	24.3	20.3	16.3	9.7	31.4	23.7	7.2	21.5	17.5	18.0	15.3	32.2	16.2	17.2	24.7	9.3	13.2	16.6	33.8	13.6	7.4	14.9	18.1	30.3	7.7	16.8	25.4	15.2	20.4	17.6	20.0	27.0	31.5	19.0	27.6	32.9	12.2	21.0	33.6	15.0	7.1	36.7	15.4	13.5	11.0	30.7	13.0	13.3	21.2	4.8	19.3	54.8	11.2	27.4	14.6	29.0	61.0	12.5	37.4	32.2	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5	6.0	14.2	29.8	33.2	55.3	30.0	40.3	43.3	29.4	23.9	59.3	17.7	34.3	82.9	17.0	137.8	37.9	1.1	0.0	40.8	46.0	41.2	21.8	61.1	44.9	24.7	120.8	14.5	19.0	5.8	151.1	46.9	25.2	35.4	14.4	13.3	17.6	29.9	0.0	55.2	66.2	21.4	25.8	64.6	105.9	127.7	57.7	18.3	28.7	20.7	22.0
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387504-154510659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.4"									"CAB037133, HPA049651"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	9.4	2.2	4.2	5.5	5.8	1.6	5.8	1.8	5.0	7.6	12.5	11.6	6.0	8.7	15.8	8.3	19.4	6.5	9.2	8.9	5.3	3.4	17.0	20.0	6.3	3.5	8.0	2.5	10.0	26.6	1.5	4.5	8.2	8.3	8.3	5.5	12.6	7.5	7.7	2.2	6.7	13.5	15.3	8.2	7.6	6.7	8.6	7.7	0.6	4.1	8.7	6.6	9.8	10.2	0.9	1.4	3.6	0.6	0.9	0.5	0.2	0.3	4.0	2.8	5.6	5.0	3.8	0.3	4.9	3.0	8.6	7.1	17.4	0.4	0.1	5.4	5.3	2.8	1.7	8.3	0.5	4.5	0.0	5.1	13.3	0.8	9.6	2.2	0.0	3.0	5.1	2.7	3.3	3.4	1.5	2.7	1.1	1.7	0.1	2.3	1.1	0.1	0.3	2.0	3.3	5.2	3.8	4.9	6.4	10.0	2.8	1.7	10.7	2.2	1.2	1.0	1.3	0.0	1.2	3.1	0.8	2.5	6.4	3.2	0.1	0.0	0.1	0.1	0.3	3.7	2.1	0.6	1.2	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.9	0.5	0.5	3.6	0.9	0.4	1.4	0.3	0.2	4.2	5.8	1.8	5.0	5.3	3.4	8.0	2.5	8.3	7.7	11.9	38.5	0.9	13.6	23.6	1.9	30.2	12.7	13.4	18.2	24.4	0.0	6.3	8.3	14.8	39.4	28.7	27.4	0.0	10.4	0.8	14.6	10.7	5.7	55.0	1.5	0.0	41.5	67.5	7.6	11.1	5.5	5.1	30.4	1.0	21.1	27.8	10.1	15.8	9.9	24.5	1.8	0.0	6.6	1.1	5.3	20.8	18.0	5.1	11.5	8.8
COA1	"C7orf44, FLJ10803, MITRAC15"	ENSG00000106603	"Cytochrome c oxidase assembly factor 1 homolog"	Q9GZY4	7	43608456-43729717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA011944	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011944: AB_1848671"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.39e-2)"	13.8	16.2	22.4	14.4	21.7	17.6	14.5	13.8	24.0	11.8	10.9	14.4	17.4	11.4	14.8	14.3	15.1	9.6	10.9	47.8	19.7	18.5	23.4	14.4	11.9	24.2	23.0	13.2	11.1	23.9	9.4	22.1	11.3	17.4	10.9	14.7	17.9	17.5	17.7	55.5	7.0	12.6	9.7	19.9	16.2	14.5	11.8	14.3	16.2	15.8	22.4	28.3	14.8	8.8	21.0	17.9	24.2	17.2	18.6	21.0	14.4	10.5	28.5	23.6	23.2	6.9	7.8	15.8	14.8	25.4	20.2	21.0	21.7	24.2	20.1	25.1	9.0	42.6	15.4	27.2	22.8	25.6	18.0	25.0	25.0	16.8	19.9	11.4	19.4	11.1	6.4	14.6	14.6	21.8	21.7	18.3	24.4	42.3	17.5	16.4	14.4	28.5	48.8	14.8	22.1	20.6	17.3	21.6	37.1	24.6	11.9	14.5	26.0	14.9	27.7	9.6	35.6	20.7	13.1	13.6	10.0	21.9	9.8	20.9	42.2	34.1	36.1	28.5	25.0	26.6	1.3	15.3	16.0	12.9	17.2	9.5	19.7	12.0	13.2	17.9	21.0	16.9	21.0	24.2	18.6	14.6	16.0	11.5	14.4	22.4	21.7	13.8	24.0	19.7	18.5	23.0	13.2	17.4	14.3	26.8	35.0	59.1	58.9	11.6	42.6	55.7	17.8	29.4	23.9	33.2	43.2	28.3	99.5	49.1	4.8	25.8	16.9	46.7	37.1	43.0	26.0	44.0	25.4	19.2	50.1	31.8	26.6	18.4	33.8	6.6	27.3	34.8	35.4	48.7	20.9	22.3	38.8	10.5	18.4	100.4	53.4	12.9	22.7	54.2	85.2	14.6	15.0	52.2	24.9	37.6
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 601.8;Proximal tubular cells: 547.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	13.4	17.8	34.5	11.1	26.7	4.6	20.6	19.5	31.8	18.7	33.7	18.0	18.2	35.9	14.0	62.6	30.2	26.2	20.0	26.3	29.3	26.0	57.2	44.1	13.7	14.1	31.2	22.2	17.0	97.0	16.2	15.0	17.8	26.1	22.0	31.6	14.9	30.3	25.1	28.7	12.6	33.5	14.5	21.6	12.2	27.1	9.5	17.1	13.1	22.8	28.6	19.8	14.1	18.1	56.1	49.2	46.0	59.1	46.2	50.5	59.7	16.2	55.2	25.4	13.9	23.5	20.0	15.6	12.8	19.6	30.7	27.8	21.7	20.6	0.9	36.4	15.5	28.9	15.9	19.5	31.3	29.1	15.9	51.3	11.0	26.0	68.6	16.6	14.8	13.3	20.3	23.6	28.9	16.6	15.7	24.3	7.9	17.5	14.1	27.1	26.7	4.8	32.4	11.6	33.5	19.9	19.4	37.1	27.9	31.1	22.5	19.0	15.9	13.1	13.9	22.2	22.9	43.2	19.4	14.8	33.5	17.5	14.1	16.9	16.7	18.0	8.7	25.1	14.8	22.6	46.0	59.1	36.8	39.8	54.9	41.6	56.1	41.4	40.2	49.2	51.2	38.4	38.2	6.3	46.2	45.5	32.9	50.5	59.7	34.5	26.7	19.5	31.8	29.3	26.0	31.2	22.2	26.1	17.1	26.8	53.5	65.9	51.4	32.6	33.1	216.0	178.3	105.7	47.8	253.0	19.6	126.9	601.8	110.3	8.4	56.1	184.6	0.0	208.4	149.1	56.0	56.9	34.6	366.5	106.3	42.9	76.7	73.6	73.2	15.0	51.8	46.4	84.4	81.2	165.8	62.7	139.6	178.9	42.5	547.1	26.6	38.8	61.8	48.1	47.3	48.6	85.5	37.4	224.0	60.3
COA4	"CHCHD8, CMC3, E2IG2"	ENSG00000181924	"Cytochrome c oxidase assembly factor 4 homolog"	Q9NYJ1	11	73872667-73876988	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040126	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA040126: AB_10795415"	"unprognostic (7.30e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.17e-2)"	19.0	46.2	18.9	17.0	17.3	10.8	18.1	12.2	20.2	17.5	23.9	25.7	27.0	24.7	18.0	22.4	24.9	20.1	31.5	35.3	17.7	17.0	33.2	74.7	14.7	20.2	20.5	16.3	23.2	37.1	17.6	17.2	18.3	19.4	21.5	21.1	17.6	21.2	28.0	33.2	14.4	31.2	16.2	21.5	20.1	19.2	13.5	19.4	16.3	38.7	27.6	18.2	21.5	18.9	23.4	32.3	5.3	20.6	16.7	21.2	15.0	20.9	39.1	16.1	23.5	14.3	17.8	16.3	21.4	14.9	25.4	21.5	28.5	26.1	17.8	43.4	17.6	20.5	21.1	24.6	28.6	19.8	23.3	22.4	29.9	24.3	26.7	27.2	20.3	23.5	22.6	27.4	42.4	27.7	14.5	23.3	17.7	25.7	17.6	22.7	39.9	16.0	31.8	21.2	82.8	40.5	18.7	34.7	47.1	26.9	19.4	14.6	24.5	19.8	22.7	57.5	16.5	31.8	20.6	15.9	21.0	18.7	42.2	27.9	21.8	23.6	60.5	11.5	25.4	23.7	5.3	20.5	4.7	15.9	20.6	20.2	23.4	18.7	16.5	24.6	20.4	20.1	21.2	1.4	16.7	19.1	32.3	19.0	15.0	18.9	17.3	12.2	20.2	17.7	17.0	20.5	16.3	19.4	19.4	32.8	29.0	44.7	53.9	47.6	19.8	62.1	89.2	49.5	36.4	52.4	21.6	140.3	109.5	72.0	22.0	43.6	113.7	46.7	82.4	84.7	46.3	77.6	61.1	154.9	85.2	17.5	69.7	28.8	37.8	8.2	50.9	50.0	27.0	51.3	90.6	41.3	87.3	73.7	36.0	190.6	16.4	6.5	34.3	51.0	36.1	44.8	102.3	34.8	108.4	86.3
COA5	"C2orf64, FLJ27524, MGC52110, Pet191"	ENSG00000183513	"Cytochrome c oxidase assembly factor 5"	Q86WW8	2	98599310-98608515	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 152.5;Proximal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057768	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA057768: AB_2683521"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.32e-3)"	"unprognostic (3.71e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.00e-5)"	13.7	21.4	30.9	12.2	29.3	9.1	20.6	31.3	28.2	18.6	15.0	20.3	18.5	15.4	20.2	33.5	11.1	20.5	13.4	19.3	28.3	26.5	28.1	23.4	13.9	15.8	30.7	29.0	23.6	16.8	21.0	19.1	14.2	23.4	19.8	15.9	13.7	16.2	20.3	30.7	18.0	13.5	14.7	32.7	15.6	16.0	15.6	21.5	15.3	24.5	10.1	16.1	13.9	15.0	24.7	30.3	28.1	25.5	18.1	30.0	22.0	12.6	5.4	16.8	12.2	19.7	16.4	14.0	7.3	5.8	7.9	8.4	10.9	10.9	6.4	13.4	5.8	14.9	9.0	14.6	7.8	9.7	16.7	13.6	8.9	11.0	17.8	14.4	8.5	8.3	15.8	16.8	5.6	7.3	14.0	8.6	18.1	12.6	7.5	8.7	10.6	11.3	15.1	11.6	13.0	11.9	6.9	12.5	14.1	17.4	6.9	12.8	16.2	6.2	7.8	18.4	20.1	9.6	17.9	7.5	12.2	11.0	7.2	6.0	12.4	17.3	8.1	14.7	18.9	9.9	18.2	25.5	28.0	25.2	22.7	21.9	23.5	23.0	24.1	24.1	24.7	28.1	27.9	28.1	18.1	23.7	30.3	30.0	22.0	30.9	29.3	31.3	25.9	28.3	26.5	30.7	29.0	23.4	21.5	14.9	23.7	29.0	25.9	9.3	26.2	56.8	43.3	42.8	15.9	45.4	5.9	31.9	152.5	31.4	11.8	26.0	22.5	0.0	21.6	31.2	23.0	26.9	26.5	53.8	45.3	20.6	25.9	27.0	33.2	9.0	30.2	29.1	27.0	31.5	39.0	31.3	29.2	21.0	32.9	133.1	22.2	12.9	25.2	75.6	33.2	10.2	27.3	20.8	36.0	29.5
COA6	C1orf31	ENSG00000168275	"Cytochrome c oxidase assembly factor 6"	Q5JTJ3	1	234373456-234384049	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028588	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA028588: AB_10601123"	"unprognostic (6.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.25e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.12e-4)"	11.0	17.8	26.4	14.4	33.9	9.4	16.6	14.3	27.5	9.7	17.7	5.7	12.9	26.4	8.4	20.3	15.5	9.4	14.2	19.1	19.3	15.7	21.4	21.4	13.6	16.2	16.3	16.1	9.1	16.7	7.6	9.5	8.7	13.4	13.3	15.6	6.0	13.6	11.6	52.7	8.7	19.7	10.6	11.4	12.5	14.4	5.8	13.3	13.1	13.6	20.2	12.0	11.6	14.6	27.5	33.3	19.7	31.3	18.3	36.6	20.2	17.8	22.9	8.3	9.4	8.7	17.3	26.4	13.1	8.0	13.8	13.0	17.6	23.9	17.8	24.4	7.5	25.9	22.8	12.9	16.2	11.0	22.1	55.1	8.0	26.0	46.6	33.6	19.6	15.6	11.4	21.8	18.1	14.0	12.1	17.0	19.8	38.8	16.1	14.9	9.5	18.6	38.1	20.4	40.3	10.9	11.1	10.0	35.0	17.2	16.9	14.8	10.8	12.7	22.6	40.4	5.5	20.0	33.9	12.8	16.4	13.6	21.9	39.2	19.2	37.2	21.8	12.5	31.2	29.2	19.7	31.3	9.7	18.5	28.5	18.2	27.5	29.9	23.0	33.3	18.0	31.3	23.1	8.1	18.3	23.8	22.5	36.6	20.2	26.4	33.9	14.3	27.5	19.3	15.7	16.3	16.1	13.4	13.3	8.9	20.0	38.5	39.3	50.8	13.8	71.2	22.9	53.5	26.1	45.4	3.9	44.1	87.9	47.5	2.9	23.3	63.5	23.3	59.9	71.2	34.2	56.7	21.9	46.9	75.0	11.1	21.4	22.1	35.3	3.4	24.2	49.2	28.7	43.3	52.3	20.6	56.3	40.3	26.5	86.4	13.3	19.4	24.5	17.2	25.3	51.3	36.5	30.0	65.5	64.8
COA7	"C1orf163, FLJ12439, RESA1, SELRC1"	ENSG00000162377	"Cytochrome c oxidase assembly factor 7 (putative)"	Q96BR5	1	52684451-52698366	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028154, HPA029926"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA028154: AB_10600656, HPA029926: AB_10602173"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	8.8	8.5	9.0	6.9	10.6	4.6	9.7	7.9	16.6	6.6	10.1	7.0	4.1	10.1	8.5	6.0	9.5	6.6	5.2	8.6	7.6	9.2	12.8	15.7	5.5	4.9	8.4	12.4	6.7	19.1	7.2	7.7	7.4	10.0	4.9	10.3	4.2	6.7	5.2	26.3	8.6	7.2	8.0	7.6	6.1	7.0	4.3	7.8	2.3	9.6	9.9	5.8	6.9	7.9	3.7	5.9	3.3	8.4	2.3	3.4	2.7	12.3	7.1	6.5	10.7	10.6	9.2	14.3	9.4	7.8	11.7	9.9	8.7	4.4	28.5	6.4	5.5	14.8	9.6	15.7	13.2	15.3	8.8	15.8	24.0	11.2	10.1	13.0	23.5	8.2	10.1	11.7	13.3	16.7	5.2	8.0	8.2	21.8	5.1	8.8	8.2	7.9	12.1	28.7	13.3	20.2	15.7	22.3	20.7	10.3	12.6	14.6	7.7	13.6	17.5	17.3	9.6	10.2	16.1	8.8	9.3	12.2	12.7	12.9	10.6	26.6	13.3	4.3	17.1	7.5	3.1	5.9	1.8	2.5	8.4	3.4	3.7	2.6	2.5	5.9	1.8	2.4	2.6	3.3	2.3	4.0	2.8	1.5	2.7	9.0	10.6	7.9	16.6	7.6	9.2	8.4	12.4	10.0	7.8	6.0	11.3	4.5	15.2	10.2	7.3	12.6	5.1	2.7	7.9	3.5	3.9	14.1	23.2	9.6	0.1	8.2	8.5	0.0	11.5	12.9	7.2	10.1	0.0	11.5	12.1	15.9	2.4	4.9	4.9	0.4	6.9	8.2	1.7	9.0	5.5	7.0	9.0	5.8	7.1	14.4	9.6	6.5	7.6	3.7	12.5	11.3	13.8	4.5	9.6	10.7
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369400-99394204	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 37.1;Distal tubular cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	5.2	7.8	8.6	4.2	10.8	3.2	7.5	13.6	16.3	4.5	8.9	4.5	4.3	6.9	4.3	6.8	8.2	4.5	3.0	21.7	8.2	7.5	10.2	12.4	2.9	7.1	6.9	12.0	6.0	5.7	11.6	7.4	2.5	9.8	6.8	11.0	7.3	11.7	7.6	28.0	5.8	6.3	6.6	4.6	4.8	5.2	2.3	6.0	4.1	4.3	16.8	7.0	7.5	4.6	6.6	8.0	9.4	7.4	9.7	12.5	5.3	12.0	6.9	8.4	11.9	5.5	6.2	11.6	10.4	6.5	15.8	18.3	9.6	5.2	11.8	7.0	7.8	10.2	11.2	14.0	16.3	19.3	12.5	17.9	14.4	9.5	10.3	7.2	20.8	5.7	3.9	10.0	9.3	9.4	3.5	9.6	14.6	21.9	9.0	8.4	11.9	9.1	17.4	10.2	11.9	13.4	4.5	8.6	15.7	12.4	10.5	13.2	7.0	7.2	11.2	13.6	5.9	13.7	13.7	3.4	6.9	10.1	10.6	15.8	3.2	5.9	18.6	8.8	20.2	10.1	9.4	3.3	2.4	6.0	7.4	6.8	6.6	7.6	9.5	8.0	3.1	12.5	9.5	0.5	9.7	6.3	5.2	5.5	5.3	8.6	10.8	13.6	16.3	8.2	7.5	6.9	12.0	9.8	6.0	3.0	3.0	6.1	8.0	3.9	7.1	37.1	7.6	0.0	5.7	3.5	0.0	13.0	28.2	10.0	0.4	4.5	3.2	0.0	9.3	11.0	4.1	2.0	1.1	7.8	5.7	6.4	0.0	3.7	0.6	0.0	7.5	3.3	5.0	1.8	6.5	10.4	7.0	6.0	5.6	8.8	7.8	6.5	8.2	3.4	12.4	3.8	5.3	4.4	9.0	3.1
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322536-128334072	"Disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021406: AB_2670691, HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favorable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favorable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	15.5	29.4	22.6	21.4	29.9	12.2	25.4	20.7	33.8	19.8	23.0	15.7	34.8	53.8	14.8	30.5	32.8	37.7	24.0	23.9	22.6	21.7	31.8	33.4	28.9	28.6	18.9	31.4	18.1	43.8	24.7	30.7	13.1	27.7	22.2	18.0	15.2	32.9	50.7	29.6	31.6	37.3	20.1	25.7	15.9	23.1	17.5	14.3	13.6	34.5	25.0	16.7	18.5	17.9	18.3	28.2	8.0	15.5	14.1	21.1	13.2	11.1	16.8	10.2	11.1	7.5	10.6	18.4	9.8	6.4	12.9	9.2	14.3	14.0	15.0	8.8	7.5	9.4	31.9	8.7	11.7	4.8	7.2	17.3	5.5	36.3	16.0	12.3	15.6	8.4	12.3	13.7	10.7	11.7	7.5	10.1	12.8	36.4	10.2	8.1	30.9	19.0	12.0	11.3	22.6	19.8	18.6	14.1	28.5	15.8	11.0	19.0	13.6	19.2	22.9	11.9	4.8	29.5	5.3	13.9	12.3	11.5	17.8	13.1	17.5	14.4	12.3	15.6	7.6	8.5	7.8	14.2	8.0	21.1	15.5	19.1	18.3	19.2	20.9	17.7	16.0	15.5	18.9	1.8	14.1	15.2	28.2	15.2	13.2	22.6	29.9	20.7	33.8	22.6	21.7	18.9	31.4	27.7	14.3	20.8	25.3	41.0	43.1	25.5	29.2	33.9	33.1	141.8	30.7	54.1	25.5	75.4	121.0	46.8	11.0	23.3	99.8	23.3	55.3	39.9	29.9	34.1	36.8	66.0	44.1	28.6	30.5	26.4	24.0	19.1	27.9	22.1	38.8	27.1	55.4	23.8	40.3	56.2	29.0	133.2	46.9	25.8	26.7	41.4	31.6	43.7	39.5	30.2	71.7	40.9
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503274-120534434	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA049487: AB_2680789"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	14.6	21.7	15.8	16.1	16.7	7.0	29.5	15.6	21.3	12.5	16.4	13.5	21.8	15.7	12.6	16.4	14.0	15.5	13.5	31.9	14.8	13.1	26.0	39.8	17.6	19.1	17.5	15.4	15.1	28.6	14.2	13.4	18.6	19.4	12.7	17.1	11.6	17.9	17.8	58.4	11.1	13.2	14.0	18.5	14.6	12.4	16.9	15.0	17.2	17.7	30.4	15.2	10.1	17.0	21.3	27.4	9.7	19.6	25.1	28.2	22.4	15.9	25.6	23.1	6.6	30.5	23.5	15.9	19.5	12.8	20.0	12.7	10.2	13.5	16.1	23.1	20.4	14.2	17.3	20.5	21.7	20.6	20.1	12.1	21.4	15.7	16.9	24.9	23.3	13.5	22.5	23.5	18.6	22.0	31.3	17.5	31.1	21.0	11.8	23.1	20.9	13.4	26.8	20.3	11.5	19.9	25.0	23.4	23.3	25.7	12.2	17.5	14.1	14.1	7.2	26.5	25.2	36.3	19.3	17.5	13.9	15.9	10.2	12.9	25.5	21.5	18.3	15.8	22.2	16.6	9.4	19.6	9.7	18.8	19.2	18.2	21.1	20.4	19.9	27.4	21.3	28.2	22.3	2.1	25.1	17.9	18.0	24.4	22.4	15.8	16.7	15.6	21.3	14.8	13.1	17.5	15.4	19.4	15.0	11.9	10.9	16.3	10.7	6.9	11.5	26.2	15.3	16.0	7.9	14.0	13.7	60.9	39.7	25.5	42.0	11.7	17.2	23.3	17.3	38.3	14.1	8.4	17.3	37.2	40.3	4.8	14.5	16.0	15.6	14.5	15.3	13.1	21.9	36.1	14.6	11.8	12.3	23.2	17.7	52.6	14.4	6.5	10.3	13.7	15.4	7.9	48.7	17.5	29.2	7.5
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 32.8;RPMI-8226: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria		NA	NA			Mitochondria		"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.1	5.8	1.5	4.4	4.7	3.0	23.4	1.5	1.3	2.1	2.8	9.1	5.1	9.4	7.2	1.0	1.2	3.7	2.9	3.3	0.5	9.9	32.8	6.6	4.8	15.0	1.0	9.9	4.0	5.9	5.0	1.7	2.3	2.1	1.0	9.7	11.3	7.8	0.3	4.3	5.7	14.6	6.4	24.3	11.9	5.7	7.0	29.9	0.7	2.4	24.1	9.9	2.9	11.7	8.5	1.7	6.2	13.5	1.2	2.5	2.3	3.4	5.4	17.5	15.3	4.9	2.3	11.3	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7	3.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	7.9	31.4	0.0	10.4	13.3	14.2	0.0	0.0	0.0	0.0	28.2	7.8	0.0	0.0	12.8	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	19.8	0.0	0.0	14.5	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0;Collecting duct cells: 12.2;Ductal cells: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.3	34.3	7.0	13.5	6.3	6.1	6.5	7.8	8.5	5.9	6.3	10.7	15.2	11.2	15.1	4.5	7.0	7.3	4.9	8.7	2.1	13.4	10.2	10.7	20.9	5.9	10.8	3.7	16.8	8.0	9.3	4.3	5.2	6.7	6.6	13.9	5.7	6.2	4.1	5.1	4.8	4.5	5.4	9.2	3.6	8.0	9.9	8.5	10.2	14.2	12.6	10.3	10.5	16.1	16.9	4.5	14.4	14.0	6.2	5.1	17.3	3.6	4.6	6.8	5.5	5.7	19.3	4.2	7.0	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7	11.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	16.0	4.5	12.2	0.0	9.4	10.0	12.4	0.0	0.0	0.0	0.0	9.5	7.9	0.0	0.0	1.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	10.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0
COQ9	"C16orf49, DKFZP434K046"	ENSG00000088682	"Coenzyme Q9"	O75208	16	57447425-57461275	"Disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.0"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 184.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040918	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA040918: AB_10794154"	"unprognostic (9.18e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.03e-11)"	"unprognostic (7.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-2)"	8.8	19.3	11.5	7.8	12.4	3.7	9.3	11.2	13.8	7.9	17.9	9.4	14.7	17.6	7.2	9.9	16.6	9.5	11.3	46.1	9.5	8.8	28.8	29.1	5.8	6.4	9.7	8.6	6.9	12.6	23.6	8.9	8.1	8.8	10.4	14.5	12.2	17.7	14.5	86.0	9.4	23.7	22.1	6.9	5.3	13.6	8.9	8.5	5.4	11.8	31.1	9.4	16.3	8.4	13.6	23.3	14.7	24.1	15.2	18.7	14.1	11.9	24.4	6.6	16.6	13.3	10.3	7.9	11.6	9.1	16.4	9.2	14.8	15.6	14.5	22.4	10.1	12.6	25.6	19.1	20.3	10.3	7.8	16.5	10.0	16.7	22.7	14.7	12.7	16.4	17.1	26.6	13.0	25.4	10.9	18.2	12.8	19.2	6.6	9.8	17.0	10.5	9.2	10.9	25.9	32.2	21.4	21.8	37.3	25.5	13.3	20.9	21.1	39.3	37.9	19.2	6.1	21.8	14.2	12.5	11.9	14.7	12.9	14.6	16.1	9.9	17.3	16.6	18.3	13.5	11.5	19.3	14.7	13.9	24.1	14.4	13.6	12.0	12.2	23.3	12.0	13.0	18.7	6.0	15.2	23.5	14.5	16.8	14.1	11.5	12.4	11.2	13.8	9.5	8.8	9.7	8.6	8.8	8.5	11.9	17.6	19.3	15.0	7.4	15.8	75.0	50.9	26.8	17.0	24.4	15.7	61.9	184.1	42.5	28.2	16.5	72.4	0.0	25.5	19.3	14.4	15.7	6.9	45.9	33.9	19.1	26.5	16.5	14.0	20.8	19.5	12.8	27.0	30.7	42.6	24.6	24.1	37.4	19.1	80.1	22.7	12.9	16.7	66.0	31.1	9.8	65.8	15.2	58.3	17.0
CORO7-PAM16		ENSG00000103426	"CORO7-PAM16 readthrough"		16	4340251-4420494	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Ciliated cells: 1.4;Club cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5"									"HPA041657, HPA053586, HPA062721"	Uncertain		Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Microtubules	"HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849"	"unprognostic (2.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.11e-4)"	"unprognostic (4.39e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.85e-1)"	2.4	3.4	5.4	5.2	7.4	6.7	2.0	3.0	6.0	2.0	2.5	10.0	0.6	3.2	2.2	2.4	2.2	2.9	3.1	2.2	4.8	4.1	2.0	2.9	3.4	11.2	10.9	3.2	2.0	2.0	2.0	1.7	2.4	4.1	2.2	2.0	1.1	2.0	3.0	2.4	3.1	2.5	2.2	10.1	4.5	2.5	4.3	9.9	4.7	2.0	1.2	4.1	2.8	1.8	0.4	0.6	2.7	1.3	0.5	0.8	1.3	0.0	0.0	0.0	0.4	0.0	0.3	0.8	0.2	0.4	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.7	0.0	0.5	0.0	0.2	1.4	0.2	0.7	0.7	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	1.9	1.5	0.0	0.0	0.6	0.1	0.6	1.2	0.1	0.0	0.1	0.0	0.0	1.3	0.9	0.8	0.7	0.7	0.3	0.4	0.3	0.6	0.4	0.3	0.3	2.7	0.5	0.4	0.3	0.3	1.3	5.4	7.4	3.0	6.0	4.8	4.1	10.9	3.2	4.1	9.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 89.2;Late spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	7.3	14.1	5.9	8.4	5.9	5.4	13.3	8.9	6.2	16.3	11.3	12.3	5.4	17.3	7.1	9.0	5.6	14.1	11.9	11.5	13.1	9.3	12.0	10.3	11.3	13.6	10.3	10.6	9.7	7.7	14.5	10.2	13.0	6.5	8.6	12.3	13.9	5.9	7.2	9.1	9.0	7.0	8.9	27.6	7.3	7.6	19.9	12.2	10.2	13.8	4.4	7.4	9.2	12.3	11.0	29.1	6.9	6.0	7.0	7.1	6.0	7.2	11.2	7.2	10.1	7.8	10.7	11.0	8.8	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9	0.0	14.3	5.2	7.2	8.7	8.0	89.2	7.6	5.3	4.5	10.4	9.8	16.5	34.9	8.0	33.1	4.9	19.0	0.0	7.5	14.8	5.1	7.4	4.7	8.9	9.4	0.0	12.1	4.9	3.8	61.2	2.0	5.4	5.0	4.6	14.2	2.8	8.6	11.0	6.3	11.4	11.6	0.0	5.1	14.6	15.9	9.2	13.5	5.3	15.1	11.8
COX14	"C12orf62, MGC14288"	ENSG00000178449	"COX14, cytochrome c oxidase assembly factor"	Q96I36	12	50111979-50120457	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 571.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044618, HPA062014"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA044618: AB_10960419, HPA062014: AB_2684657"	"unprognostic (5.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-3)"	33.1	30.2	25.9	16.7	33.7	17.5	27.8	46.4	28.9	18.5	24.0	16.7	29.7	28.1	13.9	34.0	17.6	17.1	22.1	60.1	23.4	24.9	39.5	40.4	18.2	18.6	29.6	28.7	16.6	19.6	19.5	26.1	15.0	27.8	18.5	22.0	25.1	26.4	30.5	75.4	13.1	27.1	20.5	24.8	19.0	20.9	8.4	26.6	8.7	25.4	38.5	16.7	19.3	21.8	56.8	65.7	56.4	52.2	38.7	58.6	52.5	16.7	32.2	7.1	16.2	31.7	19.4	14.3	12.9	16.7	19.1	16.5	30.7	21.8	15.8	37.3	15.7	17.1	16.3	12.1	18.3	16.5	17.3	45.4	31.0	28.6	24.7	13.2	24.2	27.6	24.5	25.3	14.3	16.6	19.8	17.4	16.8	15.0	30.8	19.4	36.7	19.5	34.4	11.7	23.7	43.4	16.1	12.5	36.2	27.6	27.9	19.0	11.4	19.8	35.8	37.6	15.2	23.8	20.5	15.2	11.9	12.9	19.3	11.3	22.6	32.2	19.2	17.3	21.0	6.4	56.4	52.2	46.0	43.2	48.9	45.4	56.8	54.5	47.6	49.5	47.1	52.0	50.9	18.8	38.7	44.3	65.7	58.6	52.5	25.9	33.7	46.4	28.9	23.4	24.9	29.6	28.7	27.8	26.6	56.6	95.2	111.2	77.0	110.9	65.4	464.4	165.6	93.7	63.7	211.1	21.6	164.5	479.1	104.3	5.5	95.2	364.2	46.7	148.2	95.7	85.9	119.9	65.6	322.2	191.9	44.5	149.9	73.6	123.3	17.9	119.7	114.8	141.7	202.0	184.1	64.2	118.9	228.0	102.9	571.4	49.0	103.5	154.3	38.4	50.3	139.3	106.6	109.0	191.6	86.0
COX15	CEMCOX2	ENSG00000014919	"COX15, cytochrome c oxidase assembly homolog"	Q7KZN9	10	99711844-99732100	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037727, HPA037728, HPA066096"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616"	"unprognostic (9.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.34e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.40e-2)"	14.0	31.6	15.5	13.5	23.8	7.8	15.3	15.2	25.6	13.8	17.9	23.0	14.2	15.5	18.2	15.5	17.3	16.4	16.8	19.3	14.4	15.5	25.3	27.1	11.0	15.4	15.2	16.2	20.7	15.3	17.0	26.7	17.1	22.7	15.9	20.1	21.9	13.5	14.0	28.8	14.4	14.1	16.0	14.6	17.0	15.1	14.2	14.0	21.0	18.9	12.0	23.0	19.4	13.6	17.4	18.0	21.7	23.1	11.7	13.0	12.9	14.6	31.6	13.4	29.3	19.4	15.1	11.0	11.2	14.4	17.0	16.1	23.6	21.0	27.3	18.5	9.8	11.1	21.6	28.7	15.8	18.4	12.6	14.1	15.7	16.1	24.4	20.4	21.1	15.0	16.5	14.7	17.9	29.0	25.9	17.7	24.6	17.7	21.2	15.5	15.4	15.1	15.5	14.9	14.7	15.0	18.8	19.6	17.6	15.7	10.6	11.0	18.2	20.2	11.1	19.0	11.4	42.3	8.8	13.9	8.9	12.6	13.2	16.7	17.3	22.4	18.4	15.6	34.2	7.5	21.7	17.4	16.4	10.7	20.1	12.4	17.4	12.2	12.3	18.0	16.5	12.6	12.9	13.3	11.7	23.1	8.3	13.0	12.9	15.5	23.8	15.2	25.6	14.4	15.5	15.2	16.2	22.7	14.0	20.8	6.7	13.3	8.0	5.5	13.2	21.4	15.3	34.8	14.8	14.0	9.8	20.0	24.9	14.4	1.6	10.6	13.4	0.0	13.8	18.5	7.1	8.1	2.3	22.2	15.6	12.7	16.8	4.9	25.1	1.4	9.8	10.9	11.8	13.6	10.9	12.4	13.3	10.5	9.6	20.3	14.9	0.0	8.2	8.4	9.8	8.2	19.0	8.7	16.6	6.8
COX16	"C14orf112, HSPC203"	ENSG00000133983	"COX16, cytochrome c oxidase assembly homolog"	Q9P0S2	14	70325081-70359731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062659	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA062659: AB_2684823"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.03e-12)"	"unprognostic (4.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.72e-1)"	19.3	25.2	23.6	15.4	20.4	10.9	23.5	14.8	23.3	16.2	19.6	16.8	16.8	21.8	12.4	29.6	19.9	18.3	18.5	24.0	19.4	20.1	30.6	40.6	15.3	16.0	20.9	16.2	16.9	32.3	12.3	18.3	19.1	20.3	19.7	21.2	13.4	28.9	16.7	39.7	17.0	24.6	11.3	20.6	23.5	24.4	11.7	15.3	19.9	25.9	29.2	18.4	14.2	14.2	22.3	22.9	11.1	17.2	20.4	19.4	18.0	30.8	14.6	18.5	17.7	11.7	18.0	14.3	16.0	14.1	14.9	15.6	10.5	28.9	10.3	11.9	14.8	9.5	12.7	13.5	16.8	19.5	9.1	14.5	11.6	11.7	10.5	6.8	13.4	14.4	16.0	12.5	9.3	9.2	12.7	16.1	19.6	8.2	16.3	18.3	24.7	20.1	13.9	18.5	32.1	22.0	14.7	18.4	16.9	19.8	14.4	20.3	17.8	15.2	30.1	10.8	13.9	22.6	19.8	15.2	13.8	25.2	14.4	15.2	14.5	12.3	9.4	24.4	5.0	16.3	11.1	16.7	3.9	13.3	17.1	15.5	22.3	17.2	15.2	17.6	17.9	17.3	17.6	1.3	20.4	17.2	22.9	19.4	18.0	23.6	20.4	14.8	23.3	19.4	20.1	20.9	16.2	20.3	15.3	47.6	45.1	20.6	6.7	75.0	8.5	6.1	50.9	77.6	44.3	22.7	2.0	13.2	44.7	40.3	1.6	19.1	23.8	0.0	56.0	16.1	13.5	10.6	31.3	50.0	16.2	1.6	30.0	28.8	37.5	2.5	17.0	50.6	91.1	28.9	36.9	14.6	53.1	24.6	14.9	32.9	8.0	6.5	33.3	15.8	21.3	88.1	9.2	27.4	37.4	11.9
COX17		ENSG00000138495	"COX17, cytochrome c oxidase copper chaperone"	Q14061	3	119654513-119677454	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042226, HPA048158"	Supported		Supported	Mitochondria		NA	NA		1000000	Mitochondria		"HPA042226: AB_2677911, HPA048158: AB_2680292"	"unprognostic (1.98e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.64e-2)"	16.6	42.9	20.0	18.2	19.4	21.2	30.4	21.1	20.4	10.2	16.8	9.2	43.5	22.0	11.9	22.9	11.7	11.0	13.6	53.5	17.2	23.0	27.6	37.0	17.8	20.3	23.2	15.2	7.9	39.9	21.1	45.7	18.2	33.7	17.2	16.2	19.4	25.6	33.3	80.4	8.7	21.0	15.4	20.8	15.3	22.3	13.4	16.7	11.1	16.6	37.1	17.2	13.7	20.1	35.6	53.5	52.8	46.9	19.8	33.9	22.0	27.7	28.9	15.8	3.9	6.1	5.7	5.7	15.5	9.3	14.3	14.9	25.5	20.1	20.1	18.8	7.4	22.1	10.5	15.7	15.8	8.6	25.2	18.8	17.4	22.9	20.1	7.0	25.3	32.5	6.5	15.2	8.9	12.3	9.8	9.2	25.2	14.1	48.2	16.6	45.1	25.4	36.5	17.8	25.2	48.4	11.2	10.7	33.1	22.2	16.3	26.4	11.6	19.1	18.4	23.2	10.4	23.1	40.3	7.3	12.3	19.3	7.7	21.3	34.4	34.3	42.5	17.5	19.4	21.2	50.1	22.4	52.8	21.8	33.2	23.0	35.6	27.2	24.7	22.9	27.2	21.7	22.6	17.7	19.8	46.9	53.5	33.9	22.0	20.0	19.4	21.1	20.4	17.2	23.0	23.2	15.2	33.7	16.7	145.9	163.6	145.9	99.6	83.6	101.3	592.3	244.5	194.1	118.3	472.8	41.2	125.7	606.8	206.9	59.6	165.4	386.9	210.2	359.2	147.4	95.8	189.0	295.2	628.7	191.0	71.5	205.8	109.2	171.8	19.7	84.3	254.2	263.2	453.6	223.0	88.7	397.0	333.1	128.7	464.7	118.6	181.1	142.8	266.2	132.2	109.7	176.4	137.1	121.4	191.1
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.7	9.2	9.3	29.0	6.4	4.8	21.9	15.5	10.3	8.9	8.0	26.2	25.7	5.6	19.7	10.4	17.3	9.6	4.9	12.4	12.0	15.6	3.4	10.8	13.5	24.1	8.6	26.4	16.6	4.3	6.0	13.1	9.2	12.8	10.1	6.3	22.2	23.3	18.3	9.1	14.2	11.8	24.6	26.6	19.2	10.5	11.5	34.0	16.5	8.7	5.4	14.9	19.4	10.2	20.1	9.8	18.9	7.6	19.6	19.8	26.0	17.2	33.2	37.0	50.7	11.9	25.2	29.5	18.9	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0	17.9	46.2	77.5	98.6	75.7	105.2	57.3	178.3	52.2	58.0	181.5	43.2	203.1	351.5	126.1	26.1	56.2	109.3	93.5	164.5	133.4	54.1	70.8	70.6	249.2	109.9	84.2	59.4	39.3	60.1	57.2	64.5	84.0	69.2	129.8	72.2	94.2	142.7	87.5	75.3	253.1	99.4	64.7	95.9	66.9	97.5	66.0	221.2	70.2	105.2	80.4
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807044	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		970000	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	41.6	38.6	101.1	54.0	100.2	66.5	60.6	51.6	86.9	38.1	87.1	38.9	43.9	77.6	33.9	69.3	54.7	50.4	59.8	218.6	82.3	73.0	59.7	69.5	29.6	49.1	100.1	65.9	45.4	71.2	55.7	36.3	36.8	57.0	37.6	98.4	40.6	65.9	53.1	172.3	48.0	76.5	51.2	58.4	40.1	56.5	21.8	38.7	46.6	49.1	112.6	70.2	47.1	52.4	123.0	144.1	74.8	130.8	74.7	121.9	222.6	44.7	73.0	49.7	66.3	92.0	86.3	85.7	40.9	83.7	77.5	38.8	123.5	67.9	73.5	50.3	65.1	42.4	90.2	70.6	82.2	69.1	24.9	73.0	41.0	61.8	119.9	83.0	37.2	30.6	100.0	127.6	63.4	86.6	81.2	80.9	60.5	68.9	30.2	65.7	161.5	74.4	115.3	66.6	99.8	86.1	84.6	31.2	64.3	114.9	88.9	59.1	48.0	86.6	55.1	66.2	55.7	80.8	103.9	56.8	38.9	45.1	35.7	43.7	60.9	57.8	168.9	59.4	73.8	43.6	50.9	130.8	74.8	72.5	112.8	88.4	123.0	96.3	85.0	144.1	116.1	121.9	100.0	50.7	74.7	98.6	107.7	102.7	222.6	101.1	100.2	51.6	86.9	82.3	73.0	100.1	65.9	57.0	38.7	256.1	363.9	981.6	971.7	1003.2	230.7	3140.6	1197.4	362.7	382.2	600.2	123.7	1081.3	2332.7	965.7	464.1	701.9	2320.1	280.4	1145.7	924.4	671.8	956.9	507.1	1060.0	1395.9	200.2	970.5	596.0	1378.7	820.3	462.0	1118.7	1086.5	1424.7	1513.6	283.9	1228.5	1740.3	336.3	1959.5	260.3	349.3	760.4	345.7	304.0	1190.3	1239.3	852.8	1984.7	1551.2
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.9	23.3	14.4	23.9	17.0	15.5	62.3	25.7	14.4	17.1	19.1	64.4	20.9	33.7	55.3	16.4	27.0	30.5	16.6	25.8	7.8	26.2	70.6	45.4	25.8	76.9	32.7	43.0	33.3	28.7	22.9	16.4	12.8	17.5	14.6	27.0	33.3	14.9	13.2	49.4	27.1	62.4	28.4	34.1	122.6	26.7	24.8	50.4	23.0	30.7	28.6	30.6	25.0	30.2	48.2	20.0	16.1	45.1	26.5	15.6	26.6	25.0	16.5	38.9	36.8	25.7	28.3	37.0	16.1	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0	205.4	224.6	375.1	495.2	343.3	204.5	3263.7	647.1	369.4	268.4	759.0	214.0	640.2	3068.8	479.5	156.4	370.1	2132.4	140.2	527.3	778.4	340.5	424.2	320.2	1125.6	767.8	133.5	711.5	338.8	489.5	270.1	325.7	488.5	865.4	798.1	1204.0	259.4	460.5	1508.0	286.4	1849.4	303.9	439.8	473.4	213.2	290.0	419.6	512.8	265.9	1320.1	744.1
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440742	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA062394: AB_2684749"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	49.2	48.0	171.0	32.1	103.0	52.6	43.8	44.4	107.5	37.3	96.8	38.5	32.4	102.8	28.0	47.0	59.3	41.8	37.6	41.5	121.5	92.0	85.8	102.6	32.4	39.6	140.0	57.9	27.7	62.7	43.8	38.3	44.4	86.9	43.1	74.3	31.3	63.8	44.2	10.6	37.7	85.7	38.1	67.2	32.1	60.8	28.1	61.2	33.7	48.2	36.0	40.1	42.1	35.0	74.5	102.2	60.5	69.8	47.8	87.4	83.0	47.2	101.2	57.6	60.1	44.4	37.9	70.6	30.1	40.3	53.5	45.7	122.3	48.3	99.6	90.1	42.5	41.4	79.1	56.1	66.1	34.7	59.7	121.0	53.4	57.9	89.5	41.1	58.5	38.4	45.5	81.6	48.8	57.9	44.2	45.0	72.6	52.3	31.2	44.4	132.3	84.4	148.2	52.5	92.1	148.4	57.7	38.6	93.3	84.4	114.0	76.0	66.1	55.2	54.2	70.7	33.5	97.2	66.9	33.9	33.4	41.3	34.4	41.8	48.5	66.6	77.1	52.4	57.4	44.4	38.5	65.5	58.3	54.4	69.5	58.5	74.5	64.3	59.5	95.1	59.2	59.1	59.3	60.5	47.8	69.8	102.2	87.4	83.0	171.0	103.0	44.4	107.5	121.5	92.0	140.0	57.9	86.9	61.2	369.2	267.5	329.6	423.0	340.5	204.2	104.8	682.8	548.7	311.7	734.5	543.9	662.2	1255.0	574.2	113.2	290.2	1336.6	93.5	578.7	601.6	281.6	433.2	262.5	840.8	680.4	138.2	495.4	264.6	384.0	100.3	279.6	388.0	497.7	739.4	694.0	232.4	574.7	1129.3	249.6	1194.5	252.8	336.3	428.1	355.7	331.5	339.1	775.3	316.6	860.7	644.8
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648223-35658861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 2503.3;Distal tubular cells: 2530.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004192	Supported		Supported	Mitochondria		NA	NA		1200000	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	37.2	32.2	62.1	32.1	58.7	46.2	42.8	31.1	57.6	34.1	65.0	25.2	41.2	52.7	27.1	70.2	52.4	36.3	39.8	132.5	51.5	52.2	61.1	68.9	24.7	40.4	57.4	60.2	29.2	41.1	41.4	28.8	30.2	39.2	30.2	77.1	31.8	54.9	44.2	168.4	35.1	63.2	37.6	38.7	30.7	42.0	21.0	29.0	42.7	37.6	110.6	52.7	33.8	31.6	110.6	115.5	111.1	116.1	61.2	107.9	167.5	36.4	87.1	37.8	50.4	49.7	50.9	35.1	29.7	45.1	49.1	49.7	71.1	36.7	41.1	52.6	46.7	32.9	26.8	60.7	50.4	48.3	47.8	41.5	70.4	46.6	69.6	39.3	63.2	36.7	59.8	63.3	45.8	26.6	47.1	47.6	44.7	43.9	61.6	49.3	70.5	44.4	46.6	28.1	184.2	58.8	38.5	41.6	68.0	111.9	72.9	33.2	38.0	47.8	82.4	29.3	46.1	32.7	68.7	28.4	28.4	32.5	30.1	46.2	37.0	44.4	55.8	37.5	49.0	36.5	87.7	108.6	94.7	65.5	116.1	62.4	110.6	90.5	76.1	111.8	92.7	89.6	79.4	111.1	61.2	107.8	115.5	107.9	167.5	62.1	58.7	31.1	57.6	51.5	52.2	57.4	60.2	39.2	29.0	226.3	220.0	458.4	406.9	379.4	129.5	2503.3	772.0	354.7	217.2	663.0	60.9	533.3	2530.0	637.7	277.5	330.3	1579.1	210.2	701.4	649.3	430.6	454.9	274.7	1065.5	910.2	84.2	601.2	320.4	754.1	587.8	303.5	609.7	710.3	822.4	1028.9	175.1	735.8	1153.8	256.7	1262.3	137.8	258.7	388.3	116.9	177.2	494.3	560.9	394.4	1027.2	623.0
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99894062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014295, CAB016244"	Enhanced		Supported	Mitochondria		NA	NA		53000	Mitochondria		"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	20.5	43.1	66.1	21.6	56.2	44.4	23.3	28.5	63.8	18.7	46.0	14.3	29.4	113.7	38.8	64.1	31.6	27.4	23.5	113.0	54.8	46.9	38.7	66.8	18.2	23.2	58.8	36.7	32.7	26.5	12.1	24.0	30.7	38.8	23.3	38.1	20.6	32.4	30.1	232.1	31.2	55.8	38.7	40.4	23.7	35.1	29.6	23.5	17.9	19.5	80.6	17.8	31.0	21.3	45.9	62.3	55.7	50.6	37.2	73.5	48.0	17.0	6.9	8.0	32.8	18.3	13.3	13.4	5.6	5.3	3.8	4.3	6.9	36.5	41.4	42.4	8.7	6.1	22.7	4.5	46.4	6.4	7.5	11.6	85.9	8.2	20.1	11.9	39.6	26.6	12.3	61.8	3.2	7.1	17.0	5.7	13.0	6.0	74.4	6.4	16.3	41.1	36.5	15.4	25.7	15.9	47.8	2.6	40.5	58.2	90.8	24.9	15.2	3.9	85.1	41.6	8.6	60.0	25.4	4.9	29.1	37.9	30.7	7.9	18.5	14.9	24.6	40.9	16.1	25.7	55.7	29.3	22.1	40.1	42.3	41.8	45.9	61.0	42.5	43.8	41.7	73.5	65.7	3.5	37.2	50.6	62.3	56.9	48.0	66.1	56.2	28.5	63.8	54.8	46.9	58.8	36.7	38.8	23.5	375.2	414.8	374.3	402.8	435.9	194.1	2063.7	626.8	575.5	377.6	574.0	96.2	831.0	1886.7	571.0	645.5	416.6	1532.5	303.7	739.7	730.3	697.7	423.0	347.2	1528.6	904.1	147.8	776.1	376.3	443.5	180.9	615.6	499.6	695.0	943.2	982.6	392.7	687.3	1094.2	552.3	1121.0	205.6	485.0	628.5	756.0	487.0	560.0	1492.7	393.7	1121.0	582.7
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	38.3	24.6	27.3	29.6	46.9	66.9	32.7	31.8	46.5	29.1	37.2	26.9	27.8	34.0	31.9	36.4	37.3	17.2	32.5	33.7	42.6	52.2	25.0	23.0	17.6	47.7	55.3	34.5	25.6	65.6	67.9	28.4	68.8	42.2	40.9	26.7	33.4	58.4	45.0	31.2	41.1	57.4	26.8	45.4	25.6	22.5	47.4	28.8	41.6	31.1	32.5	37.1	13.3	33.6	91.2	31.7	24.1	40.3	30.8	26.4	34.6	31.9	31.0	48.0	53.6	25.5	37.4	37.5	22.4	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5	29.8	61.2	171.1	166.3	235.9	115.5	140.5	132.5	96.4	51.2	141.3	35.3	190.2	547.2	206.3	15.8	157.6	103.8	23.3	199.6	263.9	167.1	184.8	86.4	193.0	204.8	123.9	277.2	113.5	243.6	17.7	149.8	177.9	209.2	287.7	202.3	182.8	197.6	161.4	149.2	386.1	95.5	109.9	206.0	195.8	267.6	214.7	275.6	186.4	235.2	168.4
CPNE2	CPN2	ENSG00000140848	"Copine 2"	Q96FN4	16	57092537-57148367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041132	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA041132: AB_2677316"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	14.1	3.9	8.4	4.6	15.1	22.8	11.4	7.9	15.4	16.4	12.0	40.6	1.1	2.0	8.8	3.1	6.4	12.0	5.6	5.9	10.6	11.6	4.8	4.3	15.5	8.2	20.8	9.8	5.1	3.3	3.7	4.9	11.5	12.9	5.1	11.9	4.6	3.7	7.4	4.9	4.0	6.6	10.5	13.5	6.0	3.7	15.3	20.1	0.2	5.8	2.2	3.2	6.4	8.3	0.0	2.1	4.0	4.2	0.5	1.2	0.9	8.4	16.3	25.2	13.9	4.5	4.4	4.2	9.2	14.6	21.1	14.8	4.5	9.8	5.0	8.5	13.9	11.7	13.3	9.9	5.5	11.5	6.2	5.8	2.1	6.5	3.8	8.2	1.7	0.2	4.2	6.2	8.2	4.0	15.8	31.0	2.8	5.6	0.1	5.3	3.9	2.5	24.7	5.7	4.1	3.5	31.5	7.9	4.2	14.0	3.2	0.5	10.2	11.7	2.5	7.0	11.9	2.7	33.7	21.8	19.3	10.5	4.8	11.9	1.2	1.0	11.3	12.5	7.4	13.5	0.0	4.2	1.9	0.7	1.2	0.7	0.0	0.4	1.2	2.1	0.0	0.3	0.6	4.0	0.5	0.4	0.1	0.5	0.9	8.4	15.1	7.9	15.4	10.6	11.6	20.8	9.8	12.9	20.1	17.9	6.1	2.9	13.5	2.1	0.0	2.2	2.5	1.4	2.3	5.2	0.0	0.6	5.0	3.9	14.0	20.4	28.0	0.0	3.4	2.1	10.4	9.0	0.0	1.6	20.0	0.0	3.5	72.4	21.2	4.7	6.4	6.9	6.8	3.6	15.7	3.3	5.9	21.0	7.1	1.6	0.0	32.3	14.4	0.5	1.7	3.8	0.7	4.4	15.9	9.9
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.6	12.3	8.5	11.0	32.7	25.5	6.9	16.7	24.9	14.0	15.8	7.9	11.9	9.5	11.1	20.3	8.5	26.8	18.2	17.7	25.2	10.1	14.3	1.5	9.0	9.4	11.3	0.8	0.8	17.3	19.2	15.5	20.6	22.6	17.1	4.9	8.5	18.3	17.2	13.4	16.6	0.5	3.2	28.7	17.8	7.9	7.7	44.4	18.1	24.9	18.0	14.1	14.6	66.7	10.5	10.2	25.4	2.6	18.2	12.5	12.2	16.6	12.9	13.2	15.8	2.6	18.0	3.6	11.5	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1	128.1	76.8	40.4	87.4	72.7	16.8	108.0	79.0	77.6	69.4	66.3	13.7	59.5	84.6	63.4	1.1	55.4	37.1	23.3	72.9	45.8	62.4	110.2	8.1	86.6	42.9	42.9	48.1	57.7	74.2	2.2	79.4	49.0	50.6	32.5	53.7	70.1	62.4	52.6	82.4	99.4	16.5	58.2	55.6	3.0	10.0	79.5	65.2	47.5	69.8	73.5
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.1	14.5	2.1	14.2	9.3	8.4	0.6	6.5	5.4	5.2	1.0	0.5	27.6	0.0	24.2	17.2	18.2	26.9	18.4	3.9	1.5	13.0	1.8	20.1	15.8	6.7	13.9	11.6	24.3	8.7	1.9	10.4	6.3	7.1	18.3	8.1	2.1	16.5	4.7	23.4	9.4	20.6	0.2	42.2	15.4	26.5	0.3	35.6	12.2	20.4	0.2	9.3	18.0	34.9	5.7	1.4	31.1	11.3	18.4	11.3	0.2	22.6	9.4	12.9	16.4	8.3	11.9	8.6	12.3	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0	35.7	36.9	11.5	7.7	8.4	4.9	22.1	28.1	32.1	22.7	22.7	60.9	12.9	16.6	11.2	9.2	25.4	82.1	0.0	8.1	4.1	13.9	7.4	27.8	79.0	14.6	1.6	15.5	37.4	42.3	15.7	8.9	13.5	0.0	11.8	44.9	12.9	9.7	40.3	30.1	9.4	41.0	38.8	16.0	12.1	8.8	6.8	6.5	16.6	59.0	6.4
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 64.6;Hepatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.7	3.2	7.5	7.3	6.5	3.8	8.5	4.8	4.9	6.9	6.4	1.6	6.5	13.2	7.3	2.2	7.8	7.7	14.0	11.0	5.9	7.3	8.2	7.5	4.3	1.3	9.5	7.1	7.3	8.2	9.4	5.0	4.2	7.7	4.7	11.7	9.6	4.7	4.2	4.5	5.5	5.8	14.0	14.4	8.6	6.4	7.2	13.9	8.6	7.2	11.2	7.6	9.6	12.2	18.1	18.1	14.2	15.2	4.5	3.9	3.1	6.8	3.9	14.5	8.9	8.1	5.0	8.2	5.7	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7	11.9	20.8	8.9	5.1	1.5	3.1	12.4	15.3	4.0	3.4	10.4	13.7	64.6	21.6	10.7	1.1	3.6	39.8	0.0	9.3	16.0	2.8	4.8	2.3	80.0	23.6	14.3	13.9	6.7	13.5	2.1	6.4	8.2	6.8	26.2	26.9	10.5	9.8	21.0	4.9	28.3	9.9	6.5	3.2	29.8	16.3	2.3	45.7	7.1	25.3	4.6
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974363	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 49.9"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 54.0;Mucus-secreting cells: 48.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			"Nucleoplasm, Nuclear membrane"	Mitochondria	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	4.3	5.0	3.2	5.4	4.0	2.9	22.6	5.7	3.5	14.6	5.1	4.3	18.3	5.0	8.5	12.1	5.1	8.8	7.9	3.2	2.5	1.4	4.5	8.4	4.7	5.5	3.2	3.0	9.3	7.9	3.7	3.4	6.6	4.0	49.9	6.9	4.7	24.7	11.4	6.1	5.9	5.3	3.4	3.3	4.5	13.2	4.3	3.0	12.9	12.5	6.6	8.3	4.5	15.1	6.6	7.3	2.6	3.5	10.9	6.0	3.1	2.3	3.3	3.1	3.4	2.2	3.3	7.8	1.9	2.2	2.6	2.3	1.5	9.7	4.2	10.1	0.8	2.0	3.7	4.6	3.0	1.4	3.4	1.8	3.1	3.6	2.7	1.8	1.4	2.7	3.5	2.9	2.5	5.7	2.4	2.3	5.1	2.4	5.3	1.2	24.9	2.7	1.1	2.1	25.3	4.0	6.2	3.2	7.8	2.8	1.6	5.9	6.3	2.0	55.0	5.2	4.2	44.1	4.5	1.4	0.8	2.4	1.6	1.5	10.0	5.1	3.1	1.7	2.6	2.5	2.2	3.5	2.6	4.5	1.5	6.0	6.3	2.6	3.3	6.4	6.6	2.5	4.8	0.1	10.9	2.1	7.3	2.1	3.1	3.2	4.0	5.7	3.5	2.5	1.4	3.2	3.0	4.0	3.0	6.0	12.5	2.0	15.5	2.6	4.7	1.7	10.2	18.7	12.5	1.8	2.0	11.1	8.3	11.1	0.0	4.9	3.2	0.0	11.8	13.3	3.3	54.0	5.7	12.3	4.8	0.0	8.6	3.1	7.9	0.0	6.6	2.2	5.0	1.8	48.0	6.0	7.4	3.5	2.1	3.6	7.5	19.4	3.3	3.6	8.7	2.6	3.5	4.4	11.8	3.5
CREBL2		ENSG00000111269	"CAMP responsive element binding protein like 2"	O60519	12	12611827-12645108	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043738	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA043738: AB_10795041"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.53e-1)"	21.9	77.6	24.3	16.5	31.9	3.0	18.9	21.4	24.6	16.4	13.4	14.6	13.5	13.2	11.4	17.5	10.4	14.9	16.4	14.3	19.8	23.0	28.7	28.2	18.5	18.8	20.2	19.8	22.6	14.2	31.7	31.5	13.8	19.7	17.1	14.2	20.5	15.4	14.4	6.6	14.1	13.3	12.0	20.0	20.2	14.1	17.1	18.3	8.6	25.9	6.7	16.6	17.7	14.0	2.0	4.2	3.6	8.7	1.6	8.1	2.2	5.5	7.2	6.3	7.1	22.3	22.6	12.2	10.9	18.4	8.0	11.1	5.2	8.1	4.8	4.2	13.2	12.2	4.7	9.5	8.3	13.7	26.8	5.7	3.8	7.2	6.3	14.6	5.3	7.1	14.6	15.0	9.4	15.5	27.5	11.7	3.8	3.8	7.6	13.5	8.9	2.8	4.4	18.9	5.3	6.6	3.8	10.9	3.0	15.4	16.1	7.4	8.5	11.0	5.4	19.0	28.5	3.0	6.1	9.4	11.1	7.1	10.9	10.7	6.4	8.5	1.2	13.2	4.6	11.4	1.7	3.8	3.6	2.8	8.7	5.0	1.5	5.5	4.4	4.2	2.0	5.5	4.5	0.7	1.6	3.6	2.1	8.1	2.2	24.3	31.9	21.4	24.6	19.8	23.0	20.2	19.8	19.7	18.3	23.8	21.6	14.3	16.0	19.7	16.9	12.3	22.9	16.0	12.5	31.4	2.0	14.7	34.9	16.6	23.6	20.4	18.6	0.0	19.2	14.9	18.4	35.5	10.3	38.9	36.4	35.0	28.8	22.7	83.1	5.0	33.4	54.7	32.1	45.9	18.1	28.7	18.7	10.5	33.2	48.0	11.0	38.8	9.1	30.0	17.4	25.5	23.0	15.3	15.1	19.2
CREBZF	ZF	ENSG00000137504	"CREB/ATF bZIP transcription factor"	Q9NS37	11	85659708-85682908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021526, HPA063652"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA021526: AB_2670738, HPA063652: AB_2685075"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.38e-3)"	15.4	18.7	16.6	19.5	23.3	13.2	19.8	31.4	21.7	23.1	18.1	23.7	18.5	22.0	29.0	19.9	15.0	22.3	18.2	13.3	16.9	10.5	14.9	16.2	17.5	25.0	34.0	18.7	31.5	27.2	30.0	23.8	18.3	20.2	21.2	20.6	20.0	19.3	17.0	13.1	18.2	24.4	20.0	21.3	26.1	20.2	12.7	24.8	21.6	27.1	11.7	21.3	19.1	21.3	3.1	2.4	2.3	2.8	1.9	3.8	0.8	3.6	11.1	9.3	3.1	3.9	4.3	11.4	5.8	3.4	5.0	6.6	11.1	17.8	9.3	5.9	3.2	20.7	13.4	7.5	3.9	7.5	7.5	9.3	9.6	32.1	3.4	3.1	9.6	5.6	4.5	9.3	5.5	8.2	4.7	2.8	6.8	8.3	15.8	4.5	5.9	8.6	13.8	3.7	11.0	5.8	17.5	10.7	6.7	4.4	7.0	9.8	9.3	9.2	13.1	2.3	4.9	15.6	15.7	4.3	10.7	8.7	17.2	8.0	5.9	5.2	12.9	2.9	6.9	8.6	1.9	1.6	1.4	2.3	1.4	3.8	3.1	1.5	1.9	2.0	2.9	2.5	2.3	2.3	1.9	2.8	2.4	1.1	0.8	16.6	23.3	31.4	21.7	16.9	10.5	34.0	18.7	20.2	24.8	17.9	19.2	20.4	20.2	36.7	100.5	11.3	12.7	14.7	14.8	21.0	86.4	13.0	8.3	10.5	19.0	26.4	25.1	23.3	7.4	12.3	29.2	26.1	21.9	26.0	8.7	85.8	37.8	22.1	18.6	13.7	28.4	14.6	32.1	9.0	23.6	57.0	8.3	20.9	31.5	5.3	112.5	12.9	28.9	20.0	5.9	36.1	12.0	25.8	19.9	21.0
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		4400000	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.8	38.8	31.7	41.1	42.1	39.2	20.6	29.9	29.4	52.7	36.8	54.7	35.2	70.1	29.4	37.7	22.6	38.9	87.5	45.0	50.4	24.3	44.5	48.1	28.2	39.4	23.6	58.8	34.6	43.1	43.0	41.3	50.1	43.4	59.1	36.6	49.8	42.1	45.9	28.8	48.7	18.1	25.2	27.2	56.1	47.5	37.2	52.9	32.6	36.4	41.6	27.3	38.7	46.1	30.3	30.8	64.1	34.3	39.2	26.6	37.3	37.5	31.5	27.8	42.3	45.6	24.5	43.4	24.9	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1	14.9	33.2	16.0	18.6	34.7	21.7	207.5	22.9	10.7	19.4	12.2	58.9	15.6	29.9	31.3	5.1	27.0	51.5	0.0	38.6	26.0	18.2	26.3	27.6	26.2	31.0	9.5	16.3	17.2	29.2	3.6	18.7	33.5	10.1	27.1	43.6	15.1	37.2	23.0	18.7	17.3	36.0	12.9	25.9	18.4	24.7	45.7	14.1	18.1	64.8	26.5
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;HEK 293: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.8	4.7	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.1	0.0	2.0	0.4	2.2	0.2	0.2	0.0	7.4	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.7	0.0	0.9	5.2	0.2	0.1	1.2	0.2	0.3	2.6	1.9	2.7	0.4	0.2	0.6	1.1	0.9	2.8	1.3	1.7	3.4	0.1	0.7	1.3	2.4	0.2	0.0	5.6	0.1	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1	3.0	1.3	0.0	0.1	0.7	28.1	1.2	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.5	0.2	6.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	86.9	0.2	0.0	0.0	0.0	19.5	0.0	0.2	17.2	1.0	0.5	0.1	0.0	0.2	0.1
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846739	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 169.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	44.5	43.6	28.2	31.6	34.8	17.6	39.6	57.1	33.4	49.0	48.4	36.7	47.7	24.4	50.4	32.9	38.0	41.9	37.7	34.6	31.2	16.5	32.8	32.6	51.3	31.3	37.1	19.9	52.5	53.9	33.7	25.4	42.9	31.0	40.5	38.6	29.3	45.8	60.9	48.8	39.9	36.1	44.1	25.7	38.1	43.1	21.0	40.9	62.9	40.1	32.8	33.9	46.1	63.0	7.3	9.3	18.7	9.7	8.2	11.5	7.1	11.0	4.8	23.1	14.7	20.8	35.9	7.7	12.0	22.8	11.9	10.7	6.1	18.1	13.6	13.8	25.5	4.6	8.9	9.6	11.7	12.5	4.5	4.1	18.8	7.4	4.9	19.4	8.5	11.0	34.3	12.4	10.8	9.2	25.6	18.6	8.3	9.8	24.1	5.9	5.1	9.1	5.1	11.7	7.0	6.1	12.2	169.3	17.8	9.3	16.1	4.3	9.6	16.7	9.6	14.4	14.7	17.4	14.9	14.9	10.6	11.6	11.9	4.2	7.2	7.7	16.4	11.9	7.9	8.2	11.5	9.7	14.7	6.9	9.0	8.2	7.3	9.9	8.0	9.3	6.5	11.5	8.7	18.7	8.2	7.7	7.7	6.4	7.1	28.2	34.8	57.1	33.4	31.2	16.5	37.1	19.9	31.0	40.9	68.5	36.0	33.5	41.6	60.0	18.7	31.1	79.0	13.4	23.9	45.4	15.7	36.7	13.3	64.0	44.2	58.1	55.7	0.0	117.0	34.7	57.1	49.1	24.3	49.7	36.0	19.1	46.8	80.4	63.9	111.0	48.1	36.8	40.5	66.7	42.3	41.1	88.4	51.8	45.6	23.9	10.8	71.1	55.2	5.8	25.8	66.6	47.0	40.6	35.4	58.0
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 254.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane, Cell Junctions, Mitochondria"		"HPA042617: AB_2678081, HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	26.2	3.9	24.2	18.4	3.6	6.1	7.7	5.2	9.2	7.7	4.9	1.9	33.5	8.1	15.1	6.7	7.9	13.4	2.8	30.9	3.5	20.4	4.3	5.2	1.2	24.4	7.6	3.9	3.1	6.8	30.6	9.8	10.0	6.6	20.7	15.3	9.2	3.8	4.7	16.1	8.7	14.6	12.8	21.2	6.8	10.0	7.1	5.2	3.9	9.0	26.6	16.8	11.8	10.8	15.7	8.6	13.2	9.7	13.5	5.0	6.1	7.5	11.4	8.4	10.9	9.5	1.8	20.0	19.7	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5	26.8	11.5	11.8	34.8	91.7	8.4	11.6	22.9	1.4	7.9	17.4	7.9	61.2	28.2	16.0	101.0	18.1	20.6	23.3	16.2	34.6	26.7	52.4	0.0	22.9	49.6	15.9	47.1	16.0	32.6	19.5	13.8	30.5	45.5	5.4	34.9	106.1	27.9	25.8	21.5	23.0	12.2	45.3	22.1	72.3	36.2	254.8	40.5	18.1	24.3	54.7
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA		14000	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.6	7.0	11.4	9.5	5.8	4.4	0.1	4.2	3.5	6.8	6.3	7.0	8.0	0.2	13.5	4.3	6.2	6.2	16.0	7.7	8.2	0.0	10.6	4.3	9.8	10.2	3.0	3.1	0.1	4.8	2.6	6.4	5.4	7.7	9.1	0.1	6.1	0.3	6.2	10.1	0.1	2.4	19.6	2.8	8.2	0.1	6.6	2.4	7.3	8.5	7.1	13.1	13.3	1.0	7.6	12.9	18.5	8.9	5.8	3.6	1.9	9.4	3.6	0.2	0.1	25.3	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8	8.9	7.0	3.7	5.0	2.9	4.9	5.2	10.2	4.0	9.1	5.2	0.0	2.9	3.3	8.7	2.8	4.9	6.0	0.0	8.4	6.2	3.9	4.8	5.8	7.5	4.5	6.4	10.9	6.7	4.9	5.8	8.3	2.6	8.5	9.0	7.4	3.4	10.3	11.0	3.9	2.2	4.4	6.5	4.1	0.0	0.2	3.3	1.3	3.8	8.1	4.8
CTU2	"C16orf84, NCS2"	ENSG00000174177	"Cytosolic thiouridylase subunit 2"	Q2VPK5	16	88706463-88715386	"Predicted intracellular proteins"	"tRNA processing"		"Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041135, HPA041894"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041135: AB_10794543, HPA041894: AB_10796463"	"unprognostic (4.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	10.9	10.5	13.0	10.9	12.8	12.0	7.8	11.6	17.4	9.0	8.8	11.7	4.6	9.5	11.4	6.7	8.1	8.8	8.5	11.0	12.8	10.2	6.5	11.4	7.7	12.2	12.9	15.3	12.5	15.7	7.0	10.9	7.5	9.9	8.3	4.4	5.8	15.6	9.6	25.4	11.5	7.8	14.7	8.7	9.1	9.5	22.8	11.2	9.3	9.7	11.1	7.9	8.3	7.2	7.5	7.7	1.4	8.0	8.1	9.3	4.6	6.9	11.0	4.3	9.3	3.7	3.8	10.7	7.4	5.6	8.2	4.0	12.9	6.6	10.4	9.9	4.7	3.8	7.0	7.2	7.2	2.2	3.1	21.6	7.2	4.6	12.9	6.3	7.0	5.4	4.2	5.3	6.5	6.9	3.0	6.9	6.4	26.4	3.0	3.1	18.8	19.1	15.9	6.5	6.1	17.9	15.5	3.4	10.9	2.9	2.7	14.4	7.0	12.0	2.2	4.6	2.7	6.5	7.7	7.7	8.6	11.0	9.8	8.0	9.7	4.8	29.3	7.2	15.2	9.3	1.4	6.4	0.0	9.3	8.0	7.8	6.9	8.4	9.0	7.7	7.5	8.9	7.1	0.5	8.1	6.5	7.6	4.7	4.6	13.0	12.8	11.6	17.4	12.8	10.2	12.9	15.3	9.9	11.2	0.0	4.1	8.9	7.8	12.2	12.7	2.2	10.2	4.0	5.7	1.8	5.9	9.5	10.0	5.8	9.8	4.5	5.8	0.0	11.6	13.2	8.0	6.1	0.0	5.9	8.8	12.7	5.2	3.1	2.2	5.5	7.5	4.6	5.0	4.6	5.0	5.7	7.9	6.0	9.2	5.8	8.2	0.0	9.9	17.9	23.5	9.4	6.8	5.7	8.9	7.1
CWC15	"AD002, C11orf5, Cwf15, HSPC148"	ENSG00000150316	"CWC15 spliceosome associated protein homolog"	Q9P013	11	94962622-94973612	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 683.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039878	Supported		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles, Mitochondria"		"HPA039878: AB_2676722"	"unprognostic (1.97e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.81e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.84e-3)"	"prognostic favorable (9.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (5.23e-2)"	9.5	9.6	9.9	7.9	12.0	10.6	13.5	12.4	11.9	10.1	9.2	7.2	7.7	5.8	8.6	14.9	10.0	9.2	5.5	14.1	9.8	9.6	14.0	15.6	8.8	8.7	10.3	10.1	11.8	8.6	7.5	12.1	11.1	12.6	9.5	8.1	6.4	10.2	9.1	24.4	9.0	10.1	7.3	11.7	10.7	9.5	17.2	12.4	11.2	11.2	14.7	9.6	9.8	10.6	31.8	31.3	36.8	33.0	26.1	35.8	25.7	10.8	8.8	26.3	12.5	25.0	22.8	13.7	16.3	23.0	27.4	22.7	39.3	24.8	16.8	33.1	23.1	20.3	11.4	15.9	20.6	29.4	21.3	14.0	21.1	10.5	17.7	21.5	26.3	13.1	22.6	23.7	18.3	24.5	22.8	26.6	20.5	24.8	14.6	24.6	14.3	25.3	35.6	12.6	30.5	22.2	17.2	16.0	17.7	27.2	13.1	14.9	11.6	18.0	17.8	14.1	25.5	28.6	21.3	14.6	18.0	14.4	25.0	16.2	6.9	17.6	23.2	10.1	30.4	17.5	36.8	25.1	34.5	26.8	27.3	35.8	31.8	34.6	32.8	31.3	27.6	34.4	34.7	29.5	26.1	33.0	29.7	35.4	25.7	9.9	12.0	12.4	11.9	9.8	9.6	10.3	10.1	12.6	12.4	68.5	52.8	80.4	76.4	52.7	51.9	156.1	96.8	103.1	97.8	48.8	13.7	121.9	187.3	96.3	683.1	78.7	55.1	140.2	125.1	102.3	82.2	67.4	99.6	99.5	111.8	38.1	27.3	83.4	57.4	99.0	104.4	88.5	67.4	94.6	54.4	99.4	104.3	80.6	87.4	170.4	46.4	135.8	50.5	192.5	186.1	55.8	99.8	69.1	59.8	59.2
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		860000	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.5	5.3	4.7	9.6	43.9	10.1	46.1	17.1	16.2	11.2	10.0	4.4	10.1	5.3	14.6	17.1	6.2	47.3	3.8	14.7	7.4	7.6	9.7	3.0	6.5	5.0	15.8	2.6	7.6	16.2	48.7	12.3	6.7	9.5	7.3	6.6	8.9	9.6	40.2	10.0	3.2	2.3	3.1	7.7	10.3	5.4	22.7	11.3	10.6	10.2	4.0	5.0	9.6	32.0	13.9	10.7	14.8	5.8	7.1	12.8	5.4	4.8	9.5	9.0	10.6	2.5	14.1	4.0	9.5	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7	20.8	24.3	13.0	30.5	166.3	19.6	98.7	33.1	58.9	20.5	27.9	27.5	100.3	6.6	35.7	4.3	29.5	11.9	23.3	41.7	159.6	29.6	19.2	27.7	36.0	54.2	9.5	18.4	23.4	39.9	5.4	27.6	33.5	60.8	9.0	10.9	56.4	53.6	10.5	29.4	32.1	25.9	12.9	34.0	24.6	2.7	137.6	245.4	17.5	14.2	47.8
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 693.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 151.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA		110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.5	13.4	28.0	11.1	12.4	25.9	12.8	15.7	32.7	21.5	35.3	27.9	31.6	29.0	17.1	15.9	33.0	29.3	25.4	12.3	19.3	38.8	33.9	42.7	32.3	20.0	20.0	22.1	18.0	31.9	20.8	41.4	11.0	19.0	21.9	30.8	28.2	17.1	80.0	37.4	18.5	15.6	62.7	151.5	33.0	18.0	55.3	26.9	35.9	36.1	15.9	35.8	49.5	26.3	7.7	40.7	30.7	14.4	20.9	44.6	23.0	39.0	31.4	22.8	23.4	26.6	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5	17.9	24.8	104.2	137.8	138.6	109.2	340.1	175.8	33.5	25.0	75.0	76.6	235.5	693.0	191.2	55.0	98.8	477.2	70.0	250.0	197.5	112.8	124.7	59.9	203.6	217.6	82.6	140.6	55.3	91.9	71.2	82.3	127.4	170.4	267.9	288.6	98.9	227.1	319.6	85.2	391.4	75.4	71.1	158.3	73.6	93.6	143.2	198.1	79.6	481.1	207.2
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	41.7	23.4	25.3	35.2	14.6	11.2	26.1	40.3	16.6	30.2	35.1	38.7	28.6	48.1	19.8	17.6	89.2	49.7	51.4	37.9	53.3	14.2	23.0	40.0	27.8	27.4	22.9	91.5	35.7	14.9	34.0	30.1	65.4	13.1	27.0	29.5	73.3	51.0	32.0	19.3	49.9	35.6	47.4	94.1	44.3	35.2	30.4	46.0	47.0	41.0	51.4	24.4	21.0	89.6	32.4	46.5	46.4	54.8	19.4	27.8	50.5	42.8	74.3	52.8	61.1	107.5	37.0	66.7	76.8	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1	77.4	123.3	298.1	610.6	612.7	158.0	675.3	165.6	120.5	170.6	174.5	72.6	180.3	1409.2	260.2	374.4	142.6	539.3	116.8	187.6	286.9	225.4	312.0	210.9	174.2	320.2	125.5	369.3	82.3	121.9	99.1	83.4	292.4	560.1	339.0	300.1	181.9	228.9	349.1	88.1	469.8	154.2	135.8	467.2	297.7	184.8	625.2	292.1	228.4	388.1	691.0
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell type enriched"	"Detected in some"	36	"Syncytiotrophoblasts: 1678.9"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	45.7	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.3	0.1	3.7	0.3	0.0	0.0	15.3	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	8.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.0	0.0	13.4	0.0	0.0	0.0	1.6	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.3	7.7	0.2	0.0	1678.9	0.0	0.0	0.0
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell type enhanced"	"Detected in many"	11	"Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.2	0.4	0.0	24.6	26.4	0.0	0.1	0.8	0.2	2.3	0.0	5.5	0.0	3.6	3.2	0.5	10.8	0.0	0.7	0.4	1.0	0.7	0.0	4.0	0.0	6.8	0.0	0.0	105.7	10.3	5.7	0.2	24.4	0.0	0.0	0.1	0.0	0.1	5.2	0.0	4.0	1.4	1.8	2.5	0.0	0.0	0.0	2.5	0.1	0.1	0.4	49.2	7.2	0.0	1.4	9.1	1.9	0.0	0.2	0.0	20.2	0.0	0.0	0.0	0.0	26.8	0.0	2.2	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2											17.9	50.6	0.5	98.2	15.8	0.9	2.7	0.0	12.0	35.2	43.6	0.0	0.4	13.3	5.0	11.7	36.8	0.0	0.0	0.5	0.7	41.1	345.6	3.5	9.7	12.6	0.0	1.7	5.5	116.2	8.6	147.9	28.1	16.9	39.7	0.3	0.5	0.4	0.0	160.5	0.8	0.3	19.4	20.8	1.0	1.8	12.4	0.2	0.0	0.8	295.9
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	16	"A549: 95.1;Hep G2: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	95.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.7	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.6	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	1.5	21.1	20.3	0.0	0.3	0.0	8.1	29.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	39.9
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.9	0.1	0.8	3.0	1.0	2.1	3.7	0.1	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	74.3	4.3	0.1	0.0	14.2	0.1	0.0	0.0	3.5	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.7	0.1	18.9	0.0	0.0	0.0	0.0	0.0	30.5	0.7	0.5	0.7	1.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.9	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7	3.0	28.2	0.9	44.4	4.6	13.8	5.0	17.8	14.7	12.5	3.5	25.5	0.9	8.3	9.2	0.9	7.1	46.1	0.0	10.8	0.5	20.2	45.1	2.3	367.9	155.3	9.5	23.5	19.6	15.9	0.6	44.0	31.1	47.2	143.3	9.0	29.6	6.6	19.3	25.1	66.2	13.7	0.0	8.5	0.3	0.0	2.8	1.0	2.5	18.7	20.0
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734579-241768816	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA056216: AB_2683070, HPA060548: AB_2732650"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	7.3	17.0	10.9	13.3	10.7	11.5	7.7	9.8	9.5	12.2	15.9	11.7	32.4	7.8	14.6	30.6	12.0	11.7	22.6	8.7	11.3	7.9	13.8	18.7	8.7	7.7	12.2	8.5	10.6	17.1	18.7	26.4	7.4	13.0	12.3	10.1	13.1	13.8	22.2	24.3	27.1	10.5	11.8	7.0	10.0	9.9	4.3	11.3	6.1	15.2	14.0	12.5	11.3	9.5	5.0	1.1	0.0	0.6	0.0	2.8	0.3	6.6	7.1	4.2	6.7	10.1	5.4	14.6	6.1	8.1	6.5	5.2	7.7	14.6	5.5	3.0	6.3	7.4	15.3	3.9	5.1	2.9	6.0	3.9	10.2	6.4	13.2	5.6	12.0	8.1	9.7	9.2	5.1	5.1	12.5	6.3	8.6	13.0	3.5	5.7	11.2	10.1	12.4	2.0	8.9	13.7	12.6	4.7	10.3	11.8	24.0	13.7	4.5	6.2	16.0	4.2	2.9	9.8	4.3	2.5	10.1	3.8	5.2	3.7	6.5	1.2	8.4	7.0	13.4	6.6	0.0	0.5	0.0	0.8	0.6	1.2	5.0	0.3	2.8	1.1	0.6	1.6	0.6	0.0	0.0	0.6	0.3	1.9	0.3	10.9	10.7	9.8	9.5	11.3	7.9	12.2	8.5	13.0	11.3	8.9	14.7	13.7	22.9	17.5	12.5	7.8	30.6	9.4	11.4	17.4	13.7	36.9	19.9	8.4	2.3	8.4	24.4	0.0	7.5	13.6	12.0	16.9	5.7	34.6	15.1	11.1	30.5	13.5	9.2	1.6	15.5	7.8	3.3	1.8	55.3	46.4	7.6	21.0	17.0	25.8	11.2	6.5	10.3	1.7	6.1	12.9	18.9	10.7	47.9	17.3
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell type enriched"	"Detected in single"	29	"Cardiomyocytes: 13.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.2	0.1	1.1	21.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3	0.0	0.0	0.0	0.2	0.1	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1
DAP		ENSG00000112977	"Death associated protein"	P51397	5	10679230-10761272	"Predicted intracellular proteins"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA029456	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"	Nucleoplasm	"HPA029456: AB_10601262"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (2.04e-2)"	17.4	36.6	13.7	17.9	12.7	10.6	23.1	3.9	11.6	23.5	25.4	11.4	63.4	26.5	21.1	34.7	14.3	18.6	44.0	22.9	13.4	9.1	40.1	78.2	21.6	22.6	10.2	10.1	26.1	178.8	30.0	28.4	26.4	21.8	24.8	20.2	22.7	71.1	76.0	5.9	15.2	42.6	18.3	10.8	23.8	31.6	23.2	9.8	15.5	31.2	12.8	18.6	25.9	16.9	18.1	32.8	27.3	33.2	13.1	17.6	22.5	19.2	14.1	17.5	16.1	32.8	39.7	19.4	47.4	73.7	35.9	41.7	10.0	16.5	8.4	31.2	58.5	22.7	3.8	10.8	28.1	40.0	44.3	7.9	11.3	27.3	24.6	31.0	21.1	8.4	20.4	9.8	23.5	42.7	20.8	66.9	9.5	13.1	28.6	35.1	15.3	11.3	13.5	6.3	26.2	32.3	15.5	7.7	13.9	47.3	35.9	11.9	16.0	48.3	19.7	12.6	14.0	15.6	31.0	32.7	22.3	24.2	14.7	25.1	16.1	20.8	12.4	22.0	41.2	33.4	14.9	33.2	18.6	14.8	29.4	17.6	18.1	15.3	13.0	32.8	12.0	11.3	11.2	27.3	13.1	28.5	26.9	16.1	22.5	13.7	12.7	3.9	11.6	13.4	9.1	10.2	10.1	21.8	9.8	14.9	40.1	32.0	53.6	17.1	8.1	11.0	56.0	12.0	30.7	50.6	5.9	59.1	112.7	83.0	10.9	31.6	98.3	0.0	168.9	84.1	36.6	77.8	35.6	106.2	46.0	4.8	42.5	36.2	35.6	22.8	27.6	32.0	27.0	38.7	87.4	19.0	105.6	63.3	32.2	50.2	7.2	0.0	21.7	33.1	6.1	15.8	84.4	24.1	65.2	69.2
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.0	19.4	12.1	7.5	9.2	13.1	15.5	12.8	10.6	18.5	14.2	18.2	26.1	15.7	17.5	10.2	12.2	29.8	33.4	21.6	25.3	17.9	16.4	13.6	9.7	12.6	9.0	11.5	12.4	9.5	9.9	18.7	19.1	5.9	18.4	11.9	27.5	12.4	15.4	8.0	14.6	6.5	23.4	32.5	17.4	17.2	15.4	28.9	16.8	9.7	15.9	14.5	14.0	31.3	20.2	19.0	32.8	15.2	8.1	9.5	15.0	13.1	20.4	9.7	24.5	18.2	5.5	12.7	20.5	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9	3.0	1.9	4.3	3.6	1.5	2.2	10.5	7.6	1.4	3.4	5.2	0.0	7.3	6.6	3.9	1.9	3.2	4.5	23.3	2.3	13.0	3.4	2.3	5.7	4.3	8.9	3.2	4.1	1.3	3.5	1.0	2.8	5.0	1.7	6.4	5.0	2.4	3.6	0.0	1.4	6.4	2.7	0.0	2.3	5.7	6.4	1.4	3.5	2.9	6.0	2.5
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.7	5.8	5.3	10.8	11.7	10.3	12.4	8.0	6.5	7.2	8.7	12.0	4.5	10.7	11.7	4.8	4.6	10.5	11.8	8.5	9.0	11.2	6.8	7.7	11.1	5.9	10.1	10.1	3.7	10.0	9.4	5.9	9.3	6.5	6.7	10.0	12.4	11.7	5.7	2.7	8.4	3.3	11.2	7.8	11.5	8.2	19.4	8.0	7.9	10.6	9.4	5.8	17.8	15.9	13.4	9.8	12.5	6.3	7.7	7.1	4.7	9.1	7.2	8.2	8.3	5.5	8.4	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2	20.8	28.4	16.7	5.9	6.1	21.3	62.5	20.4	16.0	9.1	12.2	37.3	16.0	43.1	8.1	0.6	6.7	8.1	0.0	7.2	10.3	7.5	7.4	2.3	43.1	7.4	14.3	8.7	10.4	7.5	0.9	14.1	7.8	3.3	6.4	12.5	15.6	6.7	3.5	19.8	26.5	20.8	6.5	8.1	2.4	5.5	6.4	6.9	10.0	12.7	4.6
DCAF15	"C19orf72, MGC99481"	ENSG00000132017	"DDB1 and CUL4 associated factor 15"	Q66K64	19	13952492-13961449	"Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068351			Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA068351: AB_2685977"	"unprognostic (6.91e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.72e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.97e-4)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (7.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	10.3	6.5	10.4	15.1	8.5	27.5	11.1	20.1	13.3	13.9	12.7	8.7	8.9	10.7	11.4	8.4	14.7	11.3	10.0	11.0	12.1	7.0	11.1	13.1	14.8	19.4	9.0	8.5	10.3	8.4	11.0	10.7	18.6	8.8	10.4	8.4	9.8	10.0	9.1	13.3	21.0	13.8	8.2	7.4	21.4	9.9	41.0	6.5	29.2	10.7	16.5	23.4	9.9	12.8	2.2	2.8	5.1	2.2	0.8	3.6	1.3	15.6	9.7	25.6	14.0	2.7	4.0	11.7	10.8	7.6	22.7	22.7	17.2	6.7	14.5	12.6	10.4	13.4	14.3	16.2	10.2	8.1	17.4	28.9	17.8	16.2	17.8	5.8	14.7	26.3	5.3	9.6	16.7	7.6	8.2	11.3	23.5	18.7	21.4	9.9	23.8	26.2	27.3	30.4	10.6	15.3	24.2	9.0	9.9	12.1	12.1	16.4	16.9	9.7	7.0	8.8	11.0	9.0	19.0	7.8	15.6	11.6	24.5	20.1	15.1	16.6	15.1	10.0	21.5	13.4	1.2	2.0	5.1	2.1	2.2	1.6	2.1	1.7	2.4	1.2	2.2	0.9	2.4	4.1	0.8	1.4	2.8	3.6	1.3	10.4	8.5	20.1	13.3	12.1	7.0	9.0	8.5	8.8	6.5	0.0	0.0	16.4	8.1	4.2	15.5	0.9	5.1	0.0	2.3	8.7	7.9	10.8	1.7	9.7	4.0	8.3	6.3	0.0	9.1	12.7	6.4	4.9	1.1	3.2	13.4	14.3	7.5	9.2	6.0	7.8	17.0	8.8	1.7	14.4	6.1	8.4	7.9	7.0	11.3	3.3	13.2	6.5	4.7	25.1	23.7	8.5	11.6	12.2	6.8	9.2
DCAF5	"BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22"	ENSG00000139990	"DDB1 and CUL4 associated factor 5"	Q96JK2	14	69050881-69153150	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041575, HPA048098"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041575: AB_2677558, HPA048098: AB_2680263"	"unprognostic (8.12e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-1)"	23.5	18.1	18.5	18.1	21.7	19.0	21.7	23.5	24.0	23.1	24.4	21.4	20.2	15.6	26.9	17.2	24.5	22.0	19.9	22.2	17.9	11.7	19.3	23.8	23.8	18.4	13.6	13.5	24.5	17.8	32.6	30.1	20.6	15.5	23.7	16.0	23.4	20.6	24.9	47.7	23.4	20.5	24.5	20.1	22.3	20.6	41.8	17.5	38.7	25.0	14.0	27.9	24.2	24.6	5.3	3.5	9.6	2.5	17.5	19.4	7.2	26.0	8.3	19.6	18.2	21.9	19.2	12.9	12.3	18.0	14.2	17.9	10.7	16.7	14.4	11.3	19.1	10.7	12.8	13.8	18.4	13.3	19.5	7.6	15.5	8.4	7.6	16.6	5.9	18.9	21.6	19.3	12.6	17.8	24.6	21.1	17.3	11.9	12.2	14.0	15.5	18.5	10.3	8.8	12.3	13.3	12.4	18.6	5.7	18.8	20.4	14.0	15.8	16.5	17.3	11.0	17.7	21.1	12.0	19.0	24.2	22.9	11.1	7.2	16.1	5.2	13.3	16.1	7.1	7.3	9.6	2.5	9.0	19.4	2.4	16.4	5.0	10.5	14.2	3.3	5.3	10.1	12.5	3.2	17.5	1.6	3.5	4.7	7.2	18.5	21.7	23.5	24.0	17.9	11.7	13.6	13.5	15.5	17.5	41.7	52.6	15.9	17.8	23.4	17.5	53.4	35.7	48.2	46.6	14.0	25.5	16.4	1.7	19.9	118.8	28.9	18.0	0.0	21.6	14.7	21.8	18.2	34.8	28.0	16.9	17.5	22.4	26.4	20.9	68.0	28.7	19.0	10.1	17.2	21.1	20.8	25.0	17.5	32.2	10.8	23.8	45.3	28.3	45.2	16.4	17.3	12.8	27.7	18.3	18.7
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.7	13.4	0.7	0.6	0.3	0.4	0.1	4.4	0.7	0.2	17.1	10.6	0.0	0.8	0.0	6.2	0.0	0.1	9.0	0.5	0.5	0.1	0.3	0.9	0.0	8.6	0.1	0.8	0.1	0.7	0.1	9.7	0.2	2.3	0.0	3.6	0.5	2.5	0.1	1.4	0.2	0.3	0.5	0.0	7.6	0.7	0.4	1.0	0.3	0.0	10.7	0.7	0.7	0.9	1.2	0.8	12.7	0.2	0.1	2.7	9.3	2.5	7.4	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9	26.8	17.1	39.8	83.5	59.4	4.0	32.5	38.2	33.5	17.0	78.5	27.5	13.7	150.9	113.3	87.7	94.4	114.4	0.0	28.5	24.3	96.9	77.4	109.8	27.2	186.9	0.0	143.9	57.7	101.8	14.7	167.1	97.2	97.8	79.4	47.6	79.4	71.2	98.2	143.9	116.9	22.9	103.5	127.7	2.6	12.4	51.8	15.1	33.1	63.1	53.8
DDT	DDCT	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23980469	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.8;liver: 58.4"	"Cell type enriched"	"Detected in all"	5	"Hepatocytes: 4710.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.5"									"HPA049871, HPA074115"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3.0	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4.0	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2.0	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38.0	23.8	29.0	28.6	27.1	11.6	4.0	9.4	7.7	6.8	24.5	7.9	5.3	6.9	7.2	10.2	7.9	26.0	7.4	4.1	10.2	22.5	10.0	9.8	4.5	11.0	68.5	15.6	15.8	22.2	7.8	34.2	15.7	6.8	7.5	6.9	6.1	8.0	7.4	4.1	14.1	10.5	6.9	13.3	7.5	31.0	12.1	24.0	35.0	16.5	7.5	37.1	12.3	10.0	13.7	13.2	16.3	30.9	23.2	5.7	7.8	10.8	8.5	7.2	16.0	7.3	8.2	32.4	10.7	16.3	14.1	12.7	13.8	20.7	38.0	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29.0	28.6											77.4	62.3	170.5	177.4	123.4	46.7	20.4	580.9	78.9	76.2	230.3	84.4	209.3	608.5	198.5	156.1	122.0	650.8	116.8	322.3	247.0	92.9	222.4	128.0	4710.9	242.3	41.3	249.4	161.4	217.6	261.8	108.4	147.1	150.1	220.0	322.2	63.3	238.6	309.5	104.0	969.7	70.4	77.6	140.0	72.1	40.3	164.4	250.7	154.1	488.9	247.4
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.2	4.5	5.4	6.3	3.5	10.6	4.2	6.3	10.7	7.6	8.9	9.8	23.2	6.5	5.2	5.8	11.2	6.4	10.2	6.3	3.1	10.6	8.4	4.8	9.2	8.5	13.1	9.0	6.9	11.2	8.8	8.1	3.7	5.9	15.7	14.9	3.6	4.7	13.8	13.7	18.5	11.1	6.3	6.8	13.5	4.2	24.8	7.5	7.2	9.5	6.4	17.2	4.9	9.3	5.4	9.5	14.4	4.2	4.7	4.0	6.7	6.9	8.2	9.9	22.3	5.8	10.1	6.4	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7	6.0	5.0	7.5	13.5	8.1	4.8	3.1	2.5	2.7	5.7	3.5	0.0	24.0	11.6	9.5	5.9	6.0	1.7	0.0	8.5	9.4	4.2	3.1	3.5	9.7	15.4	3.2	4.6	4.3	10.3	3.1	4.6	6.6	6.8	11.8	2.8	7.2	7.2	4.5	3.2	14.6	3.4	12.9	4.1	20.6	15.1	9.4	83.5	10.1	5.8	10.3
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919675-18928633	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	14.8	16.8	17.6	17.3	16.9	28.3	18.0	17.0	30.7	15.3	15.8	19.0	14.8	19.5	15.6	13.2	23.4	16.5	12.2	18.2	19.2	12.9	15.5	25.6	13.0	19.3	15.7	14.8	15.7	26.8	13.0	11.1	23.3	16.2	15.5	10.3	13.5	24.3	15.8	27.2	23.6	18.7	12.7	16.8	16.7	15.7	19.7	16.3	23.4	18.8	16.6	18.7	16.4	15.6	8.2	25.0	13.5	19.5	14.1	14.0	9.7	15.8	16.5	6.7	21.0	9.8	7.9	25.2	10.1	6.8	17.9	14.5	18.8	16.1	20.8	30.9	10.0	5.7	13.6	14.9	13.8	5.1	6.3	39.6	10.2	17.9	16.3	23.3	26.1	14.2	15.7	13.3	14.2	15.0	5.0	8.1	16.6	19.2	14.9	6.3	35.5	18.9	12.2	21.8	17.2	40.3	21.0	11.2	22.5	9.6	10.0	23.6	24.3	13.3	13.2	16.1	3.7	13.5	12.6	10.4	8.7	9.8	31.5	16.5	19.6	23.4	19.0	11.0	30.2	13.6	10.5	17.7	13.5	12.8	19.5	10.6	8.1	9.7	9.6	25.0	8.2	9.7	10.2	7.9	14.1	12.6	11.2	14.0	9.7	17.6	16.9	17.0	30.7	19.2	12.9	15.7	14.8	16.2	16.3	3.0	7.7	21.6	16.0	20.0	17.5	12.5	15.3	8.1	12.5	17.4	3.9	39.6	31.5	25.8	28.0	10.8	42.3	0.0	45.8	41.7	17.9	16.3	18.4	13.9	29.8	9.5	24.8	8.0	19.8	81.0	19.8	18.3	25.3	26.2	20.9	16.0	25.6	30.6	18.7	21.4	20.9	19.4	20.2	29.7	36.4	24.7	35.2	15.8	30.7	17.3
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 338.2;Proximal tubular cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.5	6.0	17.8	20.1	12.5	20.3	3.8	9.3	16.1	6.1	9.5	2.4	10.5	8.1	7.4	11.1	5.5	8.0	6.6	9.4	10.2	12.2	0.7	19.3	5.4	9.6	15.6	4.2	4.0	16.0	7.3	4.8	8.1	15.1	18.0	12.9	20.1	16.0	29.0	12.1	12.0	6.2	1.1	22.4	18.2	10.2	4.7	14.4	29.8	26.6	0.8	6.7	14.0	132.5	11.1	0.5	17.0	10.9	16.3	10.3	4.9	13.5	5.5	8.1	6.1	9.5	9.8	9.6	13.1	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5	71.5	50.7	52.5	52.8	36.7	12.7	229.8	79.0	71.0	51.2	68.0	2.0	44.0	338.2	106.7	118.9	49.7	161.9	0.0	82.2	42.9	47.8	37.6	48.5	196.2	104.2	30.2	100.6	52.2	85.9	33.7	79.1	96.9	81.0	80.2	84.9	41.0	80.5	101.7	48.4	333.3	6.5	71.1	40.1	118.4	23.4	35.9	34.3	71.9	118.0	55.4
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.9	10.6	14.0	10.4	61.0	39.4	10.9	42.0	47.3	29.5	35.5	9.8	11.5	11.9	54.6	38.0	17.9	15.9	16.3	14.3	32.8	17.4	29.1	8.6	11.7	5.9	37.1	17.2	18.7	39.2	32.0	27.1	15.3	30.9	29.1	6.6	12.6	13.2	37.8	5.5	8.7	9.3	17.4	8.2	15.7	8.0	19.8	7.7	37.5	4.1	9.1	14.7	22.3	35.2	22.2	26.8	11.9	25.1	26.5	28.4	9.0	32.6	40.9	9.4	11.1	11.0	30.6	8.6	31.8	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3	77.4	27.7	37.9	37.6	218.5	30.5	15.7	12.7	22.7	20.5	10.4	13.7	229.8	11.6	30.3	15.3	49.6	4.2	23.3	38.8	36.5	83.9	44.4	103.9	18.1	85.9	17.5	14.3	60.2	49.3	8.5	58.4	80.4	65.8	75.7	5.0	21.7	25.8	5.8	74.6	25.8	15.9	103.5	85.6	67.0	42.8	280.0	166.4	61.0	5.6	12.9
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1, autophagy regulator"	Q9NTK1	10	44970981-44978810	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 204.9;breast: 227.9"	"Cell type enhanced"	"Detected in some"	17	"Ductal cells: 96.0;Exocrine glandular cells: 99.5;Pancreatic endocrine cells: 71.2;Syncytiotrophoblasts: 251.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.2;HDLM-2: 24.4;HHSteC: 63.6;HSkMC: 49.5;HUVEC TERT2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavorable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	204.9	14.6	8.7	14.1	16.8	2.4	227.9	10.8	19.7	14.1	36.5	2.9	10.0	7.4	25.0	14.9	23.5	25.5	28.0	37.0	8.5	6.0	13.0	48.2	70.7	20.6	9.4	3.3	51.2	107.1	4.7	12.2	33.4	21.6	25.8	5.7	12.1	16.2	13.0	81.0	19.6	9.9	30.2	39.0	9.5	12.7	31.9	11.0	0.8	33.3	13.4	19.1	52.1	27.6	0.0	3.7	1.2	0.3	0.0	0.7	1.4	6.9	0.0	0.1	0.0	35.2	17.2	1.7	0.0	2.4	0.1	0.4	0.2	2.6	0.0	0.4	3.1	1.7	0.3	0.3	2.1	0.1	24.4	0.9	0.0	0.0	2.5	63.6	0.0	0.0	49.5	0.1	0.0	0.3	6.0	39.2	0.0	0.0	15.1	0.1	0.0	0.0	0.3	0.0	0.1	0.2	1.1	0.4	5.8	0.1	2.5	1.3	0.0	0.0	0.3	1.3	4.2	0.0	1.6	0.3	1.9	1.3	0.1	1.6	0.4	0.6	0.0	10.7	0.6	1.0	0.0	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.5	0.0	0.1	3.7	0.0	1.4	8.7	16.8	10.8	19.7	8.5	6.0	9.4	3.3	21.6	11.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	10.7	11.4	29.6	0.0	39.6	31.5	96.0	0.0	0.0	0.0	0.0	99.5	11.6	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	71.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	251.0	0.0	0.0	0.0
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.4	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	30.3	0.7	0.3	0.0	0.1	1.6	0.0	0.1	0.6	0.8	4.1	0.2	0.1	3.9	0.8	7.1	1.7	2.9	0.2	0.1	0.0	0.0	0.5	0.0	5.0	0.1	2.0	0.0	0.7	0.4	13.2	1.0	0.1	1.4	54.0	44.7	1.2	0.9	0.2	0.5	3.3	0.9	0.9	2.9	0.1	0.0	0.1	0.2	6.4	0.1	13.4	3.1	15.9	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5	6.0	9.4	4.5	12.1	4.6	2.2	2.2	15.3	0.0	5.7	24.4	0.0	0.5	72.9	3.3	1.3	3.6	3.9	0.0	10.6	1.5	8.2	11.1	11.5	10.5	2.8	0.0	16.0	4.3	11.8	1.1	10.9	7.6	13.5	1.8	2.9	0.9	1.3	20.9	3.2	24.6	0.4	0.0	1.7	3.2	3.2	4.8	0.3	0.0	14.7	16.9
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.2;hTERT-HME1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	4.9	4.7	7.1	31.8	8.2	9.7	4.8	6.0	10.8	8.4	13.4	3.6	3.1	20.5	6.9	4.1	42.0	4.9	7.9	3.8	4.6	2.4	3.9	1.5	7.6	28.6	2.1	4.1	4.9	6.4	6.2	3.1	10.2	3.3	10.6	11.0	4.1	16.2	5.3	1.0	33.0	27.2	5.7	3.7	23.1	4.8	4.4	2.6	117.1	4.5	9.6	57.0	13.0	15.1	7.6	4.0	5.4	2.8	5.2	30.2	10.9	6.7	4.3	3.0	4.0	7.5	9.8	0.9	15.2	15.6	6.0	4.4	2.0	11.5	3.8	3.6	10.1	2.0	12.4	3.2	42.2	7.2	3.2	0.7	6.1	9.1	1.1	6.5	1.9	6.0	8.4	22.8	8.3	44.8	20.0	12.2	22.7	0.7	5.9	16.1	0.7	12.5	2.4	0.6	5.6	5.1	5.8	1.0	0.6	14.2	19.5	0.5	1.7	5.0	0.2	0.5	8.2	2.7	2.0	10.9	3.9	2.8	0.8	0.5	0.7	0.3	9.2	4.7	5.2	1.1	5.2	2.8	5.4	6.5	2.0	11.7	7.6	24.3	11.7	4.0	6.4	30.2	18.1	5.2	5.2	1.2	4.0	26.7	10.9	7.1	8.2	6.0	10.8	4.6	2.4	2.1	4.1	3.3	2.6	3.0	6.2	15.6	8.5	13.4	0.8	2.0	0.0	0.0	11.4	5.2	0.0	13.4	0.0	4.1	6.5	3.3	38.4	0.0	8.4	4.0	3.8	8.2	6.9	0.0	3.7	0.0	2.4	4.9	4.1	4.7	3.4	10.2	0.0	16.2	7.5	4.9	15.8	6.2	2.8	0.1	0.4	6.5	3.1	3.8	2.7	12.2	22.1	20.6	5.2	18.0
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626228-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 163.5;Spermatocytes: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria		NA	Yes			Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (1.44e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.91e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	17.7	6.1	16.0	11.6	13.9	28.3	10.9	10.2	14.0	7.5	12.6	18.1	11.7	14.5	5.9	9.0	9.8	4.7	6.9	9.7	17.3	14.4	13.1	35.5	8.6	23.2	18.9	9.4	7.5	4.9	9.6	7.2	8.5	13.0	5.9	15.5	8.6	8.0	8.4	10.4	5.9	14.5	7.3	25.3	9.1	7.4	10.5	11.5	13.4	9.2	2.3	22.8	7.9	6.1	2.4	3.3	3.5	2.6	2.1	4.0	2.1	19.8	13.8	35.1	25.9	6.6	7.0	12.9	15.9	12.2	27.8	32.1	13.1	24.0	40.4	7.0	9.2	22.7	14.0	45.1	20.5	45.0	17.9	27.8	19.3	23.0	12.1	1.4	22.5	8.6	4.8	2.1	24.9	2.8	4.7	13.4	29.7	21.7	31.1	28.1	19.9	55.4	9.1	17.7	9.9	8.1	36.0	68.9	40.0	16.0	12.7	28.7	20.0	22.5	10.5	11.4	18.6	20.8	22.3	8.0	8.8	13.4	24.6	30.4	14.6	29.2	43.7	19.7	45.8	22.6	0.8	1.2	1.1	2.3	2.6	1.1	2.1	2.7	3.2	1.9	2.4	2.1	2.7	3.5	2.1	1.7	3.3	4.0	2.1	16.0	13.9	10.2	14.0	17.3	14.4	18.9	9.4	13.0	11.5	6.0	9.4	21.6	5.3	6.2	3.7	13.2	7.6	8.1	6.8	14.0	2.0	13.0	8.3	6.6	4.3	3.6	20.0	163.5	3.3	35.4	9.5	2.1	2.3	41.2	36.1	3.2	4.7	9.2	13.2	4.6	13.0	8.3	0.0	2.8	11.1	10.0	4.3	5.8	15.2	33.5	3.4	12.9	9.0	92.4	48.0	4.8	11.1	10.1	21.0	3.7
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	13	"hTERT-RPE1: 61.0"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	6.6	8.0	9.7	5.2	10.9	2.2	7.7	5.2	13.2	9.8	6.3	15.2	2.8	5.8	11.7	9.9	5.3	9.4	7.6	5.1	9.8	8.1	10.6	9.3	7.1	7.3	10.2	6.9	15.3	10.8	15.4	13.1	4.5	12.2	9.5	6.7	6.2	6.6	8.9	2.8	5.8	10.1	9.0	12.6	9.4	6.6	8.2	8.6	16.9	10.3	4.8	6.4	7.3	6.2	5.0	4.1	3.8	3.3	2.8	7.3	2.5	1.3	2.1	1.6	1.6	2.3	2.9	0.6	2.1	2.3	1.1	1.2	0.4	2.2	0.9	1.4	1.1	1.4	1.9	1.2	1.5	1.7	3.0	0.7	1.1	1.0	1.2	2.3	0.7	1.3	2.9	2.0	1.2	1.6	61.0	1.1	4.6	0.5	2.1	1.4	1.7	3.9	0.4	1.3	3.9	2.6	1.0	2.1	1.5	1.5	0.7	2.0	2.1	3.1	0.8	3.5	1.3	2.1	1.1	1.7	1.7	2.9	0.7	0.8	1.6	1.5	1.3	1.7	2.0	2.3	3.6	2.2	3.8	3.8	3.2	7.3	3.8	5.1	6.1	1.4	5.0	6.9	6.2	3.5	2.8	3.3	4.1	6.1	2.5	9.7	10.9	5.2	13.2	9.8	8.1	10.2	6.9	12.2	8.6	11.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.0	3.4	3.5	0.0	2.0	3.3	4.8	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.6	0.0	0.0	4.6	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031121, HPA078401"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No		63000	"Nucleoplasm, Mitochondria"		"HPA031121: AB_10600803, HPA078401: "	"prognostic favorable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	52.6	15.9	9.2	20.2	47.7	18.7	11.7	17.0	43.8	6.2	13.8	8.8	35.7	5.5	10.2	15.9	15.8	22.7	12.0	23.9	9.1	38.3	11.2	13.6	7.8	14.4	25.1	16.1	0.4	13.9	28.8	9.8	33.3	11.1	11.9	14.0	4.1	11.9	15.5	15.9	9.3	15.3	4.3	31.1	16.1	9.7	12.4	6.4	27.7	18.0	19.8	24.8	17.2	26.1	37.7	11.8	18.3	7.1	8.3	30.9	10.5	8.4	9.7	4.2	1.9	9.8	16.8	15.6	21.2	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0	50.6	96.5	40.4	57.0	30.2	23.6	16.5	147.7	46.8	59.1	82.0	78.5	22.0	16.6	184.7	1.5	65.9	155.6	0.0	145.2	76.8	60.2	242.6	172.3	147.5	88.2	39.7	44.6	30.1	58.9	2.0	76.2	101.1	102.9	178.5	77.9	88.0	174.5	89.2	79.2	41.6	54.4	84.1	70.6	1.1	3.1	22.2	17.4	135.7	66.0	41.6
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 213.4;Proximal tubular cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.4	8.8	13.2	10.5	8.2	4.9	16.0	5.8	3.7	10.4	9.2	5.6	6.9	8.3	1.9	3.6	4.8	16.3	13.8	4.5	11.9	4.6	6.2	4.5	3.5	4.3	8.1	1.8	1.7	6.0	3.5	6.0	2.4	4.1	5.6	10.1	7.0	6.7	2.8	22.2	6.0	3.2	7.3	10.6	2.1	10.3	4.3	7.0	6.7	2.7	3.4	15.5	11.4	20.4	6.8	14.8	45.0	6.5	2.5	3.4	2.5	7.0	4.2	6.0	4.2	5.3	4.3	3.2	5.6	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6	11.9	32.1	21.6	5.5	4.6	11.5	26.6	25.5	5.3	6.8	15.7	9.8	22.3	16.6	9.3	2.6	7.4	10.3	0.0	9.7	18.5	6.6	11.2	8.1	213.4	8.4	25.4	10.9	11.6	11.9	3.1	11.5	11.3	5.0	13.6	19.6	10.8	9.7	10.5	11.3	55.4	18.7	12.9	5.0	5.6	3.6	5.3	11.3	7.1	15.0	6.2
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	18.4	18.7	22.1	18.5	31.1	23.6	18.3	31.2	43.5	22.3	17.8	26.9	15.5	17.3	23.3	14.8	21.0	24.8	17.9	21.3	19.1	19.8	18.6	19.3	16.7	22.0	20.4	28.0	27.1	21.2	37.3	24.8	20.6	23.6	20.4	13.0	22.0	20.4	23.6	27.1	26.2	16.1	18.8	15.3	21.2	18.7	54.4	18.4	23.8	20.1	15.2	16.9	18.6	17.6	9.9	13.0	9.8	10.5	8.2	16.1	11.6	8.1	20.7	20.5	21.1	9.5	7.9	14.0	15.4	13.2	26.6	19.2	23.8	17.4	26.5	12.1	15.0	18.5	12.5	30.3	21.5	9.5	18.0	36.3	23.1	30.5	23.2	16.5	21.5	24.0	13.8	13.7	28.1	19.8	10.5	17.3	24.5	32.5	17.1	12.4	22.0	27.3	23.6	22.8	10.8	35.4	18.2	11.0	23.5	13.3	20.7	16.9	22.5	15.0	21.4	11.1	10.3	15.0	22.6	12.0	16.1	20.9	18.1	28.2	20.7	25.8	24.0	16.7	18.8	19.9	9.8	10.1	7.2	15.0	10.3	13.0	9.9	12.7	16.1	13.0	9.3	12.1	13.0	1.5	8.2	10.5	7.8	14.3	11.6	22.1	31.1	31.2	43.5	19.1	19.8	20.4	28.0	23.6	18.4	35.7	44.3	33.3	22.5	16.1	46.6	31.3	35.7	42.8	28.4	48.8	41.2	35.6	56.3	33.4	93.4	33.1	32.4	23.3	31.3	18.8	20.4	23.6	23.1	43.3	30.5	55.6	38.5	23.4	27.7	89.2	23.0	28.0	18.6	25.2	23.6	39.2	38.5	29.6	28.3	56.9	46.8	32.3	19.4	136.8	41.1	17.3	24.7	23.5	30.9	22.7
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122226568	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes		21000	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	17.2	29.7	21.9	15.5	24.0	26.7	24.8	21.9	30.1	20.4	25.9	29.0	14.3	20.6	22.2	36.6	23.5	21.8	19.2	20.3	21.2	26.8	31.7	37.2	15.8	20.9	28.3	23.6	22.4	32.6	22.9	30.6	28.5	27.0	21.1	24.2	22.4	22.2	20.2	25.8	18.2	21.3	21.8	29.2	18.5	19.8	62.7	21.8	23.2	26.9	23.0	22.8	20.5	17.9	32.8	35.0	27.5	29.1	29.9	32.1	26.8	19.2	38.3	27.1	18.4	19.5	19.1	20.8	20.1	19.8	23.7	21.3	33.1	10.1	23.6	18.9	18.1	17.6	19.2	29.5	24.0	28.1	20.4	23.0	25.9	15.8	30.3	27.7	27.8	10.8	26.3	17.1	27.9	41.9	26.9	27.3	23.6	29.6	10.0	23.0	28.8	22.7	40.9	21.8	27.7	36.0	20.7	27.0	25.9	26.7	30.1	25.7	26.2	26.8	10.8	21.8	31.9	36.3	19.6	18.6	18.3	22.5	20.7	18.1	21.9	36.6	33.8	23.3	21.5	24.0	23.6	28.9	27.5	30.4	29.1	29.1	32.8	28.4	28.4	35.0	26.0	27.9	28.2	12.7	29.9	26.5	26.8	32.1	26.8	21.9	24.0	21.9	30.1	21.2	26.8	28.3	23.6	27.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000284934	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207662-122227534	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 17.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 21.4"									HPA001825	Uncertain		Approved	Mitochondria		NA	NA		21000	Mitochondria		"HPA001825: AB_1857247"																		0.1	8.7	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.2	5.3	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.9	2.4	0.0	1.2	0.6	1.1	0.6	0.6	2.3	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.4	1.9	21.4	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.7	0.5	0.3	1.4	0.6	1.0	0.3	1.0	2.3	0.6	1.2	0.3	1.3	1.1	0.6	0.2	0.4	2.2	0.5											0.0	1.1	2.9	4.0	4.4	7.1	0.0	10.2	0.0	1.2	0.0	3.9	0.0	0.0	0.2	4.3	1.9	8.8	0.0	0.0	0.0	2.4	3.1	4.6	2.8	0.0	3.2	7.0	4.3	1.9	3.9	5.2	0.8	3.3	0.0	7.8	7.2	0.2	9.7	3.2	0.0	9.1	6.5	4.1	17.0	15.2	4.3	0.0	5.0	9.3	3.3
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 95.8;Distal tubular cells: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.1	6.2	8.3	11.0	11.6	8.7	9.9	8.5	4.9	9.4	10.7	19.7	18.2	25.3	16.7	7.7	12.8	13.3	17.2	9.1	10.7	9.1	10.8	16.1	6.6	12.1	8.3	20.3	9.2	10.5	10.0	9.4	9.5	7.2	8.5	12.5	26.2	12.1	11.0	4.8	9.2	24.3	9.7	15.8	12.1	14.3	11.2	28.5	17.2	6.5	15.9	9.7	10.2	28.9	6.4	9.9	21.4	12.6	5.7	9.4	10.2	9.4	10.9	4.0	6.3	38.4	2.6	22.2	7.3	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2	11.9	12.6	16.4	7.1	10.0	7.6	95.8	12.7	32.1	7.9	10.4	0.0	17.8	63.0	16.0	3.0	8.3	19.1	0.0	10.1	34.1	8.5	6.3	3.5	14.3	16.4	7.9	16.6	5.5	12.3	2.3	5.8	7.9	16.9	18.0	18.5	8.6	12.5	3.5	10.3	29.2	10.5	0.0	11.3	21.6	15.8	8.5	14.5	8.6	24.8	9.1
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
DLST	DLTS	ENSG00000119689	"Dihydrolipoamide S-succinyltransferase"	P36957	14	74881891-74903745	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003010	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		800000	"Nucleoplasm, Mitochondria"		"HPA003010: AB_1078679"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.13e-12)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.55e-3)"	32.2	38.6	12.0	22.7	19.9	28.5	31.3	19.1	25.6	31.2	36.0	18.5	15.9	24.7	26.3	28.3	31.4	19.2	29.7	47.6	10.8	11.8	43.7	45.1	20.8	26.7	13.5	13.7	21.5	27.1	25.8	16.2	25.2	19.7	20.9	26.8	19.2	22.3	20.1	59.2	26.9	43.2	32.9	11.4	20.8	24.3	21.0	10.4	23.5	27.2	49.8	28.4	26.9	21.1	3.8	6.3	8.4	4.3	7.7	5.3	3.2	25.8	27.0	20.7	14.6	32.5	36.9	31.7	33.8	34.4	34.6	32.4	26.5	28.1	26.3	14.4	38.8	15.6	29.2	34.8	33.4	36.6	19.0	14.6	21.5	22.6	23.2	33.6	15.2	14.8	37.7	29.3	33.5	41.4	31.2	35.6	11.9	16.4	17.9	37.5	34.7	18.0	21.6	17.7	45.7	25.4	23.1	30.4	14.5	42.9	31.8	24.6	20.9	31.9	42.6	22.0	19.3	39.0	22.0	31.5	21.1	27.6	25.7	23.1	12.7	13.2	23.1	30.8	15.8	22.0	8.4	3.0	5.0	5.0	4.3	4.5	3.8	4.5	3.9	4.7	2.7	4.0	5.3	3.0	7.7	3.9	6.3	4.4	3.2	12.0	19.9	19.1	25.6	10.8	11.8	13.5	13.7	19.7	10.4	6.0	4.5	20.7	19.3	23.5	17.5	23.4	20.4	2.7	3.4	19.2	29.5	33.7	48.0	32.5	6.2	14.6	39.3	0.0	22.3	30.6	23.8	21.8	20.7	37.3	28.4	12.7	14.3	24.5	16.2	3.4	16.7	16.5	21.9	36.1	28.3	8.5	35.0	25.9	19.4	51.5	20.0	25.8	17.9	9.3	11.7	24.8	66.5	20.3	36.1	20.8
DMAC2	"ATP5SL, FLJ10241"	ENSG00000105341	"Distal membrane arm assembly complex 2"	Q9NW81	19	41431318-41440717	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 41.9;Ductal cells: 37.6;Extravillous trophoblasts: 58.6;monocytes: 55.1;Syncytiotrophoblasts: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041427	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041427: AB_2677473"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (4.37e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (4.07e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.29e-3)"	12.9	16.2	12.3	9.9	13.5	10.3	18.3	10.9	21.9	12.1	21.4	14.1	11.1	28.9	15.8	7.2	15.8	13.1	13.5	48.1	12.5	11.1	18.6	20.0	15.2	15.7	12.9	13.7	12.3	18.3	14.2	11.3	12.2	15.4	14.9	11.9	13.6	16.3	14.4	38.7	14.0	31.4	16.2	11.6	12.9	17.3	10.6	10.9	17.9	22.3	22.0	14.1	16.8	12.1	14.3	29.4	17.0	20.3	15.0	17.8	15.1	15.6	55.6	20.3	13.5	14.5	13.3	12.1	13.2	15.3	23.3	21.1	39.5	18.0	16.4	20.2	19.2	12.2	11.8	15.4	24.0	12.0	14.9	19.6	15.3	16.0	28.6	21.5	25.7	15.5	22.4	22.3	19.0	13.4	16.0	27.7	22.6	20.7	16.4	15.8	19.4	23.5	10.7	25.2	22.3	17.0	19.5	15.6	14.4	22.5	21.9	14.5	24.1	21.1	17.5	14.2	16.8	16.4	29.3	20.6	20.3	22.2	12.2	22.5	17.3	16.3	14.7	18.1	18.7	14.5	9.7	20.3	17.0	17.2	18.8	17.8	13.1	13.1	17.1	29.4	14.3	14.2	13.4	6.7	15.0	15.4	19.1	15.3	15.1	12.3	13.5	10.9	21.9	12.5	11.1	12.9	13.7	15.4	10.9	26.8	16.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	10.3	12.2	0.0	41.9	33.2	37.6	0.0	0.0	0.0	0.0	35.0	58.6	0.0	0.0	7.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	55.1	0.0	0.0	28.2	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		440000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.7	1.3	2.3	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.1	0.0	1.9	0.3	0.0	0.0	0.0	11.5	3.2	0.0	0.0	2.7	3.3	3.6	2.6	2.5	0.0	1.3	0.0	3.6	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2	0.0	0.6	1.4	0.4	0.1	1.5	0.8	2.5	2.7	0.0	8.7	2.0	0.2	16.6	0.4	25.2	0.6	0.5	0.0	0.6	0.1	0.8	0.9	0.0	84.9	0.1	0.0	1.2	1.3	2.4	27.1	2.3	0.4	0.0	0.0	1.1	3.5	0.7	0.6	2.5	59.0	4.1	0.0	0.1	3.4	5.2	0.3	0.2	0.5	0.6	0.7
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 3.7;Intestinal endocrine cells: 1.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	1.9	0.0	1.3	4.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	3.3	3.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.9	7.2	16.5	11.6	1.9	1.3	11.6	6.9	5.8	9.9	12.2	17.2	9.1	14.3	2.6	2.1	3.8	8.6	9.4	3.6	12.0	8.8	7.1	8.7	4.5	6.6	0.5	14.9	9.4	1.0	1.5	7.0	2.1	2.5	4.4	9.5	12.7	13.0	5.7	4.9	23.0	10.8	11.6	5.9	13.6	18.0	11.4	4.6	4.2	6.5	7.5	9.0	9.5	12.1	2.3	12.2	9.3	6.3	1.8	3.8	11.9	4.8	13.1	6.6	7.4	21.4	3.2	14.3	5.0	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4	6.0	0.6	0.0	0.7	2.1	2.2	7.3	2.5	0.0	1.2	1.8	5.9	2.0	0.0	0.5	1.6	0.7	1.3	70.0	0.8	3.8	1.9	3.2	0.0	4.4	1.8	0.0	1.2	1.3	2.2	3.1	0.6	0.0	0.0	0.0	1.3	0.2	0.7	0.0	0.7	0.4	3.6	0.0	1.0	5.0	14.2	1.5	1.0	1.5	2.3	0.9
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"		19	55158661-55166722	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	12	"fallopian tube: 29.7;testis: 60.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 336.2;Late spermatids: 540.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.3;HEL: 20.1;K-562: 15.7;U-937: 11.4"									HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No			Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.2	1.0	0.7	0.1	1.7	0.0	0.4	0.1	0.5	1.9	0.3	2.5	1.8	0.0	0.9	3.8	0.3	29.7	0.6	2.9	1.2	1.5	2.5	1.7	3.3	0.1	0.5	0.1	3.1	0.8	1.0	0.3	0.1	2.7	0.2	0.0	0.4	0.8	0.6	0.2	0.3	0.1	0.1	0.2	0.2	0.2	60.1	0.8	0.2	1.5	0.1	0.4	0.1	0.1	0.0	0.9	0.5	0.4	0.0	0.0	1.6	5.5	4.6	0.4	4.5	0.0	0.0	0.5	0.1	0.0	0.6	0.5	0.2	2.6	6.7	1.7	0.2	1.3	6.7	0.9	1.9	0.2	0.0	17.3	20.1	0.2	0.3	0.1	8.5	2.0	0.1	2.8	1.1	1.5	0.6	0.3	3.0	15.7	9.1	0.2	3.6	0.2	0.2	0.3	6.0	10.0	10.4	0.6	2.0	3.5	0.1	0.6	1.8	0.7	0.7	1.0	0.1	5.6	0.3	0.7	0.5	2.6	2.6	0.1	0.2	1.5	0.3	3.2	11.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.7	1.7	0.1	0.5	1.2	1.5	0.5	0.1	2.7	0.8	0.0	0.3	0.0	0.0	2.9	0.0	3.3	2.5	49.5	6.8	7.0	0.0	0.0	6.6	2.0	336.2	0.3	0.0	0.0	0.9	0.1	1.1	0.2	0.0	0.2	0.2	0.0	0.0	0.6	0.0	540.3	4.0	0.2	0.0	0.0	0.0	1.9	0.2	0.0	2.8	4.3	0.0	0.0	0.0	70.4	14.7	1.1	0.0	0.0	0.0	0.1
DNAJA3	"hTid-1, TID1"	ENSG00000103423	"DnaJ heat shock protein family (Hsp40) member A3"	Q96EY1	16	4425805-4456775	"Predicted intracellular proteins"	Apoptosis	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016095, HPA040875, HPA044229"	Approved		Supported	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (1.79e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-1)"	10.8	26.6	10.7	11.3	15.5	6.2	13.0	15.3	20.8	10.0	14.0	13.9	11.1	17.3	11.3	8.7	15.6	12.6	12.5	28.8	13.9	12.6	19.0	44.8	9.1	13.4	13.0	13.0	13.2	18.1	21.6	12.1	13.7	14.2	11.5	13.4	10.6	14.4	13.4	46.7	12.8	13.2	11.4	12.6	11.4	12.8	15.1	11.1	13.6	16.1	16.2	13.3	13.4	11.2	10.4	6.5	2.2	7.0	7.8	11.9	7.9	9.0	18.1	6.3	12.0	7.9	7.0	11.8	11.9	9.0	16.6	13.7	15.0	12.8	17.8	11.1	7.7	11.8	13.7	20.6	14.1	9.7	12.2	17.8	9.0	15.6	14.5	19.7	15.8	8.7	8.5	16.9	14.7	24.5	8.4	8.0	14.0	23.4	14.7	9.4	20.7	14.7	11.4	13.8	16.8	16.7	18.4	10.1	33.3	12.4	9.7	15.6	6.7	13.0	29.9	19.7	5.7	17.1	13.3	7.4	12.4	8.4	29.9	14.9	15.2	20.4	24.3	6.6	15.3	14.6	0.7	4.6	2.2	9.5	7.0	11.0	10.4	9.1	8.9	6.5	8.9	11.9	9.2	0.5	7.8	5.2	4.6	7.4	7.9	10.7	15.5	15.3	20.8	13.9	12.6	13.0	13.0	14.2	11.1	11.9	7.2	17.9	16.3	14.0	22.0	30.7	10.2	8.1	12.5	24.4	9.8	35.8	38.1	17.3	52.4	10.5	15.3	0.0	10.6	24.7	13.3	14.9	12.7	36.1	14.4	22.3	16.8	6.7	10.1	12.7	17.8	10.0	20.3	14.4	15.8	19.5	13.0	14.0	20.8	21.4	20.5	12.9	11.8	35.4	34.5	14.8	23.8	15.2	28.5	13.5
DNAJC11	FLJ10737	ENSG00000007923	"DnaJ heat shock protein family (Hsp40) member C11"	Q9NVH1	1	6634168-6701924	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023707, HPA028705"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA023707: , HPA028705: AB_10603662"	"unprognostic (3.74e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (9.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.38e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.04e-1)"	13.8	24.0	20.5	16.1	25.2	10.2	12.7	19.1	31.3	13.0	23.4	17.3	10.5	22.4	14.6	11.2	19.5	12.7	11.9	26.9	15.7	13.0	33.5	25.8	11.2	14.4	13.9	19.6	16.5	15.3	21.4	13.4	15.5	25.0	12.6	27.4	15.4	13.8	12.4	44.2	16.6	19.5	15.1	14.6	19.6	16.2	12.4	14.2	12.6	12.3	17.2	18.4	14.0	12.6	8.1	12.2	7.2	13.4	10.0	10.1	8.6	16.6	16.3	19.3	17.5	16.9	11.9	17.8	16.7	14.4	33.3	23.6	19.6	24.2	26.8	16.3	19.2	14.2	22.6	33.0	27.0	29.5	15.1	22.7	27.3	31.0	19.7	16.4	32.8	15.0	17.2	7.5	30.0	19.8	11.9	15.6	20.5	34.4	12.0	16.7	13.5	20.3	16.9	19.6	23.4	28.1	22.7	16.7	19.4	21.3	14.6	25.8	18.3	19.1	39.2	20.9	17.0	15.4	17.0	15.3	19.8	10.6	16.3	19.5	13.9	15.1	35.6	19.2	35.7	9.8	7.2	9.6	3.4	9.4	12.5	9.4	8.1	6.9	10.1	12.2	8.1	7.4	5.9	0.3	10.0	13.4	5.3	7.2	8.6	20.5	25.2	19.1	31.3	15.7	13.0	13.9	19.6	25.0	14.2	8.9	10.2	8.3	3.9	17.4	16.6	8.1	2.5	14.7	7.9	12.2	27.5	18.0	29.9	12.1	11.3	7.5	24.2	0.0	11.9	18.8	12.3	3.0	4.7	10.6	14.8	19.1	14.0	5.5	7.6	7.4	7.5	11.1	27.0	8.2	26.0	12.1	9.7	21.0	4.2	25.9	17.5	6.5	14.4	13.3	12.2	15.9	19.9	4.8	33.7	4.8
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7;skin 1: 20.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Horizontal cells: 1.6;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044714			Uncertain	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.6	1.3	1.3	0.6	2.1	0.8	2.1	8.8	2.8	0.6	0.6	0.6	0.6	0.8	1.2	3.5	0.6	0.4	0.6	0.6	1.6	2.1	0.9	1.6	0.6	0.6	1.5	0.6	0.7	1.9	0.2	2.1	1.3	1.3	0.8	0.2	0.6	11.7	0.6	0.7	20.6	0.8	0.6	1.3	1.0	0.9	1.9	0.6	2.4	2.7	7.1	3.4	0.6	0.6	0.0	0.0	1.6	0.0	0.0	0.2	0.0	1.9	4.0	1.7	1.8	1.4	0.8	6.9	0.6	0.5	1.6	0.8	4.4	4.1	2.6	2.1	0.2	0.5	0.6	0.6	0.2	0.2	5.1	3.8	1.1	6.2	1.0	0.2	1.2	4.2	0.9	1.4	1.2	0.3	1.6	0.3	3.0	3.5	3.9	0.6	4.5	3.6	7.5	1.7	0.5	2.7	6.7	2.0	3.5	0.9	0.9	3.5	1.8	0.9	1.5	2.8	0.4	6.1	2.7	0.2	3.4	4.4	1.9	1.4	9.5	4.5	2.4	1.1	2.5	1.7	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	2.1	8.8	2.8	1.6	2.1	1.5	0.6	1.3	0.6	0.0	1.1	0.0	0.0	0.1	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0
DND1	"MGC34750, RBMS4"	ENSG00000256453	"DND microRNA-mediated repression inhibitor 1"	Q8IYX4	5	140670794-140673586	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.2;testis: 12.0"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059723			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA059723: "																		0.5	0.2	1.7	0.4	0.8	0.4	0.7	3.2	0.4	0.6	0.6	0.4	0.4	0.3	0.4	0.5	0.4	0.7	0.4	0.4	0.4	0.4	0.4	0.8	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.1	0.4	0.4	0.6	0.9	0.4	0.4	0.6	0.4	0.3	0.4	0.5	0.5	0.7	0.4	12.0	0.4	0.4	0.4	0.4	1.4	0.4	0.4	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.5	0.8	0.6	0.9	0.4	2.1	0.2	0.9	3.5	3.2	1.0	0.7	0.8	0.3	0.6	0.4	0.8	2.2	1.1	1.4	0.7	2.0	0.3	1.4	0.3	1.4	0.5	1.0	0.7	3.4	2.9	1.8	0.4	1.2	1.1	0.7	0.1	1.2	0.2	0.2	2.6	0.6	0.0	2.2	2.1	0.5	0.4	1.8	0.4	1.4	1.2	0.2	0.1	0.8	0.7	0.3	0.5	0.0	0.8	1.6	0.6	0.1	4.0	1.1	0.4	0.0	0.5	0.8	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	3.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.0	1.4	1.3	0.8	0.5	10.3	0.0	0.0	0.0	1.2	3.5	3.9	0.2	0.0	0.2	44.0	0.7	0.4	0.0	0.3	0.3	0.7	1.6	0.0	0.9	0.5	19.1	1.2	0.0	1.0	5.6	0.6	1.1	0.0	0.0	0.1	3.9	0.2	0.0	0.4	0.0	3.8	0.0	0.3	6.9	26.2	0.9	0.2	3.2	0.6	1.2
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363789	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.2;MCF7: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.6	11.3	13.8	13.0	11.9	13.4	10.4	8.1	13.9	9.7	8.9	9.2	4.0	12.8	10.0	6.2	13.4	7.4	7.1	29.9	11.2	9.1	13.7	14.0	8.0	14.9	11.4	3.5	13.6	25.3	5.0	6.5	7.1	8.5	11.2	2.8	6.2	9.2	7.0	29.6	7.0	7.2	9.9	8.0	13.7	8.3	6.3	6.8	11.6	11.2	7.4	8.9	8.0	9.2	8.6	4.2	8.0	3.1	0.9	6.9	1.2	4.1	7.6	2.6	7.7	1.3	2.8	6.8	6.9	3.8	5.6	2.5	9.1	4.5	9.9	25.3	5.0	4.1	9.2	1.6	4.0	0.6	40.2	10.0	3.5	3.8	3.8	5.2	8.0	6.7	3.5	4.1	4.1	2.5	1.4	2.9	4.3	5.7	7.1	3.6	31.6	9.4	13.1	11.5	6.1	20.1	28.7	3.8	11.4	6.8	4.4	11.7	16.9	7.0	6.5	6.2	1.1	8.1	7.3	6.4	9.4	8.5	6.5	10.5	6.2	8.9	8.7	6.9	3.9	8.6	8.0	1.8	0.3	3.8	3.1	4.8	8.6	5.3	5.6	2.4	5.7	5.4	4.5	1.4	0.9	1.7	4.2	6.9	1.2	13.8	11.9	8.1	11.7	11.2	9.1	11.4	3.5	8.5	6.8	0.0	0.0	1.7	0.9	7.4	0.4	0.8	0.0	0.0	1.2	5.2	0.0	0.8	1.7	0.4	0.1	0.5	0.8	0.0	1.0	0.8	1.0	0.5	0.0	0.9	0.9	0.0	0.0	0.6	0.3	0.0	1.1	1.0	1.7	0.0	1.1	0.5	0.5	0.0	1.1	2.4	0.4	0.0	3.3	0.9	4.8	8.0	0.9	0.0	1.1	1.0
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.4	17.3	1.2	0.0	0.0	0.7	0.2	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	17.2	2.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	3.7	8.7	0.0	1.0	16.1	27.2	0.1	0.0	0.2	20.2	0.0	6.7	0.0	17.9	0.0	0.0	0.0	0.2	1.2	0.3	0.4	51.7	3.4	0.0	0.1	0.2	0.0	3.5	0.0	0.0	0.0	10.9	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9	8.9	31.0	83.1	1.5	5.7	0.2	2.0	22.9	1.4	3.4	7.0	72.6	44.4	1.7	0.8	24.2	4.8	0.5	0.0	5.9	3.1	2.9	1.1	23.2	2.5	50.8	0.0	8.1	3.1	113.9	11.5	2.8	79.1	8.5	79.4	8.9	1.0	1.4	17.5	0.4	8.7	3.8	12.9	14.4	15.4	4.1	3.3	35.7	76.2	1.0	3.0
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	0.1	1.0	0.0	3.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	27.8	0.0	1.1	0.2	1.2	0.1	0.0	5.4	0.2	1.8	2.4	0.5	0.1	2.3	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4	0.0	1.0	0.0	3.2	0.0	0.2	11.9	0.0	1.4	4.5	5.2	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.0	0.0	0.1	0.0	5.8	0.0	0.0	4.8	0.9	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.4	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7
DOPEY2	"C21orf5, KIAA0933"	ENSG00000142197	"Dopey family member 2"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072065	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA072065: AB_2686486"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	4.6	2.3	5.5	7.5	9.5	17.1	4.9	28.7	11.6	5.1	11.8	3.8	6.8	9.7	2.8	3.3	13.5	3.6	6.5	4.3	4.6	4.0	3.5	7.2	7.2	5.8	3.1	5.8	2.3	3.8	43.1	3.1	4.7	9.5	9.8	12.0	2.8	15.2	9.1	11.1	7.4	13.9	3.8	3.7	5.2	15.8	3.3	3.3	9.3	3.6	7.5	10.6	5.4	6.5	12.0	6.4	6.3	3.2	1.1	3.1	1.3	14.9	3.2	2.4	4.0	2.7	5.2	23.2	7.1	8.5	10.1	6.3	2.2	1.2	2.8	1.1	5.3	7.7	3.1	4.6	1.6	8.2	5.1	4.2	6.4	0.7	0.8	2.4	6.2	3.3	1.8	3.3	6.6	1.7	6.1	4.2	6.7	2.0	4.6	2.9	16.8	4.9	6.4	2.0	17.7	3.3	8.9	1.4	13.6	5.4	6.0	6.5	3.7	4.7	21.5	6.1	3.4	7.8	7.7	7.2	3.9	1.1	5.1	5.7	3.4	8.4	1.3	5.6	13.5	2.2	1.0	3.2	6.3	3.1	3.1	1.7	8.6	2.0	1.8	2.1	12.0	1.3	1.1	5.5	1.1	2.6	6.4	1.5	1.3	5.5	9.5	28.7	11.6	4.6	4.0	3.1	5.8	9.5	3.3	0.0	5.8	31.4	6.9	2.7	5.3	4.0	10.2	6.7	3.4	8.7	3.9	1.5	3.3	8.1	0.7	3.3	17.3	0.0	2.8	9.8	2.8	21.2	8.1	8.5	15.7	0.0	28.2	6.2	15.4	0.0	2.3	12.0	5.0	7.2	56.5	1.5	7.5	24.6	2.8	1.3	3.0	0.0	2.5	4.4	13.0	4.5	6.8	7.5	19.5	10.1
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 31.6"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6"	"Cancer enhanced"	"Detected in some"		"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.7;SCLC-21H: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced	Approved	Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: AB_2680653"	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	1.1	1.5	11.8	1.5	15.7	1.0	0.9	6.4	31.6	0.8	1.0	0.9	0.0	0.9	1.0	0.8	0.8	1.0	1.0	1.0	12.4	7.7	0.8	0.8	1.0	1.1	4.5	11.3	0.9	0.9	0.9	1.3	1.1	2.0	0.9	0.9	0.0	1.2	0.8	1.1	1.2	1.0	1.3	2.1	1.1	0.8	2.5	1.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.5	3.0	12.8	9.3	0.9	0.6	1.3	3.8	2.2	6.5	5.5	2.1	0.3	5.8	2.6	2.9	2.6	2.3	15.7	2.1	2.9	5.5	3.0	1.9	1.4	0.8	0.3	1.4	1.6	0.7	0.0	3.8	1.2	0.8	1.2	4.4	4.3	0.3	6.1	4.9	3.1	0.3	2.3	1.0	3.5	5.8	6.5	1.2	0.6	1.1	18.5	6.4	4.2	0.4	0.8	1.6	1.9	0.3	1.4	9.4	3.0	2.2	3.4	2.3	7.7	7.7	4.9	2.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.8	15.7	6.4	19.6	12.4	7.7	4.5	11.3	2.0	1.2	0.0	0.0	0.0	0.0	2.1	18.4	1.1	0.0	1.4	0.0	0.0	7.9	0.1	0.0	0.0	23.8	0.3	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.0	0.2	42.9	0.0	0.0	0.0	17.6	0.6	0.0	0.0	0.0	0.0	2.6	0.1	0.0	2.5	0.0	2.9	0.0	1.3	4.9	6.8	1.0	0.1	0.0	0.0	0.0
DPY19L2	"FLJ32949, SPATA34"	ENSG00000177990	"Dpy-19 like 2"	Q6NUT2	12	63558913-63668939	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 10.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA071264, HPA078305"	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA071264: AB_2686375, HPA078305: "	"unprognostic (1.97e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-4)"	"unprognostic (2.28e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (4.22e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.79e-1)"	5.7	4.3	2.6	1.6	5.2	2.1	2.4	5.2	4.5	5.6	2.6	1.4	3.1	0.7	7.8	3.4	1.3	3.7	2.4	12.9	1.8	2.4	6.0	0.3	1.1	0.8	1.7	3.1	7.3	2.3	7.4	10.9	1.2	3.0	5.7	1.2	5.1	2.3	6.3	0.5	1.4	0.9	4.3	0.7	1.1	1.5	44.0	0.9	0.5	8.4	1.4	0.7	2.7	3.1	0.1	0.0	0.1	0.0	0.1	3.4	0.4	1.2	3.1	2.8	6.6	0.7	0.0	0.3	2.1	2.2	2.9	3.8	0.4	1.0	3.4	2.2	0.9	3.6	0.5	3.3	0.3	4.4	1.7	2.0	5.4	1.4	2.0	0.6	3.9	1.7	1.5	0.1	1.4	0.0	7.4	0.8	2.6	2.2	3.4	4.7	2.1	0.2	1.6	2.5	0.5	2.5	0.1	2.3	0.0	5.6	0.5	8.5	0.9	0.8	0.3	1.2	1.2	2.4	1.1	0.6	4.0	5.2	0.6	5.4	9.1	10.4	0.0	4.3	1.9	3.6	0.1	0.0	0.0	0.6	0.0	3.4	0.0	0.1	0.6	0.0	0.1	1.0	2.7	0.0	0.1	0.0	0.0	0.0	0.4	2.6	5.2	5.2	4.5	1.8	2.4	1.7	3.1	3.0	0.9	3.0	0.0	0.0	2.9	0.5	41.9	24.2	2.5	16.0	6.8	12.2	13.7	1.1	5.0	0.4	300.2	2.3	0.0	0.0	0.0	1.1	1.0	3.0	2.3	0.0	0.3	3.2	0.0	0.0	0.0	304.6	6.6	0.0	6.8	0.0	0.0	11.1	0.2	0.0	8.1	5.6	6.2	25.8	15.6	171.9	4.1	0.4	1.1	0.0	0.0	0.9
DPYSL4	"DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186900-132205776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;heart muscle: 19.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 33.5;Cone photoreceptor cells: 55.0;Horizontal cells: 31.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 31.1;SH-SY5Y: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA049066: AB_2680619"	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.11e-4)"	1.5	4.4	11.8	2.0	12.3	1.1	1.5	8.9	32.0	1.7	1.4	6.5	0.2	1.1	6.4	2.2	1.4	1.4	2.1	19.0	13.6	9.6	1.0	1.0	1.5	1.4	9.0	9.1	3.0	1.9	1.0	5.0	1.3	6.0	4.8	1.0	4.6	1.5	4.2	2.5	1.6	1.2	2.7	8.1	2.5	1.8	6.7	4.8	0.0	1.0	0.0	1.3	1.4	0.4	0.7	0.0	0.0	0.6	1.1	2.5	0.8	0.0	6.7	23.7	31.1	0.0	0.2	0.0	2.0	0.2	1.3	0.3	0.0	0.2	0.0	0.8	1.0	2.3	0.0	4.6	4.5	0.1	0.0	0.9	0.0	0.0	2.4	4.2	0.0	4.7	2.1	2.2	0.7	0.1	0.4	2.4	0.0	0.0	0.2	3.4	1.9	0.0	0.0	4.1	0.3	2.3	0.0	0.0	3.7	0.0	0.4	3.7	32.3	0.7	0.0	4.1	1.4	0.1	0.0	3.9	5.9	9.9	0.0	5.6	0.0	1.6	0.0	9.9	0.0	0.6	0.0	0.1	0.0	1.4	0.6	0.0	0.0	1.1	0.1	0.0	0.7	2.5	0.7	0.0	1.1	0.5	0.0	0.0	0.8	11.8	12.3	8.9	18.7	13.6	9.6	9.0	9.1	6.0	4.8	0.0	0.0	0.0	0.2	0.5	33.5	14.2	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.2	4.3	0.9	0.0	0.0	0.0	0.1	2.4	0.4	0.0	0.0	0.2	31.8	1.7	0.0	0.0	7.1	3.7	0.0	1.7	0.0	0.0	7.5	0.8	0.0	4.2	0.0	12.3	0.0	4.7	4.4	2.7	0.1	0.0	0.0	0.0	0.0
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 49.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061357	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	3.6	3.5	19.1	5.2	21.3	4.7	13.9	14.5	24.6	7.7	2.7	9.5	13.6	2.2	4.7	14.0	4.6	7.3	5.9	3.4	20.6	12.6	6.3	5.1	6.6	4.6	12.4	11.7	7.2	10.3	12.2	9.6	5.4	13.2	10.5	2.4	4.2	49.4	13.9	2.7	4.6	2.3	3.1	13.1	4.4	7.7	9.0	7.3	6.3	15.7	1.0	5.4	5.2	4.3	7.4	1.1	7.2	2.2	5.1	7.4	2.8	8.9	7.6	6.2	6.9	3.6	4.6	0.2	2.7	3.7	3.4	4.9	2.9	2.3	4.7	1.1	2.2	4.4	3.2	4.3	11.7	1.9	7.2	10.0	3.7	2.3	8.9	2.6	4.7	3.7	3.7	10.1	3.6	6.3	4.3	4.7	9.7	0.3	7.2	2.6	9.0	7.7	3.9	7.1	2.4	5.2	6.2	10.1	8.9	6.4	8.4	8.2	11.9	8.9	15.8	10.9	3.4	8.3	2.8	1.9	1.4	6.4	2.0	4.8	12.7	5.6	8.5	4.0	8.6	5.1	0.5	2.2	7.2	5.8	1.1	6.6	5.7	7.4	5.2	0.7	7.4	7.3	5.0	4.3	5.1	0.6	1.1	6.4	2.8	19.1	21.3	14.5	24.6	20.6	12.6	12.4	11.7	13.2	7.3	8.9	10.9	3.7	21.9	7.1	8.6	2.2	12.7	0.0	5.7	14.0	5.9	3.1	10.0	3.9	2.3	3.8	0.0	0.0	10.2	1.2	2.1	14.7	1.1	5.0	26.1	20.6	2.9	2.5	4.7	4.5	1.4	3.1	11.8	2.8	2.3	15.1	6.9	0.3	2.5	7.1	7.8	6.5	1.4	9.4	12.4	1.8	1.7	8.6	1.0	16.0
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675742-241686991	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.4	17.6	11.6	17.3	15.0	29.1	14.4	14.5	12.4	10.0	13.8	16.5	9.3	12.0	12.4	9.7	20.0	9.7	10.2	9.4	9.0	6.5	15.5	19.5	10.5	21.0	14.0	9.5	9.5	13.6	5.0	8.8	10.4	11.8	11.5	11.7	10.8	9.6	10.0	6.7	17.9	13.0	13.0	9.5	18.8	13.5	11.1	15.1	20.7	9.4	16.1	17.9	11.7	11.9	19.8	21.1	12.0	24.7	15.7	21.8	15.7	25.1	27.8	24.2	30.7	8.0	8.7	25.6	20.6	15.5	27.5	32.4	12.7	30.5	12.2	6.4	16.6	32.8	21.2	22.2	25.1	14.8	28.7	26.4	26.1	23.3	24.1	6.6	16.5	21.7	6.1	6.8	26.5	10.8	8.4	26.4	17.7	29.4	10.3	29.1	26.2	30.5	28.7	23.8	28.2	23.4	26.1	35.6	17.0	15.9	14.6	29.2	18.3	13.4	20.6	16.5	7.7	18.7	29.6	17.1	40.1	28.8	25.5	38.0	11.6	12.2	34.2	32.1	26.5	46.6	12.0	14.9	9.5	17.4	24.7	16.8	19.2	16.1	18.2	10.5	19.8	16.0	14.7	2.5	15.7	18.8	21.1	21.8	15.7	11.6	15.0	14.5	12.4	9.0	6.5	14.0	9.5	11.8	15.1	8.9	4.3	11.9	17.5	13.5	18.2	9.2	25.5	8.1	11.4	24.4	2.0	48.5	18.3	37.3	1.8	17.5	9.3	46.7	29.4	118.6	22.0	17.5	15.0	16.6	74.0	4.8	13.8	20.9	13.1	2.0	15.3	23.4	21.9	57.7	19.9	16.3	27.3	14.0	18.0	27.5	14.2	25.8	16.1	27.6	57.7	10.5	23.0	15.8	34.8	12.0
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109431-103479863	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Motor protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 35.7"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.9;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.0"	"Low region specificity"	"Detected in all"							"HPA039015, HPA039016"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	7.3	5.7	6.3	3.8	8.9	1.4	8.4	13.2	9.3	11.5	4.8	5.5	11.0	4.1	11.3	9.6	3.9	14.6	7.8	3.7	7.1	7.1	8.5	2.6	10.2	2.6	4.8	7.9	11.4	5.1	24.2	35.7	3.9	11.2	7.6	2.6	6.2	4.5	10.7	1.6	5.7	3.4	7.8	5.1	4.8	4.2	14.3	5.2	1.1	10.7	3.0	2.4	6.1	6.6	0.5	0.4	0.4	0.2	2.9	2.2	0.0	1.0	2.2	5.7	2.8	8.0	18.0	0.3	3.2	5.2	5.4	5.8	1.2	1.1	0.0	4.5	6.2	2.5	4.3	4.4	6.0	4.3	0.0	4.1	0.8	3.7	0.1	7.7	1.7	1.0	11.2	2.3	12.1	13.9	8.4	2.1	1.1	0.1	0.0	6.9	4.1	0.5	0.4	1.5	0.0	6.1	0.0	4.7	0.1	5.8	0.7	4.1	2.9	5.1	1.4	2.4	1.4	5.3	1.1	5.1	6.5	2.6	6.1	2.1	0.0	0.0	0.0	1.9	5.2	1.9	0.4	0.2	0.0	0.9	0.1	2.2	0.5	0.7	1.1	0.4	0.3	0.8	1.1	0.0	2.9	0.1	0.2	0.0	0.0	6.3	8.9	13.2	9.3	7.1	7.1	4.8	7.9	11.2	5.2	0.0	12.5	0.0	11.5	6.0	22.2	9.4	2.5	167.3	23.9	26.2	106.0	0.3	1.7	5.6	13.4	9.0	0.0	0.0	3.1	0.4	14.8	5.9	3.5	0.8	2.0	30.2	16.6	6.7	1.5	6.5	19.2	3.8	8.5	0.0	0.8	17.7	6.8	1.1	17.3	14.8	86.1	19.4	11.3	64.2	10.4	4.8	0.5	2.5	0.9	5.7
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.2	16.8	7.9	12.7	5.5	7.9	9.6	9.2	7.0	11.4	9.5	12.2	8.4	11.5	9.5	8.5	7.1	9.3	29.7	16.9	10.9	4.6	14.4	6.7	10.3	20.6	8.9	7.4	8.4	8.5	10.1	10.2	14.4	8.6	5.1	11.6	20.7	6.1	8.1	17.5	7.3	5.3	20.8	11.8	5.9	13.2	9.1	22.1	14.4	7.2	14.1	10.4	7.2	13.6	7.3	13.3	18.4	8.3	4.0	9.0	8.0	9.9	11.6	11.2	10.6	9.3	9.1	10.3	13.3	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4	8.9	5.1	3.0	3.5	1.9	3.8	9.8	2.5	6.7	2.3	3.5	2.0	12.9	5.0	6.5	2.1	3.5	1.3	23.3	3.1	9.9	3.3	3.5	5.7	10.5	6.3	7.9	5.2	4.3	1.8	1.9	2.3	3.1	5.0	6.4	5.5	2.8	4.1	0.0	1.8	6.8	3.7	0.0	1.9	4.3	10.4	2.6	9.5	2.5	5.5	2.7
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38832005	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		5700000	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	33.0	52.0	17.6	21.7	20.9	14.7	29.6	11.4	19.8	14.8	34.1	19.5	19.8	25.8	16.8	15.4	30.2	18.9	30.6	130.6	18.6	15.5	40.0	105.8	16.9	19.6	22.2	17.2	16.0	36.5	11.5	11.3	32.8	17.5	20.9	27.1	20.8	27.4	15.2	130.9	18.7	24.4	27.0	13.3	28.1	24.8	26.2	20.6	15.9	24.5	43.5	21.5	21.3	19.3	68.7	60.7	49.9	61.1	61.4	72.6	83.3	12.6	55.6	8.6	14.3	33.7	17.5	12.7	6.2	10.9	5.5	5.6	35.7	25.1	19.8	24.5	14.7	5.0	6.0	14.4	14.9	4.3	68.5	8.0	24.0	16.9	28.8	34.3	25.4	24.3	23.2	38.6	7.2	12.5	10.9	13.0	26.2	11.3	33.1	12.1	23.7	17.7	14.6	5.7	55.9	13.4	20.1	26.0	39.4	34.8	28.8	10.8	13.9	32.7	16.2	17.2	5.8	21.8	57.1	10.9	9.7	8.3	9.6	5.8	25.1	29.1	18.9	14.8	32.8	18.6	49.1	61.1	49.9	51.9	46.8	48.9	68.7	50.9	51.2	60.7	62.2	45.7	51.4	8.1	61.4	38.3	41.4	72.6	83.3	17.6	20.9	11.4	19.8	18.6	15.5	22.2	17.2	17.5	20.6	80.4	82.4	123.2	165.8	73.0	19.3	280.9	234.4	97.7	73.9	137.9	15.7	632.1	432.7	146.8	45.4	83.1	264.9	46.7	80.0	307.0	84.6	125.8	115.7	460.6	245.2	35.0	181.6	92.7	111.3	42.2	121.1	102.2	138.3	289.5	227.3	54.7	110.4	235.9	134.4	659.8	17.5	77.6	99.9	79.1	47.7	79.4	485.8	139.5	278.3	180.2
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.9"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 663.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.4;HHSteC: 11.1;THP-1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		NA	NA		410000	Mitochondria		"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favorable (2.70e-4)"	10.2	13.3	4.8	9.3	7.4	3.1	10.3	12.3	2.9	10.0	11.2	2.6	20.3	14.5	10.4	20.5	10.2	9.1	20.7	11.1	4.8	2.6	21.3	74.9	9.2	2.5	2.9	3.6	11.8	9.9	8.4	18.1	4.4	5.3	10.9	3.8	15.9	11.2	25.6	22.2	6.0	13.3	16.2	4.6	3.8	10.2	3.8	4.2	1.8	16.4	11.1	8.1	8.0	10.7	5.2	8.2	1.7	1.8	4.8	11.0	3.8	0.0	1.5	0.0	0.0	1.1	0.5	15.4	1.2	7.1	1.5	2.4	0.0	1.1	0.0	7.1	1.2	0.0	0.8	0.0	1.2	0.3	0.0	7.2	0.0	2.6	3.2	11.1	0.0	2.1	1.6	3.2	1.0	1.1	2.1	4.4	0.0	1.1	0.2	0.0	3.8	0.0	0.8	0.1	6.2	1.6	0.0	0.1	0.6	4.9	6.0	0.7	0.3	2.1	5.6	0.1	0.8	1.1	9.3	1.7	0.0	0.0	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.3	0.0	1.8	1.7	11.0	1.4	8.2	5.2	9.0	10.3	8.2	2.6	10.2	6.2	0.4	4.8	0.7	2.0	10.8	3.8	4.8	7.4	12.3	2.9	4.8	2.6	2.9	3.6	5.3	4.2	50.6	72.4	17.1	77.5	27.2	30.8	55.4	119.8	60.2	70.5	82.0	308.3	162.8	150.9	46.2	111.4	19.6	107.0	46.7	52.0	12.3	46.8	90.9	28.9	663.7	26.8	39.7	50.1	25.8	25.9	134.0	142.6	17.0	38.8	10.0	59.3	58.0	41.0	123.8	105.7	257.8	155.8	19.4	46.6	14.2	12.8	25.7	103.7	39.2	56.8	67.7
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.7	6.8	27.8	2.6	3.7	25.5	7.4	5.2	6.2	9.1	31.1	22.7	10.7	18.7	4.6	4.4	18.3	7.9	7.1	0.8	18.5	40.7	3.3	16.5	38.4	23.8	9.6	1.5	6.8	16.8	5.1	11.1	4.4	6.1	0.2	17.7	22.7	2.1	30.4	0.9	14.4	15.7	11.9	17.9	33.6	7.3	51.4	11.7	8.4	23.4	14.8	18.1	34.1	22.5	3.5	22.0	17.1	5.0	4.8	18.1	5.2	8.3	25.2	14.8	17.4	6.3	8.9	6.8	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6	3.0	23.3	31.8	94.0	18.9	51.2	90.1	94.3	9.4	14.8	73.3	41.2	151.4	255.4	28.6	6.2	23.5	150.2	0.0	31.7	67.6	25.6	72.7	5.7	199.4	41.4	20.6	43.7	26.4	26.7	4.2	22.7	23.7	37.1	14.4	73.5	52.4	28.1	70.2	22.6	187.7	57.7	0.0	30.2	2.5	15.8	19.4	91.9	17.5	89.4	98.4
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559601-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 334.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 310.9;Ciliated cells: 275.7;Club cells: 547.1;granulocytes: 349.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040688, HPA055316"	Enhanced		Approved	Mitochondria		NA	NA		4600000	Mitochondria		"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	46.5	38.1	33.0	41.3	40.0	60.6	84.9	30.4	56.5	53.8	45.4	30.6	29.7	40.9	48.6	43.0	71.1	61.0	35.1	62.2	34.6	24.7	49.4	64.5	41.7	98.8	29.1	31.8	105.3	103.9	29.9	31.7	41.4	51.4	50.4	49.2	29.0	58.9	35.5	207.2	88.5	45.0	38.2	39.6	48.4	45.8	236.9	28.8	43.9	41.1	118.6	70.9	47.7	66.1	203.5	136.9	27.4	83.9	114.5	251.4	334.5	88.9	94.8	99.1	140.2	149.4	193.7	99.4	77.9	141.5	97.8	75.0	105.3	113.3	264.8	124.4	123.9	56.2	105.5	117.1	114.8	89.6	85.1	108.9	69.0	106.6	107.7	162.6	139.0	81.5	221.3	208.1	96.7	237.9	162.2	134.5	93.4	138.1	127.9	115.1	183.7	151.0	248.8	119.4	79.5	83.0	126.5	127.4	251.8	130.4	117.8	85.9	107.0	46.9	159.4	211.8	66.0	182.6	155.2	90.6	56.9	79.8	109.8	67.3	89.6	86.7	132.4	64.6	103.1	79.6	27.4	83.9	21.0	87.3	78.5	173.5	203.5	167.7	112.9	136.9	187.5	251.4	169.1	12.3	114.5	64.0	108.5	119.2	334.5	33.0	40.0	30.4	56.5	34.6	24.7	29.1	31.8	51.4	28.8	140.0	310.9	21.7	1.8	7.0	0.2	0.0	15.3	275.7	547.1	1.8	2.0	15.0	3.3	107.6	3.5	4.3	75.4	0.0	165.8	22.5	5.1	2.5	349.5	4.3	11.2	0.0	142.8	8.6	9.7	16.1	2.8	8.0	1.7	204.6	135.2	0.7	121.7	69.1	2.1	8.2	0.3	0.0	5.1	1.4	0.5	5.4	17.6	20.3	189.4	2.0
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.4	0.0	20.0	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	1.3	20.9	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.0	0.0	0.0	64.6	6.9	1.5	17.2	129.3	263.2	0.0	0.0	0.0	5.6	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.3	6.5	0.0	0.4	20.2	0.0	233.1	0.1	7.0	25.8	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5	232.3	83.7	0.0	78.5	70.5	1.6	12.3	10.2	99.0	89.9	26.2	0.0	1167.9	8.3	27.4	0.3	12.2	0.0	0.0	23.4	127.3	186.9	9.1	2.3	0.4	83.0	0.0	0.0	68.7	0.6	0.8	39.4	4.3	16.9	1.0	0.0	149.0	2.2	0.0	0.0	6.9	3.9	0.0	22.5	0.0	0.2	27.7	744.0	0.0	0.0	3.9
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 1.3;Cardiomyocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.7	0.0	0.0	5.1	0.2	0.0	0.0	0.0	3.6	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.1	2.2	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	5.5	2.4	0.0	7.3	0.6	0.1	0.0	0.1	0.0	17.2	0.2	0.0	0.1	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7	0.0	0.0	0.0	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.5	14.0	19.7	20.7	25.3	50.4	27.2	23.8	33.0	30.5	33.0	38.8	42.6	50.9	36.5	28.3	39.0	31.3	32.6	33.0	43.5	19.2	21.9	29.8	16.9	30.0	24.3	37.2	28.5	33.6	37.6	22.4	50.1	44.5	37.8	26.3	24.5	30.3	24.6	27.1	27.0	19.7	27.9	38.8	22.2	23.8	25.8	59.0	31.9	24.0	25.0	26.8	14.3	22.9	37.2	23.2	33.6	34.6	22.1	19.3	18.4	27.3	45.7	52.6	27.6	46.8	24.5	32.6	9.6	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9	32.8	55.5	71.7	137.7	124.4	27.0	97.7	48.4	41.5	48.9	33.2	25.5	72.1	116.0	60.9	13.8	61.2	56.4	0.0	94.1	85.0	60.9	65.4	74.9	27.6	57.0	22.3	54.5	46.1	95.5	5.0	57.0	72.0	65.8	64.9	76.1	26.1	62.8	40.3	53.0	90.1	30.8	77.6	69.4	29.9	39.0	107.4	100.6	76.1	82.2	109.1
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.9	23.2	28.4	21.0	20.9	28.6	43.9	37.7	20.4	26.0	26.6	25.6	26.5	27.4	10.7	36.7	30.7	23.9	32.0	32.8	32.7	24.5	26.4	37.5	25.1	33.9	25.4	52.4	35.5	24.5	24.6	27.3	19.7	26.5	42.2	13.4	35.2	9.3	29.3	45.1	21.3	44.5	45.3	31.0	19.4	18.4	63.2	17.9	52.1	33.4	27.7	37.9	20.1	23.3	24.0	32.0	22.2	36.8	38.5	24.4	32.1	25.4	27.8	17.5	16.6	36.1	27.3	28.9	21.1	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5	38.7	52.3	42.4	59.6	33.8	19.5	33.6	71.4	34.8	31.8	33.2	17.7	120.6	63.0	146.2	103.8	31.0	104.8	0.0	131.7	170.6	55.5	66.8	42.7	102.9	110.3	19.1	63.4	46.1	84.3	214.1	35.4	81.8	28.7	140.7	94.2	22.7	139.4	87.7	36.4	98.2	18.3	25.8	36.6	47.9	59.9	44.7	152.5	45.7	76.5	86.7
EIF4EBP2		ENSG00000148730	"Eukaryotic translation initiation factor 4E binding protein 2"	Q13542	10	70404379-70428618	"Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019415, HPA037410, HPA061665"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580"	"unprognostic (9.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.61e-2)"	57.3	27.2	22.1	28.2	21.8	20.2	77.1	22.7	23.0	28.7	47.9	16.7	25.9	30.8	24.8	18.3	28.3	22.7	37.9	52.4	18.0	15.8	44.4	40.1	31.8	21.6	19.0	14.7	33.4	28.4	23.2	13.3	36.2	18.6	33.2	31.6	34.8	25.5	50.2	54.5	27.6	51.2	32.4	17.8	30.5	28.7	17.9	16.2	34.8	23.5	29.2	22.1	39.8	64.3	7.0	14.0	20.6	17.5	9.3	14.2	14.2	17.1	5.6	30.7	29.9	59.4	22.6	16.6	10.5	13.1	7.9	8.5	24.5	15.4	17.9	6.4	15.5	4.9	11.1	14.9	9.7	8.9	19.0	7.7	12.9	6.8	9.6	13.9	22.9	9.1	25.1	10.1	9.6	8.7	16.0	11.9	14.8	21.0	16.4	12.1	9.8	19.5	23.6	25.8	17.1	10.2	20.1	12.3	11.5	10.0	17.9	16.6	25.1	14.5	33.5	13.9	21.9	15.2	20.5	12.9	5.1	6.4	8.3	9.3	11.0	21.5	21.1	5.9	34.3	5.2	13.8	15.5	20.6	14.2	13.8	11.6	7.0	11.5	11.7	14.0	6.1	9.8	10.1	17.0	9.3	17.5	4.7	12.5	14.2	22.1	21.8	22.7	23.0	18.0	15.8	19.0	14.7	18.6	16.2	23.8	32.8	41.3	43.1	47.1	42.0	128.1	66.2	17.4	25.0	34.9	19.6	37.6	36.5	37.0	19.7	34.3	154.3	23.3	51.0	104.3	50.6	50.3	11.5	142.1	41.5	22.3	25.4	65.7	88.3	40.0	60.9	37.0	20.3	45.9	79.3	63.3	50.7	84.0	57.7	108.0	15.4	77.6	30.7	32.9	41.7	61.2	47.9	42.4	61.8	85.2
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.9	7.8	8.0	4.2	20.4	38.4	2.0	16.5	31.7	13.2	10.2	0.4	9.7	2.1	5.7	18.5	9.9	4.6	0.9	26.5	23.3	5.6	3.0	0.6	3.3	2.9	6.2	6.3	1.5	22.5	5.0	27.2	20.6	26.9	31.5	1.6	1.5	8.7	44.5	2.0	1.2	4.2	9.8	1.8	10.4	10.3	13.5	2.3	11.3	3.4	0.4	8.5	5.4	2.4	8.2	12.7	1.3	3.4	19.3	36.3	14.2	22.3	14.3	16.7	13.9	0.5	12.8	7.4	25.1	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3	6.0	30.6	17.6	31.5	29.0	0.5	4.8	5.1	91.0	54.6	5.2	3.9	0.9	5.0	18.1	0.6	133.8	0.7	0.0	13.5	3.1	34.2	29.1	16.2	3.6	20.8	0.0	1.2	151.0	36.0	1.3	10.6	22.2	11.8	3.6	3.0	4.7	36.9	2.9	9.9	0.0	0.4	12.9	24.3	0.0	14.7	23.6	0.9	15.9	2.9	67.8
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	18.5	14.5	11.0	10.5	17.4	4.9	15.0	15.4	14.7	13.4	12.0	18.4	18.6	9.5	12.7	11.6	8.7	13.8	11.5	9.2	13.2	8.6	10.7	14.4	8.4	9.0	20.2	8.8	12.0	11.4	14.4	15.6	11.7	14.2	13.7	9.7	13.0	11.6	14.5	18.8	9.7	10.6	13.4	11.1	11.1	12.1	12.3	17.4	7.6	13.0	6.8	10.2	11.9	10.7	4.5	4.5	10.8	6.6	6.1	7.6	3.9	4.0	5.2	6.0	8.8	18.7	8.4	3.5	7.5	5.8	11.2	10.3	4.3	2.1	3.1	5.8	6.0	13.7	4.3	8.3	10.3	10.2	11.0	5.8	5.4	2.9	3.0	9.8	4.1	7.2	8.6	9.1	10.6	12.2	9.4	7.9	6.4	5.5	3.7	10.3	3.1	6.0	2.4	2.8	8.4	5.5	4.3	12.2	2.9	5.1	2.5	5.6	2.9	4.6	6.4	6.9	7.1	3.5	3.1	4.4	8.0	4.3	6.9	6.8	4.6	8.2	4.2	8.0	4.8	8.1	9.1	3.9	10.8	7.6	2.6	4.0	4.5	4.9	3.0	4.5	4.1	4.2	7.3	3.5	6.1	6.6	1.2	7.3	3.9	11.0	17.4	15.4	14.7	13.2	8.6	20.2	8.8	14.2	17.4	6.0	5.9	13.7	8.8	4.1	26.2	4.8	12.7	6.7	13.6	10.4	27.5	11.6	6.6	7.1	3.8	7.2	17.8	0.0	7.9	4.9	8.7	10.2	9.2	7.3	7.6	28.6	8.1	9.2	9.2	3.6	17.8	11.0	16.9	12.6	8.9	19.7	7.8	14.0	22.3	4.8	29.2	19.4	6.6	13.0	10.1	5.6	10.4	13.8	11.9	7.1
EML6	FLJ42562	ENSG00000214595	"Echinoderm microtubule associated protein like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;lymphoid tissue: 11.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 25.5;Cone photoreceptor cells: 53.0;Horizontal cells: 36.5;Rod photoreceptor cells: 32.8"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;SCLC-21H: 20.5;U-698: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA062808: AB_2684872, HPA068759: AB_2686027"	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.1	3.3	1.8	4.0	2.8	0.0	0.2	7.2	4.2	0.0	0.6			0.6	0.0	1.3	0.3	0.4	0.1	0.0	1.9	2.1	1.3	0.2	0.1	7.9	1.5		0.0	0.5	3.0	3.4	1.4		0.4	0.8		0.1	0.4	0.6	0.8	1.8	0.3	0.5	2.7	0.4	1.5			3.1		11.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.1	0.7	0.2	1.5	0.1	0.2	0.2	0.2	0.6	0.2	7.3	0.1	0.4	0.3	0.2	1.0	0.3	0.3	0.7	0.3	0.4	0.6	2.8	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.1	4.0	0.0	1.2	0.0	0.7	1.4	0.2	0.3	0.1	1.2	0.6	0.5	0.6	0.0	0.7	20.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.6	0.4	0.4	5.0	1.3	23.3	1.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	5.2	1.6	3.3	25.5	1.4	0.0	5.3	5.7	3.5	53.0	0.4	0.0	0.1	12.7	1.7	0.4	0.0	0.4	0.4	0.7	1.5	0.0	0.8	1.0	36.5	2.4	1.8	1.3	9.6	0.6	1.0	0.0	0.0	1.7	19.3	0.1	0.0	0.7	0.5	32.8	0.0	2.1	3.9	1.9	3.9	0.1	0.0	0.2	2.3
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.1	0.2	2.7	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.9	0.1	1.1	0.1	0.0	0.7	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	1.2	0.6	0.9	0.0	2.2	0.1	0.0	1.8	5.2	0.0	0.5	0.0	0.8	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9	0.0	0.0	0.0	0.2	0.1	4.4	0.2	0.0	36.1	0.0	0.0	21.6	0.2	0.0	0.3	11.9	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	4.8	1.7	0.0	0.0	8.8	1.1	0.1	0.0	1.0	0.0	1.3	0.2	0.0	0.7	0.6	9.0	0.0	0.2	7.6	2.7	0.0	0.1	0.0	0.1	0.0
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2, transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345953	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	31.9	35.0	28.7	28.1	34.3	44.4	34.8	20.6	31.4	28.2	34.5	18.7	28.3	31.8	24.6	33.8	30.1	22.9	19.1	34.0	31.8	26.2	44.1	58.8	24.7	26.6	27.6	28.3	19.6	27.8	16.5	35.8	30.6	29.1	24.0	33.7	19.9	27.2	25.9	66.7	20.3	31.6	28.4	31.9	30.6	29.0	21.3	24.3	26.1	24.3	29.5	30.3	29.6	23.3	14.0	32.1	30.3	38.9	13.0	14.6	22.6	42.3	35.5	52.8	23.7	20.1	25.8	15.2	33.9	21.9	34.8	44.0	26.2	26.4	27.6	31.9	26.3	15.8	21.7	23.6	24.0	42.5	43.7	27.9	53.0	26.7	53.9	21.5	18.2	33.0	19.5	16.4	22.9	21.7	25.5	52.3	27.3	50.4	15.6	39.5	69.1	55.0	41.4	38.3	49.6	34.6	35.1	23.0	34.2	47.0	32.6	31.9	34.4	21.2	26.7	28.9	30.4	33.9	31.6	35.5	23.4	39.5	24.2	34.3	26.7	28.5	52.2	23.6	30.8	27.2	16.3	35.6	30.3	10.7	37.1	13.2	14.0	14.6	13.0	32.1	9.6	12.1	13.3	19.4	13.0	38.9	26.5	14.2	22.6	28.7	34.3	20.6	31.4	31.8	26.2	27.6	28.3	29.1	24.3	65.5	81.6	148.3	163.4	164.9	66.1	154.2	137.6	89.7	112.6	137.9	115.8	224.8	323.3	190.8	103.7	229.2	183.6	46.7	173.6	235.2	173.8	163.6	89.0	317.8	241.4	42.9	147.9	137.5	200.9	78.7	137.2	217.4	150.1	225.4	166.7	92.6	220.3	192.9	105.7	416.4	119.0	77.6	185.8	187.5	108.4	152.6	139.9	126.9	175.3	175.2
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28854938-28861067	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	16.2	24.8	24.1	13.3	31.6	12.7	19.4	25.1	47.9	18.4	20.9	27.1	15.8	18.0	21.5	19.2	20.6	22.2	17.2	24.5	23.0	22.0	24.9	33.7	14.8	16.0	21.3	20.2	22.0	18.1	29.3	15.4	24.7	27.6	18.0	23.4	17.3	28.2	21.2	34.1	18.3	19.7	21.8	18.4	17.0	18.2	17.3	15.5	20.4	20.3	21.5	23.8	16.1	14.8	20.1	29.0	11.1	23.1	20.8	18.2	14.9	16.2	31.5	18.4	20.9	20.4	14.0	18.0	12.9	18.6	39.4	32.4	30.7	10.5	20.8	15.8	22.3	29.8	18.0	33.7	29.5	32.9	20.6	39.5	16.8	21.0	31.0	26.1	19.9	15.3	18.2	26.4	31.9	30.3	15.5	32.1	26.5	33.3	13.2	21.9	25.4	20.7	30.7	17.0	29.8	15.1	19.1	29.3	26.9	23.8	18.5	19.6	15.8	21.2	52.1	16.7	28.6	36.7	23.4	12.9	16.1	18.1	17.7	27.3	10.6	19.3	22.3	17.5	17.4	16.3	11.1	17.9	7.1	17.8	23.1	13.4	20.1	15.2	13.0	29.0	18.6	17.6	18.2	1.4	20.8	15.6	15.0	16.3	14.9	24.1	31.6	25.1	47.9	23.0	22.0	21.3	20.2	27.6	15.5	6.0	3.2	11.5	12.7	7.1	9.6	6.0	22.9	5.3	3.4	10.4	5.9	59.5	31.5	26.1	1.1	10.9	16.0	23.3	18.8	44.1	11.4	11.1	4.7	20.3	31.0	11.1	20.7	9.8	8.2	3.6	13.3	8.0	10.1	110.0	12.7	14.5	17.0	10.5	14.9	25.0	6.5	19.4	9.5	18.9	22.2	10.2	43.3	10.9	25.2	8.4
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.9	28.7	37.5	26.4	30.5	34.2	30.7	31.8	40.7	36.6	26.5	26.2	25.9	55.9	92.3	36.6	39.9	43.8	18.0	39.8	26.1	36.7	21.9	37.9	29.7	21.4	34.7	17.3	28.9	18.8	34.5	11.8	37.6	38.0	35.0	34.3	7.8	31.7	18.5	40.5	10.8	34.4	29.6	48.9	37.7	70.2	24.9	12.6	39.9	91.2	36.1	57.7	46.9	40.2	20.2	33.4	22.7	29.2	31.8	18.6	38.1	45.1	24.1	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8	53.6	38.2	49.8	84.3	47.5	12.6	330.7	79.0	33.5	34.2	34.9	21.6	240.1	177.4	96.7	9.4	51.7	207.6	70.0	73.2	147.6	65.4	64.8	37.0	330.0	115.9	50.9	62.8	52.2	76.6	5.4	55.0	77.4	54.0	158.7	117.7	20.6	89.9	152.0	54.8	301.8	18.1	45.3	63.7	39.6	31.3	49.9	251.0	56.8	156.2	138.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1022.8;Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 183.6;OE19: 84.6"					"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.0	33.8	4.7	12.9	15.0	17.6	7.5	8.9	6.9	7.2	7.2	28.4	21.5	13.1	9.1	14.3	3.8	11.6	9.3	19.0	2.2	19.5	36.2	10.3	20.7	183.6	16.5	9.8	7.7	27.3	5.7	9.8	10.1	9.1	6.1	12.9	15.4	14.7	9.3	26.5	10.2	9.3	3.0	84.6	41.9	11.4	12.6	24.5	9.9	15.0	10.5	5.1	19.7	5.6	10.1	3.5	14.7	9.5	8.6	7.6	7.9	8.1	8.1	22.6	13.7	11.6	38.5	14.6	19.4	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9	74.5	84.5	90.8	84.9	57.8	71.3	216.3	254.8	84.3	67.1	115.1	29.5	201.1	484.1	142.6	109.5	67.1	494.9	140.2	122.3	163.1	89.1	73.5	87.6	1022.8	188.0	41.3	161.8	136.9	151.1	228.9	99.5	69.4	271.7	69.5	259.6	93.2	146.4	263.1	107.5	1001.5	53.3	97.0	80.2	54.2	48.9	55.7	133.9	91.6	302.4	92.8
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.1;OE19: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No		13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	11.5	15.3	3.1	10.9	17.1	11.6	1.2	18.0	49.1	15.5	15.9	4.5	11.8	0.0	13.5	17.2	4.9	9.4	4.5	27.1	4.1	5.8	1.4	2.9	6.6	12.7	7.7	4.3	4.1	11.9	21.3	6.0	16.8	20.5	11.5	11.2	1.9	19.5	7.6	7.8	5.0	4.0	0.8	77.6	7.4	5.7	1.3	2.5	33.7	24.1	0.0	3.9	4.6	16.5	10.8	5.3	5.0	7.2	9.6	2.5	10.7	3.0	3.3	5.5	4.3	0.3	10.9	17.9	12.9	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7	20.8	18.9	42.5	70.4	30.7	9.5	8.3	53.5	14.7	17.0	52.4	0.0	162.0	46.4	62.5	0.4	49.6	485.2	0.0	56.4	70.8	54.7	70.7	36.9	78.8	100.9	4.8	61.2	36.8	100.2	1.6	16.4	79.3	75.9	58.7	224.1	9.4	73.6	571.2	15.2	90.3	4.6	19.4	61.2	1.8	5.5	20.3	77.3	53.3	334.8	123.3
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 5.5;Fibroblasts: 5.3;Leydig cells: 10.6;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.0;BJ hTERT+: 8.9;HHSteC: 12.4;hTERT-HME1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	6.9	1.2	1.2	7.6	1.6	0.3	15.7	1.6	1.0	13.2	5.2	1.1	3.4	1.3	14.1	8.5	5.1	6.3	8.2	4.7	1.9	0.7	8.0	1.4	4.1	3.7	1.6	0.5	14.4	5.0	8.1	2.5	2.6	1.3	8.6	1.3	7.7	5.0	4.2	2.8	5.6	2.9	14.2	1.7	3.6	3.5	4.5	0.6	1.1	12.4	3.7	7.9	7.2	24.6	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	2.5	0.0	6.1	8.0	9.0	0.0	3.7	8.9	3.3	5.6	0.0	0.0	4.6	0.0	2.9	1.9	2.6	0.0	1.5	3.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	5.6	4.2	4.3	9.9	0.0	3.5	0.0	0.0	0.2	4.8	0.0	0.0	0.0	3.6	0.0	0.0	7.6	7.6	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	1.5	0.0	0.5	6.0	0.0	0.0	2.2	0.0	3.8	4.1	1.1	2.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.8	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.2	1.6	1.6	1.0	1.9	0.7	1.6	0.5	1.3	0.6	0.0	0.3	0.0	3.9	1.9	0.0	0.9	2.5	0.0	1.2	0.0	0.0	5.5	0.0	1.3	1.4	1.0	0.0	0.0	0.4	0.2	5.3	2.2	2.3	0.0	0.5	0.0	0.0	1.8	0.0	0.4	10.6	0.0	0.0	0.0	0.0	1.7	0.8	0.0	7.4	0.6	0.0	0.0	1.9	1.6	2.0	0.6	1.1	0.0	0.0	1.2
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.1	7.7	14.3	5.0	19.0	2.3	10.6	20.4	20.1	15.8	8.8	21.7	10.2	7.2	14.4	13.6	10.7	14.5	8.6	8.9	13.8	12.0	11.5	6.0	9.0	4.0	13.7	13.3	12.4	24.9	21.9	13.2	8.0	13.9	11.4	10.0	9.6	17.0	12.1	10.3	7.0	6.8	11.0	20.7	5.8	8.7	20.0	12.6	5.0	12.4	5.2	5.9	10.5	7.9	4.1	7.4	10.9	3.4	3.6	6.0	3.1	19.1	9.0	7.0	10.3	4.3	5.2	8.9	9.6	8.1	9.0	11.9	7.6	13.6	0.0	7.1	10.0	5.5	10.9	7.7	9.7	10.2	4.8	9.2	5.6	3.4	4.5	16.9	4.1	5.4	10.5	16.1	9.1	6.0	5.5	12.6	4.9	3.5	7.4	8.5	9.7	2.3	6.3	7.6	10.3	9.1	0.0	6.7	6.7	13.2	7.1	13.7	12.2	7.2	15.0	7.0	7.9	20.1	3.6	10.0	8.4	6.0	6.7	4.9	5.7	7.6	0.0	0.0	4.5	6.2	10.9	3.4	2.9	3.3	1.9	6.0	4.1	3.5	3.3	7.4	2.4	4.2	6.0	0.4	3.6	1.7	5.8	2.4	3.1	14.3	19.0	20.4	20.1	13.8	12.0	13.7	13.3	13.9	12.6	11.9	7.5	3.2	4.2	2.9	9.4	10.3	5.1	9.4	9.1	0.0	7.9	7.1	5.0	10.0	2.4	4.4	3.2	0.0	7.6	3.8	4.6	4.8	1.1	4.7	5.6	9.5	5.8	10.4	5.9	1.8	5.8	1.8	3.3	9.0	8.7	6.8	9.0	7.0	11.3	4.8	8.7	0.0	3.9	31.0	8.7	3.8	2.4	0.5	6.9	3.0
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443158-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	18.7	15.6	22.0	20.7	22.4	19.1	16.5	20.1	28.6	18.1	22.4	22.5	22.3	18.3	22.2	14.9	26.3	19.0	20.9	20.8	22.5	17.3	15.9	14.1	15.6	18.8	23.3	29.5	21.6	23.5	20.8	18.0	17.9	22.7	17.6	13.3	14.5	23.9	20.2	47.5	24.9	17.1	26.7	16.2	18.2	20.8	40.7	21.0	13.3	19.8	20.7	17.4	20.8	17.6	3.6	3.5	31.0	6.2	9.8	6.4	4.4	12.7	21.5	7.3	16.2	12.5	10.8	18.1	11.3	11.8	11.5	13.9	10.8	18.9	10.9	17.7	14.2	14.1	14.6	5.8	9.8	8.4	40.0	10.1	11.7	45.1	8.1	11.7	17.5	29.6	11.0	7.3	12.8	11.3	12.1	12.8	7.2	8.9	7.1	8.9	15.1	12.5	20.8	6.0	7.8	12.9	10.3	8.3	13.9	9.7	16.1	7.3	9.3	28.3	16.1	11.0	7.4	21.7	20.2	9.5	11.4	14.1	8.7	9.1	12.1	8.7	7.7	12.0	21.2	10.3	5.4	5.7	31.0	6.4	6.2	5.4	3.3	5.0	5.1	3.5	3.6	6.4	5.9	7.9	9.8	4.4	2.6	6.4	4.4	22.0	22.4	20.1	28.6	22.5	17.3	23.3	29.5	22.7	21.0	20.8	26.1	14.5	14.7	38.0	13.8	26.6	12.7	33.5	20.5	14.0	33.4	20.2	23.2	23.4	22.8	15.3	23.8	0.0	25.9	19.0	15.8	14.7	23.0	15.7	20.9	60.4	5.2	13.5	24.4	44.8	18.7	21.7	25.3	21.6	18.6	16.9	24.4	20.1	15.9	20.3	19.2	19.4	22.3	30.9	16.2	47.0	28.5	19.1	20.7	20.4
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA012531: AB_2732403, HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (1.92e-5)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	7.4	9.9	14.1	12.8	14.2	8.1	6.6	18.5	14.1	8.2	8.0	10.5	6.6	5.4	9.7	8.9	5.2	7.4	9.0	22.8	11.7	9.1	7.2	5.8	7.2	12.9	11.1	11.0	8.0	7.4	7.6	16.8	7.3	8.7	9.4	8.2	6.8	5.9	9.3	9.5	4.8	8.1	11.2	8.0	10.8	6.6	9.7	11.2	11.5	8.7	4.0	11.0	9.0	6.4	24.5	6.8	2.1	5.2	12.0	13.6	2.6	3.7	6.7	7.7	6.7	5.2	7.7	3.1	12.0	7.7	10.5	11.8	6.1	3.7	13.0	3.2	4.9	2.9	3.8	9.7	4.2	8.9	14.5	8.7	9.8	10.1	6.3	6.3	10.6	8.2	5.9	4.6	9.3	4.9	4.9	14.1	7.3	4.5	8.6	16.6	2.5	7.4	3.5	7.4	3.2	8.5	4.8	4.3	5.8	5.5	5.1	3.5	1.8	7.4	1.8	3.2	3.6	2.6	5.0	11.7	8.7	6.2	9.3	9.7	4.8	8.2	11.9	6.6	9.1	6.3	0.4	5.0	2.1	13.6	4.4	11.9	24.5	13.0	13.0	3.4	22.4	13.1	13.0	0.2	12.0	5.2	6.8	5.8	2.6	14.1	14.2	18.5	14.1	11.7	9.1	11.1	11.0	8.7	11.2	6.0	5.0	24.1	5.1	2.6	52.2	29.9	12.7	8.1	1.2	10.4	53.0	9.3	0.0	7.6	3.0	9.0	3.9	0.0	4.6	1.1	10.8	4.4	1.1	5.4	5.9	38.1	16.3	8.6	7.0	2.9	25.0	5.6	11.8	8.2	6.9	18.4	5.5	10.1	16.6	2.8	77.1	12.9	11.2	37.0	22.8	0.9	1.6	25.4	9.0	5.0
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 131.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.6;Hep G2: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.5	0.0	0.0	131.2	0.1	0.0	0.0	3.7	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.5	0.0	0.0
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.4	19.1	9.1	16.1	12.1	8.8	5.7	13.9	6.9	9.3	10.2	12.2	8.8	5.4	11.7	8.6	14.4	17.4	7.1	11.2	8.4	8.2	16.9	4.8	16.5	28.1	11.8	8.3	9.4	11.6	14.7	8.5	5.7	7.9	12.1	6.6	5.0	5.7	11.6	38.7	4.5	12.6	5.4	7.8	14.3	10.4	12.4	15.2	33.4	10.6	17.8	14.8	18.2	14.7	21.8	6.4	21.5	5.7	17.6	15.3	10.9	9.0	7.5	8.2	17.2	6.4	9.7	6.1	6.5	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5	23.8	16.0	12.3	12.4	12.5	20.0	37.0	22.9	17.4	17.0	40.1	25.5	18.6	43.1	43.5	88.6	14.7	72.1	23.3	34.0	12.3	14.7	9.4	4.7	30.5	26.4	17.5	28.2	8.0	8.1	38.9	13.6	18.2	15.1	23.4	22.1	16.9	34.9	30.9	14.5	175.3	22.4	12.9	14.1	7.0	8.3	21.0	12.8	10.7	41.2	8.1
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.1;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favorable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.5	3.1	15.7	4.1	12.2	4.1	9.9	23.7	18.4	8.8	6.1	5.0	24.3	2.3	8.9	6.8	3.0	9.1	7.9	21.7	10.3	14.4	6.6	6.0	4.1	2.0	8.0	5.9	8.2	3.0	16.7	4.1	5.0	7.9	10.0	3.2	9.5	8.5	19.8	17.1	3.0	3.3	10.4	11.5	30.8	5.5	14.7	4.9	0.0	8.6	3.4	2.1	7.9	9.4	0.3	0.9	13.1	6.4	0.0	0.2	0.5	0.0	1.1	4.1	0.1	1.8	0.7	1.6	7.8	9.1	5.5	2.5	0.0	0.1	0.0	1.5	5.5	4.9	0.0	3.7	0.0	4.2	0.0	3.8	0.7	1.2	4.5	6.3	1.0	0.2	6.6	1.5	0.2	3.4	0.7	0.0	1.8	0.0	0.1	4.1	0.1	0.0	2.7	3.9	5.4	1.7	0.0	4.6	0.0	13.5	0.8	4.0	4.4	0.0	0.5	0.2	5.0	3.6	0.4	0.0	3.9	2.5	0.0	2.7	1.7	0.0	0.0	1.8	0.0	4.5	0.0	1.4	13.1	0.0	3.6	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	6.4	0.0	0.1	0.5	15.7	12.2	23.7	11.8	10.3	14.4	8.0	5.9	7.9	4.9	0.0	5.6	0.0	14.2	8.8	8.8	21.8	2.5	1.4	1.2	22.7	2.0	1.5	6.6	5.9	2.2	4.7	0.0	0.0	2.5	15.0	22.7	10.6	4.6	5.7	4.3	6.4	6.9	15.4	8.1	1.4	9.2	6.3	15.1	0.0	0.0	25.5	2.6	0.0	13.8	6.1	5.4	32.3	22.3	1.7	1.5	3.6	1.3	0.5	0.0	6.7
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402085	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.8;blood: 18.0"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 18.0;eosinophil: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	28.8	0.6	1.6	1.4	1.9	5.9	16.0	0.6	1.8	4.2	2.1	1.6	0.7	1.3	2.4	2.5	2.6	1.8	1.7	2.4	2.2	2.2	1.4	2.6	5.8	0.8	2.0	0.6	2.5	0.5	9.4	0.8	12.5	1.8	3.9	1.5	4.0	1.7	0.6	4.3	2.6	1.5	3.5	2.1	0.8	1.2	2.3	0.2	1.0	2.9	0.8	1.0	3.4	2.6	0.0	5.6	18.0	2.1	3.8	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	49.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	2.1	11.6	0.1	1.6	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.1	3.8	0.5	0.0	1.7	0.7	1.6	1.9	0.6	1.8	2.2	2.2	2.0	0.6	1.8	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.1	0.2	0.0	4.6	0.2	0.4	0.0	0.0	1.3	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
FAM136A	FLJ14668	ENSG00000035141	"Family with sequence similarity 136 member A"	Q96C01	2	70295975-70302090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030103, HPA030104"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030103: AB_10600194, HPA030104: AB_10600534"	"unprognostic (2.81e-1)"	"unprognostic (5.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (4.95e-3)"	"unprognostic (3.03e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.00e-3)"	8.9	12.2	16.4	12.9	17.7	13.2	13.0	18.0	16.5	12.4	19.4	6.4	18.4	19.9	13.4	11.8	18.1	11.2	13.7	18.0	13.3	17.5	18.7	26.3	9.1	12.0	15.3	10.3	9.0	53.1	14.0	11.4	15.9	17.6	13.4	21.4	8.8	38.3	17.7	16.6	11.0	23.0	14.9	9.0	17.1	16.7	9.6	7.6	13.6	16.1	14.0	15.7	13.3	11.9	21.8	22.2	17.1	22.9	29.1	19.8	16.0	25.0	22.7	14.2	19.9	7.5	11.2	22.0	13.6	13.0	18.9	13.1	59.7	14.5	17.5	12.4	11.7	16.4	11.8	29.2	10.8	19.4	17.8	33.5	26.6	17.0	37.0	10.8	43.8	17.6	7.6	7.6	17.7	15.1	10.1	20.2	25.4	42.4	14.1	14.0	37.0	28.2	38.3	35.9	34.1	24.7	19.1	26.7	28.6	29.0	17.7	33.5	14.6	10.2	25.0	20.0	13.7	10.3	12.8	12.1	8.1	23.9	12.4	25.8	11.8	18.1	20.2	20.2	25.0	13.7	17.1	16.7	12.1	13.7	22.9	19.8	21.8	15.1	16.1	22.2	18.4	17.6	17.9	1.5	29.1	15.3	14.7	11.8	16.0	16.4	17.7	18.0	16.5	13.3	17.5	15.3	10.3	17.6	7.6	38.7	24.0	49.8	25.7	24.8	22.9	48.4	10.2	34.8	27.3	31.4	23.6	78.4	59.7	64.0	1.0	16.7	50.0	0.0	86.0	86.9	33.9	45.3	27.6	50.4	62.1	7.9	31.6	12.9	19.3	2.3	12.4	29.2	27.0	45.9	49.3	16.1	76.3	56.1	17.3	54.2	18.5	12.9	21.7	9.1	52.8	36.6	24.7	34.1	58.8	40.2
FAM160A2	"C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759"	ENSG00000051009	"Family with sequence similarity 160 member A2"	Q8N612	11	6211335-6234711	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055994, HPA063987"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055994: AB_2682999, HPA063987: AB_2685166"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.85e-1)"	13.6	12.9	11.5	10.5	21.6	29.8	15.6	23.0	23.8	16.6	20.7	15.7	20.5	26.6	19.8	11.7	11.7	18.4	18.6	10.7	9.9	6.0	12.6	17.4	14.1	12.5	12.5	12.3	20.2	21.0	19.6	15.8	10.7	12.0	14.0	22.4	16.1	15.9	15.0	11.3	18.2	25.9	12.9	9.7	12.2	15.9	26.5	9.8	10.5	20.3	9.0	12.8	14.2	14.5	2.8	3.7	6.1	6.0	1.9	6.0	3.1	10.7	10.7	7.5	11.1	10.2	11.1	16.3	6.2	7.5	9.3	8.9	9.1	20.1	8.5	6.9	7.2	15.3	14.3	7.6	11.2	5.7	9.2	10.9	2.8	17.6	4.8	8.4	7.0	9.8	10.0	14.2	8.4	14.9	12.2	9.4	13.3	9.0	10.6	5.8	8.5	6.7	13.6	11.2	14.0	10.1	7.5	3.9	6.8	8.7	7.8	10.1	6.6	8.9	10.6	5.5	8.1	7.2	10.0	8.0	11.5	8.9	17.0	6.5	14.2	12.1	6.4	12.7	5.7	10.1	1.7	6.0	5.9	6.0	2.5	3.7	2.5	2.4	4.4	3.7	2.8	1.9	3.3	6.1	1.9	1.9	1.1	0.4	3.1	11.5	21.6	23.0	23.8	9.9	6.0	12.5	12.3	12.0	9.8	17.9	14.4	13.7	10.9	11.1	13.3	4.1	7.6	12.0	7.9	12.2	15.7	10.6	6.6	9.5	12.0	12.7	61.0	0.0	9.9	8.5	8.9	10.5	6.9	20.2	8.7	6.4	24.0	11.1	16.5	4.5	9.2	9.4	13.5	5.4	31.6	6.8	12.6	40.3	7.1	6.9	22.2	12.9	8.9	27.8	20.7	13.0	9.6	15.0	30.3	7.4
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA		29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	28.8	6.2	9.2	17.1	16.9	15.7	4.7	11.8	10.6	11.3	28.8	15.4	13.3	31.4	20.6	4.0	9.3	20.2	16.6	28.8	30.2	16.2	12.4	25.4	10.7	27.5	11.1	24.8	9.1	18.1	15.1	10.7	22.7	38.0	14.9	31.0	17.1	12.6	16.1	11.3	25.2	30.2	13.6	65.2	32.8	15.2	13.2	40.9	32.7	70.4	13.8	11.0	8.8	21.0	24.1	14.4	13.1	12.2	10.5	11.2	8.0	6.5	12.2	25.0	8.5	31.8	33.2	24.3	5.1	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8	26.8	42.4	71.1	131.6	113.8	30.4	312.0	96.8	46.8	43.3	123.9	45.2	42.9	457.6	109.5	73.0	47.4	279.5	23.3	152.7	35.4	52.8	85.5	85.3	207.9	83.9	36.5	102.7	38.1	49.4	23.4	124.5	76.0	99.5	146.9	326.4	45.5	161.9	325.6	139.7	345.2	28.5	103.5	89.6	141.1	55.3	116.1	39.5	54.9	245.2	156.6
FAM167A	C8orf13	ENSG00000154319	"Family with sequence similarity 167 member A"	Q96KS9	8	11421463-11474715	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0;thyroid gland: 51.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 14.9;Distal tubular cells: 11.6;Early spermatids: 17.1;Intestinal endocrine cells: 18.3;Late spermatids: 27.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.6;RPMI-8226: 26.0;SH-SY5Y: 19.7;U-698: 19.7;U-87 MG: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023915, HPA030426"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023915: AB_1845768, HPA030426: AB_10601318"	"unprognostic (8.51e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (3.08e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-2)"	0.8	1.6	13.8	1.8	11.2	1.3	2.0	7.1	20.0	1.1	1.4	12.6	0.0	1.1	0.9	1.3	1.4	2.0	1.8	0.9	13.8	7.6	6.6	0.8	10.5	2.8	8.6	11.8	0.8	2.8	0.8	12.3	2.5	12.2	2.1	1.4	0.5	3.3	5.7	0.8	11.8	1.3	0.8	7.0	1.9	2.7	3.2	7.6	0.8	51.1	0.3	3.5	1.3	1.0	4.0	1.3	0.1	1.8	0.9	0.1	0.1	2.0	1.3	2.7	0.2	0.2	1.1	0.0	7.4	7.0	4.5	1.9	0.0	0.6	24.6	0.4	7.9	2.1	0.7	0.0	1.7	5.3	10.6	0.3	0.0	0.0	0.0	9.3	0.0	0.0	1.3	1.1	2.3	14.5	14.5	0.0	0.0	0.1	1.0	2.6	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.0	26.0	2.3	0.2	11.7	19.7	0.3	2.1	0.9	0.3	0.8	0.0	12.5	0.4	0.7	11.4	0.1	7.9	5.7	19.7	16.3	0.0	0.7	0.1	0.2	0.0	0.0	1.8	0.1	4.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.9	1.7	1.3	0.0	0.1	13.8	11.2	7.1	12.5	13.8	7.6	8.6	11.8	12.2	7.6	14.9	2.6	0.0	0.4	5.3	0.0	0.6	2.5	1.4	0.0	5.2	9.8	0.0	11.6	1.8	17.1	0.0	0.0	0.0	1.7	0.0	0.5	1.1	0.0	0.0	0.1	0.0	18.3	0.0	0.3	27.3	0.3	0.0	0.0	0.0	1.3	1.8	0.9	2.9	0.4	0.0	1.7	0.0	0.0	1.2	2.5	3.0	0.0	0.0	0.0	0.1
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186693971-186765965	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enriched"	"Detected in many"	6	"Bipolar cells: 137.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.4;U-138 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	3.1	13.1	32.0	2.0	32.6	1.1	3.7	12.7	62.0	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2.0	1.6	9.1	23.0	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2.0	2.4	1.6	10.4	0.0	2.7	0.0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.8	4.2	13.1	12.5	9.5	0.1	2.6	4.6	3.2	4.6	7.7	12.6	0.0	0.9	7.3	5.5	0.3	5.7	2.5	4.6	0.0	3.3	2.8	1.3	0.0	1.0	0.8	1.0	12.1	1.0	2.5	2.0	4.2	7.0	2.2	0.0	25.4	6.1	1.6	1.6	0.0	5.6	0.0	2.8	0.0	8.1	0.6	5.0	9.0	13.2	7.2	1.3	0.8	3.5	2.6	1.0	0.6	4.1	17.6	2.3	0.3	1.6	6.8	6.5	0.0	5.4	0.0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1.0	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32.0	32.6	12.7	30.4	25.5	13.1	9.1	23.0	9.7	10.4	0.0	0.0	0.0	2.1	7.9	137.0	0.8	10.2	0.0	2.3	0.0	13.7	7.9	0.0	0.7	1.4	10.5	0.0	0.0	0.3	0.8	6.6	1.2	0.0	0.0	1.7	22.3	4.6	8.0	0.3	2.5	7.2	1.1	3.3	1.0	0.0	16.5	0.5	0.0	13.1	0.1	15.5	0.0	4.1	0.1	1.4	4.5	6.9	0.0	0.0	0.5
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729941-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 29.6"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA			Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	1.9	2.9	18.3	1.8	13.3	1.5	1.6	16.9	29.6	2.0	1.7	18.6	0.0	1.9	2.2	1.8	1.5	2.6	1.4	2.0	19.6	11.3	2.0	1.3	1.3	1.4	17.1	13.0	2.7	1.5	1.5	1.1	1.4	17.2	1.9	1.5	0.7	3.2	2.7	1.7	1.7	2.3	1.6	16.9	1.3	1.8	1.7	16.7	0.0	2.1	0.0	1.7	2.2	0.5	0.2	0.0	0.6	0.3	0.3	0.4	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.1	0.5	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.1	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.2	6.7	1.0	3.6	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.1	3.5	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.6	0.3	0.3	0.0	0.1	0.0	18.3	13.3	16.9	11.4	19.6	11.3	17.1	13.0	17.2	16.7	0.0	0.0	0.0	0.2	0.2	0.2	2.7	0.0	0.0	0.0	5.2	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	18.0	0.0	0.0	0.4	0.0	0.8	0.0	3.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1
FAM210A	"C18orf19, HsT2329, MGC24180"	ENSG00000177150	"Family with sequence similarity 210 member A"	Q96ND0	18	13663347-13726663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014324, HPA051564"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		NA	NA			"Nucleoplasm, Golgi apparatus, Mitochondria"		"HPA014324: AB_2668972, HPA051564: AB_2681536"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.23e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.79e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.27e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.82e-2)"	10.5	8.1	7.5	8.9	7.1	4.0	9.4	8.3	8.8	5.8	9.9	7.2	5.8	11.5	6.6	4.4	13.5	5.7	5.4	27.5	6.4	7.8	12.0	17.6	5.6	7.4	7.4	6.4	8.7	5.6	7.8	7.5	9.3	8.2	7.1	8.5	6.5	7.0	7.6	27.9	5.6	10.9	8.2	9.1	6.4	6.1	10.2	7.3	5.9	8.4	16.3	8.9	14.7	7.9	9.2	8.6	4.3	10.7	7.6	9.7	5.0	12.2	7.0	4.9	4.6	5.8	6.1	7.2	8.5	7.9	9.6	11.2	9.4	6.0	12.7	10.7	6.0	17.8	6.0	9.4	10.6	15.7	8.7	4.4	8.9	5.1	6.8	6.9	15.1	8.4	5.2	8.4	9.2	32.6	6.7	6.1	7.7	12.0	7.0	11.1	8.4	9.3	9.8	5.5	24.1	7.0	7.6	11.7	14.7	7.9	7.8	3.2	5.5	7.4	11.0	20.3	7.4	5.8	7.2	6.7	24.7	24.2	15.2	10.4	7.9	9.8	14.7	13.1	7.9	9.8	3.4	7.0	4.3	8.9	10.7	9.7	8.1	7.6	7.7	8.6	9.2	9.6	9.0	1.2	7.6	5.3	5.6	7.2	5.0	7.5	7.1	8.3	8.8	6.4	7.8	7.4	6.4	8.2	7.3	8.9	8.8	20.4	10.4	49.1	53.0	60.1	5.1	1.4	11.4	7.0	19.6	19.1	18.3	16.3	6.1	15.8	11.7	0.0	7.8	31.2	17.4	9.1	6.9	19.0	18.1	28.6	10.9	5.5	8.4	3.1	8.6	16.6	8.5	11.8	8.4	17.4	10.7	0.0	9.6	21.9	29.7	6.5	16.0	27.0	29.8	50.1	21.5	11.4	17.7	10.4
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.9	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	12.0	0.2	0.1	1.0	0.3	0.7	0.5	0.8	0.0	0.2	7.7	1.8	1.5	0.4	2.7	0.1	1.1	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.5	0.2	0.1	4.8	0.3	1.5	1.3	1.4	2.4	1.0	3.5	0.5	1.5	0.6	8.5	51.4	1.1	1.6	3.4	0.2	1.9	1.3	0.1	0.2	1.4	0.6	1.0	1.3	1.7	1.0	0.1	0.8	1.7	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0	0.0	0.0	0.5	0.6	1.9	21.6	6.1	2.5	0.0	0.0	1.8	31.4	0.1	6.6	1.4	23.4	0.8	0.6	0.0	0.7	0.1	1.7	1.4	0.0	1.3	0.3	73.1	7.5	0.0	0.0	11.0	1.1	0.3	6.8	0.0	4.1	10.0	0.8	0.0	0.4	0.6	48.4	0.0	1.4	0.7	2.6	1.6	0.7	0.0	0.8	0.2
FAM234A	"C16orf9, DKFZP761D0211, FLJ32603, ITFG3"	ENSG00000167930	"Family with sequence similarity 234 member A"	Q9H0X4	16	234546-268971	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA		3700000	Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	20.2	19.1	11.3	11.7	24.3	6.4	16.5	12.2	16.2	11.6	20.3	56.0	13.7	36.3	17.4	12.6	26.4	14.0	16.0	31.1	8.3	7.3	18.3	15.6	11.4	10.5	39.8	9.0	13.4	29.6	24.3	19.2	15.4	37.8	16.8	12.4	15.5	14.1	15.4	51.4	14.9	26.8	29.0	42.0	9.7	18.8	13.0	27.2	7.2	16.6	16.2	6.3	19.0	11.7	10.3	17.8	12.5	17.4	14.2	11.5	12.5	9.0	18.7	23.4	54.2	36.4	21.7	12.3	22.0	27.9	13.4	17.3	18.9	26.1	8.2	35.8	27.7	11.9	18.3	7.4	13.2	11.2	11.3	13.1	11.5	11.7	15.2	22.2	6.1	6.9	22.5	20.5	18.9	15.5	37.1	21.6	10.8	12.7	2.1	14.5	37.2	6.9	6.8	29.5	13.2	9.5	20.9	16.5	40.8	23.1	8.8	29.7	24.0	35.6	20.9	18.6	20.5	26.7	10.6	21.5	28.3	8.3	15.1	6.7	5.0	2.0	10.8	19.9	9.8	38.5	11.3	17.4	12.5	10.8	16.9	5.6	8.0	9.6	10.2	17.8	10.3	11.1	11.5	7.6	14.2	16.5	6.3	9.3	12.5	11.3	24.3	12.2	16.2	8.3	7.3	39.8	9.0	37.8	27.2	8.9	13.0	2.2	9.1	0.0	8.6	0.0	10.2	12.0	9.1	29.6	23.6	49.9	6.6	41.4	21.8	13.9	34.2	0.0	23.0	42.1	9.7	12.0	8.1	19.8	22.9	9.5	33.9	20.9	14.5	52.2	15.5	11.9	0.0	57.7	30.3	9.3	17.1	51.6	20.5	15.1	11.9	19.4	0.0	16.4	28.1	0.0	55.4	6.9	42.9	9.8
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	23.0	0.0	7.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.3	0.0	0.0	0.0	0.0	0.1	11.0	24.3	0.0	0.2	2.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	11.8	25.4	0.5	5.1	2.5	2.7	1.2	22.7	0.0	0.1	3.3	8.6	20.7	0.8	31.6	0.0	13.2	0.1	1.6	13.1	1.1	1.0	0.2	0.0	12.6	0.0	0.8	52.5	1.7	0.9	1.7	0.0	18.3	1.0	11.4	20.1	2.1	5.0	0.7	0.0	0.8	7.2	2.2	30.2	1.1	0.0	12.7	15.2
FAM92A	"FAM92A1, FLJ38979"	ENSG00000188343	"Family with sequence similarity 92 member A"	A1XBS5	8	93698561-93731527	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.0"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 46.8;Distal tubular cells: 34.9;Proximal tubular cells: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA034760, HPA058942"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA034760: AB_10599947, HPA058942: AB_2732628"	"unprognostic (2.65e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.07e-2)"	11.2	13.3	15.9	4.2	14.7	2.8	8.4	13.6	19.1	9.4	7.0	2.9	5.5	2.8	12.0	19.9	5.5	10.1	10.5	16.3	12.9	11.2	15.3	11.4	7.1	4.2	8.4	15.9	13.8	15.1	15.2	21.6	7.5	9.7	9.8	4.8	5.2	3.3	9.2	6.9	5.1	4.1	11.1	6.2	3.7	5.4	71.0	6.4	1.8	9.4	3.1	2.7	11.6	10.6	0.9	6.2	0.3	3.8	2.8	1.6	1.0	13.6	7.3	19.7	20.3	21.3	30.6	5.3	12.5	18.3	17.0	16.4	1.3	3.1	1.1	16.3	18.4	19.5	9.8	19.9	11.9	15.4	0.4	11.0	8.0	7.3	6.7	24.5	0.3	2.0	19.3	5.3	16.6	13.6	24.5	18.1	6.7	4.7	0.6	13.3	5.1	8.4	1.4	8.3	0.3	0.4	0.8	14.8	0.2	13.3	3.1	5.7	7.3	9.0	0.1	15.1	9.3	3.0	4.2	10.0	16.7	6.7	17.3	10.1	0.9	0.9	0.4	14.6	1.1	5.8	0.3	3.8	0.0	0.4	2.2	0.5	0.9	1.1	0.4	6.2	0.2	0.2	0.7	0.1	2.8	0.3	0.8	1.6	1.0	15.9	14.7	13.6	19.1	12.9	11.2	8.4	15.9	9.7	6.4	8.9	6.5	0.0	0.0	0.0	0.0	0.0	0.0	46.8	15.9	7.0	0.0	10.8	34.9	16.9	0.0	0.0	0.0	0.0	14.8	11.6	0.0	0.0	3.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	14.6	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
FASTKD2	KIAA0971	ENSG00000118246	"FAST kinase domains 2"	Q9NYY8	2	206765357-206792509	"Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067191			Supported	Mitochondria		NA	NA			Mitochondria		"HPA067191: AB_2685801"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.36e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.57e-2)"	17.2	20.0	12.8	11.2	24.2	9.4	17.1	18.7	23.9	15.5	15.0	9.0	13.1	14.1	19.7	12.7	20.9	15.5	11.2	23.9	12.1	8.4	19.0	27.4	12.8	12.4	10.4	18.1	16.9	15.1	16.6	29.4	12.3	21.2	13.5	17.0	10.3	15.5	11.5	42.0	17.1	14.5	15.6	11.0	14.0	16.3	10.8	11.8	14.2	17.7	19.4	16.0	16.7	14.2	13.4	19.6	5.1	13.9	19.2	19.5	12.8	14.7	13.5	12.6	14.3	14.4	17.3	23.6	17.2	14.6	29.6	16.9	23.9	16.2	18.6	19.4	18.0	34.2	20.2	15.7	24.3	26.3	5.7	10.2	14.5	13.9	23.0	17.5	31.3	13.6	18.5	24.9	22.5	24.7	15.0	19.9	13.7	27.3	9.4	21.7	12.6	13.2	13.3	22.5	13.9	25.9	11.6	19.6	19.0	20.5	24.7	18.4	11.8	13.3	22.6	20.5	19.7	10.6	16.4	15.4	18.1	16.2	12.4	17.9	9.5	15.7	24.0	21.0	14.6	14.9	5.1	13.9	3.2	13.1	13.5	14.4	13.4	14.6	13.7	19.6	10.8	19.5	17.5	0.8	19.2	9.8	9.4	11.3	12.8	12.8	24.2	18.7	23.9	12.1	8.4	10.4	18.1	21.2	11.8	26.8	10.7	17.1	24.7	21.1	17.4	21.4	7.6	14.7	13.6	12.2	21.6	24.0	8.3	16.4	17.3	14.1	7.3	0.0	13.1	18.5	14.3	10.5	4.7	16.6	13.2	6.4	7.0	11.1	4.7	5.1	8.9	8.9	5.0	11.8	9.0	10.9	11.2	10.4	13.1	10.2	21.6	12.9	15.6	18.9	11.9	18.7	21.5	15.0	11.0	21.3
FASTKD3	"FLJ23274, MGC5297"	ENSG00000124279	"FAST kinase domains 3"	Q14CZ7	5	7859159-7869037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068525, HPA074462"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA068525: AB_2685999, HPA074462: AB_2686692"	"unprognostic (5.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (6.66e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.53e-4)"	7.1	15.5	8.6	9.7	13.3	7.6	12.3	9.1	15.0	8.3	10.7	8.6	7.9	10.4	8.8	10.2	8.9	7.5	6.5	7.2	8.7	7.3	17.8	14.5	8.3	10.0	9.2	13.7	9.3	8.4	13.0	10.8	6.4	8.0	8.6	13.5	8.1	11.1	15.8	10.2	9.0	12.1	7.8	8.8	12.0	9.1	6.0	7.4	12.2	8.9	7.4	12.2	9.1	7.0	9.6	6.7	7.4	7.3	4.8	10.3	4.7	7.1	6.3	6.2	8.0	3.9	4.9	12.1	6.0	5.2	9.5	7.3	9.4	7.7	24.9	12.2	6.3	12.1	7.6	15.1	8.4	13.5	6.8	7.8	8.6	20.6	7.4	5.3	14.2	7.2	5.6	3.6	8.8	5.5	4.3	5.2	10.2	11.8	4.4	7.1	5.1	9.5	8.3	5.6	7.5	9.0	11.1	7.6	5.7	7.7	7.7	4.3	4.1	18.1	8.0	8.8	5.8	7.2	6.6	3.5	9.4	9.6	9.7	9.9	5.1	4.8	15.9	6.2	13.2	7.6	3.8	5.4	7.4	6.1	7.3	8.2	9.6	9.4	6.5	6.7	6.8	10.3	9.7	0.2	4.8	5.7	3.8	10.2	4.7	8.6	13.3	9.1	15.0	8.7	7.3	9.2	13.7	8.0	7.4	14.9	5.1	5.2	1.9	2.3	2.9	3.6	7.6	5.3	0.0	0.0	0.0	6.3	5.0	7.2	0.4	4.3	8.0	0.0	10.3	7.0	4.6	2.3	3.5	9.9	7.3	4.8	6.9	4.9	7.0	0.4	4.9	5.8	1.7	14.4	6.2	3.5	9.3	3.5	4.2	14.9	5.1	0.0	5.1	3.4	5.4	4.8	3.5	6.9	6.6	1.6
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 322.6;Proximal tubular cells: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	64.2	0.0	1.1	0.2	10.4	2.3	0.0	0.2	0.4	0.0	42.1	0.2	1.2	0.1	12.3	0.0	0.2	7.3	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.2	30.5	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8	71.5	142.5	10.2	6.5	0.7	0.0	0.6	107.0	13.4	68.2	59.3	0.0	9.7	94.5	14.4	0.0	1.8	32.6	23.3	56.4	1.6	1.7	17.4	45.2	322.6	187.5	0.0	30.7	11.1	49.8	0.8	1.4	103.2	11.8	0.0	49.9	2.1	23.8	68.4	3.9	631.0	0.0	6.5	1.2	0.6	0.1	0.9	8.5	13.1	59.5	51.2
FBXL12	"Fbl12, FLJ20188"	ENSG00000127452	"F-box and leucine rich repeat protein 12"	Q9NXK8	19	9810267-9827816	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002843			Approved	Mitochondria		NA	NA			Mitochondria		"HPA002843: AB_2666679"	"unprognostic (7.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (1.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (4.07e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.77e-3)"	14.3	10.4	6.6	12.4	9.8	25.1	16.3	12.2	12.6	14.7	16.8	10.5	8.6	16.2	18.6	18.7	13.2	17.0	15.6	12.1	6.9	7.1	12.0	15.3	14.8	14.1	8.8	8.7	19.3	12.4	8.2	13.4	16.3	10.5	16.5	11.7	10.0	9.9	17.8	17.3	11.3	18.6	14.5	6.7	13.9	12.9	11.8	7.6	87.9	13.5	9.2	12.7	17.8	13.4	19.0	17.1	27.3	14.7	22.5	18.4	11.6	9.5	4.8	11.3	10.7	12.8	11.4	12.7	10.3	10.7	11.3	13.5	14.7	6.4	9.0	16.7	10.4	8.8	9.1	8.4	9.1	9.0	8.9	16.2	17.2	9.6	14.6	16.6	12.4	10.7	16.3	6.2	10.9	9.7	8.3	8.1	23.4	13.0	18.7	5.9	7.6	18.4	38.6	12.8	5.8	9.1	10.8	8.3	16.2	8.0	13.0	6.9	9.5	7.6	5.7	11.8	10.8	7.8	14.8	9.2	15.6	7.5	20.8	10.1	25.3	9.8	13.9	6.6	11.3	7.3	20.8	14.7	27.3	15.9	12.1	18.2	13.6	15.6	18.3	16.6	19.0	18.4	14.5	10.9	22.5	11.3	17.1	16.5	11.6	6.6	9.8	12.2	12.6	6.9	7.1	8.8	8.7	10.5	7.6	6.0	8.6	10.9	13.9	6.5	7.3	20.7	7.6	6.7	7.9	12.2	3.9	36.4	5.0	9.9	1.1	18.8	27.5	0.0	8.5	25.3	20.3	11.5	3.5	6.6	14.9	7.9	12.1	14.7	8.9	2.1	24.5	10.8	10.1	22.6	15.0	8.6	8.0	18.1	20.5	7.9	10.5	12.9	20.4	20.4	18.1	9.7	53.0	17.5	16.9	18.7
FBXO21	"FBX21, KIAA0875"	ENSG00000135108	"F-box protein 21"	O94952	12	117141988-117190531	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 78.4"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 208.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062411, HPA071452"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062411: AB_2684755, HPA071452: AB_2686398"	"unprognostic (6.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.29e-2)"	8.1	29.4	17.8	8.8	21.6	5.2	11.4	27.0	28.0	12.6	10.5	18.8	25.5	10.6	16.1	70.1	10.2	78.4	14.2	18.9	17.9	18.4	33.3	17.0	11.2	8.2	13.5	21.4	38.8	19.0	17.3	18.8	12.3	17.5	17.4	9.8	14.0	10.7	19.8	16.3	11.8	9.5	12.8	17.0	11.6	11.8	27.8	14.2	9.9	19.1	6.9	9.3	12.7	10.2	12.8	8.5	3.7	10.5	9.2	13.0	7.1	9.5	22.8	14.4	7.9	11.9	12.4	16.5	12.8	14.0	12.1	9.9	14.7	6.8	12.6	12.7	13.1	9.0	13.1	16.9	12.8	14.6	7.1	15.1	0.6	12.6	11.8	10.8	4.1	4.5	12.2	12.4	9.6	15.5	19.8	16.8	11.2	5.0	4.2	10.3	15.6	11.6	2.9	21.5	14.7	14.9	13.8	20.9	13.2	12.1	22.9	28.6	17.3	32.1	8.5	6.9	12.1	19.9	1.6	12.9	8.1	10.4	9.4	8.3	7.4	7.6	16.5	11.7	6.4	11.2	1.1	5.8	3.7	10.7	10.5	11.2	9.8	11.3	11.1	8.5	12.8	13.0	11.7	0.5	9.2	10.1	5.8	11.4	7.1	17.8	21.6	27.0	28.0	17.9	18.4	13.5	21.4	17.5	14.2	29.8	27.8	27.2	40.8	33.1	41.6	47.8	30.6	36.1	45.5	48.8	39.3	49.4	38.1	52.1	35.4	34.8	15.1	0.0	44.6	30.7	30.8	42.7	3.5	35.9	13.3	69.9	37.5	41.1	21.5	46.7	92.3	14.7	21.9	16.2	24.9	57.0	28.8	17.5	208.9	69.6	32.7	103.5	45.3	20.0	40.5	39.5	54.8	27.7	25.9	40.4
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944696	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 460.8;Late spermatids: 1531.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	17.6	13.9	13.3	12.4	14.4	14.7	11.8	11.2	24.3	9.8	17.0	9.6	12.7	23.7	11.1	11.8	19.5	8.5	15.9	30.7	15.3	9.6	13.4	31.0	9.0	10.8	11.8	10.9	8.4	25.9	8.8	10.5	12.8	12.0	13.7	7.5	9.3	25.7	16.1	68.2	11.5	23.4	18.2	6.5	12.7	16.4	67.8	9.6	16.2	12.8	17.3	16.0	14.4	11.6	16.3	38.7	33.0	28.4	20.1	41.2	26.0	15.1	26.3	6.0	14.7	14.7	9.6	35.8	15.9	10.9	11.1	6.1	17.5	19.8	10.4	18.4	16.2	8.7	20.0	5.4	13.8	1.8	13.9	18.3	9.0	35.9	18.0	16.3	13.1	23.3	11.0	12.4	10.1	8.4	8.9	11.3	8.1	17.5	17.2	8.3	40.1	10.2	15.7	11.1	18.4	28.8	11.5	9.2	18.9	9.6	15.5	12.7	12.8	19.6	21.2	21.1	2.4	24.4	20.7	21.9	16.6	15.0	30.9	13.7	14.4	17.1	6.9	22.6	11.7	12.5	19.6	24.8	33.0	41.2	28.4	31.3	16.3	31.3	34.5	23.3	12.9	14.0	23.2	13.1	20.1	21.9	38.7	36.3	26.0	13.3	14.4	11.2	24.3	15.3	9.6	11.8	10.9	12.0	9.6	17.9	47.9	36.0	34.0	25.4	26.7	73.4	48.4	13.4	19.4	22.7	15.7	58.4	63.0	97.4	460.8	47.6	329.2	0.0	129.2	114.9	40.1	69.0	28.8	95.6	79.2	57.2	64.6	41.1	51.5	1531.1	47.8	44.4	65.8	159.7	119.4	39.5	113.5	143.8	66.8	98.2	31.7	58.2	56.1	189.9	37.9	31.5	84.8	55.4	85.6	54.2
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429883-110464881	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.9;seminal vesicle: 55.6"	"Cell type enhanced"	"Detected in all"	11	"Syncytiotrophoblasts: 953.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	5.5	113.9	3.9	4.7	4.5	3.9	5.6	2.7	4.0	3.2	7.5	5.2	33.7	7.9	3.2	3.9	5.1	3.0	5.6	9.6	3.6	4.3	10.7	22.8	7.8	4.7	4.5	2.5	3.5	8.6	3.5	3.7	48.4	3.1	4.8	4.2	4.2	4.1	55.6	7.3	3.3	12.3	3.6	3.4	3.9	5.0	5.3	2.6	5.2	8.7	5.0	3.5	5.6	5.4	10.7	6.9	3.4	5.8	4.4	8.7	2.9	5.4	3.8	5.8	6.4	5.7	10.2	13.1	5.0	6.1	4.4	7.5	12.9	9.1	12.7	14.8	6.4	7.9	6.4	6.8	7.5	6.1	12.1	8.6	6.4	6.7	7.9	10.1	6.7	10.5	17.7	6.3	4.0	9.6	7.7	9.0	8.8	6.4	18.9	9.4	6.0	9.5	14.9	5.2	10.3	7.2	14.0	5.6	11.7	9.6	9.8	8.0	4.1	9.5	10.9	6.3	7.1	6.4	4.6	5.3	4.5	5.5	5.4	5.3	4.3	3.3	38.1	3.4	13.7	5.7	1.8	5.7	3.4	5.3	4.2	5.8	10.7	7.3	7.4	6.9	7.5	8.6	6.1	0.7	4.4	5.8	5.3	8.7	2.9	3.9	4.5	2.7	4.0	3.6	4.3	4.5	2.5	3.1	2.6	17.9	39.7	88.0	75.8	60.8	27.9	46.0	104.4	6.7	9.1	76.8	7.9	144.7	207.2	62.6	22.7	33.8	131.1	46.7	128.1	138.7	46.5	71.9	46.0	160.8	108.7	39.7	46.0	33.7	54.7	7.0	43.4	60.1	65.8	51.3	45.4	26.2	79.9	67.0	42.8	255.2	15.0	25.8	42.6	41.2	70.7	85.2	953.0	57.5	77.9	120.2
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.1;Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	4.0	21.6	3.2	3.6	2.3	3.1	30.1	4.8	5.3	2.9	5.8	6.0	3.5	9.6	0.8	2.0	1.6	8.3	2.3	6.0	0.8	9.1	5.0	7.3	3.5	55.1	6.5	1.6	25.5	10.1	6.8	3.0	1.0	2.3	14.7	3.6	11.5	1.6	4.4	17.1	6.2	3.3	1.8	3.8	4.7	3.4	5.4	5.1	2.4	6.8	1.7	4.0	3.3	7.2	3.5	3.8	15.7	1.5	6.8	2.0	17.9	3.1	2.4	4.4	0.7	2.1	5.4	2.5	6.7	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0	3.0	4.6	3.7	12.8	8.7	4.9	3.4	5.1	21.4	5.7	8.7	3.9	47.2	5.0	9.7	5.2	2.8	14.8	0.0	6.8	14.1	6.1	4.3	5.7	12.5	18.6	3.2	6.8	12.3	4.6	12.2	5.5	3.6	5.0	3.6	10.8	10.9	8.3	21.0	4.2	16.3	4.9	0.0	6.4	7.1	7.6	15.8	38.6	8.5	17.6	13.1
FGFR1OP2	DKFZp564O1863	ENSG00000111790	"FGFR1 oncogene partner 2"	Q9NVK5	12	26938383-26966650	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038308, HPA038696"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038308: AB_10672524, HPA038696: AB_10675948"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-2)"	22.4	32.2	25.5	21.4	30.5	38.5	19.9	20.8	40.1	20.4	18.1	18.2	13.8	16.9	24.0	23.0	17.5	17.9	21.9	23.5	26.9	21.0	23.4	20.5	20.1	28.5	24.7	28.5	46.6	11.6	16.4	30.7	19.8	25.6	17.0	15.4	12.1	14.5	14.9	18.7	17.4	16.9	20.4	32.5	23.3	14.8	16.7	25.7	30.4	18.3	16.3	22.1	20.3	21.6	12.5	13.4	34.0	17.3	13.3	31.8	12.7	11.5	14.1	12.2	16.4	21.1	15.4	17.6	20.3	23.6	15.6	17.1	22.1	13.5	17.0	10.0	17.7	15.0	12.3	8.4	15.1	22.3	12.7	12.1	28.8	15.8	14.7	25.0	16.4	22.1	11.1	9.9	19.0	24.8	21.5	22.3	15.5	17.0	13.1	18.2	13.7	21.8	40.7	20.1	15.0	23.6	13.2	33.7	14.2	13.8	14.2	3.7	7.4	23.0	8.6	19.7	29.4	15.3	25.5	24.2	21.0	21.0	38.2	18.7	9.2	9.3	36.1	17.5	19.4	16.9	34.0	17.3	20.9	18.2	16.2	16.4	12.5	19.2	17.5	13.4	10.4	17.9	19.3	17.5	13.3	15.3	11.2	31.8	12.7	25.5	30.5	20.8	40.1	26.9	21.0	24.7	28.5	25.6	25.7	35.7	30.4	58.0	54.3	124.7	52.2	41.1	12.7	21.4	51.2	26.2	72.6	36.4	61.3	26.5	13.6	75.5	17.5	116.8	20.3	31.3	77.3	39.0	57.8	25.1	53.4	55.6	25.8	59.5	52.7	12.7	97.5	56.4	84.4	35.1	20.1	59.9	24.4	25.9	160.5	49.5	44.4	45.3	78.4	32.9	69.0	104.6	49.8	105.0	18.4	59.2
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
FIS1	"CGI-135, Fis1, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017430	Approved		Supported	Mitochondria		NA	NA		590000	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	35.1	46.8	53.4	22.3	49.9	32.7	35.8	26.0	60.0	30.3	34.4	57.9	38.0	30.0	31.1	42.7	35.6	47.0	39.4	78.6	52.6	44.8	39.6	58.3	27.8	23.6	65.3	37.8	41.2	56.6	39.5	37.1	34.0	45.1	29.3	26.3	28.8	45.2	43.8	120.5	29.7	29.2	32.4	87.9	28.1	31.1	30.4	44.1	21.3	47.1	48.8	22.6	30.5	29.3	73.0	73.4	63.6	67.4	55.6	72.8	87.9	25.0	29.5	22.1	31.7	25.6	34.2	15.1	27.2	33.1	24.9	21.5	20.3	41.2	24.5	36.3	37.3	22.8	14.8	15.4	43.9	13.9	19.0	22.4	11.1	42.9	26.9	30.5	20.7	17.3	32.6	41.4	17.3	26.7	28.0	44.9	13.6	23.3	33.7	37.4	115.0	32.2	37.4	24.5	50.6	28.7	15.8	12.4	53.8	37.6	29.0	28.7	33.6	13.0	62.5	18.4	20.3	20.8	23.5	36.8	29.2	18.8	30.2	28.9	28.6	21.8	14.1	27.1	23.6	38.1	58.9	67.4	63.6	63.2	65.5	65.1	72.2	61.0	59.7	73.4	73.0	60.7	63.5	51.4	55.6	59.0	61.4	72.8	87.9	53.4	49.9	26.0	60.0	52.6	44.8	65.3	37.8	45.1	44.1	95.3	100.9	113.2	110.6	93.2	42.7	311.2	216.6	109.7	67.1	218.1	15.7	209.3	475.9	225.3	158.1	164.5	399.5	537.3	254.1	253.9	149.0	192.6	133.9	365.3	254.4	33.4	210.7	152.2	158.6	575.1	179.5	136.4	207.5	212.0	223.3	159.0	210.6	475.1	168.3	613.6	43.3	97.0	162.7	157.3	182.7	118.6	271.1	129.8	226.8	173.1
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 83.0;Leydig cells: 43.4;Peritubular cells: 42.1;Sertoli cells: 58.2;Smooth muscle cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		5500	Mitochondria		"HPA051171: AB_2681371, HPA057021: AB_2683312"	"unprognostic (8.30e-2)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (3.43e-5)"	"prognostic unfavorable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.2	15.0	49.1	52.8	61.7	13.2	66.9	67.0	25.2	21.8	8.4	0.6	0.0	0.9	72.6	6.4	0.1	8.9	17.8	10.7	4.4	13.5	6.4	18.3	24.0	57.7	0.0	0.0	66.2	0.0	20.6	15.8	48.4	21.4	0.0	0.2	2.3	21.0	21.1	0.0	0.0	11.7	34.3	5.5	1.3	17.7	2.1	4.3	0.0	3.7	13.1	0.1	48.1	22.4	19.8	7.5	0.4	24.2	30.4	15.8	20.2	10.2	0.1	0.0	0.0	41.7	0.0	29.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7	0.0	7.4	0.0	10.9	7.6	0.8	1.6	2.5	0.0	2.3	0.0	0.0	6.3	0.0	8.8	0.5	23.9	0.0	0.0	4.2	23.1	83.0	4.1	0.0	0.0	4.2	14.3	0.0	34.4	0.0	1.9	43.4	2.2	15.1	0.0	1.4	29.2	3.0	0.0	42.1	0.0	1.0	58.2	43.4	0.5	8.3	4.4	10.0	0.0	0.6	1.7
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 972.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA			Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.9	26.5	20.8	39.5	21.5	33.8	52.2	29.9	31.9	22.9	31.8	25.1	50.5	21.2	48.7	36.7	15.4	20.1	12.8	41.7	6.5	25.8	60.9	19.8	34.6	30.2	37.0	19.6	43.6	44.1	40.2	20.6	13.1	44.1	23.5	41.3	41.4	50.5	19.9	61.6	35.6	58.7	42.5	33.2	38.5	37.4	17.3	72.4	30.8	24.2	23.1	42.1	21.0	17.3	37.3	16.5	20.4	57.2	27.4	28.7	26.2	55.9	22.7	38.6	22.2	24.6	64.8	31.5	25.4	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9	8.9	1.4	107.1	128.1	84.6	57.2	2.0	71.4	2.7	5.7	96.0	13.7	219.4	210.5	151.9	314.6	76.6	289.8	233.6	111.8	173.9	174.8	132.3	54.0	55.9	208.7	93.8	197.7	79.8	159.9	972.7	188.7	127.3	192.3	254.3	108.6	104.6	130.6	224.5	155.6	222.1	41.3	97.0	149.9	203.6	97.7	103.1	261.7	163.0	127.0	126.6
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.4;fHDF/TERT166: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.1	13.6	5.3	21.9	50.4	58.4	7.1	38.7	40.3	12.8	20.4	5.9	17.0	0.0	15.8	71.8	20.5	14.0	7.8	18.9	14.7	0.0	2.3	1.2	14.6	5.8	21.0	0.0	2.1	37.9	11.5	11.4	11.1	30.5	16.1	0.0	2.7	1.4	26.0	6.9	0.0	3.6	1.1	14.3	7.2	0.0	14.3	0.0	14.3	2.4	5.0	12.1	22.1	11.3	13.7	14.1	7.9	3.5	21.5	21.0	20.2	13.0	8.8	4.6	8.9	0.0	20.5	0.0	41.7	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4	11.9	20.0	0.0	12.5	30.5	7.7	38.3	15.3	6.7	7.9	17.4	9.8	17.1	5.0	16.3	0.5	65.3	16.9	0.0	36.7	25.2	46.6	8.5	5.7	10.5	6.7	11.1	11.7	58.9	6.2	0.7	33.9	4.5	57.3	3.6	27.2	34.3	30.2	17.5	51.9	7.4	4.5	45.3	51.9	0.9	0.9	25.0	11.0	1.3	21.4	8.6
FMC1	"C7orf55, HSPC268"	ENSG00000164898	"Formation of mitochondrial complex V assembly factor 1 homolog"	Q96HJ9	7	139339457-139346319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 68.3;Collecting duct cells: 80.3;Distal tubular cells: 169.1;Proximal tubular cells: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045663, HPA050553"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045663: AB_2679410, HPA050553: AB_2681173"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.19e-1)"	"prognostic favorable (5.63e-6)"	"unprognostic (1.04e-3)"	"unprognostic (2.39e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (1.50e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.02e-2)"	9.2	9.7	11.2	6.0	16.9	7.0	10.2	6.2	18.6	8.4	8.8	7.2	15.1	8.4	7.1	13.6	6.5	11.5	9.7	26.7	10.3	10.0	12.2	17.5	7.2	7.9	12.8	10.2	10.6	22.1	5.5	10.7	4.4	12.2	12.9	6.2	7.1	14.2	13.2	28.3	5.2	6.0	8.1	9.2	6.0	8.7	6.4	11.9	5.3	15.4	18.7	4.0	7.9	10.9	15.9	15.0	7.4	7.7	10.4	12.1	5.3	2.4	9.1	5.4	5.6	2.9	2.5	2.2	0.8	2.3	6.3	4.6	3.0	3.3	5.9	5.5	2.7	5.8	2.0	5.1	2.2	1.4	2.9	30.8	3.0	9.3	12.7	6.1	2.4	4.0	6.3	4.4	2.0	1.7	2.4	4.8	3.9	5.6	8.6	3.5	17.6	5.8	14.6	5.1	4.2	13.1	3.5	2.7	7.6	4.9	2.3	10.2	6.8	2.8	2.3	3.8	0.9	1.1	1.8	2.3	2.2	2.1	2.7	2.3	3.0	2.9	6.5	5.4	5.3	3.6	7.4	7.7	7.4	8.3	4.6	7.4	15.9	10.3	8.3	8.4	14.6	12.1	8.7	3.5	10.4	5.0	15.0	11.3	5.3	11.2	16.9	6.2	18.6	10.3	10.0	12.8	10.2	12.2	11.9	41.7	34.6	0.0	0.0	0.0	0.0	0.0	0.0	68.3	36.4	80.3	0.0	54.8	169.1	29.3	0.0	0.0	0.0	0.0	30.9	18.2	0.0	0.0	11.6	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	22.6	0.0	0.0	24.3	0.0	0.0	98.7	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
FOCAD	"FLJ20375, KIAA1797"	ENSG00000188352	Focadhesin	Q5VW36	9	20658309-20995955	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 62.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 62.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055015	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA055015: AB_2682673"	"unprognostic (3.05e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.25e-4)"	"unprognostic (3.69e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.64e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.09e-8)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-2)"	3.6	9.0	4.5	3.6	7.2	1.9	3.9	8.7	9.0	4.9	4.8	15.0	3.6	1.8	3.9	6.3	3.6	7.4	3.6	5.3	7.1	7.3	3.8	3.6	3.7	3.6	4.4	3.6	3.6	5.5	10.4	11.8	4.1	62.1	5.6	5.6	6.8	5.8	3.7	5.1	4.2	3.6	4.7	3.6	3.6	4.2	3.6	3.6	3.6	11.8	3.6	3.6	3.6	3.6	3.4	6.9	8.9	5.7	4.5	7.1	3.1	16.3	11.3	12.3	9.2	11.6	13.3	6.5	9.7	15.5	6.9	8.0	7.5	5.6	6.7	5.2	13.9	5.8	5.7	10.7	19.3	12.1	29.8	7.9	5.2	13.9	9.2	6.0	8.7	6.8	12.2	13.3	6.9	11.4	9.7	26.4	5.7	0.1	9.9	11.5	6.3	6.5	16.4	9.7	8.7	11.4	0.0	5.6	4.5	10.8	7.0	8.2	4.1	6.4	11.0	2.6	17.3	6.9	5.1	16.1	0.0	4.5	7.6	8.8	2.4	13.7	7.6	0.0	12.3	4.1	8.9	2.8	8.0	5.3	5.7	7.1	2.7	4.7	5.1	6.9	3.4	4.2	5.0	2.2	4.5	3.1	2.8	4.3	3.1	4.5	7.2	8.7	9.0	7.1	7.3	4.4	3.6	62.1	3.6	8.9	14.3	3.9	2.7	2.6	5.7	10.0	7.6	13.4	7.9	15.7	3.9	4.1	1.7	7.4	11.0	4.4	4.1	0.0	7.4	5.7	6.2	6.5	4.7	3.4	4.6	11.1	16.8	12.3	5.4	3.7	4.6	4.3	8.5	1.0	10.9	7.3	8.1	0.0	3.5	2.8	3.8	6.5	5.7	14.9	7.8	3.1	2.7	3.5	8.9	2.6
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004222-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 16.7"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 18.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.7"	"Cell type enriched"	"Detected in single"	4	"T-reg: 3.8"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1"	"Region enhanced"	"Detected in some"		"hypothalamus: 7.7"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	0.3	0.5	4.1	0.2	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.2	0.1	6.2	0.0	0.1	0.1	1.8	6.5	0.0	0.0	0.4	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	8.4	0.1	1.8	2.6	3.7	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	2.6	0.0	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.3	11.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.3	4.1	0.6	0.0	0.1	6.2	6.5	0.0	16.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	16.8	21.2	17.5	14.3	19.2	8.7	19.1	21.3	30.5	17.7	17.1	17.1	16.9	11.2	22.2	13.7	24.2	14.6	13.4	17.1	14.9	14.9	13.0	13.6	15.2	13.6	13.7	17.2	17.6	19.2	25.4	19.8	18.6	15.6	14.9	11.7	13.8	17.1	16.3	41.5	21.6	12.6	19.9	10.3	13.2	15.5	32.3	15.8	21.8	18.6	12.4	13.9	16.4	16.4	4.0	5.9	4.1	2.9	4.1	4.4	1.6	21.7	23.3	21.8	23.8	12.6	13.9	14.6	12.8	14.8	22.5	22.9	22.6	14.0	18.6	9.3	15.8	24.8	12.7	23.2	14.8	21.3	12.7	22.2	19.2	15.4	22.2	19.9	21.4	12.9	13.1	27.1	23.7	27.1	14.0	22.7	20.2	25.6	19.1	12.3	13.0	36.3	13.6	12.5	18.0	17.8	23.9	18.6	15.4	10.3	18.4	36.2	26.7	12.7	32.4	30.2	24.3	22.8	24.8	17.7	29.7	20.8	19.9	25.8	22.1	19.5	24.1	16.0	17.9	15.6	4.1	2.9	3.3	4.4	2.2	3.5	4.0	3.3	4.2	3.3	2.8	2.6	2.9	0.5	4.1	2.3	5.9	3.4	1.6	17.5	19.2	21.3	30.5	14.9	14.9	13.7	17.2	15.6	15.8	47.6	21.9	9.3	7.3	33.1	18.1	17.3	5.1	13.4	18.2	14.0	11.8	10.2	3.3	8.5	11.5	12.8	10.5	0.0	9.1	7.5	13.1	10.0	2.3	11.4	16.3	44.5	10.5	12.9	14.6	18.8	8.6	9.2	11.8	9.0	13.5	9.1	10.2	11.5	12.4	5.4	16.1	0.0	19.6	13.2	9.5	37.6	8.1	6.9	12.1	8.9
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277979-109309220	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Spermatocytes: 1.8;Spermatogonia: 2.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enriched"	"Detected in single"	11	"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1"	"Not detected"	"Not detected"							HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.2	0.0	0.1	0.1	2.7	0.0	0.1	0.2	0.1	1.4	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.9	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.0	13.1	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	6.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	9.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.0	0.0
FOXRED1	H17	ENSG00000110074	"FAD dependent oxidoreductase domain containing 1"	Q96CU9	11	126269055-126278131	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039620, HPA046192"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039620: AB_2676602, HPA046192: AB_2679580"	"prognostic unfavorable (7.36e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	7.2	12.3	14.6	8.5	14.9	10.4	7.8	12.6	19.2	6.1	11.7	9.2	6.4	10.3	6.8	6.9	7.7	7.7	7.5	20.1	11.1	11.7	14.6	36.2	5.1	9.2	12.9	18.2	4.3	7.5	9.2	7.7	7.1	13.6	5.8	13.0	8.0	7.5	11.9	15.0	6.1	8.2	8.0	8.7	9.5	8.8	6.8	11.7	8.3	6.2	9.8	10.0	8.0	4.9	7.5	16.5	5.3	12.4	8.5	8.9	7.7	9.5	10.9	8.0	10.0	6.1	2.8	11.1	4.9	6.2	9.3	9.3	16.2	9.8	15.5	13.8	4.0	12.2	15.9	21.4	12.9	5.8	8.3	5.8	32.3	7.1	19.1	8.0	7.9	6.9	2.6	5.0	6.1	11.2	2.5	10.2	16.7	18.5	8.5	7.8	13.1	9.0	13.9	6.6	25.0	18.9	14.8	14.3	18.3	8.5	4.9	10.5	9.0	9.9	14.9	5.3	5.3	36.0	13.4	3.7	5.6	4.6	10.0	7.9	5.2	7.4	12.7	6.8	27.1	7.6	1.6	9.7	5.3	6.9	12.4	7.1	7.5	5.5	8.9	11.8	6.2	7.9	6.9	1.9	8.5	8.9	16.5	7.6	7.7	14.6	14.9	12.6	19.2	11.1	11.7	12.9	18.2	13.6	11.7	8.9	8.6	13.7	6.7	3.2	24.4	19.1	5.1	2.7	6.8	3.5	25.5	25.0	6.6	9.7	2.5	6.2	9.7	0.0	12.1	19.1	8.9	3.9	9.2	25.2	17.5	12.7	12.6	13.5	5.4	6.0	5.2	8.3	8.5	6.4	8.7	17.9	8.9	3.5	10.6	15.8	29.3	6.5	9.2	13.6	23.0	5.0	17.6	7.9	13.3	2.7
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.2	12.5	13.9	24.4	13.3	12.7	6.8	0.0	2.6	0.8	1.2	2.0	13.6	1.2	15.4	16.3	13.8	9.5	20.0	10.4	1.2	9.1	8.9	51.5	13.3	12.7	12.1	22.1	9.8	20.3	17.6	8.0	14.7	11.9	16.1	17.5	20.2	15.3	9.6	27.8	22.0	24.2	27.2	37.2	20.4	45.2	10.5	48.2	18.2	12.3	14.1	23.7	18.4	34.7	12.9	7.5	35.7	31.1	5.7	8.0	9.9	0.8	8.0	20.7	21.1	8.7	16.4	45.8	6.7	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1											0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.5	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 46.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.0	1.2	4.4	1.9	1.9	3.3	6.2	6.5	4.3	1.2	1.1	10.1	9.1	4.7	1.5	9.7	14.0	8.7	4.5	7.2	1.5	13.9	10.5	1.6	10.1	1.8	5.8	4.0	4.6	5.8	7.5	2.1	0.9	8.7	6.0	17.6	21.7	17.7	8.8	6.2	1.4	9.2	4.5	4.8	6.3	5.2	1.5	9.6	6.0	14.9	14.5	22.0	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.1	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3	0.0	4.6	7.7	21.9	28.2	16.8	5.6	7.6	4.0	2.3	14.0	3.9	4.1	10.0	2.1	31.9	4.7	16.0	0.0	4.5	15.6	4.8	26.8	1.1	8.2	7.7	11.1	13.3	3.1	18.0	31.4	2.0	6.4	10.1	1.0	28.5	4.3	4.1	17.3	2.5	2.2	16.9	0.0	7.6	1.2	3.9	46.0	6.5	5.7	27.3	25.6
FRMD6	"C14orf31, EX1, MGC17921, willin"	ENSG00000139926	"FERM domain containing 6"	Q96NE9	14	51489100-51730727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 119.7;Early spermatids: 184.0;Late spermatids: 333.9;Suprabasal keratinocytes: 120.2;Urothelial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3;naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"BJ: 58.1;fHDF/TERT166: 121.7;U-138 MG: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001297	Uncertain	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA001297: AB_1078913"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.05e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.28e-4)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.20e-2)"	7.8	6.4	2.7	7.6	5.3	0.2	12.9	14.3	4.6	44.6	9.8	4.8	14.1	2.2	52.3	11.6	32.8	8.8	16.0	9.0	4.3	2.1	2.7	4.7	5.4	4.1	3.8	2.8	12.0	2.8	1.0	2.7	10.7	4.4	21.5	5.0	13.2	10.7	23.0	3.8	20.4	4.8	27.5	3.6	8.3	5.4	14.0	2.1	5.2	4.8	20.9	23.3	20.3	18.5	0.1	0.0	3.3	0.6	0.3	2.5	0.7	12.2	2.1	3.5	6.7	7.3	11.2	1.4	58.1	30.2	32.4	29.2	7.6	2.8	0.2	1.8	121.7	10.1	12.7	1.0	18.6	39.0	0.1	1.3	0.1	1.1	0.3	9.3	0.0	0.6	9.6	7.5	26.9	33.4	14.2	9.8	0.6	0.1	3.9	33.7	1.8	1.0	0.0	0.8	0.0	4.2	0.1	13.6	0.1	6.0	18.4	0.6	7.8	4.1	0.8	5.7	7.3	0.5	0.1	36.4	49.8	19.0	12.5	12.4	3.0	2.4	0.0	3.2	0.0	19.7	3.3	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	2.5	1.9	0.2	0.3	0.6	0.0	0.0	0.7	2.7	5.3	14.3	4.6	4.3	2.1	3.8	2.8	4.4	2.1	3.0	1.0	0.0	119.7	99.0	0.4	2.2	10.2	0.0	5.7	0.0	0.0	32.7	0.0	13.0	184.0	10.3	0.0	0.0	2.5	3.7	47.2	36.8	1.1	3.4	3.3	0.0	0.0	9.8	0.3	333.9	16.4	3.3	30.4	1.0	0.0	10.1	37.9	0.0	20.8	0.3	0.2	6.5	24.7	4.4	6.4	120.2	32.6	0.0	0.0	134.9
FSIP2	FLJ34780	ENSG00000188738	"Fibrous sheath interacting protein 2"	Q5CZC0	2	185738895-185833290	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 27.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 128.1;Alveolar cells type 2: 68.3;Ciliated cells: 83.0;Early spermatids: 179.5;Spermatocytes: 69.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;OE19: 2.0;RT4: 4.7;SuSa: 2.1;U-266/70: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036139			Approved	Microtubules,Mitochondria		NA	NA			Microtubules	Mitochondria	"HPA036139: AB_10602134"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.64e-5)"	0.4	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.3	0.3	2.7	0.1	0.1	0.0	0.6	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.4	0.6	0.5	0.5	0.3	1.4	0.3	0.2	0.1	0.1	0.3	0.6	0.6	0.1	0.5	3.6	27.6	0.1	0.1	0.4	0.1	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	2.0	0.7	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1	128.1	68.3	0.8	0.2	0.5	14.6	3.2	0.0	83.0	56.9	0.0	9.8	0.2	0.0	0.5	179.5	0.6	2.6	0.0	0.2	0.1	0.6	0.3	37.2	0.0	0.3	17.5	7.5	1.8	0.0	20.4	2.0	1.4	1.7	0.0	13.3	5.8	3.2	0.0	3.5	0.0	8.0	0.0	0.5	69.0	2.7	0.3	0.2	0.0	0.6	0.1
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612564	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.5"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Approved	"Nuclear membrane,Mitochondria"	"Secreted to blood"	NA	NA			Mitochondria	"Nuclear membrane"	"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.7	2.2	8.4	1.0	14.6	3.0	1.1	18.5	18.0	1.0	1.6	1.7	0.0	1.1	0.5	2.8	3.1	1.6	0.7	0.6	1.5	3.2	4.8	0.5	2.0	0.4	1.9	10.1	0.8	2.9	7.1	4.0	6.4	2.6	2.9	1.9	1.4	1.4	0.1	1.5	5.3	1.2	0.3	1.0	0.5	2.3	2.8	4.7	0.0	1.3	0.0	1.7	10.2	1.6	2.8	1.2	3.4	1.1	0.8	2.3	1.2	4.4	7.6	0.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	6.8	0.9	0.3	6.2	0.0	0.8	0.1	0.9	0.2	0.0	0.4	0.3	0.3	7.4	0.6	0.0	0.0	0.4	0.1	1.1	0.0	0.0	0.2	0.0	0.3	3.4	4.0	0.0	7.2	0.8	0.3	8.2	7.8	0.8	0.3	0.7	7.7	0.0	8.4	33.1	0.7	1.7	1.4	0.1	7.8	2.8	0.3	0.2	0.3	1.4	0.4	0.2	11.9	11.8	0.3	0.1	0.0	0.2	3.4	1.1	0.6	1.2	0.4	2.3	2.8	1.7	1.2	0.6	2.6	2.1	1.3	2.4	0.8	0.7	1.2	1.6	1.2	8.4	14.6	18.5	18.0	1.5	3.2	1.9	10.1	2.6	4.7	0.0	1.9	0.0	1.7	1.4	10.3	7.3	0.0	6.7	7.9	0.0	13.7	0.3	0.0	0.2	31.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	8.6	0.0	0.0	13.9	0.3	0.0	10.1	0.0	0.0	3.3	0.8	0.0	0.7	2.3	2.4	6.5	0.0	0.4	0.6	1.4	0.0	0.0	0.0	2.6
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.3	9.6	15.8	7.6	7.2	10.7	15.3	8.2	7.3	12.6	9.7	5.1	7.4	20.4	6.4	8.5	13.0	12.4	18.6	18.8	15.9	23.8	21.3	28.6	6.3	37.8	12.4	20.9	12.5	11.9	15.2	12.6	13.7	4.5	16.8	12.6	21.5	20.0	11.6	11.1	5.9	9.2	21.3	23.1	19.2	14.1	10.8	13.9	14.5	9.4	12.2	5.5	8.4	5.5	8.6	11.6	6.2	6.5	10.0	8.3	14.4	10.8	11.9	5.6	4.8	12.1	3.9	17.3	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7	3.0	11.5	20.6	17.3	8.7	6.2	39.9	7.6	5.3	3.4	14.0	3.9	35.6	18.3	16.1	2.0	11.7	3.1	0.0	12.7	16.7	14.6	12.0	6.9	60.1	30.0	0.0	6.9	8.0	14.6	4.6	14.7	15.5	16.9	14.4	11.5	8.3	15.0	0.0	12.4	20.7	1.0	12.9	17.6	3.8	31.7	7.0	12.2	13.1	15.6	11.9
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"MOLT-4: 141.0;RPTEC TERT1: 323.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA		26000	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.2	0.0	0.0	0.0	0.0	141.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	323.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.1	0.8	1434.4	0.0	0.0	413.5	0.0	0.1	2501.8	465.3	14.4	1.3	0.0	0.0	8.3	0.1	1.1	0.1	0.0	2.4	2.9	0.0	14.6	5.5	4.3	15.4	8.6	2.6	0.0	14.4	0.0	0.5	33.3	0.0	7.1	3101.2	3.5	6.5	3.9	0.4	0.2	0.6	0.2	0.0	0.0	0.0
GADD45GIP1	"CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6"	ENSG00000179271	"GADD45G interacting protein 1"	Q8TAE8	19	12953119-12957236	"Predicted intracellular proteins, Ribosomal proteins"	"Cell cycle, Host-virus interaction"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055205, HPA065048, HPA071910"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: "	"unprognostic (5.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-1)"	23.9	31.8	32.7	22.3	29.1	28.1	19.3	17.2	31.4	16.9	18.9	11.2	17.9	21.1	19.2	20.0	22.3	17.5	25.0	41.9	26.4	27.6	24.3	31.5	15.3	21.0	26.0	23.6	20.7	29.6	10.1	18.5	21.3	17.7	18.7	9.7	13.1	36.2	21.7	85.5	18.4	19.2	19.5	19.3	19.8	20.0	17.2	17.1	14.8	27.0	37.9	14.8	17.5	21.5	34.2	17.7	4.8	14.1	16.1	23.6	10.6	20.1	17.2	7.2	10.1	5.1	6.6	10.1	14.9	7.5	14.9	12.3	23.7	8.2	14.6	24.9	8.9	10.7	14.1	8.8	14.5	3.9	9.5	43.2	10.3	23.2	26.6	12.4	17.1	15.8	7.8	11.8	10.3	8.5	7.9	8.6	14.1	15.6	5.7	9.2	29.6	27.0	36.0	19.9	13.1	54.3	20.1	7.3	23.3	11.4	11.9	22.2	20.3	11.1	15.0	16.8	3.7	11.7	16.2	13.9	28.9	10.1	25.1	27.3	22.7	15.8	15.1	20.1	21.5	16.6	4.1	14.1	4.8	14.4	13.4	14.5	34.2	22.1	22.8	17.7	28.0	23.6	17.4	0.9	16.1	11.3	16.9	17.5	10.6	32.7	29.1	17.2	29.1	26.4	27.6	26.0	23.6	17.7	17.1	38.7	48.8	182.3	139.8	129.1	56.0	138.4	114.7	85.6	58.0	130.9	21.6	278.6	339.8	261.6	30.0	159.5	164.2	116.8	326.4	297.6	155.1	145.6	72.7	225.1	217.4	35.0	133.6	149.8	133.3	39.7	177.2	143.5	170.4	318.4	137.1	65.9	279.8	125.8	160.1	483.6	62.7	187.5	150.4	81.2	152.0	140.6	170.8	107.6	173.2	145.0
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		1300000	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.2	14.4	21.3	23.6	15.7	16.2	24.0	19.6	16.7	23.0	24.4	27.3	25.7	40.3	11.7	13.1	30.1	16.0	44.7	30.8	33.6	21.1	26.6	60.8	17.2	17.8	21.5	33.7	16.0	14.3	21.6	27.1	39.9	11.7	21.7	32.6	70.6	25.9	20.7	14.5	35.6	22.6	46.6	44.2	17.0	29.7	39.8	57.0	18.4	16.2	22.7	20.5	27.2	21.4	25.4	20.6	27.2	21.7	15.9	15.6	18.7	13.5	21.0	25.8	35.6	44.0	16.4	39.7	23.1	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7	17.9	17.5	28.9	32.0	40.9	17.7	16.9	2.5	14.7	26.1	14.0	33.4	35.3	19.9	22.6	9.1	20.1	11.8	0.0	20.8	29.3	16.6	18.9	7.0	17.1	21.0	4.8	12.6	16.5	18.7	2.2	16.1	16.9	11.8	17.2	15.1	12.9	24.5	10.5	17.0	11.3	25.4	12.9	25.0	50.8	27.2	40.1	21.4	17.5	20.8	38.9
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761023	"Predicted intracellular proteins"	"Protein biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 317.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.2	17.0	12.3	10.5	13.6	8.2	9.2	10.7	19.8	7.3	9.7	11.2	6.4	5.8	5.9	8.9	10.1	9.1	7.0	31.3	10.7	10.8	21.4	21.8	5.3	6.8	15.8	11.1	12.1	6.8	14.6	8.4	9.9	10.6	5.9	9.9	7.8	7.7	7.1	22.7	8.5	6.3	8.1	22.6	6.9	7.4	7.8	10.4	10.5	7.7	18.9	9.3	8.0	5.8	9.1	17.0	1.5	13.2	6.8	6.8	8.3	8.8	6.9	9.9	9.5	14.5	14.0	8.6	11.7	15.3	20.8	16.3	11.6	14.5	12.0	3.1	12.1	12.7	8.3	21.2	22.4	22.3	6.7	13.0	5.5	9.6	23.9	14.2	11.3	5.5	14.4	14.4	20.0	7.0	12.0	15.4	17.1	21.4	10.5	15.9	9.7	14.1	12.2	10.1	7.4	13.0	12.0	9.5	9.5	18.8	7.4	10.3	11.4	9.4	13.0	13.7	10.0	11.0	8.2	8.4	10.5	5.7	7.2	8.0	12.6	16.3	10.0	14.7	10.0	7.6	0.7	9.4	1.5	4.0	13.2	6.3	9.1	5.3	5.6	17.0	8.2	6.8	6.4	0.9	6.8	9.4	6.7	5.4	8.3	12.3	13.6	10.7	19.8	10.7	10.8	15.8	11.1	10.6	10.4	8.9	3.7	2.2	5.5	0.0	8.7	58.8	0.0	2.7	6.8	10.4	7.9	19.7	23.2	8.8	5.7	2.9	2.6	0.0	6.4	13.2	7.4	2.9	1.1	13.6	15.4	9.5	2.4	2.5	6.5	6.0	4.9	5.8	0.0	13.6	5.9	317.1	6.9	6.5	4.2	14.9	13.6	6.5	3.6	12.2	12.0	0.0	11.2	1.5	8.8	2.6
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1105.8;Proximal tubular cells: 2889.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Group enriched"	"Detected in some"	4	"RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		Yes	NA		620000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.8	9.0	0.3	0.0	1.5	0.6	4.5	0.1	0.1	0.4	0.0	0.7	0.1	0.0	0.2	5.2	0.7	0.2	0.2	0.0	0.1	0.0	0.1	2.1	0.1	0.2	0.0	0.1	0.6	0.1	3.2	7.9	0.0	0.1	57.1	0.4	0.9	15.0	6.6	1.1	1.8	0.1	0.3	0.6	0.8	5.9	0.0	0.0	0.1	0.0	1.7	35.3	44.6	0.2	0.5	0.1	0.4	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4	3.0	0.6	33.0	12.7	48.2	8.6	29.5	191.1	2.7	5.7	68.0	0.0	1.0	250.4	36.2	7.4	7.8	4.2	23.3	255.7	0.9	9.9	3.9	3.5	1105.8	69.7	7.9	0.0	20.9	55.8	11.0	4.0	39.6	21.9	5.4	0.2	18.7	151.7	0.3	3.2	2889.0	4.0	6.5	11.3	22.9	7.4	116.9	1.5	6.9	0.4	15.5
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.8	2.3	5.9	33.9	12.3	10.0	4.2	12.7	13.4	9.7	8.2	5.1	1.0	2.8	6.0	5.7	5.7	5.2	5.9	9.0	2.2	1.2	10.8	6.2	7.4	20.3	20.1	10.9	8.1	11.7	5.5	6.4	14.1	3.1	7.9	11.4	15.7	3.3	4.5	7.8	11.4	20.2	2.5	13.9	9.4	12.0	1.3	16.2	12.2	7.0	12.3	8.4	9.9	16.1	6.8	2.2	12.9	5.3	5.9	9.8	5.3	6.5	4.4	10.8	5.3	5.8	6.7	10.2	10.2	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3	6.0	12.5	2.9	15.2	6.9	9.8	43.3	7.6	4.0	6.8	10.4	3.9	12.8	68.0	6.1	3.6	5.6	6.3	0.0	8.8	17.8	7.5	19.5	9.2	55.7	4.0	7.9	2.4	3.1	2.2	4.3	3.4	1.6	20.3	1.8	23.9	17.3	6.8	3.5	9.2	62.4	1.9	6.5	10.8	13.4	27.1	5.3	23.2	4.9	25.5	11.2
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891026-12914207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 102.5;Proximal tubular cells: 94.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (7.28e-5)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favorable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	12.5	12.1	11.4	8.6	13.3	8.2	9.5	11.5	14.0	9.5	10.5	15.5	8.6	9.1	11.7	7.3	9.1	10.5	7.5	19.8	9.3	8.0	20.2	62.6	6.3	12.1	15.5	14.1	13.7	12.3	7.9	8.7	4.9	9.7	10.4	6.9	9.6	14.7	9.7	17.5	6.6	8.1	8.2	8.7	8.6	11.3	4.9	11.8	13.0	10.9	13.7	9.0	12.0	6.6	10.9	14.5	7.2	8.1	21.7	20.6	12.3	11.2	6.3	6.8	12.5	9.9	5.0	6.3	8.4	5.0	9.8	7.5	11.5	4.8	16.3	15.9	4.6	4.9	7.1	9.3	7.2	4.9	14.0	9.9	10.5	10.9	14.1	11.4	19.7	8.4	6.3	9.0	6.9	7.5	4.0	8.4	19.3	25.4	5.1	4.9	12.3	23.1	17.3	7.7	9.8	16.2	22.1	6.9	31.7	5.7	5.2	15.0	9.0	11.8	10.4	7.2	4.5	8.0	13.1	6.0	8.0	6.0	14.9	8.1	27.5	13.9	17.2	5.6	22.6	6.9	7.2	8.1	4.6	11.7	7.1	11.6	10.7	15.0	13.7	14.5	10.9	20.6	15.5	2.0	21.7	5.3	8.6	12.5	12.3	11.4	13.3	11.5	14.0	9.3	8.0	15.5	14.1	9.7	11.8	3.0	4.0	29.5	12.5	7.0	13.8	9.2	20.4	6.7	1.2	10.4	23.6	13.5	44.7	12.0	2.2	4.9	11.4	23.3	9.8	18.6	8.7	10.2	6.9	102.5	18.9	7.9	15.0	13.5	13.0	1.2	12.0	6.9	16.9	27.1	10.8	16.7	9.8	8.6	12.0	94.5	12.2	0.0	7.8	7.2	6.4	4.5	13.6	15.0	19.3	11.8
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74321130-74488872	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.8	11.2	19.2	3.8	25.9	2.1	5.6	24.9	48.3	3.2	2.9	7.6	1.1	3.2	5.4	5.7	5.3	3.7	3.4	2.8	17.6	21.4	5.3	2.0	3.2	3.7	16.5	19.2	8.2	10.8	12.3	16.4	2.3	23.3	5.6	3.6	3.7	2.9	5.4	2.6	2.1	3.0	3.9	14.6	2.9	3.2	5.4	9.6	0.7	7.5	0.5	3.4	3.8	1.8	2.7	1.7	2.8	7.2	1.9	4.6	1.4	2.3	7.7	12.0	2.7	1.0	0.9	1.2	1.0	5.7	6.1	7.0	4.1	2.7	9.2	1.4	1.3	6.4	4.0	6.4	3.9	11.9	7.9	2.0	4.8	4.3	7.9	1.3	3.9	9.9	2.9	1.3	2.9	6.2	0.7	0.7	3.9	2.3	0.1	3.6	2.9	8.0	0.6	13.9	12.5	10.6	4.1	5.7	1.7	2.0	7.2	11.8	28.9	7.1	2.7	6.0	3.6	11.9	1.3	0.1	8.9	4.1	2.0	2.8	6.1	5.7	4.5	4.0	0.2	9.3	0.0	1.7	2.8	1.5	4.3	1.8	2.7	1.6	1.9	1.7	1.9	1.3	1.6	0.0	1.9	7.2	0.0	4.6	1.4	19.2	25.9	24.9	25.8	17.6	21.4	16.5	19.2	23.3	9.6	6.0	3.2	3.5	6.4	1.5	42.1	4.8	5.1	4.0	3.4	3.5	45.2	0.4	8.3	4.1	4.4	6.4	2.4	0.0	5.2	0.3	2.9	3.7	17.3	1.6	4.1	44.5	19.5	5.5	4.0	0.5	3.7	4.9	1.7	1.0	2.0	18.0	3.6	0.3	5.3	5.0	45.4	0.0	6.6	14.2	11.7	1.1	0.0	1.5	1.4	3.3
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 165.5;Enterocytes: 236.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.4	18.3	15.0	12.2	6.3	12.7	19.5	13.3	13.0	18.8	15.4	26.3	19.2	6.4	18.2	9.9	11.0	17.3	11.4	17.6	11.9	20.0	23.4	8.9	18.0	29.8	11.5	12.9	16.8	8.1	13.7	16.4	14.8	11.9	8.8	13.9	13.8	21.6	13.6	27.0	14.6	13.9	24.1	9.7	18.3	32.1	11.5	20.9	19.1	9.0	13.2	12.6	18.0	38.4	14.2	8.1	18.3	13.8	8.1	18.3	20.4	10.2	22.9	36.7	19.8	18.5	6.1	8.8	15.4	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8	3.0	7.0	36.5	18.9	14.2	10.7	14.9	25.5	8.1	1.2	8.7	0.0	34.0	29.9	38.0	165.5	17.1	236.0	23.3	70.3	48.9	16.9	17.7	12.7	53.9	39.8	7.9	26.2	20.9	29.7	100.1	16.1	25.1	21.9	45.1	48.7	7.8	54.6	92.1	11.7	50.8	7.9	12.9	18.9	45.9	23.0	12.9	31.4	35.2	62.4	23.3
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
GFM2	"EFG2, FLJ21661"	ENSG00000164347	"G elongation factor mitochondrial 2"	Q969S9	5	74721204-74767371	"Predicted intracellular proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.7	23.8	14.7	8.7	22.4	12.1	13.1	14.2	24.8	10.7	12.8	12.7	17.8	8.3	12.3	16.8	13.0	21.6	8.7	29.5	18.5	15.6	21.9	30.8	9.1	10.3	13.8	18.1	11.6	12.9	19.8	24.9	12.9	20.4	12.5	15.3	11.6	15.7	11.2	26.4	10.5	10.3	10.4	11.7	10.3	16.3	13.7	10.4	18.0	12.3	12.8	14.2	12.3	12.6	8.3	6.1	17.1	9.8	15.6	7.4	4.6	19.4	16.6	14.0	26.6	10.7	14.5	14.3	21.4	13.0	21.9	23.4	18.2	12.7	20.1	22.9	11.3	34.4	16.3	28.2	29.9	28.5	17.7	16.6	11.9	16.8	12.4	13.6	11.6	13.1	16.3	13.4	17.3	20.8	15.6	14.8	19.9	19.9	16.8	24.8	10.9	16.0	7.1	5.8	7.2	15.1	20.1	22.9	22.9	16.0	12.4	23.7	12.8	24.7	19.0	21.1	15.9	16.5	20.2	11.8	8.4	14.4	10.6	13.5	9.8	18.7	20.4	12.8	16.6	12.8	17.1	6.3	8.0	6.6	6.5	6.4	8.3	5.4	7.2	6.1	7.0	7.4	7.2	3.3	15.6	9.8	4.0	6.2	4.6	14.7	22.4	14.2	24.8	18.5	15.6	13.8	18.1	20.4	10.4	11.9	11.7	3.9	6.5	5.4	9.7	10.0	5.1	69.6	6.8	7.0	5.9	15.7	18.3	8.3	5.7	5.8	7.8	23.3	4.6	13.5	5.0	5.3	2.3	19.6	8.4	15.9	5.2	6.7	9.8	1.4	6.6	5.5	8.5	25.2	8.9	12.0	7.6	8.6	7.1	8.4	8.0	0.0	5.2	15.4	9.5	6.0	13.4	4.6	9.0	6.5
GHITM	"DERP2, HSPC282, My021, PTD010, TMBIM5"	ENSG00000165678	"Growth hormone inducible transmembrane protein"	Q9H3K2	10	84139440-84153245	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 1967.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016464, HPA061664"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA016464: AB_1849656, HPA061664: AB_2684579"	"unprognostic (6.26e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (5.71e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (2.32e-10)"	"unprognostic (2.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	28.7	50.7	46.0	21.9	53.3	25.3	26.0	30.9	62.7	21.4	45.5	20.2	23.9	43.3	21.2	24.5	30.0	19.9	21.8	94.9	40.8	42.8	80.5	71.6	19.2	23.2	45.2	42.4	20.7	25.1	29.9	24.0	20.9	62.8	22.6	46.0	24.3	26.0	24.5	87.6	19.9	35.6	28.9	24.6	20.1	30.1	41.7	17.5	21.5	29.3	47.6	26.6	26.1	19.1	46.8	63.7	60.6	67.5	44.4	51.6	106.0	42.0	43.7	18.7	42.8	32.2	28.7	33.3	29.0	51.3	37.7	35.4	53.1	35.0	33.3	32.7	38.3	33.2	38.0	39.7	38.0	36.5	33.2	30.1	23.6	45.7	52.3	61.0	73.5	38.8	32.3	74.7	38.9	113.5	39.3	32.5	28.6	54.7	62.3	34.6	36.7	26.0	58.8	18.9	34.4	39.0	23.7	17.2	50.0	52.3	33.9	15.3	17.9	29.3	25.7	58.6	22.6	52.5	47.3	27.5	18.4	24.7	26.7	46.7	44.1	48.0	37.4	48.3	68.2	12.7	52.6	64.3	60.6	42.2	67.5	47.1	46.8	44.2	44.9	63.7	37.2	41.5	44.4	51.3	44.4	59.6	33.0	51.6	106.0	46.0	53.3	30.9	62.7	40.8	42.8	45.2	42.4	62.8	17.5	89.3	83.5	136.2	153.4	151.3	140.5	659.4	145.2	87.0	79.6	150.1	66.8	215.6	490.7	245.2	963.4	127.2	319.8	303.7	203.3	204.3	113.7	156.4	99.3	296.0	241.3	95.3	120.5	81.0	150.4	1967.2	102.1	154.3	155.3	237.2	171.1	217.8	200.8	261.9	128.7	653.0	105.3	142.3	188.3	222.7	145.0	148.9	322.8	152.2	238.2	177.5
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573469-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.6;Late spermatids: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		53000	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	13.0	8.5	34.0	11.1	38.1	8.0	9.4	18.9	43.4	7.8	9.8	15.6	2.2	11.6	10.0	5.3	13.2	14.0	10.2	12.2	41.5	16.4	7.0	3.7	12.0	12.6	19.2	21.8	13.6	14.3	10.2	8.1	13.8	15.0	8.4	6.9	7.8	11.9	10.3	10.0	20.2	10.9	8.7	11.9	11.1	9.5	42.9	19.8	10.8	11.0	4.5	9.7	9.8	7.5	1.8	4.7	3.0	6.0	5.6	4.9	3.6	17.5	29.4	14.5	25.8	11.6	7.3	16.8	8.7	8.6	10.5	9.4	11.9	6.6	13.3	14.0	11.4	18.8	29.1	15.2	22.4	5.4	17.1	18.2	9.6	14.4	10.6	14.1	12.1	7.9	8.9	25.8	12.1	18.9	15.0	19.5	17.8	7.8	11.5	7.5	18.1	38.2	16.3	10.8	17.8	7.0	29.1	19.4	19.9	9.5	9.7	30.5	26.1	12.3	28.6	43.0	10.8	14.0	16.2	24.0	10.0	14.5	22.0	17.5	9.6	13.2	14.5	16.5	10.4	16.8	0.3	3.6	3.0	4.7	6.0	2.2	1.8	4.5	4.9	4.7	1.7	3.7	2.7	1.2	5.6	3.7	4.0	2.9	3.6	34.0	38.1	18.9	43.4	41.5	16.4	19.2	21.8	15.0	19.8	3.0	1.0	13.7	6.2	24.2	14.0	7.6	0.0	8.1	1.2	5.2	9.8	4.4	1.7	7.1	78.6	27.4	16.3	0.0	8.1	6.7	8.8	8.0	1.1	2.1	7.3	11.1	14.3	14.7	7.8	70.1	13.3	9.2	8.5	4.6	14.3	9.7	8.1	10.5	9.9	5.0	9.3	12.9	5.1	10.4	10.9	24.6	3.0	7.7	13.7	6.7
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.4	43.7	0.0	0.2	0.0	0.3	8.7	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.6	0.5	6.0	0.0	0.0	0.6	0.0	3.2	0.0	0.4	0.3	0.0	0.1	22.7	4.3	0.0	0.0	2.4	0.0	50.8	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2	3.0	0.0	0.8	8.0	62.0	0.0	0.4	5.1	0.0	3.4	1.8	0.0	0.0	0.0	3.5	0.7	0.2	19.0	0.0	8.8	0.2	1.6	7.8	0.0	24.2	0.7	0.0	4.1	0.0	0.8	0.9	0.0	1.2	1.7	8.2	3.9	0.0	8.1	15.0	0.0	14.7	0.0	0.0	2.0	0.2	0.4	25.1	0.1	0.0	19.7	15.6
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		78000	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.4	4.2	8.2	7.8	0.8	7.4	9.9	5.8	11.0	2.9	10.0	2.4	3.7	6.0	7.3	6.0	5.2	4.8	11.8	0.9	5.7	4.0	6.7	3.0	7.9	1.7	8.2	5.3	3.3	7.1	8.1	4.2	50.9	1.8	1.6	2.6	10.8	2.4	1.0	3.0	1.2	4.0	2.5	2.4	9.8	3.0	5.3	4.2	7.7	1.6	7.6	4.7	15.7	1.7	3.4	2.4	17.7	5.6	6.9	6.1	6.5	1.1	1.5	0.5	5.6	2.9	8.0	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6	0.0	12.5	5.7	9.1	4.2	10.3	6.2	7.6	25.4	5.7	10.4	9.8	20.3	5.0	10.4	3.2	13.9	15.7	0.0	12.1	9.9	5.9	4.9	2.3	24.6	13.5	7.9	19.5	16.5	14.6	3.3	5.8	7.7	8.5	11.8	26.4	12.9	12.9	23.4	16.6	14.0	15.4	12.9	3.9	13.0	13.4	5.6	27.6	4.4	26.5	12.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.6	7.2	0.0	0.1	66.8	0.0	0.0	0.0	0.0	15.9	0.1	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.3	3.8	0.0	0.0	10.6	0.0	0.0	14.5	0.0	0.0	0.5	0.0	0.2	2.7	1.2	0.0	0.1	0.3	0.3	0.2	0.0	7.8	1.2	1.2	0.3	0.0	0.1	27.7	0.3	6.4	3.3	0.0	6.2	0.0	4.1	1.4	0.0	0.9	0.1	0.2	0.8	0.3	0.3	9.2	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8	0.0	0.0	4.3	0.0	0.0	0.3	0.6	7.6	0.0	0.0	29.6	0.0	59.4	5.0	0.0	8.8	0.0	0.0	0.0	0.2	35.6	0.0	0.0	0.0	126.2	6.1	0.0	0.0	3.1	2.1	9.0	0.3	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	29.3	0.2	0.0	0.3	4.4	5.0	0.0	38.4	0.5	0.0	0.0
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761750-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.2;kidney: 10.2;liver: 7.8"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 11.6;Enterocytes: 17.1;Paneth cells: 10.5;Proximal tubular cells: 31.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;Hep G2: 2.2;K-562: 1.9;MCF7: 6.5;SCLC-21H: 1.3;T-47d: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010667	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.2	0.0	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.4	14.7	0.2	0.2	10.3	0.4	5.6	0.3	1.6	3.5	0.2	0.2	0.0	10.2	7.8	1.5	0.2	0.2	0.2	0.4	1.1	0.0	0.6	0.2	0.2	0.4	5.7	1.5	0.6	0.2	0.2	0.1	25.2	0.2	0.2	0.2	1.3	0.7	0.2	0.4	1.9	0.2	0.5	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.3	0.4	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	1.6	0.0	0.4	0.0	0.2	0.0	2.5	4.0	0.0	7.0	0.0	0.0	11.6	0.4	0.1	0.0	17.1	0.0	0.8	0.1	0.0	0.5	0.0	6.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.3	0.3	1.2	10.5	0.0	31.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.5
GLRX5	"C14orf87, GRX5, PR01238"	ENSG00000182512	"Glutaredoxin 5"	Q86SX6	14	95533503-95544724	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 439.3;Erythroid cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042465, HPA063716"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042465: AB_10794048, HPA063716: AB_2685102"	"unprognostic (2.57e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.83e-10)"	"unprognostic (1.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	13.7	24.1	19.3	11.2	16.9	54.8	9.7	10.5	17.3	7.4	16.6	7.7	8.1	17.6	9.1	10.8	10.7	8.4	12.6	45.3	16.1	14.5	22.5	43.3	7.7	8.4	15.5	9.5	15.8	19.1	8.3	9.4	27.3	10.4	9.9	9.9	13.3	11.6	11.0	68.8	7.9	15.7	12.6	8.3	9.1	12.8	24.2	7.1	19.9	14.8	25.6	9.7	10.0	10.8	6.0	9.9	5.5	4.5	4.8	8.7	3.0	14.0	18.9	8.7	11.5	8.5	6.3	39.3	10.4	6.8	9.0	8.6	24.7	15.4	20.3	15.4	5.2	5.5	14.2	12.9	10.4	7.5	13.3	19.5	17.4	12.1	36.8	9.7	27.7	18.6	7.7	8.6	6.4	9.0	4.1	9.0	15.0	20.6	16.0	6.3	39.5	21.8	28.2	14.8	11.1	21.1	39.8	30.9	12.1	9.9	17.0	23.1	14.4	9.9	12.6	14.2	7.7	19.4	11.9	10.7	5.7	12.7	13.9	14.6	8.7	10.3	15.4	12.5	16.8	13.2	1.0	3.5	5.5	5.2	4.5	6.1	6.0	6.4	7.7	5.4	5.8	5.9	5.8	2.2	4.8	2.7	9.9	8.7	3.0	19.3	16.9	10.5	17.3	16.1	14.5	15.5	9.5	10.4	7.1	26.8	28.8	35.7	48.6	96.4	37.5	144.4	68.8	8.1	12.5	90.7	31.4	78.3	439.3	9.8	246.8	42.7	50.7	490.6	13.4	138.0	62.7	73.1	14.9	132.8	51.0	47.7	51.9	30.7	26.9	69.9	50.3	48.4	82.7	7.2	63.3	72.3	13.6	31.6	69.3	215.3	32.2	58.2	72.1	35.6	88.2	109.2	45.0	39.2	74.7	69.4
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880827-190965552	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 127.9"	"Cell type enhanced"	"Detected in all"	6	"Collecting duct cells: 371.6;Proximal tubular cells: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 141.8;RPTEC TERT1: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		25000	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	16.5	37.3	37.8	20.4	24.7	10.7	34.3	43.8	47.3	11.9	13.1	5.8	8.9	36.9	14.6	11.9	7.6	11.0	17.7	15.7	23.3	22.8	127.9	5.3	22.6	25.4	20.6	36.8	14.1	17.0	26.4	10.1	14.8	35.1	9.4	13.1	10.8	9.0	13.9	7.4	13.0	40.9	15.5	11.7	19.3	8.7	6.9	12.1	15.0	17.7	8.0	22.9	14.1	16.1	5.2	5.0	6.0	2.1	3.9	9.4	1.5	6.4	7.1	5.0	6.6	15.7	11.0	13.0	19.2	14.6	14.0	16.1	8.7	6.4	13.2	141.8	40.5	7.1	8.4	8.8	7.5	20.6	32.5	5.7	21.9	10.5	10.7	14.4	12.7	10.3	9.9	7.9	11.0	7.5	14.0	18.1	5.5	10.1	26.9	31.1	3.4	8.6	12.3	13.4	3.8	11.7	11.0	12.9	11.4	65.2	11.8	6.9	7.2	26.2	5.8	24.4	18.7	2.3	7.9	12.9	20.3	14.9	10.1	23.2	8.7	19.8	18.1	7.3	10.5	16.1	6.0	1.5	2.5	5.5	2.1	9.4	4.8	6.5	7.0	2.2	5.2	6.8	8.1	3.0	3.9	1.4	5.0	5.6	1.5	37.8	24.7	43.8	47.3	23.3	22.8	20.6	36.8	35.1	12.1	175.7	95.7	52.1	47.3	155.0	91.0	32.2	30.6	16.0	40.9	371.6	198.3	3.3	43.1	22.6	4.4	51.8	120.5	23.3	20.9	10.2	63.7	42.0	35.8	4.9	25.8	25.4	56.7	57.7	27.2	3.6	26.4	55.5	84.4	88.4	25.7	10.0	29.5	31.6	40.7	372.1	117.6	19.4	70.9	10.7	11.0	142.3	3.3	62.3	28.1	52.1
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694488-52706032	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	18.6	23.7	16.1	14.5	20.9	4.7	21.0	15.3	19.9	29.3	17.3	18.3	22.1	14.6	23.5	26.8	14.1	31.9	19.9	19.3	16.6	17.0	23.2	39.4	16.8	16.0	17.9	14.4	32.4	23.6	24.3	40.8	34.7	18.1	21.1	18.9	19.7	22.0	25.2	11.5	13.0	15.2	18.7	17.4	14.8	16.0	43.3	21.6	17.5	37.8	11.6	14.7	21.8	16.8	8.6	15.7	20.5	8.4	20.1	16.3	6.6	8.1	9.7	19.7	15.5	43.7	55.6	11.0	20.6	31.9	18.2	20.9	4.5	15.5	6.9	5.9	35.7	22.0	9.3	12.4	21.1	24.1	12.4	9.0	6.5	17.8	20.6	21.0	9.7	20.5	31.9	18.8	15.6	20.2	42.3	27.0	12.0	8.3	16.0	23.8	8.3	6.5	14.9	10.0	14.4	18.2	5.0	11.2	23.3	21.2	8.9	8.1	13.9	17.1	8.4	13.9	19.2	14.1	12.8	19.7	13.2	10.3	19.1	11.4	18.1	20.5	7.7	23.1	15.5	16.6	20.5	8.4	14.1	13.3	5.7	13.2	8.6	16.0	14.3	8.1	6.4	16.3	11.5	4.8	20.1	6.0	15.7	10.6	6.6	16.1	20.9	15.3	19.9	16.6	17.0	17.9	14.4	18.1	21.6	0.0	8.1	11.5	17.3	10.8	37.5	11.3	7.6	33.5	15.9	17.4	11.8	47.2	19.9	28.5	40.0	19.6	13.1	0.0	23.8	55.2	49.3	12.9	5.7	29.3	23.5	20.6	17.9	35.0	14.5	13.6	49.8	10.6	23.6	34.3	18.6	33.9	21.1	19.2	45.6	19.8	17.9	25.8	15.9	90.1	50.7	6.9	21.9	21.5	17.5	6.7
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 357.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.1"									"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		26000000	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.5	19.8	15.6	26.4	29.7	36.6	17.1	19.4	33.6	18.8	20.7	45.8	24.1	27.6	15.9	28.3	10.8	38.7	20.3	19.5	20.2	19.9	16.0	13.4	11.9	108.1	66.3	31.3	19.4	25.2	36.9	20.9	62.6	28.7	22.4	21.8	13.5	25.0	20.3	17.8	28.2	28.1	17.8	26.7	16.0	21.4	19.9	18.0	54.1	20.1	8.0	15.0	17.4	13.8	24.7	15.7	19.0	22.1	22.2	9.8	8.7	19.8	19.7	15.0	15.4	33.0	23.6	35.9	5.8	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2	20.8	19.2	40.4	53.0	94.2	20.7	49.8	53.5	17.4	45.5	57.6	35.3	77.3	132.6	27.7	11.2	45.6	54.7	46.7	29.4	52.4	55.2	96.0	43.7	357.2	63.1	14.3	37.8	50.3	67.1	18.7	81.4	68.2	99.5	30.7	44.6	133.3	37.2	42.1	85.2	119.8	60.1	64.7	76.2	9.6	6.4	107.0	39.8	55.4	40.7	75.9
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell type enhanced"	"Detected in some"	6	"Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	1.7	0.0	0.0	1.6	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.3	0.3	2.7	5.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	2.7	1.7	0.1	1.8	0.0	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.2	0.5	0.0	0.0	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.9	1.1	0.1	2.1	0.0	0.0	0.1
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Late spermatids: 6809.8;Muller glia cells: 5699.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		28000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	3.0	1.2	14.0	0.0	141.5	100.1	10.3	5.1	16.6	3.1	2.8	7.4	3.1	2.6	5.6	9.9	2.8	7.0	6.1	36.4	2.6	7.0	17.0	34.3	5.8	14.3	7.5	15.1	27.4	86.5	43.7	3.9	46.4	4.7	6.2	8.4	28.8	1.5	11.0	1.7	23.5	14.5	10.4	4.2	6.5	8.5	3.7	4.4	5.4	13.3	9.6	6.3	1.4	18.7	2.0	11.7	18.2	19.1	4.6	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.7	8.6	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2	116.1	193.4	39.3	480.1	119.7	83.9	198.1	163.1	242.2	133.1	78.5	49.1	126.6	63.0	92.2	1437.2	175.0	45.7	210.2	99.7	54.7	230.2	354.1	758.5	179.4	734.4	41.3	312.5	129.5	692.2	6809.8	451.3	662.6	129.9	48.7	226.1	5699.1	116.5	83.4	352.5	40.4	128.3	90.5	209.3	38.8	52.4	112.0	196.8	96.9	130.8	1061.5
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 2.2;Glandular cells: 1.9;Melanocytes: 1.7;Sertoli cells: 6.5;Suprabasal keratinocytes: 1.8;Urothelial cells: 1.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.2;HAP1: 6.6;SK-BR-3: 15.8;U-2197: 7.6"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favorable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.1	0.0	1.9	5.9	2.6	4.2	0.0	0.0	0.2	0.0	1.6	1.2	0.5	6.6	0.0	2.2	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	2.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.8	0.0	0.0	0.0	0.0	0.0	2.2	0.1	7.6	2.3	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	6.5	1.0	0.0	0.0	1.8	0.0	0.0	0.0	1.8
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701466-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"	28.7	23.8	10.3	13.8	9.4	0.0	49.4	5.1	7.7	28.3	34.5	10.9	16.6	40.1	41.5	20.7	34.0	21.2	27.2	14.2	11.8	9.3	36.1	15.4	16.4	12.4	9.1	6.3	24.9	16.0	23.9	17.1	40.1	14.3	21.4	22.2	14.6	16.4	19.3	9.0	33.0	86.2	51.8	22.9	17.5	19.5	11.6	9.6	3.6	23.1	20.5	16.5	31.5	26.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.0	9.4	10.0	5.4	42.8	37.2	10.3	31.1	40.6	27.5	24.8	4.4	9.9	0.0	13.3	43.5	17.2	7.5	6.2	25.5	48.5	0.0	4.8	0.1	8.4	0.0	17.1	0.0	0.5	22.3	15.3	29.3	38.9	38.7	43.1	0.0	0.5	0.0	30.1	1.7	0.0	0.0	7.6	11.0	11.7	0.0	20.7	0.1	26.4	9.0	2.3	4.6	21.5	9.0	41.7	8.9	4.6	0.1	55.4	32.0	20.9	57.5	19.1	0.5	0.0	0.0	20.2	1.2	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.3	9.4	5.1	7.7	11.8	9.3	9.1	6.3	14.3	9.6	50.6	25.1	2.4	66.8	178.8	1.5	25.9	48.4	69.6	34.2	55.8	5.9	52.0	63.0	84.4	7.6	66.7	171.8	0.0	120.2	89.1	65.8	79.6	3.5	38.9	22.5	3.2	33.4	86.0	16.9	10.4	66.2	12.4	74.2	6.4	58.8	1.3	115.9	90.3	71.1	129.0	17.2	51.8	74.6	1.7	24.7	189.6	147.1	4.3	51.3	91.1
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	25.2	35.3	23.0	15.9	25.5	32.1	20.0	19.9	43.7	23.6	24.4	27.1	32.3	28.2	26.3	38.3	23.2	24.0	31.1	35.0	20.3	17.4	29.3	47.2	24.9	31.4	19.9	19.0	23.8	46.6	36.4	17.1	32.9	25.1	23.1	10.7	27.4	46.0	35.4	28.5	23.3	31.0	16.3	22.3	21.9	23.0	24.6	16.1	24.0	29.0	22.2	18.6	19.3	18.6	17.2	41.0	21.7	33.3	24.7	34.5	26.1	16.4	29.1	6.8	21.3	15.8	13.5	23.7	16.9	16.8	14.2	14.8	12.0	27.3	9.0	24.7	18.3	6.7	20.5	4.5	16.8	2.1	15.1	15.3	14.1	13.6	8.8	15.3	6.9	21.3	14.8	15.7	14.5	10.1	11.5	11.7	15.3	10.2	31.9	13.6	57.9	13.3	6.4	6.8	19.4	70.8	9.3	8.6	42.8	12.3	11.6	11.8	16.2	22.1	28.5	12.4	3.9	18.3	19.5	7.7	13.2	23.0	7.5	18.9	17.8	13.7	5.9	23.4	8.5	17.9	11.8	24.8	21.7	34.5	29.9	23.7	15.5	17.4	27.1	23.1	17.2	17.3	24.1	5.8	24.7	33.3	41.0	15.0	26.1	23.0	25.5	19.9	43.7	20.3	17.4	19.9	19.0	25.1	16.1	35.7	40.2	43.2	39.6	25.5	57.0	39.1	40.8	26.8	11.4	41.8	60.9	106.7	21.6	110.5	4.7	29.4	99.5	0.0	78.8	116.9	52.6	52.7	65.6	67.2	78.9	52.4	54.6	43.0	45.7	6.6	37.4	40.2	69.2	59.5	47.2	94.2	69.6	80.7	35.3	71.5	53.5	58.2	37.1	132.9	51.7	19.4	91.4	48.0	73.6	37.1
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 165.5;Horizontal cells: 42.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 76.6;Hep G2: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.8	2.1	2.9	3.8	76.6	2.8	3.8	2.7	3.1	1.9	1.5	5.0	1.7	2.0	1.5	1.9	1.8	3.6	4.6	2.3	3.7	1.4	2.4	1.8	2.3	20.6	2.3	3.2	1.0	13.4	3.9	3.5	7.1	15.0	1.7	2.8	2.3	1.8	2.2	1.6	2.7	2.5	2.4	1.6	3.0	2.7	7.6	1.4	1.3	1.9	1.2	3.6	3.7	1.8	4.2	2.8	1.8	1.1	1.3	2.3	1.4	2.8	4.2	1.8	2.0	4.2	2.6	2.8	1.7	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2	8.9	19.0	7.8	0.6	0.3	5.8	15.7	17.8	5.3	5.7	5.2	9.8	4.6	1.7	2.5	0.4	4.5	1.7	0.0	2.8	2.1	2.5	1.2	2.3	165.5	2.5	42.9	1.2	5.5	8.9	0.4	4.9	2.1	1.7	0.0	3.8	6.0	2.6	2.9	11.3	2.7	8.9	6.5	1.9	2.9	3.2	0.1	1.6	3.2	4.5	0.5
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0"	"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.0	17.5	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5											0.0	0.6	2.4	0.6	0.9	0.7	1.6	2.5	0.0	0.0	1.8	0.0	0.1	1.7	1.7	1.5	2.9	0.4	0.0	1.6	0.2	2.2	0.5	1.1	0.0	2.2	7.9	0.0	6.7	1.0	4.3	0.6	1.0	1.7	1.0	0.7	0.9	0.8	0.6	0.0	0.0	0.2	97.0	18.3	27.9	16.8	0.1	0.1	0.7	1.3	1.6
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395284-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	8.6	8.5	7.1	12.0	9.3	11.9	7.7	22.2	11.7	8.3	6.5	9.9	6.4	6.9	10.2	4.7	8.5	7.4	6.7	8.1	7.8	5.6	6.4	4.8	7.5	10.0	8.7	6.8	11.2	7.7	14.7	18.1	11.0	9.0	7.1	7.5	9.2	9.1	5.8	21.0	8.3	8.6	8.0	8.3	9.3	6.5	7.6	10.1	9.6	7.7	3.8	9.5	11.6	12.8	10.1	9.6	10.3	16.0	12.4	13.2	6.1	10.4	7.5	8.9	8.6	5.8	7.9	8.8	8.6	10.2	10.7	11.3	10.3	7.0	13.1	5.0	10.6	8.6	6.9	11.9	8.1	13.1	15.5	7.7	15.4	7.0	5.7	4.2	12.7	10.4	8.1	4.4	11.3	10.6	6.9	8.7	8.9	10.5	11.1	6.4	3.3	16.2	1.1	6.0	3.7	7.4	14.5	11.6	9.2	1.5	7.6	8.4	6.5	10.1	4.4	5.9	8.1	6.2	7.0	7.0	6.7	6.1	10.0	10.1	11.5	10.1	14.2	7.5	5.0	6.7	10.3	8.2	6.7	13.2	7.9	12.4	10.1	10.4	9.4	7.9	9.7	9.7	9.7	6.4	12.4	16.0	9.6	5.2	6.1	7.1	9.3	22.2	11.7	7.8	5.6	8.7	6.8	9.0	10.1	20.8	23.8	50.6	42.6	43.3	67.0	29.0	25.5	30.8	42.1	24.4	115.8	36.1	8.3	27.4	11.0	37.3	24.2	0.0	21.4	32.6	47.0	35.6	40.5	17.1	20.3	138.2	37.2	35.0	27.8	3.4	58.4	36.3	21.9	33.3	16.6	56.6	26.2	21.0	40.7	10.2	119.5	51.8	45.7	62.6	70.0	40.9	44.6	77.1	24.9	50.3
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		7600000	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	12.7	5.5	19.6	12.4	21.4	11.4	15.2	23.1	16.3	10.9	17.6	8.8	8.1	13.7	9.1	5.0	23.1	18.4	8.6	6.2	18.7	12.7	7.7	3.4	11.4	9.0	11.3	11.8	9.0	7.4	26.6	11.0	7.9	10.3	10.8	17.8	6.8	21.5	7.5	21.2	12.0	24.9	5.9	9.4	10.6	17.1	9.5	8.3	6.7	11.8	17.6	14.0	10.1	10.5	0.5	5.1	3.1	6.5	0.7	0.9	2.7	17.5	11.3	7.1	10.7	14.9	19.0	0.0	22.5	13.8	14.4	17.3	22.2	16.1	3.1	14.6	11.7	5.9	20.2	13.0	20.1	18.4	10.8	4.6	2.6	20.6	0.0	5.2	4.8	5.9	9.0	6.4	24.8	12.4	9.1	10.9	1.6	5.5	0.8	18.0	10.3	0.1	0.4	12.7	6.6	15.0	5.5	4.5	4.1	16.9	22.0	12.6	4.5	20.0	15.1	13.1	11.9	5.1	12.6	10.6	2.8	12.0	12.2	15.8	0.6	0.1	0.1	15.5	1.3	21.5	0.6	6.5	3.1	0.5	3.3	0.9	0.3	0.3	0.9	5.1	0.5	0.7	0.5	2.3	0.7	4.3	0.5	0.9	2.7	19.6	21.4	23.1	16.3	18.7	12.7	11.3	11.8	10.3	8.3	17.9	10.5	5.1	17.9	17.7	4.3	11.3	10.2	10.7	10.3	21.0	5.9	7.0	1.7	8.3	81.5	8.4	22.3	0.0	11.6	12.6	7.8	44.4	12.7	1.8	19.2	4.8	16.7	11.6	14.5	75.7	11.2	13.3	23.6	6.4	14.3	4.3	13.0	20.4	6.7	3.4	9.5	0.0	5.7	1.6	2.0	18.7	9.3	6.9	16.6	62.5
GPN1	"ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1"	ENSG00000198522	"GPN-loop GTPase 1"	Q9HCN4	2	27628247-27651508	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036793, HPA036794, CAB037303"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (2.88e-5)"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.50e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	24.3	24.3	18.8	18.7	23.2	28.1	26.3	22.9	27.2	18.3	21.6	20.7	13.7	19.3	21.3	21.2	26.7	21.0	18.2	21.5	17.2	22.1	29.7	29.2	18.2	29.2	20.0	16.1	24.6	35.4	19.8	18.5	31.1	23.3	18.8	25.6	14.3	23.0	17.6	30.9	25.0	25.3	22.1	16.4	26.6	20.8	30.2	15.9	29.0	26.9	22.5	28.3	21.5	24.3	29.1	35.8	28.5	28.2	39.6	38.6	29.7	32.7	18.6	17.6	12.7	16.6	17.0	17.9	18.3	18.3	26.0	19.3	20.3	17.2	20.5	17.9	20.0	24.1	14.3	24.4	22.8	26.4	19.1	17.0	23.4	15.0	24.7	21.6	34.3	12.3	17.5	20.1	26.7	25.1	18.1	27.1	18.7	29.0	19.3	30.7	19.1	20.7	25.7	30.4	25.0	18.4	20.9	52.1	21.4	21.0	18.9	15.7	24.9	20.1	22.6	20.3	17.1	13.6	19.9	22.0	22.7	33.6	11.2	42.9	22.3	24.0	55.2	32.7	29.8	18.6	28.5	24.7	21.1	33.4	28.2	36.0	29.1	31.1	38.6	35.8	25.2	27.7	34.1	3.7	39.6	26.3	18.5	30.3	29.7	18.8	23.2	22.9	27.2	17.2	22.1	20.0	16.1	23.3	15.9	11.9	7.2	7.2	18.2	19.3	7.9	9.7	17.8	10.7	14.8	14.0	3.9	36.5	19.9	46.3	69.8	14.5	10.8	0.0	31.4	38.5	20.1	18.3	24.3	8.6	29.3	11.1	16.7	15.4	18.9	67.5	13.8	19.3	21.9	33.3	13.3	12.0	35.5	10.5	10.3	15.6	9.1	12.9	20.8	26.2	22.6	16.3	27.7	33.0	19.5	16.6
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.1	25.2	0.0	33.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	44.8	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.1	13.2	0.0	0.0	5.6	0.1	0.0	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	127.1	52.7	0.0	0.0	0.0	4.0	20.5	3.5	0.0	46.3	0.0	1.3	0.1	0.2	0.0	0.0	0.6	10.3	2.1	36.4	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	59.6	171.4	0.0	0.0	178.7
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
GREB1	KIAA0575	ENSG00000196208	"Growth regulation by estrogen in breast cancer 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 74.9"	"Cell type enhanced"	"Detected in many"	18	"Leydig cells: 18.7;Peritubular cells: 51.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.2	2.0	3.0	0.6	5.0	0.5	11.1	1.3	5.4	13.7	0.5	2.8	3.0	0.7	21.3	15.6	0.6	11.2	1.8	2.3	3.9	3.0	1.3	1.5	0.6	0.6	3.9	3.5	74.9	2.9	0.6	5.0	9.4	3.8	19.2	0.5	2.8	0.7	2.4	2.1	1.2	0.6	7.3	3.2	0.4	0.8	10.9	3.2	0.0	0.5	0.5	0.5	0.8	5.7	0.8	1.0	2.8	0.6	1.0	1.3	0.4	0.0	0.4	15.1	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	2.6	0.1	1.1	0.0	0.0	1.8	1.3	0.0	0.1	14.3	0.1	0.1	0.8	0.2	0.8	0.2	0.1	0.1	0.0	1.4	0.1	0.3	0.1	22.4	0.4	0.7	4.9	0.0	0.0	10.4	0.0	0.6	0.0	0.0	4.4	15.3	0.3	0.4	11.1	2.1	51.8	0.2	0.0	1.5	0.7	0.1	0.0	2.2	1.5	8.8	2.6	4.3	0.4	2.6	0.6	0.8	0.7	0.3	0.3	0.5	0.5	0.4	0.4	0.8	0.5	1.3	2.8	1.0	0.5	1.0	0.5	0.4	3.0	5.0	1.3	5.4	3.9	3.0	3.9	3.5	3.8	3.2	0.0	0.3	0.0	1.7	0.7	3.1	7.3	7.6	5.3	1.2	0.0	2.0	0.1	0.0	0.4	0.5	1.4	0.0	0.0	0.2	2.1	5.1	9.8	3.5	6.0	2.5	3.2	0.0	0.6	0.0	1.3	18.7	0.3	5.0	0.0	0.0	0.2	0.5	0.0	51.9	1.9	0.3	0.0	0.8	0.9	1.5	0.3	0.2	0.0	0.0	2.6
GREB1L	"C18orf6, FLJ13687, KIAA1772"	ENSG00000141449	"Growth regulation by estrogen in breast cancer 1 like"	Q9C091	18	21242242-21525417	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 49.1;Leydig cells: 42.6;Peritubular cells: 33.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 22.1;BEWO: 44.8;CACO-2: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041647, HPA044218"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041647: AB_2677597, HPA044218: AB_2678859"	"unprognostic (1.88e-3)"	"unprognostic (9.01e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.32e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.30e-8)"	"unprognostic (4.72e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-1)"	5.0	3.2	12.5	0.8	5.9	0.8	5.5	2.3	4.5	2.5	1.1	4.0	25.0	0.8	4.9	12.4	0.9	6.7	0.8	9.2	5.5	3.9	1.3	3.9	0.7	0.7	5.6	2.6	7.2	0.5	0.9	3.1	5.4	5.8	3.8	0.7	1.0	1.3	14.2	15.9	2.5	1.5	2.1	2.8	0.6	1.7	12.0	3.0	0.0	7.4	0.0	0.5	0.5	1.7	0.2	0.2	2.8	0.1	0.0	0.6	0.0	0.0	0.3	22.1	0.0	5.1	0.0	44.8	1.1	1.0	1.8	1.7	20.1	1.6	0.0	2.3	3.3	0.0	4.2	8.5	1.0	3.2	0.3	4.2	0.0	5.4	0.1	0.1	0.0	0.0	0.0	0.3	0.0	4.1	0.2	0.0	0.6	0.0	0.1	4.4	1.4	0.1	0.1	2.1	0.2	2.7	0.0	0.0	0.8	2.1	3.7	1.4	0.0	0.0	0.7	0.1	6.0	1.1	0.0	9.2	0.2	1.3	2.1	0.0	0.0	0.2	0.0	0.9	0.0	0.1	2.8	0.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	12.5	5.9	2.3	4.5	5.5	3.9	5.6	2.6	5.8	3.0	0.0	0.3	0.0	0.1	0.1	49.1	10.6	0.0	4.0	1.2	3.5	2.0	1.3	0.0	0.1	6.6	0.1	0.0	0.0	0.4	11.2	1.8	0.4	0.0	3.0	0.5	0.0	0.0	0.0	0.0	11.7	42.6	0.0	1.7	0.0	0.0	0.7	1.7	0.0	33.6	0.0	1.5	6.5	0.2	0.7	4.7	0.6	1.3	0.0	0.0	0.1
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		7500	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5.0	10.9	8.0	6.0	11.0	6.6	9.3	6.2	8.0	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5.0	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.3	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.5	13.7	4.7	16.7	8.9	7.5	20.5	4.4	39.6	23.4	12.8	10.8	10.4	7.9	17.2	16.3	3.8	5.1	11.2	6.6	2.8	6.3	26.7	13.3	52.3	3.4	34.8	17.7	18.1	8.3	6.1	14.7	17.0	7.8	20.9	3.3	9.9	11.2	15.2	7.4	13.1	17.3	2.3	10.4	19.0	8.0	9.2	13.8	9.8	22.4	15.1	18.3	11.8	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9.0	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8.0	7.3	7.1	10.7	6.7	5.1	0.0	2.1	37.2	46.6	21.1	9.5	2.0	7.6	0.0	3.4	3.5	5.9	10.9	13.3	3.9	31.4	4.5	11.3	23.3	7.1	10.5	8.0	37.0	14.9	5.3	18.5	15.9	10.9	8.6	27.3	57.4	5.8	20.0	13.5	1.8	13.4	6.1	8.1	13.3	4.9	6.9	7.3	12.9	10.3	2.2	3.6	17.8	10.6	41.1	16.3	52.8
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.4"	"Cell type enriched"	"Detected in some"	168	"Cone photoreceptor cells: 310.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HeLa: 1.5;U-937: 1.8"					"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0.0		0.4	0.2	1.6	1.5	0.4	0.0	0.2	0.4	0.1	1.0			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0.0	0.1	0.1	0.6	0.4	0.0	4.1	0.1	0.0	0.0	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.2	1.5	0.2	0.0	0.4	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.4	0.2	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	310.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058906-7068197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036647	Supported		Supported	Mitochondria		NA	NA		1900000	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	14.7	35.8	11.5	7.3	10.8	20.7	11.4	10.6	15.2	7.9	9.9	9.3	8.5	8.9	7.8	8.8	11.4	8.7	7.6	22.8	10.9	11.6	22.6	46.8	8.1	9.0	12.5	10.9	10.9	12.9	9.6	7.7	11.0	14.8	8.3	9.9	7.2	9.1	8.5	38.0	10.2	10.4	8.4	11.4	17.2	10.7	14.2	11.7	8.1	9.4	15.8	10.7	11.2	8.3	17.6	22.9	24.8	16.8	15.8	21.5	15.8	9.9	9.4	5.4	10.6	10.5	8.9	6.7	13.2	10.5	14.9	11.0	16.5	13.1	21.6	8.9	10.0	23.2	10.2	21.4	15.1	17.6	5.1	13.4	23.0	8.5	17.8	12.3	23.2	11.7	8.8	20.0	13.2	16.0	7.6	13.0	14.6	13.5	9.1	17.5	10.1	18.3	28.8	8.1	18.1	31.4	12.3	20.3	9.0	14.9	10.5	15.3	7.4	10.3	10.3	11.1	5.7	9.2	13.6	11.2	10.0	6.2	14.2	22.8	9.8	14.0	14.5	13.6	15.1	7.9	6.3	16.0	24.8	15.3	16.8	21.5	17.6	16.7	17.3	22.9	12.8	21.4	16.4	5.5	15.8	13.4	13.9	16.3	15.8	11.5	10.8	10.6	15.2	10.9	11.6	12.5	10.9	14.8	11.7	23.8	27.2	41.9	79.6	118.5	28.6	86.2	40.8	37.5	30.7	36.6	9.8	62.7	112.7	73.0	41.6	39.6	43.9	0.0	41.4	65.1	35.6	36.7	55.6	100.8	54.6	27.0	17.7	21.5	28.9	58.0	25.9	42.5	60.8	70.3	20.9	23.6	69.6	25.2	27.3	143.8	22.5	0.0	77.8	36.3	49.8	109.4	72.0	46.5	36.2	76.0
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	7.4	5.1	5.4	6.5	6.4	5.3	9.8	10.9	8.9	13.3	4.8	3.7	3.9	6.0	5.4	5.8	43.1	5.1	4.3	6.3	5.5	5.6	7.5	5.7	10.2	8.1	5.1	5.2	7.5	6.8	7.2	6.5	8.5	8.4	5.1	4.8	3.7	7.2	6.7	7.8	5.4	5.8	4.3	4.4	5.9	6.1	4.9	5.1	7.4	7.9	14.4	12.8	6.1	11.5	3.5	3.8	8.2	2.5	3.7	13.5	4.6	9.1	4.9	7.2	25.6	4.6	4.7	14.3	8.1	6.9	7.9	11.1	12.0	6.1	9.4	8.6	4.2	10.7	7.0	11.4	11.7	10.1	5.0	9.5	11.9	9.4	6.8	13.7	11.1	6.1	6.9	14.4	9.7	15.3	3.3	4.7	12.4	10.3	23.4	5.8	6.4	7.3	9.6	9.4	5.6	18.0	9.1	9.9	12.5	5.1	8.5	14.8	12.2	8.1	15.1	24.1	4.9	13.2	13.4	5.3	8.6	9.5	6.1	11.9	8.6	11.5	9.2	8.6	16.3	7.7	8.2	2.5	3.3	5.1	2.4	6.2	3.5	7.7	5.7	3.8	1.9	10.3	7.7	1.9	3.7	2.5	1.0	13.5	4.6	5.4	6.4	10.9	8.9	5.5	5.6	5.1	5.2	8.4	5.1	8.9	5.4	1.4	4.4	15.9	6.6	7.7	2.5	1.4	4.5	8.7	7.9	7.8	1.7	5.1	5.7	14.0	4.5	0.0	5.1	14.0	6.0	4.4	2.3	7.5	5.1	3.2	5.8	18.4	10.1	4.0	3.7	3.6	6.8	3.6	4.4	4.3	6.3	3.5	4.9	4.8	6.6	0.0	5.1	10.3	10.8	17.1	4.7	6.9	7.0	6.7
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	32.3	22.1	26.0	27.0	27.6	32.3	37.4	39.3	24.9	29.7	24.4	22.5	33.3	46.8	30.1	40.4	15.4	12.4	46.0	30.7	39.8	25.4	15.1	24.6	22.7	31.1	34.1	35.9	14.2	27.1	29.6	29.9	20.9	35.9	30.5	26.1	28.1	27.2	41.2	34.6	59.1	25.3	27.7	35.4	23.4	24.4	40.5	19.9	36.6	40.5	27.2	24.5	18.5	52.8	64.8	31.8	22.9	17.7	27.8	27.8	29.3	22.9	24.7	22.7	18.0	30.1	23.0	23.4	27.0	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1	29.8	29.3	32.1	42.4	44.4	17.5	125.4	40.8	21.4	26.1	26.2	23.6	87.9	63.0	61.2	5.7	32.2	41.3	0.0	53.0	115.0	34.8	51.4	17.3	45.7	56.0	27.0	66.2	28.8	58.2	5.3	32.2	42.5	59.1	449.1	69.7	23.1	55.3	42.1	36.7	56.1	17.4	19.4	40.1	21.9	55.1	44.2	64.5	37.9	79.0	54.6
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 41.3;Suprabasal keratinocytes: 46.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 8.3;HaCaT: 5.9;hTCEpi: 3.1;HUVEC TERT2: 3.3;TIME: 8.7"									"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.7	41.3	0.0	2.4	0.0	0.0	3.4	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	46.4	0.0	0.0	0.0	2.3
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.9"	"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;K-562: 48.4;T-47d: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	15.8	11.1	4.9	18.2	6.6	17.3	21.4	18.0	9.5	13.5	14.9	2.9	14.6	9.7	11.0	11.7	11.6	10.9	16.1	18.7	3.8	5.8	11.1	10.1	23.5	6.5	3.8	5.7	17.8	28.0	34.4	26.9	81.9	3.7	8.7	7.2	18.2	17.7	25.2	22.5	13.3	14.8	8.8	4.2	12.1	13.2	10.4	2.1	59.0	14.9	12.0	17.4	10.2	16.9	3.5	2.5	4.5	6.0	1.9	3.2	1.1	4.5	8.2	5.5	13.8	3.5	3.2	43.6	6.2	4.3	3.5	1.3	7.0	6.3	2.7	7.5	7.0	3.1	4.3	8.7	2.3	1.8	5.0	7.3	19.8	7.7	8.6	4.6	9.1	11.3	6.1	5.7	3.7	1.8	3.6	0.9	16.1	48.4	0.5	1.1	30.7	32.6	8.0	9.6	5.0	2.4	21.5	1.8	6.9	3.2	1.7	35.9	24.9	12.2	22.9	1.1	5.2	49.9	22.8	1.5	7.2	9.0	1.9	1.6	7.5	4.5	15.9	4.1	5.8	6.3	4.0	1.6	4.5	3.2	2.9	3.1	3.5	1.2	2.0	2.5	3.4	0.6	2.4	1.3	1.9	6.0	0.0	0.0	1.1	4.9	6.6	18.0	9.5	3.8	5.8	3.8	5.7	3.7	2.1	62.5	65.7	11.5	7.5	12.5	61.9	31.4	33.1	24.1	29.6	36.6	137.4	45.4	1.7	14.3	3.8	19.0	19.6	46.7	10.5	65.7	18.6	12.3	41.7	26.7	11.0	33.4	57.4	15.4	8.9	4.7	43.7	13.5	10.1	3.6	60.0	5.2	16.5	17.3	57.7	4.4	61.6	6.5	7.1	1.8	17.8	26.2	152.4	17.0	22.4	10.5
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 252.4;OE19: 379.4"					"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	57.6	78.7	38.4	59.6	29.7	33.5	35.4	25.2	33.9	38.5	30.0	144.5	60.6	0.1	57.9	39.9	34.5	84.4	103.5	111.0	10.9	40.2	37.6	2.8	57.2	0.0	44.0	18.9	33.7	41.5	252.4	30.7	29.7	28.5	57.8	41.6	62.5	16.1	30.1	0.2	43.4	52.9	73.4	379.4	33.8	40.5	6.4	0.1	61.4	0.1	13.0	37.2	35.3	11.5	114.2	31.7	0.1	31.9	31.1	17.8	45.2	37.2	18.2	10.0	62.4	21.1	20.2	31.4	36.9	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4	1072.0	720.7	317.1	1402.4	769.0	173.6	263.2	1108.3	2518.8	1170.4	1167.2	31.4	2000.9	1530.2	1548.4	3.0	432.0	610.1	46.7	1274.3	1522.1	711.2	802.7	262.2	7.2	793.1	66.7	353.7	365.8	595.7	9.3	529.8	867.5	1452.6	2663.7	867.8	370.2	1415.0	772.2	376.2	1617.9	188.6	355.7	676.5	3.2	63.0	928.1	1376.1	396.6	983.6	3031.0
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.5	12.2	15.5	13.3	7.7	9.1	11.2	8.2	10.9	11.7	8.6	14.9	6.4	13.3	5.6	10.7	10.9	19.8	23.7	13.5	13.0	8.0	9.8	11.2	17.6	6.3	7.6	16.5	7.1	7.0	10.3	12.0	15.7	7.1	10.0	8.9	18.2	6.8	8.4	14.0	10.1	7.7	19.7	13.0	11.9	10.0	18.9	11.7	8.6	7.2	21.6	14.6	14.8	15.0	9.1	10.1	20.9	6.8	10.4	19.4	10.9	8.8	12.3	2.8	6.4	14.8	8.2	10.4	11.9	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4	17.9	8.6	7.8	6.7	27.2	15.0	11.2	2.5	18.7	6.8	3.5	13.7	6.2	6.6	7.2	4.8	9.0	3.5	0.0	5.4	6.0	11.5	9.1	1.1	7.8	5.4	19.1	12.6	7.4	7.3	2.1	17.5	4.6	3.3	2.8	7.4	11.3	5.8	7.0	18.0	5.6	16.9	0.0	7.6	15.1	12.6	35.0	5.4	6.1	8.0	4.6
GTPBP3	"FLJ14700, GTPBG3, MSS1, MTGP1, THDF1"	ENSG00000130299	"GTP binding protein 3, mitochondrial"	Q969Y2	19	17334920-17342735	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042158	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042158: AB_10964400"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (2.81e-4)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.79e-1)"	8.0	13.8	8.1	12.0	14.7	10.0	9.3	11.7	12.6	9.6	8.2	7.4	9.8	12.5	10.2	6.9	13.0	9.8	12.4	7.9	11.3	10.7	9.2	13.7	7.5	13.4	7.8	11.6	11.3	12.3	14.8	11.0	8.0	11.4	10.6	7.2	10.3	13.2	15.6	14.3	22.9	10.6	8.6	6.7	13.2	11.0	3.5	6.3	16.7	9.2	10.9	16.2	8.5	10.0	6.6	9.3	1.3	4.4	6.3	7.3	3.7	9.2	5.6	5.2	6.7	1.8	1.6	25.4	4.4	1.8	4.0	4.0	7.7	7.5	14.1	11.3	1.6	2.9	8.3	6.6	3.7	3.3	11.7	30.6	8.5	8.1	10.0	2.3	9.0	5.5	1.7	5.5	3.7	4.8	2.8	3.2	10.1	16.1	6.4	2.0	7.3	10.8	8.0	11.0	5.7	25.2	12.9	4.1	13.3	3.7	4.2	12.2	10.9	4.7	7.3	6.0	3.6	6.4	3.7	3.5	6.3	5.6	13.8	7.7	10.9	16.9	17.0	4.9	11.9	4.7	0.5	3.1	0.6	7.1	4.4	5.8	4.5	6.5	6.1	4.8	6.6	7.3	6.8	1.3	6.3	2.4	9.3	4.4	3.7	8.1	14.7	11.7	12.6	11.3	10.7	7.8	11.6	11.4	6.3	3.0	4.0	2.2	7.8	15.1	16.9	6.5	5.1	2.7	1.2	5.2	29.5	16.2	6.6	10.3	0.3	8.2	7.1	0.0	9.3	20.5	8.6	5.5	2.3	8.9	8.8	11.1	2.9	9.2	3.3	0.0	10.9	5.8	10.1	8.2	8.8	8.4	8.6	8.0	12.7	6.2	19.1	6.5	7.2	2.1	5.3	15.3	7.0	10.2	12.4	4.6
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"		X	304529-318819	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	6.3	4.9	22.2	5.6	40.5	8.1	33.6	30.5	29.9	18.9	5.2	0.6	0.6	7.0	17.0	0.6	4.7	6.3	3.1	19.7	22.7	5.9	21.1	4.0	4.1	6.0	39.5	15.0	18.2	11.9	2.1	16.6	16.6	26.4	4.1	1.6	0.6	11.2	4.7	22.8	5.7	7.6	1.9	25.5	6.4	7.5	2.4	34.2	0.6	4.1	0.6	1.9	3.7	25.4	7.3	11.1	8.1	6.3	5.3	9.2	3.8	15.2	25.3	5.6	11.7	6.5	7.1	20.9	9.5	7.1	12.1	11.1	38.7	12.8	19.2	13.6	5.3	16.4	9.5	5.9	9.2	2.0	15.9	17.2	15.8	12.4	26.4	17.6	10.6	15.5	8.8	12.3	8.0	5.9	4.5	9.7	12.8	11.6	9.0	4.9	30.2	18.8	14.0	13.7	3.1	18.1	8.4	9.9	30.6	7.0	17.9	15.8	13.5	10.4	11.8	17.5	3.2	10.6	9.3	12.8	17.7	12.3	26.1	14.6	12.3	11.0	29.6	9.2	14.0	8.1	8.1	6.3	6.7	7.8	6.3	7.6	7.3	6.9	8.7	6.1	6.0	8.5	7.7	0.9	5.3	5.8	11.1	9.2	3.8	22.2	40.5	30.5	29.9	22.7	5.9	39.5	15.0	26.4	34.2	17.9	16.3	23.9	39.0	25.0	27.0	16.8	28.1	5.3	10.3	26.2	25.5	20.5	44.7	10.7	0.9	23.7	23.1	0.0	12.8	38.8	22.6	37.4	11.5	32.1	26.3	12.7	17.1	14.1	12.6	1.4	18.1	23.2	25.3	11.8	23.0	15.2	11.3	8.6	17.7	74.7	25.1	6.5	31.3	5.1	12.1	23.2	24.6	27.7	32.2	44.8
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.6	9.0	11.9	13.4	7.3	12.6	9.5	13.6	11.8	14.0	17.5	15.8	8.5	12.9	8.0	7.5	11.3	13.5	15.8	13.1	16.1	5.7	11.1	35.3	9.0	8.2	6.9	22.5	8.7	10.0	9.4	7.7	5.5	14.5	12.8	15.2	12.4	15.3	13.4	7.7	14.3	11.0	24.5	9.9	17.1	12.2	11.0	8.2	9.8	12.4	13.8	14.0	11.0	8.7	18.1	10.7	9.8	15.3	7.7	10.2	15.1	3.7	12.7	10.0	13.1	18.0	10.2	18.7	11.2	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9	14.9	9.6	16.3	11.9	11.9	9.3	24.2	7.6	13.4	7.9	5.2	5.9	23.6	19.9	14.6	58.0	10.3	10.5	23.3	15.9	20.5	12.6	10.8	19.6	7.2	20.3	9.5	9.8	10.4	14.5	21.7	10.9	14.2	10.1	12.6	9.7	8.9	13.4	10.2	5.3	23.1	12.2	0.0	17.5	35.6	28.1	10.7	12.7	16.7	11.9	16.1
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678427-44700926	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	10.0	11.3	12.7	7.5	16.6	11.4	10.8	9.7	17.7	7.6	11.5	9.4	8.7	9.4	10.2	9.1	13.2	8.9	7.9	12.3	12.6	9.9	15.1	16.0	6.6	10.8	10.4	11.6	10.6	9.3	11.5	11.3	7.8	13.0	10.6	12.4	7.4	10.4	8.0	31.1	11.5	12.5	7.6	11.8	9.7	15.4	11.7	11.1	13.9	11.2	13.1	9.3	11.7	9.2	4.8	4.7	4.6	6.1	5.2	7.0	3.9	7.7	3.9	7.4	9.4	3.1	6.4	16.3	10.6	5.6	11.1	8.6	7.0	5.6	16.9	8.5	5.2	10.1	6.2	12.7	12.3	12.7	5.7	8.1	20.2	3.4	4.8	10.0	21.9	8.7	6.4	5.6	8.2	7.2	5.2	7.9	10.1	20.3	3.3	8.9	3.8	12.2	4.6	4.8	5.6	9.3	8.8	15.3	7.1	3.3	3.0	10.2	7.6	6.8	2.9	7.5	6.0	4.5	6.4	7.9	7.6	8.8	10.1	12.7	12.2	11.1	12.4	8.3	13.1	6.4	1.1	4.6	4.6	4.7	6.1	6.1	4.8	4.7	4.2	4.3	4.4	4.5	4.6	0.1	5.2	4.0	4.7	7.0	3.9	12.7	16.6	9.7	17.7	12.6	9.9	10.4	11.6	13.0	11.1	6.0	7.4	12.1	7.4	3.5	9.7	19.3	2.5	22.7	10.3	7.0	2.0	11.2	11.6	7.9	1.4	6.8	9.1	23.3	8.8	14.4	7.3	8.4	1.1	13.4	10.4	11.1	10.9	10.4	11.7	1.5	5.2	6.6	6.8	6.4	12.4	8.6	11.9	5.8	6.7	8.4	10.2	0.0	8.2	9.2	9.6	6.1	11.2	8.9	11.9	9.1
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		No	No		8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.7	8.2	17.7	12.9	42.7	13.8	8.6	12.9	19.2	14.0	13.8	5.9	16.5	49.8	6.9	10.5	9.1	11.8	23.6	17.8	15.5	15.2	12.3	11.6	15.6	13.0	6.8	24.4	5.4	14.3	9.5	9.9	9.1	11.5	9.4	35.0	14.3	26.5	15.8	15.9	41.4	9.7	8.4	38.7	10.9	31.6	24.9	24.9	15.1	35.6	21.5	12.3	12.4	44.5	12.7	10.8	21.2	19.3	5.2	9.9	5.6	13.9	7.0	15.0	17.3	21.6	13.5	16.6	7.6	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2	26.8	26.0	29.0	45.8	13.9	7.3	194.2	61.1	81.7	36.4	33.2	3.9	27.5	135.9	37.9	159.1	14.3	244.0	46.7	28.1	33.2	15.5	29.6	10.4	229.1	96.2	6.4	31.2	19.0	32.4	78.4	42.8	17.2	20.3	6.4	71.1	24.6	30.7	84.2	33.2	241.4	5.7	38.8	30.8	25.1	20.1	15.8	14.2	16.2	172.2	38.7
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2227464-2242164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040649, HPA048190"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	11.7	10.8	15.5	10.9	14.7	44.4	11.5	26.3	14.3	8.6	9.5	10.0	8.6	9.6	11.0	9.1	10.3	8.8	6.9	6.3	11.8	5.9	7.8	8.8	11.1	15.0	11.7	11.0	10.8	13.6	7.3	18.9	10.3	10.5	10.7	8.8	6.0	10.8	8.5	9.0	10.4	11.2	9.6	14.5	15.2	10.5	12.5	13.7	20.7	9.8	4.3	13.0	9.3	9.6	11.0	8.6	14.9	7.8	12.2	15.6	7.6	9.8	5.0	14.5	14.2	6.9	9.6	14.2	15.7	6.9	14.3	13.2	8.7	12.7	18.5	6.7	6.0	17.8	9.1	11.6	7.9	18.3	7.0	7.7	11.0	11.7	7.1	5.5	11.5	12.5	5.5	10.6	12.9	6.5	7.5	11.6	8.8	21.0	22.4	14.4	5.1	16.7	20.0	12.3	9.0	12.0	13.3	12.9	11.1	7.2	7.0	17.9	9.9	9.7	7.1	9.0	12.3	15.4	7.6	8.1	17.8	9.6	10.8	16.6	11.3	11.3	17.2	9.5	17.3	13.4	10.1	5.5	14.9	10.9	7.4	14.4	7.7	11.5	12.2	5.0	11.0	13.4	12.1	6.4	12.2	7.8	8.6	15.6	7.6	15.5	14.7	26.3	14.3	11.8	5.9	11.7	11.0	10.5	13.7	3.0	4.5	4.2	4.8	11.2	11.1	4.6	10.2	4.0	12.5	3.5	11.8	6.4	1.7	6.3	9.9	6.7	3.0	0.0	4.9	9.5	7.8	4.5	12.7	3.0	6.2	23.8	6.9	6.2	4.1	4.9	9.2	8.7	11.8	8.2	5.3	6.9	4.4	0.0	8.1	2.6	11.6	0.0	6.7	20.1	15.1	6.8	4.2	20.2	5.2	2.6
HAX1	"HCLSBP1, HS1BP1"	ENSG00000143575	"HCLS1 associated protein X-1"	O00165	1	154272511-154275875	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055141, HPA075289"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA055141: AB_2682714, HPA075289: AB_2686742"	"unprognostic (1.32e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.96e-1)"	24.0	25.4	28.6	16.0	33.9	12.2	29.2	15.1	36.6	24.9	24.8	21.9	22.9	18.6	20.2	42.7	27.7	24.5	20.2	59.5	24.7	26.3	32.1	61.7	17.3	20.3	25.8	20.3	29.3	47.8	21.0	35.2	18.4	23.5	26.1	25.0	26.6	52.0	26.3	90.4	17.8	27.8	25.1	22.6	23.2	23.9	31.3	17.0	23.8	32.4	45.8	27.7	27.0	18.6	39.1	34.9	59.1	39.6	30.9	51.8	42.8	20.5	17.6	14.9	32.7	18.5	20.7	24.2	19.6	32.2	41.6	38.7	23.3	23.2	30.0	28.5	33.2	19.5	17.8	34.2	27.1	32.2	30.7	25.6	14.6	14.5	20.1	41.3	30.3	31.7	19.2	50.2	31.2	37.5	14.6	23.1	44.0	28.4	44.8	26.7	49.6	30.4	25.1	16.5	49.0	38.6	21.6	11.0	57.6	21.9	11.5	23.0	22.9	17.5	42.5	59.3	25.7	35.1	83.9	11.5	17.3	23.3	18.1	27.0	52.3	54.5	56.2	26.4	28.0	28.5	58.3	28.4	59.1	34.2	33.5	39.1	39.1	43.1	38.7	34.0	38.2	51.8	41.2	17.2	30.9	39.6	34.9	50.8	42.8	28.6	33.9	15.1	36.6	24.7	26.3	25.8	20.3	23.5	17.0	26.8	32.8	105.0	105.1	66.2	57.5	96.8	56.0	32.1	31.8	43.6	45.2	70.2	154.2	76.6	107.7	63.1	62.2	46.7	92.7	108.3	57.2	80.6	98.1	74.9	86.5	38.1	55.3	44.8	55.3	88.4	56.7	70.8	82.7	180.3	58.5	75.4	79.5	58.8	58.4	123.1	86.4	58.2	76.2	186.3	97.5	66.9	74.3	99.1	65.0	89.4
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.7	12.5	12.0	11.8	11.4	13.3	23.4	17.9	29.6	25.4	31.0	17.0	14.4	12.1	18.8	33.0	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.3	15.4	20.9	15.7	17.7	11.1	17.5	28.2	19.3	16.0	21.0	11.1	26.8	16.8	19.9	31.5	11.4	12.8	22.7	14.1	29.0	11.2	25.1	28.4	19.9	18.3	9.0	10.7	23.4	25.5	15.0	27.6	19.7	11.4	20.6	19.2	10.4	49.2	19.9	12.3	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0	6.0	4.5	22.9	41.8	48.7	5.1	47.6	20.4	16.0	15.9	15.7	0.0	29.4	43.1	32.7	3.8	15.8	37.0	23.3	25.6	30.7	17.7	30.5	12.7	15.3	36.7	7.9	10.4	12.3	22.9	1.3	12.4	23.8	23.6	31.5	20.2	8.7	46.3	31.6	9.9	30.7	7.1	6.5	25.0	13.4	25.4	40.3	34.2	13.8	28.1	88.7
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018312, HPA078588"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA018312: AB_1850522, HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.4	20.1	13.7	17.3	5.7	4.1	20.1	6.3	4.9	7.5	6.9	21.2	10.4	28.1	16.3	8.2	12.4	12.7	14.7	10.4	3.9	14.8	17.3	16.8	16.0	16.6	3.9	20.6	27.9	6.4	6.8	13.1	5.7	4.5	8.0	20.5	23.3	17.8	5.3	21.6	28.5	26.7	17.7	10.1	12.4	33.3	11.3	16.9	5.7	14.4	15.2	16.5	11.7	12.2	6.5	6.9	11.2	18.6	10.5	14.4	17.8	12.4	20.4	28.3	38.7	35.2	11.7	20.1	13.6	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9	17.9	19.1	10.4	11.5	14.7	17.2	34.6	17.8	4.0	9.1	12.2	13.7	13.4	3.3	15.2	0.4	15.8	11.7	0.0	14.1	18.9	12.9	17.4	3.5	23.1	18.5	19.1	18.4	19.0	30.2	1.3	16.1	12.5	5.0	16.2	20.4	15.0	16.1	7.0	20.5	8.6	11.5	6.5	13.7	6.5	25.1	12.2	13.3	17.5	20.9	13.1
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.7	16.4	28.5	26.4	12.4	12.7	19.9	22.4	12.1	24.7	22.0	18.7	12.1	24.5	13.1	16.4	13.0	15.9	18.9	20.4	14.5	27.3	30.0	15.0	12.3	24.6	16.1	14.8	21.5	18.1	11.1	16.9	8.3	17.6	22.5	23.2	17.2	30.9	11.9	19.7	33.4	29.7	32.6	11.2	29.5	33.3	23.5	15.7	15.3	14.2	31.5	31.1	21.8	12.5	18.1	16.3	12.3	23.6	29.7	15.6	21.4	29.3	21.1	38.4	20.0	17.2	21.9	23.9	16.4	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	17.4	9.1	12.2	0.0	31.1	16.6	22.5	0.0	0.0	0.0	0.0	17.5	24.9	0.0	0.0	1.1	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	26.2	0.0	0.0	19.1	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0
HDHD5	CECR5	ENSG00000069998	"Haloacid dehalogenase like hydrolase domain containing 5"	Q9BXW7	22	17137511-17165287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 36.5;Ductal cells: 28.6;Exocrine glandular cells: 24.8;Extravillous trophoblasts: 35.3;Hofbauer cells: 38.3;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005548	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA005548: AB_1078497"	"unprognostic (4.04e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.54e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.21e-3)"	12.2	22.2	10.3	11.3	13.3	12.8	14.7	13.2	13.2	10.6	23.7	11.3	8.8	23.7	12.6	10.1	15.3	11.9	16.0	29.5	9.9	8.4	14.7	29.8	12.5	12.4	16.4	10.4	13.6	25.3	8.9	9.6	7.4	13.2	12.7	13.1	7.7	17.3	10.0	37.2	15.7	16.5	12.0	9.9	14.6	13.6	12.4	13.7	15.1	9.4	25.9	11.6	11.9	10.7	10.1	29.3	2.9	34.6	11.1	15.0	17.5	22.7	15.1	11.3	15.3	6.7	4.1	14.5	6.5	7.2	17.6	19.0	22.1	8.5	37.4	11.0	7.8	8.6	16.1	14.3	15.3	8.2	11.3	20.9	0.0	10.9	0.0	11.2	16.8	8.8	10.0	19.1	7.8	8.7	9.9	12.3	24.8	10.9	9.7	9.2	22.2	29.5	34.6	17.3	35.2	13.5	16.9	17.1	9.4	12.0	12.6	23.0	17.4	12.7	18.5	19.5	9.4	18.5	21.1	10.6	15.0	11.1	10.5	11.2	15.5	16.8	27.5	12.0	0.0	12.5	2.9	34.6	1.6	11.8	21.4	14.7	10.1	11.2	10.7	29.3	9.6	15.0	12.5	1.7	11.1	11.6	12.1	11.3	17.5	10.3	13.3	13.2	13.2	9.9	8.4	16.4	10.4	13.2	13.7	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.1	5.2	0.0	21.4	36.5	28.6	0.0	0.0	0.0	0.0	24.8	35.3	0.0	0.0	4.7	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	9.0	0.0	0.0	21.7	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604504	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		120000	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	14.1	11.0	9.2	14.7	11.3	15.2	13.8	15.0	13.9	10.7	10.6	8.6	8.3	7.6	15.9	9.4	14.7	12.5	8.1	9.4	10.0	5.8	9.9	13.2	10.6	16.5	12.9	6.9	15.8	17.2	13.5	12.8	10.5	11.6	11.1	10.8	8.2	12.6	9.5	12.7	14.5	11.6	13.1	6.6	16.1	11.5	20.3	13.2	18.3	12.0	12.8	17.9	12.7	12.8	9.9	5.9	1.8	4.5	6.4	10.0	2.4	14.5	17.5	9.2	13.9	12.9	14.5	20.6	11.8	7.6	13.6	12.2	17.6	12.4	23.9	13.3	10.8	8.4	17.7	20.9	12.6	18.5	12.0	24.0	17.0	12.5	15.0	11.6	30.3	11.0	11.8	11.4	20.5	17.8	6.6	15.5	11.1	38.4	8.1	13.5	7.8	14.3	8.3	36.7	18.7	7.2	16.0	13.3	22.4	8.7	14.7	8.6	19.2	14.3	10.2	12.2	6.4	12.1	11.4	14.7	13.7	12.9	17.6	29.1	15.4	19.2	28.3	12.2	17.0	20.3	1.8	3.6	1.1	7.3	4.5	6.6	9.9	7.2	7.9	4.3	8.1	10.0	9.4	0.5	6.4	4.3	5.9	5.9	2.4	9.2	11.3	15.0	13.9	10.0	5.8	12.9	6.9	11.6	13.2	3.0	10.9	8.8	9.3	17.5	11.2	3.5	12.7	12.0	14.8	5.2	17.7	7.0	3.3	7.4	5.7	10.0	2.7	0.0	7.1	8.9	9.9	7.4	31.3	8.9	6.6	6.4	4.1	11.1	10.0	0.9	13.0	7.4	1.7	6.4	5.5	4.4	10.4	2.9	9.6	3.5	10.4	0.0	9.2	21.3	30.8	14.8	4.1	10.2	8.3	9.1
HEATR6	"ABC1, FLJ22087"	ENSG00000068097	"HEAT repeat containing 6"	Q6AI08	17	60043194-60078931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 49.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030789, HPA062157"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030789: AB_10601660, HPA062157: AB_2684700"	"unprognostic (1.98e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.22e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.02e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.11e-1)"	8.3	14.5	14.6	9.2	15.4	12.0	10.3	28.5	15.1	12.2	13.0	18.0	11.1	6.8	14.4	12.6	9.4	13.0	9.1	12.3	11.2	9.9	9.0	7.1	11.8	11.0	15.3	12.6	17.8	10.3	16.7	18.4	10.7	13.7	13.2	10.6	10.0	11.3	13.0	12.6	13.3	11.2	15.0	12.8	14.1	9.5	10.5	15.8	10.0	9.5	7.2	9.7	12.3	18.9	10.8	12.8	6.8	10.4	4.1	6.8	4.6	4.7	9.3	8.2	5.6	5.5	8.1	5.9	4.7	7.9	8.9	8.6	4.0	3.5	1.7	7.7	8.3	7.3	5.7	6.5	6.4	11.6	3.3	8.3	9.1	7.3	6.0	7.1	5.7	8.2	8.1	10.4	6.5	9.2	9.8	5.1	5.2	5.2	5.7	5.9	49.1	7.6	2.1	4.2	4.3	8.7	2.9	14.2	5.0	4.8	5.8	5.4	12.4	4.4	1.6	4.7	8.1	7.1	3.9	4.7	8.3	12.6	6.2	7.7	4.8	5.2	0.0	7.3	4.4	6.3	5.1	6.1	6.8	6.8	10.4	5.5	10.8	5.5	5.7	12.8	8.4	5.9	5.1	1.2	4.1	9.9	4.4	5.6	4.6	14.6	15.4	28.5	15.1	11.2	9.9	15.3	12.6	13.7	15.8	11.9	4.6	4.7	3.2	0.8	10.6	8.2	2.5	14.7	10.3	7.0	9.8	4.9	3.3	4.0	0.7	2.2	0.9	0.0	2.9	2.8	3.1	1.8	10.5	2.6	4.1	6.4	6.4	3.7	4.1	0.7	3.1	6.5	1.7	19.8	1.5	8.2	2.4	0.0	10.6	2.8	6.3	6.5	3.3	3.4	7.5	1.9	1.7	2.5	2.5	1.1
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif-like"	Q9NQ87	1	39624153-39639945	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 66.3"	"Cell type enhanced"	"Detected in many"	13	"Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.26e-6)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.63e-5)"	10.0	8.3	2.9	4.7	6.2	0.5	6.5	1.8	4.0	14.7	4.4	2.9	5.1	1.9	21.7	13.2	4.0	11.2	13.9	28.2	3.2	4.8	12.3	3.3	12.5	2.0	6.8	2.9	14.4	66.3	1.7	8.2	22.1	7.1	8.1	2.9	10.9	2.3	11.4	8.9	1.9	2.7	18.9	2.4	4.5	3.4	25.4	4.4	0.0	11.0	6.8	1.9	6.0	8.8	1.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	2.4	4.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	1.6	0.2	0.0	1.4	0.4	0.0	0.0	2.2	0.0	0.2	0.0	2.6	4.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.5	17.6	1.4	0.0	0.0	0.0	0.2	0.1	1.1	21.7	0.1	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.9	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.2	1.8	4.0	3.2	4.8	6.8	2.9	7.1	4.4	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	0.7	0.0	0.0	3.1	0.2	3.8	0.2	0.0	0.0	0.3	1.6	0.0	1.3	0.0	11.8	24.2	1.1	5.0	0.0	0.0	0.2	4.5	0.0	53.4	0.0	3.7	51.8	35.4	0.1	1.7	0.1	0.2	0.0	0.4	0.1
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689951-92695646	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051894, HPA055460"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051894: AB_2681653, HPA055460: AB_2682820"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	6.3	8.2	2.8	12.0	3.6	28.1	13.7	0.9	2.2	4.5	3.2	3.0	1.1	2.3	3.6	3.8	2.9	2.7	18.0	7.3	2.8	2.1	2.8	33.1	15.3	29.7	3.6	0.9	1.9	15.6	0.7	1.5	6.4	2.8	4.3	2.4	2.3	1.9	1.6	2.8	2.2	8.4	9.3	2.9	18.3	2.7	1.9	2.8	1.8	71.4	2.0	11.3	6.5	7.1	25.0	13.5	21.4	17.8	0.3	0.3	4.9	3.1	5.9	3.1	0.0	0.2	0.2	0.0	1.6	13.5	2.2	1.9	1.1	0.7	3.0	26.0	0.2	0.0	0.6	2.7	0.0	2.7	0.0	3.2	28.2	2.4	19.0	6.3	16.4	31.3	0.0	0.0	1.9	0.0	1.1	30.9	0.0	42.9	0.0	0.1	0.9	0.1	28.6	0.0	8.6	3.4	9.6	0.9	0.0	0.2	1.2	1.4	0.3	1.8	0.0	0.0	0.1	0.9	8.7	10.7	0.0	0.1	0.0	0.0	0.7	0.5	6.0	0.0	22.7	14.9	7.9	14.7	21.4	0.3	16.4	0.1	21.4	0.0	0.0	11.3	25.0	0.0	0.0	11.8	0.3	17.8	13.5	0.1	4.9	2.8	3.6	0.9	2.2	2.8	2.1	3.6	0.9	2.8	2.8	0.0	4.8	30.4	1.6	5.7	0.0	2.0	94.3	1.4	2.3	0.0	0.0	0.5	0.0	86.4	0.2	66.2	0.0	0.0	10.0	0.8	2.1	2.9	6.9	48.7	58.0	0.0	5.1	65.1	61.3	0.4	0.3	22.7	6.8	1.8	0.3	0.0	14.5	0.0	1.1	0.0	0.0	0.0	1.9	0.2	1.4	3.1	0.9	5.2	0.2	0.6
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA			Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.0	18.4	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.0	9.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42784298-42804531	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 535.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 89.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	27.7	30.4	50.1	15.5	43.4	9.6	20.4	20.3	56.4	18.3	63.8	25.2	10.8	35.2	15.7	24.8	36.7	13.5	18.8	68.6	43.2	43.3	45.9	78.4	15.3	16.0	54.4	35.9	12.8	12.8	14.7	29.2	17.2	50.9	24.4	67.3	21.8	16.6	26.8	34.9	15.0	28.4	22.8	58.8	13.0	31.6	14.7	20.7	8.9	28.1	30.6	16.9	20.1	25.0	11.9	89.9	25.9	26.6	12.3	18.8	30.1	27.4	15.4	34.3	28.1	87.8	52.5	33.4	37.1	30.5	36.4	33.4	27.2	28.0	16.8	22.3	32.4	22.6	16.6	27.5	40.9	45.5	24.1	30.4	51.9	27.7	50.3	40.1	29.8	24.5	54.4	45.0	27.8	38.8	18.1	31.9	25.6	51.2	18.0	50.7	11.2	16.4	10.9	28.8	23.3	37.6	13.4	24.3	11.9	89.7	68.2	14.5	18.9	32.5	24.7	35.0	35.7	24.7	22.5	27.9	21.5	19.5	60.1	38.3	16.8	34.7	34.7	28.3	31.7	16.6	16.9	14.7	25.9	15.4	22.7	13.7	11.9	15.1	15.1	16.3	8.5	12.9	15.3	14.9	12.3	26.6	89.9	18.8	30.1	50.1	43.4	20.3	56.4	43.2	43.3	54.4	35.9	50.9	20.7	50.6	73.8	43.3	134.0	116.5	33.4	319.5	79.0	48.2	60.3	130.9	9.8	99.0	535.5	105.9	6.7	57.3	183.7	93.5	127.6	162.8	82.5	160.2	92.2	169.5	69.4	27.0	78.7	55.3	46.3	9.1	28.4	70.1	167.0	114.6	120.5	121.0	198.7	300.1	49.1	213.1	25.1	77.6	125.8	135.9	72.8	178.8	250.8	45.7	135.9	173.3
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388747-176389771	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	37.2	38.5	31.4	33.5	36.0	34.9	37.5	21.4	33.2	26.8	43.8	22.5	29.7	36.7	25.7	31.1	47.0	31.5	39.4	80.0	28.5	26.6	46.3	56.1	30.1	54.1	30.3	20.0	33.2	42.6	36.6	28.8	26.4	21.0	41.2	30.9	31.2	64.0	32.6	115.9	27.8	38.1	43.3	25.9	37.3	31.6	28.8	15.0	63.1	42.3	53.8	34.3	42.1	28.7	70.4	104.6	25.5	107.7	31.1	67.6	88.9	17.9	31.7	19.0	32.1	19.9	38.1	49.8	11.3	21.6	33.0	41.6	33.1	38.0	32.7	27.6	20.6	40.3	23.2	28.7	50.7	13.2	76.6	45.1	16.1	32.7	45.3	28.0	25.1	43.9	48.3	42.2	18.6	22.6	24.3	27.7	27.5	17.8	65.9	24.2	59.3	28.5	31.9	22.4	34.6	34.9	27.7	14.1	59.1	51.6	29.9	20.0	26.7	12.9	54.6	55.5	20.3	32.6	42.3	17.3	22.5	23.3	20.6	23.5	30.7	36.6	26.6	29.1	45.1	14.1	25.5	84.5	23.8	46.3	106.5	45.8	70.4	64.9	53.5	104.6	52.2	59.6	55.6	14.4	31.1	107.7	68.6	67.6	88.9	31.4	36.0	21.4	33.2	28.5	26.6	30.3	20.0	21.0	15.0	68.5	61.2	245.0	289.8	206.3	55.1	130.4	180.9	116.4	104.6	172.7	11.8	187.5	452.6	160.5	55.4	114.7	272.4	23.3	206.0	150.2	154.5	216.1	128.0	198.8	329.3	62.0	256.0	111.7	344.3	44.7	129.8	304.5	244.6	408.4	365.8	77.7	132.6	412.7	79.9	405.0	38.4	116.4	130.6	108.0	81.6	196.7	234.3	221.4	328.6	443.0
HIGD2B	HIGD2BP	ENSG00000175202	"HIG1 hypoxia inducible domain family member 2B"	Q4VC39	15	72675783-72686149	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	12	"testis: 11.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0"									"HPA019016, HPA042715"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019016: AB_1850711, HPA042715: AB_2678127"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"		"unprognostic (2.24e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.80e-2)"	"unprognostic (6.11e-4)"	"unprognostic (6.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.6	0.2	0.0	0.7	0.0	1.3	0.7	1.1	0.0	0.0	0.4	0.0	0.6	0.6	0.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.6	0.0	1.0	0.0	0.5	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.7	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	15.1	0.9	0.1	0.1	0.0	0.0	0.1
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	10.9	9.2	13.8	15.1	16.7	17.5	10.8	12.7	10.6	8.8	21.6	9.8	7.6	14.3	16.0	27.6	13.8	13.8	23.3	15.7	24.8	7.7	14.0	10.0	13.2	14.3	23.4	6.0	11.7	31.3	8.1	41.4	12.0	20.8	19.5	9.8	7.4	24.0	46.1	19.6	11.1	17.5	21.5	7.6	13.3	15.9	12.0	14.9	16.0	10.4	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.0	40.0	18.3	17.9	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2	20.8	10.8	63.0	60.5	40.3	34.2	96.4	124.9	53.5	13.6	76.8	19.6	143.0	537.2	101.9	54.3	49.6	142.5	46.7	149.8	55.2	58.2	44.3	18.4	366.2	96.3	19.1	92.3	63.3	58.2	111.5	37.4	47.7	114.7	71.3	106.7	69.3	83.1	158.4	42.1	463.5	36.6	45.3	71.8	32.1	82.2	40.1	47.5	67.1	120.6	54.5
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 260.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	7.0	5.6	7.8	16.1	3.1	8.4	9.7	7.6	11.0	5.9	6.1	13.6	3.9	15.3	14.2	5.1	13.1	10.6	9.9	6.4	6.9	14.4	12.8	6.4	8.4	11.4	14.4	10.1	10.9	6.6	14.3	5.9	15.0	15.2	8.8	11.4	19.9	10.3	5.8	10.6	8.0	7.3	2.6	14.4	5.4	6.7	5.3	5.1	12.1	12.9	15.7	9.7	6.9	9.9	35.6	5.9	10.0	15.5	6.2	4.0	5.6	19.2	10.8	15.0	17.2	9.7	11.4	9.6	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0	74.5	57.0	16.0	9.5	16.1	22.3	37.6	10.2	24.1	31.8	15.7	7.9	16.0	28.2	27.0	260.9	11.3	12.3	0.0	17.5	5.7	10.8	19.4	9.2	16.3	23.3	6.4	15.6	6.2	14.5	54.5	9.2	17.0	20.3	9.0	22.7	30.7	20.3	28.1	16.3	21.4	23.9	6.5	13.7	89.1	27.7	15.2	22.1	7.0	19.9	17.1
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"Human immunodeficiency virus type I enhancer binding protein 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	22.3	5.5	6.4	20.1	5.6	20.5	13.1	8.0	10.0	11.5	12.6	5.4	13.9	7.0	10.0	10.6	12.9	9.2	10.6	8.8	5.6	7.1	7.3	17.1	13.3	12.4	5.3	6.7	11.6	11.7	23.3	12.2	8.7	7.8	10.5	9.5	7.7	10.9	17.6	8.2	14.1	11.8	12.9	5.9	15.2	7.2	7.3	5.0	23.8	7.7	14.2	16.2	17.3	23.1	5.6	9.6	12.9	4.9	3.6	4.6	0.7	5.2	3.9	5.1	2.8	4.0	5.2	4.9	4.3	3.7	3.6	3.9	2.5	2.8	4.4	9.4	5.2	8.5	5.1	5.0	6.1	4.9	9.5	2.9	2.0	3.7	2.4	3.3	2.3	1.7	3.6	6.2	7.2	11.2	7.5	10.4	3.0	21.1	5.1	7.7	3.9	3.8	2.1	4.3	1.8	2.0	2.1	6.6	6.9	2.1	5.8	4.8	3.5	10.6	8.7	3.0	11.9	5.1	3.1	16.8	9.0	4.0	8.3	4.9	20.5	17.1	7.9	2.7	3.1	3.7	2.4	2.2	2.2	1.4	2.2	1.0	3.4	2.3	0.9	1.3	5.6	4.0	2.3	12.9	3.6	4.9	9.6	4.6	0.7	6.4	5.6	8.0	10.0	5.6	7.1	5.3	6.7	7.8	5.0	26.8	19.2	6.5	21.7	28.6	19.2	7.4	10.2	22.7	26.1	7.0	11.8	2.9	3.3	4.8	2.1	15.5	11.3	0.0	6.3	1.8	12.7	18.9	7.0	11.4	4.9	20.6	10.4	7.4	8.5	1.5	3.4	19.0	18.6	45.9	12.5	13.2	8.5	9.7	4.2	2.7	9.1	0.0	13.4	3.6	3.1	29.2	4.3	7.5	7.1	23.3
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.1	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.7	5.3	2.9	10.1	32.6	20.0	18.0	13.3	24.4	12.5	6.8	20.6	18.6	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	5.2	11.4	16.5	17.4	13.3	33.6	17.2	23.7	18.7	19.3	13.4	16.0	18.4	33.9	9.5	9.4	10.3	13.0	8.1	14.8	11.2	10.5	10.8	8.4	13.1	8.3	19.8	21.6	14.5	27.7	12.7	10.0	21.4	11.9	12.5	49.3	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.8	0.4	1.1	0.0	0.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	0.0	12.4	0.1	0.9	46.7	0.0	13.7	0.3	0.4	0.0	0.0	5.7	0.0	0.0	2.5	2.4	7.4	0.6	2.1	0.0	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	18.4	12.9	0.6	1.3	1.3	1.2	0.6
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.7	10.1	13.6	12.9	15.2	11.4	8.6	17.7	46.6	23.7	25.7	2.9	2.0	1.3	14.0	29.7	17.2	15.6	12.7	39.6	22.7	11.8	9.9	44.2	10.8	0.2	17.3	0.8	33.5	17.2	23.1	33.9	75.8	29.8	24.6	6.6	73.7	9.3	32.4	29.5	5.1	2.2	20.8	9.1	45.1	7.8	8.3	0.1	16.4	21.0	13.9	16.4	20.2	39.4	11.7	20.1	21.5	2.9	25.2	35.5	16.2	19.5	24.7	11.3	7.4	3.1	46.0	23.3	10.2	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6	23.8	29.6	15.8	44.3	42.8	67.3	110.0	7.6	32.1	31.8	26.2	51.1	51.0	11.6	26.4	307.9	34.4	10.3	23.3	26.9	78.8	26.0	25.9	22.0	0.8	45.7	287.6	18.0	25.8	31.3	870.1	14.1	40.6	35.4	24.4	21.8	29.7	36.4	11.5	17.3	0.7	85.2	19.4	42.8	4.3	4.4	45.2	99.4	25.4	12.6	42.9
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.5	0.1	3.8	14.0	32.9	3.4	14.3	6.4	9.4	7.3	10.5	13.2	3.0	12.0	6.2	3.0	9.4	5.7	17.5	13.6	21.2	3.4	3.7	16.3	3.8	18.2	10.4	23.8	26.9	5.8	14.8	13.8	24.3	8.2	3.4	6.9	14.2	0.0	2.1	11.8	5.7	24.4	13.9	15.7	11.5	9.3	8.1	9.3	4.4	23.4	2.8	13.7	4.1	20.9	8.2	5.8	1.1	3.8	2.8	23.3	4.1	9.6	11.7	8.3	2.3	6.0	54.3	17.5	6.0	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4	14.9	37.6	2.9	5.5	45.8	6.2	6.0	7.6	0.0	6.8	5.2	78.5	0.7	0.0	4.4	87.9	3.6	116.3	0.0	3.8	12.3	8.5	17.2	21.9	0.0	15.7	20.6	37.5	1.3	14.6	32.5	13.6	18.9	21.9	1.0	32.2	4.3	18.4	86.0	7.4	0.0	43.3	12.9	2.3	3.1	4.5	49.8	6.9	2.2	19.9	69.9
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
HKR1	ZNF875	ENSG00000181666	"HKR1, GLI-Kruppel zinc finger family member"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	13.0	25.8	14.6	13.2	22.4	12.6	24.9	29.8	27.2	20.5	14.5	22.9	21.5	7.7	24.8	24.1	12.4	22.9	17.9	26.9	14.6	15.6	19.3	12.3	12.9	14.3	14.9	17.4	22.6	14.2	31.0	35.5	17.2	21.2	27.5	13.8	49.4	18.7	19.3	18.1	27.1	13.4	17.0	13.3	20.2	14.2	22.6	15.5	16.4	30.9	13.7	20.1	15.0	15.6	12.4	7.9	10.0	5.1	9.9	14.8	5.7	4.1	10.4	13.5	17.9	9.9	8.6	9.4	7.0	10.7	13.1	14.2	5.2	4.9	14.6	17.1	7.4	5.9	3.5	8.8	9.4	13.6	7.6	15.0	5.1	12.6	5.6	13.0	4.7	12.5	12.7	11.6	8.8	19.4	13.4	7.9	10.5	0.9	0.9	9.4	8.4	10.5	9.3	27.1	7.2	6.0	7.1	5.9	5.6	11.4	16.8	16.8	22.8	7.0	9.0	8.8	20.6	12.8	9.0	7.1	10.4	7.5	7.8	10.9	18.8	19.7	15.1	1.1	5.8	11.6	10.0	4.2	6.6	8.0	5.1	14.8	10.7	10.6	11.4	6.3	12.4	14.4	12.0	4.0	9.9	3.6	7.9	12.2	5.7	14.6	22.4	29.8	27.2	14.6	15.6	14.9	17.4	21.2	15.5	6.0	2.9	7.8	6.4	4.6	45.3	16.5	2.5	18.7	11.4	10.4	102.1	9.3	16.6	7.7	9.5	11.1	2.9	0.0	6.8	4.6	6.1	9.7	11.5	5.9	6.1	39.7	9.2	9.2	3.7	5.9	11.2	5.5	8.5	9.0	5.0	22.8	5.1	3.5	12.0	10.9	129.7	6.5	7.6	15.5	16.3	5.4	8.2	8.5	5.4	7.3
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell type enhanced"	"Detected in many"	24	"Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 35.4;RT4: 63.6"	"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		NA	NA		820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.2	0.2	0.0	63.6	0.0	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3	3.0	6.7	7.5	3.6	0.1	0.0	4.5	68.8	0.0	0.0	29.6	0.0	0.2	0.0	0.0	1.5	0.0	76.1	0.0	0.0	0.1	0.0	10.3	4.6	901.4	0.2	0.0	70.2	16.0	17.8	2.7	1.4	0.0	5.0	0.0	249.3	0.0	0.1	126.7	0.0	0.3	0.0	6.5	0.0	0.5	0.4	0.3	7.9	0.0	248.3	15.4
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 45.0;Karpas-707: 66.4"					"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.9	28.8	5.0	1.6	1.2	1.6	2.5	0.4	0.7	0.7	10.9	45.0	5.1	0.7	0.4	1.9	34.8	4.1	1.1	26.3	13.9	18.8	21.2	0.3	0.5	31.2	18.6	1.3	1.1	1.8	1.7	1.6	2.3	29.0	24.8	66.4	2.9	1.0	28.4	11.1	26.2	6.3	7.6	1.1	24.6	21.2	7.1	0.8	0.2	0.7	0.2	0.6	1.9	5.3	3.6	7.4	2.6	0.9	7.7	4.5	6.1	4.6	1.9	7.2	2.8	12.3	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6	8.9	13.1	10.4	21.3	14.2	2.8	11.3	17.8	72.3	14.8	43.6	0.0	0.5	58.0	9.9	14.1	16.1	17.1	70.0	16.2	0.4	10.2	18.1	12.7	74.1	13.2	1.6	16.7	19.0	13.3	43.8	27.3	13.9	8.5	1.0	22.4	20.4	6.7	17.5	38.5	60.3	1.5	45.3	19.4	7.2	8.4	13.0	0.3	7.5	39.1	17.4
HNRNPLL	HNRPLL	ENSG00000143889	"Heterogeneous nuclear ribonucleoprotein L like"	Q8WVV9	2	38561978-38603586	"Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046084	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA046084: AB_10960895"	"unprognostic (2.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-2)"	16.6	19.5	14.9	13.3	16.2	47.3	20.0	22.1	17.5	18.2	16.4	10.8	17.0	16.2	21.9	19.4	14.4	17.6	16.5	14.3	17.8	11.8	12.5	11.6	17.6	12.1	13.2	19.2	19.9	16.8	18.8	16.4	13.8	10.9	16.8	13.0	13.5	14.0	22.8	13.1	12.0	13.6	14.2	12.8	12.0	16.3	24.8	12.4	40.0	19.2	11.5	11.5	20.8	26.4	1.0	6.9	5.3	3.6	3.6	21.7	3.5	16.8	7.9	23.2	13.6	11.3	10.7	14.5	15.9	13.1	14.0	11.7	8.9	9.8	0.2	14.3	14.2	14.9	10.8	14.6	11.9	14.4	25.1	12.7	12.3	14.9	22.5	10.7	22.9	12.7	8.4	9.5	11.5	12.9	13.8	14.5	11.3	20.8	38.2	16.3	7.8	24.9	12.5	23.3	16.3	14.5	4.9	16.3	8.2	11.9	22.2	15.9	17.8	14.0	12.3	11.7	13.5	10.4	9.9	15.0	10.5	15.7	11.4	13.0	20.9	20.9	0.1	9.0	5.7	12.7	5.3	3.6	5.1	6.2	1.8	11.0	0.2	15.1	11.6	6.9	1.0	4.6	2.9	2.5	3.6	0.7	0.1	21.7	3.5	14.9	16.2	22.1	17.5	17.8	11.8	13.2	19.2	10.9	12.4	17.9	18.9	4.2	29.5	25.4	12.6	14.4	2.5	10.7	19.4	26.2	7.9	22.8	16.6	20.6	114.5	19.1	12.9	0.0	21.3	24.7	25.6	21.8	9.2	6.4	22.1	6.4	13.8	19.6	15.4	35.0	25.6	26.7	37.1	31.5	16.9	24.6	17.7	17.5	49.1	16.3	10.4	38.8	23.7	68.1	29.6	18.6	18.5	17.5	18.7	17.6
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	35	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	47.2	0.6	0.0	0.8	0.2	11.7	3.1	2.4	0.1	0.6	0.0	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.0	0.3	13.3	0.3	0.5	0.1	0.5	0.0	0.0	0.9	0.0	0.0	2.2	0.1	5.8	8.6	16.6	0.2	9.1	0.0	2.6	0.0	7.7	0.1	0.1	9.3	0.6	6.0	29.8	4.6	0.6	0.0	2.5	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.3	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6	0.0	0.0	1.9	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.6	3.3	0.5	0.1	0.3	0.7	0.0	0.0	1.7	0.4	0.9	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	2.1	1.0	4.2	0.0	6.6	1.0
HRASLS2	FLJ20556	ENSG00000133328	"HRAS like suppressor 2"	Q9NWW9	11	63552770-63563383	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 16.1;intestine: 42.5"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 16.1;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	12	"B-cells: 16.1"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 54.4"									HPA058997	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.4	0.0	0.4	1.5	0.4	0.0	4.7	0.4	0.4	0.6	20.6	0.5	0.4	33.4	0.6	1.1	0.5	2.1	0.4	1.0	0.4	0.2	5.5	1.9	3.3	1.1	0.4	0.4	0.4	0.4	0.0	0.4	1.4	0.4	0.4	6.5	0.4	0.7	0.4	0.4	0.2	42.5	0.4	0.4	0.7	8.8	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	16.1	0.8	0.1	0.1	1.2	0.9	3.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.4	0.0	0.4	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	3.5	0.8	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	54.4	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.9	16.1	0.2	0.9	0.0	5.3	0.2	0.6	0.1	1.2	0.0	0.8	0.0	3.6	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	0.4	0.4	3.0	0.6	3.0	19.5	0.1	0.0	0.3	5.1	45.5	5.7	0.0	0.0	0.1	8.3	0.4	0.3	0.0	59.0	0.0	0.4	0.3	0.0	6.2	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	7.0	0.0	75.2	0.0	0.0	0.0	0.7	0.1	0.0	0.7	1.0	0.9	43.6
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212082-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell type enhanced"	"Detected in some"	24	"Horizontal cells: 1.6;Rod photoreceptor cells: 3.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.6;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.2;TIME: 1.2;U-2 OS: 1.6;U-2197: 1.5"									HPA031469	Uncertain		Approved	Mitochondria		No	No		210000000	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.3	0.4	0.0	0.1	0.2	0.1	0.3	0.0	1.3	0.7	0.1			0.1	0.5	0.0	1.8	0.8	0.6	0.5	0.1	0.1	1.0	0.0	0.1	0.4	0.0		1.6	1.5	0.0	0.4	0.1		0.6	0.0		0.2	0.0	0.1	4.0	0.2	0.0	0.1	0.1	0.1	1.3			1.6		0.0	0.4	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.6	1.2	0.1	1.6	1.5	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914648-87109998	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.8	28.7	15.5	9.6	25.2	2.8	7.3	8.9	15.1	10.3	9.5	6.2	5.4	8.6	9.0	9.4	6.4	6.5	9.6	6.8	14.7	10.2	12.8	15.5	8.0	9.7	9.2	13.8	12.3	9.0	15.9	12.1	7.5	10.1	8.9	8.3	8.2	8.3	9.7	5.3	7.2	8.0	7.1	7.6	18.6	7.2	8.0	7.7	16.5	11.8	4.3	10.0	9.2	7.1	5.6	1.3	9.0	4.3	1.8	3.0	1.8	9.9	8.5	25.0	16.3	13.9	40.6	8.7	9.7	12.8	8.2	9.1	32.4	12.8	21.9	9.5	6.7	14.2	6.1	11.4	8.1	13.3	17.1	9.5	26.3	9.4	25.8	5.8	13.5	13.2	16.7	7.2	13.2	11.0	13.0	12.1	12.4	17.9	11.6	11.8	3.5	13.5	8.2	8.7	10.9	5.6	16.8	23.7	4.7	10.0	20.9	5.4	8.1	12.9	11.1	11.2	6.8	7.3	6.2	10.6	10.3	12.8	18.0	12.2	10.7	7.9	20.6	6.3	9.8	10.5	9.0	2.0	1.7	2.6	1.2	3.0	2.0	2.8	2.8	1.3	5.6	2.8	1.8	2.1	1.8	4.3	1.3	1.5	1.8	15.5	25.2	8.9	15.1	14.7	10.2	9.2	13.8	10.1	7.7	14.9	11.3	8.0	7.0	14.7	8.7	11.5	15.3	9.4	19.4	19.2	3.9	8.0	11.6	13.0	3.6	12.6	10.5	0.0	10.0	7.5	16.7	8.7	18.5	24.1	29.9	7.9	22.4	17.2	12.6	3.0	6.4	11.8	11.8	5.4	13.5	26.9	11.0	3.5	19.1	14.7	16.3	0.0	14.2	7.4	13.9	13.8	3.7	7.5	13.0	6.8
HSCB	"DNAJC20, HSC20, Jac1"	ENSG00000100209	"HscB mitochondrial iron-sulfur cluster cochaperone"	Q8IWL3	22	28742031-28757515	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018447, HPA031518"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018447: AB_1853867, HPA031518: AB_2673919"	"unprognostic (8.19e-3)"	"unprognostic (6.48e-2)"	"unprognostic (9.62e-3)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.30e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.38e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.38e-4)"	9.6	18.8	13.1	9.2	13.9	4.9	12.4	13.7	12.9	14.1	11.6	9.1	20.3	13.7	11.5	8.8	11.8	10.4	11.4	9.6	12.3	8.3	12.9	29.5	7.3	15.5	15.8	9.0	16.5	15.2	6.2	16.1	8.7	10.6	15.9	7.7	8.2	28.2	17.5	14.6	9.2	10.0	8.9	12.2	10.9	12.8	6.0	13.2	6.9	14.4	8.1	10.3	15.0	10.5	12.9	11.3	7.7	14.4	9.7	8.5	5.8	9.3	6.0	2.5	3.8	4.6	11.8	4.8	6.9	9.7	10.3	6.3	2.6	3.4	10.6	3.3	3.8	2.5	6.6	4.8	4.5	4.9	10.0	19.5	3.6	4.7	7.4	9.8	6.6	5.4	7.9	9.9	5.7	9.0	5.3	7.8	3.2	5.6	9.3	4.1	13.5	3.0	6.1	6.0	10.3	14.8	6.0	7.8	11.9	11.1	2.7	8.5	7.7	3.8	14.6	18.4	2.1	6.0	4.1	4.1	14.1	7.4	13.3	6.2	13.1	10.7	9.1	9.9	4.9	9.3	7.7	7.9	3.6	6.3	14.4	7.6	12.9	6.4	7.4	11.3	9.9	7.0	8.5	0.4	9.7	11.0	5.9	4.8	5.8	13.1	13.9	13.7	12.9	12.3	8.3	15.8	9.0	10.6	13.2	20.8	15.8	20.1	22.7	10.3	4.8	6.0	22.9	32.1	26.1	19.2	5.9	13.2	24.9	21.9	3.3	15.8	10.3	0.0	24.7	12.0	16.6	18.9	22.0	33.0	23.7	4.8	19.0	17.2	14.9	2.6	17.3	18.5	13.5	19.8	13.1	9.7	21.0	7.0	11.0	37.1	8.1	6.5	15.6	12.2	16.1	13.7	11.1	17.8	19.7	12.8
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122146-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 42.9;Rod photoreceptor cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Supported	"Vesicles,Intermediate filaments,Mitochondria"		No	No			Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: AB_2679440"	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favorable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	6.0	13.4	16.9	5.6	22.1	3.1	10.2	16.5	18.7	9.7	5.8	9.0	6.7	5.1	11.3	9.4	6.7	11.1	6.0	13.1	14.5	19.5	9.1	4.1	7.6	6.8	11.5	13.2	19.6	4.3	12.6	16.7	7.6	20.8	8.6	6.1	10.5	6.3	10.0	15.2	6.5	4.9	9.4	7.4	7.0	5.3	13.5	8.7	8.6	23.2	5.0	7.5	6.6	6.2	7.4	3.1	14.5	6.6	4.2	6.5	4.4	5.6	6.6	30.5	10.4	11.1	8.0	7.7	7.3	6.9	9.2	4.9	7.3	9.8	11.7	13.1	6.5	10.1	4.0	16.4	6.3	14.6	2.5	10.0	5.6	4.4	16.7	11.6	8.7	10.2	6.1	10.7	12.9	8.3	11.7	10.9	16.0	11.6	14.8	18.1	14.0	18.9	8.7	15.5	3.3	6.9	18.6	10.7	4.3	8.8	6.2	14.4	10.9	18.2	2.9	19.9	16.0	18.2	5.1	9.3	10.4	12.6	7.4	5.8	23.5	18.6	19.1	12.2	6.3	9.4	14.5	5.2	11.7	4.4	3.8	5.6	5.4	4.7	5.2	3.1	7.4	6.1	6.5	6.2	4.2	6.6	0.0	5.6	4.4	16.9	22.1	16.5	18.7	14.5	19.5	11.5	13.2	20.8	8.7	11.9	13.1	5.1	4.6	4.2	18.8	14.1	2.5	10.7	7.9	3.5	13.7	5.9	5.0	6.5	24.6	5.7	2.9	0.0	6.0	4.8	5.4	4.7	1.1	2.9	10.4	42.9	9.1	7.4	6.3	8.8	5.5	5.3	5.0	2.8	3.0	22.6	5.7	2.9	9.6	6.2	38.1	0.0	5.2	27.0	27.0	6.0	7.3	6.7	4.1	3.3
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.0	13.5	10.2	5.1	17.7	17.5	11.7	10.3	6.4	7.4	6.2	25.9	17.0	9.7	5.7	15.1	9.5	17.3	10.9	14.5	9.1	40.5	7.2	10.0	21.8	25.3	11.0	5.6	6.5	18.6	10.5	11.0	8.0	10.8	8.5	11.9	13.9	6.5	20.1	9.9	13.9	5.3	6.0	36.1	17.5	9.1	30.7	14.2	15.6	13.7	7.3	5.2	25.9	17.2	8.7	8.7	24.3	6.9	9.7	10.7	10.0	29.7	10.0	7.7	18.9	4.6	13.2	8.4	6.2	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5	92.3	61.8	13.9	14.4	11.7	9.4	160.9	12.7	48.2	43.3	14.0	5.9	21.7	54.7	13.9	135.8	13.9	29.7	0.0	16.4	25.3	13.4	15.9	30.0	98.6	31.2	6.4	14.3	19.6	18.9	127.6	25.3	23.6	8.5	56.9	28.3	22.3	14.4	24.6	44.2	86.7	14.6	45.3	30.3	11.8	16.2	14.2	26.5	7.5	34.3	26.2
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138554882-138575444	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3100000	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	26.4	76.4	30.9	22.1	33.2	39.8	27.7	24.3	39.5	20.0	28.7	30.4	24.0	27.8	23.1	29.7	28.5	19.1	19.3	55.0	28.2	32.5	59.9	117.7	20.5	22.8	35.5	31.3	28.9	31.9	56.7	25.5	24.6	43.7	25.3	32.7	20.6	26.0	26.4	84.2	24.0	25.7	24.0	29.3	24.6	27.7	18.6	32.0	21.1	41.0	32.8	29.1	23.7	33.1	19.3	24.1	6.6	20.9	20.5	28.3	23.3	32.8	41.5	23.7	45.5	24.9	16.3	48.8	34.8	30.9	39.1	42.6	79.1	35.0	62.9	47.8	25.9	81.7	27.9	63.1	46.7	54.3	31.5	30.9	34.7	37.4	52.7	67.3	34.8	38.5	27.7	70.9	43.2	97.5	18.6	18.5	34.9	43.2	54.2	30.8	40.3	36.5	30.0	34.8	41.2	34.5	41.0	34.3	48.6	43.9	47.3	28.5	21.8	40.3	64.2	131.8	54.2	36.9	40.9	17.7	38.4	24.3	32.0	55.1	66.8	47.8	63.2	47.3	61.5	38.3	6.6	16.9	6.5	24.0	20.9	28.3	19.3	20.6	23.0	24.1	14.1	23.0	22.8	3.9	20.5	20.6	14.1	18.2	23.3	30.9	33.2	24.3	39.5	28.2	32.5	35.5	31.3	43.7	32.0	92.3	107.5	91.5	189.1	78.1	88.6	317.9	48.4	133.8	137.6	94.2	78.5	173.0	189.0	95.9	8.0	72.1	76.6	0.0	92.2	101.6	79.5	116.1	162.9	146.7	117.6	93.8	70.0	42.4	46.7	9.5	62.5	101.4	79.2	92.0	66.7	103.5	85.4	66.6	68.2	159.6	83.0	45.3	128.1	52.3	83.5	64.5	146.8	88.6	107.5	141.4
HSPBAP1	"FLJ22623, PASS1"	ENSG00000169087	"HSPB1 associated protein 1"	Q96EW2	3	122740003-122793824	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 56.9;Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044930	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044930: AB_10961122"	"unprognostic (3.40e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.70e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.24e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.12e-3)"	7.2	9.3	6.7	9.2	6.9	4.5	13.1	3.1	6.7	6.8	6.0	7.0	9.1	4.1	7.9	5.3	5.2	5.3	6.0	6.1	6.0	5.3	7.1	5.8	10.4	9.1	7.8	4.5	5.8	6.3	5.3	9.0	17.0	8.7	5.8	5.9	10.2	6.0	6.4	25.4	7.0	5.9	8.1	10.8	11.4	5.4	16.5	8.3	9.1	10.6	8.9	8.8	7.9	5.6	8.3	9.2	22.0	15.5	4.5	7.2	5.8	4.5	3.5	5.1	4.5	6.1	4.6	9.9	2.3	5.8	5.4	7.6	4.7	3.6	5.8	3.7	1.6	13.6	5.5	7.8	4.3	6.3	3.6	2.1	3.8	4.1	2.7	13.8	3.5	5.4	6.8	15.8	4.4	14.4	5.1	5.0	5.9	2.5	5.0	4.8	2.9	5.0	4.4	5.8	3.5	7.1	5.2	6.8	5.6	5.5	1.7	5.6	5.7	5.3	2.1	19.1	5.0	2.5	7.4	5.0	6.3	3.7	2.0	3.1	5.0	5.0	6.9	3.9	5.2	6.1	13.3	12.1	8.3	4.7	8.6	5.8	8.3	6.1	4.6	9.2	5.6	6.8	6.5	22.0	4.5	15.5	3.1	7.2	5.8	6.7	6.9	3.1	6.7	6.0	5.3	7.8	4.5	8.7	8.3	6.0	7.7	8.7	3.7	9.5	5.3	4.1	2.5	5.3	2.3	5.2	56.9	13.9	3.3	4.6	17.2	4.7	3.9	0.0	5.2	9.6	4.2	2.6	5.8	2.5	11.6	7.9	0.0	12.9	18.1	3.6	8.9	21.8	5.0	17.2	2.6	3.4	3.9	2.6	4.6	3.6	10.8	6.5	3.8	22.6	7.1	6.6	40.6	10.2	3.3	1.7
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	41.2	50.8	42.6	38.2	29.2	30.6	62.0	43.0	22.7	51.8	38.0	170.3	24.9	125.5	56.1	22.4	64.2	42.2	166.7	47.4	73.5	30.8	66.9	89.1	82.2	197.1	27.5	98.7	28.0	34.5	55.0	45.9	80.9	36.5	40.6	69.3	109.7	49.2	38.0	52.8	61.2	99.9	84.2	54.3	106.3	73.7	52.6	90.6	54.4	43.2	55.8	31.7	43.1	46.7	55.2	91.1	32.3	58.6	18.1	32.2	44.7	41.4	67.9	27.6	60.7	104.2	37.8	59.7	34.5	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8	154.9	133.3	218.4	1171.9	219.0	70.0	213.1	150.3	448.3	361.7	75.0	241.5	780.7	318.3	195.2	4.9	145.2	151.1	70.0	125.9	299.2	219.4	456.8	297.3	264.5	289.1	90.6	262.9	61.4	70.1	9.9	120.8	249.2	155.3	160.5	166.4	117.0	164.4	153.9	106.8	589.7	103.4	84.1	310.2	68.2	82.2	181.0	837.2	136.4	347.8	853.1
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58318574	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Club cells: 2.3;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.9	8.9	9.0	6.6	13.9	6.9	9.4	17.0	11.5	7.4	9.2	6.4	7.1	11.3	8.6	8.5	9.4	7.8	7.1	15.9	7.9	9.3	12.1	16.2	6.9	8.2	8.5	10.7	11.0	12.9	8.8	14.2	6.7	7.8	9.6	10.1	9.7	9.2	9.4	35.2	7.2	9.7	12.6	6.0	9.7	8.6	9.8	6.4	6.8	10.7	19.8	9.2	7.8	8.1	23.9	21.6	23.7	20.4	21.3	26.5	13.5	8.2	6.3	9.6	6.8	8.2	9.2	12.3	11.7	8.9	14.6	12.9	13.7	6.2	16.3	3.5	8.4	11.7	7.2	16.0	10.6	15.0	9.1	11.2	9.8	13.9	11.5	8.9	12.8	9.3	11.3	10.9	15.5	9.4	7.8	12.7	12.1	9.6	15.5	9.1	4.8	8.3	6.5	12.4	8.4	14.2	5.8	6.1	11.7	9.8	12.1	6.0	9.0	7.2	6.8	13.3	10.6	9.1	11.4	7.4	12.4	8.8	11.2	14.3	11.9	21.3	12.7	10.0	9.5	7.5	13.5	17.3	23.7	18.7	20.4	20.1	23.9	18.7	23.5	17.5	23.8	26.5	20.2	18.4	21.3	16.7	21.6	13.4	13.5	9.0	13.9	17.0	11.5	7.9	9.3	8.5	10.7	7.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529377-74533348	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	16.4	12.7	10.6	14.9	11.3	18.9	12.9	10.7	17.7	12.3	12.8	12.6	9.7	12.6	12.9	6.9	10.7	10.6	9.0	12.9	11.6	8.7	13.1	11.4	11.3	13.2	10.8	11.9	18.7	12.9	10.5	9.0	10.4	13.5	11.6	5.5	10.2	13.1	9.2	17.6	9.0	12.6	11.8	9.1	17.3	11.8	13.9	12.6	12.2	16.8	12.6	9.3	10.4	15.2	12.9	9.4	5.9	8.1	5.5	7.8	7.0	8.0	5.0	5.7	5.0	7.9	3.2	15.4	7.0	3.7	4.2	2.5	9.2	3.6	7.3	5.5	4.0	11.8	9.1	6.8	8.0	1.1	16.4	13.6	14.6	4.8	8.1	7.4	6.8	10.7	3.8	5.4	8.0	6.8	6.8	5.3	12.3	19.1	10.8	3.2	5.3	12.6	14.4	4.8	9.6	14.3	8.6	16.3	8.0	3.5	3.3	6.7	8.0	3.8	8.6	13.3	3.4	3.9	6.6	3.7	7.4	9.1	14.9	15.6	13.3	4.4	4.7	6.4	10.8	5.9	5.9	8.1	4.8	7.3	6.2	7.8	12.9	7.3	6.2	9.4	11.6	6.3	6.4	3.2	5.5	4.7	6.6	7.4	7.0	10.6	11.3	10.7	17.7	11.6	8.7	10.8	11.9	13.5	12.6	0.0	3.7	23.9	16.6	18.3	12.1	0.8	17.8	9.4	9.1	10.4	0.0	20.6	29.9	26.3	24.4	29.4	13.6	116.8	15.4	31.8	26.6	15.0	26.5	10.6	27.5	9.5	8.6	16.5	9.5	32.5	23.0	17.8	28.7	36.1	10.3	19.0	22.8	14.2	19.4	29.1	11.9	25.8	26.4	55.8	34.3	19.3	16.9	25.4	19.8	12.9
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
IBA57	"C1orf69, FLJ12734"	ENSG00000181873	"IBA57, iron-sulfur cluster assembly"	Q5T440	1	228165815-228182257	"Disease related genes, Predicted intracellular proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030555, HPA030556, HPA030557"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433"	"unprognostic (3.00e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.01e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.71e-9)"	"unprognostic (4.94e-2)"	"unprognostic (5.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (7.14e-2)"	5.2	7.5	4.7	5.3	5.5	8.2	6.1	7.8	5.1	4.7	4.5	4.1	3.8	4.5	5.3	4.2	4.7	3.8	6.8	7.9	4.9	3.2	5.8	9.5	6.3	12.7	3.5	4.5	5.9	18.3	7.4	2.9	6.4	5.2	4.5	3.9	4.9	5.3	3.1	22.9	8.0	5.7	4.9	3.5	4.9	5.3	3.1	3.2	5.0	5.2	6.4	4.7	3.6	3.7	2.8	3.4	4.7	1.7	2.8	3.5	0.9	3.3	3.5	3.8	1.7	2.0	2.3	4.6	2.0	1.0	1.6	0.9	7.3	2.9	7.2	4.5	2.2	0.9	6.2	2.9	4.4	1.4	1.5	6.3	4.3	4.3	3.5	1.7	4.8	4.8	3.1	2.7	1.8	2.2	1.5	2.2	4.6	7.1	3.4	1.5	2.6	4.8	2.9	2.8	4.6	4.0	6.0	4.3	1.2	2.3	6.9	5.8	4.0	3.4	10.5	2.6	0.7	8.3	6.6	5.1	4.3	4.0	2.9	5.1	2.5	1.2	3.7	1.9	2.0	3.2	4.7	1.7	0.8	2.3	1.4	3.5	1.5	1.9	1.8	1.2	2.8	2.8	2.6	2.7	2.8	1.5	3.4	1.7	0.9	4.7	5.5	7.8	4.6	4.9	3.2	3.5	4.5	5.2	3.2	8.9	14.1	9.1	7.6	7.2	5.4	13.5	5.1	4.0	13.6	0.0	11.8	9.6	6.6	4.4	17.2	6.7	9.9	23.3	5.8	7.0	4.2	5.1	15.0	7.3	4.8	3.2	6.9	5.5	4.3	24.4	3.4	4.4	6.8	2.8	5.6	5.4	7.1	5.3	6.7	5.4	19.9	6.5	4.1	11.9	11.2	5.3	13.6	5.4	9.5	7.4
ICA1L	"ALS2CR14, ALS2CR15"	ENSG00000163596	"Islet cell autoantigen 1 like"	Q8NDH6	2	202773150-202871985	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 62.5;Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042507	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042507: AB_10797016"	"unprognostic (4.14e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.05e-4)"	"unprognostic (1.66e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.50e-4)"	"unprognostic (4.15e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.58e-3)"	3.3	7.3	11.6	2.2	15.6	5.4	3.8	24.8	19.8	5.8	5.2	8.5	4.1	2.3	10.1	8.9	4.2	12.6	5.5	6.5	11.1	12.1	3.3	1.2	3.2	2.2	7.3	14.0	9.4	3.2	15.2	22.6	7.6	9.1	8.8	2.7	5.8	1.9	9.5	8.1	3.0	2.0	7.6	7.2	2.2	3.6	11.9	7.8	1.0	7.8	1.8	2.1	4.5	3.2	5.3	4.6	4.2	5.3	6.7	4.2	1.6	1.6	1.2	2.8	8.4	2.8	5.1	20.8	2.7	3.7	1.9	2.5	1.6	0.6	1.6	0.8	3.3	4.7	0.8	4.0	1.4	2.5	2.0	3.2	3.3	1.6	1.8	1.6	4.1	2.2	2.0	2.4	1.9	1.5	4.9	2.3	5.8	2.8	1.5	2.3	0.7	3.5	5.5	7.9	0.5	2.9	4.2	4.1	0.7	1.6	3.7	8.0	8.1	4.1	0.2	1.7	2.5	1.0	3.1	1.6	7.4	1.8	1.5	4.0	5.7	8.1	4.8	4.0	1.3	1.4	2.2	2.6	1.5	2.6	2.7	2.2	4.0	1.9	2.1	4.6	5.3	3.1	4.2	4.2	6.7	5.3	2.8	1.8	1.6	11.6	15.6	24.8	16.9	11.1	12.1	7.3	14.0	9.1	7.8	8.9	11.4	2.9	3.3	1.8	62.5	11.8	2.5	40.2	13.6	17.4	56.9	13.7	0.0	4.2	21.4	4.7	1.1	0.0	4.3	31.3	12.4	4.0	5.8	1.1	3.3	15.9	18.5	4.9	4.1	24.6	29.4	6.8	6.8	1.0	1.5	26.8	3.3	0.0	43.5	2.2	78.4	0.0	5.7	29.9	7.6	1.9	6.3	5.7	1.6	2.2
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		370000000	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.7	1.3	1.0	3.0	1.6	1.3	1.7	1.7	1.1	1.4	1.2	1.1	1.8	0.0	5.8	1.5	0.0	1.1	0.0	1.2	0.4	20.3	0.8	5.2	1.2	5.1	0.8	18.7	21.1	1.1	1.0	1.6	0.6	1.5	0.6	10.9	2.8	65.6	1.6	5.5	2.4	42.3	0.7	6.9	9.2	1.5	0.6	49.2	1.4	2.4	0.3	1.3	1.4	4.6	3.7	0.5	4.0	5.3	1.1	6.5	0.5	7.1	1.6	3.2	34.9	7.8	4.6	34.5	5.0	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0	3.0	43.3	138.5	7.1	7.2	0.1	0.0	25.5	9.4	4.5	5.2	0.0	10.4	53.0	13.7	4.2	18.0	53.5	0.0	30.7	20.6	13.1	14.3	30.0	150.6	21.1	1.6	5.2	26.4	110.3	7.2	5.8	19.9	52.3	12.6	29.1	1.5	17.7	45.3	3.9	54.2	1.2	0.0	13.3	0.5	0.9	7.3	3.9	189.2	31.2	8.4
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 682.3;Distal tubular cells: 989.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		53000000	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.3	5.9	30.6	30.3	4.3	5.2	26.0	13.0	19.8	12.3	13.2	2.8	9.0	12.3	3.7	10.7	11.7	3.6	4.4	3.9	5.8	24.2	2.9	21.0	2.2	20.6	5.2	14.4	21.3	11.0	2.2	2.9	2.3	14.9	25.1	43.6	3.1	10.6	9.4	30.2	69.1	22.4	9.1	14.2	2.4	58.6	21.9	36.7	18.9	12.5	44.1	22.4	16.1	64.4	5.2	17.8	51.9	44.5	6.0	21.9	3.2	2.8	6.0	17.5	3.2	1.4	7.0	30.3	12.6	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6	6.0	21.8	67.0	66.5	35.4	5.3	402.1	104.4	56.2	21.6	71.5	9.8	682.3	989.8	188.2	4.7	25.3	53.5	23.3	255.6	386.0	36.6	189.5	30.1	240.4	229.9	9.5	59.3	41.1	60.4	2.5	13.0	70.5	55.6	96.4	122.1	17.5	127.7	132.1	33.2	128.5	5.1	12.9	38.3	0.5	4.5	58.6	479.2	123.2	268.2	90.1
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	16.0	22.0	4.0	14.0	10.0	10.3	8.7	19.1	9.3	15.7	11.9	15.7	9.8	34.2	14.2	11.2	23.2	24.3	37.2	14.8	14.5	15.0	12.3	13.2	23.9	7.1	8.6	25.6	18.9	7.8	9.1	15.2	16.0	7.5	9.8	12.2	16.9	14.1	9.9	15.3	18.7	6.8	4.9	9.3	8.3	10.9	17.2	10.6	13.0	21.9	16.0	6.2	21.9	31.4	17.8	7.7	12.5	13.9	10.0	18.5	17.1	24.3	30.8	16.1	35.8	18.2	13.0	24.5	14.4	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8	8.9	13.9	26.8	49.8	49.7	32.4	15.3	10.2	40.2	11.4	24.4	35.3	35.1	69.6	20.4	40.5	16.4	42.3	0.0	15.5	32.0	20.6	24.1	26.5	21.2	23.7	25.4	18.5	11.1	22.8	17.5	19.2	26.5	25.3	6.4	36.6	24.2	18.9	28.8	22.3	37.6	27.3	12.9	34.3	41.4	22.6	36.0	57.2	20.3	49.2	35.8
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase 3 (NAD(+)) beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	19.5	20.0	19.4	15.5	31.7	20.6	18.5	32.1	30.5	16.4	23.9	16.9	14.5	30.5	19.2	16.7	20.7	17.9	19.2	57.3	19.8	20.0	29.7	25.2	15.1	17.6	24.0	29.4	20.2	15.2	27.6	12.2	17.0	31.2	15.4	25.6	16.2	19.3	19.5	75.5	20.9	24.9	21.5	17.1	19.2	19.9	19.6	16.0	19.7	19.1	37.7	22.5	16.7	17.4	34.7	49.4	25.8	44.7	29.5	38.6	33.9	26.5	36.0	16.5	14.4	18.2	14.4	19.0	14.3	18.3	33.8	27.0	46.4	28.0	30.0	13.1	19.6	31.2	37.5	30.4	46.4	31.1	8.3	23.8	36.4	14.0	48.0	17.9	39.6	8.0	19.0	17.9	31.5	16.6	14.9	19.9	26.0	46.0	16.8	20.5	14.6	34.4	45.4	32.0	27.4	34.2	28.2	30.1	33.7	19.4	24.9	29.8	21.5	17.6	58.5	30.1	13.3	29.3	17.6	17.7	26.4	16.6	8.9	32.8	22.9	52.4	31.7	12.4	41.0	25.0	22.2	41.7	25.8	33.9	44.7	25.6	34.7	29.4	30.7	49.4	30.6	34.4	29.8	11.9	29.5	38.3	22.9	38.6	33.9	19.4	31.7	32.1	30.5	19.8	20.0	24.0	29.4	31.2	16.0	35.7	26.2	48.5	51.6	50.5	32.7	162.9	58.6	28.1	22.7	22.7	31.4	112.2	132.6	64.7	47.2	52.0	101.0	23.3	88.6	72.5	49.7	37.2	48.4	51.2	85.2	12.7	48.7	37.4	56.7	72.9	41.7	53.5	65.8	90.2	63.3	41.3	56.4	67.7	44.6	135.3	32.3	77.6	67.4	39.5	53.0	52.4	90.7	57.9	90.9	44.0
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	29.1	26.9	15.9	22.3	24.9	20.7	19.5	15.2	21.4	27.0	28.7	22.2	22.2	37.1	26.3	24.4	22.1	21.8	24.0	20.7	9.9	12.2	30.7	13.9	36.5	17.8	28.3	19.4	29.4	23.2	15.0	20.8	22.7	17.4	20.6	15.5	7.7	20.4	21.7	40.8	22.0	22.8	7.1	27.1	35.6	19.4	13.6	32.3	30.1	18.2	20.3	13.9	9.5	32.2	15.1	6.8	13.3	16.7	18.2	17.1	10.7	25.1	35.9	28.1	7.0	47.3	28.0	24.0	18.9	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3	32.8	32.7	56.5	52.5	71.9	33.9	48.4	43.3	30.8	7.9	48.8	27.5	80.9	175.8	81.7	113.6	44.1	164.4	46.7	79.1	82.6	56.8	36.9	91.2	33.0	116.8	17.5	59.8	43.6	88.9	226.7	49.5	66.0	64.1	101.0	81.8	37.0	65.2	122.8	55.2	192.8	37.1	51.8	69.3	14.0	17.0	67.8	92.7	54.5	93.0	43.8
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 68.0;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.2	1.1	1.3	3.7	5.4	6.0	2.3	6.9	2.6	2.1	2.1	3.0	4.3	4.0	3.7	2.5	5.7	0.9	1.6	2.8	9.5	1.0	1.6	3.2	9.4	16.4	1.0	2.0	3.7	2.2	5.7	5.4	3.9	5.9	10.3	1.3	4.6	3.8	19.0	2.6	1.0	0.9	13.8	3.7	3.2	3.1	2.5	6.9	4.0	5.3	6.8	5.5	4.3	5.8	1.6	4.3	5.8	6.0	1.1	0.8	10.7	4.4	6.6	7.6	0.6	5.9	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8	11.9	5.4	5.9	2.6	6.1	7.5	8.7	15.3	22.7	9.1	5.2	0.0	6.3	68.0	10.1	0.3	6.0	10.8	0.0	14.3	3.8	8.4	5.2	19.7	37.2	10.0	9.5	7.0	3.1	9.5	1.1	4.0	7.7	11.8	27.9	10.6	17.7	5.2	11.5	3.9	149.6	3.1	0.0	9.5	1.1	1.5	5.1	2.5	17.5	7.8	2.7
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666061-27672218	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 225.6"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	32.3	27.5	24.9	13.5	28.2	37.3	10.9	14.2	36.1	11.4	13.8	22.9	6.5	16.5	26.8	68.0	8.6	11.9	113.9	19.3	23.0	42.3	44.8	23.5	31.6	5.8	20.0	17.0	14.1	21.3	5.9	60.1	225.6	34.3	13.9	10.1	31.6	111.4	10.1	7.4	5.4	12.5	17.0	26.0	27.3	35.4	15.4	6.8	24.8	35.2	7.9	9.7	7.8	7.6	9.7	19.4	84.9	58.6	15.8	27.5	16.8	1.4	0.4	2.2	1.4	7.3	4.0	9.0	4.7	21.7	134.5	157.3	0.7	5.7	0.5	54.1	2.1	35.6	0.5	0.5	1.0	4.4	11.1	1.8	3.4	1.1	0.4	1.9	1.1	4.5	4.3	0.1	8.1	0.1	2.1	1.2	3.1	0.2	9.5	1.5	0.4	4.1	14.5	0.4	2.7	4.5	2.8	1.2	1.3	1.1	0.0	3.2	2.9	5.8	1.3	95.5	0.7	0.6	4.4	2.1	1.2	1.9	0.9	0.8	11.3	6.4	0.3	2.4	10.1	3.5	29.3	44.4	39.4	22.7	58.6	22.4	9.7	23.0	20.7	19.4	8.0	24.3	23.6	84.9	15.8	38.8	2.0	27.5	16.8	24.9	28.2	14.2	36.1	23.0	42.3	20.0	17.0	34.3	6.8	131.0	105.4	20.9	17.6	20.8	10.1	13.4	73.9	88.3	37.5	61.1	9.8	3308.6	16.6	186.8	2.9	139.0	7.0	0.0	304.1	1015.8	142.9	71.5	60.2	43.3	628.8	3.2	56.0	68.2	47.6	8.5	102.4	129.6	67.4	56.9	22.2	79.9	144.2	8.7	192.3	28.3	5.5	109.9	38.2	1.7	0.9	19.6	3573.6	51.2	8.0	13.6
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327894-89340971	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 80.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 80.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;BJ hTERT+ SV40 Large T+: 82.1;BJ hTERT+ SV40 Large T+ RasG12V: 95.4"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	50.5	15.7	14.9	11.3	17.3	22.1	10.6	6.9	17.0	6.8	9.7	7.6	4.1	14.5	8.8	16.8	6.2	10.9	15.1	8.9	14.2	12.9	19.3	17.0	25.9	10.0	13.5	12.4	11.3	4.3	3.8	5.5	22.9	23.0	9.7	5.4	9.2	19.6	8.1	8.1	5.0	11.3	11.1	18.4	26.0	7.2	5.1	12.1	14.3	14.9	5.5	2.9	11.0	5.9	1.6	2.5	80.0	18.4	0.3	2.6	3.2	6.4	0.4	0.1	1.7	7.5	8.1	0.0	4.1	35.1	82.1	95.4	0.3	9.2	0.5	1.8	6.6	19.1	5.8	0.1	0.8	6.1	0.9	0.0	2.4	1.8	0.2	4.3	0.7	2.1	5.0	0.1	7.1	0.6	3.1	0.5	0.2	0.1	1.4	2.1	0.0	1.5	1.9	0.1	0.0	2.0	1.5	0.5	0.4	2.3	3.0	0.0	0.0	0.7	0.1	16.1	0.2	0.2	0.8	0.6	1.3	0.2	2.2	1.0	2.3	1.8	0.1	1.9	3.0	1.3	15.2	7.5	26.6	0.7	16.0	0.1	1.6	1.1	0.5	2.5	1.4	0.7	0.8	80.0	0.3	18.4	0.5	2.6	3.2	14.9	17.3	6.9	17.0	14.2	12.9	13.5	12.4	23.0	12.1	47.6	8.5	5.9	8.9	2.9	7.9	30.7	12.7	16.0	15.9	8.7	3.9	3.4	18.3	47.8	0.3	46.8	13.4	0.0	31.7	6.8	10.8	7.2	12.8	11.0	32.4	57.2	0.0	15.4	21.3	0.0	28.1	21.7	3.3	10.0	2.5	23.1	19.3	5.1	26.5	8.8	1.8	45.3	10.2	0.9	1.0	1.6	1.6	4.9	2.5	5.5
IFT27	"BBS19, RABL4, RAYL"	ENSG00000100360	"Intraflagellar transport 27"	Q9BW83	22	36758202-36776256	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 246.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"U-138 MG: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018418	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018418: AB_1856029"	"unprognostic (3.04e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.06e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (9.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.62e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (5.55e-4)"	10.9	17.0	21.1	12.7	27.4	8.5	9.2	13.4	20.6	14.9	12.8	15.8	21.9	13.4	12.5	22.1	10.9	40.5	13.0	18.5	19.3	20.6	16.4	17.4	10.2	9.5	19.4	16.4	14.9	17.6	20.9	30.2	8.9	20.0	16.4	11.0	16.1	15.4	19.6	14.7	9.6	12.9	9.9	17.4	9.3	13.7	20.1	14.5	18.6	23.2	6.0	9.8	11.0	11.8	17.7	27.0	23.3	22.6	14.5	19.9	13.9	6.2	7.9	9.3	10.5	7.5	7.2	5.5	5.2	6.6	6.7	6.0	0.3	5.8	6.9	9.0	4.7	9.8	5.8	5.1	5.7	5.2	13.2	13.5	1.8	1.6	0.0	13.8	2.2	8.6	5.8	9.4	7.2	3.3	5.5	7.1	5.7	3.2	5.7	4.5	11.6	2.7	1.9	5.0	12.3	10.3	13.0	0.0	3.8	6.6	4.1	9.0	9.8	5.4	4.2	12.9	8.2	9.4	3.9	4.2	60.8	3.5	7.8	0.9	13.5	8.2	2.4	9.4	5.5	12.8	8.5	22.6	23.3	18.3	16.4	18.2	16.7	15.2	16.8	27.0	17.7	15.1	14.3	8.1	14.5	19.3	20.9	19.9	13.9	21.1	27.4	13.4	20.6	19.3	20.6	19.4	16.4	20.0	14.5	6.0	17.3	15.2	23.2	20.7	32.7	16.8	20.4	246.3	38.7	38.4	27.5	18.3	89.5	24.7	40.8	18.3	24.3	0.0	20.1	14.0	30.5	29.6	33.4	18.6	34.4	28.6	51.2	27.6	14.9	13.6	25.3	19.2	33.7	9.0	39.8	51.0	18.0	14.4	29.7	43.0	34.6	12.9	18.6	105.4	16.8	29.1	14.6	23.5	29.0	23.3
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.3	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	12.2	7.5	6.2	9.6	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.1	13.5	9.5	3.7	3.3	3.8	9.7	10.4	5.0	13.7	7.5	1.4	11.6	3.2	6.3	3.6	17.4	6.8	11.7	8.1	8.6	2.8	5.2	4.1	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6	437.7	206.1	73.5	89.1	36.5	19.9	27.8	48.4	679.9	320.8	48.8	64.8	19.7	99.5	136.8	1393.1	36.5	31.6	23.3	116.3	16.0	63.9	111.6	42.8	4.9	12.7	27.0	54.9	30.7	7.3	2088.2	60.4	26.4	43.9	5.4	28.2	42.9	82.4	31.7	60.5	97.1	66.9	51.8	57.7	146.9	42.2	32.5	12.5	26.6	47.6	75.8
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704305-18726230	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"salivary gland: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 22.7;Distal tubular cells: 18.3"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RH-30: 2.9"									"CAB026459, HPA037851"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB026459: , HPA037851: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.3	0.1	0.7	0.2	3.9	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.1	0.7	0.3	0.4	1.5	0.2	0.2	0.2	0.3	0.3	0.2	1.2	0.5	0.0	0.5	0.2	0.2	0.2	0.0	0.2	22.7	0.2	0.5	4.6	0.4	0.2	0.2	0.2	0.0	2.2	0.2	0.2	0.2	1.3	0.3	0.5	0.2	0.2	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.7	3.9	0.2	1.1	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	1.5	3.6	2.2	1.3	1.5	0.0	2.7	1.2	22.7	0.0	0.0	18.3	2.6	1.0	0.0	0.7	0.0	3.8	0.0	0.6	3.7	2.3	0.0	1.3	1.6	3.5	0.6	0.3	3.2	1.4	0.8	0.0	1.0	4.9	0.5	7.4	3.5	0.7	1.4	0.9	0.0	0.5	0.0	0.4	1.5	0.0	1.7	2.9	7.5
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398775	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.3"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 26.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	17.8	2.6	1.4	8.3	1.7	12.5	11.2	0.8	1.3	8.2	8.1	0.7	6.6	5.1	4.2	5.7	4.5	4.5	14.1	10.5	1.7	1.9	7.4	8.8	39.3	29.6	2.0	0.1	3.3	2.6	0.8	4.6	10.7	1.6	6.3	3.4	5.0	3.0	28.4	2.8	3.2	10.7	7.9	1.9	19.5	4.6	2.4	0.4	2.5	3.2	3.2	6.6	8.2	12.9	0.1	6.8	5.5	0.1	26.8	10.6	1.1	0.9	0.3	0.0	0.0	0.7	0.7	1.6	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.5	0.0	1.9	0.0	13.8	0.8	2.5	0.6	0.1	29.8	5.2	20.0	6.8	1.1	2.2	3.6	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.7	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.4	2.4	0.4	0.0	0.0	0.0	0.1	32.0	2.3	5.5	0.0	2.4	4.2	0.1	10.6	0.1	2.4	3.0	2.0	0.1	0.4	0.8	4.1	26.8	0.0	6.8	2.4	1.1	1.4	1.7	0.8	1.3	1.7	1.9	2.0	0.1	1.6	0.4	0.0	13.3	0.0	1.0	0.7	0.0	1.5	0.0	5.3	3.4	1.8	0.0	0.0	1.7	0.8	0.0	7.1	0.0	0.0	0.5	0.7	2.2	0.8	104.4	6.2	0.1	0.0	0.0	13.5	3.1	0.0	0.3	19.4	3.3	0.0	0.0	0.3	0.7	0.0	0.0	0.8	0.0	6.5	0.9	0.2	0.4	0.9	0.0	22.4	0.0	0.7
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.7	37.3	60.4	55.2	13.1	18.0	35.2	29.3	24.9	49.2	38.6	42.7	26.6	57.2	29.1	26.3	30.1	41.0	65.2	39.6	44.4	36.5	58.0	74.2	32.9	39.8	18.8	53.4	37.1	17.0	17.7	39.0	43.8	18.8	42.0	33.4	63.3	45.0	28.6	37.7	88.5	85.8	72.5	24.2	41.0	65.2	57.5	39.5	19.6	48.6	66.7	48.5	37.7	30.0	21.8	28.6	25.4	34.3	33.7	40.4	38.4	41.8	57.7	38.6	52.8	69.4	22.6	57.1	43.5	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0	92.3	128.4	63.8	84.3	76.5	92.4	59.0	50.9	96.4	131.9	40.1	80.5	65.6	23.2	66.6	12.8	60.9	40.0	46.7	69.0	90.4	57.8	80.9	92.6	46.1	63.0	89.0	109.3	33.7	53.5	14.4	70.8	66.0	37.1	46.9	68.0	70.5	72.3	56.1	58.7	38.2	92.6	32.3	67.0	108.6	117.8	67.2	59.3	68.2	82.6	87.0
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.2	15.0	39.6	11.7	5.3	3.6	7.4	13.6	3.0	5.7	4.4	11.4	7.9	10.7	9.5	5.8	16.5	11.9	13.6	10.3	8.6	14.4	28.8	12.6	22.4	14.5	5.7	16.5	12.2	3.0	9.2	3.3	7.4	15.9	6.1	21.7	20.2	12.9	5.4	12.7	20.7	23.7	8.0	42.7	13.2	16.3	34.2	10.4	19.4	12.7	10.9	12.5	15.8	7.9	13.5	26.8	18.0	16.9	2.9	13.4	13.3	10.4	21.7	11.8	24.4	18.6	17.6	11.3	13.1	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6	32.8	10.5	28.2	25.1	16.3	29.6	46.2	20.4	24.1	9.1	57.6	31.4	31.7	101.2	15.6	27.8	14.6	14.3	23.3	21.0	26.9	15.5	23.7	20.9	35.9	18.2	41.3	54.3	17.8	9.5	7.0	12.4	11.6	8.5	10.8	27.6	51.1	14.4	21.0	19.4	81.2	35.9	32.3	15.3	62.7	19.8	23.8	19.8	28.7	31.9	22.3
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.9	4.7	2.8	11.8	7.6	7.8	5.0	5.5	5.5	3.7	3.9	2.3	9.2	13.0	15.0	4.7	6.8	4.5	3.0	10.9	6.1	8.1	3.1	4.4	18.9	6.4	11.7	8.2	0.5	13.5	14.6	1.5	10.2	16.7	4.8	12.2	14.2	10.1	2.7	5.5	10.8	9.2	2.8	15.1	7.4	2.3	23.7	6.8	13.3	3.4	3.4	10.5	2.4	11.2	30.2	8.5	4.5	4.8	3.0	5.6	5.9	5.6	6.5	5.8	1.5	7.9	6.2	3.9	29.5	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6	17.9	10.4	9.1	30.1	29.2	10.8	17.3	10.2	12.0	18.2	45.4	7.9	18.7	135.9	25.4	7.3	16.5	7.1	0.0	7.2	20.5	12.8	27.2	3.5	21.5	10.0	7.9	18.6	7.4	5.9	4.0	45.8	4.9	20.3	14.4	6.8	10.4	12.7	5.9	32.9	52.2	15.8	12.9	24.0	17.5	9.1	23.2	13.6	4.3	10.0	16.1
IMMT	"HMP, Mic60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195770	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		240000	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	20.0	36.9	15.6	17.0	23.5	15.3	15.4	17.5	27.1	13.6	24.8	16.0	15.4	25.1	16.5	13.6	19.1	13.9	12.3	67.3	15.1	18.0	37.5	35.1	14.3	17.7	18.4	18.8	13.3	23.1	31.4	17.6	21.6	32.2	12.8	26.3	17.3	16.7	21.2	78.6	15.4	25.6	17.9	12.1	20.0	22.0	28.3	15.0	29.1	16.2	38.3	19.9	18.0	14.1	10.9	21.5	7.6	21.6	13.2	16.1	14.4	33.9	33.5	30.4	13.9	29.6	27.3	31.1	24.4	25.6	33.0	30.1	48.1	27.0	52.0	24.5	25.8	27.2	25.3	38.9	35.2	40.5	21.0	31.7	41.1	21.2	56.9	30.1	39.6	28.2	31.2	25.7	31.1	37.2	20.8	37.2	30.1	40.0	29.6	31.9	29.2	39.4	41.4	36.2	52.1	26.7	26.3	65.1	46.8	37.7	38.5	37.0	27.5	25.0	38.1	37.2	25.1	21.6	28.1	27.9	23.7	26.2	34.3	30.2	23.6	29.8	35.7	27.0	47.3	28.7	7.5	18.6	7.6	16.1	21.6	14.6	10.9	14.4	13.3	21.5	8.8	13.1	15.5	2.5	13.2	19.9	11.1	14.9	14.4	15.6	23.5	17.5	27.1	15.1	18.0	18.4	18.8	32.2	15.0	50.6	42.2	33.5	27.5	20.7	39.1	201.3	17.8	52.2	63.7	38.4	31.4	84.0	112.7	49.3	128.3	35.3	53.1	23.3	46.0	62.7	35.8	15.4	45.2	57.1	62.8	22.3	53.9	35.6	49.3	95.4	25.6	41.4	16.9	81.2	42.6	25.5	37.2	31.7	34.6	68.6	39.4	6.5	37.2	87.7	51.5	21.8	82.4	36.6	63.4	30.8
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.2	9.7	2.6	4.6	3.4	2.5	60.5	1.6	4.3	0.7	1.0	7.8	5.0	1.3	3.8	2.3	5.7	4.3	3.1	1.6	0.2	7.4	3.8	0.0	12.7	6.7	2.0	10.7	0.5	5.8	8.7	2.3	1.2	2.0	0.9	7.0	1.5	0.0	2.5	6.2	4.3	5.6	9.1	67.8	7.3	7.3	7.3	6.4	29.2	3.5	3.5	0.0	36.5	8.3	3.5	3.4	7.8	13.4	0.0	1.3	2.5	17.9	1.6	5.0	13.3	3.7	5.8	7.2	2.2	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0	17.9	25.4	6.9	15.2	93.8	0.2	10.6	45.9	9.4	9.1	21.0	0.0	35.5	373.0	57.8	2.3	5.8	44.1	0.0	96.5	196.1	13.1	33.2	2.3	62.3	36.5	0.0	16.8	8.6	39.4	4.7	4.4	16.7	13.5	4.6	70.8	21.8	73.4	51.8	3.5	383.7	0.9	103.5	9.5	0.4	11.7	123.6	88.9	4.4	78.2	45.7
INTS14	"C15orf44, DKFZP564O1664, VWA9"	ENSG00000138614	"Integrator complex subunit 14"	Q96SY0	15	65578753-65611289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 32.4;Extravillous trophoblasts: 24.9;Syncytiotrophoblasts: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040255, HPA040651"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria"		No	No			"Nucleoplasm, Nuclear bodies, Mitochondria"	"Nuclear membrane"	"HPA040255: AB_10805710, HPA040651: AB_10796559"	"unprognostic (2.92e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.30e-1)"	16.6	20.2	12.1	14.1	14.9	13.1	20.2	12.0	19.1	20.1	20.0	20.8	17.3	12.3	25.5	25.3	19.6	22.3	18.4	12.4	11.3	12.9	22.7	23.2	14.4	17.5	14.1	10.4	20.2	22.0	16.1	23.5	23.5	13.9	18.9	21.6	19.9	27.5	21.7	11.8	17.5	19.9	17.0	11.9	23.5	17.5	19.7	9.9	32.4	26.1	16.1	24.0	17.7	16.2	13.4	13.6	12.9	8.6	14.8	20.3	10.4	12.0	21.9	22.1	17.6	12.3	15.5	14.2	13.3	17.3	22.3	20.6	19.5	28.6	19.8	18.8	16.6	18.5	24.5	47.0	22.4	19.6	17.3	28.5	17.2	16.3	21.1	24.6	17.6	22.2	15.0	22.4	16.9	26.0	16.5	24.1	30.8	23.6	11.6	15.6	19.2	19.9	17.0	16.1	30.6	12.2	17.2	18.6	22.6	17.3	22.6	15.9	12.6	16.1	16.4	22.3	19.7	15.3	20.5	11.8	15.4	16.2	13.7	21.0	11.5	21.3	26.7	15.5	32.2	17.9	12.9	7.5	3.9	14.3	8.6	16.2	13.4	14.8	16.3	13.6	10.5	15.7	14.3	0.8	14.8	6.2	12.0	20.3	10.4	12.1	14.9	12.0	19.1	11.3	12.9	14.1	10.4	13.9	9.9	20.8	7.5	0.0	0.0	0.0	0.0	0.0	0.0	20.1	10.3	12.2	0.0	32.4	18.3	15.6	0.0	0.0	0.0	0.0	13.7	24.9	0.0	0.0	7.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	16.2	0.0	0.0	12.8	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	41.6	0.0	0.0	0.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.5;U-937: 15.3"									"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.2	7.2	1.8	2.1	0.0	1.5	3.2	1.8	5.6	0.6	2.6	6.2	5.3	1.3	4.5	4.6	7.0	2.0	1.4	4.6	2.5	5.2	0.5	0.0	1.6	5.3	0.4	2.8	2.0	2.1	2.1	3.2	2.3	4.1	3.3	9.8	1.3	4.5	5.2	16.5	2.9	6.4	2.6	4.3	2.2	5.0	1.5	2.5	1.0	2.3	2.1	2.1	0.2	2.8	2.2	10.0	1.3	4.8	2.7	0.0	1.7	11.3	8.9	9.2	1.6	15.3	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4	11.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	3.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	23.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	10.6	0.0	0.2	0.1	0.1	1.8	6.8	0.1	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.6	1.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.8	0.0	0.0	3.3	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.9	0.1	0.0	0.0	0.0
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383391-51394738	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 30.3"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 82.3"	"Group enriched"	"Detected in some"	8	"basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5"	"Group enriched"	"Detected in some"	11	"basal ganglia: 8.5;hypothalamus: 8.6"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.2	1.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	14.4	1.6	0.0	4.2	2.3	1.3	0.5	0.2	0.0	0.2	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.8	10.0	2.0	13.2	2.5	6.4	1.0	30.3	0.1	1.1	0.7	0.6	0.1	0.0	10.7	1.6	0.7	3.1	0.3	0.2	0.4	2.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.6	1.2	0.9	0.0	0.0	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.8	0.0	0.0	0.0	5.3	82.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.0	0.0	0.2	0.0	5.5	0.0	0.0	2.0	0.7	0.0	0.0	0.0	3.5	1.3	118.7	0.3	0.0	0.0	0.0	0.0	3.9	20.5	0.0	0.0	13.2	0.1	0.0	0.0	0.0	8.9	0.4	1.2	0.0	0.0	2.3	41.3	87.9	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.6	3.4	6.8	0.0	0.0	0.0	11.3	0.0	0.1	0.7	0.7	0.9	28.6	0.0	0.0	3.7
ISOC2	FLJ23469	ENSG00000063241	"Isochorismatase domain containing 2"	Q96AB3	19	55452985-55462343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.9"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 256.8;Proximal tubular cells: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 68.8"					"Low region specificity"	"Detected in all"			HPA043142	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		230000	Mitochondria	Cytosol	"HPA043142: AB_10794653"	"unprognostic (2.74e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.90e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.09e-2)"	12.7	16.4	13.4	12.8	15.0	10.5	28.1	9.0	15.6	10.9	15.9	9.9	17.1	20.6	8.9	13.5	14.7	10.7	19.2	20.9	13.4	12.9	33.2	93.9	11.2	10.2	15.4	11.2	9.1	23.8	12.8	14.2	5.5	14.6	12.0	10.0	7.2	23.3	21.2	47.2	10.0	20.5	12.0	13.9	15.8	12.9	23.3	13.4	5.9	14.9	22.9	11.8	12.8	8.8	11.5	18.1	0.5	20.0	14.1	10.4	9.1	12.7	19.4	5.4	14.4	3.7	7.8	17.2	9.1	9.6	12.1	12.4	9.6	22.8	24.4	17.0	11.1	11.7	12.9	10.4	12.0	4.0	9.3	68.8	13.8	4.7	31.5	14.9	15.4	42.4	11.5	11.6	7.7	5.9	5.5	10.9	10.0	22.5	16.3	7.7	25.3	0.0	18.1	8.3	29.0	55.4	17.5	11.1	31.9	20.0	12.1	6.4	18.1	8.8	20.0	10.3	3.3	16.7	27.6	7.8	8.8	12.6	9.9	10.9	19.8	17.1	19.0	13.9	19.7	15.2	0.4	9.9	0.5	8.3	20.0	8.2	11.5	7.7	10.4	18.1	8.8	7.8	7.8	0.4	14.1	16.1	14.8	9.1	9.1	13.4	15.0	9.0	15.6	13.4	12.9	15.4	11.2	14.6	13.4	6.0	4.6	47.7	58.7	52.9	10.1	19.8	40.8	6.7	4.5	59.3	2.0	32.1	137.6	59.7	16.0	29.2	194.8	0.0	59.2	95.0	50.3	45.4	46.0	256.8	86.3	12.7	68.5	30.1	38.8	34.9	35.9	49.5	59.1	27.9	102.3	53.5	50.1	94.8	29.0	330.6	8.4	25.8	37.6	55.3	11.7	60.0	18.1	24.9	124.1	54.8
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	28.5	71.2	5.1	12.9	48.3	14.1	26.4	30.6	19.0	5.7	9.2	14.2	37.3	0.1	14.9	51.9	28.1	22.9	4.6	15.9	5.0	0.3	3.1	10.1	11.0	14.9	8.4	0.0	18.5	8.4	3.7	14.3	7.5	81.6	19.1	0.0	9.0	15.3	19.5	29.0	0.1	0.1	22.9	16.0	7.9	0.0	8.2	10.7	16.1	6.3	0.1	10.7	22.7	33.8	25.8	9.4	19.1	0.6	49.1	21.5	32.5	18.6	15.8	2.6	2.7	0.1	22.5	0.1	74.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7	6.0	7.9	2.2	18.8	15.2	6.2	26.4	43.3	5.3	10.3	27.9	3.9	56.6	10.0	34.5	7.5	22.6	19.6	0.0	16.3	4.7	30.7	22.0	0.0	32.1	60.3	33.4	3.4	41.1	27.6	2.3	18.7	16.7	10.1	0.0	13.3	47.4	43.9	27.4	15.6	10.2	15.2	38.8	35.3	1.4	6.4	19.4	46.1	0.0	15.0	12.0
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"WM-115: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	32.0	10.2	44.3	11.9	49.5	12.2	14.4	19.3	50.5	23.8	20.0	29.7	9.6	34.9	20.2	10.2	18.7	15.9	16.1	18.4	49.0	30.6	11.4	13.4	13.0	7.6	42.1	27.1	11.4	15.0	13.2	5.3	11.2	18.5	15.1	13.6	14.5	8.3	19.1	9.4	5.5	36.6	19.4	44.8	14.1	11.9	9.4	26.1	3.4	10.0	3.2	5.5	16.7	16.2	1.9	3.9	24.2	13.0	1.3	1.9	2.4	10.3	21.5	4.0	10.2	9.0	5.0	10.8	4.4	6.7	8.9	5.4	12.3	18.7	6.6	22.2	7.0	3.4	12.3	11.5	19.1	2.8	24.4	5.0	14.5	5.7	10.6	6.7	6.6	16.2	3.2	11.5	4.5	10.4	3.9	8.7	6.9	7.9	7.6	4.3	27.9	5.6	9.4	8.4	13.6	9.7	10.8	5.9	9.8	6.0	17.5	10.9	13.8	11.2	22.8	19.0	3.2	30.6	8.1	6.8	6.2	6.8	10.4	7.0	7.5	6.8	4.2	5.7	5.2	42.6	2.5	5.2	9.5	1.9	8.6	1.1	1.9	1.2	1.2	3.9	0.7	0.7	1.3	24.2	1.3	13.0	1.9	1.7	2.4	44.3	49.5	19.3	50.5	49.0	30.6	42.1	27.1	18.5	26.1	11.9	12.0	6.7	6.5	6.5	9.7	21.5	15.3	4.0	5.7	27.9	17.7	6.9	11.6	20.4	8.3	10.1	79.1	0.0	23.9	8.8	7.8	13.3	16.1	25.9	18.3	6.4	27.6	12.3	38.1	17.6	13.8	26.0	25.3	15.4	25.6	15.5	29.8	38.6	45.3	17.0	9.3	19.4	15.3	2.8	12.8	3.9	5.7	9.6	25.9	7.9
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		66000	Mitochondria	Nucleoplasm	"HPA041391: AB_2677449, HPA044250: AB_2678875"	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.7	17.4	15.4	13.5	0.4	13.5	13.2	17.3	10.8	19.8	7.6	0.3	25.8	17.0	14.9	10.3	18.4	19.9	10.7	12.6	14.8	22.7	15.4	19.0	27.1	9.2	22.6	20.6	6.9	9.6	20.2	20.0	17.1	24.4	1.0	1.1	15.5	13.8	11.4	14.3	8.2	0.5	16.9	16.7	13.3	10.4	20.5	23.7	16.6	9.2	18.6	40.5	8.2	9.4	34.9	40.7	14.5	14.4	9.4	10.1	10.8	21.8	14.9	0.3	13.5	9.2	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7	26.8	46.2	14.3	16.6	2.1	24.6	72.6	45.9	42.8	40.9	41.8	13.7	16.5	81.2	15.9	4.4	18.0	17.7	23.3	13.0	4.8	15.4	16.0	32.5	123.8	25.1	15.9	18.9	17.2	20.2	4.9	19.0	13.9	5.0	31.5	22.5	25.1	14.1	3.5	23.3	60.9	18.9	19.4	13.9	19.0	4.3	0.5	8.2	12.2	33.1	11.2
JADE1	"JADE-1, PHF17"	ENSG00000077684	"Jade family PHD finger 1"	Q6IE81	4	128809623-128875224	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020016	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020016: AB_1855292"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.93e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (8.22e-6)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.68e-1)"	20.5	14.6	5.7	12.7	7.9	25.9	27.9	16.3	9.7	10.8	9.8	4.6	18.9	5.6	8.4	9.0	8.1	11.8	14.3	14.2	5.7	7.1	22.1	7.4	12.6	13.2	6.9	4.9	18.6	55.7	17.4	10.8	7.2	7.3	12.0	4.3	8.5	25.6	16.8	10.5	8.6	10.6	16.3	5.4	10.2	12.5	6.1	8.5	13.3	28.7	7.2	7.9	12.1	31.1	12.6	6.9	23.0	14.3	20.1	18.4	10.4	6.1	12.3	12.2	9.0	16.8	11.9	16.1	10.0	6.0	10.9	10.0	10.7	11.0	19.1	11.9	5.7	4.8	2.2	14.3	3.5	12.3	14.8	6.3	10.6	16.9	9.7	29.0	17.3	8.6	13.2	5.7	13.3	9.9	9.1	11.8	12.5	16.9	26.4	8.5	7.5	21.8	13.0	32.8	6.3	6.2	15.6	8.4	10.3	17.4	3.0	15.9	11.6	9.6	7.8	7.7	17.9	6.3	9.8	8.1	10.8	17.8	8.2	11.7	17.5	13.9	21.7	11.8	17.4	8.8	17.2	7.2	23.0	12.3	11.6	15.3	9.5	13.4	13.5	6.9	12.6	18.4	14.5	9.1	20.1	14.3	3.3	9.4	10.4	5.7	7.9	16.3	9.7	5.7	7.1	6.9	4.9	7.3	8.5	35.7	20.1	17.2	15.1	13.3	37.9	30.3	33.1	32.1	19.4	47.1	47.1	22.1	16.6	28.2	2.8	23.2	6.3	0.0	42.1	12.0	18.5	12.6	17.3	35.0	9.1	27.0	9.8	16.5	28.2	3.2	33.4	11.9	20.3	4.6	7.2	27.1	37.2	7.6	45.3	28.6	26.8	84.1	34.0	4.8	22.2	11.7	3.3	31.9	7.3	5.2
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977688	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006514	Approved		Approved	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	23.9	30.2	28.5	23.0	32.7	43.2	32.6	30.7	32.3	31.8	36.0	23.6	51.3	35.9	25.1	41.0	30.4	26.1	37.1	36.2	25.4	23.9	34.2	81.1	27.7	34.7	27.7	19.8	26.9	106.8	24.8	49.8	30.0	24.4	33.4	36.0	24.9	100.6	45.9	42.1	23.4	45.6	21.6	20.5	35.9	42.4	15.3	25.2	30.5	58.5	32.0	34.0	25.2	33.0	47.4	54.1	60.7	43.0	30.4	46.4	30.2	38.4	26.6	11.5	21.0	37.7	23.5	32.4	28.1	27.4	18.8	18.9	25.6	32.0	36.8	39.9	32.5	11.6	35.2	29.0	21.6	15.4	34.7	58.0	21.4	31.7	25.9	39.7	41.0	32.9	22.2	40.9	19.8	23.5	26.0	22.2	42.9	31.6	27.1	13.2	67.0	29.6	52.8	24.6	75.6	47.0	31.3	15.6	73.9	23.8	21.1	31.5	31.9	22.2	64.8	37.6	22.0	40.6	59.7	17.3	9.3	16.1	28.1	35.8	40.4	45.0	39.9	22.9	39.5	20.0	32.6	43.0	60.7	29.4	30.3	35.5	47.4	41.1	46.4	33.4	45.2	42.4	33.7	39.9	30.4	33.4	54.1	33.6	30.2	28.5	32.7	30.7	32.3	25.4	23.9	27.7	19.8	24.4	25.2	74.5	93.5	143.8	144.8	139.2	56.2	87.0	188.5	84.3	73.9	94.2	21.6	271.1	218.8	215.2	5.3	130.2	265.0	46.7	360.4	333.7	188.8	298.2	81.8	277.1	261.0	54.0	203.5	111.1	203.5	13.6	140.4	174.8	161.9	144.3	351.4	98.5	241.9	276.3	116.0	209.1	47.9	103.5	125.2	54.7	68.8	166.2	242.1	188.1	283.1	216.6
KCNAB3	"AKR6A9, KCNA3B"	ENSG00000170049	"Potassium voltage-gated channel subfamily A regulatory beta subunit 3"	O43448	17	7921859-7929803	"Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 36.1;endometrium 1: 17.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 123.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"cerebellum: 36.1;cerebral cortex: 31.6"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 14.9;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077993			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077993: AB_2686872"	"unprognostic (3.02e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.84e-4)"	"unprognostic (2.19e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.27e-4)"	"unprognostic (7.47e-3)"	"unprognostic (3.03e-6)"	"unprognostic (2.12e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.97e-2)"	"unprognostic (9.54e-3)"	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0.0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1.0	0.8	4.9	1.6	5.9	2.3	2.0	3.8	1.3	1.4	1.0	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0.0	3.3	1.0	1.0	0.1	1.7	0.5	0.2	0.0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	2.0	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.2	0.4	1.5	0.7	6.0	1.8	2.3	0.7	0.9	0.0	5.1	0.2	3.0	2.2	1.6	4.6	0.2	0.2	0.3	6.1	0.5	0.3	0.7	1.0	0.8	2.6	0.8	0.0	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.1	0.4	0.0	0.9	0.2	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	3.0	1.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.2	0.2	0.5	0.0	0.0	1.7	0.0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9	3.0	2.4	0.0	0.6	0.5	22.9	0.8	0.0	0.0	1.2	0.0	3.9	0.2	0.0	0.5	0.3	0.1	0.4	0.0	0.5	0.2	1.1	0.6	1.1	0.2	0.7	123.9	0.0	0.6	0.0	0.0	1.7	0.8	0.0	1.8	0.3	12.0	0.5	0.0	0.7	0.0	6.3	0.0	0.3	3.1	1.5	0.4	0.1	0.0	0.2	0.1
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539157-49558308	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5"	"Group enriched"	"Detected in many"	11	"amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0"	"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.9	3.8	24.3	1.5	18.5	1.4	1.0	5.8	30.7	0.9	0.8	0.5	0.0	0.9	1.3	0.9	0.7	8.7	1.7	1.2	22.0	3.0	1.6	0.7	1.2	1.9	1.9	13.0	0.8	1.4	6.3	9.3	0.8	0.0	1.2	0.7	0.0	1.1	1.6	0.8	1.1	1.0	1.0	0.6	1.4	1.4	2.6	2.1	0.0	1.7	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.8	0.4	3.6	0.5	1.0	9.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.3	2.3	0.7	0.2	0.0	0.1	0.4	0.0	0.5	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.3	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	11.8	0.0	1.8	0.3	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.0	12.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.0	3.6	0.0	0.3	1.1	0.1	0.0	1.1	2.6	0.6	0.4	0.1	0.0	0.4	0.5	24.3	18.5	5.8	30.7	22.0	3.0	1.9	13.0	0.0	2.1	0.0	0.3	0.0	0.2	0.1	0.0	0.6	2.5	9.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.6	2.4	1.3	0.8	3.6	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.9	2.5	0.3	0.0	1.0	0.0	0.0
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7;Late spermatids: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 11.2;NB-4: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	3.0	2.0	0.7	2.9	0.7	1.2	3.3	0.2	0.6	1.8	2.0			1.9	2.0	2.3	0.7	1.0	2.4	1.8	1.0	0.9	2.2	4.0	1.2	2.9	1.1		1.6	5.3	3.7	2.1	6.6		2.9	2.2		2.7	1.4	0.5	0.6	2.2	1.9	1.5	5.9	2.6	4.5			2.4		2.6	1.9	1.5	3.5	0.3	2.3	0.4	3.6	1.0	0.0	3.0	0.7	1.2	0.0	1.4	1.1	1.9	0.8	0.5	1.3	0.6	6.5	2.6	0.1	3.0	0.6	2.7	1.1	0.0	0.2	1.5	3.8	0.4	11.2	2.9	2.5	1.2	0.2	3.7	1.9	0.6	0.9	0.0	1.0	1.1	0.1	0.4	0.1	1.5	1.8	0.1	7.6	0.0	1.2	2.3	3.3	0.0	0.1	1.0	2.1	1.5	0.4	1.0	1.2	0.7	1.1	3.1	6.1	0.7	0.6	1.1	0.3	0.9	1.0	0.4	3.6	0.6	4.3	0.8	2.3	0.4	0.5	1.0	0.3	0.6	3.5	0.6	0.8	0.1	2.1	0.4	0.7	1.9	3.6	0.1	0.3	0.9	0.0											0.0	2.2	0.8	1.8	0.2	2.3	0.6	2.5	1.4	2.3	0.0	13.7	1.0	0.0	4.3	8.0	2.7	1.5	0.0	3.1	1.0	1.2	1.6	2.3	1.5	1.0	0.0	4.7	1.8	1.6	10.9	2.6	0.8	0.0	1.0	1.3	1.9	2.7	0.0	2.8	0.0	5.3	6.5	1.4	1.6	1.4	0.1	1.0	0.0	1.1	0.7
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880166-76886390	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 180.7;Intestinal endocrine cells: 371.5;Kupffer cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	17	"dendritic cells: 5.9;granulocytes: 1.6;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;HUVEC TERT2: 61.5;TIME: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria		NA	NA		19000000	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	29.6	7.5	12.1	14.3	17.9	2.1	24.7	11.7	9.4	13.1	10.3	10.3	5.1	5.5	14.2	9.2	10.7	21.6	15.1	10.3	10.5	8.2	8.5	6.4	17.2	21.5	17.0	5.9	13.6	6.8	8.2	6.6	22.9	13.8	9.9	11.7	13.8	8.4	4.9	11.2	7.7	8.4	17.9	14.0	21.3	8.3	10.0	13.5	3.1	8.4	5.8	8.4	11.0	15.0	0.0	5.9	1.6	6.4	0.0	0.2	1.4	0.4	0.4	4.1	0.0	31.0	14.7	1.1	1.8	0.4	1.1	1.5	0.1	0.0	0.0	1.0	4.9	1.3	14.4	1.7	17.6	0.9	0.3	9.4	0.0	10.6	0.0	1.3	4.8	0.0	5.9	5.8	0.7	13.4	2.3	61.5	3.5	0.0	0.0	14.5	0.3	2.1	0.0	2.1	4.3	2.0	0.1	2.0	5.1	4.7	0.0	1.1	2.1	4.6	0.1	0.6	5.2	0.2	3.1	49.3	0.7	1.3	0.1	3.6	0.7	0.1	0.0	11.6	1.0	4.3	0.0	6.4	1.1	0.0	4.1	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.2	1.6	0.0	2.3	3.0	0.0	1.4	12.1	17.9	11.7	7.5	10.5	8.2	17.0	5.9	13.8	13.5	23.8	9.6	6.7	2.5	35.5	1.8	19.3	2.5	116.4	23.9	92.5	13.7	2.6	14.9	3.0	3.1	150.3	2.9	0.0	0.5	82.6	78.3	3.2	6.9	2.1	180.7	0.0	371.5	47.3	375.3	5.6	145.6	119.3	49.0	2.8	70.7	4.3	0.6	0.0	42.1	5.4	1.0	25.8	26.9	1.4	6.0	30.1	3.5	2.2	48.5	1.4
KCTD18	"6530404F10Rik, FLJ31322, FLJ37818"	ENSG00000155729	"Potassium channel tetramerization domain containing 18"	Q6PI47	2	200488952-200519784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045498, HPA058028"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045498: AB_10959387, HPA058028: AB_2683583"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	14.3	14.6	13.7	13.1	15.4	11.5	14.3	9.2	14.8	12.3	13.8	17.4	15.5	11.6	13.5	19.4	16.1	12.5	16.5	14.8	13.6	11.2	13.8	13.3	11.4	14.9	16.3	11.4	15.0	16.5	17.1	13.2	10.0	14.9	15.9	11.7	13.7	14.1	14.0	14.7	12.3	11.3	24.0	17.6	13.0	12.9	9.3	14.6	18.0	19.4	19.9	14.6	17.4	11.7	7.2	7.2	11.4	7.9	7.1	9.6	5.6	7.3	6.8	3.4	12.6	16.4	20.4	8.7	9.0	11.5	5.8	7.7	5.4	8.4	5.2	6.9	9.1	9.5	7.1	3.3	10.9	7.5	12.4	3.6	7.4	4.9	3.8	11.1	6.0	8.8	13.6	20.7	6.7	12.9	13.6	5.0	7.8	5.0	7.1	10.3	7.5	12.9	5.9	1.9	6.3	6.2	9.0	7.7	6.0	7.6	7.3	3.9	5.4	7.1	6.2	10.7	7.7	8.2	9.7	8.3	11.9	2.7	6.0	4.3	13.6	9.8	5.9	13.7	6.4	8.4	11.4	5.5	10.4	5.9	7.9	9.0	7.2	7.7	8.5	5.9	7.1	9.6	9.6	4.4	7.1	5.2	7.2	8.5	5.6	13.7	15.4	9.2	14.8	13.6	11.2	16.3	11.4	14.9	14.6	6.0	6.5	7.5	5.0	3.9	7.0	5.3	10.2	8.1	6.8	3.5	0.0	6.5	1.7	5.8	17.3	5.1	5.9	0.0	7.5	5.9	5.4	4.4	2.3	7.8	6.5	9.5	1.2	9.2	8.3	4.5	10.9	7.6	6.8	16.2	7.9	10.0	5.1	7.0	11.7	9.4	9.3	19.4	4.7	17.6	14.5	3.4	4.2	6.7	8.0	3.1
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492114-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	7.8	8.4	15.3	4.4	13.2	13.5	11.4	35.9	21.8	11.1	7.9	10.0	6.4	5.6	12.3	28.8	10.9	12.4	8.8	7.7	16.9	11.7	15.4	12.2	6.6	9.1	15.3	10.5	13.1	7.1	10.4	14.4	10.9	11.9	9.2	8.1	14.7	7.3	9.4	6.8	7.5	5.3	11.2	12.5	8.8	5.7	5.7	12.4	6.3	14.1	6.3	7.3	6.4	11.9	13.0	20.2	17.1	14.6	8.2	15.6	6.6	5.5	5.3	15.9	6.8	14.0	10.0	5.9	6.7	6.0	9.9	11.7	5.1	3.1	11.0	2.2	4.8	11.7	3.0	12.8	3.9	8.9	11.3	5.8	5.1	12.1	6.3	6.6	4.0	4.1	6.0	6.2	7.9	5.0	23.6	6.5	3.9	2.8	5.3	8.6	5.2	5.9	6.1	11.7	5.0	10.1	5.9	4.4	7.7	9.4	2.6	9.0	7.8	3.8	8.8	4.8	12.7	35.4	2.9	3.5	9.1	8.2	11.6	10.0	5.8	8.9	13.0	7.8	8.2	6.9	17.1	14.6	9.8	13.7	14.6	15.6	13.0	10.1	12.8	20.2	10.3	11.5	9.8	5.0	8.2	10.5	7.8	9.5	6.6	15.3	13.2	35.9	16.2	16.9	11.7	15.3	10.5	11.9	12.4	3.0	2.4	0.9	10.6	7.9	14.6	7.5	7.6	5.3	10.3	8.7	23.6	8.7	16.6	7.1	3.7	9.0	2.1	0.0	3.7	6.3	12.4	5.1	0.0	4.7	6.2	23.8	8.7	4.9	10.3	1.7	10.0	7.2	11.8	4.6	4.2	19.3	3.3	5.5	11.3	24.5	17.9	0.0	12.0	5.6	20.7	8.8	7.3	0.0	7.0	3.0
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 19.4;Spermatocytes: 29.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	2.9	2.9	10.3	2.0	12.9	0.9	2.2	8.8	14.6	4.7	1.3	2.6	1.2	0.6	3.9	3.3	2.7	6.2	2.6	3.4	8.5	8.4	1.3	0.4	1.8	3.1	8.6	5.7	7.4	4.4	5.0	9.6	1.5	4.7	4.4	1.4	2.9	1.3	3.6	2.7	1.0	1.1	2.4	6.2	0.9	2.9	8.2	4.1	5.4	5.9	1.7	3.4	2.2	2.1	2.7	2.6	3.8	0.2	2.5	5.2	2.0	2.9	4.2	0.8	2.3	4.0	4.6	2.0	5.7	5.5	8.8	13.1	4.0	2.3	6.2	2.2	2.5	4.5	2.8	5.9	1.2	6.7	5.9	4.2	4.1	3.4	0.0	5.2	2.0	0.1	5.9	2.5	8.7	2.4	3.7	1.9	6.5	3.0	7.5	3.5	6.9	0.4	1.9	3.9	0.5	8.4	0.9	0.0	5.0	1.4	0.1	10.5	2.2	3.2	0.1	0.2	2.9	0.1	6.2	0.1	1.9	4.0	1.1	6.0	12.7	7.6	4.5	0.1	1.7	0.7	3.8	0.2	0.0	4.4	0.0	2.6	2.7	2.8	4.9	0.7	1.9	2.2	3.4	0.0	2.5	0.0	2.6	5.2	2.0	10.3	12.9	8.8	12.4	8.5	8.4	8.6	5.7	4.7	4.1	0.0	1.0	3.0	3.2	0.7	7.8	1.8	0.0	0.0	2.3	3.5	2.0	1.5	1.7	0.8	9.3	0.3	0.0	0.0	3.3	0.3	3.1	1.7	0.0	0.0	0.4	12.7	0.0	0.0	0.0	12.1	2.0	0.0	3.3	1.0	0.5	11.5	2.3	0.0	3.2	0.0	6.8	19.4	1.9	29.8	12.9	0.5	0.1	4.3	0.9	0.4
KIAA0391	"MRPP3, PRORP"	ENSG00000100890	KIAA0391	O15091	14	35121846-35277614	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	13.9	26.1	18.8	17.6	20.1	12.5	17.5	23.1	21.9	17.4	22.4	20.6	15.6	16.6	13.0	19.4	26.1	14.7	13.2	16.7	17.6	16.3	31.1	29.5	20.9	29.5	20.2	17.7	10.8	16.5	29.8	27.4	13.4	19.2	14.1	24.9	15.8	18.0	21.8	22.2	23.0	16.5	15.0	23.0	18.7	15.8	17.1	20.9	31.2	18.9	21.3	24.8	18.2	16.0	10.0	9.7	10.9	5.4	12.1	25.5	12.4	22.8	18.3	12.7	16.8	13.9	16.5	11.2	15.4	13.8	19.7	17.1	17.3	14.2	25.1	20.1	14.6	5.6	17.8	23.3	26.6	22.3	19.7	7.2	11.3	14.1	36.9	14.4	13.9	12.4	17.6	20.5	18.6	17.2	17.0	28.5	21.6	18.2	7.3	24.0	25.9	21.0	15.3	13.6	19.8	18.1	20.2	21.1	14.5	27.7	23.4	11.8	13.4	19.9	22.1	12.8	17.1	32.2	11.5	21.6	15.2	13.7	11.7	13.2	8.0	18.6	26.3	7.7	15.1	15.9	10.9	5.4	3.4	15.4	5.2	22.4	10.0	23.8	16.6	7.2	7.0	21.2	15.6	6.3	12.1	4.3	9.7	25.5	12.4	18.8	20.1	23.1	21.9	17.6	16.3	20.2	17.7	19.2	20.9	3.0	1.3	1.3	0.5	0.0	1.3	1.5	0.0	1.4	2.3	0.0	0.0	0.8	1.7	1.0	0.0	1.0	1.4	0.0	0.8	0.5	0.8	1.0	2.3	1.6	1.0	0.0	0.0	1.8	0.8	0.0	0.6	0.8	0.0	0.0	0.9	1.2	1.5	0.0	0.4	1.4	1.5	0.0	0.3	0.5	1.1	0.0	0.6	0.0	1.6	0.9
KIAA0930	"bK268H5.C22.1, C22orf9"	ENSG00000100364	KIAA0930	Q6ICG6	22	45190338-45240769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 60.5;Kupffer cells: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038091	Uncertain		Approved	"Nuclear membrane,Mitochondria"		No	No			"Nuclear membrane, Mitochondria"		"HPA038091: AB_10675627"	"unprognostic (4.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (6.90e-8)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (8.95e-7)"	"unprognostic (6.89e-3)"	"unprognostic (5.32e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.15e-1)"	13.4	18.0	51.3	17.1	50.0	14.4	12.9	9.9	41.3	15.3	11.6	52.8	10.3	9.6	8.3	28.4	14.2	10.0	10.7	6.6	50.2	39.9	5.9	12.7	12.5	16.6	48.2	36.8	6.7	8.2	10.2	5.6	7.9	28.9	9.5	7.6	4.9	8.6	18.1	15.6	34.2	12.9	10.3	29.3	15.4	8.5	10.1	50.0	6.5	5.2	6.7	14.3	14.1	9.6	1.8	9.8	6.5	12.9	1.5	2.2	2.6	12.4	8.1	5.0	9.9	17.2	8.1	5.0	6.9	6.9	7.4	6.4	7.4	6.8	8.3	10.3	10.9	5.9	14.0	7.6	30.6	2.8	8.9	12.0	0.0	10.0	8.5	6.9	22.2	5.1	4.6	15.5	7.1	12.0	5.6	6.9	6.1	2.9	13.8	4.4	14.3	9.8	20.7	4.9	9.0	6.8	12.1	3.4	27.4	11.1	7.6	4.2	7.4	10.9	15.0	18.9	10.1	7.3	83.1	9.3	7.6	13.5	10.3	3.9	11.8	7.9	8.0	8.9	33.9	7.8	0.9	9.1	6.5	2.0	11.1	1.3	1.8	0.8	2.2	9.8	1.6	0.8	1.4	2.2	1.5	12.9	8.2	1.5	2.6	51.3	50.0	9.9	41.3	50.2	39.9	48.2	36.8	28.9	50.0	6.0	9.1	9.0	15.2	46.9	4.4	9.9	7.6	5.3	4.5	17.4	5.9	1.5	0.0	16.3	2.3	10.3	12.9	0.0	17.8	4.7	23.4	14.4	2.3	19.8	60.5	4.8	10.3	20.9	61.7	6.1	10.0	44.0	42.2	22.6	10.8	5.5	15.6	11.6	13.8	11.2	4.7	0.0	16.9	7.5	4.7	50.1	2.3	10.7	10.2	23.7
KIF16B	"C20orf23, dJ971B4.1, FLJ20135, SNX23"	ENSG00000089177	"Kinesin family member 16B"	Q96L93	20	16272104-16573434	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051198	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA051198: AB_2681385"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.52e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (4.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.61e-2)"	11.3	26.2	10.5	14.8	11.2	4.8	15.1	6.3	11.2	9.4	21.6	10.3	15.7	15.1	10.6	12.8	10.3	6.1	9.4	10.7	10.3	8.4	16.6	10.9	12.9	5.6	12.1	7.0	13.0	8.4	25.7	13.9	5.7	8.4	8.4	17.8	6.6	8.5	28.2	22.8	11.3	23.7	11.7	15.3	9.9	11.6	5.7	11.1	6.5	10.5	8.6	8.2	10.6	15.0	5.2	5.8	0.9	3.7	8.2	5.0	2.6	4.9	12.6	6.0	5.5	4.7	3.4	5.9	4.8	3.0	3.0	3.3	6.1	12.2	6.9	3.2	5.1	8.5	4.5	7.1	7.2	4.5	3.6	4.1	3.1	3.2	11.2	2.9	0.0	7.0	5.4	14.3	3.6	7.2	4.7	1.1	5.3	5.5	0.0	4.9	7.8	0.1	1.2	1.7	16.0	5.7	5.1	4.8	12.1	4.8	7.9	2.7	5.3	5.2	25.3	15.4	7.5	7.5	4.0	2.4	4.7	4.0	7.6	2.2	0.0	3.0	2.0	4.5	2.0	9.4	0.1	3.7	0.9	3.7	3.0	5.0	4.2	4.1	2.8	5.8	5.2	4.5	3.2	0.4	8.2	2.9	2.8	2.7	2.6	10.5	11.2	6.3	11.2	10.3	8.4	12.1	7.0	8.4	11.1	17.9	34.3	9.9	14.0	16.9	8.4	24.2	2.5	14.7	18.2	5.2	17.7	11.8	3.3	5.5	9.6	11.9	40.0	0.0	10.9	4.8	7.6	7.9	9.2	12.8	15.8	35.0	22.4	9.8	9.5	6.6	10.6	15.8	10.1	1.0	36.6	8.0	10.1	28.1	13.8	16.1	10.7	6.5	8.6	8.4	15.9	19.6	31.4	4.1	18.2	19.6
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.4	25.1	12.2	7.3	7.4	6.0	9.5	14.5	10.4	14.9	11.5	13.6	6.1	9.3	14.0	10.7	19.2	17.3	12.5	14.0	5.0	14.8	15.8	1.8	19.8	9.2	14.3	4.1	9.9	6.0	18.6	17.4	14.2	9.6	6.9	11.2	9.9	12.5	11.8	28.8	23.2	6.2	12.1	5.9	20.9	8.9	6.3	12.6	11.6	11.5	33.4	16.1	10.6	9.5	17.3	7.1	15.7	2.8	11.3	24.5	21.9	29.6	19.0	13.1	10.9	5.0	17.3	2.8	9.8	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0	3.0	1.0	5.6	8.0	7.9	32.1	1.4	0.0	5.3	1.2	12.2	11.8	8.8	11.6	15.0	8.9	4.5	2.9	0.0	7.2	16.4	4.8	12.0	0.0	2.1	2.7	52.4	35.6	4.3	4.6	3.4	8.1	2.8	11.8	10.0	5.8	14.1	13.4	3.6	13.1	9.1	26.5	0.0	16.2	24.4	25.6	8.4	10.6	3.3	3.7	7.1
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075099	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 103.2;Paneth cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	6.1	9.7	13.1	8.5	11.5	5.3	6.9	25.0	15.2	7.6	35.0	10.2	8.1	35.1	8.5	12.3	5.6	9.3	15.2	12.2	13.8	10.8	13.6	47.2	8.2	5.8	12.2	13.7	11.2	9.1	17.6	13.3	5.9	12.1	8.6	17.4	9.0	11.4	8.4	9.9	8.7	55.7	7.4	9.2	6.6	16.0	22.6	13.2	6.7	10.9	4.5	5.4	10.2	9.9	5.6	12.2	9.0	3.7	6.1	7.0	3.3	3.5	3.2	8.7	10.4	8.6	8.5	7.7	2.9	4.8	5.3	8.2	5.3	6.3	5.3	10.7	7.0	7.0	6.3	8.7	8.2	4.3	5.3	10.6	6.2	9.2	23.4	8.3	3.0	4.9	11.1	10.3	6.4	6.3	16.8	6.7	11.0	4.2	7.1	4.4	7.2	7.9	6.5	3.4	35.5	4.4	6.4	4.9	10.2	8.1	3.6	14.3	7.0	5.7	5.0	11.1	8.3	9.1	7.6	4.8	6.1	7.2	3.0	3.0	14.1	5.0	12.9	3.3	4.5	2.1	2.6	3.7	4.4	4.0	3.6	5.1	5.6	5.5	3.9	4.2	4.3	7.0	4.8	9.0	6.1	3.6	12.2	6.4	3.3	13.1	11.5	25.0	15.2	13.8	10.8	12.2	13.7	12.1	13.2	14.9	11.8	3.9	8.3	3.3	20.8	10.2	22.9	21.4	5.7	14.0	27.5	9.4	16.6	6.6	6.1	4.4	103.2	0.0	8.7	4.1	5.1	5.1	6.9	51.3	5.8	11.1	21.5	5.5	3.7	6.8	9.5	2.5	3.3	6.4	36.2	15.8	6.6	59.6	6.3	20.0	25.7	12.9	4.4	20.9	15.5	4.0	11.3	4.9	35.1	5.0
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385217-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA049057: AB_2680615, HPA057379: AB_2683422"	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	9.5	20.8	8.9	6.4	14.5	0.8	7.4	9.0	11.7	6.7	9.4	2.6	5.2	2.6	10.9	3.5	5.4	4.8	10.7	3.3	6.7	7.5	4.7	5.4	6.2	5.7	3.6	9.0	4.0	4.7	5.8	17.7	7.6	6.3	10.8	3.4	11.7	4.2	11.7	12.0	6.9	4.2	7.2	2.7	10.6	5.5	2.5	3.7	0.5	1.9	1.8	4.0	7.5	6.4	0.1	0.4	0.0	0.0	0.9	0.7	0.0	1.0	0.9	6.0	3.0	5.7	3.8	10.3	6.1	4.7	2.5	1.8	0.0	0.3	3.9	2.1	2.3	13.5	0.2	1.4	5.2	1.7	0.0	6.3	0.0	5.1	0.0	2.0	0.0	7.9	2.7	7.1	3.3	9.3	0.8	4.2	0.1	0.0	0.0	1.3	0.5	1.3	0.0	3.0	0.0	1.8	0.3	15.4	0.0	4.6	1.8	9.0	1.8	0.8	0.6	3.5	2.5	0.0	0.0	4.2	2.5	11.7	5.3	2.1	0.1	0.0	0.0	9.5	0.4	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.9	0.0	0.4	0.0	0.0	8.9	14.5	9.0	11.7	6.7	7.5	3.6	9.0	6.3	3.7	6.0	4.0	0.0	9.1	4.1	2.3	2.0	5.1	1.4	1.2	1.8	25.5	0.7	0.0	1.0	1.7	1.4	0.0	0.0	0.2	0.9	1.7	1.7	0.0	0.4	0.2	1.6	4.1	0.6	0.0	0.0	4.6	0.0	1.7	0.0	0.6	1.3	0.4	0.0	3.9	1.3	23.5	6.5	5.1	0.0	1.1	5.1	0.7	0.0	0.2	1.3
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 38.7;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	14.0	9.9	4.1	3.9	2.0	1.3	11.5	4.7	2.6	7.4	8.8	15.8	6.5	11.0	5.5	1.9	5.9	10.3	12.3	4.9	8.3	8.8	7.0	23.9	6.8	2.2	1.9	8.4	8.3	1.2	3.1	4.9	4.3	1.8	3.2	11.5	8.3	7.0	1.9	16.9	9.5	3.8	5.9	12.0	10.5	9.0	13.3	8.6	6.9	16.5	8.4	6.0	13.8	10.5	6.0	5.7	13.8	2.3	2.9	4.7	13.2	5.4	6.2	6.4	14.5	15.6	2.6	4.3	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0	38.7	16.3	4.4	2.3	3.3	15.6	12.6	0.0	32.1	35.2	12.2	53.0	4.7	13.3	3.5	21.5	2.1	4.7	0.0	3.8	5.8	2.1	2.4	17.4	13.9	1.9	11.1	7.5	3.1	1.5	5.6	2.3	1.4	1.7	2.8	5.3	6.1	2.4	2.9	4.2	18.5	40.7	0.0	2.1	11.6	10.6	5.5	4.1	3.3	6.8	1.8
LACTB	"FLJ14902, MRPL56"	ENSG00000103642	"Lactamase beta"	P83111	15	63121800-63142061	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protease"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 175.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036361, HPA036362"	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA036361: AB_10672244, HPA036362: AB_10670798"	"unprognostic (6.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.25e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.64e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.88e-3)"	26.5	22.7	9.2	13.1	12.2	31.5	9.3	7.3	9.1	6.8	11.4	6.3	4.0	12.5	7.0	6.9	9.8	5.7	9.2	24.9	7.9	6.1	20.5	38.3	18.8	12.9	8.5	6.1	7.2	9.3	6.7	10.4	7.4	9.5	7.6	10.4	5.8	9.3	4.7	37.3	10.1	19.6	8.1	8.0	21.6	8.3	13.2	9.8	8.3	8.4	11.1	9.0	11.5	12.8	3.3	10.4	5.8	8.9	2.3	3.1	2.0	21.5	13.6	3.9	2.7	19.6	10.6	3.3	9.5	14.6	16.3	30.4	3.4	13.9	2.9	11.7	13.7	17.7	6.1	13.1	6.1	20.5	19.8	3.2	5.6	4.6	8.5	18.3	5.0	9.7	14.3	13.1	16.7	13.8	24.4	16.7	17.0	5.3	8.2	27.5	8.2	3.8	6.0	5.8	13.2	4.2	2.8	10.0	6.6	8.8	33.9	3.5	1.6	6.8	7.7	20.4	14.2	5.8	8.3	29.9	22.0	17.2	9.8	11.9	8.6	7.6	0.7	16.8	14.2	10.0	3.6	8.8	4.6	1.3	8.9	2.0	3.3	1.1	1.0	10.4	2.9	1.0	1.6	5.8	2.3	7.6	0.9	3.1	2.0	9.2	12.2	7.3	9.1	7.9	6.1	8.5	6.1	9.5	9.8	23.8	19.9	13.7	23.6	51.7	5.9	40.8	17.8	9.4	7.9	12.2	11.8	13.0	21.6	45.5	42.5	22.5	20.6	0.0	37.1	32.4	22.4	24.9	64.7	50.3	87.0	7.9	7.0	9.2	54.2	26.0	13.3	86.6	25.3	175.9	24.0	5.8	61.1	20.1	15.2	52.5	10.6	6.5	32.5	93.3	10.6	52.4	15.1	15.8	15.3	33.8
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.1;lung: 6.8"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 17.2;HMC-1: 5.6;K-562: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA005470: AB_2134886, HPA076575: AB_2732315"	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	1.2	0.8	0.7	0.3	2.3	0.9	0.4	2.5	2.4	1.2	3.8	0.7	0.2	0.6	0.5	0.3	4.6	0.2	0.9	0.7	1.1	2.8	0.4	0.2	6.8	0.4	1.3	1.3	1.3	0.2	0.1	1.7	0.2	2.2	0.6	2.8	2.5	1.1	0.9	1.0	2.6	1.1	1.9	1.8	0.2	2.2	1.8	0.9	0.2	1.2	1.7	1.2	1.8	2.9	0.3	0.2	7.1	0.2	1.1	1.8	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	2.5	0.3	0.0	0.0	0.3	17.2	1.8	0.0	0.0	0.0	5.6	0.0	0.5	0.0	0.1	0.0	0.3	0.0	3.9	0.0	1.2	0.0	0.2	0.3	0.4	0.2	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	1.2	0.0	0.0	1.6	0.7	0.0	0.0	2.9	0.0	0.4	7.1	0.2	0.9	1.0	0.2	0.8	0.2	0.4	1.8	0.1	0.3	0.1	1.0	1.1	1.1	0.2	0.2	0.6	0.7	0.7	2.3	2.5	2.4	1.1	2.8	1.3	1.3	2.2	0.9	3.0	2.6	0.0	1.1	7.8	0.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.2	0.1	0.4	0.5	1.1	0.0	0.1	3.2	1.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.5	1.3	0.9	1.4	0.0	1.4	0.0	1.7	0.2	1.7	3.9	0.1	1.0	0.6	2.2
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.4	8.0	9.4	8.9	8.6	9.7	10.1	10.0	10.3	18.7	13.9	14.2	8.9	13.3	8.6	11.6	13.7	7.0	34.9	20.9	14.2	11.6	8.8	14.4	13.0	13.8	9.0	20.8	5.3	12.5	12.9	17.8	9.4	9.7	11.6	16.1	22.3	7.5	11.6	7.0	14.9	7.6	23.5	10.8	14.9	8.5	9.3	14.8	16.6	15.5	7.4	9.3	15.9	9.0	8.3	11.2	14.3	12.2	10.2	11.4	8.5	9.5	12.0	6.0	10.8	14.2	13.5	14.1	10.1	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8	0.0	1.3	2.7	1.1	1.0	5.0	7.8	2.5	2.7	1.2	5.2	3.9	4.1	5.0	2.5	0.6	3.8	2.3	0.0	2.4	4.2	1.6	2.2	1.1	6.7	4.4	1.6	4.6	2.5	3.7	1.1	1.1	1.6	1.7	2.8	4.3	3.6	2.8	6.6	2.1	2.1	4.4	0.0	1.2	0.7	2.4	1.1	2.4	1.8	6.3	1.6
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856247	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	16.9	15.3	11.9	11.2	13.1	9.9	16.8	17.3	19.9	6.7	23.7	10.0	7.5	20.3	8.5	6.9	22.0	8.1	15.0	18.9	10.2	10.2	16.2	20.4	9.4	10.7	10.6	10.5	9.5	19.7	13.0	8.7	7.6	10.7	8.2	16.3	9.2	9.7	7.2	17.2	18.5	19.4	8.0	7.7	10.6	15.6	12.6	9.0	50.7	10.9	19.9	16.6	8.0	9.7	5.0	14.7	3.8	5.6	6.7	7.1	2.1	12.0	20.6	6.4	19.8	9.9	6.9	11.5	12.0	5.9	12.1	9.5	19.0	13.5	20.0	8.6	12.5	18.9	12.3	16.3	16.9	7.4	13.2	17.0	20.4	16.7	13.6	12.8	20.7	16.8	11.3	12.2	13.8	12.2	5.6	10.4	12.3	26.8	12.6	8.3	13.3	29.9	23.7	16.8	13.2	23.7	17.2	9.0	11.7	9.4	16.9	16.4	14.4	13.7	17.3	7.1	5.8	16.3	10.8	15.6	13.9	8.3	11.7	19.9	11.0	16.8	15.9	12.3	18.1	11.1	3.8	4.5	2.1	7.1	5.6	7.0	5.0	6.0	6.1	4.7	4.6	4.0	5.9	0.7	6.7	5.3	14.7	4.6	2.1	11.9	13.1	17.3	19.9	10.2	10.2	10.6	10.5	10.7	9.0	14.9	7.8	27.6	25.3	35.5	17.1	18.2	7.6	1.4	9.1	26.2	31.4	14.6	26.6	22.9	25.3	14.3	78.7	23.3	27.0	18.4	16.4	20.8	10.3	24.1	19.6	14.3	15.0	16.5	15.3	31.9	18.7	15.0	18.6	10.0	27.0	11.6	31.9	43.2	15.6	38.2	26.2	12.9	19.8	34.8	40.1	44.7	12.7	20.2	29.9	41.9
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: AB_2686682"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (3.16e-4)"	25.7	27.5	23.0	18.1	31.2	17.1	27.1	23.1	37.5	18.6	26.8	18.8	21.5	31.9	22.9	22.4	16.2	30.0	23.5	16.4	21.2	19.0	29.3	35.1	16.6	18.5	20.6	21.3	34.3	38.6	28.5	20.2	12.3	21.6	19.1	26.1	22.6	28.2	24.0	23.8	18.5	28.5	18.7	21.4	17.5	22.6	15.5	14.3	19.9	34.1	10.7	20.1	20.3	14.8	11.3	7.2	2.9	11.6	8.6	17.1	9.3	7.4	6.7	5.0	13.5	22.8	37.4	5.1	7.7	12.8	8.1	9.2	16.2	15.4	19.7	9.6	8.3	5.9	13.9	10.3	10.4	9.4	7.1	12.9	14.1	9.3	12.7	15.1	12.7	10.3	31.5	33.7	9.6	22.8	24.8	8.2	19.1	14.6	14.3	11.1	11.6	8.9	12.3	3.4	9.3	18.3	7.6	6.1	10.7	10.2	11.4	15.0	6.9	5.8	13.1	17.6	5.3	20.7	11.6	6.2	5.1	5.5	8.4	4.4	13.0	20.2	8.4	9.5	8.3	3.6	2.5	7.3	2.9	8.6	7.8	12.5	11.3	14.2	10.6	7.2	8.1	17.1	15.5	2.4	8.6	11.6	6.4	12.6	9.3	23.0	31.2	23.1	37.5	21.2	19.0	20.6	21.3	21.6	14.3	20.8	22.7	30.4	41.1	44.1	20.2	12.5	22.9	25.4	11.4	22.7	9.8	40.0	77.9	12.6	6.3	19.6	22.0	23.3	28.4	18.9	32.4	29.0	25.3	16.3	26.2	17.5	26.7	20.3	41.0	11.9	30.2	21.2	37.1	17.2	34.4	24.4	16.0	28.1	28.7	31.5	16.5	25.8	38.1	20.6	19.4	38.8	23.3	42.4	49.8	24.8
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 46.8;Hep G2: 26.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.0	46.8	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	26.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	9.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.1	0.2	0.7	0.7	2.7	0.9	0.4	1.9	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4	6.0	4.6	32.7	0.1	15.1	0.0	0.1	800.0	1.4	2.3	27.9	0.0	0.1	107.8	20.9	0.0	0.1	838.5	0.0	175.0	0.2	3.5	0.1	2.3	0.6	27.7	0.0	70.9	0.6	23.7	0.0	0.6	71.1	23.6	13.6	374.8	0.0	476.7	354.2	0.0	1320.5	0.0	0.0	6.2	0.0	0.2	10.8	0.2	2.5	571.4	0.1
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	4.0	3.1	4.0	3.8	8.4	8.2	3.4	4.6	2.6	4.3	2.9	5.0	5.5	14.6	5.3	1.7	10.9	3.6	11.3	6.3	5.8	1.6	2.8	6.1	1.6	5.0	7.7	13.2	4.0	7.9	10.5	5.1	16.2	9.6	4.9	9.1	14.4	3.6	5.2	2.5	7.4	17.0	5.3	10.6	10.1	6.5	10.8	8.8	5.1	2.1	4.4	3.8	2.7	3.6	14.9	5.8	4.0	6.1	1.8	3.5	7.7	4.5	10.7	7.1	10.8	10.2	5.4	15.4	3.0	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2	8.9	9.3	13.4	11.9	8.7	24.0	16.5	10.2	20.1	13.6	17.4	9.8	21.5	18.3	10.7	82.3	7.1	13.1	0.0	5.5	12.9	8.0	5.2	17.3	17.0	15.4	9.5	17.4	5.5	11.7	80.7	9.5	10.9	1.7	17.2	12.1	15.2	9.0	10.5	11.7	23.2	23.3	0.0	9.5	47.0	20.9	8.2	8.0	12.9	18.1	8.4
LINGO3	"LERN2, LRRN6B"	ENSG00000220008	"Leucine rich repeat and Ig domain containing 3"	P0C6S8	19	2289784-2292024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.9;brain: 15.7;lymphoid tissue: 7.1"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 32.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"					"Cell type enhanced"	"Detected in some"		"eosinophil: 6.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 6.9"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 19.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5"	"HPA043781, HPA059558"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043781: AB_2678668, HPA059558: AB_2684062"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.16e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.03e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	0.1	0.2	2.2	3.1	15.7	2.8	0.0	4.6	2.9	0.0	0.4			0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.2	2.7	1.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.3	0.1	1.2	0.0	0.4	7.1	1.2	0.1			0.0		0.0	0.0	0.0	1.0	0.1	6.9	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	2.1	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	2.6	0.2	0.0	0.1	1.9	0.0	4.8	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1.9	0.1	6.9	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.0	0.1	0.0	2.9	0.3	0.1	0.0	0.6	0.0											0.0	0.0	0.0	0.0	0.1	32.9	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.2	3.2	0.0	0.0	2.1	0.0	0.0	0.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848202-109872315	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 17.1"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.6	0.6	0.7	0.6	1.2	0.4	1.7	2.0	1.3	1.2	0.6	0.6	0.6	0.3	0.7	1.8	0.6	1.0	0.6	0.6	0.8	0.7	4.4	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.6	0.6	0.6	0.9	0.5	17.1	0.8	0.6	1.6	3.2	0.6	0.6	0.6	0.8	0.2	1.3	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.1	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.0	0.6	0.6	0.0	0.0	0.1	1.3	0.1	0.2	0.3	1.6	0.3	0.4	0.2	0.1	1.3	0.0	0.0	2.0	0.1	0.3	0.2	0.1	1.3	0.3	0.6	0.0	0.0	0.9	1.0	0.2	0.8	0.2	0.6	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.4	0.0	0.3	0.1	1.2	0.0	0.3	0.3	0.6	0.3	0.6	1.0	0.0	0.3	0.9	0.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	1.2	2.0	1.3	0.8	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	31.4	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589024	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 22.6"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 22.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	6.1	5.3	10.7	4.0	23.4	2.1	4.7	11.3	16.3	7.4	5.1	4.3	5.1	3.3	18.2	4.5	4.6	6.9	8.1	14.2	8.7	6.5	7.2	1.6	4.8	1.6	4.6	9.5	6.9	5.4	13.0	11.0	5.6	7.1	7.4	5.3	3.3	5.0	6.8	11.8	5.1	3.1	20.2	4.1	3.8	3.8	5.0	5.2	18.0	7.4	3.4	2.4	6.2	5.4	0.0	0.3	22.6	0.4	0.4	1.0	0.2	7.3	4.3	8.8	15.4	10.0	8.0	1.9	21.1	21.2	7.4	10.4	0.9	7.3	0.0	8.5	19.9	8.9	3.3	3.6	9.0	15.9	13.7	3.4	11.5	2.0	0.3	6.2	0.1	9.3	10.6	6.4	12.3	10.1	26.8	3.8	9.0	2.4	0.0	26.4	1.2	10.5	0.2	2.2	0.6	7.5	0.8	8.6	1.6	5.9	0.3	11.3	6.9	6.7	0.3	18.0	6.9	2.0	2.2	10.5	20.4	13.2	6.5	13.6	10.0	7.8	0.0	11.0	0.0	22.3	22.6	0.2	3.5	0.1	0.4	1.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	10.7	23.4	11.3	16.3	8.7	6.5	4.6	9.5	7.1	5.2	14.9	2.1	0.0	5.3	10.2	16.6	9.8	7.6	4.0	3.4	14.0	5.9	0.2	0.0	3.9	3.3	6.7	0.8	0.0	3.9	0.3	9.4	5.6	8.1	0.5	5.1	27.0	13.8	3.7	7.3	1.6	8.1	4.8	6.8	8.2	2.3	4.8	4.4	0.0	8.5	2.9	7.4	6.5	9.0	7.2	11.0	9.5	0.2	4.9	1.7	4.3
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Cell type enhanced"	"Detected in many"	23	"Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 21.9;CACO-2: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0	6.0	39.5	0.0	0.1	0.2	1.9	1.7	2.5	4.0	4.5	3.5	82.5	52.4	14.9	0.0	1.4	0.0	0.0	0.0	0.0	1.9	0.8	0.0	2.3	0.0	4.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	250.3	18.0	0.0	0.0	0.0	0.5	0.0	19.3	0.0	0.0	0.1
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856868-46918642	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;skin 1: 33.0"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 17.0;SuSa: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	1.2	1.9	16.0	1.3	20.3	0.5	2.1	7.3	23.7	3.0	5.4	11.6	0.6	3.9	2.1	1.3	2.4	2.0	2.5	7.2	20.4	5.8	1.2	0.7	3.4	0.5	9.6	12.6	5.4	2.7	9.3	3.3	3.1	14.5	2.7	4.1	1.3	2.1	3.0	4.4	33.0	5.3	2.0	9.7	4.2	9.6	1.6	19.0	0.0	2.9	1.0	0.8	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.5	17.0	5.2	10.6	2.9	3.9	0.7	1.5	2.3	2.5	2.2	0.0	0.0	1.1	8.7	2.4	3.0	9.5	5.8	1.8	0.0	7.9	0.8	3.0	5.2	2.2	0.1	1.5	3.6	3.4	3.5	0.9	2.0	1.9	2.1	0.7	0.0	1.3	0.6	0.1	0.2	9.2	0.0	0.7	1.2	5.8	0.0	0.2	2.2	0.0	11.2	0.9	0.0	2.8	13.6	0.2	0.4	0.1	4.6	2.9	5.2	1.6	0.0	0.0	0.3	3.4	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	20.3	7.3	17.3	20.4	5.8	9.6	12.6	14.5	19.0	0.0	3.4	0.0	2.5	7.2	0.4	4.8	0.0	0.0	2.3	1.8	39.3	1.8	1.7	0.0	0.4	0.7	6.3	0.0	0.3	0.4	4.3	0.3	4.7	0.0	0.2	0.0	0.0	1.3	0.0	0.0	1.7	0.0	1.7	1.0	2.2	8.7	0.5	2.3	1.1	0.2	2.6	0.0	1.2	0.1	0.7	9.5	1.1	0.0	1.8	0.7
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886508-43996005	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		16000	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	20.6	25.5	20.2	27.7	24.8	26.7	37.2	34.3	51.8	16.4	31.7	15.1	15.9	21.8	21.5	19.2	22.5	18.6	15.2	36.6	24.3	21.9	41.7	31.6	26.3	38.0	21.9	22.9	23.6	28.0	33.3	19.7	17.6	29.2	18.9	32.5	13.6	17.8	22.8	63.2	22.4	19.1	32.6	17.9	18.0	20.7	20.7	16.0	25.4	20.5	30.5	19.9	20.4	17.8	15.8	15.5	5.5	11.7	13.2	18.1	12.4	30.3	25.0	15.7	20.0	15.5	20.7	27.0	20.3	14.7	22.2	17.1	39.9	16.1	43.7	19.6	12.5	14.8	25.8	29.4	21.7	29.6	26.3	18.5	39.5	19.7	52.9	22.9	56.8	18.0	20.5	19.0	20.4	33.2	12.9	17.8	13.2	58.2	17.7	19.4	16.8	29.8	65.8	26.2	31.0	17.7	33.4	35.2	35.5	24.3	28.0	27.9	27.0	22.9	30.8	36.9	21.5	22.6	34.5	15.3	16.0	21.9	16.8	21.6	18.1	20.3	38.1	15.3	35.3	13.8	5.5	10.7	1.8	9.5	10.8	18.0	15.2	12.8	12.6	15.5	15.8	18.1	15.4	0.8	13.2	11.7	6.2	10.5	12.4	20.2	24.8	34.3	51.8	24.3	21.9	21.9	22.9	29.2	16.0	20.8	25.6	25.1	22.2	41.1	62.9	81.9	33.1	20.1	33.0	43.6	29.5	31.3	18.3	23.0	4.4	27.5	30.2	0.0	15.2	17.8	26.0	19.8	28.8	45.9	22.1	62.0	26.4	20.9	34.3	4.2	23.3	24.7	20.3	26.2	41.4	27.0	20.3	28.1	22.3	48.9	54.5	12.9	37.3	27.9	28.6	38.8	27.8	19.2	70.4	27.0
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 131.5;Late spermatids: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		No	No			Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623"	"unprognostic (4.84e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	9.1	9.5	7.5	5.3	12.7	7.4	7.3	12.7	15.4	7.7	10.4	8.1	6.1	15.8	6.9	7.6	9.9	5.0	8.8	10.8	7.5	6.5	17.7	42.3	6.2	6.3	6.9	8.4	5.8	18.1	9.1	10.8	5.9	9.8	6.3	9.5	9.3	8.6	6.9	18.0	12.1	18.2	7.8	6.7	6.3	9.1	24.1	5.2	17.7	7.4	8.2	8.6	7.9	7.3	4.8	6.0	21.8	6.9	3.4	7.0	4.2	2.9	7.1	7.1	9.1	10.2	14.4	3.0	3.1	8.7	5.3	6.3	5.5	6.3	5.9	5.7	7.3	6.6	6.5	5.1	9.8	7.8	3.6	7.5	4.0	3.3	5.5	9.0	3.9	6.5	8.5	13.6	5.0	10.0	12.0	16.7	9.5	3.5	5.9	11.0	5.6	10.6	6.5	2.9	22.4	2.5	6.5	6.0	5.3	11.3	9.3	3.2	4.1	7.3	4.0	11.4	11.2	6.2	7.4	6.0	5.2	3.6	4.0	6.0	12.1	16.7	3.6	6.7	3.8	9.7	15.6	6.9	21.8	5.5	5.5	4.3	4.8	5.2	5.7	6.0	4.1	4.8	4.1	3.6	3.4	5.3	5.0	7.0	4.2	7.5	12.7	12.7	15.4	7.5	6.5	6.9	8.4	9.8	5.2	14.9	2.6	9.7	11.4	12.2	20.0	13.3	10.2	10.7	6.8	10.4	21.6	15.0	23.2	11.2	131.5	10.5	25.7	23.3	25.7	18.2	9.3	9.5	2.3	32.1	16.9	20.6	8.7	11.1	19.8	330.3	11.8	8.6	13.5	17.2	15.4	14.3	13.6	20.1	8.1	54.9	19.0	0.0	12.0	42.3	35.8	13.8	10.9	15.0	13.6	11.9
LRRC57	FLJ36812	ENSG00000180979	"Leucine rich repeat containing 57"	Q8N9N7	15	42537820-42548802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040894	Approved		Approved	Mitochondria,Cytosol		NA	NA		230000	"Mitochondria, Cytosol"		"HPA040894: AB_10794996"	"unprognostic (8.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (7.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	13.9	14.7	15.8	11.6	13.6	32.7	19.2	12.4	19.1	11.8	16.0	10.6	9.7	12.3	15.7	12.2	18.0	15.3	10.2	15.6	18.0	8.4	14.2	11.1	15.9	11.2	11.8	16.5	17.6	14.5	13.2	12.2	14.4	9.9	12.3	18.9	16.4	15.7	11.6	11.0	16.5	14.5	12.8	10.3	13.0	14.1	12.4	11.3	14.9	15.1	10.0	12.8	13.1	15.6	4.8	6.9	22.1	12.0	11.1	6.7	4.3	10.4	7.9	14.4	10.8	12.0	9.5	7.8	15.0	8.0	10.6	11.2	16.3	8.4	4.9	10.5	11.6	12.0	17.2	9.6	11.7	10.8	10.4	9.0	19.5	17.4	7.3	11.6	12.0	12.6	10.4	15.7	9.6	11.9	7.6	16.9	13.0	15.0	11.8	9.6	4.9	7.0	5.4	3.8	17.7	7.1	11.0	13.9	7.7	7.3	17.1	7.4	8.9	17.3	12.5	8.7	9.9	11.6	14.4	17.2	12.8	9.0	13.1	11.1	10.0	24.8	20.3	7.3	12.1	15.6	22.1	6.5	20.5	5.4	9.4	6.7	4.2	5.2	4.9	6.9	4.8	4.3	5.3	8.5	11.1	12.0	4.0	5.2	4.3	15.8	13.6	12.4	19.1	18.0	8.4	11.8	16.5	9.9	11.3	8.9	13.3	5.4	11.0	5.0	13.4	9.5	10.2	21.4	7.9	8.7	56.9	9.9	11.6	9.6	13.9	12.9	11.6	0.0	8.5	15.7	7.4	12.9	13.9	6.4	12.0	19.1	12.0	18.4	11.9	13.2	8.9	12.9	6.8	22.6	13.5	18.4	11.4	10.2	15.2	6.6	81.1	6.5	8.2	5.0	5.3	4.8	13.3	10.9	11.9	10.1
LRRD1	IMAGE:4798971	ENSG00000240720	"Leucine rich repeats and death domain containing 1"	A4D1F6	7	92112159-92179531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 19.1"	"Group enriched"	"Detected in some"	82	"Early spermatids: 257.1;Late spermatids: 670.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055670, HPA079440"	Enhanced		Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA055670: , HPA079440: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.13e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	19.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.7	3.8	0.6	0.7	0.8	0.1	0.9	0.2	0.9	0.9	0.4	1.7	0.6	0.8	0.0	0.5	0.4	0.3	1.3	0.9	0.2	0.0	0.5	0.7	0.1	0.0	0.7	0.9	0.9	0.6	1.0	0.3	0.4	3.3	1.1	0.2	0.4	0.7	0.3	0.9	0.5	1.3	1.2	2.4	0.9	2.0	0.8	2.5	0.4	0.1	0.7	0.5	0.9	0.5	0.1	0.7	0.7	0.6	0.1	0.3	0.1	0.7	0.5	0.4	1.3	1.0	1.2	1.0	0.7	1.2	0.3	1.3	0.4	0.9	0.4	3.8	0.6	0.4	0.5	0.3	0.4	0.5	0.5	0.4	0.1	1.0	0.4	0.5	1.9	0.7	0.4	0.7	0.8	0.1	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.7	0.2	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	257.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.1	0.0	0.1	1.6	0.0	0.0	0.0	670.8	4.4	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.8	0.0	0.4	0.0	0.1	5.6	2.7	0.3	0.0	0.0	0.0	0.3
LRRIQ4	LRRC64	ENSG00000188306	"Leucine rich repeats and IQ motif containing 4"	A6NIV6	3	169821922-169837775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 7.1"	"Group enriched"	"Detected in some"	51	"Early spermatids: 39.4;Late spermatids: 18.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 2.6;JURKAT: 2.3;RT4: 4.8;T-47d: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036271, HPA036706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036271: , HPA036706: AB_2675264"	"unprognostic (5.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-4)"	"unprognostic (5.26e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.56e-3)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	1.0			0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1		0.3	0.0	0.0	0.2	0.0		0.1	0.1		0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.6	7.1			0.0		0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.3	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.7	0.3	0.2	1.6	0.0	0.7	0.0	0.4	2.0	0.1	2.6	0.0	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.2	0.0	0.1	0.5	0.4	1.1	0.7	1.0	0.0	0.0	0.1	4.8	1.9	0.6	0.1	0.4	0.0	0.0	4.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 30.0;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.8	0.0	0.0	7.4	7.6	0.0	2.9	2.1	2.7	1.9	0.8	2.1	23.5	1.1	7.8	0.0	4.8	0.7	0.5	1.4	0.4	1.1	7.1	1.1	0.0	0.5	3.8	5.5	6.0	1.0	1.7	1.5	0.7	4.7	0.0	1.2	17.3	0.5	0.0	0.0	2.4	0.2	4.3	2.0	1.7	0.4	6.4	0.0	0.0	0.0	1.7	1.8	2.7	5.4	0.0	0.3	4.6	5.4	0.0	0.8	1.0	0.0	8.8	15.6	15.2	0.3	0.5	4.4	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4	14.9	12.8	11.9	6.5	2.9	0.6	2.8	2.5	8.1	7.9	0.0	5.9	8.4	0.0	3.6	3.0	5.7	12.0	0.0	2.7	3.1	3.5	6.3	1.1	0.0	9.5	0.0	13.2	12.3	14.3	2.4	30.0	14.0	3.3	32.5	12.8	0.8	6.7	10.5	20.1	0.3	0.4	6.5	2.1	5.2	1.1	3.0	3.0	0.5	10.8	9.3
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	23.8	24.5	30.4	26.5	30.9	25.3	24.0	42.6	30.0	21.9	20.1	29.9	25.8	21.3	29.4	37.7	15.5	19.2	24.5	12.7	34.1	26.5	26.9	19.9	18.8	31.0	33.1	24.3	29.3	24.2	31.2	40.3	23.1	25.4	35.2	18.2	24.3	25.1	25.2	20.3	28.8	23.9	24.4	29.2	32.1	22.6	29.8	33.1	23.2	40.2	15.9	21.0	16.6	26.3	6.5	11.1	3.5	11.7	3.9	6.9	5.6	5.4	24.4	25.9	9.7	10.0	7.7	11.4	10.1	7.7	16.5	12.0	25.4	6.4	9.9	13.3	5.8	8.7	6.9	30.8	9.2	16.6	17.7	21.1	12.1	16.6	29.7	11.2	14.0	13.6	6.9	10.7	13.3	5.3	14.3	12.7	8.6	14.3	6.4	13.2	26.2	23.0	24.4	38.6	12.3	11.8	19.8	11.3	10.4	23.6	5.8	15.4	17.3	10.9	7.6	9.4	16.0	9.8	7.6	10.3	12.0	18.1	5.0	12.1	7.0	9.3	10.5	3.6	10.0	10.7	0.3	9.1	3.5	6.7	10.4	5.2	6.5	6.3	6.5	9.8	3.0	3.7	2.8	1.2	3.9	11.7	11.1	6.9	5.6	30.4	30.9	42.6	30.0	34.1	26.5	33.1	24.3	25.4	33.1	47.6	61.1	29.6	38.6	47.3	48.4	18.3	12.7	40.2	58.0	22.7	35.3	24.9	10.0	29.4	34.2	45.0	22.2	0.0	18.2	33.5	35.8	31.0	39.4	10.0	21.2	42.9	40.6	25.2	14.5	14.7	30.2	28.9	37.1	35.1	16.5	30.8	22.7	28.1	30.4	11.3	61.8	25.8	46.4	62.1	51.9	47.4	41.8	27.7	17.1	27.1
LYSMD2	MGC35274	ENSG00000140280	"LysM domain containing 2"	Q8IV50	15	51723011-51751585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 122.7;monocytes: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040460	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA040460: AB_10794874"	"unprognostic (7.71e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.98e-1)"	"unprognostic (4.17e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	5.3	13.4	17.7	13.8	26.2	7.9	5.1	19.9	35.8	6.5	6.1	7.9	7.2	10.0	6.1	7.5	4.6	6.9	7.6	3.6	17.9	19.1	6.7	13.9	9.3	17.2	14.6	17.6	5.8	8.6	7.1	15.2	6.1	25.2	6.2	6.5	4.1	4.3	9.8	10.9	2.7	8.1	7.8	8.2	12.9	7.7	15.6	5.9	6.1	4.9	2.3	16.7	7.4	4.6	17.0	18.2	38.7	20.4	11.9	16.3	12.2	6.0	4.5	0.8	6.0	2.0	3.5	0.0	7.2	4.2	9.2	11.9	0.5	5.5	23.7	1.0	4.0	10.7	8.6	4.9	4.8	6.5	20.0	2.3	7.0	4.2	0.1	4.4	16.3	3.0	3.9	9.8	3.6	3.9	4.1	5.4	9.1	0.3	0.0	2.8	9.1	6.1	20.5	1.9	0.2	5.1	9.3	0.1	8.8	8.9	5.0	18.2	4.5	6.7	0.1	12.1	1.2	5.1	12.5	3.2	9.0	4.6	9.4	10.0	0.0	0.0	0.1	4.5	33.3	6.7	0.0	13.2	24.4	10.9	15.9	16.3	17.0	11.0	13.1	11.1	16.2	13.3	11.0	38.7	11.9	20.4	18.2	6.4	12.2	17.7	26.2	19.9	35.8	17.9	19.1	14.6	17.6	25.2	5.9	3.0	7.4	58.5	17.6	17.2	14.3	1.8	17.8	2.7	5.7	14.0	0.0	1.0	21.6	16.6	122.7	22.4	5.2	23.3	16.1	0.8	13.6	16.4	12.7	13.4	37.2	30.2	76.7	23.4	39.6	55.5	15.0	28.8	6.8	101.8	13.3	5.6	9.7	15.9	14.9	23.3	3.6	25.8	20.0	3.5	3.8	14.2	0.7	47.3	20.3	17.2
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8;testis: 13.2"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 8.7;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.1;RT4: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA045420: AB_10961177, HPA059302: AB_2683972"	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.7	0.6	5.2	0.2	1.5	3.7	3.7	1.2	3.4	4.6	0.2	0.3	1.0	0.2	2.1	0.5	0.3	4.6	0.5	0.1	0.9	1.8	1.5	0.1	0.6	0.1	0.5	1.6	0.3	0.4	1.7	8.8	1.2	0.9	0.2	0.0	2.0	1.5	1.0	0.1	0.2	0.2	0.2	0.7	0.4	0.7	13.2	0.2	1.0	3.6	0.0	0.5	0.9	0.5	0.0	0.9	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.5	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	6.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	5.2	1.5	1.2	3.4	0.9	1.8	0.5	1.6	0.9	0.2	0.0	1.4	0.0	0.0	0.1	0.3	0.3	0.0	2.7	0.0	3.5	0.0	0.3	0.0	0.2	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	3.1	0.0	2.3	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	8.7	22.0	0.0	0.2	0.0	0.0	0.1
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MACC1, MET transcriptional regulator"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.5;kidney: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	4.8	2.6	0.5	5.6	0.4	0.7	4.5	0.4	0.5	8.3	13.7	0.0	4.4	10.1	0.7	6.1	14.1	0.9	9.6	0.5	0.5	0.5	23.9	1.0	13.3	1.1	0.4	0.0	1.3	11.3	0.1	4.0	1.6	0.1	3.9	3.3	0.1	11.4	6.0	0.5	4.5	29.5	0.1	0.8	6.0	5.0	0.8	0.0	1.7	1.5	16.0	13.6	4.0	5.1	2.3	1.0	1.4	1.0	0.8	0.6	0.5	41.3	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	9.2	9.7	5.8	0.4	0.0	0.0	29.1	0.1	0.4	0.0	0.0	0.1	5.5	0.1	0.0	0.0	2.3	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	5.9	2.8	0.0	3.4	0.0	0.5	0.4	8.1	0.0	0.0	0.3	4.4	7.3	2.8	0.1	0.2	0.0	3.3	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.0	0.1	8.9	0.4	2.2	0.0	0.3	0.0	1.0	0.6	0.3	0.3	0.7	0.6	2.3	0.2	0.5	0.3	2.0	0.3	0.3	1.4	0.8	1.0	1.0	0.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.4	0.0	0.1	0.0	65.5	63.4	1.4	71.9	2.5	2.1	0.6	22.9	58.9	103.5	38.4	2.0	0.5	6.6	49.2	2.2	0.7	25.7	0.0	55.2	0.1	2.3	64.3	11.6	1.0	4.6	1.6	37.1	3.7	2.4	0.8	2.0	4.4	1.7	13.6	15.0	0.5	96.6	14.0	2.5	12.9	1.0	0.0	0.4	0.2	0.4	3.4	0.2	3.9	13.3	233.0
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216511	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 114.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.9;NK-cells: 14.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	45.8	15.4	5.0	10.7	10.7	18.8	32.9	4.1	10.4	16.5	14.7	5.1	6.4	5.1	17.1	4.9	21.5	18.3	27.2	17.2	5.2	5.4	8.6	16.5	31.5	2.9	9.8	1.5	24.5	12.4	3.5	6.2	114.6	12.6	20.1	6.9	5.9	8.8	34.0	60.7	14.3	8.6	15.0	6.5	4.2	13.9	6.9	8.4	0.9	11.3	10.3	8.2	28.6	34.4	0.6	0.9	16.9	2.2	14.1	2.2	1.2	7.5	1.2	1.7	2.6	2.7	8.7	7.9	15.3	21.2	7.8	8.4	2.2	6.2	0.2	1.5	6.5	11.8	5.1	0.4	6.1	13.3	1.4	0.2	0.8	0.8	1.9	7.3	0.5	2.7	3.7	10.2	31.3	17.4	7.0	16.4	0.8	1.5	7.3	6.1	1.7	0.3	2.0	1.2	8.4	6.2	0.5	1.4	1.5	7.9	11.6	0.9	1.4	2.3	6.1	37.2	4.4	1.3	0.6	21.4	9.9	7.3	7.3	5.1	2.7	2.8	0.3	15.0	0.6	6.2	16.9	0.3	0.2	2.2	0.5	2.1	0.6	1.2	1.5	0.9	0.4	1.6	1.2	5.9	14.1	2.2	0.1	0.5	1.2	5.0	10.7	4.1	10.4	5.2	5.4	9.8	1.5	12.6	8.4	50.6	43.7	7.5	289.5	111.8	2.2	13.7	33.1	29.4	33.0	10.4	0.0	30.6	6.6	37.6	0.4	35.0	98.6	0.0	21.5	52.9	80.2	257.7	21.9	5.0	23.2	0.0	100.5	14.7	7.8	0.0	9.2	26.4	55.6	17.2	43.3	16.8	51.3	62.0	3.5	2.4	2.0	19.4	116.4	0.9	1.0	90.2	400.7	27.7	35.7	321.4
MAIP1	"C2orf47, DKFZp666A212, FLJ22555"	ENSG00000162972	"Matrix AAA peptidase interacting protein 1"	Q8WWC4	2	199955317-200008540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 31.5;Ductal cells: 26.6;Extravillous trophoblasts: 27.2;Proximal tubular cells: 51.4;Syncytiotrophoblasts: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064013, HPA072231"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA064013: AB_2685175, HPA072231: AB_2732196"	"unprognostic (4.89e-2)"	"unprognostic (7.36e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.02e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-2)"	11.3	16.7	10.5	8.6	10.7	14.4	18.5	13.6	14.4	7.1	12.6	5.9	9.2	18.3	8.2	7.5	11.6	8.3	11.0	16.2	8.3	8.1	26.8	39.4	11.3	14.6	10.3	8.4	7.6	14.7	7.6	7.2	10.5	9.0	8.5	11.9	6.1	9.3	8.8	18.1	9.2	16.3	8.8	7.8	8.7	11.4	5.2	10.4	13.6	9.1	12.7	8.9	8.6	7.8	13.2	16.9	9.0	13.1	8.9	14.0	8.3	12.9	12.1	11.0	8.6	9.8	9.9	25.4	11.8	11.4	17.6	16.9	32.8	11.8	8.6	17.0	8.1	14.6	14.4	16.1	12.6	16.6	13.4	18.5	14.5	11.2	29.9	13.2	19.8	10.3	10.5	10.4	11.6	12.6	10.1	11.1	16.8	18.9	11.2	11.4	17.1	14.9	18.5	14.0	13.8	29.2	14.4	13.0	17.2	20.7	16.9	12.5	8.7	12.1	13.8	21.4	14.5	12.2	12.2	9.8	10.3	14.8	8.8	13.0	10.7	12.4	18.6	15.5	11.6	10.5	7.2	13.1	9.0	11.4	12.5	14.0	13.2	11.6	8.2	16.9	12.0	11.1	9.4	2.2	8.9	11.9	13.7	13.6	8.3	10.5	10.7	13.6	14.4	8.3	8.1	10.3	8.4	9.0	10.4	8.9	12.2	0.0	0.0	0.0	0.0	0.0	0.0	10.7	9.1	3.5	0.0	24.6	31.5	26.6	0.0	0.0	0.0	0.0	24.5	27.2	0.0	0.0	3.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	11.8	0.0	0.0	20.2	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	7.9	11.3	9.5	6.9	9.4	7.6	11.0	8.6	11.1	7.9	8.4	8.3	5.8	5.1	9.2	10.2	12.3	10.1	7.6	29.8	8.8	9.1	12.5	21.2	8.2	10.2	8.9	7.2	10.3	10.1	8.0	7.8	12.6	12.7	7.9	7.8	17.2	10.6	10.3	20.1	6.7	7.0	8.9	8.1	6.9	7.5	13.7	5.6	8.5	14.8	14.9	8.0	9.2	7.5	6.1	4.8	3.5	5.4	4.2	7.3	5.1	4.8	6.1	4.5	26.3	4.4	3.1	4.5	3.7	2.7	3.5	3.2	10.2	4.1	4.9	4.1	2.4	14.3	5.0	4.4	2.3	4.3	2.4	7.9	2.9	8.3	15.7	2.9	6.4	1.8	2.6	3.6	2.9	3.2	20.9	3.1	4.5	8.7	1.3	4.4	3.4	4.4	20.0	8.2	9.1	16.4	3.8	3.7	6.5	3.4	4.4	4.1	4.9	3.1	5.0	7.7	9.1	2.5	3.8	5.5	2.8	2.5	5.3	6.6	2.0	4.8	8.5	10.6	7.9	8.7	3.4	5.4	3.5	4.4	4.0	5.0	6.1	6.1	4.9	4.7	5.7	7.3	4.9	3.4	4.2	3.3	4.8	5.7	5.1	9.5	9.4	8.6	11.1	8.8	9.1	8.9	7.2	12.7	5.6	35.7	32.4	26.7	44.7	38.8	30.2	85.9	30.6	44.2	29.6	41.8	15.7	68.8	97.8	85.3	113.0	32.3	23.8	23.3	83.4	55.2	42.4	35.4	13.9	91.2	47.7	17.5	18.5	37.4	30.7	19.1	45.8	21.4	33.7	38.7	30.2	34.9	64.5	28.1	46.3	93.2	28.6	32.3	41.9	55.6	72.8	38.6	41.6	20.8	44.3	42.7
MANBAL	dJ1141E15.2	ENSG00000101363	"Mannosidase beta like"	Q9NQG1	20	37289638-37317260	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052348	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA052348: AB_2681795"	"unprognostic (1.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-3)"	"prognostic unfavorable (7.07e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.70e-2)"	17.3	25.2	19.6	10.7	27.6	2.9	29.8	11.4	32.7	22.5	22.1	15.9	21.9	17.0	26.7	29.7	22.1	28.9	23.3	13.9	20.8	20.1	19.0	14.5	15.1	19.3	18.9	23.2	28.5	21.4	15.1	16.9	16.1	22.1	24.0	20.3	27.5	16.6	32.9	7.1	19.8	15.6	33.5	13.4	11.1	18.7	17.6	11.2	9.8	23.2	13.7	13.7	20.5	28.3	18.0	21.7	25.4	19.3	14.5	17.3	11.1	17.2	33.9	17.3	17.4	28.4	20.7	15.0	24.1	25.2	23.4	18.5	39.9	23.6	4.4	29.0	29.3	23.9	23.8	16.3	37.7	16.1	3.3	16.9	4.7	14.2	35.4	30.7	4.9	3.0	22.5	26.8	21.7	36.1	23.6	16.3	5.9	7.5	4.9	23.3	20.3	6.2	6.5	13.7	29.0	31.8	3.7	22.7	5.2	22.2	24.1	16.6	19.0	24.5	36.9	19.8	15.5	24.8	8.0	17.8	43.2	16.2	24.2	18.5	6.6	8.9	3.7	31.0	2.7	22.2	9.2	17.0	23.7	11.8	19.3	13.6	18.0	14.2	14.0	15.5	17.8	17.3	16.6	25.4	14.5	15.1	21.7	9.3	11.1	19.6	27.6	11.4	32.7	20.8	20.1	18.9	23.2	22.1	11.2	23.8	31.4	8.3	66.3	26.8	21.0	16.9	33.1	13.4	25.0	41.8	3.9	82.3	33.2	65.8	4.1	25.8	22.5	0.0	96.6	107.8	49.0	70.0	7.0	18.7	26.4	19.1	29.3	30.7	12.6	5.7	43.4	19.2	43.9	21.6	32.4	50.8	77.2	44.8	64.3	47.6	11.3	19.4	44.2	23.2	48.1	26.6	64.3	10.7	32.7	98.7
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 13.2;Ito cells: 14.7;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	20.4	5.7	14.2	7.5	17.3	0.8	8.2	22.0	23.7	6.6	2.7	2.8	1.0	1.9	8.2	6.2	5.3	7.0	8.8	8.8	11.7	9.1	5.0	1.5	8.5	8.5	7.2	19.9	5.3	3.1	6.4	10.9	8.4	6.6	7.2	2.7	4.1	5.7	8.0	5.0	6.4	2.6	9.8	5.5	7.3	4.6	3.1	4.1	0.9	4.5	5.3	6.1	6.0	4.4	1.1	0.0	0.0	0.3	0.0	0.9	0.0	1.7	4.2	4.7	17.6	6.2	9.4	0.1	6.6	4.7	4.4	1.7	1.7	3.2	0.0	5.9	6.1	7.3	4.3	3.1	2.6	0.3	9.1	2.1	6.2	5.6	0.4	7.1	1.5	9.7	13.0	7.8	1.2	0.5	4.9	9.6	6.7	5.0	17.0	4.3	7.5	0.3	5.7	0.4	5.2	4.9	17.0	0.1	6.0	6.6	0.0	4.4	11.8	5.6	2.3	4.6	0.6	7.7	4.9	15.0	13.2	11.0	0.9	2.4	0.7	2.0	7.2	6.7	1.8	11.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.4	0.2	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	14.2	17.3	22.0	23.7	11.7	9.1	7.2	19.9	6.6	4.1	0.0	1.4	1.3	1.1	1.6	2.6	2.8	0.0	0.0	0.0	0.0	5.9	0.0	1.7	0.8	3.7	13.2	0.0	0.0	0.2	0.3	1.7	3.3	0.0	1.0	0.2	0.0	0.0	14.7	2.6	5.7	2.8	0.0	5.0	0.0	0.0	5.6	0.7	0.0	2.1	1.4	10.9	0.0	1.0	1.2	2.1	1.1	0.0	1.0	0.0	0.9
MARC1	"FLJ22390, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786759-220819657	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 71.3;breast: 81.3"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5"	"Group enriched"	"Detected in many"	32	"granulocytes: 28.5;monocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028702	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	71.3	3.0	4.6	7.5	6.1	7.3	81.3	3.1	4.0	3.4	7.8	2.1	18.7	3.3	1.4	5.5	3.4	2.8	6.4	6.7	3.7	4.6	3.4	33.6	4.3	4.3	4.0	3.3	2.5	4.0	4.0	3.3	9.7	4.3	14.9	6.8	4.4	27.8	10.5	4.2	1.4	3.8	2.6	2.6	4.3	3.2	0.6	1.4	0.1	22.0	2.7	1.4	3.9	7.5	0.2	0.7	28.5	20.6	0.0	0.1	4.9	5.7	3.1	2.0	0.0	0.4	0.1	51.6	0.5	0.4	0.3	0.5	17.0	0.3	0.0	2.1	0.5	0.0	0.0	10.7	1.0	0.7	0.0	10.9	0.0	22.0	25.3	1.3	0.1	0.1	2.0	0.6	0.0	0.0	0.0	0.3	0.0	1.6	0.1	0.3	5.6	0.0	10.9	21.8	16.8	9.5	0.0	0.0	0.1	2.4	6.4	6.1	14.2	3.1	3.8	0.0	6.0	14.4	13.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.0	20.6	8.1	0.1	1.5	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	28.5	0.0	0.4	0.2	0.0	4.9	4.6	6.1	3.1	4.0	3.7	4.6	4.0	3.3	4.3	1.4	0.0	12.8	0.9	0.0	0.8	5.7	5.1	0.0	2.7	0.0	8.7	0.0	94.8	1.7	0.0	4.4	2.9	6.3	0.0	0.0	36.6	1.0	0.0	2.3	22.1	10.4	0.0	4.1	3.1	22.0	2.6	0.6	0.2	0.0	0.0	22.2	12.4	0.0	9.5	5.6	2.5	1.4	0.0	3.1	0.0	0.7	0.5	62.8	0.0	9.5	0.0
MARCH5	"FLJ20445, MARCH-V, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291163-92353964	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria		NA	NA			Mitochondria		"HPA056596: AB_2683181"	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	18.2	21.7	17.5	17.7	18.3	20.7	27.1	16.8	25.7	15.5	15.4	12.7	20.7	15.8	19.3	18.8	28.0	14.8	15.4	18.4	15.8	15.1	21.7	27.6	16.5	16.6	16.3	17.9	20.9	16.7	16.3	12.3	16.3	14.8	22.2	14.8	14.5	19.4	19.3	42.6	13.7	16.0	18.1	14.0	12.1	14.4	20.1	13.5	25.0	24.5	21.5	17.3	14.7	21.0	7.3	9.4	16.8	10.2	6.5	8.7	6.6	16.2	8.8	17.5	20.0	11.9	12.4	9.0	14.6	16.1	18.2	18.7	5.9	11.7	9.5	10.1	14.2	8.0	13.4	12.1	12.2	26.2	7.1	14.3	7.6	8.3	13.8	14.5	12.1	7.6	12.7	16.5	12.0	25.2	24.3	16.0	10.2	8.3	11.9	14.5	10.3	10.7	14.0	4.1	10.6	13.3	11.6	17.9	5.6	18.6	10.5	8.1	15.0	12.6	9.4	15.4	8.7	16.4	9.5	15.5	8.6	9.4	9.3	19.9	12.1	9.2	8.4	7.8	16.9	5.7	5.2	8.3	9.0	7.6	10.2	7.6	7.3	8.4	8.0	9.4	6.7	8.7	8.3	16.8	6.5	8.5	6.2	7.8	6.6	17.5	18.3	16.8	25.7	15.8	15.1	16.3	17.9	14.8	13.5	20.8	22.1	26.1	0.0	78.5	12.2	22.9	20.4	9.4	9.1	19.2	7.9	35.2	72.9	0.0	116.8	22.5	30.7	0.0	0.0	36.8	29.4	0.0	28.8	32.6	30.8	9.5	28.6	20.3	24.8	37.2	27.3	19.9	37.1	0.0	22.9	18.6	0.0	23.0	17.3	56.2	10.9	19.4	24.5	37.4	28.3	68.3	54.6	25.5	24.7	0.0
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		230000	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	15.9	13.9	13.0	15.5	17.7	10.8	25.5	17.7	15.7	12.3	18.5	17.2	15.1	17.2	14.9	10.6	17.3	13.8	12.2	15.4	12.3	8.0	13.3	13.9	18.1	17.4	19.9	9.0	18.9	22.5	23.4	13.7	12.0	13.8	13.1	18.6	13.6	15.3	22.4	39.4	22.1	17.0	17.1	13.7	12.7	15.8	5.9	17.1	15.1	14.6	14.0	14.3	18.2	21.6	5.1	5.6	6.4	6.9	5.9	4.8	4.6	16.6	19.4	7.9	9.8	21.8	14.9	6.2	10.1	13.0	10.8	7.9	15.1	10.8	7.2	6.2	14.1	30.8	21.0	9.4	15.1	11.1	4.4	4.6	13.9	7.2	24.0	12.1	8.7	5.9	15.0	12.9	18.3	10.9	10.8	10.9	9.5	15.6	5.6	10.5	15.0	13.1	7.4	5.0	8.3	10.7	9.9	11.0	7.2	11.4	16.7	5.9	6.2	11.5	22.5	9.7	11.7	12.0	8.1	16.4	14.8	5.5	17.4	11.7	11.4	13.7	5.1	5.8	10.7	7.5	4.4	6.9	6.1	4.8	5.1	3.6	3.8	3.8	3.7	4.4	5.1	4.4	4.4	6.4	5.9	5.5	5.6	3.0	4.6	13.0	17.7	17.7	15.7	12.3	8.0	19.9	9.0	13.8	17.1	53.6	40.3	27.3	12.5	1.9	31.8	52.6	66.2	25.4	35.2	27.9	15.7	28.8	11.6	21.9	0.9	25.1	79.6	23.3	26.2	23.2	18.1	15.7	8.1	39.0	21.3	42.9	33.4	41.1	29.1	1.5	28.4	13.1	1.7	17.2	28.4	23.6	28.0	21.0	26.5	18.3	34.3	32.3	8.1	4.2	3.8	1.8	15.1	19.2	45.8	14.3
MBD3L2		ENSG00000230522	"Methyl-CpG binding domain protein 3 like 2"	Q8NHZ7	19	7049321-7051735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.9"									HPA060924			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.6		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L2B		ENSG00000196589	"Methyl-CpG binding domain protein 3 like 2B"	A0A1B0GVZ6	19	7018969-7021450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	18	"testis: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-2 OS: 2.7"									HPA060924			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L3		ENSG00000182315	"Methyl-CpG binding domain protein 3 like 3"	A6NE82	19	7056209-7058640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	19	"testis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.3"									HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L4		ENSG00000205718	"Methyl-CpG binding domain protein 3 like 4"	A6NDZ8	19	7037748-7040179	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	5	"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.6"									HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBD3L5		ENSG00000237247	"Methyl-CpG binding domain protein 3 like 5"	A6NJ08	19	7030578-7033011	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"smooth muscle: 1.0;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060924			Approved	Mitochondria		NA	NA			Mitochondria		"HPA060924: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458203-90474768	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	5.2	7.4	11.2	5.7	16.8	2.7	9.5	16.7	14.7	8.7	5.7	7.4	7.4	6.1	9.6	6.6	7.2	7.5	5.0	5.2	12.7	14.2	9.3	11.1	5.5	11.1	10.6	9.8	16.3	7.4	21.8	10.0	5.4	9.7	8.6	6.2	4.8	7.8	7.8	4.3	9.5	5.4	7.1	10.7	6.6	4.8	6.1	7.0	8.1	9.7	3.1	7.0	6.5	6.9	5.3	2.9	1.1	3.8	3.3	4.8	2.3	5.8	2.5	4.4	5.5	5.8	7.9	5.4	4.6	4.3	4.0	4.3	1.9	4.4	13.7	2.8	4.1	5.6	6.0	5.7	7.0	6.3	7.7	3.9	6.1	4.1	4.4	6.1	6.0	2.7	6.8	9.4	2.9	11.2	4.7	5.1	7.4	9.2	7.6	6.8	3.6	5.8	8.3	2.8	1.2	12.3	6.3	7.3	18.6	6.1	2.2	7.6	8.9	4.2	6.2	11.2	2.7	5.1	4.5	6.3	5.0	3.5	6.1	6.0	5.4	6.0	6.1	4.3	12.7	6.8	0.0	1.5	1.1	3.2	3.8	3.9	3.1	3.6	3.5	2.9	5.3	4.8	3.7	0.1	3.3	1.9	1.0	1.3	2.3	11.2	16.8	16.7	14.7	12.7	14.2	10.6	9.8	9.7	7.0	3.0	2.2	1.4	0.8	2.4	6.4	4.0	5.1	2.7	1.2	1.8	7.9	3.0	1.7	1.6	0.3	4.4	2.0	0.0	1.1	2.7	2.2	0.8	0.0	4.9	2.2	3.2	4.1	3.7	5.3	0.6	3.7	1.2	1.7	1.0	2.8	5.6	2.0	0.0	4.9	3.9	6.2	0.0	2.7	2.8	4.6	2.9	0.7	2.1	3.5	0.7
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	8.9	18.6	8.9	9.1	11.3	14.0	4.3	13.3	13.6	12.7	11.1	7.4	12.3	7.8	6.9	14.2	24.8	8.4	12.3	7.6	15.7	5.8	9.8	3.8	11.8	6.1	15.5	8.2	3.8	13.2	8.3	19.1	14.1	12.9	9.7	4.6	10.6	8.7	14.4	5.6	3.3	4.3	8.3	4.7	13.8	4.2	16.6	8.7	8.8	4.6	2.2	18.3	18.7	11.9	16.4	12.4	15.9	7.1	11.5	16.0	3.7	23.2	9.9	10.7	13.5	3.8	17.8	3.4	15.3	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0	8.9	7.8	3.0	3.4	4.8	11.7	12.0	7.6	10.7	6.8	7.0	17.7	5.6	0.0	5.1	0.3	4.6	3.3	0.0	7.7	5.4	8.9	6.6	10.4	16.1	8.0	28.6	2.4	10.4	9.5	0.9	9.8	4.4	10.1	3.6	3.3	7.7	5.3	3.1	12.4	7.5	14.0	0.0	6.9	2.8	1.7	2.4	4.0	4.3	4.2	4.1
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132206-43143394	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003122: AB_2666795, HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favorable (2.18e-4)"	"prognostic favorable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.4	18.2	13.3	8.2	17.2	11.0	12.8	10.4	24.6	10.6	11.9	9.4	10.7	9.5	11.0	17.2	12.3	20.7	21.4	12.9	14.4	14.2	25.6	24.3	8.6	7.1	12.0	12.0	14.4	16.2	20.3	14.3	9.2	15.1	12.8	10.6	9.9	14.5	10.2	17.7	11.7	9.7	8.6	6.0	7.6	12.1	19.6	5.2	18.4	20.1	14.0	9.9	8.5	8.1	10.2	13.9	2.5	9.5	11.6	10.3	5.6	7.2	9.5	6.8	11.8	5.7	6.1	6.9	8.1	7.2	11.0	10.2	9.5	7.4	12.2	8.4	6.0	6.2	12.2	12.8	10.7	8.2	4.2	37.8	4.5	11.0	10.5	9.1	21.6	5.5	4.5	10.5	10.7	8.5	6.4	7.8	7.4	10.7	5.0	5.3	13.3	10.0	23.5	6.5	10.2	16.9	13.3	6.6	19.3	13.7	6.3	8.9	4.7	8.7	17.1	12.3	3.2	8.8	14.0	4.6	4.8	9.4	10.3	11.4	8.9	9.2	8.8	10.3	8.3	5.7	0.0	9.5	0.7	7.7	9.1	10.3	8.3	8.6	10.1	13.9	10.2	10.1	7.1	2.5	11.6	5.5	13.7	5.5	5.6	13.3	17.2	10.4	24.6	14.4	14.2	12.0	12.0	15.1	5.2	6.0	5.0	6.7	9.1	15.9	10.0	8.7	30.6	10.7	4.5	19.2	0.0	16.7	43.1	25.8	13.8	7.1	10.0	0.0	19.0	8.4	9.3	14.1	3.5	20.8	13.6	6.4	13.9	16.5	8.2	9.0	6.9	4.8	6.8	8.2	12.4	9.5	19.8	17.5	15.6	67.4	8.7	19.4	9.8	29.0	10.4	18.3	7.7	4.9	22.7	9.5
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.2	5.4	3.4	3.6	15.1	6.9	7.0	6.6	9.2	7.2	8.2	7.5	5.7	15.8	10.7	5.8	12.6	7.4	5.2	4.3	9.3	5.3	5.8	13.4	6.2	7.9	10.0	8.9	7.7	7.8	5.0	3.4	7.8	4.9	9.7	13.9	7.4	8.3	8.1	11.7	8.7	4.5	3.9	22.4	6.0	7.2	7.8	20.2	10.6	22.7	7.7	5.6	25.2	34.7	7.1	3.7	53.1	12.7	4.7	5.6	4.5	4.4	9.7	8.5	15.5	16.0	6.1	12.9	5.2	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4	8.9	42.2	11.0	15.2	6.3	10.8	27.0	33.1	25.4	13.6	26.2	9.8	24.8	28.2	16.0	4.4	5.2	9.2	0.0	14.9	3.5	6.7	11.8	7.0	30.1	14.2	7.9	5.8	5.5	9.7	4.1	8.1	11.7	6.8	10.0	11.7	12.1	18.1	19.5	9.9	36.0	11.4	6.5	8.1	6.4	3.2	5.1	23.7	10.1	22.9	19.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.9	16.5	7.1	27.1	7.6	7.8	12.1	5.7	9.6	11.8	8.5	28.9	15.2	27.7	21.0	8.3	9.2	9.9	12.3	19.0	14.8	14.7	15.7	15.0	8.5	31.7	13.3	7.4	14.3	10.0	10.0	10.8	8.6	5.3	10.3	8.0	18.9	10.4	8.1	32.6	0.1	13.6	9.3	10.5	9.3	14.5	20.4	40.7	30.6	21.6	11.2	12.4	24.9	36.9	12.1	3.5	30.6	18.9	7.5	4.8	7.5	8.7	15.3	7.5	13.8	17.2	7.9	20.7	11.9	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9	14.9	23.4	22.9	14.2	11.7	12.8	60.9	17.8	16.0	18.2	15.7	5.9	40.3	18.3	18.3	3.1	14.2	19.6	0.0	16.1	19.0	8.9	25.3	12.7	79.8	15.6	3.2	28.4	8.0	10.8	7.4	12.7	12.2	11.8	19.0	22.7	19.0	14.2	17.5	19.1	48.4	11.4	6.5	9.1	3.9	13.3	12.0	53.2	12.9	28.8	18.5
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 335.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria		Yes	No			Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	10.0	5.2	9.7	5.8	19.6	20.6	13.2	12.3	12.7	13.0	10.5	6.4	8.3	12.8	7.3	8.8	7.0	13.5	7.3	14.8	13.1	10.5	5.0	5.2	8.3	7.4	15.4	8.8	11.9	11.3	17.0	12.7	24.8	12.1	14.3	3.9	11.7	18.6	17.0	11.1	4.3	6.7	17.8	8.6	9.1	6.6	7.8	6.7	14.3	7.3	7.5	10.1	8.8	12.0	15.9	15.3	7.6	13.6	17.5	8.3	8.7	5.2	15.5	23.8	27.9	335.8	14.2	7.0	10.8	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0	184.6	337.7	161.5	413.1	434.6	37.7	75.0	170.7	65.6	141.0	31.4	56.9	80.9	34.9	139.8	191.3	189.6	281.5	23.3	149.6	178.6	195.3	286.6	340.1	210.0	235.2	11.1	249.0	192.8	356.1	271.6	67.3	381.9	259.8	113.6	185.2	58.8	165.7	122.2	57.3	57.2	70.9	77.6	218.3	33.9	33.0	500.0	226.1	179.7	132.6	219.4
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		1400000	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	8.2	6.5	6.3	9.4	6.1	12.3	9.8	41.0	6.8	7.0	19.8	4.1	8.5	19.1	10.9	7.4	13.4	7.8	11.5	6.9	4.8	4.3	11.1	7.2	10.1	7.4	3.4	4.1	5.8	12.1	8.2	5.5	8.8	5.5	4.6	21.9	5.1	9.5	5.8	41.4	9.0	23.0	11.0	3.8	4.9	29.4	4.7	3.5	4.9	5.4	14.9	7.3	10.1	15.0	3.4	5.4	16.6	7.6	1.9	4.6	3.6	19.7	32.0	8.3	6.0	12.7	14.3	8.5	12.2	17.4	12.2	13.1	19.0	18.9	8.4	9.8	14.9	6.6	18.1	10.9	14.5	16.4	9.2	10.2	10.5	12.0	10.5	9.9	26.3	8.9	14.5	12.4	10.9	23.4	19.2	14.6	9.0	6.5	6.3	11.3	11.5	7.1	5.7	9.2	21.6	6.7	7.4	17.8	2.2	16.5	10.8	8.9	3.9	15.0	16.8	3.6	10.5	3.3	6.9	11.8	5.9	10.2	12.7	8.1	4.7	5.9	5.9	7.9	13.2	4.5	1.7	6.1	16.6	2.9	6.7	3.1	3.4	3.0	3.5	5.4	1.7	2.3	2.6	8.2	1.9	7.6	1.9	4.6	3.6	6.3	6.1	41.0	6.8	4.8	4.3	3.4	4.1	5.5	3.5	32.8	13.4	2.7	10.4	10.4	3.0	5.9	10.2	18.7	26.1	17.4	2.0	6.4	1.7	7.2	10.7	7.4	22.6	0.0	22.1	8.3	6.7	8.1	8.1	5.0	6.3	0.0	8.1	8.6	6.3	4.7	4.9	3.7	8.5	2.8	24.0	4.8	27.5	8.6	3.9	6.1	3.3	12.9	8.9	3.9	4.9	10.8	7.8	2.5	20.4	20.7
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative beta subunit"	Q9NWR8	4	109560205-109688726	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 39.3;lymphoid tissue: 45.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	11.6	2.2	4.1	21.0	3.2	8.3	16.6	0.4	3.7	8.2	4.9	4.6	1.4	3.5	12.3	5.5	9.2	6.3	7.3	14.9	4.5	4.7	3.9	2.1	7.8	44.2	3.5	2.6	7.5	2.1	2.3	5.1	9.9	6.5	5.4	6.1	4.1	6.5	2.2	4.3	7.6	8.8	8.4	8.5	13.8	4.2	3.6	1.9	45.3	4.7	9.5	24.8	7.3	9.0	14.0	15.7	1.1	16.0	20.0	39.3	25.7	10.4	4.5	2.5	12.8	2.8	7.4	9.7	9.0	5.5	9.9	8.9	0.2	8.5	36.7	1.9	7.7	5.5	3.0	9.4	5.5	8.8	23.3	7.4	4.4	5.0	0.6	4.9	8.9	0.1	4.7	1.5	6.0	5.1	7.0	13.2	13.6	1.3	23.4	7.5	12.8	20.4	0.1	11.6	1.8	6.5	7.8	19.4	4.1	11.6	4.6	10.3	4.5	9.7	28.9	3.0	2.1	3.6	0.4	9.4	3.9	5.1	20.6	15.6	9.1	6.3	8.9	12.0	1.9	2.7	0.0	16.0	0.2	6.3	9.7	9.0	13.5	26.7	19.0	15.7	14.0	39.3	22.2	1.1	20.0	7.2	11.0	22.4	25.7	4.1	3.2	0.4	3.7	4.5	4.7	3.5	2.6	6.5	1.9	8.9	6.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	5.2	0.0	107.3	0.0	22.4	0.0	0.0	0.0	0.0	99.3	82.0	0.0	0.0	1.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	25.2	0.0	0.0	50.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50878734-50954257	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.6	18.1	17.1	18.4	16.2	11.6	10.7	13.2	16.0	9.4	26.4	14.3	16.8	30.2	10.5	7.7	10.6	9.3	10.5	34.6	15.8	17.8	12.1	12.1	10.3	24.1	18.7	14.0	11.1	16.7	20.6	20.2	10.5	47.7	11.8	26.6	9.4	8.8	23.1	29.5	7.1	44.8	16.9	18.9	36.6	20.3	15.3	8.7	24.3	9.0	7.8	17.3	14.2	15.7	4.9	9.6	14.3	17.4	6.7	6.0	4.5	13.0	13.1	17.5	20.4	8.0	8.9	8.1	10.9	8.2	14.3	12.1	6.0	7.2	46.7	4.3	9.7	13.1	10.9	26.1	11.1	16.5	19.3	4.0	11.9	8.3	7.0	23.6	39.6	14.3	5.5	13.6	18.0	29.3	9.4	18.3	27.8	12.6	11.4	9.7	2.7	28.6	3.9	11.7	9.4	5.4	18.8	8.7	13.5	15.6	2.8	21.7	11.5	10.2	6.3	10.9	11.0	4.8	19.3	11.3	10.2	11.4	5.3	14.5	21.3	8.6	22.9	10.3	28.3	10.8	5.0	11.6	14.3	5.0	13.1	4.1	4.9	3.3	6.0	9.6	4.9	2.9	3.5	13.3	6.7	17.4	3.2	3.1	4.5	17.1	16.2	13.2	16.0	15.8	17.8	18.7	14.0	47.7	8.7	8.9	11.0	34.0	15.3	13.5	17.4	93.2	7.6	5.3	26.1	14.0	13.7	14.6	33.2	28.0	13.4	14.8	44.5	0.0	34.2	14.5	10.8	15.2	15.1	7.4	87.2	7.9	11.5	30.7	83.1	4.7	10.6	39.2	11.8	27.9	24.3	13.0	27.5	20.1	15.6	14.0	55.9	6.5	15.4	50.9	20.4	9.4	7.2	26.1	35.2	14.8
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192873-29230942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.29e-4)"	16.4	11.9	16.0	6.6	17.0	6.0	12.3	7.8	17.7	13.0	9.7	8.6	7.1	7.8	10.5	8.4	9.4	10.9	8.5	24.8	15.7	11.5	11.0	13.7	8.3	10.0	14.7	16.3	11.7	14.3	8.1	10.0	10.8	12.8	7.5	8.9	10.8	12.6	10.0	45.5	11.3	5.9	10.2	10.7	5.4	8.1	8.2	10.5	4.4	8.3	12.8	7.6	8.0	7.2	8.3	14.7	0.3	11.5	11.6	13.1	6.5	10.2	9.8	4.8	22.2	4.9	8.7	17.6	7.8	8.8	10.2	9.9	7.4	21.0	13.5	15.6	7.6	3.2	12.8	6.0	15.8	6.3	9.2	12.4	11.7	6.3	9.4	15.2	12.9	6.0	8.6	14.1	5.4	19.9	8.5	11.2	17.3	10.0	14.0	12.7	11.5	10.9	7.1	12.9	19.5	12.5	6.7	8.1	23.7	10.8	5.9	7.3	11.3	11.5	16.4	14.4	9.8	6.0	12.5	11.3	7.4	8.0	11.5	11.4	13.4	5.5	10.0	20.0	17.2	14.0	0.1	7.0	0.0	8.3	11.5	13.1	8.3	7.8	6.7	14.7	7.4	8.4	8.5	0.3	11.6	7.0	8.6	6.3	6.5	16.0	17.0	7.8	17.7	15.7	11.5	14.7	16.3	12.8	10.5	11.9	3.8	8.2	13.8	4.9	12.0	17.1	15.3	2.7	11.4	19.2	9.8	41.0	34.9	18.9	31.2	8.0	7.8	0.0	17.2	32.6	12.7	8.1	5.7	18.3	18.3	7.9	7.5	4.9	4.9	60.9	12.7	6.0	15.1	12.6	9.8	10.9	14.2	7.0	10.3	32.7	62.2	12.9	8.9	6.7	15.0	6.5	23.3	4.9	19.9	15.6
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358497-82479236	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Uncertain		Uncertain	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	8.3	9.2	8.7	8.5	8.1	5.0	11.1	23.6	8.3	8.2	7.7	8.1	9.0	7.5	8.2	9.1	10.0	8.0	5.8	8.7	9.1	3.1	8.8	6.3	6.5	8.1	7.6	5.7	10.8	6.5	7.8	25.9	6.8	7.6	8.0	9.2	5.8	10.5	6.0	10.7	9.7	8.2	7.5	5.8	8.6	6.7	11.0	13.0	9.9	10.2	8.7	7.4	8.8	8.5	7.9	13.2	14.4	7.6	9.8	7.6	3.8	1.4	3.3	4.5	0.9	5.1	6.0	4.6	7.0	4.0	3.7	2.7	4.3	3.9	8.6	1.5	5.1	0.9	1.5	8.9	1.1	2.4	8.2	7.5	4.1	1.8	4.1	3.1	7.2	5.0	4.4	4.2	1.2	0.0	7.3	7.6	3.1	3.1	3.9	3.8	4.9	3.1	6.3	6.8	3.9	1.0	1.7	2.7	4.4	11.5	5.2	3.4	2.6	2.5	4.2	4.4	3.9	3.7	6.8	2.8	1.7	1.6	2.8	3.9	4.9	3.0	3.2	2.8	4.4	3.9	14.4	7.6	4.4	4.9	6.4	7.3	6.4	5.3	4.0	6.0	7.9	7.6	5.4	13.6	9.8	5.7	13.2	4.5	3.8	8.7	8.1	23.6	8.3	9.1	3.1	7.6	5.7	7.6	13.0	8.9	8.1	3.7	6.4	4.0	6.1	10.1	7.6	16.0	3.4	3.5	5.9	10.0	6.6	4.2	2.8	6.2	4.5	0.0	2.7	4.4	6.1	4.2	3.5	3.9	5.0	3.2	7.0	6.7	3.1	1.1	4.4	5.4	5.0	15.4	4.2	3.5	4.1	5.5	9.9	6.8	9.7	0.0	5.1	11.8	6.4	5.4	6.5	4.9	5.5	3.1
METTL27	WBSCR27	ENSG00000165171	"Methyltransferase like 27"	Q8N6F8	7	73834590-73842535	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 56.2;Collecting duct cells: 19.2;Distal tubular cells: 24.9;Proximal tubular cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.6;RPMI-8226: 40.8;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA022420, HPA074662"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA022420: AB_2304370, HPA074662: "	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.24e-2)"	5.7	2.7	1.5	1.4	2.6	0.3	5.2	4.2	3.9	10.2	3.6	3.8	14.5	3.3	5.3	4.4	5.8	9.3	12.4	0.9	1.4	1.3	9.2	2.7	4.7	6.0	1.2	6.0	5.2	11.1	10.0	4.0	8.7	2.8	8.0	1.3	2.4	20.3	12.4	2.3	2.0	4.5	1.3	1.3	5.1	1.7	10.6	0.8	3.0	6.6	0.9	3.1	4.3	3.6	2.4	1.4	2.0	3.4	0.0	9.2	0.3	6.4	7.9	0.0	0.6	1.2	3.5	1.3	0.0	0.1	0.2	0.2	0.4	9.6	1.5	1.5	1.3	5.6	0.6	0.0	2.5	0.1	1.0	0.1	0.0	2.3	2.4	1.4	0.0	0.0	1.4	0.6	4.1	2.0	0.4	1.5	0.5	0.1	1.3	0.9	1.8	0.0	0.0	0.1	5.1	2.0	0.4	1.8	40.8	2.1	1.2	0.7	0.2	0.9	0.7	0.7	1.9	11.9	0.4	1.7	2.5	0.6	4.9	2.5	1.8	0.6	0.0	0.5	0.0	0.8	0.0	1.0	2.0	0.1	3.4	0.0	2.4	0.6	0.0	1.4	1.0	1.2	0.8	1.0	0.0	0.8	1.0	9.2	0.3	1.5	2.6	4.2	3.9	1.4	1.3	1.2	6.0	2.8	0.8	6.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	56.2	4.5	19.2	0.0	3.4	24.9	12.8	0.0	0.0	0.0	0.0	1.9	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040061: AB_10697713, HPA046734: AB_2732532"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	13.2	8.9	10.1	13.5	15.7	6.1	15.8	18.4	15.6	13.5	10.6	8.6	15.7	9.7	14.0	12.3	11.9	11.1	10.9	9.9	10.1	11.8	10.5	9.2	11.2	19.9	15.9	8.5	13.9	8.6	16.3	23.6	10.4	14.2	12.9	12.7	10.1	17.7	15.6	6.4	11.0	14.6	12.6	17.3	19.9	10.0	12.4	15.8	15.3	16.2	7.2	19.5	13.8	16.8	7.5	3.5	14.4	2.5	5.6	9.4	4.8	7.8	3.4	10.8	6.4	4.9	7.6	12.4	12.3	11.2	12.9	12.8	6.9	5.9	16.5	7.8	5.8	10.5	7.0	17.4	6.6	16.6	11.9	6.0	6.3	6.8	5.9	7.5	14.6	8.4	4.9	14.8	13.2	8.5	7.4	13.3	10.2	8.8	20.7	11.0	3.8	10.9	4.8	6.2	6.9	5.6	7.5	8.6	11.3	7.6	4.9	19.4	8.9	9.8	6.8	12.9	9.5	7.6	10.1	8.6	14.8	18.5	14.3	17.6	10.3	26.4	9.6	9.9	10.3	17.1	14.4	2.5	6.5	6.6	2.3	8.0	6.8	7.6	8.6	1.9	7.5	9.4	8.6	10.1	5.6	2.0	3.5	8.4	4.8	10.1	15.7	18.4	15.6	10.1	11.8	15.9	8.5	14.2	15.8	11.9	8.0	10.0	10.0	4.2	10.1	3.1	5.1	13.4	12.5	3.5	13.7	6.4	0.0	4.9	2.5	9.0	7.8	0.0	6.3	7.9	5.7	9.4	6.9	3.8	5.1	7.9	2.4	12.9	7.6	2.6	11.8	5.7	3.3	1.8	5.1	8.0	6.6	4.2	10.3	4.0	5.8	12.9	6.6	27.0	20.9	4.3	8.7	10.9	4.9	15.4
MFF	"C2orf33, GL004"	ENSG00000168958	"Mitochondrial fission factor"	Q9GZY8	2	227325151-227357836	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 827.2;Late spermatids: 1262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010968, HPA074625"	Enhanced		Supported	Mitochondria		No	No			Mitochondria		"HPA010968: AB_1845714, HPA074625: AB_2686704"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.22e-1)"	20.2	23.9	31.6	18.0	27.6	22.3	21.3	25.7	38.4	19.6	22.5	26.5	14.7	22.1	21.9	20.9	21.5	18.0	17.1	40.5	27.8	28.4	33.7	24.4	16.6	27.1	30.2	20.2	25.7	27.6	25.0	19.3	17.7	28.0	20.6	22.5	25.6	20.6	27.6	37.4	16.7	18.6	22.9	33.4	16.9	18.8	97.0	20.6	25.9	19.8	22.2	23.3	20.7	17.8	40.2	34.9	59.9	33.8	29.3	44.1	33.1	23.2	20.0	24.6	33.8	31.9	30.7	32.7	23.2	31.4	28.3	30.3	21.7	16.6	13.3	27.8	25.3	29.8	19.3	40.4	29.5	38.5	28.1	32.5	28.1	51.6	54.4	42.1	27.1	25.2	27.5	38.9	26.8	28.7	37.1	24.4	30.7	24.4	40.0	25.0	23.4	28.6	41.8	33.3	25.0	21.2	26.0	31.1	25.7	41.3	22.0	26.1	24.5	50.9	23.7	33.8	21.2	15.2	26.9	16.4	27.6	23.3	40.8	25.7	32.6	22.1	26.7	36.5	24.2	37.5	42.4	32.9	59.9	32.8	33.8	35.3	40.2	34.5	32.0	34.5	38.2	36.6	31.0	31.0	29.3	30.6	34.9	44.1	33.1	31.6	27.6	25.7	38.4	27.8	28.4	30.2	20.2	28.0	20.6	29.8	37.7	68.1	54.7	42.8	34.0	71.6	35.7	26.8	52.4	57.6	29.5	82.2	107.8	83.0	827.2	38.3	47.7	93.5	82.7	82.5	63.5	55.3	20.9	54.0	67.9	38.1	31.0	41.1	54.0	1262.3	81.4	51.9	77.6	56.9	59.6	185.4	78.7	66.6	80.6	97.9	56.3	58.2	52.6	274.7	48.3	41.4	76.9	53.7	69.3	60.3
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"		3	179347692-179394931	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	13.7	16.5	12.2	12.1	17.2	9.9	15.4	24.3	22.4	18.4	16.5	15.9	19.4	12.0	19.6	21.3	19.6	18.5	13.4	31.1	12.0	11.4	17.9	14.9	12.3	16.0	16.9	14.5	16.6	29.9	18.2	22.3	12.4	21.5	17.7	14.6	12.8	17.4	17.4	21.7	19.6	16.6	15.7	16.0	18.2	17.8	11.8	17.0	16.9	14.5	20.1	19.6	17.6	15.1	10.5	4.1	8.9	4.5	4.1	7.3	2.1	16.7	5.0	9.7	15.8	14.0	13.0	12.9	10.5	10.8	11.1	13.2	12.5	7.0	5.7	11.0	15.4	22.4	9.9	13.6	10.3	19.5	9.0	10.5	9.3	11.6	6.8	11.5	4.9	9.0	9.0	9.1	11.9	8.5	9.2	14.0	9.6	6.8	7.6	15.4	8.9	7.2	3.7	11.5	16.9	9.3	5.1	15.3	21.1	10.6	17.8	9.2	13.1	9.8	26.3	14.2	10.4	36.0	3.6	11.7	9.7	10.8	15.0	15.3	10.2	11.0	9.5	10.8	8.3	10.5	5.5	3.8	8.5	4.3	4.5	7.3	7.8	4.9	4.4	3.4	10.5	4.6	5.1	8.9	4.1	3.6	4.1	4.4	2.1	12.2	17.2	24.3	22.4	12.0	11.4	16.9	14.5	21.5	17.0	23.8	33.7	14.5	9.5	14.8	16.0	28.0	10.2	33.5	27.3	17.4	37.3	9.7	8.3	11.0	2.3	9.4	11.7	23.3	15.0	8.4	13.8	17.9	8.1	16.6	7.2	11.1	9.8	17.2	10.7	2.5	12.4	11.3	11.8	6.4	16.0	11.5	14.1	8.6	16.6	10.3	16.6	6.5	13.9	25.4	11.5	23.6	11.0	7.4	13.3	20.1
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 308.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	26.0	15.9	18.1	23.8	18.3	13.8	21.0	20.6	19.1	28.3	22.1	26.3	17.4	19.1	22.4	24.9	18.6	27.9	29.9	47.8	25.4	69.2	22.7	27.3	25.6	20.4	19.0	27.7	17.2	17.4	36.9	39.8	36.9	12.2	19.9	10.3	28.2	16.8	20.9	13.1	16.8	12.7	12.5	17.5	23.5	19.7	26.4	17.8	17.0	17.4	21.1	13.8	24.2	25.8	23.9	14.2	13.9	16.7	19.9	19.0	19.0	28.8	21.5	20.1	21.1	31.3	22.5	31.2	20.5	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9	20.8	18.6	11.5	8.2	20.3	24.8	308.6	12.7	12.0	14.8	14.0	11.8	12.2	18.3	12.7	3.6	12.0	31.1	23.3	17.3	13.2	9.3	12.5	10.4	39.2	14.2	28.6	17.3	13.5	18.1	4.4	6.6	11.8	16.9	10.0	20.9	11.6	13.9	14.0	14.2	13.3	18.6	12.9	14.4	27.7	16.8	26.3	21.1	9.6	22.1	12.9
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 59.6;WM-115: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	25.9	13.0	15.4	19.0	14.4	23.5	9.3	10.4	22.9	8.1	8.9	24.3	11.2	12.5	10.2	12.7	11.1	14.3	10.0	7.6	23.9	12.8	38.0	21.5	13.8	15.2	20.7	10.0	9.7	19.8	15.7	11.9	46.6	15.6	10.2	5.7	13.5	23.7	10.5	8.1	43.6	13.8	9.9	18.6	19.7	14.1	7.5	16.1	37.0	9.1	6.1	11.8	7.9	7.8	2.4	12.9	2.6	7.9	0.5	3.1	1.6	17.0	13.8	3.4	8.9	7.1	5.5	12.3	10.5	5.7	12.3	13.5	5.9	5.8	4.8	8.0	5.5	19.6	10.7	4.4	5.4	4.4	10.5	12.5	2.8	44.2	6.0	8.9	6.0	9.5	4.9	8.2	12.6	2.9	4.7	3.3	7.2	13.4	7.0	3.1	10.2	5.9	10.8	6.4	7.5	11.2	4.3	4.9	20.3	5.1	7.3	12.9	6.5	20.7	9.7	59.6	4.4	3.3	12.6	13.5	5.6	8.2	22.7	11.8	8.0	4.5	4.4	24.6	15.6	113.8	0.1	4.0	2.6	2.1	7.9	2.1	2.4	3.1	1.6	2.8	1.7	2.7	2.1	1.3	0.5	7.6	12.9	0.5	1.6	15.4	14.4	10.4	22.9	23.9	12.8	20.7	10.0	15.6	16.1	6.0	3.2	15.2	3.8	23.6	15.8	1.6	12.7	4.0	4.5	19.2	5.9	10.7	0.0	19.3	101.3	10.8	13.8	0.0	26.4	117.0	8.0	13.6	0.0	19.2	73.9	35.0	26.9	8.6	19.6	20.9	2.3	32.4	185.5	19.8	9.3	8.3	29.4	17.3	3.2	33.8	11.5	12.9	5.0	4.2	9.1	22.2	77.5	7.5	8.6	13.2
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266163-139280338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 88.9;retina: 30.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;cerebellum: 8.0"	"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4"					"Low region specificity"	"Detected in some"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	3.2	88.9	1.0	0.5	4.5	0.4	1.2	8.0	1.2	3.6	1.0	2.1	1.1	0.4	2.6	3.0	0.5	0.8	1.3	6.1	0.8	1.4	1.0	0.4	0.5	0.6	1.0	0.0	20.1	0.5	0.4	15.3	0.5	1.5	2.0	0.5	30.7	0.4	2.0	0.6	0.5	0.4	2.3	0.7	0.6	0.4	5.9	0.5	0.0	0.5	0.0	0.5	2.1	1.0	0.5	0.0	0.0	0.3	0.5	1.7	0.3	0.0	0.5	0.3	0.2	0.8	0.4	0.0	10.7	0.0	1.6	0.0	0.0	0.1	0.0	0.1	15.9	4.6	0.2	2.3	0.0	0.9	0.0	1.0	0.0	0.0	0.1	12.9	0.1	0.1	3.9	0.3	1.7	0.1	3.8	32.4	0.1	0.2	0.2	2.6	0.0	0.4	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	4.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.7	0.4	0.0	0.3	1.6	0.7	0.0	0.5	0.2	0.0	0.3	0.3	1.0	4.5	8.0	1.2	0.8	1.4	1.0	0.0	1.5	0.5	0.0	0.0	0.0	0.7	1.4	140.5	2.5	0.0	0.0	0.0	0.0	7.9	0.2	1.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.4	0.3	0.0	0.0	0.5	197.0	0.0	0.6	0.0	0.0	15.8	0.0	0.0	0.0	0.0	424.1	0.1	0.0	23.3	7.6	28.7	0.0	0.4	0.7	0.3	0.6	0.2	0.0	0.0	0.3
MGME1	"bA504H3.4, C20orf72, DDK1"	ENSG00000125871	"Mitochondrial genome maintenance exonuclease 1"	Q9BQP7	20	17968913-17991122	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040913	Approved		Supported	Mitochondria		NA	Yes			Mitochondria		"HPA040913: AB_10962835"	"unprognostic (5.81e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (5.31e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.89e-2)"	8.7	14.2	6.4	12.0	7.6	10.9	14.9	7.0	6.7	8.4	10.5	11.7	8.2	10.2	7.3	8.6	14.3	5.4	6.5	10.5	7.3	4.8	10.5	11.3	6.5	13.9	11.5	7.2	5.8	9.6	7.1	14.1	19.9	8.4	8.5	10.7	10.4	11.0	7.8	17.8	26.9	10.9	5.2	9.8	19.5	7.6	12.9	8.3	31.8	15.5	7.6	16.9	10.6	9.6	13.2	10.9	24.1	8.5	8.8	9.2	4.5	17.1	20.0	16.4	15.4	6.7	12.0	22.0	14.5	10.7	14.0	19.2	24.6	17.5	20.4	8.2	6.4	15.9	25.8	16.9	21.6	21.3	7.5	13.9	13.3	11.1	37.1	5.0	8.6	22.8	7.2	15.1	20.8	11.0	6.6	11.1	10.4	18.0	13.4	28.1	12.8	15.4	11.8	14.4	10.3	17.7	11.7	36.8	19.4	12.1	12.6	12.7	10.6	10.2	25.1	21.9	13.9	23.9	6.1	8.9	24.3	19.7	12.0	15.6	10.1	22.3	17.5	6.2	6.7	17.7	24.0	8.5	24.1	4.9	8.1	6.4	11.4	6.3	6.4	6.8	13.2	4.5	4.3	8.2	8.8	7.5	10.9	9.2	4.5	6.4	7.6	7.0	6.7	7.3	4.8	11.5	7.2	8.4	8.3	0.0	11.4	23.1	13.1	41.2	6.4	10.5	20.4	5.3	12.5	7.0	7.9	18.8	33.2	9.6	4.5	11.3	18.3	0.0	8.9	21.7	7.5	9.0	45.2	8.9	26.4	7.9	6.9	17.8	29.3	4.2	7.8	16.2	20.3	6.4	12.9	10.8	8.6	7.0	5.3	20.9	9.6	12.9	5.7	31.1	51.2	40.9	15.1	15.3	19.0	10.2
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	16.8	36.4	22.9	14.4	25.3	17.0	15.4	56.3	30.7	18.2	16.9	18.9	11.6	20.9	29.7	14.3	13.3	20.5	18.6	24.0	23.3	21.7	58.9	64.7	16.7	11.2	20.9	22.7	25.0	11.6	21.1	23.4	16.3	25.2	14.9	19.2	15.1	15.5	13.8	36.9	16.3	21.5	22.2	17.5	18.1	24.1	11.8	15.0	15.1	13.8	14.6	11.9	20.0	15.2	6.5	9.5	39.0	21.7	5.6	6.5	11.5	15.8	28.1	17.9	21.0	29.0	27.3	8.1	17.5	39.9	26.3	36.3	16.5	30.2	21.5	14.9	24.6	21.5	19.1	22.5	15.8	31.1	19.2	18.4	14.5	15.7	23.8	23.0	19.9	16.1	27.2	14.4	28.8	26.9	36.2	22.6	20.8	22.4	25.5	30.5	14.5	17.5	18.9	7.5	17.2	6.9	19.2	24.1	14.2	32.2	11.9	13.8	19.9	20.8	26.0	16.1	18.8	15.5	19.4	13.9	13.1	20.3	25.8	14.5	13.5	22.5	15.1	26.1	26.7	8.8	7.3	21.7	39.0	6.5	18.3	5.7	5.8	5.8	6.0	9.5	6.5	5.7	4.8	18.3	5.6	18.4	6.1	5.5	11.5	22.9	25.3	56.3	30.7	23.3	21.7	20.9	22.7	25.2	15.0	50.6	25.2	26.6	13.0	8.9	30.3	31.7	30.6	44.2	53.4	33.2	19.6	16.4	68.0	29.8	7.7	21.6	24.5	0.0	23.4	16.0	19.5	12.8	17.4	51.2	30.8	15.9	13.8	19.0	33.9	7.9	24.7	24.0	11.8	20.8	23.9	57.0	39.7	23.0	24.4	60.0	30.6	6.5	15.5	61.4	40.5	12.4	18.0	14.9	22.1	12.3
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604214	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	14.8	32.4	23.9	23.5	23.2	20.9	22.9	28.6	25.4	19.5	25.4	17.3	16.1	18.0	16.7	21.1	19.9	17.8	16.3	41.7	22.9	24.1	52.8	24.5	15.6	16.8	23.4	25.6	17.0	16.9	19.5	30.3	31.2	20.6	20.3	23.9	14.5	16.9	23.6	39.6	15.5	21.0	14.7	28.1	19.4	20.1	17.5	22.6	25.2	26.3	25.6	19.4	15.6	15.4	33.2	21.8	26.5	23.5	22.8	30.7	17.2	11.8	6.8	16.2	10.3	14.5	19.5	14.0	20.1	16.5	21.5	15.0	9.9	19.2	18.5	13.1	19.1	11.1	15.9	15.9	16.9	29.7	18.7	16.5	31.9	7.4	11.4	17.5	23.9	18.6	16.8	16.8	12.1	8.6	19.3	14.3	17.5	11.2	8.3	35.0	10.2	15.9	22.8	11.0	41.9	10.8	17.5	41.4	12.3	42.3	9.7	13.1	10.1	13.7	16.2	13.0	14.8	15.8	22.6	17.6	9.4	8.4	19.0	16.5	6.2	8.2	13.5	9.2	20.0	23.2	22.1	20.1	26.5	26.1	23.5	24.1	33.2	23.0	26.0	21.8	20.8	20.9	26.0	18.7	22.8	19.3	20.1	30.7	17.2	23.9	23.2	28.6	25.4	22.9	24.1	23.4	25.6	20.6	22.6	35.7	23.2	29.6	35.2	26.7	24.7	68.6	30.6	50.9	37.5	48.8	21.6	50.6	122.7	36.4	20.1	21.0	30.6	23.3	23.9	37.2	35.7	25.7	24.3	21.3	32.4	39.7	29.2	19.6	34.1	10.0	31.4	30.0	45.5	39.7	26.0	60.5	29.6	54.7	33.9	82.6	49.4	58.2	27.8	59.5	48.0	22.3	58.8	35.4	29.2	26.8
MIEF1	"FLJ20232, MiD51, SMCR7L"	ENSG00000100335	"Mitochondrial elongation factor 1"	Q9NQG6	22	39499432-39518132	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 232.6;Late spermatids: 280.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA061059			Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Intermediate filaments, Mitochondria"		"HPA061059: "	"unprognostic (5.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.96e-5)"	"unprognostic (1.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.30e-1)"	14.9	12.6	14.5	15.1	14.9	16.2	12.3	17.3	21.3	10.0	15.1	12.3	12.9	17.5	12.1	12.9	13.9	10.9	14.2	11.6	13.0	12.9	19.6	26.2	10.8	15.5	13.6	15.9	12.1	14.3	16.6	8.3	12.6	12.1	10.6	14.2	12.5	15.6	14.1	16.7	11.5	16.6	10.3	10.8	18.0	11.7	43.1	10.7	15.9	12.6	11.1	16.6	11.5	13.8	7.1	8.1	5.9	8.3	8.7	9.2	7.6	8.0	8.1	9.0	14.2	8.5	9.3	10.3	7.7	9.2	8.9	8.2	13.3	4.2	22.4	6.5	8.3	5.9	10.3	20.2	10.7	11.1	9.5	18.7	9.2	11.4	13.4	16.4	32.5	12.3	12.2	13.1	7.9	16.9	8.6	9.4	7.6	16.2	12.4	8.8	5.4	10.2	9.0	8.3	16.7	8.9	14.1	12.7	22.8	10.2	9.8	8.2	6.8	8.6	14.9	22.0	9.8	6.6	11.8	9.2	8.4	11.9	7.4	9.4	22.7	23.6	22.8	9.7	14.2	12.9	0.6	7.4	5.9	7.6	8.3	9.2	7.0	7.3	7.2	8.1	7.1	8.1	7.5	0.7	8.7	7.8	4.5	6.3	7.6	14.5	14.9	17.3	21.3	13.0	12.9	13.6	15.9	12.1	10.7	11.9	16.0	5.2	10.4	17.3	18.5	15.7	12.7	8.1	5.7	15.7	23.6	16.0	21.6	10.9	232.6	9.8	16.0	0.0	11.7	16.5	10.1	14.5	9.2	34.2	14.0	6.4	9.4	20.3	15.4	280.8	14.4	13.6	15.1	8.2	10.7	19.8	14.0	3.5	13.1	20.3	13.5	0.0	8.5	17.2	27.1	20.1	10.9	7.7	18.9	14.7
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 27.0;Collecting duct cells: 22.7;Proximal tubular cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	11.7	11.0	12.2	6.9	23.7	8.1	19.2	18.1	25.4	10.5	8.2	20.3	7.2	9.7	12.0	7.5	8.7	9.1	10.3	8.6	15.7	16.1	20.2	11.2	8.3	6.6	19.2	19.7	12.7	8.9	28.0	13.9	10.1	26.4	13.3	8.0	7.6	12.1	9.6	15.7	7.6	10.6	10.1	29.9	7.5	9.8	7.6	18.8	5.9	21.8	5.1	5.9	10.5	8.1	6.2	3.7	7.3	6.8	5.8	6.7	3.2	8.6	5.6	3.5	4.5	8.7	11.4	9.3	12.5	5.9	7.4	7.6	6.2	6.0	3.8	13.9	8.6	8.9	6.0	4.7	7.4	14.1	5.5	4.8	4.4	6.9	2.9	8.9	4.1	3.4	8.1	8.1	15.1	11.0	10.6	7.4	3.4	2.4	5.2	11.2	1.4	3.9	2.3	3.0	4.3	7.0	2.1	8.6	1.9	9.0	9.4	7.1	5.8	5.8	8.8	16.0	6.1	3.3	2.7	11.8	10.6	4.9	16.0	13.1	3.1	4.3	2.4	9.4	3.6	4.6	7.3	5.5	6.6	5.9	6.8	6.2	4.6	4.7	4.7	3.7	6.2	6.7	5.9	3.5	5.8	4.3	3.0	4.3	3.2	12.2	23.7	18.1	25.4	15.7	16.1	19.2	19.7	26.4	18.8	32.8	27.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	22.7	0.0	13.4	5.0	13.8	0.0	0.0	0.0	0.0	12.6	10.5	0.0	0.0	11.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	4.6	0.0	0.0	15.3	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0
MINOS1	"C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial inner membrane organizing system 1"	Q5TGZ0	1	19596977-19629821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059930	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	10.1	9.7	22.0	8.1	21.3	5.4	12.6	20.4	22.2	17.7	16.3	7.2	7.5	10.6	14.5	13.7	15.1	15.2	13.7	25.4	18.3	21.4	19.8	12.5	9.7	8.3	20.6	15.5	14.0	13.3	14.5	16.6	8.3	17.0	17.2	18.3	9.3	13.8	17.8	25.2	10.1	17.4	18.2	12.1	8.9	11.4	5.0	11.8	7.7	13.7	20.3	11.8	13.9	10.9	7.0	8.4	9.0	10.5	3.7	11.3	8.9	7.6	10.6	6.0	6.6	11.6	11.1	3.7	6.7	7.6	7.9	8.0	7.4	7.1	6.5	5.6	8.8	6.4	5.6	10.5	8.8	12.8	9.8	7.3	5.7	17.0	10.2	5.1	8.8	4.3	9.0	14.5	7.9	9.7	6.0	11.5	4.9	12.1	4.9	11.8	13.6	4.5	11.5	5.1	10.0	13.5	4.5	7.3	8.6	19.3	4.7	12.5	5.6	7.4	6.0	5.8	5.0	5.9	4.9	7.6	6.2	4.8	7.8	6.6	3.1	5.2	6.7	4.8	16.9	5.8	5.6	8.1	9.0	6.4	10.5	5.8	7.0	8.7	7.0	8.2	6.7	11.3	8.1	5.5	3.7	10.5	8.4	7.8	8.9	22.0	21.3	20.4	22.2	18.3	21.4	20.6	15.5	17.0	11.8	157.8	125.9	175.7	110.6	149.9	78.1	411.9	318.5	207.5	112.6	347.2	43.2	260.0	704.6	351.8	112.1	128.1	424.9	46.7	394.4	215.9	199.3	157.4	195.4	297.4	460.5	85.8	231.3	133.8	238.8	184.5	222.6	223.0	214.2	236.3	403.3	76.4	343.8	474.2	207.9	655.8	74.3	64.7	206.0	163.1	143.3	192.6	153.4	121.5	528.4	124.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	7.8	8.9	4.4	10.3	10.1	13.7	9.4	5.7	8.9	8.6	7.3	11.8	15.7	9.3	5.8	4.6	7.6	19.9	10.1	12.0	10.7	5.4	6.4	4.0	4.2	10.1	8.3	9.4	2.2	6.7	15.0	8.9	7.9	7.3	10.7	7.1	7.7	1.5	13.4	5.8	6.7	5.3	6.1	35.4	9.0	7.5	11.9	8.0	19.2	5.2	10.3	3.4	6.1	10.0	12.0	5.8	10.3	5.3	5.9	5.2	4.4	8.6	6.1	1.5	2.1	5.0	9.1	4.8	6.5	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9	14.9	7.5	0.8	5.9	35.4	3.2	80.7	15.3	36.1	10.3	8.7	5.9	8.4	24.9	20.8	6.6	3.7	5.5	0.0	9.4	7.7	4.5	5.6	2.3	5.6	8.7	14.3	5.8	2.5	2.7	5.9	6.4	4.1	5.0	3.6	6.4	5.2	8.0	8.6	8.1	18.1	10.7	0.0	5.2	9.5	19.0	36.9	4.2	2.9	12.4	3.8
MMAB	"cblB, CFAP23"	ENSG00000139428	"Methylmalonic aciduria (cobalamin deficiency) cblB type"	Q96EY8	12	109553737-109573874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	7.3	26.1	12.7	7.2	12.2	5.2	13.0	7.2	17.2	7.0	12.2	12.6	9.4	12.7	7.7	21.9	14.8	9.8	11.8	18.1	11.6	11.5	13.6	47.9	11.8	13.0	12.4	8.2	14.2	20.2	9.1	11.7	5.3	14.0	15.7	8.3	11.2	15.1	10.6	16.5	8.9	8.5	8.7	15.7	6.7	10.7	7.8	14.8	4.3	16.6	15.7	7.5	6.0	7.5	14.1	9.4	3.8	8.1	8.5	13.9	9.2	13.4	9.1	9.5	7.5	3.9	8.0	4.9	3.0	6.9	4.4	4.7	10.6	12.6	8.6	8.7	3.4	8.4	14.1	6.2	23.3	2.0	3.4	25.6	3.5	6.8	17.4	13.9	7.5	3.1	10.6	14.6	9.6	4.2	5.4	4.1	6.9	11.2	6.6	3.1	31.1	6.8	12.1	11.7	1.4	13.1	5.7	3.6	22.4	19.5	12.7	14.8	6.4	6.7	12.6	5.2	2.7	26.2	21.2	2.3	3.8	1.6	2.7	4.3	5.2	3.8	9.7	8.3	9.2	10.3	3.8	5.9	0.8	13.5	8.1	10.8	11.1	9.9	10.7	9.4	14.1	13.9	13.1	1.7	8.5	8.0	7.7	4.7	9.2	12.7	12.2	7.2	17.2	11.6	11.5	12.4	8.2	14.0	14.8	32.8	66.2	26.6	23.6	9.2	31.3	44.8	66.2	65.6	43.3	40.1	27.5	51.9	127.6	40.5	30.4	16.2	42.1	0.0	62.2	27.8	17.9	25.9	16.1	187.6	29.6	98.5	31.8	24.5	19.7	56.0	37.4	16.3	25.3	35.1	43.5	29.1	27.3	31.6	28.7	102.6	27.3	12.9	16.0	30.5	15.1	17.2	51.7	21.7	53.3	20.1
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 30.1;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.9	2.4	0.1	0.0	2.2	2.9	1.5	4.1	2.3	2.0	5.1	1.5	2.2	0.0	1.3	6.6	0.5	4.3	1.5	6.5	2.8	1.2	1.2	0.1	6.9	5.7	7.6	0.0	2.0	4.5	20.8	7.7	25.6	0.2	0.3	0.0	2.3	0.0	3.2	1.8	0.0	0.0	0.4	1.6	2.0	0.0	0.0	0.0	2.8	9.1	0.0	0.6	27.4	1.7	19.1	0.4	1.3	0.1	1.3	1.6	1.9	3.4	0.7	0.0	0.0	0.0	4.0	0.0	0.7	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2	11.9	5.3	3.4	1.2	0.6	0.2	0.4	0.0	2.7	6.8	0.0	2.0	0.4	0.0	2.7	5.7	0.9	2.6	0.0	10.9	3.3	1.5	1.2	0.0	30.1	0.5	0.0	2.9	0.0	0.6	1.7	1.7	1.4	3.3	20.8	2.3	7.6	4.3	2.8	8.5	0.0	0.3	0.0	0.5	0.1	0.2	1.1	1.9	0.0	2.8	2.2
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	18.0	11.2	15.6	15.4	16.4	28.0	17.5	30.9	16.3	20.3	15.3	10.1	14.1	10.6	22.5	10.6	23.0	17.9	13.5	12.5	14.6	7.9	11.6	13.0	17.0	20.6	17.5	12.1	29.3	11.3	14.8	25.1	20.6	16.6	16.1	12.1	7.3	20.6	14.2	28.1	20.1	14.8	21.4	21.0	19.1	14.0	10.8	18.2	25.5	15.0	17.6	20.0	22.9	23.5	11.2	7.6	21.9	10.7	8.2	11.9	6.6	12.2	4.7	11.4	7.5	11.8	12.8	16.1	11.6	20.3	13.4	11.1	7.6	8.0	5.9	4.5	13.3	13.3	6.2	8.9	11.6	14.1	11.1	7.0	24.4	5.1	5.6	7.7	12.5	21.8	8.0	14.5	12.8	17.7	14.0	10.7	9.3	19.5	15.1	10.8	4.0	8.0	6.8	9.4	15.0	5.7	9.9	5.7	10.6	5.9	12.8	4.7	12.3	13.5	8.8	13.8	9.2	9.9	10.5	14.3	13.0	3.2	8.7	10.0	6.7	5.9	5.7	8.4	19.9	9.3	21.9	7.5	16.1	8.4	9.4	8.3	10.0	9.2	7.9	7.6	11.2	11.9	8.5	11.7	8.2	10.7	4.9	11.3	6.6	15.6	16.4	30.9	16.3	14.6	7.9	17.5	12.1	16.6	18.2	26.8	20.8	20.5	44.0	60.8	20.0	17.6	12.7	32.1	25.0	21.0	7.9	13.4	3.3	14.1	38.2	20.4	10.1	23.3	10.9	15.8	35.2	39.4	46.2	13.6	15.7	15.9	10.9	12.9	25.7	13.5	17.3	33.9	23.6	21.6	14.7	15.5	17.4	14.4	25.1	5.3	11.9	12.9	20.2	24.7	32.9	71.4	21.1	24.5	9.0	52.9
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 34.8;Rod photoreceptor cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: AB_2686299"	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	4.2	4.0	6.9	5.6	15.1	2.5	4.9	25.8	6.6	7.3	4.4	6.1	14.4	4.5	9.3	13.9	3.7	23.5	7.4	3.0	5.5	5.7	7.8	4.1	5.8	3.5	3.9	8.0	15.2	8.6	4.9	11.6	2.5	11.7	6.7	3.1	8.8	9.1	11.7	4.7	6.4	4.3	6.0	4.9	4.6	5.4	17.3	4.8	5.8	15.0	3.3	3.8	3.5	4.6	2.1	3.7	4.2	4.3	0.8	2.6	1.0	6.4	7.8	5.4	4.9	1.9	0.9	5.6	2.0	1.4	3.2	2.7	3.7	7.3	1.7	4.2	1.2	2.4	8.0	1.1	3.1	3.1	3.9	8.3	1.7	14.3	4.2	1.6	2.1	0.9	1.1	0.7	3.0	2.7	2.4	2.2	3.4	2.7	2.0	1.1	8.9	2.1	0.8	3.2	3.4	6.9	2.2	5.0	2.7	2.5	2.9	8.9	4.3	5.2	9.5	4.1	2.5	5.0	0.6	0.7	3.7	5.3	2.6	2.3	4.8	1.7	1.1	7.4	1.3	2.5	0.0	0.8	0.2	1.4	0.3	0.8	1.0	1.5	1.1	1.0	2.1	2.6	1.2	4.2	0.8	4.3	3.7	0.1	1.0	6.9	15.1	25.8	6.6	5.5	5.7	3.9	8.0	11.7	4.8	3.0	2.7	1.5	3.6	1.4	8.5	3.2	5.1	34.8	4.5	14.0	19.6	3.1	3.3	1.8	16.8	1.0	2.1	0.0	1.2	1.4	2.1	2.7	5.7	1.0	2.3	9.5	5.2	1.8	0.6	19.5	2.3	0.6	1.7	1.0	0.6	8.4	1.4	0.0	2.8	7.9	21.9	0.0	2.0	19.2	5.9	1.9	1.6	0.8	1.9	2.3
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
MPDU1	"CDGIf, Lec35, PQLC5, SL15"	ENSG00000129255	"Mannose-P-dolichol utilization defect 1"	O75352	17	7583529-7592789	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Transport		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014845	Uncertain		Supported	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA014845: AB_1854072"	"unprognostic (1.96e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.93e-1)"	15.4	24.6	12.6	10.3	16.5	16.6	16.7	9.1	26.2	16.0	27.3	22.8	4.6	18.5	8.2	15.3	20.5	14.2	16.4	9.1	11.6	10.3	36.0	80.1	15.4	12.3	12.9	8.4	10.8	24.3	21.0	9.3	27.4	15.7	15.1	30.0	17.3	17.2	9.6	11.0	14.7	39.0	11.8	13.3	23.8	20.3	9.1	10.9	17.6	21.4	12.5	17.5	15.5	11.3	7.5	19.7	5.5	26.8	6.4	10.0	8.7	12.5	26.3	19.2	12.6	24.3	22.4	11.6	20.8	30.6	39.5	29.0	13.7	21.2	7.5	15.1	36.0	17.0	24.4	29.1	35.7	33.7	15.6	26.6	13.6	17.4	23.4	30.4	11.3	21.2	22.8	29.5	36.8	21.8	18.3	29.8	21.0	22.2	9.7	42.7	18.0	7.4	7.0	20.7	29.3	12.5	17.2	14.8	12.7	39.6	12.3	12.1	22.0	27.1	18.9	7.2	17.9	22.1	9.2	20.0	16.3	8.4	9.5	25.9	4.9	9.0	6.2	23.3	14.7	23.2	5.5	16.2	4.8	6.7	26.8	5.5	7.5	6.5	9.0	19.7	7.5	6.7	7.6	2.6	6.4	24.2	18.5	10.0	8.7	12.6	16.5	9.1	26.2	11.6	10.3	12.9	8.4	15.7	10.9	8.9	26.0	42.4	30.9	9.5	15.5	4.3	40.8	17.4	12.5	22.7	11.8	99.2	29.9	56.7	2.3	16.3	81.1	0.0	66.5	77.5	25.4	35.1	13.9	42.4	70.3	15.9	35.7	27.0	31.6	3.6	15.8	35.1	23.6	39.7	56.4	28.4	60.1	66.6	6.0	39.4	20.1	25.8	11.3	19.7	30.4	11.0	131.8	21.8	53.6	36.1
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 89.3;Early spermatids: 63.3;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026486, HPA073483"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA026486: AB_1854085, HPA073483: "	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.1	5.0	12.1	2.1	11.8	1.1	3.1	19.5	26.3	3.5	5.1	19.8	2.7	1.9	4.6	31.0	4.1	3.3	3.0	9.0	13.8	14.2	2.0	0.9	2.0	1.2	15.3	14.4	2.8	4.4	31.1	8.4	3.4	11.5	7.1	2.0	6.5	2.3	10.7	1.7	2.0	2.0	6.5	20.3	1.3	2.5	13.8	12.3	0.0	4.5	0.0	1.4	3.6	2.8	0.1	0.0	0.0	0.1	0.0	1.9	0.7	4.9	7.2	7.8	11.3	1.1	0.7	4.3	1.7	0.2	6.8	6.4	2.5	3.3	7.1	4.0	1.7	8.7	2.0	10.5	4.1	5.3	0.0	8.0	0.6	6.7	0.1	0.2	0.0	2.1	1.1	0.3	4.9	0.0	3.8	0.4	11.6	2.6	0.0	2.0	1.9	1.0	0.5	14.0	0.6	4.5	5.0	11.2	0.5	0.1	0.1	8.4	7.8	2.1	0.7	2.9	7.3	17.2	3.4	0.1	7.5	9.6	2.9	3.1	2.4	4.9	0.0	11.4	4.8	1.4	0.0	0.1	0.0	1.4	0.0	0.2	0.0	0.5	1.2	0.0	0.1	1.6	1.9	0.0	0.0	0.0	0.0	0.1	0.7	12.1	11.8	19.5	22.5	13.8	14.2	15.3	14.4	11.5	12.3	0.0	0.0	0.0	1.5	0.3	89.3	8.5	0.0	0.0	0.0	0.0	2.0	4.5	0.0	0.5	63.3	0.5	0.0	0.0	0.3	0.3	2.4	0.0	0.0	0.0	0.6	33.4	0.0	0.0	0.0	16.0	3.4	0.0	0.0	0.0	0.0	15.3	0.8	0.0	5.3	0.0	6.4	0.0	2.8	18.2	18.0	0.1	2.3	0.0	0.0	0.0
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 31.0;thyroid gland: 30.0"	"Cell type enhanced"	"Detected in many"	21	"Cone photoreceptor cells: 269.0;Horizontal cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			Nucleoli	"Vesicles, Mitochondria"	"HPA062575: AB_2684797"	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.9	7.0	6.3	1.7	19.3	1.1	5.5	4.6	8.9	31.0	4.2	1.8	4.4	1.5	8.3	7.9	1.6	11.1	1.9	4.6	8.5	9.7	12.2	1.2	1.1	0.9	7.0	6.7	1.2	2.5	5.0	10.7	2.5	11.2	15.6	1.4	7.1	12.1	10.1	5.7	1.0	1.4	5.1	4.6	3.1	1.9	3.8	3.4	9.1	30.0	1.2	1.0	4.7	4.9	1.3	0.7	0.3	0.2	2.0	4.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	11.4	0.0	0.0	0.0	2.1	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.8	0.0	0.2	3.2	0.1	0.0	0.0	3.1	0.2	0.0	8.0	0.1	6.1	0.0	0.0	3.1	1.3	1.7	0.0	0.1	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.9	0.0	4.8	0.0	0.0	0.6	0.4	1.3	1.3	0.2	0.2	2.0	0.0	0.7	0.1	0.2	6.3	19.3	4.6	8.8	8.5	9.7	7.0	6.7	11.2	3.4	0.0	2.1	0.0	47.3	0.9	23.4	3.1	0.0	5.3	0.0	43.6	269.0	0.2	21.6	2.9	1.6	5.0	0.0	0.0	0.0	0.1	4.1	21.0	4.7	0.2	3.2	77.9	0.0	0.6	15.9	0.5	0.3	2.3	5.0	0.0	0.0	40.1	0.1	0.0	3.2	2.2	17.1	0.0	1.4	0.1	0.7	1.0	0.5	0.0	0.0	18.4
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.3	17.0	8.3	17.1	9.8	6.1	13.2	7.8	7.1	8.6	11.5	16.2	6.4	22.6	11.4	5.6	5.7	10.1	7.2	11.4	1.2	13.6	40.3	8.7	7.4	38.0	31.0	9.4	12.2	10.6	22.2	5.6	5.2	7.9	17.3	11.2	15.5	6.6	2.3	11.1	0.8	32.0	15.7	18.8	17.7	24.3	9.9	16.8	8.6	4.7	4.2	32.0	5.2	8.3	14.9	4.4	8.9	15.2	13.3	7.4	21.0	8.1	5.3	11.6	5.3	6.8	2.6	11.5	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1	32.8	55.2	24.6	70.3	72.5	4.6	26.6	188.5	1.4	19.4	57.6	0.0	50.1	112.7	124.1	138.8	35.9	780.2	116.8	129.7	102.0	53.0	67.5	17.3	473.7	65.5	3.2	104.3	84.7	67.1	60.3	84.3	59.9	55.6	57.7	299.4	16.4	119.7	550.6	79.5	318.0	2.6	45.3	28.3	7.9	12.0	133.6	41.9	42.6	311.7	103.6
MRM1	FLJ22578	ENSG00000278619	"Mitochondrial rRNA methyltransferase 1"	Q6IN84	17	36601572-36608971	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021598	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021598: AB_1854097"	"unprognostic (9.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.74e-2)"	2.2	6.8	2.9	3.9	6.4	2.9	3.5	1.9	4.9	1.2	4.2	5.2	3.2	5.9	3.2	3.4	3.6	4.0	3.4	3.8	3.7		2.4	4.0	2.2	4.6	6.5	3.0	4.2	4.1	0.9	0.9	1.0	2.8	2.1	5.6	2.4	2.9	4.7	5.9	2.2	4.5	1.2	3.4	5.2	2.5	1.5	3.5	0.9	3.2	1.8	3.8	3.4	0.0	6.7	3.3	0.0	4.4	7.3	7.6	3.7	0.9	6.1	0.0	3.6	3.2	3.8	11.8	0.2	0.0	0.0	0.0	0.4	0.1	0.4	7.1	0.0	3.0	15.1	0.1	0.2	0.0	4.7	2.1	10.5	3.5	6.4	1.9	5.2	5.5	3.0	0.3	7.5	0.0	1.1	3.7	4.7	6.2	4.0	4.3	0.1	10.5	3.2	0.1	14.7	0.1	8.4	0.0	13.5	3.1	7.1	2.8	1.8	0.0	4.4	4.6	4.5	4.6	1.8	1.8	3.6	6.0	4.1	0.0	9.3	10.8	4.5	0.0	5.9	2.6	0.0	2.9	0.0	4.3	4.4	7.6	6.7	3.6	4.1	2.9	6.1	5.5	5.8	0.0	7.3	1.8	3.3	2.8	3.7											0.0	1.0	2.9	2.8	1.0	0.7	7.3	0.0	0.0	1.2	3.5	3.9	6.2	8.3	3.1	0.0	2.9	4.3	0.0	1.6	4.9	2.3	2.6	0.0	1.6	5.5	6.4	1.7	1.3	1.5	0.0	3.1	1.3	1.7	2.8	4.6	1.5	2.7	7.0	1.4	4.1	1.2	0.0	1.4	0.9	2.7	0.4	1.5	0.8	9.7	1.7
MRM3	"FLJ10581, HC90, RMTL1, RNMTL1"	ENSG00000171861	"Mitochondrial rRNA methyltransferase 3"	Q9HC36	17	782273-792509	"Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 22.9;Distal tubular cells: 16.6;Ductal cells: 16.4;Exocrine glandular cells: 16.0;Extravillous trophoblasts: 19.4;monocytes: 18.0;Proximal tubular cells: 15.9;Syncytiotrophoblasts: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022534, HPA023031, HPA023292"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388"	"unprognostic (1.66e-1)"	"unprognostic (5.83e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (3.82e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.42e-2)"	10.0	13.8	7.2	12.4	11.9	16.4	10.5	12.8	11.8	7.1	9.1	7.8	8.0	8.6	8.6	8.2	12.0	9.4	10.1	14.7	7.1	7.2	11.1	20.5	6.5	11.9	9.7	7.7	10.3	21.2	8.3	9.2	7.6	10.1	8.2	8.9	7.0	11.4	8.6	31.0	14.6	8.2	8.7	4.8	10.8	12.4	21.4	8.9	12.2	10.1	13.8	10.1	8.7	10.8	22.1	14.8	8.0	14.2	17.6	20.2	14.8	13.5	28.3	6.1	10.6	9.1	7.8	12.1	7.3	6.9	14.7	12.6	16.5	6.3	24.5	7.6	5.8	7.1	11.5	18.1	6.5	14.2	8.2	29.5	9.4	16.4	14.3	9.2	8.1	8.6	9.1	9.1	15.6	13.7	7.7	11.2	15.0	15.8	11.0	7.8	14.6	13.8	10.6	9.0	10.2	14.9	17.0	4.4	13.0	9.8	7.4	8.1	9.4	10.4	8.8	13.6	5.3	10.9	7.3	8.7	7.9	6.1	11.4	20.0	4.3	6.1	9.9	9.9	11.4	10.6	4.9	14.2	8.0	15.2	11.3	16.4	22.1	16.6	18.5	14.8	20.9	20.2	17.6	1.1	17.6	10.9	11.8	17.2	14.8	7.2	11.9	12.8	11.8	7.1	7.2	9.7	7.7	10.1	8.9	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	5.2	0.0	22.9	16.6	16.4	0.0	0.0	0.0	0.0	16.0	19.4	0.0	0.0	3.5	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	18.0	0.0	0.0	11.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862520-77952790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043656	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	13.6	16.5	14.8	10.9	16.0	13.5	14.0	12.3	20.3	13.6	16.2	4.4	9.6	11.8	12.5	13.6	17.2	10.5	6.9	23.5	18.5	14.7	22.4	22.4	7.6	12.4	13.5	14.0	12.0	12.0	10.5	18.9	16.1	16.6	17.3	17.9	4.3	11.1	11.5	46.6	8.2	12.0	20.3	12.1	15.4	12.3	5.4	9.5	11.9	11.7	24.7	13.4	17.2	14.3	14.9	12.0	4.7	10.1	12.6	18.3	8.9	12.2	7.7	15.2	12.7	11.7	15.4	13.2	14.1	8.8	18.2	12.5	15.6	22.2	21.7	17.6	11.3	11.7	10.4	21.9	25.3	23.8	14.5	11.5	18.4	8.3	16.4	15.5	38.0	9.0	11.9	23.9	16.1	16.4	12.0	21.8	15.5	26.6	7.3	22.8	13.1	23.9	24.7	16.9	28.6	10.2	27.3	19.0	12.4	35.4	11.8	16.5	8.4	10.9	28.3	26.0	12.8	13.7	19.2	12.8	12.1	18.2	12.1	19.9	6.5	8.2	22.6	10.2	21.6	15.4	4.7	6.5	3.9	12.7	10.1	12.5	14.9	14.0	13.9	12.0	14.3	16.8	18.3	1.1	12.6	8.5	9.8	16.6	8.9	14.8	16.0	12.3	20.3	18.5	14.7	13.5	14.0	16.6	9.5	23.8	33.1	40.2	16.9	11.3	24.1	104.6	61.1	17.4	22.7	31.4	17.7	59.7	114.4	39.4	8.2	35.1	21.4	23.3	31.6	43.1	28.8	13.4	40.5	105.0	42.2	23.8	46.0	44.8	26.3	4.9	28.7	23.1	15.1	31.5	58.4	19.3	32.8	17.5	31.5	99.5	36.0	38.8	23.7	17.6	52.2	11.2	29.2	50.3	64.2	8.9
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831534	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	20.8	23.2	18.3	23.8	25.2	17.7	34.3	22.2	25.9	19.2	24.7	11.5	24.4	21.2	22.8	26.5	20.3	25.6	28.7	44.0	18.9	18.1	21.6	26.0	29.6	39.6	18.0	19.4	42.9	34.7	17.8	12.3	19.3	16.9	17.6	19.6	16.5	18.2	27.5	43.2	15.5	17.6	37.9	21.4	19.6	23.8	18.6	13.2	19.2	20.4	26.6	21.2	26.0	19.6	17.7	20.4	11.2	18.3	11.6	31.6	17.7	12.8	28.5	12.0	12.2	28.8	26.5	22.4	11.3	19.1	19.5	16.8	54.8	17.7	20.9	26.5	14.6	12.9	12.3	17.1	22.1	17.4	20.1	27.1	16.8	15.3	38.3	24.9	15.0	9.4	29.8	19.2	23.2	32.9	23.1	18.7	20.1	22.4	21.0	15.0	25.3	15.3	18.9	19.8	22.1	27.4	12.3	23.5	23.2	21.3	12.7	14.5	23.3	8.6	9.9	24.2	23.7	29.6	15.9	11.5	17.6	14.6	11.8	15.9	36.9	28.5	16.8	15.5	11.4	11.8	11.2	17.6	8.2	31.6	18.3	29.8	15.9	21.8	27.9	20.4	17.7	18.6	21.9	7.1	11.6	14.7	12.4	24.3	17.7	18.3	25.2	22.2	25.9	18.9	18.1	18.0	19.4	16.9	13.2	6.0	9.9	19.7	19.4	11.1	14.0	30.8	12.7	4.0	12.5	14.0	5.9	74.6	39.7	34.5	17.5	17.7	16.1	23.3	47.8	49.4	18.8	14.3	8.1	12.3	36.0	30.2	8.2	18.4	26.5	24.9	22.7	16.2	15.1	35.1	19.1	17.0	35.4	10.5	22.6	32.9	10.6	6.5	35.8	15.6	29.8	10.9	64.6	59.9	28.1	15.7
MRPL11		ENSG00000174547	"Mitochondrial ribosomal protein L11"	Q9Y3B7	11	66435075-66466738	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057685	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA057685: AB_2683502"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	13.9	12.9	10.1	18.9	10.6	18.2	25.6	10.6	12.5	13.7	20.7	7.0	13.5	15.7	16.5	16.2	22.3	16.3	17.5	32.0	8.5	8.7	19.4	33.1	15.7	27.5	9.0	7.5	20.2	36.6	15.1	9.5	14.8	7.7	15.2	23.2	10.8	21.5	17.7	41.4	13.5	21.8	18.5	7.5	18.5	18.5	14.0	6.7	23.3	19.8	29.7	19.0	16.4	17.7	23.4	25.5	3.4	20.2	16.3	20.9	19.2	18.9	15.1	14.4	13.8	7.2	8.1	20.6	11.1	12.7	21.2	16.3	42.3	23.6	23.9	19.3	10.5	23.6	16.6	21.0	21.7	15.0	11.0	14.0	15.0	13.0	22.3	8.7	24.8	10.1	9.6	13.0	13.0	16.2	10.2	15.7	23.1	21.8	10.5	9.1	32.3	28.5	39.6	26.3	51.3	22.2	18.2	28.7	29.9	9.2	13.1	15.1	13.1	12.2	18.5	38.1	12.8	21.0	13.1	8.8	12.8	17.2	12.0	13.0	7.7	12.1	27.0	13.2	16.0	8.6	0.8	16.3	3.4	17.7	20.2	18.9	23.4	19.7	17.4	25.5	19.3	20.9	19.1	1.1	16.3	17.7	15.4	19.8	19.2	10.1	10.6	10.6	12.5	8.5	8.7	9.0	7.5	7.7	6.7	11.9	27.0	69.2	72.1	44.3	19.7	56.0	53.5	49.5	43.3	31.4	7.9	118.1	104.5	54.8	29.3	52.4	58.7	23.3	74.3	168.1	46.4	55.6	30.1	63.8	111.5	19.1	49.0	46.6	43.8	7.0	46.9	58.8	64.1	89.2	93.5	22.6	57.8	56.1	43.2	94.3	17.9	25.8	49.5	69.9	31.1	42.9	64.8	67.3	153.6	64.7
MRPL12	"MRPL7, MRPL7/L12, RPML12"	ENSG00000262814	"Mitochondrial ribosomal protein L12"	P52815	17	81703357-81707526	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022853, HPA023043"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA022853: AB_1854099, HPA023043: AB_1854100"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.97e-2)"	"unprognostic (5.97e-3)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (1.78e-1)"	"unprognostic (6.47e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.26e-2)"	15.7	18.6	15.3	14.5	16.9	14.4	27.7	13.6	18.6	9.8	27.2	8.3	14.9	25.2	10.7	8.6	24.4	12.6	14.8	63.7	14.8	13.7	22.8	64.9	15.4	20.4	17.8	10.5	8.9	40.7	13.3	10.7	12.8	13.1	11.6	20.5	9.3	19.6	13.9	79.1	12.6	18.2	11.4	9.4	17.2	15.2	14.4	7.5	16.1	12.2	50.4	16.0	10.9	11.2	24.7	34.6	5.0	30.0	14.7	20.5	17.7	28.1	48.3	12.9	15.1	9.9	10.9	24.0	22.1	13.6	33.4	25.0	40.3	13.6	43.9	13.4	14.5	22.6	24.0	16.6	28.4	17.1	10.2	83.3	33.5	25.8	45.1	14.6	36.7	17.6	12.5	20.8	23.0	25.7	10.7	27.7	21.9	32.5	14.6	16.5	35.6	31.1	54.4	20.3	30.8	63.0	29.8	21.1	32.4	24.7	23.6	33.2	42.7	16.2	70.2	36.2	14.0	35.7	33.5	14.4	25.5	30.2	19.9	44.8	28.3	9.7	24.9	17.4	26.6	19.1	5.0	24.1	3.2	15.0	30.0	20.5	24.7	15.1	16.6	34.6	23.1	16.0	14.3	2.6	14.7	17.3	28.4	12.9	17.7	15.3	16.9	13.6	18.6	14.8	13.7	17.8	10.5	13.1	7.5	17.9	10.9	51.4	58.7	47.4	14.4	76.5	94.3	20.1	20.5	43.6	3.9	154.3	185.6	101.2	30.5	40.0	177.2	46.7	102.2	149.2	34.5	46.3	31.0	198.0	146.6	22.3	99.8	41.1	56.4	97.4	36.5	37.4	55.6	57.7	173.6	25.5	108.9	97.9	30.8	211.9	12.4	32.3	36.8	47.3	51.0	52.9	94.1	34.1	243.5	97.4
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113454-44127457	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 116.6"	"Low region specificity"	"Detected in all"							"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	10.1	16.1	12.5	9.6	12.8	7.9	11.7	10.5	12.7	10.5	16.4	9.6	8.4	16.2	12.1	12.3	15.7	10.4	14.8	18.5	10.0	8.4	12.4	35.5	25.9	10.4	10.9	11.5	7.1	17.5	4.9	9.6	11.8	10.6	9.7	16.3	13.7	14.0	9.4	61.4	16.0	14.0	12.7	7.9	10.2	12.7	19.0	10.4	13.1	26.3	27.8	12.4	12.3	10.0	33.2	36.4	9.0	36.1	46.7	32.5	30.3	39.8	17.1	12.1	16.7	10.5	10.3	15.5	14.9	14.9	19.9	20.0	35.6	14.1	17.4	16.9	12.7	19.2	16.3	13.6	24.3	15.9	20.6	37.1	17.9	15.1	43.5	13.0	17.0	12.6	9.5	13.2	18.8	11.2	15.4	16.4	15.0	37.6	11.2	17.6	40.3	20.3	26.8	10.6	116.6	16.4	14.6	13.6	23.6	32.8	19.8	27.1	10.5	9.6	18.8	18.5	11.0	17.2	17.5	13.1	17.8	26.6	12.7	25.8	14.0	12.3	40.8	20.1	16.9	12.9	9.0	36.1	7.5	25.4	32.7	29.9	33.2	32.5	28.6	32.4	30.2	25.8	26.5	2.0	46.7	21.9	36.4	21.9	30.3	12.5	12.8	10.5	12.7	10.0	8.4	10.9	11.5	10.6	10.4	348.4	202.5	87.1	148.9	205.3	26.8	126.7	117.2	72.3	125.1	54.1	29.5	154.6	172.5	198.2	197.3	76.8	185.2	23.3	191.9	163.1	85.4	198.8	43.8	284.0	228.8	31.8	89.7	48.5	40.9	90.3	69.0	86.6	65.8	216.4	126.1	48.1	252.2	194.7	50.2	212.2	55.1	45.3	85.8	91.7	125.6	245.9	133.9	72.7	153.8	317.1
MRPL15	"HSPC145, L15mt, MRP-L15, MRP-L7, RPML7"	ENSG00000137547	"Mitochondrial ribosomal protein L15"	Q9P015	8	54135210-54147901	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.5"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044425	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA044425: AB_10969629"	"unprognostic (5.67e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (9.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.06e-2)"	13.7	15.2	16.2	10.2	17.7	6.7	16.1	10.7	28.0	11.6	21.8	8.7	7.4	18.4	11.3	10.2	16.9	11.8	10.9	54.2	14.4	16.3	31.2	32.3	9.1	14.5	17.5	15.4	10.1	14.9	16.8	9.0	20.9	18.7	9.9	22.1	12.3	15.2	10.8	77.5	16.2	16.5	13.9	10.2	12.7	14.2	5.4	8.1	11.3	12.4	25.0	16.7	15.8	10.9	28.2	38.5	8.2	32.2	13.6	21.2	21.9	30.3	25.4	19.2	22.2	15.2	22.6	24.6	25.7	18.1	32.6	28.8	27.2	35.0	46.3	32.9	20.1	30.7	30.5	37.5	30.5	38.7	21.7	28.1	32.6	13.6	35.0	22.3	17.1	32.4	21.4	33.6	30.1	32.0	15.7	66.2	18.7	37.6	14.9	47.5	32.8	44.5	38.8	38.9	59.0	16.1	31.2	12.3	24.1	42.7	28.7	11.1	17.2	13.0	36.7	29.9	20.5	36.0	17.3	24.7	17.5	22.5	27.3	27.3	18.9	23.5	38.0	17.3	26.5	27.3	8.2	25.9	7.4	15.4	32.2	18.6	28.2	19.4	20.1	38.5	21.6	18.4	17.2	1.0	13.6	28.9	24.1	21.2	21.9	16.2	17.7	10.7	28.0	14.4	16.3	17.5	15.4	18.7	8.1	23.8	11.8	46.2	33.1	20.9	28.0	114.6	56.0	24.1	19.4	34.9	27.5	128.1	210.5	90.3	14.2	23.7	36.5	23.3	61.2	122.6	25.7	20.9	25.3	57.8	93.7	23.8	17.3	29.4	48.6	3.2	23.0	37.9	32.1	61.3	48.9	22.6	78.0	35.1	21.2	95.0	46.9	12.9	17.9	7.9	32.5	30.1	166.4	20.2	75.9	40.0
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	21.3	33.9	22.5	13.0	25.2	8.8	21.1	15.9	26.7	23.0	19.5	24.1	12.1	16.8	19.1	19.6	25.7	13.9	15.6	24.4	21.3	20.4	40.8	44.9	13.0	13.5	26.0	21.2	17.3	17.8	30.9	20.6	18.4	26.6	16.4	23.0	13.2	17.7	19.6	47.3	17.2	16.3	21.1	27.7	18.1	16.3	12.0	24.4	19.2	27.3	22.0	17.3	15.1	15.9	18.5	23.7	9.6	17.1	15.5	18.0	11.1	36.3	21.2	20.1	18.1	22.1	26.6	28.6	23.5	21.2	29.8	23.8	32.7	15.1	20.6	23.7	25.6	27.9	25.8	31.3	35.5	45.0	22.8	26.9	28.0	16.6	41.3	23.6	29.8	16.9	17.6	27.4	30.2	27.7	19.0	31.3	22.6	30.8	12.1	29.4	22.2	27.0	23.5	26.3	37.5	23.7	34.2	44.0	27.1	50.5	22.8	22.3	19.3	23.0	26.7	26.1	21.2	22.8	12.0	21.0	26.1	28.9	23.1	34.6	12.6	18.9	17.0	20.6	29.6	22.7	9.6	14.1	9.2	16.0	17.1	18.0	18.5	16.5	16.9	19.9	16.1	14.7	18.0	0.9	15.5	15.4	23.7	17.4	11.1	22.5	25.2	15.9	26.7	21.3	20.4	26.0	21.2	26.6	24.4	17.9	23.5	28.2	24.4	25.8	35.5	37.0	20.4	25.4	29.6	47.1	49.1	79.0	106.1	76.8	15.8	17.3	26.5	23.3	53.4	71.7	27.2	28.3	18.5	62.2	42.7	46.1	26.6	25.2	15.1	7.8	32.8	25.7	32.1	33.3	32.5	38.9	50.8	31.6	34.3	130.8	48.5	19.4	25.3	60.1	14.7	24.7	48.3	20.8	41.3	30.5
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059806	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	16.9	19.9	17.4	13.1	22.5	16.0	14.2	13.6	21.8	13.0	15.6	13.3	16.4	20.3	14.1	16.9	13.6	16.2	15.5	31.7	16.0	16.8	20.9	55.0	12.9	16.2	18.8	20.3	15.7	17.4	25.8	17.8	11.7	15.3	12.9	15.0	12.6	21.1	19.6	53.2	13.8	15.2	13.4	12.4	11.5	13.4	21.0	13.2	17.5	15.7	25.5	12.3	12.4	11.9	21.0	26.9	14.3	18.5	17.5	16.9	13.6	10.9	12.6	6.3	11.0	7.7	6.2	9.8	4.9	7.0	12.8	11.5	24.1	3.8	15.5	12.3	6.8	9.5	11.6	13.6	13.1	8.0	9.0	28.2	12.5	10.2	29.1	15.2	10.4	6.1	8.1	13.9	14.8	20.1	6.7	9.0	19.8	20.9	10.4	6.8	21.3	13.4	37.0	5.7	42.2	14.9	15.6	6.3	19.8	9.6	6.9	15.2	7.9	4.8	8.5	15.0	5.6	9.6	18.7	8.1	7.5	10.1	9.9	13.6	12.1	11.0	32.0	5.5	16.8	7.3	6.8	18.5	14.3	13.5	17.2	16.9	20.4	15.6	16.0	25.2	21.0	15.9	16.1	5.5	17.5	13.4	26.9	16.6	13.6	17.4	22.5	13.6	21.8	16.0	16.8	18.8	20.3	15.3	13.2	20.8	15.2	33.7	27.7	21.6	18.7	34.1	35.7	29.4	27.3	57.6	25.5	66.2	157.5	45.9	72.1	31.5	50.7	46.7	46.7	41.8	35.6	25.5	27.7	68.6	44.0	4.8	29.4	30.1	23.0	24.4	50.9	27.0	50.6	45.1	37.0	29.6	38.4	49.5	48.4	109.4	17.2	25.8	39.1	33.4	34.3	23.7	53.1	27.7	57.2	21.0
MRPL20	FLJ10024	ENSG00000242485	"Mitochondrial ribosomal protein L20"	Q9BYC9	1	1401908-1407313	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047074	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047074: AB_10964064"	"unprognostic (4.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.64e-1)"	36.7	36.2	44.4	31.0	40.7	22.6	41.2	30.3	46.8	24.8	33.4	24.2	38.8	30.7	28.1	52.3	33.8	32.7	39.9	75.3	37.3	38.6	40.1	48.8	31.5	59.7	39.9	31.4	26.5	72.8	28.4	36.3	27.2	35.6	35.1	33.1	29.1	50.5	47.7	121.8	27.3	28.9	44.5	39.1	30.5	33.6	27.7	29.7	22.8	34.3	54.8	35.9	27.1	26.9	50.6	77.5	37.5	52.1	40.5	59.9	51.7	39.6	38.5	28.9	29.2	22.3	24.3	21.3	35.6	27.3	46.4	33.3	45.7	48.6	42.5	50.0	30.5	21.7	25.4	47.1	38.4	36.1	36.7	66.6	45.9	67.7	44.9	31.0	67.4	29.7	28.3	14.9	35.6	38.4	27.0	34.3	40.7	46.3	25.4	38.9	39.8	51.8	51.5	30.0	46.4	77.9	34.5	26.7	54.1	36.2	26.7	51.4	42.4	33.9	71.0	52.2	25.3	30.4	50.0	29.3	28.4	33.0	42.4	43.9	39.0	55.4	82.8	43.8	54.9	19.7	27.8	52.1	37.5	46.8	49.1	52.4	50.6	52.3	46.4	53.2	47.5	59.9	57.3	24.1	40.5	37.7	77.5	45.0	51.7	44.4	40.7	30.3	46.8	37.3	38.6	39.9	31.4	35.6	29.7	62.5	114.8	142.1	105.7	115.6	77.1	229.7	152.8	116.4	110.3	153.5	33.4	194.5	449.3	166.0	28.9	116.1	135.5	210.2	283.0	213.3	100.7	167.9	100.8	326.9	195.7	47.7	132.8	120.3	122.8	28.2	99.8	123.4	131.6	174.1	154.0	179.7	210.2	161.2	104.3	475.5	87.1	64.7	124.6	122.1	210.0	137.9	189.1	99.7	179.2	143.3
MRPL21		ENSG00000197345	"Mitochondrial ribosomal protein L21"	Q7Z2W9	11	68891276-68903835	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051657	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"HPA051657: AB_2681565"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.12e-1)"	16.5	18.0	30.5	21.4	29.7	25.5	26.5	27.7	28.0	19.6	24.0	13.3	26.8	18.9	20.4	25.2	24.2	23.0	28.3	47.3	24.6	26.1	33.1	33.7	12.4	30.0	27.6	21.0	21.4	23.8	13.2	17.7	16.1	25.6	18.0	21.8	14.4	56.9	39.4	56.6	17.9	25.0	17.6	16.4	14.9	19.3	18.7	21.9	21.3	22.2	40.3	20.4	17.2	16.5	49.1	42.2	20.3	39.3	29.1	36.4	34.6	23.1	32.2	19.6	18.7	13.8	15.1	23.3	16.2	17.4	30.6	21.1	65.9	29.9	35.9	36.2	17.5	28.1	28.9	32.7	30.8	24.1	23.5	24.6	25.3	24.8	39.5	27.6	43.5	19.2	22.2	15.9	30.5	36.3	14.9	21.0	25.6	49.1	27.3	18.2	42.7	20.5	46.1	17.9	68.0	47.5	29.2	23.7	55.8	30.1	26.8	31.9	25.4	20.6	41.4	64.1	16.6	42.8	25.2	17.5	21.0	21.0	45.9	29.5	20.4	31.4	50.5	28.0	26.8	28.4	20.3	39.3	19.4	25.9	39.3	27.2	49.1	34.1	28.7	42.2	33.4	32.7	27.0	10.8	29.1	36.1	31.0	36.4	34.6	30.5	29.7	27.7	28.0	24.6	26.1	27.6	21.0	25.6	21.9	32.8	37.1	55.8	62.8	44.6	34.3	172.9	79.0	53.5	53.4	76.8	7.9	109.3	253.7	83.0	140.3	46.6	123.2	70.0	91.4	93.2	51.5	65.5	62.5	89.7	95.9	11.1	59.3	38.1	59.5	153.5	69.3	54.4	74.2	72.1	93.9	45.9	78.4	86.8	67.8	152.2	34.6	25.8	64.9	54.9	57.3	45.4	68.0	41.5	111.2	58.8
MRPL22	"HSPC158, MRP-L25, RPML25"	ENSG00000082515	"Mitochondrial ribosomal protein L22"	Q9NWU5	5	154941070-154969411	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047063	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047063: AB_2679919"	"unprognostic (9.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.29e-2)"	16.3	29.7	16.7	14.5	21.8	25.9	20.2	18.8	19.6	15.2	21.0	18.8	8.3	19.3	16.5	20.6	23.0	14.6	11.9	29.7	16.8	16.2	27.8	38.9	14.7	19.2	21.1	19.5	14.6	25.2	15.9	22.6	19.2	21.6	14.5	21.6	15.6	24.4	18.8	28.2	16.5	18.4	18.3	17.7	20.0	19.3	29.0	16.0	20.1	19.7	20.7	19.3	17.3	15.8	35.7	34.0	21.6	29.5	30.6	36.7	30.7	20.5	20.3	18.0	24.9	14.1	17.9	21.4	14.7	17.4	29.8	37.8	58.5	25.7	28.5	26.4	12.3	31.7	18.9	25.9	27.8	31.9	9.7	29.4	10.9	21.1	33.1	18.5	24.3	14.9	11.7	18.8	20.0	24.5	13.3	50.3	26.2	16.4	25.7	18.3	30.3	22.0	23.5	13.6	22.5	15.8	20.3	15.6	29.4	28.9	15.6	20.7	7.7	19.3	27.9	31.0	13.6	40.8	21.7	14.6	18.4	18.4	16.0	27.1	13.7	16.9	31.2	18.5	30.3	17.2	15.3	26.1	21.6	26.1	29.5	26.1	35.7	28.8	27.7	34.0	29.4	26.9	30.6	10.1	30.6	28.8	26.4	36.7	30.7	16.7	21.8	18.8	19.6	16.8	16.2	21.1	19.5	21.6	16.0	23.8	22.6	43.2	46.3	56.7	28.3	207.4	50.9	54.9	33.0	57.6	25.5	126.5	189.0	94.4	21.3	64.6	46.2	23.3	110.2	113.6	72.3	40.4	43.9	83.1	86.1	30.2	47.6	52.2	29.7	19.6	61.2	50.3	49.0	79.4	45.4	23.0	97.4	77.2	70.7	152.4	21.6	32.3	60.8	102.1	69.2	57.5	65.7	42.4	71.2	45.7
MRPL23	"L23MRP, RPL23L"	ENSG00000214026	"Mitochondrial ribosomal protein L23"	Q16540	11	1947278-1984522	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 117.7"									HPA050406	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA050406: AB_2681116"	"unprognostic (5.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.33e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.08e-2)"	19.4	32.7	19.3	21.8	19.3	37.3	22.1	14.0	25.1	18.1	21.0	17.2	22.5	28.7	19.9	31.4	31.5	30.7	29.9	39.8	16.6	16.8	25.1	43.8	17.4	42.9	18.4	16.9	29.4	69.1	22.6	25.8	14.5	17.4	17.9	21.0	21.2	48.7	25.9	61.0	35.5	23.8	15.9	14.3	22.4	25.6	11.1	11.4	32.5	21.1	44.3	30.1	12.7	17.9	24.1	20.2	12.6	14.5	6.8	22.1	3.3	23.6	27.9	15.0	17.9	6.1	17.3	21.9	7.1	10.5	12.1	9.0	1.7	28.8	24.1	14.2	16.4	16.7	23.7	24.2	33.1	5.8	26.8	117.7	8.6	8.7	34.1	16.3	22.7	13.6	13.6	12.9	8.3	2.4	14.3	8.6	14.1	6.5	13.0	17.5	26.0	18.1	4.7	20.5	21.3	21.2	25.0	7.8	25.1	10.7	9.3	30.2	25.6	8.9	21.1	13.1	8.8	0.5	28.7	10.8	16.5	10.2	4.1	15.6	18.2	16.2	22.6	25.7	19.8	0.0	1.9	14.5	12.6	7.0	10.7	5.6	24.1	10.3	7.8	20.2	20.3	22.1	6.7	0.8	6.8	7.8	8.6	14.6	3.3	19.3	19.3	14.0	25.1	16.6	16.8	18.4	16.9	17.4	11.4	11.9	4.6	111.7	57.4	165.5	6.8	63.0	104.4	28.1	33.0	36.6	0.0	122.5	104.5	95.9	8.1	41.5	179.4	93.5	203.3	208.2	58.0	53.8	97.8	151.5	158.7	4.8	130.7	55.3	173.8	10.3	21.3	115.0	190.6	101.8	117.6	20.1	153.1	173.2	34.3	212.5	8.2	38.8	82.9	24.7	40.3	226.1	75.7	66.0	150.6	57.5
MRPL28	"MAAT1, p15"	ENSG00000086504	"Mitochondrial ribosomal protein L28"	Q13084	16	367384-370527	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030594, CAB033542, HPA055589"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855"	"unprognostic (2.39e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.45e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.56e-2)"	18.3	21.7	32.2	18.6	36.6	25.1	19.5	17.9	38.4	15.3	26.0	19.1	14.6	21.7	16.8	21.3	21.1	21.2	20.0	49.6	30.9	22.5	26.9	35.5	15.1	24.5	24.9	20.9	15.7	21.4	23.6	15.5	15.8	17.7	16.2	12.0	16.8	21.7	18.4	42.1	16.0	19.2	19.6	16.8	18.1	15.8	25.7	10.4	24.9	20.3	36.3	20.4	16.9	14.7	38.0	47.1	48.2	42.0	28.0	47.7	33.7	17.8	41.8	17.9	21.5	10.1	13.1	24.5	21.0	27.4	37.9	37.5	51.3	24.9	26.4	23.9	21.2	19.5	23.5	27.4	44.2	20.2	23.7	66.4	19.3	32.3	42.1	32.7	23.9	26.1	19.6	22.0	35.3	28.4	18.3	27.8	26.0	35.4	19.8	23.6	72.3	37.8	27.4	28.8	17.8	26.7	47.1	21.9	37.8	31.0	11.0	30.9	28.2	25.9	26.5	21.5	17.9	34.1	25.0	21.8	23.4	32.6	18.5	23.3	31.3	24.1	34.9	15.7	17.5	36.5	30.4	42.0	45.8	30.1	40.8	24.6	34.3	26.2	28.4	37.7	38.0	18.6	23.8	48.2	28.0	40.7	47.1	47.7	33.7	32.2	36.6	17.9	38.4	30.9	22.5	24.9	20.9	17.7	10.4	35.7	28.5	54.4	43.0	30.8	29.9	47.6	43.3	36.1	30.7	66.3	7.9	72.2	164.2	92.3	75.5	43.2	76.2	46.7	97.0	87.9	37.6	40.1	25.5	57.1	86.3	27.0	61.5	39.9	64.5	166.1	35.4	45.0	67.4	176.7	45.6	55.2	87.0	56.0	36.0	146.8	31.1	38.8	39.2	91.0	46.2	28.2	38.3	40.5	57.0	41.7
MRPL36	"BRIP1, L36mt, MRP-L36, PRPL36, RPMJ"	ENSG00000171421	"Mitochondrial ribosomal protein L36"	Q9P0J6	5	1798386-1801366	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 90.2"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 359.0;Late spermatids: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047238	Approved		Supported	"Nuclear bodies,Mitochondria"		No	No			"Nuclear bodies, Mitochondria"		"HPA047238: AB_10965331"	"unprognostic (2.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.03e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (8.53e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	16.8	20.7	14.3	12.9	14.8	8.2	17.9	9.3	15.4	12.3	15.9	9.0	13.7	14.1	13.5	15.1	20.8	12.7	19.0	32.4	13.5	13.0	22.4	44.6	11.6	13.6	14.2	8.6	16.5	28.9	9.0	10.1	13.9	12.3	17.0	10.5	9.6	27.3	12.3	52.5	11.7	16.2	16.1	11.9	11.5	14.4	46.0	11.1	14.1	18.1	35.8	15.3	16.3	14.4	24.5	90.2	12.9	20.3	18.4	25.8	24.1	23.2	34.6	16.1	30.4	29.8	24.7	21.2	20.4	18.0	24.4	23.4	25.0	19.0	31.4	37.1	21.8	35.9	25.5	36.2	33.6	17.7	34.1	40.3	15.2	76.9	39.6	38.2	19.7	12.0	21.7	26.0	27.2	35.3	21.4	23.6	18.6	23.1	20.3	34.6	42.7	23.0	44.5	15.6	25.8	42.6	18.5	12.0	37.8	22.0	19.1	18.0	12.3	44.4	34.7	21.2	15.5	20.3	21.4	14.2	21.2	23.0	14.3	22.5	19.5	24.3	41.3	26.6	36.5	28.8	12.9	20.3	12.5	18.6	19.4	22.1	24.5	21.0	22.4	24.3	17.9	18.6	22.1	5.8	18.4	16.5	90.2	25.8	24.1	14.3	14.8	9.3	15.4	13.5	13.0	14.2	8.6	12.3	11.1	29.8	25.3	33.5	68.7	94.2	19.7	152.3	53.5	38.8	42.1	55.8	5.9	78.6	260.2	71.7	359.0	51.5	50.4	0.0	65.2	52.4	60.6	90.8	27.6	108.3	76.3	14.3	25.3	34.4	38.0	373.3	69.3	34.3	57.3	73.9	47.9	48.5	78.1	49.2	56.3	144.3	22.1	64.7	83.4	78.8	62.6	109.2	73.1	35.2	55.9	94.5
MRPL37	"MRP-L2, RPML2"	ENSG00000116221	"Mitochondrial ribosomal protein L37"	Q9BZE1	1	54184041-54225464	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025767, HPA025826, HPA025951"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107"	"unprognostic (2.00e-1)"	"unprognostic (6.81e-2)"	"prognostic favorable (6.99e-4)"	"unprognostic (1.71e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.67e-3)"	21.3	35.0	16.2	15.8	24.0	26.0	18.0	16.9	34.8	15.8	22.9	18.0	13.9	23.5	17.6	13.7	29.0	18.2	18.6	32.0	15.4	14.0	25.1	65.2	13.8	20.6	16.0	14.6	21.2	30.8	15.4	10.9	19.4	23.0	16.2	25.2	20.1	33.5	15.3	68.0	24.0	25.0	19.3	11.9	17.9	20.9	20.0	9.0	31.4	18.1	39.9	28.1	16.2	17.5	39.0	40.8	14.8	35.3	29.1	37.4	38.5	39.4	22.8	20.8	28.0	21.1	28.3	37.2	26.9	25.3	48.1	41.9	45.6	18.3	53.8	24.4	30.1	45.9	31.9	40.9	39.8	37.7	26.2	51.6	46.2	48.3	46.0	36.2	54.6	21.6	31.1	34.2	49.8	39.1	27.0	42.9	42.3	51.0	16.2	34.2	29.1	37.6	53.3	42.6	32.0	50.9	41.4	42.4	45.3	27.4	29.6	41.2	19.2	37.2	64.1	49.4	28.7	27.7	62.0	21.3	30.9	28.1	38.8	53.9	20.6	28.9	41.9	40.2	55.8	29.2	14.8	35.3	14.6	24.1	29.9	28.2	39.0	29.8	27.2	40.8	32.8	30.3	27.0	1.9	29.1	27.9	34.1	37.4	38.5	16.2	24.0	16.9	34.8	15.4	14.0	16.0	14.6	23.0	9.0	20.8	18.9	20.8	36.7	30.8	8.2	68.7	48.4	18.7	17.0	17.4	2.0	102.8	68.0	71.3	25.7	28.2	48.4	46.7	83.7	118.7	37.0	38.0	13.9	148.6	76.9	6.4	31.9	38.1	35.8	43.5	24.2	28.1	21.9	58.7	48.4	9.1	62.0	31.6	26.9	83.4	6.9	12.9	26.2	21.7	38.3	32.6	61.8	25.9	80.6	43.8
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898643-75905413	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (9.21e-5)"	10.8	14.1	12.4	6.7	14.8	6.0	8.2	8.4	20.8	9.6	11.7	23.3	6.5	10.6	9.5	7.8	11.2	15.4	10.2	21.2	11.7	9.2	11.7	17.6	8.4	8.1	15.7	18.1	12.0	17.5	8.7	7.7	7.3	14.8	8.7	8.2	8.8	17.1	13.6	41.8	9.5	8.9	17.9	11.3	8.8	10.3	15.1	14.7	8.3	8.8	14.1	9.5	10.9	7.5	28.5	29.4	9.9	21.8	24.0	24.6	21.3	17.7	24.9	5.0	6.1	7.4	6.1	20.5	6.0	10.5	23.4	17.0	30.4	10.7	17.2	7.1	10.3	12.2	12.6	17.9	16.3	6.1	5.1	33.7	11.4	7.0	27.2	18.5	15.2	10.3	8.8	18.6	15.1	12.2	5.9	22.7	20.5	14.3	7.8	8.3	37.1	18.3	15.1	6.4	23.2	24.7	13.8	17.3	18.5	17.4	8.9	9.8	11.0	11.2	26.3	24.3	5.0	24.6	15.2	6.9	8.9	15.4	7.0	15.8	10.2	6.4	4.9	10.8	11.8	8.2	4.5	20.0	9.9	23.7	21.8	23.8	28.3	24.5	22.2	29.4	28.5	24.6	23.7	1.6	24.0	17.5	20.9	24.5	21.3	12.4	14.8	8.4	20.8	11.7	9.2	15.7	18.1	14.8	14.7	17.9	5.3	2.7	0.6	1.3	0.9	1.7	0.0	16.0	7.9	3.5	0.0	4.3	3.3	19.9	0.9	1.0	9.8	0.0	18.4	3.7	2.3	1.2	3.5	2.0	2.9	1.6	9.9	3.1	0.3	0.9	2.8	2.7	6.8	22.6	12.2	0.9	17.8	18.7	2.8	5.1	2.7	0.0	3.1	2.3	1.7	1.3	2.9	2.9	18.8	0.5
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	15.3	29.4	18.7	14.4	22.7	12.0	17.1	24.0	25.6	11.7	17.8	12.8	13.6	15.8	14.1	27.3	20.9	13.1	9.9	38.2	22.1	13.8	24.9	33.5	12.9	19.4	23.4	23.9	13.7	18.8	28.9	13.6	16.0	19.6	13.1	20.6	8.3	14.8	13.3	35.0	15.5	14.3	16.7	16.6	13.9	17.2	35.9	21.6	13.2	12.7	26.7	21.9	13.7	14.3	28.8	19.7	14.4	13.3	15.4	24.9	8.8	28.7	14.2	20.2	12.8	10.2	14.9	31.3	18.7	16.6	26.1	22.0	27.9	16.3	31.8	10.5	11.6	23.7	8.5	42.7	25.3	29.2	16.0	22.3	32.5	15.4	29.4	11.9	32.8	10.8	12.0	22.6	25.8	21.2	14.5	19.3	33.3	35.7	26.3	25.7	18.1	21.4	17.9	32.1	29.0	22.1	25.1	32.8	33.4	26.9	11.7	12.8	12.3	17.1	31.6	24.3	14.9	22.9	18.7	12.1	14.0	20.7	14.8	22.6	18.6	23.6	39.6	20.8	35.5	20.9	14.4	8.1	9.0	18.1	13.3	22.5	28.8	22.1	20.3	14.0	22.6	22.1	19.5	1.3	15.4	9.3	19.7	24.9	8.8	18.7	22.7	24.0	25.6	22.1	13.8	23.4	23.9	19.6	21.6	23.8	8.0	16.6	17.4	17.7	21.4	70.6	5.1	33.5	17.0	24.4	9.8	41.0	26.6	27.7	164.4	23.3	8.5	0.0	29.4	36.2	20.2	11.4	15.0	17.9	26.8	9.5	7.5	13.5	8.8	22.4	13.8	14.2	18.6	18.0	9.1	19.0	23.6	5.8	21.9	40.7	14.3	45.3	21.7	74.3	25.8	14.8	30.9	13.8	18.9	10.9
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	8.1	13.1	13.9	15.9	11.9	11.8	21.3	10.5	6.6	13.3	20.2	15.0	7.0	13.1	15.5	10.4	18.6	9.5	9.4	4.4	42.5	11.1	13.6	10.1	7.8	8.9	3.6	18.7	12.5	7.4	14.5	5.3	16.8	5.6	7.6	7.0	15.3	12.9	19.2	5.2	11.4	8.8	11.8	18.8	17.4	7.4	9.7	10.6	14.2	16.9	12.3	10.2	13.6	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6											41.7	33.6	52.8	60.0	35.8	28.7	83.9	76.5	109.7	53.4	45.4	11.8	118.0	220.5	67.0	81.1	33.6	39.3	0.0	84.9	110.0	43.1	49.9	33.4	122.0	116.9	20.6	33.6	40.5	35.4	118.1	67.0	37.7	81.0	100.0	42.0	80.3	63.8	42.4	67.8	201.9	38.4	45.3	58.7	83.7	70.0	33.6	52.6	34.6	45.0	39.2
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551199-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 55.8;skeletal muscle: 60.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 826.6;Distal tubular cells: 824.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 49.0;PC-3: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	15.3	8.0	12.8	3.5	14.4	3.1	2.8	4.1	10.7	2.4	8.3			7.1	2.3	1.0	1.7	2.1	1.5	16.4	10.3	7.7	6.8	10.7	2.6	3.3	8.5		4.2	6.3	1.8	2.9	1.6		9.5	2.2		10.8	3.8	60.6	5.3	6.2	1.5	4.0	6.2	10.5	2.1			2.0		1.5	2.7	2.1	38.3	55.8	43.7	42.5	21.8	42.2	42.8	10.0	17.0	2.9	6.8	4.3	3.6	13.2	12.9	3.3	5.9	4.8	11.8	5.7	7.4	16.9	3.1	8.9	21.4	3.8	6.1	0.6	10.8	21.1	6.8	9.3	18.4	9.9	11.0	31.4	7.1	8.4	5.3	1.9	2.6	5.4	6.5	14.8	3.2	3.1	49.0	3.7	35.8	10.9	12.8	48.0	4.6	4.9	10.3	5.0	6.7	9.4	10.2	8.5	15.8	20.9	1.7	15.0	10.0	10.6	10.3	14.3	18.5	16.7	9.6	13.3	13.1	11.9	10.9	7.8	43.7	42.5	31.5	31.2	34.1	29.5	38.3	33.8	35.9	34.6	28.5	32.2	30.2	5.1	21.8	31.1	55.8	42.2	42.8											26.8	28.1	87.8	111.7	124.4	47.8	826.6	188.5	41.5	37.5	249.5	9.8	105.5	824.0	135.5	238.0	93.7	424.6	0.0	166.2	127.5	105.3	182.0	54.1	733.3	213.4	27.0	257.8	98.2	123.7	565.6	112.8	114.0	212.6	190.2	235.6	66.7	187.8	270.0	98.3	497.0	34.2	109.9	97.6	90.9	72.6	145.2	68.8	110.7	282.5	152.7
MRPL42	"HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31"	ENSG00000198015	"Mitochondrial ribosomal protein L42"	Q9Y6G3	12	93467488-93516213	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 276.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039398	Approved		Supported	"Plasma membrane,Mitochondria"		NA	NA			"Plasma membrane, Mitochondria"		"HPA039398: AB_10673529"	"unprognostic (9.32e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (6.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.12e-4)"	18.4	35.6	16.7	13.9	23.6	14.6	22.5	23.2	24.4	22.0	21.5	16.6	16.3	17.0	18.7	16.5	26.7	20.5	15.1	24.2	16.8	16.4	31.0	28.9	16.0	15.3	21.4	16.7	18.4	16.3	26.1	35.8	18.5	26.2	19.3	26.4	13.7	17.8	19.0	15.1	15.8	18.4	19.8	20.4	18.8	18.1	34.5	17.1	25.7	19.5	14.9	21.5	19.1	21.0	29.9	18.8	23.3	23.1	29.3	32.0	21.0	17.3	18.7	30.1	24.4	18.0	27.1	25.4	21.5	21.8	32.9	26.6	25.1	13.9	24.5	9.4	19.6	15.6	15.7	38.7	29.0	50.4	28.7	29.9	28.2	12.8	31.1	24.6	32.6	14.2	20.0	31.8	28.5	42.3	24.9	31.8	27.6	37.2	13.4	37.4	18.5	36.5	25.5	45.0	27.7	34.4	30.3	15.2	29.9	36.3	35.7	36.9	20.1	18.4	30.8	23.1	25.6	30.5	18.0	15.7	24.2	13.8	15.3	28.8	16.0	23.2	27.0	9.5	25.7	36.2	18.0	17.7	23.3	19.0	23.1	24.4	29.9	24.9	20.9	18.8	23.9	26.1	26.8	7.4	29.3	21.5	13.3	32.0	21.0	16.7	23.6	23.2	24.4	16.8	16.4	21.4	16.7	26.2	17.1	26.8	28.6	54.8	70.8	59.8	33.3	73.5	40.8	62.9	31.8	43.6	56.9	85.2	180.8	81.9	276.9	50.6	37.0	0.0	67.3	120.5	56.8	91.3	58.7	45.9	48.2	44.5	89.3	28.3	38.6	81.3	47.8	37.0	57.3	27.9	49.8	19.9	75.9	42.1	52.6	106.7	35.0	51.8	64.3	114.9	71.6	65.6	79.9	55.1	63.5	104.3
MRPL43	bMRP36a	ENSG00000055950	"Mitochondrial ribosomal protein L43"	Q8N983	10	100969458-100987515	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA073022			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073022: "	"unprognostic (2.65e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.11e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.53e-2)"	34.6	34.5	25.9	20.1	24.2	22.5	25.0	24.0	32.9	26.0	26.1	32.5	25.5	28.5	24.7	29.9	31.8	25.9	30.2	25.0	24.4	20.9	37.2	39.6	20.5	20.3	26.5	19.3	32.7	62.2	16.7	21.4	26.6	22.9	31.9	8.3	30.1	61.4	34.4	100.4	26.8	30.1	25.5	32.1	24.8	32.0	28.6	20.3	23.5	45.2	35.2	25.6	27.6	22.6	36.2	36.6	41.3	32.3	36.4	39.4	33.4	30.1	34.3	7.2	12.7	7.5	9.7	22.4	21.1	19.2	16.4	16.7	19.5	23.7	26.0	28.8	8.8	8.9	18.9	2.6	17.6	2.2	19.6	44.6	20.5	24.9	30.2	16.2	16.1	16.5	15.1	13.8	13.9	6.1	7.8	15.4	16.6	10.1	13.3	4.9	31.9	15.0	36.7	11.6	8.2	32.4	16.2	24.1	17.4	9.1	15.6	8.1	20.9	15.4	7.5	23.6	2.4	40.1	7.8	18.8	15.4	20.6	16.5	22.1	27.9	21.2	13.1	19.7	30.2	11.1	41.3	32.3	35.1	32.3	30.0	33.2	36.2	35.7	32.1	36.6	33.3	34.7	30.9	11.0	36.4	28.8	28.6	39.4	33.4	25.9	24.2	24.0	32.9	24.4	20.9	26.5	19.3	22.9	20.3	41.7	35.1	68.5	70.1	49.5	43.4	32.2	84.1	78.9	51.2	71.5	39.3	112.8	152.5	84.3	53.4	47.0	56.3	70.0	110.7	118.6	57.0	57.6	45.1	59.7	86.2	17.5	58.7	51.5	39.7	31.5	79.1	47.5	60.8	68.5	68.0	64.2	77.6	84.2	69.3	155.7	46.0	51.8	80.4	138.2	73.5	59.8	86.7	61.0	79.0	55.9
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957404-223967714	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria"		NA	NA			Mitochondria	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: AB_2675863"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.4	29.2	15.3	16.8	16.4	32.7	26.7	15.1	24.2	11.7	17.9	12.8	9.2	16.0	13.9	12.6	18.3	14.1	14.8	29.0	14.6	16.9	31.0	38.9	13.0	24.1	15.2	17.0	13.5	26.1	11.0	12.7	17.3	13.8	13.3	19.6	11.8	14.1	13.9	35.3	14.7	15.5	12.3	15.6	18.8	14.9	18.4	12.8	23.6	16.2	22.9	21.0	14.1	11.3	31.5	28.2	39.8	30.1	21.2	26.9	23.3	12.1	10.3	15.4	17.7	14.5	17.3	24.4	13.7	15.4	22.3	23.6	36.5	15.3	18.4	14.9	11.7	20.5	16.2	25.0	18.9	20.7	17.3	17.7	20.0	11.9	28.6	21.4	22.1	15.5	20.2	23.7	13.5	18.2	18.9	21.8	18.9	19.1	14.6	17.9	14.1	16.5	28.1	23.0	24.5	10.8	19.5	18.9	11.3	29.7	10.3	21.0	12.1	10.1	22.7	33.0	23.7	19.1	32.0	14.3	14.9	11.6	12.7	11.0	16.1	11.2	26.3	15.1	21.2	16.3	31.5	30.1	22.6	20.5	29.1	25.9	31.5	22.1	24.4	28.2	27.0	26.9	23.5	39.8	21.2	25.6	22.6	22.2	23.3	15.3	16.4	15.1	24.2	14.6	16.9	15.2	17.0	13.8	12.8	6.0	12.5	45.0	23.7	15.9	18.2	9.7	28.1	22.7	12.5	26.2	0.0	79.5	69.6	38.7	3.8	18.8	20.4	23.3	30.7	52.2	18.6	18.3	18.4	47.4	42.1	11.1	12.6	20.3	28.6	5.9	16.7	21.2	32.1	33.3	21.1	13.5	34.8	17.5	17.0	71.1	10.4	19.4	10.3	34.2	56.9	14.4	40.7	18.4	24.3	31.4
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 12.6;Daudi: 30.3;K-562: 18.4;REH: 14.8;RT4: 11.3;U-266/84: 17.5;U-698: 22.4"	"Low region specificity"	"Detected in all"							"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	3.1	0.6	1.4	2.6	2.4	1.8	4.9	1.8	6.3	9.6	3.6	1.4	0.7	0.3	10.3	1.1	2.1	0.4	5.8	3.7	1.2		5.9	7.0	2.6	9.6	1.7	1.7	3.9	9.1	0.3	2.4	2.5	2.7	7.7	6.9	1.8	3.8	1.1	11.1	2.4	13.2	1.4	1.8	1.2	1.4	1.7	1.3	1.2	2.6	2.8	10.5	0.9	1.5	6.1	9.3	1.6	5.9	6.9	8.7	4.3	0.0	0.1	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.7	30.3	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	14.8	0.0	11.2	0.0	11.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	8.8	17.5	22.4	0.0	0.0	0.1	0.4	5.7	1.6	4.7	5.9	5.5	6.1	7.0	3.7	9.3	5.2	8.7	5.3	0.1	6.9	1.2	3.3	5.2	4.3											11.9	8.9	24.2	33.1	26.9	10.5	39.2	33.1	21.4	12.5	24.4	7.9	57.8	51.4	33.7	13.9	22.5	11.9	0.0	32.6	54.7	20.5	25.4	23.1	26.1	37.2	15.9	15.6	16.5	31.0	11.5	19.2	19.8	18.6	45.9	24.4	10.9	32.1	10.5	15.6	50.2	9.8	6.5	28.8	16.4	16.6	28.2	59.5	18.3	41.0	29.2
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459476-88467419	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050166	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039"	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	11.0	28.3	14.2	11.9	14.7	5.4	13.2	15.8	15.6	7.3	12.4	8.5	10.0	11.1	9.6	11.5	13.3	10.5	8.3	40.8	11.8	11.3	19.3	38.7	7.4	10.4	13.2	13.0	11.4	8.9	8.1	9.2	13.7	13.8	9.0	13.8	7.8	9.3	9.5	57.0	8.2	9.3	11.1	11.4	9.7	12.0	13.7	11.7	12.2	10.0	17.9	11.0	11.1	13.4	31.8	24.6	13.2	24.5	24.3	31.9	25.1	10.0	32.2	10.6	11.3	15.2	11.1	19.6	14.4	13.5	21.8	19.5	39.6	22.2	23.9	14.8	13.0	19.5	24.6	40.7	17.7	17.6	9.7	32.4	19.9	23.2	41.3	9.5	19.4	15.5	12.8	21.6	16.4	11.4	11.0	18.8	23.7	21.8	10.2	15.8	21.5	16.3	24.6	16.4	18.6	19.6	18.8	14.6	18.1	16.9	32.3	16.1	10.5	13.7	21.6	29.5	18.6	24.3	24.2	11.6	17.0	16.1	9.0	20.7	9.5	19.6	19.4	18.7	21.4	12.8	9.9	19.6	13.2	26.8	24.5	30.5	31.8	28.7	26.1	24.6	28.4	31.9	28.4	3.5	24.3	17.6	20.9	26.9	25.1	14.2	14.7	15.8	15.6	11.8	11.3	13.2	13.0	13.8	11.7	0.0	6.4	19.3	18.4	12.2	20.3	64.9	30.6	16.0	10.3	34.9	25.5	77.8	101.2	30.3	48.5	15.4	23.1	0.0	32.9	37.0	13.4	13.1	21.9	82.5	31.2	14.3	27.2	17.2	12.6	6.8	13.3	9.2	6.8	63.1	17.9	17.8	28.5	17.5	17.7	80.1	22.7	25.8	10.5	30.3	24.5	20.5	67.5	22.7	28.6	26.5
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604654	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	17.4	23.5	22.3	16.4	21.7	29.6	20.2	23.9	25.0	14.2	22.5	12.8	13.0	16.7	16.8	17.3	21.3	13.3	13.4	35.5	21.1	21.8	34.0	31.8	14.8	19.3	25.6	19.4	15.2	12.1	18.1	23.8	17.8	28.5	15.9	23.6	11.2	14.5	14.7	31.7	13.5	20.3	17.8	20.1	20.2	17.4	32.8	22.0	25.3	20.1	27.8	20.7	16.3	13.9	21.0	28.2	24.6	29.0	22.7	28.1	18.9	32.1	12.5	21.9	20.1	13.9	14.6	25.0	18.9	16.9	29.8	24.9	50.8	13.5	26.4	37.5	16.1	36.4	24.4	26.8	19.8	32.1	30.3	23.5	25.3	12.6	28.4	27.1	45.4	14.4	13.4	17.3	22.0	22.6	14.2	20.0	24.8	14.8	21.3	23.0	25.0	24.3	42.5	37.9	29.3	30.0	26.0	21.4	44.3	31.3	20.4	19.0	22.1	20.8	33.7	37.2	17.2	52.0	34.9	15.9	16.2	23.2	20.3	51.5	27.0	44.1	57.8	18.9	37.4	19.6	15.9	19.3	24.6	20.0	24.8	19.9	21.0	22.2	21.5	28.2	17.4	19.9	20.2	5.1	22.7	29.0	24.4	28.1	18.9	22.3	21.7	23.9	25.0	21.1	21.8	25.6	19.4	28.5	22.0	20.8	17.1	55.1	67.4	66.5	17.4	73.3	66.2	62.9	26.1	54.1	9.8	90.1	218.8	97.2	290.3	43.8	39.9	46.7	100.3	89.9	50.5	55.2	55.4	55.9	88.0	9.5	52.6	46.1	44.3	51.4	39.7	53.0	45.5	92.0	41.1	32.9	97.8	52.6	46.3	153.7	21.7	58.2	63.4	159.6	42.8	61.6	87.1	52.9	59.0	80.8
MRPL48	CGI-118	ENSG00000175581	"Mitochondrial ribosomal protein L48"	Q96GC5	11	73787316-73865133	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040241, HPA040864"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA040241: AB_2676899, HPA040864: AB_2677175"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.30e-1)"	9.3	15.5	20.8	13.3	31.0	12.4	25.2	21.5	22.6	18.3	19.9	17.9	14.0	15.8	10.8	17.9	13.2	16.3	7.1	14.6	23.1	19.5	21.2	17.0	10.8	13.8	25.5	17.0	15.7	23.0	18.9	9.4	11.9	32.4	12.7	18.9	8.6	15.7	13.9	29.0	9.5	13.3	9.7	31.7	11.9	13.6	5.2	24.0	14.8	14.5	16.7	15.9	10.8	13.3	18.9	22.3	18.9	19.0	16.9	22.5	19.0	10.0	11.7	13.1	7.3	7.7	6.0	5.6	6.3	7.0	9.5	8.1	22.2	9.3	24.4	12.9	8.6	6.7	12.4	12.8	13.1	8.6	9.7	14.7	12.5	13.1	15.6	8.8	20.7	9.0	5.0	14.2	8.5	11.8	8.8	13.6	14.2	15.7	13.5	9.6	16.0	24.9	20.2	9.9	33.0	12.6	11.0	15.9	27.9	10.7	12.3	10.3	10.2	5.0	17.4	50.9	6.4	11.1	13.2	4.8	7.9	10.2	5.5	8.3	6.5	12.9	35.2	3.4	13.5	6.3	18.9	14.7	7.7	17.8	19.0	18.6	18.9	20.8	21.5	21.7	17.3	22.5	21.9	2.9	16.9	16.9	22.3	21.8	19.0	20.8	31.0	21.5	22.6	23.1	19.5	25.5	17.0	32.4	24.0	8.9	15.6	36.3	30.6	17.1	8.9	30.8	35.7	34.8	14.8	24.4	3.9	80.3	74.6	33.4	4.8	17.5	30.2	23.3	34.6	61.0	20.6	25.6	20.7	20.3	37.7	14.3	23.2	20.9	28.1	13.7	17.0	20.0	42.2	23.4	34.8	17.4	30.1	42.1	17.0	57.3	7.1	0.0	20.2	9.8	24.9	17.2	50.0	32.8	45.5	29.4
MRPL51	"bMRP64, CDA09, HSPC241, MRP64"	ENSG00000111639	"Mitochondrial ribosomal protein L51"	Q4U2R6	12	6491886-6493841	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 738.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039923	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039923: AB_10795373"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.33e-2)"	21.4	32.4	36.3	30.4	31.8	24.4	29.1	14.7	29.5	21.0	29.2	18.8	27.2	20.7	22.0	35.2	35.8	20.8	26.8	48.9	29.3	29.6	38.5	50.1	18.1	29.8	36.9	21.3	20.9	52.7	18.8	26.2	26.6	28.4	23.2	30.0	15.8	36.2	28.7	74.0	19.5	24.3	21.5	28.9	27.3	24.0	46.6	25.8	37.5	32.8	52.1	36.7	21.7	26.7	58.4	85.4	59.7	56.2	50.2	61.2	69.5	35.2	43.1	51.1	34.6	33.5	30.5	54.8	24.7	30.5	37.2	36.0	59.5	47.2	43.7	17.3	37.2	47.8	31.5	35.5	40.2	56.6	53.8	44.9	30.2	62.7	50.5	31.1	41.1	30.0	29.4	32.0	34.4	44.8	52.3	34.1	40.7	21.5	16.4	47.9	55.1	48.1	66.1	103.8	66.0	43.8	33.4	49.7	37.5	34.1	48.2	18.4	32.7	37.9	52.2	42.8	101.3	15.8	47.1	26.1	33.6	47.2	27.0	55.2	16.2	23.3	112.5	42.8	31.3	44.7	49.1	56.2	59.7	52.2	51.2	58.7	58.4	56.4	57.5	63.4	54.4	57.6	59.4	21.2	50.2	49.6	85.4	61.2	69.5	36.3	31.8	14.7	29.5	29.3	29.6	36.9	21.3	28.4	25.8	98.3	68.5	97.5	142.6	120.9	43.2	273.6	168.2	99.0	78.5	162.3	11.8	231.8	397.9	217.7	738.9	110.2	117.5	23.3	240.5	337.1	125.9	189.7	91.1	309.5	231.7	41.3	144.0	136.9	142.5	334.3	141.8	111.9	183.9	403.0	155.0	81.7	214.9	150.8	139.0	412.8	36.2	109.9	124.6	380.4	168.5	137.1	180.2	102.2	183.9	151.7
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	24.3	29.4	31.8	31.8	36.8	27.8	54.5	18.8	34.7	22.7	35.5	13.5	31.4	43.7	21.3	23.5	37.5	20.8	39.2	73.7	28.3	31.0	34.1	41.9	36.9	55.9	35.5	27.8	17.2	58.5	21.6	20.7	20.9	40.1	22.4	22.4	12.7	41.6	43.0	79.5	24.3	35.1	22.9	37.0	27.6	39.9	30.6	24.0	27.8	27.4	38.4	25.2	15.6	31.6	43.9	50.6	25.4	39.0	21.9	30.7	29.7	43.9	34.6	18.9	23.4	11.8	13.9	46.1	30.7	22.2	27.5	26.2	42.4	61.7	33.5	33.9	21.1	28.0	40.1	15.5	42.5	20.7	35.4	25.5	24.9	13.8	96.1	35.9	39.1	35.9	20.8	29.4	35.6	30.4	21.8	43.6	42.7	25.5	33.4	20.1	61.7	31.6	59.5	34.8	54.8	76.5	39.2	23.6	39.5	28.7	26.3	18.9	24.4	23.8	23.3	32.6	14.1	22.4	37.5	33.5	28.8	33.7	36.0	46.5	33.1	39.0	40.8	26.2	26.9	45.9	25.4	36.0	18.0	25.4	39.0	23.2	43.9	27.9	22.9	50.6	37.7	26.4	25.3	6.1	21.9	28.7	41.9	30.7	29.7	31.8	36.8	18.8	34.7	28.3	31.0	35.5	27.8	40.1	24.0	68.5	78.6	124.3	65.2	107.6	20.6	96.4	201.2	95.0	89.9	129.1	17.7	163.2	235.4	222.3	47.9	83.9	246.5	93.5	272.5	246.5	72.7	86.6	121.1	226.4	208.7	19.1	132.6	105.6	152.4	44.5	51.8	104.0	118.1	247.9	188.7	49.5	303.7	207.0	46.3	360.5	27.7	64.7	84.5	124.7	106.0	130.4	105.4	86.1	183.5	87.8
MRPL53		ENSG00000204822	"Mitochondrial ribosomal protein L53"	Q96EL3	2	74471958-74473322	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034612, HPA056185"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034612: , HPA056185: AB_2683060"	"unprognostic (2.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.16e-8)"	"unprognostic (8.76e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.45e-2)"	16.8	26.4	15.8	16.9	15.2	14.0	23.2	14.8	17.7	14.1	16.9	15.2	8.5	18.6	15.1	14.6	19.4	17.5	16.8	40.2	14.0	13.2	25.5	44.8	16.0	28.2	16.6	12.3	23.8	31.2	14.8	18.4	19.9	13.3	18.6	8.9	20.1	36.9	19.8	44.1	12.5	16.3	16.1	15.5	20.3	17.8	13.2	12.2	27.7	28.9	20.3	18.9	14.3	14.6	45.9	42.9	26.1	35.6	19.0	42.5	38.9	8.0	29.8	9.9	6.4	11.1	10.1	14.5	8.6	8.1	10.3	8.2	33.6	11.3	6.7	5.3	7.8	13.6	9.7	4.4	14.3	3.7	16.9	26.1	9.1	11.1	22.1	8.1	5.7	9.2	12.5	8.7	13.3	6.7	11.3	9.8	16.5	9.5	18.8	8.8	41.0	13.8	17.1	6.3	23.4	16.4	10.6	17.9	16.4	10.5	7.3	10.7	10.1	5.9	18.7	10.6	7.0	8.4	7.2	6.1	13.7	12.2	11.1	10.7	19.7	18.3	12.7	10.2	7.4	11.9	24.7	35.6	14.3	21.6	31.9	26.3	44.8	30.2	23.8	29.3	45.9	42.5	31.2	26.1	19.0	29.9	42.9	34.9	38.9	15.8	15.2	14.8	17.7	14.0	13.2	16.6	12.3	13.3	12.2	8.9	18.0	20.8	5.8	15.2	1.7	1.2	5.1	71.0	12.5	10.4	0.0	12.7	18.3	27.3	7.1	11.7	28.4	0.0	49.2	14.7	14.3	5.6	32.4	21.7	15.5	1.6	38.2	13.5	30.7	2.1	8.1	19.3	25.3	46.9	25.4	2.2	34.1	43.2	4.2	18.9	2.8	6.5	14.1	8.8	7.0	22.0	13.2	20.6	22.1	5.8
MRPL54		ENSG00000183617	"Mitochondrial ribosomal protein L54"	Q6P161	19	3762664-3768575	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042117, HPA046767"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA042117: AB_2677856, HPA046767: AB_2679795"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.54e-3)"	23.8	34.2	26.2	20.7	27.0	42.4	24.4	19.4	28.8	16.5	27.8	12.7	32.9	25.0	20.5	29.2	26.2	27.5	32.3	34.1	22.2	20.7	28.9	56.7	26.2	35.5	23.2	30.0	20.6	54.0	16.0	26.4	28.6	19.5	22.3	20.7	16.5	44.4	29.7	32.9	19.8	22.1	25.8	21.8	21.8	26.0	38.2	16.0	20.6	26.7	26.9	22.4	18.7	19.5	46.1	45.6	26.0	43.0	41.5	54.4	45.4	33.7	19.3	18.0	17.6	10.7	17.2	15.3	16.2	20.8	39.0	33.6	16.5	12.0	24.4	16.9	19.9	14.7	21.6	23.6	21.3	16.6	15.6	35.9	12.4	11.1	21.0	28.0	26.2	29.4	20.1	37.0	16.3	28.7	15.2	31.9	17.1	23.2	48.2	20.3	22.9	23.5	27.8	23.8	23.7	14.2	20.5	10.2	36.1	29.4	17.2	25.2	20.9	13.2	31.7	24.0	9.0	21.3	37.7	22.7	24.8	14.3	42.0	34.6	29.6	39.2	23.7	24.5	41.9	18.4	24.9	41.7	26.0	37.0	43.0	34.1	46.1	40.8	43.3	45.6	42.5	39.4	36.2	12.0	41.5	40.9	41.4	54.4	45.4	26.2	27.0	19.4	28.8	22.2	20.7	23.2	30.0	19.5	16.0	71.5	74.8	103.6	80.6	43.6	44.6	48.7	79.0	56.2	61.4	75.0	17.7	113.4	303.4	100.7	72.5	51.5	181.4	23.3	166.5	107.6	51.5	96.0	105.0	203.6	139.3	36.5	101.2	58.3	100.5	47.0	52.0	71.8	67.4	108.2	157.0	67.6	120.5	178.9	42.1	295.9	62.3	25.8	55.3	118.3	50.5	50.1	147.9	79.9	127.3	97.4
MRPL57	MRP63	ENSG00000173141	"Mitochondrial ribosomal protein L57"	Q9BQC6	13	21176645-21179084	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039779, HPA059370"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039779: AB_10673362, HPA059370: AB_2683993"	"unprognostic (1.00e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.68e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.78e-2)"	14.0	28.8	23.2	13.8	21.4	16.2	16.5	16.1	22.6	14.6	15.3	12.6	12.9	18.4	13.4	21.0	16.1	17.3	18.7	29.3	20.5	24.7	24.8	40.9	15.0	16.5	21.3	17.9	19.6	30.2	12.3	26.8	12.5	17.1	21.6	12.3	15.1	23.2	18.8	48.0	15.3	17.5	16.4	17.8	16.6	18.1	20.2	13.0	26.4	25.1	24.7	13.8	13.4	12.8	26.1	43.9	23.0	31.5	21.8	32.8	28.8	7.9	14.6	10.3	9.3	7.9	6.5	10.8	9.6	6.0	9.2	6.9	19.1	14.8	4.6	11.3	6.0	7.2	13.8	9.0	9.2	6.9	12.1	15.0	21.0	10.4	21.3	11.7	11.5	10.5	6.6	10.2	7.3	6.9	5.6	8.7	19.0	9.1	6.1	6.4	27.9	25.0	30.4	7.5	26.0	17.1	15.2	15.5	8.1	11.2	9.8	20.6	9.6	7.8	9.8	14.1	7.2	9.9	10.8	6.0	4.8	8.9	10.1	8.5	8.5	6.8	8.2	4.2	13.6	11.9	17.8	31.5	23.0	22.8	24.4	25.8	26.1	29.0	24.3	27.5	25.8	32.8	26.1	4.8	21.8	20.1	43.9	28.8	28.8	23.2	21.4	16.1	22.2	20.5	24.7	21.3	17.9	17.1	13.0	74.5	108.6	101.9	96.1	0.0	88.1	472.9	142.7	148.5	103.5	167.5	43.2	199.3	431.0	129.5	227.3	87.5	174.6	233.6	212.5	168.5	71.9	127.0	69.4	399.2	201.5	73.1	143.6	104.3	112.5	263.9	106.7	94.5	0.0	186.7	167.4	115.5	147.0	171.7	93.0	484.9	81.9	51.8	53.6	92.6	52.4	0.0	186.6	94.7	179.9	93.6
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003634	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003634: AB_1851388"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	12.4	23.4	13.9	18.4	14.8	13.7	17.6	18.1	15.7	10.6	15.2	9.8	17.5	13.1	12.5	15.1	19.4	12.5	16.3	31.2	12.2	12.0	25.7	41.7	10.2	15.2	14.3	14.0	10.5	24.2	13.5	9.1	13.9	14.0	13.6	16.3	10.1	17.7	22.5	57.3	16.5	13.4	14.8	12.9	14.6	15.1	7.6	14.0	13.2	14.8	31.2	15.7	14.3	11.6	18.3	28.9	11.2	22.0	20.0	33.5	20.9	26.1	36.9	12.3	14.1	13.3	13.2	17.2	15.5	16.9	32.4	27.6	28.3	16.5	18.2	12.8	15.4	20.0	18.7	25.2	26.7	34.3	9.3	29.9	14.3	17.5	23.5	25.1	29.8	9.8	14.2	12.8	21.5	34.5	11.0	24.6	18.9	23.0	13.3	18.3	32.7	25.7	20.5	9.3	40.8	50.0	13.3	21.9	26.5	23.8	19.4	11.5	22.0	13.4	24.5	30.1	16.5	32.8	24.6	10.4	17.5	19.2	18.4	29.2	13.9	11.0	20.1	20.0	33.4	14.4	11.2	22.0	10.5	17.3	20.7	14.9	18.3	21.1	17.2	28.9	14.8	15.7	17.6	2.0	20.0	17.4	19.4	33.5	20.9	13.9	14.8	18.1	15.7	12.2	12.0	14.3	14.0	14.0	14.0	29.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	38.8	14.8	24.4	0.0	56.1	48.0	41.8	0.0	0.0	0.0	0.0	52.2	30.7	0.0	0.0	1.1	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	26.2	0.0	0.0	44.8	0.0	0.0	104.5	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0
MRPL9		ENSG00000143436	"Mitochondrial ribosomal protein L9"	Q9BYD2	1	151759643-151763564	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008579	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA008579: AB_1079412"	"unprognostic (2.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.43e-3)"	"unprognostic (7.66e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.04e-7)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.30e-2)"	28.5	22.3	23.3	26.3	25.3	23.0	26.4	27.3	30.9	22.1	26.7	22.2	19.8	21.7	26.8	25.4	28.4	22.5	24.3	24.5	21.7	24.6	29.9	35.1	19.5	28.7	24.0	19.4	33.2	31.9	35.1	18.4	29.0	27.6	29.0	22.3	19.7	40.6	25.3	50.7	25.7	23.1	23.7	21.2	28.5	23.0	24.0	18.3	41.2	38.2	34.2	29.3	25.3	23.5	30.6	31.5	15.0	16.5	24.4	37.6	21.6	29.4	24.2	15.9	18.7	11.5	12.9	26.1	16.4	15.7	25.6	20.6	36.9	27.6	19.3	33.3	16.5	16.6	26.1	27.8	20.6	20.4	26.3	26.8	15.2	20.5	23.4	18.7	42.2	14.4	14.1	19.1	22.8	28.7	17.0	24.7	29.6	31.6	25.4	19.7	68.7	26.1	30.2	34.5	33.6	35.0	23.1	19.1	37.3	15.5	23.3	26.3	26.9	19.5	28.1	22.9	22.7	42.5	51.1	18.3	20.3	20.6	17.4	36.3	28.5	40.4	61.4	25.4	27.9	22.6	15.0	13.6	8.8	27.8	16.5	31.8	30.6	32.1	32.3	31.5	27.8	30.9	28.8	1.6	24.4	14.2	26.5	37.6	21.6	23.3	25.3	27.3	30.9	21.7	24.6	24.0	19.4	27.6	18.3	26.8	17.9	43.1	41.8	27.8	17.4	3.8	28.1	38.8	33.0	31.4	5.9	85.5	54.7	60.9	60.3	38.8	18.1	0.0	55.8	100.4	33.3	38.4	39.4	26.1	56.9	17.5	27.5	39.9	21.1	21.0	36.2	30.2	33.7	78.5	26.7	30.6	59.8	24.6	44.2	67.2	17.1	71.1	34.0	37.2	31.7	27.7	62.4	44.9	45.9	35.0
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206801-42217865	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	17.3	21.0	16.6	14.2	23.3	15.3	16.3	16.4	22.9	15.5	15.0	17.2	8.6	13.9	16.2	14.0	34.3	12.0	11.9	33.4	15.2	16.8	21.7	30.5	11.7	16.2	16.8	14.7	13.7	14.1	13.0	20.3	18.8	22.1	14.1	17.9	17.1	16.9	13.5	47.7	14.7	14.9	18.1	16.2	14.7	14.2	13.3	16.5	19.3	18.7	25.6	21.4	15.6	18.4	22.5	28.4	14.4	22.7	21.2	25.7	20.1	26.3	9.5	10.0	17.0	14.0	13.6	9.0	17.5	17.4	17.0	15.0	10.8	10.5	18.8	11.7	16.3	19.1	9.7	16.5	23.8	23.0	17.1	13.5	16.7	9.3	18.0	14.7	24.6	10.9	11.8	18.4	15.9	34.1	11.6	17.2	20.1	29.0	14.8	20.5	16.9	16.0	17.9	8.5	79.3	15.7	13.8	15.1	17.8	29.2	12.0	15.4	11.3	10.0	13.8	32.2	9.8	22.9	33.6	11.0	14.6	14.4	14.0	26.0	11.1	16.7	40.1	9.9	24.6	14.5	13.4	19.6	14.4	19.3	22.7	22.4	22.5	23.7	22.8	22.0	20.5	24.4	23.7	10.1	21.2	20.4	28.4	25.7	20.1	16.6	23.3	16.4	22.9	15.2	16.8	16.8	14.7	22.1	16.5	20.8	16.3	43.8	41.8	35.9	25.1	113.8	17.8	58.9	15.9	36.6	29.5	90.5	77.9	52.6	6.7	35.8	23.6	23.3	40.9	53.7	40.1	48.9	31.3	52.1	47.5	30.2	14.3	25.8	22.9	4.7	26.7	35.2	28.7	161.5	23.3	46.4	50.7	26.6	34.3	69.7	55.4	19.4	33.3	60.2	77.9	35.5	63.0	30.5	27.3	62.1
MRPS11	"FLJ22512, FLJ23406, HCC-2"	ENSG00000181991	"Mitochondrial ribosomal protein S11"	P82912	15	88467453-88480773	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043752, HPA050345"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043752: AB_2678653, HPA050345: AB_2681100"	"unprognostic (2.66e-1)"	"prognostic favorable (3.60e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.45e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.44e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	12.4	19.1	19.5	9.0	18.3	6.1	13.5	11.2	19.6	7.0	13.4	8.0	11.0	17.6	7.3	9.3	15.1	11.4	10.3	31.0	19.1	17.3	16.5	28.5	8.2	10.5	18.3	15.0	6.0	22.5	9.6	9.3	9.0	15.8	8.9	8.6	8.0	11.4	10.4	44.3	11.5	13.1	10.0	13.7	9.5	10.7	9.9	10.4	12.9	17.7	12.9	10.4	9.7	7.9	18.5	23.0	18.9	19.0	20.9	24.4	17.4	5.6	22.4	3.2	5.7	7.8	3.9	9.2	4.7	8.0	5.9	6.5	15.4	8.8	5.1	9.5	3.8	6.4	8.0	9.3	6.3	2.9	6.8	24.4	6.9	14.5	16.8	9.3	2.4	4.6	7.6	6.2	5.1	5.1	3.2	8.0	6.7	5.0	2.2	9.9	23.9	4.7	10.0	9.3	7.3	23.9	10.2	6.4	12.0	8.3	15.3	11.3	5.5	4.9	11.8	18.3	3.0	11.1	13.6	3.7	8.5	9.4	5.6	6.6	4.7	8.5	5.9	10.6	5.8	8.8	18.9	18.4	13.2	11.7	19.0	13.3	18.5	13.3	13.6	21.2	12.9	14.1	13.7	6.7	20.9	12.1	23.0	24.4	17.4	19.5	18.3	11.2	19.6	19.1	17.3	18.3	15.0	15.8	10.4	6.0	17.8	35.0	31.0	20.3	31.6	5.0	30.6	29.4	22.7	43.6	45.2	79.4	114.4	52.5	21.7	29.2	79.0	46.7	58.5	79.5	31.0	23.1	32.4	74.4	78.6	25.4	23.7	36.2	33.0	25.4	30.8	35.9	30.4	78.5	44.3	37.2	56.5	73.7	40.0	99.0	41.4	19.4	23.9	62.1	38.8	24.7	74.9	44.1	54.1	29.0
MRPS14	HSMRPS14	ENSG00000120333	"Mitochondrial ribosomal protein S14"	O60783	1	175010789-175023425	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051087	Uncertain		Supported	"Nuclear membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Nuclear membrane"	"HPA051087: AB_2681339"	"unprognostic (9.24e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-2)"	17.7	23.6	31.8	11.8	27.6	4.5	23.7	19.6	26.3	19.5	14.9	22.9	18.3	13.8	20.1	25.6	15.4	18.0	15.8	16.6	26.9	26.5	23.4	29.7	14.7	16.0	32.7	14.5	21.8	19.1	28.3	26.1	17.1	22.5	23.6	18.1	15.4	18.4	20.4	13.7	12.7	14.7	17.2	33.5	17.4	15.3	15.8	24.5	22.6	26.5	14.5	16.2	14.3	11.7	14.5	13.6	6.5	12.9	14.3	19.2	11.6	11.0	8.9	21.2	7.5	24.0	17.3	6.8	9.7	11.9	16.6	17.3	11.6	9.8	14.1	11.9	13.0	7.3	9.9	13.1	11.3	17.7	15.5	18.0	11.6	17.5	13.2	10.2	12.8	10.4	18.8	14.0	9.7	6.8	14.7	13.7	12.3	14.0	12.5	11.5	6.1	14.0	9.3	11.6	20.8	4.7	12.2	11.2	16.7	11.4	9.0	17.9	12.6	14.1	13.1	9.3	17.4	15.5	13.7	11.2	5.6	6.3	11.8	8.7	13.8	11.7	17.6	8.1	12.2	11.8	6.5	12.9	6.2	13.4	12.7	18.8	14.5	14.2	14.1	13.6	13.5	19.2	16.2	4.5	14.3	9.7	11.8	15.1	11.6	31.8	27.6	19.6	22.6	26.9	26.5	32.7	14.5	22.5	24.5	26.8	23.2	38.7	45.3	19.6	13.8	73.8	40.8	34.8	34.2	52.4	13.7	85.5	116.0	57.8	11.2	35.8	23.6	46.7	38.9	90.2	43.7	47.0	17.4	59.4	70.3	1.6	30.5	34.4	33.2	8.5	43.1	29.4	47.2	88.4	32.3	32.0	49.2	49.1	40.3	89.3	18.4	38.8	36.4	71.7	37.5	25.6	46.9	31.0	46.9	40.3
MRPS15	FLJ11564	ENSG00000116898	"Mitochondrial ribosomal protein S15"	P82914	1	36455718-36464437	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 621.9;Late spermatids: 1487.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028100, HPA028134, HPA067137"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787"	"unprognostic (2.05e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.39e-1)"	22.6	20.7	17.8	16.9	17.3	24.0	23.8	9.5	16.0	13.2	19.9	9.3	13.7	14.3	13.3	23.0	23.0	10.4	16.6	43.2	15.0	15.2	30.6	61.7	16.6	23.3	17.5	10.6	13.8	23.3	14.3	14.3	23.7	18.3	15.0	18.2	13.8	24.0	14.7	89.5	14.1	18.4	15.7	12.3	17.3	18.8	65.5	10.6	20.3	19.1	41.3	19.3	16.0	12.9	24.5	40.7	7.0	28.7	20.3	28.1	28.6	40.5	22.6	24.7	30.1	24.6	35.7	61.5	22.7	32.6	56.3	51.8	39.9	43.8	37.6	37.1	29.8	33.9	35.8	36.0	57.3	50.8	24.4	45.7	38.4	29.3	43.6	46.1	47.5	27.2	32.9	51.2	50.1	40.6	21.8	45.9	28.3	41.5	29.7	34.7	27.9	45.7	50.9	44.4	34.8	39.9	35.4	43.5	55.0	49.7	34.2	36.7	20.3	31.4	40.2	58.2	38.5	24.8	32.7	21.6	31.7	33.7	39.1	47.8	29.9	41.0	52.5	36.1	32.3	44.2	4.9	26.7	7.0	22.0	28.7	27.2	24.5	25.2	25.0	40.7	21.6	23.9	23.2	1.8	20.3	18.9	27.7	28.1	28.6	17.8	17.3	9.5	16.0	15.0	15.2	17.5	10.6	18.3	10.6	35.7	41.7	43.3	52.5	58.2	23.2	120.0	53.5	38.8	28.4	68.0	13.7	219.1	273.5	113.2	621.9	59.7	89.2	116.8	140.3	210.6	61.7	96.5	41.5	122.3	137.3	12.7	63.4	52.8	79.0	1487.0	58.1	81.5	54.0	95.6	78.7	16.2	134.3	66.6	70.0	248.1	19.2	64.7	69.1	202.9	79.7	70.3	235.5	61.8	99.8	87.6
MRPS16	CGI-132	ENSG00000182180	"Mitochondrial ribosomal protein S16"	Q9Y3D3	10	73248843-73252693	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050081, HPA054538"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA050081: AB_2681007, HPA054538: AB_2682519"	"unprognostic (9.19e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (1.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.84e-2)"	16.6	28.4	16.4	16.9	15.8	15.8	28.6	12.6	26.6	13.3	22.1	12.4	18.0	20.8	16.3	16.8	22.7	16.5	20.8	42.2	17.6	15.7	23.4	35.1	17.7	30.0	16.2	16.0	16.5	37.0	15.7	15.5	17.0	15.9	15.4	21.1	14.4	18.4	19.0	53.2	16.8	18.4	18.0	14.7	18.4	18.3	13.7	9.8	32.7	16.9	26.1	20.1	15.5	13.9	30.0	28.3	17.0	24.2	17.7	22.3	24.3	22.8	33.1	12.8	16.9	10.3	8.4	18.8	10.6	18.5	14.8	15.4	39.2	22.5	27.7	11.8	11.1	13.4	21.4	14.7	21.1	9.3	15.6	14.4	17.4	17.9	29.6	17.4	22.5	15.6	12.7	16.1	15.1	36.3	12.9	16.1	24.5	25.5	15.6	15.3	25.4	24.2	20.8	15.5	15.1	62.2	22.0	17.2	20.0	15.5	13.7	8.6	15.9	12.1	50.0	23.2	8.2	35.2	12.0	12.7	14.1	24.6	15.2	20.5	23.4	24.8	21.6	15.4	26.2	9.5	16.7	22.7	17.0	19.0	24.2	20.5	28.7	20.8	17.8	18.5	30.0	22.3	19.6	10.4	17.7	19.1	28.3	20.6	24.3	16.4	15.8	12.6	26.6	17.6	15.7	16.2	16.0	15.9	9.8	6.0	25.9	52.8	58.4	31.1	26.8	89.2	63.7	37.5	47.8	45.4	29.5	103.9	210.5	89.2	46.6	48.4	69.2	23.3	103.5	134.8	44.9	77.2	30.0	123.8	134.2	19.1	52.3	41.7	57.2	29.0	57.5	59.6	62.4	83.0	89.7	45.0	115.2	38.6	39.3	179.3	33.2	0.0	45.3	128.1	75.4	38.6	89.4	44.9	103.6	86.7
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.7	5.9	4.7	6.7	7.2	9.7	8.7	3.6	8.4	11.5	7.1	9.2	4.6	10.0	8.4	5.7	8.6	7.8	10.9	10.2	11.3	6.0	11.6	9.7	4.6	10.7	6.3	9.1	4.2	8.4	12.8	9.4	26.1	7.8	6.4	9.5	14.7	9.6	10.4	7.4	6.0	5.6	3.4	7.8	7.6	8.0	6.4	19.1	10.7	4.1	10.3	3.3	3.2	13.6	13.7	4.6	17.6	4.8	3.7	7.5	7.3	4.3	6.2	8.2	9.8	8.5	3.6	13.8	11.0	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2	56.6	44.3	53.6	61.6	32.6	43.2	135.7	101.9	53.5	46.6	45.4	60.9	106.9	164.2	89.2	46.6	63.4	48.4	23.3	80.0	101.6	52.1	46.2	36.9	95.6	72.2	41.3	30.1	49.1	44.0	26.6	65.0	42.1	57.3	93.8	55.1	39.2	65.0	59.6	42.1	161.2	51.1	51.8	67.0	22.6	60.7	39.3	80.7	41.7	80.3	30.1
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	18.5	31.7	15.6	14.8	18.4	17.7	32.1	17.9	28.9	15.2	19.6	12.6	31.3	20.9	19.7	15.7	20.7	33.3	20.6	43.6	15.0	15.5	24.5	48.6	17.8	32.7	15.4	15.1	25.6	37.1	21.7	15.5	16.5	14.1	18.3	16.2	15.0	25.7	29.3	43.0	19.7	16.0	22.0	12.8	18.4	20.6	12.3	10.6	18.5	22.5	28.4	18.2	18.5	15.7	20.6	16.2	7.3	15.8	14.5	22.3	13.7	16.4	27.3	10.0	13.6	11.4	12.8	17.3	12.1	11.0	20.5	15.3	41.0	15.6	20.9	16.6	11.1	21.8	37.3	25.1	28.3	8.0	12.8	39.4	10.3	27.6	27.4	20.0	20.9	12.7	17.1	22.1	22.3	16.0	13.2	19.1	21.0	34.0	15.4	11.9	50.6	20.4	36.5	22.9	30.5	44.1	22.4	16.4	43.9	17.0	14.0	30.3	16.0	16.4	31.6	17.4	7.0	26.2	16.6	11.8	15.1	16.9	25.9	21.7	17.0	33.3	23.1	15.5	19.1	13.8	4.8	15.8	7.3	18.0	14.9	20.4	20.6	18.1	19.2	16.2	20.3	19.7	19.6	1.3	14.5	12.2	13.9	22.3	13.7	15.6	18.4	17.9	28.9	15.0	15.5	15.4	15.1	14.1	10.6	11.9	16.0	41.4	32.0	39.8	20.6	28.6	30.6	12.0	28.4	12.2	5.9	59.6	61.3	46.7	11.0	25.6	22.5	0.0	33.5	47.9	22.6	23.0	8.1	40.9	37.4	23.8	20.8	19.0	15.9	24.2	22.5	14.8	18.6	40.5	34.8	16.9	37.7	28.1	21.5	65.5	14.5	32.3	24.7	7.2	19.4	40.0	31.2	29.7	51.6	29.8
MRPS21		ENSG00000266472	"Mitochondrial ribosomal protein S21"		1	150293720-150308979	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078289			Supported	Mitochondria		NA	NA			Mitochondria		"HPA078289: AB_2686881"	"unprognostic (3.48e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.46e-1)"	10.5	17.7	10.8	8.6	16.5	8.6	14.2	8.7	18.8	9.7	8.5	8.1	9.7	10.1	10.4	15.1	9.5	12.1	9.3	15.0	8.9		13.3	12.2	8.1	10.3	8.4	16.7	16.4	11.5	10.9	13.6	8.3	15.9	9.3	7.5	10.0	9.9	12.2	16.9	9.0	8.6	10.3	7.9	9.6	9.9	10.3	9.3	6.2	13.8	11.7	11.7	8.7	9.4	37.8	43.7	15.7	25.8	21.2	36.9	30.3	25.9	21.8	28.2	14.3	27.0	26.8	23.3	19.2	16.4	19.1	18.5	4.5	24.8	26.6	13.3	21.0	5.6	24.9	24.1	20.5	17.1	17.9	31.0	15.4	32.3	31.7	21.4	23.0	13.5	29.6	21.9	23.0	26.2	11.4	24.1	23.4	25.4	35.2	25.4	59.7	19.5	21.1	48.0	50.2	38.2	17.8	14.6	45.2	22.0	19.2	21.8	45.9	16.2	32.9	31.2	32.2	17.9	33.7	17.0	7.4	14.1	19.8	21.1	30.5	32.1	26.5	9.6	12.8	14.1	11.8	25.8	15.7	24.8	24.5	29.7	37.8	32.2	28.3	28.6	33.1	36.9	31.3	6.0	21.2	21.9	43.7	30.1	30.3											104.2	104.0	163.5	169.4	106.9	66.9	259.0	229.3	202.1	128.5	249.5	31.4	245.7	446.0	195.9	694.8	155.8	149.1	70.0	269.9	209.7	167.2	161.3	128.3	304.8	248.0	46.1	133.1	141.8	166.8	412.5	213.2	158.3	172.1	281.3	121.3	85.2	275.1	103.0	219.2	414.9	47.8	97.0	163.5	202.6	93.1	128.6	196.7	126.4	148.9	171.7
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	17.6	45.3	16.9	14.5	24.9	22.1	18.3	15.5	26.7	16.3	22.7	14.6	12.2	24.0	17.0	14.7	26.7	14.5	13.8	39.2	23.4	15.0	24.9	43.3	12.9	20.2	18.2	19.7	15.7	22.4	13.6	15.2	16.9	22.6	11.6	22.0	8.8	15.3	15.8	50.8	17.2	21.1	16.8	18.1	14.0	19.0	21.9	19.9	15.3	15.1	31.0	16.0	16.5	16.9	24.9	27.9	21.7	31.6	21.1	27.8	20.9	30.7	13.3	11.3	13.7	17.0	14.4	26.1	18.1	23.4	32.5	26.7	42.3	22.2	21.2	34.1	22.0	32.1	35.0	20.4	24.7	31.3	12.0	19.0	33.9	11.5	29.3	19.0	31.7	18.5	15.4	19.4	19.5	20.4	14.5	19.8	24.5	46.8	13.4	19.6	22.7	15.8	24.9	20.2	30.3	23.4	20.1	19.3	29.7	23.5	18.3	13.5	12.1	29.3	43.2	45.9	11.7	30.2	28.7	14.1	13.0	13.8	25.8	17.0	20.8	11.4	38.0	16.1	22.6	12.6	21.7	24.0	21.2	22.9	31.6	27.6	24.9	24.7	25.7	27.9	21.6	27.3	25.3	5.4	21.1	30.3	17.8	27.8	20.9	16.9	24.9	15.5	26.7	23.4	15.0	18.2	19.7	22.6	19.9	17.9	11.2	18.2	23.5	20.3	19.9	43.4	25.5	37.5	14.8	17.4	13.7	54.0	58.0	36.5	37.3	20.4	26.9	0.0	52.8	37.9	24.4	15.6	26.5	34.2	42.5	19.1	15.0	18.4	17.7	5.6	21.6	21.0	15.1	38.7	25.1	18.5	38.5	20.1	22.3	37.0	25.3	38.8	24.2	73.7	46.5	17.9	63.0	22.4	39.6	26.5
MRPS23	"CGI-138, HSPC329, MRP-S23"	ENSG00000181610	"Mitochondrial ribosomal protein S23"	Q9Y3D9	17	57834781-57850056	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023453	Supported		Supported	"Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nuclear membrane"	"HPA023453: AB_1854125"	"unprognostic (3.84e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (3.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.39e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.83e-1)"	15.1	28.5	23.0	19.0	27.5	16.0	19.9	16.4	32.0	13.4	16.4	17.6	28.3	18.1	18.0	23.1	18.1	19.3	17.2	53.5	22.5	22.1	36.6	19.9	16.5	21.3	23.6	26.2	16.3	29.9	17.3	16.7	15.5	23.7	28.3	16.0	15.3	16.9	24.7	39.2	14.1	15.5	17.0	19.4	17.4	25.7	21.9	17.2	14.8	28.4	19.8	19.7	15.3	16.5	25.1	30.8	33.4	26.7	23.5	24.3	22.8	32.4	32.8	17.8	18.6	10.8	12.6	20.5	21.1	15.9	29.5	22.8	24.7	19.6	41.2	62.9	16.2	27.3	16.1	28.0	24.9	24.7	32.7	32.5	29.8	13.7	42.6	20.7	39.0	28.9	11.5	22.5	21.8	22.8	13.5	18.5	22.2	44.1	14.9	23.1	27.8	36.1	22.5	21.5	36.9	34.3	26.3	29.7	34.4	22.8	15.6	23.9	37.2	15.9	13.4	42.0	13.6	41.8	29.1	15.7	25.1	32.0	25.0	44.6	32.8	69.1	45.9	23.9	24.5	23.0	24.9	21.8	33.4	22.4	26.7	23.4	23.6	22.4	22.6	30.8	25.1	24.3	24.0	3.5	23.5	18.8	29.0	21.4	22.8	23.0	27.5	16.4	32.0	22.5	22.1	23.6	26.2	23.7	17.2	44.7	28.1	29.0	30.7	29.8	41.5	148.1	33.1	41.5	36.4	45.4	11.8	68.7	126.0	75.4	4.7	33.0	13.5	0.0	86.9	68.6	37.0	43.2	22.0	38.1	75.9	47.7	21.2	24.5	28.2	7.0	30.2	38.1	38.8	71.3	27.2	49.9	70.7	17.5	37.1	149.9	53.1	25.8	28.4	27.1	87.3	28.4	35.6	32.4	38.2	27.8
MRPS25	"DKFZp313H0817, FLJ00023, MRP-S25, RPMS25"	ENSG00000131368	"Mitochondrial ribosomal protein S25"	P82663	3	15042460-15065335	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Late spermatids: 1039.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043490	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043490: AB_10794888"	"unprognostic (3.98e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (3.60e-7)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.91e-3)"	14.8	18.5	18.7	18.4	28.3	12.0	14.3	24.9	21.9	11.7	20.9	13.1	15.2	31.6	16.8	15.8	15.6	15.4	15.0	41.7	15.2	16.5	18.4	27.5	14.4	17.7	16.3	24.0	18.1	24.1	18.1	21.4	11.4	16.8	14.9	23.3	20.3	14.9	17.4	47.6	18.8	26.4	24.5	13.2	17.4	17.3	33.3	15.0	10.2	28.5	15.7	18.6	14.8	13.5	21.1	16.1	3.6	18.6	6.8	15.3	9.4	8.4	12.6	10.3	14.3	10.9	9.4	32.9	11.6	4.5	9.4	8.1	14.3	9.2	22.3	6.2	5.1	6.3	11.0	14.9	11.0	8.1	8.9	20.9	18.4	25.9	17.8	7.7	16.3	14.1	11.3	10.5	14.8	4.5	6.4	8.7	15.1	19.5	13.4	7.0	27.0	12.6	15.8	10.7	19.8	19.8	17.2	8.9	23.0	11.7	14.7	8.2	12.3	8.5	16.2	16.7	6.6	21.9	14.2	10.7	8.5	12.5	11.6	14.5	13.0	13.9	16.0	8.6	21.0	7.9	1.1	15.4	3.6	10.1	18.4	11.8	21.1	9.6	10.4	16.1	18.2	15.3	12.5	1.0	6.8	18.6	13.3	7.4	9.4	18.7	28.3	24.9	21.9	15.2	16.5	16.3	24.0	16.8	15.0	47.6	31.7	62.5	44.0	34.2	56.6	264.1	53.5	44.2	52.4	34.9	155.1	83.6	189.0	44.3	290.5	31.6	105.8	0.0	29.4	55.3	41.2	30.5	25.4	89.4	82.4	63.5	51.9	19.6	22.7	1039.4	42.6	38.5	35.4	39.7	65.2	21.4	40.9	52.6	28.3	157.3	98.1	71.1	42.0	60.3	28.0	42.4	60.8	27.3	108.1	58.0
MRPS26	"C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13"	ENSG00000125901	"Mitochondrial ribosomal protein S26"	Q9BYN8	20	3045945-3048254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045472, HPA054610"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045472: AB_10962052, HPA054610: AB_2682541"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.14e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.93e-3)"	20.2	30.4	27.1	14.4	29.2	13.4	20.9	25.9	31.7	19.2	19.8	15.3	32.3	22.5	18.1	30.6	19.6	24.4	21.2	25.8	24.4	28.2	28.8	39.6	14.7	15.4	24.6	27.0	28.9	43.4	21.0	28.1	16.4	20.0	31.0	16.4	15.2	32.3	27.9	37.1	22.3	20.1	27.8	19.0	16.2	22.1	13.3	20.7	12.3	28.9	23.0	16.9	18.4	19.2	36.5	28.4	10.3	24.4	29.2	30.8	23.0	26.8	36.2	8.2	14.9	9.0	6.8	21.5	10.5	7.1	12.1	9.3	31.6	12.4	26.7	13.4	5.4	16.0	25.5	16.2	21.7	7.1	6.8	34.6	12.2	13.1	52.4	12.5	19.2	6.0	7.7	16.9	10.0	15.2	8.5	8.9	16.1	19.6	6.3	7.2	23.2	19.8	33.8	40.5	20.5	35.8	22.0	14.2	28.5	11.8	18.0	25.8	33.5	12.1	40.5	24.3	8.5	18.2	10.9	8.4	7.9	12.6	14.2	19.4	28.7	36.9	16.2	5.1	16.1	8.8	7.6	21.4	10.3	24.0	24.4	30.0	36.5	26.6	25.6	28.4	34.9	30.8	26.4	1.7	29.2	19.0	17.2	20.6	23.0	27.1	29.2	25.9	31.7	24.4	28.2	24.6	27.0	20.0	20.7	14.9	23.2	55.8	62.3	72.8	37.0	58.1	63.7	30.8	29.6	52.4	33.4	157.2	177.4	69.1	3.0	39.5	65.6	46.7	47.8	88.9	56.4	71.2	13.9	99.1	71.1	44.5	52.9	30.7	23.5	7.5	63.9	31.3	64.1	32.5	77.7	64.3	51.7	49.1	58.0	189.5	37.6	58.2	67.0	32.2	73.4	80.7	65.7	38.5	105.3	45.7
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219409-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071751	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA071751: AB_2686442"	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	26.9	32.3	19.0	20.9	26.8	13.6	26.1	24.6	31.8	25.1	21.0	20.1	21.8	16.5	28.6	23.7	33.6	26.3	18.0	43.6	18.9	17.5	25.1	30.9	14.9	27.4	18.1	21.7	33.9	25.1	24.5	23.7	17.5	23.5	26.2	26.4	25.5	31.0	26.5	43.7	23.9	17.5	25.0	17.5	22.2	20.9	12.1	12.6	34.2	32.1	26.7	32.4	25.9	21.0	19.6	23.3	6.1	14.1	21.5	21.5	16.1	16.4	22.1	19.7	32.5	25.9	33.5	25.4	15.9	22.8	30.3	24.5	27.5	23.4	42.7	22.3	18.5	33.1	18.4	38.2	56.4	32.9	16.0	23.6	21.9	26.6	30.2	25.9	19.2	17.1	31.3	23.9	31.7	35.6	27.7	32.2	31.5	21.9	12.9	25.0	19.8	28.7	23.3	22.7	12.0	13.9	30.6	32.7	43.8	27.9	17.7	30.5	16.3	26.6	22.0	19.7	19.0	33.7	23.4	18.2	12.4	18.3	17.4	28.5	13.1	19.7	30.1	21.3	31.7	19.5	6.1	12.1	4.1	14.0	14.1	20.6	19.6	17.4	17.0	23.3	16.5	20.3	21.5	1.8	21.5	11.3	8.9	17.8	16.1	19.0	26.8	24.6	31.8	18.9	17.5	18.1	21.7	23.5	12.6	8.9	9.4	25.3	22.2	18.1	10.8	88.0	7.6	10.7	13.6	10.4	15.7	35.7	21.6	16.5	1.7	15.7	8.5	0.0	14.9	37.9	17.7	10.8	7.0	28.9	21.9	9.5	15.5	16.5	33.5	3.0	17.5	13.4	10.1	34.3	21.2	15.6	15.4	17.5	23.7	18.8	12.2	12.9	17.5	8.0	17.4	15.4	24.1	22.3	29.1	12.1
MRPS28	"HSPC007, MRP-S28, MRPS35"	ENSG00000147586	"Mitochondrial ribosomal protein S28"	Q9Y2Q9	8	79918717-80030289	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027202	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA027202: AB_1854126"	"unprognostic (3.63e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.55e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.48e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-2)"	18.1	36.9	27.4	13.2	26.7	10.9	19.9	16.7	23.3	14.1	20.9	20.5	10.9	13.4	11.5	16.5	18.1	14.7	12.0	40.4	24.0	24.7	32.5	44.2	12.2	13.7	32.2	17.9	13.4	19.1	20.6	20.2	18.7	21.9	13.1	17.2	16.7	14.2	14.8	56.9	11.8	12.7	13.4	27.8	12.6	14.0	9.7	19.0	18.1	22.4	27.8	15.7	14.0	11.7	19.6	41.7	26.0	28.1	25.4	26.7	18.0	20.1	20.1	18.2	4.3	15.5	20.2	20.0	22.6	21.1	30.9	26.2	17.5	16.4	25.4	26.3	18.3	30.9	16.7	25.2	25.8	24.9	20.1	22.1	30.9	18.4	27.2	17.4	13.7	13.9	17.0	22.1	18.0	24.7	17.0	20.0	20.8	21.8	10.7	30.5	19.3	31.4	22.3	7.4	52.4	34.3	21.5	14.6	14.7	38.8	19.5	8.6	14.6	10.0	88.9	21.0	22.1	21.4	16.6	14.3	11.6	29.1	20.2	19.8	11.6	18.5	22.6	19.7	15.9	8.9	26.0	20.7	10.9	19.0	28.1	20.7	18.7	21.4	23.8	36.7	19.6	25.9	24.9	4.5	25.4	24.9	41.7	26.7	18.0	27.4	26.7	16.7	23.3	24.0	24.7	32.2	17.9	21.9	19.0	20.8	14.5	24.1	17.8	31.3	11.9	51.2	35.7	61.6	34.2	31.4	3.9	66.8	86.2	58.9	11.1	30.8	18.0	0.0	40.7	64.7	23.7	12.0	48.5	58.0	43.9	4.8	35.9	25.8	28.4	7.6	16.4	35.7	42.2	47.7	21.5	17.5	34.1	14.0	20.8	78.1	13.9	32.3	25.0	16.5	34.1	33.1	49.7	23.5	36.8	15.4
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729135-40771173	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Ciliated cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	14.2	20.1	19.3	17.9	21.2	13.2	18.2	27.7	22.9	14.4	16.4	16.9	10.7	15.4	18.0	15.4	18.9	16.6	10.9	24.3	18.4	16.9	26.7	29.9	12.1	22.5	17.9	17.1	21.5	15.0	10.7	35.3	13.1	22.1	12.6	17.0	12.4	14.7	12.5	32.5	14.2	16.3	16.3	16.0	16.0	15.3	17.9	23.3	22.9	21.1	17.2	25.1	18.0	15.9	22.2	11.8	17.2	10.4	15.9	25.7	10.9	8.0	7.7	13.1	8.6	9.0	10.6	13.1	10.3	7.2	13.7	9.2	19.8	12.0	47.3	10.1	5.9	18.4	21.3	16.4	12.9	16.3	12.4	12.4	19.6	5.8	12.6	7.5	20.0	9.5	8.5	9.5	11.2	9.5	9.1	10.4	13.6	13.1	5.0	8.7	9.1	15.5	19.6	12.7	27.5	9.2	14.9	10.8	8.8	17.9	9.3	5.7	8.4	7.1	11.9	16.2	16.4	10.4	17.7	6.3	4.3	7.2	9.9	10.7	3.9	7.2	23.8	8.7	14.3	8.1	17.2	9.6	14.4	19.1	9.7	18.6	22.2	21.4	19.2	11.8	18.9	25.7	22.6	7.0	15.9	10.4	11.6	21.4	10.9	19.3	21.2	27.7	22.9	18.4	16.9	17.9	17.1	22.1	23.3	44.7	16.3	16.4	28.7	8.7	32.3	61.3	30.6	350.7	67.1	21.0	17.7	53.8	92.9	37.0	42.6	34.6	21.2	23.3	29.4	40.9	23.6	14.3	22.0	64.5	22.6	39.7	22.4	35.6	18.6	4.9	32.8	19.5	18.6	45.9	31.0	30.1	28.6	21.0	28.7	51.9	47.6	45.3	25.8	51.0	45.1	11.7	56.9	27.4	31.5	26.5
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	26.8	30.5	15.6	14.1	18.3	21.1	17.8	20.2	26.8	11.5	28.0	14.7	19.2	28.4	15.1	13.6	24.7	13.7	17.9	21.9	14.0	13.1	22.5	27.7	12.9	14.8	14.0	13.1	12.6	42.0	13.0	15.5	12.6	16.3	21.2	7.0	12.5	46.6	19.4	89.8	21.9	23.6	10.8	13.6	25.8	36.5	8.8	15.1	21.5	21.0	28.1	21.1	14.7	15.7	55.5	54.6	27.2	50.8	41.0	51.9	45.5	14.1	15.8	2.2	5.5	1.9	2.2	18.2	15.6	3.0	5.4	4.1	10.7	8.3	17.9	25.1	1.9	3.0	16.7	3.2	7.5	0.8	12.6	75.4	12.5	14.0	11.3	4.1	22.9	13.4	2.0	3.6	3.3	1.4	2.4	4.1	9.3	20.9	3.8	1.5	22.9	12.4	40.9	21.1	3.7	48.5	28.1	10.7	39.1	2.0	4.0	28.0	20.9	17.5	8.7	15.0	0.6	11.2	9.3	10.4	5.8	18.7	7.8	12.7	32.5	22.4	28.5	4.5	13.0	7.3	15.7	50.8	27.2	41.0	44.0	43.4	50.5	45.8	43.5	54.6	55.5	43.7	39.2	11.0	41.0	37.4	51.0	51.9	45.5	15.6	18.3	20.2	26.8	14.0	13.1	14.0	13.1	16.3	15.1	35.7	27.7	77.0	57.3	89.2	43.8	53.0	94.3	24.1	39.8	92.5	9.8	160.1	212.2	101.1	4.7	53.7	189.8	23.3	157.7	146.2	58.0	69.5	34.7	145.9	153.3	52.4	87.5	63.8	98.1	8.9	67.3	58.7	77.6	88.4	128.4	65.1	127.2	138.9	65.7	174.9	30.5	19.4	65.7	20.0	41.9	105.5	57.2	77.3	177.0	60.1
MRPS35	"MDS023, MRPS28"	ENSG00000061794	"Mitochondrial ribosomal protein S35"	P82673	12	27710773-27756295	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 205.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038513	Supported		Approved	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA038513: AB_10794084"	"prognostic unfavorable (9.41e-4)"	"unprognostic (8.35e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.51e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	18.3	32.3	21.0	19.4	22.4	14.2	23.2	21.2	25.7	14.0	31.0	16.3	18.5	27.7	17.1	17.6	25.0	16.1	20.5	31.9	19.5	20.6	42.2	52.1	15.9	20.2	20.1	19.4	17.3	18.4	18.2	11.9	18.8	24.4	17.5	33.2	11.9	17.6	14.8	46.3	15.1	24.5	19.9	18.1	17.3	23.1	13.5	13.5	19.3	28.9	27.6	18.5	17.8	14.3	12.4	17.4	4.2	24.8	14.2	14.7	12.6	23.6	26.0	10.9	16.7	15.7	19.2	40.8	15.8	13.5	22.1	20.2	31.9	33.9	22.1	23.3	16.0	17.2	17.9	22.6	19.9	26.0	18.8	22.3	25.0	11.0	25.8	15.6	34.0	13.4	16.3	24.8	18.6	37.6	20.3	17.8	18.8	27.3	15.2	20.0	14.4	23.9	56.5	41.3	58.3	39.1	25.4	28.5	36.3	33.9	19.5	6.3	12.7	21.7	33.9	26.3	25.6	34.6	27.1	13.9	13.5	14.6	30.6	28.0	6.0	9.0	47.7	18.0	26.3	17.6	4.2	12.2	4.1	9.3	21.4	14.5	12.4	11.7	11.3	17.4	11.9	13.9	12.4	0.7	14.2	24.8	8.1	14.7	12.6	21.0	22.4	21.2	25.7	19.5	20.6	20.1	19.4	24.4	13.5	68.5	32.3	38.3	32.8	42.0	19.5	84.0	50.9	89.7	45.5	48.8	3.9	92.7	205.6	67.5	9.7	23.4	54.6	0.0	51.8	95.3	26.6	44.8	53.1	52.9	64.9	17.5	57.9	16.5	31.2	5.0	23.6	48.6	40.5	65.9	65.4	26.2	51.0	42.1	23.0	153.4	13.6	25.8	33.1	24.4	24.8	45.7	51.6	29.9	92.5	38.4
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230129	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035802: AB_10600933, HPA056795: AB_2683237"	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	13.6	13.7	16.7	9.1	21.4	12.8	13.8	10.4	24.8	8.0	16.8	4.7	12.6	17.1	9.1	11.7	14.4	8.2	10.9	42.8	17.6	13.5	34.8	26.5	17.0	12.2	16.3	14.3	8.8	21.7	11.7	10.4	9.3	17.7	10.8	17.8	6.4	9.6	9.5	29.8	8.1	20.9	13.9	11.4	8.0	13.9	6.8	10.0	10.8	12.7	22.3	11.5	9.9	9.0	27.9	24.4	24.7	27.5	21.5	34.7	14.9	15.0	14.5	10.3	14.1	18.1	18.4	27.1	13.5	13.0	17.4	21.5	20.1	16.9	16.2	28.2	11.4	39.0	15.5	17.1	20.5	17.3	19.0	17.9	11.1	17.2	22.3	21.4	11.7	15.1	19.1	14.7	16.6	7.9	18.2	12.8	16.9	13.0	12.2	15.3	16.3	17.9	18.0	7.6	13.9	17.0	10.6	17.9	24.8	29.9	17.1	14.4	14.0	13.9	20.3	23.4	17.6	15.5	17.1	9.2	7.8	13.3	17.2	23.1	12.9	21.1	21.6	13.6	22.0	10.1	24.4	20.4	24.7	21.4	27.5	23.6	27.9	24.5	23.9	24.4	22.4	22.2	23.4	22.0	21.5	24.7	24.1	34.7	14.9	16.7	21.4	10.4	24.8	17.6	13.5	16.3	14.3	17.7	10.0	107.2	66.5	83.4	83.7	72.4	23.1	309.5	66.2	80.3	67.1	83.7	13.7	104.2	339.8	101.8	99.7	60.0	188.1	70.0	121.7	153.6	58.7	76.5	55.4	177.7	110.9	27.0	89.1	47.3	85.0	30.9	59.8	70.3	101.3	140.7	126.9	34.5	120.5	134.0	65.0	323.7	35.2	71.1	78.8	34.6	32.8	67.1	103.1	62.3	150.9	95.7
MRPS5	"MRP-S5, S5mt"	ENSG00000144029	"Mitochondrial ribosomal protein S5"	P82675	2	95087207-95149434	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055765	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA055765: AB_2682911"	"unprognostic (1.18e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (7.98e-7)"	"unprognostic (7.51e-3)"	"unprognostic (6.30e-3)"	"prognostic unfavorable (7.73e-5)"	"unprognostic (8.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.25e-1)"	17.7	25.0	17.6	16.2	24.1	24.0	15.3	31.7	22.7	14.8	24.7	22.6	15.0	27.2	17.6	14.9	23.8	17.3	12.7	36.7	17.9	17.7	30.9	40.4	16.8	17.2	23.4	15.9	18.5	21.2	20.7	30.1	14.7	20.0	14.6	27.8	14.3	19.1	18.0	45.6	12.8	22.0	18.6	19.3	18.2	19.6	13.3	24.5	20.8	19.9	20.4	20.6	17.2	22.8	24.9	29.3	17.5	38.4	19.3	30.5	20.7	36.5	23.1	16.9	14.5	14.8	19.2	31.6	19.6	9.0	17.3	18.0	45.9	21.6	29.0	16.1	16.1	38.1	24.0	24.6	20.4	24.5	24.4	30.5	20.4	21.0	41.9	24.0	27.3	16.3	18.9	16.7	23.7	25.4	19.9	21.4	23.1	28.6	14.7	17.6	22.5	38.6	31.1	15.9	34.1	36.5	22.8	16.6	37.3	28.6	30.6	23.0	14.8	15.5	29.1	32.8	26.5	13.7	25.2	18.3	21.1	26.2	28.1	29.0	18.1	15.8	26.3	16.4	29.2	18.0	13.4	33.7	17.5	21.9	38.4	21.3	24.9	27.1	23.0	27.5	23.6	24.2	24.1	6.3	19.3	34.7	29.3	30.5	20.7	17.6	24.1	31.7	22.7	17.9	17.7	23.4	15.9	20.0	24.5	74.5	72.9	43.9	46.5	30.9	51.5	113.0	66.2	72.3	66.0	62.8	47.1	71.4	157.5	66.7	42.9	42.6	68.4	0.0	47.7	68.6	45.1	45.4	38.3	122.2	65.2	44.5	57.1	46.6	47.9	32.4	47.5	57.4	42.2	44.1	58.4	32.1	45.5	45.6	50.2	80.6	66.4	38.8	60.9	57.2	78.4	28.0	33.0	50.3	84.0	42.3
MRPS6	"C21orf101, MRP-S6, RPMS6"	ENSG00000243927	"Mitochondrial ribosomal protein S6"	P82932	21	34073224-34143034	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 633.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007861, HPA008163, HPA049676"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846"	"unprognostic (2.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.16e-3)"	"unprognostic (4.01e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.13e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.06e-5)"	25.3	29.3	26.1	17.5	27.3	8.5	62.4	20.6	25.3	12.6	28.7	12.9	23.6	14.1	21.8	24.5	14.8	22.7	14.0	23.3	28.6	25.6	67.4	24.2	14.4	23.7	28.9	13.0	18.8	9.9	9.6	17.4	28.3	33.2	15.7	18.8	28.0	12.1	25.7	41.7	20.2	16.1	20.1	35.6	12.4	21.0	26.4	22.8	15.8	98.7	12.4	25.3	19.6	52.1	30.9	42.8	22.2	21.1	41.7	40.5	29.9	15.7	12.4	47.7	17.3	16.8	16.8	16.3	17.8	38.8	14.7	15.4	40.3	29.5	24.0	12.1	21.1	20.8	6.3	27.7	23.3	14.1	42.4	15.7	20.5	7.7	9.5	8.3	9.4	6.8	7.3	23.7	28.1	25.3	22.1	10.0	10.7	25.7	5.9	28.2	13.4	16.2	23.7	30.9	27.2	28.9	22.7	8.8	22.6	61.8	11.1	43.2	11.4	18.9	9.2	22.1	24.0	19.7	11.6	5.7	14.5	8.5	24.7	9.7	30.3	26.3	20.9	47.2	25.7	14.1	22.0	21.1	22.2	38.8	20.2	30.2	30.9	30.9	36.3	22.0	19.4	40.5	39.9	17.5	41.7	20.1	42.8	29.9	29.9	26.1	27.3	20.6	25.3	28.6	25.6	28.9	13.0	33.2	22.8	20.8	33.4	82.3	175.5	237.0	30.2	47.6	20.4	73.6	45.5	239.0	9.8	167.8	633.3	35.0	75.6	32.3	45.3	0.0	31.5	200.0	124.7	236.7	137.1	83.4	108.6	7.9	87.8	28.8	34.4	54.0	25.9	104.8	96.2	214.6	155.9	23.0	44.7	112.2	96.5	119.4	20.4	116.4	46.4	94.2	130.9	289.3	152.5	90.0	91.6	157.8
MRPS7	"MRP-S, RP-S7, RPMS7"	ENSG00000125445	"Mitochondrial ribosomal protein S7"	Q9Y2R9	17	75261674-75266373	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 335.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022522, HPA023007"	Supported		Approved	Mitochondria		No	No			Mitochondria		"HPA022522: AB_1854131, HPA023007: AB_1854132"	"unprognostic (1.24e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (5.82e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.05e-3)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.95e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.15e-1)"	17.4	22.1	16.8	15.7	17.9	11.6	15.3	15.6	23.5	11.0	19.6	11.2	15.5	19.8	11.2	14.0	20.9	15.0	16.7	56.7	15.0	14.7	22.9	30.6	12.3	15.0	17.8	13.1	12.2	18.1	15.7	14.0	19.6	14.9	13.6	17.1	13.9	16.9	16.9	79.5	11.1	19.6	13.5	12.1	15.1	16.2	29.4	9.4	17.4	16.2	33.9	15.8	13.4	12.2	30.6	38.0	9.9	33.6	26.4	30.8	43.9	23.7	41.1	16.0	12.7	13.0	7.5	31.0	15.9	11.7	28.6	20.8	44.8	20.3	21.3	14.1	15.5	18.4	23.0	25.0	26.3	16.3	11.4	43.4	28.6	27.9	41.8	12.2	26.4	15.0	11.2	26.0	22.0	21.8	14.2	34.6	25.4	28.0	19.2	17.3	44.6	30.4	23.8	18.8	30.2	41.0	21.2	49.8	29.4	25.0	24.6	29.4	27.4	20.8	51.3	29.5	17.6	40.0	23.0	15.8	26.9	28.1	14.0	32.1	21.8	12.7	22.1	19.4	18.6	20.4	7.1	33.6	9.9	26.1	33.2	28.0	30.6	25.9	28.3	36.8	27.5	30.8	28.1	2.6	26.4	27.8	38.0	29.0	43.9	16.8	17.9	15.6	23.5	15.0	14.7	17.8	13.1	14.9	9.4	47.6	42.4	81.1	60.2	35.0	65.6	62.9	61.1	75.0	37.5	54.1	92.3	161.9	195.6	96.6	117.8	44.3	99.5	70.0	90.2	134.4	47.3	56.2	38.1	79.5	131.5	44.5	45.6	37.4	62.3	335.2	44.8	54.2	40.5	135.3	66.7	64.2	79.3	63.1	37.4	178.2	99.5	58.2	54.7	64.1	74.1	36.6	115.3	60.9	107.4	67.2
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105037983-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	13.9	25.0	14.1	16.9	18.5	13.3	15.4	13.2	20.6	13.7	18.9	15.9	14.3	19.0	17.6	13.2	16.7	16.2	8.9	39.1	14.4	15.3	24.5	23.5	10.0	14.5	18.1	15.7	21.0	17.3	22.0	23.9	8.4	25.2	15.8	22.0	10.9	15.3	16.4	56.8	14.0	17.0	16.6	15.0	14.0	17.4	20.6	16.6	20.7	15.6	28.7	16.8	15.2	12.4	22.1	20.4	7.1	17.2	20.0	22.8	14.5	22.3	9.7	20.4	18.8	10.8	11.2	23.9	14.4	13.8	22.8	20.6	51.5	15.7	23.4	14.3	11.3	23.9	20.3	40.0	20.9	24.3	14.4	26.3	23.1	14.3	31.1	18.0	17.0	10.3	13.3	14.3	18.8	15.8	13.3	17.5	28.8	32.9	12.2	15.5	17.9	22.9	22.4	32.3	19.1	21.3	29.3	17.5	32.4	28.6	15.7	17.7	10.7	16.6	24.5	19.4	21.0	20.1	17.3	11.4	13.5	27.3	13.4	15.4	11.3	13.3	18.7	11.7	26.2	11.3	7.1	11.6	4.6	19.9	14.6	22.0	22.1	22.0	20.9	20.4	16.5	22.3	21.9	1.3	20.0	17.2	15.2	22.8	14.5	14.1	18.5	13.2	20.6	14.4	15.3	18.1	15.7	25.2	16.6	20.8	23.3	15.2	20.5	17.3	23.1	95.6	17.8	37.5	18.2	21.0	11.8	34.7	91.2	34.3	24.9	25.9	18.2	46.7	36.9	32.2	14.4	14.6	22.0	28.2	25.1	7.9	18.9	15.4	11.5	6.6	22.2	16.4	28.7	28.9	24.6	17.9	21.3	14.0	25.5	53.7	28.2	38.8	20.6	54.8	38.2	11.5	17.0	24.5	35.4	15.6
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 81405.0;Enterocytes: 59874.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 872.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	114.5	173.2	235.7	256.3	540.3	247.5	249.9	261.4	87.1	66.0	110.6	208.4	373.6	302.7	125.7	198.6	65.0	435.2	26.9	231.6	94.6	143.0	165.0	181.7	872.7	389.9	74.8	104.9	230.2	288.6	241.1	65.3	145.0	306.7	79.4	172.7	115.3	217.3	195.5	277.4	85.7	469.5	59.9	156.0	141.8	112.3	70.4	181.6	334.7	303.0	112.7	150.2	90.6	351.3	163.0	296.6	201.5	352.9	316.5	264.7	180.2	259.8	131.1	103.0	98.6	68.6	130.7	276.7	128.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5											2694.8	3022.9	23660.6	9171.4	8678.3	0.0	81405.0	28094.1	4463.5	5243.5	18590.0	0.0	0.0	3606.0	6482.3	1224.4	4243.1	59874.1	34807.7	4485.9	0.0	3116.3	8181.6	3594.1	45857.2	0.0	0.0	7240.0	18002.1	27410.8	6497.0	10830.0	8032.7	6539.1	13021.9	32338.6	0.0	5722.6	29051.7	7980.9	24852.9	0.0	13394.3	6634.5	9840.4	12887.5	10030.7	0.0	18830.6	25753.2	17251.8
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 324.2;skeletal muscle: 302.1"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 61379.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 490.3;HeLa: 493.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400, HPA074796"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: "	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	78.0	52.4	98.5	14.7	143.5	14.4	32.3	38.4	59.6	30.9	54.0			55.6	25.0	43.6	28.0	25.0	21.2	222.5	93.9	68.0	128.7	144.7	19.6	13.7	83.6		25.3	51.4	33.6	23.7	32.6		32.9	57.7		59.2	49.5	302.1	63.5	37.2	37.4	44.3	15.7	55.2	20.2			20.9		20.6	23.6	14.7	183.7	78.7	324.2	155.7	90.0	146.7	57.6	73.4	99.2	123.0	131.3	490.3	78.9	99.1	84.7	35.1	22.2	38.5	97.6	162.5	188.2	41.5	100.3	26.6	231.5	18.2	104.1	54.5	91.9	81.5	105.1	493.3	174.0	92.4	59.0	128.5	170.3	155.3	42.0	90.5	150.2	56.2	76.8	53.7	118.5	113.1	202.8	54.8	121.7	27.3	71.8	67.4	64.8	48.4	117.8	176.2	171.6	43.9	77.6	59.0	111.5	83.4	192.8	162.6	203.7	176.1	77.9	101.9	141.8	65.0	32.5	43.6	80.6	46.8	92.0	48.9	324.2	155.7	235.1	102.8	94.4	135.3	150.5	118.7	132.0	78.0	183.7	128.3	146.7	148.0	90.0	96.8	78.7	79.8	57.6											1101.8	1182.9	10535.1	6605.8	2949.0	0.0	61379.6	10280.2	2941.7	2205.5	7087.1	0.0	0.0	1833.6	2297.4	679.0	1928.7	15168.1	14904.3	3076.0	0.0	1463.9	4337.7	1777.7	14746.0	0.0	0.0	2756.0	7288.5	8580.4	3048.7	7355.0	2431.1	2478.3	3811.6	11241.0	0.0	2672.3	10113.2	5078.0	11513.5	0.0	5704.4	3210.7	4468.4	3767.8	2992.1	0.0	6827.7	9828.0	8723.5
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 392.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 130137.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 821.0"	"Low region specificity"	"Detected in all"							HPA053928	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41.0	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26.0	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53.0	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40.0	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821.0	271.8	49.3	113.1	134.0	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257.0	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81.0	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148.0	93.0	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89.0	87.6	67.6	53.0											1179.2	1324.7	15760.8	7514.4	3912.5	0.0	130137.0	15452.1	2295.3	2103.1	12148.5	0.0	0.0	2064.1	2636.7	917.0	2449.9	17720.8	23127.3	3538.6	0.0	2017.3	5309.0	2067.8	31565.1	0.0	0.0	4902.7	11944.3	15339.0	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0.0	3353.9	12846.0	5441.2	13683.6	0.0	6208.8	3859.5	7259.5	5529.7	4316.1	0.0	9799.9	18174.2	10097.1
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 16050.3;Hepatocytes: 4100.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 885.9"	"Low region specificity"	"Detected in all"							HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	97.1	90.4	163.1	166.1	571.6	120.3	71.9	208.6	52.3	32.7	59.8	150.2	89.8	241.1	85.5	140.9	53.6	185.3	25.3	223.3	65.2	94.9	104.4	173.3	885.9	279.0	83.9	178.2	155.8	210.6	228.8	62.4	218.5	246.4	65.5	125.0	95.5	172.9	119.9	173.6	67.7	228.6	41.1	103.4	109.2	39.3	70.3	107.2	174.1	205.2	49.5	67.0	102.3	162.1	69.9	366.4	115.3	224.3	209.4	86.0	107.1	125.8	79.8	156.5	73.2	128.4	61.7	242.4	40.1	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8											208.4	153.9	1221.6	193.7	203.1	0.0	16050.3	1630.6	940.9	684.7	307.1	0.0	0.0	76.3	127.4	46.0	141.8	949.6	2499.6	297.1	0.0	116.0	126.2	448.0	4100.6	0.0	0.0	246.6	1665.3	1966.8	217.5	386.3	249.3	243.0	242.5	657.8	0.0	237.0	573.3	217.1	415.7	0.0	342.8	211.1	226.8	167.2	211.8	0.0	631.2	458.3	137.0
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642623	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 432.9;Proximal tubular cells: 398.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038390	Approved		Approved	Mitochondria		NA	NA		55000	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	13.6	19.6	15.6	12.8	20.3	8.3	12.5	14.1	21.3	10.4	22.3	19.3	8.7	28.3	12.6	15.1	21.6	9.9	11.6	15.0	14.0	13.8	40.8	74.8	9.1	13.9	15.2	12.2	9.3	14.4	16.8	9.3	9.5	15.4	11.8	24.7	13.6	13.4	10.0	31.4	12.1	33.9	16.1	11.4	11.4	10.1	44.2	10.2	15.1	15.5	24.9	16.4	11.6	10.7	13.7	25.7	7.9	21.3	12.1	13.6	17.5	18.9	20.8	17.8	24.0	21.1	19.6	13.2	20.6	18.9	27.8	26.4	16.5	19.4	26.2	11.2	25.2	30.1	23.9	31.9	27.1	33.9	13.1	29.8	15.0	29.7	32.9	29.1	31.2	15.1	22.1	21.4	18.5	27.7	16.2	25.1	22.6	27.7	15.8	33.9	27.6	23.9	23.5	19.3	37.2	31.6	22.4	27.1	18.8	32.2	24.6	21.2	14.9	28.2	28.5	14.5	17.6	41.0	14.7	20.8	25.7	22.4	42.5	26.4	16.8	19.1	29.6	21.2	27.2	22.9	5.9	19.8	7.9	12.7	21.3	12.0	13.7	11.1	11.7	25.7	10.9	9.7	11.2	1.9	12.1	17.0	16.9	13.6	17.5	15.6	20.3	14.1	21.3	14.0	13.8	15.2	12.2	15.4	10.2	20.8	33.9	37.2	43.0	41.8	0.0	61.0	81.5	46.8	37.5	50.6	0.0	75.5	154.2	136.5	432.9	25.1	133.4	0.0	95.3	101.6	32.1	64.6	35.9	265.9	146.4	0.0	76.7	35.0	64.2	110.8	26.7	50.7	77.6	112.8	82.5	0.0	85.1	63.1	54.8	398.6	0.0	32.3	38.1	327.5	81.0	47.3	106.9	37.6	134.8	50.4
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880720	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	8.9	11.5	16.1	10.9	18.1	13.9	14.4	23.2	18.9	10.4	11.8	12.1	10.0	11.5	11.6	11.0	13.4	9.8	8.3	8.7	15.2	10.5	13.2	17.6	8.3	19.4	20.3	13.1	14.7	11.4	10.0	18.0	10.6	18.8	11.6	12.1	8.5	12.5	9.2	9.3	9.9	13.6	9.7	22.7	17.6	12.5	10.0	18.5	11.9	12.2	10.3	19.0	12.0	11.4	15.0	9.4	24.8	8.8	9.8	19.0	10.0	10.4	9.1	8.8	5.9	8.5	9.0	7.7	8.9	9.0	9.6	11.9	11.0	10.0	21.5	7.4	7.0	14.1	9.2	13.1	7.9	13.7	1.2	9.5	9.7	9.8	8.5	7.6	17.1	10.8	10.7	10.5	10.5	11.2	7.6	8.3	5.4	17.7	8.9	11.1	13.3	17.9	19.6	13.2	12.9	10.2	5.1	11.7	14.7	9.9	11.4	8.1	15.6	9.0	19.0	17.9	16.8	6.6	12.3	5.3	11.4	14.0	15.4	9.0	12.8	12.9	29.1	8.2	5.6	15.9	24.8	8.8	11.9	10.6	7.5	12.7	14.6	13.8	15.2	9.4	15.0	19.0	15.1	4.2	9.8	8.2	7.4	13.2	10.0	16.1	18.1	23.2	18.9	15.2	10.5	20.3	13.1	18.8	18.5	8.9	11.7	3.4	3.4	0.0	0.0	4.5	5.1	2.7	4.5	3.5	0.0	8.2	5.0	5.1	0.9	2.9	3.8	0.0	4.5	6.1	1.9	2.9	4.7	8.9	4.5	0.0	1.2	6.7	7.6	1.1	6.4	5.3	0.0	7.2	3.2	0.0	3.2	3.5	6.7	6.2	0.0	12.9	1.4	11.2	9.8	0.0	3.8	8.6	4.6	1.8
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007355			Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA007355: "	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	13.8	16.4	14.2	15.9	20.1	9.9	22.9	17.8	18.0	14.8	13.8	12.3	17.4	11.9	15.4	23.8	12.6	13.2	12.9	21.9	17.3	15.3	15.9	22.2	18.5	18.3	18.1	16.0	13.7	14.8	18.9	14.1	16.1	23.7	15.5	14.5	9.8	12.1	17.9	28.8	16.1	11.6	21.9	13.2	16.9	12.8	10.9	13.5	16.0	15.0	14.1	18.1	13.9	12.3	15.3	18.0	18.6	11.6	16.7	17.8	7.8	18.9	12.2	18.4	14.5	13.1	13.6	8.4	14.6	12.0	21.5	21.7	8.7	14.1	17.1	30.9	8.5	10.9	10.7	19.0	11.4	26.2	16.4	13.9	24.4	9.4	10.5	18.5	8.2	10.0	13.6	17.1	17.4	16.4	11.1	17.5	18.4	20.5	9.0	21.5	12.3	34.9	24.3	9.6	33.5	19.1	21.2	15.1	13.3	15.7	10.1	12.6	9.9	10.9	3.2	15.5	12.4	16.5	11.6	7.8	15.1	10.2	17.4	12.9	10.3	12.9	19.9	16.4	22.1	19.7	18.6	10.3	4.3	12.4	11.6	17.8	15.3	14.1	14.0	14.8	13.2	16.1	16.1	1.8	16.7	11.0	18.0	13.3	7.8	14.2	20.1	17.8	18.0	17.3	15.3	18.1	16.0	23.7	13.5	3.0	5.8	10.9	13.1	0.0	0.0	27.8	10.2	9.4	10.3	5.2	0.0	26.6	11.6	10.9	4.4	8.2	0.8	23.3	8.6	17.4	15.8	7.5	5.8	7.3	14.3	0.0	0.0	6.2	4.9	3.1	12.7	6.3	0.0	21.6	3.8	0.0	7.5	3.5	13.1	8.7	0.0	12.9	10.0	24.4	18.8	0.0	14.5	4.4	6.2	9.1
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.7	8.3	16.5	9.5	22.5	10.1	12.3	14.9	16.6	14.5	20.7	5.7	13.2	13.6	5.4	17.3	16.5	9.9	22.5	21.3	19.7	18.4	16.3	17.4	15.9	25.1	14.8	20.7	13.3	17.2	20.9	17.0	19.7	18.9	16.5	18.6	15.5	6.0	17.4	12.4	15.1	14.3	18.9	18.1	14.3	14.8	18.8	7.7	13.8	17.6	15.2	13.2	12.2	15.2	11.3	11.7	11.2	10.7	22.8	13.4	13.1	15.7	13.3	16.1	4.1	33.2	11.3	13.2	12.3	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3	11.9	23.0	29.4	17.6	0.0	0.0	17.5	25.5	32.1	23.9	19.2	0.0	24.9	34.9	21.1	40.5	13.6	19.2	23.3	21.3	22.9	13.5	15.6	10.5	27.2	22.0	0.0	10.5	14.7	21.8	48.5	21.6	18.0	0.0	19.8	26.7	0.0	20.5	25.8	24.8	32.1	0.0	38.8	15.9	42.6	38.1	0.0	19.8	30.5	22.5	14.8
MTFP1	"HSPC242, MTP18"	ENSG00000242114	"Mitochondrial fission process 1"	Q9UDX5	22	30425530-30429053	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 56.3;Exocrine glandular cells: 45.3;monocytes: 60.5;Pancreatic endocrine cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077396			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077396: AB_2686837"	"unprognostic (2.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.20e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-2)"	8.9	9.6	6.4	13.0	6.6	9.8	13.5	3.7	6.5	7.6	13.3	2.8	14.5	11.7	2.9	16.2	12.3	2.8	10.2	18.3	5.0	6.0	27.4	20.8	8.3	17.3	7.2	2.2	9.3	12.9	10.3	5.7	9.2	9.8	8.5	12.9	9.8	9.0	4.4	14.6	4.6	10.2	4.1	3.8	17.4	11.3	3.2	5.9	5.3	11.2	8.9	13.0	7.7	5.6	13.0	7.6	0.7	6.4	4.8	25.7	9.9	26.2	19.5	6.8	11.0	1.4	0.7	8.2	2.5	1.7	15.0	23.4	9.2	16.0	27.9	7.1	1.4	11.9	12.2	23.8	18.3	13.1	15.1	27.1	8.1	11.6	19.3	4.1	20.4	15.7	2.1	7.2	8.1	13.9	3.8	10.3	13.1	12.8	11.0	5.0	31.5	18.4	23.0	12.3	24.7	20.0	23.7	6.8	26.7	19.0	6.9	12.3	12.8	5.3	28.4	10.3	6.8	8.7	10.1	5.2	16.0	21.5	8.2	6.6	5.7	3.9	25.0	6.3	23.0	6.7	0.0	5.5	0.0	19.3	6.4	25.7	13.0	16.2	16.5	7.6	9.3	16.8	19.6	0.7	4.8	3.8	3.7	13.3	9.9	6.4	6.6	3.7	6.5	5.0	6.0	7.2	2.2	9.8	5.9	6.0	4.0	28.4	1.4	4.9	0.0	4.0	7.6	0.0	3.4	3.5	0.0	10.1	13.3	56.3	0.0	3.1	25.2	0.0	45.3	27.0	4.3	3.0	9.2	12.5	15.5	0.0	8.1	4.3	8.7	0.0	0.6	3.7	3.3	60.5	17.7	0.0	42.1	11.5	0.4	9.2	0.0	0.0	1.9	0.4	1.4	4.8	14.1	14.6	36.7	1.6
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 350.9;Late spermatids: 606.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	10.7	17.7	6.6	5.5	11.7	3.9	9.5	10.1	8.8	9.7	10.7	10.8	14.2	11.1	9.9	11.9	12.3	7.2	6.2	8.7	6.8	5.5	28.4	37.7	7.1	3.9	10.3	5.4	7.9	19.1	8.0	15.0	16.2	9.7	8.1	11.2	14.8	11.0	11.5	11.7	8.3	16.2	8.8	11.3	6.5	13.2	16.8	11.7	5.4	13.0	11.2	9.3	10.5	9.7	1.7	3.1	4.3	2.8	0.8	2.9	1.7	14.1	10.6	8.4	9.8	11.7	11.5	6.8	9.3	8.6	11.6	12.3	9.0	14.8	7.9	3.0	9.0	11.3	9.3	19.1	12.7	15.7	2.8	10.3	9.8	7.8	18.1	14.6	2.5	4.8	7.8	13.7	14.9	47.7	6.6	14.1	5.8	13.3	8.2	13.4	12.7	8.6	6.0	8.9	31.3	9.5	4.4	11.6	6.6	14.3	12.8	3.8	5.6	9.3	15.9	12.4	9.0	17.6	5.6	10.6	7.1	9.8	16.7	8.1	8.0	5.2	5.8	8.6	10.4	9.3	4.3	2.8	1.2	2.0	2.5	2.9	1.7	2.6	2.2	3.1	1.4	2.6	2.9	0.7	0.8	1.2	1.9	2.5	1.7	6.6	11.7	10.1	8.8	6.8	5.5	10.3	5.4	9.7	11.7	17.9	6.0	12.0	9.6	14.9	0.0	6.4	12.7	10.7	3.4	10.4	0.0	20.7	48.0	16.4	350.9	6.4	10.7	23.3	21.3	22.9	9.7	11.6	4.7	33.1	8.6	0.0	4.6	8.6	5.4	606.6	15.5	6.1	13.5	2.8	11.8	0.0	17.5	7.0	11.3	91.0	0.0	6.5	16.5	66.0	16.8	16.9	32.7	5.0	14.1	15.2
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 175.3;Late spermatids: 418.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favorable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	13.2	43.5	17.8	8.1	23.9	6.2	14.0	19.4	26.5	13.8	20.2	17.1	21.6	18.2	16.7	23.3	19.2	17.1	13.4	58.7	16.8	17.6	27.7	25.1	10.7	9.0	17.7	20.7	26.8	14.5	38.7	16.4	15.6	19.2	19.9	14.8	24.2	16.3	28.8	76.9	11.4	15.3	28.0	13.0	13.4	16.4	46.4	15.0	5.8	16.5	23.1	9.9	21.1	16.6	10.1	21.1	41.1	20.3	10.3	10.6	18.1	7.6	10.6	21.5	21.8	27.9	26.4	9.1	17.9	25.6	18.4	20.3	3.5	16.1	2.6	16.0	31.7	16.2	7.0	17.6	15.3	18.1	17.3	15.8	22.0	17.8	13.9	26.8	18.0	22.1	27.1	14.5	19.6	14.7	27.3	15.1	10.8	13.3	11.8	26.2	8.1	10.2	12.8	11.8	10.1	15.6	10.2	19.4	7.7	18.9	7.0	22.0	20.1	13.4	13.0	26.7	15.1	10.9	16.7	15.6	15.2	12.1	35.5	11.2	12.4	7.4	9.2	26.6	24.5	16.9	20.4	19.4	41.1	10.4	18.8	6.2	10.1	9.9	9.3	21.1	10.0	10.6	9.7	5.2	10.3	20.3	8.5	10.3	18.1	17.8	23.9	19.4	26.5	16.8	17.6	17.7	20.7	19.2	15.0	14.9	23.2	21.5	23.3	11.9	0.0	129.8	15.3	8.1	15.9	21.0	0.0	46.0	87.9	28.6	175.3	16.8	19.0	0.0	29.3	32.3	25.4	13.0	34.7	29.4	29.9	0.0	15.0	16.5	13.4	418.5	31.7	18.9	42.2	59.5	13.1	0.0	23.1	14.8	36.7	58.4	0.0	25.8	29.7	84.9	35.7	11.3	49.7	10.2	18.8	11.5
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133421307	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037826, HPA037827"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.03e-5)"	14.5	29.4	16.5	20.2	19.0	14.8	17.9	23.9	19.2	16.1	19.7	23.0	16.7	26.6	19.9	13.5	21.7	20.5	17.9	14.1	14.4	13.1	26.6	47.0	14.4	19.3	17.3	14.5	20.0	27.9	18.1	22.3	16.6	16.4	19.8	16.4	16.9	23.8	24.4	26.4	18.2	22.5	17.7	14.1	27.3	21.3	29.1	20.8	21.3	19.5	12.3	21.2	15.1	15.8	22.9	20.2	10.4	18.2	21.0	14.2	9.9	16.7	20.5	12.9	27.9	7.8	6.1	18.5	9.9	10.6	18.6	15.7	25.9	12.1	12.5	15.1	10.1	7.7	14.5	14.1	19.7	8.8	11.6	18.7	12.0	10.6	23.3	19.9	8.8	13.2	15.7	11.1	17.6	28.2	13.0	26.7	12.8	10.5	2.2	14.2	21.4	8.6	12.3	17.4	21.4	7.1	12.1	12.4	2.9	16.3	13.7	4.9	16.0	14.1	14.6	21.7	7.7	13.3	13.2	15.1	6.5	12.4	6.7	11.2	4.0	2.8	17.7	11.8	8.0	9.2	0.2	10.6	10.4	13.9	16.1	14.2	18.7	12.4	11.6	9.7	22.9	9.7	10.2	1.5	21.0	18.2	20.2	12.5	9.9	16.5	19.0	23.9	19.2	14.4	13.1	17.3	14.5	16.4	20.8	8.9	2.2	13.7	5.3	3.8	0.0	1.4	2.5	6.7	4.5	3.5	0.0	7.7	5.0	11.3	2.0	6.2	9.7	0.0	8.5	6.5	4.3	5.7	5.8	4.3	4.7	0.0	12.1	7.4	4.6	3.8	8.3	4.1	5.0	10.0	6.7	0.0	9.0	8.6	4.6	5.4	0.0	12.9	5.2	8.6	7.9	3.0	5.6	10.0	9.2	6.5
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	12.0	10.5	13.7	33.7	3.6	12.6	33.5	19.0	20.8	19.1	23.6	21.1	11.3	44.5	12.7	29.0	11.3	12.9	21.9	18.5	23.8	18.3	19.9	18.5	18.7	19.3	22.6	33.8	3.0	14.9	23.7	18.5	33.8	17.2	31.9	24.9	43.9	23.3	19.6	25.4	16.5	7.0	14.0	12.1	9.7	19.8	10.2	19.8	12.9	5.9	13.7	10.2	25.1	11.1	15.5	13.0	3.5	23.7	24.2	12.8	28.1	28.4	26.9	19.4	18.0	46.4	21.3	31.6	16.5	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6	0.0	1.7	10.7	5.1	5.8	0.0	2.4	2.5	4.0	2.3	14.0	0.0	18.7	6.6	10.4	19.2	7.1	0.9	0.0	15.4	107.1	15.4	4.1	0.0	1.0	21.7	0.0	1.2	3.7	2.4	3.4	0.6	10.1	33.7	1.0	2.5	0.0	15.0	0.8	7.4	12.2	0.0	0.0	6.1	0.5	6.4	3.0	61.6	3.2	3.5	39.1
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74198562-74217565	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 263.3;Smooth muscle cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	26.2	5.7	5.8	21.6	14.1	12.1	21.9	3.0	8.0	15.1	12.4	5.9	12.6	10.1	15.8	8.7	14.1	17.5	10.5	12.1	10.0	8.2	12.0	3.4	15.9	21.0	19.0	1.5	20.6	39.7	1.5	15.6	8.2	16.1	12.7	15.3	3.0	32.9	12.0	39.4	8.6	9.2	21.0	25.6	26.3	15.3	11.9	11.8	8.4	11.4	16.7	23.5	20.3	41.8	4.8	11.4	13.6	19.7	10.7	12.7	6.3	18.6	6.9	7.8	26.6	8.6	9.7	20.6	23.5	15.9	13.8	19.6	15.9	7.9	39.4	6.3	12.7	15.4	6.6	25.9	13.8	26.1	21.2	10.8	38.0	3.9	15.4	35.2	27.6	25.4	20.0	44.1	17.2	74.8	7.1	9.2	63.6	17.5	57.4	13.5	11.7	17.3	34.2	17.0	27.2	11.5	19.3	21.9	34.7	7.9	5.5	20.4	14.9	8.1	24.4	55.1	5.9	20.9	38.4	4.0	4.3	34.7	9.8	26.3	47.5	21.0	32.0	11.9	33.9	12.2	13.6	8.1	9.6	3.3	19.7	4.8	4.8	6.0	3.6	11.4	3.0	4.3	3.3	1.1	10.7	19.1	5.0	12.7	6.3	5.8	14.1	3.0	8.0	10.0	8.2	19.0	1.5	16.1	11.8	14.9	26.5	62.1	28.1	79.3	0.0	8.2	7.6	2.7	13.6	1.8	0.0	20.5	3.3	54.8	3.2	18.0	6.9	93.5	92.6	49.1	52.6	48.5	53.0	0.6	64.6	0.0	18.3	13.5	55.9	2.9	21.0	92.7	67.4	263.3	33.2	0.0	75.9	5.8	19.8	1.4	0.0	135.8	264.7	30.1	55.8	65.2	11.7	30.5	21.6	55.0
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA006021: AB_2147687, HPA061422: AB_2684514"	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	13.8	17.8	13.6	12.0	15.8	9.6	15.5	9.4	17.7	12.0	21.1	11.2	17.7	21.0	10.0	15.9	17.5	10.6	11.2	24.5	13.5	12.1	27.4	32.2	10.6	17.5	15.5	11.8	10.4	24.6	20.2	20.2	12.5	22.6	12.2	25.1	9.7	16.3	14.3	31.5	12.3	26.9	15.0	16.9	16.3	16.3	9.0	14.6	16.1	20.6	27.1	15.2	14.5	11.6	9.6	13.9	9.4	12.8	17.2	12.7	6.9	15.5	15.1	8.9	15.3	11.1	15.2	20.5	14.3	11.5	13.8	12.1	17.9	15.1	25.6	27.2	13.1	15.5	13.9	21.2	20.6	22.9	28.4	16.3	23.6	11.8	33.0	21.2	37.1	14.0	16.7	21.4	19.1	40.0	12.3	11.0	14.4	41.7	14.7	14.3	12.9	11.4	25.0	19.0	19.5	18.6	12.1	28.7	24.7	13.4	13.8	16.1	10.2	12.7	21.1	25.8	11.4	11.2	12.4	10.9	14.5	16.6	17.2	23.4	27.6	24.6	7.0	15.3	27.8	11.4	5.4	11.0	9.4	10.1	12.8	12.6	8.3	10.3	9.4	13.9	9.6	12.5	12.7	4.2	17.2	10.7	6.8	11.7	6.9	13.6	15.8	9.4	17.7	13.5	12.1	15.5	11.8	22.6	14.6	20.8	20.5	13.7	15.4	6.8	0.0	72.4	30.6	30.8	15.9	7.0	0.0	25.4	24.9	27.1	13.6	7.9	20.9	0.0	29.3	25.7	10.8	11.5	20.8	25.5	21.3	0.0	18.5	9.2	18.0	14.8	8.3	15.7	8.5	36.1	15.7	0.0	26.3	17.5	9.9	20.7	0.0	6.5	11.7	27.4	16.2	6.5	13.6	8.3	32.1	12.4
MTIF3	"IF-3mt, IF3(mt)"	ENSG00000122033	"Mitochondrial translational initiation factor 3"	Q9H2K0	13	27435643-27450591	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 461.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039791	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA039791: AB_10795296"	"unprognostic (1.82e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (8.41e-4)"	36.9	30.4	29.8	21.9	26.3	8.5	28.4	22.8	26.7	21.5	24.8	16.9	25.9	23.7	15.1	38.5	25.5	16.5	20.5	55.7	27.5	22.8	41.5	38.7	15.1	22.2	28.9	19.7	23.1	28.3	14.5	40.3	20.2	28.3	22.7	24.8	17.4	43.3	28.1	46.1	21.6	29.7	18.2	28.7	24.9	22.7	28.3	26.2	29.7	22.9	38.5	24.0	27.8	16.4	25.3	44.3	35.9	26.5	18.5	24.1	19.4	12.6	8.8	19.9	10.0	22.3	33.5	10.1	18.7	20.5	13.8	14.0	11.7	15.7	13.8	12.7	20.3	9.6	10.9	10.7	14.7	19.0	14.5	13.2	17.5	8.1	14.5	21.8	18.1	16.7	18.8	27.1	11.3	14.4	31.2	23.9	13.7	10.0	5.6	20.8	22.3	15.8	22.1	10.3	40.0	10.0	9.3	10.8	15.8	28.4	13.0	14.6	8.9	11.3	16.7	21.2	22.5	13.0	27.3	16.3	9.3	5.5	24.0	12.7	4.3	6.0	8.0	9.7	18.2	13.3	34.2	26.5	35.9	17.1	25.5	18.4	25.3	21.8	17.2	27.9	21.7	19.3	19.6	17.7	18.5	22.1	44.3	24.1	19.4	29.8	26.3	22.8	26.7	27.5	22.8	28.9	19.7	28.3	26.2	26.8	39.6	74.4	31.9	30.2	0.0	153.3	114.7	80.3	53.4	109.9	0.0	82.5	276.8	69.3	461.6	70.4	109.5	70.0	91.1	54.9	56.4	44.1	70.4	186.6	88.5	0.0	61.7	75.5	115.6	139.9	129.5	86.8	101.3	78.5	97.0	0.0	94.2	104.0	117.4	273.1	0.0	122.9	55.6	149.2	77.3	37.1	47.5	55.4	92.5	39.3
MTPAP	"FLJ10486, mtPAP, PAPD1, SPAX4"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Early spermatids: 194.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11.0	10.4	7.0	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13.0	11.4	18.9	9.5	7.2	10.0	11.4	8.0	12.0	8.2	10.7	10.2	22.3	13.1	10.0	14.3	9.0	9.3	9.7	10.6	8.3	6.7	11.0	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.3	9.1	13.1	9.0	8.5	11.8	10.0	3.5	10.2	10.7	15.1	20.1	20.4	7.1	6.5	9.4	16.9	17.5	11.6	12.5	10.3	13.7	20.7	13.5	15.2	9.4	13.5	16.3	8.3	10.8	11.4	6.8	5.7	11.0	19.2	22.3	16.1	7.6	11.9	16.2	12.0	6.1	10.8	7.7	16.4	16.1	19.0	9.4	9.5	15.0	12.1	9.0	9.4	13.9	8.9	9.1	8.7	10.6	10.8	13.9	15.0	11.0	3.6	8.7	27.9	9.2	24.8	3.8	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3.0	16.9	18.1	12.0	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13.0	11.4	8.3	8.9	6.1	9.7	10.8	22.3	0.0	15.3	5.1	10.7	11.4	3.5	0.0	12.2	16.6	7.7	194.2	12.0	7.8	0.0	7.9	9.8	11.5	8.6	4.7	12.1	12.7	0.0	4.1	10.4	12.3	17.1	11.2	11.5	8.5	10.8	13.7	0.0	8.4	0.0	15.6	11.0	0.0	12.9	11.4	21.9	17.2	21.8	9.6	9.6	16.6	14.0
MTX1	"MTX, MTXN"	ENSG00000173171	"Metaxin 1"	Q13505	1	155208699-155213824	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 517.8;Late spermatids: 1060.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011543	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011543: AB_1853824"	"unprognostic (2.57e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-2)"	15.4	19.8	11.6	9.9	12.6	22.9	15.8	5.7	18.1	15.8	15.9	12.2	14.8	12.4	14.9	13.9	18.0	21.4	13.5	11.8	10.8	10.0	24.4	36.4	12.8	18.7	11.8	12.9	14.0	26.3	23.4	12.0	28.4	11.7	12.3	12.7	14.6	20.7	19.2	10.4	13.8	13.7	12.7	10.2	17.1	14.7	60.0	9.0	14.5	19.3	14.3	18.0	11.6	11.5	14.4	23.1	43.8	26.8	12.2	14.0	14.4	17.4	28.7	9.2	13.1	17.2	15.5	29.1	9.0	18.3	26.9	18.8	35.7	29.2	14.4	29.9	20.7	8.5	17.5	13.5	25.5	9.8	10.5	31.7	9.1	23.0	34.4	27.2	16.8	12.9	19.8	23.9	27.7	18.7	10.3	23.7	21.3	18.4	7.2	15.9	42.3	18.8	21.2	18.3	24.8	33.4	15.5	5.8	34.1	24.2	15.1	15.0	18.7	11.2	35.6	10.3	14.7	28.8	27.3	9.8	12.9	14.5	8.5	15.1	13.9	11.5	14.6	17.0	8.6	13.7	10.2	26.8	6.3	9.8	13.7	9.2	14.4	12.1	10.3	23.1	12.4	12.1	10.9	43.8	12.2	7.9	12.4	14.0	14.4	11.6	12.6	5.7	18.1	10.8	10.0	11.8	12.9	11.7	9.0	8.9	17.1	31.2	37.1	18.0	0.0	1.1	30.6	36.1	9.1	33.2	0.0	91.6	82.9	61.0	517.8	26.4	34.8	0.0	73.6	112.1	34.7	39.6	26.5	48.6	89.5	0.0	19.0	20.9	42.2	1060.3	40.0	30.1	47.2	74.9	33.2	0.0	60.6	41.8	37.1	103.2	0.0	45.3	25.4	80.9	35.8	18.3	74.1	22.4	48.1	34.2
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 170.8;Spermatocytes: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	13.2	26.4	21.3	12.0	22.3	5.5	18.8	15.0	44.9	13.0	20.7	18.5	16.6	15.4	15.5	27.9	22.2	20.0	12.0	33.6	23.6	26.3	31.5	20.2	10.6	8.9	21.5	16.5	13.2	16.4	23.7	25.7	17.3	21.8	18.9	24.6	16.3	24.7	16.5	45.0	12.5	14.8	17.6	25.7	9.4	14.6	40.6	14.0	10.2	14.7	19.8	13.6	14.4	13.6	16.2	12.1	4.7	12.6	15.1	13.4	7.9	17.5	10.4	21.2	13.0	14.3	16.5	20.4	18.9	17.7	17.4	20.3	17.9	19.2	22.5	32.1	16.7	28.1	11.8	23.1	23.3	24.0	22.3	16.6	21.4	13.1	31.5	22.6	33.1	7.2	18.4	29.1	18.2	31.4	21.3	24.7	22.0	28.4	17.5	20.4	16.0	11.6	33.7	20.2	34.4	16.5	0.0	15.4	20.0	49.2	31.9	30.3	26.0	15.8	21.1	39.0	42.7	11.7	21.6	21.7	17.4	15.4	18.2	19.7	19.6	20.4	26.9	21.6	16.7	21.0	4.7	7.7	3.2	8.5	12.6	11.5	16.2	10.9	9.6	12.1	11.4	13.2	13.4	0.0	15.1	10.9	9.8	13.4	7.9	21.3	22.3	15.0	44.9	23.6	26.3	21.5	16.5	21.8	14.0	17.9	16.9	20.4	33.1	27.6	0.0	60.5	28.1	33.5	20.5	54.1	0.0	65.7	170.8	45.6	18.6	25.5	29.0	0.0	34.6	53.9	27.4	37.9	42.7	32.0	41.3	0.0	39.9	12.3	17.8	12.3	32.8	24.8	33.7	34.3	41.6	0.0	41.1	17.5	30.8	83.3	0.0	38.8	36.0	167.0	118.7	36.6	54.3	16.2	51.9	46.0
MTX3		ENSG00000177034	"Metaxin 3"	Q5HYI7	5	79976731-79991265	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047858, HPA062061"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047858: AB_2680185, HPA062061: AB_2684672"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (5.08e-5)"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (8.58e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.28e-1)"	9.4	13.9	11.8	8.9	18.7	8.6	12.0	10.9	20.7	9.9	9.4	8.5	5.9	6.2	13.4	10.1	10.6	11.2	6.4	8.5	14.5	5.8	10.7	6.5	7.6	11.8	7.4	10.8	17.7	9.9	21.0	11.1	6.8	15.9	12.0	7.6	8.3	12.0	11.1	11.6	10.0	12.2	13.0	12.0	8.5	9.3	6.2	8.2	2.8	12.3	7.0	11.6	12.2	10.1	3.7	0.9	1.2	1.1	1.4	3.6	1.0	6.8	4.6	10.2	5.8	4.9	10.1	2.6	6.1	5.0	5.7	6.7	1.7	7.6	10.8	2.0	6.2	9.1	7.9	0.0	14.8	10.2	2.8	7.1	4.3	11.3	4.7	9.4	0.0	5.5	7.7	13.9	9.9	16.8	7.5	4.0	0.0	2.5	6.8	9.2	6.9	0.0	0.1	10.5	2.0	4.2	0.0	15.7	4.6	4.5	8.0	14.2	10.4	8.8	5.7	12.0	8.8	9.7	6.9	4.0	10.1	8.4	8.0	14.0	9.0	9.0	9.8	14.6	0.0	11.6	0.7	0.8	1.2	2.6	1.1	1.9	3.7	2.9	3.5	0.4	2.6	3.6	2.8	1.0	1.4	0.5	0.9	1.4	1.0	11.8	18.7	10.9	20.7	14.5	5.8	7.4	10.8	15.9	8.2	26.8	4.0	1.9	4.1	1.3	0.0	8.7	12.7	16.0	11.4	12.2	0.0	4.1	5.0	3.7	2.1	4.2	2.8	0.0	2.2	2.2	4.6	7.9	1.1	6.8	2.8	0.0	0.0	9.2	4.3	3.1	11.8	3.3	0.0	1.8	6.8	0.0	4.3	5.3	11.7	6.7	0.0	12.9	2.8	7.1	6.3	3.0	1.5	6.9	6.4	4.2
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	17.1	16.6	9.6	19.8	20.8	11.7	10.4	17.0	20.4	21.2	20.5	10.2	28.5	12.9	19.1	24.0	16.1	26.1	17.2	24.6	15.5	12.8	13.6	9.9	11.2	14.8	24.5	13.5	17.0	19.1	32.5	21.7	22.6	12.5	13.8	11.7	12.9	15.8	23.0	8.7	8.1	9.1	9.8	14.3	15.9	8.0	12.1	16.7	25.0	9.6	9.8	14.5	15.3	16.4	20.9	8.1	11.5	13.0	15.6	20.7	11.9	18.0	15.2	18.5	16.1	13.9	16.2	18.4	19.1	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6	20.8	9.3	11.7	7.8	4.6	12.5	14.6	12.7	9.4	6.8	17.4	5.9	33.7	10.0	21.4	1.6	9.7	12.0	0.0	20.3	20.8	12.1	8.1	3.5	11.9	19.7	12.7	8.2	10.4	11.4	2.8	12.0	7.7	18.6	21.6	11.8	15.6	19.7	11.5	14.5	8.7	10.5	19.4	8.5	10.6	13.4	6.1	31.5	10.8	10.1	9.0
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.4	4.8	14.5	16.9	28.9	27.5	8.0	12.1	16.0	12.8	19.0	5.5	7.0	12.5	9.7	12.9	19.4	7.7	16.1	8.6	18.1	10.6	11.7	6.6	11.0	14.4	21.1	8.5	6.4	16.6	12.8	13.0	15.2	11.5	12.3	13.6	12.0	15.0	15.0	8.4	9.9	8.4	6.2	14.2	3.5	8.9	18.2	17.2	14.8	12.9	13.5	9.4	13.3	9.6	20.0	15.9	8.3	13.6	8.8	11.9	8.8	16.1	16.3	5.9	6.7	10.7	16.8	10.0	10.4	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9	17.9	17.4	10.4	16.2	17.7	16.5	60.2	22.9	18.7	21.6	31.4	2.0	21.2	24.9	14.4	5.7	10.0	27.4	0.0	12.8	11.2	13.8	13.3	10.4	117.7	10.8	19.1	50.0	14.1	10.0	2.1	22.2	9.4	8.5	2.8	23.1	28.2	10.5	23.0	26.2	34.2	15.2	32.3	12.2	18.6	14.3	17.6	27.9	7.9	21.2	11.5
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.5	1.5	2.2	1.6	5.0	2.5	8.4	3.9	2.2	1.9	1.3	4.9	2.8	2.0	2.0	1.5	1.9	12.6	4.2	7.8	2.0	1.1	5.1	4.2	4.5	4.9	16.8	5.0	4.2	2.8	13.3	4.4	20.4	2.4	2.4	2.1	7.3	8.1	1.2	2.8	2.4	10.1	0.6	5.2	2.5	1.1	2.3	5.0	2.5	4.2	7.3	3.1	5.2	7.0	2.7	2.7	1.0	3.0	9.6	2.8	0.8	3.0	3.7	5.5	9.3	0.8	2.9	8.9	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7	35.7	30.8	18.2	23.9	22.9	27.8	4.8	7.6	10.7	11.4	1.8	51.1	7.9	6.6	10.8	12.4	9.0	212.1	0.0	14.8	5.1	13.6	61.3	26.5	6.7	26.9	9.5	93.4	6.2	48.3	15.3	4.4	71.5	15.1	20.8	115.5	40.4	44.4	91.2	2.5	5.1	17.8	0.0	28.7	8.1	2.0	49.3	88.6	20.8	26.6	110.0
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9"									"HPA000508, HPA076518"	Uncertain		Uncertain	Mitochondria	"Secreted - unknown location"	NA	NA		1700000	Mitochondria		"HPA000508: AB_2147995, HPA076518: "	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.8	0.0	7.6	49.0	0.0	0.0	0.0	0.2	0.0	0.6	23.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3	0.0	0.0	0.0	3.9	34.2	0.0	1.6	0.0	1.4	5.7	29.6	0.0	0.0	0.0	1.7	0.0	2.2	0.0	0.0	53.2	0.2	19.5	0.1	0.0	0.0	0.3	0.0	0.0	17.2	0.8	0.0	0.0	0.0	16.9	1.0	0.0	0.0	47.4	0.0	1.4	0.0	0.1	0.0	9.2	0.0	0.0	19.1	0.2	0.0	0.0	1.4
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in single"	33	"Alveolar cells type 2: 2.2"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862964-38874105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	8.6	10.5	4.8	13.6	7.4	9.0	14.5	4.6	4.9	11.6	14.9	3.6	21.3	10.5	9.6	18.2	23.4	17.7	15.6	16.8	5.2	4.9	26.5	21.1	16.1	20.7	4.6	3.1	9.3	20.0	13.9	12.5	24.8	11.2	13.6	15.6	6.6	22.9	17.3	11.8	12.0	24.4	14.6	4.9	16.8	13.1	28.9	5.2	16.8	24.3	18.1	19.6	13.0	11.9	9.0	21.7	32.1	15.1	11.0	12.9	8.1	18.5	8.1	7.2	5.2	4.2	7.4	28.7	14.9	4.9	15.1	11.9	9.5	22.3	15.3	16.6	6.8	2.4	13.9	11.2	19.4	18.3	19.2	18.6	16.3	11.6	10.0	1.1	40.4	14.8	6.6	15.5	12.5	7.9	5.8	11.0	17.6	23.6	14.2	15.8	10.9	12.9	19.4	18.2	28.1	20.4	12.4	21.2	21.4	19.7	15.7	13.6	9.3	14.3	19.0	9.6	17.2	13.0	19.5	8.7	7.9	13.3	12.1	17.0	9.5	17.0	16.9	7.9	23.8	10.3	14.8	12.6	32.1	7.8	15.1	8.9	9.0	9.7	9.3	16.0	6.4	8.4	9.3	25.1	11.0	13.5	21.7	12.9	8.1	4.8	7.4	4.6	4.9	5.2	4.9	4.6	3.1	11.2	5.2	8.9	13.3	18.6	14.6	9.4	0.6	7.3	22.9	163.3	36.4	26.2	0.0	96.0	54.7	19.6	63.4	10.8	26.5	23.3	23.9	75.4	7.3	14.2	26.4	13.4	19.0	9.5	9.2	6.2	15.1	16.8	6.6	15.9	18.6	23.4	25.1	3.8	23.0	38.6	8.5	34.2	4.5	6.5	12.2	22.9	68.8	15.6	73.7	21.5	26.9	20.0
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.2	1.8	10.8	8.6	11.2	3.8	8.1	13.2	22.8	24.3	7.6	10.0	17.6	4.8	14.5	5.2	10.3	14.4	8.1	7.6	13.6	3.0	9.5	6.2	11.5	7.1	12.1	24.8	12.9	8.6	12.9	4.8	4.3	13.0	13.5	4.1	7.2	12.0	8.3	19.8	3.9	7.7	17.2	12.1	8.5	2.3	7.5	11.7	19.3	0.8	4.0	11.5	55.1	7.1	1.5	8.6	13.7	12.0	4.5	2.7	20.7	7.7	10.7	11.8	13.1	8.7	21.1	9.7	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1	6.0	14.6	17.4	10.4	12.8	0.9	1.5	7.6	10.7	11.4	5.2	0.0	12.2	6.6	22.7	0.7	10.5	25.9	0.0	24.0	20.1	9.1	11.9	24.2	27.6	30.3	0.0	9.2	9.8	75.0	0.6	12.7	48.3	3.3	18.0	16.3	3.5	43.6	34.5	9.9	9.2	0.0	12.9	7.0	2.1	0.4	15.1	10.1	20.3	13.1	37.7
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 96.0;Cytotrophoblasts: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 56.0"	"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.3	8.8	56.0	18.7	7.3	8.8	25.2	11.2	10.1	13.6	14.6	23.7	2.0	0.1	7.4	11.0	7.4	1.3	27.8	13.4	15.2	0.3	22.6	15.5	5.7	20.6	17.2	1.3	1.0	12.5	4.9	17.5	6.8	8.4	21.8	18.1	21.5	0.0	8.4	5.3	16.4	0.4	26.3	0.9	1.9	26.3	16.6	0.0	15.4	5.6	4.6	25.2	17.5	0.8	17.9	44.9	4.7	0.9	0.7	12.8	9.4	0.0	9.6	2.1	2.6	3.4	0.0	1.2	28.6	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9	20.8	13.1	0.5	8.0	4.1	35.4	26.9	7.6	26.8	14.8	96.0	47.1	123.2	14.9	10.8	44.7	37.5	0.0	23.3	1.6	73.0	63.0	8.6	1.1	13.1	13.8	33.4	2.4	60.2	3.8	18.2	3.4	1.4	1.7	1.0	1.4	23.8	2.7	0.0	37.4	12.9	34.3	0.0	10.8	8.2	29.6	3.4	64.0	2.2	1.7	3.1
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell type enriched"	"Detected in some"	65	"Cardiomyocytes: 3031.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.7	0.1	3031.1	0.0	0.0	0.0	1.8	0.0	0.4	46.4	0.0	2.0	0.3	0.0	0.0	0.0	5.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.7	46.2	0.4	6.5	1.3	0.0	0.4	0.4	0.7	0.0	0.0	0.0
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell type enhanced"	"Detected in some"	24	"Distal tubular cells: 3.3;Exocrine glandular cells: 2.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in some"	31	"RH-30: 56.5"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	56.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495633-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 50.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	5.2	1.9	3.1	5.4	6.2	7.8	4.7	2.7	6.5	4.7	7.7	7.0	6.8	7.5	4.3	4.1	9.8	3.4	4.1	1.4	4.7		5.7	7.0	3.8	5.2	6.1	3.1	2.9	5.8	9.8	7.2	8.1	5.0	2.8	11.2	4.8	9.5	9.3	6.3	13.1	7.9	5.2	5.4	3.0	8.3	8.0	5.7	5.8	4.2	5.6	7.2	3.3	2.8	2.2	3.4	1.7	1.7	3.7	3.9	1.4	14.0	17.2	8.2	9.4	4.5	4.5	10.0	14.0	11.2	22.3	22.8	17.0	14.7	8.8	5.5	9.5	7.6	21.2	19.4	14.6	15.9	6.3	13.2	14.1	18.8	10.7	3.0	13.6	15.3	4.3	7.3	15.9	17.4	5.3	9.9	10.7	16.5	9.3	11.3	10.6	9.5	11.1	9.1	15.2	10.2	11.1	13.2	10.5	10.4	11.4	14.1	8.8	18.6	11.4	5.9	12.4	18.7	5.6	6.4	12.5	14.2	17.0	24.6	7.2	14.1	8.1	7.8	8.4	14.6	1.7	1.7	1.7	3.8	1.2	2.8	2.2	2.4	2.6	3.4	1.7	1.7	3.9	0.1	3.7	0.5	1.9	2.0	1.4											8.9	8.1	14.1	10.0	26.3	17.4	3.6	15.3	2.7	5.7	5.2	33.4	7.0	1.7	8.7	50.4	9.5	18.8	0.0	11.4	18.5	7.3	9.0	2.3	7.8	9.6	3.2	10.4	6.2	3.9	17.2	11.5	7.5	3.3	10.0	20.3	5.6	12.4	10.5	9.2	3.6	25.6	0.0	8.2	19.0	17.7	20.6	6.1	12.7	27.7	11.1
MYOM2		ENSG00000036448	"Myomesin 2"	P54296	8	2045040-2165552	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"heart muscle: 170.7;skeletal muscle: 75.9"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 554.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3"	"Not detected"	"Not detected"							"HPA001765, HPA005953"	Enhanced		Approved	Mitochondria		NA	NA		120000	Mitochondria		"HPA001765: AB_1079443, HPA005953: AB_1854258"	"unprognostic (2.81e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.30e-5)"	"unprognostic (1.10e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.14e-1)"	2.0	0.0	0.3	0.1	0.4	0.0	1.7	0.9	0.9	0.2	0.2	0.0	0.2	0.0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	1.2	1.0	75.9	0.2	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.6	8.9	1.2	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	10.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.2	0.0	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0.0	0.1	0.0	6.0	4.0	0.0	2.3	3.2	2.8	554.8	17.8	6.7	0.0	3.5	0.0	0.0	11.6	3.4	5.4	2.3	1.0	0.0	1.5	0.0	1.4	1.0	5.7	6.4	1.4	6.4	0.0	5.5	2.8	6.2	0.6	2.3	3.3	3.6	2.5	7.0	2.5	0.0	1.4	21.4	4.1	0.0	17.0	36.9	22.7	2.5	0.1	8.7	1.1	1.4
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366670-34376853	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	6.3	5.6	16.7	4.7	20.5	2.1	3.5	6.9	16.0	2.0	19.9	9.8	1.3	20.9	2.2	2.8	4.8	3.6	11.6	2.9	11.1	8.7	11.7	31.8	3.1	1.7	11.2	12.6	1.6	16.6	2.0	4.0	15.4	10.7	3.2	13.1	0.5	4.7	4.9	56.1	3.6	26.7	4.8	7.0	1.7	9.9	1.7	6.9	0.0	2.2	6.4	2.1	3.5	1.9	1.1	0.8	1.9	0.8	1.9	3.3	0.6	4.1	2.9	4.9	2.9	2.0	0.7	10.4	0.8	0.6	0.4	0.7	7.1	4.3	2.3	8.4	0.7	2.1	8.4	3.4	7.8	0.6	0.7	1.9	0.4	13.0	17.6	0.3	0.4	1.4	1.0	3.8	1.3	1.6	2.3	1.9	1.7	0.5	2.4	1.1	6.8	1.3	0.7	2.9	13.7	2.3	2.1	2.5	0.7	2.6	1.5	0.7	6.8	5.8	29.4	0.5	4.3	27.3	0.7	1.7	1.1	6.0	0.9	1.8	1.5	3.2	0.9	0.9	1.6	0.9	1.9	0.6	1.2	3.3	0.6	2.6	0.8	2.0	1.9	0.3	1.1	1.3	1.6	1.6	1.9	0.8	0.8	2.6	0.6	16.7	20.5	6.9	16.0	11.1	8.7	11.2	12.6	10.7	6.9	8.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	3.5	0.0	41.5	1.7	5.6	0.0	0.0	0.0	0.0	10.3	1.9	0.0	0.0	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	9.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095285	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 71.6;Late spermatids: 228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	15.3	9.0	27.4	10.9	26.3	2.7	12.8	16.3	37.3	10.0	15.5	14.5	11.7	8.3	11.4	6.9	11.6	10.1	16.6	16.8	20.7	16.7	8.0	15.2	8.3	7.6	30.3	6.4	10.3	10.0	6.2	3.8	3.9	15.2	12.7	5.5	10.2	9.9	23.8	12.6	5.8	9.5	31.7	33.4	7.8	8.2	7.8	11.0	0.0	5.8	4.7	3.1	21.8	4.6	0.0	2.4	5.7	4.5	0.5	1.7	1.4	3.1	17.3	1.9	26.3	8.5	4.8	2.4	7.7	5.2	2.5	0.8	7.3	5.7	0.0	9.3	12.2	4.0	12.4	4.2	4.2	0.8	9.6	3.8	2.1	16.6	9.1	8.7	0.0	4.0	8.0	3.9	2.3	2.3	10.3	6.9	0.0	6.5	0.0	4.8	10.6	0.0	6.0	5.9	5.0	10.8	0.0	2.0	5.2	10.3	3.6	0.7	0.8	10.9	9.2	9.5	9.2	9.3	19.8	11.4	6.7	7.6	5.6	5.3	0.0	0.0	0.1	8.9	0.7	13.4	2.8	4.5	1.5	1.7	3.6	0.7	0.0	0.6	1.5	2.4	0.0	0.5	0.6	5.7	0.5	3.4	0.3	0.4	1.4	27.4	26.3	16.3	17.7	20.7	16.7	30.3	6.4	15.2	11.0	11.9	5.3	1.5	4.0	4.0	2.1	25.0	10.2	1.4	4.5	5.2	0.0	0.6	0.0	10.1	71.6	13.0	6.8	0.0	11.7	1.6	6.4	8.7	2.3	31.1	6.9	3.2	2.4	17.8	38.6	228.0	16.7	10.8	5.0	5.4	4.1	16.7	15.4	8.6	18.0	12.6	1.8	25.8	18.9	1.8	4.5	4.4	0.3	2.9	4.5	7.0
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192592-36242279	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 128.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		28000	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	5.7	10.2	13.7	4.1	12.5	4.4	6.8	6.7	13.4	6.6	6.0	13.3	5.9	7.0	5.9	4.1	4.9	6.0	5.5	8.3	14.3	8.5	10.0	128.6	4.0	4.2	11.6	12.0	8.8	12.2	4.8	3.1	7.2	11.6	9.5	6.2	3.9	5.6	7.7	11.1	3.3	5.5	24.8	20.3	3.8	7.6	7.3	11.4	2.5	7.6	3.5	5.1	15.2	5.9	5.1	3.3	9.1	4.2	9.5	3.2	1.7	9.1	6.0	9.2	10.5	14.1	12.0	12.6	8.6	5.7	7.9	5.9	16.8	11.5	32.9	6.4	9.8	9.8	6.4	8.6	6.3	11.1	9.1	7.6	8.8	17.8	9.8	10.4	19.1	3.5	13.2	9.7	8.7	13.2	9.8	8.3	12.8	23.2	11.8	7.9	3.6	17.8	7.3	5.1	7.4	8.7	17.3	22.8	7.0	10.1	7.8	4.1	9.3	44.4	14.1	4.6	7.6	10.0	16.8	6.2	15.4	8.4	11.6	10.2	10.8	13.0	9.7	6.5	24.9	6.0	9.1	2.0	1.9	2.1	2.0	2.7	2.2	3.2	2.5	3.3	5.1	2.7	2.2	0.1	9.5	4.2	1.5	2.9	1.7	13.7	12.5	6.7	11.4	14.3	8.5	11.6	12.0	11.6	11.4	3.0	5.8	6.7	5.9	6.1	5.5	25.5	22.9	8.1	7.9	5.2	7.9	6.8	21.6	3.9	231.1	6.8	5.2	0.0	8.0	6.9	11.2	12.7	1.1	160.3	7.5	3.2	6.9	13.5	8.9	119.7	18.4	4.9	13.5	2.8	11.7	15.3	8.4	7.0	21.5	19.6	5.0	0.0	13.0	16.7	10.5	5.0	6.1	5.7	12.3	8.1
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.4	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.4	0.0	0.1	1.5	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.7	6.6	0.0	0.0	2.8	0.1	0.2	0.0	0.6	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	2.7	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.1	0.2	0.1	8.1	3.0	0.8	0.2	0.7	0.2	0.2	0.2	12.1	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1	3.0	3.4	0.5	0.8	1.3	0.4	2.4	5.1	1.4	4.5	12.2	0.0	0.9	6.6	1.6	4.4	0.9	10.4	0.0	3.6	1.6	0.6	0.4	0.0	18.8	1.0	0.0	6.9	1.3	2.6	2.2	1.4	4.2	0.0	9.0	2.6	0.9	3.7	3.2	0.7	14.6	0.5	0.0	1.0	5.5	1.5	0.6	0.3	1.5	3.3	0.6
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.3	10.3	10.8	7.1	7.6	6.4	9.0	6.1	6.0	9.5	7.9	17.7	7.9	18.2	15.9	3.9	9.2	9.7	18.2	11.9	13.3	11.9	9.8	12.8	8.0	15.0	6.3	13.7	4.8	4.5	7.7	8.4	15.0	8.6	8.1	15.4	19.3	5.0	10.6	8.6	14.2	22.2	11.8	30.0	12.5	14.9	17.7	24.6	12.7	10.4	12.9	8.1	9.1	11.7	15.7	12.2	11.0	5.5	4.9	13.0	15.3	14.8	10.3	8.4	14.1	40.1	2.5	12.4	8.8	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3	17.9	17.1	9.0	12.7	11.9	5.3	8.3	2.5	10.7	7.9	5.2	2.0	17.3	24.9	8.2	11.0	6.3	5.0	0.0	6.5	20.2	10.4	14.0	8.1	16.3	10.6	0.0	11.5	2.5	6.5	3.9	7.2	6.1	16.9	1.0	7.7	5.7	6.1	13.3	4.6	22.1	8.7	6.5	8.3	7.4	18.1	12.0	12.8	5.1	13.7	7.5
NAT14	KLP1	ENSG00000090971	"N-acetyltransferase 14 (putative)"	Q8WUY8	19	55485004-55487568	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 60.2;Horizontal cells: 139.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047187			Approved	Mitochondria		NA	NA			Mitochondria		"HPA047187: AB_2679974"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (7.00e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.58e-1)"	3.6	10.1	15.8	5.7	19.6	4.5	5.5	25.8	25.8	8.2	7.0	8.9	3.1	3.5	12.6	10.1	2.9	24.1	6.5	5.9	15.4	16.7	9.2	2.5	7.8	4.6	10.8	15.5	14.1	5.6	11.2	19.2	8.5	10.6	6.8	3.1	7.8	5.0	10.5	2.9	4.1	3.4	11.1	6.5	3.7	5.6	4.9	9.5	42.2	9.8	1.3	3.8	6.0	4.3	1.8	1.8	2.3	0.3	0.3	1.0	0.6	2.4	8.9	9.8	18.1	4.1	5.1	6.2	9.2	10.7	10.1	14.4	3.1	7.9	1.0	3.2	5.9	5.0	3.3	6.4	5.6	6.2	9.9	55.3	8.0	11.9	6.7	7.4	5.9	8.1	7.3	2.1	7.4	1.9	19.9	7.3	14.5	9.9	2.8	5.8	3.0	9.9	9.0	14.0	4.7	4.9	9.8	6.3	3.6	23.0	4.6	30.3	20.6	3.7	5.4	8.1	3.8	4.4	5.7	8.8	3.7	10.2	0.5	7.3	5.7	2.3	4.2	8.2	1.0	9.2	0.0	0.3	0.2	0.5	0.3	1.0	0.6	0.4	0.3	0.0	1.8	0.7	0.7	2.3	0.3	0.3	1.8	0.0	0.6	15.8	19.6	25.8	25.8	15.4	16.7	10.8	15.5	10.6	9.5	6.0	2.7	7.3	6.1	2.6	60.2	4.5	2.5	14.7	2.3	27.9	33.4	10.6	13.3	14.0	1.4	4.3	0.7	0.0	1.0	6.9	8.2	4.4	0.0	2.9	2.6	139.8	12.2	4.9	0.8	1.7	10.9	0.7	5.0	3.6	1.8	34.9	4.7	0.0	9.9	3.5	34.0	0.0	9.2	4.1	2.9	0.5	5.0	1.3	0.9	1.4
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 76.3;Muller glia cells: 25.6"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.6	3.6	7.3	0.7	0.0	4.2	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	1.1	0.1	8.2	0.0	0.1	0.0	9.6	0.1	1.4	4.7	1.2	10.1	5.0	0.0	0.1	0.0	0.0	1.4	0.0	2.5	7.8	0.0	0.3	4.4	0.1	14.7	10.3	0.0	3.0	0.5	1.7	0.2	0.1	0.3	19.0	6.3	4.8	0.0	15.1	0.6	0.5	5.9	0.0	0.0	2.5	0.1	3.9	0.0	0.0	0.1	0.0	4.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2	0.0	0.0	0.0	0.0	0.2	7.1	2.0	0.0	0.0	0.0	1.8	5.9	0.0	0.0	4.2	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.7	76.3	1.7	0.0	0.0	3.1	0.0	0.1	10.1	0.0	0.0	25.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	33.6	36.4	26.0	27.7	31.4	19.9	32.6	26.6	24.3	18.7	23.4	20.3	28.2	27.5	41.1	27.8	40.0	32.5	36.5	25.6	21.5	37.9	50.4	28.5	66.4	45.5	24.4	43.5	31.7	32.4	34.8	19.9	15.5	30.6	23.2	28.1	15.5	42.7	25.7	59.6	30.9	41.2	38.4	87.9	65.0	31.3	24.8	82.5	56.4	48.0	19.0	25.1	54.7	67.9	36.5	36.6	17.2	51.3	29.9	16.0	16.2	33.2	51.9	39.4	48.8	35.9	29.0	51.7	19.7	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1	148.9	173.3	221.0	195.7	189.9	139.0	3052.5	636.9	330.6	205.9	533.9	74.6	331.6	1856.9	408.0	28.1	249.5	1244.9	256.9	444.8	351.6	251.4	215.4	204.5	881.4	567.3	77.9	441.2	254.8	408.9	27.3	272.7	346.6	541.6	587.1	745.3	168.3	446.0	706.9	268.0	1089.7	161.0	213.4	269.6	46.1	78.8	217.9	318.3	243.7	663.1	282.7
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025402	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		12000	Mitochondria		"CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756"	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	19.0	37.5	19.7	18.2	30.4	20.3	19.5	26.2	31.5	14.5	31.0	24.5	18.6	30.4	14.8	18.4	28.5	18.8	17.1	66.0	28.6	18.7	36.3	40.6	13.1	13.8	21.4	27.7	19.8	23.5	25.1	15.5	15.9	33.4	13.7	34.7	16.2	20.6	26.7	67.0	26.1	24.3	18.6	27.0	13.8	24.9	15.4	19.8	13.2	16.9	34.1	20.2	19.3	17.7	24.6	35.7	11.0	27.7	21.2	24.6	24.5	16.9	16.6	12.4	20.8	15.0	25.0	20.3	14.4	18.6	20.8	20.9	16.6	21.2	12.6	6.7	16.0	15.5	22.8	27.9	25.8	26.7	16.7	18.5	16.5	15.7	35.5	22.6	22.5	13.4	24.2	21.1	16.6	22.7	18.1	26.3	20.4	25.0	8.9	22.2	25.9	21.3	23.2	14.6	26.3	18.1	21.8	27.6	22.0	29.5	33.3	19.6	12.9	14.2	32.2	22.5	9.4	29.9	22.9	16.4	14.8	15.1	18.8	16.0	15.3	6.8	20.1	16.1	20.6	17.7	6.3	26.1	11.0	18.9	27.7	24.6	24.6	19.1	20.5	35.7	18.3	19.0	19.0	5.8	21.2	23.4	12.7	22.0	24.5	19.7	30.4	26.2	31.5	28.6	18.7	21.4	27.7	33.4	19.8	71.5	71.5	70.9	81.5	93.2	72.1	304.5	79.0	77.6	80.8	73.3	58.9	175.7	263.6	95.5	40.3	66.1	150.4	0.0	68.2	97.5	68.1	53.9	64.6	119.2	111.3	47.7	89.3	62.6	83.6	48.6	46.3	74.1	106.3	115.4	134.7	70.1	74.8	106.6	46.3	181.4	103.3	64.7	75.1	53.2	69.0	104.0	182.4	62.3	201.1	84.3
NDUFA11	B14.7	ENSG00000174886	"NADH:ubiquinone oxidoreductase subunit A11"	Q86Y39	19	5891276-5904006	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA072209			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA072209: AB_2686495"	"unprognostic (2.24e-1)"	"prognostic favorable (4.54e-5)"	"unprognostic (8.20e-3)"	"prognostic favorable (3.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.16e-3)"	32.3	70.8	50.2	40.9	41.3	43.4	49.3	29.9	75.2	35.3	45.1	25.8	41.2	41.6	35.9	36.9	53.1	38.4	41.4	149.3	41.9	45.8	44.1	59.8	37.9	51.9	48.3	45.8	38.4	70.9	13.5	33.8	32.5	35.9	35.1	19.6	35.9	76.3	41.1	106.0	32.4	39.5	45.2	40.2	31.5	38.8	21.2	27.0	37.3	37.8	72.1	30.5	38.3	37.2	63.3	90.2	54.3	87.4	44.8	73.7	121.4	49.2	38.1	28.4	46.2	23.3	37.9	31.8	34.1	39.4	62.5	57.8	45.5	26.3	48.7	53.8	32.5	26.8	32.6	19.6	39.7	15.1	42.0	73.5	20.0	36.6	72.7	61.0	29.7	29.8	51.8	36.1	35.4	16.8	24.1	40.7	44.8	42.2	54.3	31.4	37.5	77.1	53.0	43.0	39.3	95.9	53.5	35.5	69.7	38.6	33.0	41.1	43.7	26.5	43.6	60.0	12.7	33.5	63.4	36.4	34.9	33.5	69.3	55.6	82.6	71.6	63.0	58.8	71.4	44.7	54.3	87.4	47.7	53.5	68.0	54.8	63.3	59.6	54.0	74.9	54.6	56.7	49.5	39.2	44.8	57.7	90.2	73.7	121.4	50.2	41.3	29.9	75.2	41.9	45.8	48.3	45.8	35.9	27.0	134.0	182.8	195.8	195.3	182.6	52.9	357.1	252.3	159.3	142.1	277.4	23.6	487.2	712.9	246.9	126.8	162.6	455.6	140.2	261.1	500.5	250.4	204.0	208.9	654.2	369.3	47.7	337.5	259.7	354.1	271.6	180.4	216.7	271.7	380.5	351.7	119.5	275.3	350.7	157.3	766.8	60.4	116.4	219.2	83.0	80.8	212.9	496.2	182.7	391.9	191.2
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003770	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Group enriched"	"Detected in all"	5	"Cardiomyocytes: 2083.1;Distal tubular cells: 525.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	24.0	24.8	36.0	17.9	36.8	19.7	19.7	27.2	36.5	17.9	35.5	12.5	20.0	27.4	17.0	21.9	23.3	19.4	14.4	82.8	31.2	32.0	33.2	34.6	18.1	20.1	37.0	29.9	17.0	18.4	22.3	22.4	21.1	31.3	19.1	35.7	13.1	18.7	20.7	129.0	17.4	26.7	24.0	24.2	23.9	20.9	14.2	23.5	21.0	27.9	40.0	28.1	21.9	21.4	60.8	78.4	69.7	67.9	59.1	93.8	100.6	41.6	45.3	37.9	26.9	31.1	29.0	28.2	19.9	29.3	43.5	39.5	55.9	21.5	47.9	11.8	30.4	24.1	31.5	38.9	45.9	49.4	41.3	46.7	40.1	37.8	56.3	32.0	56.8	49.0	31.1	58.0	36.4	44.7	45.5	35.6	41.7	37.4	22.3	42.1	60.4	39.3	87.8	28.7	51.2	78.9	30.1	32.8	54.6	42.6	62.6	36.1	21.9	33.7	49.2	25.8	34.2	48.6	37.4	40.6	23.1	23.5	33.5	33.8	36.4	54.0	73.1	13.9	47.6	35.2	69.7	59.5	29.8	52.1	67.9	48.2	60.8	71.6	62.5	78.4	50.7	93.8	68.6	8.6	59.1	63.3	48.0	74.8	100.6	36.0	36.8	27.2	36.5	31.2	32.0	37.0	29.9	31.3	23.5	68.5	58.6	79.6	121.2	96.5	65.8	2083.1	160.5	77.6	45.5	102.9	60.9	215.5	525.6	141.2	192.8	157.8	177.2	46.7	143.2	214.5	94.4	120.9	56.6	123.1	168.7	35.0	81.9	98.8	95.5	70.6	90.3	125.9	151.8	218.2	146.8	79.4	169.8	188.7	125.5	242.6	113.4	103.5	149.9	130.8	119.2	111.7	175.3	96.5	189.4	182.6
NDUFA13	"B16.6, CDA016, CGI-39, GRIM-19, GRIM19"	ENSG00000186010	"NADH:ubiquinone oxidoreductase subunit A13"	Q9P0J0	19	19515736-19529054	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.3;testis: 140.2"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 2344.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041213	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041213: AB_10794988"	"unprognostic (2.87e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-2)"	17.9	16.9	20.0	11.7	23.9	15.4	14.4	20.7	25.2	11.0	19.2	8.7	16.5	16.5	9.7	19.6	12.2	11.7	12.9	68.0	16.4	13.9	18.9	20.8	8.4	11.9	19.9	22.3	10.6	17.8	10.6	12.1	12.1	20.0	12.9	11.9	9.8	15.2	15.5	79.7	9.5	14.9	12.1	13.4	10.1	15.0	140.2	16.2	7.6	11.3	28.1	8.4	9.6	10.2	73.7	74.9	61.4	76.8	44.8	72.7	116.3	33.1	24.5	45.3	45.0	46.2	37.5	42.5	39.5	43.8	44.6	43.5	39.7	49.8	44.1	93.0	47.6	27.8	27.0	32.0	42.9	18.4	26.9	72.4	33.7	39.1	48.6	41.3	63.3	47.6	50.3	39.0	31.2	36.0	31.5	32.0	51.6	37.2	63.2	35.4	65.9	75.1	62.9	46.1	85.3	68.2	43.1	29.4	67.4	65.0	47.6	43.0	54.4	40.2	47.4	39.3	26.4	29.3	87.2	33.3	43.7	14.8	50.9	49.0	45.0	35.4	47.5	38.5	49.2	31.9	61.4	76.8	57.8	51.2	72.9	45.5	73.7	58.9	56.0	74.9	60.5	56.9	51.1	26.9	44.8	60.8	61.2	72.7	116.3	20.0	23.9	20.7	25.2	16.4	13.9	19.9	22.3	20.0	16.2	122.1	153.3	217.5	53.6	114.6	57.3	436.5	216.6	210.1	204.8	237.3	23.6	341.6	517.3	485.5	369.3	147.4	952.4	140.2	502.5	299.6	215.0	71.6	253.9	389.3	292.2	39.7	534.5	181.7	314.3	2344.2	142.1	234.7	249.7	531.2	516.2	105.2	438.1	641.8	121.3	667.2	59.7	90.5	183.3	59.7	92.9	111.0	416.8	195.8	508.5	65.7
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055323, HPA078265"	Approved		Approved	Mitochondria		NA	NA		18000	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	11.4	19.7	33.6	38.7	19.1	18.0	15.5	14.5	13.8	13.7	12.1	24.7	31.5	22.4	13.9	20.9	37.5	20.3	22.3	17.3	15.0	11.0	16.3	18.7	23.2	23.0	16.7	25.8	18.5	19.3	17.4	16.7	14.8	26.1	19.0	20.2	27.8	30.5	28.5	22.1	11.5	22.7	36.8	78.1	40.0	15.6	24.0	25.1	34.7	24.9	21.1	21.9	23.1	66.5	13.1	49.0	42.0	31.7	16.6	16.3	22.6	23.4	24.0	18.5	23.6	25.7	22.6	27.9	50.7	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2	455.6	386.9	389.1	472.6	361.6	472.0	3966.4	996.2	704.0	533.5	903.7	251.3	756.7	3355.6	748.9	115.7	549.6	532.5	186.9	833.3	599.3	543.2	716.7	552.0	1498.2	844.7	149.4	201.3	748.3	552.8	81.7	457.0	587.9	868.9	625.8	610.1	384.0	636.5	584.4	737.2	2069.7	472.4	329.8	932.8	105.9	274.8	422.2	550.9	350.3	618.2	678.3
NDUFA4L2	"FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4, mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.5;skin 1: 93.4"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 315.5;Sertoli cells: 1112.4;Smooth muscle cells: 398.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	24	"B-cells: 2.4;T-cells: 2.8"	"Cell line enriched"	"Detected in many"	7	"AN3-CA: 55.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA055323, HPA078265"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	24.5	9.6	8.3	4.9	15.5	1.3	11.5	7.7	10.4	19.1	4.4	8.3	1.1	4.6	4.6	5.4	82.5	3.6	11.0	30.9	9.8	7.3	5.4	4.2	12.7	4.6	10.9	10.7	6.1	6.7	4.6	6.2	42.7	13.2	6.8	2.4	13.7	10.3	7.4	19.0	93.4	4.7	5.6	5.6	29.9	4.3	3.0	8.9	0.7	12.0	14.8	11.9	10.2	31.4	2.4	0.1	0.0	0.0	0.0	2.8	0.3	0.3	0.5	0.1	55.4	2.3	1.3	0.1	0.8	0.6	0.2	0.5	0.0	0.6	2.2	2.3	0.8	0.0	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.1	0.0	7.9	1.6	0.8	5.1	1.0	0.1	2.0	0.3	0.0	3.1	0.2	2.9	0.1	1.1	0.4	0.0	0.1	0.2	1.0	0.8	0.4	4.2	0.0	0.0	3.0	1.0	0.1	0.1	1.8	0.0	0.6	5.8	0.2	0.5	0.0	0.4	0.2	4.2	1.3	1.0	2.0	3.9	0.3	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.7	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.3	8.3	15.5	7.7	10.4	9.8	7.3	10.9	10.7	13.2	8.9	0.0	0.3	0.9	0.7	134.3	28.0	0.8	0.0	0.0	0.0	0.0	17.7	0.8	0.0	1.0	1.0	3.6	0.0	0.0	0.0	0.8	18.6	1.5	9.2	0.0	1.5	11.1	0.0	4.9	0.0	1.3	2.8	1.4	28.7	1.8	0.0	315.5	7.7	0.0	2.1	0.0	17.5	1112.4	398.4	8.1	0.9	141.0	0.9	0.0	0.0	0.9
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321396	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.6"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA059251: AB_2683960, HPA071866: AB_2686465"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	17.7	30.0	28.0	15.5	30.5	15.3	18.9	15.4	32.0	9.0	17.2	11.3	15.7	12.6	9.9	32.1	18.9	26.2	16.1	69.1	22.1	21.0	26.5	30.9	20.3	22.1	25.9	19.7	10.1	28.5	11.9	30.2	13.0	26.7	20.5	17.6	16.7	23.0	20.7	110.6	16.2	16.0	13.1	18.5	14.7	19.3	13.8	11.1	19.3	22.0	47.5	16.8	14.3	9.1	30.6	65.5	25.1	39.7	24.9	33.5	26.7	15.4	13.2	16.8	8.7	11.5	6.1	9.5	4.4	5.7	16.6	11.1	13.9	13.1	8.7	6.8	10.6	9.5	13.4	7.6	23.2	7.8	22.8	48.1	6.4	20.3	33.0	17.9	9.7	8.9	12.4	15.1	8.9	8.2	13.4	19.3	42.1	11.0	45.4	20.6	16.8	18.5	48.1	13.6	30.4	50.4	10.3	3.1	18.9	33.7	9.2	14.1	10.8	6.4	19.8	11.0	9.9	7.5	16.0	5.7	9.3	7.5	13.0	12.5	17.8	13.7	10.4	13.3	16.8	14.6	14.2	38.9	25.1	22.6	39.7	24.4	29.9	24.7	22.2	47.9	30.6	24.1	23.4	9.7	24.9	34.4	65.5	33.5	26.7	28.0	30.5	15.4	32.0	22.1	21.0	25.9	19.7	26.7	11.1	41.7	57.7	13.4	8.7	0.0	12.0	0.0	28.1	129.8	37.5	50.6	5.9	55.6	84.6	128.2	25.6	8.7	82.6	23.3	137.5	37.8	2.0	14.6	19.8	58.9	45.6	7.9	84.3	27.6	40.8	12.2	12.4	28.3	0.0	190.2	132.6	19.5	142.9	146.3	12.4	67.1	13.2	6.5	0.0	18.4	23.7	0.0	39.2	27.7	136.7	10.8
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159819	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 105.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 528.1;Distal tubular cells: 520.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		14000	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	15.4	20.0	35.9	9.5	40.5	7.3	16.5	18.8	36.8	14.2	23.4	12.4	19.6	19.4	12.6	26.9	17.0	18.9	16.9	105.4	32.3	27.5	29.0	23.6	10.9	11.2	31.3	30.3	11.3	16.8	21.8	15.3	14.1	22.4	17.9	26.6	14.6	25.1	19.7	68.3	11.1	17.4	22.0	19.1	10.9	18.0	25.1	16.8	10.0	18.5	30.9	15.8	15.6	15.3	29.7	39.7	22.2	34.3	25.5	30.8	24.3	17.9	33.3	22.1	29.1	23.9	22.0	27.4	21.0	24.9	28.8	24.3	42.2	17.9	26.3	20.8	24.5	52.6	45.3	41.8	45.3	28.4	25.8	28.9	20.7	55.9	36.4	25.8	36.5	21.4	24.0	44.3	28.8	18.5	26.5	41.2	29.5	31.5	19.8	32.8	45.7	22.6	23.8	20.2	81.0	64.2	18.2	34.9	38.3	41.4	25.0	38.3	15.1	32.9	39.1	26.0	23.6	41.4	17.6	26.7	16.0	16.1	30.0	23.4	22.4	36.1	26.0	33.3	23.7	26.4	5.1	29.4	22.2	29.1	34.3	27.8	29.7	27.0	28.4	38.1	29.3	29.0	30.5	4.8	25.5	28.8	39.7	30.8	24.3	35.9	40.5	18.8	36.8	32.3	27.5	31.3	30.3	22.4	16.8	26.8	30.2	50.6	59.9	42.8	43.3	528.1	56.0	69.6	48.9	78.5	27.5	106.7	520.6	91.1	282.6	89.5	102.7	46.7	88.4	95.7	43.5	75.0	19.7	93.1	108.4	42.9	74.3	58.3	41.0	68.2	52.3	46.0	89.4	88.4	92.7	52.1	87.8	87.7	70.7	161.2	38.8	25.8	56.7	227.6	125.0	49.7	105.8	45.0	118.7	71.0
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.9	19.8	9.8	13.0	7.2	7.2	28.3	8.4	8.5	16.3	12.4	42.9	22.1	12.4	4.5	9.1	18.4	18.5	14.1	12.4	10.6	24.0	24.8	12.1	21.1	32.4	15.8	17.6	13.1	9.2	12.1	11.1	15.1	10.1	12.2	17.8	8.4	23.5	12.0	21.3	17.6	20.3	25.2	20.7	16.5	24.9	14.4	12.9	22.4	25.1	7.1	8.0	10.6	28.5	14.7	22.2	5.9	16.9	8.5	12.4	25.2	11.3	19.4	4.6	5.4	20.5	13.0	11.0	13.6	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3	26.8	28.0	46.2	52.9	43.0	46.1	165.0	50.9	41.5	36.4	61.1	55.0	100.9	140.9	108.0	102.8	42.7	83.0	23.3	114.3	98.5	39.0	37.2	56.6	65.2	101.8	31.8	45.5	34.4	33.6	461.4	26.2	46.0	52.3	57.7	92.6	40.4	94.0	94.8	34.6	133.6	48.3	19.4	42.6	28.8	28.1	41.3	83.5	45.7	120.3	64.7
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 1253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	28.2	20.9	26.2	23.3	18.7	20.2	36.4	21.8	16.2	22.0	18.1	18.1	23.0	46.8	35.8	15.7	27.4	23.4	45.5	25.9	17.5	26.5	52.6	25.1	37.5	88.9	19.6	46.6	20.9	18.8	36.0	16.2	17.5	20.7	27.9	42.3	52.6	23.8	23.8	42.8	36.0	70.9	68.0	42.2	48.6	49.6	29.5	63.7	20.2	25.4	36.0	28.1	24.4	44.7	40.7	30.1	36.1	39.0	21.9	20.2	21.2	19.5	29.9	30.4	44.2	52.5	22.6	37.7	22.8	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5	92.3	83.8	96.1	105.6	108.4	80.0	1253.7	109.5	175.3	81.9	106.4	43.2	246.2	600.2	140.5	81.4	113.0	204.9	70.0	182.7	251.9	115.6	117.8	83.1	281.9	233.1	49.3	194.3	96.3	110.6	24.0	89.8	100.2	148.5	155.9	210.6	118.9	192.1	168.4	114.2	541.1	90.3	90.5	123.0	114.6	115.3	124.3	187.8	90.6	317.0	150.7
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387349-41402519	"Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	11.1	22.0	15.0	6.4	14.0	3.0	9.8	13.3	17.8	7.8	7.7	12.4	5.3	8.4	8.3	10.7	9.6	7.9	7.1	29.7	13.2	13.4	21.9	27.5	7.0	8.5	14.7	14.4	7.0	7.7	11.9	9.7	7.0	13.1	8.5	8.1	8.4	8.5	9.8	38.6	6.2	7.7	10.3	13.5	7.5	8.5	14.1	12.0	6.5	9.6	15.8	9.1	8.8	5.8	14.5	19.1	25.2	16.2	13.9	15.9	8.7	9.2	6.6	8.7	9.0	20.0	20.4	9.6	17.7	14.5	15.6	13.0	12.2	5.1	10.6	24.6	15.5	11.0	15.3	11.8	11.9	14.1	19.9	13.7	15.0	13.9	7.2	17.1	16.0	10.6	22.7	11.4	12.9	13.0	13.6	11.1	19.2	22.8	11.5	22.8	8.5	12.8	13.3	7.0	16.1	11.1	10.0	11.7	21.9	23.8	15.0	10.5	8.3	9.0	20.1	6.7	11.6	16.5	30.9	11.5	12.7	5.9	19.0	14.6	9.4	20.3	16.0	14.2	25.4	12.1	25.2	13.7	16.4	9.6	16.2	9.9	14.5	11.5	12.3	12.1	12.6	13.0	10.3	12.8	13.9	12.4	19.1	15.9	8.7	15.0	14.0	13.3	17.8	13.2	13.4	14.7	14.4	13.1	12.0	11.9	8.5	15.6	13.8	4.1	14.0	56.8	12.7	16.0	5.7	21.0	11.8	32.1	54.7	26.4	36.4	11.3	11.9	0.0	27.1	30.5	15.5	11.6	6.9	25.2	26.1	6.4	6.4	6.7	14.8	5.4	15.3	14.8	10.1	26.2	6.8	19.5	18.8	2.9	15.2	56.4	17.6	25.8	9.9	67.2	17.8	6.8	42.1	10.2	8.1	13.6
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945129-61153037	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	25.5	25.9	22.5	16.7	24.9	11.4	27.1	13.6	24.4	16.9	20.5	11.7	8.2	16.0	16.3	12.2	19.3	12.6	15.0	33.6	19.9	21.2	19.1	27.2	11.9	13.4	20.5	14.2	23.5	41.2	14.2	25.3	9.8	18.5	19.0	18.2	13.2	16.0	16.8	56.3	12.9	13.3	23.9	18.3	10.0	17.2	20.1	12.6	4.9	17.7	16.0	12.3	26.9	19.5	15.9	20.9	1.5	13.1	17.3	20.3	9.1	30.8	16.3	11.3	36.2	21.9	31.1	21.3	36.1	19.3	22.9	28.2	27.1	22.3	38.8	37.3	24.5	44.1	12.8	19.2	31.6	28.4	20.5	27.6	13.3	29.1	25.3	33.1	19.3	7.9	16.7	34.1	20.8	63.4	15.3	20.4	17.3	22.0	20.7	23.9	24.4	17.1	28.5	9.3	11.9	38.7	19.0	31.0	52.6	21.8	13.3	23.7	10.6	22.5	19.5	35.0	10.5	23.3	13.7	18.9	16.5	25.2	35.5	39.9	15.2	21.9	42.6	21.9	34.8	19.2	0.0	13.1	1.5	12.5	11.9	14.3	15.9	15.9	14.6	20.9	11.0	13.9	14.3	0.6	17.3	9.1	7.5	20.3	9.1	22.5	24.9	13.6	24.4	19.9	21.2	20.5	14.2	18.5	12.6	11.9	21.7	43.3	50.0	53.8	27.8	79.5	45.9	24.1	34.2	36.6	11.8	19.0	79.6	47.4	137.5	33.3	26.9	0.0	48.4	45.3	50.0	52.9	19.7	80.5	44.4	39.7	23.7	33.7	26.7	9.8	71.1	42.3	42.2	10.8	49.7	19.5	60.3	45.8	58.4	88.8	22.6	25.8	60.6	82.5	68.2	55.7	11.9	24.5	59.0	51.4
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889313-96897881	"Disease related genes, Predicted intracellular proteins"		Calmodulin-binding	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	7.9	10.1	16.1	5.4	19.0	2.7	9.0	20.4	27.4	8.9	9.1	5.0	5.7	6.2	7.3	6.4	7.1	6.0	6.0	30.2	18.7	17.3	17.3	18.1	4.3	5.4	18.1	12.3	10.4	7.2	7.3	6.5	6.1	28.5	9.5	9.7	4.5	7.7	12.8	25.0	6.2	6.5	7.3	9.6	7.6	6.4	5.7	8.4	4.9	9.5	11.2	5.8	8.2	5.1	6.4	4.5	0.6	4.3	3.3	10.0	4.1	1.5	4.3	7.5	10.1	7.5	4.4	4.0	4.2	4.0	6.3	4.8	5.8	2.6	14.1	7.7	3.8	6.0	3.1	17.4	6.5	6.1	9.9	13.7	15.7	2.3	5.0	8.2	16.4	6.6	4.1	10.1	5.4	5.5	3.2	4.9	10.0	14.1	9.6	9.8	4.8	10.5	8.9	14.2	7.8	7.1	5.0	4.2	7.3	10.4	4.2	12.8	6.0	2.1	7.6	11.9	7.7	2.3	11.0	4.0	3.3	2.5	11.5	6.8	2.2	3.6	13.9	4.5	12.4	4.8	0.2	2.2	0.6	5.1	4.3	6.6	6.4	6.7	6.7	3.8	6.3	10.0	8.8	0.4	3.3	2.6	4.5	6.8	4.1	16.1	19.0	20.4	27.4	18.7	17.3	18.1	12.3	28.5	8.4	8.9	16.6	43.3	52.1	96.7	15.5	108.1	25.5	17.4	27.3	22.7	0.0	40.6	142.6	37.3	2.3	31.6	17.5	23.3	23.9	34.6	34.7	26.3	19.7	43.9	47.0	25.4	37.6	25.8	18.0	4.4	24.2	27.4	52.3	15.4	38.0	14.0	21.1	10.5	23.3	99.4	12.4	25.8	69.8	36.9	55.8	84.6	27.5	27.9	48.2	38.3
NDUFAF8	C17orf89	ENSG00000224877	"NADH:ubiquinone oxidoreductase complex assembly factor 8"	A1L188	17	81239239-81241281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 237.1;Exocrine glandular cells: 106.9;Hofbauer cells: 113.1;Proximal tubular cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA057732	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057732: AB_2683513"	"unprognostic (4.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (5.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	21.6	24.6	44.7	16.6	45.9	19.1	18.2	16.9	33.3	13.0	18.5	18.3	14.0	13.6	10.1	22.5	12.6	12.1	17.5	28.5	36.6	25.0	23.9	30.0	13.4	14.8	34.8	23.2	13.3	24.5	14.6	15.8	9.3	17.0	14.7	19.3	15.0	22.9	15.1	78.1	9.0	11.7	19.1	22.8	11.5	15.4	10.8	16.4	8.4	11.3	29.0	19.2	10.3	8.8	34.2	46.7	22.9	27.8	25.7	36.5	25.3	29.8	45.4	16.8	16.4	18.9	19.9	17.6	25.9	11.2	18.9	11.0	23.0	13.6	27.4	12.9	19.2	15.8	14.9	15.6	26.3	22.7	6.7	87.6	21.3	48.5	51.4	19.8	30.0	13.6	26.7	32.1	13.6	29.0	20.4	30.1	23.4	25.5	17.6	24.3	28.6	40.7	30.9	9.1	25.4	57.4	25.1	24.0	21.2	20.2	21.5	19.3	24.1	21.9	18.8	26.2	25.9	26.2	28.4	16.9	23.6	34.1	16.8	26.6	23.0	8.1	26.5	21.3	15.9	18.1	12.9	27.8	22.9	26.4	21.3	27.0	34.2	29.9	32.8	28.7	29.3	36.5	35.2	3.7	25.7	24.2	46.7	29.3	25.3	44.7	45.9	16.9	33.3	36.6	25.0	34.8	23.2	17.0	16.4	17.9	15.9	0.0	0.0	0.0	0.0	0.0	0.0	6.7	17.0	96.0	0.0	100.5	237.1	95.7	0.0	0.0	0.0	0.0	106.9	76.2	0.0	0.0	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	89.2	0.0	0.0	100.1	0.0	0.0	188.8	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 161.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 2033.2;Hepatocytes: 1436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	38.3	48.3	47.8	22.4	43.1	30.2	22.1	30.9	53.6	12.4	39.7	13.4	28.1	36.4	14.8	39.2	23.2	15.9	20.0	142.2	38.4	35.7	51.2	64.6	28.1	24.9	40.6	36.0	16.5	48.5	9.9	30.6	13.2	41.8	19.3	26.9	22.9	54.1	35.9	161.6	12.6	32.9	25.9	31.3	19.3	29.4	10.0	26.4	11.9	21.6	48.9	21.3	17.1	16.3	61.7	98.6	116.1	93.9	45.1	70.1	95.0	27.1	55.1	44.7	28.8	29.3	21.9	20.5	33.5	18.9	19.9	18.4	33.2	46.3	24.5	31.2	18.7	29.1	34.0	25.6	27.2	18.0	38.6	58.5	47.5	86.5	39.5	23.3	37.5	27.2	27.0	16.5	20.8	18.4	47.1	17.7	47.1	25.8	50.5	27.2	102.8	37.0	33.6	22.6	103.1	67.5	33.1	42.5	36.4	49.6	67.3	29.9	21.7	65.6	40.0	42.6	39.3	59.8	58.6	39.5	12.7	24.1	25.3	22.3	40.0	62.3	54.5	38.2	27.8	26.2	58.1	93.9	67.8	43.7	63.5	50.2	61.7	64.7	49.8	82.6	52.0	65.4	60.4	116.1	45.1	58.1	98.6	70.1	95.0	47.8	43.1	30.9	53.6	38.4	35.7	40.6	36.0	41.8	26.4	154.9	246.4	237.3	88.1	114.4	72.8	2033.2	565.6	282.4	178.6	369.9	37.3	225.4	988.2	197.4	98.7	145.0	655.0	280.4	371.9	86.0	164.5	117.3	207.1	1436.2	359.0	52.4	305.2	426.6	707.7	29.0	243.1	282.3	315.5	296.6	433.5	108.9	268.5	512.0	226.7	864.5	130.9	219.9	185.4	133.6	144.5	153.9	172.1	204.2	467.2	90.1
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145504	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	16.9	33.4	26.1	21.2	24.8	25.2	29.2	18.9	29.7	17.6	23.3	10.5	24.7	24.2	14.3	25.1	23.3	18.8	24.0	64.4	22.4	20.6	24.4	48.8	18.1	36.5	22.5	22.0	14.9	50.9	15.6	24.5	14.2	24.4	18.1	21.2	13.0	37.0	30.2	164.0	17.3	22.8	16.0	18.3	19.2	22.8	9.7	12.3	30.4	38.5	53.6	21.2	14.3	20.5	58.9	69.0	22.2	44.7	27.7	54.6	59.5	19.9	29.7	23.5	27.1	20.3	17.5	25.0	14.5	16.9	23.8	23.1	31.6	24.5	24.6	12.6	15.8	25.1	25.6	26.4	15.4	16.0	23.7	70.6	14.1	40.6	26.1	20.4	23.6	21.7	19.1	14.1	20.6	13.7	15.3	17.7	32.1	16.8	32.4	13.3	45.1	27.8	65.3	36.7	23.8	54.6	30.3	23.2	55.8	24.1	21.3	43.3	32.0	27.6	31.8	22.0	31.3	45.6	30.9	13.5	16.7	22.8	31.0	17.0	32.0	27.9	27.5	18.2	14.8	22.2	22.2	44.7	19.8	34.0	32.0	42.2	58.9	48.4	39.0	52.8	52.8	54.6	43.6	9.5	27.7	23.7	69.0	51.0	59.5	26.1	24.8	18.9	29.7	22.4	20.6	22.5	22.0	24.4	12.3	98.3	106.3	255.4	204.6	230.6	88.2	209.9	272.6	84.3	121.7	275.7	35.3	385.7	494.0	274.0	3.3	148.1	318.7	303.7	319.8	368.1	203.9	216.1	191.4	557.4	340.7	52.4	317.3	186.6	292.7	7.4	168.2	251.5	251.4	301.2	382.3	151.0	288.4	321.1	165.9	606.1	75.5	161.7	184.4	17.2	37.7	253.9	377.1	200.3	398.2	277.3
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 153.5"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	25.1	31.2	45.1	19.9	52.5	20.2	27.3	29.1	43.3	21.5	39.0	26.0	25.1	28.3	20.1	29.5	27.7	22.0	25.7	105.5	37.0	36.0	46.6	41.2	18.4	23.8	46.0	35.6	14.5	47.0	26.5	23.9	17.7	33.3	20.7	30.8	28.1	37.6	27.4	127.2	17.2	28.1	38.1	37.7	19.7	26.9	14.3	25.2	15.6	57.6	48.1	21.1	25.5	17.5	94.7	116.5	55.2	108.5	75.9	87.8	153.5	41.1	67.0	24.0	52.4	38.6	39.2	34.9	29.9	26.2	31.0	29.6	51.7	41.1	31.3	44.8	36.2	58.7	20.4	21.4	42.1	24.7	52.2	73.6	22.9	57.3	58.1	30.6	35.3	30.9	43.6	36.5	29.4	18.1	26.6	46.1	44.5	38.7	37.9	42.9	122.0	55.3	91.1	55.6	84.7	76.6	31.9	23.4	72.2	62.1	81.8	48.9	48.3	41.0	67.2	35.9	28.6	29.2	40.5	38.4	41.0	24.1	48.4	51.5	36.2	67.2	54.9	62.4	56.8	51.3	55.2	108.5	48.1	83.5	107.8	71.3	94.7	82.1	81.4	116.5	72.9	87.8	87.7	9.0	75.9	97.1	92.8	73.9	153.5	45.1	52.5	29.1	43.3	37.0	36.0	46.0	35.6	33.3	25.2	175.7	232.0	217.4	229.1	201.1	175.8	3102.3	435.7	235.5	197.9	638.6	92.3	489.8	1692.7	343.0	795.3	237.8	727.9	70.0	273.3	377.8	291.6	360.2	272.6	944.1	632.0	131.9	411.8	215.5	261.6	154.7	206.2	385.8	411.7	381.5	493.4	197.7	268.8	531.3	229.1	1640.6	200.8	194.1	278.2	77.7	190.5	245.3	430.7	214.4	506.9	369.0
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.3	37.5	44.9	44.9	28.3	33.8	36.5	28.9	38.4	37.6	41.6	36.4	39.5	26.1	58.7	32.3	47.2	49.8	34.6	36.8	28.4	40.0	39.8	40.3	39.4	36.6	17.2	35.4	47.8	30.5	49.1	18.3	24.1	45.6	46.9	49.7	23.8	40.2	40.3	40.3	70.0	51.3	35.7	84.6	102.8	40.6	25.6	57.4	60.9	32.1	50.6	51.8	33.9	38.0	61.5	31.3	64.0	56.5	36.0	33.3	43.9	14.1	40.2	49.6	44.7	78.9	52.6	49.9	45.1	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6	151.8	116.9	147.4	227.4	197.5	114.3	1416.5	333.7	208.8	175.1	303.6	55.0	310.4	1039.5	474.7	797.6	248.2	436.8	93.5	541.7	349.0	180.0	247.2	169.9	411.5	288.6	79.4	286.7	153.4	221.7	73.1	254.9	235.4	411.7	399.5	378.0	175.1	503.3	436.8	260.6	758.9	123.5	252.2	270.2	329.1	90.3	219.8	294.7	162.0	391.3	307.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.4	6.6	16.4	19.9	21.7	29.2	22.2	14.9	18.8	21.3	21.6	19.7	17.1	20.5	45.2	12.6	36.6	26.0	17.7	19.7	21.5	42.4	14.8	22.0	12.0	16.4	19.9	26.3	17.5	26.9	25.5	12.0	20.0	22.1	24.4	20.0	18.6	29.9	22.8	16.7	15.1	20.4	23.7	45.5	26.7	16.8	19.0	63.6	38.6	18.1	11.7	19.6	9.0	50.9	35.1	15.4	77.6	42.9	15.7	14.1	13.4	19.2	35.4	39.8	41.2	30.3	22.8	28.2	20.0	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4	44.7	44.0	87.9	92.8	75.7	45.3	340.1	112.1	52.2	53.4	83.7	31.4	192.8	431.0	110.3	85.8	85.1	125.2	0.0	92.5	115.9	83.1	75.7	92.3	108.0	222.8	38.1	112.9	97.6	229.9	13.7	75.1	156.2	128.2	124.4	173.7	74.4	86.7	189.4	65.7	379.0	54.1	71.1	81.4	233.1	125.2	77.5	192.3	81.2	242.9	137.2
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 591.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	30.2	18.6	20.7	23.7	14.1	13.2	13.3	20.3	16.6	18.8	20.8	18.2	13.7	22.6	21.2	13.9	19.5	17.2	19.5	22.4	14.1	31.0	31.3	53.7	28.6	18.8	13.8	26.7	13.9	13.6	10.9	16.9	12.9	14.2	16.9	34.7	17.1	25.5	20.9	17.5	36.0	63.1	21.9	26.0	41.4	24.8	17.4	20.9	21.0	11.4	20.9	23.6	23.5	27.0	13.6	16.2	25.5	20.8	15.0	20.5	31.1	22.6	29.7	11.4	21.2	36.6	34.3	18.9	9.6	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1	116.1	94.0	77.4	80.5	83.7	39.2	514.3	107.0	155.2	108.1	102.9	5.9	175.9	452.6	143.9	591.4	96.3	138.7	93.5	145.0	113.2	93.0	79.2	86.8	170.4	141.7	17.5	62.0	71.8	59.8	88.6	84.8	89.6	151.8	111.8	116.6	72.0	133.2	118.5	84.5	440.9	40.8	103.5	124.6	143.8	114.3	84.6	87.1	65.4	146.3	88.4
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 742.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	35.2	39.8	86.7	27.0	67.4	35.6	26.1	39.3	81.5	25.4	37.7	23.8	23.1	38.8	24.7	42.3	36.8	28.8	28.2	110.0	70.6	62.8	50.4	50.6	19.8	28.1	63.9	54.1	27.7	36.3	31.5	31.4	19.9	49.9	26.6	36.2	25.7	39.7	34.5	88.5	24.3	33.8	41.5	38.9	22.1	31.5	12.0	41.4	18.3	28.3	49.2	27.8	25.2	21.5	76.6	88.6	62.2	74.4	60.5	105.9	129.7	42.2	71.3	38.5	68.3	29.2	28.4	42.6	28.9	62.8	44.4	48.1	96.6	49.3	44.8	26.1	32.3	32.8	50.7	28.8	46.9	35.4	29.4	73.6	31.5	60.5	78.2	39.6	64.3	54.3	34.9	42.4	44.3	59.8	32.2	48.5	59.6	32.7	28.5	38.2	51.3	62.0	81.0	25.8	54.4	66.6	43.3	42.1	59.1	52.0	48.4	26.7	37.4	21.3	40.5	41.9	27.6	60.3	57.6	32.5	25.4	28.8	27.1	50.5	51.7	46.9	55.6	50.5	68.2	28.3	35.1	74.4	62.2	59.0	72.9	69.5	76.6	73.6	67.8	80.4	64.1	79.8	76.7	17.1	60.5	61.4	88.6	105.9	129.7	86.7	67.4	39.3	81.5	70.6	62.8	63.9	54.1	49.9	41.4	71.5	126.9	126.6	146.5	0.0	174.3	341.7	234.4	156.6	88.7	188.5	55.0	285.1	742.8	226.5	20.4	131.5	123.8	116.8	230.9	258.4	136.0	175.3	101.1	286.9	348.6	144.6	101.8	146.7	171.1	43.8	202.0	160.0	0.0	261.5	229.2	129.5	225.4	259.6	204.4	592.8	122.1	168.1	220.6	53.7	79.5	0.0	257.3	174.0	305.7	185.2
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539103-124568510	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 254.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	26.9	20.8	61.0	19.6	45.1	43.7	33.3	26.9	63.7	20.7	40.4	15.0	25.4	35.5	17.4	30.0	27.9	19.4	23.8	125.1	44.2	39.0	50.1	52.9	23.8	38.2	60.0	49.1	16.8	51.7	20.6	16.3	15.8	46.7	20.6	37.5	13.4	39.9	24.0	221.3	18.0	26.1	31.3	44.8	15.3	28.9	44.1	31.1	13.5	27.7	80.7	19.3	16.7	16.5	53.8	52.7	52.1	54.4	37.5	71.2	64.2	28.8	26.7	20.5	27.7	21.3	18.2	17.2	14.2	16.2	25.9	19.6	35.1	27.9	28.6	36.9	16.3	13.5	32.9	29.7	22.6	24.5	33.2	40.5	69.5	19.0	42.0	28.4	21.6	19.0	21.2	32.9	23.7	51.3	14.1	23.5	20.8	42.9	24.1	20.7	90.1	34.0	43.3	20.6	104.1	59.4	23.0	15.6	39.0	34.0	24.4	28.6	22.4	30.9	254.6	30.4	12.9	35.0	29.3	18.7	15.1	39.4	14.1	33.4	31.1	41.4	32.8	26.3	43.3	19.9	52.1	54.4	27.5	48.3	37.2	47.9	53.8	64.0	53.9	52.7	42.5	63.4	52.2	11.2	37.5	27.2	39.6	71.2	64.2	61.0	45.1	26.9	63.7	44.2	39.0	60.0	49.1	46.7	31.1	116.1	101.5	163.0	206.1	193.5	71.0	877.9	259.9	172.6	153.6	272.2	92.3	413.9	678.1	287.5	321.0	148.3	490.6	46.7	353.1	228.0	195.3	239.3	136.2	450.4	353.4	35.0	224.5	179.2	208.1	585.5	147.0	181.9	234.5	201.0	282.2	86.2	298.7	372.2	143.5	593.2	52.3	168.1	258.4	306.2	277.3	164.6	437.4	148.2	397.6	262.6
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Cell type enhanced"	"Detected in all"	8	"Cardiomyocytes: 1810.7;Distal tubular cells: 963.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.7	3.7	10.7	13.3	7.7	8.4	8.6	10.8	7.2	8.0	6.1	6.5	11.0	3.8	3.9	7.6	7.9	5.2	20.9	7.1	6.3	5.5	6.7	6.1	7.1	10.4	9.7	5.0	3.3	12.1	10.7	7.6	11.2	10.3	7.9	8.8	14.0	16.4	5.5	6.2	7.4	12.4	8.2	16.4	5.0	6.3	6.6	29.1	12.8	5.7	9.1	6.9	7.7	9.5	4.9	9.0	10.4	9.9	3.9	7.9	3.7	5.5	6.1	13.2	23.2	9.6	8.5	13.3	6.3	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5	83.4	126.2	85.5	146.6	124.6	118.7	1810.7	239.5	211.5	137.6	417.0	31.4	127.4	963.3	232.9	260.2	150.4	371.3	93.5	293.9	141.6	109.0	170.1	69.5	334.5	190.8	112.8	212.7	108.1	87.2	30.8	156.8	98.4	253.1	220.0	288.1	223.0	228.9	313.4	194.1	826.9	103.1	97.0	148.0	386.4	224.2	156.7	98.7	62.3	275.8	158.3
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068304-78080219	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	55.0	70.8	40.8	23.3	44.4	32.3	46.2	51.4	58.4	22.5	41.1	31.2	68.0	63.4	31.8	32.8	41.8	35.6	31.9	60.4	41.0	44.5	37.5	89.6	30.1	36.4	43.2	47.0	27.3	48.4	25.3	34.7	31.8	40.8	27.3	20.3	29.7	79.5	59.0	122.8	29.0	55.3	23.7	41.1	24.5	36.6	28.6	23.2	26.9	63.5	43.7	23.3	31.9	24.1	50.3	78.2	70.3	73.2	44.5	46.3	81.2	36.0	45.0	24.5	15.4	23.3	14.7	30.2	44.1	26.5	35.1	25.0	120.6	40.5	21.6	80.9	20.8	28.7	38.1	18.4	25.9	13.4	40.9	52.1	23.2	46.7	94.9	39.8	50.7	23.1	20.4	24.1	26.9	10.2	21.6	23.8	23.2	45.7	36.5	19.6	62.1	33.1	91.4	27.6	88.8	56.9	29.0	46.6	73.1	26.5	54.3	34.6	30.7	31.4	64.8	22.7	22.3	51.3	42.1	31.1	34.2	42.2	81.4	37.8	33.6	65.8	49.7	19.5	30.5	32.7	65.8	73.2	70.3	39.4	58.2	36.2	50.3	45.6	41.5	77.2	45.5	39.6	41.3	21.0	44.5	48.0	78.2	46.3	81.2	40.8	44.4	51.4	58.4	41.0	44.5	43.2	47.0	40.8	23.2	154.9	160.2	100.4	139.2	84.8	134.1	213.8	247.1	202.1	144.5	371.6	62.8	347.5	258.6	334.7	231.4	158.7	177.9	70.0	374.9	317.5	154.4	190.2	148.0	738.1	305.1	85.8	161.2	184.1	179.8	53.3	199.6	133.3	232.8	193.8	274.2	214.0	379.3	301.9	189.5	354.7	91.8	232.8	163.6	380.6	170.3	100.0	323.7	113.3	343.3	186.0
NDUFC2-KCTD14		ENSG00000259112	"NDUFC2-KCTD14 readthrough"	E9PQ53	11	78016971-78079865	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Alveolar cells type 2: 1.3;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.4;EFO-21: 8.5;RPMI-8226: 7.5;U-2 OS: 13.0"									"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"																		7.1	11.3	6.3	5.8	7.9	9.7	8.9	13.8	11.7	9.6	7.4	5.5	13.8	27.3	8.8	5.9	9.5	9.7	5.6	11.3	7.7	7.1	6.9	18.7	6.6	6.7	6.4	9.1	6.6	8.8	5.4	5.6	5.6	7.7	8.4	6.3	5.1	18.0	11.8	10.1	5.7	10.6	5.9	5.9	5.9	15.9	4.9	3.7	4.5	12.7	8.3	4.8	4.6	6.1	30.7	37.7	30.7	33.7	16.5	33.2	39.7	0.0	2.1	0.6	0.6	0.6	0.0	1.4	1.5	0.9	1.3	2.9	10.4	1.2	0.2	8.5	0.0	1.8	0.3	1.7	0.0	0.7	5.9	0.0	1.2	0.0	0.0	0.7	0.8	2.1	0.0	0.3	0.3	1.8	1.8	0.9	6.4	0.3	0.1	0.2	0.0	3.0	1.1	5.2	1.0	0.3	1.0	0.1	7.5	0.0	0.0	1.5	2.3	0.0	1.1	3.3	0.0	0.6	1.1	0.9	0.5	13.0	4.2	0.0	1.2	1.4	3.0	0.8	0.3	1.4	22.5	33.7	30.7	24.5	24.1	19.3	30.7	22.8	23.0	37.7	23.7	20.5	21.5	10.0	16.5	25.7	37.5	33.2	39.7	6.3	7.9	13.8	11.7	7.7	7.1	6.4	9.1	7.7	3.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 534.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	12.9	18.8	13.6	17.6	14.3	21.9	19.1	20.6	31.9	23.2	33.5	15.2	14.7	16.9	23.8	31.7	18.2	25.1	18.5	28.4	6.7	11.8	29.3	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	14.3	24.8	18.6	31.7	14.9	20.7	16.2	17.4	14.0	17.4	21.9	23.1	17.6	26.3	25.4	26.4	23.7	18.4	14.4	22.0	21.6	31.2	26.9	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.6	17.5	17.9	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1	56.6	24.1	13.7	19.6	14.3	94.7	534.9	63.7	60.2	35.2	36.6	113.9	40.2	79.6	36.7	9.9	33.7	63.8	0.0	24.5	26.7	24.7	17.4	35.9	83.9	29.8	111.2	49.0	33.7	34.6	5.2	31.1	25.2	28.7	27.1	47.3	60.7	29.2	35.1	42.1	80.9	78.2	32.3	27.8	28.6	37.3	14.4	43.8	18.7	52.8	23.9
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	17.2	27.8	17.6	20.4	25.9	23.0	15.2	15.7	23.1	31.1	24.5	30.5	18.0	22.0	29.6	24.2	17.1	23.2	28.1	28.1	27.5	14.6	23.6	21.4	20.9	26.6	26.9	23.2	19.9	33.1	24.8	25.1	28.7	20.6	35.5	23.0	27.4	12.0	29.2	19.9	14.7	12.4	32.1	60.6	25.7	12.7	18.2	30.9	36.9	20.7	18.7	27.8	19.0	46.9	26.8	26.3	42.1	60.8	22.7	15.1	12.9	10.6	21.2	16.9	26.7	18.4	23.1	19.6	19.4	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3	32.8	43.7	52.8	39.4	34.6	72.7	193.6	76.5	68.3	35.2	73.3	29.5	125.8	281.8	158.0	7.1	61.2	199.4	23.3	126.2	94.3	73.7	24.9	68.1	177.0	131.6	87.4	69.2	58.9	83.7	4.7	40.3	64.2	79.2	127.2	94.1	51.2	124.2	89.2	31.5	226.7	49.8	45.3	68.0	36.7	32.1	37.9	132.5	50.1	138.8	41.7
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	22.0	18.6	19.4	16.1	16.7	15.9	11.0	18.8	27.2	25.9	32.3	20.4	25.8	11.0	15.7	19.3	21.4	26.3	19.8	22.2	13.8	42.5	15.6	30.9	31.2	16.6	38.1	20.3	16.3	14.3	10.3	17.0	11.6	17.1	21.3	22.7	17.8	17.6	35.4	26.1	49.4	26.4	32.0	31.2	31.8	26.9	21.2	23.3	18.1	20.9	15.1	14.1	24.2	24.9	11.6	27.0	36.4	11.9	16.3	18.3	18.9	24.8	20.5	27.1	28.5	16.5	29.3	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4	50.6	35.2	47.4	60.2	58.3	41.3	154.2	96.8	75.0	45.5	66.3	39.3	103.3	343.2	99.0	93.6	59.9	204.6	23.3	97.2	97.6	64.9	43.1	56.6	108.3	166.7	57.2	81.3	52.8	54.3	46.0	62.5	73.9	113.1	83.8	120.8	100.0	80.5	103.7	65.0	231.7	51.0	103.5	79.3	76.9	75.2	66.4	74.5	62.9	167.5	58.5
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683340	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favorable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	27.5	26.5	29.8	15.7	35.7	14.3	34.0	23.3	35.3	20.8	30.0	12.9	21.3	27.6	24.0	24.2	27.0	22.9	20.9	65.1	24.4	23.2	45.3	48.1	18.7	14.9	28.5	34.4	35.7	19.5	22.2	24.9	20.7	26.7	22.9	30.5	16.4	24.4	26.3	105.5	23.0	25.5	34.3	27.0	13.6	24.1	20.9	24.6	12.9	25.1	67.3	19.3	21.7	22.4	24.3	41.0	6.7	32.8	24.5	25.2	21.9	30.0	26.7	53.2	31.4	36.3	52.8	44.7	36.6	35.7	40.7	49.9	32.5	39.6	21.4	48.2	31.2	39.1	22.2	18.8	43.6	47.1	19.7	35.9	14.7	26.5	29.2	38.7	35.3	25.5	43.7	50.5	28.0	49.5	45.0	35.3	24.3	12.5	23.4	37.1	28.1	26.6	29.7	16.1	11.5	30.2	32.1	30.0	42.1	43.3	29.0	24.5	26.6	25.1	24.4	43.0	29.7	39.1	37.2	27.0	25.0	26.7	18.1	47.7	18.0	22.4	25.8	26.7	51.9	36.0	6.7	28.9	2.4	17.5	32.8	19.5	24.3	22.2	20.2	41.0	16.5	25.1	25.2	2.4	24.5	32.4	31.0	23.5	21.9	29.8	35.7	23.3	35.3	24.4	23.2	28.5	34.4	26.7	24.6	35.7	44.6	76.7	128.0	111.7	41.6	329.5	76.5	76.3	71.7	80.3	39.3	136.6	469.2	144.1	42.2	91.5	124.0	0.0	145.6	142.3	128.2	89.3	73.9	126.2	125.7	28.6	86.8	73.6	66.4	51.2	145.9	104.9	111.3	170.5	117.4	77.9	141.9	140.3	143.5	309.1	67.6	122.9	122.6	70.4	45.1	88.7	150.5	58.9	149.5	126.8
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 706.2;Proximal tubular cells: 686.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.4	65.7	18.2	24.7	13.6	12.2	23.9	18.8	16.3	29.1	22.7	61.1	28.3	20.5	34.3	16.3	26.2	32.7	20.8	22.8	10.5	24.5	48.0	18.6	41.9	32.1	32.5	17.4	20.5	15.4	23.7	21.4	24.5	16.1	19.5	28.9	19.1	22.2	19.0	62.7	38.3	37.3	22.3	70.4	55.7	26.7	17.7	66.2	36.6	21.5	22.9	18.6	13.7	31.7	66.4	13.6	43.5	19.1	15.1	28.3	24.9	40.9	25.9	30.5	32.0	17.4	45.5	21.0	19.7	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7	83.4	69.0	76.7	81.4	75.9	80.5	251.3	155.4	84.3	69.4	202.4	51.1	253.0	706.2	176.2	170.4	79.8	264.8	0.0	174.1	132.3	109.2	89.4	94.6	216.5	241.0	47.7	197.0	64.4	119.9	632.4	93.2	101.9	155.3	202.8	173.3	94.1	168.6	178.9	101.5	686.8	98.3	58.2	128.2	84.2	59.4	101.6	144.2	120.4	242.9	99.3
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	25.9	27.9	14.2	28.5	17.8	17.9	26.6	16.2	15.6	25.4	17.0	52.8	31.5	48.0	34.2	13.9	20.7	35.0	30.0	25.3	8.0	24.4	23.7	19.6	37.9	26.0	25.2	26.7	22.0	26.5	24.6	20.6	18.5	16.1	22.5	35.2	35.7	39.3	15.4	39.0	31.2	52.9	13.9	59.1	35.2	36.3	27.6	77.9	20.6	19.5	22.7	21.4	20.5	71.8	54.1	9.9	36.4	27.2	17.8	24.7	18.4	35.1	17.0	38.4	21.8	23.9	28.7	28.3	23.7	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3	56.6	80.9	64.0	70.8	71.3	67.0	408.9	66.2	72.3	67.1	82.0	47.1	180.6	336.5	96.7	57.0	53.7	205.0	23.3	97.8	127.6	79.5	47.7	59.0	122.2	121.6	60.4	94.7	53.4	67.1	159.3	60.7	67.5	108.0	83.8	141.7	63.1	68.4	126.7	55.5	398.9	60.4	45.3	98.9	77.2	78.1	70.4	158.1	71.2	225.4	78.9
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003404, HPA077896"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	20.0	34.5	25.2	18.0	23.7	31.1	25.6	20.6	37.3	15.6	26.1	13.1	20.3	23.1	14.7	21.5	27.5	13.9	17.6	82.6	22.7	23.8	40.7	89.1	17.2	29.9	26.7	19.4	11.2	36.3	14.9	14.9	21.6	26.2	20.8	27.8	17.8	20.1	20.2	122.6	17.4	24.4	23.5	20.8	19.3	25.2	19.0	12.7	20.5	20.5	59.5	22.7	20.4	14.1	55.6	74.7	49.3	45.1	27.0	53.5	48.1	18.6	19.6	22.7	21.1	16.8	24.0	19.2	23.5	37.4	31.1	29.6	36.6	15.4	28.8	21.6	22.0	28.7	9.5	22.0	24.4	29.8	14.5	19.4	18.4	20.2	49.3	19.4	51.2	22.9	20.1	20.5	19.2	20.8	22.5	33.5	26.0	29.3	91.0	28.5	23.4	35.7	44.9	18.9	103.3	24.4	17.0	16.8	109.2	49.6	30.3	23.8	17.7	23.2	26.5	29.5	16.9	24.8	39.0	20.5	39.7	28.2	28.4	30.5	26.3	39.0	32.2	28.3	22.7	25.6	49.3	39.9	44.1	30.2	45.1	37.6	55.6	45.5	35.7	56.6	43.6	40.0	36.9	18.0	27.0	41.6	74.7	53.5	48.1	25.2	23.7	20.6	37.3	22.7	23.8	26.7	19.4	26.2	12.7	74.5	120.4	122.8	254.8	131.4	96.8	61.3	175.8	207.5	127.4	143.1	82.5	309.8	742.8	337.2	214.8	108.5	232.3	46.7	461.4	265.4	107.6	372.3	115.7	324.6	267.7	89.0	102.4	92.7	98.1	135.7	113.1	187.8	219.4	393.1	177.0	104.6	465.3	175.4	95.8	576.3	143.4	103.5	138.2	182.6	170.4	129.0	242.0	118.9	207.0	348.6
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 701.2;Late spermatids: 1042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.4	11.0	18.0	13.6	11.9	13.6	19.2	11.0	11.5	9.6	20.7	11.9	10.7	15.2	7.2	15.6	10.5	12.8	16.9	7.5	6.1	15.5	35.3	13.3	16.2	21.4	12.0	18.5	13.3	14.7	11.6	18.4	10.4	14.4	7.4	27.9	14.0	13.1	18.9	8.0	18.2	14.4	21.5	22.4	13.9	8.0	33.4	15.4	12.8	8.1	8.4	19.3	22.8	12.7	6.2	19.6	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.2	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3	50.6	37.7	43.0	46.0	17.6	69.1	701.2	89.2	92.3	27.3	85.5	64.8	46.1	195.6	69.0	416.9	34.9	128.4	140.2	87.3	49.8	41.1	75.6	30.1	285.4	97.8	54.0	75.1	62.0	81.5	1042.9	61.5	68.7	35.4	67.7	73.4	56.3	83.6	77.2	58.7	265.4	102.6	71.1	47.2	216.7	86.2	20.6	75.2	34.6	82.9	49.3
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 149.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	12.9	15.9	22.6	13.3	25.9	5.5	18.5	30.2	26.0	17.6	13.6	19.8	12.2	11.0	16.9	17.0	10.5	15.2	13.1	17.3	21.6	19.6	20.0	15.1	12.7	11.5	19.4	25.6	22.9	16.5	34.1	19.0	19.4	20.9	16.1	14.7	12.1	14.4	20.5	14.8	12.0	12.1	14.5	21.4	11.9	13.0	15.4	21.5	11.6	31.1	7.6	12.4	15.3	19.5	2.3	0.7	6.5	0.4	0.9	8.4	1.0	9.8	12.9	15.7	8.4	13.4	17.5	7.9	8.6	15.5	12.7	14.4	11.6	6.7	9.5	2.5	16.0	15.0	17.3	14.2	12.0	21.5	4.6	8.9	8.4	12.1	5.9	9.5	15.0	7.0	13.8	7.7	13.5	16.5	14.4	6.1	10.1	12.0	9.5	12.1	7.8	12.5	5.5	4.6	6.1	4.3	9.8	24.0	7.6	9.6	14.2	6.5	9.8	15.9	5.3	8.8	11.6	16.2	9.6	8.9	10.2	14.2	12.0	3.2	8.7	4.2	10.5	8.3	6.3	10.5	6.5	0.4	0.9	2.3	0.2	1.6	2.3	4.4	3.9	0.5	2.1	3.3	3.2	1.0	0.9	0.4	0.7	8.4	1.0	22.6	25.9	30.2	23.5	21.6	19.6	19.4	25.6	20.9	21.5	29.8	23.6	12.7	38.9	34.3	61.1	39.2	40.8	29.4	20.5	38.4	129.6	44.8	19.9	23.9	149.0	31.8	28.2	0.0	19.3	22.1	28.2	47.4	10.4	31.7	18.9	66.7	19.0	31.9	24.3	70.0	34.5	21.8	20.3	16.2	26.8	49.7	28.6	35.4	47.4	23.7	66.0	45.3	36.7	28.2	25.6	29.6	41.2	18.5	22.6	60.1
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469688-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	20.1	17.6	17.2	19.3	23.6	35.7	26.9	28.9	25.8	17.8	17.8	21.2	18.7	15.0	29.1	22.3	17.4	21.7	12.1	14.8	17.6	15.7	20.6	21.0	15.5	20.4	23.5	17.4	27.2	16.6	20.9	20.7	19.7	19.1	19.7	19.4	17.4	24.0	19.9	32.8	22.7	17.9	21.0	21.6	19.7	17.5	19.0	25.2	19.6	23.7	17.2	22.8	17.3	19.7	42.0	26.7	18.9	23.4	35.2	44.6	28.2	11.0	21.9	16.8	15.7	16.3	11.8	22.2	14.6	15.3	31.3	25.4	21.6	20.2	27.4	10.8	13.3	22.2	19.2	33.2	18.1	36.9	18.2	17.5	24.5	13.3	66.7	22.2	32.4	17.5	14.7	23.1	24.6	29.4	12.4	15.8	21.2	27.1	19.6	15.2	26.2	24.1	24.5	21.2	25.4	29.5	19.7	20.1	14.0	20.0	21.0	17.2	19.4	17.3	20.8	23.9	17.8	12.9	20.8	11.9	14.8	17.6	13.9	21.2	24.5	42.5	39.8	6.4	16.6	15.8	17.5	21.5	18.9	31.6	23.4	33.5	42.0	34.3	32.1	25.3	36.6	44.6	35.1	6.6	35.2	22.4	26.7	37.4	28.2	17.2	23.6	28.9	25.8	17.6	15.7	23.5	17.4	19.1	25.2	32.8	26.9	41.2	49.3	62.7	21.0	17.7	17.8	28.1	29.6	26.2	15.7	50.7	28.2	31.1	4.1	34.3	17.4	23.3	31.3	36.0	37.0	25.4	43.9	18.1	26.5	23.8	23.6	16.0	16.4	4.5	32.5	29.5	30.4	36.1	18.8	20.7	28.1	19.9	26.5	27.0	24.7	19.4	38.7	57.2	69.0	59.1	47.8	41.5	22.0	44.2
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90278141	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	13.3	21.3	49.2	11.0	43.2	19.4	18.7	27.6	61.5	18.5	15.6	13.8	8.4	9.3	18.9	21.0	13.1	15.2	14.1	19.1	38.9	42.2	11.2	13.3	15.3	11.9	38.9	37.7	19.4	18.9	21.1	17.1	12.3	30.9	15.5	12.1	11.4	14.4	14.5	47.6	17.7	11.3	12.4	25.7	14.0	13.9	13.8	14.0	3.8	23.3	15.4	11.4	12.7	15.4	5.2	2.4	6.0	3.1	4.2	4.8	2.5	2.9	7.4	9.8	15.4	8.6	3.7	1.2	4.2	3.3	4.0	2.9	3.5	1.7	4.7	2.8	5.0	3.4	4.9	9.5	2.4	5.8	1.9	8.8	4.5	4.5	5.4	5.5	5.2	3.4	5.1	8.7	3.7	4.8	3.8	3.6	4.8	5.6	5.8	2.4	3.5	4.9	2.2	4.6	3.6	4.4	7.5	5.5	2.3	4.2	13.1	9.8	12.3	8.1	6.5	3.5	7.0	2.6	7.4	5.8	9.6	4.1	6.2	7.5	3.8	20.0	5.0	4.2	5.4	7.8	6.0	2.3	3.6	3.2	3.1	4.0	3.5	3.1	2.7	1.2	5.2	3.7	4.4	5.0	4.2	1.9	2.4	4.8	2.5	49.2	43.2	27.6	61.5	38.9	42.2	38.9	37.7	30.9	14.0	17.9	20.6	6.7	10.6	6.4	10.7	7.8	2.5	103.1	36.4	5.2	9.8	5.1	5.0	27.1	1.5	8.4	7.3	0.0	20.6	3.7	5.0	7.7	19.7	3.4	3.7	15.9	25.4	5.5	4.0	2.2	8.3	5.9	8.5	17.2	15.6	13.3	25.7	17.5	8.1	6.7	10.4	12.9	8.6	4.8	3.6	4.4	5.6	8.5	15.7	6.4
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	566996-569495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 17.3"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 9.4;Collecting duct cells: 22.7;Erythroid cells: 23.3;Leydig cells: 7.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HMC-1: 13.8;REH: 3.6;RPMI-8226: 5.8"	"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	1.3	6.9	1.6	1.4	2.3	3.4	1.4	1.4	1.8	2.4	0.9	1.7	9.5	1.4	2.5	21.1	0.7	17.3	1.5	1.8	2.4	2.4	7.0	0.3	4.8	3.8	0.5	0.9	5.1	0.2	5.9	1.4	1.5	2.0	2.2	0.3	2.1	3.1	10.9	2.3	0.3	1.7	0.5	0.8	4.8	0.8	2.8	0.7	7.8	0.4	0.4	1.2	1.3	0.7	1.1	4.4	5.0	0.5	0.7	1.5	0.7	0.0	0.0	0.6	0.1	0.1	0.3	0.1	0.0	0.8	0.2	0.2	0.1	0.2	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.0	2.4	0.2	4.6	0.0	1.0	1.0	0.3	13.8	2.9	0.0	0.1	0.3	0.0	0.3	0.8	1.4	1.6	0.0	0.0	0.5	3.4	0.3	0.0	0.0	3.6	0.0	5.8	0.3	0.2	0.0	1.3	0.0	0.0	0.5	0.1	0.6	0.7	0.7	0.0	0.1	0.0	0.0	2.1	1.9	0.9	0.0	0.2	0.4	0.0	0.5	5.0	0.4	0.2	0.7	1.1	1.3	0.6	0.6	0.7	1.5	0.8	0.0	0.7	0.2	4.4	1.4	0.7	1.6	2.3	1.4	1.8	2.4	2.4	0.5	0.9	2.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	9.4	2.3	22.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.3	0.2	0.0	0.4	0.2	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	7.5	0.5	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	0.0	6.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 97.3;skeletal muscle: 144.4"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 161.9;Distal tubular cells: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	14.5	19.3	18.4	8.4	22.9	8.6	16.6	11.8	24.5	12.6	14.6	8.9	11.8	8.1	11.0	11.1	12.9	13.4	8.0	97.3	18.7	15.9	16.6	5.2	13.2	16.6	17.0	16.7	9.5	13.5	11.8	8.6	8.0	17.2	14.3	14.2	6.8	18.9	15.5	144.4	6.3	8.3	21.6	19.3	6.5	11.6	5.8	12.1	7.4	22.6	39.8	7.2	12.4	7.8	14.3	34.1	14.1	33.1	15.2	14.1	24.7	80.6	14.3	18.9	31.4	10.9	19.1	9.3	6.8	16.1	19.7	15.2	9.9	17.9	11.8	11.4	12.7	19.1	10.8	14.2	14.4	19.6	7.5	20.9	8.4	8.5	12.6	15.7	18.1	8.5	17.3	22.1	6.7	18.3	22.4	20.7	17.2	14.9	11.7	15.2	3.5	18.0	18.8	18.5	18.0	14.5	18.3	8.8	24.3	26.5	12.7	20.2	22.8	15.5	18.7	21.0	15.6	36.2	19.6	12.0	9.0	13.6	3.1	14.0	9.6	8.1	21.9	9.9	11.4	26.5	13.4	33.1	14.1	8.7	31.8	10.6	14.3	11.7	9.3	34.1	12.3	14.1	10.1	5.8	15.2	23.9	14.1	13.6	24.7	18.4	22.9	11.8	24.5	18.7	15.9	17.0	16.7	17.2	12.1	47.6	42.3	0.0	0.0	0.0	0.0	0.0	0.0	161.9	79.6	59.3	0.0	65.3	192.3	62.3	0.0	0.0	0.0	0.0	50.1	44.3	0.0	0.0	15.1	0.0	79.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	69.5	0.0	0.0	39.8	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0
NLGN2	KIAA1366	ENSG00000169992	"Neuroligin 2"	Q8NFZ4	17	7404874-7419860	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 31.6;Horizontal cells: 54.0;Muller glia cells: 23.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1"	"Low region specificity"	"Detected in all"							"HPA055321, HPA069278"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055321: AB_2682783, HPA069278: AB_2686105"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.81e-2)"	13.0	10.9	31.3	9.9	45.3	2.4	7.4	32.7	47.0	16.9	11.3	18.3	9.5	4.4	25.3	16.4	9.0	13.8	15.5	6.6	28.8	16.0	5.7	3.3	6.2	6.1	13.9	27.5	24.3	7.4	20.7	8.3	8.5	21.3	11.6	5.9	11.2	6.5	19.2	6.3	8.7	5.4	24.3	19.4	7.5	5.9	4.8	15.9	0.0	4.8	1.7	5.0	9.8	11.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.2	5.9	26.1	15.1	8.0	11.2	0.6	7.0	11.1	11.9	11.0	1.3	1.4	0.0	3.4	9.7	7.0	2.4	4.8	2.9	6.4	6.3	4.9	1.8	5.3	1.0	4.1	1.8	6.4	9.0	2.4	9.8	1.6	18.0	4.0	2.3	1.7	3.4	5.0	4.0	0.8	1.8	4.4	0.2	2.8	7.5	3.1	0.8	3.5	0.9	0.4	10.5	3.2	1.5	1.8	5.4	4.2	0.2	5.5	10.3	13.1	6.5	3.4	3.9	1.3	0.7	10.7	1.7	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.3	45.3	32.7	37.2	28.8	16.0	13.9	27.5	21.3	15.9	0.0	1.6	0.0	2.5	4.1	31.6	10.9	0.0	0.0	0.0	0.0	7.9	0.3	0.0	2.7	1.3	5.2	0.0	0.0	0.3	5.7	11.2	2.1	0.0	2.1	0.8	54.0	0.0	4.9	0.3	2.5	15.8	0.0	1.7	1.0	0.0	23.0	2.1	0.0	20.8	1.0	15.3	32.3	10.3	0.3	1.3	3.3	0.7	1.0	0.0	1.0
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
NLRP4	"CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2"	ENSG00000160505	"NLR family pyrin domain containing 4"	Q96MN2	19	55836578-55881854	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.4;lymphoid tissue: 9.0;testis: 12.1"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 10.4;Late spermatids: 5.5;Spermatogonia: 2.3"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.4"	"Cell line enriched"	"Detected in some"	8	"Daudi: 42.9"									HPA062128			Approved	Mitochondria		NA	NA			Mitochondria		"HPA062128: "	"unprognostic (2.48e-1)"			"unprognostic (7.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"		0.2	0.2	1.9	1.0	1.8	0.0	0.2	0.2	2.9	0.2	0.2	2.7	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.2	1.0	0.3	0.2	0.2	0.2	2.8	5.1	0.6	0.4	0.2	0.1	0.3	0.0	2.9	0.2	0.1	0.0	0.8	0.0	0.2	0.2	0.3	0.1	9.4	0.3	0.2	12.1	2.2	0.0	0.2	0.4	9.0	0.2	0.2	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.8	0.2	2.9	1.0	0.3	5.1	0.6	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA		35000	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.1	12.2	1.3	9.7	4.2	4.8	1.9	5.5	6.4	2.8	4.8	0.7	10.2	7.4	16.9	7.0	4.1	10.3	3.7	3.1	0.9	9.5	4.0	9.7	4.2	6.6	6.4	3.4	5.7	5.4	13.2	3.6	7.0	5.6	5.6	9.9	0.1	4.9	2.8	10.9	5.7	8.2	6.0	5.3	6.8	11.2	1.7	2.4	6.6	5.3	1.8	6.4	8.1	4.3	3.5	2.0	14.0	10.1	6.5	5.5	4.9	4.9	2.8	1.8	1.9	2.5	0.8	10.4	3.9	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3	0.0	6.4	1.7	1.6	2.3	1.2	10.8	5.1	6.7	2.3	7.0	2.0	3.0	1.7	6.0	1.5	3.0	4.2	0.0	3.4	1.7	2.5	1.8	0.0	9.6	5.7	0.0	2.4	4.3	5.3	2.7	1.1	1.9	1.7	5.4	4.1	5.6	5.1	7.0	1.1	4.3	3.2	0.0	2.1	1.9	1.9	4.1	0.5	0.5	4.5	0.9
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	50.4	44.8	61.6	18.0	31.6	10.0	23.7	28.6	35.9	30.9	33.6	29.3	0.5	17.9	37.8	13.0	0.6	24.2	25.5	10.6	20.3	36.2	24.4	6.9	44.9	34.0	17.8	9.0	40.6	13.4	22.0	2.1	25.9	23.0	35.1	25.3	4.3	26.7	41.3	15.5	22.4	45.7	12.3	11.2	78.4	10.0	12.7	24.9	0.2	13.1	71.0	6.0	0.4	22.1	17.2	30.0	41.8	28.7	25.7	37.4	17.1	5.9	0.5	0.3	13.3	11.2	3.2	29.6	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9	0.0	11.5	29.0	48.4	28.6	13.9	34.0	35.7	4.0	4.5	55.8	2.0	59.9	212.2	109.2	3.5	43.9	11.0	186.9	35.0	20.4	74.3	109.3	29.9	119.9	107.7	7.9	43.4	47.9	41.0	14.6	82.6	23.2	59.1	66.7	34.5	18.6	75.4	17.3	89.1	59.0	5.4	51.8	95.1	1.4	43.5	21.5	18.2	14.9	56.3	48.5
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	3.0	3.3	3.7	0.8	0.7	4.4	2.9	0.4	0.5	0.4	3.9	5.2	4.8	8.8	0.6	3.3	3.5	2.3	1.0	0.7	4.4	3.9	22.3	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	7.0	0.5	2.9	3.9	10.6	0.5	4.7	4.0	3.7	7.5	12.0	2.9	3.5	3.7	3.2	1.0	5.2	7.2	4.4	6.9	3.8	2.5	6.5	9.5	11.2	3.9	4.7	10.4	5.6	4.3	17.6	8.3	3.4	3.2	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4	527.0	437.0	3.0	5.2	3.7	2.5	7.5	2.5	459.0	396.9	8.7	3.9	0.3	10.0	2.6	101.2	2.3	2.0	0.0	2.7	0.3	4.7	3.7	256.9	2.1	1.9	1.6	6.4	3.1	2.6	164.7	7.2	4.0	6.8	0.0	5.5	7.8	0.7	3.5	6.0	12.0	18.2	6.5	1.2	39.2	2.6	8.4	0.1	0.0	11.4	3.8
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 303.5;Hepatocytes: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		1100000	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.2	14.3	26.6	16.7	18.6	4.5	8.4	14.4	10.4	9.4	7.1	13.9	8.6	10.5	16.0	11.0	8.0	56.7	2.0	11.0	13.6	15.3	12.4	33.3	8.7	9.6	20.7	18.5	16.0	6.3	5.9	8.5	18.2	20.5	12.5	8.9	34.4	24.7	5.7	22.3	11.2	2.8	0.0	5.6	25.1	33.8	30.8	19.7	7.4	21.1	17.6	30.9	0.4	19.1	3.1	21.6	20.9	11.2	15.2	14.8	6.3	4.1	18.5	19.0	13.2	3.1	27.7	9.8	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1	50.6	27.8	20.7	7.7	10.2	17.5	303.5	28.1	24.1	31.8	26.2	33.4	7.2	23.2	10.7	12.2	12.6	17.2	23.3	9.3	2.1	17.9	10.5	23.3	274.2	21.7	6.4	19.1	20.3	31.4	3.4	13.8	18.2	13.5	10.8	24.6	13.2	9.5	11.5	18.0	21.1	11.9	0.0	15.1	2.1	1.2	7.0	1.7	27.7	25.8	7.6
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963370-56978823	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 22.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	4.5	4.7	2.6	3.0	3.2	5.4	5.3	4.3	2.8	4.3	5.3			7.0	5.9	3.8	6.1	6.0	2.9	3.5	2.5	2.1	3.6	2.8	3.3	5.1	2.1		5.6	13.9	3.6	2.1	2.3		3.8	4.9		5.9	3.7	10.5	6.8	4.9	3.2	2.6	3.8	6.0	1.7			4.0		5.8	6.7	4.5	20.2	16.5	7.0	14.1	20.3	22.3	14.3	7.5	7.0	5.2	9.2	9.6	17.2	14.3	6.0	10.8	6.9	7.0	12.0	14.2	27.1	10.4	5.0	5.7	8.1	9.8	10.6	6.6	5.0	12.7	6.8	6.2	13.0	7.5	12.3	7.4	15.9	12.9	6.4	11.2	14.7	11.5	11.9	11.4	9.8	9.3	10.9	17.6	16.5	6.8	14.5	10.8	12.3	5.6	10.2	9.9	11.3	12.0	10.2	6.1	25.0	8.9	6.9	11.2	8.8	7.5	5.6	13.4	6.7	11.1	12.6	5.2	14.1	5.7	7.9	7.1	6.2	14.1	7.0	12.2	13.0	18.3	20.2	18.2	15.2	16.5	17.0	22.3	18.4	4.8	20.3	11.2	13.3	21.1	14.3											3.0	4.3	15.3	14.0	22.6	6.3	12.0	12.7	18.7	10.3	7.0	3.9	27.0	16.6	15.6	19.3	11.3	11.0	0.0	19.7	29.3	15.0	12.7	8.1	4.3	16.0	1.6	16.8	6.7	17.8	9.1	15.0	14.6	11.8	19.0	19.9	8.0	18.7	21.0	21.9	11.2	8.0	12.9	16.5	7.5	10.5	21.7	23.3	19.1	38.8	19.5
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.8;Ito cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074367			Approved	Mitochondria		NA	NA			Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	15.2	3.2	3.9	11.1	3.7	6.6	18.3	2.0	2.4	6.5	6.2	4.3	5.0	2.2	8.7	8.9	6.1	7.3	10.1	10.9	2.9	2.1	5.0	2.9	13.8	6.0	3.2	2.2	13.6	4.6	3.8	4.6	13.3	4.7	5.5	4.7	6.4	7.7	7.6	7.2	7.1	6.2	16.3	4.7	12.4	6.9	3.2	3.5	5.1	27.2	6.4	11.1	7.6	6.1	10.9	8.2	13.3	6.2	8.7	9.8	2.4	4.3	2.3	3.2	9.6	2.1	9.9	5.0	3.0	2.1	5.1	6.5	2.0	5.2	6.1	3.6	3.8	5.7	10.1	3.2	5.2	3.5	3.2	2.7	8.6	7.1	2.0	2.6	3.8	6.5	9.1	2.3	3.2	2.8	4.6	16.7	9.3	4.5	2.2	4.6	2.5	5.4	6.8	3.8	4.7	4.1	6.5	3.7	5.5	1.7	3.4	0.6	11.7	3.8	9.9	3.3	4.7	3.3	8.6	7.0	4.5	7.4	5.5	4.1	2.0	6.8	0.2	3.3	13.5	4.6	12.7	3.9	13.3	8.8	5.2	9.8	7.6	6.1	5.7	3.4	10.9	5.6	4.5	3.0	8.7	6.2	8.2	4.6	2.4	3.9	3.7	2.0	2.4	2.9	2.1	3.2	2.2	4.7	3.5	3.0	10.8	0.0	0.4	0.7	0.6	4.0	0.0	4.0	7.9	5.2	0.0	4.5	0.0	1.3	0.0	6.0	2.0	0.0	1.8	2.0	3.4	0.2	2.3	0.8	3.8	0.0	0.0	10.4	4.3	0.0	0.6	4.4	5.0	3.6	5.7	0.9	1.1	0.0	1.8	0.5	0.0	0.0	4.7	0.0	0.5	1.6	1.3	2.9	5.2	0.9
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.1	20.7	1.5	0.0	13.6	15.2	1.8	15.9	19.1	13.8	15.9	1.5	13.6	9.0	7.3	23.3	16.1	9.6	0.1	12.5	17.1	5.0	7.1	2.3	28.0	4.5	12.8	9.3	7.2	11.0	16.2	22.6	22.1	17.2	5.1	4.1	3.3	34.3	12.1	3.6	5.4	6.6	4.1	1.7	4.4	1.9	14.4	19.1	4.0	0.7	2.7	2.1	27.8	4.0	6.6	1.8	1.8	13.4	12.2	33.4	6.6	15.9	12.0	6.9	6.3	14.1	17.5	9.6	11.6	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2	62.5	66.3	52.2	35.5	52.2	11.3	38.3	43.3	45.5	46.6	24.4	15.7	34.4	14.9	27.4	129.9	67.3	15.8	0.0	28.6	30.5	63.9	36.5	86.6	160.0	47.2	35.0	27.0	55.3	56.4	113.7	58.4	78.4	50.6	53.3	2.3	41.2	29.3	21.0	67.1	50.1	55.0	148.8	81.5	18.0	35.6	49.2	30.6	85.5	12.0	12.3
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267856-90332137	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	7.3	9.1	7.3	7.7	10.1	16.4	8.0	17.6	9.3	6.9	8.1	10.8	4.4	13.5	14.6	8.0	8.1	7.7	6.3	6.3	6.2	5.4	7.4	9.8	7.1	6.8	8.2	4.2	8.7	7.2	10.6	13.8	11.6	8.5	7.0	6.5	10.8	9.2	6.1	23.5	11.1	9.7	7.3	8.4	8.5	7.9	7.1	8.7	11.3	9.4	4.8	8.3	9.2	10.2	3.3	3.5	6.0	2.7	2.2	2.6	0.6	1.3	2.6	3.6	2.2	0.5	1.9	2.5	2.6	1.8	1.9	2.1	3.2	2.3	2.3	1.4	2.5	2.4	3.4	2.0	3.4	3.5	4.4	3.3	3.0	8.6	2.2	1.0	8.0	4.2	3.5	2.5	1.8	1.1	3.9	1.6	5.9	1.4	3.6	1.7	2.5	3.6	3.4	1.2	1.2	2.1	3.2	5.2	0.9	1.1	5.2	3.3	3.9	1.1	6.9	1.7	1.4	3.0	3.3	2.2	2.9	1.3	1.7	1.1	3.0	3.2	2.5	2.7	1.5	3.3	4.5	2.7	3.4	2.6	1.5	2.0	2.5	1.9	2.1	1.3	3.3	1.9	2.2	6.0	2.2	1.2	3.5	1.6	0.6	7.3	10.1	17.6	9.3	6.2	5.4	8.2	4.2	8.5	8.7	32.8	27.2	20.3	6.2	5.3	73.0	12.2	43.3	12.0	22.7	17.4	82.5	15.8	6.6	13.7	6.1	16.9	26.2	46.7	12.8	11.1	11.2	6.9	37.0	37.6	10.5	50.9	23.7	28.8	15.7	6.7	21.9	12.0	8.5	18.0	20.3	40.1	11.2	16.5	31.1	10.3	104.0	0.0	12.0	20.7	37.9	5.5	21.1	16.6	20.3	5.8
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.0"					"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.3	6.0	3.5	4.0	4.9	3.9	6.5	5.5	3.3	3.9	2.5	4.1	0.9	5.6	1.1	6.5	4.3	3.8	4.9	10.9	5.7	4.1	4.0	7.0	2.2	4.7	2.8	3.7	1.9	3.4	2.4	5.0	22.0	8.0	2.3	2.9	11.0	2.9	8.7	3.0	3.2	6.0	4.3	4.8	6.5	4.5	6.1	2.1	6.2	2.3	4.7	1.9	4.6	5.2	6.5	3.3	2.9	3.5	3.0	3.9	4.7	5.3	11.0	2.6	3.1	4.2	3.7	5.7	5.6	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7	0.0	2.9	0.8	17.0	3.9	1.5	2.8	2.5	9.4	2.3	1.8	0.0	4.2	0.0	1.8	8.8	1.6	1.6	0.0	1.8	4.4	3.9	10.0	0.0	4.3	1.7	9.5	39.5	1.3	3.5	7.4	4.6	2.5	0.0	2.8	9.1	0.8	2.3	0.0	7.8	1.5	4.9	0.0	8.0	0.5	3.1	3.9	3.4	0.9	9.0	8.6
NUBPL	"C14orf127, FLJ12660, huInd1, IND1"	ENSG00000151413	"Nucleotide binding protein like"	Q8TB37	14	31489956-31861224	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029203	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA029203: AB_10602810"	"unprognostic (1.49e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.64e-8)"	"unprognostic (2.82e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.56e-2)"	12.0	16.0	11.4	11.6	10.7	2.1	12.1	5.7	11.5	7.5	10.1	10.6	9.1	6.6	14.7	13.3	7.6	9.0	7.4	22.5	11.5	9.2	16.5	16.2	10.2	6.9	11.0	8.9	11.3	7.8	14.1	19.0	7.4	12.7	8.9	10.7	10.0	15.4	9.0	16.7	8.1	7.7	11.3	13.5	8.5	8.0	19.2	12.2	6.2	10.8	6.3	8.7	9.7	7.5	4.9	7.5	0.7	2.0	4.1	5.4	1.5	10.5	6.7	5.1	2.5	7.3	13.5	8.9	5.4	6.5	6.9	8.4	4.6	12.2	7.5	7.2	7.1	5.9	9.4	6.8	11.7	12.4	5.4	8.7	2.7	5.0	23.6	7.2	7.9	2.4	8.8	13.8	4.8	10.5	5.9	4.0	5.4	4.9	4.0	7.8	5.8	5.8	5.5	4.2	8.4	10.2	6.6	10.6	4.1	8.3	7.9	4.9	5.0	9.2	8.7	11.3	6.1	17.0	4.2	3.8	7.0	4.8	4.5	5.3	6.4	6.4	7.4	4.7	5.7	6.3	0.0	2.0	0.6	3.9	2.0	3.1	4.9	4.5	4.2	7.5	2.9	5.4	4.2	0.7	4.1	1.1	3.6	2.5	1.5	11.4	10.7	5.7	11.5	11.5	9.2	11.0	8.9	12.7	12.2	11.9	9.8	3.9	7.4	8.5	14.6	31.5	15.3	22.7	14.8	8.7	19.6	9.4	6.6	5.5	15.6	8.0	6.3	0.0	5.0	8.4	9.8	4.9	13.9	11.6	4.4	9.5	6.9	4.9	3.3	5.3	6.1	7.2	11.8	1.0	10.0	15.8	4.2	2.9	11.0	14.6	27.1	12.9	6.5	13.7	5.2	10.2	4.8	4.4	16.8	5.5
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
NYAP2	KIAA1486	ENSG00000144460	"Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2"	Q9P242	2	225399710-225654018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.9;pituitary gland: 13.5"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 17.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045531, HPA056945"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045531: AB_10960749, HPA056945: "	"unprognostic (2.49e-1)"	"unprognostic (3.34e-1)"		"unprognostic (1.24e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"		"unprognostic (6.13e-3)"		"unprognostic (3.33e-1)"	"unprognostic (2.08e-1)"		"unprognostic (1.32e-8)"	"unprognostic (9.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.27e-1)"	0.8	1.1	10.8	1.0	16.4	1.4	0.7	17.9	11.9	0.6	0.7	0.8	0.0	1.0	0.7	0.7	1.2	0.6	0.8	0.7	8.5	2.5	0.7	0.7	1.9	1.1	2.6	8.5	0.6	0.8	0.6	13.5	0.7	2.5	0.7	0.8	0.0	0.7	0.6	2.6	1.2	0.9	0.6	2.7	0.9	0.8	1.0	2.9	0.0	0.6	0.0	0.8	1.2	0.6	0.5	0.5	2.1	0.3	0.2	0.4	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.7	1.0	2.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.1	0.0	0.5	0.3	0.4	1.2	0.2	0.2	0.5	0.1	0.1	10.8	16.4	17.9	11.9	8.5	2.5	2.6	8.5	2.5	2.9	0.0	2.9	0.0	1.1	1.1	17.8	0.3	0.0	0.0	1.2	0.0	2.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	1.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	42.0	7.6	5.0	17.9	51.0	49.3	17.1	25.5	52.1	22.8	25.0	19.5	5.5	0.0	18.6	43.0	21.7	44.8	22.8	47.7	24.8	7.4	31.6	47.1	5.3	14.5	26.3	0.0	31.1	32.2	24.6	20.5	24.0	37.8	26.5	8.7	81.0	9.1	31.8	10.9	12.4	2.6	10.0	12.9	10.8	11.6	19.1	11.4	21.8	0.7	10.5	11.2	16.0	42.8	35.9	30.1	14.2	11.6	20.4	13.0	12.2	21.5	15.8	7.8	8.1	11.4	18.0	12.7	6.2	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4	17.9	38.8	36.2	123.3	134.4	27.8	14.0	22.9	44.2	75.1	33.2	25.5	97.9	76.3	32.5	16.9	35.8	49.1	303.7	12.0	67.3	125.7	58.3	43.8	69.3	56.5	41.3	41.3	35.6	32.6	9.0	96.4	49.4	81.0	20.8	48.6	32.0	11.7	36.8	112.8	114.0	21.3	77.6	123.8	32.5	27.0	110.2	40.3	40.6	67.9	76.5
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044803	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	28.8	43.6	59.9	24.7	73.5	21.8	35.9	55.3	82.2	37.4	37.6	36.1	35.4	33.5	34.1	49.3	28.1	41.6	29.9	47.9	62.7	61.9	57.8	79.0	27.7	32.0	51.4	60.7	40.4	34.6	52.4	53.5	29.0	53.6	34.8	39.6	29.1	34.8	36.4	53.5	23.9	30.1	33.4	51.0	23.7	31.0	23.7	35.1	29.1	55.1	37.2	31.0	31.6	24.0	33.2	35.9	30.7	33.6	41.9	43.2	30.0	25.3	18.6	38.3	26.2	38.0	45.9	29.6	41.5	64.9	42.7	50.1	18.1	72.1	29.4	41.5	36.4	50.3	22.2	36.3	38.4	51.9	24.4	24.3	45.8	18.9	14.7	56.3	47.1	49.6	48.9	56.2	33.5	41.4	50.5	43.7	28.7	50.9	16.5	49.6	17.3	40.4	47.1	31.5	31.6	17.5	28.2	37.2	31.1	82.7	25.6	22.5	41.4	20.4	16.2	45.9	31.9	32.7	41.3	33.0	28.3	32.7	19.4	51.7	42.8	59.3	46.3	34.5	37.8	34.5	17.6	26.0	30.7	30.5	28.5	41.6	33.2	34.7	36.2	32.5	29.3	43.2	37.2	21.2	41.9	33.6	35.9	29.0	30.0	59.9	73.5	55.3	82.2	62.7	61.9	51.4	60.7	53.6	35.1	148.9	102.8	64.1	94.0	70.7	125.5	130.0	91.7	135.1	126.3	115.1	62.8	145.3	116.0	119.6	27.3	96.7	127.3	23.3	111.9	141.2	103.1	99.3	136.5	146.0	135.1	84.2	124.9	116.0	90.1	28.7	122.6	103.2	82.7	75.7	122.7	180.6	107.9	109.4	130.8	136.7	91.1	122.9	84.8	156.2	74.3	66.4	137.8	88.7	125.2	76.6
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	10.2	22.4	13.8	21.5	18.1	9.2	15.8	10.6	14.6	14.5	16.4	14.1	20.1	12.1	15.4	15.1	17.1	15.9	12.1	15.8	12.6	10.0	23.0	23.8	19.1	17.9	16.7	9.6	15.0	18.2	15.7	20.9	8.9	13.0	17.8	16.1	11.3	20.6	22.7	20.9	10.2	16.1	24.2	18.2	17.2	13.9	6.9	19.4	18.4	18.3	14.5	16.4	17.0	20.6	22.5	9.5	18.6	19.5	18.6	22.8	10.2	13.5	5.7	3.8	3.5	19.2	18.0	10.9	5.6	6.1	4.9	6.2	1.6	8.2	30.6	11.9	5.8	17.2	13.9	13.4	13.6	5.8	23.4	7.5	9.5	4.4	6.6	9.5	23.3	6.7	16.9	15.3	4.8	10.0	11.1	4.3	15.3	18.0	9.2	13.4	8.3	7.9	8.3	5.6	20.5	12.4	9.9	12.5	12.8	10.7	9.1	4.0	1.9	11.4	18.8	15.8	18.3	8.5	9.0	2.5	2.5	5.1	12.6	5.8	7.5	9.8	20.1	7.8	18.3	6.2	10.8	9.2	18.6	12.8	14.5	16.5	22.5	15.7	15.0	9.5	21.4	22.8	20.8	10.6	18.6	19.5	5.0	13.9	10.2	13.8	18.1	10.6	14.6	12.6	10.0	16.7	9.6	13.0	19.4	17.9	11.5	14.7	15.7	5.4	7.2	25.0	10.2	54.9	11.4	24.4	11.8	19.1	21.6	7.7	5.0	4.9	6.9	0.0	4.8	7.8	8.6	15.0	5.8	15.5	13.6	1.6	5.8	8.6	10.7	9.7	9.2	10.4	6.8	7.2	15.0	10.0	5.2	10.4	8.1	20.7	19.6	6.5	4.4	11.7	12.1	5.9	15.3	13.8	13.0	17.5
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	6.6	17.0	8.6	6.5	12.1	2.6	11.1	12.9	10.9	7.3	5.6	14.8	2.9	5.0	11.8	9.1	7.0	8.1	4.8	13.0	8.4	7.3	13.0	11.6	5.8	11.2	18.9	9.3	13.8	6.1	7.5	9.8	6.1	11.6	6.9	6.1	9.0	9.7	6.1	16.6	9.2	6.5	8.1	13.4	9.6	5.8	9.4	15.4	10.6	8.2	7.3	9.2	8.0	5.8	9.3	6.0	2.1	2.6	6.6	11.5	3.0	5.6	3.1	13.9	10.6	11.0	6.1	8.3	8.8	6.2	12.5	13.5	3.7	5.9	3.8	9.9	3.7	7.0	8.3	12.4	10.4	14.3	9.7	9.5	12.3	7.7	4.8	5.8	6.9	6.4	6.7	8.9	9.4	4.7	8.6	9.3	9.7	4.4	6.0	8.2	3.2	5.4	8.0	6.7	7.7	14.5	5.9	11.2	6.5	8.1	3.2	8.5	9.4	5.9	10.8	19.2	18.1	8.4	7.6	3.9	8.2	7.2	11.9	5.4	6.1	5.1	6.1	10.8	8.9	8.9	0.2	2.6	2.1	7.3	2.4	10.5	7.4	7.7	8.4	3.5	9.3	11.5	10.2	0.4	6.6	2.1	6.0	5.9	3.0	8.6	12.1	12.9	10.9	8.4	7.3	18.9	9.3	11.6	15.4	6.0	2.2	1.3	2.3	1.6	8.0	8.1	2.5	8.1	1.2	0.0	11.8	8.6	6.6	2.4	0.6	2.3	0.9	0.0	2.0	6.1	3.8	1.2	3.5	3.0	3.8	9.5	0.0	4.3	1.0	0.0	10.3	2.3	1.7	0.0	1.1	12.4	1.5	0.0	7.8	8.4	10.0	25.8	3.1	10.7	12.6	1.8	1.8	5.0	2.3	0.5
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 74.1;Ito cells: 20.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;NB-4: 1.7;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	1.7	0.0	0.2	0.0	0.0	0.0	0.0	74.1	0.0	0.0	1.2	20.3	1.9	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.5	0.0
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699711	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	10.0	7.4	5.9	22.6	7.8	32.3	8.4	7.2	6.6	8.2	9.3	8.3	8.9	10.7	9.5	7.7	13.8	6.1	10.8	15.5	6.7	4.9	8.5	19.5	11.1	16.0	9.6	2.8	9.1	12.2	7.5	9.8	11.8	7.0	11.1	7.0	7.7	10.6	10.8	16.5	18.1	11.7	8.1	10.5	12.5	7.1	11.5	7.4	15.0	7.8	9.7	19.3	8.5	15.8	3.4	2.9	3.1	3.0	1.0	4.6	0.9	6.4	7.5	7.5	8.5	7.0	7.3	8.3	6.5	4.6	9.3	7.0	10.1	4.8	11.6	12.8	4.2	13.4	7.4	9.3	8.5	6.4	20.0	7.7	8.3	23.9	5.4	6.0	7.9	14.3	4.1	10.5	7.6	6.5	5.1	7.8	9.8	8.2	18.6	6.6	4.0	7.8	6.9	4.6	6.8	8.0	12.1	6.8	4.6	6.0	6.7	3.4	5.6	23.1	5.2	5.0	9.6	5.7	9.1	7.2	12.1	13.7	9.0	8.5	8.4	12.7	13.2	6.9	15.1	6.2	0.4	2.0	3.1	1.0	2.2	3.0	0.9	2.5	3.4	2.9	3.4	1.8	3.9	2.2	1.0	3.0	2.5	4.6	0.9	5.9	7.8	7.2	6.6	6.7	4.9	9.6	2.8	7.0	7.4	3.0	8.6	13.4	20.2	0.0	10.9	13.4	15.3	9.4	7.9	5.2	13.7	13.2	6.6	4.2	7.3	8.7	13.9	0.0	5.0	8.6	4.9	19.7	10.3	32.7	12.3	7.9	9.1	8.0	11.8	2.5	9.8	10.6	0.0	13.6	11.6	13.0	7.1	8.4	6.0	8.9	32.3	0.0	6.2	23.8	30.4	0.0	11.9	15.0	8.9	19.3
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L, mitochondrial inner membrane protein"	Q15070	14	22766522-22773041	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	27.8	36.0	11.9	21.2	15.5	25.1	28.4	13.5	23.0	25.4	30.9	18.5	24.3	27.2	22.7	23.9	30.2	21.5	30.6	48.3	12.9	13.0	31.9	58.4	25.8	45.0	15.2	10.9	31.4	59.6	30.0	12.3	18.3	17.9	25.3	24.2	28.1	24.9	27.5	76.3	24.9	32.8	23.9	13.5	32.9	29.9	17.0	10.3	32.7	37.3	49.0	38.3	31.3	22.3	22.1	39.9	7.2	29.4	16.3	22.6	19.9	21.3	29.5	13.3	22.3	37.8	56.3	24.5	16.3	34.4	23.7	27.5	22.1	24.5	40.2	21.9	18.9	18.4	30.6	25.6	31.7	23.9	16.7	16.5	19.9	20.4	80.9	42.3	37.1	24.8	55.1	35.3	19.6	30.4	30.4	68.2	23.6	14.7	32.9	26.0	31.4	21.9	14.4	13.5	28.4	37.2	22.5	22.0	30.5	30.3	26.8	9.1	17.6	23.7	52.8	31.2	16.5	22.5	30.1	21.8	14.2	16.5	25.8	18.6	24.8	19.7	18.8	11.1	21.4	15.2	4.8	27.9	7.2	13.4	29.4	16.3	22.1	19.2	16.9	39.9	21.9	21.9	16.3	6.3	16.3	22.9	11.3	22.6	19.9	11.9	15.5	13.5	23.0	12.9	13.0	15.2	10.9	17.9	10.3	44.7	38.2	84.8	43.0	61.7	27.2	99.9	84.1	38.8	36.4	27.9	9.8	61.8	63.0	75.1	6.3	57.3	51.9	23.3	140.4	103.7	55.7	38.4	77.5	82.5	125.3	17.5	39.0	57.7	124.8	10.2	52.9	86.1	49.0	93.8	66.6	20.9	92.6	80.7	34.6	95.3	30.4	38.8	51.5	34.7	25.8	58.8	47.8	70.4	100.6	68.0
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 212.2;Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 56.9;SiHa: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.9	0.3	6.6	7.9	20.5	11.0	0.0	14.3	9.1	11.9	7.2	1.2	5.4	20.7	3.5	10.9	6.1	4.7	18.0	12.9	14.0	17.7	2.1	14.5	56.9	2.7	8.9	28.2	4.9	10.3	3.5	11.6	19.6	5.8	10.8	18.9	2.9	26.7	13.6	1.0	23.5	1.3	1.4	0.0	5.7	18.7	18.5	15.6	9.7	0.6	6.6	6.8	74.0	0.0	8.7	0.6	0.1	6.1	6.5	9.5	12.4	16.2	11.5	4.4	3.6	0.8	14.3	20.7	7.2	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3	6.0	8.6	7.5	12.0	13.2	13.1	212.2	7.6	5.3	18.2	10.4	2.0	5.2	159.2	4.7	14.3	5.6	2.3	0.0	0.6	9.8	8.4	11.2	9.2	0.0	29.1	12.7	12.7	4.9	1.0	5.6	5.8	4.4	15.1	3.6	13.4	11.3	3.9	3.5	7.1	11.3	19.5	12.9	15.6	36.7	14.9	18.9	5.7	17.3	15.5	5.2
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	15.2	3.9	11.4	22.1	35.2	27.1	9.5	44.7	40.5	17.3	41.6	6.5	11.9	5.2	17.1	44.2	10.5	17.3	7.1	16.3	37.9	6.6	2.7	4.4	3.7	7.7	14.7	8.1	3.1	16.4	9.5	14.7	19.5	94.8	8.1	4.4	6.8	2.7	14.9	4.0	3.2	7.8	4.1	7.1	17.3	2.9	7.6	9.3	9.7	6.6	1.0	6.4	9.1	27.0	10.6	26.9	4.1	7.6	7.7	21.2	8.7	5.9	10.4	15.6	5.6	2.5	38.0	11.8	10.3	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9	6.0	27.9	18.6	25.1	32.3	12.9	37.9	2.5	56.2	31.8	22.7	25.5	25.0	0.0	26.6	10.0	23.3	10.7	0.0	17.0	76.6	76.1	22.0	39.3	25.1	39.6	11.1	9.9	19.0	44.8	4.7	48.1	41.1	42.2	36.1	7.6	33.4	37.2	18.2	44.2	22.8	17.6	38.8	31.1	35.7	35.8	20.8	27.8	13.8	6.5	17.3
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 92.2;Late spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	15.3	10.8	18.8	7.7	25.5	6.1	13.3	20.5	29.8	8.0	7.7	41.7	6.5	8.4	10.0	8.1	8.9	9.6	8.7	15.1	23.9	18.0	6.8	3.7	9.3	6.1	36.8	13.9	11.8	21.3	10.3	8.1	6.9	26.3	7.6	5.5	6.7	11.8	9.8	63.8	7.2	9.1	8.1	65.7	10.9	7.4	13.4	26.8	2.7	7.1	7.0	4.4	8.3	7.3	0.6	5.4	0.3	4.0	2.1	2.0	0.9	9.3	12.9	12.2	11.5	12.2	11.9	14.5	7.1	8.3	6.1	5.4	5.6	17.8	10.2	12.1	10.8	7.9	10.8	7.4	10.2	4.4	12.7	6.1	4.6	5.1	8.3	16.1	3.8	8.5	13.8	9.8	4.3	10.0	7.8	11.1	10.4	2.9	9.6	5.3	29.3	6.4	5.1	4.7	11.9	10.7	14.4	7.4	6.5	5.2	21.6	27.5	14.6	6.8	6.2	10.6	8.0	15.6	7.1	16.8	9.1	4.2	14.3	7.1	12.7	8.2	3.8	13.9	6.9	8.8	0.0	1.6	0.2	0.9	2.7	1.7	0.2	0.8	1.0	2.7	0.6	0.3	1.0	0.3	2.1	4.0	5.4	2.0	0.9	18.8	25.5	20.5	18.9	23.9	18.0	36.8	13.9	26.3	26.8	8.9	14.3	0.8	6.5	8.0	30.2	17.8	7.6	1.4	13.6	5.2	11.8	3.8	11.6	11.7	47.3	15.8	19.0	0.0	19.9	2.8	11.2	8.4	1.1	7.8	15.0	92.2	12.5	19.6	14.3	63.1	16.1	13.3	25.3	8.2	13.4	14.7	14.0	10.5	15.6	10.5	22.4	6.5	12.7	12.9	11.3	7.3	2.9	5.3	16.6	7.1
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687450-49695993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 18.2"	"Cell type enhanced"	"Detected in some"	30	"Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3"									HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	37.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.7	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	32.3	0.0	65.7	164.4	0.0	0.0	0.0	0.0	0.0
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220355-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 32.0"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 84.1;Spermatogonia: 158.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.5"	"Group enriched"	"Detected in some"	164	"Karpas-707: 67.1;U-266/84: 141.6"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052619: AB_2681887, HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	32.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	4.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	141.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	4.5	0.3	3.8	1.6	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.3	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	9.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	6.5	0.0	84.1	158.4	0.1	0.0	0.0	0.0	0.0
PAM16	"Magmas, Tim16, TIMM16"	ENSG00000217930	"Presequence translocase associated motor 16"	Q9Y3D7	16	4331549-4355607	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 36.3"									HPA062721			Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Microtubules	"HPA062721: AB_2684849"	"unprognostic (2.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (7.25e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"prognostic favorable (1.33e-4)"	10.9	15.2	12.9	8.4	14.1	17.0	10.0	9.3	15.1	7.0	9.5	5.6	8.2	14.0	7.8	11.8	11.2	7.5	7.5	19.9	11.1	10.7	9.2	33.7	9.8	10.9	9.8	11.3	8.5	26.1	7.1	10.3	8.0	9.2	8.8	8.0	7.8	13.2	11.0	54.5	12.6	10.1	8.2	8.3	9.5	10.1	16.2	7.3	7.3	12.0	17.8	9.6	8.4	9.9	16.0	19.8	11.2	15.3	11.5	14.3	12.3	3.9	7.7	4.2	10.3	2.8	3.9	10.9	9.5	2.3	3.6	2.9	5.4	5.8	11.5	10.6	2.8	3.7	8.1	3.9	4.2	1.7	11.2	25.4	12.0	7.2	3.8	4.6	8.4	9.0	5.8	5.4	4.3	4.7	3.2	2.8	8.1	14.1	5.5	3.0	10.6	7.6	14.7	6.8	2.5	17.2	14.5	3.5	11.1	3.7	3.8	16.0	12.4	8.2	7.0	9.7	3.3	9.2	10.2	3.5	7.2	9.3	36.3	10.4	8.2	8.8	14.3	2.6	8.2	6.8	0.2	15.3	2.3	12.3	9.5	10.5	16.0	11.2	11.3	10.7	15.5	14.3	13.7	11.2	11.5	10.2	19.8	12.7	12.3	12.9	14.1	9.3	15.1	11.1	10.7	9.8	11.3	9.2	7.3	3.0	4.5	2.2	0.9	3.5	0.5	0.4	10.2	6.7	5.7	0.0	0.0	1.9	6.6	3.1	2.6	0.7	2.1	0.0	2.6	2.3	2.7	1.0	1.1	10.9	1.5	1.6	0.0	4.3	7.8	0.8	4.6	1.1	1.7	7.2	2.1	0.3	5.2	3.4	3.5	3.0	0.6	6.5	1.4	8.9	12.9	5.1	1.0	1.7	3.4	1.0
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.7	1.2	0.0	25.7	32.8	0.0	35.4	30.3	21.6	15.6	0.1	0.7	0.0	1.8	89.6	0.6	1.5	2.6	2.5	24.7	0.0	1.9	1.6	2.6	0.0	38.9	0.0	0.7	11.6	0.0	12.4	1.0	26.0	17.9	0.2	0.0	16.7	15.1	13.5	0.0	0.1	1.4	0.8	4.6	0.0	0.0	0.0	22.5	1.6	0.1	0.3	17.2	0.6	0.2	2.5	2.5	0.9	22.4	7.3	4.3	24.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3	223.4	31.0	5.2	0.8	2.1	0.0	3.5	5.1	2.7	14.8	8.7	0.0	0.4	11.6	4.4	0.9	11.3	147.6	0.0	25.2	0.6	18.5	2.7	0.0	93.7	11.5	0.0	12.1	28.8	29.3	0.2	16.1	25.7	1.7	1.8	25.6	1.0	24.6	48.9	4.9	8.4	0.0	12.9	11.3	0.4	0.6	1.1	1.1	1.3	42.4	0.9
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	24.2	20.6	26.2	19.2	30.1	21.2	30.4	22.1	29.6	22.7	29.0	24.4	19.4	21.5	20.2	43.8	21.4	19.6	21.2	30.9	23.1	23.4	27.0	26.7	20.3	26.5	28.4	20.3	20.3	47.5	22.0	20.6	18.5	19.5	22.1	31.3	25.9	35.1	33.4	41.2	22.3	27.0	38.1	19.4	22.3	24.5	22.2	18.9	22.1	20.7	25.4	24.3	23.2	18.2	21.5	45.4	44.3	50.0	21.5	25.9	35.4	32.6	15.5	11.5	9.8	11.2	12.9	23.9	12.3	16.7	23.7	18.6	47.7	17.1	14.6	27.4	15.6	21.3	14.6	18.3	18.9	26.7	20.7	22.5	22.0	10.4	26.1	16.8	21.8	18.6	17.5	24.3	16.6	20.3	11.2	16.8	23.2	12.5	13.6	19.4	35.4	41.6	53.4	30.9	27.4	15.9	18.4	22.5	26.5	22.1	27.3	11.6	16.5	14.6	47.2	30.0	14.7	48.5	41.4	9.8	8.8	19.2	18.2	31.2	27.4	18.5	33.6	16.9	22.2	10.5	27.6	50.0	44.3	19.0	35.4	21.7	21.5	21.6	22.1	45.4	19.9	25.9	21.1	14.5	21.5	26.2	27.0	24.4	35.4	26.2	30.1	22.1	29.6	23.1	23.4	28.4	20.3	19.5	18.9	20.8	26.1	28.3	47.3	27.0	33.9	33.9	20.4	18.7	15.9	29.6	29.5	49.5	99.5	41.8	15.3	30.4	28.2	0.0	73.6	40.6	37.9	39.4	69.2	28.2	68.8	31.8	32.4	30.1	52.8	7.4	26.7	58.0	40.5	60.5	36.5	35.7	49.3	35.1	25.5	71.7	38.7	6.5	49.1	43.3	46.0	26.2	35.2	38.5	49.1	46.1
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6"					"Not detected"	"Not detected"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.3	0.6	0.1	0.0	0.0	1.9	0.2	10.6	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	0.4	2.4	6.6	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.2	0.3	4.9	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.6	0.8	5.1	12.6	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4	17.9	12.8	22.9	0.0	0.5	0.0	0.4	0.0	18.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.5	0.5	6.6	0.0	0.0	2.5	3.5	0.0	0.0	3.2	1.7	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	12.9	0.0	0.0
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764514	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	6.8	8.4	4.7	4.0	8.2	0.5	6.2	5.2	7.9	6.5	9.0	9.5	8.3	6.0	7.9	7.5	7.0	10.4	4.1	6.6	6.5	4.4	9.6	11.3	4.1	5.8	4.5	5.3	11.5	13.6	7.0	6.6	5.6	4.9	7.1	8.3	5.0	7.2	6.9	8.7	6.7	5.1	4.9	4.3	4.9	6.2	11.5	9.4	8.7	6.7	5.9	5.2	6.0	5.2	7.3	8.9	5.3	11.6	8.1	10.5	6.0	4.7	7.8	5.1	6.7	6.3	5.4	11.5	4.0	5.0	7.2	5.2	9.0	3.1	8.3	6.4	3.6	10.5	7.6	9.2	6.4	5.4	5.3	8.3	8.0	4.8	6.6	9.8	4.6	2.8	5.8	9.8	9.3	8.4	6.2	5.3	9.2	14.0	1.1	5.4	5.0	6.4	6.1	11.8	9.0	10.1	5.0	10.1	9.6	6.1	3.4	5.3	5.4	5.8	7.7	10.5	10.3	4.4	5.9	2.8	5.4	5.6	7.6	5.0	8.2	6.9	3.3	4.0	5.5	3.1	1.5	6.6	5.3	6.4	9.7	7.6	6.1	7.0	6.8	8.9	7.3	10.5	7.0	0.6	8.1	11.6	7.1	9.3	6.0	4.7	8.2	5.2	7.9	6.5	4.4	4.5	5.3	4.9	9.4	0.0	0.6	0.5	0.9	0.6	2.1	1.0	2.5	0.0	1.2	0.0	0.0	5.8	8.3	3.9	6.5	0.0	1.7	0.0	2.4	4.0	0.6	1.1	0.0	1.9	2.6	4.8	0.0	0.0	1.2	5.3	3.4	0.7	0.0	1.0	2.5	2.8	2.1	0.0	2.8	4.5	1.3	0.0	0.4	8.1	10.4	0.9	2.7	0.0	4.3	0.6
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Group enriched"	"Detected in some"	19	"Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.5	1.0	0.0	1.7	1.4	2.4	1.3	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	0.3	8.1	1.2	8.1	0.0	30.7	5.4	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.8	0.0	1.2	0.0	0.0	3.5	2.0	0.8	0.1	4.6	0.5	0.0	0.1	1.2	13.2	0.0	0.0	0.0	0.0	4.6	2.3	0.0	0.8	4.1	0.9	0.7	3.5	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.1	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.8	0.0	0.3	0.0	29.4	14.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.6	15.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.3	0.1	0.0	0.2	10.8
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.9	14.9	0.0	0.8	0.2	1.6	0.7	0.0	0.0	0.0	0.3	4.0	1.9	0.0	0.8	0.0	0.2	27.2	0.1	0.0	0.0	0.0	7.0	0.0	0.0	20.9	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.1	0.9	0.3	7.7	1.6	0.4	0.0	1.3	0.0	0.0	1.1	0.0	0.0	2.6	23.6	0.5	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	6.1	0.0	0.3	1.5	0.0	12.6	15.1	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1	0.0	0.0	1.4	0.1	0.2	151.7	2.8	0.0	0.0	1.2	1.8	47.1	0.0	0.0	0.1	29.4	0.5	0.0	0.0	0.2	0.1	1.3	0.9	0.0	0.0	0.4	109.7	2.9	2.5	0.0	60.8	7.8	0.2	3.3	0.0	0.0	29.6	1.4	0.0	12.0	0.0	75.1	0.0	5.3	25.0	12.0	0.0	0.0	0.0	0.0	0.3
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 84.6;Proximal tubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		120000	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.3	5.9	9.8	3.2	9.4	8.2	5.5	3.3	5.0	3.1	2.9	7.3	4.5	0.2	5.1	3.2	4.0	3.8	2.9	4.6	5.1	5.5	3.2	7.7	4.2	15.8	5.2	0.3	3.7	7.5	5.0	2.9	4.8	7.6	6.4	4.2	3.0	4.4	5.6	3.6	0.8	17.3	6.1	11.8	2.6	6.7	4.2	5.4	54.3	6.6	30.1	3.6	2.2	12.6	5.5	11.1	9.1	13.7	4.6	3.2	2.7	2.2	2.3	4.3	3.9	0.1	6.1	41.9	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9	3.0	8.3	7.3	25.7	1.6	15.4	8.7	38.2	10.7	10.3	19.2	27.5	21.2	84.6	13.8	14.8	9.9	14.0	0.0	7.3	5.4	7.1	14.3	13.9	41.9	10.3	27.0	3.5	11.6	10.2	7.9	8.1	7.2	5.0	2.8	10.1	10.4	6.2	14.0	12.7	63.9	32.3	12.9	8.9	4.8	4.3	3.3	25.3	4.9	26.5	19.5
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Horizontal cells: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8"	"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"		NA	NA			"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.1	7.7	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1	0.0	2.2	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966235-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 14.1;parathyroid gland: 52.5"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 36.9"									HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	1.1	1.7	5.7	1.0	9.2	0.5	0.7	13.6	14.1	1.5	0.9	2.3	0.0	0.7	1.2	0.6	0.6	0.8	3.2	1.2	4.5	5.2	0.9	1.3	2.5	2.2	2.9	6.4	0.7	0.9	52.5	3.1	2.2	3.8	0.9	0.9	2.7	1.1	0.7	0.6	0.6	0.7	1.4	2.0	2.1	1.0	2.4	1.7	0.0	1.6	0.0	1.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.7	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.5	0.0	0.7	4.0	0.0	0.0	0.1	0.0	8.4	0.0	0.5	0.0	0.0	0.1	5.5	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.6	6.6	0.0	0.0	0.1	0.8	1.4	0.2	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.2	13.6	14.1	4.5	5.2	2.9	6.4	3.8	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
PCDHB15	PCDH-BETA15	ENSG00000113248	"Protocadherin beta 15"	Q9Y5E8	5	141245349-141249365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.2;Early spermatids: 5.6;Horizontal cells: 4.8;Peritubular cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 9.3;LHCN-M2: 7.7;WM-115: 7.5"									"HPA007172, CAB026471, HPA074676"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	8.6	3.6	7.9	5.5	8.4	0.6	4.0	15.1	17.1	8.5	5.3	8.0	0.3	1.5	12.9	6.0	3.5	7.2	4.7	8.6	5.9	4.1	3.8	2.6	5.4	2.0	4.9	6.0	13.6	5.7	2.7	5.7	3.6	8.9	6.4	2.6	3.7	3.1	5.1	2.9	2.6	2.7	9.1	9.4	5.6	4.8	9.1	7.6	0.0	4.5	4.4	1.6	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.1	9.3	1.2	2.5	2.6	0.1	0.7	1.8	0.1	0.5	0.0	0.5	0.0	1.8	1.4	2.4	0.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.3	0.0	0.0	1.2	2.2	0.1	0.3	2.4	0.4	0.0	0.1	1.7	7.7	0.0	0.0	0.2	2.3	0.0	0.1	0.3	0.6	0.0	0.6	0.0	0.5	1.3	0.3	0.5	2.5	1.3	0.4	0.0	0.0	0.7	1.0	2.9	0.1	0.1	1.2	0.0	1.2	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.4	15.1	7.3	5.9	4.1	4.9	6.0	8.9	7.6	0.0	0.0	0.0	0.1	0.1	4.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.7	0.0	0.0	1.3	0.0	0.5	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	2.0	0.6	0.0	1.7	0.0	0.0	1.5	1.0	0.0	3.2	0.3	0.5	0.0	2.0	1.8	0.1	0.5	0.0	0.0	0.0	0.2
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	17.6	15.2	21.8	33.5	23.3	32.1	21.1	29.7	21.3	22.1	19.7	13.6	30.8	14.0	25.6	36.8	21.9	23.4	20.8	14.0	21.7	10.0	15.7	14.5	24.0	25.8	26.6	15.4	28.9	16.1	22.4	32.5	18.9	19.2	25.6	17.9	13.8	22.5	28.5	27.0	32.5	21.2	21.4	20.6	27.2	17.7	20.1	27.4	29.4	23.4	22.5	25.1	24.8	29.3	11.4	6.8	17.5	7.2	13.0	10.5	5.3	11.2	8.1	13.1	11.2	15.8	15.5	10.6	10.8	8.0	10.5	8.0	13.7	11.3	25.4	8.2	7.8	9.9	11.4	19.1	7.4	10.1	18.0	6.5	14.8	10.5	9.6	8.9	17.4	16.6	10.9	14.5	7.9	11.6	14.1	10.5	17.1	17.2	12.4	9.7	12.0	16.3	19.4	13.7	19.3	9.1	15.6	16.6	15.2	9.1	16.8	11.0	12.2	13.2	10.6	10.6	12.7	10.5	12.1	10.8	14.9	7.7	11.0	7.1	11.2	18.7	54.0	6.5	11.6	11.5	12.0	7.2	14.2	10.5	6.9	9.1	11.4	7.4	7.6	6.7	10.4	8.6	8.5	17.5	13.0	5.1	6.8	5.1	5.3	21.8	23.3	29.7	21.3	21.7	10.0	26.6	15.4	19.2	27.4	38.7	59.9	50.4	59.3	47.7	46.6	38.1	30.6	25.4	48.9	43.6	31.4	24.8	21.6	18.2	150.1	49.7	50.2	23.3	15.9	22.0	35.6	61.5	34.8	18.3	32.9	52.4	30.6	53.4	42.5	25.5	55.8	46.3	27.0	28.9	46.6	43.9	16.5	42.1	42.5	12.6	55.5	38.8	61.3	43.2	16.6	54.7	33.0	57.3	41.7	58.5
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.5	3.1	0.9	5.9	3.7	3.7	15.0	6.9	8.3	5.8	9.4	5.1	6.4	14.1	0.8	10.6	1.9	8.1	6.0	8.9	4.8	7.2	0.2	2.5	1.7	27.5	35.3	4.9	11.1	4.3	34.3	3.6	8.9	1.6	4.6	16.4	7.2	26.1	2.2	23.9	1.2	2.5	1.0	12.5	4.2	2.8	3.4	8.0	1.7	8.6	3.7	5.9	5.3	6.8	32.5	0.9	9.2	7.6	0.8	1.2	6.7	1.8	1.9	17.9	5.6	3.5	3.5	7.7	3.1	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3	11.9	22.0	24.4	8.8	3.0	4.1	1.2	20.4	2.7	3.4	17.4	0.0	3.4	29.9	17.2	49.9	3.5	152.4	0.0	67.0	11.6	5.3	6.8	1.1	291.7	56.2	0.0	8.7	10.4	15.0	15.5	3.1	14.5	6.8	29.7	43.0	5.6	27.0	63.4	2.8	166.4	5.4	0.0	5.1	8.6	0.9	4.3	2.5	9.6	63.5	11.9
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Rod photoreceptor cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA057849: AB_2683544"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	18.5	22.6	24.2	28.9	24.9	9.7	32.4	49.7	27.3	20.1	14.9	21.1	19.2	14.9	26.0	33.5	15.2	17.2	21.2	26.2	19.8	20.2	22.9	20.2	20.0	25.6	18.5	22.8	38.9	18.1	20.4	21.8	26.3	18.0	19.9	13.6	57.8	20.5	16.9	25.7	42.1	15.7	17.3	19.6	22.1	13.7	17.0	18.2	31.2	19.5	10.5	18.5	17.7	18.1	9.5	7.5	8.3	6.6	14.1	18.1	7.9	10.9	4.0	15.9	12.4	15.4	19.1	15.2	6.8	7.5	9.9	6.1	9.4	17.6	16.4	12.1	8.1	7.8	13.6	8.7	11.0	13.4	3.5	11.9	7.9	17.9	15.7	13.0	8.2	12.1	27.0	15.3	5.2	9.0	17.7	14.3	16.7	14.5	14.8	8.0	7.1	18.8	27.1	11.7	15.2	16.9	15.7	6.3	19.5	15.0	12.7	25.3	29.9	13.0	15.0	17.5	26.0	16.0	16.5	10.4	14.9	5.3	9.5	5.4	18.0	14.6	15.8	9.8	8.7	8.6	7.6	6.6	7.6	8.4	4.5	10.0	8.9	12.5	9.5	7.5	9.5	17.7	12.7	8.3	14.1	4.1	4.7	18.1	7.9	24.2	24.9	49.7	27.3	19.8	20.2	18.5	22.8	18.0	18.2	20.8	21.1	17.1	14.0	18.1	110.9	54.5	20.4	30.8	22.7	27.9	88.4	26.4	19.9	6.5	7.3	34.6	6.7	46.7	7.9	6.2	23.4	15.8	12.7	26.8	12.1	35.0	21.9	52.8	33.3	8.2	39.7	12.8	45.5	5.4	18.1	55.9	9.2	16.7	29.0	18.4	170.0	25.8	19.8	42.9	28.3	18.6	18.3	17.5	14.0	7.8
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"RT4: 16.1;T-47d: 10.5"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	16.1	2.2	0.0	0.0	0.3	0.0	0.2	10.5	0.4	0.2	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3	3.0	5.4	0.0	23.9	0.0	34.5	0.2	0.0	0.0	7.9	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.2	1.8	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	1.8	0.0	4.1	19.4	9.5	0.2	0.2	0.3	1.5	0.0	0.0	42.7
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358007-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Rod photoreceptor cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted - unknown location"	NA	NA		930000	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	4.8	6.6	4.5	7.2	13.5	6.9	4.0	15.9	19.0	6.5	4.4	8.2	2.7	2.3	6.2	2.7	4.6	7.9	5.8	5.2	4.6	8.9	3.7	1.2	4.2	9.6	5.5	9.9	7.9	6.7	27.0	6.4	6.2	13.7	6.4	2.1	9.4	3.4	6.6	1.6	6.6	5.6	6.0	4.6	6.3	5.8	11.5	2.4	5.8	3.3	3.1	7.4	5.0	4.7	1.8	13.5	3.9	9.6	4.5	7.2	4.5	2.1	1.5	2.9	6.3	2.4	1.5	2.1	5.1	1.0	2.5	5.3	0.4	3.5	9.7	15.4	1.6	14.7	4.3	3.2	7.2	0.3	4.7	4.7	4.5	0.0	0.3	7.0	2.9	4.2	6.4	1.2	5.0	4.4	3.4	7.9	8.4	2.6	19.2	0.2	3.4	2.7	4.2	2.7	3.2	9.2	5.2	2.3	25.7	1.0	0.6	5.9	7.7	10.0	3.6	7.9	1.4	9.5	5.5	4.6	2.9	3.1	7.2	2.0	11.3	15.2	5.5	6.1	17.8	7.4	3.0	7.1	3.9	3.0	9.6	4.0	1.8	5.7	2.3	13.5	1.2	6.8	4.7	1.2	4.5	9.1	1.3	7.2	4.5	4.5	13.5	15.9	19.0	4.6	8.9	5.5	9.9	13.7	2.4	8.9	1.7	0.0	1.1	0.9	4.5	4.5	5.1	1.4	2.3	1.8	0.0	4.0	0.0	2.2	2.8	3.8	0.9	0.0	2.1	6.2	2.8	0.7	2.3	0.0	6.4	11.1	0.0	2.5	4.7	1.1	3.1	4.8	1.7	3.6	1.7	6.8	1.7	1.1	2.5	0.3	12.8	0.0	1.2	0.9	3.3	1.4	1.0	2.1	2.2	0.6
PDCD2L	MGC13096	ENSG00000126249	"Programmed cell death 2 like"	Q9BRP1	19	34404384-34426168	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 28.8;Spermatogonia: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA052181	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052181: AB_2681751"	"unprognostic (5.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.98e-2)"	6.2	6.6	7.7	7.3	8.9	4.5	6.1	8.8	15.6	5.4	5.8	6.8	6.3	4.6	5.8	6.1	5.8	6.9	6.3	9.3	7.1	7.8	4.5	9.7	4.0	7.1	5.8	6.2	6.9	16.0	4.0	6.8	4.4	5.7	5.7	6.1	5.5	8.9	8.1	26.7	7.4	4.2	5.4	5.8	5.8	7.3	22.9	4.3	6.2	6.1	12.2	7.7	5.3	4.2	9.9	17.4	0.5	3.8	8.5	10.5	4.1	10.5	18.1	2.3	4.4	1.1	2.2	7.2	3.4	2.5	5.7	5.8	16.8	7.8	8.8	15.1	2.0	6.1	3.6	9.2	7.7	5.8	12.9	19.0	8.7	2.8	13.2	7.6	16.7	4.9	2.7	6.8	3.4	11.4	2.3	5.8	14.5	17.2	4.7	5.2	13.5	6.3	6.2	8.9	24.0	18.0	9.6	4.1	13.0	7.4	6.2	13.5	4.7	0.3	11.1	6.1	4.4	4.7	7.0	3.0	3.8	4.7	4.6	11.4	10.4	15.8	16.0	4.7	14.8	3.2	0.0	2.5	0.0	7.3	3.8	10.0	9.9	7.2	7.0	5.1	7.5	10.5	8.0	0.5	8.5	2.3	17.4	8.1	4.1	7.7	8.9	8.8	15.6	7.1	7.8	5.8	6.2	5.7	4.3	3.0	3.7	6.0	8.7	7.2	3.2	4.3	10.2	5.3	3.4	3.5	2.0	6.8	6.6	13.4	17.6	2.9	0.7	0.0	13.2	5.8	4.6	6.0	4.6	3.9	6.6	1.6	11.6	4.3	2.8	2.3	4.9	3.8	3.3	9.0	3.4	5.0	11.7	6.6	6.3	8.0	2.5	0.0	5.6	28.8	36.7	9.4	1.5	7.0	6.8	9.1
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69328621-69330595	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in single"	21	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	6.6	7.9	4.8	7.8	4.5	5.3	4.8	3.1	6.9	3.6	7.6	3.8	3.3	7.1	5.3	5.6	8.4	4.4	6.5	3.8	4.6	3.3	14.9	30.2	3.7	7.0	3.0	5.2	5.0	14.2	8.2	3.9	4.9	4.4	5.3	4.1	4.3	12.8	4.6	10.4	6.0	5.2	3.4	2.3	5.0	8.3	3.7	2.0	10.2	7.3	9.2	6.2	3.7	4.0	10.3	3.2	2.5	2.8	1.7	6.9	1.5	9.0	6.1	1.2	2.9	1.8	1.4	10.7	7.6	2.0	5.4	4.7	15.0	6.4	16.7	10.1	2.6	2.5	13.0	3.7	4.0	2.2	4.0	31.0	8.5	5.8	21.4	3.7	11.8	6.8	2.8	7.1	4.8	2.3	0.9	3.1	8.6	20.3	1.9	2.9	11.6	9.2	12.4	7.8	3.3	11.2	21.7	1.9	15.5	4.3	5.7	10.4	8.3	13.1	2.3	6.4	0.5	12.9	3.8	4.7	4.7	8.8	5.4	8.7	15.8	10.5	19.7	3.1	8.8	6.0	0.0	2.8	2.5	1.2	1.6	3.1	4.3	3.9	3.9	3.0	10.3	6.9	2.5	0.0	1.7	1.5	3.2	3.0	1.5	4.8	4.5	3.1	6.9	4.6	3.3	3.0	5.2	4.4	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 422.4;Distal tubular cells: 300.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		15000	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.6	31.9	23.1	24.3	22.4	17.2	28.4	17.7	15.8	36.7	28.4	45.4	16.5	43.8	13.2	21.3	49.1	33.5	70.9	30.7	38.7	14.5	39.5	21.7	54.9	39.9	23.8	34.7	17.8	22.1	28.6	33.8	33.6	18.6	22.3	27.4	19.1	18.6	25.6	33.9	28.9	35.6	23.5	47.1	55.8	29.9	38.8	53.6	63.2	26.2	12.8	13.6	28.2	35.8	32.0	52.0	37.7	24.4	13.8	19.0	17.1	51.6	22.4	15.8	16.2	29.0	17.9	24.3	16.4	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0	41.7	37.7	36.5	48.9	26.6	58.2	422.4	79.0	26.8	50.0	144.8	31.4	91.3	300.1	74.7	2.0	28.6	76.1	23.3	52.1	102.6	45.2	31.9	42.6	65.5	65.3	23.8	40.3	16.0	21.0	2.9	32.8	35.5	54.0	51.3	52.9	37.8	43.3	57.5	38.2	164.1	60.9	32.3	48.4	17.4	13.0	29.2	111.6	30.9	97.8	51.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 alpha 2 subunit"	P29803	4	95840019-95841474	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 60.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 311.1;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	311.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	45.9	1.6	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.3	24.1	30.2	35.7	36.8	48.2	18.5	40.8	13.6	30.5	33.1	11.1	33.7	22.1	27.3	23.6	24.8	36.4	50.5	36.3	28.6	29.5	20.5	30.3	20.5	28.7	16.9	41.9	30.7	34.1	18.7	18.4	38.7	18.2	27.9	31.0	38.2	20.2	30.4	13.3	21.6	39.3	56.3	26.2	19.3	21.2	22.3	32.2	24.0	41.8	47.6	31.7	22.5	19.1	25.5	20.0	27.2	25.8	36.6	28.7	29.3	35.1	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5	56.6	28.0	47.4	32.8	24.7	30.0	245.7	48.4	69.6	48.9	33.2	23.6	144.4	195.6	84.1	43.2	62.9	34.8	23.3	63.6	85.4	31.9	17.8	38.1	61.1	74.4	54.0	55.7	43.6	38.0	10.4	55.8	41.0	54.0	89.2	44.3	51.8	51.0	41.3	48.1	105.9	44.7	64.7	61.8	85.0	80.3	26.1	131.5	46.0	47.8	28.8
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 117.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	24.0	13.9	5.5	10.2	12.1	13.6	17.1	14.0	19.4	18.9	31.0	8.5	12.6	11.2	14.4	22.7	17.8	26.9	14.4	19.3	11.3	22.5	11.8	25.3	35.6	22.2	22.3	14.0	12.3	17.9	10.6	14.5	11.2	14.0	10.8	25.3	11.6	15.2	15.6	13.8	13.8	11.3	25.2	14.4	12.1	24.9	10.9	29.0	24.1	14.7	10.7	15.1	22.9	23.4	14.5	25.7	13.8	9.7	14.4	16.2	14.8	18.9	11.1	22.0	15.6	11.3	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0	32.8	21.1	9.0	18.1	23.1	25.5	117.0	20.4	18.7	19.4	5.2	27.5	53.6	54.7	18.3	35.0	10.9	12.8	23.3	12.6	28.3	19.4	19.1	5.7	22.1	23.1	19.1	8.6	9.8	15.0	31.1	10.0	15.5	20.3	28.9	16.0	18.1	13.9	14.4	12.7	22.7	23.2	0.0	20.9	40.9	33.4	22.2	69.5	10.4	19.0	16.9
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.2	11.1	10.0	11.8	8.9	1.2	7.0	10.4	10.5	10.2	0.8	7.0	8.1	11.7	19.5	7.1	3.1	7.4	2.8	10.3	16.3	10.3	7.2	9.1	6.8	6.3	0.0	7.8	18.7	10.8	6.8	0.5	18.5	9.1	10.4	2.9	8.1	5.9	8.2	6.0	0.0	2.4	19.5	9.0	9.1	24.9	10.9	5.7	5.5	7.4	11.2	9.9	3.1	4.7	14.2	18.3	7.2	4.7	12.3	10.1	8.4	5.1	16.0	15.1	4.4	18.0	2.6	7.9	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4	8.9	9.3	13.6	13.9	13.5	20.8	5.0	10.2	1.4	11.4	19.2	5.9	15.1	49.7	8.0	7.3	8.3	46.6	0.0	7.9	3.4	19.5	7.6	1.1	39.8	16.7	41.3	13.3	13.5	13.7	15.0	22.5	7.9	23.6	15.4	45.3	33.6	7.9	43.6	49.5	118.5	9.2	19.4	12.1	3.3	4.4	16.4	6.6	15.8	37.1	8.4
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.6	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.1	9.2	1.9	0.7	10.5	2.1	11.3	6.9	10.0	7.8	5.4	4.9	5.3	2.6	1.3	4.2	4.8	0.7	3.1	0.9	0.9	0.4	5.5	9.6	0.9	14.0	0.5	17.0	7.8	5.4	7.0	9.7	5.4	4.0	7.0	13.5	3.2	17.7	2.5	3.2	14.7	6.0	4.6	6.2	8.3	1.6	0.2	2.6	3.8	4.8	3.2	9.0	6.9	11.0	7.1	6.4	5.4	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8	3.0	1.3	2.9	8.6	4.0	3.4	6.3	0.0	1.4	2.3	1.8	0.0	4.0	3.3	3.6	53.4	2.8	4.5	0.0	4.5	26.4	3.2	5.2	5.7	4.2	13.2	7.9	4.1	4.3	18.9	22.4	3.4	9.6	15.1	8.2	2.4	3.2	2.8	0.0	5.3	11.3	3.9	0.0	9.2	6.4	6.3	3.9	14.9	14.9	3.3	7.1
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.9	5.5	10.8	14.9	7.7	6.9	3.8	14.8	8.9	13.4	18.1	5.2	10.2	5.5	5.3	8.5	9.3	16.0	8.6	8.6	2.4	8.1	5.1	4.5	11.8	8.1	6.5	9.0	5.8	6.5	12.6	13.1	9.7	3.8	11.5	9.8	7.3	7.9	4.8	12.6	4.7	6.5	4.9	11.3	12.5	7.7	16.0	4.7	7.8	11.1	6.3	12.3	5.0	4.6	4.5	6.7	3.2	3.5	5.4	7.4	3.3	5.6	13.0	12.0	10.1	7.5	5.2	5.4	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9	8.9	18.5	5.9	4.3	4.6	7.9	4.5	7.6	1.4	4.5	8.7	13.7	9.1	6.6	2.7	0.1	1.8	5.1	0.0	2.5	1.6	4.2	6.7	5.8	11.5	2.1	4.8	3.5	6.7	0.6	1.9	2.8	0.8	3.3	0.0	4.0	8.4	2.8	5.8	4.2	8.1	6.3	0.0	3.1	4.4	1.3	2.0	3.0	1.9	5.8	7.0
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3"									"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	27.7	2.0	6.3	29.8	10.9	0.5	30.3	5.0	6.7	21.4	12.8	11.0	4.1	2.5	16.8	15.3	8.9	19.8	23.7	18.6	5.7	6.5	1.9	0.8	17.8	10.4	10.0	2.4	18.4	3.9	0.7	2.3	71.8	13.5	11.3	6.4	26.6	6.0	8.6	21.9	10.0	7.6	18.6	17.5	0.7	15.1	9.7	7.9	3.2	5.7	9.7	9.9	27.3	28.9	0.4	0.2	3.1	0.4	0.3	0.4	0.1	0.0	0.0	30.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	72.6	1.7	0.0	0.1	50.4	9.0	0.0	0.1	9.2	0.0	0.0	0.0	44.7	0.0	0.0	6.1	16.8	3.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.1	48.3	8.5	7.3	0.1	0.0	0.0	0.0	0.1	18.1	0.0	0.0	1.0	0.4	0.6	0.2	0.2	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.3	3.1	0.3	0.2	0.2	0.2	0.1	6.3	10.9	5.0	4.8	5.7	6.5	10.0	2.4	13.5	7.9	98.3	9.1	0.0	29.7	12.9	1.2	6.9	0.0	6.7	29.6	0.0	3.9	1.8	0.0	0.4	0.5	7.4	0.0	0.0	0.0	1.6	108.5	3.5	1.1	0.0	6.5	0.0	0.0	7.4	0.0	0.4	18.7	4.1	6.8	202.8	0.0	85.7	0.5	0.0	59.1	0.0	2.8	0.0	6.2	0.9	8.6	6.0	2.4	0.0	0.0	3.4
PDPR	PDP3	ENSG00000090857	"Pyruvate dehydrogenase phosphatase regulatory subunit"	Q8NCN5	16	70113626-70162537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048092, HPA070386"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048092: AB_2680261, HPA070386: AB_2686263"	"unprognostic (8.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.04e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.36e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.24e-2)"	11.9	13.3	12.0	13.3	15.4	14.4	11.6	21.1	16.0	14.0	12.5	23.8	10.4	9.3	18.7	14.5	11.1	12.9	11.7	14.7	9.9	6.7	18.4	7.7	9.8	15.8	10.2	12.6	15.1	13.5	14.2	9.9	10.8	10.7	10.0	12.9	15.4	11.1	17.3	20.9	11.9	13.4	19.7	9.0	14.1	12.0	19.9	10.3	16.0	13.5	9.5	12.6	16.4	10.0	6.0	5.4	5.1	5.0	3.2	7.1	3.1	3.6	10.4	9.8	17.1	17.0	11.5	6.5	5.9	10.5	9.6	7.3	13.0	7.3	7.3	10.3	18.7	8.6	14.2	14.1	12.4	11.3	1.8	4.8	18.7	6.4	8.6	4.8	20.7	15.2	14.9	11.6	13.8	12.5	13.0	10.1	14.0	12.8	3.6	7.9	10.4	12.9	11.3	14.6	2.4	5.1	25.7	10.0	7.9	7.1	8.7	4.5	6.6	16.3	3.1	4.3	13.0	12.9	6.2	5.8	11.1	15.1	9.4	9.3	8.3	9.1	27.5	5.0	7.0	7.1	5.1	4.9	4.5	5.0	5.0	7.1	3.5	3.9	4.8	5.4	6.0	4.8	5.2	4.1	3.2	4.6	5.2	4.3	3.1	12.0	15.4	21.1	16.0	9.9	6.7	10.2	12.6	10.7	10.3	20.8	12.8	7.5	4.2	2.5	19.2	17.7	17.8	20.1	13.6	1.8	29.5	6.2	5.0	4.6	42.6	14.3	8.2	0.0	5.7	6.1	7.4	7.2	17.4	9.8	13.7	30.2	4.7	18.4	16.5	14.2	10.0	11.2	6.8	1.8	10.9	12.4	4.9	3.5	15.6	3.3	21.1	19.4	4.2	7.5	15.6	1.6	4.1	12.2	12.4	4.1
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 168.4;Peritubular cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.2	27.3	7.2	18.8	15.4	10.8	10.8	9.1	8.2	12.5	9.9	15.9	9.7	12.5	16.6	9.3	9.4	17.0	10.6	5.5	3.2	9.2	37.0	6.2	14.9	22.8	17.0	5.5	9.3	11.0	11.5	8.3	12.7	4.2	6.7	17.6	5.9	5.3	5.5	27.2	9.8	9.9	10.1	27.3	22.4	9.2	11.6	11.4	10.3	5.3	7.2	17.2	6.5	4.4	16.3	14.5	6.7	2.1	5.8	12.3	12.4	20.5	7.9	7.3	4.9	2.2	11.4	7.7	10.1	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2	14.9	13.7	17.0	16.7	16.3	4.4	12.5	12.7	16.0	26.1	26.2	0.0	16.2	14.9	26.3	2.2	18.3	14.6	0.0	33.6	18.8	27.5	23.7	12.7	168.4	21.4	4.8	66.0	9.2	11.1	6.8	87.8	10.8	20.3	1.0	24.8	26.7	26.0	10.5	326.0	21.4	4.8	6.5	30.9	11.1	18.5	15.8	12.2	7.0	22.8	16.6
PET100	C19orf79	ENSG00000229833	"PET100 homolog"	P0DJ07	19	7629737-7631956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 106.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067288			Approved	Mitochondria		NA	NA			Mitochondria		"HPA067288: AB_2732762"	"unprognostic (7.02e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.97e-4)"	"unprognostic (4.89e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (2.44e-4)"	18.7	27.8	24.9	21.3	23.3	42.3	22.9	16.1	27.8	13.2	21.9	9.7	29.3	22.2	13.4	27.4	18.0	11.0	24.0	47.3	31.6	18.3	24.7	36.8	14.9	20.5	19.8	25.3	11.9	24.7	11.0	20.7	18.0	21.0	16.4	16.4	14.7	29.9	30.1	41.1	14.8	18.8	12.9	21.3	18.2	25.6	14.4	12.4	16.4	17.5	29.9	17.5	10.2	13.6	52.6	86.9	106.6	82.2	33.8	60.1	72.1	18.4	16.6	30.5	18.2	14.8	10.7	11.2	15.8	9.1	10.9	10.7	14.8	12.5	12.3	27.9	11.9	13.5	16.4	13.7	14.4	9.0	28.1	27.8	17.6	35.1	23.6	7.4	30.0	16.9	12.1	9.3	7.3	7.7	17.4	15.4	30.3	12.7	47.7	11.4	20.1	32.2	47.2	19.7	21.4	36.3	20.3	17.3	28.6	21.9	22.5	17.0	20.3	21.0	18.9	17.0	19.5	13.8	39.8	16.7	8.6	10.6	17.2	23.5	42.9	33.5	22.4	15.8	23.2	10.2	106.6	82.2	89.2	41.9	63.7	39.0	52.6	48.6	43.8	49.8	51.0	45.4	47.7	77.2	33.8	56.1	86.9	60.1	72.1	24.9	23.3	16.1	27.8	31.6	18.3	19.8	25.3	21.0	12.4	140.0	188.2	119.3	34.8	44.6	49.0	48.4	231.8	145.9	121.7	246.0	21.6	109.5	182.4	187.3	33.6	64.6	254.8	210.2	275.3	108.9	79.7	58.6	101.9	470.9	149.2	17.5	184.1	168.8	266.1	38.0	94.0	169.6	108.0	232.6	239.3	60.6	286.3	280.5	78.1	209.8	67.5	84.1	54.7	111.8	89.1	51.7	149.5	147.2	189.2	40.8
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	12.2	16.5	11.7	14.3	14.0	12.5	18.6	14.6	22.1	8.4	13.9	8.3	9.9	13.6	10.4	9.9	22.0	11.5	13.4	22.6	14.2	12.1	13.9	26.3	8.5	17.6	9.9	11.8	11.9	30.2	8.1	9.6	10.3	10.4	10.1	10.4	8.5	16.0	11.4	27.4	15.2	12.0	10.2	7.5	13.0	11.7	13.6	5.1	17.6	16.3	17.4	14.5	11.6	12.9	4.0	6.7	7.7	3.1	3.3	3.7	1.4	19.2	37.1	7.9	22.3	5.6	4.5	18.6	9.9	6.2	16.7	9.4	46.2	11.2	24.9	18.4	8.6	8.6	16.9	37.2	18.7	6.9	12.2	29.3	29.9	17.4	24.1	12.7	28.3	17.5	5.6	13.8	19.5	21.1	5.5	12.2	20.4	37.4	10.3	6.5	34.9	38.3	28.3	30.1	16.9	26.3	29.4	8.8	19.9	10.8	26.8	29.1	16.4	17.2	24.2	10.7	6.6	30.6	15.7	10.5	8.5	18.6	17.1	24.1	21.6	31.7	35.8	11.1	23.2	14.2	7.7	2.4	0.7	2.5	2.5	3.7	3.6	2.9	2.8	2.0	4.0	2.9	3.6	2.0	3.3	3.1	6.7	2.0	1.4	11.7	14.0	14.6	22.1	14.2	12.1	9.9	11.8	10.4	5.1	3.0	6.7	6.7	10.3	10.2	9.2	12.6	20.4	4.0	0.0	5.2	13.7	5.6	5.0	4.0	12.9	5.3	6.3	0.0	6.7	12.5	3.3	9.0	0.0	21.9	6.4	6.4	12.6	4.3	6.9	15.9	5.5	4.8	3.3	2.8	8.9	3.9	6.9	5.8	6.3	9.0	12.2	6.5	5.5	9.8	9.4	15.2	5.1	4.4	14.0	11.6
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in many"	16	"Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"BEWO: 93.4;HUVEC TERT2: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.3	0.4	0.0	93.4	0.8	0.8	0.4	0.5	2.2	0.1	0.0	2.0	0.6	0.0	0.1	0.4	4.2	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.1	1.0	1.7	0.4	0.1	44.0	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.4	0.0	0.7	0.0	11.6	0.0	0.1	0.2	7.0	3.8	0.0	0.1	1.6	5.9	0.0	0.1	8.9	0.0	2.3	0.0	3.7	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0	8.9	5.8	0.8	13.0	21.9	0.8	2.8	0.0	1.4	7.9	0.0	13.7	75.1	0.0	0.9	0.1	15.8	0.5	0.0	0.4	1478.5	42.9	3.3	5.8	0.0	33.1	0.0	6.8	7.4	0.3	0.6	12.0	4.5	20.3	0.0	1.1	1.9	0.6	0.2	18.4	0.4	7.5	103.5	62.6	0.2	3.4	17.1	1775.1	0.9	1.7	4.7
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330318-74398473	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.6"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria		No	No		64000	Mitochondria		"HPA056995: AB_2683305, HPA060948: AB_2684394"	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	3.0	4.0	30.6	4.9	19.8	4.0	3.2	6.3	48.6	6.1	4.5	1.3	1.0	2.3	6.1	1.9	2.1	4.7	4.8	1.6	30.1	15.1	2.5	2.1	2.7	4.0	9.7	20.4	1.7	4.4	1.4	4.5	2.1	11.7	3.8	5.1	2.9	3.2	2.5	7.1	1.7	2.6	5.6	2.6	2.5	3.4	2.3	0.3	10.0	4.1	1.3	4.0	5.2	2.6	2.4	1.7	2.5	0.6	3.0	7.5	1.1	2.1	3.0	11.8	2.1	3.6	1.6	0.3	2.8	2.1	2.4	2.7	1.1	5.5	0.2	7.0	1.8	4.3	1.0	2.3	0.5	2.3	0.8	1.2	1.6	1.6	0.9	0.4	1.9	2.6	0.8	0.5	5.5	1.0	2.7	13.4	4.0	2.1	1.5	16.0	0.3	7.6	1.7	2.3	1.6	2.7	2.4	15.4	0.1	6.4	0.4	0.5	2.3	4.5	1.0	2.0	3.4	0.2	0.3	11.1	5.5	5.1	2.2	2.9	2.0	2.9	0.2	0.5	2.7	1.3	2.5	0.6	1.1	2.1	0.6	2.8	2.4	3.5	2.3	0.5	1.8	3.3	1.9	0.7	3.0	0.3	1.7	7.5	1.1	30.6	19.8	6.3	24.4	30.1	15.1	9.7	20.4	11.7	0.3	6.0	5.4	13.7	35.5	6.8	10.1	6.1	12.7	76.3	30.7	8.7	15.7	0.6	5.0	31.7	9.2	20.2	5.3	70.0	109.6	4.7	15.4	55.2	8.1	0.9	4.8	7.9	11.3	20.3	20.4	2.3	2.3	14.4	15.1	3.6	15.9	5.0	102.3	7.0	3.5	3.3	9.9	25.8	11.3	17.6	14.5	4.5	0.1	17.0	18.7	42.9
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404049-49414905	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 190.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		3800000	Mitochondria		"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.58e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	27.4	31.6	21.8	19.9	24.9	19.0	30.6	12.9	25.9	21.6	38.9	24.0	17.0	26.9	24.1	17.7	28.6	24.3	18.6	41.6	21.9	20.9	54.0	53.7	19.2	18.5	27.6	21.4	27.1	24.1	27.8	18.8	24.1	22.0	25.3	40.7	24.7	41.8	20.2	41.7	19.5	32.7	26.6	20.5	22.7	25.0	16.6	18.2	23.3	42.5	35.6	22.3	22.4	24.0	33.4	84.6	6.3	28.0	28.4	34.7	40.2	36.2	67.8	16.3	31.9	21.9	17.3	45.3	26.9	17.9	43.6	28.6	190.5	32.7	67.3	49.2	24.7	40.2	23.7	44.2	38.8	45.2	29.2	58.1	33.9	44.0	86.1	16.2	67.0	21.0	19.2	26.9	47.1	17.4	16.1	31.8	33.3	60.5	18.2	28.3	61.8	46.4	41.9	30.2	90.0	64.8	37.1	61.8	55.2	29.6	38.5	33.0	28.1	20.3	23.8	37.7	31.7	40.4	31.2	27.7	41.4	32.0	32.3	57.6	23.3	63.7	65.1	27.1	44.6	35.8	6.3	25.3	6.2	32.3	28.0	34.7	33.4	28.7	31.0	38.1	29.9	30.4	30.9	2.5	28.4	21.0	84.6	28.1	40.2	21.8	24.9	12.9	25.9	21.9	20.9	27.6	21.4	22.0	18.2	44.7	38.5	91.0	108.8	104.4	37.8	5.0	99.3	58.9	45.5	80.3	35.3	200.2	344.8	205.1	11.2	83.1	152.0	0.0	137.6	226.4	92.2	139.6	72.6	90.4	199.3	20.6	126.7	58.9	47.1	19.5	82.8	74.2	150.1	170.5	170.0	63.9	145.3	121.0	108.2	332.8	35.0	51.8	84.4	14.9	52.8	108.4	127.5	73.5	226.1	142.5
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970825	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		780000	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	36.2	46.2	20.0	41.5	21.3	33.5	37.1	21.6	29.7	42.7	48.6	19.8	42.8	40.0	46.3	36.2	55.6	37.7	29.1	44.3	17.9	17.2	36.0	72.8	24.0	64.9	18.8	18.8	68.9	92.3	28.0	22.1	27.4	17.2	48.6	39.5	25.8	62.7	29.1	72.9	39.5	46.3	56.0	17.5	36.6	37.5	20.5	19.0	57.2	50.4	77.4	45.7	46.4	39.9	36.4	47.6	20.9	35.9	38.1	41.6	34.4	36.9	35.7	30.0	40.6	24.3	42.5	67.0	26.2	33.8	46.4	36.8	56.4	38.9	77.0	11.6	25.3	28.7	30.2	54.7	46.2	37.6	42.7	45.7	40.4	23.1	52.9	40.9	65.1	29.8	43.8	31.6	29.4	64.1	46.8	45.5	22.5	36.0	17.7	32.7	36.7	59.8	59.6	114.6	32.2	31.9	42.0	48.1	47.8	37.1	41.6	15.5	53.6	21.1	60.4	67.7	63.9	9.5	52.2	27.4	20.0	32.8	15.8	55.2	17.8	21.6	79.2	27.0	34.0	28.4	20.9	30.0	14.6	30.8	35.9	37.3	36.4	35.3	35.8	47.6	34.8	32.0	31.8	12.4	38.1	30.4	44.4	41.6	34.4	20.0	21.3	21.6	29.7	17.9	17.2	18.8	18.8	17.2	19.0	44.7	42.0	120.9	90.2	66.1	40.4	39.9	81.5	40.2	38.7	33.2	37.3	183.0	97.8	103.8	2.2	69.9	132.2	46.7	140.2	226.3	64.5	78.8	63.4	148.3	144.5	17.5	96.5	85.3	105.7	4.4	90.0	74.4	69.2	134.3	123.4	72.7	115.8	66.6	64.7	112.8	33.1	71.1	81.1	32.6	58.9	66.7	142.2	78.4	212.2	93.2
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219704-22232341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.4;skin 1: 37.9"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.9;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	5.4	18.6	25.0	2.3	71.8	1.3	3.5	58.9	89.4	3.2	2.1	3.0	0.0	2.2	6.0	3.4	7.1	9.8	6.2	2.9	31.2	12.3	2.2	1.4	1.8	1.4	7.3	40.3	2.3	2.2	1.3	5.5	3.0	21.1	3.6	1.7	0.0	1.4	5.9	1.7	37.9	2.4	7.2	3.5	3.6	1.6	5.8	10.4	0.0	2.0	0.0	1.4	7.8	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.5	0.0	0.3	0.8	1.1	0.3	1.3	0.4	0.4	0.1	2.0	0.0	2.2	0.6	1.4	3.8	0.0	0.7	0.1	0.0	0.2	0.0	4.0	1.5	1.7	0.0	0.0	0.9	0.0	0.8	0.0	3.6	2.5	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.9	0.7	0.3	0.0	0.2	12.9	0.0	0.0	4.3	5.0	2.9	0.0	3.4	0.3	0.0	0.3	1.1	0.0	2.1	1.6	0.7	1.0	0.2	0.0	2.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	71.8	58.9	82.9	31.2	12.3	7.3	40.3	21.1	10.4	0.0	0.0	0.0	5.1	16.8	0.7	1.2	0.0	0.0	2.3	3.5	0.0	0.1	0.0	0.2	0.6	1.3	0.5	0.0	1.8	0.2	2.3	0.5	0.0	0.9	0.2	0.0	0.0	1.3	0.0	1.3	2.8	0.0	1.7	0.0	0.3	0.4	0.4	0.0	3.5	2.2	0.9	0.0	7.8	0.2	0.0	9.5	1.8	0.0	0.0	3.9
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208497-178232791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		Yes	No		190000	Mitochondria		"HPA036461: AB_10670717, HPA063608: AB_2685059"	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	18.7	13.1	10.5	25.0	10.8	9.8	15.5	8.3	10.9	13.9	24.3	13.4	14.4	15.1	13.5	14.9	10.7	13.6	17.5	15.5	8.9	4.9	18.1	44.4	14.7	16.8	13.7	9.3	13.2	18.0	11.9	11.9	11.8	10.2	12.4	23.9	12.1	12.3	13.7	20.2	7.6	29.8	14.1	10.7	20.2	15.3	16.4	11.7	16.3	16.6	10.5	17.4	14.0	11.8	13.9	32.8	16.7	21.7	10.7	14.0	14.3	5.8	2.4	5.8	2.3	14.7	11.7	8.8	3.7	4.1	4.9	7.9	6.2	7.5	7.6	11.2	11.2	6.2	3.8	5.0	9.4	5.7	15.6	5.0	9.7	9.8	4.4	23.9	5.5	6.3	13.3	9.9	6.2	15.1	10.1	16.3	11.4	7.1	17.7	7.4	8.5	7.7	2.9	1.2	7.3	8.0	5.1	2.8	15.3	8.9	5.3	3.6	3.3	5.8	3.4	6.1	7.1	3.7	4.5	6.6	5.1	4.6	3.3	3.9	11.3	3.1	4.6	1.5	5.9	3.4	6.3	19.5	16.7	10.0	21.7	10.1	13.9	11.3	11.4	25.2	12.6	14.0	11.3	4.4	10.7	21.3	32.8	12.9	14.3	10.5	10.8	8.3	10.9	8.9	4.9	13.7	9.3	10.2	11.7	17.9	14.7	36.2	35.3	9.5	20.4	15.7	33.1	12.0	9.1	22.7	23.6	14.0	16.6	17.9	16.8	22.4	97.5	0.0	16.2	15.1	23.7	24.7	12.7	27.6	27.2	14.3	18.5	22.7	23.8	45.2	39.4	30.7	23.6	63.1	33.9	26.4	14.7	54.6	23.7	31.0	26.5	12.9	16.5	28.6	23.7	9.2	18.4	34.6	33.9	31.3
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14.0	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12.0	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11.0	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5.0	1.1	14.6	5.0	8.0	7.4	19.0	22.2	5.9	9.4	12.7	9.3	14.7	4.3	10.9	13.4	16.1	11.2	13.2	6.0	6.6	8.1	13.5	22.4	5.8	18.4	5.5	3.8	9.1	10.3	10.5	14.0	8.6	10.2	11.7	10.4	13.3	9.7	9.1	15.0	13.3	5.8	7.9	9.3	6.4	7.3	6.8	12.0	8.1	16.1	7.3	9.0	4.5	7.7	10.2	9.1	12.2	7.3	15.2	8.9	14.0	8.7	5.7	13.7	9.3	7.3	10.3	24.1	7.9	7.8	5.1	2.1	3.8	1.6	5.0	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3.0	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8	29.8	23.2	13.7	15.2	13.1	26.3	15.4	7.6	18.7	17.0	7.0	29.5	8.1	1.7	9.8	1.7	21.4	4.9	0.0	11.9	5.0	18.3	27.3	30.1	17.4	9.5	36.5	2.4	29.4	21.2	1.6	30.2	16.4	13.5	16.2	9.6	15.6	13.1	12.7	37.1	11.2	26.2	25.8	22.1	9.6	7.6	13.0	7.3	14.0	9.2	27.6
PILRB	"FDFACT1, FDFACT2"	ENSG00000121716	"Paired immunoglobin-like type 2 receptor beta"	Q9UKJ0	7	100352176-100367733	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"testis: 80.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.1;neutrophil: 34.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 51.1;monocytes: 16.8"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.3"									HPA026750	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	Yes			Mitochondria		"HPA026750: AB_10670828"	"unprognostic (8.33e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.35e-3)"	10.6	11.3	8.2	11.2	8.2	11.2	10.2	25.2	10.3	9.9	8.2	8.2	8.2	11.4	10.3	12.6	8.2	10.0	8.8	8.2	8.2	5.0	18.6	17.6	8.2	13.2	8.2	8.2	12.1	12.9	19.0	27.6	9.8	8.2	13.6	10.2	8.2	12.0	10.7	12.3	15.8	10.1	8.2	10.5	16.7	9.2	80.1	8.2	8.2	18.3	8.2	11.0	9.9	8.2	0.3	4.3	51.1	16.8	4.0	2.9	4.7	14.0	11.9	13.7	23.7	15.2	3.5	13.3	8.5	3.8	6.1	6.0	8.4	16.4	11.5	16.3	4.4	10.9	15.1	7.5	9.0	4.2	9.4	11.1	10.6	39.9	7.2	3.4	10.6	27.6	4.4	10.6	8.2	16.8	7.6	5.1	17.2	11.3	28.0	4.2	19.0	16.7	55.3	5.9	11.8	6.3	9.8	4.0	11.7	27.5	23.1	12.8	9.2	7.2	81.3	10.1	15.3	14.2	16.5	12.2	21.8	13.9	13.9	11.0	16.9	21.5	13.9	6.1	15.9	12.8	4.1	8.5	51.1	2.9	14.0	1.7	0.1	0.3	1.8	4.3	0.3	0.3	0.7	34.8	4.0	16.8	0.1	0.1	4.7	8.2	8.2	25.2	10.3	8.2	5.0	8.2	8.2	8.2	8.2	35.7	41.6	25.1	19.4	14.0	37.1	1.1	63.7	37.5	42.1	14.0	64.8	10.8	1.7	5.8	13.5	16.4	15.8	0.0	4.9	9.6	8.9	14.5	23.3	62.2	8.5	71.5	28.3	17.8	14.3	9.1	68.4	12.3	18.6	10.0	23.8	26.5	6.4	17.3	48.1	3.4	60.9	25.8	12.0	43.6	9.8	11.8	13.2	66.0	24.8	10.8
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1"	ENSG00000254093	"PIN2/TERF1 interacting telomerase inhibitor 1"	Q96BK5	8	10764963-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	14.3	14.4	9.9	16.0	13.9	14.8	13.8	14.5	16.5	12.6	14.2	12.6	7.1	11.5	15.7	8.9	19.3	10.7	9.3	11.7	10.6	10.1	13.1	19.4	11.2	19.2	13.2	10.9	16.1	17.2	7.6	10.7	13.3	17.6	11.4	12.0	15.6	14.9	8.5	21.2	19.0	11.3	15.9	11.1	14.8	11.7	24.0	9.7	18.7	12.4	17.8	19.6	11.5	14.3	9.8	8.8	4.4	8.4	8.9	16.0	8.4	6.4	8.7	9.4	8.9	8.0	6.5	10.8	9.9	4.5	10.9	7.4	9.1	5.7	17.4	3.5	5.3	13.4	13.1	23.8	18.3	14.1	7.0	7.1	7.3	6.1	9.8	9.0	7.8	4.6	5.4	11.7	8.6	16.1	3.9	15.1	11.9	23.1	10.8	10.7	7.7	25.5	9.8	21.6	28.3	9.7	20.9	11.5	15.9	8.1	8.0	7.8	8.1	6.6	7.9	21.7	12.0	8.4	9.7	9.1	6.6	14.3	8.4	12.7	4.9	12.7	31.7	6.8	14.8	14.9	1.5	6.8	4.4	12.5	8.4	16.0	9.7	10.9	13.1	8.8	9.8	15.0	11.6	0.4	8.9	7.3	6.8	12.3	8.4	9.9	13.9	14.5	16.5	10.6	10.1	13.2	10.9	17.6	9.7	3.0	4.1	9.9	14.8	23.7	5.2	3.3	7.6	10.7	9.1	3.5	11.8	14.9	10.0	0.0	29.6	11.4	4.0	0.0	0.0	9.6	8.0	5.2	13.9	6.6	14.3	3.2	8.1	11.6	4.0	22.3	8.6	9.6	6.8	0.0	3.9	6.2	0.0	4.8	6.0	8.2	21.5	0.0	6.2	24.9	25.1	25.0	40.3	11.7	7.7	8.0
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 149.7;Late spermatids: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	26.7	39.4	22.7	20.4	34.4	31.0	21.5	29.7	47.8	21.6	23.4	29.8	19.1	19.1	27.6	27.2	25.0	21.3	23.7	41.0	22.1	19.3	28.8	47.1	23.6	21.2	22.9	25.6	35.3	25.7	31.2	26.0	17.8	38.8	27.2	22.4	29.2	25.1	23.8	62.0	28.0	25.3	26.3	19.1	18.9	21.6	41.6	20.4	48.6	28.7	33.0	26.8	26.0	22.4	11.5	13.7	6.0	13.9	12.4	13.9	9.1	25.7	20.9	8.3	11.2	23.6	25.6	9.5	38.2	17.9	30.6	16.7	18.8	15.8	13.0	13.3	23.9	11.8	19.9	13.3	29.5	23.1	22.4	18.9	18.3	17.1	14.1	13.4	7.1	21.9	21.1	22.0	33.4	19.1	20.9	31.7	20.2	18.5	17.1	40.3	22.3	17.8	7.3	5.7	33.1	25.4	8.8	11.5	18.4	24.3	19.8	10.6	6.5	29.0	21.2	16.1	12.2	24.7	8.5	39.0	24.2	6.8	59.1	18.3	13.7	14.4	13.4	36.9	13.0	11.8	6.0	9.4	4.9	13.1	12.0	12.9	11.5	11.3	12.2	13.7	6.8	12.1	13.9	1.4	12.4	13.9	7.6	13.8	9.1	22.7	34.4	29.7	47.8	22.1	19.3	22.9	25.6	38.8	20.4	26.8	22.3	6.5	17.3	6.1	13.1	36.4	10.2	22.7	29.6	3.5	19.6	10.5	6.6	14.9	149.7	11.3	11.1	0.0	25.0	16.4	10.8	18.9	13.9	13.0	12.9	6.4	17.3	7.4	9.4	75.9	15.8	9.4	18.6	13.6	10.9	5.8	26.9	8.6	13.8	7.5	19.1	6.5	14.2	25.1	19.3	5.0	11.3	8.7	12.4	15.7
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"NB-4: 44.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.3	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.1	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.2	0.1	44.9	0.0	4.4	0.3	0.1	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.0	9.9	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7	0.0	0.3	0.0	0.2	1.1	0.6	1.4	10.2	2.7	2.3	0.0	0.0	3.3	1.7	3.6	2.8	0.5	2.9	0.0	1.8	0.3	0.9	0.4	0.0	0.0	1.5	0.0	0.0	1.3	3.1	1.0	0.3	1.5	0.0	1.0	7.8	0.3	2.7	6.5	1.1	0.6	2.8	0.0	0.8	0.7	1.5	0.1	0.8	0.0	4.7	0.0
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178461409	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.2"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.5"	"Cell line enhanced"	"Detected in many"		"SuSa: 11.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	2.2	1.4	2.5	1.0	3.5	0.7	4.4	1.3	3.7	2.1	1.5	1.2	3.5	0.7	3.5	7.2	2.2	2.6	2.6	1.0	2.7	2.2	2.1	2.2	1.0	1.3	2.8	4.4	7.0	1.0	1.4	3.9	1.0	2.0	2.3	0.9	2.4	2.1	2.7	2.7	3.5	1.3	1.7	2.7	1.0	0.9	35.2	1.3	1.0	2.3	1.7	1.2	1.6	1.2	1.5	6.5	0.6	0.3	0.4	1.3	0.1	0.4	2.7	3.5	2.8	4.7	5.2	1.8	2.2	2.2	2.0	3.1	1.0	4.5	3.1	2.3	1.3	1.6	1.4	2.5	1.4	1.3	1.0	0.9	1.0	3.7	0.6	4.5	0.8	0.2	4.9	3.4	2.2	4.9	5.8	2.3	6.1	0.5	2.0	2.3	0.4	2.9	1.9	4.2	0.3	1.1	3.9	2.6	1.9	3.1	1.4	2.5	2.1	1.0	0.5	0.8	11.0	1.0	0.9	1.5	2.3	0.9	0.7	0.2	6.4	4.0	1.0	1.1	1.7	0.9	0.0	0.3	0.0	0.3	0.2	0.4	0.8	0.4	0.2	0.1	1.5	1.3	0.7	0.6	0.4	0.0	6.5	0.0	0.1	2.5	3.5	1.3	3.7	2.7	2.2	2.8	4.4	2.0	1.3	6.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.8	0.0	0.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G16	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754."	ENSG00000176485	"Phospholipase A2 group XVI"	P53816	11	63573195-63616883	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.6"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 759.2;Proximal tubular cells: 471.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 52.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.4;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	113.6	15.2	32.0	4.4	39.4	1.6	33.9	4.8	30.2	6.1	7.2	46.6	6.1	4.0	5.0	11.5	5.9	13.9	12.9	39.0	37.6	25.2	24.7	28.9	13.5	4.5	58.4	22.2	30.9	13.2	15.1	8.1	16.2	30.5	5.9	3.7	8.8	10.1	13.2	37.8	2.4	7.5	8.0	70.4	6.4	10.2	17.8	48.9	0.1	17.1	11.1	2.3	8.0	4.7	2.1	52.4	0.4	6.2	5.3	16.0	6.4	20.6	32.7	0.9	0.0	37.1	6.4	6.0	0.7	6.6	5.5	2.7	7.4	59.7	0.0	13.8	1.6	18.0	1.0	30.9	1.6	4.2	25.5	1.2	0.3	7.8	1.2	22.1	0.0	0.3	3.8	0.1	13.6	0.5	22.0	8.6	0.0	0.3	2.3	5.8	3.6	0.0	0.1	2.6	13.0	10.6	0.0	0.0	2.0	17.3	2.9	0.4	2.4	4.4	12.5	6.8	14.0	27.1	1.0	12.6	2.4	0.1	8.3	1.8	9.8	6.4	0.0	9.9	0.0	0.2	0.0	6.2	0.0	16.0	2.4	8.8	2.1	3.7	11.6	1.7	0.3	1.2	9.4	0.4	5.3	0.1	52.4	2.4	6.4	32.0	39.4	4.8	21.9	37.6	25.2	58.4	22.2	30.5	48.9	95.3	77.4	17.6	17.3	10.3	10.6	128.7	96.8	113.8	45.5	109.9	3.9	112.1	96.2	54.1	56.9	116.5	22.2	0.0	99.5	300.4	35.3	29.0	56.6	210.7	56.9	38.1	3.4	165.7	48.0	16.0	28.7	51.4	25.3	759.2	4.5	120.3	123.3	14.4	20.5	471.4	17.2	12.9	42.8	135.2	4.9	8.2	243.0	69.8	1.7	59.6
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No			Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	4.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	4.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.5	0.0	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0
PLEKHJ1	FLJ10297	ENSG00000104886	"Pleckstrin homology domain containing J1"	Q9NW61	19	2230084-2237704	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 300.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048989	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA048989: AB_2680590"	"unprognostic (5.11e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.03e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (1.10e-5)"	"prognostic favorable (6.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.26e-3)"	13.6	18.0	15.2	30.2	15.6	18.7	15.7	10.1	22.9	9.5	41.3	10.6	12.0	58.9	10.1	15.7	16.8	9.1	30.0	17.9	14.3	11.9	27.5	21.0	18.2	26.1	14.9	14.5	13.6	36.7	5.0	11.0	14.2	15.8	12.1	19.6	9.6	30.4	12.1	43.6	13.9	51.4	11.3	9.3	18.4	35.5	29.0	10.0	18.5	24.3	17.7	16.3	10.2	11.8	47.3	55.9	43.2	34.7	16.9	38.0	30.8	26.4	11.0	20.1	24.4	6.6	8.6	11.9	14.9	7.0	16.0	14.6	28.2	12.5	25.1	12.5	10.2	10.4	20.7	19.1	9.8	4.9	25.6	24.2	13.1	12.2	36.7	10.5	27.9	20.4	12.5	10.2	7.6	6.9	6.4	10.2	22.0	27.7	29.9	11.6	17.5	27.0	24.9	36.1	15.8	15.1	32.4	14.0	30.8	16.3	26.6	50.6	27.9	9.4	17.4	29.3	8.5	23.0	27.8	10.8	6.8	20.5	20.5	16.1	43.8	26.8	28.2	20.3	26.9	8.7	23.8	27.4	43.2	32.8	33.0	28.7	42.5	32.3	34.0	28.4	47.3	26.5	25.7	23.2	16.9	34.7	55.9	38.0	30.8	15.2	15.6	10.1	22.9	14.3	11.9	14.9	14.5	15.8	10.0	35.7	22.6	77.8	44.5	30.9	21.7	37.5	86.6	29.4	15.9	43.6	15.7	77.8	139.3	111.2	53.1	25.1	300.7	0.0	157.2	79.5	36.4	58.9	18.4	42.7	81.8	23.8	51.9	21.5	41.7	91.2	43.7	34.6	28.7	88.4	170.2	26.6	125.6	146.2	33.2	109.9	19.1	32.3	32.5	70.5	91.9	37.3	39.9	29.2	192.0	49.9
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 60.7"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 188.6;Late spermatids: 315.7;monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria		NA	NA			Mitochondria		"HPA061018: AB_2684416"	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	10.9	17.0	14.2	34.4	22.1	10.2	10.5	17.0	14.4	9.6	44.5	5.4	6.4	11.8	16.9	7.7	16.8	11.9	14.1	17.8	10.2	6.9	5.8	5.8	12.9	29.0	8.2	13.1	13.5	2.5	1.4	3.5	10.1	8.0	18.2	8.3	7.9	4.7	12.1	15.8	3.6	17.4	60.7	6.5	29.4	22.3	24.8	7.3	15.0	3.8	3.1	17.4	29.3	17.7	11.0	16.0	18.7	15.8	2.1	5.1	5.4	5.1	1.2	17.5	13.6	5.6	5.0	1.4	9.0	12.5	12.3	10.9	0.3	0.1	0.1	1.8	10.6	9.1	0.4	8.7	0.4	4.0	31.1	4.4	1.0	0.7	3.2	10.7	7.1	29.6	7.4	0.4	15.3	2.3	11.7	11.6	14.5	1.9	13.7	16.7	2.4	27.1	14.2	16.4	0.0	2.4	24.7	9.5	5.9	2.0	1.5	11.0	17.9	0.7	0.0	6.8	8.8	0.9	7.1	16.2	8.1	9.2	8.4	10.8	5.2	0.1	3.2	32.3	0.0	3.1	1.5	15.8	0.3	3.5	14.1	3.8	11.0	5.1	3.7	11.7	10.5	3.5	3.0	18.7	2.1	12.8	16.0	3.7	5.4	14.2	22.1	17.0	14.4	10.2	6.9	8.2	13.1	8.0	7.3	32.8	12.8	62.7	62.8	19.2	5.4	33.9	5.1	0.0	2.3	0.0	0.0	1.4	1.7	6.5	188.6	39.6	0.0	0.0	6.7	2.5	27.6	51.8	5.7	0.9	96.3	7.9	17.0	51.5	68.8	315.7	16.1	106.5	23.6	146.1	0.1	32.6	10.1	0.0	23.0	0.0	6.1	71.1	83.4	126.2	12.1	12.4	1.3	24.5	0.3	24.4
PLGRKT	"AD025, C9orf46, FLJ14688, MDS030, Plg-RKT"	ENSG00000107020	"Plasminogen receptor with a C-terminal lysine"	Q9HBL7	9	5357973-5437878	"Predicted intracellular proteins"	"Chemotaxis, Inflammatory response, Plasminogen activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 74.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008214, HPA011144"	Supported		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA008214: AB_1078363, HPA011144: AB_1078364"	"prognostic favorable (5.56e-4)"	"unprognostic (5.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.09e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	11.3	15.6	10.6	12.9	12.1	6.8	15.5	8.7	17.6	11.4	24.0	12.6	11.8	25.6	9.6	17.3	16.4	11.9	9.3	34.5	8.9	7.5	23.1	13.9	13.3	36.5	9.9	9.8	9.2	10.9	7.8	10.1	16.7	14.1	10.6	28.4	13.1	10.7	10.5	30.5	12.1	20.6	15.6	13.3	12.0	11.9	7.4	10.1	18.2	15.2	26.3	14.8	10.7	9.9	14.1	12.9	59.3	7.2	14.1	21.4	13.5	16.3	4.7	9.9	7.1	6.4	9.0	0.0	8.0	9.0	7.0	8.1	0.0	7.4	3.8	4.3	6.0	10.3	3.8	6.8	22.2	14.7	74.5	4.3	29.4	4.0	5.2	14.0	8.8	7.0	9.8	8.1	6.5	13.4	6.0	10.0	12.7	1.6	26.8	16.9	3.6	9.4	10.0	6.4	13.4	2.8	6.0	4.9	11.9	15.8	3.5	7.9	10.3	7.9	12.7	15.1	7.4	10.2	12.5	7.1	8.9	10.9	7.7	15.5	5.1	7.4	7.7	15.4	5.6	5.0	59.3	5.7	10.7	13.6	7.2	16.9	14.1	17.3	17.9	8.1	11.8	16.7	16.5	6.7	14.1	4.8	12.9	21.4	13.5	10.6	12.1	8.7	17.6	8.9	7.5	9.9	9.8	14.1	10.1	11.9	26.7	19.3	18.6	23.5	10.6	52.9	22.9	46.8	23.9	21.0	0.0	76.9	92.9	68.8	0.6	17.9	129.2	23.3	44.8	96.5	28.0	25.8	88.9	24.3	72.3	9.5	25.5	17.2	19.0	1.5	15.3	35.1	32.1	139.7	115.7	18.3	64.0	135.5	18.7	58.8	11.6	0.0	20.9	11.9	8.5	26.5	55.0	34.1	97.8	17.5
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291504	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4;MAIT T-cell: 9.4"	"Lineage enriched"	"Detected in single"	52	"T-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"A549: 34.1;CAPAN-2: 37.1;OE19: 63.6"	"Low region specificity"	"Detected in many"							HPA055540	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055540: AB_2682839"	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	1.4	4.7	8.3	5.3	20.9	0.2	17.5	2.0	11.1	30.4	18.2	28.1	13.4	27.5	7.7	4.1	9.1	38.1	31.2	1.5	13.6	7.1	4.7	1.1	3.7	0.8	37.1	6.5	2.4	19.8	0.6	4.1	1.8	16.6	10.7	15.3	6.7	45.8	19.0	0.3	19.0	21.9	3.3	26.0	1.4	22.2	2.2	25.8	0.7	2.2	5.9	5.0	12.1	5.7	0.0	0.1	0.1	0.0	0.0	9.4	0.3	20.0	34.1	0.5	0.0	0.0	0.1	0.0	2.0	0.0	6.3	4.9	9.8	37.1	0.0	21.9	2.9	0.0	11.1	0.0	4.4	2.9	0.2	0.6	0.0	13.7	0.0	7.6	0.0	1.3	1.3	1.9	3.2	4.3	13.9	1.0	0.0	0.1	0.0	0.0	22.8	0.1	0.0	15.2	63.6	0.0	0.0	0.0	0.5	16.0	3.2	4.3	10.2	5.6	9.4	14.7	1.5	12.3	0.6	1.1	13.9	9.2	0.1	14.8	0.1	23.3	16.5	3.9	0.0	11.4	0.0	0.0	0.0	4.4	0.0	9.4	0.0	2.0	2.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	8.3	20.9	2.0	11.1	13.6	7.1	37.1	6.5	16.6	25.8	6.0	6.9	0.0	113.1	0.0	17.7	0.0	188.5	167.3	64.8	21.0	9.8	0.2	3.3	295.2	0.2	3.3	108.1	0.0	125.6	5.1	0.0	71.8	1.1	0.4	0.9	15.9	8.2	0.0	1.3	1.4	0.0	1.3	0.0	4.6	39.9	12.1	100.4	109.1	0.0	1.0	190.0	0.0	0.0	0.3	28.1	0.0	0.7	0.0	113.0	167.4
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394843	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.0;Ductal cells: 5.1;Exocrine glandular cells: 3.2;monocytes: 3.6;Pancreatic endocrine cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA048387: AB_2680381, HPA068609: AB_2686011"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	21.9	11.5	6.2	17.8	6.1	5.2	31.0	4.4	7.9	24.0	12.7	7.4	16.3	5.6	29.2	22.0	21.6	15.6	17.7	25.3	5.6	5.7	15.3	12.9	25.0	67.2	5.8	7.6	19.9	10.0	10.1	9.0	17.3	8.4	15.4	6.3	10.2	12.5	17.8	16.1	17.8	10.5	21.4	13.1	29.0	11.6	8.6	6.4	12.1	12.2	26.0	21.0	21.5	20.1	12.9	9.5	1.9	13.3	6.6	30.8	12.1	14.3	3.2	2.7	8.4	10.4	18.3	3.7	13.0	12.0	11.1	10.5	4.9	3.3	3.6	10.7	18.8	4.8	19.6	3.5	21.3	5.7	9.8	1.9	3.4	4.4	3.4	14.0	1.2	4.5	13.2	14.5	11.2	16.8	17.8	17.3	7.7	2.0	2.8	14.5	7.3	3.8	1.0	2.5	4.0	9.2	7.9	2.3	3.8	10.5	9.3	2.4	8.1	6.6	4.8	3.1	2.7	8.3	0.6	28.0	7.7	7.8	8.8	5.4	3.2	3.6	1.4	12.0	4.3	8.9	1.9	10.0	1.1	16.8	13.3	17.1	12.9	30.5	17.1	9.5	12.0	25.2	15.0	1.0	6.6	10.9	1.1	30.8	12.1	6.2	6.1	4.4	7.9	5.6	5.7	5.8	7.6	8.4	6.4	3.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148723-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.5;retina: 40.6"	"Cell type enhanced"	"Detected in many"	14	"Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.2;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066899			Approved	Mitochondria		NA	NA		82000	Mitochondria		"HPA066899: AB_2685743"	"unprognostic (1.49e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.48e-2)"	6.6	7.5	7.1	16.1	6.9	12.6	3.9	16.8	8.6	8.0	5.1	3.1	0.8	3.1	7.3	2.2	4.9	4.3	8.3	4.1	6.3	15.2	3.2	2.0	15.2	43.5	4.5	7.7	13.0	2.3	0.5	6.3	7.5	5.2	4.3	5.4	40.6	3.7	3.7	2.9	6.6	5.0	5.7	4.9	28.6	3.4	12.1	3.3	8.6	3.3	2.7	10.2	9.6	6.5	2.4	2.5	14.2	6.7	0.9	1.7	1.5	0.4	0.2	1.2	0.2	0.7	0.5	0.1	0.6	0.8	0.8	2.4	4.1	0.0	9.8	0.0	0.9	0.7	0.0	15.3	0.6	0.5	6.8	0.3	0.5	0.2	2.7	8.5	2.0	3.4	8.4	0.0	0.9	0.4	1.0	0.0	0.9	0.2	11.9	0.2	0.1	0.4	1.0	2.5	0.1	0.5	1.6	0.4	5.3	0.0	0.7	1.0	0.7	0.1	0.1	19.0	3.1	0.0	1.6	0.3	0.2	1.1	0.1	0.3	30.1	31.3	0.6	0.1	5.3	0.6	0.0	3.0	12.2	1.4	5.2	1.6	2.4	1.6	1.7	2.5	1.4	1.4	1.5	14.2	0.9	6.7	0.9	1.0	1.5	7.1	6.9	16.8	8.6	6.3	15.2	4.5	7.7	5.2	3.3	3.0	3.7	11.2	0.2	5.5	2.1	3.7	2.5	4.0	0.0	0.0	0.0	0.1	1.7	0.2	6.7	1.8	0.2	0.0	0.5	0.1	2.6	0.2	16.1	0.8	19.6	0.0	19.0	9.8	41.4	5.9	1.4	32.1	91.1	19.8	1.6	0.0	0.4	0.0	3.2	3.1	0.6	6.5	1.4	1.5	1.2	1.4	0.1	3.2	1.0	0.1
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2"	ENSG00000127838	"Paroxysmal nonkinesigenic dyskinesia"	Q8N490	2	218270392-218346793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA		31000	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	21.8	28.3	33.2	15.9	41.0	13.4	16.4	26.6	51.1	29.8	27.5	14.3	28.9	18.1	14.6	37.0	13.3	28.3	30.4	37.3	31.0	26.5	42.4	107.0	23.4	34.2	33.2	23.6	18.1	18.8	22.3	15.6	28.1	26.8	34.8	25.1	15.9	27.3	27.1	33.8	12.9	15.9	16.6	25.7	18.0	29.5	23.3	20.6	11.6	29.7	15.3	16.3	19.0	13.4	64.0	32.7	44.9	35.4	38.4	43.3	38.9	15.3	20.2	14.8	23.2	22.3	18.9	27.4	9.7	21.0	23.1	26.0	33.1	15.2	18.0	19.5	16.1	25.5	16.0	28.5	18.2	16.2	37.4	35.6	26.3	37.0	48.9	24.4	16.9	11.7	25.7	18.0	15.7	4.6	15.5	24.9	14.3	19.3	23.6	20.4	44.2	22.0	40.5	14.7	35.6	20.7	21.7	14.9	15.1	26.5	23.4	14.4	12.1	6.9	47.4	27.5	16.6	15.7	16.5	15.3	9.6	16.5	11.3	13.2	9.8	10.0	19.4	24.4	28.0	11.6	33.7	35.4	44.9	32.1	34.1	30.4	64.0	35.1	38.3	32.7	52.0	38.8	37.3	9.8	38.4	31.0	30.4	43.3	38.9	33.2	41.0	26.6	51.1	31.0	26.5	33.2	23.6	26.8	20.6	65.5	73.4	56.6	80.2	49.0	53.5	126.7	104.4	100.4	62.6	186.7	5.9	149.0	431.0	54.5	7.7	70.9	168.7	0.0	43.7	85.9	107.8	126.2	56.5	206.0	114.9	33.4	116.6	73.1	82.4	10.5	95.5	48.6	129.9	72.1	149.8	127.6	39.4	144.0	116.7	212.9	34.8	90.5	76.9	45.9	44.3	54.5	64.6	55.8	176.1	86.0
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072482-153075018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	15	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA045007: AB_2679181, HPA052115: AB_2681734"	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favorable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.3	2.0	7.2	0.1	6.2	0.2	0.3	7.0	16.3	3.7	0.2			0.5	1.8	7.0	0.1	1.5	0.9	2.1	6.5	11.0	6.2	7.9	0.1	0.2	5.5		3.1	0.7	0.4	3.9	0.1		0.1	0.1		0.9	0.7	0.0	0.3	0.3	0.6	1.6	0.5	0.5	0.8			1.8		0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	5.3	0.1	1.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.9	0.4	0.9	0.0	2.9	0.0	0.0	0.0	0.6	0.0	0.3	0.2	8.0	3.2	6.9	1.2	0.0	0.1	0.0	0.2	0.2	5.7	1.3	0.0	0.1	0.4	1.1	0.0	3.4	5.8	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.9	0.4	0.0	6.6	0.3	0.0	4.1	0.0	0.0	15.2	0.0	0.0	5.8	4.3	8.3	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.0	21.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	2.5	3.2	22.3	0.0	0.6	0.0	0.4	2.6	0.0	0.0	0.0	0.0	18.8	0.4	0.0	2.8	20.3	7.1	0.0	0.2	1.0	2.2	0.0	0.0	0.0	0.0	0.1
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634265-55693910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	11.1	11.7	13.3	6.5	21.7	11.7	10.8	13.3	18.8	5.7	8.2	12.8	5.4	5.7	8.3	8.8	9.5	7.9	5.8	11.0	12.4	10.9	9.8	11.4	9.1	7.1	24.1	7.4	6.9	9.1	7.4	14.3	5.1	15.2	7.7	10.1	4.2	9.0	6.3	23.5	10.1	7.0	7.9	17.6	10.4	7.6	13.5	22.5	9.6	10.0	7.8	5.9	5.3	7.4	9.8	7.4	6.1	6.5	3.8	8.6	4.7	6.8	3.7	5.1	2.3	3.6	6.4	6.8	10.2	6.2	16.2	10.9	10.7	3.2	14.3	4.3	4.7	5.2	5.5	6.5	7.9	7.5	5.1	14.4	8.3	4.7	5.4	9.7	18.6	5.6	7.1	5.5	6.7	5.8	3.9	4.9	6.0	8.7	3.2	6.4	3.9	11.3	13.1	12.3	7.2	6.2	11.3	8.5	12.6	6.8	4.3	12.4	7.4	3.6	11.3	12.4	4.7	3.0	8.3	5.1	3.8	3.2	3.4	10.4	14.5	1.1	3.1	7.4	16.3	6.5	4.2	6.5	6.1	8.1	5.7	4.8	5.4	3.7	8.6	2.8	9.8	6.9	7.9	6.1	3.8	5.1	7.4	2.4	4.7	13.3	21.7	13.3	18.8	12.4	10.9	24.1	7.4	15.2	22.5	44.7	72.6	7.5	15.0	21.5	40.4	23.8	12.7	46.8	69.4	19.2	55.0	17.7	8.3	14.2	15.0	19.3	7.4	0.0	13.8	18.9	14.2	10.3	54.6	14.7	13.8	28.6	9.8	12.9	11.1	1.9	16.1	15.2	15.1	9.0	12.3	27.5	11.7	14.1	17.3	16.7	61.4	25.8	18.4	39.0	20.0	17.7	10.3	17.3	16.4	14.2
POLDIP2	"DKFZP586F1524, PDIP38"	ENSG00000004142	"DNA polymerase delta interacting protein 2"	Q9Y2S7	17	28347177-28357522	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007700			Approved	Mitochondria		NA	NA			Mitochondria		"HPA007700: AB_2667900"	"unprognostic (5.71e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.39e-2)"	12.5	24.4	15.3	11.2	16.5	10.0	14.4	9.1	20.6	11.2	14.0	11.0	14.1	12.2	9.0	12.1	17.0	11.0	15.2	42.0	14.6	11.1	26.8	50.6	9.2	15.2	13.2	11.5	10.8	26.9	15.5	9.3	10.7	11.8	11.2	14.9	10.6	14.1	13.1	63.5	11.3	15.1	13.8	10.2	13.3	16.4	15.3	7.1	17.0	14.8	22.0	12.5	10.3	8.8	29.3	37.5	24.9	29.5	19.7	29.0	28.6	19.3	36.0	13.1	21.1	20.6	19.8	16.1	20.2	21.5	43.8	31.3	115.5	11.5	35.1	19.8	26.3	22.7	26.0	31.0	21.9	32.6	27.4	33.2	12.4	21.1	24.0	32.3	26.7	15.5	22.5	32.9	30.3	25.0	19.6	24.3	25.0	28.2	20.8	25.8	27.0	30.9	17.1	15.6	33.1	18.4	23.6	28.3	35.6	24.3	18.1	18.9	17.5	36.2	73.4	20.4	21.4	38.5	20.2	20.6	19.7	14.9	22.5	35.9	18.3	21.9	24.3	27.4	18.8	19.7	20.0	29.5	24.9	22.5	28.3	23.0	29.3	23.7	29.0	37.5	20.4	25.9	25.2	12.1	19.7	20.2	25.1	24.9	28.6	15.3	16.5	9.1	20.6	14.6	11.1	13.2	11.5	11.8	7.1	8.9	14.9	31.5	25.9	24.5	23.6	84.4	50.9	4.0	9.1	45.4	3.9	71.3	160.8	71.6	35.4	24.5	60.0	23.3	124.6	81.0	28.2	34.3	11.5	114.6	61.8	27.0	22.5	22.7	29.9	99.3	28.4	29.4	55.6	67.7	37.2	28.7	92.5	28.1	31.1	161.2	15.9	12.9	29.7	58.1	43.2	26.3	68.0	23.5	59.3	34.4
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	17.8	15.2	19.8	19.0	19.2	16.8	24.6	23.2	20.9	14.1	16.0	14.6	13.6	20.0	17.6	9.0	20.7	14.3	14.0	17.4	16.7	8.8	14.9	19.5	17.8	21.8	17.3	15.3	16.6	17.9	17.7	12.9	16.2	16.0	15.4	13.2	10.5	15.9	12.0	35.9	19.8	18.5	14.1	12.7	22.9	16.2	12.4	17.3	29.0	15.4	12.1	19.2	16.5	18.9	6.0	9.0	9.0	6.5	9.2	10.9	6.7	6.7	12.8	8.8	11.5	14.4	9.2	11.2	13.4	7.2	13.8	10.9	18.6	16.8	10.6	20.7	10.5	16.5	14.6	23.5	11.4	4.7	22.8	20.2	16.0	13.4	6.7	12.2	14.9	26.5	8.3	16.7	9.5	8.2	12.3	16.4	30.2	14.1	11.9	11.1	11.8	16.9	15.2	8.0	13.4	5.7	17.4	10.8	15.0	7.9	16.5	19.6	7.2	19.1	14.0	15.6	10.9	11.6	16.7	12.3	18.7	12.9	27.4	12.8	12.8	7.5	14.7	12.0	17.1	14.9	4.9	6.3	9.0	9.2	6.5	8.0	3.3	7.6	10.9	9.0	6.0	6.6	6.9	2.3	9.2	5.2	6.0	4.3	6.7	19.8	19.2	23.2	20.9	16.7	8.8	17.3	15.3	16.0	17.3	11.9	11.0	15.5	9.7	10.9	6.8	15.7	10.2	1.4	6.8	10.4	2.0	12.0	8.3	9.0	0.9	12.1	12.3	0.0	9.3	13.6	11.4	12.5	8.1	14.0	11.4	3.2	5.2	17.2	19.0	1.1	13.3	12.7	18.6	20.8	23.4	6.0	10.2	17.0	9.9	6.2	6.2	6.5	15.1	7.4	12.9	10.5	18.2	16.6	15.7	12.0
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497036	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017030, HPA023202"	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies"	Mitochondria	"CAB017030: , HPA023202: AB_1855523"	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavorable (6.59e-4)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	6.7	9.3	5.4	17.5	10.0	8.1	8.2	10.9	8.7	7.7	7.8	7.0	11.1	7.9	10.2	6.8	6.4	7.5	7.9	7.3	5.6	4.4	7.8	7.8	10.4	12.2	10.8	5.2	13.0	9.4	5.0	9.9	6.9	8.7	8.0	5.7	5.8	8.6	11.9	10.7	10.5	8.4	9.3	5.6	11.5	6.9	24.2	7.9	9.8	9.6	5.4	13.3	6.6	11.5	12.2	10.5	6.5	8.2	6.0	12.2	4.4	6.9	8.5	6.1	7.5	5.8	4.7	7.4	4.1	3.9	6.3	5.4	8.8	5.5	12.7	5.0	2.2	6.5	5.7	8.3	3.9	7.9	3.5	9.7	8.6	10.3	8.7	6.5	12.1	9.6	4.7	4.5	5.0	7.5	8.7	4.5	7.7	15.1	4.9	6.1	9.2	12.9	16.1	6.4	7.6	9.5	12.0	20.1	13.4	5.7	2.0	8.6	9.6	3.3	7.4	7.6	9.9	7.3	10.2	5.0	6.8	9.0	5.8	10.7	8.7	5.9	9.6	5.3	11.4	4.7	6.5	5.9	6.5	7.9	3.5	7.5	12.2	8.8	7.6	10.5	12.1	12.2	11.6	1.2	6.0	8.2	4.8	8.4	4.4	5.4	10.0	10.9	8.7	5.6	4.4	10.8	5.2	8.7	7.9	11.9	23.4	11.1	7.7	7.2	4.0	15.7	17.8	5.3	14.8	3.5	0.0	10.9	0.0	4.3	9.2	12.4	11.2	0.0	3.2	12.2	9.9	9.7	12.7	3.8	8.2	6.4	10.5	18.4	7.8	5.0	6.1	6.9	6.8	3.6	13.9	3.0	2.7	16.7	2.8	4.3	8.4	6.5	8.6	52.0	8.2	7.5	3.3	10.2	18.2	4.7
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617224-633604	"Enzymes, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 63.9;Spermatogonia: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	10.2	10.7	10.1	16.3	11.9	6.9	8.1	12.1	20.7	9.5	11.6	12.3	4.4	16.7	9.8	12.2	14.4	8.7	12.7	24.7	11.5	8.9	12.9	21.4	7.3	11.8	9.4	15.1	10.1	15.9	9.5	10.7	6.2	9.7	10.2	8.8	8.5	9.6	11.7	42.2	16.7	12.8	10.8	8.4	12.8	11.2	32.1	6.3	11.6	11.1	8.6	10.4	10.1	7.8	8.2	7.3	3.1	5.5	7.5	9.0	5.3	10.5	19.1	4.4	19.2	9.2	5.2	16.1	4.9	5.9	7.4	6.7	19.2	7.3	10.8	10.1	4.5	3.7	10.9	16.2	9.4	5.5	12.1	38.5	8.4	11.9	24.6	9.6	14.2	16.1	5.0	13.3	7.5	9.1	5.3	10.3	15.2	15.8	10.9	6.7	14.9	18.8	19.5	17.4	13.8	13.4	18.2	6.0	18.5	9.7	9.0	14.0	10.0	4.5	12.2	12.3	4.9	6.9	13.0	6.1	8.0	10.2	12.5	14.5	25.9	21.3	16.5	17.1	11.9	9.7	0.0	3.7	3.1	9.0	5.2	7.1	7.8	6.7	6.6	7.3	8.2	5.7	6.3	0.6	7.5	5.5	7.2	4.1	5.3	10.1	11.9	12.1	20.7	11.5	8.9	9.4	15.1	9.7	6.3	11.9	14.4	8.8	5.0	7.1	17.9	15.6	10.2	4.0	9.1	15.7	17.7	13.3	6.6	5.3	31.3	7.1	22.6	0.0	6.7	7.0	6.0	5.1	12.7	22.5	9.2	11.1	12.5	8.6	7.9	63.9	11.5	9.2	10.1	3.6	12.0	7.8	5.6	11.5	12.4	14.6	15.8	6.5	9.9	30.7	84.7	6.4	6.4	8.7	19.1	5.4
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		8300	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.4	5.4	10.6	18.0	6.8	5.4	7.7	6.5	8.5	8.0	5.7	12.1	16.8	9.4	8.6	5.2	6.4	5.7	21.2	10.3	9.4	13.3	7.6	8.4	8.8	11.0	5.3	19.9	8.2	5.2	10.6	5.5	4.3	9.1	7.6	16.5	14.0	13.0	7.2	14.5	17.0	14.4	7.7	22.3	18.5	15.1	6.5	9.3	26.3	8.8	11.0	6.5	4.4	26.6	9.4	6.5	13.9	16.3	4.0	5.7	11.2	6.2	11.2	11.5	14.5	9.8	10.1	10.8	7.7	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7	8.9	50.5	30.0	71.8	44.4	30.3	55.7	53.5	57.6	43.3	31.4	15.7	106.7	223.8	100.3	91.0	35.1	73.1	23.3	104.8	78.8	31.9	70.3	43.9	59.7	73.9	20.6	63.1	23.4	36.7	95.8	25.6	65.5	72.6	46.9	86.9	28.4	66.2	97.6	30.4	222.1	16.9	38.8	49.5	16.1	9.4	50.4	70.8	45.8	109.9	75.5
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Enzymes, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		16000	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	23.4	36.3	18.9	20.5	21.9	10.7	30.7	12.0	26.0	23.2	32.0	12.4	27.3	25.5	18.2	34.4	31.6	14.5	30.9	22.1	17.8	16.4	41.4	43.9	26.5	28.1	19.3	14.9	19.6	47.0	22.8	16.1	37.6	17.2	27.2	27.3	19.6	36.6	35.0	19.6	21.9	41.0	27.6	18.9	24.4	27.2	13.5	13.4	22.6	31.3	26.0	20.5	24.0	19.4	41.9	44.4	76.1	55.7	42.0	41.0	52.0	22.9	9.6	5.6	8.7	17.4	18.1	20.9	11.6	13.4	15.7	13.9	8.1	28.1	6.9	22.9	14.7	9.1	13.5	3.7	17.6	13.2	18.3	11.1	11.6	10.6	9.6	23.9	11.9	20.6	15.9	31.9	11.0	20.4	19.3	14.5	8.6	4.7	5.0	16.0	13.7	5.8	11.8	6.4	21.2	14.9	6.6	5.7	12.3	34.3	21.7	6.6	7.3	14.2	34.8	36.0	17.0	16.4	52.7	9.1	8.6	11.5	13.1	13.2	16.5	10.3	5.0	3.6	13.8	17.6	58.1	55.7	76.1	30.7	55.1	35.7	41.9	37.0	33.0	44.4	39.9	41.0	34.9	41.2	42.0	51.8	33.2	36.4	52.0	18.9	21.9	12.0	26.0	17.8	16.4	19.3	14.9	17.2	13.4	53.6	69.7	61.9	43.1	20.7	9.2	94.6	86.6	54.9	59.1	61.1	5.9	137.5	336.5	81.6	2.8	50.7	119.1	0.0	120.2	108.8	45.6	37.4	54.4	103.6	97.2	11.1	30.1	43.0	68.9	3.4	56.1	87.5	77.6	111.0	116.6	40.7	82.5	122.6	59.8	254.9	21.8	25.8	44.7	8.4	19.2	31.7	112.6	52.4	93.7	42.7
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.8;OE19: 37.0;RT4: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	6.9	6.0	9.2	11.6	13.3	3.1	8.5	6.6	12.9	7.0	13.7	21.4	38.7	12.2	5.7	17.3	17.7	8.4	14.0	6.3	10.0	6.3	17.2	22.1	5.9	6.5	24.0	4.0	8.4	6.0	56.2	3.3	10.0	10.2	12.0	13.3	15.3	34.9	55.9	12.4	20.3	15.4	7.0	10.8	8.0	20.2	18.7	19.3	0.8	17.7	10.2	15.9	20.0	15.3	12.1	7.0	5.4	11.8	2.0	6.1	4.5	0.6	11.9	2.1	1.3	2.9	0.1	29.8	2.7	6.1	1.8	1.7	9.7	1.7	3.3	1.3	1.8	5.8	5.6	8.6	0.8	1.5	1.6	0.8	0.0	0.0	6.1	3.9	7.0	3.2	4.7	2.8	0.0	2.2	0.1	0.5	0.7	0.3	10.0	1.4	6.5	0.0	6.6	13.9	37.0	0.0	1.0	0.0	5.5	0.0	41.4	0.5	4.6	0.3	11.0	7.8	6.0	1.6	5.4	0.1	0.7	1.0	2.3	0.2	4.9	3.6	2.9	0.9	1.6	4.7	2.0	7.9	5.4	2.8	9.4	2.1	12.1	4.4	2.0	7.0	7.1	6.1	4.5	3.8	2.0	11.8	0.5	0.8	4.5	9.2	13.3	6.6	12.9	10.0	6.3	24.0	4.0	10.2	19.3	14.9	9.9	22.3	17.5	4.8	0.0	4.3	10.2	9.4	19.4	14.0	17.7	6.7	8.3	4.4	43.7	2.8	23.1	0.0	8.2	50.5	9.5	11.3	6.9	11.6	6.8	0.0	3.5	1.8	6.0	33.0	4.4	7.2	15.1	18.0	19.2	1.2	7.7	20.7	6.7	13.5	3.1	0.0	6.1	11.9	3.0	8.7	4.0	0.5	15.6	17.4
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		27000000	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.6	15.2	10.7	21.0	10.0	13.0	13.7	20.8	27.3	45.8	43.4	35.5	17.3	37.1	11.6	14.6	32.6	21.4	33.1	19.4	71.5	11.7	31.2	58.1	14.9	62.4	17.0	40.0	13.8	30.4	13.9	45.4	45.5	14.9	8.0	14.6	56.5	45.8	15.5	18.3	10.3	33.5	9.0	16.4	84.5	17.8	16.5	19.0	17.8	33.3	21.3	15.8	10.7	43.3	16.0	7.3	18.9	30.9	7.2	20.1	18.3	23.6	40.0	21.3	21.6	30.0	19.9	52.1	5.4	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0	6.0	5.0	34.4	26.4	37.8	4.4	106.2	15.3	12.0	9.1	12.2	5.9	70.1	77.9	37.7	11.0	13.8	22.2	46.7	24.2	113.4	24.0	17.4	13.8	70.1	83.0	7.9	20.7	8.6	32.4	11.1	5.8	60.2	33.7	33.3	62.3	9.9	40.0	17.5	5.6	31.1	4.9	19.4	24.1	7.0	22.2	33.0	119.0	17.5	63.7	28.5
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 417.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.2	0.7	2.8	5.0	4.3	5.6	1.1	3.5	6.4	11.8	14.0	5.7	0.5	27.5	3.9	2.2	5.7	0.2	8.4	2.7	4.7	21.2	3.5	4.9	2.2	5.1	3.3	6.7	2.6	3.7	1.3	7.2	6.3	2.4	1.9	11.9	7.3	24.0	3.4	3.1	8.8	3.7	1.7	1.6	1.1	5.0	4.7	10.5	4.1	0.9	2.2	1.9	2.2	0.2	2.6	4.9	11.4	1.9	0.4	4.1	2.1	1.3	2.0	7.6	6.9	23.0	4.5	5.5	6.8	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4	44.7	11.3	104.3	16.5	8.8	97.4	417.4	7.6	24.1	17.0	47.1	17.7	9.4	132.6	5.9	6.1	17.6	2.0	46.7	5.4	2.6	28.3	31.2	18.5	22.1	23.1	81.0	9.2	20.3	11.1	6.2	22.2	13.9	20.3	111.0	15.6	19.2	6.3	4.9	29.7	39.1	14.1	25.8	38.7	35.6	21.3	4.6	2.4	54.8	2.9	5.7
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.1	6.6	9.9	6.4	7.5	8.0	3.3	4.9	5.7	6.1	8.1	7.7	6.9	5.6	11.9	3.4	3.1	4.9	7.6	7.9	5.5	3.9	15.0	6.7	14.8	17.6	8.0	2.2	3.7	6.4	8.0	5.9	8.4	9.2	11.5	5.2	19.9	8.7	4.4	6.7	8.9	7.1	7.1	9.0	14.1	10.9	6.8	13.2	11.6	3.1	7.8	12.7	6.0	8.7	9.9	12.5	15.8	10.5	4.0	5.6	6.2	4.9	6.3	15.5	11.3	8.6	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7	3.0	13.6	4.5	7.2	10.6	16.2	7.7	7.6	62.9	13.6	7.0	21.6	17.7	18.3	8.8	8.4	9.1	4.9	0.0	4.9	8.3	10.3	3.6	5.8	5.8	8.0	14.3	5.8	8.0	4.3	10.0	9.5	7.9	1.7	10.0	6.5	9.6	6.4	3.6	6.3	14.8	17.3	6.5	6.7	9.6	6.1	13.0	8.7	13.1	7.6	4.7
PPP1R3D	PPP1R6	ENSG00000132825	"Protein phosphatase 1 regulatory subunit 3D"	O95685	20	59936668-59940297	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041146	Approved		Approved	Nucleoli,Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"	Nucleoli	"HPA041146: AB_10793870"	"unprognostic (2.50e-3)"	"unprognostic (3.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.48e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (5.71e-2)"	8.2	6.1	9.3	8.2	9.5	9.9	17.2	8.6	9.5	9.1	8.2	6.4	7.1	9.5	9.0	6.5	13.3	7.4	6.5	11.3	8.4	7.8	7.8	2.0	10.0	16.8	9.5	5.4	8.8	17.5	13.3	12.1	9.8	9.3	12.0	5.6	7.6	9.1	11.2	12.9	9.1	10.1	7.1	8.9	11.2	9.6	4.7	6.6	4.0	8.0	8.8	8.9	9.1	8.8	0.7	1.2	6.0	3.5	0.8	1.0	0.4	4.0	2.5	1.7	3.5	3.9	4.1	14.4	5.4	5.8	6.6	3.2	3.9	5.6	1.7	6.7	4.5	4.1	12.0	3.5	3.8	4.3	3.9	2.8	4.5	3.3	2.1	3.6	1.8	12.7	2.9	10.6	2.3	2.0	3.5	3.6	1.1	0.8	0.4	4.2	6.3	1.5	5.9	1.2	7.7	6.0	1.9	0.8	2.6	4.4	6.6	3.3	2.0	6.7	20.3	5.8	3.4	7.4	6.6	3.8	3.9	1.6	4.1	0.8	1.4	3.5	0.4	2.9	6.5	2.4	0.6	1.6	6.0	1.0	0.7	0.9	0.7	0.7	0.8	1.2	0.6	0.9	0.6	4.2	0.8	3.5	0.5	1.0	0.4	9.3	9.5	8.6	9.5	8.4	7.8	9.5	5.4	9.3	6.6	8.9	0.3	2.4	4.4	1.1	6.1	4.7	7.6	4.0	4.5	5.2	2.0	12.2	5.0	1.9	0.3	5.8	4.2	0.0	2.7	3.7	2.6	5.9	5.7	0.2	4.6	12.7	1.7	9.2	8.9	0.0	2.8	3.4	5.0	1.0	3.1	10.3	3.0	6.5	4.2	5.0	10.8	6.5	4.0	0.2	4.3	2.8	4.1	7.5	2.8	7.8
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295643-23302848	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 61.2;Early spermatids: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	4.2	7.6	14.5	8.2	22.5	5.5	6.8	27.3	22.9	6.5	5.8	17.5	8.4	9.7	8.2	16.6	4.3	6.5	5.4	4.7	12.4	12.6	9.3	6.9	5.1	13.6	27.0	20.7	11.8	7.1	11.7	14.3	4.4	20.8	9.3	9.6	7.4	6.3	10.4	13.6	16.9	8.8	5.8	21.6	11.0	7.8	11.5	25.9	5.9	13.8	4.9	12.3	5.2	7.0	3.0	1.1	1.6	4.7	0.9	1.7	1.0	0.8	2.2	2.7	1.9	5.2	2.3	1.3	0.9	1.6	1.5	1.3	1.2	4.2	8.0	0.6	1.1	1.6	5.6	1.6	0.8	1.8	2.9	1.6	1.4	4.2	2.8	1.4	1.6	3.3	1.9	3.3	0.9	4.6	2.5	0.7	4.4	1.3	7.3	1.2	1.9	1.5	2.6	0.6	2.6	2.0	2.4	1.8	5.1	0.8	1.8	3.3	0.9	1.3	1.1	0.8	1.4	1.4	0.6	1.2	1.8	1.0	3.1	0.6	30.7	3.2	3.7	1.4	2.9	1.1	0.5	1.3	0.5	1.5	3.9	1.7	3.0	0.5	0.7	1.1	2.3	1.7	1.0	1.6	0.9	4.7	1.0	1.0	1.0	14.5	22.5	27.3	22.9	12.4	12.6	27.0	20.7	20.8	25.9	3.0	3.7	10.8	7.8	4.9	61.2	7.7	2.5	2.7	4.5	19.2	35.3	6.1	5.0	1.8	92.4	6.0	10.7	0.0	2.9	1.6	3.9	5.5	3.5	6.4	6.2	30.2	8.1	8.6	7.8	50.4	25.3	8.2	10.1	1.0	6.4	22.9	2.8	4.8	24.4	5.9	38.7	12.9	2.8	24.7	9.1	8.0	4.3	10.1	8.3	7.8
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.8	17.0	5.7	25.4	8.2	10.3	15.3	13.5	24.4	23.8	12.5	7.2	9.6	12.7	16.3	16.0	15.1	26.8	16.3	16.3	21.9	31.9	11.9	14.9	9.0	20.0	34.8	6.0	14.3	14.8	7.7	8.4	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.8	12.9	16.5	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.5	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9	3.0	11.0	18.2	26.7	22.8	52.0	42.6	10.2	13.4	11.4	17.4	19.6	17.9	53.0	15.6	5.9	18.3	10.2	0.0	16.6	13.6	21.4	23.8	20.7	12.3	17.9	36.5	40.9	17.2	30.2	7.6	31.1	18.8	25.3	27.1	12.3	32.9	15.6	14.4	27.3	25.6	28.0	6.5	37.1	38.5	44.0	27.6	18.5	15.7	14.4	19.3
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	64.7	119.4	49.2	62.6	55.9	47.8	105.4	73.7	76.7	80.1	66.6	59.4	28.1	57.2	77.8	79.1	97.3	67.2	106.9	71.3	79.2	44.0	82.6	43.3	168.6	166.0	24.3	50.0	56.7	41.0	53.3	79.4	18.8	44.0	91.7	68.2	79.1	19.8	79.4	52.0	67.1	48.9	154.3	144.4	125.2	118.3	62.1	75.4	143.8	55.9	65.5	32.9	67.6	183.7	4.7	150.5	49.9	40.5	77.9	32.0	72.4	68.4	98.1	13.8	77.4	109.1	52.9	34.8	18.7	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6	485.3	206.7	314.1	835.1	539.4	156.1	25.5	438.2	477.8	340.1	586.2	98.2	1056.6	802.4	878.0	14.3	395.3	667.0	116.8	386.1	1465.8	343.6	670.3	319.6	809.1	1307.1	195.5	167.4	307.6	343.8	26.3	461.7	625.9	551.7	763.8	204.7	292.0	608.7	403.3	386.1	1911.4	290.8	304.0	372.5	90.5	393.1	462.1	932.4	124.6	344.7	1354.4
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167703-119178833	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 898.6;Proximal tubular cells: 684.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		14000000	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	34.0	100.7	28.8	18.8	28.3	14.4	29.1	16.1	28.9	23.0	27.1	20.7	25.1	28.1	25.5	26.3	30.6	24.8	21.8	55.8	26.7	28.2	78.8	114.8	16.3	20.0	29.9	23.2	19.2	34.1	25.2	24.6	29.9	33.6	27.4	29.6	21.2	40.5	29.3	80.9	10.3	34.6	26.8	24.1	27.4	24.6	14.0	24.6	24.3	48.9	46.1	20.5	25.9	17.9	30.9	65.7	41.4	74.9	20.9	34.2	73.0	54.1	62.1	37.9	43.0	40.1	43.5	23.7	38.9	66.4	59.4	62.5	47.6	54.3	63.6	34.1	45.8	28.3	24.8	62.6	47.0	67.1	62.2	65.9	28.6	27.0	84.2	42.0	53.5	34.7	50.9	30.3	47.4	44.2	42.7	42.9	39.1	35.1	13.3	54.3	21.7	40.4	45.3	35.4	41.3	36.8	43.0	55.1	43.9	100.3	26.0	16.7	24.3	41.3	55.8	51.0	34.2	28.9	64.5	30.2	19.4	29.3	27.7	50.4	20.8	30.3	51.0	30.5	79.5	17.2	19.5	74.9	40.8	20.3	61.8	25.9	30.9	27.1	24.5	65.7	24.3	28.3	25.2	41.4	20.9	53.2	36.8	34.2	73.0	28.8	28.3	16.1	28.9	26.7	28.2	29.9	23.2	33.6	24.6	44.7	64.4	72.5	95.3	62.0	25.6	212.3	122.3	104.4	39.8	139.6	9.8	296.9	898.6	109.2	4.2	70.9	99.7	70.0	65.9	187.6	95.6	106.7	51.9	340.4	218.6	38.1	106.5	71.2	159.0	8.6	71.7	113.7	126.5	146.1	117.2	58.7	65.7	98.2	95.1	684.3	19.1	71.1	104.2	10.0	22.8	45.9	129.6	54.3	181.8	109.3
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318088-64321811	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		19000000	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	28.7	69.7	70.3	38.6	60.3	57.0	35.5	69.3	73.9	47.2	79.3	31.9	49.0	49.5	26.6	54.8	69.6	94.9	44.8	102.4	56.7	74.2	57.3	54.2	50.3	25.0	68.6	70.2	42.2	72.0	36.0	53.7	49.1	71.4	30.7	71.2	33.9	77.5	62.6	104.7	27.0	51.2	30.9	44.1	27.3	64.5	35.0	29.3	25.1	82.0	64.8	33.5	34.4	50.4	55.2	69.2	115.0	66.9	48.4	40.5	75.3	26.3	53.8	32.6	53.9	35.1	52.9	37.7	33.0	52.9	24.3	30.3	39.1	54.1	38.6	57.8	52.7	87.4	60.3	30.4	70.1	15.4	53.6	24.0	39.0	84.6	44.5	72.1	14.7	33.3	53.6	91.6	40.7	41.3	47.5	36.8	45.9	21.9	91.9	34.1	66.8	25.7	64.1	49.3	41.7	68.8	24.8	33.5	136.5	90.8	52.3	27.6	52.6	27.6	61.3	94.1	32.6	44.9	33.6	35.5	34.7	32.3	40.1	14.5	47.0	56.0	45.5	42.0	29.8	27.0	79.8	66.9	85.4	37.7	59.6	32.7	53.8	35.0	30.8	52.4	55.2	34.8	35.0	115.0	48.4	52.5	69.2	40.5	75.3	70.3	60.3	69.3	73.9	56.7	74.2	68.6	70.2	71.4	29.3	247.1	407.2	232.2	603.5	290.1	156.4	523.8	356.7	1310.3	342.4	427.5	66.8	1002.3	1366.1	644.2	57.6	187.4	757.5	163.5	919.1	972.3	308.0	330.5	103.7	331.1	418.0	87.4	770.7	194.0	207.8	207.7	258.3	234.8	413.3	423.8	875.2	180.0	1093.8	547.1	213.2	1094.9	109.1	194.1	199.4	113.7	345.0	225.2	818.7	191.8	959.8	988.5
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303774-177306959	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	18.9	25.0	21.9	33.9	20.3	30.3	21.6	12.0	31.1	16.9	44.6	14.8	15.4	43.5	18.3	15.5	35.6	17.4	20.6	16.8	19.3	18.6	46.1	62.3	18.9	43.0	20.2	14.7	20.3	91.6	12.3	17.7	29.4	21.0	19.8	35.0	18.9	40.1	16.4	11.9	26.2	70.6	19.0	14.8	43.5	24.6	12.9	13.5	25.2	29.3	27.2	33.7	18.0	18.9	27.1	77.4	111.7	94.2	30.4	26.4	49.2	32.3	30.4	18.5	49.4	16.6	18.0	61.7	23.1	16.2	33.8	32.7	68.1	37.1	27.5	27.3	21.7	36.8	18.4	33.0	61.8	23.1	117.7	45.7	23.8	31.5	45.3	17.5	37.3	33.4	16.2	22.3	26.6	22.8	14.0	41.8	19.8	26.1	39.9	32.8	84.0	23.9	54.6	37.7	37.8	50.4	7.7	37.4	49.4	22.0	27.1	29.6	37.2	21.6	43.1	40.1	24.1	27.8	46.0	23.0	31.0	27.1	25.4	55.3	22.4	38.2	40.0	26.7	50.4	32.1	31.5	75.7	111.7	26.4	94.2	25.8	27.1	21.9	26.2	77.4	21.1	19.3	21.1	55.2	30.4	90.3	28.3	23.3	49.2	21.9	20.3	12.0	31.1	19.3	18.6	20.2	14.7	21.0	13.5	20.8	22.6	181.8	227.7	309.4	61.7	0.3	145.2	13.4	28.4	99.5	21.6	650.2	257.0	407.3	4.8	123.4	610.0	116.8	488.9	446.5	187.8	329.7	110.3	191.7	318.8	57.2	151.0	114.8	245.1	15.2	105.6	182.1	243.0	153.3	210.5	81.8	553.8	343.7	102.6	293.8	49.9	45.3	167.5	80.1	183.7	367.9	738.9	173.0	351.5	462.0
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 49.8;Smooth muscle cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		1600000	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.6	20.1	10.8	0.0	0.0	1.0	3.2	0.8	0.8	0.0	0.0	27.6	0.2	0.6	2.5	0.0	2.0	0.0	1.6	0.7	2.2	9.2	0.0	0.0	3.0	0.1	1.3	0.1	0.0	0.0	0.0	0.9	12.1	1.5	16.6	0.8	0.0	2.0	3.7	0.1	4.9	0.0	0.8	1.1	0.0	0.0	0.0	0.0	3.3	4.8	1.5	0.3	1.0	6.9	0.6	1.9	6.8	1.0	2.6	0.0	1.9	0.6	0.0	71.0	0.7	4.8	9.6	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6	3.0	1.0	0.8	1.4	2.2	29.0	26.0	10.2	6.7	1.2	7.0	9.8	0.0	0.0	1.7	6.2	15.5	0.0	0.0	0.0	0.4	5.1	5.9	4.6	0.0	1.5	4.8	0.0	14.1	14.0	4.7	27.6	10.4	16.9	13.6	0.5	5.5	0.2	2.6	49.8	0.6	9.1	19.4	35.8	1.6	4.5	2.0	0.0	2.9	1.9	3.9
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"OE19: 39.9;RPTEC TERT1: 19.8"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	3.8	2.3	20.8	2.8	19.3	2.0	3.3	9.8	21.3	2.0	3.5	16.2	0.1	13.8	2.3	2.2	8.8	2.4	2.2	4.6	22.2	10.8	9.9	6.6	8.6	2.3	14.9	21.8	2.4	2.2	1.9	1.5	2.4	13.5	2.6	2.6	7.4	2.1	2.4	15.5	13.0	48.9	1.9	12.6	2.2	2.1	3.5	9.8	0.1	4.3	4.1	3.7	2.1	2.3	0.4	0.4	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.4	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.4	39.9	0.0	0.0	0.0	0.2	19.8	0.4	0.0	0.1	0.4	0.6	0.1	2.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	20.8	19.3	9.8	21.3	22.2	10.8	14.9	21.8	13.5	9.8	14.9	24.6	0.0	0.2	4.5	0.0	1.6	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.0	0.3	13.2	0.0	0.0	0.4	0.1
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 25.8"	"Group enriched"	"Detected in some"	8	"Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.5	1.0	2.2	1.3	5.8	3.5	0.8	2.6	2.9	1.0	0.5	0.7	0.6	0.7	0.8	0.8	1.0	0.9	1.1	0.3	1.8	1.6	0.7	0.9	0.6	0.9	0.9	0.8	0.9	0.5	1.0	0.8	1.2	1.7	0.9	0.5	0.6	1.0	0.8	0.6	1.3	0.8	0.7	1.6	0.7	0.6	25.8	1.0	1.3	0.8	0.3	0.9	0.8	0.5	3.1	2.3	2.8	2.2	2.6	2.9	1.3	3.9	6.1	3.3	4.5	0.2	0.3	3.5	2.3	1.8	5.4	5.1	2.5	3.8	0.7	7.0	1.9	4.0	1.3	1.6	1.7	1.2	2.6	1.5	4.2	3.6	1.5	1.2	1.1	2.6	1.8	2.4	3.5	0.7	1.1	0.9	4.4	2.2	2.0	2.4	9.3	3.9	2.0	3.5	3.7	0.0	1.6	0.6	0.4	1.8	3.4	7.6	3.0	3.2	2.3	0.9	1.1	3.0	1.5	1.2	3.6	5.3	0.9	3.1	0.4	1.4	1.2	3.8	2.9	3.6	2.8	2.2	0.6	2.4	1.8	0.8	3.1	1.7	2.3	2.3	2.2	2.3	1.3	2.4	2.6	0.7	1.5	2.9	1.3	2.2	5.8	2.6	2.9	1.8	1.6	0.9	0.8	1.7	1.0	0.0	0.3	0.0	0.7	0.6	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.7	1.7	0.9	22.2	0.5	0.4	0.0	1.0	0.6	0.4	0.4	0.0	0.2	0.7	1.6	0.0	0.0	0.0	45.8	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.1	0.5	0.1	0.0	0.6	32.9	25.6	0.6	0.5	0.0	0.5	0.4
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		15000000	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	52.1	54.7	46.6	55.8	52.8	50.4	64.1	30.8	67.2	89.9	63.1	73.2	70.5	47.5	93.4	51.5	47.8	52.4	47.3	57.9	51.3	66.2	47.8	32.8	41.0	54.7	57.1	45.7	45.2	55.0	55.4	84.4	34.7	45.8	62.7	51.3	53.0	93.0	63.3	139.7	54.8	53.9	119.2	77.4	71.0	52.6	34.1	83.8	73.4	42.7	51.8	61.5	35.8	78.3	103.0	60.3	70.7	72.5	39.7	39.5	42.1	41.9	67.6	92.7	106.1	91.6	58.3	40.7	83.0	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3	142.9	125.8	60.3	65.1	68.1	51.9	108.2	81.5	179.3	134.2	68.0	15.7	176.7	87.9	106.1	12.6	85.2	80.0	46.7	168.6	123.7	82.9	62.0	103.4	133.7	108.0	46.1	63.8	90.9	107.2	13.4	96.7	88.1	91.1	226.4	73.7	84.2	122.6	66.6	99.0	122.6	44.8	64.7	80.2	38.6	45.3	66.4	223.6	74.3	80.9	77.2
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	13.9	12.7	12.6	13.0	26.1	14.3	16.0	18.5	14.4	15.8	15.1	11.8	11.3	17.3	16.7	23.1	16.9	13.4	18.7	12.9	11.4	14.0	13.1	18.1	11.0	15.2	10.7	12.2	13.8	30.9	8.9	16.2	9.6	10.7	15.5	8.9	13.6	21.0	18.8	36.6	17.9	16.8	18.1	10.6	11.9	17.4	13.3	9.8	13.5	17.2	16.5	14.6	13.1	11.3	25.6	18.5	12.2	20.1	16.2	24.4	13.2	21.5	10.6	6.4	15.7	5.8	8.6	11.0	9.8	7.3	9.4	15.3	8.9	7.5	7.2	26.7	5.8	7.6	10.1	5.3	6.5	6.1	12.2	22.8	5.8	10.9	23.0	6.9	16.7	6.2	7.3	7.3	6.8	10.2	5.4	11.7	14.5	22.5	5.6	5.0	20.6	9.5	31.0	7.8	11.1	20.9	12.8	3.5	40.1	7.4	8.6	27.4	8.0	4.3	6.2	20.9	6.3	7.9	7.5	11.1	8.0	7.6	8.9	9.4	18.2	25.7	13.3	5.6	12.1	10.8	6.2	20.1	12.2	14.8	18.4	17.0	25.3	24.4	17.8	15.5	25.6	24.4	20.9	4.8	16.2	18.1	18.5	20.5	13.2	12.6	26.1	18.5	14.4	11.4	14.0	10.7	12.2	10.7	9.8	20.8	13.9	20.9	23.8	24.7	28.8	18.6	35.7	16.0	19.4	41.8	7.9	32.9	71.3	34.8	24.9	32.9	22.0	0.0	76.0	30.2	26.7	25.6	21.9	55.5	30.7	23.8	21.9	29.4	18.9	9.7	34.2	21.2	28.7	31.5	27.1	15.1	47.9	24.6	21.5	42.5	26.2	45.3	30.9	29.8	76.7	33.4	10.1	20.6	32.0	22.6
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.7;HMC-1: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		7100000	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.9	5.6	2.8	2.0	1.7	4.3	1.5	0.0	0.3	1.8	0.0	13.7	7.7	10.6	2.5	0.0	1.2	37.7	1.9	0.0	2.3	2.2	41.9	1.9	13.2	1.9	6.3	1.8	4.0	0.0	9.0	0.0	8.8	1.3	0.3	0.0	0.9	0.0	0.0	0.0	2.9	1.8	4.2	13.8	0.1	0.8	0.9	3.9	0.1	11.4	12.4	4.4	2.9	0.2	3.2	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2	11.9	15.2	6.9	15.7	12.2	0.6	2.8	2.5	2.7	13.6	0.0	0.0	21.1	3.3	8.8	1.9	2.2	0.4	0.0	3.3	2.5	3.8	21.9	41.7	16.3	12.6	0.0	1.2	10.4	40.3	5.0	2.6	35.6	6.8	6.4	2.6	9.5	20.5	0.0	2.1	2.9	0.2	6.5	6.2	0.5	1.1	8.9	7.3	12.5	2.2	17.0
PTCD1	KIAA0632	ENSG00000106246	"Pentatricopeptide repeat domain 1"	O75127	7	99416739-99466163	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 22.3"									"HPA020106, HPA047679"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020106: AB_2176551, HPA047679: AB_2680119"	"unprognostic (4.70e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.10e-3)"	10.3	11.4	9.9	12.0	11.9	21.9	10.6	13.9	16.3	9.4	15.7	5.3	12.0	13.2	12.4	10.6	17.7	12.7	13.2	22.9	10.5	9.1	18.3	29.5	11.5	14.8	9.2	13.1	13.5	19.9	9.3	9.7	9.8	10.7	13.4	7.4	9.1	17.4	13.6	43.8	19.7	18.9	6.4	8.6	15.8	11.6	18.0	7.5	16.0	12.2	30.8	11.3	12.4	10.5	6.2	4.7	4.5	5.0	4.1	8.0	3.2	3.6	7.5	2.6	7.2	2.4	2.0	7.3	5.0	1.9	3.7	2.6	22.3	4.4	7.3	5.9	1.4	6.1	3.9	3.1	4.6	1.3	5.7	8.7	3.7	6.0	5.4	3.8	3.6	7.1	1.6	2.9	3.0	3.0	2.5	1.1	4.7	7.4	5.0	1.8	10.2	6.7	9.6	4.8	3.6	6.3	4.1	3.4	9.0	1.9	3.9	4.8	5.2	5.6	18.8	4.8	3.9	4.0	4.0	2.0	5.6	6.5	10.8	5.4	7.6	6.5	7.8	5.7	5.1	7.6	3.5	4.5	1.8	8.0	5.0	5.2	4.2	5.0	5.2	3.2	6.2	5.9	7.1	4.5	4.1	3.5	4.7	3.3	3.2	9.9	11.9	13.9	16.3	10.5	9.1	9.2	13.1	10.7	7.5	0.0	4.3	11.3	3.5	5.6	7.8	5.5	2.5	8.1	3.4	5.2	9.8	8.1	1.7	4.4	1.0	4.3	3.0	0.0	5.9	4.6	5.0	3.0	12.7	5.9	5.8	7.9	7.0	3.7	1.6	1.5	3.4	4.8	3.3	3.6	5.8	4.6	3.6	3.4	2.8	2.4	8.3	0.0	5.4	6.5	7.1	3.6	4.7	5.7	5.6	2.4
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106182-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (6.86e-4)"	13.9	18.6	18.5	12.2	23.2	18.0	14.5	24.5	22.7	13.0	17.5	19.7	11.3	14.3	15.2	15.5	12.7	13.6	9.6	35.0	17.7	16.6	18.0	21.9	11.7	15.4	20.2	19.0	20.2	13.8	17.9	22.7	13.2	21.4	13.0	19.7	11.4	11.1	12.9	45.4	14.2	14.2	13.4	17.9	15.8	14.8	22.8	20.5	20.4	14.9	13.1	15.3	12.4	13.0	13.4	9.4	6.3	11.1	11.9	14.7	7.5	7.8	18.9	11.2	9.4	8.4	8.8	13.5	17.3	7.0	9.2	9.3	35.1	7.6	19.7	6.1	9.1	9.9	14.5	22.6	8.9	11.8	8.8	19.9	15.6	11.8	29.0	8.7	12.6	11.9	10.4	6.5	7.0	12.6	9.7	8.0	14.8	16.2	7.5	8.1	7.3	10.4	15.1	10.2	15.6	12.1	14.1	15.9	14.9	12.6	15.8	12.3	7.5	7.6	12.7	14.8	11.0	6.7	7.8	5.6	7.3	7.9	7.5	9.5	17.7	22.8	16.0	7.1	14.5	5.6	3.4	8.6	6.3	11.6	5.9	13.6	13.4	10.5	12.2	9.4	13.4	14.7	10.7	0.3	11.9	11.1	9.4	11.8	7.5	18.5	23.2	24.5	22.7	17.7	16.6	20.2	19.0	21.4	20.5	53.6	27.4	22.3	21.6	23.1	60.5	94.8	17.8	24.1	42.1	22.7	62.8	46.9	21.6	16.2	23.2	22.4	21.0	0.0	10.3	21.6	24.3	12.7	32.4	38.0	18.9	35.0	29.9	22.7	15.0	17.5	25.0	13.2	8.5	16.2	21.0	49.5	14.2	22.4	18.4	24.4	63.1	12.9	16.5	90.5	54.4	21.7	30.7	24.5	35.3	17.5
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.7	35.8	4.0	14.8	3.6	3.7	12.2	9.8	5.5	12.4	6.6	26.7	20.0	11.3	15.7	3.9	9.7	33.2	5.8	12.1	1.7	8.1	15.6	5.8	27.1	24.9	11.1	11.7	11.6	5.0	8.8	10.0	6.9	3.8	8.5	12.0	12.8	7.0	4.1	39.5	14.0	22.4	12.8	15.4	29.0	10.6	7.9	28.8	8.4	9.6	20.0	12.0	14.2	22.6	9.5	2.0	20.2	6.3	11.1	12.8	15.8	17.2	17.8	16.2	7.9	11.0	9.7	9.1	11.8	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8	14.9	5.4	25.3	29.8	20.4	34.7	606.9	35.7	0.0	6.8	22.7	19.6	69.1	124.3	64.1	1.9	21.1	88.3	0.0	44.8	49.4	20.3	34.0	14.9	33.3	50.6	35.0	43.4	15.4	22.9	3.2	28.4	33.8	54.0	154.1	52.3	18.2	52.2	51.8	20.5	79.0	38.1	19.4	28.3	2.3	56.6	21.5	55.7	21.7	83.1	40.8
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 106.7;Paneth cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042300			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	4.9	3.0	0.0	1.2	1.0	2.7	0.0	0.1	2.7	0.5	1.1	1.3	7.0	0.0	0.2	0.5	6.2	0.0	0.0	0.0	0.6	0.0	0.1	0.4	0.1	3.5	9.1	0.0	3.6	0.7	2.2	1.7	2.7	0.3	0.1	0.0	10.6	0.5	0.0	0.0	0.0	0.2	0.0	22.4	7.2	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.1	15.9	0.0	0.0	1.4	0.0	0.7	1.1	0.3	0.0	0.0	2.6	0.0	0.8	0.1	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5	0.0	0.0	0.0	2.4	1.5	0.0	0.6	20.4	0.0	0.0	1.8	0.0	0.0	0.0	11.7	0.0	0.2	106.7	0.0	22.9	0.0	0.2	3.1	0.0	5.1	0.2	15.9	4.6	1.3	0.0	0.0	0.0	0.8	0.0	1.0	14.0	0.2	20.1	38.6	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.0	0.1	0.0	15.6	17.9
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	15.9	22.9	17.1	12.4	17.1	9.9	20.7	12.5	22.1	15.6	17.2	11.8	16.3	11.6	14.3	36.7	16.4	13.8	13.1	12.6	19.3	17.8	14.8	34.7	12.1	12.5	16.7	15.2	14.2	19.9	10.3	18.3	13.6	21.0	15.9	20.7	8.1	13.7	18.7	23.3	11.4	11.0	16.8	17.1	15.5	14.3	15.7	18.1	9.0	11.8	13.5	16.9	13.0	10.5	15.6	21.6	12.6	29.3	13.1	15.5	13.0	18.9	36.2	11.7	10.6	22.2	19.1	12.5	18.3	16.1	15.7	23.0	23.4	14.9	13.8	27.8	15.3	26.9	18.9	25.1	23.6	22.9	26.5	34.1	24.6	18.8	42.8	34.3	21.7	14.0	21.5	30.7	24.3	28.3	11.2	26.1	9.7	27.4	15.4	23.3	45.8	18.5	17.7	10.0	49.3	28.7	10.1	19.6	20.1	26.1	27.3	15.1	19.6	9.4	10.3	22.4	14.0	24.1	15.5	17.1	20.5	20.7	12.2	19.8	20.0	22.2	20.4	13.5	13.6	15.6	1.9	25.8	1.1	9.2	24.4	12.4	15.6	10.8	10.4	18.5	13.1	15.5	11.1	12.6	13.1	29.3	21.6	12.3	13.0	17.1	17.1	12.5	22.1	19.3	17.8	16.7	15.2	21.0	18.1	14.9	12.8	13.4	31.9	32.5	3.3	14.8	7.6	30.8	50.0	10.4	3.9	22.1	10.0	25.9	17.7	18.3	9.1	0.0	22.0	20.6	19.7	23.3	22.0	27.3	15.2	7.9	6.4	11.6	7.3	7.9	16.1	18.7	13.5	10.0	9.7	6.6	25.9	13.9	9.2	13.2	3.2	12.9	21.7	16.7	11.4	31.1	26.5	8.3	13.2	31.5
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051636: AB_2681560, HPA057593: AB_2683479"	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.4	20.2	4.8	8.5	4.6	7.9	29.5	11.9	5.0	9.1	5.9	22.3	10.1	18.4	13.8	6.5	7.1	19.6	15.8	11.3	5.9	8.1	31.9	18.5	9.8	19.4	12.5	31.7	17.1	8.0	9.2	10.4	8.9	4.4	8.9	12.9	22.9	5.7	5.2	26.8	20.8	28.5	25.3	12.6	30.8	19.9	6.8	19.1	7.4	21.5	13.4	7.5	10.0	13.7	11.0	4.9	15.0	34.3	7.7	7.3	15.6	15.4	17.2	15.6	11.7	21.9	7.5	25.4	10.0	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4	0.0	6.7	10.0	16.1	26.3	5.2	4.5	12.7	4.0	3.4	5.2	21.6	12.0	5.0	9.3	0.6	9.0	4.5	0.0	8.2	14.4	9.6	13.4	16.1	11.3	13.6	0.0	13.8	8.0	7.3	2.0	7.2	8.9	6.8	8.2	17.2	4.6	12.7	7.0	8.9	10.4	9.6	6.5	11.8	16.5	22.1	19.8	7.2	7.5	15.5	13.7
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridylate synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: AB_2680824"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	7.0	8.7	7.4	5.0	7.3	3.9	7.3	6.8	7.9	4.8	10.0	5.1	3.0	9.2	7.7	9.1	5.0	5.4	6.4	4.6	6.5	6.9	8.5	17.6	6.3	6.5	8.5	4.6	6.8	7.2	6.3	10.3	4.2	5.9	6.6	6.0	6.7	6.2	3.9	6.7	4.3	19.8	3.6	7.1	5.9	4.2	7.8	8.0	9.1	10.4	4.1	8.3	4.4	4.4	5.2	4.9	9.8	6.9	4.8	4.3	1.8	2.7	1.6	4.5	7.7	4.0	4.4	5.2	5.7	5.3	5.6	5.3	4.3	3.9	8.7	5.9	3.2	5.2	3.0	5.1	4.6	6.8	8.8	2.5	7.9	2.1	13.4	7.1	8.7	5.0	5.2	5.4	3.9	9.5	6.9	7.0	8.7	8.1	6.1	3.8	2.5	6.9	7.0	4.1	2.1	3.0	6.8	6.0	4.4	3.2	5.3	2.6	3.6	4.5	8.0	9.1	3.2	3.1	5.6	5.3	5.4	4.2	3.5	4.1	7.4	3.2	18.6	4.6	5.2	6.0	9.8	1.9	2.0	3.9	2.2	4.3	5.2	2.5	2.6	1.6	3.2	3.0	3.4	4.1	4.8	6.9	4.9	1.5	1.8	7.4	7.3	6.8	7.9	6.5	6.9	8.5	4.6	5.9	8.0	0.0	11.0	1.9	2.2	2.2	6.8	4.2	0.0	10.7	3.4	3.5	0.0	5.2	6.6	2.6	1.5	3.9	16.5	0.0	4.4	3.8	2.8	2.9	0.0	11.6	5.3	1.6	1.2	6.2	5.1	1.1	2.8	3.2	1.7	10.8	2.0	6.5	4.3	2.9	1.4	5.1	6.3	6.5	2.1	7.1	10.9	1.9	10.4	5.7	3.3	4.3
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA056873: AB_2683263"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	21.4	37.2	25.7	24.0	28.2	29.5	17.2	14.3	38.2	21.8	17.4	40.0	25.8	16.1	25.3	20.0	17.7	33.2	24.6	38.0	27.9	28.3	23.4	35.0	22.0	30.3	34.0	30.8	34.5	29.0	26.6	29.8	22.2	29.5	22.4	13.7	21.5	26.3	32.1	36.0	15.3	16.7	22.3	38.4	25.9	20.1	17.6	24.7	35.0	19.2	20.0	23.5	24.6	16.2	19.3	25.9	16.4	12.7	28.3	36.1	18.1	16.9	14.0	8.6	14.4	9.7	10.1	18.1	17.9	11.2	12.2	10.9	18.3	14.1	29.8	38.5	13.1	9.6	19.6	12.3	14.1	7.0	35.8	25.6	28.5	14.6	18.3	15.1	25.0	46.8	9.7	17.8	13.8	15.9	10.9	11.6	25.0	41.1	20.0	12.3	13.9	31.4	28.4	47.9	26.7	19.5	28.2	19.2	61.8	15.8	13.5	10.8	14.0	14.9	11.9	37.4	7.2	15.3	47.9	9.7	9.6	11.5	20.3	24.6	32.0	35.1	29.5	15.1	19.1	26.5	15.1	8.7	16.4	21.1	12.7	22.2	15.9	20.6	19.5	13.6	19.3	36.1	29.2	6.0	28.3	10.8	25.9	18.6	18.1	25.7	28.2	14.3	38.2	27.9	28.3	34.0	30.8	29.5	24.7	17.9	21.4	27.4	51.9	13.2	13.0	38.6	15.3	60.2	17.0	33.2	13.7	79.6	41.4	44.2	5.9	22.9	13.5	46.7	30.3	34.9	22.5	33.6	38.1	16.3	35.3	12.7	25.4	19.0	20.8	5.6	35.4	21.2	32.1	65.9	14.1	38.4	25.0	13.9	35.3	24.0	36.1	25.8	18.9	33.6	40.3	11.2	34.9	45.7	13.6	34.4
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415184	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.8"	"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 28.6;U-937: 18.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favorable (3.37e-4)"	11.0	15.5	5.1	9.0	7.0	2.7	9.2	2.6	6.3	12.2	6.5	12.0	14.2	2.5	8.3	15.5	4.1	11.6	13.1	9.5	5.3	3.8	6.7	11.7	8.6	2.9	12.6	3.0	11.5	4.3	7.5	6.0	5.0	9.6	12.9	5.8	12.5	26.9	11.3	9.6	3.2	4.1	12.2	8.1	5.2	5.5	3.7	10.7	4.3	9.2	2.3	3.0	11.9	6.9	0.0	0.5	50.8	0.0	11.3	1.8	0.4	2.1	5.3	3.0	0.1	4.7	9.5	1.1	3.5	10.9	2.0	3.8	0.0	7.4	0.0	6.3	3.7	0.5	1.0	0.9	1.2	2.1	0.2	0.8	4.3	8.8	0.4	6.1	0.0	10.0	5.6	1.6	1.6	1.9	28.6	1.5	2.0	0.1	0.1	3.0	6.5	0.1	10.2	0.9	4.1	1.8	1.3	1.1	0.0	2.9	3.3	0.2	0.1	3.8	0.5	2.6	4.3	3.1	4.8	2.0	0.0	2.3	0.6	3.4	0.7	0.4	0.0	3.5	18.7	0.3	1.1	0.0	50.8	1.8	0.0	0.4	0.0	0.6	1.5	0.5	0.0	0.3	1.1	0.1	11.3	0.0	0.1	0.1	0.4	5.1	7.0	2.6	6.3	5.3	3.8	12.6	3.0	9.6	10.7	8.9	3.2	0.0	5.5	0.5	0.0	8.1	0.0	13.4	6.8	1.8	0.0	4.5	6.6	2.1	0.2	3.1	2.0	0.0	2.2	3.3	4.6	2.8	2.3	2.4	7.5	0.0	1.2	4.3	3.8	0.2	3.1	2.5	1.7	1.0	4.9	3.1	1.1	0.0	3.5	7.3	0.8	6.5	4.2	2.6	1.5	0.5	1.5	4.4	6.0	8.4
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.6	22.8	9.0	12.5	21.9	11.1	15.9	16.6	7.0	15.5	13.6	18.2	15.4	4.3	10.7	9.2	17.3	6.6	12.8	18.8	9.7	13.1	2.6	11.8	11.8	43.0	13.2	15.3	1.1	13.7	11.9	9.7	13.4	8.3	7.8	11.0	12.6	9.9	16.6	6.0	22.8	24.6	15.3	11.0	15.4	9.5	6.9	17.2	16.0	6.4	17.1	21.8	11.0	1.8	47.2	10.3	5.0	5.9	13.5	9.0	16.1	8.9	13.2	15.4	24.0	30.2	18.0	13.5	14.9	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7	26.8	26.9	18.2	16.6	17.7	34.9	59.2	38.2	4.0	14.8	36.6	7.9	65.3	92.9	37.2	0.8	17.8	14.2	0.0	20.5	28.8	26.3	26.4	25.3	298.8	69.8	77.9	167.4	25.8	34.9	3.3	21.0	26.9	145.1	20.8	22.6	301.8	17.0	7.0	35.7	369.1	26.6	25.8	26.4	3.3	60.7	14.1	15.3	16.7	36.6	11.1
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	14.0	18.4	20.6	13.4	29.1	14.2	11.5	18.0	21.3	11.3	14.5	13.3	19.4	12.8	15.3	11.6	14.6	15.8	13.5	19.5	19.7	13.1	11.8	18.9	8.4	13.5	22.9	19.3	22.1	33.9	5.8	12.0	9.8	19.9	13.7	6.6	10.5	26.6	12.7	20.5	12.6	14.2	13.3	12.7	11.5	12.5	5.0	22.2	5.3	19.0	11.9	10.3	12.0	10.3	19.6	19.1	0.9	14.4	18.5	18.8	10.4	17.2	13.9	6.6	19.3	7.0	8.4	8.7	8.8	7.9	10.3	10.2	11.1	6.6	19.5	21.7	5.0	6.2	11.6	6.0	10.6	3.4	11.5	8.4	12.8	5.6	23.3	12.1	19.0	11.3	12.4	9.1	6.7	9.9	4.7	10.5	10.8	14.1	22.4	5.1	26.9	16.3	23.7	17.5	10.8	21.5	17.2	8.8	30.1	8.4	11.1	21.5	9.3	13.5	14.8	11.5	2.9	9.5	8.0	8.1	15.9	8.9	25.4	20.5	24.7	19.0	9.5	8.6	23.1	19.2	0.9	8.3	0.2	15.1	14.4	18.8	19.6	16.3	13.1	16.4	19.0	17.5	13.9	0.6	18.5	7.3	19.1	17.7	10.4	20.6	29.1	18.0	21.3	19.7	13.1	22.9	19.3	19.9	22.2	0.0	5.0	26.7	54.7	56.6	36.4	5.6	28.1	12.0	5.7	54.1	47.1	41.0	54.7	20.6	1.3	27.0	191.9	70.0	23.8	30.6	33.2	38.0	16.1	26.7	26.1	85.8	185.1	16.5	20.2	1.1	46.9	9.6	47.2	7.2	232.5	24.4	15.1	244.4	35.3	58.5	54.3	19.4	30.3	12.1	28.9	36.6	23.5	26.2	247.9	33.9
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Cell type enriched"	"Detected in many"	14	"Proximal tubular cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No			"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8.0	7.8	5.6	7.5	2.1	12.3	10.0	12.4	6.9	4.6	6.1	9.0	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8.0	7.0	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9	3.0	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4.0	6.8	5.2	5.9	0.8	23.2	1.4	1.0	2.5	6.4	0.0	1.0	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0.0	0.0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3.0	1.9	0.7	2.6	4.1	0.3
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113242-88175467	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.5;tongue: 38.1"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Region enriched"	"Detected in single"	5	"pons and medulla: 3.2"	"Group enriched"	"Detected in many"	5	"NK-cell: 15.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.2;NK-cells: 15.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	1.8	15.6	0.4	1.2	0.4	0.4	4.6	0.3	0.6	10.8	1.6	1.2	2.8	1.0	7.0	8.7	29.9	2.8	8.2	1.7	0.6	0.5	2.6	0.8	5.3	0.4	0.5	0.2	3.0	2.3	0.9	4.6	7.7	3.2	4.0	0.4	35.5	4.9	5.2	0.5	24.9	2.4	2.7	0.7	1.3	0.9	5.3	0.1	1.6	6.6	38.1	21.0	4.2	13.3	0.0	4.2	0.5	1.3	15.3	1.8	0.6	2.3	0.3	0.0	0.1	0.0	0.5	0.1	1.4	5.8	2.3	4.3	1.0	1.0	0.1	1.4	1.5	0.2	15.9	1.2	19.4	3.2	0.2	1.1	11.7	1.5	0.0	0.2	0.1	0.1	0.5	69.6	0.3	62.0	2.9	2.7	0.2	0.0	0.2	0.0	0.0	0.1	3.9	1.8	0.1	0.0	0.1	0.0	0.1	4.5	8.9	0.4	0.2	0.0	0.0	37.4	1.4	3.5	1.0	1.5	0.0	1.0	0.0	0.2	0.3	1.4	0.0	0.3	0.4	0.2	0.0	0.6	0.1	1.6	0.6	0.9	0.0	0.5	1.8	1.5	0.0	0.1	0.9	0.5	15.3	1.3	4.2	0.9	0.6	0.4	0.4	0.3	0.6	0.6	0.5	0.5	0.2	3.2	0.1	0.0	4.1	0.0	12.1	41.2	0.0	0.1	0.0	4.0	7.9	0.0	0.0	78.5	3.3	1.3	0.0	1.5	1.1	0.0	1.0	6.8	6.7	2.1	16.1	0.0	14.7	0.0	0.0	0.0	1.0	0.0	3.1	4.9	124.9	10.8	0.0	0.5	1.8	1.1	1.1	3.2	5.9	0.0	2.8	0.0	3.2	86.1	45.8	1.5	2.1	22.8
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 79.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.7	18.3	11.3	12.4	6.2	5.3	25.8	8.6	4.0	11.6	14.8	7.8	10.2	9.3	12.8	5.9	15.3	6.0	15.1	12.2	21.6	22.6	31.3	13.1	20.6	29.4	6.1	16.8	11.7	3.2	11.0	12.9	10.5	6.2	12.9	15.6	20.3	12.8	9.9	79.0	23.8	23.4	3.0	10.5	17.0	15.3	17.9	17.5	7.0	9.9	14.0	13.0	6.9	3.4	13.0	3.0	10.2	17.8	4.1	9.8	26.0	8.8	10.5	12.0	44.5	27.2	9.9	16.6	11.2	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7	17.9	11.5	15.2	17.6	10.5	14.6	54.1	10.2	10.7	13.6	15.7	5.9	46.3	49.7	22.6	78.9	14.9	4.2	70.0	16.3	78.6	13.4	14.4	23.0	12.5	29.2	15.9	6.4	14.1	13.4	51.1	16.1	22.9	23.6	22.6	13.1	21.7	12.0	10.5	14.5	19.5	23.0	32.3	22.1	113.9	80.6	9.4	30.3	21.3	12.5	8.4
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic alpha subunit 1"	Q6GYQ0	14	35538352-35809304	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 371.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.9	21.8	19.5	13.1	25.6	8.3	22.5	31.7	28.3	20.2	18.3	23.2	13.6	10.7	21.0	19.2	15.1	15.0	13.0	11.7	21.8	22.2	17.1	13.9	13.4	11.7	21.5	17.9	28.1	15.4	43.6	42.6	10.1	28.1	20.4	20.2	14.2	15.0	15.2	15.9	27.0	13.8	17.5	23.6	11.6	14.1	13.7	21.3	14.9	21.3	12.2	13.0	15.0	19.2	1.6	1.5	0.1	1.1	2.3	3.3	0.5	5.7	6.7	9.1	8.0	13.8	10.7	5.8	4.3	4.8	5.4	5.1	4.2	5.1	5.7	6.4	5.7	7.6	9.5	10.8	8.3	5.5	12.2	4.7	5.2	8.7	20.2	7.2	8.7	8.5	7.7	15.0	4.8	12.1	9.1	7.6	11.5	5.0	14.5	5.0	9.2	6.6	4.1	3.9	14.3	10.8	5.3	6.4	3.4	10.9	9.2	8.5	13.8	9.2	15.4	7.4	9.1	14.7	4.3	6.9	5.5	4.1	6.2	5.3	11.8	10.7	7.3	2.6	5.7	5.9	0.0	0.6	0.1	2.4	1.1	3.3	1.6	2.5	3.1	1.1	1.3	1.8	2.5	0.1	2.3	0.9	1.5	2.7	0.5	19.5	25.6	31.7	26.0	21.8	22.2	21.5	17.9	28.1	21.3	14.9	25.7	18.7	22.2	33.9	87.3	18.1	17.8	18.7	31.8	22.7	371.1	9.0	0.0	11.1	12.0	26.1	25.2	0.0	13.7	4.6	28.2	31.9	54.1	13.9	8.1	49.3	29.9	16.0	7.8	4.7	31.7	16.0	18.6	13.6	22.7	37.9	12.8	28.1	27.3	8.2	125.6	38.8	34.0	37.1	36.6	40.4	12.7	20.0	26.9	23.1
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87514378-87590003	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	27.0	44.1	13.3	21.1	15.9	16.0	22.9	24.0	17.3	25.1	21.4	18.6	25.2	17.5	35.5	25.5	20.4	21.1	19.2	21.5	14.4	12.8	23.7	32.1	20.5	24.4	17.3	14.2	22.2	30.1	20.5	36.9	28.3	17.2	20.7	23.1	24.0	23.5	27.7	23.0	20.4	30.5	24.7	16.8	21.1	20.5	23.9	13.6	28.0	21.2	20.5	27.3	24.3	20.2	16.7	18.9	22.8	20.2	18.1	28.8	16.2	10.1	10.1	24.3	26.4	24.7	27.0	17.3	24.4	29.2	16.9	21.5	19.4	11.4	12.9	14.5	25.0	17.1	14.2	20.4	14.0	24.0	9.5	19.3	13.3	12.8	30.8	31.1	15.7	11.5	26.9	13.6	14.2	18.1	23.7	22.2	13.6	30.7	12.8	24.9	18.7	5.1	16.7	15.8	21.8	10.9	10.3	24.5	11.3	20.8	21.4	22.0	29.7	12.8	6.4	17.1	21.4	11.9	24.0	15.1	11.2	9.0	12.3	20.1	13.6	22.8	10.7	17.6	16.6	19.4	15.9	19.1	22.8	18.1	19.3	21.3	16.7	23.4	17.0	16.7	16.2	23.0	19.1	11.6	18.1	20.2	18.9	28.8	16.2	13.3	15.9	24.0	17.3	14.4	12.8	17.3	14.2	17.2	13.6	17.9	14.1	14.5	30.7	15.3	13.2	19.7	7.6	20.1	26.1	10.4	19.6	27.0	38.1	25.7	69.3	24.2	16.2	0.0	41.3	37.9	29.7	24.9	17.4	13.2	18.2	6.4	8.6	22.7	14.8	27.7	23.6	14.2	18.6	22.6	23.2	12.1	29.9	21.8	22.6	23.7	15.6	25.8	24.7	38.7	31.1	15.7	33.1	21.8	24.1	29.1
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100791-180209153	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 27.4;testis: 7.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.5;Late spermatids: 3.2;Spermatocytes: 5.5;Syncytiotrophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;HEK 293: 2.8;MCF7: 3.9;SCLC-21H: 12.6;U-2 OS: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	1.1	1.1	7.0	1.1	5.4	0.6	1.4	27.4	22.0	1.4	2.3	9.2	0.0	0.8	0.6	0.8	1.2	1.7	1.2	1.5	4.5	2.8	0.6	0.6	0.6	0.6	5.1	4.9	0.8	0.9	0.8	0.2	0.8	7.7	0.8	1.1	0.4	3.0	2.7	0.7	1.1	1.4	1.0	8.3	0.7	0.8	7.1	4.7	0.0	2.1	0.0	0.6	0.8	0.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.2	0.0	3.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.0	5.4	27.4	11.1	4.5	2.8	5.1	4.9	7.7	4.7	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.5	0.9	0.0	1.6	0.0	0.0	0.0
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 534.5;Horizontal cells: 406.8;Late spermatids: 509.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA038163: AB_2675874, HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	9.8	14.1	14.6	6.4	14.0	1.3	14.6	8.0	10.4	20.9	12.7	10.3	7.0	2.5	23.9	10.5	6.7	10.0	14.6	11.9	16.0	8.5	19.7	5.2	12.5	2.2	15.1	8.0	26.3	5.2	4.3	16.1	10.6	14.8	14.2	4.6	14.7	4.4	12.7	12.0	3.3	4.4	17.3	19.9	5.0	7.0	44.7	13.6	0.3	9.7	5.2	2.2	10.1	18.8	0.6	4.1	0.9	0.3	1.4	0.6	0.1	3.3	2.7	11.8	1.4	18.3	20.8	16.4	18.2	26.7	7.7	8.5	5.8	1.0	0.2	14.4	19.6	8.6	1.3	2.5	2.1	9.9	1.2	3.4	0.6	6.7	0.3	9.1	2.0	0.1	12.3	2.1	17.1	11.5	12.0	9.2	4.2	0.6	2.4	8.9	4.5	2.4	0.4	11.7	0.0	25.2	3.1	11.4	0.1	4.7	5.0	0.5	8.5	9.6	0.1	8.9	10.7	1.7	1.7	10.8	15.3	7.9	38.7	13.6	1.0	0.7	0.3	14.1	0.2	21.4	0.7	0.3	0.2	0.6	0.1	0.2	0.3	0.2	0.2	0.0	0.6	0.3	0.2	0.9	1.4	0.1	4.1	0.1	0.1	14.6	14.0	8.0	10.4	16.0	8.5	15.1	8.0	14.8	13.6	35.7	16.5	0.0	33.0	6.9	12.8	30.8	17.8	1.4	12.5	21.0	9.8	8.1	11.6	7.5	534.5	18.0	0.0	0.0	3.6	14.5	30.9	26.1	1.1	6.7	4.5	406.8	0.0	9.8	1.8	509.0	16.7	7.4	13.5	0.0	0.0	27.8	4.4	0.0	14.2	17.4	9.6	12.9	18.6	20.9	8.9	4.6	3.8	0.0	0.0	12.6
RBFA	"C18orf22, FLJ21172, HsT169"	ENSG00000101546	"Ribosome binding factor A"	Q8N0V3	18	80034358-80046397	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040485, HPA041479"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040485: AB_10795368, HPA041479: AB_10795697"	"unprognostic (5.31e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.00e-3)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.82e-1)"	"unprognostic (5.00e-3)"	19.4	21.0	11.3	14.4	15.8	16.7	30.9	20.4	17.3	12.1	12.5	15.9	10.0	14.8	13.6	14.3	17.7	11.4	12.9	13.8	10.6	8.6	14.5	36.9	11.0	18.5	12.5	14.2	12.3	20.0	12.5	9.7	12.6	12.7	11.8	12.7	11.3	13.4	12.3	21.3	18.6	11.1	18.3	13.8	13.2	12.1	13.8	12.8	9.9	11.6	18.6	15.7	14.0	14.2	10.7	8.3	0.3	10.1	7.5	11.7	5.7	14.3	16.2	11.4	10.5	11.6	13.8	14.8	12.3	7.8	18.1	16.3	9.4	12.7	30.3	4.6	11.0	12.4	13.6	12.7	15.8	14.5	11.0	13.2	18.0	11.7	24.9	8.9	28.4	8.9	13.2	15.4	12.0	17.3	6.4	15.1	19.2	9.6	18.9	11.0	13.8	28.2	19.6	11.9	9.7	16.1	19.0	10.6	37.0	17.3	16.9	19.7	11.9	11.0	13.1	8.3	10.3	9.5	14.3	10.3	20.6	19.2	3.0	13.2	7.0	12.1	25.3	11.9	24.7	11.7	0.0	5.1	0.0	7.5	7.0	11.7	10.7	7.6	7.3	8.3	8.3	8.4	7.9	0.3	7.5	10.1	6.5	5.8	5.7	11.3	15.8	20.4	17.3	10.6	8.6	12.5	14.2	12.7	12.8	29.8	7.5	26.0	20.9	16.5	12.9	9.2	12.7	17.4	25.0	26.2	17.7	41.8	26.6	23.9	14.1	14.8	9.2	0.0	21.0	42.0	21.6	15.3	12.7	36.5	21.9	30.2	20.1	14.1	6.7	12.1	17.5	17.6	32.1	7.2	20.5	9.5	20.1	2.9	17.3	34.6	21.4	19.4	20.8	28.3	58.3	20.6	20.8	10.1	22.1	13.9
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 25.3;HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	6.1	0.4	0.0	0.0	0.0	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	50.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	5.6	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0	6.0	4.3	0.8	3.8	5.6	19.4	229.0	2.5	0.0	0.0	3.5	3.9	0.0	59.7	5.8	22.0	10.8	0.0	0.0	2.1	0.0	5.6	1.7	0.0	0.2	0.1	28.6	24.1	0.0	0.3	11.0	27.0	1.8	30.4	0.0	0.3	167.3	4.3	0.0	47.4	1.4	8.0	97.0	159.7	0.7	0.9	6.5	0.0	0.0	0.1	1.1
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	0.4	3.2	3.8	2.3	0.2	1.6	10.1	2.0	4.7	3.7	0.9	4.8	1.4	1.3	0.9	1.9	1.4	0.7	2.8	1.6	4.0	1.0	0.7	5.2	0.8	3.1	0.8	6.9	4.7	2.5	1.0	10.0	1.3	5.5	2.2	2.7	2.8	8.0	3.6	0.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0	14.9	16.2	5.1	19.9	9.5	17.3	22.2	28.1	6.7	11.4	14.0	39.3	30.2	10.0	12.3	18.5	6.5	27.1	0.0	5.7	26.9	6.0	23.1	8.1	6.0	9.9	23.8	11.5	16.5	4.1	11.2	3.4	5.0	6.8	1.8	19.8	10.0	11.4	26.2	3.2	3.4	27.0	6.5	5.1	1.4	9.6	15.3	175.4	8.7	21.9	72.9
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439386-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"		NA	NA		390000	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (6.70e-4)"	21.8	31.1	13.5	15.8	14.2	16.2	30.0	14.9	12.6	31.4	36.0	11.2	24.0	8.4	38.4	24.8	33.5	17.7	23.9	64.3	13.3	10.5	35.7	28.6	20.1	13.9	17.0	13.1	28.5	27.7	61.2	24.9	45.0	15.3	32.0	17.7	11.6	61.6	22.8	27.8	22.7	15.8	44.6	15.7	18.6	31.5	29.6	14.5	9.9	20.0	25.2	15.2	34.9	40.6	15.5	28.6	19.0	7.9	18.1	30.5	12.2	27.8	16.2	6.3	16.9	50.7	53.8	15.0	47.3	37.0	23.9	30.5	42.6	47.7	15.3	47.7	41.7	36.3	17.8	14.1	41.8	39.5	14.9	10.9	16.9	22.4	26.5	66.7	12.3	5.4	37.2	40.1	30.2	32.1	42.0	42.7	15.9	31.2	9.4	53.5	6.6	8.9	15.5	19.4	22.3	28.7	7.9	20.6	55.8	34.2	22.7	11.2	7.0	21.7	16.8	19.9	27.5	34.1	6.5	40.4	30.8	36.8	23.7	28.9	7.4	8.8	25.9	21.2	29.1	16.4	19.0	6.0	8.8	14.3	7.9	16.5	15.5	21.6	17.9	7.8	11.7	19.9	16.1	1.5	18.1	7.9	28.6	30.5	12.2	13.5	14.2	14.9	12.6	13.3	10.5	17.0	13.1	15.3	14.5	98.3	49.6	36.3	126.2	123.4	12.0	342.7	43.3	89.7	68.2	90.7	2.0	149.0	235.4	121.0	59.3	101.2	22.2	93.5	62.0	153.2	153.3	156.6	32.2	67.6	83.4	4.8	77.7	89.6	17.6	35.4	195.1	39.5	229.5	53.3	64.2	27.2	110.2	31.6	166.2	264.0	6.7	51.8	115.4	227.9	71.1	142.2	225.1	37.4	70.7	116.6
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 19.9;Horizontal cells: 58.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.3	7.2	0.5	0.0	0.0	0.0	0.4	3.7	4.0	6.9	0.0	0.1	3.6	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.9	0.3	0.2	0.0	7.4	0.0	0.0	0.0	6.0	6.5	0.4	0.3	0.3	0.2	0.0	0.0	2.8	0.0	7.4	0.4	8.0	0.0	4.3	0.0	1.1	0.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8	0.0	0.0	0.8	0.0	0.0	19.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	58.8	6.9	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	2.0	0.0	0.0	6.4	9.3	0.0	0.0	0.0	0.0	0.0
RHOT2	"ARHT2, C16orf39, MIRO-2"	ENSG00000140983	"Ras homolog family member T2"	Q8IXI1	16	668086-674174	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 288.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012624, HPA012895"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA012624: AB_1856272, HPA012895: AB_1856271"	"unprognostic (1.59e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (4.68e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-2)"	15.2	22.8	19.9	26.4	22.3	25.8	16.4	33.3	22.6	14.6	27.2	14.7	19.5	29.5	16.4	27.6	17.3	17.3	28.5	26.5	18.4	11.5	21.8	23.0	15.7	23.4	20.1	20.5	17.3	25.1	18.1	25.3	17.7	19.9	23.3	8.9	30.5	31.7	20.2	21.9	25.3	25.1	13.8	10.4	27.0	24.5	15.8	15.3	20.2	22.1	14.6	20.8	16.6	16.3	11.0	16.4	16.9	18.6	8.7	20.1	13.2	9.4	18.2	10.6	16.4	5.3	5.6	18.9	15.8	7.4	13.5	10.3	25.3	14.5	10.6	11.3	6.4	4.7	17.8	7.5	15.0	3.5	15.1	31.1	12.6	22.5	18.1	9.8	11.6	17.3	9.0	12.9	10.0	5.9	7.9	9.6	14.6	22.9	8.9	7.1	38.6	12.2	12.8	26.2	8.2	12.6	28.3	11.9	22.1	8.6	18.0	23.0	27.2	14.9	19.7	8.6	6.3	20.3	18.2	15.4	10.6	17.0	8.9	11.4	23.9	15.1	14.8	6.9	11.0	15.0	4.5	16.1	16.9	20.1	18.6	12.2	10.1	16.0	15.9	15.9	11.0	12.2	10.3	13.8	8.7	14.3	16.4	18.0	13.2	19.9	22.3	33.3	22.6	18.4	11.5	20.1	20.5	19.9	15.3	29.8	28.0	27.6	25.8	30.0	90.3	21.7	30.6	17.4	15.9	27.9	249.4	51.8	18.3	35.5	4.3	24.8	52.3	0.0	31.1	43.7	26.8	20.0	50.7	31.0	31.5	81.0	41.2	21.5	34.9	4.0	25.0	26.4	27.0	56.9	37.2	36.1	33.9	37.1	24.1	19.5	288.4	51.8	33.5	28.6	51.3	27.7	56.1	51.2	38.3	20.5
RICTOR	"AVO3, KIAA1999, MGC39830, PIA"	ENSG00000164327	"RPTOR independent companion of MTOR complex 2"	Q6R327	5	38937919-39074408	"Predicted intracellular proteins"	"Host-virus interaction"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 22.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 22.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037802, HPA037803"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037802: AB_10672286, HPA037803: AB_2675676"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-2)"	15.4	10.0	12.4	14.2	15.7	35.5	16.4	25.6	20.1	14.7	12.7	18.8	9.8	9.4	17.7	12.7	10.8	12.7	11.0	16.1	13.6	9.8	12.7	13.2	18.7	17.7	20.0	10.1	18.0	12.7	14.3	20.0	21.6	24.1	12.1	11.8	10.0	12.9	9.7	22.1	15.2	15.3	17.9	16.3	16.4	12.4	15.2	21.4	31.6	15.1	8.3	15.3	17.1	14.4	3.5	3.6	22.2	2.2	2.5	4.6	0.5	4.7	8.6	6.3	6.3	8.1	9.3	9.3	6.6	15.4	7.3	7.4	5.2	8.6	7.8	2.5	6.5	11.1	7.8	5.5	7.2	8.8	6.8	4.9	9.1	20.5	6.3	5.2	7.6	12.2	7.9	5.4	9.0	9.9	7.2	12.0	6.4	7.4	15.0	4.9	2.5	7.8	12.8	4.0	2.5	6.7	6.3	11.3	6.8	6.0	7.9	5.4	3.7	17.2	6.4	8.9	6.2	4.5	8.4	10.2	14.9	7.2	6.0	4.9	6.7	4.1	7.8	6.3	10.3	5.4	6.1	1.0	5.6	3.7	1.0	3.0	2.6	3.7	3.2	1.0	3.5	3.9	4.6	22.2	2.5	2.2	3.6	2.2	0.5	12.4	15.7	25.6	20.1	13.6	9.8	20.0	10.1	24.1	21.4	59.6	45.8	63.3	35.5	43.4	67.6	32.3	28.1	14.7	25.0	26.2	192.4	33.1	0.0	20.7	1.7	43.5	22.5	23.3	13.7	15.3	41.7	48.0	32.3	32.1	16.9	49.3	41.9	46.6	42.1	3.2	44.0	44.8	32.1	30.7	25.5	31.6	22.7	22.6	30.4	11.3	174.9	12.9	23.1	37.5	29.4	39.4	80.7	76.2	19.0	39.4
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620679-40665657	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.7"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 1.8;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 4.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA055285: AB_2682771"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.3	7.2	13.6	2.2	19.2	3.7	3.1	21.5	47.7	1.4	3.4	3.4	0.0	1.1	3.0	2.2	2.9	2.1	1.3	1.5	7.8	17.4	1.4	0.7	3.1	2.0	7.4	22.3	2.5	1.1	4.0	0.5	3.8	4.9	3.2	3.8	2.0	2.0	4.1	0.6	2.7	1.7	4.8	3.4	1.7	2.5	3.1	4.4	0.7	2.8	0.0	2.8	1.7	1.0	0.1	4.6	0.1	0.3	0.1	1.8	0.1	1.9	0.7	2.9	3.1	0.1	0.0	0.4	0.0	0.0	0.5	0.6	0.3	0.6	37.3	0.0	0.0	1.4	0.3	1.9	0.3	0.3	6.4	0.9	2.1	0.2	1.0	0.1	0.3	1.7	0.0	1.5	0.1	0.1	0.1	0.1	13.2	1.8	1.4	0.0	3.4	5.5	0.2	1.8	0.3	0.2	2.5	2.6	6.9	0.5	0.5	10.0	17.7	0.4	1.8	1.2	4.0	0.4	10.4	0.0	0.3	3.0	0.0	0.5	0.3	2.7	8.2	16.3	0.6	0.3	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	4.6	0.4	0.1	13.6	19.2	21.5	47.7	7.8	17.4	7.4	22.3	4.9	4.4	6.0	0.0	0.0	0.2	0.5	6.3	1.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	10.7	0.1	1.7	0.0	1.3	0.1	0.3	0.4	1.1	0.0	2.4	4.8	0.0	0.0	2.1	23.5	0.0	1.1	0.0	1.0	1.9	12.8	2.3	0.8	0.7	0.3	0.6	0.0	2.2	3.3	1.1	0.1	0.2	0.0	0.6	0.1
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	22.9	17.3	29.0	12.4	26.4	16.0	15.5	22.6	29.6	15.2	14.6	20.7	9.3	34.4	10.2	10.5	14.9	15.4	14.7	12.1	27.2	21.1	14.7	28.4	27.8	11.1	26.0	29.3	12.0	21.6	17.6	7.3	15.3	18.4	14.1	6.7	10.6	25.3	13.4	12.7	12.9	39.6	9.6	29.4	9.8	14.4	12.2	22.9	7.8	16.1	11.6	8.5	13.6	10.4	7.6	25.5	2.5	9.7	28.1	14.4	10.6	8.4	7.7	9.3	16.0	7.7	7.3	16.2	22.0	8.6	15.7	11.5	27.7	9.5	7.2	29.4	11.3	11.0	29.2	10.3	16.4	0.6	18.9	14.7	23.1	22.6	13.6	29.0	15.5	18.5	14.1	14.8	11.0	9.2	6.6	10.5	14.4	24.2	20.0	5.9	17.1	11.6	10.0	7.4	20.7	15.4	18.3	11.2	16.7	11.5	14.3	22.4	8.2	17.5	23.7	8.1	3.2	18.5	16.9	16.4	17.1	12.2	22.8	18.4	15.3	17.8	11.5	12.1	16.5	18.6	1.9	6.2	2.5	14.4	8.2	12.6	7.6	10.5	13.0	6.8	6.7	8.2	8.9	1.0	28.1	9.7	25.5	9.1	10.6	29.0	26.4	22.6	26.9	27.2	21.1	26.0	29.3	18.4	22.9	29.8	25.5	4.5	14.2	14.0	19.2	7.0	10.2	26.8	21.6	17.4	3.9	36.6	1.7	25.3	2.0	16.5	16.9	0.0	19.5	23.1	16.9	15.9	18.5	30.9	113.0	17.5	4.7	17.8	15.6	3.1	15.5	10.9	18.6	11.8	11.5	20.0	17.9	14.4	13.4	13.3	15.2	6.5	11.4	31.1	42.8	10.5	52.5	18.5	18.8	19.0
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452181	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.9	15.7	9.0	6.8	12.1	4.0	17.0	14.5	15.6	10.5	12.8	7.7	6.4	13.2	10.9	11.7	8.3	12.2	8.0	11.4	9.9	11.7	34.0	29.1	7.8	8.2	10.1	13.5	15.7	9.9	6.9	11.2	14.4	14.0	8.0	11.5	10.5	7.3	8.0	10.9	7.9	14.9	11.2	8.9	6.9	8.0	8.6	7.0	11.2	18.9	6.0	9.5	10.6	11.9	11.3	7.2	6.8	12.2	13.2	11.3	5.0	8.2	3.8	8.5	17.6	11.5	26.1	11.6	12.9	12.6	10.1	13.9	10.8	6.2	7.9	9.3	8.2	12.4	7.1	15.5	8.1	17.5	9.0	12.4	12.4	6.1	22.2	23.4	27.7	4.0	18.2	10.4	14.3	21.9	12.1	13.0	11.8	13.5	6.4	15.2	26.9	9.4	8.9	6.3	9.3	7.6	10.7	10.5	9.7	14.2	3.7	14.2	13.7	9.2	11.7	15.4	10.7	19.5	17.9	7.4	7.9	10.3	16.3	10.1	6.5	8.6	9.0	19.7	21.7	9.1	2.1	5.9	6.8	7.1	8.2	11.2	11.3	8.5	9.9	7.2	9.0	11.2	10.2	2.9	13.2	12.2	3.3	11.3	5.0	9.0	12.1	14.5	15.6	9.9	11.7	10.1	13.5	14.0	7.0	0.0	12.8	7.3	6.0	3.4	8.7	9.8	2.5	13.4	14.8	12.2	11.8	23.3	14.9	13.6	7.0	4.5	7.3	0.0	9.2	18.4	4.8	2.6	9.2	13.5	12.0	4.8	2.9	8.6	8.6	3.3	6.4	11.6	3.3	13.6	9.9	6.4	9.4	13.9	6.0	30.5	6.7	0.0	9.5	10.4	15.6	2.4	14.1	5.0	12.6	3.1
RNF10	"KIAA0262, RIE2"	ENSG00000022840	"Ring finger protein 10"	Q8N5U6	12	120533480-120577594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052643	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA052643: AB_2681897"	"unprognostic (1.54e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.58e-2)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (5.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.40e-1)"	26.2	37.7	32.6	23.0	34.5	64.3	64.2	33.4	44.0	27.7	30.5	25.3	30.1	23.8	24.1	41.4	40.2	22.5	32.2	79.6	32.4	27.0	36.0	37.9	43.8	44.8	27.2	27.0	25.2	34.0	36.0	27.0	26.5	21.9	25.2	27.7	23.8	26.6	33.8	118.9	26.6	29.5	32.1	26.9	29.0	28.1	46.0	23.5	23.9	25.7	45.0	27.0	28.4	51.7	11.3	17.7	49.7	15.2	13.1	17.2	14.0	29.9	39.7	19.5	31.0	38.3	30.4	23.1	28.2	32.2	23.5	25.1	32.7	13.9	35.6	25.9	46.6	18.4	20.7	35.7	38.3	33.6	34.9	20.0	36.3	22.2	33.6	51.5	32.5	25.7	30.9	44.4	33.0	45.4	40.9	47.5	26.9	36.1	24.7	35.2	34.5	21.4	35.8	29.6	28.0	39.6	19.2	25.1	50.8	46.5	61.7	19.2	20.9	39.3	25.4	21.6	28.3	40.9	18.9	37.7	17.1	19.2	27.3	18.2	21.4	38.2	25.2	28.4	22.2	18.3	41.0	15.2	49.7	14.3	13.2	15.5	11.3	14.1	16.3	17.7	10.0	12.8	12.8	35.1	13.1	14.8	9.1	17.2	14.0	32.6	34.5	33.4	44.0	32.4	27.0	27.2	27.0	21.9	23.5	23.8	27.5	42.7	46.5	55.1	36.2	82.7	25.5	8.1	20.5	45.4	21.6	51.8	139.3	44.1	48.0	40.9	63.6	23.3	51.0	58.9	41.3	56.3	36.8	39.4	32.6	52.4	47.3	42.4	43.0	33.1	52.6	32.9	54.0	43.3	45.8	30.4	52.5	56.8	51.6	53.3	50.7	51.8	51.4	131.6	55.8	57.5	93.5	44.8	40.1	68.6
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.3	4.7	5.8	4.3	10.7	14.0	4.7	8.6	16.0	6.4	7.8	5.1	4.1	8.0	9.8	12.2	6.3	8.0	6.4	5.9	6.9	8.0	4.2	6.4	6.1	4.7	6.7	9.9	14.8	8.1	5.2	6.4	7.8	7.3	8.1	6.3	6.3	13.1	11.5	8.6	7.2	6.3	7.3	7.2	10.0	7.0	5.8	6.6	12.4	3.8	5.9	8.1	7.0	8.6	6.4	7.5	9.5	9.5	10.0	9.3	7.3	5.6	9.1	11.0	10.4	8.4	4.7	6.7	5.9	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4											14.9	29.8	29.4	28.9	18.3	96.0	134.9	25.5	24.1	26.1	17.4	108.0	23.1	28.2	34.8	52.4	66.1	14.0	23.3	69.3	24.5	48.2	51.0	31.1	28.7	32.3	77.9	26.0	66.3	32.6	18.4	36.5	29.9	37.1	88.4	19.7	66.7	49.7	20.9	76.0	37.2	104.3	58.2	49.2	78.7	54.1	15.7	16.6	66.0	23.8	32.8
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Group enriched"	"Detected in many"	16	"Early spermatids: 845.1;Late spermatids: 2984.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria		NA	NA			Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	9.1	5.4	22.4	11.1	2.9	6.1	12.7	9.3	5.3	11.7	13.6	6.4	6.4	22.0	11.7	6.1	7.6	9.5	11.7	10.5	16.0	12.2	19.6	17.3	7.0	7.8	11.5	47.6	15.4	5.9	10.6	12.9	18.4	6.8	11.9	19.7	23.8	9.0	7.5	8.7	32.1	21.3	25.0	15.8	7.5	33.2	14.1	12.6	10.7	6.8	25.4	12.7	12.5	7.2	9.7	10.7	4.7	20.1	9.1	14.1	10.3	3.4	10.4	15.0	19.9	38.1	7.7	26.6	13.8	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1	14.9	22.4	13.8	29.1	61.6	6.1	6.7	25.5	16.0	18.2	15.7	0.0	25.9	14.9	15.3	845.1	21.2	16.7	0.0	16.0	16.6	21.4	26.1	22.0	14.7	21.1	7.9	28.7	20.3	27.6	2984.7	27.3	30.7	25.3	10.8	21.0	8.0	10.5	20.1	20.8	10.7	4.8	32.3	25.9	118.9	102.4	45.7	7.4	27.7	27.0	31.8
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.7	3.3	3.6	0.0	0.1	55.9	15.4	0.6	0.2	4.8	0.0	4.7	4.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.8	1.3	4.0	1.5	16.5	1.2	0.0	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.3	0.2	0.5	3.3	10.0	3.1	0.5	0.0	0.3	7.1	5.3	0.4	8.4	0.1	16.5	2.6	0.5	0.2	0.3	0.0	0.0	47.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9	41.7	12.9	4.2	36.0	563.5	0.9	10.4	10.2	21.4	36.4	36.6	2.0	9.7	16.6	8.2	1.6	32.1	1.0	0.0	7.7	2.9	12.4	85.1	3.5	17.4	13.8	0.0	1.2	28.8	98.2	1.6	1.1	68.0	57.3	44.1	1.3	16.0	6.0	2.9	2.8	16.3	1.0	0.0	10.1	1.7	2.6	1312.2	1.3	3.2	2.4	20.3
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879618-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	17.5	22.1	19.9	14.4	27.5	9.0	19.9	20.5	35.9	14.8	14.2	16.9	16.4	11.9	15.7	17.4	18.9	17.2	10.2	14.4	17.6	16.5	18.8	23.5	11.9	16.5	14.9	20.4	17.4	16.9	22.9	22.4	15.1	17.9	17.0	17.0	13.2	17.4	14.4	19.9	16.3	12.8	16.5	13.9	15.4	13.7	33.0	14.5	25.1	17.8	15.6	20.3	13.7	13.3	15.4	12.5	10.2	13.6	16.4	18.6	10.6	31.3	10.0	17.8	28.5	16.8	21.7	12.1	25.1	18.3	24.4	20.2	24.8	12.0	47.2	22.8	21.1	19.9	15.1	40.4	30.6	40.6	24.7	30.4	25.1	14.1	22.4	18.5	38.7	19.5	22.2	23.5	32.0	31.0	16.6	23.9	20.9	48.5	16.3	22.2	23.1	22.0	25.2	17.9	96.5	14.8	25.3	20.0	29.9	19.0	19.9	34.1	20.8	21.5	16.5	26.4	14.7	22.1	37.5	22.8	23.7	19.8	18.7	43.3	20.6	32.1	71.8	13.2	36.8	24.6	5.6	11.4	10.2	14.9	13.6	18.6	13.3	14.6	15.5	10.8	15.4	15.5	14.9	2.6	16.4	11.9	12.5	12.0	10.6	19.9	27.5	20.5	35.9	17.6	16.5	14.9	20.4	17.9	14.5	71.5	90.2	79.6	70.6	50.7	62.2	36.8	43.3	96.4	85.3	40.1	31.4	75.2	72.9	77.0	9.5	60.8	22.6	93.5	57.9	63.9	52.5	52.0	48.7	57.8	46.3	68.3	90.5	48.5	37.5	8.6	73.4	44.1	28.7	74.9	39.6	69.6	70.8	31.6	67.1	57.2	58.0	51.8	56.9	40.4	84.8	52.7	66.9	64.5	43.4	52.0
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809647-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 318.8"	"Low region specificity"	"Detected in all"							HPA053635	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		730000	Mitochondria		"HPA053635: AB_2682212"	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	165.8	66.1	52.7	134.4	47.8	132.4	240.5	28.0	42.6	110.3	108.3	43.2	78.6	82.6	103.7	95.7	160.7	76.7	99.1	129.1	45.8	37.0	67.4	118.5	103.2	499.1	51.9	28.5	190.5	241.9	20.4	49.2	75.3	35.9	118.4	70.3	53.1	154.6	97.8	160.3	125.6	95.7	108.6	52.4	176.3	75.7	60.0	32.4	207.7	111.3	106.1	155.0	136.0	190.6	232.5	127.3	27.8	82.7	82.7	233.6	233.4	79.6	85.0	46.1	63.1	65.4	69.0	64.9	47.9	32.7	52.6	42.7	131.8	67.3	101.6	35.5	43.9	46.0	76.6	53.4	75.0	25.9	47.0	318.8	51.8	72.3	190.7	74.4	99.2	59.1	89.1	113.5	21.2	67.1	75.2	53.0	96.2	92.4	68.5	36.4	98.5	92.1	160.8	100.6	138.3	225.4	106.2	42.7	112.8	51.3	62.9	62.6	92.3	31.2	98.7	109.5	40.6	36.8	134.5	51.4	33.3	43.3	29.4	61.8	116.0	93.1	99.1	54.1	76.5	39.7	27.8	82.7	27.2	100.7	65.2	140.1	232.5	189.1	142.1	94.0	222.8	233.6	178.0	11.9	82.7	51.5	127.3	106.4	233.4	52.7	47.8	28.0	42.6	45.8	37.0	51.9	28.5	35.9	32.4	991.6	1490.9	7641.0	5455.0	5430.4	205.9	564.1	2489.2	1006.5	1874.5	1519.7	74.6	4512.3	2196.7	2810.0	1146.6	3224.8	2324.9	2733.2	6455.7	6707.6	3165.9	4519.9	1638.7	2939.5	3968.0	138.2	2281.0	3329.3	4720.2	2348.5	5919.8	5263.8	2832.5	3803.6	5348.0	406.2	4700.1	3847.1	2652.5	3432.0	167.5	1959.6	3005.2	957.2	2076.7	6894.6	4884.8	5234.3	6955.8	5526.4
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.7	3.6	0.0	3.4	3.4	0.0	7.7	4.1	3.4	2.9	2.8	3.0	0.0	0.0	4.1	0.0	0.1	9.1	6.1	8.1	0.0	4.6	0.0	0.1	0.0	3.1	0.0	0.0	1.9	0.0	0.0	3.8	3.8	0.8	0.0	0.0	0.2	2.7	0.0	1.3	0.1	11.0	0.0	11.9	0.0	14.6	0.0	0.6	8.5	0.0	11.7	0.0	4.2	0.0	5.2	2.0	0.0	0.0	0.1	4.4	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7	8.9	2.4	2.0	4.4	0.2	19.9	2.0	12.7	6.7	3.4	17.4	23.6	2.1	1.7	0.4	0.4	0.6	3.4	0.0	1.1	0.6	0.3	7.4	0.0	1.5	0.2	1.6	24.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	5.0	2.8	1.3	2.9	5.6	3.3	18.2	0.0	0.6	3.7	6.3	0.4	1.9	0.0	5.3	4.2
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridylate synthase domain containing 4"	Q96CM3	11	126202094-126211692	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	7.5	6.8	5.1	7.7	7.8	6.0	7.8	8.2	9.6	6.3	6.0	4.8	7.6	6.4	7.0	6.8	7.8	7.2	5.2	13.2	5.1	4.9	6.3	10.2	5.0	7.7	6.5	8.1	10.1	16.1	5.7	5.1	4.5	7.2	6.9	6.9	5.2	9.5	8.2	72.0	8.9	5.9	8.3	4.8	7.6	9.3	7.0	7.1	6.2	7.7	18.2	9.3	6.2	12.0	9.8	11.0	1.0	8.5	8.4	15.2	8.7	6.6	6.7	8.0	9.6	12.6	16.5	5.7	7.5	10.5	8.2	7.3	20.5	13.2	15.7	7.4	6.7	11.4	11.7	18.3	11.5	8.7	13.1	10.1	36.6	7.1	19.2	8.3	19.2	8.4	15.1	17.4	8.9	11.2	12.3	16.4	12.9	22.8	11.6	9.6	6.5	12.0	22.2	8.8	22.7	11.8	14.1	12.2	14.5	12.5	9.7	13.9	9.5	9.6	14.3	7.0	8.7	21.4	10.2	9.9	9.2	6.4	6.9	8.8	4.9	5.2	13.5	4.2	21.9	9.4	1.0	8.5	0.8	10.8	7.7	14.0	9.8	13.3	10.3	11.0	9.5	15.2	12.2	0.7	8.4	8.3	4.7	12.2	8.7	5.1	7.8	8.2	9.6	5.1	4.9	6.5	8.1	7.2	7.1	3.0	6.7	16.7	17.9	24.5	8.9	30.7	12.7	8.1	5.7	7.0	7.9	11.7	8.3	10.7	1.1	11.3	9.7	0.0	16.9	13.7	10.1	10.5	5.7	11.1	11.8	11.1	14.9	8.6	10.2	1.4	8.9	8.5	10.1	21.6	9.3	4.5	13.0	7.0	8.1	11.8	7.6	6.5	10.8	7.7	15.4	21.0	11.1	15.9	15.7	13.3
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285287-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	10.3	7.2	8.9	8.0	9.9	8.5	11.6	11.6	10.4	8.4	8.0	5.5	5.4	5.3	10.1	7.1	8.7	8.9	5.0	11.4	8.6	6.3	9.3	10.7	7.5	8.3	8.0	5.0	9.8	8.4	12.1	10.0	8.7	8.6	7.8	7.2	5.8	7.9	6.4	33.5	8.5	6.8	11.8	9.4	10.3	7.6	6.3	9.0	6.5	8.9	10.5	8.3	8.5	9.4	5.1	3.3	0.6	2.4	3.1	5.7	1.6	8.1	6.1	6.8	4.9	5.0	7.0	5.9	8.3	6.3	8.8	6.4	11.9	7.5	11.8	11.5	6.4	5.9	7.4	11.6	11.0	14.7	4.7	8.7	9.1	5.8	6.6	10.3	14.1	5.0	4.8	6.8	11.4	15.3	3.9	5.6	5.5	18.6	3.9	9.8	7.5	9.3	6.9	13.6	6.5	12.8	6.6	4.2	11.6	7.0	7.6	8.0	11.5	7.1	13.3	12.2	8.5	9.5	10.2	7.9	7.1	6.6	12.5	15.4	4.7	7.2	12.2	8.1	6.9	11.2	0.6	1.6	0.2	3.5	2.4	4.8	4.7	4.2	2.9	2.4	5.1	5.7	5.5	0.5	3.1	2.1	3.3	2.5	1.6	8.9	9.9	11.6	10.4	8.6	6.3	8.0	5.0	8.6	9.0	29.8	25.5	31.5	28.8	58.0	29.7	58.0	17.8	13.4	30.7	34.9	9.8	32.1	23.2	30.7	5.9	26.0	2.9	0.0	44.6	48.1	26.3	14.3	30.1	37.6	29.3	25.4	11.6	19.0	13.3	2.7	34.8	25.8	20.3	17.2	18.6	20.3	31.8	2.9	23.3	23.5	21.8	25.8	28.8	46.4	75.7	41.7	15.1	22.4	25.7	22.8
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Nucleoli,Mitotic chromosome,Mitochondria"		NA	NA			Mitochondria	"Nucleoli, Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	5.7	19.7	9.5	15.6	16.3	13.3	3.4	10.2	9.9	13.1	11.1	19.5	7.4	15.7	22.6	7.1	13.0	5.5	10.7	14.2	11.3	17.3	19.5	21.1	8.8	18.9	11.4	12.7	14.9	9.7	15.7	8.7	16.9	10.9	12.7	38.8	16.3	15.0	10.9	13.5	21.2	9.3	3.8	24.6	21.3	8.7	10.9	14.2	15.8	8.8	5.2	17.8	2.6	12.2	13.1	12.6	18.4	13.0	8.9	13.7	14.6	10.4	11.9	23.5	16.4	6.1	10.3	18.2	9.5	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1	3.0	12.5	11.2	4.6	9.0	12.3	23.6	12.7	1.4	6.8	15.7	2.0	15.8	19.9	10.9	7.3	13.7	8.7	0.0	25.4	9.6	10.3	5.5	3.5	15.8	14.2	7.9	24.2	6.7	7.8	5.4	14.4	9.6	16.9	10.8	12.6	30.7	11.1	3.5	10.3	8.7	7.4	12.9	12.4	8.4	21.2	8.7	8.5	13.1	13.0	2.8
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425836-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	3.2	4.9	17.1	3.9	24.2	0.4	7.1	3.9	23.6	5.6	8.7	29.7	7.3	21.2	5.1	4.0	8.0	9.0	9.7	7.2	22.2	13.7	27.0	39.0	6.3	1.9	34.8	7.7	3.6	16.3	12.8	5.3	7.9	17.2	6.5	8.8	6.0	17.3	7.0	7.5	21.1	16.4	4.4	36.3	2.2	6.0	1.4	29.4	1.9	7.4	5.3	4.3	3.1	5.6	1.7	9.7	0.0	0.0	3.1	0.4	0.6	16.8	5.2	6.7	19.8	4.1	4.8	29.0	2.6	3.3	3.8	2.8	26.2	9.4	0.1	7.5	2.5	4.7	23.2	2.5	16.9	1.8	3.3	10.9	4.0	0.9	33.0	2.5	0.0	0.0	2.9	13.5	3.3	10.8	7.0	1.9	0.2	2.0	0.1	5.6	12.0	0.6	3.3	7.3	24.5	10.5	3.7	21.0	2.5	18.6	0.1	6.8	6.5	7.2	28.1	14.9	6.5	15.7	1.5	0.2	7.2	5.0	3.2	3.5	1.7	1.1	0.6	6.9	0.0	6.7	0.0	0.0	0.0	0.4	0.0	0.3	1.1	0.2	0.3	0.9	1.7	0.0	0.1	0.0	3.1	0.0	9.7	0.0	0.6	17.1	24.2	3.9	14.9	22.2	13.7	34.8	7.7	17.2	29.4	8.9	10.2	1.7	19.9	17.7	0.0	2.5	17.8	2.7	17.0	10.4	2.0	38.3	18.3	38.6	0.8	7.0	35.9	0.0	17.8	4.0	10.3	22.4	1.1	34.6	8.2	0.0	29.6	3.1	2.6	0.4	11.8	0.0	27.0	1.0	15.4	5.8	24.3	31.6	8.1	43.3	0.4	6.5	3.4	1.1	3.4	18.9	27.9	2.9	21.8	14.5
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lung: 67.6"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 1628.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"T-reg: 15.4"	"Lineage enriched"	"Detected in single"	47	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 25.5;HaCaT: 20.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0.0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3.0	0.3	0.2	0.3	0.1	0.2	15.4	0.2	25.5	1.4	13.7	6.3	0.0	0.1	3.3	3.7	4.3	4.2	6.7	10.6	5.1	0.1	1.6	1.4	4.3	20.5	7.6	0.6	4.4	3.6	5.2	4.2	3.1	4.4	0.0	5.7	3.3	0.2	0.3	5.2	0.5	2.3	0.6	6.8	0.2	0.2	5.6	3.2	11.0	7.3	5.8	3.8	5.2	9.5	14.6	0.0	2.7	11.1	7.5	8.6	2.4	8.6	3.5	4.2	7.8	3.1	0.0	1.9	12.5	0.1	9.3	0.1	0.0	9.8	2.5	0.0	3.0	0.1	0.1	0.1	1.3	0.0	0.1	0.1	2.1	0.4	0.0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1	1628.8	44.5	0.9	8.3	4.1	0.6	0.4	0.0	4.0	15.9	0.0	0.0	3.0	0.0	1.4	376.8	0.1	0.4	0.0	1.4	4.9	2.5	7.0	3.5	0.0	2.1	0.0	1.7	1.8	0.6	65.6	2.0	2.2	1.7	0.0	5.9	0.4	9.1	0.0	1.8	1.4	0.5	0.0	1.9	21.3	23.6	1.6	1.7	12.7	3.3	87.2
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497491-46500949	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	91	"liver: 43.3"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 59.6"	"Group enriched"	"Detected in some"	17	"liver cancer: 22.9;testis cancer: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SiHa: 15.1"									HPA075932			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favorable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	59.6	0.0	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151994390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 148.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4"	"Cell line enhanced"	"Detected in many"		"OE19: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		230000	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	36.7	19.9	7.3	12.1	9.4	4.5	30.7	7.3	10.7	19.0	42.3	8.4	7.3	23.4	7.3	10.1	87.1	8.5	10.7	16.7	7.3	4.4	19.1	10.2	33.5	7.3	7.3	7.3	11.5	7.3	1.6	7.3	18.7	11.1	8.5	49.8	9.5	21.1	7.3	7.3	21.8	21.7	14.0	9.6	7.3	8.6	61.4	7.3	7.3	7.3	22.1	13.6	8.1	37.7	17.8	148.1	21.4	89.2	25.9	85.4	74.8	63.5	65.2	0.2	13.5	73.8	98.4	48.6	36.0	48.7	32.3	32.8	117.1	88.5	0.0	35.0	62.8	38.3	111.1	18.5	140.1	30.1	11.4	5.3	7.7	29.7	27.4	26.4	2.9	6.7	25.5	118.1	35.2	40.5	29.0	71.4	4.2	0.1	0.1	42.9	55.1	0.5	18.6	8.8	273.2	72.5	0.0	12.6	1.2	136.1	18.9	0.5	0.5	58.8	21.1	27.4	77.4	46.6	7.4	75.8	15.5	38.8	73.4	25.1	1.7	0.3	10.9	91.1	2.6	54.2	21.4	89.2	21.0	33.3	54.4	35.2	17.8	52.6	42.3	148.1	8.6	19.6	29.5	3.2	25.9	46.5	24.2	85.4	74.8	7.3	9.4	7.3	10.7	7.3	4.4	7.3	7.3	11.1	7.3	2373.2	509.0	165.5	824.9	1416.6	10.1	91.6	634.4	507.3	913.4	902.0	3.9	1028.8	1291.5	1817.5	320.0	1052.4	1898.6	46.7	1882.2	473.9	2108.7	1493.1	280.8	168.1	1060.4	15.9	1037.0	742.7	952.8	225.8	599.2	1623.9	1548.8	1432.9	1679.7	14.1	2865.9	3115.1	60.8	287.0	25.8	142.3	345.1	12.6	80.7	1085.7	314.3	441.6	1750.5	1802.8
S1PR4	EDG6	ENSG00000125910	"Sphingosine-1-phosphate receptor 4"	O95977	19	3172346-3180332	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 50.4;Hofbauer cells: 26.6;Kupffer cells: 27.5;T-cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.0;HL-60: 14.7;NB-4: 14.5;REH: 41.0;U-937: 14.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA060601, HPA067232"			Supported	Mitochondria		NA	NA			Mitochondria		"HPA060601: AB_2797261, HPA067232: AB_2797271"	"prognostic favorable (3.13e-4)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.58e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (2.98e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (6.64e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.15e-3)"	2.0	0.5	0.7	8.3	0.3	14.9	1.3	0.6	0.7	0.5	0.9	0.4	0.2	0.8	0.7	0.7	1.2	1.4	0.7	2.1	0.3	0.2	1.2	1.4	6.4	35.9	0.3	0.4	0.7	0.3	0.0	0.2	1.7	0.6	0.7	0.0	1.0	1.3	0.2	1.1	0.4	7.1	0.2	0.5	34.2	3.9	0.3	0.3	10.2	1.5	0.2	10.7	1.9	0.6	14.1	7.3	44.2	15.3	5.4	23.1	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	4.7	0.1	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.1	0.0	41.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	14.0	0.0	16.4	10.4	27.4	11.8	11.6	10.5	11.3	14.7	11.4	7.3	14.1	12.4	11.9	44.2	5.4	15.3	6.6	23.1	7.2	0.7	0.3	0.6	0.7	0.3	0.2	0.3	0.4	0.6	0.3	3.0	5.8	50.4	0.2	1.1	0.0	0.4	0.0	0.0	2.3	1.8	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.1	0.1	0.2	5.7	0.0	26.6	0.0	0.0	3.1	27.5	0.0	0.0	13.2	1.7	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.0	64.7	0.0	0.3
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087840-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	Mitochondria	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favorable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (7.98e-5)"	"prognostic favorable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	16.0	9.5	23.5	17.4	20.2	19.6	47.9	17.2	21.2	15.3	21.3	19.7	12.2	20.6	14.7	9.8	18.2	14.0	12.8	16.8	21.2	17.9	13.1	11.1	15.9	20.1	20.9	10.3	14.5	20.3	7.2	7.3	11.3	16.5	12.7	15.5	7.8	15.4	16.1	27.2	25.9	21.5	12.4	21.3	18.0	16.7	11.4	16.1	79.1	14.8	10.8	17.9	12.9	20.5	3.5	2.3	4.5	2.9	8.0	2.7	1.5	22.8	17.4	15.4	21.7	9.7	9.9	23.5	12.6	3.0	12.9	10.4	13.1	11.3	39.9	17.2	8.1	6.1	18.6	16.8	9.4	6.5	26.7	13.8	17.4	23.1	23.6	8.6	10.2	10.9	6.9	15.6	8.9	3.0	12.5	7.6	25.6	21.1	10.9	7.4	34.4	21.7	40.3	31.6	16.7	15.5	29.6	13.6	28.6	10.9	11.1	28.3	28.3	11.1	15.1	8.4	8.7	9.5	22.0	8.2	22.6	20.8	22.6	15.9	20.7	17.8	32.9	13.5	28.0	9.1	0.3	2.9	4.5	1.7	0.9	2.0	3.5	1.9	2.0	2.3	2.1	2.7	2.0	0.5	8.0	1.0	1.8	2.1	1.5	23.5	20.2	17.2	19.6	21.2	17.9	20.9	10.3	16.5	16.1	3.0	7.9	9.7	3.5	10.2	27.7	10.1	20.4	2.7	2.3	10.4	5.9	1.6	1.7	9.4	0.3	9.0	29.0	23.3	9.6	7.2	8.0	6.8	8.1	13.5	13.4	49.3	23.8	14.7	17.4	0.5	17.8	9.4	10.1	9.0	25.3	18.6	10.9	17.3	17.7	5.0	8.6	12.9	8.4	0.7	16.2	15.1	1.5	4.9	24.7	3.9
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in many"	10	"Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 11.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058929	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favorable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	1.2	5.2	4.9	1.0	12.9	2.1	2.0	9.1	5.8	1.5	16.6	7.4	0.6	2.6	1.8	4.5	1.1	3.7	1.4	1.7	4.8	2.3	1.7	0.4	0.7	0.8	7.9	6.5	0.5	2.3	1.0	2.3	0.5	4.5	3.4	19.4	0.4	13.6	1.9	7.6	1.2	3.0	2.1	5.1	1.5	5.6	12.4	8.5	3.5	8.6	2.0	0.4	2.7	0.7	0.6	1.4	11.2	0.8	0.7	0.5	0.3	0.7	2.5	1.2	4.0	4.3	4.3	2.7	0.3	0.3	0.3	0.3	0.2	4.0	4.2	7.5	0.2	0.8	0.8	0.4	1.3	0.6	2.2	2.1	1.5	1.8	0.3	1.1	4.8	0.1	1.5	1.9	0.1	1.2	3.0	10.1	9.5	0.6	1.2	1.2	1.2	6.2	0.6	4.0	3.2	2.6	0.7	3.1	1.6	7.9	2.7	1.6	6.2	0.1	0.2	9.2	1.7	1.2	4.5	1.6	1.4	0.4	0.4	1.1	3.2	0.6	7.2	0.5	4.3	1.2	11.2	0.4	0.0	0.1	0.8	0.3	0.2	0.1	0.1	0.9	0.6	0.5	0.5	0.2	0.7	0.3	1.4	0.0	0.3	4.9	12.9	9.1	5.8	4.8	2.3	7.9	6.5	4.5	8.5	0.0	1.1	0.0	0.6	0.3	1.0	1.2	5.1	1.4	1.2	1.8	0.0	3.4	5.0	1.3	3.9	1.3	6.2	0.0	0.6	0.6	2.0	2.8	5.7	0.0	1.4	0.0	10.9	1.8	1.6	3.1	1.7	0.9	8.5	0.0	19.6	2.6	0.9	35.1	2.5	2.2	0.0	0.0	0.1	20.4	2.0	0.3	0.7	0.0	16.6	1.3
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955421-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA		3700000	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	21.7	25.1	12.4	13.9	13.6	10.2	16.0	10.5	20.1	17.4	15.6	11.2	17.2	18.9	12.6	13.5	14.6	16.3	18.2	34.3	11.3	11.9	18.5	18.8	8.9	18.6	12.7	14.7	16.0	16.7	60.6	12.2	7.6	16.4	10.4	13.7	14.3	19.3	13.6	79.5	15.8	21.2	14.2	12.3	12.2	18.5	11.5	8.6	17.4	10.8	34.6	15.1	11.5	11.0	27.7	34.0	22.4	19.6	18.2	29.3	18.5	22.3	21.2	20.7	25.1	26.8	28.5	29.0	22.0	23.6	32.5	28.1	30.3	16.5	37.1	16.2	25.0	18.8	27.0	30.6	29.4	29.3	10.2	37.8	20.1	27.9	35.7	18.8	63.6	30.3	32.8	23.6	28.0	13.0	22.9	33.4	17.8	17.1	12.3	29.1	31.9	24.8	25.0	20.2	27.1	25.5	29.2	22.4	30.0	27.1	28.7	12.4	20.2	24.3	26.1	35.9	23.1	24.4	21.0	20.5	21.1	25.4	19.4	17.9	18.3	25.2	28.6	26.4	23.2	21.0	19.2	19.6	22.4	21.2	19.2	29.3	27.7	19.8	21.5	34.0	24.5	20.8	19.5	3.2	18.2	14.7	13.4	22.7	18.5	12.4	13.6	10.5	20.1	11.3	11.9	12.7	14.7	16.4	8.6	32.8	17.6	39.3	18.4	18.3	20.2	60.5	22.9	37.5	22.7	8.7	7.9	36.5	51.4	35.6	27.0	31.5	56.1	23.3	48.0	43.0	24.4	14.5	26.5	35.8	45.7	30.2	17.9	21.5	29.2	33.7	24.2	25.7	15.1	39.7	29.6	27.1	37.2	38.6	28.7	78.9	23.3	19.4	21.1	41.3	20.6	19.7	17.2	32.0	51.0	12.9
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 94.3"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.9	11.1	0.0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.2	1.4	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.7	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.3	0.1	8.3	0.0	0.2	7.0	1.9	13.5	1.4	1.7	1.0	0.1	0.9	11.6	23.4	0.0	0.1	1.0	9.3	0.0	0.3	2.3	0.5	1.5	0.1	0.0	2.1	2.0	0.2	0.0	0.1	0.0	0.8	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0.0	3.4	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	1.0	0.2	1.1	94.3	0.1	0.0	1.2	2.5	2.4	0.2	4.4	0.2	0.0	0.0	0.0	2.1	0.2	0.0	2.8	14.7	0.2	0.0	1.0	0.1	0.9	0.1	0.0	2.9	0.0	0.1
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 34.4;Late spermatids: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: AB_2681929, HPA056957: AB_2683286"	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	5.8	16.5	9.9	7.2	12.8	11.1	7.4	10.7	20.4	8.0	9.2	11.3	11.4	12.3	9.0	9.4	12.9	11.5	8.2	12.3	8.3	8.6	13.4	20.6	6.3	11.0	10.9	7.8	9.5	14.4	11.2	11.4	10.7	15.0	11.0	8.5	11.8	13.6	9.9	15.5	15.6	9.9	8.1	7.2	11.3	11.1	8.8	11.5	11.4	13.8	9.5	12.6	11.0	8.3	6.3	12.7	0.4	7.2	6.5	8.0	4.3	5.7	17.4	7.0	4.1	2.9	6.0	9.6	4.0	5.5	9.5	7.5	14.2	7.1	6.5	5.8	5.7	3.8	5.4	7.3	11.4	2.4	5.5	9.4	12.9	7.5	12.2	6.9	11.0	12.9	9.1	6.2	6.2	4.3	4.7	6.7	10.5	11.1	6.4	4.8	12.2	8.3	10.0	7.1	9.0	3.5	12.0	6.3	7.1	10.1	13.9	12.0	7.6	5.4	14.5	3.6	2.7	7.4	7.4	4.3	5.9	6.8	4.6	3.9	4.7	2.7	5.1	3.8	7.7	4.9	0.0	4.1	0.4	8.0	7.2	6.4	6.3	5.9	8.0	12.7	5.7	4.3	4.9	0.3	6.5	6.4	5.0	6.6	4.3	9.9	12.8	10.7	20.4	8.3	8.6	10.9	7.8	15.0	11.5	6.0	6.4	9.5	3.4	3.8	7.2	8.1	10.2	4.0	4.5	5.2	7.9	34.4	13.3	13.2	10.2	3.2	5.1	0.0	11.2	19.0	5.1	2.3	5.7	8.1	11.2	4.8	10.9	6.2	6.2	42.6	4.4	3.5	3.3	6.4	7.1	2.9	7.8	3.5	4.6	5.6	13.4	0.0	2.1	1.5	7.2	3.6	24.4	6.9	16.6	2.6
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 24.2"	"Cell type enriched"	"Detected in single"	25	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA078322			Approved	Mitochondria		NA	NA			Mitochondria		"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0			0.2	0.0	0.0	1.7	0.0	0.1	24.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	3.3	5.6	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	2.5	0.1	0.6	0.2	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCO2	"MYP6, SCO1L"	ENSG00000130489	"SCO2, cytochrome c oxidase assembly protein"	O43819	22	50523568-50525606	"Disease related genes, Predicted membrane proteins"		Chaperone	"Cardiomyopathy, Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	296	"Cytotrophoblasts: 22.9;Extravillous trophoblasts: 29.8;Hofbauer cells: 52.1;Syncytiotrophoblasts: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046943, HPA056254"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046943: AB_2732536, HPA056254: AB_2683080"	"unprognostic (8.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.51e-2)"	13.0	11.6	8.8	20.6	9.0	27.9	16.6	15.2	14.7	8.1	25.1	4.5	7.9	21.6	7.4	9.0	19.7	22.9	10.1	19.7	8.8	10.9	21.3	28.0	14.9	12.3	7.4	11.3	8.0	18.4	2.6	8.9	10.0	7.2	7.7	6.6	5.5	22.1	4.6	9.9	14.3	18.8	8.1	8.0	13.9	8.9	8.4	5.0	6.9	12.2	13.8	14.1	10.1	6.9	17.4	23.8	7.0	7.9	11.7	22.1	15.1	15.0	14.3	6.9	9.2	6.8	9.3	10.4	10.2	8.2	13.5	11.8	17.6	8.5	20.4	7.9	8.0	8.6	17.9	7.0	11.8	2.4	5.8	38.3	6.5	22.0	23.1	15.8	17.2	12.7	13.8	17.9	6.9	5.9	5.7	8.9	6.1	7.3	27.9	5.7	28.1	8.5	34.6	7.1	11.0	23.6	14.1	8.8	22.9	10.2	10.6	10.4	12.8	11.5	32.7	23.4	3.2	12.7	16.5	10.7	11.8	11.4	13.2	11.1	13.3	6.7	9.1	16.1	13.3	10.0	5.2	6.3	2.9	22.1	7.3	20.9	17.4	18.6	21.8	10.6	15.4	14.6	17.0	7.0	11.7	7.9	23.8	15.4	15.1	8.8	9.0	15.2	14.7	8.8	10.9	7.4	11.3	7.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
SCO2		ENSG00000284194	"SCO2, cytochrome c oxidase assembly protein"		22	50523568-50526439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 13.0"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 107.9;Paneth cells: 129.8;Suprabasal keratinocytes: 86.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 13.6"									"HPA046943, HPA056254"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046943: AB_2732536, HPA056254: AB_2683080"																		2.4	1.1	0.7	6.3	0.6	13.0	6.7	0.6	1.2	1.5	2.3	0.0	1.1	0.6	0.6	0.7	4.6	0.8	2.4	4.3	0.1		2.8	4.2	3.7	9.3	0.4	0.0	1.2	0.8	0.0	0.0	0.9	0.6	1.6	0.5	0.1	4.2	0.2	0.7	1.8	3.5	1.6	1.7	5.7	1.9	0.4	0.6	10.6	1.0	1.4	2.6	1.6	0.7	10.3	17.6	10.4	12.6	4.0	10.3	10.7	4.0	2.8	0.1	2.6	0.0	0.5	2.3	2.8	1.9	2.5	1.9	0.4	3.8	7.0	2.0	0.9	1.4	2.5	1.0	0.0	0.0	1.3	10.7	3.6	0.7	0.4	4.9	9.4	2.9	3.3	1.2	1.3	0.5	0.8	0.5	0.0	4.5	9.5	1.4	1.5	1.1	9.9	1.4	0.2	4.1	6.5	0.8	13.6	1.8	1.1	0.6	2.4	1.2	0.4	9.6	0.3	1.4	7.3	3.2	1.7	3.7	2.9	2.4	8.1	2.5	9.7	4.0	2.1	1.7	8.4	12.6	8.7	7.2	7.3	8.7	10.3	9.4	7.8	17.6	8.9	6.9	5.5	10.4	4.0	6.8	12.6	10.3	10.7											3.0	2.4	30.9	16.7	76.1	6.2	14.5	22.9	1.4	2.3	0.0	2.0	0.0	0.0	0.0	13.8	19.1	107.9	0.0	0.0	0.0	13.8	24.3	16.1	48.9	0.0	11.1	24.8	19.0	25.2	16.0	15.3	20.8	40.5	0.0	50.5	4.2	0.1	129.8	10.3	0.0	6.9	0.0	21.5	12.0	26.6	86.4	0.0	15.0	77.7	19.3
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869467-30908761	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 52.5;WM-115: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	17.9	48.8	35.4	11.6	44.7	1.9	9.2	10.4	53.1	20.4	20.8	21.7	10.9	6.9	25.6	7.1	9.8	13.7	15.9	11.1	26.8	32.2	4.7	11.5	12.0	15.4	36.1	16.4	6.2	4.4	6.1	5.4	9.7	34.1	14.8	8.1	8.2	8.6	29.2	17.7	5.7	9.1	33.1	28.3	45.3	9.3	2.4	15.5	2.6	5.5	1.7	4.2	14.4	6.0	1.2	1.0	3.2	2.5	2.1	1.2	0.9	2.7	2.0	16.3	7.6	12.6	3.0	3.2	6.8	9.7	3.2	2.0	0.3	2.5	0.2	17.3	19.0	4.6	3.7	1.7	1.5	2.1	1.4	1.4	0.0	0.8	0.4	12.1	0.0	1.8	7.3	7.5	0.2	3.2	17.9	4.0	0.7	1.3	0.2	6.2	2.9	0.1	0.1	8.3	1.9	2.4	0.1	15.6	0.6	4.0	2.9	6.4	4.1	8.6	1.2	52.5	10.9	1.2	1.2	4.4	4.0	6.9	0.5	1.5	0.0	0.1	0.2	0.4	0.0	73.1	3.2	1.3	1.0	0.8	2.5	1.2	0.8	0.8	0.9	0.9	1.2	1.0	1.0	2.5	2.1	1.8	1.0	0.9	0.9	35.4	44.7	10.4	29.5	26.8	32.2	36.1	16.4	34.1	15.5	0.0	2.1	0.8	2.8	2.3	8.1	3.2	15.3	0.0	2.3	45.4	0.0	2.1	0.0	9.0	17.7	8.7	0.0	0.0	2.6	2.8	10.0	6.9	0.0	0.2	13.2	0.0	2.9	28.8	157.7	63.3	2.0	2.2	18.6	5.4	0.9	1.5	6.1	0.6	7.4	0.3	25.6	0.0	5.6	0.7	0.4	1.9	3.0	0.0	1.2	3.7
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SDHAF1	LYRM8	ENSG00000205138	"Succinate dehydrogenase complex assembly factor 1"	A6NFY7	19	35995199-35996315	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064277			Approved	Mitochondria		NA	NA			Mitochondria		"HPA064277: AB_2685231"	"unprognostic (2.01e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.59e-2)"	11.2	15.7	13.5	11.1	14.7	7.3	14.0	24.5	23.4	14.0	16.7	17.0	13.1	25.0	12.4	13.1	14.8	12.1	11.9	11.1	14.8	13.7	14.4	23.5	10.4	17.6	19.0	10.3	13.6	24.5	11.2	15.1	10.5	12.5	13.9	10.0	9.9	23.7	13.8	17.4	12.4	20.6	15.3	14.3	15.0	16.8	7.7	14.4	14.4	21.9	12.6	11.2	15.8	14.0	31.5	28.5	33.4	26.4	32.7	33.2	20.9	5.9	15.7	4.7	10.8	4.6	5.9	8.1	5.8	6.3	6.4	7.4	11.2	4.6	11.2	11.4	3.8	4.3	6.0	6.1	3.3	3.1	20.9	14.4	4.9	6.5	14.6	5.6	5.8	8.2	5.1	10.7	3.9	4.2	2.5	3.5	11.8	15.1	12.2	2.8	14.6	11.1	11.5	7.2	19.7	7.6	12.2	5.2	12.5	6.1	7.7	18.4	13.7	9.4	15.4	9.9	4.0	8.8	9.9	4.6	7.3	11.0	6.9	8.8	16.6	7.6	13.0	6.4	11.3	6.5	23.3	22.1	33.4	27.5	24.3	29.4	27.6	29.4	26.5	22.7	31.5	33.2	27.8	12.1	32.7	26.4	28.5	30.2	20.9	13.5	14.7	24.5	23.4	14.8	13.7	19.0	10.3	12.5	14.4	6.0	2.6	23.0	10.5	26.7	20.4	8.1	10.2	0.0	1.2	17.4	5.9	20.4	23.2	18.6	20.9	18.2	23.8	0.0	25.7	29.5	18.8	16.9	4.6	19.6	19.5	17.5	27.6	16.5	20.2	5.1	21.3	15.6	23.6	27.1	29.0	15.0	19.4	32.5	27.6	23.7	11.9	25.8	11.9	9.8	14.1	36.4	19.3	29.4	31.0	14.4
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61447529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	23.7	33.0	22.2	22.4	27.2	34.1	24.8	19.9	33.8	20.5	22.1	23.4	21.0	22.3	23.3	33.5	25.3	25.8	21.1	32.5	20.8	26.9	26.8	39.1	19.9	36.7	24.3	25.0	25.7	22.7	23.3	38.4	26.7	25.2	26.1	24.9	32.0	28.1	21.5	31.4	22.9	27.9	26.6	20.8	32.2	24.3	19.2	21.1	36.1	27.0	20.2	30.9	24.0	19.2	31.3	23.2	44.6	25.4	32.7	43.7	26.7	15.4	22.3	13.2	9.2	19.2	15.7	10.3	12.0	17.4	16.3	12.5	20.8	16.7	15.6	22.1	17.4	22.2	16.8	17.2	17.1	17.5	23.1	16.3	13.4	18.3	30.0	20.0	15.8	18.8	19.4	20.9	17.7	17.3	11.6	26.2	16.8	15.4	20.1	19.6	34.2	16.1	35.9	20.4	15.9	32.8	17.4	17.1	28.8	23.2	23.0	14.2	17.7	16.5	19.3	33.4	14.1	30.1	18.9	16.3	16.6	13.5	19.7	14.2	12.4	19.3	19.9	16.1	14.1	17.4	41.9	25.4	44.6	32.4	22.8	38.4	31.3	35.9	34.7	20.3	29.9	39.5	38.4	37.0	32.7	17.9	23.2	43.7	26.7	22.2	27.2	19.9	33.8	20.8	26.9	24.3	25.0	25.2	21.1	32.8	38.1	35.3	31.0	18.3	14.0	20.5	12.7	32.1	21.6	27.9	5.9	61.5	46.4	50.2	11.4	29.8	27.1	23.3	52.7	47.1	28.8	26.8	31.2	37.0	45.9	14.3	32.8	36.8	33.7	13.8	29.1	32.1	42.2	81.2	28.5	36.7	49.4	31.7	29.0	38.3	14.1	32.3	24.7	15.8	23.5	19.6	83.3	44.5	23.9	29.9
SDHAF3	"ACN9, DC11, LYRM10, Sdh7"	ENSG00000196636	"Succinate dehydrogenase complex assembly factor 3"	Q9NRP4	7	97116590-97181763	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 126.0;Proximal tubular cells: 122.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020515, HPA020523"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020515: , HPA020523: AB_2670464"	"unprognostic (3.94e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.61e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.34e-1)"	"unprognostic (8.45e-2)"	8.2	16.0	11.8	11.6	12.0	11.4	9.6	5.4	15.5	6.7	12.3	7.9	11.1	15.2	8.3	11.8	12.0	8.8	12.5	22.0	11.3	12.8	17.6	20.1	10.2	14.6	12.9	11.5	7.4	16.2	5.8	13.7	5.8	16.6	8.4	12.8	9.4	16.8	12.4	18.3	9.7	13.2	9.8	15.7	11.5	12.1	14.9	9.6	15.6	14.6	11.2	8.7	9.6	7.9	12.0	25.9	11.3	8.7	6.4	15.0	12.2	7.4	6.1	3.2	20.7	2.0	1.7	3.2	2.3	1.5	2.4	4.1	1.1	6.0	12.1	7.6	2.1	3.6	2.7	7.9	6.6	5.3	8.7	11.1	8.3	6.2	11.2	3.7	17.3	3.3	3.6	4.1	4.3	5.8	1.7	2.2	10.0	21.5	0.3	4.9	0.0	20.3	24.4	7.0	11.2	6.7	4.2	2.9	17.5	3.1	5.5	15.5	8.1	8.9	11.7	10.4	5.8	0.1	4.7	3.6	0.9	11.6	19.0	2.3	7.1	17.0	32.3	3.4	30.6	11.8	5.4	6.9	2.7	9.1	8.7	12.1	12.0	11.6	14.3	9.5	9.8	15.0	14.9	11.3	6.4	8.2	25.9	10.2	12.2	11.8	12.0	5.4	15.5	11.3	12.8	12.9	11.5	16.6	9.6	17.9	8.4	34.0	19.4	0.0	13.1	32.7	25.5	29.4	12.5	24.4	3.9	33.2	126.0	25.1	89.5	10.1	4.6	0.0	33.8	22.6	9.5	17.7	4.7	49.5	26.9	9.5	12.9	17.8	19.4	10.2	21.0	16.4	0.0	4.6	30.6	28.6	20.6	35.1	23.3	122.5	16.9	32.3	12.2	18.4	51.7	0.0	8.0	25.9	48.7	19.2
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	13.4	14.5	18.1	6.5	20.1	6.1	14.3	15.7	25.7	8.3	9.5	7.9	10.3	7.9	9.0	14.6	9.8	16.0	8.5	17.6	18.0	21.2	14.9	10.7	8.4	10.6	14.7	17.4	9.7	14.2	10.5	18.3	10.2	15.5	10.6	10.6	11.1	9.7	8.9	30.5	9.7	7.9	8.8	13.0	6.9	8.8	7.3	9.7	7.4	11.5	10.2	7.8	8.1	6.9	10.5	13.4	9.1	10.5	9.6	9.3	6.2	10.0	3.3	14.3	8.8	7.3	10.9	2.8	5.4	4.2	2.6	4.0	2.9	8.5	6.9	10.4	2.8	6.4	1.8	4.9	4.8	3.9	14.4	3.3	4.8	1.4	2.9	12.4	4.7	3.8	7.8	15.4	2.0	11.8	9.2	6.5	11.6	3.2	10.7	8.6	6.9	4.2	11.7	6.8	5.1	3.3	4.7	9.7	8.0	11.4	3.3	13.2	9.6	3.2	1.6	6.8	6.4	7.3	12.2	4.8	2.7	2.1	2.2	5.8	5.0	3.4	2.2	3.0	11.2	6.4	6.0	10.5	9.1	7.7	9.2	8.0	8.7	8.5	9.0	11.3	10.5	9.3	8.5	7.1	9.6	9.5	13.4	9.1	6.2	18.1	20.1	15.7	25.7	18.0	21.2	14.7	17.4	15.5	9.7	11.9	15.2	2.2	7.2	0.0	7.5	17.6	7.6	25.4	10.3	7.0	7.9	8.8	19.9	8.0	4.0	5.2	3.3	0.0	10.1	7.4	5.1	7.1	4.7	11.3	9.1	17.5	3.5	3.7	4.1	2.2	11.5	8.5	0.0	12.6	6.6	9.9	9.8	3.5	6.3	11.8	5.8	12.9	3.1	10.7	5.3	0.0	4.2	4.4	6.4	6.9
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	26.0	25.8	14.7	18.8	28.7	28.5	16.8	22.8	29.3	52.3	47.2	36.3	31.3	35.7	28.5	30.7	33.8	30.7	58.7	45.4	59.0	20.9	48.1	32.1	26.9	27.8	35.1	50.2	23.9	29.3	30.0	45.2	76.6	27.8	36.9	31.4	26.8	41.4	36.3	21.5	33.3	28.7	12.2	41.9	51.9	24.0	28.4	44.2	48.1	14.8	27.8	15.2	30.9	38.7	64.9	16.3	22.7	28.4	18.3	20.1	22.7	36.9	30.0	17.3	21.3	36.5	30.8	76.6	22.2	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7	59.6	39.6	77.3	79.1	46.2	28.1	395.8	109.5	78.9	40.9	45.4	13.7	93.2	300.1	104.4	146.0	54.0	212.4	116.8	130.5	121.6	58.6	70.1	65.7	198.8	162.9	35.0	46.7	41.7	81.2	13.8	53.5	90.6	60.8	125.4	89.5	52.1	97.2	192.9	63.6	355.3	35.5	38.8	60.4	85.9	68.4	47.7	101.8	52.3	135.8	97.0
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.5;SK-BR-3: 3.4"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.0	0.9	0.0	0.8	0.1	0.2	0.6	0.1	0.1	1.6	3.4	0.7	0.1	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8	0.0	1.1	21.2	0.2	2.2	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.3	0.0	23.3	0.3	0.7	0.8	0.2	0.0	317.5	211.0	0.0	0.0	10.4	27.7	0.0	0.0	55.6	1.7	169.5	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.8	2.1	3.3	0.0	0.0
SELENOO	SELO	ENSG00000073169	"Selenoprotein O"	Q9BVL4	22	50200979-50217616	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 22.6;Club cells: 10.3;Distal tubular cells: 13.3;Proximal tubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071795, HPA079100"	Approved		Supported	"Mitotic chromosome,Mitochondria"	"Intracellular and membrane"	NA	NA			Mitochondria	"Mitotic chromosome"	"HPA071795: , HPA079100: "	"unprognostic (1.79e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (8.32e-4)"	8.5	8.7	8.0	5.7	10.5	16.3	10.5	24.5	9.4	5.9	8.0	8.8	8.2	10.6	7.6	4.2	9.6	7.0	5.8	6.3	6.6	3.5	7.7	31.0	5.7	8.2	8.4	5.5	6.9	17.6	3.6	5.8	4.2	7.9	6.9	2.9	6.0	10.0	6.0	13.0	10.7	8.4	3.5	7.5	8.1	8.2	4.9	8.1	5.3	6.4	5.6	7.6	6.9	7.3	0.8	3.4	3.5	3.5	0.3	1.6	0.9	8.3	5.5	3.0	3.4	4.2	3.1	6.3	8.4	4.0	5.1	4.0	7.4	5.3	5.6	6.8	3.3	2.8	18.6	4.7	7.6	1.0	1.6	21.6	4.0	10.9	4.5	2.1	7.3	5.0	4.0	5.3	3.2	2.6	3.3	4.1	3.8	5.4	4.1	2.1	12.9	3.9	11.4	2.6	2.0	11.2	12.3	4.3	8.2	3.2	10.8	6.1	6.8	9.1	8.2	5.1	1.6	6.2	5.2	6.8	4.5	6.2	4.8	5.0	10.2	2.5	3.3	4.9	4.8	2.5	0.0	3.5	3.5	0.6	1.2	1.6	0.1	0.8	1.5	3.4	0.8	0.4	1.4	1.4	0.3	1.1	1.4	0.7	0.9	8.0	10.5	24.5	9.4	6.6	3.5	8.4	5.5	7.9	8.1	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	6.7	10.3	8.7	0.0	2.7	13.3	3.2	0.0	0.0	0.0	0.0	4.0	2.0	0.0	0.0	3.5	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	3.6	0.0	0.0	4.9	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.7	0.0	46.7	9.4	7.1	5.3	0.0	0.2	0.0	0.0	32.9	12.4	80.4	0.0	25.6	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.6	1.1	26.0	0.3	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	44.0	1.6	0.9	4.4	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	70.6	0.0	0.0	0.0	1.4	1.2	0.0	0.0	1.2	0.0	49.1	0.0	0.0	0.0	0.0	7.8	68.8	1.1	2.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	2.8	0.0	0.0	169.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	19.2	5.1	0.0	0.0	2.5
SETD3	"C14orf154, FLJ23027"	ENSG00000183576	"SET domain containing 3"	Q86TU7	14	99397746-99480889	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003591, HPA003639"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003591: AB_1079930, HPA003639: AB_1079931"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-1)"	"prognostic favorable (1.89e-15)"	"unprognostic (6.81e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-3)"	17.1	12.5	24.7	13.3	26.8	9.2	16.6	14.6	23.8	14.3	22.7	18.7	26.9	16.2	14.2	39.6	16.9	21.7	13.4	34.1	24.1	17.9	43.4	21.0	16.7	11.9	23.7	13.9	11.7	16.9	17.4	14.5	19.4	18.4	16.9	17.6	16.2	24.9	20.2	68.7	14.1	16.5	26.0	25.3	13.7	15.4	39.1	15.3	11.5	25.6	20.3	10.9	24.0	21.4	9.2	18.6	19.9	17.4	16.0	18.2	11.3	13.8	15.9	12.0	11.4	14.0	15.8	42.8	17.5	13.4	18.4	18.9	15.3	23.5	13.6	14.4	19.7	14.5	18.0	14.7	19.7	29.4	13.3	7.8	12.3	10.3	14.0	17.5	18.5	18.6	11.0	26.0	16.3	23.9	13.9	22.8	20.5	9.7	20.6	20.3	25.9	19.2	20.1	7.1	34.6	18.1	11.7	24.6	11.2	26.4	17.1	21.5	10.0	15.7	16.4	13.4	22.8	22.2	16.2	20.1	8.3	11.5	55.9	13.3	14.7	16.7	14.7	15.7	18.5	12.6	6.4	15.0	19.9	15.5	17.4	18.2	9.2	13.4	14.5	18.6	7.6	11.2	13.9	9.4	16.0	14.8	11.7	9.7	11.3	24.7	26.8	14.6	23.8	24.1	17.9	23.7	13.9	18.4	15.3	23.8	35.6	13.7	15.9	21.6	24.5	76.3	25.5	34.8	29.6	24.4	25.5	52.8	28.2	21.0	146.2	23.8	28.2	0.0	24.3	35.0	18.6	20.9	31.3	24.9	31.6	17.5	20.8	15.4	28.0	98.0	17.5	26.8	10.1	16.2	24.4	39.5	20.0	21.0	19.8	84.0	33.4	6.5	22.0	89.9	86.5	28.2	25.1	20.3	27.1	17.3
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.2	32.6	16.7	18.1	5.7	12.4	26.9	26.3	11.1	22.2	21.5	40.8	20.8	21.5	20.5	13.7	27.4	13.2	31.9	45.8	24.1	52.5	26.7	15.8	29.4	17.8	8.4	30.8	20.0	10.1	9.0	24.6	10.8	13.2	17.0	20.0	22.6	17.1	16.1	36.0	35.9	2.4	13.1	17.4	10.7	30.2	17.1	23.0	8.4	40.4	28.5	18.2	25.3	24.0	12.8	14.4	11.6	10.2	16.5	17.6	27.9	12.9	34.2	21.8	25.6	49.1	28.9	27.8	18.3	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0	3.0	15.7	26.8	27.4	17.3	52.5	14.8	12.7	13.4	11.4	17.4	45.2	35.0	21.6	24.5	0.9	12.0	58.5	23.3	16.4	61.7	22.4	20.3	9.2	86.9	14.8	73.1	30.0	7.4	9.4	2.0	43.7	8.0	10.1	7.2	18.2	24.5	26.6	17.5	32.9	46.2	47.8	25.8	27.4	3.0	3.0	18.9	25.9	42.7	18.0	23.5
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 31.4;Proximal tubular cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	2.4	3.1	2.3	5.1	5.8	3.8	4.0	2.9	3.5	3.3	4.4	3.7	6.3	3.7	4.8	8.3	2.9	6.0	3.5	1.8	2.4	1.9	24.2	13.7	3.0	10.1	2.8	1.4	8.4	8.1	11.0	9.2	4.7	3.1	4.1	4.3	7.3	17.5	6.4	1.5	2.6	3.3	1.7	1.7	3.3	4.9	2.2	2.5	15.3	7.1	2.0	6.8	3.0	2.3	5.6	3.2	2.5	1.2	3.3	6.3	1.4	3.0	1.5	2.7	2.8	1.0	0.7	3.8	1.0	0.4	1.4	0.7	5.2	1.4	6.6	2.0	0.9	0.7	2.3	0.5	3.5	0.8	1.1	2.1	9.6	2.9	3.2	0.4	5.4	0.8	0.8	0.5	1.3	1.4	1.0	1.2	5.7	4.3	3.1	0.8	2.9	7.9	1.8	1.6	2.9	0.7	4.0	3.3	0.9	1.3	2.4	2.0	2.1	0.9	2.3	0.4	1.1	28.7	1.2	0.9	1.1	3.3	1.4	2.3	3.4	4.5	5.7	1.3	6.6	0.8	2.5	1.2	0.4	3.7	0.5	3.5	1.6	3.9	3.9	1.5	5.6	6.3	5.3	2.5	3.3	0.9	3.2	3.8	1.4	2.3	5.8	2.9	3.5	2.4	1.9	2.8	1.4	3.1	2.5	0.0	8.5	1.5	2.5	0.8	5.0	2.4	0.0	0.0	2.3	1.8	31.4	6.7	8.3	1.7	0.8	1.4	2.0	0.0	2.5	3.0	1.1	3.6	0.0	13.4	7.6	0.0	3.5	5.5	5.6	0.0	2.0	1.6	0.0	1.0	3.4	0.9	1.6	0.0	1.4	24.5	14.4	0.0	1.9	1.2	1.2	1.1	3.8	0.8	7.2	1.0
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA		81000	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	14.4	8.1	11.5	8.7	13.9	4.1	10.7	40.2	22.9	14.5	19.0	15.5	13.6	24.4	13.8	17.7	6.5	14.9	12.9	11.3	12.5	9.8	9.2	3.4	16.4	5.4	18.3	13.7	10.6	7.0	17.1	6.9	16.2	18.4	8.8	8.4	9.1	8.4	13.8	2.7	15.7	44.8	19.9	13.7	8.3	8.2	5.6	16.9	4.3	7.5	5.1	5.5	10.7	11.2	2.2	15.7	8.9	14.8	4.3	9.8	8.3	15.2	5.9	0.6	1.8	16.0	17.0	1.6	9.3	32.9	11.9	9.6	9.7	16.8	0.6	8.9	21.7	10.0	11.2	2.8	20.3	5.2	4.2	3.6	1.8	9.8	7.0	11.0	1.4	14.8	11.7	3.0	10.4	9.9	33.2	26.0	4.4	0.1	0.5	19.3	2.5	0.6	2.2	0.7	5.6	14.3	1.4	11.7	4.1	17.5	2.4	3.2	15.9	5.1	0.6	13.8	4.4	4.9	10.8	21.4	10.5	8.3	9.3	4.5	2.4	0.9	0.0	25.6	8.2	8.4	8.9	14.8	7.1	9.8	11.1	7.5	2.2	6.7	6.6	15.7	1.0	4.1	5.1	2.8	4.3	6.1	2.5	7.0	8.3	11.5	13.9	40.2	22.9	12.5	9.8	18.3	13.7	18.4	16.9	11.9	4.0	0.9	4.8	12.4	61.6	2.4	12.7	18.7	3.4	5.2	45.2	0.9	1.7	28.4	54.3	14.7	10.8	0.0	13.5	37.4	14.4	3.9	13.9	0.8	32.6	9.5	5.2	17.2	20.0	97.0	16.1	21.3	32.1	7.2	5.7	7.8	29.0	5.8	13.8	12.3	23.1	12.9	13.0	1.1	0.5	9.5	9.2	13.1	2.5	2.6
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.3;liver: 31.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	4.0	10.1	26.1	4.9	24.6	12.8	3.1	10.1	28.3	3.4	6.6	12.9	3.7	7.6	3.2	18.4	2.7	5.2	4.4	3.6	25.3	12.7	12.7	31.4	3.7	3.6	16.0	18.6	2.9	2.7	3.4	3.1	4.5	14.9	5.2	6.8	2.6	2.1	5.4	6.3	3.2	7.3	4.5	9.6	5.2	5.1	2.9	13.3	1.6	4.3	1.7	3.7	5.0	2.1	3.0	4.2	6.4	8.9	5.8	1.3	2.1	3.4	7.4	11.8	9.1	2.8	1.9	4.3	7.0	4.0	11.2	5.9	11.4	8.9	2.1	7.3	7.3	8.1	3.0	9.1	10.1	5.3	8.5	5.9	8.6	7.3	14.9	3.6	4.3	9.4	4.9	2.8	7.8	0.9	4.0	6.5	2.6	7.4	1.8	3.0	6.7	1.2	6.6	14.5	6.7	4.7	8.1	9.7	2.6	6.5	8.2	7.6	2.1	6.5	3.3	2.7	6.7	1.7	2.2	4.7	3.4	11.2	4.8	8.0	3.0	2.9	2.5	11.7	8.1	4.0	4.8	8.9	4.2	0.9	3.9	1.3	1.6	0.5	1.0	4.2	3.0	0.6	0.8	6.4	5.8	4.3	2.9	1.0	2.1	26.1	24.6	10.1	26.3	25.3	12.7	16.0	18.6	14.9	13.3	0.0	4.1	8.8	4.0	4.1	24.0	5.4	5.1	0.0	4.5	34.9	31.4	7.6	3.3	4.4	100.9	6.0	15.1	23.3	7.9	1.9	7.5	2.9	0.0	53.3	10.6	19.1	13.2	8.6	4.0	111.2	9.8	7.0	8.5	10.0	5.8	76.6	6.2	5.3	10.6	20.2	38.4	12.9	7.7	7.9	13.0	8.2	3.5	5.7	6.8	1.6
SGIP1	DKFZp761D221	ENSG00000118473	"SH3 domain GRB2 like endophilin interacting protein 1"	Q9BQI5	1	66533383-66748299	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	6.2	7.5	19.6	3.8	30.2	1.3	2.7	26.2	36.5	7.5	2.7	11.4	1.3	3.4	17.1	8.0	5.2	4.7	8.1	6.8	22.9	12.4	14.0	1.7	9.6	2.0	10.8	26.3	3.6	1.2	1.9	7.0	3.9	26.4	5.4	3.4	5.8	3.5	9.1	3.2	1.7	3.2	7.0	11.3	1.4	5.1	7.4	14.9	0.0	8.0	0.8	1.5	6.1	5.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	17.0	22.0	1.3	2.0	0.0	0.0	0.0	0.0	13.9	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	3.9	0.0	0.0	2.4	0.0	1.3	0.0	9.2	6.4	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.4	8.8	0.0	0.0	0.0	0.3	0.0	0.6	1.1	16.1	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	19.6	30.2	26.2	35.0	22.9	12.4	10.8	26.3	26.4	14.9	0.0	0.0	0.0	0.2	0.9	91.2	1.6	2.5	0.0	0.0	8.7	329.9	0.0	6.6	0.3	0.5	11.1	0.0	0.0	0.0	0.0	4.1	0.4	9.3	0.0	0.2	69.9	0.0	0.6	0.0	0.5	2.0	0.0	10.1	0.0	0.0	55.4	0.0	0.0	10.6	0.0	347.4	12.9	52.6	0.0	0.0	0.9	0.2	0.0	0.0	0.3
SH3GL3	"CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13"	ENSG00000140600	"SH3 domain containing GRB2 like 3, endophilin A3"	Q99963	15	83447228-83618743	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 30.3;testis: 31.6"	"Group enriched"	"Detected in many"	10	"Early spermatids: 502.6;Late spermatids: 937.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 21.8;HEK 293: 10.8;K-562: 17.0;RH-30: 6.7;SuSa: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039381, HPA077877"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039381: AB_10794635, HPA077877: AB_2686863"	"unprognostic (1.10e-3)"	"unprognostic (6.62e-2)"		"unprognostic (4.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.01e-2)"		"unprognostic (2.37e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.43e-6)"	"unprognostic (4.42e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.78e-4)"	1.1	1.3	12.5	1.1	26.6	1.4	1.3	6.3	30.3	1.2	1.1	28.2	0.0	1.2	1.8	2.0	2.9	3.5	1.1	1.2	14.2	9.9	2.3	1.1	4.1	1.3	25.5	14.6	1.2	1.0	1.1	0.7	1.8	17.6	1.7	1.2	0.0	1.0	1.8	1.0	1.6	1.2	1.2	16.7	1.1	1.2	31.6	26.0	1.2	1.2	0.5	1.9	1.6	0.7	0.4	0.7	0.7	0.3	0.0	0.4	0.3	0.0	0.0	1.8	1.3	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	21.8	1.3	0.0	0.0	10.8	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	4.5	17.0	0.0	0.0	0.6	1.3	0.0	2.6	0.0	0.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	9.5	0.0	0.0	0.3	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.3	0.7	0.0	0.1	0.7	0.2	0.3	12.5	26.6	6.3	18.5	14.2	9.9	25.5	14.6	17.6	26.0	8.9	1.7	0.0	1.3	0.8	4.1	0.4	0.0	1.4	0.0	3.5	0.0	0.6	0.0	0.4	502.6	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.0	0.0	0.3	73.1	0.0	0.0	0.0	937.4	8.6	0.0	1.7	0.0	0.0	2.5	0.5	0.0	3.9	0.0	1.1	0.0	0.2	9.5	6.8	0.1	0.6	0.0	0.0	0.1
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 212.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	25.1	11.7	11.8	31.2	9.3	14.3	23.4	13.6	22.2	18.3	16.8	16.7	12.2	46.6	22.6	16.8	7.6	16.1	21.3	22.2	9.9	26.0	19.0	19.2	7.2	11.8	68.7	31.7	17.0	18.3	32.2	14.7	49.2	16.6	18.1	24.8	20.0	44.3	13.8	16.5	25.2	17.4	10.1	10.1	19.0	17.0	212.4	43.1	9.1	11.6	25.3	12.1	7.1	16.8	49.3	4.5	22.8	39.0	11.4	7.4	15.1	9.6	18.5	59.5	32.5	39.5	16.0	29.6	13.3	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3	8.9	13.1	58.9	19.1	30.8	6.2	7.5	20.4	9.4	12.5	3.5	0.0	53.0	11.6	41.7	0.4	13.5	11.0	46.7	41.3	42.8	21.6	14.9	28.8	158.5	43.3	7.9	9.2	20.3	38.1	0.2	16.7	22.7	37.1	27.1	21.6	42.4	40.1	21.0	15.2	48.7	4.9	6.5	22.6	2.1	7.2	28.4	31.2	26.2	37.7	17.6
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.6	7.8	16.9	15.1	14.6	12.8	17.3	8.1	11.0	12.1	5.9	5.9	11.3	11.2	9.0	10.2	8.4	10.1	11.6	11.8	14.9	4.5	9.4	6.0	6.1	15.4	20.4	5.9	9.3	15.3	21.3	7.0	16.4	13.5	10.1	10.5	9.7	10.7	9.8	5.9	15.9	12.1	20.6	9.6	12.1	18.6	25.4	11.8	11.2	10.9	19.3	17.1	24.0	12.0	20.7	15.2	7.6	13.7	10.7	12.9	11.7	7.0	8.6	14.0	5.8	20.6	9.6	7.4	11.6	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0	11.9	11.9	16.4	51.3	76.1	18.3	12.0	10.2	9.4	10.3	15.7	7.9	161.7	26.6	21.4	60.8	27.0	18.8	0.0	19.9	25.3	52.6	43.7	4.6	19.5	29.5	33.4	21.7	28.8	18.3	53.9	21.0	23.2	47.2	38.7	18.3	30.7	19.2	14.4	18.4	21.1	16.5	19.4	37.1	68.6	47.5	66.1	624.0	13.4	16.7	38.7
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777243-45851736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.2;fallopian tube: 11.8"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.6	1.3	5.1	0.9	8.3	0.9	0.6	5.6	10.2	4.1	0.6	0.0	0.1	0.8	1.7	2.0	0.6	11.8	0.7	0.6	4.0	2.8	1.7	0.6	0.8	0.8	3.4	6.6	0.7	0.6	0.5	0.4	0.5	8.9	0.6	0.7	2.8	1.7	3.6	0.6	0.8	0.8	0.8	1.3	0.8	0.7	0.8	0.7	0.4	0.6	0.0	0.9	0.7	0.4	0.1	0.1	0.5	0.1	0.2	1.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	5.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.7	0.5	0.2	0.0	0.1	0.0	0.0	5.1	8.3	5.6	10.2	4.0	2.8	3.4	6.6	8.9	0.7	0.0	0.0	0.0	0.0	0.0	9.0	0.3	0.0	4.0	0.0	1.8	2.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12.0	16.0	14.3	10.5	7.2	17.6	6.3	7.7	10.0	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10.0	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12.0	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11.0	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27.0	15.3	1.4	9.1	5.2	25.5	5.7	5.0	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29.0	16.4	13.5	15.1	1.8	16.9	7.0	6.4	10.5	18.4	6.3	13.4	0.0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574529-13615158	"FDA approved drug targets, Predicted intracellular proteins"		Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 47.2;Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	5.9	6.2	8.8	6.8	10.4	5.9	9.2	11.1	13.5	4.9	7.2	6.4	12.5	8.1	6.8	6.7	5.7	8.0	6.6	22.9	8.5	8.3	9.9	29.9	9.8	6.9	9.5	6.9	8.8	10.5	12.9	7.6	5.3	8.3	6.5	8.3	6.2	8.6	8.7	25.8	8.8	8.5	6.2	6.9	9.5	7.6	6.6	6.1	7.5	8.5	7.0	6.5	6.8	6.0	9.2	4.6	10.9	9.3	7.3	10.0	5.6	5.8	4.6	5.9	7.6	3.7	4.8	4.4	3.0	3.2	3.3	5.0	7.3	7.0	8.4	18.3	2.4	7.3	9.5	4.1	5.9	5.0	3.8	6.8	5.3	4.2	11.8	6.1	4.3	4.6	5.2	12.1	2.9	10.4	7.2	6.0	11.9	7.5	3.2	3.9	7.1	4.7	8.5	4.9	9.1	7.3	8.4	3.8	15.3	6.8	6.4	9.7	3.5	3.4	5.9	13.4	16.7	6.8	2.8	5.3	5.1	2.9	3.1	3.3	7.8	8.8	5.7	2.9	4.3	4.8	0.5	4.5	10.9	8.1	6.1	8.2	9.2	10.0	7.9	4.6	9.1	9.5	8.5	1.5	7.3	9.3	4.6	7.2	5.6	8.8	10.4	11.1	13.5	8.5	8.3	9.5	6.9	8.3	6.1	26.8	2.7	9.1	9.2	3.7	6.4	47.2	10.2	21.4	17.0	10.4	0.0	17.1	44.7	10.5	2.2	8.7	9.6	23.3	6.0	9.0	4.9	5.7	0.0	22.2	8.5	1.6	5.8	10.4	10.4	0.5	7.5	6.1	5.0	5.4	12.6	8.4	6.7	13.9	5.3	24.0	6.2	0.0	5.0	6.5	7.8	4.0	8.9	6.9	16.5	7.3
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	11.3	15.1	12.8	9.6	26.2	9.6	20.8	14.7	22.1	20.8	11.3	38.2	8.4	35.3	12.3	12.7	17.3	15.4	12.1	12.9	14.5	14.2	16.1	18.0	18.6	7.9	40.0	15.4	10.4	20.6	29.8	21.7	16.4	29.7	18.0	11.8	18.7	26.9	14.8	17.6	15.6	11.6	11.0	33.1	9.5	12.5	8.7	31.0	15.8	29.9	8.7	16.5	12.9	13.9	4.1	9.8	3.0	9.5	8.3	7.1	4.6	7.7	10.0	13.2	12.1	14.7	12.5	44.4	8.4	30.5	8.0	9.4	12.6	14.6	4.8	16.6	9.4	15.3	10.7	11.9	7.9	9.4	6.9	7.2	11.4	12.1	14.3	15.6	7.7	23.0	13.7	9.9	14.9	15.2	19.6	9.5	9.8	9.8	2.4	9.3	8.9	9.1	5.2	19.6	8.2	6.9	5.9	12.1	8.5	9.7	11.6	9.1	8.1	6.4	19.5	8.5	16.0	21.9	5.1	11.4	8.2	6.9	9.2	4.4	6.0	8.1	2.0	23.1	4.2	3.4	0.7	6.6	2.4	6.4	9.5	5.8	3.6	5.0	6.3	9.8	4.1	7.1	6.6	3.0	8.3	6.0	4.1	3.8	4.6	12.8	26.2	14.7	22.1	14.5	14.2	40.0	15.4	29.7	31.0	35.7	40.3	11.5	22.2	13.7	23.8	12.0	28.1	45.5	43.3	54.1	17.7	20.6	3.3	25.3	0.8	14.3	8.6	70.0	24.8	18.3	17.5	32.8	67.2	38.4	29.8	27.0	15.7	9.8	13.3	1.5	8.9	25.8	25.3	9.0	13.5	27.5	20.6	14.7	8.1	8.8	16.5	6.5	12.4	5.5	12.8	11.7	16.2	7.9	16.1	19.0
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.8;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA			Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	3.0	22.8	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.1	3.7	0.0	0.0	8.1	0.2	1.1	1.4	1.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3	3.0	3.8	0.0	1.5	0.0	0.0	2.0	2.5	8.1	4.5	14.0	0.0	14.3	13.3	0.0	3.0	1.1	0.0	0.0	3.7	0.6	1.1	0.8	1.1	1.7	1.1	3.2	17.4	0.6	0.0	3.0	25.0	1.0	0.0	0.0	0.0	0.0	3.5	0.0	25.1	55.2	0.3	12.9	1.4	0.1	0.2	0.3	7.6	0.0	0.0	1.4
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 579.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.5	1.9	2.2	6.0	13.8	0.0	0.0	0.8	1.9	34.7	1.7	0.0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0.0	0.1	0.0	0.4	0.4	0.1	11.1	13.0	5.3	2.2	0.4	0.0	0.4	0.0	0.1	3.6	0.0	0.0	0.1	2.5	0.0	2.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	2.1	6.3	0.3	10.5	0.0	1.0	0.0	1.9	3.2	0.0	7.6	0.0	0.0	0.0	8.8	14.5	4.9	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3.0	0.3	0.5	10.4	9.5	7.7	33.9	0.0	5.3	1.2	0.0	2.0	25.3	0.0	0.4	0.6	1.1	0.0	0.0	0.0	13.5	11.8	3.2	0.0	0.2	38.2	3.2	0.0	1.3	63.4	1.9	4.0	11.0	6.8	3.6	0.0	579.8	0.3	0.0	0.0	0.0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0.0	0.0	3.3
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294443-132344206	"Disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ciliated cells: 89.7;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 23.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.1;U-138 MG: 14.9"	"Region enhanced"	"Detected in all"		"cerebellum: 72.4"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB015468: , HPA036974: AB_2732474"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	2.7	4.1	3.5	3.8	5.0	22.4	3.1	3.1	4.7	2.4	5.9	4.4	1.8	4.6	2.1	3.2	0.8	14.7	2.6	3.0	3.9	4.9	15.4	1.6	7.2	3.8	3.2	2.0	5.0	1.0	7.7	6.9	6.8	12.6	5.4	3.1	13.8	2.6	4.1	9.2	1.7	18.1	1.5	9.9	7.7	2.2	0.9	2.7	0.5	1.0	2.7	0.8	2.5	2.2	0.0	1.7	23.0	3.5	0.0	0.0	0.6	1.1	1.7	0.1	0.4	0.8	0.6	0.5	7.6	35.1	5.9	6.1	0.7	1.9	0.3	2.1	4.4	4.4	1.9	0.0	1.2	4.1	1.4	0.2	0.1	3.3	0.1	0.6	2.3	0.0	1.4	0.2	3.2	3.0	2.1	2.5	0.2	3.0	4.0	4.5	0.6	0.0	5.4	0.2	0.1	1.9	0.0	0.4	0.2	0.9	0.1	0.5	0.2	8.3	0.5	0.2	0.2	0.3	1.4	3.1	14.9	1.4	5.8	1.9	0.0	1.5	0.0	4.4	2.7	1.7	0.0	3.5	3.5	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	23.0	0.0	0.2	0.2	0.0	0.6	3.5	5.0	3.1	4.7	3.9	4.9	3.2	2.0	12.6	2.7	3.0	0.0	0.0	1.0	0.7	1.6	0.8	2.5	89.7	13.6	0.0	0.0	0.6	0.0	3.2	0.0	2.1	5.3	70.0	0.3	1.6	1.4	2.2	0.0	0.0	4.2	3.2	1.2	0.6	1.5	0.0	0.6	4.3	0.0	0.0	0.4	1.5	1.2	1.4	0.0	4.9	0.3	0.0	1.0	0.4	0.2	0.4	2.1	0.0	1.1	0.9
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 22.3;SiHa: 23.0"									HPA063062			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.6	8.7	0.5	7.0	2.8	1.3	12.1	1.6	1.8	2.8	3.9	6.4	7.5	1.7	3.8	1.6	8.1	8.7	5.8	4.3	3.3	2.2	7.1	0.9	22.3	2.9	4.7	1.4	1.5	1.3	8.1	1.9	9.9	4.8	0.7	3.2	4.0	1.1	2.6	6.2	2.1	1.4	0.6	6.3	3.8	0.8	0.0	9.4	8.4	9.1	3.0	2.1	23.0	18.0	4.4	1.9	8.3	1.8	0.4	0.5	2.5	5.9	2.0	3.8	7.4	0.1	1.8	3.6	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7	8.9	5.1	2.7	5.9	6.8	6.5	5.2	20.4	6.7	3.4	15.7	11.8	16.6	1.7	8.8	1.4	3.0	46.4	0.0	4.5	4.8	4.0	12.8	0.0	5.9	4.0	9.5	6.9	1.3	8.7	2.3	6.1	2.6	5.0	0.0	12.6	8.7	5.4	25.9	3.9	23.2	7.4	0.0	1.9	7.2	2.5	5.5	6.9	2.9	16.1	7.8
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.4;SK-BR-3: 38.8"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.2	26.4	2.5	12.6	0.9	0.7	5.0	6.0	2.0	7.8	5.9	16.0	6.1	6.4	4.7	1.4	3.8	9.2	3.6	6.3	1.4	4.7	20.4	5.2	16.1	50.4	1.1	11.7	6.4	0.5	3.3	5.5	1.1	1.5	4.5	9.1	8.7	8.1	2.6	26.8	17.1	12.4	2.6	6.0	19.9	13.0	5.4	20.2	6.9	12.9	16.7	11.3	5.7	38.8	1.3	0.7	16.6	6.5	1.9	6.0	19.8	8.7	11.0	5.0	2.5	3.7	2.6	12.4	5.2	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5	0.0	2.1	0.0	5.5	0.0	2.9	3.3	17.8	13.4	5.7	14.0	0.0	11.3	21.6	15.4	23.8	0.5	9.3	0.0	20.3	4.7	0.9	3.9	0.0	37.7	6.8	0.0	4.7	3.1	0.3	65.6	2.0	0.3	0.0	1.0	15.4	1.5	9.6	24.6	1.8	75.1	3.8	0.0	0.2	8.4	2.3	0.0	3.5	1.5	28.8	4.3
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.1	14.3	16.5	5.7	2.8	2.3	23.2	4.1	3.1	10.0	10.1	25.6	15.2	7.3	19.6	2.6	21.8	9.7	18.5	5.9	11.8	2.8	12.2	8.3	13.5	19.9	6.7	10.5	6.5	6.1	6.3	8.5	7.7	3.8	11.4	1.1	23.3	2.8	4.8	17.8	0.0	9.8	29.1	17.3	8.9	4.1	9.8	16.8	23.8	15.3	7.9	26.0	14.2	30.2	24.3	28.7	9.0	8.1	6.6	7.4	16.6	17.5	12.4	5.7	14.3	4.6	9.1	10.1	12.2	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6	8.9	9.3	10.5	6.9	6.5	34.3	7.1	38.2	14.7	6.8	17.4	51.1	25.9	23.2	17.3	9.5	16.9	23.5	0.0	16.5	20.5	14.8	9.8	13.9	124.1	20.1	9.5	36.2	12.3	22.7	6.7	12.0	19.6	20.3	2.8	19.4	22.1	18.9	24.6	14.9	50.8	47.6	12.9	8.3	5.4	9.1	6.9	16.7	5.7	23.3	12.2
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.9	9.1	6.5	4.8	4.4	4.2	3.5	5.2	7.0	10.2	10.2	3.6	4.2	4.7	18.2	7.0	12.5	3.9	9.4	3.9	10.1	6.0	11.9	1.5	8.4	8.5	6.2	5.9	2.8	3.9	4.7	12.8	3.9	6.0	5.6	6.6	4.1	6.7	16.1	10.6	6.2	8.3	5.5	7.5	15.0	5.3	8.5	9.4	5.9	3.0	8.2	7.3	5.5	5.6	8.8	4.5	3.6	3.3	3.7	5.5	3.6	12.5	10.5	6.3	16.1	4.1	10.0	7.3	4.9	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2	6.0	2.1	8.3	6.8	8.9	8.8	3.2	7.6	26.8	1.2	3.5	2.0	8.0	14.9	9.4	9.0	4.4	3.8	0.0	7.9	7.3	6.0	4.1	3.5	3.8	4.6	6.4	8.6	4.9	3.3	5.1	4.6	5.1	8.5	2.8	4.0	8.5	7.5	4.5	7.8	8.3	12.7	6.5	6.2	21.6	39.2	7.3	4.5	7.0	5.2	4.7
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477999-68527474	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	18.7	8.0	6.4	5.5	8.9	7.0	15.5	9.6	13.5	5.1	6.9	8.1	4.8	8.1	7.7	7.8	5.9	5.4	8.8	5.9	8.4	7.3	12.0	22.6	10.2	9.2	7.8	8.6	6.3	21.1	6.9	7.3	7.1	9.2	17.3	6.4	8.5	15.0	6.6	9.4	6.5	11.0	8.4	6.3	6.4	9.4	3.5	6.6	6.4	7.8	4.8	7.7	6.4	5.4	3.2	2.9	5.0	2.7	2.4	2.5	1.2	3.0	1.2	3.5	4.8	4.7	5.7	3.8	4.1	4.5	2.7	2.9	7.1	2.0	3.2	3.0	8.1	1.4	1.8	11.0	2.1	6.8	2.4	6.8	1.7	3.2	3.1	5.8	5.4	3.8	4.9	5.4	5.0	7.1	4.0	2.2	2.9	1.9	5.4	5.6	2.8	3.1	3.9	0.8	0.8	15.9	1.7	2.5	1.0	7.3	9.8	2.5	2.0	5.9	5.8	4.6	2.5	3.2	2.2	9.5	4.1	5.3	6.6	4.7	5.5	2.9	5.2	3.9	4.5	1.8	4.0	2.7	2.7	1.7	1.9	1.6	1.7	1.6	1.4	1.8	3.2	1.6	2.5	5.0	2.4	1.5	2.9	1.7	1.2	6.4	8.9	9.6	13.5	8.4	7.3	7.8	8.6	9.2	6.6	41.7	20.2	6.9	5.6	5.7	16.9	8.0	15.3	13.4	7.9	12.2	37.3	14.4	10.0	6.6	7.7	5.8	13.8	0.0	16.7	23.1	7.2	16.0	8.1	35.0	9.4	19.1	14.5	14.7	7.2	9.2	2.8	5.8	1.7	3.6	7.8	8.5	12.2	7.0	7.4	19.2	31.5	0.0	8.9	4.1	2.5	5.9	50.0	4.3	7.4	8.6
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;BEWO: 12.9"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.5	0.9	3.4	0.6	5.7	0.0	12.9	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.0	3.7	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.4	0.0	0.6	0.1	0.8	2.9	1.3	2.1	4.2	1.2	0.0	0.1	0.6	1.2	0.5	0.4	0.6	1.0	2.6	3.7	1.4	0.2	0.2	0.5	0.3	0.4	1.4	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6	26.8	15.9	0.0	0.2	0.0	0.5	1.4	0.0	28.1	12.5	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.5	4.6	5.8	67.6	0.2	0.0	0.0	2.5	4.6	0.6	0.9	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.6	3.2	0.0	0.0	2.7	4.8	0.1	1.5	0.0	0.0	0.1
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.4;RPMI-8226: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA		13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.5	3.6	5.0	11.5	4.4	0.7	8.0	4.3	5.6	5.8	5.6	6.9	6.6	5.7	12.6	6.8	1.4	8.8	3.5	4.2	16.8	4.2	9.2	7.0	7.1	5.2	9.6	17.8	5.6	4.0	7.5	1.2	2.2	7.2	10.1	8.2	35.4	7.3	3.7	10.5	4.8	1.8	8.1	10.2	3.8	2.1	48.7	6.0	3.5	1.4	5.1	7.4	0.0	4.0	5.2	11.3	4.5	5.8	6.4	1.1	9.3	5.8	13.1	9.1	7.7	9.1	6.8	8.4	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6	6.0	2.4	7.5	2.3	1.5	1.1	31.1	7.6	5.3	2.3	0.0	5.9	1.7	3.3	3.2	1.1	3.1	38.0	0.0	3.7	1.9	4.1	2.4	1.1	55.2	15.8	0.0	7.0	9.2	13.2	1.0	9.8	7.5	1.7	40.5	10.8	2.8	4.0	13.5	11.7	12.5	1.1	0.0	2.2	7.1	7.0	1.1	1.0	13.8	12.8	2.0
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.4	15.2	8.9	8.0	3.8	6.8	8.4	11.2	9.4	12.5	7.9	15.0	16.1	7.0	8.4	9.3	14.2	20.8	9.8	13.5	2.8	13.2	18.1	6.4	7.5	9.2	16.2	10.4	10.9	6.8	8.2	9.5	10.2	3.9	5.7	8.3	13.1	11.1	5.5	14.2	10.8	9.8	19.3	14.5	23.4	12.8	4.9	16.6	7.4	3.9	44.3	19.9	6.4	15.5	8.0	1.4	7.5	5.3	5.6	14.0	9.4	6.4	10.5	9.7	5.7	9.0	16.8	9.3	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6	6.0	10.4	2.2	6.3	11.2	147.0	1.8	5.1	2.7	4.5	8.7	31.4	5.9	3.3	22.2	11.5	4.9	7.0	0.0	17.0	8.9	7.4	13.6	2.3	15.3	4.0	41.3	12.5	1.8	1.8	5.6	4.4	2.6	3.3	6.4	7.3	13.4	14.1	7.0	4.6	5.6	29.9	0.0	6.1	1.4	6.3	11.7	2.6	5.2	5.0	8.1
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	12.1	13.0	68.2	5.2	97.6	0.4	6.3	21.5	51.7	12.5	22.3	17.6	10.3	18.2	13.0	11.9	31.2	16.1	10.1	36.2	66.2	25.1	17.9	13.0	11.3	4.0	25.6	33.1	15.8	10.0	24.5	5.5	2.2	28.0	14.3	23.5	12.2	32.1	20.3	37.0	11.9	18.6	30.7	16.9	4.3	9.9	3.7	25.9	1.2	29.2	9.7	14.1	16.8	9.3	2.5	0.9	0.8	0.0	0.7	4.5	0.9	20.0	8.1	11.8	37.1	15.9	7.0	5.4	5.8	9.6	11.4	13.8	20.4	13.4	11.2	14.3	14.7	12.5	17.1	24.0	14.0	9.1	0.0	20.2	8.1	17.2	16.2	14.8	0.5	19.2	20.0	12.3	10.1	4.4	23.3	11.9	12.5	23.3	14.3	2.2	14.6	7.0	11.5	8.5	21.6	25.0	3.4	3.2	17.2	30.5	3.6	0.8	11.6	4.2	25.8	10.7	13.4	13.5	17.8	4.1	3.6	15.4	0.9	3.8	2.6	3.5	9.9	1.6	19.1	5.6	0.8	0.0	0.0	4.5	0.0	1.1	2.5	2.7	2.3	0.4	1.0	4.0	3.4	0.0	0.7	0.0	0.9	2.6	0.9	68.2	97.6	21.5	51.7	66.2	25.1	25.6	33.1	28.0	25.9	8.9	18.1	7.0	8.3	9.3	9.8	34.8	48.4	1.4	4.5	43.6	7.9	1.2	16.6	52.9	16.5	5.5	100.4	0.0	24.8	1.5	5.8	13.9	6.9	27.0	2.1	7.9	13.3	12.9	2.1	45.5	17.5	2.2	16.9	1.8	35.6	14.6	40.3	35.4	27.6	22.6	16.4	12.9	6.2	0.3	3.2	20.5	0.7	4.3	23.9	24.3
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	24.2	5.4	16.6	5.1	11.4	15.1	8.3	8.5	10.0	15.1	16.7	6.6	8.1	0.0	7.8	15.6	6.7	9.5	4.9	13.7	20.5	6.0	2.5	1.5	8.1	3.2	9.5	3.9	3.2	11.2	9.7	8.8	11.3	9.8	11.5	3.5	4.1	8.2	19.1	15.9	2.2	0.8	9.8	10.0	6.2	4.1	21.7	7.2	10.2	12.5	3.2	5.5	12.0	8.6	11.2	16.4	8.3	6.9	7.8	8.6	4.4	15.3	9.1	2.3	1.3	0.0	2.9	7.1	5.1	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5	50.6	26.7	15.9	17.7	13.9	14.1	12.9	20.4	57.6	36.4	17.4	7.9	5.8	18.3	29.1	2.2	20.4	70.3	0.0	32.1	55.2	18.8	10.7	21.9	0.4	48.5	9.5	17.4	36.8	51.2	2.1	18.1	43.2	21.9	26.2	43.1	8.9	48.3	51.2	17.0	19.3	31.4	51.8	17.9	4.3	1.3	13.0	5.1	13.1	47.4	29.8
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	29.2	15.8	7.3	8.1	12.8	5.5	10.6	8.8	20.0	14.4	7.2	6.3	20.0	7.9	14.6	8.2	22.7	17.5	31.6	5.6	7.6	9.0	9.5	48.4	12.4	6.7	7.5	8.0	13.6	52.6	12.1	19.0	7.6	15.0	8.5	5.5	13.6	7.6	63.5	31.3	9.5	10.0	17.3	8.7	7.8	10.5	7.3	5.3	5.4	10.8	20.2	9.7	8.6	9.6	2.9	4.6	3.8	8.4	1.5	7.6	3.9	5.7	6.1	8.6	12.4	6.5	5.6	5.7	12.0	11.2	10.1	6.7	10.9	6.1	7.5	3.7	5.5	5.6	10.3	6.8	3.9	3.8	8.7	5.6	4.3	12.2	6.5	10.4	5.0	10.0	7.2	3.8	9.9	7.3	3.3	6.8	12.6	15.6	16.2	6.3	13.9	8.7	5.1	8.7	18.7	9.5	8.7	7.4	15.7	3.9	6.0	21.4	9.2	12.6	8.1	16.7	3.5	8.9	2.9	4.3	11.5	6.8	8.6	11.8	14.2	24.8	8.0	7.8	2.7	9.4	3.8	2.3	1.2	4.8	7.3	2.4	1.7	5.3	4.8	4.6	2.9	4.5	7.6	0.4	1.5	8.4	1.5	3.9	3.9	7.3	12.8	8.8	20.0	7.6	9.0	7.5	8.0	15.0	5.3	20.8	41.7	5.2	37.8	23.2	18.1	2.0	33.1	21.4	9.1	19.2	119.8	8.5	10.0	10.3	0.3	33.7	36.7	23.3	10.0	10.4	16.9	26.9	8.1	58.9	8.4	17.5	49.5	19.0	13.3	0.6	8.6	18.9	20.3	18.0	17.3	12.8	10.0	28.1	7.8	8.6	65.5	19.4	63.4	4.1	8.6	37.6	19.2	8.7	15.3	47.7
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.2	3.8	7.7	8.5	8.8	8.0	5.3	10.2	7.2	6.8	8.1	8.5	6.5	3.2	9.7	8.8	4.7	4.4	9.9	7.4	6.8	10.3	9.9	4.9	11.7	10.2	13.8	8.4	12.0	19.7	5.7	13.8	6.9	5.3	13.2	4.4	8.7	8.6	7.9	5.8	15.9	11.1	14.4	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	7.0	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.8	8.4	10.5	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6	29.8	20.3	23.3	31.4	31.8	17.7	96.8	20.4	13.4	12.5	17.4	11.8	29.9	29.9	25.2	20.6	19.7	19.1	0.0	38.7	36.6	33.9	31.6	18.5	34.2	26.5	11.1	17.9	9.2	19.0	19.2	15.0	17.8	35.4	20.8	25.5	22.4	26.4	14.0	20.5	46.3	21.5	19.4	29.5	21.4	30.2	32.1	27.3	46.5	33.0	33.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA			Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.4	2.4	8.0	9.1	6.3	0.1	1.1	3.7	1.1	0.2	0.0	2.9	0.8	5.5	2.0	2.6	4.1	1.1	3.5	0.7	0.0	11.8	0.0	26.3	2.9	4.8	0.1	0.3	9.8	14.8	0.0	9.4	5.8	0.2	8.0	0.1	0.0	0.9	0.8	0.0	0.1	1.2	2.0	3.1	0.0	3.1	0.1	6.0	7.5	7.3	0.8	5.5	0.3	2.9	3.6	5.9	0.0	0.8	5.0	3.3	0.5	1.0	3.2	0.0	16.2	0.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9	3.0	2.9	0.0	3.6	0.8	20.5	7.0	0.0	6.7	2.3	5.2	27.5	0.0	0.0	0.6	23.2	3.1	0.3	0.0	0.6	0.0	2.5	5.8	1.1	1.7	0.2	19.1	5.8	2.5	0.3	16.0	2.8	0.1	1.7	0.0	1.3	8.3	0.3	0.0	4.9	0.5	38.2	0.0	2.3	0.5	0.7	2.0	0.0	0.0	1.5	2.1
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	74.7	58.4	77.5	64.2	70.6	117.4	99.9	65.6	87.5	85.1	71.2	104.8	39.3	102.2	39.0	79.5	38.5	64.4	78.6	88.7	89.8	38.4	62.7	60.9	43.1	69.5	86.9	71.3	48.4	111.0	79.4	61.8	88.9	128.1	120.1	53.0	65.6	30.3	101.4	55.8	66.1	79.6	71.7	64.7	96.0	75.6	80.8	113.4	110.0	75.1	39.8	53.4	78.5	70.7	108.3	68.5	95.5	78.0	80.7	47.4	44.8	52.0	65.6	51.4	60.4	71.5	37.4	42.1	61.0	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1	199.5	265.4	295.0	454.5	334.1	211.9	1401.5	384.7	145.9	192.2	204.1	74.6	677.0	741.1	434.4	31.9	273.0	744.3	163.5	762.2	755.9	400.5	371.4	205.5	373.5	527.3	276.5	300.1	249.2	430.8	19.5	236.2	288.2	415.0	543.8	392.0	226.4	536.4	501.2	241.1	802.3	176.2	297.5	387.5	94.1	178.4	316.8	681.4	269.7	620.6	559.0
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 113.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	113.2	11.9	0.0	0.0	0.0	0.0	0.0
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024763, HPA047402"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	24.1	14.9	11.1	19.6	17.0	21.6	21.6	22.1	21.9	16.3	14.7	15.4	8.8	11.0	19.4	13.0	13.1	18.8	19.6	16.4	12.6	16.5	15.2	29.6	16.1	23.9	16.4	11.6	21.0	13.4	17.3	30.1	16.5	24.2	14.9	14.2	15.7	13.0	13.1	17.8	13.9	14.1	18.5	14.1	25.1	14.4	15.3	13.6	17.2	14.9	11.7	19.8	18.3	14.2	8.9	5.0	1.8	4.6	5.7	9.3	6.5	15.0	5.4	7.4	9.0	10.1	11.8	4.9	12.8	18.1	14.4	15.0	6.6	9.3	32.8	12.2	13.8	8.6	9.7	10.6	10.8	22.4	20.0	7.5	24.2	4.6	8.4	17.6	11.8	11.0	11.6	9.0	16.2	24.2	5.8	14.9	9.6	14.9	12.9	14.3	6.0	20.1	9.7	8.9	17.7	10.9	15.1	7.9	22.6	9.8	6.9	20.7	9.0	6.2	10.3	21.4	6.2	9.1	8.5	10.3	17.9	11.9	20.6	16.5	9.2	8.6	34.2	15.2	17.3	13.2	0.7	3.9	1.8	7.7	4.4	9.3	8.9	8.3	8.8	5.0	6.5	8.6	8.7	1.1	5.7	4.6	4.3	6.5	6.5	11.1	17.0	22.1	21.9	12.6	16.5	16.4	11.6	24.2	13.6	3.0	3.5	26.5	13.0	20.5	8.9	9.9	10.2	1.4	3.4	5.2	5.9	10.3	6.6	7.8	3.0	19.4	3.2	0.0	8.2	11.5	13.8	8.2	9.2	13.0	9.3	7.9	10.9	16.5	5.0	2.8	8.6	7.4	10.1	10.0	6.3	7.1	8.1	3.5	8.1	7.4	7.4	19.4	12.6	20.0	17.9	22.6	11.7	13.1	6.2	14.0
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 16.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.8	0.6	1.4	1.9	0.9	0.8	0.7	1.8	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.1	0.5	0.6	0.4	2.2	0.8	2.7	1.0	0.5	2.2	0.4	4.6	0.6	3.2	0.6	1.8	3.7	2.0	2.9	0.4	1.0	1.9	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.4	3.4	1.9	2.5	1.7	1.7	2.2	2.3	0.6	3.8	3.5	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2	0.0	0.0	0.0	0.3	0.2	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.7	16.0	0.0	0.2	0.2	0.7	0.3	0.0	2.1	1.2	3.2	3.4	2.5	2.6	0.4	0.9	0.1	0.0	1.8	2.4	1.7	0.2	5.3	0.4	3.0	1.4	0.0	0.9	0.5	0.6	0.1	1.1	0.0	4.1	0.4
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.5	12.5	2.1	9.4	7.2	2.8	5.2	2.9	2.7	3.3	3.6	1.5	11.7	5.2	3.1	3.4	6.7	10.1	2.7	3.6	1.8	2.8	3.3	4.4	9.2	1.8	2.7	0.5	11.9	5.9	2.1	6.2	1.1	2.3	5.1	6.1	1.2	1.8	2.7	2.5	4.7	2.4	0.7	3.1	4.2	5.1	1.5	2.3	2.5	11.6	1.1	2.8	8.6	5.2	3.7	2.3	11.6	3.3	6.7	2.2	1.7	5.3	2.5	4.0	2.4	1.8	5.7	7.8	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2	0.0	4.8	5.4	1.5	0.7	3.7	1.2	2.5	0.0	1.2	10.4	7.9	7.3	10.0	2.4	2.4	2.2	2.5	0.0	6.2	2.0	1.3	1.8	4.7	2.4	5.9	1.6	8.6	2.5	3.7	3.6	1.4	2.7	0.0	8.2	2.7	6.8	2.6	3.1	1.1	5.7	8.9	0.0	0.7	27.9	0.7	0.3	14.5	3.8	3.0	1.1
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140979933	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	20.2	16.9	14.9	13.4	20.5	36.5	25.2	18.7	31.3	23.5	19.4	18.3	17.3	22.3	25.6	37.3	12.2	25.1	13.7	29.5	15.9	19.0	29.0	3.1	22.4	18.6	15.6	16.7	32.6	33.9	29.7	26.3	19.1	21.6	20.6	14.8	21.1	17.5	17.7	60.6	16.2	17.2	20.4	18.5	14.1	23.6	24.4	12.2	15.4	23.7	15.1	12.7	20.7	18.5	17.0	14.9	15.7	13.1	18.1	16.6	10.9	23.8	5.4	17.5	14.3	16.1	20.6	22.1	9.0	11.5	10.1	14.3	14.9	11.4	19.9	22.4	7.6	14.5	16.0	21.2	8.8	20.7	15.2	17.2	16.4	13.0	9.4	24.2	23.4	10.2	23.2	29.6	7.4	22.7	22.7	10.6	14.7	8.7	12.9	14.7	10.3	13.9	16.1	17.4	5.9	10.1	15.1	15.6	28.2	11.9	8.2	11.3	18.5	12.2	22.2	39.1	16.0	15.4	13.3	10.7	14.1	7.9	24.9	8.6	26.2	17.0	23.2	18.2	9.8	6.9	10.5	10.4	15.7	11.4	13.1	13.3	17.0	11.7	12.5	14.9	16.0	16.6	15.7	1.8	18.1	13.1	10.9	10.2	10.9	14.9	20.5	18.7	31.3	15.9	19.0	15.6	16.7	21.6	12.2	92.3	107.7	22.2	58.2	60.7	96.5	82.2	38.2	133.8	62.6	68.0	125.7	48.2	54.7	22.9	5.0	40.0	22.6	0.0	33.6	33.4	49.8	72.0	63.6	0.4	22.8	87.4	57.0	29.4	35.2	11.5	55.3	36.5	54.0	29.7	27.0	70.1	26.8	17.5	55.9	52.8	122.5	58.2	54.2	29.3	61.1	47.6	41.3	41.1	40.3	64.7
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 3550.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"HEL: 47.7;hTERT-RPE1: 27.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3.0	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3.0	1.0	2.2	47.7	7.0	1.4	4.9	2.7	1.9	6.2	8.0	4.8	4.8	27.9	3.4	5.0	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3.0	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35.0	24.5	60.7	19.4	95.7	12.5	47.1	47.0	15.3	22.7	43.1	139.3
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 4236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3.0	0.3	5.0	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2.0	3.3	2.6	2.6	10.4	2.9	2.2	4.0	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2.0	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68.0	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0.0	65.1	47.9	24.6	55.0	11.5	83.9	50.1	151.0	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24.0	35.3	15.8	33.9	10.7	48.8	46.9
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063999-19112888	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	6	"B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low region specificity"	"Detected in all"							HPA049449	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	4.8	5.7	13.8	4.5	12.2	7.5	4.9	22.5	15.4	7.0	4.8	5.9	4.5	5.7	6.8	4.4	4.5	7.4	4.7	8.9	9.7	7.8	26.7	42.3	5.4	8.5	5.9	7.8	13.8	7.4	6.5	9.6	3.2	7.9	7.6	3.0	12.2	11.0	6.3	26.7	5.2	5.6	5.7	6.1	7.3	4.6	4.5	8.1	6.6	17.1	7.3	12.2	5.5	5.4	6.2	0.7	0.2	0.6	2.8	5.1	1.5	6.2	0.8	1.6	2.8	6.1	5.1	2.5	3.0	4.6	4.7	5.4	1.2	12.5	4.5	7.1	2.8	4.7	1.1	3.2	2.5	2.7	1.1	6.2	1.5	1.7	10.0	4.9	0.7	3.2	5.1	1.8	3.6	2.2	3.8	2.1	14.7	17.5	8.1	2.5	5.6	7.5	7.1	0.9	1.7	6.5	5.8	2.8	8.6	1.8	1.1	1.8	1.3	3.2	0.1	1.3	2.2	5.7	3.5	1.9	3.5	2.0	7.3	2.9	9.4	5.1	3.5	3.7	9.6	1.8	0.0	0.2	0.2	5.1	0.5	2.8	6.2	2.9	4.3	0.3	5.1	1.9	2.8	0.0	2.8	0.6	0.7	2.9	1.5	13.8	12.2	22.5	15.4	9.7	7.8	5.9	7.8	7.9	8.1	0.0	9.6	8.9	2.4	2.9	68.0	8.9	2.5	1.4	3.4	8.7	17.7	5.7	11.6	1.4	1.2	3.5	5.4	0.0	2.7	2.7	3.6	2.6	3.5	44.5	1.5	3.2	8.1	4.3	0.3	0.6	4.6	1.1	3.3	0.0	4.0	11.9	1.9	2.9	6.0	27.0	42.5	6.5	5.7	7.9	6.4	2.5	3.9	11.4	2.9	1.3
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 176.3;Late spermatids: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	16.9	15.6	11.9	12.7	19.3	11.3	13.6	17.6	25.7	12.5	14.0	12.2	8.5	15.7	13.4	9.5	16.4	9.5	10.0	20.8	10.4	10.0	18.7	22.0	11.4	13.7	14.5	14.8	10.2	12.4	12.7	20.2	11.5	27.7	10.2	14.7	8.3	14.2	10.7	55.6	13.0	15.4	13.9	15.0	12.1	12.9	15.8	12.3	20.4	12.5	14.3	17.5	13.1	10.9	14.6	15.1	20.2	17.3	17.7	16.3	14.9	12.5	9.7	9.2	7.4	21.3	20.2	3.7	15.7	20.4	18.0	22.5	13.2	10.7	33.8	16.1	18.3	23.9	10.4	14.5	26.0	20.4	21.7	8.3	14.5	14.1	9.5	19.0	12.6	14.6	17.0	7.7	21.2	15.0	9.4	11.2	12.9	10.9	21.3	18.6	10.0	18.4	5.4	6.9	8.2	9.7	9.0	20.6	25.1	11.4	14.7	16.2	12.0	13.6	10.5	16.5	9.1	11.4	10.5	14.7	15.9	8.0	14.4	18.8	40.9	25.6	25.4	16.5	14.8	8.5	20.2	14.7	11.5	12.3	17.3	12.4	14.1	13.7	12.6	15.1	14.6	14.8	14.8	6.2	17.7	15.2	10.6	16.3	14.9	11.9	19.3	17.6	25.7	10.4	10.0	14.5	14.8	27.7	12.3	20.8	22.7	11.9	7.5	20.4	16.0	56.7	5.1	12.0	7.9	19.2	21.6	18.8	16.6	15.0	176.3	20.2	27.2	23.3	22.2	16.5	20.2	7.3	18.5	39.4	23.8	17.5	22.5	30.1	24.3	325.8	19.5	18.9	28.7	22.6	25.4	21.5	14.4	25.7	20.8	30.4	13.6	19.4	20.6	20.0	10.2	23.5	17.2	25.4	19.0	5.5
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 2147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7800000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	82.0	78.9	30.9	53.1	19.8	29.2	57.4	30.7	33.5	64.8	58.0	65.5	52.1	104.2	41.3	29.4	46.8	57.8	75.8	64.1	59.2	27.5	73.1	35.1	47.7	46.6	25.1	95.3	58.0	31.7	72.1	66.7	42.6	24.7	67.2	53.7	28.1	43.2	35.3	182.7	84.3	96.8	65.0	112.7	127.2	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.3	62.1	32.9	33.1	48.3	27.9	30.7	44.4	68.3	110.0	50.7	62.9	83.4	33.9	97.5	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1	151.8	244.7	335.6	401.9	724.7	105.3	125.5	328.6	187.4	221.8	177.9	56.9	945.1	2147.0	467.3	2.7	209.6	1628.0	163.5	919.2	321.7	246.2	228.4	191.3	343.1	785.8	25.4	385.2	119.1	477.4	13.9	134.6	447.5	519.6	300.2	755.1	85.2	524.3	956.2	104.0	1138.1	131.4	129.4	460.4	8.9	116.7	839.4	1329.0	292.0	958.7	657.9
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 74.4;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	17.6	9.1	11.7	9.9	12.9	21.2	27.6	11.3	14.2	12.0	10.7	12.0	10.8	15.3	10.3	10.2	12.6	8.1	10.7	11.5	12.9	9.3	13.3	9.7	14.6	10.8	11.9	14.9	11.0	16.7	20.6	12.8	9.7	11.9	10.5	9.0	8.2	13.3	8.4	15.9	11.7	13.4	12.2	11.4	12.6	9.7	18.8	12.4	14.4	9.8	7.6	12.9	9.1	10.2	3.1	1.4	13.4	3.9	2.1	3.6	1.1	8.2	6.6	5.1	8.0	24.5	10.7	5.2	7.0	7.3	6.1	8.9	8.6	3.6	17.4	4.1	16.6	8.6	4.1	13.6	9.9	11.8	11.9	4.2	5.3	18.2	12.0	13.8	8.3	7.8	10.7	11.6	9.1	11.7	9.7	11.0	16.7	11.6	13.9	13.0	4.7	10.0	1.9	6.3	8.5	4.8	7.0	6.8	10.7	6.1	6.0	10.7	6.9	5.6	6.8	4.0	9.0	3.7	9.1	11.9	10.3	12.1	4.8	8.7	5.3	11.2	12.2	13.5	6.1	8.5	13.4	1.9	3.2	2.1	3.9	3.6	3.1	2.3	3.0	1.4	2.2	2.2	2.5	1.5	2.1	1.6	0.6	3.4	1.1	11.7	12.9	11.3	14.2	12.9	9.3	11.9	14.9	11.9	12.4	8.9	0.6	4.2	5.0	4.1	4.3	5.7	2.5	1.4	2.3	1.8	3.9	3.2	14.9	8.3	74.4	3.4	5.1	0.0	6.3	11.8	4.2	3.9	3.5	3.2	10.5	1.6	3.5	0.6	5.9	125.5	3.4	5.0	1.7	9.0	4.2	3.4	7.2	7.0	3.9	13.4	3.4	0.0	3.1	10.2	10.3	5.1	3.3	3.2	3.5	3.4
SLC25A52	MCART2	ENSG00000141437	"Solute carrier family 25 member 52"		18	31759562-31760880	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	17	"testis: 18.2"	"Group enriched"	"Detected in some"	10	"Early spermatids: 41.8;Late spermatids: 77.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"									"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (8.97e-2)"	"unprognostic (4.85e-2)"			"unprognostic (2.93e-1)"	"unprognostic (4.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.30e-4)"	"unprognostic (7.15e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.3	0.4	0.4	0.0	0.8	0.4	0.5	1.3	0.4	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.2	0.5	0.0	0.9	2.5	0.6	0.0	1.5	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.9	0.7	1.0	0.0	0.0	1.3	0.1	0.3	0.3	0.0	1.1	0.9	0.0	0.0	0.4	0.7	1.5	0.8	1.0	0.2	0.1	0.6	1.7	1.3	0.6	0.6	0.5	0.7	1.3	1.5	0.7	0.8	0.6	1.2	0.8	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.4	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	0.0
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7200000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.2	48.7	34.6	35.3	24.0	46.8	37.5	34.1	32.7	25.2	25.1	64.4	27.2	82.8	27.6	22.4	38.0	14.5	23.2	40.7	7.9	20.7	73.8	45.2	33.4	73.5	56.3	32.5	55.2	77.2	75.0	19.7	29.0	32.7	37.3	26.1	31.5	19.5	24.6	47.4	60.1	62.3	43.9	8.8	65.7	30.4	28.6	64.2	30.7	56.0	56.6	88.9	23.1	70.1	97.0	21.0	38.9	67.0	42.7	25.7	14.4	50.2	34.0	50.6	8.1	55.8	3.8	31.4	13.9	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2											137.0	195.3	871.5	1042.4	1022.6	282.9	87.0	257.4	128.5	280.9	300.1	92.3	1322.2	1405.9	633.0	8.9	418.0	863.0	303.7	1275.3	963.9	807.0	855.9	337.0	132.8	1090.5	228.8	892.0	411.9	1235.3	26.5	618.4	976.3	715.3	1354.4	1107.0	100.8	835.0	866.6	344.4	1021.3	199.6	336.3	860.1	13.3	52.8	1155.2	1458.6	553.5	1380.0	1328.6
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;SK-MEL-30: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.1	17.6	9.8	2.1	2.6	7.0	3.0	4.5	0.2	11.3	1.2	5.0	4.4	2.8	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	12.5	2.0	2.4	0.4	0.7	1.9	1.5	2.0	2.9	0.7	3.6	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	29.1	1.6	3.2	0.9	1.2	5.9	3.9	4.7	1.8	2.5	1.8	0.4	6.1	3.2	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3	3.0	14.0	1.5	14.9	6.0	8.2	16.7	10.2	4.0	9.1	8.7	25.5	3.7	1.7	9.3	0.7	4.7	0.1	0.0	4.1	14.7	9.7	10.3	2.3	5.8	24.7	6.4	5.2	9.2	20.6	1.7	19.8	9.1	8.5	5.4	2.6	9.7	4.9	0.0	11.0	2.7	17.6	6.5	5.2	8.1	4.3	4.0	1.9	6.1	1.3	7.0
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 43.2"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048185, HPA050695, HPA060150"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	3.0	2.5	2.4	7.4	2.2	1.3	2.7	2.1	2.4	7.4	8.1	1.8	3.8	8.4	2.6	4.8	5.0	6.2	5.9	2.4	3.7	2.6	5.6	2.0	4.0	7.7	2.4	2.2	3.4	3.4	0.3	2.6	9.7	1.9	10.6	9.8	5.2	43.2	2.7	2.3	8.5	7.4	1.8	4.2	2.7	2.8	3.7	2.3	1.8	3.2	6.7	6.9	3.4	3.7	9.3	5.9	0.5	0.2	2.9	11.2	1.6	8.5	5.6	0.6	7.9	4.7	7.0	8.1	2.0	1.1	5.3	6.8	24.2	9.0	14.2	20.3	5.9	28.6	17.9	11.3	18.1	10.5	11.8	10.4	7.9	5.5	10.0	7.7	18.5	4.0	4.8	10.5	17.5	37.9	15.9	27.6	11.3	20.7	5.9	3.7	5.1	7.6	17.8	6.0	18.9	54.7	15.5	7.2	18.6	28.3	7.8	13.8	5.8	6.4	14.9	3.9	7.9	11.0	3.9	20.5	9.7	16.1	0.2	20.4	15.4	17.4	15.6	6.2	5.9	6.3	0.1	0.2	0.0	2.8	0.1	7.3	9.3	4.8	4.9	5.9	6.1	1.8	2.5	0.5	2.9	0.0	0.3	11.2	1.6	2.4	2.2	2.1	2.4	3.7	2.6	2.4	2.2	1.9	2.3	8.9	1.0	11.1	30.1	40.9	1.1	0.5	0.0	0.0	15.9	3.5	11.8	0.7	3.3	10.1	0.3	5.8	14.0	0.0	7.2	13.5	5.1	19.0	2.3	0.0	5.0	0.0	5.8	0.0	0.8	0.9	0.9	3.9	21.9	6.4	10.2	1.3	17.0	10.5	2.5	5.5	7.5	6.5	4.1	0.3	4.9	44.0	3.8	2.5	22.6	15.2
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"liver: 42.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	2.1	3.7	4.8	4.8	3.7	1.4	3.7	7.8	5.9	1.7	5.0	2.7	13.6	26.0	2.6	15.9	2.5	4.0	6.9	4.6	3.7	4.9	29.6	42.2	3.3	4.7	3.7	3.1	3.3	15.5	5.9	2.2	3.3	2.3	4.3	5.3	3.0	4.6	13.6	27.7	2.0	6.7	1.9	3.1	3.4	1.8	4.5	1.4	2.9	3.3	3.3	2.4	1.7	2.3	1.2	0.7	2.7	3.7	2.0	4.1	1.2	0.4	7.2	2.6	1.9	4.7	1.9	1.5	0.2	5.9	1.6	4.1	16.4	1.2	1.8	4.0	2.3	3.4	0.4	1.1	8.2	2.5	2.1	17.3	5.4	1.6	21.6	1.7	3.1	0.9	0.0	2.3	0.8	4.4	6.6	5.4	0.4	2.1	4.8	2.7	15.1	0.1	6.9	0.1	1.6	8.6	4.4	0.0	8.5	1.8	7.6	3.3	3.3	0.0	0.4	2.7	3.5	3.2	2.3	0.0	0.0	2.6	0.1	2.8	0.8	1.3	0.5	0.7	7.9	0.7	0.0	1.9	2.7	3.3	3.7	2.8	1.2	1.9	4.1	0.7	1.1	1.6	2.3	0.0	2.0	1.5	0.2	2.1	1.2	4.8	3.7	7.8	5.9	3.7	4.9	3.7	3.1	2.3	1.4	3.0	5.6	6.7	7.2	1.5	6.4	3.6	183.4	8.1	4.5	15.7	0.0	22.4	26.6	25.4	9.2	6.3	26.5	23.3	22.1	16.5	3.7	9.0	0.0	134.8	24.5	15.9	23.7	21.5	9.1	1.9	8.9	7.0	3.3	16.2	17.5	96.7	18.6	24.6	9.9	134.4	11.0	0.0	4.1	7.1	22.6	2.4	12.7	4.6	37.7	5.1
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 256.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 49.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.2	49.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3.0	1.0	1.5	0.2	0.0	12.5	0.3	63.7	0.0	0.0	40.1	9.8	0.0	53.0	18.3	10.9	0.0	32.7	0.0	12.6	0.0	0.2	1.4	0.0	2.8	0.1	20.6	0.0	0.6	0.0	3.3	1.1	0.0	0.0	2.8	3.8	1.6	3.4	7.2	0.4	256.0	11.9	0.0	0.1	0.7	0.3	0.1	0.1	0.0	8.0	0.5
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.8	9.6	6.1	9.7	7.6	7.5	8.3	11.2	11.0	11.4	10.1	4.8	6.2	15.7	7.1	10.2	9.5	11.3	5.9	8.2	3.9	28.8	9.0	3.8	9.5	0.7	7.3	0.0	11.0	9.5	6.9	13.0	9.3	9.5	7.0	12.8	7.0	6.6	9.1	6.7	7.0	1.1	7.2	2.9	4.4	8.3	18.3	3.8	2.6	13.5	5.1	6.5	8.6	7.7	7.0	5.3	5.5	4.0	8.7	13.6	8.8	12.4	11.6	22.0	14.6	5.2	10.6	5.0	8.4	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3	3.0	16.5	12.6	19.3	18.4	12.9	157.4	10.2	9.4	12.5	0.0	47.1	1.7	1.7	8.2	1.5	20.4	0.0	0.0	9.4	12.7	8.0	15.4	6.9	1.8	2.7	17.5	5.8	4.3	2.2	1.7	9.2	3.2	8.5	0.0	0.8	18.0	8.8	0.6	8.9	13.7	21.3	0.0	19.4	6.8	15.0	15.8	2.6	8.5	1.0	20.0
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Cell type enriched"	"Detected in many"	6	"Enterocytes: 518.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.9	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	14.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.0	2.5	10.7	0.0	0.0	0.0	0.0	11.6	0.0	48.8	0.0	518.3	0.0	0.0	0.0	0.0	0.0	4.6	1.5	0.1	0.0	1.7	0.6	0.0	9.7	0.3	0.0	0.0	0.0	7.7	0.0	0.0	84.2	0.0	54.0	0.0	6.5	0.0	1.5	0.4	0.0	0.1	0.0	19.7	0.0
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039249	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 56.2;liver: 75.6"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced		Uncertain	Mitochondria		No	NA			Mitochondria		"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.8	2.1	32.2	1.6	31.0	3.0	1.8	15.1	56.2	2.0	1.7	25.4	0.0	1.7	1.9	3.9	4.3	2.4	2.3	3.3	22.2	16.6	2.1	75.6	2.5	1.7	22.7	25.3	2.4	1.4	9.3	1.0	2.0	17.0	2.1	1.8	1.7	1.6	5.0	3.3	1.7	1.7	1.8	13.7	1.9	1.7	4.4	14.3	0.5	1.9	0.0	1.7	1.9	0.9	1.0	0.8	1.2	0.3	0.2	0.8	0.2	0.8	0.6	1.9	1.3	1.5	0.4	1.1	0.7	0.2	0.8	1.1	1.5	1.0	1.6	0.3	0.4	1.8	1.3	2.3	0.9	0.7	0.2	1.8	1.3	4.6	2.8	0.7	2.2	2.3	1.1	0.2	0.2	1.3	0.5	0.3	1.7	1.1	3.7	0.2	1.1	0.7	1.8	0.8	1.2	1.4	1.2	0.2	0.1	0.6	1.8	0.8	0.3	1.0	0.7	0.2	1.1	1.0	1.0	0.3	0.8	0.5	0.7	0.7	1.1	0.3	1.2	0.9	1.7	0.4	0.3	0.3	1.1	0.5	0.1	0.8	0.9	0.6	0.5	0.3	1.0	0.3	0.5	1.2	0.2	0.3	0.8	0.3	0.2	32.2	31.0	15.1	41.5	22.2	16.6	22.7	25.3	17.0	14.3	0.0	0.3	0.0	0.0	0.2	1.8	1.4	17.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.5	0.0	0.0	0.0	0.0	1.0	0.2	5.2	0.0	0.0	0.0	0.0	41.9	0.0	0.0	9.6	0.1	3.3	12.9	2.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	0.4	1.7	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.6	4.8	1.5	28.3	0.8	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7	0.0	0.0	0.0	0.0	0.5	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	3.6	0.0	0.4	0.0	1.1	0.4	0.1	0.0	0.0	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 43.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.1	1.1	1.1	1.1	3.1	0.9	0.9	1.4	2.0	0.9	0.8	3.7	0.0	0.8	2.6	2.3	0.7	0.9	1.6	0.9	1.6	1.0	0.8	0.7	1.1	2.4	2.4	1.1	1.5	1.3	1.2	2.4	0.9	3.1	1.1	0.8	2.8	0.7	0.9	0.7	1.9	0.8	0.7	4.4	1.0	0.8	43.1	2.3	4.2	1.1	0.0	1.7	1.2	0.9	2.0	1.9	0.6	0.6	0.4	4.9	0.6	0.4	0.0	2.2	3.3	4.4	3.3	0.7	0.8	1.1	0.0	0.2	0.0	0.2	1.7	0.6	1.7	0.7	0.0	1.7	0.9	1.5	3.2	2.3	2.5	2.0	0.0	0.0	0.7	0.5	0.5	1.0	0.0	1.8	0.9	1.3	4.5	1.2	1.7	1.7	1.3	1.0	2.2	0.8	0.5	0.0	2.7	1.8	0.5	0.9	0.5	2.1	5.0	0.6	0.8	2.5	1.5	0.4	1.7	0.7	0.9	0.3	1.0	1.1	5.5	4.0	1.4	1.2	1.0	2.4	0.6	0.6	0.1	1.5	0.4	1.7	1.8	1.2	1.8	0.7	2.0	4.9	2.8	0.3	0.4	0.3	1.9	1.7	0.6	1.1	3.1	1.4	2.0	1.6	1.0	2.4	1.1	3.1	2.3	3.0	1.0	1.9	0.5	1.1	1.9	0.8	0.0	0.0	0.0	0.0	15.7	0.4	1.7	0.3	118.1	0.7	0.0	0.0	0.4	0.2	1.5	0.8	0.0	0.0	1.1	3.2	0.0	0.6	4.1	86.8	4.9	0.8	1.7	1.8	0.0	2.7	0.7	0.0	2.8	0.6	5.0	0.0	1.4	121.2	8.1	0.5	0.5	1.0	0.0	0.5
SLIRP	"C14orf156, DC50"	ENSG00000119705	"SRA stem-loop interacting RNA binding protein"	Q9GZT3	14	77708071-77761104	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1046.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020291	Approved		Supported	Mitochondria		No	No		38000	Mitochondria		"HPA020291: AB_1845563"	"unprognostic (9.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	31.9	36.0	65.2	25.0	55.1	33.6	49.9	24.3	54.7	29.2	49.8	30.6	23.2	37.2	23.7	65.1	38.1	24.4	26.5	63.6	47.5	50.5	57.5	69.8	19.1	24.3	53.7	40.6	26.1	49.3	19.3	34.8	30.0	44.9	25.2	46.7	27.8	36.9	30.6	105.7	20.5	42.1	31.9	46.3	26.3	32.0	31.7	34.4	16.5	27.4	72.9	34.6	27.9	23.5	35.2	52.2	20.9	59.6	18.3	33.0	40.5	41.5	82.6	33.9	33.0	22.4	22.5	45.7	23.6	22.3	46.9	41.0	111.7	38.1	30.2	24.9	26.8	29.7	41.1	61.8	48.1	62.3	16.5	69.4	30.5	78.1	111.0	34.3	20.2	22.0	24.1	31.7	37.6	41.9	23.3	38.5	39.3	29.8	17.3	40.8	134.5	30.9	55.3	52.6	89.7	116.8	28.4	28.4	33.7	48.1	79.3	43.4	28.4	25.0	53.2	34.0	38.8	55.7	35.9	22.4	24.0	43.1	25.9	41.1	18.7	34.0	56.5	32.9	39.7	30.7	17.4	59.6	20.9	23.8	56.5	25.0	35.2	31.7	23.3	50.8	31.2	33.0	27.3	19.1	18.3	56.9	52.2	31.7	40.5	65.2	55.1	24.3	54.7	47.5	50.5	53.7	40.6	44.9	34.4	101.3	132.2	131.6	134.2	158.9	62.3	1046.2	321.0	215.5	236.6	251.2	45.2	353.2	653.2	329.0	411.9	162.1	390.6	186.9	458.2	301.6	205.6	130.6	164.3	649.5	274.7	41.3	237.0	176.8	193.5	63.4	155.6	186.2	237.8	215.6	299.7	100.1	358.6	298.1	159.8	577.8	85.2	168.1	217.8	171.1	196.1	187.3	201.2	82.8	331.8	147.8
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;liver: 12.8"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 4.5;Hepatocytes: 2.4"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		No	NA		1400000	Mitochondria		"HPA017636: AB_1857232, HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.6	0.6	7.4	2.0	12.0	0.4	0.5	10.6	17.4	9.9	3.0	1.5	0.3	1.1	12.1	2.0	7.6	12.6	0.8	1.0	13.2	5.5	0.6	12.8	0.9	0.5	3.7	6.5	2.5	0.4	0.4	0.3	0.4	4.2	3.3	3.1	0.3	0.8	9.6	0.9	0.5	1.5	6.2	2.3	0.4	0.8	1.0	2.4	0.0	0.6	0.0	0.5	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	12.0	10.6	15.7	13.2	5.5	3.7	6.5	4.2	2.4	0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.1	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	1.4	2.6	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.3	2.9	5.0	2.1	3.1	5.1	3.5	5.9	4.9	5.3	1.1	5.7	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	1.6	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9	77.4	85.3	270.8	168.6	148.1	59.5	296.6	234.4	179.3	92.1	193.7	19.6	251.6	485.7	138.8	92.3	121.8	346.2	0.0	174.6	167.3	105.2	269.9	91.0	309.5	220.1	52.4	331.5	110.5	164.5	80.6	175.2	186.8	200.8	116.4	276.7	86.2	148.7	295.1	140.0	446.7	82.0	122.9	137.7	196.7	54.5	239.6	258.2	167.5	271.3	230.0
SMG9	"C19orf61, FLJ12886"	ENSG00000105771	"SMG9, nonsense mediated mRNA decay factor"	Q9H0W8	19	43727992-43754990	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 79.9;Late spermatids: 263.1;Syncytiotrophoblasts: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041763, HPA042096"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA041763: AB_2677659, HPA042096: AB_2677845"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.71e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.88e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (8.09e-4)"	10.0	14.6	18.1	16.9	24.5	12.4	14.9	25.0	24.8	13.2	12.0	21.6	11.5	13.4	11.6	13.8	11.2	10.9	11.7	9.4	16.5	15.6	10.2	8.5	11.9	19.3	36.0	14.2	10.2	8.1	14.9	14.2	16.6	23.1	14.7	11.0	9.2	14.0	12.7	9.1	12.3	11.7	13.9	20.4	17.1	14.2	40.9	29.6	13.2	10.8	4.1	19.3	11.1	12.0	9.2	8.0	3.6	12.2	4.6	8.3	10.7	12.5	13.9	10.2	6.5	7.1	10.2	6.8	18.0	10.8	20.1	15.2	9.7	16.7	13.8	8.8	12.3	6.9	5.5	11.8	10.0	13.2	10.5	6.7	24.7	9.9	6.4	8.3	18.6	13.6	5.4	8.6	14.6	15.7	17.0	8.1	12.8	18.5	12.3	9.3	8.9	19.7	5.2	4.9	24.2	9.4	10.5	8.4	6.1	10.7	10.3	17.0	8.4	18.7	14.3	10.6	8.5	8.6	10.3	9.8	31.6	18.5	11.6	13.7	6.0	12.8	16.5	9.5	14.3	25.6	1.0	6.1	3.6	6.3	9.0	5.6	9.2	6.4	5.3	8.0	6.7	8.3	5.7	1.5	4.6	12.2	7.0	4.6	10.7	18.1	24.5	25.0	24.8	16.5	15.6	36.0	14.2	23.1	29.6	29.8	8.8	13.4	13.4	8.2	12.2	3.6	5.1	8.1	3.4	8.7	3.9	39.8	1.7	10.4	79.9	8.0	8.1	0.0	7.6	12.2	8.3	12.6	9.2	2.6	18.5	12.7	4.1	9.2	8.2	263.1	12.0	10.7	10.1	21.6	8.3	5.6	10.0	5.8	11.3	5.7	9.1	6.5	4.7	16.3	15.8	6.1	79.8	10.0	9.0	8.8
SMIM12	"C1orf212, FLJ90372"	ENSG00000163866	"Small integral membrane protein 12"	Q96EX1	1	34712737-34859816	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065331	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA065331: AB_2685470"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (7.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.52e-2)"	26.6	28.8	16.4	19.0	21.9	16.0	21.0	14.2	27.1	12.2	22.6	14.2	12.4	22.6	14.8	15.5	22.4	13.9	15.7	25.5	15.6	21.7	31.7	61.5	17.1	21.4	19.0	18.7	13.3	25.5	10.9	15.3	19.3	19.8	11.3	21.8	15.4	17.3	16.8	32.2	15.7	23.1	23.9	13.8	19.2	17.0	13.7	13.1	20.3	18.1	20.1	20.1	15.7	16.8	25.7	38.5	54.4	35.1	25.5	36.6	35.3	21.7	16.7	18.8	13.6	24.6	19.4	13.0	23.7	20.7	30.7	26.6	16.8	27.8	22.9	21.4	24.3	24.2	22.0	23.8	31.8	23.6	27.8	16.7	40.7	26.8	20.0	22.9	44.3	24.1	29.4	31.2	33.2	27.0	11.1	31.2	20.0	28.9	31.3	27.0	15.8	21.4	22.9	30.3	17.1	21.8	18.3	18.4	29.8	27.1	22.9	18.0	14.2	22.0	20.8	33.3	24.7	14.1	12.6	29.3	21.1	21.6	32.2	27.8	17.6	24.2	23.2	19.8	26.5	13.8	36.4	34.7	54.4	31.1	35.1	36.6	25.4	29.2	33.9	38.5	25.7	24.4	31.4	22.8	25.5	28.0	27.6	32.5	35.3	16.4	21.9	14.2	27.1	15.6	21.7	19.0	18.7	19.8	13.1	23.8	12.5	54.1	17.0	60.7	14.8	28.3	56.0	26.8	17.0	21.0	9.8	43.4	72.9	68.9	51.5	46.6	46.3	70.0	73.0	49.7	30.1	24.0	23.1	74.6	73.0	19.1	20.9	44.2	34.6	23.8	13.8	47.4	37.1	111.8	21.6	21.4	68.8	33.2	21.9	69.5	14.5	12.9	67.9	35.2	22.7	66.0	48.5	47.4	34.9	38.3
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 211.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	23.0	8.1	9.5	24.0	11.2	5.8	19.4	10.5	4.9	12.1	10.6	9.9	6.2	10.0	4.8	4.4	12.2	12.2	3.1	8.4	4.9	6.6	24.6	9.4	23.2	19.9	17.0	11.1	13.1	12.5	5.2	10.2	7.4	6.6	11.0	11.0	12.4	15.0	8.1	10.0	10.3	15.6	16.1	12.7	17.3	7.1	9.1	19.7	6.7	10.1	10.3	13.0	20.5	6.8	19.8	5.6	7.0	9.4	9.7	6.7	22.0	31.6	21.3	17.5	19.0	21.9	36.8	20.9	9.2	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6	44.7	44.8	30.4	29.5	24.2	16.1	211.3	61.1	62.9	77.3	50.6	11.8	35.0	180.8	36.8	15.8	36.5	60.3	0.0	74.3	16.7	27.7	17.7	56.7	143.5	98.6	3.2	76.2	60.8	84.6	8.0	60.1	52.8	35.4	17.2	57.4	43.6	50.1	28.1	95.1	134.6	12.7	45.3	51.1	7.7	15.8	30.2	23.1	25.9	67.6	18.2
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 208.6;Proximal tubular cells: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.2	3.0	1.4	22.3	10.1	9.6	5.0	13.5	1.5	3.3	1.6	1.3	0.0	0.7	3.1	4.1	2.4	0.8	2.5	1.3	0.0	2.6	1.1	5.1	4.2	14.3	0.0	0.0	12.3	18.3	1.4	2.7	6.0	2.7	0.0	1.8	0.0	6.2	4.4	0.0	0.1	0.5	28.0	3.9	0.0	5.3	0.1	7.4	2.0	2.2	0.0	0.7	9.1	12.7	2.0	1.5	0.7	5.2	3.0	1.7	0.3	3.2	0.0	0.0	0.0	4.3	2.3	6.7	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2	3.0	16.2	2.2	20.4	47.7	2.8	3.6	22.9	5.3	3.4	5.2	3.9	117.9	48.0	19.1	0.1	5.8	208.6	0.0	22.5	35.4	27.9	13.5	9.3	67.1	54.3	3.2	46.8	24.5	86.5	1.1	14.4	9.9	33.7	1.0	51.3	11.4	17.1	87.7	13.4	122.4	5.9	12.9	8.3	0.9	3.9	66.5	96.2	4.3	33.0	12.8
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
SMYD5	"NN8-4AG, RAI15, RRG1, ZMYND23"	ENSG00000135632	"SMYD family member 5"	Q6GMV2	2	73214222-73227237	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015514, HPA049002"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA015514: AB_2669205, HPA049002: AB_2680595"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.66e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.58e-7)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.40e-1)"	13.9	16.5	16.9	14.9	23.6	11.2	20.1	18.3	24.5	14.5	11.3	18.5	16.0	8.3	16.2	23.0	17.0	22.7	9.4	19.1	16.4	18.2	15.9	19.0	10.6	18.3	15.3	15.0	33.4	27.1	22.6	13.9	15.2	15.7	13.4	13.2	17.1	13.4	16.4	16.4	15.0	10.3	16.8	13.1	14.7	9.7	15.7	14.5	9.4	16.4	13.2	17.2	12.4	17.6	6.8	3.2	0.0	4.1	4.2	12.0	4.3	11.7	22.8	13.6	13.0	10.0	14.8	23.2	11.3	11.5	22.0	13.6	29.1	12.1	21.0	10.6	19.0	26.5	12.1	21.0	24.4	20.0	12.7	14.8	20.3	9.2	31.8	13.5	19.9	8.4	12.4	15.8	20.1	24.2	9.8	13.3	16.9	21.4	10.2	13.9	16.5	18.6	13.1	21.2	24.8	18.2	12.5	25.6	17.3	14.4	17.1	8.8	13.2	10.3	15.4	13.0	13.0	12.6	7.1	9.1	15.2	23.9	18.4	18.5	11.2	8.3	18.7	17.1	17.2	12.1	0.0	1.3	0.0	5.5	3.8	12.0	6.5	7.6	7.3	3.2	6.8	7.7	8.3	0.0	4.2	4.1	3.0	3.1	4.3	16.9	23.6	18.3	24.5	16.4	18.2	15.3	15.0	15.7	14.5	3.0	6.4	5.1	3.6	4.5	8.5	6.9	2.5	0.0	5.7	5.2	3.9	7.7	1.7	8.2	0.5	4.3	0.9	0.0	7.6	8.1	3.3	2.3	6.9	4.7	5.2	4.8	0.0	2.5	1.6	2.5	2.6	2.0	5.0	5.4	4.0	3.5	5.0	0.0	2.8	6.8	5.6	6.5	3.1	6.5	10.8	3.0	4.0	2.5	5.0	3.0
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266316-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.2"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	2.9	5.0	26.7	3.0	22.5	1.6	1.8	14.4	36.2	3.5	3.5	3.1	5.9	3.1	4.5	3.9	3.6	4.7	4.8	4.7	26.8	15.3	2.1	0.9	2.6	3.1	12.8	17.5	2.4	6.1	6.2	5.8	1.7	17.1	5.5	2.2	3.1	9.9	19.2	6.1	1.9	3.1	8.1	3.8	2.1	5.1	2.7	4.4	0.1	4.5	0.1	2.0	3.6	1.6	0.1	0.4	0.0	0.0	0.0	3.5	1.2	2.2	6.6	0.1	6.7	8.0	4.4	0.0	4.0	5.3	4.5	2.1	0.2	0.7	0.4	2.4	4.9	11.2	1.2	1.0	5.7	0.8	1.4	1.8	4.2	1.1	0.1	4.2	0.0	6.9	2.8	2.8	4.5	0.9	4.5	5.7	4.5	0.8	0.2	4.1	0.0	0.4	0.2	2.4	0.0	5.6	0.0	1.4	0.1	6.0	3.2	0.4	2.0	3.9	0.2	5.8	0.7	0.3	0.1	9.7	7.3	5.4	6.4	1.1	0.6	1.2	0.0	3.9	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.1	0.8	0.9	0.1	0.1	3.5	3.2	0.0	0.0	0.0	0.4	0.4	1.2	26.7	22.5	14.4	36.2	26.8	15.3	12.8	17.5	17.1	4.4	0.0	0.0	0.0	0.1	0.1	19.5	4.3	5.1	0.0	0.0	3.5	5.9	0.0	0.0	0.4	8.3	0.6	0.0	0.0	0.5	0.0	0.8	0.9	0.0	0.0	0.2	28.6	8.1	1.8	0.0	3.2	1.4	0.0	0.0	0.0	0.9	2.9	1.7	0.0	3.9	1.3	19.9	6.5	1.0	0.6	0.1	0.1	0.0	0.0	1.3	0.0
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130875436-130916509	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	22.3	23.1	24.0	16.9	30.6	10.0	17.2	18.0	38.0	17.1	23.8	35.6	25.3	17.1	22.9	32.5	17.9	19.8	20.4	22.6	22.8	22.2	24.1	25.6	17.5	15.3	31.0	15.3	20.6	26.6	32.9	28.5	18.5	28.0	21.7	22.2	23.7	23.1	27.2	26.4	19.0	17.8	26.0	30.8	18.5	22.3	36.2	28.2	24.6	31.1	12.1	18.1	23.0	16.4	5.9	5.4	11.3	6.6	3.6	6.2	5.2	6.7	7.5	9.6	13.4	29.0	20.4	6.4	18.0	21.4	9.1	9.5	8.4	13.0	6.4	12.6	19.9	20.3	12.3	1.4	12.9	11.7	10.3	5.8	11.7	7.4	0.0	21.0	0.0	9.1	23.2	16.0	9.3	10.2	18.8	11.1	8.8	10.3	0.0	19.4	4.9	9.4	7.7	2.9	16.8	9.5	7.2	9.1	3.7	9.9	12.2	9.4	8.8	7.7	12.4	6.1	7.8	22.0	7.3	14.7	12.8	9.5	10.5	10.5	2.2	0.0	0.0	5.3	7.7	14.6	11.3	6.0	4.4	4.8	6.4	6.2	5.9	4.7	5.7	5.3	4.4	5.6	4.4	3.6	3.6	6.6	5.4	4.1	5.2	24.0	30.6	18.0	38.0	22.8	22.2	31.0	15.3	28.0	28.2	23.8	6.4	10.9	5.9	3.5	22.7	17.9	22.9	14.7	13.6	22.7	9.8	7.7	8.3	10.2	23.3	9.3	11.8	0.0	14.0	4.7	7.4	8.7	18.4	18.8	8.9	15.9	10.9	15.4	11.9	35.0	12.7	10.3	3.3	2.8	10.6	21.3	13.4	11.4	14.9	8.7	37.1	12.9	8.3	31.9	11.5	3.8	11.7	6.5	8.5	9.1
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	182.1	6.5	15.1	9.5	2.1	7.5	16.0	5.9	70.6	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.8	7.5	3.4	80.3	7.7	20.6	15.4	4.6	3.3	4.8	10.8	9.0	6.2	3.9	6.2	4.8	6.9	4.4	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	1.6	3.5	3.6	3.1	19.2	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	286.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in many"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	0.7	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	14.2	15.6	30.0	0.1	0.0	1.1	4.3	47.6	4.5	9.9	2.6	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	17.3	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0											184.6	59.8	33.5	82.0	99.9	88.8	228.6	341.4	161.9	235.4	146.5	11.8	61.5	56.3	757.4	3.9	238.0	78.0	0.0	523.0	358.6	243.9	126.1	56.8	5.8	33.0	46.1	327.2	70.6	85.2	8.3	11.2	56.1	231.2	80.2	156.9	228.7	1059.7	155.6	10.6	77.4	25.8	6.5	198.6	3.7	175.2	81.3	25.3	23.5	265.6	178.0
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.2;lymphoid tissue: 46.8"	"Group enriched"	"Detected in many"	4	"B-cells: 77.6;Erythroid cells: 23.3;T-cells: 44.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;HDLM-2: 30.1;Karpas-707: 15.0;RPMI-8226: 9.3"									"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.9	0.8	0.9	39.1	1.1	2.9	1.1	0.5	0.7	0.7	2.3	0.5	0.0	1.4	0.6	0.9	3.5	0.8	1.4	0.8	0.9	1.0	1.1	1.1	6.3	26.9	1.4	0.0	0.7	0.4	0.0	0.9	0.6	0.6	1.0	2.0	1.0	8.9	0.1	0.3	0.7	13.1	0.3	2.0	34.9	2.3	1.3	0.7	4.0	1.3	1.7	46.8	4.8	0.9	36.2	3.0	12.6	3.6	5.1	10.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	18.0	0.0	0.0	3.1	0.0	0.0	0.0	1.1	30.1	0.0	0.0	0.0	0.4	0.1	2.5	0.1	0.3	0.0	0.3	0.4	0.2	0.0	0.1	0.0	15.0	0.3	0.0	0.0	0.8	0.8	0.0	0.0	0.0	1.7	9.3	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.8	0.0	0.0	5.5	2.2	0.6	1.3	0.4	0.0	0.0	1.3	4.1	9.0	2.6	10.0	36.2	9.0	9.7	3.0	25.1	4.6	6.1	12.6	5.1	3.6	0.2	7.8	3.6	0.9	1.1	0.5	0.7	0.9	1.0	1.4	0.0	0.6	0.7	0.0	2.9	77.6	0.0	0.8	0.7	0.4	0.0	2.7	1.2	0.0	7.9	0.1	0.0	0.0	10.8	0.6	0.0	23.3	0.0	0.1	0.9	0.1	0.0	0.8	10.0	0.0	0.0	3.1	6.3	3.0	0.0	10.1	6.8	10.0	0.0	0.5	0.2	0.0	1.1	0.3	1.6	0.0	0.4	1.4	0.4	1.0	0.2	44.0	0.0	0.1
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334946-174338492	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 5.1;skin 1: 4.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.0;fHDF/TERT166: 6.8;HEK 293: 2.8;THP-1: 14.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 6.0;olfactory region: 14.4"	"Region enriched"	"Detected in many"	4	"olfactory region: 44.8"	HPA062616	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.7	0.3	4.6	0.3	12.4	0.3	1.1	0.0	6.1	0.6	0.3	0.4	0.0	0.3	0.4	0.3	0.3	5.1	0.3	0.3	2.3	2.2	0.3	0.3	0.3	0.4	1.1	4.3	0.3	0.3	0.3	0.0	1.1	1.0	0.3	0.3	0.0	0.4	0.3	0.6	4.5	0.3	0.3	0.5	0.3	0.3	2.0	1.4	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	6.8	0.0	0.1	0.2	0.0	0.0	0.0	2.8	0.6	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	12.4	0.0	6.1	2.3	2.2	1.1	4.3	1.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"epididymis: 55.8;fallopian tube: 29.1;testis: 53.8"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	2.7	6.0	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7.0	7.0	8.9	7.0	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3.0	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8.0	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3.0	2.9	3.8	6.0	3.0	5.6	3.3	7.8	3.5	1.6	1.9	2.1	3.2	2.7	4.6	5.9	3.9	1.2	2.3	1.7	1.9	0.5	6.1	0.5	2.9	5.7	3.7	2.8	1.3	3.6	1.6	2.3	2.6	0.5	1.5	0.7	6.7	1.4	0.2	6.7	7.7	4.3	4.8	7.3	2.0	32.5	0.5	1.7	4.7	4.2	4.9	5.6	0.7	3.7	2.0	2.3	0.7	1.4	7.1	0.7	0.9	3.2	5.3	0.9	4.2	2.5	7.0	0.5	1.9	3.8	2.6	3.6	0.5	0.7	1.1	1.7	7.0	0.5	1.8	5.6	2.2	3.6	2.2	2.0	2.5	6.0	2.4	1.3	3.0	4.7	2.9	2.6	3.1	7.8	3.3	1.0	3.5	1.6	7.8	8.4	4.3	9.3	7.0	8.9	7.2	7.3	6.9	5.1	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	116.4	9.1	22.7	0.0	14.2	28.2	6.2	0.0	0.0	0.0	0.0	6.2	10.9	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.4	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051331-52097292	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 41.7;testis: 65.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 536.7;Late spermatids: 1836.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	4.2	2.6	1.2	3.3	0.0	3.7	0.1	1.1	6.8	2.3	3.6	5.3	1.2	2.5	9.9	4.9	41.7	11.5	1.5	3.1	2.8	3.7	4.4	12.0	0.3	0.6	0.6	7.6	1.6	4.2	6.1	1.8	12.5	3.5	3.5	1.4	13.2	6.0	1.1	4.3	2.8	1.8	0.8	0.5	2.9	65.7	0.8	1.3	1.6	4.1	3.1	2.3	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	0.0	8.0	20.1	15.1	5.6	9.7	0.3	0.4	0.0	0.9	0.0	0.0	7.4	0.1	0.1	0.0	4.3	0.2	0.0	0.6	0.0	0.0	4.7	7.1	0.0	0.0	18.5	17.8	0.6	2.8	3.2	4.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	0.6	0.0	0.0	6.3	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.3	0.1	1.1	3.1	2.8	0.6	0.6	12.5	0.8	8.9	4.0	0.0	6.6	4.6	0.0	2.4	7.6	115.1	18.2	0.0	0.0	1.4	1.7	0.9	536.7	0.4	1.1	0.0	2.4	1.1	2.3	5.1	2.3	1.7	0.3	0.0	1.7	2.5	1.2	1836.3	10.0	1.2	0.0	0.0	1.6	0.0	1.2	2.9	10.3	5.4	0.0	0.0	1.8	11.7	6.8	6.6	0.7	0.0	3.8	6.4
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696343-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.8	5.3	6.3	5.4	10.3	8.8	3.7	6.8	14.1	4.1	6.9	1.6	4.9	12.3	4.7	7.2	3.9	4.6	7.7	2.8	7.2	4.9	7.5	11.4	6.3	3.6	3.4	7.6	5.4	17.0	5.1	12.9	6.5	2.8	4.2	2.2	4.9	6.1	3.4	1.8	5.0	10.7	3.3	2.0	5.6	7.7	4.6	2.6	6.7	5.6	0.7	5.4	4.0	2.2	5.8	5.9	16.5	7.8	2.4	7.3	4.7	5.3	4.2	1.5	7.0	1.2	1.2	8.2	3.7	1.7	1.7	1.1	8.0	4.5	1.8	5.0	1.2	2.3	9.3	1.3	2.0	0.3	1.7	15.1	1.2	1.5	10.8	3.9	1.0	3.7	1.2	2.6	2.8	0.8	2.0	1.9	2.1	5.5	1.3	1.2	24.2	3.1	5.7	4.3	5.4	5.7	6.8	0.7	5.2	2.5	1.9	8.3	5.4	3.9	4.0	4.5	0.7	10.3	4.1	4.8	1.7	6.4	0.3	1.7	3.2	1.9	1.6	5.3	3.0	3.2	3.3	4.9	6.0	7.3	7.8	5.1	4.8	5.2	5.3	5.3	5.8	4.6	4.9	16.5	2.4	5.8	5.9	3.9	4.7	6.3	10.3	6.8	14.1	7.2	4.9	3.4	7.6	2.8	2.6	3.0	0.3	1.4	16.6	14.0	6.6	0.4	5.1	0.0	0.0	10.4	0.0	7.5	1.7	11.7	4.4	4.9	29.5	0.0	11.8	4.1	5.7	10.1	4.6	5.0	6.8	3.2	22.8	5.5	7.5	1.0	2.6	7.2	8.5	3.6	6.8	5.1	10.5	17.3	2.1	8.4	7.4	0.0	9.2	1.0	2.5	17.3	20.8	5.0	6.2	11.6
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.6"	"Group enriched"	"Detected in many"	24	"Early spermatids: 817.6;Late spermatids: 902.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	6.3	7.2	7.8	2.8	10.3	2.2	7.1	18.0	12.5	6.1	4.5	6.5	4.5	2.9	7.7	8.5	3.7	9.6	6.5	5.3	8.1	7.4	10.5	5.9	5.0	3.0	6.4	9.7	13.6	6.9	9.2	15.0	3.6	13.3	5.8	4.1	5.5	4.6	5.9	4.7	6.6	2.8	6.4	5.8	3.7	4.3	55.6	5.9	3.3	13.5	3.9	2.0	5.7	4.4	3.7	4.4	1.7	3.0	0.9	5.6	2.2	2.1	3.3	4.9	6.8	8.1	15.4	5.0	3.7	8.4	4.7	3.1	0.9	4.1	1.5	2.3	5.0	3.5	2.1	2.3	3.5	4.4	2.5	1.6	0.1	1.6	1.1	12.1	3.4	0.3	7.3	5.9	1.9	3.6	15.4	8.6	4.2	1.1	2.4	4.3	2.5	1.5	3.1	0.6	2.6	4.2	3.5	5.1	0.8	7.5	1.3	2.9	4.5	4.7	6.4	3.8	5.1	5.5	3.7	4.4	2.9	3.8	4.8	2.0	2.4	1.2	0.5	5.8	1.0	2.4	0.0	2.2	0.6	4.8	3.0	5.6	3.7	4.0	2.2	4.4	0.9	2.2	4.2	1.7	0.9	1.8	4.3	1.4	2.2	7.8	10.3	18.0	12.5	8.1	7.4	6.4	9.7	13.3	5.9	11.9	5.3	0.8	8.2	2.2	10.8	10.9	5.1	36.1	10.3	3.5	19.6	2.1	8.3	7.6	817.6	5.2	1.1	0.0	6.3	3.2	6.4	3.4	1.1	3.4	5.0	14.3	15.6	6.2	8.6	902.3	19.0	3.3	8.5	4.6	4.4	10.6	5.8	4.8	15.9	19.9	19.4	6.5	5.0	18.2	13.5	1.8	0.9	3.8	4.6	2.7
SPATA9	"FLJ35906, NYD-SP16"	ENSG00000145757	"Spermatogenesis associated 9"	Q9BWV2	5	95652181-95698711	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.5"	"Group enriched"	"Detected in some"	15	"Early spermatids: 467.1;Late spermatids: 349.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA010848, HPA076967"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010848: AB_1857422, HPA076967: "	"unprognostic (4.46e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.49e-13)"	"unprognostic (3.39e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-2)"	0.9	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	2.7	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.3	0.8	2.8	0.0	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.6	0.6	0.5	1.6	0.0	0.6	0.0	0.9	0.6	1.1	1.7	0.0	2.1	0.0	0.7	2.3	0.8	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.4	0.5	0.0	4.0	0.0	0.7	0.2	0.5	0.4	0.0	0.2	0.0	0.0	0.4	1.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	467.1	0.0	0.0	0.0	0.0	27.7	0.4	0.2	0.0	0.0	1.1	1.6	0.0	0.0	0.3	349.3	3.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.2	0.0	0.2	0.0	0.5	3.6	2.9	0.1	3.5	0.0	0.0	0.1
SPSB3	"C16orf31, SSB-3"	ENSG00000162032	"SplA/ryanodine receptor domain and SOCS box containing 3"	Q6PJ21	16	1776712-1793700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 138.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046602	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046602: AB_2679717"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.25e-7)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.72e-4)"	8.5	19.4	7.8	8.2	8.3	12.8	9.5	25.3	11.3	10.5	10.4	10.1	11.0	10.0	7.6	9.5	14.1	9.0	17.7	9.1	6.7	5.7	8.2	138.5	8.3	7.8	11.1	8.8	15.9	19.5	7.5	5.6	7.6	8.4	9.3	4.2	10.6	14.0	12.9	29.4	18.1	8.3	9.4	6.9	8.3	8.6	5.8	8.3	16.3	10.5	6.5	8.9	8.5	9.3	18.0	15.9	32.6	16.8	15.6	34.5	17.0	3.4	5.3	6.5	7.6	9.1	8.9	10.6	4.3	7.0	7.6	8.3	3.8	11.7	1.7	8.6	3.9	2.7	7.0	3.2	6.6	1.2	6.1	7.8	3.4	7.6	5.0	12.6	1.3	6.0	7.8	17.3	4.9	5.7	11.6	11.5	12.0	3.9	9.2	3.7	12.6	8.8	8.6	4.4	6.8	2.6	14.8	2.5	14.1	6.7	0.7	8.5	8.4	5.5	17.2	15.8	4.9	8.5	8.1	8.1	3.5	5.3	6.2	2.9	13.6	15.7	4.4	2.8	4.9	4.0	32.3	16.8	29.7	26.1	15.2	32.6	18.0	24.4	24.1	15.4	16.8	17.6	18.4	32.6	15.6	13.3	15.9	34.5	17.0	7.8	8.3	25.3	11.3	6.7	5.7	11.1	8.8	8.4	8.3	35.7	28.0	37.1	47.6	87.3	69.1	0.2	22.9	26.8	21.6	52.4	37.3	52.7	44.7	43.7	41.0	35.3	65.2	23.3	41.4	63.9	36.6	44.8	33.6	50.8	28.6	85.8	46.8	45.4	33.5	65.6	71.4	44.0	72.6	62.3	50.2	76.4	42.2	71.9	70.4	41.0	84.0	38.8	49.2	18.6	35.8	112.0	53.9	76.1	48.8	50.3
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria		Yes	No			Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	12.1	8.0	6.1	6.7	6.3	8.0	10.5	18.1	13.4	12.5	13.1	10.1	27.1	12.1	4.6	18.3	6.4	15.0	16.3	10.1	19.0	5.3	4.8	34.4	6.2	6.0	5.4	3.5	11.4	5.2	5.0	8.1	9.1	7.1	17.5	8.4	6.7	5.9	7.1	10.5	9.1	11.9	4.0	19.2	7.2	9.9	6.3	4.1	14.4	27.3	5.9	7.5	6.5	21.8	6.8	11.3	26.8	6.4	11.0	11.5	8.2	4.2	4.1	3.3	5.5	8.2	7.6	12.4	6.5	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9	26.8	23.5	25.0	21.1	28.7	13.3	7.3	10.2	24.1	27.3	45.4	33.4	10.3	1.7	21.2	1.4	32.3	28.5	46.7	14.2	10.9	16.6	24.2	49.7	6.6	21.7	4.8	12.7	57.1	63.4	1.5	13.6	29.2	18.6	15.4	36.9	10.3	24.7	28.1	14.9	9.1	18.8	32.3	8.6	6.7	16.0	25.5	5.5	22.7	27.5	47.7
SQOR	"CGI-44, SQR, SQRDL"	ENSG00000137767	"Sulfide quinone oxidoreductase"	Q9Y6N5	15	45631148-45691294	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ductal cells: 93.9;Exocrine glandular cells: 153.6;Hofbauer cells: 133.1;monocytes: 269.7;Pancreatic endocrine cells: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 64.9;RPTEC TERT1: 41.1"									"HPA017079, HPA041589"	Enhanced		Supported	Mitochondria		NA	NA		30000	Mitochondria		"HPA017079: AB_1857467, HPA041589: AB_2677565"	"unprognostic (6.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.44e-2)"	"unprognostic (4.38e-1)"	23.6	8.6	4.4	33.5	5.7	12.0	16.7	1.6	3.8	11.9	54.7	3.0	12.1	14.2	11.7	11.4	38.7	8.4	15.2	12.2	2.8	2.3	16.9	34.2	27.1	22.4	6.8	2.3	8.7	27.7	7.4	7.5	7.0	4.8	18.0	48.5	11.2	21.5	15.2	66.9	14.3	31.5	21.5	4.9	21.4	19.7	4.6	3.1	11.7	19.0	36.6	30.3	24.6	20.7	11.0	27.8	62.3	43.5	10.0	29.2	29.2	7.7	13.9	0.0	0.8	28.7	34.5	0.0	8.4	28.5	5.1	7.8	0.5	12.2	7.2	8.2	6.4	16.1	7.0	0.4	64.9	3.1	24.4	0.2	0.6	3.1	9.7	8.3	3.9	1.1	10.1	19.2	11.9	27.3	13.4	14.1	6.4	0.0	8.9	5.5	6.1	2.4	9.2	0.0	31.7	8.3	0.3	1.4	9.7	41.1	11.4	0.2	0.2	2.1	5.6	2.7	0.1	12.0	12.6	15.7	2.1	0.5	30.2	1.8	11.3	11.8	0.4	20.7	21.3	2.2	18.4	43.5	16.2	16.3	32.9	22.8	11.0	21.6	18.3	27.8	9.5	11.3	12.2	62.3	10.0	29.0	8.1	29.2	29.2	4.4	5.7	1.6	3.8	2.8	2.3	6.8	2.3	4.8	3.1	29.8	54.4	0.0	0.0	0.0	0.0	0.0	0.0	44.2	27.3	14.0	0.0	0.6	10.0	93.9	0.0	0.0	0.0	0.0	153.6	0.6	0.0	0.0	10.5	0.0	133.1	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	269.7	0.0	0.0	118.9	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SRBD1	FLJ10379	ENSG00000068784	"S1 RNA binding domain 1"	Q8N5C6	2	45388680-45612165	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030567, HPA030568"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA030567: AB_10611244, HPA030568: AB_10601856"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.20e-3)"	"unprognostic (4.14e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.29e-1)"	11.7	9.8	5.5	12.2	7.5	6.8	10.9	6.3	6.8	13.8	10.4	6.3	15.7	6.7	19.3	14.9	8.0	8.6	7.4	9.4	5.5	5.8	11.6	13.2	8.7	11.0	6.4	4.7	11.2	14.9	25.1	20.9	11.5	8.7	12.7	9.9	8.4	16.6	14.5	9.5	8.4	10.7	8.3	7.3	13.9	9.9	12.2	8.0	16.5	12.5	6.1	11.3	9.7	9.4	6.1	7.0	14.3	13.0	9.2	7.7	4.9	13.7	7.1	14.7	9.8	5.4	12.0	11.6	10.6	9.3	10.2	9.4	5.9	5.9	11.9	7.9	7.5	7.6	6.5	14.4	13.4	18.9	16.2	8.0	15.8	5.7	12.7	6.4	13.1	9.3	7.2	5.6	12.0	14.1	4.5	12.2	4.4	11.2	9.0	15.0	12.4	17.5	10.0	16.7	8.9	7.8	12.1	21.1	10.8	11.6	9.0	12.9	10.5	9.3	10.1	10.3	8.0	6.2	4.8	11.3	14.3	11.4	6.8	9.1	9.6	3.5	7.2	8.0	13.0	10.2	3.4	7.2	14.3	6.6	7.9	5.8	6.1	4.9	7.7	7.0	5.3	6.9	6.2	2.6	9.2	13.0	6.7	5.0	4.9	5.5	7.5	6.3	6.8	5.5	5.8	6.4	4.7	8.7	8.0	17.9	4.8	7.3	3.2	3.2	7.6	8.5	12.7	9.4	13.6	3.5	3.9	7.0	8.3	6.5	2.8	8.7	5.4	0.0	8.0	5.9	6.6	2.8	8.1	11.0	8.7	12.7	6.9	6.7	9.9	1.5	6.9	9.2	6.8	10.0	8.2	14.7	4.6	6.8	6.0	8.5	13.5	12.9	3.4	24.1	26.4	3.3	4.7	9.6	4.7	1.3
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42595114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	12.7	11.6	24.5	17.8	26.4	29.9	20.8	25.2	23.8	14.0	14.8	14.4	9.1	19.4	9.1	20.6	16.6	10.6	11.8	10.8	23.5	20.6	15.8	26.2	11.9	34.8	20.5	15.9	13.5	29.0	10.9	16.1	10.7	17.4	22.2	15.5	11.3	18.6	10.8	10.1	14.9	19.3	8.4	24.0	19.7	15.6	6.4	14.9	20.4	18.7	14.7	32.0	16.0	11.1	48.0	30.0	32.8	25.9	31.0	53.5	32.9	16.1	7.4	14.9	13.5	19.2	15.6	9.3	10.5	12.0	15.7	17.8	14.2	14.8	22.1	9.6	7.2	16.5	9.1	17.8	14.7	17.3	11.0	20.8	24.0	14.5	23.8	13.8	31.3	18.9	12.2	9.5	12.6	11.9	10.9	17.1	19.7	21.7	33.4	12.6	15.3	22.0	38.9	23.6	21.8	18.2	11.7	10.9	30.7	17.4	20.4	8.4	12.0	8.9	14.0	14.1	16.8	18.3	29.3	10.0	9.2	15.1	22.1	19.1	24.3	38.4	37.5	13.6	34.4	8.8	19.0	23.5	32.8	38.4	25.9	51.6	48.0	50.5	45.3	24.9	40.8	43.9	44.1	31.1	31.0	19.2	30.0	53.5	32.9	24.5	26.4	25.2	23.8	23.5	20.6	20.5	15.9	17.4	14.9	11.9	11.8	77.1	64.6	95.1	14.4	16.1	38.2	14.7	15.9	26.2	7.9	47.4	48.0	38.3	2.3	39.4	43.1	23.3	43.1	65.4	37.6	63.9	45.0	58.7	58.5	22.3	52.9	28.3	37.6	2.5	31.9	41.0	49.0	61.3	42.2	24.6	41.3	53.7	14.9	68.9	23.5	12.9	39.1	13.2	24.0	120.8	31.2	95.9	48.0	96.2
SSBP1	"mtSSB, SSBP"	ENSG00000106028	"Single stranded DNA binding protein 1"	Q04837	7	141738321-141787922	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002866	Supported		Supported	Mitochondria		NA	NA		250000	Mitochondria		"HPA002866: AB_1080092"	"unprognostic (2.95e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (3.68e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.23e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.58e-2)"	41.1	52.5	45.4	40.9	52.6	41.7	51.6	26.8	44.3	41.7	42.4	33.9	38.7	36.9	45.2	58.9	61.0	37.1	36.8	57.8	38.6	38.6	55.2	83.4	31.0	56.0	42.7	41.0	45.2	49.6	40.7	44.4	47.2	44.4	38.8	44.8	34.1	41.2	39.0	62.9	42.4	40.8	45.5	36.7	50.7	44.6	38.3	33.3	62.9	45.6	67.4	54.7	42.8	38.6	42.6	41.2	31.3	35.9	36.3	48.7	40.8	39.6	46.0	41.1	51.7	18.3	29.8	37.8	28.6	27.6	36.6	41.2	48.5	45.5	62.0	40.6	24.0	60.0	29.9	47.6	50.0	52.1	29.8	49.7	30.4	34.6	42.8	36.2	89.1	24.2	28.0	34.1	38.3	54.0	26.0	44.6	39.0	76.6	26.3	50.0	58.2	63.1	116.4	90.6	64.7	57.6	36.6	37.4	80.7	47.9	39.1	37.0	50.9	33.5	44.5	44.4	32.2	30.1	39.3	32.1	26.1	25.2	40.2	75.9	47.4	62.7	111.0	53.5	80.3	56.9	31.3	29.1	26.6	30.1	35.5	44.0	42.6	48.7	40.2	36.8	37.0	45.1	48.1	7.5	36.3	35.9	41.2	46.4	40.8	45.4	52.6	26.8	44.3	38.6	38.6	42.7	41.0	44.4	33.3	95.3	94.9	115.3	144.9	103.0	51.8	257.7	158.0	105.7	114.9	143.1	39.3	266.1	296.8	270.0	118.1	112.7	85.6	46.7	306.8	254.8	138.8	122.4	145.8	187.5	221.5	41.3	92.5	95.8	119.0	35.7	127.1	153.1	99.5	206.4	126.8	92.4	270.9	108.7	116.3	344.0	71.9	97.0	135.8	228.3	170.8	113.2	218.9	139.5	153.1	201.9
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208825	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	17.3	26.6	30.3	20.6	27.1	11.5	32.1	26.5	28.7	14.4	22.6	24.4	15.2	21.6	13.9	12.8	17.0	18.0	13.5	66.7	26.1	24.5	32.5	29.1	24.0	30.1	34.1	17.1	12.4	24.6	28.2	11.7	11.4	23.6	16.1	22.8	17.3	24.2	19.7	74.4	14.4	22.2	15.0	24.1	21.7	17.4	8.1	29.9	26.3	22.7	24.1	32.9	16.4	15.2	26.4	25.0	14.5	18.6	18.1	24.1	13.7	32.3	20.1	26.3	27.2	35.5	17.8	39.8	31.9	27.3	31.4	33.9	47.2	29.9	57.7	35.3	24.7	24.9	26.3	46.6	26.9	41.1	39.1	35.8	50.9	19.8	54.4	16.3	39.0	28.6	17.2	19.9	26.0	25.8	20.0	31.3	23.9	52.6	22.9	27.8	28.1	44.1	39.6	44.8	27.4	30.1	43.7	40.5	57.3	18.9	41.0	50.7	24.2	16.1	51.8	28.5	34.2	15.4	42.9	26.1	26.1	27.1	29.1	31.8	30.6	28.4	51.8	24.1	44.0	28.8	14.5	14.9	13.9	16.4	18.6	16.9	26.4	14.1	17.1	22.7	21.5	16.2	15.0	1.7	18.1	11.8	25.0	24.1	13.7	30.3	27.1	26.5	28.7	26.1	24.5	34.1	17.1	23.6	29.9	125.0	43.6	35.0	37.3	56.6	26.0	163.8	63.7	30.8	52.4	43.6	102.1	30.8	63.0	27.4	2.1	47.5	46.7	0.0	32.7	31.1	29.1	59.0	15.1	103.7	60.0	38.1	42.7	37.4	105.5	5.2	21.6	53.5	40.5	98.2	56.1	31.6	31.3	10.5	23.7	53.6	55.8	25.8	48.4	12.4	39.7	50.2	29.6	41.5	67.9	31.4
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"	"Low cell line specificity"	"Detected in all"											HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	15.2	7.1	17.3	16.1	20.6	29.3	10.5	16.9	16.5	14.1	14.7	4.4	16.9	13.9	15.1	25.5	13.7	6.3	16.6	21.3	19.2	17.4	13.7	21.9	8.2	10.7	20.3	22.2	14.2	18.0	24.4	16.8	15.7	21.3	11.6	18.2	23.5	12.6	30.9	18.9	31.6	25.6	34.0	21.2	18.2	16.0	18.5	23.0	39.2	8.0	21.9	21.1	22.5	15.7	15.7	17.5	6.3	24.6	18.9	13.8	11.2	24.4	23.5	14.6	21.0	27.0	42.5	23.2	24.9	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0	38.7	43.1	0.0	0.0	0.0	0.0	0.0	0.0	62.9	51.2	92.5	0.0	209.3	167.5	157.0	0.0	0.0	0.0	0.0	84.6	217.6	0.0	0.0	52.3	0.0	164.1	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	256.1	0.0	0.0	115.5	0.0	0.0	171.0	0.0	0.0	0.0	0.0	0.0	0.0	230.3	0.0	0.0	0.0
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 204.8;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	15.7	18.3	23.3	13.9	26.7	20.1	14.0	24.2	27.1	25.2	17.1	32.5	18.0	22.2	18.5	23.6	15.1	22.0	30.7	23.0	31.9	21.2	26.3	24.9	17.4	21.0	18.6	25.1	14.6	19.0	27.1	17.1	20.3	21.0	18.5	25.7	16.8	8.0	25.0	10.9	25.9	28.8	24.1	54.9	23.4	22.1	21.3	17.2	36.4	15.3	12.9	15.4	20.1	18.7	14.2	26.8	16.5	22.4	14.1	14.0	9.0	19.9	16.7	8.4	13.0	25.8	8.7	18.4	20.5	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4	23.8	12.6	14.3	29.8	28.7	43.5	135.6	17.8	20.1	17.0	29.6	11.8	41.8	139.3	28.6	204.8	21.5	31.6	0.0	15.6	35.7	34.0	31.8	33.4	11.5	26.3	42.9	18.5	18.4	16.2	235.9	34.2	23.7	40.5	27.9	17.8	38.6	17.5	36.8	43.5	98.7	33.0	38.8	40.8	31.2	27.2	27.7	43.6	13.1	28.8	31.9
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 792.5;Proximal tubular cells: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		330000	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	20.8	23.0	18.2	22.1	34.2	23.1	31.5	23.8	20.4	30.7	22.5	52.6	17.3	28.8	16.5	28.5	24.7	30.5	37.4	28.1	36.5	27.7	34.0	25.0	19.8	29.9	29.0	25.4	20.4	27.4	23.0	25.9	35.3	18.8	27.3	23.6	25.3	23.7	27.9	31.9	36.0	23.2	9.5	78.5	41.2	22.9	42.2	31.5	41.2	25.4	22.1	12.3	19.0	39.5	37.9	17.8	24.1	20.0	22.1	24.1	23.4	29.5	29.2	20.8	29.5	24.8	28.2	35.3	21.2	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0	59.6	67.8	89.4	89.8	31.5	32.1	379.6	132.5	91.0	108.1	134.3	21.6	202.1	792.5	102.4	24.5	56.3	282.3	23.3	99.5	100.2	83.9	68.7	90.0	177.6	116.1	42.9	102.0	59.5	64.6	28.6	50.6	82.9	113.1	78.5	140.8	56.0	65.8	217.5	69.6	1327.5	31.0	51.8	72.6	79.7	46.4	36.1	157.6	70.5	304.8	88.9
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 290.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		290000	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	12.8	11.2	11.1	13.5	18.7	32.4	13.5	15.4	22.5	18.1	20.3	12.3	28.7	16.4	5.0	21.6	11.9	6.6	8.6	21.2	23.5	6.9	5.9	14.8	10.1	19.2	24.1	19.5	10.4	24.2	18.5	14.2	32.6	22.5	19.2	12.6	11.3	15.0	39.4	9.0	7.3	6.2	10.4	58.8	6.9	5.1	17.2	24.5	30.7	19.9	2.2	7.5	24.4	28.2	20.3	7.8	21.7	12.5	16.7	18.0	11.9	19.7	18.2	10.3	15.0	11.5	26.5	15.3	21.1	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1	32.8	40.3	57.4	34.0	33.0	2.6	146.2	84.1	61.6	42.1	76.8	7.9	46.8	207.2	71.1	2.4	35.8	224.3	46.7	70.7	37.8	47.4	43.6	29.0	290.2	50.0	4.8	55.9	44.8	60.1	4.1	38.3	46.7	40.5	32.5	187.4	22.3	55.1	140.3	44.6	211.1	3.8	32.3	67.3	1.4	6.8	43.2	31.8	55.8	241.0	45.3
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180232-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	12.8	17.0	11.1	12.6	17.3	26.1	17.7	21.9	19.9	10.8	14.4	12.6	7.8	11.2	13.5	12.4	13.2	11.9	12.6	19.2	12.0	11.3	16.4	22.2	9.6	15.2	9.9	13.1	15.8	18.2	15.4	14.7	10.9	16.1	11.4	16.7	12.4	11.8	13.9	31.1	15.6	12.5	13.9	9.9	15.5	13.0	26.6	9.9	12.7	14.1	13.4	14.8	12.4	11.6	10.1	7.3	5.6	7.7	7.4	13.7	6.2	11.5	8.1	7.3	22.3	8.2	7.0	9.6	7.2	11.2	14.6	13.8	20.8	9.8	20.8	5.9	7.2	10.4	13.3	17.4	11.2	14.1	8.7	13.7	9.1	6.4	10.9	20.7	21.6	6.9	8.8	14.2	13.4	30.8	10.0	8.4	13.3	23.7	10.9	8.0	7.5	13.1	13.4	8.7	11.0	44.4	12.1	10.3	9.1	6.6	5.6	10.4	7.9	9.9	20.8	18.9	8.4	6.4	9.5	5.2	5.8	10.5	8.8	13.9	8.6	10.0	19.5	9.6	22.9	3.6	5.6	5.2	4.3	12.3	7.7	13.7	10.1	8.9	10.5	7.3	8.3	9.9	10.6	0.9	7.4	5.2	4.0	8.7	6.2	11.1	17.3	21.9	19.9	12.0	11.3	9.9	13.1	16.1	9.9	6.0	9.0	10.0	9.6	21.2	21.5	19.6	10.2	14.7	13.6	7.0	3.9	15.0	10.0	10.0	8.2	8.5	7.8	0.0	7.4	9.9	9.7	6.9	7.0	10.9	8.7	11.1	8.6	6.7	3.1	3.4	6.4	5.6	5.0	5.4	8.6	10.8	8.0	9.0	8.5	12.2	11.3	6.5	13.4	28.6	24.5	19.4	18.8	15.8	11.8	9.5
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 302.5;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	3.0	2.9	4.7	3.4	7.4	4.9	5.2	20.0	8.6	3.1	3.8	1.6	2.1	3.2	3.8	2.3	4.0	3.0	3.2	2.4	5.4	2.8	3.5	3.8	2.7	3.6	3.3	4.4	4.2	2.4	2.4	6.3	5.1	3.3	3.9	4.7	1.6	2.4	3.6	2.4	3.3	2.9	3.7	3.0	3.4	2.7	41.8	4.4	10.3	2.8	4.9	4.0	3.3	2.8	0.8	3.1	0.5	1.8	5.6	4.0	0.8	13.7	13.1	22.0	12.5	4.1	5.0	8.6	7.5	4.6	14.0	19.9	19.6	7.9	11.1	6.8	4.5	12.3	9.7	16.3	9.1	17.3	11.3	10.8	16.7	9.3	12.1	2.4	7.5	8.0	2.4	3.2	14.2	4.4	3.1	9.6	18.9	21.5	7.5	10.3	13.5	14.8	2.1	13.6	12.6	3.5	18.4	14.5	8.9	5.9	6.6	7.3	8.1	11.7	7.3	6.3	13.5	12.9	6.5	5.6	10.1	16.3	12.3	11.9	4.3	16.1	25.5	6.2	8.2	6.5	0.5	0.4	0.3	2.8	1.8	4.0	0.8	2.4	3.5	2.2	0.6	3.8	3.6	0.3	5.6	0.5	3.1	3.7	0.8	4.7	7.4	20.0	8.6	5.4	2.8	3.3	4.4	3.3	4.4	0.0	1.0	0.0	7.0	7.3	7.4	2.4	0.0	4.0	7.9	1.8	9.8	11.4	5.0	3.5	302.5	5.2	0.9	0.0	1.8	20.4	5.5	6.6	2.3	2.9	4.3	11.1	3.4	1.8	1.8	78.4	4.4	2.4	1.7	1.0	2.8	2.4	2.2	1.1	2.5	5.0	9.8	6.5	6.6	37.0	52.7	7.8	7.4	1.8	3.9	10.9
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366496-70417061	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	12.0	13.8	10.8	8.2	13.0	1.7	11.2	15.8	13.7	11.8	20.1	14.1	14.1	21.0	12.5	10.4	16.3	9.5	11.7	15.7	10.5	8.9	32.0	25.9	10.4	6.8	11.0	6.4	10.3	11.0	28.9	22.2	12.0	13.4	15.3	16.7	11.6	13.2	15.0	27.4	6.7	32.2	15.2	12.4	11.3	16.8	16.9	9.9	7.0	16.9	14.4	7.9	15.4	9.1	4.6	5.1	0.6	5.3	3.8	7.4	1.9	9.7	6.3	11.1	7.4	8.6	10.0	7.8	7.5	7.9	5.4	6.1	6.1	9.2	0.0	7.3	8.7	5.4	8.4	11.1	8.2	12.8	1.3	5.6	3.6	9.7	7.9	7.6	0.0	1.2	7.7	6.8	6.7	3.8	9.6	11.7	4.2	2.1	2.0	9.6	7.0	5.0	1.5	8.1	9.8	7.7	6.3	16.1	2.7	11.7	14.8	8.1	14.2	10.4	8.7	6.1	7.5	16.3	2.5	12.8	12.9	9.0	4.9	6.1	2.7	10.3	0.0	11.4	1.2	10.6	0.6	5.3	0.1	4.3	5.1	4.9	4.6	5.2	5.0	5.1	3.9	7.4	5.9	0.6	3.8	3.3	3.2	3.9	1.9	10.8	13.0	15.8	13.7	10.5	8.9	11.0	6.4	13.4	9.9	35.7	36.9	17.6	23.9	5.4	40.6	75.0	53.5	22.7	35.2	71.5	76.6	33.0	119.3	39.0	15.9	38.3	52.7	0.0	34.4	27.1	19.9	26.7	9.2	42.3	21.8	28.6	19.0	31.3	22.7	5.4	28.1	19.1	13.5	30.7	45.5	35.5	32.5	35.1	38.9	59.1	83.2	25.8	20.2	26.1	10.2	4.3	9.2	29.8	56.5	28.8
SYNJ2BP-COX16		ENSG00000258644	"SYNJ2BP-COX16 readthrough"		14	70326064-70417074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Club cells: 1.2;Distal tubular cells: 1.7;Early spermatids: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA000866, HPA062659"	Approved	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA000866: AB_2276678, HPA062659: AB_2684823"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.41e-2)"	"unprognostic (6.73e-4)"	"unprognostic (6.68e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	5.5	7.1	3.8	4.7	5.7	7.7	5.7	7.1	7.4	5.1	9.3	6.2	6.2	8.2	4.3	4.3	7.4	2.1	5.4	7.0	3.9		15.4	12.3	4.1	4.9	3.4	2.3	4.7	14.0	0.9	10.4	5.2	5.9	6.9	3.6	5.0	3.4	6.7	30.7	2.5	15.5	6.8	3.6	5.4	7.3	16.3	4.1	2.6	7.7	6.4	3.1	6.9	1.6	16.2	18.2	11.1	13.4	18.3	15.8	13.5	18.5	3.4	15.1	10.0	2.4	1.9	10.4	13.4	4.8	6.0	4.1	1.4	19.3	2.2	8.7	3.3	9.0	9.8	1.8	1.8	7.1	0.4	2.0	6.1	6.1	2.5	3.2	3.6	9.8	3.2	1.6	4.5	2.5	9.5	3.5	15.4	2.3	10.4	2.4	3.2	19.9	7.1	15.2	12.4	2.7	14.0	10.0	2.7	3.7	9.8	9.7	7.8	8.0	20.4	14.0	9.8	21.1	13.9	7.7	13.3	33.7	12.4	5.7	13.4	7.2	12.0	15.3	4.0	14.8	11.1	12.1	0.9	11.8	13.4	12.9	16.2	15.6	12.4	14.8	15.7	13.8	14.4	0.4	18.3	8.9	18.2	15.8	13.5											0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.3	1.7	0.2	1.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.4	0.7	0.2	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.3	0.0
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600872-63608365	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 76.5;Proximal tubular cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	8.3	11.3	8.7	6.3	11.1	4.9	6.9	6.4	14.2	5.9	12.1	7.6	6.2	13.0	7.6	7.2	7.5	6.7	10.1	21.2	7.6	8.6	20.7	42.5	7.0	7.3	9.3	7.2	6.0	10.7	8.3	5.7	7.5	9.3	6.4	11.4	8.1	11.4	6.9	37.5	6.1	15.7	6.9	6.5	7.3	8.0	8.1	6.2	8.7	8.7	15.9	8.1	6.3	5.1	8.9	9.9	7.9	8.1	16.6	13.6	7.9	17.3	27.4	8.8	9.1	7.7	11.1	11.8	12.7	12.1	25.7	20.5	18.0	10.4	14.3	9.8	14.6	17.9	16.0	19.3	18.6	24.3	7.6	26.9	14.1	14.0	31.4	21.3	16.6	9.9	13.5	13.0	22.2	23.6	9.6	13.3	11.0	19.1	10.9	12.0	31.3	19.3	12.6	7.6	18.8	28.5	12.2	21.7	17.9	15.0	12.2	13.5	14.8	8.7	29.0	24.2	12.1	24.1	13.0	11.7	18.4	13.9	12.5	22.4	11.9	11.6	17.0	14.0	11.4	13.3	2.1	8.1	7.9	9.5	7.5	10.6	7.1	13.6	9.5	9.9	8.9	12.8	10.3	1.4	16.6	6.6	6.4	9.0	7.9	8.7	11.1	6.4	14.2	7.6	8.6	9.3	7.2	9.3	6.2	3.0	4.6	12.3	7.4	2.3	7.5	50.4	10.2	6.7	5.7	14.0	2.0	28.9	46.4	24.0	12.5	12.8	41.2	0.0	23.8	23.1	9.4	8.0	9.2	76.5	23.2	6.4	13.3	10.4	10.3	37.7	10.9	8.5	10.1	29.7	21.7	13.2	23.6	24.1	10.6	101.0	10.4	19.4	9.0	23.2	15.5	3.8	16.6	11.5	31.0	5.7
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199321-117204782	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 2168.1;Sertoli cells: 2819.8;Smooth muscle cells: 4737.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 19.0;non-classical monocyte: 26.6"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ: 136.7;BJ hTERT+ SV40 Large T+: 130.0;CACO-2: 122.7;EFO-21: 163.1;fHDF/TERT166: 139.3;hTERT-RPE1: 106.3;LHCN-M2: 96.2;U-138 MG: 126.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 176.0"	"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		8000000	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	73.3	22.6	2.3	67.6	5.9	0.2	60.8	2.1	7.7	278.3	328.7	6.1	156.2	22.3	399.7	156.8	337.9	133.3	227.5	48.7	3.1	3.0	49.5	12.9	44.1	38.6	7.1	11.8	159.2	9.3	1.5	8.0	36.2	14.9	237.5	51.6	39.1	24.1	347.5	36.6	17.9	81.0	481.9	9.1	26.0	114.7	65.1	2.1	1.1	47.3	30.0	11.2	473.0	78.1	2.6	1.4	0.8	26.6	0.0	0.3	0.9	1.2	0.3	21.4	0.5	10.0	9.0	18.0	136.7	59.3	130.0	48.7	122.7	1.9	0.2	163.1	139.3	0.1	3.2	0.3	1.1	37.0	0.4	0.2	0.3	4.6	8.3	55.9	0.1	0.3	23.7	4.6	19.0	2.4	106.3	0.2	0.2	0.2	0.4	96.2	0.2	0.1	1.0	6.5	1.1	0.1	0.1	1.6	0.6	0.2	1.7	0.1	0.5	2.1	0.7	0.1	53.6	0.6	0.3	14.6	126.7	21.3	0.9	5.8	0.6	0.4	1.0	0.7	0.4	0.3	0.8	1.1	0.0	0.1	19.0	0.2	1.6	0.0	0.0	1.4	2.6	0.1	0.0	0.1	0.0	26.6	0.7	0.3	0.9	2.3	5.9	2.1	7.7	3.1	3.0	7.1	11.8	14.9	2.1	35.7	6.7	4.5	353.2	56.7	9.9	1.2	5.1	13.4	5.7	38.4	17.7	30.6	0.0	230.9	2.4	73.9	6.2	0.0	68.1	27.0	232.5	54.7	1.1	9.3	37.9	1.6	2.9	944.1	20.6	8.9	44.8	43.3	91.1	9.0	9.0	3.3	40.6	3.5	2168.1	1.3	10.5	2819.8	4737.3	6.1	4.4	53.2	26.9	10.0	2.6	40.6
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	"TAO kinase 3"	Q9H2K8	12	118149801-118372945	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 324.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017160	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA017160: AB_1851994"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	14.6	16.2	31.9	24.1	31.0	30.8	14.6	44.3	33.5	11.6	21.2	17.2	10.3	23.1	15.2	11.4	16.0	9.8	16.9	15.1	27.8	31.7	14.0	15.3	19.4	26.3	25.7	20.8	17.5	10.9	20.2	23.6	11.9	20.7	25.6	21.3	12.0	13.6	14.6	18.5	17.0	31.6	15.3	23.7	24.2	20.9	8.9	28.6	28.3	18.1	9.9	26.9	18.5	18.3	20.9	22.4	38.2	37.8	36.4	27.8	17.1	8.3	5.8	4.3	3.8	10.7	13.1	4.9	8.8	10.0	5.1	6.7	2.9	13.0	25.6	2.9	11.7	7.4	7.6	3.7	7.8	8.0	9.2	3.2	30.2	2.9	3.8	12.5	30.9	42.6	8.8	9.4	16.1	23.7	10.8	16.3	15.3	17.5	3.0	9.3	5.9	16.3	20.3	1.7	3.9	3.1	9.5	5.9	2.7	4.8	14.5	0.8	4.3	8.1	3.7	11.2	2.0	7.6	23.2	25.3	8.8	1.5	8.2	7.5	2.9	2.8	20.3	12.5	21.4	11.8	38.2	17.0	37.6	27.8	23.3	26.2	20.9	21.2	24.1	22.4	19.3	18.8	24.5	37.7	36.4	37.8	20.9	19.3	17.1	31.9	31.0	44.3	33.5	27.8	31.7	25.7	20.8	20.7	28.6	32.8	78.2	81.8	42.2	31.3	72.1	47.4	63.7	6.7	30.7	43.6	200.3	29.7	59.7	35.4	11.4	29.2	94.6	23.3	52.0	83.1	34.9	47.7	159.8	52.0	71.7	38.1	24.1	26.4	84.7	8.2	35.9	117.0	33.7	141.5	60.6	40.4	64.9	98.2	44.9	27.2	324.3	45.3	40.5	20.5	22.8	27.5	36.6	86.3	58.2	47.4
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	37.4	27.4	20.2	14.3	22.5	35.2	26.4	19.6	23.7	21.8	20.2	17.0	19.8	15.1	22.9	15.4	20.2	15.1	20.4	15.4	16.9	16.4	22.3	32.9	24.5	19.0	28.9	18.7	22.7	26.3	19.1	38.0	25.4	23.8	18.0	14.8	12.0	20.6	14.4	44.0	19.2	20.8	19.5	26.3	21.4	17.8	19.4	27.5	22.2	25.9	14.5	18.6	27.5	16.3	5.9	6.3	13.9	8.8	7.2	13.5	6.7	13.9	13.9	11.7	12.0	23.5	23.5	17.8	15.1	34.2	18.8	23.8	9.8	11.8	17.7	10.1	13.8	14.4	8.8	14.4	10.5	20.6	15.6	12.2	16.8	13.4	9.9	19.8	21.4	12.3	22.8	13.3	14.4	27.3	26.8	15.6	16.5	16.2	9.9	16.0	10.3	14.2	13.3	24.3	13.4	12.0	11.3	13.4	19.7	14.1	13.5	12.9	11.1	19.9	17.6	16.8	17.5	18.0	15.6	15.7	16.2	7.3	18.4	8.9	25.6	23.5	22.7	9.7	14.1	14.6	2.0	6.8	8.6	8.1	7.0	9.3	5.7	10.1	7.9	6.3	5.9	12.9	11.1	13.9	7.2	8.8	3.8	13.5	6.7	20.2	22.5	19.6	23.7	16.9	16.4	28.9	18.7	23.8	27.5	44.7	61.3	35.0	26.8	52.1	32.3	22.6	17.8	62.9	40.9	17.4	9.8	16.5	11.6	22.6	88.2	47.2	16.6	0.0	22.2	13.1	33.3	37.8	31.4	33.4	20.8	49.3	13.2	81.0	48.0	11.5	32.2	32.3	30.4	19.8	19.1	26.9	22.6	11.5	30.8	28.6	24.5	19.4	30.7	44.0	22.1	59.8	32.0	28.8	14.5	29.8
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.4"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	3.2	7.3	7.3	5.5	8.8	2.4	5.0	3.9	11.1	5.7	3.5	4.8	3.8	4.5	5.1	4.1	4.1	4.8	5.6	3.5	7.0	4.1	4.5	1.8	3.2	3.0	8.1	7.8	6.5	4.0	9.7	25.4	8.2	8.0	5.0	2.4	4.2	4.6	3.2	1.7	5.5	4.6	2.4	7.0	3.1	3.8	9.2	7.9	8.1	7.0	2.1	3.2	3.7	5.1	6.4	10.7	5.8	1.3	3.4	3.7	0.4	1.6	2.0	3.2	4.2	2.9	4.4	1.6	1.8	2.7	3.1	4.6	0.1	1.1	2.9	3.1	2.0	4.7	1.5	1.5	1.6	3.8	22.0	2.1	3.7	0.6	0.7	1.3	1.8	1.5	1.7	1.1	2.9	2.0	3.7	0.6	3.7	2.1	0.0	2.4	1.0	2.1	1.1	1.9	1.0	0.7	1.8	1.6	0.3	1.7	0.8	6.6	3.3	2.3	1.3	1.0	1.8	2.0	1.5	0.4	2.1	2.1	0.5	2.1	1.5	0.0	1.3	2.8	1.0	3.2	5.8	1.3	1.7	2.6	0.7	1.9	3.4	1.9	1.8	0.8	6.4	3.7	2.8	1.1	3.4	1.1	10.7	2.1	0.4	7.3	8.8	3.9	11.1	7.0	4.1	8.1	7.8	8.0	7.9	3.0	5.9	1.5	3.2	5.5	27.8	2.9	5.1	24.1	13.6	7.0	41.2	3.8	0.0	2.2	3.4	3.2	4.2	0.0	1.9	1.3	6.1	2.8	3.5	1.0	1.2	12.7	5.2	3.7	1.3	2.1	2.3	3.3	1.7	1.0	5.2	5.8	0.9	3.5	1.8	1.0	111.1	0.0	3.1	12.6	7.9	4.4	1.9	3.2	2.8	1.8
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	13.7	16.8	10.8	16.0	15.6	14.9	13.0	12.9	22.1	10.5	20.8	15.6	14.1	21.8	14.2	8.2	20.1	12.8	12.4	26.2	9.8	10.0	20.9	27.7	10.5	17.0	10.6	8.9	15.6	16.9	11.3	10.1	16.2	14.7	13.6	14.1	10.8	14.2	12.4	42.6	16.9	17.8	13.9	9.9	16.2	14.0	22.5	9.5	15.0	13.8	23.7	20.3	14.5	13.3	15.8	20.1	10.9	24.2	9.7	21.0	17.5	13.0	30.4	9.7	21.3	8.8	8.2	19.6	10.6	9.8	20.6	17.1	32.9	18.4	25.0	16.4	10.8	28.5	34.2	22.6	24.2	10.5	12.9	21.1	17.1	19.9	22.4	14.7	19.5	17.7	10.8	22.5	19.6	14.1	7.3	12.6	21.5	47.4	12.6	12.6	22.0	19.8	44.7	30.8	29.3	24.3	17.6	12.5	36.4	12.1	13.4	19.3	18.3	10.8	60.2	20.9	13.2	26.8	32.5	9.8	15.3	18.5	9.3	17.2	22.7	22.6	36.5	14.1	28.1	34.4	7.4	13.3	10.9	18.4	24.2	17.6	15.8	15.4	17.8	20.1	12.3	21.0	19.9	1.0	9.7	20.4	7.5	14.6	17.5	10.8	15.6	12.9	22.1	9.8	10.0	10.6	8.9	14.7	9.5	3.0	18.9	26.9	23.8	31.1	14.5	24.1	15.3	5.3	9.1	19.2	0.0	53.3	36.5	29.7	12.3	11.7	28.7	0.0	16.1	61.7	16.9	15.1	13.9	27.7	30.7	11.1	21.4	10.4	12.6	14.5	15.3	17.8	16.9	45.9	30.0	14.0	25.4	21.0	11.0	36.6	12.9	12.9	19.4	46.1	32.2	25.6	40.0	17.0	44.5	25.9
TCIRG1	"a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7"	ENSG00000110719	"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3"	Q13488	11	68039016-68050895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 102.9;Kupffer cells: 127.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.6;RPMI-8226: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038742	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038742: AB_10795138"	"unprognostic (5.35e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.50e-11)"	"unprognostic (2.48e-3)"	"unprognostic (7.88e-3)"	"unprognostic (2.50e-1)"	"prognostic favorable (9.45e-6)"	25.8	24.1	5.0	20.1	7.2	39.5	10.2	1.3	5.4	20.1	21.8	3.9	19.9	20.1	14.1	27.1	11.9	12.5	16.4	5.9	2.4	1.6	8.9	25.2	24.1	20.7	7.1	2.2	11.4	69.6	2.6	4.7	14.4	6.9	15.7	4.1	6.8	18.3	11.0	3.5	5.2	25.8	10.8	7.7	44.7	17.4	4.2	5.5	7.5	11.7	8.3	24.3	13.0	13.4	3.3	13.4	40.4	36.8	8.2	4.9	10.7	9.2	17.1	0.2	0.0	7.9	6.2	12.0	18.4	9.0	5.3	5.0	0.3	27.8	0.8	10.1	6.5	8.1	11.7	1.1	7.1	1.1	24.1	0.5	6.4	20.8	5.5	7.3	4.7	40.6	7.2	4.1	6.5	0.4	0.0	3.6	0.3	3.3	2.5	1.7	3.1	0.2	28.2	1.0	13.2	4.3	7.9	0.3	40.4	5.0	5.2	0.9	0.2	7.8	10.2	5.0	1.9	11.1	12.1	12.6	10.3	8.1	28.6	3.3	0.4	0.3	1.3	23.0	7.9	4.9	5.5	16.6	18.8	4.5	28.8	3.7	3.3	3.4	4.9	13.4	2.2	2.0	2.1	40.4	8.2	36.8	9.0	3.3	10.7	5.0	7.2	1.3	5.4	2.4	1.6	7.1	2.2	6.9	5.5	26.8	66.3	28.6	11.5	5.6	0.7	1.2	17.8	29.4	27.3	7.0	0.0	18.1	0.0	29.8	0.3	15.8	46.0	0.0	58.5	45.5	19.9	9.3	48.5	16.3	102.9	0.0	23.0	17.8	127.9	0.2	5.5	82.1	5.0	46.9	25.2	0.9	44.8	87.7	12.4	2.1	0.7	38.8	16.5	0.1	3.0	4.5	22.2	49.4	25.3	17.1
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	7.0	9.6	11.8	10.2	13.7	4.0	11.1	23.3	16.6	7.5	8.1	7.4	7.2	10.6	8.6	9.6	9.7	7.6	6.8	12.7	10.1	6.9	13.0	12.3	6.9	10.0	15.4	8.5	10.5	7.3	10.8	16.8	10.4	10.6	10.6	10.3	8.6	7.9	10.4	7.7	8.5	9.1	9.6	11.0	13.7	7.4	5.7	13.3	8.6	10.7	6.7	9.8	7.9	11.8	6.7	6.4	4.9	10.0	4.3	6.7	4.8	6.1	9.9	5.9	7.4	4.6	6.0	5.1	6.1	5.1	13.7	11.4	6.5	2.9	7.9	6.0	4.5	7.2	8.7	10.9	4.4	11.9	2.5	13.6	3.8	9.9	6.5	4.9	6.9	4.9	4.5	5.2	7.8	3.0	3.7	5.8	5.5	8.5	7.1	9.0	4.4	5.9	10.1	4.4	7.1	5.1	3.1	10.4	6.2	10.2	5.8	10.1	3.0	5.5	4.4	5.2	5.7	9.9	4.7	4.0	5.3	6.3	6.0	5.8	3.4	5.7	5.5	4.2	5.7	5.2	3.5	6.6	4.9	4.6	10.0	5.8	6.7	5.6	4.2	6.4	6.4	6.7	6.6	1.9	4.3	7.3	5.8	5.7	4.8	11.8	13.7	23.3	16.6	10.1	6.9	15.4	8.5	10.6	13.3	14.9	11.7	4.2	7.2	3.7	18.6	4.4	10.2	17.4	9.1	8.7	7.9	22.7	21.6	11.8	8.8	6.8	5.1	0.0	7.5	14.1	6.6	4.6	4.7	9.0	17.4	15.9	5.2	12.3	9.1	4.4	7.5	10.2	6.8	14.4	6.2	17.1	10.5	5.8	7.1	13.4	18.2	19.4	8.4	23.6	17.0	3.8	14.9	5.4	7.3	3.5
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	11.1	8.5	7.6	14.0	10.1	12.2	11.3	12.6	11.1	12.2	9.5	7.7	7.5	6.1	14.2	9.9	12.5	12.1	10.3	10.4	7.7	7.1	7.5	7.9	9.7	15.1	7.3	5.9	14.9	10.3	9.8	13.5	25.4	9.4	10.2	8.1	6.3	10.2	9.1	25.4	16.2	8.7	11.8	9.9	14.4	9.2	24.5	7.2	32.9	10.0	10.2	15.0	11.2	11.9	13.0	9.3	12.4	9.0	9.9	12.6	7.2	11.7	12.9	17.0	19.0	6.2	11.1	26.3	14.8	15.4	19.4	18.1	13.2	13.9	33.4	8.0	9.6	17.9	16.0	24.2	19.1	22.8	13.4	10.7	18.1	8.4	11.5	13.4	26.2	13.6	9.6	10.8	19.7	20.9	9.6	10.5	11.9	20.2	11.0	25.0	18.4	19.1	16.8	34.7	22.9	15.6	18.7	29.0	10.1	14.3	7.7	15.1	12.8	8.1	13.5	13.1	10.9	5.6	7.7	10.7	13.0	11.5	17.3	13.8	7.8	13.2	13.4	13.2	11.8	13.4	12.4	7.6	2.5	9.8	9.0	10.7	12.7	10.0	9.8	9.3	13.0	10.7	12.6	1.9	9.9	6.7	5.4	11.4	7.2	7.6	10.1	12.6	11.1	7.7	7.1	7.3	5.9	9.4	7.2	3.0	9.4	10.0	8.3	19.7	6.7	10.6	0.0	6.7	17.0	8.7	11.8	44.5	3.3	5.8	9.9	8.3	2.1	0.0	7.5	12.7	13.0	6.1	16.2	6.8	8.4	7.9	5.1	6.7	3.8	10.0	8.1	7.5	16.9	7.2	5.2	3.4	6.3	5.3	7.4	3.0	5.9	0.0	12.8	28.4	34.5	19.7	38.6	6.5	6.0	7.1
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	158	"testis: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385022-58399221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 617.4;Late spermatids: 619.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	19.3	21.2	11.1	21.0	12.1	28.5	15.3	15.4	13.9	16.8	21.0	7.7	12.5	17.6	20.7	12.1	17.4	15.3	11.0	15.9	10.2	11.2	22.4	31.4	11.5	21.5	12.5	10.7	18.4	14.3	12.3	23.9	22.2	12.9	17.2	14.7	9.2	16.3	10.6	21.7	10.2	18.7	16.1	10.8	21.0	14.5	40.2	11.6	35.4	22.2	14.8	18.4	16.6	11.8	13.1	14.1	7.2	9.5	14.3	13.1	6.8	21.5	12.3	13.9	14.4	4.1	5.1	15.9	9.8	9.8	12.3	13.8	43.3	23.2	43.0	14.4	4.5	9.3	16.9	25.4	13.8	19.6	18.3	22.6	16.3	9.4	16.1	6.4	41.2	13.4	5.1	6.4	15.0	13.8	5.9	10.6	12.9	38.4	19.9	8.6	11.8	32.6	16.2	26.3	9.9	12.9	26.0	30.0	19.3	7.6	14.6	18.6	12.8	19.6	27.4	24.1	11.9	29.7	12.3	8.1	9.2	29.4	10.5	26.3	20.2	30.8	54.2	11.8	31.8	6.9	1.0	9.5	3.7	8.5	9.0	11.0	12.2	10.3	8.9	11.5	13.1	13.1	10.4	7.2	14.3	7.2	14.1	8.5	6.8	11.1	12.1	15.4	13.9	10.2	11.2	12.5	10.7	12.9	11.6	50.6	24.7	36.3	36.6	44.5	22.3	31.1	43.3	37.5	61.4	19.2	15.7	83.2	74.6	32.4	617.4	32.7	10.6	23.3	38.6	59.4	34.2	33.1	27.8	54.6	37.5	36.5	14.9	23.9	17.8	619.6	38.3	33.8	21.9	26.2	34.1	37.2	30.5	21.0	29.0	61.4	19.4	25.8	30.9	42.9	56.9	47.8	43.8	30.2	47.6	24.4
TFAP4	"AP-4, bHLHc41"	ENSG00000090447	"Transcription factor AP-4"	Q01664	16	4257186-4273075	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001912	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA001912: AB_1080251"	"unprognostic (1.61e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.30e-1)"	8.2	7.0	9.6	11.8	9.6	3.4	7.3	31.6	15.6	10.0	6.8	6.6	5.7	11.1	10.1	3.7	9.9	12.5	7.0	4.8	8.0	6.3	4.4	6.3	5.5	11.1	11.1	7.1	18.7	22.2	6.3	6.7	6.9	8.8	9.0	3.9	6.1	13.2	7.0	8.6	12.2	10.1	5.5	12.8	10.2	8.3	3.1	14.9	13.0	8.4	4.5	7.3	7.4	11.0	1.7	0.5	0.9	0.1	0.1	1.2	1.0	7.0	7.4	6.4	9.4	2.7	7.3	10.7	2.7	7.3	4.8	5.2	3.8	11.1	24.2	7.2	2.7	2.2	10.5	11.7	9.4	1.5	14.2	8.3	7.4	6.9	9.9	3.8	13.0	4.3	6.7	6.1	5.2	14.7	2.2	3.1	8.2	13.7	6.5	1.8	11.1	18.3	21.5	14.7	7.1	9.8	16.1	14.3	25.1	1.8	5.3	13.3	10.0	9.2	9.8	9.0	1.0	4.8	10.2	2.0	6.6	5.1	22.9	7.1	10.6	8.8	20.4	4.4	13.0	4.5	0.0	0.0	0.9	0.4	0.0	1.2	1.7	0.2	0.0	0.3	0.4	0.3	0.7	0.0	0.1	0.1	0.5	0.2	1.0	9.6	9.6	31.6	15.6	8.0	6.3	11.1	7.1	8.8	14.9	3.0	0.0	9.1	8.8	19.2	4.4	2.0	10.2	1.4	1.2	26.2	0.0	7.1	6.6	3.4	0.0	2.9	5.4	0.0	4.9	10.4	8.4	3.9	0.0	2.4	3.7	0.0	7.5	4.9	4.1	0.0	10.9	2.9	3.3	0.0	13.4	1.9	2.7	3.5	4.9	3.8	2.1	6.5	6.6	0.9	0.7	19.4	1.8	8.7	15.8	3.3
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540560-246566324	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	10.6	23.1	4.2	7.2	8.4	15.5	9.0	8.4	9.9	7.0	8.9	6.5	9.4	8.2	9.5	7.2	9.5	6.9	8.5	11.3	4.3	5.5	15.5	42.3	5.9	8.7	4.8	5.7	6.5	19.7	5.6	7.8	10.5	7.6	8.9	9.6	5.9	13.6	8.9	21.4	8.7	10.3	6.8	6.5	9.0	9.6	8.7	5.7	13.0	15.6	7.3	12.0	9.1	6.5	10.6	11.0	1.2	7.5	12.6	10.4	4.5	12.6	12.2	4.7	8.4	5.9	8.5	16.6	9.3	9.6	10.6	9.8	14.8	12.3	22.7	14.6	9.4	6.9	11.0	11.4	9.9	14.7	8.8	4.4	11.5	7.5	13.0	9.8	20.2	10.4	8.4	11.9	9.1	10.3	5.8	8.2	8.1	33.1	7.8	9.1	5.9	10.2	9.1	21.1	22.2	12.5	10.2	9.4	27.5	9.6	14.0	10.5	21.3	9.0	16.4	30.8	5.5	11.9	19.5	6.0	7.4	9.0	10.4	24.3	22.6	37.7	17.9	9.1	20.0	9.3	0.2	4.7	1.2	8.4	4.8	10.4	10.6	7.5	8.8	11.0	10.4	9.6	8.2	1.0	12.6	7.5	9.5	10.3	4.5	4.2	8.4	8.4	9.9	4.3	5.5	4.8	5.7	7.6	5.7	6.0	6.5	9.3	11.9	47.4	3.0	15.1	2.5	8.1	17.0	15.7	9.8	20.8	24.9	11.2	1.0	11.7	6.8	0.0	13.3	23.0	10.8	10.8	13.9	32.0	10.9	0.0	10.9	6.2	9.7	1.9	6.1	7.6	5.0	5.4	12.1	4.5	9.1	8.6	4.2	28.3	3.6	12.9	16.0	7.2	22.3	39.3	17.6	8.7	19.0	9.2
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.4	0.2	2.7	2.7	0.0	0.0	1.9	9.4	0.0	0.0	0.0	0.0	0.3	0.0	10.8	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.3	1.2	26.7	19.3	8.3	0.0	1.0	0.0	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3	6.0	20.8	0.0	45.7	1.4	0.0	2.2	25.5	0.0	12.5	75.0	0.0	23.2	26.6	2.2	0.1	0.1	75.7	0.0	1.3	1.2	0.6	33.2	0.0	0.2	4.3	0.0	9.8	0.0	5.4	0.0	0.3	2.1	6.8	0.0	37.4	0.4	4.7	34.0	0.0	23.2	0.0	0.0	0.1	0.0	0.2	2.9	16.9	0.0	34.7	33.5
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		No	No			Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: AB_2685782"	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	14.2	17.2	16.4	11.4	16.8	12.9	31.4	21.5	20.3	16.5	16.6	13.8	11.8	12.0	15.2	13.6	11.8	16.3	11.9	19.0	16.0	14.5	17.2	17.3	10.8	15.5	18.1	14.1	23.7	28.8	12.1	14.2	11.4	17.6	17.0	7.2	11.5	24.8	16.7	20.9	14.2	11.4	12.7	13.0	15.3	12.0	11.9	16.3	11.6	22.6	9.0	12.9	17.2	21.6	22.2	18.0	10.6	14.7	17.0	22.0	15.0	9.9	9.4	8.6	12.4	14.3	12.9	8.3	9.0	11.8	24.0	15.0	12.6	6.3	8.8	12.2	9.9	8.9	7.9	13.6	8.0	8.4	15.1	22.3	10.1	12.6	11.2	17.9	7.1	10.5	12.0	10.3	15.1	13.3	14.7	10.3	15.5	10.2	11.4	8.8	6.9	12.4	16.2	7.4	11.7	16.0	11.9	10.5	12.7	10.7	2.4	11.4	12.9	11.0	15.2	20.8	7.5	9.7	12.9	9.3	12.8	7.7	8.7	14.0	12.9	13.7	11.6	10.8	15.4	7.2	10.2	14.7	10.6	20.1	11.7	20.2	17.1	19.7	20.8	18.0	22.2	22.0	18.5	9.0	17.0	9.1	16.4	19.3	15.0	16.4	16.8	21.5	20.3	16.0	14.5	18.1	14.1	17.6	16.3	0.0	6.9	9.8	10.6	12.5	10.9	5.6	7.6	14.7	3.4	8.7	5.9	12.9	16.6	9.6	5.3	14.0	11.6	23.3	9.0	15.6	14.6	13.0	5.7	10.0	13.4	4.8	7.5	10.4	13.2	2.3	17.3	8.3	10.1	22.6	7.7	9.8	9.8	8.4	21.9	15.1	6.9	12.9	20.6	8.1	16.0	12.9	13.7	9.2	11.5	13.7
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 33.8;Late spermatids: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	3.5	4.0	6.1	4.8	11.4	4.2	7.6	5.6	7.8	4.9	3.7	5.0	6.8	3.6	5.9	8.8	3.4	4.4	3.4	5.9	7.0	5.5	7.3	7.4	4.6	3.9	11.8	4.3	7.9	6.1	8.5	10.3	5.9	7.5	6.0	4.1	3.0	6.6	10.5	20.5	4.2	3.9	3.7	8.8	3.7	3.5	14.0	13.4	6.0	9.8	5.9	3.9	4.6	5.2	3.7	2.6	0.3	4.0	1.5	3.5	1.7	1.5	2.1	8.2	4.5	2.5	3.0	5.7	1.5	2.6	1.6	1.5	3.1	2.8	8.6	2.9	2.1	3.0	2.0	6.4	2.6	2.0	3.3	2.4	3.7	3.2	4.0	2.9	3.4	3.0	3.1	4.2	0.8	4.0	2.5	2.5	7.1	3.2	5.9	2.0	2.1	8.1	4.1	6.5	3.0	1.2	7.5	3.4	5.0	2.9	1.8	6.8	4.7	3.1	4.2	5.6	7.1	2.6	3.0	1.6	2.1	2.3	1.6	1.1	3.9	1.7	8.4	2.5	2.0	3.1	0.0	2.3	0.3	1.6	4.0	2.0	3.7	1.1	1.4	2.6	3.1	3.5	2.9	0.1	1.5	2.7	1.7	0.6	1.7	6.1	11.4	5.6	7.8	7.0	5.5	11.8	4.3	7.5	13.4	3.0	2.2	0.5	2.6	0.7	2.1	5.0	0.0	1.4	2.3	1.8	5.9	2.7	0.0	1.3	33.8	1.5	1.1	0.0	2.2	1.8	1.1	2.3	1.1	0.9	1.1	0.0	2.9	1.3	0.8	43.1	1.7	1.8	0.0	1.0	1.5	4.1	0.9	0.0	0.0	2.1	4.6	6.5	1.2	4.8	5.3	1.5	2.7	0.0	1.4	1.4
THNSL1	"FLJ22002, TSH1"	ENSG00000185875	"Threonine synthase like 1"	Q8IYQ7	10	25016658-25026664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037585	Uncertain		Approved	"Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"	Mitochondria	"HPA037585: AB_10696940"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.11e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.84e-3)"	"unprognostic (3.06e-2)"	2.2	8.0	8.6	2.4	10.1	0.8	4.7	4.6	10.4	5.5	3.5	5.4	3.6	3.3	4.7	6.5	2.6	7.2	2.7	4.6	8.9	6.6	12.3	26.0	2.1	5.5	9.5	5.5	9.6	8.7	7.9	13.0	2.3	8.5	3.8	4.0	2.8	4.4	3.7	5.2	2.9	3.0	3.0	9.1	3.2	3.5	7.0	7.7	5.1	10.5	2.1	3.3	2.9	3.9	5.2	3.8	0.6	0.7	11.5	10.4	3.3	5.3	6.2	3.9	7.8	4.0	5.0	1.0	2.6	1.0	2.9	1.9	4.0	6.8	24.8	8.4	1.2	3.2	3.0	5.6	4.9	3.0	3.4	3.1	9.1	1.7	2.6	4.5	0.0	1.5	3.1	9.1	2.1	4.5	5.1	2.0	10.3	7.7	2.9	6.2	8.3	4.9	1.7	7.2	9.4	3.0	2.6	1.0	10.6	8.3	1.2	6.5	3.7	5.2	4.7	9.3	2.2	4.7	0.5	1.9	3.5	3.1	4.6	2.4	2.2	2.8	0.0	5.8	5.0	2.7	0.1	0.4	0.0	3.0	0.5	5.4	5.2	4.4	4.0	2.2	4.0	10.4	6.8	0.6	11.5	0.7	3.8	2.0	3.3	8.6	10.1	4.6	10.4	8.9	6.6	9.5	5.5	8.5	7.7	3.0	2.7	2.0	2.6	0.6	4.1	6.3	2.5	9.4	6.8	3.5	0.0	5.2	13.3	2.8	20.6	1.6	1.4	0.0	1.1	3.3	2.1	1.2	0.0	6.8	1.8	3.2	1.2	1.8	1.6	4.1	2.0	1.0	0.0	1.8	1.1	6.3	1.6	0.0	1.4	8.9	4.7	0.0	1.0	6.4	13.2	0.9	0.8	0.9	3.5	0.9
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528463-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	22.2	19.5	29.1	16.7	28.5	18.3	27.4	14.8	34.3	16.6	21.6	17.1	25.9	16.8	13.7	29.1	20.2	16.0	15.4	25.2	25.1	22.7	26.7	41.3	13.1	25.1	27.2	24.6	13.0	25.8	18.3	14.3	13.8	19.9	14.4	23.1	15.8	23.8	20.2	32.3	15.3	12.4	17.2	21.0	20.1	15.9	20.5	16.1	18.4	18.5	25.9	29.8	13.6	12.1	45.1	38.8	5.9	22.6	16.5	33.4	32.4	27.1	41.5	19.5	18.7	17.0	14.5	24.7	23.3	18.8	37.3	21.3	30.5	23.9	51.8	26.9	20.7	32.6	20.9	27.7	27.1	33.8	17.6	20.5	32.8	15.9	39.3	18.0	43.0	37.1	13.6	22.0	36.1	25.2	9.9	23.0	34.6	36.3	23.7	27.3	57.9	23.1	57.6	20.5	23.7	44.7	38.9	41.2	45.2	18.9	18.9	15.9	20.4	24.6	49.1	29.8	20.1	36.7	16.5	14.4	21.5	40.3	36.9	44.7	33.2	43.4	41.7	19.9	21.7	35.8	5.9	22.6	5.0	19.9	21.4	22.8	45.1	24.5	21.9	38.7	41.9	33.4	29.1	1.3	16.5	19.8	38.8	21.3	32.4	29.1	28.5	14.8	34.3	25.1	22.7	27.2	24.6	19.9	16.1	11.9	8.3	59.6	36.7	109.2	16.9	112.2	84.1	14.7	31.8	41.8	3.9	61.1	179.1	67.1	101.9	57.3	85.0	70.0	108.7	85.9	56.1	50.4	51.9	191.0	112.4	7.9	25.9	41.1	52.6	211.2	42.8	77.1	77.6	106.4	36.8	30.6	73.4	48.9	48.1	130.8	11.8	12.9	87.7	92.4	50.6	113.3	33.1	41.5	65.1	45.8
TIMM13	"Tim13, TIMM13B"	ENSG00000099800	"Translocase of inner mitochondrial membrane 13"	Q9Y5L4	19	2425624-2427894	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048985	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA048985: AB_2680589"	"unprognostic (5.47e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.15e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (8.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.91e-2)"	"prognostic favorable (3.88e-5)"	"unprognostic (4.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.47e-2)"	18.5	38.2	21.7	21.3	19.9	25.0	15.7	15.9	28.6	14.6	26.4	18.5	19.8	43.0	14.2	20.4	32.5	17.1	22.9	28.1	20.6	19.1	29.4	49.8	13.6	20.7	23.1	19.3	22.5	57.0	9.7	16.9	21.5	21.1	20.6	14.7	16.7	32.7	26.1	56.6	22.3	34.5	13.7	17.3	21.7	25.6	33.3	17.4	23.6	20.0	44.6	18.5	15.7	17.4	21.1	72.7	10.5	36.1	19.6	21.0	24.5	29.0	30.5	11.1	21.9	6.3	6.3	15.3	17.0	6.0	12.5	9.2	43.9	14.8	17.5	6.1	5.6	9.2	21.5	17.2	23.1	3.5	16.1	60.4	14.6	29.6	33.4	18.0	28.2	16.0	14.8	12.5	13.7	9.4	8.6	15.0	23.2	29.5	26.3	4.9	12.1	33.2	38.8	31.0	23.7	44.8	25.1	8.9	47.1	12.1	25.0	41.3	38.0	7.7	31.4	19.5	5.2	20.9	31.4	14.0	14.8	16.4	27.6	33.8	41.5	21.3	18.3	15.2	38.7	22.4	6.3	36.1	10.5	14.5	33.2	17.8	21.1	16.6	15.2	32.6	19.9	21.0	17.9	2.3	19.6	19.5	72.7	16.3	24.5	21.7	19.9	15.9	28.6	20.6	19.1	23.1	19.3	21.1	17.4	47.6	68.0	116.2	113.2	207.0	40.2	121.0	165.6	61.6	52.4	123.9	3.9	298.1	356.4	234.7	53.8	96.6	287.7	46.7	331.2	342.2	152.2	160.2	61.1	358.4	276.3	25.4	184.3	95.2	160.0	96.5	119.0	123.6	214.2	119.0	243.4	60.1	263.5	192.9	93.0	418.3	36.8	51.8	100.2	95.0	119.4	241.4	237.7	84.3	327.1	151.1
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	26.4	27.0	24.5	29.3	20.7	21.7	41.4	42.3	30.3	34.8	31.3	31.6	27.6	36.7	15.6	36.2	25.5	21.2	44.9	25.3	37.5	26.9	28.1	20.2	35.9	29.9	21.4	43.1	21.8	25.0	28.2	35.5	29.8	25.1	36.3	23.2	51.0	20.6	40.8	16.9	23.1	23.4	31.1	26.7	14.6	22.9	28.5	46.0	42.7	25.2	37.0	26.2	25.9	66.4	39.1	32.5	36.7	29.3	29.0	23.3	24.7	27.0	43.9	31.3	33.7	30.8	24.8	32.9	25.9	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2	35.7	37.0	55.2	74.7	81.9	22.9	117.0	40.8	46.8	42.1	36.6	33.4	102.6	116.0	97.2	44.4	41.4	33.9	0.0	74.9	170.0	67.6	57.0	54.3	165.4	105.8	33.4	32.6	35.6	45.4	26.9	31.1	72.6	50.6	99.2	41.2	32.7	83.8	23.0	36.0	93.3	25.4	25.8	62.2	38.1	50.8	86.4	222.1	56.4	49.3	91.8
TIMM17B	"DXS9822, JM3"	ENSG00000126768	"Translocase of inner mitochondrial membrane 17B"	O60830	X	48893447-48898143	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029093	Approved		Approved	Microtubules,Mitochondria		NA	NA			Microtubules	Mitochondria	"HPA029093: AB_10600913"	"unprognostic (7.87e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (8.44e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.67e-2)"	"prognostic favorable (7.88e-4)"	14.0	21.1	23.6	15.0	24.2	18.6	16.4	15.1	30.8	16.9	22.3	18.9	13.3	19.2	15.1	19.2	27.4	21.0	19.4	40.6	19.8	17.7	26.2	40.1	19.6	18.3	19.0	15.8	17.8	28.7	19.3	22.9	28.2	15.4	22.4	15.0	19.8	21.5	22.8	54.3	16.1	24.8	15.7	20.5	22.1	18.8	16.7	12.5	36.4	31.1	27.2	19.5	21.6	13.7	36.7	41.5	56.2	41.2	22.9	26.7	35.5	18.5	34.4	21.7	21.2	6.8	5.5	17.9	8.4	13.0	22.4	14.7	30.1	25.3	13.9	13.1	7.4	36.3	14.2	34.0	18.3	8.5	29.2	38.3	10.0	19.7	26.5	19.2	14.7	9.8	7.2	18.4	16.8	22.4	11.2	10.3	24.4	14.7	32.5	10.2	48.3	23.1	36.1	28.0	24.7	32.2	16.4	14.1	49.4	21.9	11.0	21.6	19.3	13.1	21.0	12.5	28.6	45.8	25.9	7.0	10.3	20.2	24.7	14.4	30.1	34.9	16.6	14.3	26.4	12.1	44.4	41.2	56.2	23.4	39.0	26.7	36.7	23.7	26.4	39.5	36.1	23.1	21.2	46.5	22.9	31.5	41.5	23.4	35.5	23.6	24.2	15.1	30.8	19.8	17.7	19.0	15.8	15.4	12.5	23.8	27.5	51.4	44.2	26.9	39.2	36.7	45.9	28.1	17.0	69.8	15.7	89.4	157.5	83.6	4.1	21.6	57.2	46.7	63.8	82.3	26.4	51.5	51.8	47.3	83.3	33.4	78.4	21.5	43.0	6.3	22.2	43.6	42.2	101.8	59.2	31.6	75.0	89.2	21.5	129.9	28.0	32.3	40.1	19.4	36.8	30.1	66.6	44.6	55.4	49.4
TIMM23	TIM23	ENSG00000265354	"Translocase of inner mitochondrial membrane 23"	O14925	10	45972449-46003734	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA031408	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA031408: AB_10600828"	"unprognostic (4.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.79e-4)"	"unprognostic (4.41e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.21e-1)"	5.7	4.6	1.2	6.8	3.8	6.0	13.6	4.1	8.6	2.6	4.2	1.5	5.8	6.1	2.9	7.3	4.2	2.4	3.2	11.5	5.3		6.6	8.3	4.8	9.9	1.6	2.5	2.2	2.8	3.0	3.4	8.1	5.5	3.4	4.1	2.6	7.5	5.2	16.2	2.4	3.5	3.6	2.2	2.5	2.8	17.2	1.4	4.5	4.5	4.0	4.4	3.3	1.7	29.5	39.7	18.5	45.3	26.7	29.8	39.6	40.7	43.0	28.6	28.8	23.8	22.3	27.9	33.7	40.5	41.1	43.7	54.2	32.5	36.5	28.0	35.4	29.5	35.2	43.6	36.0	40.8	27.0	43.0	23.3	32.3	58.2	38.4	43.2	26.1	26.7	32.2	35.1	50.0	17.1	37.9	31.9	41.1	20.6	36.0	40.8	38.5	60.1	34.5	30.2	13.4	29.9	27.6	26.7	46.1	28.6	33.6	30.9	18.7	41.7	33.7	23.1	44.1	25.9	27.8	19.9	34.7	25.4	47.9	22.1	36.4	51.3	37.0	62.6	16.5	15.7	35.6	18.5	28.0	45.3	28.7	29.5	27.1	29.8	39.7	27.9	24.6	27.2	8.2	26.7	39.3	32.8	29.6	39.6											8.9	17.4	24.2	12.4	19.5	13.0	86.5	30.6	28.1	19.4	12.2	7.9	39.3	38.1	39.5	62.9	13.7	15.7	23.3	26.2	38.0	14.2	16.2	26.6	23.3	30.2	0.0	9.8	17.8	17.5	15.7	16.4	18.4	21.9	33.3	15.8	22.1	29.8	14.0	11.0	47.3	9.2	6.5	16.5	85.7	48.5	18.9	29.7	13.8	23.3	16.0
TIMM29	C19orf52	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928733-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	13.4	11.4	13.8	11.0	18.0	18.4	8.0	19.9	16.4	8.5	9.9	10.3	7.6	17.5	11.3	7.1	13.8	8.6	9.4	12.5	15.1	8.9	10.5	13.5	8.1	11.6	13.5	9.3	8.3	17.1	7.0	10.8	12.2	11.9	9.9	5.1	11.3	16.8	9.5	30.9	12.1	12.4	10.3	8.3	11.7	15.0	11.3	13.2	12.0	9.2	8.9	9.7	10.1	10.6	13.6	10.3	8.7	8.7	10.9	12.0	3.2	10.7	3.9	3.1	5.2	2.7	2.6	8.9	7.5	3.8	5.4	5.0	7.0	3.5	9.1	13.3	3.4	2.9	10.0	1.6	4.4	0.9	10.9	13.1	10.5	4.0	4.7	4.3	7.5	8.0	2.2	4.3	3.7	1.5	2.1	3.2	7.8	11.4	7.7	2.0	8.8	8.5	14.6	11.3	3.2	17.4	11.6	4.5	11.0	2.2	4.1	8.1	8.4	8.6	4.5	8.8	1.2	6.5	8.2	5.4	8.7	5.3	11.1	11.4	26.7	26.0	9.7	5.4	9.6	7.2	3.5	7.9	8.7	5.6	8.7	8.8	13.6	10.8	12.0	5.6	10.6	10.1	8.5	1.7	10.9	6.7	10.3	11.0	3.2	13.8	18.0	19.9	16.4	15.1	8.9	13.5	9.3	11.9	13.2	3.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	15.7	0.0	31.3	16.6	17.6	0.0	0.0	0.0	0.0	9.2	25.5	0.0	0.0	1.1	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	26.2	0.0	0.0	13.2	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943920	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	12.8	15.3	11.8	13.0	12.4	7.5	12.7	16.2	17.2	10.8	15.3	8.5	14.1	16.1	12.1	11.8	19.4	10.8	12.6	39.2	12.9	10.3	13.5	19.7	9.0	9.2	11.7	7.7	13.8	20.2	7.4	10.3	8.9	12.3	10.8	6.3	8.5	17.3	21.4	48.8	12.6	10.5	17.7	9.0	12.2	12.2	9.4	11.6	5.8	12.5	26.6	8.8	13.0	9.4	9.0	16.2	10.1	12.2	9.6	12.1	8.4	18.5	10.8	5.8	10.2	10.1	9.4	8.5	11.2	9.1	15.5	14.1	23.8	4.0	27.2	12.9	9.3	12.4	13.0	23.8	12.5	3.9	12.7	36.2	13.6	9.2	20.0	24.8	16.3	5.7	11.0	16.1	13.2	16.4	5.3	9.8	17.5	25.0	9.7	6.7	18.8	14.2	10.7	16.8	17.9	46.0	15.0	8.3	12.7	6.8	12.0	13.9	7.2	9.9	13.5	31.7	5.2	8.3	15.9	5.2	7.4	11.6	18.7	21.1	19.1	24.0	26.4	5.2	23.7	12.5	10.1	11.7	3.7	12.1	12.2	10.7	8.7	11.1	11.2	16.2	9.0	10.7	10.4	0.6	9.6	7.2	13.2	9.4	8.4	11.8	12.4	16.2	17.2	12.9	10.3	11.7	7.7	12.3	11.6	32.8	13.1	36.5	29.5	24.7	51.6	31.9	30.6	10.7	12.5	27.9	39.3	33.9	56.3	37.7	8.0	22.3	35.7	0.0	36.8	32.1	23.8	24.1	32.3	52.9	31.0	49.3	38.5	21.5	16.7	9.9	33.9	18.0	20.3	11.8	35.3	22.0	38.9	24.6	27.6	29.0	55.4	32.3	29.2	35.1	33.3	17.3	27.2	20.3	48.5	25.1
TIMM50	TIM50L	ENSG00000105197	"Translocase of inner mitochondrial membrane 50"	Q3ZCQ8	19	39480412-39493785	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	RNA-binding	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048843, HPA056448"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA048843: , HPA056448: AB_2683137"	"unprognostic (1.49e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.04e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.04e-2)"	21.3	20.2	17.9	17.0	25.8	23.0	15.7	14.3	38.2	13.4	18.4	18.0	14.4	18.0	19.0	11.7	22.6	15.8	12.5	42.2	17.6	17.4	23.9	28.0	14.2	16.6	17.8	20.2	16.4	19.8	16.4	13.4	20.0	22.0	15.3	12.0	18.1	18.3	14.6	58.1	14.0	16.1	16.5	12.7	15.1	16.9	40.4	14.7	18.5	24.0	25.5	16.9	16.9	18.2	19.3	27.4	10.3	25.3	17.0	19.9	27.8	26.5	63.9	11.9	29.6	10.5	9.5	21.6	21.0	10.8	25.0	20.4	45.7	18.8	30.1	22.4	14.2	14.0	15.3	23.8	21.7	13.3	26.2	34.6	27.9	18.7	31.6	15.9	54.3	19.3	12.2	15.5	18.7	17.1	7.1	16.2	35.8	44.6	18.1	15.7	35.2	33.2	20.9	20.7	31.3	24.4	33.9	23.7	23.2	17.2	36.7	31.5	17.7	25.3	36.8	43.2	8.6	17.2	29.6	16.2	31.0	28.9	25.5	48.9	17.1	31.4	45.4	23.3	27.3	34.4	10.3	25.3	6.1	16.9	24.0	17.3	19.3	16.2	18.5	27.4	18.1	18.4	17.0	2.1	17.0	22.4	20.6	19.9	27.8	17.9	25.8	14.3	38.2	17.6	17.4	17.8	20.2	22.0	14.7	20.8	24.2	14.2	35.2	23.1	10.0	41.2	22.9	12.0	23.9	24.4	11.8	72.5	56.3	52.0	155.0	24.1	24.2	0.0	44.6	67.0	29.8	28.0	39.2	29.6	59.4	27.0	22.4	19.6	11.8	445.2	21.6	26.0	28.7	22.6	20.3	12.8	42.9	14.4	19.8	53.1	10.4	6.5	34.0	92.9	48.7	23.3	79.1	17.5	42.6	40.9
TIMM8A	"DDP, DFN1, MTS"	ENSG00000126953	"Translocase of inner mitochondrial membrane 8A"	O60220	X	101345659-101349196	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	"Deafness, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 90.8;Suprabasal keratinocytes: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003628	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003628: AB_1080284"	"prognostic unfavorable (7.89e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (8.87e-5)"	"unprognostic (2.06e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.86e-3)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.86e-2)"	6.8	6.9	7.6	7.5	12.2	7.0	8.0	5.2	13.3	5.6	7.8	6.1	3.1	6.9	6.5	5.7	10.4	6.2	4.1	11.8	7.6	7.2	12.1	27.7	4.9	8.4	8.6	8.2	7.2	17.0	5.5	4.5	6.9	11.9	7.5	8.6	5.7	6.7	4.2	10.1	8.1	7.4	5.4	6.1	6.3	5.6	4.0	6.5	6.5	7.1	16.4	9.4	4.9	6.5	14.1	11.6	1.9	5.3	5.8	11.1	4.8	10.8	9.5	5.4	10.1	4.2	4.6	7.1	7.6	3.7	6.8	13.6	8.5	6.8	11.2	10.3	5.8	11.4	8.5	14.3	8.3	10.0	5.2	9.6	21.8	12.5	14.1	4.0	12.4	76.4	4.3	6.7	9.7	6.0	3.1	6.8	4.8	15.6	12.8	8.7	16.1	6.0	12.2	18.3	14.4	15.9	9.7	9.9	15.8	5.9	7.4	7.2	6.3	9.5	7.3	6.8	6.3	6.1	6.2	5.1	8.9	10.9	12.4	8.5	6.2	14.2	14.9	4.8	16.6	6.7	1.9	4.4	0.2	6.7	5.3	7.8	12.2	7.3	7.7	5.1	14.1	11.1	9.3	0.6	5.8	3.0	11.6	3.8	4.8	7.6	12.2	5.2	13.3	7.6	7.2	8.6	8.2	11.9	6.5	3.0	4.1	13.7	25.8	90.8	6.5	25.4	2.5	8.1	11.4	10.4	5.9	30.9	33.2	12.5	0.4	9.0	6.3	0.0	9.3	35.1	15.4	10.7	16.1	57.6	18.6	3.2	8.1	4.9	6.7	0.0	6.1	7.0	13.5	2.8	7.0	5.2	13.1	7.0	2.5	33.5	7.7	0.0	15.0	1.7	9.6	77.3	30.7	10.0	18.4	19.7
TIMM9	TIM9A	ENSG00000100575	"Translocase of inner mitochondrial membrane 9"	Q9Y5J7	14	58408494-58427614	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002932	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA002932: AB_1080287"	"prognostic favorable (8.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (9.89e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.39e-5)"	"unprognostic (3.41e-1)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.77e-2)"	22.2	20.8	23.0	14.6	33.9	14.6	25.0	18.7	25.2	18.2	22.5	16.4	19.5	19.7	20.3	29.7	23.3	18.8	19.7	18.7	20.8	19.1	23.7	21.4	14.5	25.9	20.2	20.6	31.8	42.8	11.9	18.9	17.5	22.1	19.5	15.0	15.4	29.1	20.3	33.5	17.8	13.9	25.9	20.9	18.5	20.2	21.4	22.3	20.1	25.2	24.8	19.3	26.6	17.9	17.6	14.3	4.0	10.6	16.5	19.2	7.6	25.2	21.6	17.2	16.5	19.8	36.0	23.5	24.6	13.0	18.6	16.4	21.9	27.3	33.8	26.5	14.3	17.0	17.7	22.7	23.8	27.2	22.7	12.9	17.6	14.6	24.9	49.7	28.2	16.9	28.5	30.4	18.1	36.9	30.2	19.1	17.4	28.3	21.0	18.7	42.8	26.2	35.2	14.7	37.9	38.1	22.2	26.1	21.3	24.7	22.5	22.0	13.2	15.6	40.5	42.8	20.8	28.8	16.6	19.0	23.6	32.4	15.6	26.6	14.4	14.3	31.0	18.5	27.5	27.6	4.0	9.0	2.2	9.4	10.1	17.4	17.6	15.0	13.9	13.1	14.4	19.2	17.7	0.9	16.5	10.6	14.3	15.1	7.6	23.0	33.9	18.7	25.2	20.8	19.1	20.2	20.6	22.1	22.3	29.8	18.3	54.9	38.9	31.4	13.2	16.9	22.9	17.4	21.6	14.0	21.6	67.7	61.3	33.7	21.8	22.4	19.6	0.0	46.4	80.4	30.9	38.4	35.8	26.1	53.0	4.8	24.2	33.7	38.6	24.7	68.7	33.3	32.1	26.2	36.7	19.3	38.9	24.6	48.4	88.0	21.4	19.4	36.3	66.9	15.8	34.6	61.4	30.6	54.6	36.6
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.3	13.5	6.7	5.8	26.2	17.7	15.2	4.2	14.1	12.2	14.0	9.1	8.8	10.5	7.3	14.8	8.4	6.8	16.9	13.7	20.0	8.8	6.1	7.7	6.3	10.2	13.8	6.0	5.1	15.5	21.1	9.8	12.8	7.8	17.2	9.9	10.5	10.1	22.4	17.8	6.3	12.7	9.0	12.1	16.8	5.3	4.7	13.8	18.3	7.2	8.9	16.6	4.3	6.6	16.1	9.5	10.8	16.5	8.6	6.9	5.2	6.3	7.3	6.5	6.1	14.3	11.7	15.3	10.8	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6	23.8	35.3	16.0	40.6	33.3	24.2	144.4	40.8	61.6	37.5	38.4	13.7	129.0	127.6	61.0	5.3	55.2	40.2	23.3	54.8	92.7	41.0	35.4	40.4	45.5	75.0	20.6	27.6	31.3	30.4	5.2	43.7	39.7	42.2	83.0	41.1	57.9	47.3	40.1	51.2	112.8	25.9	71.1	52.6	99.3	50.0	36.8	148.4	31.6	44.9	43.4
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	4.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	0.0	3.6	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.9	0.5	7.5	7.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.4	0.0	1.6	0.1	0.0	0.0	7.7	9.5	0.0	0.2	0.4	0.0	1.8	0.2	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5	6.0	64.7	0.8	1.1	1.0	0.0	1.2	5.1	2.7	12.5	3.5	0.0	0.1	0.0	4.8	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.0	3.5	0.9	16.3	0.0	0.0	2.5	106.5	0.0	0.6	52.5	1.7	0.0	0.1	0.0	3.1	0.0	0.4	1.0	0.3	12.9	0.4	0.2	0.4	1.0	0.1	0.7	0.0	1.4
TMCO6	"FLJ39769, PRO1580"	ENSG00000113119	"Transmembrane and coiled-coil domains 6"	Q96DC7	5	140639427-140645408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037473, HPA037474"	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA037473: AB_10671049, HPA037474: AB_10671050"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.20e-2)"	9.0	15.9	4.0	10.2	6.0	4.9	9.1	9.9	7.9	10.0	10.3	9.6	5.8	5.6	9.6	8.0	9.6	11.8	9.0	5.2	4.4	5.2	6.1	21.4	5.8	9.9	6.1	5.8	13.2	9.9	6.1	7.2	10.5	6.0	7.5	4.3	6.0	16.9	5.9	5.4	7.4	8.5	5.6	6.6	12.0	6.7	19.0	5.2	14.7	8.4	5.5	11.4	7.7	7.7	9.1	7.6	13.4	10.2	4.3	11.3	4.8	3.0	5.9	4.0	5.8	4.0	4.2	14.8	2.5	2.7	3.0	3.2	9.1	5.5	12.1	6.4	1.8	3.5	6.0	3.1	6.7	1.4	4.4	11.2	9.3	2.7	6.3	5.4	5.3	3.5	6.9	1.6	3.8	6.0	2.1	7.1	10.2	3.8	4.0	3.6	5.9	12.1	11.9	4.5	6.9	9.2	10.3	8.3	12.2	3.6	2.7	7.0	2.9	6.9	13.1	6.1	2.5	10.6	6.1	3.3	0.1	2.9	1.1	0.9	7.0	4.1	5.5	1.9	8.2	3.6	10.6	7.3	5.8	6.1	9.9	6.8	9.1	8.1	6.2	7.6	6.4	11.3	4.8	13.4	4.3	10.2	2.1	8.7	4.8	4.0	6.0	9.9	7.9	4.4	5.2	6.1	5.8	6.0	5.2	6.0	1.3	5.1	6.5	1.6	5.0	0.6	2.5	5.3	0.0	10.4	5.9	6.3	0.0	3.2	1.7	4.2	3.5	0.0	2.1	6.8	2.8	3.2	0.0	8.5	4.1	0.0	7.0	6.2	4.1	0.9	3.7	2.7	1.7	4.6	3.7	3.9	3.4	4.3	4.6	1.6	4.2	6.5	2.2	16.6	15.1	1.9	5.3	9.6	6.8	5.7
TMEM11	"C17orf35, PM1, PMI"	ENSG00000178307	"Transmembrane protein 11"	P17152	17	21197280-21214624	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051795, HPA062854"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA051795: AB_2681612, HPA062854: AB_2684882"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.61e-2)"	9.7	6.5	5.5	6.2	5.8	13.2	9.7	6.2	8.7	6.1	6.1	6.3	4.3	5.4	6.8	7.6	8.5	5.1	5.2	8.3	5.1	5.1	8.0	9.0	5.9	5.0	5.6	4.5	6.2	10.7	4.5	5.1	10.6	6.5	7.4	4.1	6.4	11.0	6.2	30.2	8.2	7.2	6.3	5.3	6.0	6.5	8.4	4.5	7.3	8.8	12.8	7.9	5.9	5.7	8.0	7.0	11.7	12.2	5.5	6.5	7.6	3.9	2.9	4.1	2.9	6.0	3.3	5.1	8.1	2.2	7.1	5.0	9.3	1.7	3.8	4.4	6.2	6.0	5.1	5.8	5.9	1.6	4.0	5.8	2.7	2.6	1.6	6.6	3.1	3.8	4.5	4.7	8.0	3.7	2.8	3.5	4.3	3.4	1.4	3.3	2.4	5.0	4.8	4.4	11.6	2.4	3.5	7.7	2.3	3.2	1.1	2.4	4.0	3.2	3.8	3.9	15.4	2.4	2.8	2.9	4.0	6.0	5.7	7.5	2.0	1.9	9.0	3.2	4.1	2.3	4.7	12.2	11.7	5.4	8.7	4.9	6.1	5.5	4.9	7.0	8.0	6.5	4.9	9.8	5.5	10.9	6.1	4.9	7.6	5.5	5.8	6.2	8.7	5.1	5.1	5.6	4.5	6.5	4.5	44.7	17.9	37.9	46.1	75.4	30.4	45.2	22.9	26.8	25.0	34.9	17.7	67.7	43.1	50.5	14.5	32.3	46.6	23.3	35.6	65.2	47.1	49.3	26.5	27.3	48.0	22.3	30.7	35.0	22.9	14.1	33.1	25.2	38.8	55.1	46.9	25.0	41.8	51.8	54.1	42.6	36.5	32.3	48.9	36.2	38.5	80.9	76.0	34.4	42.0	71.1
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Predicted membrane proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	15.5	17.0	28.9	13.5	28.0	6.4	22.1	26.7	33.2	19.7	21.2	12.2	15.5	21.7	21.9	35.4	16.5	15.9	19.1	26.2	27.2	31.7	27.5	19.9	16.5	18.9	28.7	25.7	15.9	15.3	13.9	28.0	14.6	28.8	19.8	20.0	14.2	16.8	16.6	15.7	15.1	20.8	24.2	24.9	19.3	18.9	11.7	27.0	15.1	22.6	17.5	18.8	20.8	14.3	14.0	14.9	12.5	13.2	15.8	19.6	11.5	13.8	11.4	13.0	6.1	24.5	19.6	4.1	12.3	13.5	9.8	15.0	31.7	14.1	14.7	27.2	10.4	11.0	16.8	20.7	12.7	9.3	20.4	18.7	11.2	20.2	13.9	13.9	27.3	13.8	14.3	16.2	14.9	18.2	15.8	15.0	18.5	26.5	12.2	24.3	17.8	10.8	33.8	14.0	47.8	18.9	9.4	9.7	12.4	19.3	15.6	11.8	7.3	11.6	9.5	12.0	17.4	19.2	16.9	7.8	15.0	10.6	37.9	12.9	5.7	31.9	17.9	7.6	22.2	7.9	12.5	11.7	5.7	15.4	13.2	19.6	14.0	19.1	18.4	14.9	12.9	19.1	18.9	4.5	15.8	9.6	13.4	18.3	11.5	28.9	28.0	26.7	33.2	27.2	31.7	28.7	25.7	28.8	27.0	20.8	31.8	41.0	29.3	23.2	28.2	69.0	56.0	48.2	33.0	38.4	13.7	35.1	142.6	63.7	3.8	48.7	36.2	0.0	43.2	44.9	49.7	26.1	41.5	37.6	71.4	22.3	33.3	35.0	32.1	5.6	61.5	48.5	69.2	48.7	36.7	41.5	48.0	50.1	83.1	128.5	25.6	38.8	51.5	30.7	40.3	32.2	21.1	60.8	44.7	37.9
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924463-60937159	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.1"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 240.0;Muller glia cells: 177.4;Rod photoreceptor cells: 141.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 46.0;MCF7: 45.5;SK-BR-3: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced		Approved	Mitochondria		No	No		1900000	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	3.6	6.1	28.6	9.2	25.2	1.2	4.4	23.9	58.1	14.0	3.2	11.3	0.8	3.4	14.4	2.2	4.8	3.2	6.2	4.0	17.0	22.9	3.1	1.3	4.5	2.4	20.4	21.4	6.9	3.9	1.5	6.6	19.8	13.8	4.1	2.0	19.3	21.5	2.9	4.3	1.8	2.6	4.6	9.3	2.5	8.5	3.4	9.7	0.0	2.0	1.0	6.0	4.9	2.0	0.4	0.1	1.6	0.1	0.0	0.1	0.1	9.0	12.7	11.4	24.3	0.9	0.5	20.2	6.8	22.2	6.3	5.2	4.4	8.6	0.0	46.0	2.0	22.1	17.2	2.6	11.9	2.4	0.1	3.7	0.2	8.1	8.3	8.5	0.1	0.3	2.1	2.3	11.7	1.8	10.3	10.8	1.8	0.5	0.6	2.0	45.5	0.2	0.0	15.1	0.3	7.3	0.1	4.8	1.0	9.5	4.7	11.4	27.0	4.9	46.7	4.1	6.0	32.4	0.1	12.6	2.4	11.6	0.7	12.9	0.1	0.0	0.4	20.5	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.1	28.6	25.2	23.9	36.8	17.0	22.9	20.4	21.4	13.8	9.7	0.0	0.0	0.0	2.1	1.1	42.9	0.7	2.5	0.0	3.4	5.2	17.7	20.0	1.7	65.2	0.4	8.2	0.0	0.0	11.6	24.7	6.1	6.7	0.0	0.0	2.9	240.0	15.0	8.0	0.3	0.6	1.7	0.0	0.0	5.4	1.8	177.4	47.3	0.0	3.2	0.3	141.6	6.5	1.0	1.0	3.6	0.6	22.7	0.0	2.1	6.3
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.4;T-47d: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	15.0	11.0	9.8	6.1	12.4	10.0	21.2	8.5	13.4	10.6	8.5	14.5	13.7	14.5	13.3	9.2	9.6	22.6	4.2	25.0	3.4	10.5	7.6	8.1	6.1	16.1	18.1	8.4	10.1	9.6	42.9	8.1	23.0	12.1	15.7	19.3	8.0	7.8	13.8	30.8	11.5	6.5	4.7	64.4	12.4	9.6	10.3	42.7	24.0	8.5	16.5	7.4	9.2	35.1	9.6	8.8	62.6	8.2	10.7	7.6	6.0	13.8	5.5	5.1	7.9	7.7	11.4	12.2	10.8	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8	53.6	66.5	48.0	79.9	36.1	13.8	38.7	140.1	40.2	47.8	111.7	7.9	153.9	530.6	139.6	35.4	42.8	541.1	0.0	69.3	125.8	30.6	159.7	40.5	149.9	127.7	4.8	198.8	60.2	56.6	92.7	34.8	37.5	81.0	99.2	409.6	43.5	87.4	627.8	28.0	354.2	22.0	45.3	28.3	48.3	42.6	54.8	229.4	48.4	378.9	92.2
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 195.0;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.7;hTCEpi: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.6	7.1	0.1	1.4	5.2	7.8	23.7	1.2	1.9	1.1	1.7	8.9	9.8	0.0	1.4	0.3	5.1	1.2	3.3	11.0	1.5	0.0	3.2	4.4	2.2	7.9	1.8	5.5	1.4	5.6	13.6	4.6	1.6	0.3	5.9	1.1	2.9	0.1	8.2	3.0	0.0	0.0	1.8	7.3	1.7	0.0	0.0	0.3	2.0	7.5	1.1	0.0	0.2	9.6	2.7	4.3	6.8	1.5	1.2	2.2	1.8	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4	8.9	7.8	0.0	6.7	2.7	0.0	10.6	17.8	5.3	4.5	0.0	0.0	11.5	0.0	9.5	195.0	3.6	34.8	0.0	11.4	5.8	2.0	5.7	4.6	1.0	24.1	0.0	4.7	3.1	19.9	77.6	9.8	10.7	3.3	3.6	17.2	1.3	10.6	14.7	8.5	5.6	0.0	0.0	2.2	1.2	1.7	4.4	7.3	0.0	14.5	4.2
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 127.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	127.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4	0.0	6.9	29.6	0.4	6.5	48.5	19.4	150.3	14.7	15.9	190.1	3.9	0.5	129.3	42.7	0.1	9.6	542.2	0.0	23.6	0.8	57.1	2.4	26.7	864.2	53.0	0.0	71.1	29.4	40.2	0.5	55.8	35.8	5.0	525.8	156.3	73.3	68.7	691.0	7.1	954.7	4.4	0.0	20.0	0.7	1.5	7.3	1.1	7.2	159.5	0.9
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 41.7;Horizontal cells: 62.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	1.1	20.2	11.8	1.5	18.9	0.9	0.9	10.3	30.4	1.0	1.8	3.4	0.0	1.4	1.0	1.6	1.1	1.1	1.1	1.2	12.4	21.7	1.0	1.1	0.9	0.9	13.7	7.2	1.0	4.8	1.0	23.0	2.3	8.3	1.4	1.4	2.2	1.1	1.3	1.0	1.0	1.8	1.4	6.1	0.9	1.8	3.1	4.5	0.0	1.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	8.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	18.9	10.3	16.7	12.4	21.7	13.7	7.2	8.3	4.5	0.0	0.0	0.0	0.0	0.0	41.7	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	4.3	0.0	0.1	0.6	3.2	0.0	0.0	0.0	0.0	0.0
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	667335-677439	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.9	22.1	13.7	11.3	14.4	12.9	23.4	10.0	18.7	17.6	17.4	16.0	12.0	13.9	19.3	19.5	16.1	15.6	18.1	12.3	13.4	14.5	17.3	18.1	12.2	12.5	14.8	15.6	43.7	31.7	13.2	13.5	19.6	12.3	19.2	9.5	18.3	19.5	16.5	28.3	14.2	15.5	18.4	21.9	12.5	13.4	19.1	11.4	23.9	23.1	19.7	13.8	15.0	14.1	17.3	19.7	5.8	14.4	16.2	14.8	11.2	9.8	9.4	11.6	13.1	12.9	19.8	12.3	13.6	10.8	12.2	11.6	1.8	16.1	14.0	25.6	16.7	6.3	14.0	4.7	15.7	10.1	21.8	11.3	8.2	5.6	20.2	16.6	8.2	7.4	14.1	16.0	20.7	14.1	10.5	3.7	23.8	8.3	8.7	16.3	33.2	19.1	19.8	8.5	8.6	13.9	11.1	6.2	10.6	11.2	10.7	9.6	15.6	7.9	14.6	14.7	5.3	9.8	15.3	11.6	11.2	15.3	7.4	20.5	11.6	19.0	12.1	13.7	9.1	7.8	3.7	14.4	5.8	11.3	13.8	11.8	17.3	12.5	9.2	14.9	13.6	14.8	13.9	1.2	16.2	14.1	19.7	14.4	11.2	13.7	14.4	10.0	18.7	13.4	14.5	14.8	15.6	12.3	11.4	20.8	26.2	26.8	25.3	31.9	18.7	21.3	28.1	34.8	27.3	26.2	7.9	62.0	26.6	32.1	11.2	32.9	25.7	46.7	39.9	50.7	45.7	34.7	28.9	31.8	43.3	19.1	19.0	31.9	30.8	9.1	58.7	29.1	38.8	26.2	36.8	41.0	36.0	43.2	48.1	36.3	27.2	19.4	40.1	80.7	64.7	37.8	67.9	17.3	41.4	31.5
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792021	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	10.9	20.6	12.8	13.4	19.5	8.7	11.6	11.1	25.5	11.7	15.2	13.4	12.0	16.6	12.7	15.5	12.3	11.9	11.8	21.7	12.6	12.8	19.5	20.4	10.5	16.2	12.4	15.6	12.5	38.7	10.4	13.0	10.9	13.2	14.8	11.6	13.9	22.4	15.0	21.3	16.2	18.2	8.4	11.1	16.1	16.2	8.2	11.6	19.0	13.4	10.6	14.2	11.1	10.2	32.4	28.0	8.9	16.6	23.1	30.7	15.3	15.3	13.2	7.9	10.8	6.3	7.3	10.8	8.3	7.3	9.4	7.9	11.5	18.9	11.6	20.5	5.9	12.4	23.5	9.5	10.2	5.4	18.3	17.8	8.6	14.8	13.7	11.7	10.5	10.2	7.8	10.4	6.2	7.8	11.1	7.2	15.4	13.0	8.7	6.9	22.4	10.5	23.4	15.6	16.1	16.0	13.1	9.6	25.8	14.5	9.8	13.5	17.9	8.7	17.7	21.9	8.4	26.4	9.9	7.5	11.3	13.6	10.3	9.8	17.9	14.2	13.2	13.4	9.5	11.7	7.3	16.1	8.9	28.4	16.6	27.2	28.2	28.1	27.6	17.5	32.4	30.7	29.8	7.5	23.1	10.5	28.0	23.9	15.3	12.8	19.5	11.1	25.5	12.6	12.8	12.4	15.6	13.2	11.6	11.9	3.5	22.6	13.7	11.9	18.5	16.8	40.8	36.1	13.6	19.2	11.8	41.9	53.0	32.8	1.9	17.5	26.1	0.0	38.3	35.7	20.6	16.0	19.6	34.8	32.6	6.4	19.8	31.3	19.6	2.6	30.2	16.6	18.6	16.2	29.2	14.8	31.4	14.0	24.8	47.6	17.3	19.4	9.6	6.3	21.2	12.2	11.9	29.9	38.6	14.5
TMEM246	"C9orf125, MGC12992"	ENSG00000165152	"Transmembrane protein 246"	Q9BRR3	9	101473171-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.4	10.2	10.8	3.1	19.4	0.8	2.9	23.2	31.1	17.1	12.6	7.6	1.6	8.0	5.9	4.0	11.0	13.5	7.0	27.3	17.6	20.6	4.6	2.6	5.4	0.8	10.8	14.3	19.4	10.9	19.6	9.2	1.0	23.2	7.0	10.8	8.1	4.6	9.7	4.3	11.2	7.1	6.7	8.5	1.8	15.1	2.9	4.0	0.0	4.3	4.4	2.9	4.7	8.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	8.1	6.3	0.0	0.2	0.1	0.0	5.4	7.9	3.9	7.9	0.4	4.3	0.0	1.8	9.8	0.4	12.8	0.0	8.9	2.4	0.0	3.2	4.4	6.1	0.0	0.3	0.0	0.0	3.5	14.4	0.0	2.1	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	7.8	26.2	0.0	0.0	3.2	0.0	5.9	1.5	10.7	10.1	3.0	0.0	0.0	1.6	0.0	7.5	0.0	6.1	3.8	0.0	0.0	0.5	0.0	0.0	8.7	0.0	2.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	10.8	19.4	23.2	31.1	17.6	20.6	10.8	14.3	23.2	4.0	20.8	0.3	0.0	13.2	4.7	38.3	42.4	33.1	9.4	10.3	15.7	3.9	0.0	0.0	12.9	2.2	5.9	16.1	0.0	15.0	0.1	1.5	11.6	0.0	6.2	0.0	15.9	23.6	1.3	0.3	0.8	4.9	0.0	0.0	1.0	35.3	1.4	12.8	38.6	10.6	4.2	4.4	12.9	5.2	2.3	1.0	8.7	0.0	0.0	26.7	23.0
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.2	9.0	7.2	7.5	8.5	7.3	7.4	9.6	8.7	10.7	8.7	8.4	6.5	15.2	8.3	6.4	9.1	10.2	13.8	9.2	12.1	9.8	9.4	15.2	5.9	11.2	8.5	8.2	8.1	6.8	8.6	6.8	3.6	4.1	9.0	7.7	11.4	7.5	11.4	8.3	18.8	15.6	6.7	14.4	11.2	13.3	7.1	12.9	11.3	10.6	16.4	7.3	5.9	43.0	12.1	6.0	8.9	7.6	5.7	6.3	7.6	11.4	9.0	11.2	9.6	14.9	9.1	6.4	6.9	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1	14.9	36.2	37.2	32.5	59.8	24.1	39.1	15.3	42.8	23.9	21.0	7.9	61.6	56.3	28.4	11.2	35.3	22.8	0.0	55.5	44.6	47.0	32.0	38.2	44.2	119.9	9.5	13.3	28.3	89.0	5.6	27.6	68.1	38.8	36.1	27.6	19.7	38.3	37.1	27.3	55.5	15.9	38.8	44.8	32.9	28.3	52.1	58.8	34.8	29.0	23.3
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.8	8.2	0.3	0.6	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.2	0.9	33.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	1.3	0.9	0.6	4.2	0.0	7.0	1.4	0.0	1.6	1.3	0.7	0.0	0.2	0.1	1.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.4	0.5	0.7	3.4	0.0	1.6	0.0	5.8	19.5	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4	0.0	4.8	4.2	1.0	0.8	0.0	14.8	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.1	0.0	3.1	0.0	0.0	1.3	23.3	3.6	0.0	22.7	5.0	0.0	0.0	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	41.5	0.0	5.1
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	33	"intestine: 47.3"	"Cell type enriched"	"Detected in some"	14	"Enterocytes: 341.7"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021946			Approved	Mitochondria		NA	NA			Mitochondria		"HPA021946: AB_1858140"			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.2	0.0	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2	26.8	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	1.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.9	0.2	0.2	0.2	0.2	0.0	47.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	341.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	24.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	18.0	8.3	13.2	6.0	8.9	6.2	9.0	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	11.7	12.3	9.8	9.5	5.6	12.9	5.7	7.7	7.2	1.9	13.2	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	7.0	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.8	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2	0.0	2.9	10.0	9.7	4.6	3.6	6.5	7.6	9.4	4.5	8.7	0.0	7.2	19.9	8.9	0.0	5.6	8.6	0.0	6.6	5.8	7.5	2.7	9.3	11.3	10.9	0.0	5.8	5.5	14.6	0.0	7.8	11.4	11.8	10.8	6.9	7.2	8.0	7.0	5.3	11.3	5.2	0.0	8.2	0.4	1.7	3.6	5.6	6.9	7.6	8.7
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.2	0.0	1.6	16.5	1.2	1.2	26.9	0.6	0.9	7.8	0.0	0.0	0.0	20.4	0.1	0.0	1.1	0.9	1.2	0.0	0.9	0.2	0.8	27.9	0.7	0.0	0.3	7.8	0.2	7.8	0.1	0.5	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.7	9.6	1.7	0.0	4.5	0.0	2.8	0.1	10.7	1.8	0.0	0.0	46.5	1.3	0.0	0.1	0.0	3.9	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.9	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1	0.0	17.3	0.0	3.6	55.3	0.6	19.1	2.5	84.3	14.8	8.7	7.9	0.2	0.0	9.9	1.1	2.9	0.0	0.0	0.9	0.0	9.8	18.5	1.1	0.6	0.1	0.0	0.0	0.0	0.0	0.8	10.6	0.2	13.5	0.0	0.0	3.0	7.4	0.0	13.1	18.8	2.5	0.0	5.7	0.9	2.1	70.1	0.0	0.5	0.0	0.5
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 2506.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Not detected"	"Not detected"			"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		260000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.1	16.0	16.2	0.1	0.1	0.0	25.3	0.4	0.0	0.2	0.2	0.0	0.7	0.0	1.9	0.7	0.0	0.0	0.2	0.2	5.4	0.2	0.0	1.0	0.8	1.2	4.6	0.0	0.0	0.1	2.5	0.0	1.5	9.8	0.2	0.0	0.0	37.5	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0	116.1	13.0	0.0	0.6	1.3	0.2	2506.5	0.0	0.0	7.9	3.5	2.0	44.2	23.2	6.6	0.6	0.0	0.7	0.0	11.8	4.0	14.0	0.6	0.0	0.6	4.1	0.0	318.5	0.6	0.0	3.6	20.8	1.0	5.0	0.0	0.3	1.5	4.4	0.0	166.9	0.5	0.0	0.0	15.5	1.2	0.4	0.6	26.0	0.8	1.5	4.1
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.7	19.4	16.2	13.6	13.7	16.3	41.9	15.5	14.6	8.6	9.2	8.0	19.2	14.9	15.3	22.7	19.2	24.4	9.3	18.5	7.3	6.5	5.9	9.4	16.6	12.9	11.9	31.0	34.9	16.4	21.9	17.1	19.9	12.5	9.6	13.5	13.4	8.4	10.9	36.1	7.3	38.0	1.4	14.3	14.9	8.1	8.0	11.0	7.0	27.8	7.1	16.9	12.0	31.9	11.5	7.6	33.3	32.2	24.0	24.9	35.1	14.8	11.1	12.1	12.5	14.1	14.0	22.1	29.0	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6	8.9	31.9	1.4	3.1	8.2	56.8	6.2	15.3	6.7	11.4	14.0	2.0	12.8	1.7	4.5	12.0	10.7	16.9	0.0	5.5	3.6	11.3	4.6	13.9	22.9	9.5	47.7	30.1	29.4	40.0	12.0	17.0	11.9	5.0	3.6	27.0	23.8	8.0	5.8	18.7	4.2	3.7	19.4	11.9	0.5	2.0	7.8	8.4	6.4	21.8	2.6
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109336-235128936	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	27.2	35.0	46.3	15.3	60.2	32.7	52.8	40.0	66.2	36.1	25.5	28.4	29.0	24.4	34.5	39.0	28.0	40.0	27.9	33.9	47.1	48.7	41.2	35.2	24.2	33.6	42.5	40.5	50.9	63.6	38.6	25.4	27.1	48.2	34.0	28.2	23.5	47.8	30.7	33.4	33.0	21.3	33.8	54.5	19.0	27.2	16.3	23.0	18.0	58.7	28.4	21.9	36.2	28.9	15.9	20.9	16.4	13.8	9.8	22.6	14.2	35.9	19.0	25.0	21.0	19.7	39.8	38.8	25.9	22.4	24.4	17.8	24.5	25.4	43.8	34.5	22.4	6.9	28.8	27.7	25.1	32.2	10.5	59.2	26.7	25.4	46.3	33.0	59.8	16.1	35.5	34.5	24.4	33.7	33.2	26.4	17.2	56.0	16.2	26.7	10.5	25.4	27.1	56.2	24.0	10.3	31.1	19.1	56.7	27.4	25.9	32.9	77.1	20.1	28.2	55.1	10.7	43.6	65.8	23.3	21.5	13.0	27.1	54.9	38.4	36.1	32.1	25.2	28.7	36.3	16.4	12.4	4.1	13.9	12.9	17.1	15.9	18.1	17.3	15.1	12.7	22.6	17.6	3.9	9.8	13.8	20.9	15.5	14.2	46.3	60.2	40.0	66.2	47.1	48.7	42.5	40.5	48.2	23.0	128.1	138.6	191.4	199.9	237.5	49.8	120.5	135.0	99.0	162.7	47.1	27.5	147.0	135.9	142.1	230.8	135.2	112.6	46.7	180.7	308.9	116.9	237.5	153.6	148.6	144.2	47.7	154.1	102.5	169.4	269.0	143.5	148.5	141.7	101.0	251.0	122.3	199.7	133.3	144.2	188.2	47.6	103.5	156.9	79.9	69.4	250.1	166.8	109.0	224.1	238.8
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681948-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003037	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	27.6	26.2	25.6	30.1	24.3	29.5	29.4	17.6	28.2	22.2	26.8	14.7	22.4	28.0	20.1	25.6	34.1	24.4	23.8	31.6	23.2	21.0	29.4	46.0	18.1	32.1	24.0	19.8	27.8	47.5	10.9	12.6	27.6	18.5	21.0	32.8	15.8	31.4	26.7	38.2	24.6	29.7	22.8	20.0	27.7	23.3	24.7	11.3	44.2	27.4	40.4	33.5	24.1	30.2	22.5	29.7	6.9	22.9	18.0	21.3	28.6	19.9	11.8	18.1	19.2	13.4	12.5	19.6	16.6	11.5	24.3	18.3	21.4	12.0	20.3	13.7	16.2	16.7	16.6	27.5	25.1	19.6	17.5	30.2	27.3	9.3	20.5	17.5	72.2	19.4	17.1	17.9	21.8	14.3	12.7	17.8	19.9	20.6	16.3	16.1	15.5	21.6	33.6	27.8	26.5	24.1	24.1	23.5	19.2	16.1	14.7	21.3	14.1	19.3	24.6	18.8	12.9	17.0	23.9	18.0	14.9	28.0	13.6	24.9	22.5	27.2	31.4	18.7	25.1	20.3	4.7	22.9	6.9	16.9	22.0	21.3	22.5	18.3	17.8	29.7	18.0	18.7	20.0	2.2	18.0	18.1	25.8	21.1	28.6	25.6	24.3	17.6	28.2	23.2	21.0	24.0	19.8	18.5	11.3	23.8	38.6	136.2	98.0	148.4	29.1	63.5	89.2	22.7	36.4	68.0	15.7	155.1	189.0	110.6	102.3	74.4	68.7	23.3	115.2	191.6	75.3	74.7	74.8	86.3	145.2	27.0	100.8	54.6	102.5	107.7	51.2	105.1	108.0	150.5	120.6	48.5	110.8	66.6	51.2	199.7	22.3	71.1	82.1	92.7	139.6	183.8	113.4	104.6	157.8	129.1
TOMM34	"HTOM34P, TOM34"	ENSG00000025772	"Translocase of outer mitochondrial membrane 34"	Q15785	20	44942130-44960486	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.2;testis: 53.2"	"Cell type enhanced"	"Detected in many"	12	"monocytes: 303.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018845, HPA056875"	Enhanced		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Vesicles, Mitochondria"	"HPA018845: AB_1858184, HPA056875: AB_2683264"	"unprognostic (4.96e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (4.47e-5)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (2.55e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (5.79e-3)"	4.4	17.9	14.9	6.4	56.2	8.7	7.3	4.2	18.1	7.2	7.1	5.3	5.6	5.8	7.1	25.6	7.2	24.9	6.8	6.3	35.3	11.0	11.9	7.9	5.9	8.8	8.6	14.4	13.9	8.2	11.2	10.5	15.1	13.9	7.6	9.3	8.0	6.3	9.0	6.3	5.5	5.6	7.7	5.7	5.8	7.0	53.2	5.6	7.0	8.3	7.2	10.4	8.8	6.3	18.8	26.1	9.5	11.5	8.7	12.3	10.7	33.1	11.7	10.4	22.1	9.6	9.5	23.5	19.3	28.2	24.2	17.7	47.2	12.5	22.8	16.7	15.1	24.7	21.0	25.4	41.8	28.3	4.0	11.8	17.9	15.5	33.2	12.3	11.7	11.1	10.3	11.7	33.8	60.8	21.3	24.6	9.4	20.3	9.4	22.9	21.9	12.3	16.2	12.2	17.7	44.5	10.7	11.0	24.6	19.7	18.7	17.9	10.6	26.4	18.4	22.8	8.4	13.8	10.2	14.5	32.0	21.1	15.3	28.8	8.2	9.6	18.9	29.2	14.0	12.4	8.3	11.1	9.5	10.4	11.5	11.0	17.3	10.9	11.0	26.1	18.8	12.3	9.7	3.1	8.7	11.2	13.7	12.3	10.7	14.9	56.2	4.2	18.1	35.3	11.0	8.6	14.4	13.9	5.6	6.0	8.6	13.0	69.8	12.2	3.6	9.0	7.6	64.3	18.2	12.2	3.9	98.4	26.6	29.7	14.0	10.8	6.7	0.0	26.6	29.1	11.6	59.4	9.2	9.6	19.7	3.2	11.5	5.5	3.9	24.2	6.4	10.5	6.8	303.0	8.2	13.2	32.2	9.3	6.0	16.5	4.1	0.0	12.2	45.4	36.6	9.7	47.3	6.9	12.8	47.8
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	23.9	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	7.9	14.5	22.0	48.2	15.9	16.4	38.5	42.3	28.7	33.4	44.1	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	11.1	16.7	39.6	11.9	29.2	29.6	20.3	57.8	17.2	35.6	44.7	21.6	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8	14.9	5.3	28.9	52.0	77.6	63.2	14.2	30.6	0.0	10.3	29.6	27.5	84.7	33.2	54.9	9.5	29.3	31.6	23.3	33.2	145.9	33.4	37.4	19.5	20.8	91.8	66.7	28.2	11.1	20.4	5.6	24.7	36.1	37.1	39.7	43.5	43.9	41.3	28.8	23.0	28.3	55.9	19.4	40.6	53.5	60.1	78.2	61.0	26.6	93.2	64.9
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592642	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048712	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	33.2	37.8	34.5	31.2	39.7	28.3	44.1	24.3	38.5	26.7	34.7	13.1	28.3	37.5	28.7	32.7	36.9	25.4	31.1	39.6	30.9	34.7	44.3	45.3	24.4	37.4	37.6	26.3	27.4	83.8	12.7	28.8	19.6	32.3	25.2	31.2	17.3	49.6	36.2	51.5	24.1	34.8	34.1	23.9	38.9	31.2	33.0	27.2	24.5	36.3	46.1	37.8	26.7	35.3	59.1	43.1	14.0	33.9	40.2	54.9	50.5	55.1	64.4	38.2	34.2	43.9	43.2	21.1	42.1	27.0	41.1	44.0	68.5	22.9	37.8	34.6	39.9	41.9	19.2	33.9	50.2	42.9	53.1	53.6	33.2	89.6	98.1	36.1	54.4	22.0	37.2	27.6	45.2	44.8	19.5	46.8	42.5	80.8	42.5	41.7	44.2	45.8	47.9	66.5	46.6	40.8	38.9	31.9	55.6	47.0	34.6	33.1	30.4	21.6	29.5	30.7	33.9	20.6	63.8	31.7	28.5	61.0	44.8	64.9	16.2	46.8	63.1	34.9	47.1	43.8	12.3	32.2	14.0	43.0	33.9	52.7	59.1	53.1	47.7	39.0	49.1	54.9	50.5	3.7	40.2	28.5	43.1	42.1	50.5	34.5	39.7	24.3	38.5	30.9	34.7	37.6	26.3	32.3	27.2	26.8	30.2	43.6	35.9	99.7	4.4	20.1	58.6	49.5	53.4	43.6	11.8	22.0	68.0	47.4	168.9	45.6	41.0	0.0	110.0	44.6	34.2	29.9	44.0	129.9	59.4	1.6	17.4	52.2	57.8	127.0	32.5	43.7	59.1	81.2	44.0	6.7	88.5	35.1	29.4	80.6	6.2	0.0	32.3	51.5	22.8	128.0	21.1	47.8	53.1	48.7
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 16.0;Ciliated cells: 30.8;Club cells: 19.4;granulocytes: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 201.9"	"Low region specificity"	"Detected in all"							HPA004801	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA004801: AB_1859553"																		44.1	68.7	54.2	47.4	51.9	55.4	66.4	26.0	52.6	44.0	44.7	43.6	37.1	29.1	38.9	83.4	62.1	49.0	32.1	64.6	45.3	43.8	80.9	92.6	37.7	60.4	45.1	36.3	56.9	84.5	31.6	39.7	49.9	42.3	47.1	53.1	48.4	83.1	43.8	80.2	47.2	48.7	39.4	41.5	58.7	42.0	53.1	37.2	56.7	65.9	78.3	71.9	44.7	38.7	66.2	75.2	39.0	70.5	33.8	56.9	89.2	56.8	28.4	34.4	34.8	32.4	39.2	36.6	28.6	30.3	37.0	35.7	49.3	26.6	26.1	35.0	34.1	41.8	18.2	54.8	47.4	47.7	36.6	57.8	46.8	36.4	80.1	25.6	62.3	30.5	35.1	49.8	40.5	34.8	26.4	44.4	36.9	116.5	32.0	45.3	67.2	44.7	98.9	30.2	201.9	29.0	32.8	21.6	76.7	49.7	29.3	30.5	42.5	19.5	33.8	47.5	38.2	41.1	126.6	31.0	25.4	31.5	25.2	42.6	29.7	63.3	114.8	14.4	53.0	32.7	15.1	69.1	39.0	49.1	68.7	47.7	66.2	50.2	48.7	72.0	61.8	56.9	55.4	9.0	33.8	70.5	75.2	46.5	89.2	54.2	51.9	26.0	52.6	45.3	43.8	45.1	36.3	42.3	37.2	3.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401398	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA		120000	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	21.7	16.1	16.2	12.4	52.4	9.6	21.3	23.6	26.5	16.9	18.2	12.5	13.8	19.4	17.4	15.0	20.8	14.2	12.2	25.2	16.5	19.8	24.9	40.7	10.5	13.5	16.1	20.6	21.7	18.0	20.1	17.1	15.5	29.0	19.0	20.6	13.3	14.5	19.4	42.8	13.3	17.8	22.3	14.0	12.1	14.8	14.7	15.6	18.7	20.5	19.9	16.6	22.3	22.5	4.3	3.0	2.5	2.5	5.6	5.4	1.8	23.5	16.5	14.1	20.2	20.0	21.8	18.4	20.3	17.2	18.5	19.2	23.4	13.6	28.2	17.8	17.0	16.7	23.4	25.4	18.5	27.4	10.7	11.8	32.4	11.0	22.7	12.5	39.4	14.9	19.4	17.1	16.5	26.9	16.5	13.5	13.9	23.0	23.1	22.0	17.4	26.6	15.9	19.4	36.5	35.3	24.5	28.6	30.0	15.0	17.8	25.6	21.3	14.7	23.6	26.4	14.1	30.6	22.4	12.1	16.4	21.7	9.1	15.0	25.2	35.9	48.0	15.7	23.9	12.4	2.2	2.2	2.5	4.1	2.2	5.1	4.3	5.1	4.5	2.9	3.1	5.3	5.4	0.6	5.6	2.5	3.0	2.0	1.8	16.2	52.4	23.6	26.5	16.5	19.8	16.1	20.6	29.0	15.6	6.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	20.5	14.0	0.0	22.5	10.0	17.3	0.0	0.0	0.0	0.0	16.9	28.8	0.0	0.0	7.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	10.0	0.0	0.0	19.2	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	11.7	13.5	8.1	13.7	9.8	33.0	22.1	2.2	10.3	14.7	10.7	4.5	3.9	6.0	10.0	7.4	14.9	11.3	11.0	5.9	8.8	5.6	9.6	22.5	8.5	11.4	6.9	8.1	27.0	15.9	5.9	8.6	5.9	7.3	14.7	8.0	5.9	11.0	10.8	5.7	15.4	8.3	8.8	6.8	11.4	9.3	18.1	6.4	25.1	19.2	9.6	11.4	14.0	30.9	16.7	18.8	11.7	5.5	0.2	14.3	4.7	7.6	11.8	4.9	18.6	7.1	8.0	8.8	3.5	4.6	6.5	6.7	14.8	11.1	22.5	13.5	4.9	4.6	8.2	10.5	6.6	5.6	8.8	16.1	19.8	6.6	14.9	8.0	13.2	21.6	8.1	7.0	5.4	7.9	5.6	7.8	6.5	23.7	8.8	5.7	32.1	58.6	26.4	8.6	16.7	20.2	7.4	6.5	33.7	4.8	12.4	8.9	10.8	10.2	9.1	18.4	6.4	6.0	22.0	5.1	4.5	18.4	5.1	9.1	4.8	5.0	11.5	7.6	19.8	5.4	11.7	5.5	0.2	3.5	3.2	3.6	16.7	6.4	4.8	18.8	8.0	14.3	10.4	0.4	0.2	0.6	16.4	1.7	4.7	8.1	9.8	2.2	10.3	8.8	5.6	6.9	8.1	7.3	6.4	6.0	7.5	9.0	28.1	21.1	1.4	2.0	7.6	4.0	13.6	8.7	0.0	10.3	6.6	9.5	19.8	7.3	2.7	23.3	7.8	19.8	11.7	15.2	6.9	7.8	10.8	3.2	4.7	6.7	5.9	6.7	8.1	10.1	20.3	4.6	8.7	1.4	9.6	8.6	4.2	12.3	0.1	6.5	13.4	31.6	39.0	20.8	8.5	6.4	19.3	18.6
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693395	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 77.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 35.7;Bipolar cells: 18.7;Horizontal cells: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 8.6;AN3-CA: 6.4;SCLC-21H: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favorable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.5	5.8	27.0	1.3	29.6	1.0	2.7	17.0	77.5	2.1	3.2	69.0	0.1	4.6	2.3	1.3	9.0	8.6	2.1	6.0	33.9	23.9	3.2	2.3	8.3	1.0	25.8	25.0	1.8	5.2	2.4	4.4	2.4	30.1	2.4	2.2	0.2	4.8	3.7	6.2	5.6	7.5	3.5	24.7	2.7	3.8	1.6	4.3	0.0	6.0	1.9	1.8	3.4	0.6	0.0	0.2	1.5	0.0	1.0	0.5	0.1	0.3	8.6	0.4	6.4	0.9	0.0	1.2	0.2	0.0	0.0	0.0	0.3	1.0	0.2	0.6	0.0	2.2	3.4	3.4	0.0	0.0	1.7	2.9	0.2	3.6	0.2	1.0	0.3	0.4	0.0	0.8	0.0	0.2	0.2	0.1	0.2	0.1	3.2	0.0	0.3	0.2	0.5	0.2	0.9	0.9	0.3	0.1	1.2	0.3	1.2	15.8	1.9	0.9	0.4	4.2	0.4	0.8	0.2	0.1	0.2	3.4	0.1	0.2	1.2	0.3	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.2	0.1	0.1	27.0	29.6	17.0	40.8	33.9	23.9	25.8	25.0	30.1	4.3	35.7	7.7	0.0	1.0	3.7	18.7	16.1	5.1	16.0	9.1	1.8	0.0	0.0	1.7	1.7	6.9	0.0	8.5	0.0	0.6	0.1	0.7	0.6	4.6	2.0	2.5	39.7	9.8	1.3	0.0	3.6	0.3	0.0	1.7	0.0	5.7	0.8	1.0	5.8	0.4	1.1	2.1	0.0	1.9	1.4	0.2	2.8	0.0	0.0	4.1	2.4
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185915-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	8.9	10.3	8.3	28.8	13.4	45.5	12.0	15.3	11.4	10.6	14.7	7.4	19.9	15.9	9.3	15.6	19.9	9.2	18.1	10.0	9.0	4.9	13.4	20.0	13.1	25.6	12.4	6.1	10.2	42.9	5.9	12.0	9.6	9.5	14.8	6.0	8.4	24.6	19.5	14.0	13.0	18.3	9.3	9.6	19.5	16.5	9.7	11.8	21.0	13.2	13.2	33.1	11.5	13.1	6.9	33.0	23.0	14.2	14.7	13.6	9.2	22.6	15.0	5.4	8.9	2.9	3.5	13.7	7.9	5.2	6.6	5.6	9.5	10.9	14.1	7.8	3.6	5.2	14.2	6.9	14.0	1.3	9.8	32.5	8.0	23.3	16.0	11.7	16.4	16.1	5.6	8.6	4.8	6.6	3.8	6.4	13.6	9.9	23.0	2.8	25.1	11.3	18.6	7.9	7.6	14.3	31.7	7.4	29.6	5.1	22.0	6.3	10.7	6.8	24.6	11.2	2.4	10.5	16.6	7.1	5.6	13.8	7.2	8.8	28.1	4.9	16.8	6.8	11.4	8.6	7.0	14.2	23.0	10.9	12.5	10.2	6.9	9.8	9.8	15.4	3.6	6.7	7.7	19.5	14.7	7.6	33.0	13.6	9.2	8.3	13.4	15.3	11.4	9.0	4.9	12.4	6.1	9.5	11.8	8.9	22.9	69.8	39.9	37.4	31.1	8.3	12.7	13.4	18.2	31.4	17.7	22.9	23.2	46.8	13.0	20.2	51.8	0.0	54.3	43.7	24.4	43.9	27.6	21.2	42.8	41.3	17.3	12.3	48.9	6.3	30.0	57.1	40.5	126.2	38.4	28.4	67.6	66.2	30.4	24.5	29.9	19.4	25.5	52.8	29.8	39.9	25.6	58.6	43.9	81.4
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36487027-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	13.0	11.0	12.9	8.5	17.0	31.8	11.9	18.1	15.0	10.6	10.7	13.6	8.2	9.5	12.9	9.8	12.4	11.5	9.4	13.9	9.8	7.1	11.2	12.3	15.2	9.2	14.8	10.6	14.6	11.3	11.0	11.9	10.3	12.7	9.6	10.5	10.5	11.0	9.3	13.9	12.7	12.5	12.1	10.1	13.0	10.3	15.0	12.8	18.5	15.6	6.7	10.8	11.3	13.0	10.6	7.7	27.7	11.4	9.6	13.1	8.5	5.2	6.6	12.9	7.2	12.2	8.9	5.6	7.9	8.6	7.4	9.6	5.8	3.5	6.9	4.9	8.4	8.5	9.9	10.2	8.0	12.2	11.3	11.9	6.6	5.2	5.2	7.8	7.3	8.2	8.2	11.3	3.9	12.1	7.2	10.3	9.3	9.9	7.6	9.2	6.4	11.7	4.0	7.0	6.0	6.1	7.8	17.5	3.9	8.9	10.9	2.1	11.3	7.9	7.7	5.6	9.0	8.9	7.2	8.1	10.5	9.3	9.6	9.6	8.8	7.4	7.5	5.9	5.3	7.8	27.7	8.0	20.9	11.9	11.4	11.7	10.6	10.3	11.6	7.7	8.1	10.0	13.1	11.1	9.6	8.2	4.5	8.0	8.5	12.9	17.0	18.1	15.0	9.8	7.1	14.8	10.6	12.7	12.8	8.9	6.1	5.0	10.6	11.3	2.6	6.9	10.2	1.4	1.2	3.5	5.9	5.6	5.0	7.6	3.2	9.2	7.2	0.0	6.4	5.2	6.0	9.7	18.5	5.6	6.2	7.9	4.1	20.3	8.1	2.7	2.3	6.6	6.8	11.8	5.5	3.9	5.9	5.7	3.9	4.3	2.6	12.9	10.5	9.1	8.3	10.9	5.4	8.5	3.2	10.6
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	2.1	4.3	7.8	1.1	10.0	0.3	7.3	5.6	14.9	4.6	1.8	9.4	0.0	0.9	3.4	10.5	1.6	6.8	3.1	2.2	8.8	8.6	11.9	0.5	2.9	1.0	8.5	5.9	4.1	5.0	0.6	8.5	1.2	10.3	7.5	2.2	4.5	2.5	4.7	0.7	4.1	1.1	3.6	10.3	1.2	3.2	5.9	7.4	0.0	8.4	0.3	0.9	3.2	1.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	1.4	1.0	4.5	2.2	0.0	0.0	0.0	0.6	0.5	0.9	2.7	0.1	5.2	0.0	0.5	1.2	5.8	0.1	2.1	2.4	3.7	0.0	0.1	1.2	1.2	0.6	1.3	1.3	0.0	4.9	2.1	1.1	0.0	3.8	0.0	0.0	0.0	2.7	7.3	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.8	0.0	0.8	0.3	2.6	9.6	0.0	3.8	4.4	2.5	6.5	1.4	3.1	11.8	5.2	0.1	1.8	9.6	2.1	0.0	4.5	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	7.8	10.0	5.6	13.9	8.8	8.6	8.5	5.9	10.3	7.4	0.0	1.0	0.0	0.2	0.8	6.9	0.6	0.0	4.0	2.3	1.8	3.9	1.7	1.7	2.1	0.1	1.0	0.0	0.0	0.6	0.2	2.2	0.2	0.0	0.0	0.3	4.8	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.1	3.1	0.3	0.0	1.8	1.8	2.9	0.0	0.9	1.7	5.1	1.3	0.2	0.0	0.0	0.0
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717597	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1100000	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	19.1	20.3	19.1	15.9	29.7	14.2	17.5	21.1	38.5	16.8	23.0	18.1	13.1	18.6	17.1	14.2	34.4	28.5	20.8	40.0	22.1	20.4	24.6	62.6	12.3	20.6	17.1	30.7	23.5	54.7	18.3	13.6	15.5	23.2	15.4	17.8	16.4	19.7	13.7	80.3	31.2	14.1	20.9	12.3	15.2	19.7	20.0	15.1	16.4	16.0	39.8	21.2	17.2	18.2	20.0	24.6	1.3	17.0	12.7	22.3	13.8	19.1	48.1	10.0	26.4	11.1	11.4	29.7	11.6	10.6	27.0	17.0	59.8	27.4	61.7	22.1	11.2	7.3	36.1	39.0	29.1	11.9	23.6	42.6	18.0	41.3	41.8	19.1	32.2	12.4	13.4	20.3	21.4	33.6	9.8	18.5	21.0	56.4	22.5	8.8	62.6	23.1	23.9	18.5	22.8	24.5	53.2	21.0	85.1	20.0	14.3	47.7	18.2	12.1	44.8	23.3	8.4	32.4	23.4	10.4	11.4	20.3	19.9	16.9	24.1	26.5	48.5	7.1	26.0	15.5	0.0	10.8	0.3	11.7	17.0	22.3	20.0	17.1	14.8	24.6	13.9	20.3	17.1	1.3	12.7	12.3	3.6	14.2	13.8	19.1	29.7	21.1	38.5	22.1	20.4	17.1	30.7	23.2	15.1	20.8	17.4	12.6	35.8	22.6	26.7	1.7	43.3	20.1	14.8	29.6	9.8	94.7	74.6	58.6	17.5	15.5	13.6	0.0	47.2	42.8	18.6	22.2	16.1	41.4	41.2	44.5	34.1	14.1	14.2	10.0	15.3	15.9	11.8	36.1	32.9	17.6	32.3	3.5	20.1	84.4	17.9	19.4	30.1	35.4	77.7	24.6	56.2	10.2	65.0	31.9
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443961-120446412	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	11.7	16.8	10.6	12.5	13.1	14.6	20.6	9.1	12.4	9.4	12.5	8.0	12.0	10.0	9.9	11.6	15.4	9.3	12.7	17.3	13.6	8.3	12.5	34.5	14.2	13.6	15.5	11.9	7.7	36.5	5.7	8.6	17.8	13.5	12.4	17.0	6.8	19.3	8.6	29.1	16.8	12.1	11.1	10.4	12.3	12.3	11.2	11.6	11.7	11.2	21.5	13.9	12.0	10.0	17.4	28.2	9.0	24.8	22.2	25.5	19.6	15.9	21.9	20.1	13.7	17.5	27.1	48.2	21.0	15.0	18.7	15.5	18.2	8.9	31.7	17.9	17.1	7.5	11.0	23.3	34.7	19.8	14.0	26.0	19.2	15.3	47.8	26.1	32.2	14.9	27.9	43.8	18.3	26.3	18.8	38.6	17.6	30.7	8.2	27.2	20.1	24.1	43.5	28.7	19.6	17.8	20.1	19.0	32.8	24.0	17.9	19.8	13.0	24.2	8.3	17.9	33.2	27.8	18.9	21.8	12.1	18.2	12.1	12.7	21.2	33.4	34.0	18.5	25.0	21.0	9.0	22.0	8.0	20.7	24.8	24.9	17.4	20.3	19.7	28.2	15.8	25.5	22.0	1.9	22.2	16.5	25.4	17.6	19.6	10.6	13.1	9.1	12.4	13.6	8.3	15.5	11.9	13.5	11.6	3.0	14.6	36.3	21.1	45.4	8.2	10.2	45.9	17.4	6.8	7.0	5.9	113.6	56.3	43.3	5.9	25.3	16.1	0.0	43.5	66.9	27.2	25.9	17.3	49.7	46.9	3.2	21.2	22.7	22.8	3.9	15.3	20.8	37.1	53.3	21.2	9.4	40.3	14.0	17.3	36.6	9.3	19.4	26.9	34.9	34.6	62.4	63.0	29.9	38.3	23.3
TRIM3	"BERP, HAC1, RNF22, RNF97"	ENSG00000110171	"Tripartite motif containing 3"	O75382	11	6448613-6474459	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043396, HPA048233"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043396: AB_2678460, HPA048233: AB_2680321"	"unprognostic (1.24e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (4.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	6.9	5.4	9.0	5.8	8.8	1.6	6.2	34.0	17.1	6.3	8.1	9.4	3.4	22.6	8.7	2.6	3.7	5.9	5.3	6.1	6.8	7.0	3.9	3.8	6.2	3.0	8.1	9.6	5.8	5.3	2.8	3.8	5.3	14.3	7.7	6.5	6.1	9.2	7.7	9.3	7.1	19.5	8.9	7.3	4.9	8.6	3.0	7.0	0.7	4.2	2.5	2.1	6.6	5.8	0.5	3.9	1.8	3.0	2.0	1.9	1.5	4.3	7.5	3.0	5.1	5.1	4.9	4.1	6.2	3.7	4.8	5.4	4.5	3.0	2.4	2.2	4.7	5.6	3.0	3.1	4.6	1.8	2.8	4.6	0.7	7.5	3.0	3.1	0.2	2.5	4.2	2.2	3.7	2.0	2.0	4.8	1.7	1.0	2.9	4.6	9.0	0.2	0.6	2.2	8.9	6.5	1.4	2.6	2.9	1.1	2.2	3.1	4.9	3.4	33.9	4.0	1.6	12.8	0.8	8.1	12.7	6.0	9.2	4.1	3.4	2.0	0.5	6.9	1.0	4.7	0.0	3.0	1.8	1.7	2.9	1.3	0.4	1.4	1.4	3.9	0.5	0.5	1.9	0.0	2.0	0.8	0.8	1.5	1.5	9.0	8.8	34.0	17.1	6.8	7.0	8.1	9.6	14.3	7.0	6.0	0.0	2.0	2.6	4.2	8.5	1.7	2.5	2.7	0.0	0.0	9.8	1.6	0.0	2.8	3.1	4.7	17.1	0.0	2.9	2.0	6.1	4.0	1.1	1.9	4.1	7.9	4.6	4.3	1.0	3.9	5.5	2.8	6.8	3.6	10.7	1.7	2.6	5.7	4.9	2.4	8.7	12.9	10.2	1.9	4.9	4.6	0.7	0.7	5.2	1.6
TRIM42	"FLJ40097, PPP1R40, T4A1"	ENSG00000155890	"Tripartite motif containing 42"	Q8IWZ5	3	140678039-140701150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 43.2"	"Group enriched"	"Detected in some"	113	"Early spermatids: 249.5;Late spermatids: 89.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003581, HPA022481"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003581: AB_1080383, HPA022481: AB_1858301"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	249.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39841022-39883511	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.5	10.3	12.9	10.4	19.1	8.0	19.8	25.8	18.4	15.1	13.4	15.9	22.7	11.4	19.3	21.3	19.8	18.4	9.1	15.9	12.5	12.0	14.6	13.2	11.9	14.8	13.9	10.4	16.7	27.7	14.1	26.7	17.6	14.4	21.4	15.8	13.5	15.1	23.9	10.1	22.9	11.7	18.0	9.8	14.0	12.9	17.3	17.9	15.4	19.2	9.4	14.7	17.2	17.5	3.9	13.4	0.9	6.6	2.4	5.2	2.8	14.7	6.8	14.8	15.1	7.4	11.2	22.4	9.8	13.2	15.8	17.8	13.1	19.5	8.6	13.0	8.4	9.5	15.1	21.3	16.9	22.2	10.4	10.8	18.3	15.8	8.1	17.1	17.7	10.0	9.4	15.3	19.8	19.6	16.2	12.7	18.9	24.7	10.3	9.9	7.2	13.5	19.1	19.9	11.2	6.2	14.4	18.6	19.6	15.0	19.0	16.8	11.2	14.1	9.6	10.8	16.4	10.7	30.4	9.1	10.6	13.0	18.2	16.2	14.0	11.0	17.3	13.4	18.1	9.1	0.0	6.6	0.9	2.7	4.9	5.2	3.9	2.6	2.9	13.4	3.2	3.4	3.5	0.1	2.4	5.8	11.6	2.7	2.8	12.9	19.1	25.8	18.4	12.5	12.0	13.9	10.4	14.4	17.9	20.8	5.6	4.4	14.1	13.2	3.1	8.9	7.6	20.1	10.3	7.0	2.0	27.7	6.6	9.5	3.6	5.1	3.2	0.0	8.1	30.0	8.3	6.6	2.3	5.8	7.2	14.3	9.8	8.6	6.2	2.0	8.9	6.8	5.0	7.2	8.2	5.2	9.2	7.0	10.6	7.0	7.3	0.0	5.2	18.6	16.7	14.9	13.8	3.5	8.9	9.0
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	21.0	10.3	13.7	13.8	12.6	10.8	12.8	12.6	12.3	16.4	18.4	15.6	14.3	43.8	16.4	7.8	13.3	21.3	26.4	19.2	22.7	15.6	13.0	29.4	8.2	11.3	9.7	25.8	12.5	12.6	20.0	14.3	13.4	8.8	15.9	16.8	24.9	9.8	17.6	14.4	20.6	18.9	25.5	27.4	22.4	15.4	11.2	19.5	21.0	17.9	34.2	19.5	9.8	20.9	27.6	12.6	27.6	28.4	10.5	9.0	17.0	5.9	13.2	11.4	20.8	42.0	15.2	18.6	13.4	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6	20.8	20.0	45.2	114.9	83.8	27.3	45.1	15.3	44.2	47.8	27.9	13.7	57.1	44.7	44.7	22.0	33.0	12.7	0.0	29.3	34.7	35.1	33.3	46.1	46.1	28.0	20.6	34.3	28.8	19.4	6.3	34.5	28.4	13.5	36.9	26.7	27.5	31.9	14.0	35.3	55.3	29.1	32.3	41.5	61.4	51.3	91.8	54.8	41.7	40.3	115.3
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.2"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	10.8	11.6	16.7	8.4	20.9	4.1	15.0	13.8	18.3	11.8	9.5	8.0	6.8	7.5	11.9	10.7	9.6	13.2	8.6	9.9	19.4	9.9	12.9	9.8	9.8	11.8	13.6	14.3	8.8	10.1	14.7	17.7	8.9	14.7	12.0	11.2	7.8	12.0	11.0	18.0	9.9	9.6	14.3	12.9	11.0	10.6	11.7	13.4	9.1	14.9	12.0	10.7	10.2	8.5	5.8	5.0	6.3	6.1	5.1	7.6	4.4	7.4	6.5	5.4	4.2	10.3	5.3	1.3	4.7	5.6	7.0	6.0	4.0	5.2	7.6	6.6	4.8	4.5	5.2	7.7	7.8	8.3	7.5	5.9	7.3	6.2	1.3	8.1	0.0	6.0	6.6	10.4	6.8	8.7	2.0	5.8	8.0	10.2	5.3	4.3	37.2	8.6	3.1	0.0	17.4	6.1	2.7	3.6	5.0	6.4	8.1	9.2	7.4	7.0	26.2	9.8	4.8	7.4	3.1	4.6	4.9	12.8	3.6	5.3	5.5	7.7	2.9	4.4	2.6	3.9	0.5	6.1	6.3	4.5	4.9	5.6	4.0	6.1	4.6	5.0	5.8	7.6	7.4	2.4	5.1	5.5	1.5	3.7	4.4	16.7	20.9	13.8	18.3	19.4	9.9	13.6	14.3	14.7	13.4	8.9	6.9	5.9	5.4	4.6	5.6	2.7	7.6	8.1	1.2	3.5	15.7	5.8	5.0	4.9	11.1	5.2	3.6	0.0	5.4	4.5	3.3	3.4	9.2	5.1	4.5	7.9	2.9	3.7	3.2	14.2	3.7	3.3	5.0	2.8	4.2	3.9	3.6	3.5	5.6	6.6	8.3	0.0	5.5	10.7	3.8	3.8	4.1	4.3	3.7	4.3
TRMT61A	"C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61"	ENSG00000166166	"TRNA methyltransferase 61A"	Q96FX7	14	103529184-103537073	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024269			Approved	Mitochondria		NA	NA			Mitochondria		"HPA024269: "	"unprognostic (5.12e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.70e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-1)"	12.4	10.6	9.0	10.4	16.4	9.1	8.2	10.3	16.7	9.7	16.7	16.0	9.2	10.5	14.9	8.9	10.6	14.3	10.9	6.2	10.7	8.1	9.1	9.6	7.5	8.0	11.7	8.7	10.5	20.7	6.7	5.9	6.7	10.5	13.1	4.6	9.0	14.4	18.3	9.7	15.5	8.6	19.9	9.1	7.9	9.7	10.9	11.3	6.0	11.9	7.5	7.5	11.9	8.5	3.8	4.1	0.3	12.2	3.0	3.7	2.6	5.5	13.9	2.1	4.4	2.2	2.4	8.9	6.2	2.8	7.8	4.3	18.9	9.6	9.0	7.8	3.2	4.5	14.4	4.6	4.7	2.2	6.1	8.6	6.9	5.2	10.0	4.0	8.9	5.4	2.6	6.1	6.8	2.8	1.8	1.3	6.6	10.2	4.4	2.6	16.1	10.8	6.8	7.5	11.7	28.3	13.5	6.8	7.8	3.1	8.3	11.4	7.1	7.1	6.7	8.3	0.9	12.5	5.2	2.6	7.1	7.6	18.6	12.6	6.0	3.8	11.4	7.6	7.1	13.4	0.0	2.6	0.3	3.4	6.5	2.5	3.4	2.7	3.7	4.1	3.8	3.2	3.1	0.1	3.0	12.2	2.8	2.0	2.6	9.0	16.4	10.3	16.7	10.7	8.1	11.7	8.7	10.5	11.3	0.0	8.9	7.7	12.9	23.2	11.5	45.6	5.1	2.7	2.3	7.0	3.9	11.1	14.9	15.6	3.6	11.3	7.4	0.0	10.4	11.8	12.7	10.0	2.3	7.8	10.9	28.6	10.3	4.3	7.3	11.9	10.3	6.1	10.1	16.2	7.8	7.5	15.5	8.6	17.3	12.7	10.7	0.0	19.1	6.6	10.8	26.2	10.1	7.5	13.3	9.6
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	10.0	4.3	9.7	8.1	5.7	10.8	11.3	8.0	16.1	12.6	14.1	2.8	7.1	8.1	10.1	7.0	9.7	18.2	10.1	13.8	4.6	24.5	8.5	15.3	16.6	6.9	16.2	5.8	5.4	11.4	16.7	5.3	6.7	10.3	3.7	11.7	1.7	9.8	11.4	6.3	13.2	16.1	6.6	17.6	7.4	9.2	13.2	8.0	7.6	10.2	12.3	10.0	11.8	19.0	5.6	6.7	6.7	7.5	7.2	12.9	10.2	12.6	4.2	4.5	7.6	10.2	11.8	14.5	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9	8.9	6.7	12.6	9.5	5.6	25.1	12.4	5.1	9.4	5.7	10.4	15.7	20.8	23.2	18.2	0.8	11.9	11.4	23.3	16.7	17.5	10.3	9.9	9.2	16.6	13.8	12.7	12.0	15.4	11.8	1.7	14.1	8.3	8.5	17.2	9.8	11.0	16.7	10.5	15.9	22.8	26.2	6.5	11.7	18.2	13.2	8.4	12.8	10.1	15.3	8.2
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	12.0	17.4	13.5	7.7	16.1	13.8	14.4	13.8	11.5	13.8	14.3	16.1	14.8	22.0	9.2	13.3	22.0	8.7	17.8	12.4	17.6	16.3	8.6	20.4	18.6	16.1	21.5	21.6	16.6	12.9	17.6	14.2	4.8	11.6	13.6	17.0	15.9	9.2	23.7	22.5	13.9	19.5	10.6	18.0	12.7	13.3	18.2	21.4	18.4	18.0	7.7	11.1	20.0	14.5	11.5	19.0	13.4	12.3	11.1	15.6	13.6	16.1	17.7	9.5	18.9	27.7	11.7	19.4	17.4	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1	14.9	8.3	13.9	18.6	13.2	12.9	12.1	2.5	10.7	13.6	17.4	13.7	21.8	38.1	16.1	1.5	22.5	9.6	0.0	8.7	14.3	13.9	19.8	22.0	7.8	11.6	9.5	8.1	10.4	12.9	1.9	10.0	11.3	6.8	18.0	9.7	15.8	10.1	8.6	8.1	25.6	16.8	0.0	17.7	20.0	16.9	11.4	23.7	13.8	11.5	18.2
TRPT1	MGC11134	ENSG00000149743	"TRNA phosphotransferase 1"	Q86TN4	11	64223799-64226254	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038705, HPA038706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038705: AB_2676161, HPA038706: AB_10671863"	"unprognostic (2.50e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.71e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.58e-3)"	8.1	12.2	10.8	11.1	12.6	4.4	9.1	6.4	12.1	8.8	15.1	10.9	37.4	12.5	7.8	15.3	13.3	10.4	13.5	34.4	10.9	10.3	16.9	13.7	7.0	8.3	13.6	8.5	8.7	23.3	9.1	11.6	8.5	10.8	11.3	10.8	9.9	22.3	33.5	58.8	10.8	13.1	7.0	10.1	10.3	12.2	18.9	10.3	17.2	13.3	23.9	13.2	11.9	7.7	22.9	31.7	14.5	16.2	12.4	13.2	6.5	10.7	10.7	11.9	19.1	14.8	10.9	14.8	7.3	14.1	12.9	10.9	7.0	16.4	10.9	29.3	11.9	10.0	15.1	5.2	15.7	4.5	10.5	6.4	5.5	10.8	12.1	21.4	6.9	9.8	8.1	9.3	14.3	12.7	24.3	9.0	21.8	9.6	12.2	10.7	25.5	12.8	14.8	7.6	14.6	11.9	17.0	8.9	30.8	33.2	12.9	10.6	15.3	5.8	14.4	21.1	8.5	16.6	11.2	10.5	8.9	6.8	17.3	7.1	24.4	6.0	6.9	21.3	3.6	14.2	6.0	9.4	14.5	10.9	16.2	8.4	20.8	10.5	11.2	13.0	22.9	11.9	13.2	8.3	12.4	13.9	31.7	13.2	6.5	10.8	12.6	6.4	12.1	10.9	10.3	13.6	8.5	10.8	10.3	8.9	17.2	12.7	16.5	11.7	9.7	39.2	35.7	49.5	14.8	26.2	0.0	38.4	81.2	35.4	121.1	14.3	67.0	23.3	51.2	36.0	16.3	24.7	23.2	22.7	21.9	9.5	25.8	19.6	13.4	59.9	18.4	14.8	35.4	36.1	72.6	18.7	41.3	45.6	15.9	57.2	10.3	6.5	28.3	51.6	13.5	16.2	30.1	17.8	33.0	17.7
TSFM	"EF-TS, EF-Tsmt"	ENSG00000123297	"Ts translation elongation factor, mitochondrial"	P43897	12	57782589-57808071	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 157.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006204			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA006204: AB_1080405"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.93e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (8.82e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	14.5	46.2	16.6	14.7	21.5	15.3	18.5	18.2	24.3	12.7	18.8	13.3	17.6	17.8	11.6	13.7	16.1	12.4	10.3	27.7	14.6	15.6	27.0	30.2	10.1	14.6	15.4	20.8	10.3	19.6	17.0	13.1	11.6	17.8	11.7	18.3	11.1	13.5	14.1	33.5	14.7	13.4	17.7	11.6	12.5	14.0	23.2	13.6	11.3	15.4	26.9	13.4	14.4	13.0	18.5	18.7	9.0	16.8	20.0	23.5	16.0	8.4	9.8	5.9	8.8	5.5	5.5	8.6	7.1	6.3	11.6	8.1	11.4	11.2	21.2	13.6	6.2	6.5	10.0	9.9	10.2	8.8	8.6	12.0	12.9	8.3	10.0	8.4	16.4	7.8	6.4	10.5	8.8	5.0	8.9	7.1	12.0	16.6	11.5	8.7	9.8	9.7	17.9	9.1	12.3	13.1	11.8	157.2	19.0	11.0	9.6	12.8	7.9	7.6	13.4	12.9	5.5	23.2	12.0	5.2	6.3	8.9	9.2	7.6	8.5	17.4	16.5	8.9	9.9	7.5	3.7	14.8	9.0	18.6	13.8	23.5	18.5	20.9	18.4	18.7	16.4	21.2	21.7	4.2	20.0	16.8	14.7	18.1	16.0	16.6	21.5	18.2	24.3	14.6	15.6	15.4	20.8	17.8	13.6	17.9	9.6	15.6	12.7	23.0	19.8	29.9	35.7	20.1	13.6	43.6	13.7	59.0	81.2	56.0	69.4	9.6	12.7	23.3	75.2	41.0	20.6	14.1	21.9	32.5	31.6	14.3	13.3	17.8	7.3	33.2	21.0	18.6	25.3	102.8	18.4	20.6	51.6	17.5	22.6	110.7	16.3	58.2	17.6	36.4	60.1	31.7	39.8	15.0	32.8	9.2
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151514-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 139.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	33.9	21.2	9.8	17.8	11.0	117.3	48.7	2.7	8.1	24.9	23.9	12.3	10.3	20.5	12.3	13.6	83.2	14.3	36.8	32.1	8.0	5.4	18.0	22.0	39.8	40.0	15.4	5.2	13.3	13.2	4.0	6.7	15.5	9.7	23.1	9.7	16.4	34.6	9.2	13.2	46.6	23.0	12.7	11.4	27.2	39.0	10.5	10.0	9.4	17.9	44.3	50.0	19.1	41.3	22.9	99.9	91.4	139.5	28.5	43.8	104.8	47.6	23.6	1.6	22.4	9.0	29.9	1.8	35.6	17.4	17.9	19.1	4.6	36.5	0.0	24.7	27.6	8.8	39.5	4.5	27.6	2.3	7.9	18.6	4.8	25.9	1.6	32.7	10.8	24.4	23.2	45.5	10.6	9.5	21.1	42.4	0.0	3.9	9.0	18.3	39.9	0.1	30.2	1.9	24.6	59.0	10.7	0.0	81.4	22.9	28.8	2.3	11.0	16.9	33.8	41.5	0.0	12.7	42.0	43.7	22.3	16.7	22.7	14.9	3.6	0.6	0.4	28.9	35.1	28.5	43.8	139.5	75.3	28.4	86.3	22.2	16.3	39.5	27.8	99.9	22.9	30.4	24.5	91.4	28.5	57.1	17.7	43.8	104.8	9.8	11.0	2.7	8.1	8.0	5.4	15.4	5.2	9.7	10.0	148.9	135.1	105.0	344.2	325.8	2.2	79.7	336.3	127.2	167.2	195.4	2.0	9.0	313.4	570.0	2.1	215.5	499.4	46.7	512.5	126.3	307.4	297.1	261.1	99.0	745.0	3.2	187.3	163.2	688.0	6.1	76.5	573.3	686.7	477.9	485.1	116.9	963.2	644.9	148.2	97.5	17.1	103.5	217.3	1.1	4.9	468.6	16.7	155.6	529.3	666.0
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 16.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"OE19: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		2800000	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	8.5	29.7	6.0	13.5	7.6	5.7	6.1	5.0	10.5	9.5	38.4	12.9	10.9	37.4	5.9	4.0	16.6	6.8	38.4	14.1	5.1	4.9	19.7	102.1	6.2	3.2	8.2	7.0	7.2	23.9	1.8	2.3	5.0	5.9	8.1	21.6	6.2	13.6	6.9	8.3	5.4	39.5	3.8	4.7	3.5	22.8	3.3	6.7	1.8	8.5	12.8	10.5	7.2	9.2	1.6	16.0	14.3	11.5	2.2	1.2	5.2	11.1	24.9	3.1	10.6	7.7	3.0	5.9	6.2	5.3	3.6	5.4	7.2	7.3	3.0	5.2	4.9	3.5	9.6	2.3	6.2	0.8	8.7	13.9	3.1	4.7	14.0	19.2	4.3	7.4	5.9	7.0	2.7	2.3	5.1	8.8	1.6	3.6	5.2	1.7	25.6	0.1	13.9	5.4	73.6	10.9	10.0	3.4	5.2	10.2	10.5	1.8	4.8	6.5	11.8	8.4	3.2	12.2	10.9	6.6	4.1	7.7	6.8	1.9	3.9	3.9	0.9	1.5	12.4	2.4	5.3	11.5	4.9	0.6	3.0	1.1	1.6	0.5	0.4	16.0	0.8	0.3	0.2	14.3	2.2	0.8	1.1	1.2	5.2	6.0	7.6	5.0	10.5	5.1	4.9	8.2	7.0	5.9	6.7	26.8	66.9	14.5	10.5	1.1	0.8	32.5	203.8	21.4	19.4	19.2	0.0	9.5	39.7	35.3	1.4	5.0	300.1	0.0	38.8	6.0	15.5	9.3	13.9	350.5	13.2	1.6	33.0	36.2	24.7	2.7	12.0	8.3	1.7	17.2	154.8	25.4	33.8	284.5	7.4	229.1	0.6	0.0	3.6	0.7	0.1	2.0	9.5	10.9	155.4	15.2
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999380-16045015	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	8.5	13.6	10.3	10.1	16.6	16.4	11.2	16.5	22.6	10.1	13.8	10.3	10.5	18.7	11.1	8.9	9.3	9.9	11.8	13.4	17.0	10.4	15.4	13.2	10.8	7.9	9.2	15.3	12.7	24.8	11.5	15.5	10.1	15.7	12.0	9.6	13.1	14.0	12.7	8.6	13.9	16.1	7.2	8.9	8.3	13.3	6.3	6.8	6.0	18.7	8.0	8.4	10.0	10.9	3.5	2.8	9.0	2.0	1.7	3.3	1.0	6.9	5.9	6.0	10.1	5.1	5.0	4.5	5.9	4.1	2.8	3.0	5.8	12.4	9.9	13.1	3.3	3.8	8.9	8.2	6.8	3.4	16.1	13.9	8.1	7.3	4.9	7.9	8.1	12.5	5.1	5.6	2.3	9.7	7.4	5.9	11.2	4.8	7.1	5.8	6.6	8.7	5.0	9.9	9.3	4.1	13.1	6.7	7.0	8.9	8.3	6.3	4.7	7.6	8.1	14.9	19.1	6.9	3.5	10.9	3.8	1.6	5.4	7.4	5.8	2.5	4.6	9.1	9.1	8.7	9.0	2.0	3.8	2.0	2.0	3.3	2.8	2.5	3.3	2.5	3.5	2.8	3.1	1.7	1.7	1.6	2.8	2.6	1.0	10.3	16.6	16.5	22.6	17.0	10.4	9.2	15.3	15.7	6.8	38.7	30.5	47.9	58.4	93.5	137.2	30.7	33.1	18.7	28.4	43.6	135.5	60.2	59.7	46.3	34.1	65.0	53.6	46.7	35.9	32.8	37.1	61.4	31.1	29.4	22.9	122.3	43.8	28.8	19.2	4.8	38.0	31.9	52.3	30.7	45.4	81.2	37.0	52.6	31.5	37.9	170.0	45.3	31.9	17.6	28.1	102.0	54.8	55.3	51.6	61.7
TTC21B	"FLJ11457, IFT139B, JBTS11, NPHP12, THM1"	ENSG00000123607	"Tetratricopeptide repeat domain 21B"	Q7Z4L5	2	165857475-165953843	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035494, HPA035495, HPA073293"	Supported		Supported	Mitochondria		Yes	No			Mitochondria		"HPA035494: AB_2674650, HPA035495: AB_10672866, HPA073293: "	"unprognostic (1.63e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.84e-2)"	10.4	9.0	11.3	7.0	18.3	8.6	11.7	39.6	19.8	12.3	9.2	7.1	5.3	6.5	13.8	10.0	6.7	15.3	7.5	10.4	10.1	8.1	12.5	8.9	9.4	8.9	12.3	11.9	17.5	10.1	10.4	17.6	9.8	15.7	14.9	8.9	6.3	9.1	10.2	16.4	10.7	8.2	9.7	12.2	8.4	8.5	9.7	13.8	16.2	9.4	7.1	8.0	9.8	11.8	3.8	3.1	8.7	2.7	3.7	4.7	1.8	5.0	3.9	17.7	7.2	12.0	11.7	4.7	10.1	8.2	8.1	8.0	5.5	3.3	11.7	6.1	7.1	7.7	5.3	11.9	6.3	9.7	8.2	5.9	9.6	6.8	13.4	7.0	9.0	0.0	6.3	4.1	9.4	6.8	10.3	8.8	9.1	12.7	8.9	10.3	2.7	11.0	7.1	7.3	5.6	9.6	12.2	14.3	4.0	6.3	10.8	12.7	7.5	7.9	1.9	8.8	9.0	3.0	6.4	6.4	14.4	6.5	8.0	7.4	5.1	7.1	10.8	6.0	5.6	9.0	8.7	1.9	3.3	2.9	2.3	4.2	3.8	3.4	2.9	3.1	3.2	4.4	4.7	0.8	3.7	2.7	1.6	4.2	1.8	11.3	18.3	39.6	19.8	10.1	8.1	12.3	11.9	15.7	13.8	3.0	9.8	4.1	7.8	8.1	21.3	11.8	0.0	38.8	13.6	5.2	31.4	2.6	0.0	2.9	2.1	6.3	3.9	0.0	1.6	3.0	6.1	7.1	5.8	7.4	10.3	14.3	6.9	11.1	9.2	2.3	9.8	4.2	10.1	1.0	5.4	11.5	1.0	7.0	12.0	6.9	22.2	6.5	6.1	6.5	11.9	3.3	2.4	8.7	6.0	4.3
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria		No	No		11000	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	18.4	18.2	7.0	18.8	11.5	9.9	17.8	8.6	10.7	16.4	11.9	16.1	12.0	8.2	25.1	13.6	17.5	14.7	8.5	14.3	8.2	6.9	11.0	15.7	10.8	13.6	12.5	8.1	18.6	17.7	15.7	19.4	11.9	8.9	14.7	13.1	13.2	17.2	14.7	18.7	16.8	11.0	15.3	11.0	19.3	13.4	17.4	10.3	16.4	14.9	15.5	20.4	14.6	14.6	9.6	9.6	0.3	9.0	8.4	12.5	5.7	22.0	10.7	7.4	5.8	6.2	12.7	3.8	9.2	7.6	14.2	12.5	16.5	13.4	19.3	8.3	13.8	14.8	11.1	11.9	14.3	20.9	9.2	14.6	21.9	5.9	22.4	12.1	20.9	11.6	8.4	13.2	17.2	18.7	7.1	12.9	4.9	30.1	5.7	12.7	8.8	16.5	7.3	13.6	10.0	11.2	11.1	16.2	16.9	11.0	12.9	6.2	8.9	7.6	7.2	8.5	9.0	8.8	5.0	10.7	9.1	10.0	10.7	15.7	8.3	2.1	21.9	9.8	16.3	9.7	0.0	4.5	0.0	9.1	9.0	10.0	9.3	10.0	8.9	9.6	9.6	12.5	9.8	0.3	8.4	6.1	4.7	8.7	5.7	7.0	11.5	8.6	10.7	8.2	6.9	12.5	8.1	8.9	10.3	8.9	7.2	4.5	8.0	4.9	5.4	6.7	0.0	16.0	9.1	0.0	3.9	10.8	6.6	7.7	14.7	6.3	1.7	0.0	8.3	10.2	6.2	5.0	11.5	3.9	7.0	3.2	7.0	4.3	7.2	0.9	7.8	4.6	5.0	7.2	4.6	4.6	5.3	5.9	6.7	3.8	5.6	6.5	7.1	18.4	10.4	5.0	5.4	6.1	7.6	5.4
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 42.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003099			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA003099: AB_1079195"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	4.6	3.0	1.4	1.1	2.0	0.0	4.2	0.6	1.3	6.0	4.1			1.4	7.6	6.5	3.0	5.7	3.7	2.8	1.2	1.0	2.8	2.1	4.7	0.5	0.9		11.8	2.7	3.2	2.4	5.4		3.3	1.3		3.7	4.4	2.6	1.6	2.1	5.3	1.0	1.6	3.1	5.0			4.3		0.2	4.3	3.4	1.0	2.5	0.4	0.2	0.9	0.6	0.5	0.0	5.3	13.8	5.9	8.3	12.4	0.3	4.0	7.5	5.7	5.0	0.4	0.0	0.0	5.6	11.7	1.9	0.8	8.9	0.2	3.1	0.5	5.9	0.8	6.7	5.0	3.8	0.1	5.5	12.3	0.3	3.7	2.6	3.9	10.4	3.6	3.4	0.5	1.3	1.9	0.1	0.4	2.5	0.0	3.4	5.4	3.5	0.1	2.7	0.2	3.9	8.6	5.6	0.2	3.7	4.0	2.8	0.5	9.6	6.8	3.4	4.4	3.0	1.8	0.2	0.1	2.4	0.1	2.9	0.4	0.2	0.1	0.5	0.1	0.3	0.3	0.4	0.3	0.3	1.0	0.6	0.5	0.4	0.9	0.2	2.5	0.1	0.5											3.0	12.2	2.0	4.6	5.4	32.1	8.9	7.6	2.7	2.3	12.2	17.7	4.5	0.0	4.3	7.2	28.6	2.6	0.0	5.2	1.2	19.2	5.3	1.1	12.4	3.2	27.0	8.6	29.4	5.9	5.6	29.1	4.8	10.1	1.0	4.9	12.1	5.1	5.1	42.8	14.1	22.1	12.9	18.6	22.9	11.4	3.3	2.1	4.9	6.7	3.0
TTC32		ENSG00000183891	"Tetratricopeptide repeat domain 32"	Q5I0X7	2	19896643-19901986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036024	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036024: AB_10673493"	"unprognostic (2.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.92e-3)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (5.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.27e-2)"	11.8	8.9	12.8	10.8	24.7	30.1	17.4	24.1	18.9	10.8	11.0	17.5	11.9	11.5	13.6	28.5	7.8	11.8	11.8	7.3	14.9	11.8	9.4	12.6	10.1	13.7	29.6	9.2	16.9	8.7	13.4	17.0	8.2	16.9	16.6	10.4	14.5	11.4	13.1	19.6	14.2	12.1	9.4	18.4	13.9	10.6	12.9	23.6	15.5	13.7	12.9	9.5	11.9	11.7	9.3	5.4	21.6	5.9	4.5	12.8	3.8	14.4	9.2	8.3	6.1	3.8	8.3	1.7	3.1	5.3	5.3	3.5	4.6	16.7	9.1	1.8	3.3	6.4	9.2	3.9	10.3	3.4	13.3	15.8	9.3	12.3	8.3	8.2	9.1	16.8	7.8	6.3	5.8	14.1	4.2	4.9	15.0	17.3	18.8	4.4	4.4	6.5	13.5	6.5	5.6	16.3	7.8	5.6	15.3	14.5	5.7	13.7	12.8	10.8	5.8	11.5	10.2	7.9	3.5	3.4	7.4	8.2	7.7	4.2	19.0	17.3	15.4	12.0	8.9	4.3	6.1	5.9	16.5	5.9	4.3	6.7	8.8	9.2	6.1	5.4	9.3	12.8	9.7	21.6	4.5	4.8	3.8	10.9	3.8	12.8	24.7	24.1	18.9	14.9	11.8	29.6	9.2	16.9	23.6	8.9	11.8	18.3	25.0	16.8	36.8	13.2	12.7	44.2	14.8	12.2	13.7	11.6	38.1	9.2	12.5	15.7	9.3	0.0	21.9	9.3	13.9	17.2	8.1	23.3	8.0	39.7	27.2	5.5	7.1	4.6	18.4	17.0	6.8	11.8	16.5	44.9	10.9	15.0	9.2	18.7	34.7	12.9	16.5	86.3	21.3	22.8	8.0	17.3	13.6	17.4
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell type enhanced"	"Detected in some"	26	"Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	25.1	1.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0	0.0	0.0	0.0	0.0	0.0	37.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	17.5	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.7	0.0	7.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.2	0.1
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039644-43089428	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria		No	No			Nucleoli	Mitochondria	"HPA048392: AB_2680384"	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.3	16.5	3.6	12.0	2.9	6.8	12.8	16.6	7.6	4.6	8.8	0.9	2.5	7.1	12.5	5.7	14.6	5.7	12.5	13.9	12.6	6.1	2.1	5.3	4.9	9.2	14.1	8.3	4.2	8.5	9.8	3.9	13.2	7.7	4.6	6.8	4.7	6.0	4.4	5.8	2.9	5.9	10.0	4.5	5.4	14.0	8.4	4.7	10.3	1.8	4.8	5.4	4.6	4.7	10.4	7.0	6.5	9.9	14.1	6.2	0.8	1.5	12.8	9.7	14.5	12.9	0.6	4.3	4.8	2.5	4.2	0.1	1.9	0.9	3.1	7.9	1.5	0.6	1.1	1.1	2.5	1.1	2.1	1.3	0.7	1.2	10.4	3.2	1.7	10.6	16.6	1.6	4.1	10.7	8.2	10.9	0.3	8.3	9.2	4.2	3.0	5.2	1.7	3.4	0.9	7.4	7.2	0.7	4.6	1.1	3.2	6.1	3.4	1.7	11.8	6.9	5.1	5.4	7.8	2.7	1.8	6.2	0.6	2.9	0.8	0.3	6.8	5.9	4.8	5.2	5.9	7.0	13.0	6.5	12.2	3.1	11.4	14.1	10.4	4.7	9.7	12.2	1.7	9.9	4.9	6.7	6.9	6.2	16.5	12.0	12.8	16.6	13.9	12.6	9.2	14.1	13.2	8.4	0.0	2.4	0.5	2.5	2.1	5.3	4.0	2.5	24.1	4.5	1.8	5.9	2.5	13.3	5.5	30.7	3.3	0.5	0.0	4.2	1.2	5.1	3.2	1.1	0.4	4.3	4.8	0.0	6.7	2.1	14.5	3.7	2.3	8.5	4.6	2.6	5.5	4.4	7.0	5.6	5.7	10.1	6.5	1.4	8.6	37.7	2.4	0.6	2.9	1.5	1.3
TTLL4	KIAA0173	ENSG00000135912	"Tubulin tyrosine ligase like 4"	Q14679	2	218710845-218755416	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell type enhanced"	"Detected in many"	13	"Muller glia cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027091, HPA050252"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA027091: AB_10601828, HPA050252: AB_2681064"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (3.83e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (6.63e-12)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.29e-3)"	6.1	9.0	10.6	11.1	15.1	7.1	9.0	11.2	12.7	5.9	7.7	17.7	5.9	7.9	8.5	5.5	9.2	10.5	7.0	5.9	10.9	6.8	6.3	7.7	8.7	8.0	16.6	6.3	6.9	9.1	8.8	14.5	11.0	13.1	8.4	9.3	11.2	8.9	5.8	7.0	10.8	8.0	7.6	16.7	7.6	12.6	39.1	14.1	8.6	5.3	5.3	11.9	6.1	7.7	4.0	6.8	13.5	11.3	1.8	3.2	3.9	9.0	6.1	16.3	8.2	4.2	3.3	23.0	6.3	4.9	10.0	8.6	25.7	10.7	7.1	5.4	4.6	9.7	10.1	17.1	8.3	11.8	8.5	15.6	9.2	9.2	24.4	6.0	11.3	6.8	5.4	5.1	9.0	10.2	4.3	9.5	8.0	26.0	11.2	5.5	5.2	6.2	7.7	18.7	6.5	4.3	14.9	7.4	9.3	10.0	7.1	6.7	6.5	4.6	6.9	11.9	26.1	5.5	5.8	4.0	9.0	9.4	6.2	5.9	5.9	4.9	16.1	4.7	7.1	11.6	0.1	11.3	0.7	3.2	5.7	2.9	4.0	2.3	2.2	6.8	3.2	1.5	1.4	13.5	1.8	7.4	4.0	1.4	3.9	10.6	15.1	11.2	12.7	10.9	6.8	16.6	6.3	13.1	14.1	3.0	4.3	2.9	9.9	4.0	5.9	1.4	2.5	1.4	4.5	7.0	25.5	5.5	0.0	4.7	28.9	2.3	2.6	0.0	3.3	6.9	3.7	11.6	1.1	1.7	7.0	3.2	5.2	2.5	3.2	13.2	2.8	5.4	3.3	7.2	4.4	91.9	5.0	2.9	1.4	1.4	12.6	0.0	3.1	14.4	12.1	3.6	4.8	2.5	4.4	10.3
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.3	55.9	17.9	37.4	26.0	23.9	36.8	21.5	25.1	34.4	32.6	60.2	32.5	66.1	39.8	21.5	19.7	57.6	42.4	41.7	20.6	26.3	64.9	25.2	45.2	72.8	30.9	45.1	23.5	30.5	33.0	37.1	37.0	22.4	40.9	36.7	56.5	26.1	24.9	59.8	43.2	44.1	40.1	36.1	34.7	59.9	32.5	96.1	29.7	28.8	31.4	38.4	18.8	67.2	29.4	15.4	40.0	36.8	26.0	20.6	24.0	25.4	32.8	39.9	41.3	28.8	26.3	56.7	26.9	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5	65.5	70.3	105.7	207.8	149.3	93.5	117.0	178.3	137.9	64.8	167.5	82.5	299.6	283.5	183.0	309.9	94.4	289.0	23.3	252.4	240.7	112.6	188.4	103.9	224.8	230.1	69.9	142.6	95.8	162.5	472.6	101.2	129.8	131.6	183.1	194.4	129.6	169.5	172.7	105.0	374.4	91.2	84.1	142.8	184.3	182.3	136.4	240.1	147.2	348.8	236.5
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467036-36482030	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	22.1	69.9	33.4	24.7	33.2	23.5	41.9	23.2	51.1	23.0	25.9	20.8	24.5	36.9	19.8	22.7	28.7	26.9	27.6	60.1	28.0	28.6	33.4	51.7	27.9	35.5	30.3	31.7	35.0	51.1	30.8	17.3	19.6	30.4	21.6	26.2	24.6	25.0	27.5	72.3	21.0	28.1	26.3	35.6	25.2	26.7	19.1	21.2	16.2	29.2	37.3	23.0	23.0	19.8	31.7	51.3	14.4	43.3	32.0	30.0	45.1	14.4	19.7	21.6	36.9	32.5	35.4	24.8	19.9	31.1	33.5	38.1	23.9	15.3	36.5	18.4	30.9	14.6	22.0	41.4	34.0	19.5	25.0	36.0	41.6	26.9	35.2	27.4	50.0	39.8	47.3	27.0	28.0	21.9	28.1	30.3	20.4	43.5	30.2	29.9	21.3	22.7	38.8	17.5	44.7	26.0	20.8	22.8	25.3	33.9	23.5	30.1	30.4	20.0	43.9	35.7	18.0	30.9	48.5	23.8	37.4	29.2	20.5	19.4	24.6	17.4	35.5	33.7	31.2	21.2	5.2	40.8	7.1	25.7	43.3	26.8	31.7	25.6	27.0	51.3	29.0	30.0	27.9	14.4	32.0	35.2	39.1	24.8	45.1	33.4	33.2	23.2	51.1	28.0	28.6	30.3	31.7	30.4	21.2	56.6	49.0	65.6	79.6	74.1	107.9	96.0	79.0	53.5	53.4	66.3	37.3	190.8	257.0	78.1	16.6	64.6	168.3	0.0	93.1	240.7	63.4	47.2	68.1	102.9	150.9	109.7	86.0	69.3	73.9	27.8	52.3	81.0	74.2	82.0	111.4	131.5	75.1	94.7	47.7	140.1	54.1	19.4	58.7	50.5	41.1	78.4	173.2	69.9	151.3	64.8
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430590-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.1;Rod photoreceptor cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted - unknown location"	NA	NA			Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	7.0	5.2	10.2	5.9	12.5	5.4	8.6	20.5	15.0	12.1	7.0	7.4	16.1	5.1	8.5	18.4	4.8	5.4	6.5	5.6	9.2	9.4	6.4	8.9	6.1	5.0	9.5	11.3	13.4	7.8	8.6	9.4	7.0	8.9	32.8	7.4	8.1	5.6	24.2	4.2	6.5	5.9	5.6	14.0	11.5	7.4	8.2	10.5	9.7	5.1	3.4	4.8	7.8	7.3	1.2	5.3	3.6	6.3	1.1	4.7	2.2	6.1	0.6	6.9	3.8	5.1	3.8	5.4	2.0	2.7	3.5	6.8	2.2	5.0	10.0	6.9	1.6	2.1	5.8	7.9	2.8	5.4	4.1	10.3	4.6	5.1	2.0	3.7	5.4	2.2	7.0	2.6	4.4	3.3	3.1	3.8	4.4	5.8	15.6	3.0	2.9	6.7	3.8	7.6	4.1	3.7	13.6	13.0	9.0	4.4	6.3	22.5	7.8	9.9	10.4	2.8	6.0	6.6	4.0	2.1	4.7	2.4	5.3	3.4	4.3	5.8	10.1	1.3	5.7	2.7	2.4	6.3	2.5	2.7	4.8	2.9	1.2	2.8	2.0	5.3	0.8	1.4	1.4	3.6	1.1	5.2	2.2	4.7	2.2	10.2	12.5	20.5	15.0	9.2	9.4	9.5	11.3	8.9	10.5	8.9	5.4	5.2	5.3	6.0	35.7	7.9	7.6	5.3	6.8	7.0	7.9	1.7	1.7	3.1	3.3	6.3	5.2	23.3	3.5	1.5	3.3	19.5	2.3	10.5	3.0	9.5	17.7	12.9	15.9	2.7	25.6	5.0	1.7	1.0	17.2	8.4	1.5	9.5	49.1	2.6	45.5	0.0	4.4	9.8	8.4	7.3	0.9	5.7	8.7	3.5
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.5	13.0	9.4	22.2	17.9	11.4	13.8	15.8	16.8	11.3	17.3	10.7	6.5	10.3	22.6	14.3	13.5	13.1	17.7	16.2	14.3	9.3	12.4	10.8	15.6	14.2	10.1	10.4	20.3	16.5	16.2	19.5	25.4	18.1	15.5	13.6	6.2	19.1	16.3	6.9	14.8	13.3	11.7	19.9	11.5	12.2	12.7	14.4	18.8	12.1	22.4	16.1	21.9	10.7	15.9	22.4	10.8	16.5	20.8	6.0	10.6	9.8	13.9	11.5	11.5	20.7	8.5	17.2	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3	11.9	10.8	6.7	10.0	4.5	20.4	32.1	10.2	14.7	14.8	15.7	31.4	15.7	10.0	16.0	11.8	13.5	15.1	23.3	13.2	9.3	8.4	15.1	9.2	16.0	11.1	20.6	8.6	12.9	17.1	24.6	11.5	11.0	10.1	14.4	15.8	16.7	18.8	10.5	9.2	17.7	25.0	6.5	8.5	9.6	12.7	6.4	19.8	10.9	13.8	12.2
UBE3C	"KIAA0010, KIAA10"	ENSG00000009335	"Ubiquitin protein ligase E3C"	Q15386	7	157138913-157269372	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039915	Approved		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA039915: AB_10795264"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.01e-3)"	"unprognostic (8.64e-2)"	"prognostic favorable (9.18e-6)"	"unprognostic (9.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-2)"	24.7	21.0	14.0	17.9	23.1	12.4	19.8	25.5	29.9	21.3	23.4	17.2	15.3	17.4	28.8	16.8	26.8	18.8	24.8	31.8	14.4	13.8	21.2	30.5	16.7	16.7	14.5	15.1	20.7	22.1	29.6	20.3	21.3	22.3	19.0	21.0	20.2	31.7	21.5	51.2	21.2	23.9	25.7	16.1	20.5	21.8	35.9	11.1	20.3	15.6	24.5	24.4	23.1	19.1	2.5	4.0	2.1	4.6	3.7	6.6	2.9	22.8	18.2	11.7	23.3	21.0	22.1	12.9	25.3	21.9	21.4	21.7	16.3	19.1	12.4	22.5	27.9	27.9	14.5	18.1	23.3	25.4	22.5	16.6	12.6	12.7	11.7	20.9	18.8	18.5	19.5	21.6	23.7	19.7	16.3	24.9	10.4	18.3	13.8	30.2	20.0	18.4	11.9	18.5	20.5	21.9	10.6	13.1	25.4	22.1	25.2	18.7	19.3	24.9	21.5	18.5	13.6	11.1	13.2	22.3	27.0	5.8	66.1	31.3	13.9	13.9	12.5	31.0	28.1	30.8	0.5	3.5	2.1	4.8	4.6	6.6	2.5	5.2	5.2	4.0	2.5	4.9	5.9	1.3	3.7	4.5	3.6	5.2	2.9	14.0	23.1	25.5	29.9	14.4	13.8	14.5	15.1	22.3	11.1	20.8	19.5	9.7	13.9	24.5	31.4	31.5	28.1	16.0	9.1	24.4	62.8	12.2	8.3	17.0	8.4	19.9	22.1	0.0	15.2	14.4	14.7	19.9	9.2	39.2	13.9	30.2	23.5	24.5	21.2	8.5	14.4	15.0	5.0	12.6	20.6	10.9	22.5	10.5	24.1	16.5	42.8	0.0	17.6	20.4	27.4	29.1	12.6	13.8	22.4	27.3
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974667-73983307	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 219.1;lymphoid tissue: 144.8"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	19.8	9.8	5.3	40.4	9.5	24.5	15.9	1.1	4.9	8.1	7.7	10.2	20.3	11.4	4.2	12.0	4.5	37.9	13.1	11.5	4.4	5.5	12.8	10.6	20.2	85.6	7.8	2.4	7.2	4.7	1.2	6.2	8.7	6.5	6.5	8.9	14.2	17.4	17.2	45.3	4.3	24.7	6.4	9.0	91.1	12.3	5.5	5.9	144.8	17.9	19.3	55.7	19.4	2.9	141.6	219.1	101.8	135.3	119.8	180.2	172.1	0.1	14.3	3.3	9.8	1.9	0.0	2.5	2.4	1.6	9.8	2.8	25.1	12.2	68.0	34.0	3.7	0.8	0.6	2.3	0.0	4.6	17.2	0.8	39.7	6.0	5.2	5.9	20.8	16.7	2.2	0.0	9.3	0.0	1.9	1.3	26.2	18.2	27.8	1.9	24.5	21.5	11.2	2.6	1.5	2.9	19.9	22.7	38.5	27.4	40.6	5.0	6.1	12.8	87.6	4.8	9.9	25.8	18.6	1.8	0.0	12.6	2.9	4.7	9.5	4.5	56.6	1.7	8.3	0.1	45.7	81.5	101.8	112.6	135.3	69.9	141.6	92.3	95.0	88.4	134.2	86.9	91.1	11.4	119.8	111.3	219.1	180.2	172.1	5.3	9.5	1.1	4.9	4.4	5.5	7.8	2.4	6.5	5.9	3.0	35.4	250.6	2.3	3.1	0.9	3.6	2.5	93.7	23.9	87.2	7.9	6.6	6.6	1.2	16.1	5.0	4.2	420.4	6.5	10.3	6.7	15.6	84.3	0.6	378.7	0.0	285.5	11.6	244.1	37.5	0.9	160.3	25.3	710.6	23.4	2.9	2.5	37.6	0.4	1.9	6.3	6.5	5.3	14.4	13.4	4.0	9.4	172.7	24.7	21.6
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.5	14.5	13.9	9.3	47.4	61.5	58.3	35.6	29.1	19.2	22.9	37.1	23.4	28.9	10.7	38.2	17.5	12.1	16.8	22.3	31.2	19.3	7.1	18.3	10.3	25.3	22.7	16.1	16.1	40.3	40.9	18.0	18.6	25.9	26.6	9.8	9.1	11.7	80.1	10.8	21.8	15.2	33.3	45.0	10.2	17.9	27.6	16.6	34.0	16.0	7.3	6.0	28.4	36.6	13.5	44.1	10.4	11.5	36.3	20.1	31.7	29.9	18.7	21.0	9.4	36.6	24.1	25.3	61.3	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5	26.8	52.5	51.7	74.0	67.3	48.5	238.8	89.2	73.6	69.4	45.4	60.9	359.1	205.6	116.3	61.0	61.3	412.6	0.0	90.6	369.3	148.4	77.6	65.8	448.9	107.3	82.6	42.9	66.3	100.6	64.7	73.4	90.8	91.1	173.1	112.3	37.4	81.0	167.8	72.9	209.2	49.4	71.1	124.3	71.2	57.5	50.6	395.3	112.8	144.5	90.3
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.2	0.1	1.7	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.2	5.8	21.5	6.4	0.5	0.1	5.1	9.1	0.0	0.0	0.0	0.1	4.5	0.1	9.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.1	5.4	1.3	0.0	0.1	0.1	0.7	2.5	41.1	3.2	0.6	10.3	0.1	21.3	0.2	12.1	1.8	0.0	1.9	0.3	0.4	0.3	2.1	0.4	0.5	7.3	0.3	6.8	2.1	0.3	0.2	10.6	0.3	6.6	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6	6.0	1.0	8.1	1.2	0.0	0.0	0.4	7.6	2.7	6.8	24.4	0.0	0.0	8.3	1.8	5.5	0.1	20.6	0.0	11.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	46.4	0.0	0.0	1.7	1.1	0.7	1.7	0.0	25.7	0.0	9.1	17.5	0.0	1.3	0.0	0.0	0.2	10.6	36.2	0.1	0.0	0.0	21.1	0.9
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 279.5;Late spermatids: 329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.3	1.7	2.7	3.0	1.1	1.7	4.6	2.5	2.6	3.1	2.6	0.9	2.2	8.6	1.4	5.8	3.0	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.4	2.9	3.9	5.6	1.7	1.6	2.2	15.0	3.1	3.9	2.1	5.9	1.9	7.2	2.2	5.9	7.0	4.5	3.3	1.8	3.1	1.6	8.5	3.7	6.5	7.1	1.4	9.9	2.6	1.2	2.1	1.8	3.0	1.8	6.2	2.0	2.2	13.2	2.1	4.3	8.0	3.6	11.0	5.9	2.4	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4	8.9	5.8	1.9	2.8	1.8	5.4	12.8	5.1	53.5	4.5	3.5	51.1	2.8	0.0	2.3	279.5	4.4	1.1	0.0	2.1	3.9	3.3	1.2	1.1	5.9	6.5	11.1	1.7	1.8	4.1	329.6	6.1	5.6	0.0	6.4	1.1	11.2	2.8	0.0	3.9	5.0	25.1	6.5	3.3	29.9	8.7	3.1	3.5	4.4	1.7	0.8
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710435-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077812	Enhanced		Approved	"Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol"		Yes	No			"Cytokinetic bridge, Mitotic spindle"	"Mitochondria, Cytosol"	"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	12.7	33.5	18.1	9.2	18.6	9.5	16.3	17.0	17.2	16.0	12.1	15.0	18.7	8.6	20.7	15.0	11.6	42.8	14.9	13.2	18.9	19.7	27.1	14.7	14.0	9.3	14.2	16.0	33.7	17.1	40.8	25.8	13.4	20.4	18.4	12.3	14.6	14.1	23.8	6.7	13.6	11.4	17.5	15.5	13.4	14.5	21.9	15.2	16.1	38.6	7.3	13.7	12.1	16.3	2.1	2.5	2.1	5.8	2.5	4.0	1.4	11.5	11.2	23.4	20.0	23.5	17.5	19.9	14.4	16.8	16.4	7.4	13.4	4.8	11.7	5.7	16.0	7.9	12.3	24.7	16.1	17.0	9.1	12.5	5.4	8.3	8.3	15.9	14.8	8.6	13.7	16.6	12.2	18.9	26.5	18.4	17.8	13.1	1.3	13.8	10.2	13.5	12.2	28.9	13.2	13.9	16.3	15.6	6.0	19.6	24.3	14.1	17.8	34.4	6.8	11.8	17.3	26.8	10.2	11.5	15.3	10.5	6.5	9.6	9.5	8.2	7.2	18.1	7.5	16.5	0.2	1.1	1.3	3.3	0.6	2.1	1.8	3.0	3.8	1.2	2.1	4.0	3.2	2.1	2.5	5.8	2.5	2.8	1.4	18.1	18.6	17.0	17.2	18.9	19.7	14.2	16.0	20.4	15.2	3.0	6.9	2.9	6.5	2.6	8.1	3.5	5.1	18.7	5.7	17.4	9.8	9.1	13.3	6.6	11.8	6.3	3.5	0.0	6.7	4.0	6.2	10.2	2.3	5.5	2.7	7.9	13.7	8.6	3.7	2.2	12.0	1.8	5.0	0.0	6.1	11.2	6.9	5.8	15.2	11.8	9.8	12.9	5.0	11.4	14.5	2.9	4.3	9.2	8.0	6.4
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 791.0;Late spermatids: 864.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	13.4	22.9	26.1	13.3	31.4	14.6	17.7	15.0	22.9	12.4	15.8	12.0	12.3	12.8	17.4	23.4	15.2	10.9	9.2	71.0	19.2	23.0	18.3	23.4	8.9	12.3	22.8	22.6	11.5	25.3	7.9	24.5	14.4	20.6	15.7	17.2	18.9	19.6	14.3	76.4	12.2	10.4	20.0	20.0	12.9	15.9	30.9	18.3	12.3	19.0	22.0	14.9	10.9	11.0	39.7	38.9	7.2	39.6	21.9	31.5	34.8	42.7	30.8	34.5	29.9	28.7	28.9	27.2	24.4	24.5	34.0	33.7	49.4	18.1	17.2	39.5	29.4	52.4	23.1	23.4	34.1	30.3	21.9	38.5	33.7	20.4	68.3	47.1	31.4	27.6	29.5	55.0	27.3	44.2	19.7	25.3	33.2	35.9	35.7	39.9	46.0	30.4	65.3	20.9	32.8	35.1	22.0	28.3	58.3	24.1	40.7	59.4	21.1	26.9	41.3	33.7	19.1	36.2	80.0	23.4	39.1	33.2	25.2	50.2	27.5	38.2	29.1	11.8	47.6	45.1	7.2	27.0	5.2	24.0	39.6	29.1	39.7	30.3	27.4	31.9	32.8	31.5	28.4	2.6	21.9	32.7	38.9	31.1	34.8	26.1	31.4	15.0	22.9	19.2	23.0	22.8	22.6	20.6	18.3	26.8	27.7	65.4	71.0	52.0	115.5	791.0	94.3	38.8	39.8	73.3	47.1	122.2	331.5	87.4	273.9	53.4	58.0	93.5	155.9	94.8	61.5	91.6	57.8	134.7	186.1	66.7	95.6	51.5	60.7	864.2	72.8	62.9	79.2	67.7	57.9	48.7	112.6	54.0	78.8	214.9	98.9	0.0	58.5	99.8	96.6	66.7	79.8	40.6	79.2	104.5
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673687	"Disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA046851: AB_2679839"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	10.0	13.4	8.9	11.4	8.5	10.6	14.7	8.7	9.9	7.3	15.4	4.7	19.7	16.5	7.3	8.5	14.5	6.5	12.4	13.2	8.0	8.7	10.7	13.4	5.6	8.3	8.5	8.7	9.5	15.4	5.3	7.6	6.2	7.7	12.3	4.9	7.1	22.9	14.1	27.8	8.6	14.8	6.0	6.2	9.6	12.2	5.7	5.4	6.4	13.5	12.3	9.1	8.0	18.1	23.7	21.2	15.2	20.8	14.0	19.4	15.5	12.0	24.5	3.6	5.6	2.2	2.2	3.0	4.8	1.6	3.6	3.6	14.3	10.5	7.8	10.0	1.6	4.9	12.0	3.4	5.6	1.1	3.9	12.7	4.4	12.8	9.1	3.0	7.1	3.6	2.1	4.8	3.2	3.6	2.3	2.8	3.8	9.4	5.7	2.0	36.8	6.9	17.5	4.0	4.8	13.9	8.1	5.5	13.9	2.7	6.0	7.3	7.4	5.3	19.4	7.1	1.1	18.4	6.7	3.6	7.9	9.3	8.2	10.6	8.8	4.8	8.1	6.5	6.2	5.7	9.1	20.8	15.2	18.1	14.4	17.1	23.5	18.0	15.9	15.8	23.7	16.6	13.3	8.9	14.0	12.7	21.2	19.4	15.5	8.9	8.5	8.7	9.9	8.0	8.7	8.5	8.7	7.7	5.4	41.7	23.5	61.4	42.6	0.0	20.8	31.7	66.2	22.7	29.6	61.1	15.7	44.7	119.3	51.7	1.4	26.8	115.3	46.7	67.1	41.2	21.0	70.4	4.7	99.1	47.7	17.5	33.9	39.9	38.4	2.3	44.8	22.9	0.0	43.3	98.1	39.6	57.0	91.2	33.9	137.3	26.2	38.8	31.1	2.7	33.7	0.0	24.3	25.9	101.8	45.4
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		1300000	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.1	16.5	6.0	3.6	8.8	8.1	27.1	18.8	15.2	15.6	14.2	25.6	3.0	26.3	11.9	8.4	18.3	9.8	7.5	21.8	2.9	15.6	35.9	27.0	14.3	27.7	17.5	16.9	11.7	11.1	24.8	10.6	17.5	7.4	15.5	17.4	14.5	1.8	9.4	17.7	12.2	19.3	15.0	15.0	65.5	8.3	16.0	21.5	16.1	11.1	6.4	11.4	25.4	3.1	15.0	1.7	6.5	2.7	15.5	4.3	16.5	13.6	19.3	16.0	14.1	15.2	9.6	19.5	13.9	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4	53.6	50.3	63.6	133.4	104.5	38.0	576.9	142.7	78.9	46.6	115.1	27.5	292.1	310.0	150.4	116.4	44.8	496.0	46.7	145.4	266.4	68.1	72.4	80.8	173.2	214.8	38.1	138.8	44.2	110.4	218.8	54.1	87.6	113.1	113.6	228.6	55.4	138.8	252.6	66.4	309.3	39.8	58.2	92.9	102.7	76.4	92.1	281.6	56.5	307.7	117.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1206.2;Distal tubular cells: 877.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	21.8	37.0	13.8	12.4	22.6	17.3	15.3	17.1	17.9	23.7	26.3	22.4	13.6	19.9	18.1	19.3	19.4	23.3	30.1	20.4	28.7	13.5	30.1	28.2	14.6	20.3	19.2	26.8	24.8	20.8	22.1	16.2	24.7	14.0	18.9	24.9	20.0	12.5	25.4	20.2	18.7	20.1	14.4	46.7	14.4	17.1	18.4	15.1	29.5	26.4	16.8	8.2	15.6	30.9	19.6	16.1	14.4	22.4	11.9	16.1	24.5	11.0	17.7	6.0	11.3	18.4	14.2	23.3	11.4	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5	50.6	43.5	83.4	229.0	131.1	67.3	1206.2	170.7	48.2	45.5	108.2	15.7	255.3	877.0	208.2	176.6	94.4	303.4	70.0	204.7	204.0	122.3	162.8	88.9	250.4	234.4	49.3	153.7	93.9	135.6	102.8	85.4	113.1	156.9	178.5	238.4	96.8	186.1	196.4	76.7	532.4	58.7	97.0	163.6	296.9	77.1	140.0	319.3	108.3	325.0	307.9
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3256.1;Hepatocytes: 4283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.5	63.7	37.6	91.0	56.4	45.9	32.6	33.1	46.7	53.0	66.1	89.7	53.3	18.7	70.0	43.3	67.4	46.2	34.3	80.6	45.6	34.2	72.0	24.8	100.5	70.5	49.0	28.1	42.8	48.9	56.2	37.8	52.2	35.5	41.3	40.4	31.7	60.4	55.5	86.2	64.6	64.9	26.7	85.4	57.6	42.4	41.7	80.5	68.5	89.0	63.1	52.5	40.9	46.2	70.6	27.0	68.8	64.9	25.7	48.6	61.4	39.8	66.8	66.8	88.7	33.5	64.6	52.5	48.3	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8	232.3	318.2	275.9	309.6	309.4	83.7	3256.1	1189.8	321.2	221.8	746.8	113.9	633.7	1536.9	621.2	357.1	305.7	1715.1	233.6	826.7	362.7	374.6	615.6	285.5	4283.6	668.1	68.3	527.7	324.1	428.0	786.4	261.5	374.1	678.2	396.8	861.3	232.4	704.3	1273.0	271.5	1804.0	170.0	181.1	456.8	296.8	123.0	449.3	470.6	222.6	1052.4	401.6
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.9	7.1	16.8	12.1	14.6	18.0	16.6	18.8	12.8	12.7	16.8	6.5	15.3	16.8	12.7	17.0	9.9	13.8	20.6	15.2	19.3	16.3	14.1	35.9	26.5	11.8	13.0	18.0	19.2	14.6	13.1	12.8	14.3	17.4	37.2	12.8	28.2	47.5	15.5	7.4	14.9	23.4	10.5	15.3	12.8	21.0	16.9	19.6	14.5	12.6	20.5	12.8	17.7	16.3	42.5	23.5	8.3	21.8	26.4	13.7	11.2	16.7	10.9	38.2	27.1	16.7	13.2	22.3	20.0	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6	50.6	38.5	34.3	22.6	19.7	74.8	58.2	22.9	32.1	20.5	19.2	58.9	51.8	21.6	25.0	51.8	24.5	18.7	70.0	17.5	50.1	30.9	20.6	47.5	21.2	26.0	47.7	20.8	28.3	22.2	33.0	32.2	24.7	55.6	47.7	26.9	29.1	20.0	17.5	48.4	16.5	69.2	32.3	25.0	42.9	48.2	22.5	27.2	35.5	30.2	17.1
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625953	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Glandular cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	2.9	1.7	12.3	2.5	33.8	0.5	7.7	7.9	21.3	7.9	7.8	43.8	1.8	2.5	4.2	4.5	10.2	7.7	3.1	4.0	14.1	6.8	2.7	1.6	9.0	0.6	49.5	14.2	4.0	6.3	7.1	3.4	1.2	28.6	5.8	11.1	3.4	8.8	3.6	12.0	6.1	2.9	4.0	25.4	1.5	11.3	4.7	42.8	0.4	24.3	1.2	3.6	5.6	4.0	2.4	2.2	1.3	2.4	1.5	3.2	2.3	6.3	6.6	10.2	9.6	2.7	3.2	3.2	3.4	6.7	5.7	6.6	5.5	10.5	4.8	4.0	3.5	4.4	8.8	6.5	2.4	7.6	2.3	6.1	3.0	4.8	3.7	2.2	3.3	1.2	2.5	2.3	6.6	6.6	11.6	2.6	3.5	4.7	0.7	3.9	3.2	3.2	2.1	4.7	17.8	24.0	4.8	9.1	1.8	4.1	6.2	3.3	3.2	6.5	8.0	7.7	6.3	10.4	3.0	3.5	2.2	6.7	4.3	4.3	1.7	3.1	3.4	5.4	3.1	2.0	0.8	2.3	1.3	1.6	1.9	3.1	2.4	2.7	2.5	1.9	1.0	3.2	1.9	0.1	1.5	2.4	2.2	3.0	2.3	12.3	33.8	7.9	21.3	14.1	6.8	49.5	14.2	28.6	42.8	44.7	23.5	0.0	4.6	2.4	7.1	5.6	5.1	17.4	15.9	12.2	15.7	0.6	0.0	4.1	1.6	4.5	11.4	0.0	7.1	0.8	2.9	59.6	3.5	1.7	1.2	4.8	9.9	3.1	0.6	1.7	3.1	1.4	8.5	1.0	20.7	13.0	8.8	7.0	10.3	1.1	11.1	6.5	3.8	8.0	6.6	3.4	1.1	1.3	10.5	10.5
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30908242-30926459	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	7.2	7.8	6.3	12.5	8.6	6.9	6.8	21.4	11.4	4.2	6.5	8.9	6.2	6.2	8.8	6.2	20.6	6.3	7.4	4.9	7.4	6.4	12.0	13.5	7.3	12.9	5.6	9.3	8.8	12.5	8.5	9.7	5.1	7.9	6.0	8.1	4.6	8.2	10.5	9.4	11.0	7.4	4.4	6.3	7.8	8.6	8.3	3.4	13.4	8.2	4.6	10.0	4.8	6.1	1.8	1.3	0.1	0.9	0.2	1.8	0.5	8.6	6.9	3.7	14.8	3.1	2.3	0.1	1.2	0.8	1.2	1.1	6.0	4.9	6.5	5.1	0.9	3.4	0.0	10.4	0.0	1.9	3.4	8.9	7.8	5.8	0.6	2.7	1.6	0.0	1.8	2.6	3.7	0.8	0.4	0.9	11.0	0.0	7.4	3.0	0.0	2.5	0.0	0.9	0.0	0.9	6.1	0.0	6.3	4.9	0.0	4.5	0.1	0.0	3.3	3.7	3.2	10.1	4.1	1.6	9.2	0.6	0.5	0.1	6.8	10.5	13.5	0.0	0.3	6.1	0.0	0.2	0.0	1.1	0.9	1.8	1.8	1.0	1.6	1.0	0.7	0.6	0.3	0.1	0.2	0.6	1.3	1.2	0.5	6.3	8.6	21.4	11.4	7.4	6.4	5.6	9.3	7.9	3.4	6.0	15.1	9.3	4.8	3.5	6.2	11.0	10.2	6.7	4.5	8.7	0.0	7.5	1.7	5.3	1.2	3.8	10.5	0.0	6.1	9.2	3.5	2.0	12.7	19.2	8.2	7.9	12.6	8.6	7.5	0.5	3.7	4.9	1.7	8.2	7.2	2.9	6.7	5.9	3.9	10.7	5.7	0.0	3.4	9.1	8.1	3.6	2.9	7.5	8.6	3.3
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043475	Enhanced		Supported	Mitochondria		NA	NA		4000000	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (4.51e-4)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	26.2	31.9	27.8	18.7	40.5	25.1	59.7	34.2	55.4	29.0	39.1	24.2	19.9	31.8	25.5	20.3	63.7	25.0	18.5	141.7	28.1	24.1	38.2	24.4	23.2	23.0	27.6	37.7	29.6	38.9	37.6	18.4	24.1	36.5	24.2	40.3	23.0	30.5	30.6	99.7	30.7	30.5	43.7	27.9	17.8	31.1	30.4	16.9	15.6	27.5	31.9	30.0	33.7	39.1	44.8	63.2	39.0	62.9	36.0	49.6	54.6	41.9	34.7	42.0	53.2	37.5	51.1	44.1	54.6	61.6	59.9	56.6	52.3	40.2	50.0	30.7	45.6	33.3	56.5	76.9	54.1	58.9	27.1	44.8	29.1	29.4	59.0	37.5	55.2	32.4	45.2	64.2	51.0	109.3	84.4	44.2	31.7	49.1	40.8	62.9	31.0	35.5	45.0	36.1	47.6	134.3	42.6	33.3	31.7	58.9	26.4	26.7	31.5	30.1	101.0	63.8	51.3	58.8	24.8	34.1	29.9	41.0	44.2	58.5	32.9	44.8	51.6	43.4	54.7	25.4	39.0	51.5	38.0	32.5	54.0	39.6	44.8	44.7	36.4	63.2	36.0	45.5	41.7	17.7	36.0	62.9	30.8	49.6	54.6	27.8	40.5	34.2	55.4	28.1	24.1	27.6	37.7	36.5	16.9	89.3	45.7	134.1	325.8	338.7	144.0	304.7	142.7	73.6	99.0	106.4	41.2	263.8	567.0	389.3	129.8	150.9	543.9	46.7	300.7	379.6	156.9	217.1	110.7	72.5	237.9	122.3	143.7	133.8	127.5	75.8	157.3	179.7	212.6	317.4	241.2	222.4	375.0	269.6	156.3	255.3	119.1	174.6	229.6	245.4	142.7	367.4	331.6	102.2	304.0	486.8
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405897	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 187.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		9300000	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	19.9	18.8	26.0	13.7	29.8	18.6	17.3	38.3	39.1	16.0	23.7	14.5	12.3	19.1	19.1	17.7	26.8	21.5	13.9	85.8	28.2	35.3	27.9	22.1	12.5	14.6	32.5	24.6	18.1	15.0	17.5	16.5	15.4	44.3	17.6	26.2	16.0	22.2	20.8	187.5	13.0	22.7	22.1	19.6	17.3	16.6	27.4	13.0	20.5	21.6	39.7	18.4	23.1	13.3	34.4	59.4	47.5	44.4	31.4	52.4	81.9	48.6	49.1	38.6	41.1	32.6	28.4	19.2	39.0	33.3	50.2	46.0	37.8	41.7	50.0	37.5	33.0	45.3	31.2	52.1	41.8	55.3	25.4	43.0	76.1	32.8	53.8	23.3	36.6	42.5	22.1	31.8	38.0	17.7	33.5	60.9	44.5	59.6	35.0	51.0	27.0	78.2	42.1	45.9	62.4	32.0	41.4	71.1	35.4	53.9	43.4	34.1	29.3	24.7	29.3	24.5	29.8	61.9	28.0	32.5	19.5	34.1	48.6	37.7	32.6	54.2	57.1	26.2	51.8	32.9	31.1	44.4	47.5	42.1	43.8	42.4	34.4	45.1	41.7	59.4	24.2	45.1	43.3	22.0	31.4	38.5	43.8	52.4	81.9	26.0	29.8	38.3	39.1	28.2	35.3	32.5	24.6	44.3	13.0	41.7	19.5	49.6	71.1	57.4	83.7	294.5	58.6	89.7	33.0	62.8	33.4	118.8	260.2	101.6	108.7	64.1	58.2	46.7	78.4	84.2	75.7	46.5	54.3	48.2	122.7	130.3	45.9	60.2	53.6	110.3	64.2	66.6	69.2	161.5	75.4	54.5	76.5	66.6	91.6	145.2	76.0	64.7	82.1	279.8	154.0	61.9	48.7	63.7	98.4	64.8
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 23.9;Exocrine glandular cells: 24.1;Hofbauer cells: 29.0;monocytes: 28.9;Pancreatic endocrine cells: 26.6;Proximal tubular cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	23.5	29.1	14.2	15.9	17.4	16.5	17.0	17.1	19.4	16.2	23.4	20.8	12.1	25.5	17.8	13.8	20.6	15.4	17.6	21.3	17.1	11.9	29.2	28.6	19.9	18.1	18.3	16.9	16.8	23.9	14.5	14.7	20.9	15.6	15.9	23.7	22.1	17.3	15.3	30.8	16.8	31.2	19.7	17.4	24.6	21.5	7.4	17.8	21.3	16.7	13.3	20.6	23.0	16.1	19.6	24.2	40.3	30.2	24.9	26.9	24.5	12.2	5.8	12.8	10.8	23.6	21.3	14.2	12.3	27.4	11.4	16.7	8.0	13.4	8.8	4.6	28.3	26.8	6.1	13.6	13.2	10.9	21.1	9.8	14.9	5.9	7.7	20.6	11.0	10.2	18.4	13.1	13.0	21.1	20.1	21.0	16.6	9.4	19.7	21.5	5.8	18.9	9.4	14.2	19.4	5.7	17.5	6.1	12.9	13.9	9.5	10.3	14.0	8.5	16.6	26.1	17.1	15.7	8.9	16.6	12.9	4.5	13.6	7.1	30.3	30.5	12.2	20.4	18.9	14.1	23.5	24.5	40.3	26.9	30.2	25.0	19.6	23.2	24.4	24.2	14.7	21.5	22.6	25.4	24.9	26.3	9.6	26.7	24.5	14.2	17.4	17.1	19.4	17.1	11.9	18.3	16.9	15.6	17.8	8.9	21.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	8.7	0.0	13.0	18.3	23.9	0.0	0.0	0.0	0.0	24.1	21.0	0.0	0.0	8.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	28.9	0.0	0.0	26.6	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0
VPS35L	"C16orf62, MGC16824"	ENSG00000103544	"VPS35 endosomal protein sorting factor like"	Q7Z3J2	16	19555240-19706793	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 24.9;Distal tubular cells: 24.9;Hofbauer cells: 37.3;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042969, HPA053547"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042969: AB_10794920, HPA053547: AB_2682183"	"unprognostic (7.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.31e-8)"	"unprognostic (1.82e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-2)"	19.1	22.5	21.3	13.5	28.6	10.6	15.3	20.1	35.0	21.4	16.5	44.4	9.9	12.5	27.9	21.4	16.1	18.6	16.4	16.1	21.8	21.1	20.7	15.9	14.7	13.9	23.5	14.0	22.7	14.3	37.9	24.6	18.7	28.8	15.4	18.4	22.6	15.4	18.6	18.2	12.5	13.5	23.8	23.9	25.5	12.6	26.1	21.6	16.0	21.5	9.3	15.3	17.2	14.5	11.7	25.5	12.6	23.8	21.9	14.7	15.6	9.0	16.1	15.0	12.0	19.3	27.1	2.3	13.4	22.4	14.7	17.0	2.3	15.8	11.0	29.2	22.1	0.1	2.5	11.8	7.1	16.2	0.6	6.5	6.4	14.5	0.2	25.7	10.4	13.5	19.4	10.3	13.5	8.6	20.8	23.4	5.4	8.8	2.6	23.9	6.4	9.1	2.7	9.7	1.5	2.0	7.8	4.8	2.7	16.2	2.0	9.3	9.4	16.4	0.5	7.4	12.2	5.5	9.1	24.3	7.5	7.1	10.5	1.4	10.1	17.9	4.1	14.7	8.5	11.9	12.6	21.1	9.4	11.9	23.8	14.7	9.2	11.5	11.7	25.5	11.7	13.4	11.9	2.5	21.9	20.8	6.7	12.0	15.6	21.3	28.6	20.1	35.0	21.8	21.1	23.5	14.0	28.8	21.6	6.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	14.8	15.7	0.0	24.9	24.9	16.2	0.0	0.0	0.0	0.0	14.9	15.4	0.0	0.0	3.5	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	12.6	0.0	0.0	10.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 7.7;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028007, HPA069692"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA028007: , HPA069692: AB_2686172"	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favorable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.3	4.5	6.1	6.4	7.8	17.6	6.6	5.8	8.3	6.1	7.3	11.3	4.7	15.2	9.5	9.3	3.7	7.0	10.9	9.9	9.4	8.2	14.2	7.2	12.1	10.8	15.9	11.6	4.1	13.4	7.7	8.9	16.3	8.1	9.1	6.7	11.2	11.1	11.3	12.0	6.9	6.7	8.2	7.8	9.3	5.1	20.2	7.7	16.7	14.5	9.0	5.5	9.1	12.7	13.1	11.2	5.6	9.1	6.9	6.7	8.0	12.5	11.0	5.4	3.6	6.7	8.2	9.8	12.3	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1	8.9	10.5	8.8	16.5	8.5	6.3	9.2	7.6	16.0	10.3	10.4	5.9	14.1	14.9	9.0	52.2	6.8	5.2	0.0	10.3	13.0	10.8	11.7	8.1	7.3	8.4	6.4	6.4	1.8	7.3	24.7	9.2	6.3	10.1	15.4	9.5	4.9	9.1	3.5	7.8	12.6	7.7	6.5	9.5	3.5	5.9	9.4	16.7	6.4	14.6	11.3
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	6.2	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.7	26.8	8.7	12.9	14.7	21.1	6.6	10.5	9.9	18.6	12.4	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	21.1	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7	98.3	43.8	19.4	25.3	99.0	23.8	42.4	45.9	41.5	50.0	33.2	29.5	23.4	5.0	19.2	178.7	37.6	21.6	0.0	20.3	11.8	51.5	39.3	46.2	31.0	44.5	36.5	34.0	44.2	119.9	79.7	34.2	49.8	43.9	12.6	40.3	16.9	26.6	25.9	26.5	17.0	22.9	19.4	41.9	36.4	24.6	107.0	57.1	31.6	23.8	59.3
WDR70	FLJ10233	ENSG00000082068	"WD repeat domain 70"	Q9NW82	5	37379212-37753435	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043064, HPA048149"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA043064: , HPA048149: AB_2680287"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.11e-2)"	17.5	13.4	15.4	21.9	22.8	16.3	17.7	30.9	21.1	15.7	16.3	12.0	16.9	10.4	19.6	13.5	15.0	15.6	10.0	13.0	15.8	8.7	11.2	11.8	13.0	18.8	16.2	13.0	18.6	13.9	12.6	14.4	14.0	17.9	13.2	14.3	7.9	15.6	14.4	36.3	17.2	13.3	16.2	18.3	14.0	13.9	12.7	16.5	13.9	13.2	8.4	15.1	17.4	15.7	12.7	15.8	12.6	17.5	11.1	10.3	7.1	9.2	6.1	12.2	15.3	12.4	12.2	16.6	11.8	11.1	13.6	11.6	10.0	9.6	15.1	7.0	11.4	10.6	8.6	10.1	10.8	15.3	14.4	12.6	11.4	18.7	7.0	9.3	19.1	10.2	11.7	8.3	10.4	14.5	10.5	11.2	11.4	14.2	6.3	8.5	6.2	12.3	9.4	8.4	7.4	10.9	14.2	30.5	15.4	6.9	11.1	10.5	9.9	39.1	8.7	8.5	9.7	11.4	12.1	12.8	12.5	12.0	12.1	9.3	8.4	12.5	17.5	8.3	17.1	10.3	6.2	14.5	12.6	8.8	17.5	9.7	11.4	10.3	9.5	15.3	12.7	10.2	9.8	3.5	11.1	15.8	15.8	9.8	7.1	15.4	22.8	30.9	21.1	15.8	8.7	16.2	13.0	17.9	16.5	29.8	26.1	27.6	11.3	8.1	35.4	17.3	12.7	30.8	12.5	8.7	35.3	21.8	16.6	16.0	16.9	15.5	15.1	0.0	18.0	22.3	13.1	6.6	19.6	20.9	16.6	23.8	13.3	18.4	24.4	5.4	27.3	19.8	11.8	21.6	20.9	20.1	14.0	17.5	21.2	10.3	56.8	12.9	11.7	31.2	27.5	6.8	18.5	20.2	23.2	8.6
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;ovary: 44.7"	"Group enriched"	"Detected in many"	8	"Leydig cells: 46.9;Peritubular cells: 94.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.5;HEK 293: 4.1;K-562: 6.3;NTERA-2: 5.2;RPMI-8226: 11.1;SK-MEL-30: 4.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 234.6"					"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favorable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.8	6.6	13.4	1.6	40.6	1.1	1.9	5.5	15.1	1.2	1.4	3.8	1.0	3.6	4.2	21.8	2.1	9.9	3.5	4.6	30.0	5.1	3.3	1.3	1.3	1.4	4.0	12.1	44.7	2.4	1.6	5.6	1.0	1.5	5.5	1.3	0.8	4.5	5.9	23.0	1.7	3.5	5.2	1.7	1.7	6.3	27.6	7.8	0.0	2.8	2.9	2.3	3.2	0.8	0.8	2.1	2.6	1.2	0.9	1.3	0.2	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	18.5	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.1	0.0	0.1	5.2	0.0	3.6	0.0	0.0	11.1	0.0	0.0	1.8	1.6	0.1	0.1	4.5	2.6	0.4	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.6	0.5	0.9	0.3	0.7	0.6	0.7	0.9	0.3	0.3	0.8	1.3	0.8	1.2	0.9	1.2	2.1	0.5	0.2	13.4	40.6	5.5	15.1	30.0	5.1	4.0	12.1	1.5	7.8	0.0	0.0	0.0	1.3	1.9	4.9	8.9	0.0	8.1	2.3	3.5	2.0	0.0	3.3	3.7	1.3	1.1	1.3	0.0	3.1	0.1	0.9	1.1	0.0	0.4	4.7	4.8	1.7	0.6	0.0	3.0	46.9	0.0	5.0	0.0	0.5	5.4	2.3	0.8	94.4	3.5	2.7	6.5	2.1	0.5	3.0	0.4	0.0	0.0	1.9	0.3
WISP3	CCN6	ENSG00000112761	"WNT1 inducible signaling pathway protein 3"	O95389	6	112054072-112070969	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;cerebellum: 5.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 11.2;THP-1: 3.6;U-2197: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA			Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0.0	0.3	0.4	0.3	1.1	0.0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2.0	0.5	1.7	1.2	0.2	0.1	0.0	0.3	1.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.3	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.7	0.3	0.1	0.0	0.2	0.9	0.4	0.1	0.2	0.3	0.1	0.3	0.0	11.2	0.5	0.6	0.1	0.2	0.9	0.4	0.2	3.6	0.2	0.2	0.2	2.6	0.3	0.3	0.0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2.0	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9	0.0	0.0	0.0	2.7	0.7	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	82.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	6.5	0.0	0.6	0.7	0.6	0.1	0.0	0.0	2.1
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	32.9	18.7	19.1	36.3	45.0	36.4	26.1	15.4	28.7	37.9	26.5	59.6	17.6	23.8	47.1	34.6	21.7	34.8	45.8	28.7	23.4	20.7	31.5	15.0	48.4	26.9	56.2	29.6	38.4	21.0	18.0	25.8	61.9	39.5	26.9	27.1	37.6	17.7	29.1	17.0	18.3	23.2	38.1	57.4	55.7	26.0	18.1	48.0	17.9	22.0	12.9	28.8	29.5	30.9	10.6	26.3	27.9	31.1	8.2	12.1	9.0	11.9	8.5	26.7	15.3	16.9	21.0	28.7	10.7	15.2	8.4	16.4	12.7	4.8	12.1	12.2	14.6	10.7	11.4	16.1	7.9	12.8	33.4	13.1	19.2	15.3	12.8	31.9	13.2	28.4	25.3	10.8	12.3	7.5	13.0	33.6	12.7	19.2	11.6	15.0	7.4	16.9	15.1	7.9	6.5	7.0	13.9	14.5	7.2	12.6	9.8	8.6	11.7	11.1	11.2	14.5	33.5	9.0	17.6	18.6	10.5	8.0	14.2	10.1	5.2	13.2	12.3	9.9	10.5	9.3	21.4	16.2	27.9	9.4	28.1	11.2	9.1	7.8	10.2	26.3	10.6	7.5	8.5	15.2	8.2	31.1	8.6	12.1	9.0	19.1	45.0	15.4	28.7	23.4	20.7	56.2	29.6	39.5	48.0	205.4	388.8	133.9	158.7	221.3	81.0	61.8	112.1	108.4	153.6	226.8	327.9	278.3	23.2	90.7	148.8	245.0	158.8	46.7	56.5	165.8	262.8	163.6	159.4	41.9	187.7	77.9	186.5	265.8	360.3	17.5	130.9	273.2	187.3	65.9	159.4	241.1	67.5	164.9	115.2	20.0	357.0	122.9	185.4	104.8	96.4	245.0	597.5	103.6	107.7	135.9
XAF1	"BIRC4BP, HSXIAPAF1, XIAPAF1"	ENSG00000132530	"XIAP associated factor 1"	Q6GPH4	17	6755447-6775647	"Predicted intracellular proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2"									HPA057302	Approved		Supported	"Nucleoplasm,Mitochondria,Rods & Rings"		Yes	NA			Mitochondria	"Nucleoplasm, Rods & Rings"	"HPA057302: AB_2683405"	"unprognostic (6.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.09e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.08e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.73e-7)"	"unprognostic (2.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.15e-3)"	32.8	7.5	12.2	27.0	13.2	17.5	14.4	4.3	14.0	12.8	10.5	8.9	11.4	15.3	15.6	22.4	11.8	12.0	20.1	13.1	10.7	7.9	19.1	37.9	25.1	15.8	11.0	9.6	34.6	2.7	2.2	8.6	15.2	16.4	13.2	10.1	9.9	26.4	9.0	9.1	10.7	14.4	14.7	10.8	35.0	14.0	5.4	11.0	17.3	10.5	9.2	11.3	12.0	13.4	4.3	7.7	13.1	11.6	7.7	8.5	5.3	2.0	0.1	0.2	0.5	2.8	6.3	0.2	2.5	10.4	33.1	34.2	0.2	3.0	0.5	0.8	3.8	11.9	1.2	0.0	0.5	3.8	4.5	0.1	0.7	0.3	0.4	15.2	0.4	3.1	2.9	0.0	4.4	0.1	0.1	2.7	9.6	0.2	10.8	1.0	0.1	2.2	8.8	0.2	0.1	0.8	4.3	0.1	0.2	0.0	1.9	0.2	0.2	1.2	0.2	5.5	0.2	0.3	12.1	0.3	0.4	0.3	0.9	0.2	1.6	0.5	0.2	0.9	7.2	0.8	13.1	8.8	4.2	7.5	11.6	5.7	3.3	5.9	5.2	7.7	4.3	4.0	4.1	10.6	7.7	10.7	0.8	8.5	5.3	12.2	13.2	4.3	14.0	10.7	7.9	11.0	9.6	16.4	11.0	56.6	31.7	5.4	5.3	4.6	0.2	1.6	12.7	36.1	50.0	0.0	0.0	0.1	0.0	1.1	3.1	24.8	8.1	23.3	1.7	3.5	8.7	2.7	46.3	13.6	15.0	0.0	1.7	28.8	16.4	0.6	33.6	22.5	5.0	3.6	8.4	1.0	6.2	0.0	25.8	0.2	0.3	19.4	3.9	0.3	0.6	2.4	0.3	13.8	6.6	5.4
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.4	0.1	0.0	0.4	1.6	8.9	0.0	0.0	0.0	2.4	25.2	1.4	0.0	0.0	13.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.2	6.4	0.1	0.9	0.1	11.9	3.2	0.4	3.2	0.0	0.0	11.4	0.0	0.6	2.4	0.0	0.4	0.8	0.0	0.5	1.2	3.2	0.0	0.0	0.4	0.0	1.4	5.5	9.1	0.0	0.1	6.9	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2	0.0	0.6	0.0	0.2	0.3	0.5	5.9	0.0	1.4	0.0	0.0	5.9	0.1	0.0	0.0	0.9	0.0	21.1	23.3	2.6	0.1	0.0	1.1	0.0	0.8	0.1	3.2	5.8	0.0	0.0	0.2	0.0	0.0	1.7	0.0	12.1	0.0	1.2	8.6	0.7	0.0	0.9	0.0	1.7	4.6	4.3	1.0	0.0	0.0	10.8	0.4
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669365-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.1"	"Cell type enriched"	"Detected in many"	11	"Spermatocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;hTCEpi: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0.0	4.9	0.7	2.5	1.1	0.7	4.1	1.0	2.3	1.5	1.0	7.5	2.1	1.0	1.3	7.3	1.0	1.3	0.3	2.1	0.8	7.4	1.4	1.0	2.6	2.0	0.2	0.9	1.7	9.6	3.5	1.7	1.0	3.6	17.1	0.7	0.0	1.0	0.0	1.0	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.9	0.3	0.8	0.4	0.0	1.0	0.6	1.6	0.8	0.5	1.7	5.4	0.4	0.5	2.7	0.1	1.9	0.1	0.1	0.9	2.0	0.8	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	11.1	0.3	0.0	0.5	0.0	2.6	0.2	3.9	0.3	0.5	0.7	0.6	2.2	0.1	0.5	0.5	1.1	0.2	0.3	2.9	2.4	0.4	0.9	1.6	0.5	0.3	0.5	0.2	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.5	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7	6.0	2.1	0.0	3.1	2.4	2.3	0.4	2.5	4.0	4.5	0.0	7.9	0.8	0.0	1.0	4.0	0.1	1.2	0.0	3.9	0.3	0.7	1.1	0.0	0.5	0.3	1.6	0.0	0.0	0.0	2.9	0.9	0.2	0.0	0.0	1.0	1.5	5.3	0.2	0.4	0.3	5.4	0.0	0.3	89.2	5.1	0.6	0.8	0.0	0.1	1.8
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 196.2;Late spermatids: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	8.2	13.6	7.5	5.8	9.2	4.7	9.7	5.2	7.8	7.3	6.1	10.8	11.6	32.3	10.7	12.3	7.2	9.4	10.5	11.2	7.6	7.1	9.8	19.0	6.6	10.6	7.9	6.1	10.7	10.5	8.0	15.0	6.1	10.7	7.3	6.2	9.3	8.5	13.6	12.0	11.5	20.9	7.1	9.3	7.7	6.8	18.9	8.2	11.5	9.1	7.3	8.8	12.6	8.2	5.9	6.0	6.4	10.0	1.2	4.4	4.0	3.3	4.7	3.2	7.1	9.0	6.0	2.2	4.1	3.1	2.3	2.3	3.9	2.1	6.5	2.3	7.9	9.7	7.6	6.0	3.2	3.4	3.9	12.4	4.2	9.3	7.3	4.1	7.4	0.7	5.3	5.0	7.2	4.3	3.5	4.0	4.6	3.5	5.9	4.9	5.0	3.5	3.9	1.9	6.0	9.6	4.9	4.3	3.7	6.5	4.4	2.8	2.5	4.1	6.1	3.8	3.5	7.1	3.4	4.0	4.7	4.1	4.3	2.4	5.6	4.2	7.9	7.2	9.6	3.2	4.0	4.4	4.4	3.4	3.9	1.8	5.9	2.1	2.2	3.1	3.7	4.4	3.3	6.4	1.2	10.0	6.0	3.0	4.0	7.5	9.2	5.2	7.8	7.6	7.1	7.9	6.1	10.7	8.2	6.0	21.2	6.5	6.9	11.7	14.9	17.6	20.4	29.4	13.6	8.7	17.7	17.8	13.3	11.7	196.2	11.7	4.2	0.0	14.7	16.0	11.3	6.7	13.9	32.1	12.4	15.9	13.3	11.1	13.5	233.7	18.4	13.0	16.9	2.8	9.5	12.1	10.8	9.7	14.5	18.6	19.3	32.3	13.2	50.5	32.5	14.3	16.7	5.0	10.6	6.2
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755902	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	12.6	15.8	11.0	12.6	15.3	13.9	13.8	11.6	14.9	13.1	11.8	11.5	18.4	9.8	13.3	12.9	17.5	11.3	9.1	12.1	11.9	9.7	12.4	16.3	9.2	15.5	10.8	11.7	13.3	21.0	11.0	16.6	15.9	13.5	12.9	13.7	11.3	17.4	10.0	15.9	12.0	10.8	11.1	12.6	13.3	12.3	12.5	12.6	17.5	12.3	16.0	16.4	13.3	11.8	11.8	9.5	9.4	9.9	12.9	12.7	5.2	9.4	11.4	6.7	7.9	7.3	8.6	21.0	7.2	7.4	9.0	8.8	28.5	12.1	17.1	11.9	7.3	13.0	12.3	13.2	19.1	10.2	7.4	20.7	11.3	8.6	15.8	10.6	12.0	6.6	8.0	12.2	8.5	15.5	11.6	14.2	9.1	15.9	7.9	9.4	7.7	8.9	14.5	36.6	6.3	14.0	10.1	14.2	10.1	11.4	13.6	10.3	5.0	11.1	9.7	7.1	27.1	18.1	10.9	9.5	8.5	9.0	13.8	12.2	4.7	5.0	17.8	7.9	9.0	7.0	9.4	7.0	4.1	10.1	8.9	10.6	8.8	10.7	10.4	9.5	11.8	11.2	12.7	1.4	12.9	9.9	9.3	9.3	5.2	11.0	15.3	11.6	14.9	11.9	9.7	10.8	11.7	13.5	12.6	6.0	4.1	13.7	17.3	9.0	16.5	6.9	2.5	5.3	7.9	10.4	19.6	29.4	6.6	17.0	4.4	5.7	5.2	23.3	14.2	29.0	10.7	7.9	6.9	4.5	17.9	14.3	6.9	5.5	7.0	2.8	9.8	5.5	5.0	19.0	6.6	11.6	12.2	10.4	8.1	9.3	18.8	12.9	6.2	4.9	14.7	7.3	15.0	12.1	11.5	11.4
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 137.6;Syncytiotrophoblasts: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	11.8	16.4	9.2	8.3	9.3	13.5	12.9	12.0	16.8	16.0	13.8	11.9	15.3	17.0	14.4	26.7	17.1	17.6	16.7	11.9	9.7	10.6	16.4	34.3	11.8	9.6	10.7	10.3	18.4	56.4	11.1	40.7	35.5	11.9	14.0	8.4	16.6	53.5	20.7	11.1	11.2	14.6	8.8	8.4	10.2	18.4	52.0	10.6	11.0	22.1	12.9	12.5	13.9	13.8	10.8	22.3	16.2	14.7	7.2	9.8	6.7	23.4	8.7	5.8	9.2	14.7	13.8	11.9	18.8	21.8	12.8	18.2	25.8	19.4	4.6	30.7	19.3	6.3	18.3	4.5	18.0	3.6	15.1	16.3	9.1	9.7	13.9	24.0	15.3	19.0	13.5	12.8	9.0	14.0	18.5	9.9	11.6	11.4	25.1	8.7	40.0	9.6	15.6	11.1	16.3	20.9	8.4	5.4	23.4	12.2	11.1	17.4	8.7	13.1	20.9	17.7	5.9	19.9	21.3	14.5	16.1	6.0	23.4	13.3	37.4	14.5	8.5	25.7	26.9	17.1	16.2	13.2	5.6	9.8	14.7	7.6	10.8	7.9	9.0	14.8	7.2	7.0	9.8	2.1	7.2	12.4	22.3	7.8	6.7	9.2	9.3	12.0	16.8	9.7	10.6	10.7	10.3	11.9	10.6	14.9	20.5	9.3	35.0	6.1	17.3	0.4	20.4	21.4	17.0	33.2	15.7	94.1	23.2	58.8	86.2	17.8	35.4	23.3	70.3	97.9	24.7	46.0	21.8	21.7	35.3	17.5	41.7	19.0	13.7	19.8	32.5	13.1	5.0	26.2	53.9	20.9	45.9	45.6	24.1	19.5	15.3	6.5	13.3	137.6	10.6	6.0	145.8	12.8	47.0	38.9
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.8"	"Group enriched"	"Detected in many"	16	"Early spermatids: 137.6;Late spermatids: 456.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEK 293: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060789	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060789: AB_2684366"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	1.2	0.9	24.2	1.4	47.8	0.8	1.0	0.8	26.5	1.1	1.3	1.1	0.0	1.0	1.3	6.6	1.0	1.6	0.9	0.8	29.5	8.3	1.0	0.8	1.4	1.4	7.7	10.2	1.1	1.0	1.7	0.8	1.3	3.6	2.0	1.6	4.1	0.9	1.5	1.6	3.0	1.6	1.2	1.0	1.1	1.4	7.1	5.1	0.0	1.7	0.0	1.3	1.5	0.0	0.5	0.5	0.3	1.1	0.0	2.2	0.3	0.3	0.8	1.9	0.8	0.3	0.5	11.4	0.5	0.1	0.5	0.7	0.9	0.6	0.4	1.5	0.1	0.2	1.1	0.3	0.2	0.0	0.1	13.4	0.0	1.6	0.0	0.1	0.3	0.6	0.1	0.6	0.3	0.4	0.1	0.0	0.9	0.9	0.6	0.0	1.0	0.0	0.1	3.6	0.0	2.6	2.1	0.4	0.4	0.0	0.1	0.3	3.2	0.2	0.0	0.2	0.6	1.3	1.6	0.7	0.3	0.7	3.5	0.8	3.2	2.2	0.6	0.2	1.7	0.4	0.0	0.7	0.0	0.7	1.1	0.8	0.3	1.2	0.6	0.5	0.5	0.7	1.1	0.3	0.0	0.7	0.0	2.2	0.3	24.2	47.8	0.8	26.5	29.5	8.3	7.7	10.2	3.6	5.1	8.9	0.3	1.3	2.5	1.8	18.1	1.6	2.5	2.7	6.8	0.0	9.8	1.3	1.7	1.7	137.6	1.6	4.7	0.0	0.5	1.0	2.7	2.1	1.1	1.0	1.0	9.5	5.2	1.8	0.3	456.0	3.4	1.5	1.7	0.0	6.3	7.2	0.5	3.5	1.8	0.3	14.9	6.5	3.9	14.0	9.6	3.6	1.5	2.9	5.0	0.9
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200968-44214294	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No			Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	26.5	21.9	35.1	21.4	30.6	31.1	23.1	19.0	32.2	21.8	27.6	26.5	27.9	21.1	21.0	32.6	31.1	16.0	16.8	22.3	34.9	33.5	24.4	17.3	19.6	25.7	36.1	24.0	14.3	51.2	29.7	21.6	25.7	26.8	21.3	26.7	18.3	39.1	24.6	29.1	21.8	21.7	27.1	31.4	20.5	24.9	27.3	25.1	22.2	21.0	23.4	26.3	17.5	15.5	7.7	11.1	15.7	12.8	7.2	12.4	6.3	22.6	23.9	20.1	28.1	25.3	22.2	16.6	45.7	35.1	25.6	26.0	25.1	18.8	21.6	20.6	44.8	49.3	28.0	24.6	30.2	32.7	26.0	23.5	12.6	17.7	15.7	31.7	26.7	23.1	20.7	29.6	31.2	33.4	22.7	30.8	19.9	29.2	16.0	33.9	23.4	19.9	29.7	49.2	30.4	40.0	21.9	18.2	18.6	21.1	19.1	23.6	46.4	21.7	34.7	24.7	29.8	27.3	27.6	35.2	27.5	34.1	27.2	50.2	42.7	47.1	32.1	37.4	23.7	53.8	5.9	11.2	15.7	7.8	12.8	11.0	6.9	9.2	12.4	10.3	7.7	8.8	8.6	9.5	7.2	12.1	11.1	9.4	6.3	35.1	30.6	19.0	32.2	34.9	33.5	36.1	24.0	26.8	25.1	11.9	10.3	13.7	14.7	23.1	6.4	17.3	7.6	1.4	6.8	19.2	9.8	21.7	21.6	42.1	21.1	14.0	30.8	0.0	71.4	49.0	21.6	29.1	1.1	14.3	36.6	12.7	13.3	11.1	19.6	5.9	9.2	17.2	25.3	55.1	24.1	9.8	58.9	17.5	12.7	18.2	7.7	0.0	18.4	15.6	18.8	22.6	41.2	8.5	18.3	28.6
YME1L1		ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110112-27155266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA066953: AB_2685753"	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	27.8	37.3	22.7	25.0	26.2	41.4	39.2	27.8	27.5	27.6	24.3	15.7	29.8	22.3	29.9	35.9	34.5	25.3	24.4	34.1	23.4	21.5	26.8	45.4	26.9	38.7	19.3	25.5	32.5	33.8	27.8	28.6	33.4	22.0	25.9	26.3	23.3	28.1	31.3	79.0	26.8	25.3	34.6	20.2	26.5	24.7	24.7	20.9	41.7	30.9	32.0	28.9	36.4	28.9	55.6	79.2	73.9	53.0	45.5	56.0	45.9	40.9	30.8	36.8	18.2	36.2	38.9	30.1	40.5	23.7	41.5	47.7	41.5	50.4	43.6	26.9	44.6	29.8	39.6	44.2	35.7	45.9	39.6	26.5	41.5	27.4	29.1	39.7	28.3	34.1	31.9	42.3	36.2	36.7	36.7	43.4	39.9	48.1	44.5	45.8	27.7	52.3	16.4	29.2	34.2	14.4	45.3	59.1	40.4	33.9	19.5	28.4	36.4	40.4	31.4	40.5	31.8	30.1	35.5	42.5	25.2	35.2	42.2	36.2	22.4	32.8	55.8	35.8	52.6	19.2	53.0	53.0	55.2	55.3	44.8	56.0	51.4	53.8	51.2	42.6	55.6	49.7	51.9	73.9	45.5	47.3	79.2	52.6	45.9	22.7	26.2	27.8	27.5	23.4	21.5	19.3	25.5	22.0	20.9	62.5	66.8	93.1	70.6	62.3	52.1	93.2	25.5	80.3	70.5	27.9	78.5	53.8	13.3	45.6	37.7	61.8	166.4	0.0	41.6	60.0	62.5	67.3	107.5	64.8	64.5	47.7	48.2	55.3	92.4	21.3	53.5	112.2	54.0	43.3	68.3	59.1	53.7	84.2	40.7	38.2	67.9	71.1	75.6	83.7	30.3	56.8	79.3	84.7	70.3	58.6
YRDC	"FLJ23476, IRIP, SUA5"	ENSG00000196449	"YrdC N6-threonylcarbamoyltransferase domain containing"	Q86U90	1	37802944-37808185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 58.4;Urothelial cells: 71.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030147	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030147: AB_10603327"	"unprognostic (2.98e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.43e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.46e-2)"	10.8	10.0	7.7	9.3	8.0	41.6	13.0	10.6	13.1	8.2	9.6	9.8	7.2	8.2	8.3	8.8	16.3	8.8	13.5	9.0	8.6	9.0	11.7	22.5	9.3	16.2	8.1	7.4	8.1	19.7	7.5	11.3	22.2	8.5	9.2	12.2	8.7	12.5	6.6	13.0	14.6	11.9	9.5	7.5	11.2	10.2	20.6	7.0	13.5	9.3	11.5	12.0	9.1	9.2	1.6	1.6	9.6	1.1	0.9	2.1	0.7	10.5	7.6	8.2	10.4	5.7	6.6	23.7	8.8	7.1	13.9	8.8	10.1	10.2	25.5	14.4	8.7	16.0	8.6	15.4	14.1	13.0	15.3	15.4	17.8	9.3	10.5	12.6	23.1	18.5	6.8	21.2	15.4	22.4	9.1	9.7	19.7	27.6	11.5	11.0	7.5	13.4	13.7	30.8	15.4	16.2	13.6	13.3	16.6	11.4	10.8	21.4	22.1	9.5	12.3	30.0	15.3	6.7	10.3	9.0	12.0	12.5	13.1	28.9	23.7	33.2	21.2	10.5	15.1	19.1	9.6	1.1	0.9	1.2	1.1	1.1	1.0	1.7	0.9	0.9	1.6	1.9	2.1	1.3	0.9	0.7	1.6	1.7	0.7	7.7	8.0	10.6	13.1	8.6	9.0	8.1	7.4	8.5	7.0	0.0	8.6	8.3	58.4	45.0	10.7	3.4	15.3	4.0	4.5	5.2	5.9	21.5	19.9	5.2	2.7	12.0	6.4	0.0	7.9	42.6	12.4	31.3	6.9	9.8	11.4	20.6	15.0	7.4	6.7	1.8	3.7	9.6	5.0	3.6	9.8	9.4	12.2	5.8	3.9	11.7	8.0	6.5	18.9	15.1	35.7	43.2	34.0	10.0	9.6	71.6
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
ZBTB3	FLJ23392	ENSG00000185670	"Zinc finger and BTB domain containing 3"	Q9H5J0	11	62748319-62754188	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035321, HPA035322"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA035321: AB_2674569, HPA035322: AB_10610567"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (5.52e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (1.65e-5)"	"prognostic favorable (9.98e-4)"	"unprognostic (3.37e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.43e-2)"	4.7	6.0	5.8	5.3	10.7	5.5	7.7	6.5	10.9	5.3	6.0	17.8	7.4	5.8	7.9	5.3	6.2	11.1	5.9	7.6	6.1	4.8	5.6	6.8	7.3	5.5	13.1	7.1	6.8	11.5	6.8	4.2	5.6	8.5	5.2	5.6	7.2	8.6	6.2	6.3	14.2	6.7	4.8	6.6	7.9	12.2	9.7	12.1	10.8	7.2	4.2	7.2	5.9	6.0	6.0	7.2	12.3	10.0	6.7	7.9	7.4	3.3	5.0	4.2	5.5	8.0	4.0	3.6	3.5	3.9	4.1	3.7	3.3	4.3	5.2	5.4	3.7	3.0	7.1	3.7	3.9	2.0	6.0	6.2	2.8	10.6	3.9	3.9	4.3	6.0	4.3	4.6	3.2	4.9	5.3	3.4	4.4	4.9	5.7	4.1	6.6	5.2	4.8	12.4	2.5	2.5	4.0	3.3	5.1	3.2	4.3	3.9	3.6	3.7	4.8	2.6	6.3	6.8	3.1	3.1	6.3	2.8	4.4	2.0	5.8	4.1	4.4	6.0	2.5	2.5	2.2	10.0	12.3	6.0	7.8	7.2	6.0	6.1	7.1	7.2	5.5	7.1	5.5	3.6	6.7	6.4	2.1	7.9	7.4	5.8	10.7	6.5	10.9	6.1	4.8	13.1	7.1	8.5	12.1	3.0	2.4	0.8	1.5	0.7	2.3	2.5	2.5	0.0	1.2	0.0	5.9	3.2	6.6	2.4	11.4	1.1	1.3	0.0	1.7	1.8	1.9	0.7	0.0	2.5	2.0	0.0	0.0	0.6	2.1	6.6	1.4	0.8	0.0	0.0	2.9	1.5	1.8	3.7	2.8	1.9	4.1	0.0	1.0	3.4	2.4	1.0	2.1	0.7	1.9	1.1
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	11.9	10.4	10.7	11.8	12.2	5.2	12.9	17.7	13.2	13.7	9.4	9.0	10.7	10.4	12.6	8.2	11.6	9.4	7.3	9.7	10.2	9.4	11.0	9.2	12.4	26.2	15.6	10.3	13.8	10.0	11.6	14.0	14.1	10.5	10.2	9.0	6.3	9.9	11.4	14.0	10.0	15.0	10.0	13.2	14.0	9.7	9.5	14.4	22.7	13.8	10.1	16.0	11.1	9.3	2.1	2.3	11.8	3.9	3.8	4.0	2.4	4.1	4.8	7.9	7.2	8.4	8.1	8.0	7.0	8.6	7.0	6.3	5.0	5.3	6.6	4.4	6.3	6.3	19.0	8.2	8.6	8.8	9.3	6.5	7.0	10.4	4.6	8.3	9.2	12.7	6.6	13.1	6.4	10.7	8.7	6.4	8.4	7.3	8.2	10.1	7.7	9.3	6.2	9.9	12.3	8.3	5.0	21.7	9.2	7.4	6.8	10.0	12.9	10.8	10.6	6.6	8.7	13.3	6.1	6.5	7.7	6.0	7.8	8.0	14.4	17.2	1.8	9.0	6.3	7.8	11.8	2.3	3.3	2.0	2.5	2.7	2.1	2.8	1.9	2.3	1.7	4.0	3.5	3.0	3.8	3.9	1.3	2.9	2.4	10.7	12.2	17.7	12.1	10.2	9.4	15.6	10.3	10.5	14.4	6.0	2.2	0.0	2.7	1.9	7.3	2.8	7.6	4.0	9.1	1.8	9.8	1.7	0.0	2.1	7.6	2.9	2.6	0.0	2.1	1.0	2.5	3.2	7.0	2.4	2.1	6.4	2.9	7.4	9.2	3.2	2.8	5.4	1.7	1.8	4.2	7.4	2.6	3.4	7.4	3.3	9.1	6.5	2.5	5.2	3.0	2.4	1.6	5.1	3.3	2.7
ZC2HC1C	"C14orf140, FAM164C"	ENSG00000119703	"Zinc finger C2HC-type containing 1C"	Q53FD0	14	75064170-75079987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 75.7"	"Group enriched"	"Detected in many"	8	"Ciliated cells: 48.2;Early spermatids: 103.8;Late spermatids: 150.0;Spermatocytes: 54.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA050928, HPA065062"	Enhanced		Approved	"Nuclear speckles,Mitochondria"		No	No			"Nuclear speckles"	Mitochondria	"HPA050928: AB_2681277, HPA065062: AB_2732728"	"unprognostic (8.01e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (4.63e-13)"	"unprognostic (4.69e-3)"	"unprognostic (7.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.81e-1)"	0.7	2.1	2.3	0.5	5.3	0.2	1.3	1.8	3.4	1.5	2.0	2.3	4.6	2.5	1.0	18.2	1.3	8.2	1.5	2.9	3.0	3.0	4.3	6.8	2.2	0.1	2.3	2.3	0.8	3.6	5.2	10.9	3.3	4.7	1.0	1.8	1.2	2.3	5.7	3.0	1.1	1.9	1.0	1.9	0.6	1.2	75.7	2.3	0.6	5.9	0.5	0.4	1.2	0.4	1.6	0.6	0.8	0.3	3.8	3.8	0.8	6.0	4.7	1.0	5.3	0.3	0.3	2.8	0.5	2.1	2.7	1.2	7.7	11.1	5.6	4.3	0.5	3.7	2.4	0.0	0.1	1.9	5.9	0.6	1.4	1.6	2.7	3.7	0.1	3.7	1.1	0.6	3.4	0.1	3.1	1.6	0.4	8.0	2.5	1.3	1.3	0.6	0.7	1.7	3.5	3.3	0.1	0.3	2.7	6.0	0.4	9.7	2.3	3.5	3.1	2.8	1.0	4.4	1.8	0.8	1.7	1.9	2.9	1.1	5.6	8.3	2.9	2.4	1.0	0.9	0.8	0.3	0.8	1.9	0.0	0.5	1.6	1.6	0.5	0.3	0.8	0.7	0.8	0.4	3.8	0.2	0.6	3.8	0.8	2.3	5.3	1.8	3.4	3.0	3.0	2.3	2.3	4.7	2.3	6.0	8.9	0.9	1.5	1.5	4.4	5.6	5.1	48.2	10.3	10.4	9.8	1.9	3.3	3.2	103.8	1.7	2.6	0.0	1.2	1.0	1.3	2.0	1.1	3.9	1.4	11.1	5.1	1.8	1.0	150.0	2.8	0.9	3.3	1.0	3.1	3.1	1.5	0.0	2.5	5.7	8.4	6.5	0.5	54.1	5.3	0.6	4.2	0.0	3.3	0.8
ZCCHC24	"C10orf56, FLJ90798, Z3CXXC8"	ENSG00000165424	"Zinc finger CCHC-type containing 24"	Q8N2G6	10	79382325-79445627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038348	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA038348: AB_10669538"	"unprognostic (3.47e-3)"	"unprognostic (8.70e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.35e-6)"	"unprognostic (1.84e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.95e-3)"	27.9	9.0	30.9	9.5	54.4	1.8	9.8	11.1	36.0	22.9	19.8	56.8	4.2	4.6	18.0	6.9	10.3	15.5	16.8	19.1	30.6	19.7	3.5	13.5	10.2	4.8	56.7	23.5	20.1	4.0	3.9	3.0	11.4	36.2	14.5	6.8	4.5	6.2	20.7	34.8	5.0	5.4	25.6	36.8	7.0	9.0	6.6	51.9	0.0	6.0	2.5	3.2	14.9	7.3	0.0	3.4	0.6	2.4	0.7	0.9	0.5	0.9	0.9	3.2	2.8	43.5	37.4	0.8	7.5	28.5	4.5	5.2	0.8	0.0	0.0	4.1	15.1	1.5	0.0	0.5	0.1	3.8	1.8	2.0	0.4	2.3	0.9	11.3	1.1	0.6	38.8	0.4	4.0	1.1	13.3	0.9	0.2	1.4	1.6	3.8	0.3	0.0	4.4	0.7	0.2	9.3	0.2	3.8	0.6	0.5	1.2	0.1	4.0	2.3	0.3	9.4	3.2	1.1	2.1	0.6	4.3	4.0	11.7	2.5	2.9	1.9	0.0	8.8	1.4	15.3	0.0	2.4	0.6	0.9	1.1	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.2	0.6	0.7	0.1	3.4	0.4	0.5	30.9	54.4	11.1	36.0	30.6	19.7	56.7	23.5	36.2	51.9	0.0	1.6	0.0	1.5	6.8	0.0	16.5	7.6	1.4	1.2	0.0	0.0	0.6	0.0	0.8	1.7	17.0	0.0	0.0	0.7	0.8	40.7	3.6	1.1	44.7	8.5	0.0	0.0	57.1	15.9	3.7	63.6	6.8	15.1	1.0	0.4	16.4	0.7	0.0	61.5	1.4	0.7	12.9	21.2	0.7	1.0	4.0	1.3	4.3	0.0	1.1
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	0.9	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.3	0.4	2.6	7.3	0.0	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	8.4	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1	17.9	9.6	0.0	0.3	1.6	2.0	6.7	0.0	42.8	23.9	0.0	0.0	0.2	0.0	0.4	6.6	0.8	1.7	0.0	0.0	0.1	1.7	0.4	3.5	1.7	0.3	6.4	1.7	1.3	0.0	6.8	0.6	0.0	0.0	0.0	2.0	0.3	0.2	1.1	0.0	0.8	1.7	6.5	1.0	9.3	3.8	1.4	0.2	0.0	1.1	0.3
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710360-766952	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.3	1.8	2.9	0.0	3.7	0.0	0.6	11.7	5.3	0.0	1.1			3.8	0.5	0.4	2.8	3.4	0.5	3.8	3.9	2.9	0.4	0.6	5.3	0.0	2.8		0.8	2.4	1.5	3.7	0.1		0.6	1.9		1.0	0.4	3.3	4.8	5.9	0.0	2.5	3.3	3.8	0.8			0.7		0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.9	0.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.2	1.0	0.3	0.0	0.8	2.4	5.1	0.2	0.0	3.1	2.3	0.1	1.9	0.9	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.3	0.0	0.0	4.5	0.1	1.5	6.6	1.9	0.1	0.0	0.6	0.6	0.1	7.2	0.1	0.0	2.6	0.0	0.0	2.5	0.8	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1											17.9	16.5	0.0	1.0	2.4	6.1	7.3	2.5	36.1	10.3	3.5	0.0	0.0	0.0	0.6	1.1	1.1	2.4	0.0	0.7	0.0	1.1	0.4	1.1	1.6	1.3	9.5	2.9	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.3	0.5	0.1	0.6	0.0	0.3	0.2	6.5	2.1	1.0	0.8	2.8	0.0	0.0	1.7	0.8
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
ZKSCAN1	"KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33"	ENSG00000106261	"Zinc finger with KRAB and SCAN domains 1"	P17029	7	100015572-100041689	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006672	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		Yes	No			"Nuclear bodies"	"Nucleoplasm, Mitochondria"	"HPA006672: AB_1080707"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.09e-3)"	11.7	19.5	16.1	12.1	23.9	8.1	23.6	15.0	23.9	16.8	21.2	38.9	16.3	18.1	16.2	18.3	19.8	23.0	25.1	10.8	18.8	15.2	14.2	47.6	11.7	12.2	26.1	27.3	20.6	26.7	18.3	14.3	11.1	27.6	24.3	24.3	14.7	25.0	19.4	11.9	32.5	16.5	14.3	23.6	13.5	33.0	16.4	23.1	17.3	12.5	11.4	12.1	14.4	17.5	6.1	7.3	13.3	10.0	11.7	7.5	4.5	9.2	6.8	18.1	19.8	18.7	22.8	6.8	10.4	12.7	6.2	6.3	4.1	8.8	10.5	13.3	11.6	11.0	7.7	10.4	9.0	12.0	10.1	6.4	8.5	8.3	10.6	10.6	16.1	10.2	15.3	14.4	8.4	28.3	17.0	13.7	12.5	19.5	9.2	12.3	12.3	15.3	9.6	7.3	17.4	8.6	9.1	9.2	9.4	10.5	14.6	21.1	25.2	16.2	21.3	18.3	10.8	10.8	10.8	20.6	13.7	13.4	15.9	10.5	10.7	18.5	10.9	9.3	11.6	17.9	13.3	4.7	5.0	6.8	4.0	6.7	5.1	5.4	6.7	7.3	6.1	7.5	5.3	5.3	11.7	10.0	5.2	4.3	4.5	16.1	23.9	15.0	23.9	18.8	15.2	26.1	27.3	27.6	23.1	23.8	39.4	30.6	38.6	13.4	91.6	37.3	142.7	161.9	56.9	43.6	141.4	32.1	13.3	46.0	35.7	43.9	59.0	0.0	38.3	12.7	32.9	84.1	33.6	124.6	17.1	84.2	212.3	35.6	28.8	14.6	47.5	27.1	38.8	27.9	82.8	74.9	41.8	84.2	50.2	23.0	68.3	19.4	22.2	28.9	14.6	18.7	55.2	18.7	98.9	47.9
ZMAT2	"FLJ31121, hSNU23, Snu23"	ENSG00000146007	"Zinc finger matrin-type 2"	Q96NC0	5	140698680-140706676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036518	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA036518: AB_10671960"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.38e-3)"	"unprognostic (6.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.84e-2)"	25.3	25.1	36.7	19.9	50.4	32.1	31.9	31.2	52.4	23.6	26.7	16.0	24.9	17.7	27.7	29.1	29.7	27.1	17.6	18.1	60.2	27.6	31.2	29.4	21.3	25.3	28.4	53.8	26.5	17.6	36.5	21.9	24.1	33.6	22.7	30.0	13.9	24.6	26.5	102.9	25.1	19.9	25.2	36.1	26.2	24.7	15.2	19.8	24.4	23.7	29.8	33.9	20.9	30.7	12.3	11.8	42.5	15.1	11.2	17.1	11.5	22.3	37.6	24.5	41.7	40.2	27.0	33.0	23.4	25.6	32.5	35.6	57.6	37.4	25.2	37.9	40.0	36.5	21.5	34.6	46.7	41.4	27.5	30.8	20.4	45.5	40.0	25.5	47.5	27.1	31.0	36.0	33.5	39.2	32.5	27.4	40.6	22.7	28.1	29.9	34.3	38.4	33.4	18.2	15.8	24.2	26.9	28.9	27.4	28.5	32.8	29.1	22.3	32.9	33.1	34.3	36.3	45.3	41.8	22.7	28.6	15.4	14.8	35.7	18.4	37.3	28.5	30.5	33.2	21.7	20.9	15.1	23.6	13.4	12.3	17.1	12.3	14.8	13.7	10.9	12.0	14.0	14.7	42.5	11.2	12.0	11.8	13.9	11.5	36.7	50.4	31.2	52.4	60.2	27.6	28.4	53.8	33.6	19.8	47.6	66.5	76.7	61.0	50.5	28.3	71.2	79.0	100.4	79.6	66.3	5.9	109.7	99.5	67.5	6.5	62.6	68.8	163.5	58.5	105.3	53.9	57.5	77.7	83.2	72.9	15.9	66.0	46.6	91.4	9.8	52.3	72.0	55.6	129.0	47.6	71.0	61.9	73.7	54.5	126.4	18.0	51.8	51.5	36.1	75.4	55.3	173.5	79.8	53.0	81.0
ZMIZ2	"DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7"	ENSG00000122515	"Zinc finger MIZ-type containing 2"	Q8NF64	7	44748581-44769881	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040716	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA040716: AB_10805826"	"unprognostic (2.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.15e-3)"	14.3	16.0	31.7	24.5	31.5	19.8	13.3	24.0	43.2	12.7	15.2	22.9	17.5	23.8	16.4	16.8	16.8	17.3	17.3	15.9	28.2	15.4	19.0	10.1	18.3	24.0	17.0	27.2	17.9	32.3	19.8	23.0	11.0	17.0	16.4	12.5	16.5	32.5	23.0	18.7	31.1	22.2	17.9	16.5	28.8	21.3	20.8	17.5	16.7	25.1	14.0	19.1	15.5	13.2	4.9	4.1	1.0	2.4	3.4	2.5	0.9	14.4	16.6	7.8	15.0	5.3	3.5	8.2	7.4	7.1	6.4	7.7	9.4	22.7	9.9	11.7	7.7	15.9	19.8	4.8	8.4	3.8	23.5	9.2	4.0	15.6	7.4	10.9	5.7	8.9	5.4	5.2	10.0	6.6	5.7	11.8	10.8	11.7	22.6	9.3	13.8	12.7	15.9	14.7	11.0	16.2	15.9	4.3	12.9	7.5	11.1	27.7	18.3	10.0	19.6	4.5	7.7	18.6	8.9	17.5	6.1	13.4	16.4	17.0	33.3	10.5	7.7	11.8	10.2	24.9	1.0	1.6	0.7	2.5	2.4	1.6	2.7	1.2	1.8	1.6	4.9	0.8	0.9	0.7	3.4	1.2	4.1	1.1	0.9	31.7	31.5	24.0	43.2	28.2	15.4	17.0	27.2	17.0	17.5	11.9	19.2	10.7	3.8	9.0	10.7	14.5	2.5	8.1	11.4	22.7	13.7	6.7	1.7	15.0	24.7	12.3	15.8	0.0	13.5	2.1	9.7	8.2	13.9	14.5	9.7	11.1	19.1	15.4	17.9	62.4	12.4	14.8	13.5	32.5	17.7	4.9	20.5	14.0	17.0	6.9	6.9	6.5	9.8	4.5	5.3	16.2	6.1	9.6	20.0	8.4
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 32.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 13.4;Rod photoreceptor cells: 24.7;Spermatocytes: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA063685	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA063685: AB_2685090"	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	4.7	3.3	4.8	4.1	6.8	2.5	6.3	4.3	5.2	3.8	2.6	7.1	2.9	3.3	5.6	14.4	4.6	9.1	6.9	4.7	4.9	4.1	5.6	3.4	4.5	3.4	3.0	4.4	4.8	6.4	3.9	32.0	1.7	6.8	3.6	2.2	5.2	4.9	3.2	9.0	6.9	3.4	2.6	4.5	3.1	3.0	18.7	5.5	3.0	8.9	2.0	2.6	2.8	1.9	6.1	3.5	4.4	2.5	2.5	4.3	1.7	2.5	1.7	5.7	6.2	2.8	3.8	3.7	3.0	1.4	2.4	3.0	3.8	6.3	4.5	4.1	1.6	3.8	2.4	3.0	2.9	1.1	2.7	3.3	4.6	4.1	4.9	0.9	4.9	4.1	5.0	3.8	2.8	5.3	4.8	2.3	6.2	2.9	4.2	1.8	3.5	3.3	3.6	2.9	1.1	4.5	2.1	4.7	1.8	2.9	5.5	9.1	5.8	6.1	1.8	5.0	4.2	4.5	3.7	2.7	6.2	3.1	4.3	3.5	4.0	3.3	1.7	5.6	3.0	3.4	4.4	2.4	2.1	3.1	2.2	1.3	5.4	3.4	3.0	1.9	6.1	4.3	3.9	4.3	2.5	2.5	3.5	1.4	1.7	4.8	6.8	4.3	4.8	4.9	4.1	3.0	4.4	6.8	5.5	0.0	2.7	0.5	2.0	0.2	3.2	1.1	0.0	13.4	2.3	1.8	9.8	1.1	5.0	3.4	2.4	1.1	1.7	0.0	1.2	0.7	1.0	1.6	0.0	2.9	1.2	9.5	1.2	2.5	0.6	3.6	0.6	0.6	0.0	1.0	1.5	3.8	2.2	1.4	1.8	2.1	24.7	6.5	1.0	14.6	7.0	0.5	0.5	0.9	1.2	0.7
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.3"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 31.6;Spermatocytes: 38.8;Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA018981: AB_1859021, HPA059310: AB_2683974"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	5.4	5.5	4.4	7.5	5.4	3.0	5.7	8.6	7.0	5.1	4.9	6.0	4.7	5.5	6.0	6.8	5.1	5.9	4.7	5.2	4.0	4.3	4.8	6.4	5.2	9.5	4.6	3.3	6.2	3.9	7.3	7.1	8.2	5.6	5.3	5.0	4.2	5.1	4.7	4.0	4.1	5.4	5.3	3.8	10.4	4.7	27.3	5.0	9.6	6.8	2.9	8.3	5.8	4.9	5.8	5.0	19.3	5.1	8.7	10.1	5.4	4.9	5.2	11.7	8.3	4.3	4.6	14.1	6.4	8.0	8.9	8.2	7.8	4.2	9.7	5.0	5.2	5.2	3.7	9.1	7.0	10.6	9.0	8.4	8.0	6.9	6.4	5.8	13.6	19.1	4.6	5.8	6.5	5.9	5.1	7.6	6.9	8.8	7.4	7.7	4.5	9.7	7.1	18.4	6.1	5.0	11.8	16.1	11.3	5.5	2.8	6.7	9.9	6.1	4.7	5.3	8.3	6.7	15.3	5.2	9.1	8.5	3.1	5.6	19.0	18.6	8.3	2.2	8.5	7.0	19.3	3.9	13.6	8.5	5.1	8.2	5.8	7.8	10.1	5.0	5.6	8.0	8.9	16.9	8.7	4.7	3.1	9.0	5.4	4.4	5.4	8.6	7.0	4.0	4.3	4.6	3.3	5.6	5.0	3.0	3.0	0.5	4.1	2.9	5.3	3.4	7.6	2.7	5.7	3.5	11.8	5.9	3.3	3.9	31.6	7.0	2.6	23.3	3.4	5.3	5.1	3.4	4.7	3.8	6.0	0.0	6.4	6.7	7.1	17.1	5.2	6.9	6.8	3.6	4.0	5.7	2.9	4.0	2.8	1.9	6.1	6.5	5.7	38.8	31.2	2.8	4.9	6.5	3.3	4.2
ZNF211	"CH2H2-25, ZNF-25"	ENSG00000121417	"Zinc finger protein 211"	Q13398	19	57630395-57642779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA011340, HPA049967"	Approved		Approved	"Mitochondria,Rods & Rings"		NA	NA			Mitochondria	"Rods & Rings"	"HPA011340: AB_2668488, HPA049967: AB_2680973"	"unprognostic (6.47e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.72e-3)"	8.8	11.3	11.1	10.1	13.5	24.2	11.7	18.3	14.2	10.1	10.0	17.5	14.8	5.2	12.3	13.2	7.2	10.9	9.3	11.5	11.0	10.4	11.3	6.5	11.1	13.3	12.0	12.4	13.4	7.3	25.7	16.7	13.9	12.2	12.6	10.2	15.4	8.7	14.9	6.8	12.0	12.5	10.3	10.7	17.7	17.6	6.1	9.1	17.7	16.5	5.4	15.1	12.9	10.3	10.5	7.6	12.7	6.2	7.0	13.7	6.5	3.9	2.5	11.6	10.4	6.8	6.8	6.8	5.5	6.8	7.9	5.3	2.0	2.3	3.7	2.4	5.8	4.7	0.9	5.5	8.3	16.8	4.6	13.6	7.2	5.7	4.8	5.9	5.0	7.6	6.3	10.1	5.9	5.6	11.7	6.0	6.8	1.6	4.8	9.7	1.8	10.2	3.4	4.7	5.1	6.1	6.3	8.7	3.3	6.8	15.2	5.4	7.5	6.6	3.3	2.5	13.6	3.5	7.1	3.8	8.1	3.9	3.4	4.6	6.7	8.5	7.8	2.2	4.1	4.7	7.9	6.2	12.7	8.4	5.9	13.7	8.8	11.1	12.1	7.6	10.5	13.2	9.3	8.3	7.0	3.9	1.6	11.8	6.5	11.1	13.5	18.3	14.2	11.0	10.4	12.0	12.4	12.2	9.1	3.0	4.3	11.2	1.1	1.0	3.9	4.5	2.5	10.7	1.2	1.8	7.9	6.2	0.0	2.9	0.4	3.8	3.2	0.0	1.0	4.0	1.9	1.8	5.7	1.5	3.4	0.0	1.2	5.5	6.3	0.4	1.1	2.9	1.7	3.6	3.0	4.2	1.3	0.0	2.1	1.0	6.6	12.9	2.5	2.7	3.0	1.5	14.9	7.0	2.4	2.5
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067991	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 21.6"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	6.5	8.0	6.6	5.9	14.7	3.2	10.1	19.8	17.3	7.6	8.0	9.6	6.0	7.1	7.7	11.3	6.5	7.5	9.5	8.8	9.4	8.5	7.5	4.7	7.0	6.0	6.7	7.4	7.7	6.2	10.8	9.8	9.7	15.3	12.3	10.7	7.1	7.7	9.4	3.5	8.8	9.2	7.8	5.7	8.6	8.8	6.2	7.9	6.7	11.7	4.6	7.6	9.0	6.2	4.4	7.7	11.6	7.1	6.6	9.3	2.6	2.5	1.4	5.5	1.3	3.6	4.6	0.1	3.9	4.3	3.5	5.1	2.6	4.3	0.0	3.7	3.0	2.1	2.5	0.0	4.4	3.8	0.0	4.1	5.1	3.9	3.5	2.7	0.2	0.1	4.5	3.5	3.0	2.9	5.0	3.9	0.1	0.2	0.0	3.9	2.0	0.0	1.8	4.1	1.7	1.9	0.0	2.2	1.2	4.2	21.6	3.4	8.1	6.8	0.9	2.7	7.4	3.9	4.7	3.9	3.3	3.2	1.8	1.4	2.6	4.4	0.0	1.4	0.0	3.2	11.6	5.8	8.7	2.8	7.1	4.3	3.6	4.7	2.4	6.4	4.4	9.3	4.0	0.5	6.6	2.9	7.7	4.0	2.6	6.6	14.7	19.8	17.3	9.4	8.5	6.7	7.4	15.3	7.9	0.0	0.6	0.0	0.5	0.0	2.9	0.8	2.5	1.4	0.0	1.8	2.0	1.6	3.3	1.9	2.7	2.1	0.7	0.0	0.4	0.4	0.2	0.5	0.0	0.6	1.4	3.2	0.0	2.5	1.6	0.8	1.4	1.2	0.0	1.0	2.4	1.5	1.1	0.0	1.8	1.0	1.2	0.0	0.0	1.9	1.9	0.0	0.8	0.0	2.1	0.7
ZNF230	FDZF2	ENSG00000159882	"Zinc finger protein 230"	Q9UIE0	19	44002948-44013926	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA006172			Approved	Mitochondria		No	No			Mitochondria		"HPA006172: AB_2667532"	"unprognostic (3.55e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.08e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.42e-5)"	7.2	6.0	6.0	7.8	6.4	7.2	8.3	13.3	7.8	8.1	5.2	4.4	5.2	3.4	6.2	5.8	4.3	6.6	4.2	4.7	5.1	4.2	5.3	5.6	6.2	8.9	6.9	4.4	11.3	4.3	7.7	10.2	6.1	5.9	7.2	5.3	6.2	5.3	6.8	2.6	7.3	6.4	4.9	7.2	11.1	5.2	6.8	5.5	16.6	8.6	3.9	9.6	9.0	9.3	5.5	4.3	13.9	4.8	3.2	6.0	3.4	2.9	2.4	5.1	5.2	4.1	5.1	2.0	4.3	4.3	3.9	7.1	1.5	1.7	2.4	2.9	3.1	2.5	2.5	4.2	3.9	5.9	3.0	5.3	4.2	5.4	1.8	2.4	5.3	3.6	3.8	3.6	4.4	4.5	5.3	2.7	2.9	0.8	0.1	4.0	1.5	6.0	3.9	2.9	2.0	2.4	4.5	7.1	1.2	2.3	3.6	2.8	6.5	6.0	2.1	3.1	3.7	1.8	12.5	3.4	6.2	4.6	1.8	3.2	3.1	3.0	0.4	3.0	4.0	3.8	7.6	4.1	9.8	4.7	4.8	4.9	4.8	5.3	4.8	4.3	5.5	6.0	5.5	13.9	3.2	2.3	2.6	4.5	3.4	6.0	6.4	13.3	7.8	5.1	4.2	6.9	4.4	5.9	5.5	0.0	2.1	4.5	2.9	2.5	8.5	5.3	12.7	0.0	3.4	3.5	15.7	3.4	3.3	2.6	1.5	3.8	3.2	0.0	2.2	2.7	3.9	1.9	1.1	3.0	2.8	7.9	1.2	3.7	2.1	1.2	6.1	4.6	3.3	8.2	2.4	5.2	0.8	0.0	4.2	1.4	8.9	6.5	4.1	15.0	4.1	2.4	2.6	7.2	2.6	1.7
ZNF26	"FLJ20755, KOX20"	ENSG00000198393	"Zinc finger protein 26"	P17031	12	132986365-133032952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA018329, HPA042406"	Uncertain		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA018329: AB_1859157, HPA042406: AB_2677982"	"unprognostic (7.31e-3)"	"unprognostic (7.60e-3)"	"unprognostic (7.26e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-12)"	"unprognostic (8.24e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.64e-4)"	9.9	7.7	7.3	10.5	10.6	19.4	13.2	11.1	12.8	7.8	7.7	11.3	10.2	7.8	12.7	18.3	7.6	9.5	11.6	6.7	7.6	6.6	9.1	11.6	9.5	12.8	9.9	8.1	11.4	11.9	7.7	11.9	8.8	9.9	12.4	8.5	11.1	11.2	8.6	7.4	13.0	9.5	8.8	7.5	15.7	7.6	11.8	11.3	12.0	11.6	9.2	12.8	8.6	9.6	7.5	3.5	9.3	2.9	6.5	9.6	5.5	4.3	3.7	4.7	5.6	2.0	3.0	9.5	3.4	4.2	4.9	3.7	1.7	3.5	3.0	5.0	3.4	3.5	3.0	3.3	3.3	6.0	2.2	5.5	7.1	3.5	2.0	3.3	11.8	8.1	3.8	4.0	5.5	7.7	3.9	2.7	4.9	5.4	0.8	4.2	3.8	9.0	8.1	11.5	2.3	6.0	8.7	7.0	5.8	2.4	6.8	5.8	12.6	4.3	3.2	4.2	3.2	9.5	7.7	4.5	6.2	5.9	5.4	5.2	3.5	0.2	14.6	3.8	5.4	7.2	9.3	2.6	6.0	8.2	2.9	8.6	5.5	7.4	6.5	3.5	7.5	9.6	8.0	2.4	6.5	2.2	3.0	6.1	5.5	7.3	10.6	11.1	12.8	7.6	6.6	9.9	8.1	9.9	11.3	20.8	16.5	11.0	7.4	0.0	26.6	4.0	10.2	5.3	14.8	5.2	23.6	5.4	3.3	6.7	0.6	8.4	3.8	0.0	4.9	3.7	4.8	5.2	9.2	4.3	4.5	25.4	8.1	9.8	9.5	1.1	7.5	3.9	0.0	2.8	5.4	8.8	6.6	3.5	5.6	2.3	24.5	0.0	3.2	7.2	9.5	0.0	4.0	13.6	5.6	7.1
ZNF398	"KIAA1339, P51, P71, ZER6"	ENSG00000197024	"Zinc finger protein 398"	Q8TD17	7	149126416-149182802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071533			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA071533: AB_2686412"	"unprognostic (4.11e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.97e-2)"	"unprognostic (9.27e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.89e-1)"	8.9	8.1	12.7	10.2	12.5	15.6	10.6	25.9	16.0	11.7	10.7	10.2	10.5	8.8	9.8	10.2	14.3	10.4	8.6	9.3	10.9	9.0	9.3	10.7	9.2	10.0	10.7	11.4	11.1	13.4	14.7	20.9	8.6	9.8	12.7	8.6	8.5	11.2	12.5	10.0	17.2	9.5	9.7	9.8	12.6	11.1	18.1	12.6	13.0	8.7	7.4	12.3	9.9	11.1	2.9	1.6	6.1	2.0	1.9	3.8	1.2	7.6	6.4	5.0	9.7	7.5	5.3	6.4	4.7	6.0	5.4	5.9	5.4	3.6	8.9	5.4	7.8	4.8	6.4	8.6	5.9	3.8	5.9	11.9	5.9	5.1	3.5	5.2	6.6	6.2	6.0	8.7	5.8	6.2	3.9	3.6	3.6	9.1	3.2	5.7	9.6	9.8	6.8	36.0	6.4	6.8	7.7	5.7	6.7	4.0	12.8	7.5	8.3	6.5	8.0	3.9	5.6	5.0	7.4	4.8	5.5	1.6	9.8	5.8	10.3	4.9	6.9	7.5	5.5	5.3	5.1	1.6	6.1	3.1	2.0	3.7	2.9	2.1	3.4	1.5	2.5	3.3	3.8	3.1	1.9	1.7	1.6	3.0	1.2	12.7	12.5	25.9	16.0	10.9	9.0	10.7	11.4	9.8	12.6	6.0	2.9	3.7	3.5	6.9	7.4	5.8	0.0	2.7	4.5	5.2	5.9	3.1	0.0	3.6	19.4	4.5	3.3	0.0	2.5	4.0	4.7	4.5	4.6	2.8	3.2	3.2	1.7	4.9	4.7	19.2	6.6	3.4	8.5	2.8	3.3	5.3	4.4	2.6	8.5	2.4	9.7	0.0	2.5	16.6	7.9	7.4	2.6	1.8	3.3	8.1
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607219-43619874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA042596: AB_2678070, HPA048072: AB_2680249"	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	18.8	31.2	36.8	15.8	37.6	18.9	9.2	25.9	48.8	13.7	14.2	14.4	8.8	17.0	18.8	14.9	8.8	13.0	18.4	19.9	31.3	28.7	17.4	15.5	13.1	15.5	27.0	31.1	19.2	19.4	9.8	19.2	12.7	18.0	20.1	6.3	14.8	21.7	13.2	37.7	6.6	13.7	17.2	22.2	16.8	16.6	19.7	17.0	17.8	16.6	8.7	8.9	10.0	11.4	7.8	7.1	9.4	3.2	3.1	8.5	1.0	11.2	9.0	14.1	23.3	5.4	4.0	6.6	8.5	3.9	6.0	6.3	5.5	7.5	19.0	19.5	6.5	3.8	2.8	5.6	1.6	2.0	15.9	23.9	20.7	9.4	9.3	10.6	16.2	17.2	7.3	3.6	5.3	2.8	6.2	8.4	13.6	21.6	12.0	6.2	11.9	40.0	29.1	9.4	5.0	6.3	39.9	6.5	13.9	7.2	6.8	27.1	31.6	12.3	7.6	19.0	3.9	4.6	23.3	16.5	7.2	20.5	6.8	13.0	13.4	16.1	33.2	10.4	16.6	15.8	2.5	2.5	9.4	7.8	1.4	4.4	5.2	7.1	7.4	2.7	7.8	8.5	3.7	1.3	3.1	3.2	7.1	4.1	1.0	36.8	37.6	25.9	48.8	31.3	28.7	27.0	31.1	18.0	17.0	0.0	3.8	39.5	61.1	28.5	98.9	17.9	63.7	4.0	3.4	62.8	13.7	115.0	126.0	77.7	112.3	58.4	31.5	0.0	69.0	37.8	99.2	49.9	36.8	47.0	89.6	54.0	155.7	74.9	36.5	48.8	82.3	46.8	108.0	43.3	49.3	108.0	64.6	46.0	85.2	176.5	53.3	71.1	93.7	20.4	56.9	22.6	46.1	73.0	46.0	41.6
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431720-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 34.4;Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	6.8	6.4	8.3	6.4	10.9	4.5	7.5	16.5	10.9	8.6	7.1	11.7	8.0	5.1	13.6	7.7	5.2	8.3	6.1	6.3	7.7	7.0	6.3	7.5	6.7	6.6	11.3	10.5	13.0	7.6	16.1	13.9	7.1	7.9	8.6	6.6	9.9	8.1	8.2	11.2	8.2	5.7	12.3	6.6	7.0	7.3	6.5	8.9	14.2	6.9	4.8	8.1	6.7	8.2	1.1	1.1	4.1	2.5	1.9	1.5	0.5	2.5	2.9	9.1	7.1	5.1	5.2	4.1	3.5	2.9	5.3	5.3	4.4	2.3	4.5	2.2	3.6	3.4	2.1	6.1	2.4	6.4	4.9	2.3	8.3	5.9	4.3	3.2	10.5	7.0	3.6	3.0	5.9	3.8	4.5	3.7	6.4	6.4	3.4	4.2	1.7	10.0	7.1	6.2	1.6	2.7	4.5	5.7	2.2	2.9	5.3	4.5	5.6	5.4	2.8	1.4	7.1	5.2	4.6	4.4	7.5	6.7	4.6	4.4	2.7	2.0	3.8	2.8	5.3	4.5	2.7	1.3	2.3	1.2	0.8	1.1	0.7	0.9	0.9	0.9	1.1	1.5	1.1	4.1	1.9	2.5	1.1	0.4	0.5	8.3	10.9	16.5	10.9	7.7	7.0	11.3	10.5	7.9	8.9	11.9	16.7	7.3	4.1	3.7	34.4	7.8	2.5	12.0	10.3	10.4	35.3	3.3	1.7	4.4	1.9	6.8	2.6	0.0	7.3	1.5	6.1	5.2	10.5	8.5	4.7	27.0	6.9	10.4	14.0	1.6	8.6	7.7	0.0	1.0	6.5	13.4	4.4	3.5	9.2	2.3	30.0	12.9	6.1	5.7	6.1	2.3	1.1	5.7	6.9	3.4
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 47.5;Distal tubular cells: 33.2;Kupffer cells: 44.2;Muller glia cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.1;EFO-21: 11.0;HMC-1: 12.8;MCF7: 10.6;SK-BR-3: 10.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.2	22.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.8	0.1	11.0	0.1	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.2	0.0	0.0	6.8	0.0	12.8	4.6	1.1	0.0	0.1	8.0	2.4	0.5	2.0	0.5	0.0	10.6	0.4	1.1	0.3	0.9	6.9	1.7	0.0	8.2	1.5	0.0	1.2	1.0	0.0	10.0	0.0	1.1	12.4	1.3	5.4	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.8	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0	0.0	0.3	0.0	0.5	3.2	47.5	1.7	0.0	1.4	1.2	0.0	2.0	0.2	33.2	4.8	0.3	15.5	0.0	0.0	2.5	0.1	4.7	1.2	0.0	5.7	19.3	6.4	2.9	24.5	44.2	0.0	1.4	17.6	1.7	8.2	0.0	69.9	2.2	0.0	1.8	7.5	5.5	0.0	3.1	0.1	2.0	6.5	0.3	1.5	0.0	0.3
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	5.6	7.7	8.9	9.1	9.8	4.4	6.7	15.7	16.1	9.1	11.5	10.1	12.1	9.0	12.8	5.7	5.5	10.7	9.5	6.7	8.9	8.7	6.6	6.4	8.0	10.0	9.0	8.5	6.7	15.1	18.8	8.8	4.7	7.1	7.6	6.1	8.0	9.7	12.6	12.1	6.3	6.4	11.2	5.7	7.3	7.9	3.9	9.8	16.1	7.5	7.2	7.3	9.0	8.3	1.4	1.6	1.3	0.2	2.6	3.1	0.5	4.7	8.1	19.8	15.8	2.5	2.0	6.7	3.3	6.0	7.9	7.1	3.8	6.2	8.9	6.6	3.0	2.1	3.8	9.6	5.2	4.2	6.5	11.8	3.9	3.9	5.5	3.6	5.2	5.6	1.5	6.7	6.2	4.2	6.9	6.5	8.6	6.8	4.2	3.1	15.3	12.1	6.4	16.8	3.8	3.0	28.1	4.3	11.8	4.2	3.7	15.4	19.2	1.4	10.6	1.4	5.6	7.0	5.2	2.8	4.5	5.1	4.2	4.0	5.1	5.8	8.7	2.4	3.3	1.0	0.0	0.2	1.3	3.1	0.2	2.4	1.1	1.7	1.8	0.5	1.4	2.1	2.3	0.0	2.6	0.1	1.6	1.7	0.5	8.9	9.8	15.7	16.1	8.9	8.7	9.0	8.5	7.1	9.8	3.0	2.1	6.4	2.6	2.7	10.3	4.8	7.6	0.0	4.5	3.5	7.9	3.1	1.7	8.9	0.1	3.8	2.6	0.0	6.4	1.6	2.2	2.2	17.3	2.8	2.4	15.9	9.2	3.1	2.6	0.0	2.6	1.9	1.7	10.8	3.6	6.0	7.2	5.3	6.3	3.1	7.0	0.0	3.7	3.2	3.0	4.5	0.2	3.2	5.5	1.5
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 35.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.0"					"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	4.9	6.2	6.3	9.9	7.4	2.6	8.5	18.2	10.1	6.7	4.4	8.3	8.3	4.3	10.4	11.9	4.7	6.7	6.3	5.1	7.5	7.0	6.1	5.3	4.8	5.3	6.8	7.3	7.8	7.1	13.5	10.9	5.5	6.2	6.1	5.3	6.6	4.2	9.4	10.2	6.7	4.1	7.7	7.8	6.8	5.4	22.4	7.8	7.4	9.2	4.2	4.4	4.5	4.8	6.8	4.4	6.4	5.0	2.9	7.3	2.6	1.8	1.1	5.5	14.0	2.9	2.7	4.6	4.2	1.9	1.7	2.9	1.4	2.3	1.8	1.4	3.4	2.3	3.6	1.5	3.3	2.1	1.4	2.1	3.9	3.4	1.3	3.2	1.7	1.9	6.2	0.5	1.9	3.0	2.7	1.3	6.1	2.4	6.0	9.8	5.9	4.3	1.6	2.9	3.6	1.3	2.0	1.2	3.3	5.5	3.3	3.1	8.3	2.8	1.4	2.0	2.9	4.2	5.1	3.3	4.1	1.2	0.3	1.8	2.1	5.3	2.2	4.9	1.5	2.6	6.4	2.8	4.5	4.8	2.3	6.7	6.4	5.2	4.2	3.6	6.8	6.2	7.3	3.1	2.9	5.0	4.4	5.6	2.6	6.3	7.4	18.2	10.1	7.5	7.0	6.8	7.3	6.2	7.8	3.0	2.4	0.0	0.7	0.3	8.1	2.8	0.0	5.3	2.3	1.8	2.0	1.8	3.3	1.5	35.2	2.2	1.0	0.0	1.5	1.2	1.1	0.6	4.7	0.9	0.9	11.1	0.0	3.1	0.6	11.0	3.7	0.5	0.0	0.0	1.5	4.0	1.1	0.0	1.1	1.6	8.5	0.0	0.9	10.2	3.9	0.4	1.3	0.8	1.2	0.1
ZNF608	"DKFZp434M098, KIAA1281, NY-REN-36"	ENSG00000168916	"Zinc finger protein 608"	Q9ULD9	5	124636913-124748807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.2;naive B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.1;AN3-CA: 16.0;REH: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005545, HPA076984"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA005545: AB_1080742, HPA076984: "	"unprognostic (3.82e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (3.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.56e-2)"	8.5	14.7	17.0	7.5	17.2	2.0	10.1	25.5	16.5	11.5	10.4	28.3	2.8	15.7	7.5	7.1	5.4	13.6	10.1	12.5	19.7	8.8	8.2	3.9	15.3	10.8	21.8	10.7	9.6	12.0	9.1	11.6	4.5	18.0	8.5	10.7	14.1	8.3	7.1	8.9	4.8	9.1	6.4	22.9	3.9	9.8	13.0	24.5	4.6	13.4	3.3	11.0	6.6	6.6	3.1	1.1	5.2	0.0	0.0	0.0	0.0	0.1	0.4	25.1	16.0	3.7	6.1	0.0	0.0	0.6	0.1	1.5	2.6	7.5	8.2	8.4	0.0	4.0	0.3	1.7	1.5	0.1	0.0	4.0	0.0	0.0	0.1	5.8	0.0	0.7	6.1	4.5	0.7	0.7	3.8	5.3	0.0	0.8	0.1	1.3	0.0	0.0	0.0	10.6	0.2	0.3	43.6	2.2	0.0	3.6	0.3	3.8	13.2	0.0	0.3	5.6	14.9	1.4	0.7	1.4	5.1	9.8	0.1	1.5	4.0	3.9	14.8	1.3	0.2	7.2	5.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	3.1	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	17.0	17.2	25.5	14.3	19.7	8.8	21.8	10.7	18.0	24.5	29.8	27.0	3.7	10.9	1.1	34.0	19.7	10.2	20.1	60.3	14.0	37.3	0.6	3.3	12.1	10.4	13.7	9.3	0.0	7.7	3.3	4.7	3.1	0.0	0.9	0.6	39.7	38.4	11.6	0.3	5.7	2.0	1.2	6.8	3.6	5.3	38.4	5.6	7.6	1.4	5.7	37.0	0.0	1.6	12.0	5.8	0.6	0.3	0.0	7.0	1.6
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA052422	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA052422: AB_2681825"	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.98e-4)"	10.2	7.4	11.9	6.0	16.4	7.5	10.1	20.7	12.2	8.2	8.8	7.3	6.9	5.2	12.0	7.8	6.5	9.8	7.6	8.5	8.5	7.1	9.5	6.1	7.6	6.2	11.7	9.8	15.7	7.5	16.6	17.8	8.3	9.9	26.9	5.8	8.0	7.7	11.0	7.2	7.2	6.0	9.6	12.8	7.9	6.7	5.5	13.6	7.3	11.7	3.8	6.1	11.1	8.8	4.7	4.8	6.9	4.4	12.0	7.8	3.8	1.3	5.2	5.8	11.8	10.6	7.7	4.4	3.9	6.6	5.4	5.6	1.1	1.4	2.1	2.2	4.7	3.4	1.4	4.0	2.5	5.0	0.3	8.9	6.7	5.2	3.9	8.3	0.0	4.0	6.5	2.8	8.5	9.1	10.0	2.9	2.1	0.0	0.0	4.1	0.4	0.0	3.5	6.0	0.2	8.8	4.2	9.1	3.7	3.7	9.1	5.2	4.5	4.8	4.5	3.2	6.4	6.5	3.3	5.2	5.1	5.9	3.3	2.8	4.0	10.4	2.6	3.0	0.0	8.2	6.9	3.0	5.8	3.7	4.4	7.8	3.9	6.6	5.3	4.8	4.7	6.6	4.3	4.1	12.0	2.7	2.9	5.7	3.8	11.9	16.4	20.7	12.2	8.5	7.1	11.7	9.8	9.9	13.6	6.0	4.5	3.2	1.9	2.5	7.1	5.9	2.5	4.0	1.2	3.5	5.9	3.2	3.3	1.6	0.9	2.9	1.1	0.0	1.0	2.2	3.8	5.2	0.0	1.9	2.6	3.2	8.6	3.7	3.3	0.9	2.3	3.2	6.8	1.8	2.6	3.0	1.3	3.7	3.9	2.4	6.2	6.5	5.7	2.6	2.1	3.4	4.2	4.4	2.1	1.8
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	4.9	5.2	6.7	3.4	5.4	3.8	8.5	11.2	8.3	7.2	5.1	5.6	7.5	2.8	8.3	10.6	4.7	6.0	4.7	3.7	6.0	8.8	6.0	2.8	4.8	5.2	6.6	5.5	13.1	5.4	6.9	9.4	6.4	6.4	7.3	3.5	7.5	4.0	7.1	2.0	7.3	3.3	6.6	4.7	5.8	3.8	4.6	2.9	1.0	8.7	3.2	3.9	7.3	7.2	1.4	0.4	1.3	0.5	2.9	2.1	0.7	0.7	0.0	6.5	10.8	2.8	2.0	1.1	2.7	3.5	4.0	4.4	0.1	0.2	0.0	5.0	2.1	3.0	0.6	0.0	3.5	3.8	0.0	2.0	2.9	0.0	2.9	1.3	0.2	4.1	1.7	1.4	3.3	2.1	2.8	3.1	0.2	0.0	0.0	6.0	2.1	0.1	1.3	7.8	0.0	3.9	0.2	5.8	0.0	3.4	8.7	4.4	3.0	0.0	0.1	2.2	8.3	4.7	0.2	2.4	9.3	4.2	6.9	3.6	7.1	5.6	0.0	2.2	0.0	3.3	0.7	0.4	0.2	0.7	0.5	0.9	0.5	1.0	1.2	0.4	1.4	1.5	1.2	1.3	2.9	0.1	0.3	2.1	0.7	6.7	5.4	11.2	6.8	6.0	8.8	6.6	5.5	6.4	2.9	3.0	1.0	0.0	0.5	0.3	5.4	0.0	5.1	4.0	0.0	1.8	9.8	3.6	3.3	2.8	0.1	1.5	0.0	0.0	2.7	3.1	1.9	0.5	0.0	0.6	1.2	4.8	1.2	6.2	4.5	1.3	0.6	1.0	0.0	2.8	0.3	4.4	3.1	1.7	1.4	2.1	8.7	0.0	2.3	1.9	8.3	0.6	1.0	0.0	1.2	0.3
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.9	13.5	1.5	3.4	7.2	2.7	2.7	4.1	4.4	2.6	2.6	8.3	7.2	1.2	2.2	4.0	7.0	1.8	6.8	3.5	13.4	3.9	2.5	1.6	2.7	6.6	10.6	3.0	3.4	2.5	5.3	3.1	3.9	9.3	9.9	13.1	4.5	1.7	9.1	2.3	10.4	3.0	5.4	7.1	7.7	3.2	3.0	6.5	5.1	9.9	4.1	4.9	2.0	6.1	6.8	8.4	2.5	5.1	4.9	4.6	5.6	4.2	9.6	9.1	2.1	1.2	5.3	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5	3.0	5.3	4.7	3.6	2.1	11.6	3.6	5.1	5.3	4.5	3.5	3.9	1.8	1.7	3.3	0.6	4.7	1.5	0.0	4.4	2.1	3.4	5.6	3.5	1.6	1.4	1.6	9.2	3.7	3.7	0.2	6.9	2.2	0.0	1.8	3.9	4.2	2.9	4.5	2.5	1.1	6.7	0.0	2.1	7.2	10.0	0.5	1.1	7.5	2.6	3.4
ZNF7	"HF.16, KOX4"	ENSG00000147789	"Zinc finger protein 7"	P17097	8	144827464-144847509	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030296, HPA059090"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030296: AB_10671095, HPA059090: AB_2683901"	"unprognostic (1.11e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.46e-8)"	"unprognostic (1.15e-1)"	"unprognostic (5.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (6.53e-2)"	18.5	12.7	11.4	14.9	17.5	14.7	20.4	34.1	21.1	18.3	15.5	17.9	19.8	12.1	18.4	22.2	18.1	16.7	15.5	14.3	11.9	11.0	13.3	14.7	14.1	16.0	15.1	18.3	22.8	21.3	19.1	16.2	17.0	14.7	19.5	15.5	15.7	16.0	17.4	24.3	21.0	16.0	15.7	11.8	21.2	13.6	24.8	15.2	15.8	19.0	14.9	17.8	16.7	18.0	15.7	10.4	22.5	14.6	12.9	18.6	7.6	10.1	13.9	13.6	13.3	11.7	17.9	12.5	10.9	13.9	14.8	12.7	7.0	13.1	14.2	12.8	11.8	8.1	8.9	12.3	15.9	16.2	9.4	10.2	25.3	18.2	8.1	13.6	7.3	11.9	17.1	19.4	11.5	28.6	14.4	9.1	12.0	25.2	10.2	16.4	16.7	19.8	8.0	13.9	13.5	16.8	13.8	12.1	11.2	10.4	14.0	13.4	16.4	23.8	13.7	13.2	13.7	16.5	11.8	10.2	11.2	20.0	8.4	10.4	8.3	5.8	15.5	11.6	9.5	13.7	22.5	9.3	8.8	12.5	8.4	15.2	15.7	14.1	10.8	10.4	13.6	18.6	12.7	9.4	12.9	14.6	8.3	13.1	7.6	11.4	17.5	34.1	21.1	11.9	11.0	15.1	18.3	14.7	15.2	17.9	12.3	9.6	14.4	6.3	34.1	10.1	2.5	8.1	9.1	3.5	27.5	13.8	5.0	11.1	9.6	9.7	7.4	0.0	9.8	10.7	12.0	13.5	3.5	7.4	7.9	27.0	9.2	11.6	6.7	3.2	16.4	10.9	8.5	10.0	7.9	18.9	10.7	7.0	14.9	5.6	29.0	6.5	7.5	40.5	25.2	8.2	16.2	15.2	9.2	11.7
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001392-90082206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 79.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	2.6	2.1	5.6	8.7	6.7	4.3	3.2	2.9	5.0	3.1	4.3	6.6	1.7	5.3	3.3	4.1	9.5	2.9	4.8	5.9	3.9	3.5	2.7	3.4	6.4	7.9	4.0	4.1	3.4	79.6	1.5	2.5	3.2	5.0	4.2	4.0	3.5	5.2	2.6	18.3	6.7	4.5	4.3	6.3	8.6	5.9	2.4	4.1	11.7	3.5	5.2	7.0	4.4	4.9	0.3	2.3	3.0	7.9	0.4	0.8	0.9	5.8	6.9	13.3	5.0	1.8	2.7	7.0	6.1	5.7	4.5	5.8	4.9	5.4	6.0	2.9	5.9	4.2	4.0	3.4	8.7	2.5	3.8	6.3	10.9	2.8	8.2	3.7	3.1	17.0	4.4	4.8	9.6	5.3	2.1	7.7	6.6	3.6	4.1	1.7	15.1	7.0	8.8	10.4	7.2	4.5	8.6	3.0	6.5	1.8	7.3	12.2	8.3	8.2	29.5	4.2	3.6	6.4	10.9	11.0	9.3	4.6	2.8	4.7	3.3	1.7	5.8	7.1	9.4	4.8	0.0	2.6	1.8	0.4	5.7	0.3	0.2	0.2	0.3	1.9	0.3	0.8	0.8	3.0	0.4	7.9	2.3	0.7	0.9	5.6	6.7	2.9	4.3	3.9	3.5	4.0	4.1	5.0	4.1	3.0	8.0	1.5	3.9	4.7	1.8	7.6	7.6	1.4	6.8	10.4	2.0	2.0	0.0	2.9	0.6	2.9	3.5	0.0	5.3	2.6	2.7	5.9	1.1	1.0	10.4	3.2	4.6	8.0	13.9	2.9	2.3	12.8	1.7	9.0	8.1	0.9	8.0	10.5	2.8	0.7	0.8	6.5	2.3	0.2	1.9	6.6	1.9	2.9	5.8	12.9
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816472-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	5.3	4.2	7.4	7.4	8.4	2.5	7.6	19.8	8.0	7.5	5.3	6.9	5.9	6.1	7.9	8.5	5.2	5.5	5.8	4.0	6.8	4.5	7.1	5.5	4.4	5.9	5.9	4.8	9.3	12.7	11.8	15.1	4.9	7.7	7.5	6.9	5.4	8.0	7.3	9.2	8.6	7.1	5.3	6.5	6.4	6.6	13.9	8.3	6.0	8.8	2.5	7.4	5.6	10.8	2.3	0.2	0.7	0.5	1.0	2.2	0.4	2.9	2.3	5.8	8.9	1.6	2.2	4.0	2.8	2.8	4.6	3.4	2.7	3.1	5.7	3.7	2.0	5.4	4.1	5.1	1.8	4.5	5.7	2.2	5.3	4.7	2.7	1.7	7.3	3.7	1.3	3.8	3.7	1.9	2.2	1.5	7.0	7.0	5.8	2.7	5.0	7.6	3.6	4.3	5.2	5.1	6.8	7.1	1.9	3.1	1.9	5.9	4.5	3.8	2.3	3.0	4.9	4.3	4.2	3.3	6.0	3.5	6.0	3.1	5.5	3.9	2.7	2.5	1.8	4.3	0.0	0.5	0.2	1.1	0.5	2.2	2.0	1.0	0.0	0.2	2.3	0.9	0.7	0.7	1.0	0.2	0.2	0.6	0.4	7.4	8.4	19.8	8.0	6.8	4.5	5.9	4.8	7.7	8.3	0.0	5.5	0.9	1.4	1.6	5.7	1.4	0.0	1.4	0.0	1.8	7.9	0.7	0.0	1.3	5.6	1.6	1.7	0.0	1.5	0.2	0.5	1.7	5.7	1.0	1.1	3.2	0.0	1.8	0.6	6.9	1.7	0.7	0.0	3.6	1.4	2.2	1.0	0.0	2.8	1.6	6.5	0.0	1.0	8.6	2.4	0.9	0.6	0.7	1.2	1.8
ZNF787		ENSG00000142409	"Zinc finger protein 787"		19	56087366-56121280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035140	Supported		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			Nucleoplasm	"Nucleoli, Mitochondria"	"HPA035140: AB_10602358"	"unprognostic (1.97e-2)"	"unprognostic (5.86e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-3)"	7.4	8.0	4.3	7.8	5.2	18.8	7.1	4.7	7.0	8.0	9.8	5.1	8.5	12.8	5.8	6.5	9.8	8.7	8.7	10.2	4.0	4.3	6.4	18.0	6.9	7.7	4.8	4.0	8.7	13.9	3.3	6.6	4.8	4.6	10.0	3.9	7.9	9.6	7.2	28.2	9.3	10.5	6.8	3.1	14.9	11.0	6.8	4.6	4.8	10.0	8.2	5.7	8.7	10.1	3.0	5.5	4.9	2.1	1.2	1.6	0.7	12.0	11.9	3.9	8.1	1.1	2.5	10.1	6.2	2.4	4.3	4.8	7.0	7.5	8.6	0.4	2.6	3.8	9.5	2.4	5.0	1.9	11.4	43.9	13.7	6.0	10.5	6.3	13.1	12.0	3.3	5.0	3.5	6.2	2.6	3.1	4.9	16.3	9.7	2.5	7.6	8.1	16.5	12.3	11.1	22.4	10.2	5.7	10.9	4.3	8.0	14.9	14.4	6.6	13.0	11.5	2.3	8.0	18.6	6.7	16.1	11.5	6.7	17.1	20.6	15.1	8.3	9.3	8.8	7.5	1.7	2.1	2.6	1.2	1.5	1.6	2.3	0.8	1.0	2.2	3.0	1.3	0.7	4.9	1.2	1.4	5.5	1.3	0.7	4.3	5.2	4.7	7.0	4.0	4.3	4.8	4.0	4.6	4.6	11.9	2.4	6.7	8.9	5.5	52.1	9.0	12.7	0.0	4.5	10.4	104.1	2.9	1.7	5.9	1.5	6.7	15.4	0.0	14.2	4.0	5.0	8.6	5.7	28.4	7.5	33.4	8.7	12.9	6.5	2.9	4.6	6.8	1.7	4.6	17.1	29.5	12.9	15.3	4.2	3.7	60.0	6.5	6.2	2.5	7.9	6.4	1.6	3.2	16.9	11.7
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838367-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 11.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (8.66e-4)"	7.1	9.7	12.7	11.2	15.5	7.5	11.8	22.6	13.6	11.1	10.0	16.7	18.8	6.6	12.1	18.1	9.0	13.7	12.2	8.0	13.1	8.7	11.3	9.4	9.6	12.8	17.1	12.1	15.1	14.7	22.6	17.7	5.8	12.2	11.5	10.7	12.3	16.9	14.5	8.6	24.1	10.8	10.0	12.6	13.2	9.4	7.4	19.8	18.7	18.2	6.7	13.2	9.9	9.1	3.1	3.0	1.6	4.3	1.6	6.9	2.0	2.9	3.2	7.2	11.3	8.3	9.1	0.2	6.1	6.0	2.1	3.3	0.3	7.8	1.4	8.0	6.9	2.8	2.0	2.0	2.9	1.5	4.4	3.1	1.3	2.2	0.0	7.3	2.1	1.3	10.0	10.8	2.0	3.2	9.0	4.9	8.3	1.5	5.6	3.4	7.5	2.5	5.5	2.4	5.6	3.2	4.5	0.9	8.0	5.8	1.8	2.8	9.6	5.3	3.9	5.3	3.6	3.0	2.6	8.7	5.2	0.2	11.7	2.2	8.7	4.7	1.3	8.8	5.7	5.9	0.0	2.4	1.6	6.9	4.3	1.9	3.1	2.6	3.6	3.0	1.3	3.1	2.7	0.2	1.6	1.3	3.0	1.8	2.0	12.7	15.5	22.6	13.6	13.1	8.7	17.1	12.1	12.2	19.8	0.0	1.0	0.0	0.6	0.7	5.1	3.2	2.5	2.7	3.4	7.0	11.8	0.9	1.7	1.5	1.1	1.7	1.0	0.0	1.2	0.2	1.0	1.5	4.6	2.1	0.9	9.5	1.7	1.3	1.2	1.0	1.4	2.1	0.0	1.0	2.6	2.8	1.2	2.3	2.1	0.7	5.8	0.0	1.0	0.9	2.3	1.1	2.2	2.6	1.3	0.8
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.8	9.1	2.2	3.1	12.1	9.5	3.7	8.0	18.9	50.3	21.0	10.4	4.9	4.9	10.3	15.9	14.3	11.4	4.1	10.8	17.5	4.6	1.3	5.8	6.6	4.5	10.5	4.6	7.1	10.0	10.2	11.2	8.4	9.2	7.6	2.9	4.4	6.1	12.5	2.4	5.0	3.1	2.1	5.1	7.7	3.2	7.5	1.3	8.3	8.1	2.2	1.6	11.8	23.0	8.2	2.8	5.9	3.9	18.8	24.7	7.0	8.9	7.7	4.0	1.4	2.7	9.9	3.2	5.4	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6	38.7	29.3	17.4	18.7	24.6	14.7	11.4	12.7	29.4	22.7	19.2	9.8	5.5	0.0	20.8	27.6	39.1	15.6	0.0	19.7	6.0	27.4	21.6	26.5	11.5	14.0	11.1	12.6	26.4	25.9	16.0	21.0	25.7	18.6	27.9	11.0	37.0	25.1	17.5	25.5	6.3	12.7	0.0	28.4	41.6	5.7	19.1	9.5	15.2	9.7	31.2
ZNHIT3	TRIP3	ENSG00000273611	"Zinc finger HIT-type containing 3"	Q15649	17	36486629-36499310	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 213.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060019, HPA078211"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060019: AB_2684188, HPA078211: "	"unprognostic (5.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.03e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.19e-2)"	5.0	8.2	9.7	7.4	12.9	8.6	9.9	9.1	18.4	6.2	6.5	6.1	6.8	6.0	6.9	11.1	6.9	7.8	5.4	7.8	8.2		9.4	9.5	6.6	10.0	10.2	9.6	10.7	9.1	7.8	5.7	5.9	9.9	7.4	9.2	4.1	7.1	8.0	14.2	6.2	5.4	7.4	12.3	5.8	5.2	11.8	8.6	8.8	9.0	7.3	10.9	7.6	3.9	23.8	18.0	15.8	16.5	12.9	24.1	15.6	14.7	22.5	24.2	16.1	11.3	17.3	12.7	13.5	17.9	20.5	23.2	18.3	17.7	22.0	13.7	11.5	25.7	13.3	18.3	17.6	22.9	14.0	30.7	13.2	14.3	21.4	14.3	27.3	11.6	12.9	18.8	13.3	20.7	20.4	13.8	26.1	23.6	13.8	21.9	15.8	29.7	29.2	15.3	15.9	17.4	13.4	24.8	18.5	20.2	12.7	18.5	15.3	17.6	8.1	21.5	22.7	27.6	21.0	10.9	9.9	22.4	15.9	19.1	15.1	23.6	27.6	17.0	16.3	15.5	15.8	13.0	9.6	17.8	13.5	21.4	23.8	20.8	18.0	16.5	21.8	24.1	22.2	6.9	12.9	16.5	18.0	22.5	15.6											23.8	18.2	51.6	33.1	41.2	22.8	9.6	28.1	22.7	20.5	31.4	11.8	78.2	74.6	50.4	213.4	31.7	25.9	0.0	44.3	85.9	32.3	37.4	33.5	22.9	58.3	14.3	41.8	20.3	46.6	61.6	34.2	37.7	50.6	62.3	31.5	32.3	51.9	37.9	41.8	67.6	24.2	45.3	40.1	105.1	65.2	38.1	64.5	57.3	43.5	30.8
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143020	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Enterocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	11.3	11.7	8.0	13.5	10.2	21.1	10.5	14.4	14.3	11.3	23.8	17.5	9.2	17.7	11.6	11.0	12.8	9.9	11.1	10.7	7.7	7.7	8.8	9.6	12.1	15.6	8.3	8.4	12.0	15.3	18.0	12.6	13.1	11.3	11.4	17.3	17.6	10.1	11.8	37.7	13.9	42.4	10.9	7.5	16.1	12.8	8.1	9.7	22.5	12.1	6.5	14.2	12.4	9.8	1.5	1.8	3.8	3.4	1.1	4.2	1.5	10.5	16.5	6.0	8.1	15.0	8.5	7.2	9.2	11.6	10.8	10.5	8.1	3.7	10.1	6.2	12.3	7.2	12.1	12.0	6.3	11.0	11.7	12.5	9.6	13.3	5.3	10.2	8.1	19.2	10.9	8.5	10.6	12.5	5.6	13.8	10.2	7.0	10.3	6.7	7.2	10.1	4.8	3.6	10.2	6.4	11.3	7.3	4.3	6.1	10.9	4.7	7.0	10.4	6.5	8.9	6.2	6.4	6.2	16.2	9.5	4.8	11.8	12.0	4.5	2.4	5.2	9.5	7.3	8.8	2.8	2.3	2.3	3.2	3.2	4.2	1.5	2.2	2.0	1.8	1.3	1.5	2.5	3.8	1.1	3.4	1.7	1.4	1.5	8.0	10.2	14.4	14.3	7.7	7.7	8.3	8.4	11.3	9.7	53.6	63.9	15.9	4.6	6.4	30.7	15.7	20.4	26.8	45.5	8.7	92.3	6.0	0.0	6.4	43.0	14.8	92.3	0.0	9.7	5.4	7.4	9.7	24.4	11.5	10.5	38.1	12.7	24.5	24.0	17.3	13.8	14.5	11.8	7.2	30.4	16.0	11.9	29.4	9.2	4.1	53.7	6.5	10.3	10.4	11.3	8.8	7.4	20.8	24.7	7.6
